,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
3715,GO:0007399,8.68970618804005e-11,1,41,2236,nervous system development,BP,GAS7;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;LRP2;DLL3;CPNE6;SLC17A7;MAG;EPHB6;PADI2;RGS4;SPP1;GDA;PACSIN1;MYRF;HAPLN2;MOG;SNCA;SLC39A12;NKX6-2;NRGN;S100A1;SERPINI1;HHIP;KLK6;MOBP;GJB1;EMX2;NINJ2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;MBP;LPAR1
3726,GO:0007417,9.42811922541826e-09,0.999999998140276,24,965,central nervous system development,BP,MAOB;DCX;SYNJ2;LRP2;SLC17A7;MAG;EPHB6;PADI2;RGS4;MYRF;HAPLN2;MOG;NKX6-2;NRGN;S100A1;SERPINI1;KLK6;EMX2;MAL;BOK;CNTN2;OPALIN;MBP;LPAR1
3673,GO:0007272,1.7156933807961e-08,0.999999998854531,10,134,ensheathment of neurons,BP,CLDN11;BCAS1;MAG;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
4020,GO:0008366,1.7156933807961e-08,0.999999998854531,10,134,axon ensheathment,BP,CLDN11;BCAS1;MAG;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
10754,GO:0042552,2.01532470172555e-07,0.999999985129673,9,132,myelination,BP,BCAS1;MAG;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
13088,GO:0048731,2.50904957959106e-07,0.999999914968592,52,4260,system development,BP,GAS7;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;TESPA1;ENPP2;MOG;SNCA;CXCL14;SLC39A12;NKX6-2;NRGN;TPPP3;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;EMX2;NINJ2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;MBP;LPAR1;RYR2
13142,GO:0048856,1.15823821547583e-06,0.999999579354718,57,5145,anatomical structure development,BP,GAS7;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;SLC39A12;NKX6-2;NRGN;CSRP1;CBR1;TPPP3;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;EMX2;NINJ2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;MBP;LPAR1;RYR2
3675,GO:0007275,3.41632393415103e-06,0.99999870832485,53,4743,multicellular organism development,BP,GAS7;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;TESPA1;ENPP2;MOG;SNCA;CXCL14;SLC39A12;NKX6-2;NRGN;TPPP3;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;EMX2;NINJ2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;MBP;LPAR1;RYR2
13079,GO:0048709,3.86966662727942e-06,0.999999727344351,7,100,oligodendrocyte differentiation,BP,MAG;MYRF;NKX6-2;BOK;CNTN2;OPALIN;LPAR1
5087,GO:0014003,9.1749472378225e-06,0.999999632264129,5,44,oligodendrocyte development,BP,MAG;MYRF;NKX6-2;CNTN2;LPAR1
6995,GO:0022010,9.22431686063488e-06,0.999999803840105,4,21,central nervous system myelination,BP,MAG;MYRF;NKX6-2;CNTN2
8279,GO:0032291,9.22431686063488e-06,0.999999803840105,4,21,axon ensheathment in central nervous system,BP,MAG;MYRF;NKX6-2;CNTN2
8442,GO:0032501,1.45687443835884e-05,0.999994137534355,62,6269,multicellular organismal process,BP,GAS7;CLDN11;BCAS1;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;SLC39A12;NKX6-2;NRGN;SLC24A2;CSRP1;TPPP3;ICOSLG;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;EMX2;NINJ2;SYNPO;MAL;BOK;S1PR5;CNTN2;CCK;SERPINA3;OPALIN;MBP;LPAR1;RYR2;FXYD1
10970,GO:0043005,1.73902924931978e-05,0.999994865452412,22,1264,neuron projection,CC,CLDN11;CAMK2A;DCX;LRP2;CPNE6;NEFM;SLC17A7;MAG;EPHB6;PACSIN1;ERMN;SNCA;NRGN;S100A1;LGI3;SYNPO;CNTN2;SV2B;CCK;MBP;LPAR1;GRM3
8443,GO:0032502,1.87716083425103e-05,0.999992325490343,57,5572,developmental process,BP,GAS7;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;SLC39A12;NKX6-2;NRGN;CSRP1;CBR1;TPPP3;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;EMX2;NINJ2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;MBP;LPAR1;RYR2
6687,GO:0019911,2.97564178846505e-05,0.999999674882728,3,10,structural constituent of myelin sheath,MF,MOBP;MAL;MBP
7349,GO:0030424,4.45057237005739e-05,0.999989731521966,14,612,axon,CC,CLDN11;LRP2;CPNE6;NEFM;SLC17A7;MAG;PACSIN1;ERMN;SNCA;NRGN;CNTN2;CCK;MBP;GRM3
14017,GO:0051960,5.041440517606e-05,0.999986352183739,17,878,regulation of nervous system development,BP,CAMK2A;LRP2;DLL3;CPNE6;MAG;SPP1;PACSIN1;MYRF;SNCA;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;OPALIN;LPAR1
14457,GO:0060284,5.48791603812396e-05,0.999985036903565,17,884,regulation of cell development,BP,CAMK2A;LRP2;DLL3;CPNE6;MAG;RGS4;SPP1;PACSIN1;DOCK5;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;OPALIN;LPAR1
11530,GO:0044304,7.44777805600483e-05,0.999995242058403,5,66,main axon,CC,MAG;ERMN;CNTN2;CCK;MBP
10692,GO:0042417,8.37620310188505e-05,0.999996660238265,4,36,dopamine metabolic process,BP,MAOB;MOXD1;SNCA;GPR37
17600,GO:0097435,9.38963863937294e-05,0.999976714188876,14,656,supramolecular fiber organization,BP,GAS7;TF;NEFM;RGS4;PACSIN1;PDGFRA;ERMN;SNCA;SLC39A12;CSRP1;TPPP3;GREM1;SYNPO;LPAR1
10985,GO:0043025,9.69376889845641e-05,0.999978797029985,12,499,neuronal cell body,CC,CD22;CPNE6;ERMN;SNCA;NRGN;PDE1C;SERPINI1;SYNPO;CNTN2;CCK;MBP;LPAR1
16474,GO:0071944,0.000103430619798814,0.999954872536181,47,4460,cell periphery,CC,GAS7;CD22;CLDN11;ASIC4;SYNJ2;LRP2;FOLH1;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;FGF1;RGS4;PACSIN1;PDGFRA;CLDN10;ERMN;ENPP2;MOG;SNCA;DOCK5;SLC39A12;NRGN;SLC24A2;SLC5A11;ICOSLG;HHIP;MOBP;GJB1;GPR37;NINJ2;MAL;S1PR5;GPR62;CNTN2;SV2B;NKAIN2;OPALIN;MBP;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;FXYD1
6863,GO:0021762,0.000114297376011345,0.999995028513115,4,39,substantia nigra development,BP,MAOB;PADI2;S100A1;MBP
6993,GO:0022008,0.000136502176012435,0.999952242018583,23,1553,neurogenesis,BP,GAS7;CAMK2A;DCX;LRP2;DLL3;CPNE6;MAG;EPHB6;SPP1;PACSIN1;MYRF;SLC39A12;NKX6-2;SERPINI1;HHIP;KLK6;EMX2;BOK;S1PR5;CNTN2;CCK;OPALIN;LPAR1
13334,GO:0050767,0.0001525834458156,0.999958252501715,15,777,regulation of neurogenesis,BP,CAMK2A;LRP2;DLL3;CPNE6;MAG;SPP1;PACSIN1;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;OPALIN;LPAR1
13355,GO:0050793,0.000182544727177185,0.999927026383439,30,2379,regulation of developmental process,BP,CAMK2A;LRP2;DLL3;CPNE6;MAG;RARRES2;FGF1;RGS4;SPP1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ERMN;ENPP2;SNCA;CXCL14;DOCK5;SLC39A12;NKX6-2;S100A1;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;OPALIN;MBP;LPAR1
11091,GO:0043209,0.000202276645597227,0.999989686337425,4,45,myelin sheath,CC,MAG;ERMN;CNTN2;MBP
4537,GO:0009713,0.00023246462214554,0.99999419078622,3,19,catechol-containing compound biosynthetic process,BP,MOXD1;SNCA;GPR37
10696,GO:0042423,0.00023246462214554,0.99999419078622,3,19,catecholamine biosynthetic process,BP,MOXD1;SNCA;GPR37
10271,GO:0036477,0.000235441593818549,0.99993285469985,15,810,somatodendritic compartment,CC,CD22;CAMK2A;LRP2;CPNE6;ERMN;SNCA;NRGN;PDE1C;SERPINI1;SYNPO;CNTN2;CCK;MBP;LPAR1;GRM3
8902,GO:0033269,0.000246307577525173,0.999998955358209,2,4,internode region of axon,CC,ERMN;MBP
3245,GO:0006584,0.000279832364041273,0.999984382241081,4,49,catecholamine metabolic process,BP,MAOB;MOXD1;SNCA;GPR37
4536,GO:0009712,0.000279832364041273,0.999984382241081,4,49,catechol-containing compound metabolic process,BP,MAOB;MOXD1;SNCA;GPR37
11525,GO:0044297,0.000308450972631418,0.999923281207875,12,566,cell body,CC,CD22;CPNE6;ERMN;SNCA;NRGN;PDE1C;SERPINI1;SYNPO;CNTN2;CCK;MBP;LPAR1
2584,GO:0005509,0.000318091838695366,0.999920613238092,12,563,calcium ion binding,MF,LRP2;DLL3;CPNE6;PADI2;NECAB1;ENPP2;SNCA;PAMR1;S100A1;VSNL1;SPOCK3;RYR2
14488,GO:0060322,0.000334789813939925,0.99990572947409,14,743,head development,BP,MAOB;SYNJ2;LRP2;SLC17A7;PADI2;RGS4;PDGFRA;NRGN;S100A1;EMX2;BOK;CNTN2;MBP;LPAR1
13447,GO:0050920,0.000341263370741147,0.999949907112357,7,202,regulation of chemotaxis,BP,RARRES2;FGF1;PADI2;PDGFRA;CXCL14;GREM1;LPAR1
21468,GO:2000026,0.000363664312555782,0.999858164377734,25,1889,regulation of multicellular organismal development,BP,CAMK2A;LRP2;DLL3;CPNE6;MAG;FGF1;RGS4;SPP1;PACSIN1;MYRF;CHI3L1;TESPA1;ENPP2;SNCA;SLC39A12;NKX6-2;S100A1;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;OPALIN;MBP;LPAR1
13071,GO:0048699,0.000402974383180038,0.999853585142503,21,1455,generation of neurons,BP,GAS7;CAMK2A;DCX;LRP2;DLL3;CPNE6;MAG;EPHB6;SPP1;PACSIN1;SLC39A12;NKX6-2;SERPINI1;HHIP;KLK6;EMX2;S1PR5;CNTN2;CCK;OPALIN;LPAR1
13634,GO:0051239,0.000446309537088862,0.999805146608999,33,2873,regulation of multicellular organismal process,BP,CAMK2A;LRP2;DLL3;TF;CPNE6;MAG;FGF1;RGS4;SPP1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ENPP2;MOG;SNCA;DOCK5;SLC39A12;NKX6-2;ICOSLG;S100A1;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;CCK;OPALIN;MBP;LPAR1;RYR2;FXYD1
13143,GO:0048857,0.000471787000194074,0.999969554118509,4,56,neural nucleus development,BP,MAOB;PADI2;S100A1;MBP
5635,GO:0016021,0.000473024587665668,0.999780182390518,42,4061,integral component of membrane,CC,HHATL;CD22;CLDN11;MAOB;ASIC4;MOXD1;LRP2;FOLH1;DLL3;SLC17A7;MAG;EPHB6;MYRF;EVI2A;PDGFRA;CLDN10;MOG;GALNT6;SLC39A12;SLC24A2;SLC5A11;ICOSLG;TMEM144;HHIP;GJB1;GPR37;NINJ2;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;SV2B;NKAIN2;OPALIN;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;FXYD1
7702,GO:0031224,0.000478804042551851,0.999776384875459,43,4199,intrinsic component of membrane,CC,HHATL;CD22;CLDN11;MAOB;ASIC4;MOXD1;LRP2;FOLH1;DLL3;SLC17A7;MAG;EPHB6;MYRF;EVI2A;PDGFRA;CLDN10;MOG;GALNT6;SLC39A12;SLC24A2;SLC5A11;ICOSLG;TMEM144;HHIP;GJB1;GPR37;NINJ2;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;CNTN2;SV2B;NKAIN2;OPALIN;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;FXYD1
10529,GO:0042063,0.000507210093164543,0.999907409452942,8,282,gliogenesis,BP,LRP2;MAG;MYRF;NKX6-2;BOK;CNTN2;OPALIN;LPAR1
4620,GO:0010001,0.000538153466932584,0.999914625065914,7,217,glial cell differentiation,BP,MAG;MYRF;NKX6-2;BOK;CNTN2;OPALIN;LPAR1
12114,GO:0045915,0.000604709484357467,0.999994900567469,2,6,positive regulation of catecholamine metabolic process,BP,MAOB;GPR37
12152,GO:0045964,0.000604709484357467,0.999994900567469,2,6,positive regulation of dopamine metabolic process,BP,MAOB;GPR37
2799,GO:0005886,0.000609609345952997,0.999710209916357,44,4367,plasma membrane,CC,GAS7;CD22;CLDN11;ASIC4;SYNJ2;LRP2;FOLH1;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RGS4;PACSIN1;PDGFRA;CLDN10;ENPP2;MOG;SNCA;DOCK5;SLC39A12;NRGN;SLC24A2;SLC5A11;ICOSLG;HHIP;GJB1;GPR37;NINJ2;MAL;S1PR5;GPR62;CNTN2;SV2B;NKAIN2;OPALIN;MBP;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;FXYD1
3728,GO:0007420,0.000645561149496205,0.999814914363067,13,701,brain development,BP,MAOB;SYNJ2;LRP2;SLC17A7;PADI2;RGS4;NRGN;S100A1;EMX2;BOK;CNTN2;MBP;LPAR1
12955,GO:0048488,0.000679327485869513,0.99995149444366,4,61,synaptic vesicle endocytosis,BP,SYNJ2;SLC17A7;PACSIN1;SNCA
18564,GO:0140238,0.000679327485869513,0.99995149444366,4,61,presynaptic endocytosis,BP,SYNJ2;SLC17A7;PACSIN1;SNCA
7948,GO:0031646,0.000720417446583026,0.999947708866803,4,62,positive regulation of nervous system process,BP,MAG;RGS4;MYRF;CCK
12943,GO:0048468,0.00072338107563101,0.999703261259091,25,1970,cell development,BP,GAS7;CAMK2A;DCX;LRP2;DLL3;CPNE6;MAG;EPHB6;RGS4;SPP1;PACSIN1;MYRF;HAPLN2;PDGFRA;DOCK5;SLC39A12;NKX6-2;CSRP1;SERPINI1;KLK6;S1PR5;CNTN2;CCK;OPALIN;LPAR1
10961,GO:0042995,0.00073748663266668,0.999692473272676,26,2092,cell projection,CC,CLDN11;CAMK2A;DCX;SYNJ2;LRP2;CPNE6;NEFM;SLC17A7;MAG;EPHB6;SPP1;PACSIN1;PDGFRA;ERMN;SNCA;NRGN;S100A1;HHIP;LGI3;SYNPO;CNTN2;SV2B;CCK;MBP;LPAR1;GRM3
7087,GO:0030001,0.000780961023680892,0.999759844084479,14,814,metal ion transport,BP,CAMK2A;ASIC4;LRP2;TF;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;SLC5A11;S100A1;NKAIN2;RYR2;FXYD1
7082,GO:0023052,0.000838693834344051,0.999587081956195,51,5417,signaling,BP,CD22;MAOB;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NRGN;PDE1C;SLC24A2;ICOSLG;S100A1;VSNL1;HHIP;GREM1;KLK6;GJB1;GPR37;SYNPO;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;SV2B;CCK;MBP;LPAR1;RYR2;GRM3;FXYD1
10694,GO:0042420,0.000846169946021036,0.999991068023009,2,7,dopamine catabolic process,BP,MAOB;MOXD1
5096,GO:0014013,0.000850018316969528,0.999905943321733,5,113,regulation of gliogenesis,BP,LRP2;MAG;NKX6-2;CNTN2;OPALIN
6878,GO:0021782,0.000860611869083352,0.999904507306214,5,113,glial cell development,BP,MAG;MYRF;NKX6-2;CNTN2;LPAR1
4613,GO:0009986,0.000872716970116963,0.999741263632065,13,730,cell surface,CC,CD22;LRP2;FOLH1;TF;PDGFRA;MOG;ICOSLG;HHIP;GREM1;GPR37;CNTN2;MBP;LPAR1
11997,GO:0045685,0.000988511227726078,0.999921591806956,4,68,regulation of glial cell differentiation,BP,MAG;NKX6-2;CNTN2;OPALIN
11929,GO:0045595,0.00106577365140707,0.999572143164306,22,1685,regulation of cell differentiation,BP,CAMK2A;LRP2;DLL3;CPNE6;MAG;RARRES2;RGS4;SPP1;PACSIN1;PDGFRA;TESPA1;CXCL14;DOCK5;SLC39A12;NKX6-2;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;OPALIN;LPAR1
6571,GO:0019614,0.00112400034095787,0.999985765976051,2,8,catechol-containing compound catabolic process,BP,MAOB;MOXD1
10697,GO:0042424,0.00112400034095787,0.999985765976051,2,8,catecholamine catabolic process,BP,MAOB;MOXD1
13635,GO:0051240,0.0011575326702639,0.999541355942612,21,1586,positive regulation of multicellular organismal process,BP,LRP2;TF;CPNE6;MAG;FGF1;RGS4;SPP1;PACSIN1;MYRF;CHI3L1;TESPA1;ENPP2;DOCK5;NKX6-2;S100A1;SERPINI1;GREM1;CCK;MBP;LPAR1;RYR2
2796,GO:0005883,0.00117594393379585,0.999984762802944,2,8,neurofilament,CC,CLDN11;NEFM
10262,GO:0036465,0.0011961633227994,0.999899943765667,4,71,synaptic vesicle recycling,BP,SYNJ2;SLC17A7;PACSIN1;SNCA
3669,GO:0007268,0.001224540659458,0.999642522105519,12,661,chemical synaptic transmission,BP,CAMK2A;CPNE6;SLC17A7;RGS4;SNCA;NRGN;SLC24A2;SYNPO;CNTN2;SV2B;MBP;GRM3
17969,GO:0098916,0.001224540659458,0.999642522105519,12,661,anterograde trans-synaptic signaling,BP,CAMK2A;CPNE6;SLC17A7;RGS4;SNCA;NRGN;SLC24A2;SYNPO;CNTN2;SV2B;MBP;GRM3
18159,GO:0099537,0.00135773674833796,0.999598703488548,12,669,trans-synaptic signaling,BP,CAMK2A;CPNE6;SLC17A7;RGS4;SNCA;NRGN;SLC24A2;SYNPO;CNTN2;SV2B;MBP;GRM3
8892,GO:0033240,0.00142745283078386,0.999979007260787,2,9,positive regulation of cellular amine metabolic process,BP,MAOB;GPR37
14492,GO:0060326,0.00146823131982122,0.999722536675151,7,260,cell chemotaxis,BP,RARRES2;FGF1;PADI2;PDGFRA;CXCL14;GREM1;LPAR1
3963,GO:0008277,0.0015654491862525,0.999800600790982,5,130,regulation of G protein-coupled receptor signaling pathway,BP,CAMK2A;RGS4;SNCA;KLK6;CNTN2
2587,GO:0005516,0.00167144997672821,0.999727423737092,6,189,calmodulin binding,MF,CAMK2A;RGS4;NRGN;PDE1C;MBP;RYR2
3588,GO:0007154,0.00171328982972114,0.999122030420465,50,5427,cell communication,BP,CD22;MAOB;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NRGN;PDE1C;SLC24A2;ICOSLG;S100A1;VSNL1;HHIP;GREM1;KLK6;GJB1;GPR37;SYNPO;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;SV2B;CCK;MBP;LPAR1;RYR2;GRM3
18158,GO:0099536,0.00171707839302786,0.999477893171098,12,688,synaptic signaling,BP,CAMK2A;CPNE6;SLC17A7;RGS4;SNCA;NRGN;SLC24A2;SYNPO;CNTN2;SV2B;MBP;GRM3
7138,GO:0030100,0.00173231511817654,0.999715354320956,6,195,regulation of endocytosis,BP,CD22;TF;SLC17A7;PACSIN1;SNCA;GREM1
7545,GO:0030901,0.00180710256214384,0.999830202258807,4,80,midbrain development,BP,MAOB;PADI2;S100A1;MBP
14092,GO:0052548,0.00190682865890587,0.999570909122652,8,349,regulation of endopeptidase activity,BP,SNCA;ST18;SERPINI1;BOK;CCK;SPOCK3;SERPINA3;MBP
18205,GO:0099612,0.00192802694749042,0.999966235550862,2,10,protein localization to axon,BP,MAL;CNTN2
18434,GO:0120025,0.00198865565576551,0.999130922621461,24,1998,plasma membrane bounded cell projection,CC,CLDN11;CAMK2A;DCX;LRP2;CPNE6;NEFM;SLC17A7;MAG;EPHB6;PACSIN1;PDGFRA;ERMN;SNCA;NRGN;S100A1;HHIP;LGI3;SYNPO;CNTN2;SV2B;CCK;MBP;LPAR1;GRM3
7083,GO:0023056,0.00199427974550415,0.999172088478931,21,1659,positive regulation of signaling,BP,LRP2;TF;FGF1;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;SNCA;ST18;NRGN;SLC24A2;VSNL1;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
7200,GO:0030182,0.00201161977986134,0.99921894182505,18,1314,neuron differentiation,BP,GAS7;CAMK2A;DCX;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;SLC39A12;NKX6-2;SERPINI1;KLK6;EMX2;S1PR5;CNTN2;CCK;LPAR1
7398,GO:0030544,0.0020481457898801,0.999884455464707,3,39,Hsp70 protein binding,MF,FGF1;SNCA;GPR37
8676,GO:0032879,0.00209372277501835,0.999032598854106,28,2496,regulation of localization,BP,CD22;MAOB;CAMK2A;TF;SLC17A7;RARRES2;FGF1;PADI2;RGS4;SPP1;PACSIN1;PDGFRA;CLDN10;ENPP2;SNCA;CXCL14;DOCK5;S100A1;VSNL1;GREM1;LGI3;BOK;CCK;NKAIN2;SPOCK3;LPAR1;RYR2;FXYD1
3791,GO:0007612,0.00213626306668257,0.999707534530227,5,138,learning,BP,NRGN;SLC24A2;SYNPO;CNTN2;CCK
10691,GO:0042416,0.00217458652704392,0.999958806647575,2,11,dopamine biosynthetic process,BP,SNCA;GPR37
6487,GO:0019336,0.00218676661746273,0.999958457770443,2,11,phenol-containing compound catabolic process,BP,MAOB;MOXD1
5049,GO:0010959,0.00222161483267683,0.999487548093298,8,356,regulation of metal ion transport,BP,CAMK2A;TF;RGS4;SNCA;S100A1;NKAIN2;RYR2;FXYD1
13002,GO:0048584,0.00231986836350216,0.998973354955525,24,2035,positive regulation of response to stimulus,BP,CD22;LRP2;TF;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;TESPA1;MOG;SNCA;CXCL14;ST18;ICOSLG;VSNL1;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;CCK;LPAR1
12261,GO:0046189,0.00236966972477257,0.999858908158978,3,41,phenol-containing compound biosynthetic process,BP,MOXD1;SNCA;GPR37
3455,GO:0006897,0.00241507172550105,0.999324138694721,10,531,endocytosis,BP,CD22;SYNJ2;LRP2;TF;SLC17A7;PACSIN1;ENPP2;SNCA;GREM1;CNTN2
13695,GO:0051336,0.00261311806998791,0.999016383437084,16,1136,regulation of hydrolase activity,BP,CAMK2A;ADAP1;RGS4;PDGFRA;SNCA;DOCK5;ST18;SERPINI1;PPP1R14A;RCAN2;BOK;CCK;SPOCK3;SERPINA3;MBP;LPAR1
3401,GO:0006812,0.00264185225941786,0.999036841410024,15,1031,cation transport,BP,MAOB;CAMK2A;ASIC4;LRP2;TF;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;SLC5A11;S100A1;NKAIN2;RYR2;FXYD1
11130,GO:0043269,0.00266585948702734,0.999191436612938,11,632,regulation of ion transport,BP,MAOB;CAMK2A;TF;RGS4;CLDN10;SNCA;S100A1;CCK;NKAIN2;RYR2;FXYD1
13152,GO:0048869,0.00266688140551965,0.998653756307842,37,3702,cellular developmental process,BP,GAS7;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;MAG;EPHB6;RARRES2;FGF1;RGS4;SPP1;PACSIN1;MYRF;HAPLN2;PDGFRA;TESPA1;ENPP2;CXCL14;DOCK5;SLC39A12;NKX6-2;CSRP1;CBR1;SERPINI1;HHIP;GREM1;KLK6;EMX2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;LPAR1
16423,GO:0071872,0.00275746412453239,0.999940203693108,2,12,cellular response to epinephrine stimulus,BP,SNCA;RYR2
8903,GO:0033270,0.0027580361977794,0.999940184946425,2,12,paranode region of axon,CC,MAG;ERMN
7123,GO:0030054,0.00287828553686527,0.998722804709278,23,1935,cell junction,CC,CLDN11;BCAS1;CAMK2A;SYNJ2;CPNE6;SLC17A7;PACSIN1;PDGFRA;CLDN10;SNCA;NRGN;CSRP1;LGI3;GJB1;SYNPO;CNTN2;SV2B;CCK;OPALIN;MBP;LPAR1;GRM3;FXYD1
14091,GO:0052547,0.00292957574673394,0.999292899824282,8,374,regulation of peptidase activity,BP,SNCA;ST18;SERPINI1;BOK;CCK;SPOCK3;SERPINA3;MBP
7943,GO:0031641,0.00293108377417822,0.999811221401314,3,44,regulation of myelination,BP,MAG;MYRF;NKX6-2
3403,GO:0006814,0.00305475219645976,0.99943699025723,6,218,sodium ion transport,BP,ASIC4;SLC17A7;SLC24A2;SLC5A11;NKAIN2;FXYD1
12532,GO:0046850,0.00311109539535933,0.999795140138789,3,45,regulation of bone remodeling,BP,TF;SPP1;GREM1
3589,GO:0007155,0.00318257264569197,0.998741389787533,17,1261,cell adhesion,BP,CD22;CLDN11;MAG;SPP1;HAPLN2;PDGFRA;CLDN10;TESPA1;MOG;DOCK5;CSRP1;ICOSLG;SERPINI1;GREM1;NINJ2;CNTN2;MBP
7028,GO:0022610,0.00334058868299801,0.998672394268941,17,1267,biological adhesion,BP,CD22;CLDN11;MAG;SPP1;HAPLN2;PDGFRA;CLDN10;TESPA1;MOG;DOCK5;CSRP1;ICOSLG;SERPINI1;GREM1;NINJ2;CNTN2;MBP
7688,GO:0031175,0.00342145100390185,0.998762602239455,14,947,neuron projection development,BP,GAS7;CAMK2A;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
7785,GO:0031344,0.00344536983356388,0.998918923331518,11,650,regulation of cell projection organization,BP,CPNE6;MAG;SPP1;PACSIN1;ERMN;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;LPAR1
11094,GO:0043218,0.00358883474165537,0.999909020759393,2,14,compact myelin,CC,MAG;MBP
7250,GO:0030246,0.00360927335908915,0.999311534801949,6,228,carbohydrate binding,MF,CD22;MAG;CHI3L1;ENPP2;GALNT6;CNTN2
11607,GO:0044548,0.00361684186615948,0.999907944739603,2,14,S100 protein binding,MF,FGF1;S100A1
18103,GO:0099170,0.00371864407929909,0.999903997313886,2,14,postsynaptic modulation of chemical synaptic transmission,BP,NRGN;SYNPO
7177,GO:0030154,0.00372656651064291,0.998085635014334,36,3636,cell differentiation,BP,GAS7;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;MAG;EPHB6;RARRES2;FGF1;RGS4;SPP1;PACSIN1;MYRF;HAPLN2;PDGFRA;TESPA1;CXCL14;DOCK5;SLC39A12;NKX6-2;CSRP1;CBR1;SERPINI1;HHIP;GREM1;KLK6;EMX2;MAL;BOK;S1PR5;CNTN2;CCK;OPALIN;LPAR1
6367,GO:0018958,0.00380532733819004,0.999558295862113,4,98,phenol-containing compound metabolic process,BP,MAOB;MOXD1;SNCA;GPR37
5041,GO:0010950,0.00382197644068736,0.999399701443364,5,160,positive regulation of endopeptidase activity,BP,SNCA;ST18;BOK;CCK;MBP
4861,GO:0010721,0.00383797085642136,0.999137720313031,7,305,negative regulation of cell development,BP,DLL3;MAG;RGS4;SPP1;NKX6-2;CNTN2;LPAR1
8752,GO:0032989,0.00399083261982072,0.998652580540231,12,756,cellular component morphogenesis,BP,GAS7;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;PDGFRA;ENPP2;CSRP1;CNTN2;CCK
11776,GO:0045125,0.00404971837082164,0.999889862759118,2,15,bioactive lipid receptor activity,MF,S1PR5;LPAR1
6040,GO:0016805,0.00408775178339123,0.999888293756992,2,15,dipeptidase activity,MF,FOLH1;CNDP1
13043,GO:0048666,0.0041100067123017,0.998427466610004,15,1073,neuron development,BP,GAS7;CAMK2A;DCX;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
16422,GO:0071871,0.00429116254986127,0.999879774546252,2,15,response to epinephrine,BP,SNCA;RYR2
4820,GO:0010647,0.00430643795083493,0.998120216537735,20,1651,positive regulation of cell communication,BP,LRP2;TF;FGF1;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;ST18;NRGN;SLC24A2;VSNL1;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
12945,GO:0048471,0.00438684965712899,0.998578071914353,11,674,perinuclear region of cytoplasm,CC,HHATL;SYNJ2;TF;SPP1;PACSIN1;CHI3L1;GALNT6;SNCA;SLC39A12;TPPP3;MOBP
2402,GO:0005102,0.00453451565970277,0.998140492310867,17,1316,signaling receptor binding,MF,CD22;CAMK2A;DLL3;TF;MAG;RARRES2;FGF1;PADI2;SPP1;PDGFRA;TESPA1;MOG;CXCL14;ICOSLG;GREM1;BOK;CCK
5061,GO:0010975,0.00458447645335908,0.998695130635519,9,486,regulation of neuron projection development,BP,CPNE6;MAG;SPP1;PACSIN1;SLC39A12;SERPINI1;KLK6;CNTN2;LPAR1
327,GO:0000902,0.00461786876166614,0.998271125503487,14,979,cell morphogenesis,BP,GAS7;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;ERMN;ENPP2;DOCK5;GREM1;CNTN2;CCK;LPAR1
1190,GO:0002689,0.00464322462079233,0.99986355614266,2,16,negative regulation of leukocyte chemotaxis,BP,PADI2;GREM1
3478,GO:0006935,0.0047051412126712,0.998552399078428,10,584,chemotaxis,BP,EPHB6;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;GREM1;CNTN2;LPAR1
12828,GO:0048168,0.00476833794548493,0.999632217973482,3,52,regulation of neuronal synaptic plasticity,BP,CAMK2A;SYNPO;CNTN2
10649,GO:0042330,0.0048204228286727,0.998511726826113,10,586,taxis,BP,EPHB6;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;GREM1;CNTN2;LPAR1
11081,GO:0043197,0.00505054939482002,0.999152237058874,5,169,dendritic spine,CC,CAMK2A;NRGN;SYNPO;LPAR1;GRM3
13772,GO:0051480,0.00513364827074636,0.998782803349353,7,323,regulation of cytosolic calcium ion concentration,BP,PDGFRA;SNCA;SLC24A2;SYNPO;BOK;LPAR1;RYR2
14994,GO:0061134,0.00516254096377848,0.999128692597806,5,172,peptidase regulator activity,MF,SNCA;SERPINI1;MAL;SPOCK3;SERPINA3
11535,GO:0044309,0.0053120211473448,0.999097462200008,5,171,neuron spine,CC,CAMK2A;NRGN;SYNPO;LPAR1;GRM3
13992,GO:0051928,0.0053439322562017,0.99931609395556,4,108,positive regulation of calcium ion transport,BP,CAMK2A;SNCA;S100A1;RYR2
1189,GO:0002688,0.00535355973140945,0.99931437796257,4,109,regulation of leukocyte chemotaxis,BP,RARRES2;PADI2;CXCL14;GREM1
12045,GO:0045780,0.00538856399443788,0.999827973223765,2,17,positive regulation of bone resorption,BP,TF;SPP1
12534,GO:0046852,0.00538856399443788,0.999827973223765,2,17,positive regulation of bone remodeling,BP,TF;SPP1
3790,GO:0007611,0.00546041593143331,0.998865175465788,6,245,learning or memory,BP,SLC17A7;NRGN;SLC24A2;SYNPO;CNTN2;CCK
7448,GO:0030665,0.00572299227959731,0.999252950760868,4,110,clathrin-coated vesicle membrane,CC,LRP2;TF;SLC17A7;NRGN
5800,GO:0016338,0.00582694438229454,0.999805257235623,2,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11;CLDN10
1362,GO:0003002,0.00586097445939617,0.998575514712257,7,331,regionalization,BP,LRP2;DLL3;FGF1;NKX6-2;HHIP;GREM1;EMX2
10523,GO:0042053,0.00589625482715328,0.999801735315246,2,18,regulation of dopamine metabolic process,BP,MAOB;GPR37
10530,GO:0042069,0.00589625482715328,0.999801735315246,2,18,regulation of catecholamine metabolic process,BP,MAOB;GPR37
11131,GO:0043270,0.0059975141605272,0.998728645617454,6,252,positive regulation of ion transport,BP,CAMK2A;SNCA;S100A1;CCK;RYR2;FXYD1
7945,GO:0031643,0.00600128036393488,0.999796357358448,2,18,positive regulation of myelination,BP,MAG;MYRF
5043,GO:0010952,0.00611741409247963,0.998924410079313,5,179,positive regulation of peptidase activity,BP,SNCA;ST18;BOK;CCK;MBP
3668,GO:0007267,0.00630423221571877,0.997200935285907,19,1587,cell-cell signaling,BP,MAOB;CAMK2A;CPNE6;SLC17A7;RGS4;SPP1;SNCA;CXCL14;NRGN;SLC24A2;VSNL1;GREM1;GJB1;SYNPO;CNTN2;SV2B;MBP;RYR2;GRM3
17852,GO:0098737,0.00632103864775198,1,1,1,protein insertion into plasma membrane,BP,MAL
18425,GO:0120003,0.00632103864775198,1,1,1,hinge region between urothelial plaques of apical plasma membrane,CC,MAL
3400,GO:0006811,0.00632836409103954,0.9972484398938,18,1473,ion transport,BP,MAOB;CAMK2A;ASIC4;LRP2;TF;SLC17A7;RGS4;CLDN10;SNCA;SLC39A12;SLC24A2;SLC5A11;S100A1;CYB5R2;CCK;NKAIN2;RYR2;FXYD1
19831,GO:1903366,0.00633491196860702,1,1,1,negative regulation of fear response,BP,CCK
22018,GO:2000986,0.00633491196860702,1,1,1,negative regulation of behavioral fear response,BP,CCK
12625,GO:0047021,0.00634325896875639,1,1,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,CBR1
13200,GO:0050221,0.00634325896875639,1,1,1,prostaglandin-E2 9-reductase activity,MF,CBR1
13050,GO:0048673,0.00636588652654471,1,1,1,collateral sprouting of intact axon in response to injury,BP,SPP1
13059,GO:0048683,0.00636588652654471,1,1,1,regulation of collateral sprouting of intact axon in response to injury,BP,SPP1
13060,GO:0048685,0.00636588652654471,1,1,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,SPP1
14437,GO:0060254,0.00638136079296381,1,1,1,regulation of N-terminal protein palmitoylation,BP,HHATL
14442,GO:0060262,0.00638136079296381,1,1,1,negative regulation of N-terminal protein palmitoylation,BP,HHATL
2612,GO:0005576,0.00640936602592998,0.996636550552593,33,3370,extracellular region,CC,CD22;BCAS1;MOXD1;LRP2;FOLH1;TF;CPNE6;EPHB6;RARRES2;FGF1;PADI2;SPP1;HAPLN2;CHI3L1;ERMN;ENPP2;SNCA;CXCL14;SLC39A12;PAMR1;CNDP1;CSRP1;CBR1;ICOSLG;S100A1;SERPINI1;HHIP;GREM1;KLK6;LGI3;CCK;SPOCK3;SERPINA3
17611,GO:0097453,0.0064207325889332,1,1,1,mesaxon,CC,MAG
21126,GO:1990015,0.0064207325889332,1,1,1,ensheathing process,CC,MAG
20403,GO:1904492,0.00643281114573471,1,1,1,Ac-Asp-Glu binding,MF,FOLH1
20404,GO:1904493,0.00643281114573471,1,1,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,FOLH1
3842,GO:0008068,0.00645509897199107,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
5391,GO:0015319,0.00645509897199107,1,1,1,sodium:inorganic phosphate symporter activity,MF,SLC17A7
17586,GO:0097401,0.00645509897199107,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
20432,GO:1904565,0.00646297975839259,1,1,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
20433,GO:1904566,0.00646297975839259,1,1,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
9773,GO:0035543,0.00646523311983902,1,1,1,positive regulation of SNARE complex assembly,BP,SNCA
13820,GO:0051585,0.00646523311983902,1,1,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,SNCA
13847,GO:0051622,0.00646523311983902,1,1,1,negative regulation of norepinephrine uptake,BP,SNCA
14006,GO:0051945,0.00646523311983902,1,1,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,SNCA
19780,GO:1903282,0.00646523311983902,1,1,1,regulation of glutathione peroxidase activity,BP,SNCA
19781,GO:1903284,0.00646523311983902,1,1,1,positive regulation of glutathione peroxidase activity,BP,SNCA
2971,GO:0006173,0.00648800877981134,1,1,1,dADP biosynthetic process,BP,AK5
9743,GO:0035498,0.00650817860441643,1,1,1,carnosine metabolic process,BP,CARNS1
9744,GO:0035499,0.00650817860441643,1,1,1,carnosine biosynthetic process,BP,CARNS1
12729,GO:0047730,0.00650817860441643,1,1,1,carnosine synthase activity,MF,CARNS1
18249,GO:0102102,0.00650817860441643,1,1,1,homocarnosine synthase activity,MF,CARNS1
18752,GO:1900158,0.00651870337864336,1,1,1,negative regulation of bone mineralization involved in bone maturation,BP,GREM1
18195,GO:0099588,0.0065916744925766,1,1,1,positive regulation of postsynaptic cytosolic calcium concentration,BP,SYNPO
20848,GO:1905355,0.0065916744925766,1,1,1,spine apparatus assembly,BP,SYNPO
7165,GO:0030136,0.00659546522533514,0.998819136127548,5,181,clathrin-coated vesicle,CC,LRP2;TF;CPNE6;SLC17A7;NRGN
2957,GO:0006147,0.00661637693369783,1,1,1,guanine catabolic process,BP,GDA
4235,GO:0008892,0.00661637693369783,1,1,1,guanine deaminase activity,MF,GDA
9049,GO:0033691,0.00662734664851822,0.999762133133804,2,19,sialic acid binding,MF,CD22;MAG
2366,GO:0005018,0.00671575144853859,1,1,1,platelet-derived growth factor alpha-receptor activity,MF,PDGFRA
13657,GO:0051270,0.00673619816868507,0.997459836366747,13,920,regulation of cellular component movement,BP,CAMK2A;TF;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;SPOCK3;LPAR1;RYR2
16024,GO:0071206,0.00681148082123893,1,1,1,establishment of protein localization to juxtaparanode region of axon,BP,CNTN2
3437,GO:0006875,0.00692448239674051,0.997897214962063,9,523,cellular metal ion homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
12827,GO:0048167,0.00704854454545497,0.998717561943678,5,183,regulation of synaptic plasticity,BP,CAMK2A;NRGN;SLC24A2;SYNPO;CNTN2
13363,GO:0050804,0.00714224351145748,0.997997112624875,8,430,modulation of chemical synaptic transmission,BP,CAMK2A;RGS4;SNCA;NRGN;SLC24A2;SYNPO;CNTN2;GRM3
18109,GO:0099177,0.00723541815004596,0.997966440533616,8,431,regulation of trans-synaptic signaling,BP,CAMK2A;RGS4;SNCA;NRGN;SLC24A2;SYNPO;CNTN2;GRM3
5896,GO:0016540,0.00724661256476772,0.999726422916358,2,20,protein autoprocessing,BP,MYRF;KLK6
19604,GO:1902932,0.00728752360215374,0.999724075692143,2,20,positive regulation of alcohol biosynthetic process,BP,FGF1;SNCA
11819,GO:0045202,0.00731227234070161,0.996926742776952,16,1258,synapse,CC,BCAS1;CAMK2A;SYNJ2;CPNE6;SLC17A7;PACSIN1;SNCA;NRGN;LGI3;SYNPO;CNTN2;SV2B;CCK;MBP;LPAR1;GRM3
13637,GO:0051246,0.00733278468197253,0.996335007506041,26,2473,regulation of protein metabolic process,BP,HHATL;LRP2;TF;RARRES2;FGF1;RGS4;NECAB1;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
8260,GO:0032268,0.00735959719030459,0.99636180318936,25,2347,regulation of cellular protein metabolic process,BP,HHATL;LRP2;TF;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
13353,GO:0050790,0.00749397361554784,0.996382782088248,23,2100,regulation of catalytic activity,BP,CAMK2A;TF;ADAP1;EPHB6;FGF1;RGS4;CHI3L1;PDGFRA;SNCA;DOCK5;ST18;S100A1;SERPINI1;GREM1;PPP1R14A;RCAN2;BOK;CCK;SPOCK3;SERPINA3;MBP;LPAR1;GRM3
11401,GO:0043924,0.00774926985085732,1,1,1,suramin binding,MF,RYR2
13548,GO:0051094,0.00779473696092397,0.996700547874196,16,1271,positive regulation of developmental process,BP,LRP2;CPNE6;MAG;RARRES2;FGF1;PACSIN1;MYRF;CHI3L1;TESPA1;ENPP2;DOCK5;NKX6-2;S100A1;SERPINI1;GREM1;LPAR1
19093,GO:1901616,0.0078387166835729,0.999271981320351,3,63,organic hydroxy compound catabolic process,BP,MAOB;SYNJ2;MOXD1
16758,GO:0072503,0.0078810011030506,0.997751899934231,8,440,cellular divalent inorganic cation homeostasis,BP,PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
13974,GO:0051900,0.00801016146532679,0.999680247135339,2,21,regulation of mitochondrial depolarization,BP,BOK;CCK
3416,GO:0006837,0.00802326232731185,0.999679452727403,2,21,serotonin transport,BP,MAOB;SNCA
11985,GO:0045664,0.00822938441767239,0.997251196356811,10,631,regulation of neuron differentiation,BP,CPNE6;MAG;SPP1;PACSIN1;SLC39A12;SERPINI1;KLK6;S1PR5;CNTN2;LPAR1
13335,GO:0050768,0.00826145748872954,0.998125909862689,6,268,negative regulation of neurogenesis,BP,DLL3;MAG;SPP1;NKX6-2;CNTN2;LPAR1
13523,GO:0051049,0.00845597946525834,0.996132856947158,19,1631,regulation of transport,BP,CD22;MAOB;CAMK2A;TF;SLC17A7;RGS4;SPP1;PACSIN1;CLDN10;SNCA;S100A1;VSNL1;GREM1;LGI3;BOK;CCK;NKAIN2;RYR2;FXYD1
21532,GO:2000145,0.00862922175370738,0.996778466031569,12,843,regulation of cell motility,BP,CAMK2A;TF;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;SPOCK3;LPAR1
4741,GO:0010517,0.00871852870314495,0.999157544716831,3,65,regulation of phospholipase activity,BP,PDGFRA;SNCA;LPAR1
19099,GO:1901623,0.00873770386479089,0.999633826114884,2,22,regulation of lymphocyte chemotaxis,BP,PADI2;CXCL14
11139,GO:0043280,0.00877083687691324,0.998703394032225,4,125,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,SNCA;ST18;BOK;CCK
13959,GO:0051882,0.00879477983589029,0.999630186088043,2,22,mitochondrial depolarization,BP,BOK;CCK
10480,GO:0040011,0.00899701803212437,0.995859293555034,19,1638,locomotion,BP,CAMK2A;DCX;TF;MAG;EPHB6;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;EMX2;GPR37;CNTN2;CCK;SPOCK3;LPAR1
20374,GO:1904427,0.00904725161860371,0.999113511849791,3,66,positive regulation of calcium ion transmembrane transport,BP,SNCA;S100A1;RYR2
18439,GO:0120035,0.00913743795273169,0.996899516485708,10,641,regulation of plasma membrane bounded cell projection organization,BP,CPNE6;MAG;SPP1;PACSIN1;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;LPAR1
7099,GO:0030018,0.00932609154368919,0.998597306172809,4,122,Z disc,CC,CSRP1;S100A1;SYNPO;RYR2
7164,GO:0030135,0.00941680529890701,0.99780294655953,6,277,coated vesicle,CC,LRP2;TF;CPNE6;SLC17A7;PACSIN1;NRGN
9140,GO:0034103,0.00943595770044729,0.999060715528077,3,67,regulation of tissue remodeling,BP,TF;SPP1;GREM1
3917,GO:0008198,0.00965324125303835,0.999572594631146,2,23,ferrous iron binding,MF,TF;SNCA
16761,GO:0072507,0.00980431202624249,0.997094590837078,8,457,divalent inorganic cation homeostasis,BP,PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
13422,GO:0050890,0.0100251236976831,0.997629421270931,6,279,cognition,BP,SLC17A7;NRGN;SLC24A2;SYNPO;CNTN2;CCK
13092,GO:0048738,0.0100719776665023,0.998000100984591,5,197,cardiac muscle tissue development,BP,LRP2;RGS4;PDGFRA;GREM1;RYR2
2269,GO:0004866,0.0102814555320816,0.998407324485494,4,131,endopeptidase inhibitor activity,MF,SNCA;SERPINI1;SPOCK3;SERPINA3
18441,GO:0120039,0.0102876178279856,0.996446110208902,10,650,plasma membrane bounded cell projection morphogenesis,BP,GAS7;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;ENPP2;CNTN2;CCK
14010,GO:0051953,0.0103648470648208,0.999522391145029,2,24,negative regulation of amine transport,BP,RGS4;SNCA
12483,GO:0046697,0.010446174060133,0.999516679622726,2,24,decidualization,BP,SPP1;TPPP3
12027,GO:0045745,0.0104475217414887,0.999516584777706,2,24,positive regulation of G protein-coupled receptor signaling pathway,BP,KLK6;CNTN2
747,GO:0001965,0.0105291583806985,0.999510827436429,2,24,G-protein alpha-subunit binding,MF,RGS4;LPAR1
17854,GO:0098742,0.0105346075806487,0.997884604780569,5,201,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;MAG;CLDN10;CNTN2;MBP
19861,GO:1903421,0.0106423516463731,0.999502805492817,2,24,regulation of synaptic vesicle recycling,BP,SLC17A7;SNCA
5098,GO:0014015,0.0106705303923684,0.998887583629351,3,70,positive regulation of gliogenesis,BP,LRP2;MAG;NKX6-2
13144,GO:0048858,0.0107016245202433,0.996280819780475,10,654,cell projection morphogenesis,BP,GAS7;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;ENPP2;CNTN2;CCK
7946,GO:0031644,0.0112034601330683,0.998220183287769,4,133,regulation of nervous system process,BP,MAG;RGS4;MYRF;CCK
3616,GO:0007186,0.0113575355102317,0.995796408990644,11,774,G protein-coupled receptor signaling pathway,BP,CAMK2A;RGS4;SNCA;KLK6;GPR37;S1PR5;GPR62;CNTN2;CCK;LPAR1;GRM3
11016,GO:0043085,0.0113622363624913,0.994980776671331,16,1326,positive regulation of catalytic activity,BP,TF;ADAP1;EPHB6;FGF1;RGS4;CHI3L1;PDGFRA;SNCA;DOCK5;ST18;S100A1;GREM1;BOK;CCK;MBP;LPAR1
20208,GO:1904064,0.0113970999232734,0.998180132867598,4,134,positive regulation of cation transmembrane transport,BP,SNCA;S100A1;RYR2;FXYD1
7345,GO:0030414,0.0114011153328849,0.998179080402671,4,135,peptidase inhibitor activity,MF,SNCA;SERPINI1;SPOCK3;SERPINA3
4714,GO:0010460,0.0114274620269943,0.999444457910074,2,25,positive regulation of heart rate,BP,RGS4;RYR2
3631,GO:0007204,0.0116704361024678,0.997147837134228,6,290,positive regulation of cytosolic calcium ion concentration,BP,PDGFRA;SNCA;SLC24A2;SYNPO;LPAR1;RYR2
3986,GO:0008306,0.0116918137032509,0.998738551784517,3,72,associative learning,BP,NRGN;SYNPO;CCK
10481,GO:0040012,0.0118904794960665,0.995364233879495,12,880,regulation of locomotion,BP,CAMK2A;TF;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;SPOCK3;LPAR1
7025,GO:0022604,0.0120161833480438,0.996308830637749,8,470,regulation of cell morphogenesis,BP,CPNE6;MAG;SPP1;ERMN;ENPP2;DOCK5;CNTN2;LPAR1
14018,GO:0051961,0.0120561720207259,0.997032729618004,6,291,negative regulation of nervous system development,BP,DLL3;MAG;SPP1;NKX6-2;CNTN2;LPAR1
7081,GO:0023051,0.0120804275496816,0.993423013170762,31,3228,regulation of signaling,BP,CD22;MAOB;CAMK2A;LRP2;TF;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;SNCA;ST18;NRGN;SLC24A2;VSNL1;HHIP;GREM1;KLK6;GPR37;SYNPO;MAL;RCAN2;BOK;GPR62;CNTN2;LPAR1;RYR2;GRM3;FXYD1
12507,GO:0046785,0.0120834847929479,0.99867990844324,3,73,microtubule polymerization,BP,SNCA;SLC39A12;TPPP3
5082,GO:0012505,0.0121204782572785,0.99317594793628,37,4056,endomembrane system,CC,HHATL;CD22;MOXD1;LRP2;TF;CPNE6;SLC17A7;RARRES2;PADI2;SPP1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;GALNT6;SNCA;CXCL14;NRGN;S100A1;SERPINI1;CYB5R2;KLK6;LGI3;GJB1;GPR37;SYNPO;MAL;BOK;GPR62;AIFM3;SV2B;SERPINA3;OPALIN;LPAR1;RYR2;TMEM235
14925,GO:0061024,0.0122084772765547,0.995434187097811,11,778,membrane organization,BP,CAMK2A;SYNJ2;LRP2;TF;PACSIN1;MYRF;SNCA;MAL;BOK;CNTN2;MBP
19917,GO:1903531,0.0123039418312021,0.997989958174177,4,138,negative regulation of secretion by cell,BP,CD22;MAOB;SNCA;VSNL1
9142,GO:0034105,0.0123298343129305,0.999374786703712,2,26,positive regulation of tissue remodeling,BP,TF;SPP1
13080,GO:0048710,0.0123494047440996,0.999373274814653,2,26,regulation of astrocyte differentiation,BP,MAG;CNTN2
7965,GO:0031674,0.0123591671426857,0.997979512220353,4,133,I band,CC,CSRP1;S100A1;SYNPO;RYR2
5271,GO:0015081,0.0125610892373374,0.997935734162927,4,137,sodium ion transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC24A2;SLC5A11
14995,GO:0061135,0.0125640077333195,0.997934633330898,4,139,endopeptidase regulator activity,MF,SNCA;SERPINI1;SPOCK3;SERPINA3
12624,GO:0047020,0.0126455606957383,0.999960170044448,1,2,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,CBR1
19688,GO:1903060,0.0126513331620139,0.999960133555529,1,2,negative regulation of protein lipidation,BP,HHATL
4871,GO:0010731,0.0126726797126253,0.999959998473636,1,2,protein glutathionylation,BP,FXYD1
4872,GO:0010732,0.0126726797126253,0.999959998473636,1,2,regulation of protein glutathionylation,BP,FXYD1
4873,GO:0010734,0.0126726797126253,0.999959998473636,1,2,negative regulation of protein glutathionylation,BP,FXYD1
8753,GO:0032990,0.0127226764811255,0.995459534216486,10,672,cell part morphogenesis,BP,GAS7;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;ENPP2;CNTN2;CCK
20507,GO:1904700,0.0127257751444836,0.999959661486165,1,2,granulosa cell apoptotic process,BP,BOK
20513,GO:1904708,0.0127257751444836,0.999959661486165,1,2,regulation of granulosa cell apoptotic process,BP,BOK
3169,GO:0006500,0.0127438099536263,0.999959546698676,1,2,N-terminal protein palmitoylation,BP,HHATL
9505,GO:0034774,0.0127636850232482,0.996818802907934,6,299,secretory granule lumen,CC,TF;RARRES2;PADI2;CHI3L1;SERPINI1;SERPINA3
4373,GO:0009183,0.0127738868055281,0.999959354901155,1,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,AK5
18874,GO:1900923,0.0127771876940568,0.999959333823867,1,2,regulation of glycine import across plasma membrane,BP,RGS4
18875,GO:1900924,0.0127771876940568,0.999959333823867,1,2,negative regulation of glycine import across plasma membrane,BP,RGS4
10562,GO:0042137,0.0128017479611427,0.999959176825589,1,2,sequestering of neurotransmitter,BP,SLC17A7
13846,GO:0051621,0.0128054133090676,0.999959153369226,1,2,regulation of norepinephrine uptake,BP,SNCA
617,GO:0001791,0.0128066700505762,0.999959145325158,1,2,IgM binding,MF,CD22
10295,GO:0036505,0.0128361119513281,0.999958956647296,1,2,prosaposin receptor activity,MF,GPR37
18749,GO:1900154,0.0128508153153089,0.999958862257256,1,2,regulation of bone trabecula formation,BP,GREM1
18750,GO:1900155,0.0128508153153089,0.999958862257256,1,2,negative regulation of bone trabecula formation,BP,GREM1
2009,GO:0004500,0.0128602514056213,0.999958801623634,1,2,dopamine beta-monooxygenase activity,MF,MOXD1
3248,GO:0006589,0.0128602514056213,0.999958801623634,1,2,octopamine biosynthetic process,BP,MOXD1
12298,GO:0046333,0.0128602514056213,0.999958801623634,1,2,octopamine metabolic process,BP,MOXD1
21997,GO:2000866,0.0128655104537997,0.999958767810987,1,2,positive regulation of estradiol secretion,BP,SPP1
19623,GO:1902957,0.0128672885372246,0.999958756375778,1,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,SNCA
20892,GO:1905447,0.0128672885372246,0.999958756375778,1,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,SNCA
21740,GO:2000470,0.0128704755967289,0.99995873587517,1,2,positive regulation of peroxidase activity,BP,SNCA
21262,GO:1990443,0.0128758020153246,0.99995870160179,1,2,peptidyl-threonine autophosphorylation,BP,CAMK2A
12192,GO:0046056,0.0128895679261339,0.99995861295731,1,2,dADP metabolic process,BP,AK5
12683,GO:0047391,0.0128897090947976,0.99995861204777,1,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,ENPP2
18751,GO:1900157,0.0128956345573262,0.999958573861356,1,2,regulation of bone mineralization involved in bone maturation,BP,GREM1
9051,GO:0033693,0.0129028861681543,0.999958527104514,1,2,neurofilament bundle assembly,BP,NEFM
10243,GO:0036413,0.012905204795511,0.999958512148898,1,2,histone H3-R26 citrullination,BP,PADI2
516,GO:0001641,0.0129206794386632,0.999958412264816,1,2,group II metabotropic glutamate receptor activity,MF,GRM3
20496,GO:1904685,0.0129477480958671,0.999958237254252,1,2,positive regulation of metalloendopeptidase activity,BP,MBP
4958,GO:0010848,0.0129637579256582,0.999958133569698,1,2,regulation of chromatin disassembly,BP,PADI2
2480,GO:0005234,0.0129703188389518,0.999958091041837,1,2,extracellularly glutamate-gated ion channel activity,MF,SLC17A7
19782,GO:1903285,0.0129794325460624,0.999958031930698,1,2,positive regulation of hydrogen peroxide catabolic process,BP,SNCA
17943,GO:0098886,0.01299257231961,0.999957946632841,1,2,modification of dendritic spine,BP,SYNPO
17197,GO:0090291,0.0130151240087492,0.999957800033618,1,2,negative regulation of osteoclast proliferation,BP,GREM1
4588,GO:0009897,0.0130969660544272,0.99671744059004,6,299,external side of plasma membrane,CC,CD22;LRP2;TF;PDGFRA;MOG;ICOSLG
14385,GO:0060168,0.0131363618020149,0.999957007515743,1,2,positive regulation of adenosine receptor signaling pathway,BP,CNTN2
9523,GO:0034986,0.0131689803377558,0.999956793024939,1,2,iron chaperone activity,MF,TF
13153,GO:0048870,0.0131989633391538,0.993926757071188,17,1462,cell motility,BP,CAMK2A;DCX;TF;MAG;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;EMX2;CNTN2;CCK;SPOCK3;LPAR1
13873,GO:0051674,0.0131989633391538,0.993926757071188,17,1462,localization of cell,BP,CAMK2A;DCX;TF;MAG;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;EMX2;CNTN2;CCK;SPOCK3;LPAR1
22050,GO:2001056,0.0132843277207463,0.997779739475159,4,141,positive regulation of cysteine-type endopeptidase activity,BP,SNCA;ST18;BOK;CCK
16672,GO:0072275,0.0133126912542534,0.999955841621278,1,2,metanephric glomerulus morphogenesis,BP,PDGFRA
16673,GO:0072276,0.0133126912542534,0.999955841621278,1,2,metanephric glomerulus vasculature morphogenesis,BP,PDGFRA
16674,GO:0072277,0.0133126912542534,0.999955841621278,1,2,metanephric glomerular capillary formation,BP,PDGFRA
14409,GO:0060205,0.0133551924939141,0.996638192099943,6,302,cytoplasmic vesicle lumen,CC,TF;RARRES2;PADI2;CHI3L1;SERPINI1;SERPINA3
7024,GO:0022603,0.0134125430942252,0.994475382509997,13,1004,regulation of anatomical structure morphogenesis,BP,CPNE6;MAG;FGF1;SPP1;CHI3L1;ERMN;ENPP2;DOCK5;S100A1;GREM1;CNTN2;MBP;LPAR1
6595,GO:0019730,0.0134744932865042,0.998464994216492,3,78,antimicrobial humoral response,BP,TF;RARRES2;CXCL14
19092,GO:1901615,0.0136240791390736,0.995719519033871,8,486,organic hydroxy compound metabolic process,BP,MAOB;SYNJ2;MOXD1;LRP2;FGF1;SNCA;CYB5R2;GPR37
14218,GO:0055065,0.0136560386375471,0.995369731278904,9,584,metal ion homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
17811,GO:0098657,0.0137146252288436,0.997058280112174,5,217,import into cell,BP,LRP2;RGS4;SNCA;SLC39A12;SLC24A2
8105,GO:0031983,0.0137910777475418,0.996503927210175,6,304,vesicle lumen,CC,TF;RARRES2;PADI2;CHI3L1;SERPINI1;SERPINA3
7106,GO:0030030,0.0138011542151088,0.993617701983766,17,1465,cell projection organization,BP,GAS7;CAMK2A;DCX;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;ERMN;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
10559,GO:0042133,0.0140252344313993,0.999235886437167,2,28,neurotransmitter metabolic process,BP,MAOB;MOXD1
13275,GO:0050660,0.0141165412174016,0.998363910339825,3,78,flavin adenine dinucleotide binding,MF,MAOB;CYB5R2;AIFM3
13571,GO:0051128,0.0141200946631215,0.992767489191268,23,2212,regulation of cellular component organization,BP,CD22;TF;CPNE6;SLC17A7;MAG;PADI2;RGS4;SPP1;PACSIN1;PDGFRA;ERMN;ENPP2;SNCA;SLC39A12;TPPP3;SERPINI1;GREM1;KLK6;SYNPO;BOK;CNTN2;CCK;LPAR1
17959,GO:0098904,0.0141247234299185,0.999950269679424,1,2,regulation of AV node cell action potential,BP,RYR2
17961,GO:0098907,0.0145516630930826,0.999947206400489,1,2,regulation of SA node cell action potential,BP,RYR2
18129,GO:0099503,0.014572351588524,0.994156742440685,12,911,secretory vesicle,CC,MOXD1;TF;SLC17A7;RARRES2;PADI2;CHI3L1;SNCA;SERPINI1;KLK6;LGI3;SV2B;SERPINA3
21534,GO:2000147,0.0146022307947218,0.995354685533284,8,490,positive regulation of cell motility,BP,TF;RARRES2;FGF1;PDGFRA;ENPP2;CXCL14;DOCK5;LPAR1
1480,GO:0003220,0.0146131022672368,0.999946757985072,1,2,left ventricular cardiac muscle tissue morphogenesis,BP,RYR2
13525,GO:0051051,0.014949320167772,0.995648821743006,7,399,negative regulation of transport,BP,CD22;MAOB;RGS4;PACSIN1;SNCA;VSNL1;BOK
3622,GO:0007193,0.0151815694069681,0.998191259464622,3,80,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,BP,GPR37;LPAR1;GRM3
13703,GO:0051345,0.0151987877184484,0.994423623541656,10,697,positive regulation of hydrolase activity,BP,ADAP1;RGS4;PDGFRA;SNCA;DOCK5;ST18;BOK;CCK;MBP;LPAR1
12972,GO:0048522,0.0152699999836881,0.991071596633234,43,4959,positive regulation of cellular process,BP,MAOB;CAMK2A;LRP2;TF;CPNE6;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ENPP2;SNCA;CXCL14;DOCK5;ST18;NKX6-2;NRGN;SLC24A2;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;GREM1;KLK6;GPR37;SYNPO;MAL;BOK;GPR62;CNTN2;CCK;MBP;LPAR1;RYR2;FXYD1
3525,GO:0007015,0.0152712094786849,0.995536796839667,7,395,actin filament organization,BP,GAS7;TF;RGS4;PACSIN1;ERMN;SYNPO;LPAR1
17853,GO:0098739,0.0153617375409196,0.997318814057782,4,146,import across plasma membrane,BP,LRP2;RGS4;SLC39A12;SLC24A2
7089,GO:0030003,0.0153675366065753,0.994685726798482,9,596,cellular cation homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
13990,GO:0051924,0.0153801009119618,0.996604261172928,5,224,regulation of calcium ion transport,BP,CAMK2A;RGS4;SNCA;S100A1;RYR2
9501,GO:0034767,0.0155471174147697,0.997276535471561,4,147,positive regulation of ion transmembrane transport,BP,SNCA;S100A1;RYR2;FXYD1
17881,GO:0098793,0.0155543690024544,0.994994949108909,8,495,presynapse,CC,SYNJ2;SLC17A7;PACSIN1;SNCA;LGI3;SV2B;CCK;GRM3
19094,GO:1901617,0.0160507956641241,0.996417589235012,5,227,organic hydroxy compound biosynthetic process,BP,MOXD1;FGF1;SNCA;CYB5R2;GPR37
440,GO:0001505,0.0161835139405573,0.996380675483137,5,226,regulation of neurotransmitter levels,BP,MAOB;CAMK2A;MOXD1;SLC17A7;SNCA
13413,GO:0050877,0.0163203084483503,0.993351538706291,12,920,nervous system process,BP,LRP2;SLC17A7;MAG;RGS4;MYRF;NKX6-2;NRGN;SLC24A2;SYNPO;CNTN2;CCK;MBP
3469,GO:0006919,0.0165388610377449,0.997964016542717,3,83,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,SNCA;BOK;CCK
14009,GO:0051952,0.016582685548316,0.997956606479936,3,83,regulation of amine transport,BP,RGS4;SNCA;CCK
13971,GO:0051897,0.0166716942724308,0.997017562530642,4,150,positive regulation of protein kinase B signaling,BP,LRP2;FGF1;CHI3L1;PDGFRA
3435,GO:0006873,0.0169602111996071,0.994036844754442,9,606,cellular ion homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
11088,GO:0043204,0.0169734944388274,0.99694705015437,4,151,perikaryon,CC,CPNE6;SERPINI1;SYNPO;CCK
10486,GO:0040017,0.0170362603612092,0.994426528321178,8,504,positive regulation of locomotion,BP,TF;RARRES2;FGF1;PDGFRA;ENPP2;CXCL14;DOCK5;LPAR1
12996,GO:0048566,0.0172042253301326,0.998950778618473,2,31,embryonic digestive tract development,BP,RARRES2;PDGFRA
13659,GO:0051272,0.0172109679530699,0.99435886555572,8,505,positive regulation of cellular component movement,BP,TF;RARRES2;FGF1;PDGFRA;ENPP2;CXCL14;DOCK5;LPAR1
3523,GO:0007010,0.0173018544868212,0.992170050566045,15,1262,cytoskeleton organization,BP,GAS7;DCX;TF;NEFM;RGS4;PACSIN1;PDGFRA;ERMN;SNCA;SLC39A12;CSRP1;TPPP3;SYNPO;CNTN2;LPAR1
14400,GO:0060191,0.0173045440219803,0.997832893357875,3,84,regulation of lipase activity,BP,PDGFRA;SNCA;LPAR1
12531,GO:0046849,0.0173465427713189,0.997825665573754,3,84,bone remodeling,BP,TF;SPP1;GREM1
3436,GO:0006874,0.0174725730306452,0.994754118290189,7,410,cellular calcium ion homeostasis,BP,PDGFRA;SNCA;SLC24A2;SYNPO;BOK;LPAR1;RYR2
593,GO:0001764,0.0175790236806165,0.996804984039646,4,151,neuron migration,BP,CAMK2A;DCX;CNTN2;CCK
14708,GO:0060627,0.0175810603866479,0.994215098293288,8,507,regulation of vesicle-mediated transport,BP,CD22;TF;SLC17A7;PACSIN1;SNCA;VSNL1;GREM1;LGI3
12038,GO:0045766,0.0176997084189821,0.996775880701038,4,153,positive regulation of angiogenesis,BP,FGF1;CHI3L1;S100A1;GREM1
4819,GO:0010646,0.0180564126642293,0.989897755739365,30,3188,regulation of cell communication,BP,CD22;MAOB;CAMK2A;LRP2;TF;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;SNCA;ST18;NRGN;SLC24A2;VSNL1;HHIP;GREM1;KLK6;GPR37;SYNPO;MAL;RCAN2;BOK;GPR62;CNTN2;LPAR1;RYR2;GRM3
14019,GO:0051962,0.0180887267283768,0.994017051541846,8,508,positive regulation of nervous system development,BP,LRP2;CPNE6;MAG;PACSIN1;MYRF;NKX6-2;SERPINI1;LPAR1
4632,GO:0010039,0.0182008034005047,0.998854751524463,2,32,response to iron ion,BP,TF;SNCA
16419,GO:0071868,0.0184162073986585,0.997638111423474,3,86,cellular response to monoamine stimulus,BP,RGS4;SNCA;RYR2
16421,GO:0071870,0.0184162073986585,0.997638111423474,3,86,cellular response to catecholamine stimulus,BP,RGS4;SNCA;RYR2
13522,GO:0051048,0.0184999322660774,0.996584438908286,4,156,negative regulation of secretion,BP,CD22;MAOB;SNCA;VSNL1
21757,GO:2000503,0.0189281952438228,0.999880760612317,1,3,positive regulation of natural killer cell chemotaxis,BP,CXCL14
4602,GO:0009953,0.0189318399740566,0.997546110525328,3,87,dorsal/ventral pattern formation,BP,NKX6-2;HHIP;GREM1
19100,GO:1901624,0.0190888290058497,0.999878719311996,1,3,negative regulation of lymphocyte chemotaxis,BP,PADI2
20954,GO:1905576,0.0191335527705812,0.999878147861562,1,3,ganglioside GT1b binding,MF,MAG
4372,GO:0009182,0.019135346256102,0.999878124917346,1,3,purine deoxyribonucleoside diphosphate metabolic process,BP,AK5
20518,GO:1904715,0.0191422517712547,0.999878036554145,1,3,negative regulation of chaperone-mediated autophagy,BP,SNCA
4156,GO:0008597,0.0191447312799243,0.999878004818389,1,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,RCAN2
1820,GO:0004117,0.0191978961571097,0.999877323347923,1,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,PDE1C
12810,GO:0048101,0.0191978961571097,0.999877323347923,1,3,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,PDE1C
13505,GO:0051025,0.019243980660394,0.999876731084911,1,3,negative regulation of immunoglobulin secretion,BP,CD22
3840,GO:0008065,0.0192497662942404,0.99987665662818,1,3,establishment of blood-nerve barrier,BP,HAPLN2
17195,GO:0090289,0.0192633112273554,0.999876482226448,1,3,regulation of osteoclast proliferation,BP,GREM1
6947,GO:0021912,0.0192818962534859,0.999876242727257,1,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,NKX6-2
12216,GO:0046098,0.0193076524647382,0.999875910428465,1,3,guanine metabolic process,BP,GDA
10364,GO:0038098,0.0193122572273965,0.99987585097186,1,3,sequestering of BMP from receptor via BMP binding,BP,GREM1
11464,GO:0044093,0.0193697700865511,0.990501577843217,18,1652,positive regulation of molecular function,BP,CAMK2A;TF;ADAP1;EPHB6;FGF1;RGS4;CHI3L1;PDGFRA;SNCA;DOCK5;ST18;S100A1;GREM1;BOK;CCK;MBP;LPAR1;RYR2
21524,GO:2000124,0.0194039208895905,0.999874664423026,1,3,regulation of endocannabinoid signaling pathway,BP,CAMK2A
14384,GO:0060167,0.019416486531713,0.999874501322183,1,3,regulation of adenosine receptor signaling pathway,BP,CNTN2
8237,GO:0032227,0.0194287652674014,0.999874341842002,1,3,negative regulation of synaptic transmission, dopaminergic,BP,SNCA
15679,GO:0070494,0.0194297593057097,0.999874328926642,1,3,regulation of thrombin-activated receptor signaling pathway,BP,SNCA
15680,GO:0070495,0.0194297593057097,0.999874328926642,1,3,negative regulation of thrombin-activated receptor signaling pathway,BP,SNCA
10021,GO:0035938,0.0194794725824448,0.999873682156896,1,3,estradiol secretion,BP,SPP1
21996,GO:2000864,0.0194794725824448,0.999873682156896,1,3,regulation of estradiol secretion,BP,SPP1
13816,GO:0051581,0.019479495881367,0.999873681853385,1,3,negative regulation of neurotransmitter uptake,BP,SNCA
13843,GO:0051612,0.019479495881367,0.999873681853385,1,3,negative regulation of serotonin uptake,BP,SNCA
20111,GO:1903899,0.0194974610334075,0.999873447714498,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
7444,GO:0030659,0.0195848645922029,0.992520586713067,10,725,cytoplasmic vesicle membrane,CC,CAMK2A;MOXD1;LRP2;TF;SLC17A7;PACSIN1;SNCA;NRGN;SV2B;RYR2
2365,GO:0005017,0.0195894011487214,0.999872246039737,1,3,platelet-derived growth factor-activated receptor activity,MF,PDGFRA
1501,GO:0003257,0.0196562557069742,0.999871368640325,1,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
17428,GO:0097108,0.0196974605936399,0.99987082635823,1,3,hedgehog family protein binding,MF,HHIP
10355,GO:0038086,0.0197111191632142,0.999870646348924,1,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
10357,GO:0038091,0.0197111191632142,0.999870646348924,1,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,PDGFRA
21738,GO:2000468,0.0197461563963055,0.999870184007188,1,3,regulation of peroxidase activity,BP,SNCA
4860,GO:0010720,0.0198510118320937,0.99332082436066,8,517,positive regulation of cell development,BP,LRP2;CPNE6;MAG;PACSIN1;DOCK5;NKX6-2;SERPINI1;LPAR1
14225,GO:0055074,0.0198948409451492,0.99386879332661,7,421,calcium ion homeostasis,BP,PDGFRA;SNCA;SLC24A2;SYNPO;BOK;LPAR1;RYR2
20503,GO:1904694,0.0199957056665345,0.999866866948517,1,3,negative regulation of vascular associated smooth muscle contraction,BP,DOCK5
11794,GO:0045163,0.0201252125377181,0.999865128872843,1,3,clustering of voltage-gated potassium channels,BP,CNTN2
16418,GO:0071867,0.0201525718194011,0.997324573295536,3,89,response to monoamine,BP,RGS4;SNCA;RYR2
16420,GO:0071869,0.0201525718194011,0.997324573295536,3,89,response to catecholamine,BP,RGS4;SNCA;RYR2
5304,GO:0015144,0.0202920136430476,0.998643761532507,2,34,carbohydrate transmembrane transporter activity,MF,SLC5A11;TMEM144
15839,GO:0070838,0.0203662473470908,0.993693809249364,7,422,divalent metal ion transport,BP,CAMK2A;RGS4;SNCA;SLC39A12;SLC24A2;S100A1;RYR2
10647,GO:0042327,0.0203917914007292,0.991426199038061,12,952,positive regulation of phosphorylation,BP,TF;EPHB6;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;LPAR1
15653,GO:0070447,0.0204017376481402,0.999861379626033,1,3,positive regulation of oligodendrocyte progenitor proliferation,BP,LRP2
14012,GO:0051955,0.0204210655060599,0.998630544986074,2,34,regulation of amino acid transport,BP,RGS4;CCK
5634,GO:0016020,0.0205727169163509,0.987599852858332,60,7600,membrane,CC,GAS7;HHATL;CD22;CLDN11;MAOB;CAMK2A;ASIC4;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RGS4;PACSIN1;MYRF;EVI2A;PDGFRA;CLDN10;TESPA1;ENPP2;MOG;GALNT6;SNCA;DOCK5;SLC39A12;NRGN;SLC24A2;SLC5A11;ICOSLG;VSNL1;TMEM144;HHIP;CYB5R2;GJB1;GPR37;NINJ2;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AIFM3;CNTN2;SV2B;NKAIN2;OPALIN;MBP;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;FXYD1
13360,GO:0050801,0.0207211833897399,0.992014768906222,10,733,ion homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;CCK;LPAR1;RYR2
14232,GO:0055082,0.0209759668119016,0.991900675384612,10,735,cellular chemical homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;VSNL1;SYNPO;BOK;LPAR1;RYR2
3713,GO:0007389,0.0210059652449701,0.993454782374326,7,425,pattern specification process,BP,LRP2;DLL3;FGF1;NKX6-2;HHIP;GREM1;EMX2
5544,GO:0015837,0.0210929367070466,0.997149930740335,3,91,amine transport,BP,RGS4;SNCA;CCK
13524,GO:0051050,0.0211415283907441,0.991423688712895,11,843,positive regulation of transport,BP,CAMK2A;TF;SPP1;SNCA;S100A1;VSNL1;GREM1;BOK;CCK;RYR2;FXYD1
7184,GO:0030162,0.0213255388061658,0.992203397189156,9,632,regulation of proteolysis,BP,SNCA;ST18;SERPINI1;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP
9897,GO:0035725,0.0214167789494654,0.995866645358204,4,161,sodium ion transmembrane transport,BP,ASIC4;SLC17A7;SLC24A2;FXYD1
12090,GO:0045862,0.0214315279801116,0.994006487430939,6,334,positive regulation of proteolysis,BP,SNCA;ST18;BOK;CNTN2;CCK;MBP
694,GO:0001893,0.0216202457692744,0.998503675038889,2,35,maternal placenta development,BP,SPP1;TPPP3
20754,GO:1905167,0.0216898601049813,0.999843230611297,1,3,positive regulation of lysosomal protein catabolic process,BP,LRP2
11930,GO:0045596,0.0217304642298026,0.992029781182404,9,631,negative regulation of cell differentiation,BP,DLL3;MAG;RGS4;SPP1;CXCL14;NKX6-2;GREM1;CNTN2;LPAR1
4642,GO:0010092,0.0217704467112417,0.998487733019321,2,35,specification of animal organ identity,BP,LRP2;FGF1
16763,GO:0072511,0.0218164630752075,0.99314976007708,7,428,divalent inorganic cation transport,BP,CAMK2A;RGS4;SNCA;SLC39A12;SLC24A2;S100A1;RYR2
21907,GO:2000725,0.0218849092441479,0.998475544087593,2,35,regulation of cardiac muscle cell differentiation,BP,RGS4;GREM1
16635,GO:0072210,0.0219165401890053,0.998472169651471,2,35,metanephric nephron development,BP,PDGFRA;GREM1
2608,GO:0005547,0.0223364291961668,0.998427125584502,2,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ADAP1;NRGN
18440,GO:0120036,0.0224989454322596,0.989223134003079,16,1426,plasma membrane bounded cell projection organization,BP,GAS7;CAMK2A;DCX;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
8262,GO:0032270,0.0225031997240573,0.989220601507061,16,1437,positive regulation of cellular protein metabolic process,BP,LRP2;TF;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
9648,GO:0035295,0.0225482022411429,0.990381561837484,12,961,tube development,BP,LRP2;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;S100A1;HHIP;GREM1;GJB1;EMX2;RYR2
7819,GO:0031410,0.0226425220855549,0.987993156649471,22,2189,cytoplasmic vesicle,CC,CD22;CAMK2A;MOXD1;LRP2;TF;CPNE6;SLC17A7;RARRES2;PADI2;PACSIN1;CHI3L1;SNCA;NRGN;SERPINI1;KLK6;LGI3;BOK;GPR62;SV2B;SERPINA3;LPAR1;RYR2
3414,GO:0006835,0.0229559496658264,0.996796049292166,3,93,dicarboxylic acid transport,BP,LRP2;SLC17A7;CCK
17715,GO:0097708,0.0230784750568944,0.987737774734028,22,2193,intracellular vesicle,CC,CD22;CAMK2A;MOXD1;LRP2;TF;CPNE6;SLC17A7;RARRES2;PADI2;PACSIN1;CHI3L1;SNCA;NRGN;SERPINI1;KLK6;LGI3;BOK;GPR62;SV2B;SERPINA3;LPAR1;RYR2
3456,GO:0006898,0.0231530683145418,0.994324145720603,5,248,receptor-mediated endocytosis,BP,LRP2;TF;SNCA;GREM1;CNTN2
5083,GO:0012506,0.0231553200268579,0.99091551185607,10,745,vesicle membrane,CC,CAMK2A;MOXD1;LRP2;TF;SLC17A7;PACSIN1;SNCA;NRGN;SV2B;RYR2
5241,GO:0014911,0.0234581876282948,0.998302493643056,2,36,positive regulation of smooth muscle cell migration,BP,DOCK5;LPAR1
7105,GO:0030029,0.023571824547669,0.990725672501309,10,741,actin filament-based process,BP,GAS7;TF;RGS4;PACSIN1;PDGFRA;ERMN;CSRP1;SYNPO;LPAR1;RYR2
1861,GO:0004180,0.0237449336978505,0.998268635413715,2,37,carboxypeptidase activity,MF,FOLH1;CNDP1
17788,GO:0098609,0.0238680480621301,0.990589793642726,10,747,cell-cell adhesion,BP,CLDN11;MAG;PDGFRA;CLDN10;TESPA1;CSRP1;ICOSLG;NINJ2;CNTN2;MBP
13121,GO:0048812,0.0239092212877342,0.991084857713493,9,636,neuron projection morphogenesis,BP,GAS7;LRP2;CPNE6;MAG;EPHB6;SPP1;PACSIN1;CNTN2;CCK
19995,GO:1903672,0.0240185834963199,0.998237965882735,2,37,positive regulation of sprouting angiogenesis,BP,FGF1;S100A1
5856,GO:0016477,0.0241909173354279,0.988580879533997,15,1323,cell migration,BP,CAMK2A;DCX;MAG;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;EMX2;CNTN2;CCK;LPAR1
12058,GO:0045807,0.0241985741692128,0.996553034651145,3,95,positive regulation of endocytosis,BP,TF;SNCA;GREM1
18885,GO:1901021,0.0242619972429155,0.998210524696619,2,37,positive regulation of calcium ion transmembrane transporter activity,BP,S100A1;RYR2
3599,GO:0007165,0.0244246977100143,0.985224380050962,42,4951,signal transduction,BP,CD22;CAMK2A;DCX;LRP2;DLL3;TF;SLC17A7;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NRGN;PDE1C;ICOSLG;S100A1;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;MBP;LPAR1;RYR2;GRM3
7446,GO:0030662,0.0247386675339356,0.995009163487646,4,170,coated vesicle membrane,CC,LRP2;TF;SLC17A7;NRGN
7305,GO:0030324,0.0249344626452397,0.994957967068418,4,169,lung development,BP,FGF1;CHI3L1;PDGFRA;HHIP
7169,GO:0030141,0.0249482075620135,0.990092385052845,10,759,secretory granule,CC,MOXD1;TF;RARRES2;PADI2;CHI3L1;SNCA;SERPINI1;KLK6;SV2B;SERPINA3
3377,GO:0006775,0.0251056674563401,0.998112234590316,2,38,fat-soluble vitamin metabolic process,BP,LRP2;CBR1
15257,GO:0061760,0.0252007434716214,0.99976170628336,1,4,antifungal innate immune response,BP,RARRES2
12066,GO:0045823,0.025236350788766,0.998097146640583,2,38,positive regulation of heart contraction,BP,RGS4;RYR2
6597,GO:0019732,0.0252374443955522,0.999761007944528,1,4,antifungal humoral response,BP,RARRES2
19775,GO:1903276,0.025299083955342,0.999759832753574,1,4,regulation of sodium ion export across plasma membrane,BP,FXYD1
19776,GO:1903278,0.025299083955342,0.999759832753574,1,4,positive regulation of sodium ion export across plasma membrane,BP,FXYD1
11775,GO:0045124,0.0253424725130177,0.998084863019818,2,38,regulation of bone resorption,BP,TF;SPP1
16331,GO:0071673,0.0253541759256433,0.99975877993006,1,4,positive regulation of smooth muscle cell chemotaxis,BP,LPAR1
4378,GO:0009189,0.0253637289178384,0.99975859713281,1,4,deoxyribonucleoside diphosphate biosynthetic process,BP,AK5
4697,GO:0010387,0.0253921791857088,0.999758052320112,1,4,COP9 signalosome assembly,BP,TESPA1
21611,GO:2000295,0.0254272847655764,0.999757379204907,1,4,regulation of hydrogen peroxide catabolic process,BP,SNCA
4633,GO:0010040,0.025461578643165,0.99975672074059,1,4,response to iron(II) ion,BP,SNCA
14378,GO:0060160,0.025471290715793,0.999756534098696,1,4,negative regulation of dopamine receptor signaling pathway,BP,RGS4
9805,GO:0035594,0.0254861677377759,0.999756248059018,1,4,ganglioside binding,MF,MAG
4637,GO:0010044,0.0254877390428438,0.99975621783771,1,4,response to aluminum ion,BP,MAOB
20065,GO:1903804,0.0254898994999158,0.999756176282001,1,4,glycine import across plasma membrane,BP,RGS4
6594,GO:0019725,0.0255092419529887,0.989350343636858,11,871,cellular homeostasis,BP,TF;SLC17A7;PDGFRA;SNCA;SLC39A12;SLC24A2;VSNL1;SYNPO;BOK;LPAR1;RYR2
19180,GO:1901856,0.0255172757708016,0.999755649397951,1,4,negative regulation of cellular respiration,BP,SNCA
14405,GO:0060199,0.0255403597383312,0.999755204676871,1,4,clathrin-sculpted glutamate transport vesicle,CC,SLC17A7
14408,GO:0060203,0.0255403597383312,0.999755204676871,1,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SLC17A7
6948,GO:0021913,0.025544193774128,0.999755130773184,1,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,NKX6-2
595,GO:0001766,0.0255547272069886,0.999754927675948,1,4,membrane raft polarization,BP,MAL
4866,GO:0010726,0.0255568277779145,0.999754887164239,1,4,positive regulation of hydrogen peroxide metabolic process,BP,SNCA
11450,GO:0044057,0.0255726658541932,0.990978991089062,8,544,regulation of system process,BP,MAG;RGS4;MYRF;DOCK5;S100A1;CCK;RYR2;FXYD1
9818,GO:0035609,0.0255740000686948,0.999754555851691,1,4,C-terminal protein deglutamylation,BP,FOLH1
20169,GO:1903999,0.0255756837143927,0.999754523356199,1,4,negative regulation of eating behavior,BP,CCK
5985,GO:0016715,0.025661590686241,0.999752862407615,1,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,MOXD1
2131,GO:0004668,0.0256675285367548,0.99975274739441,1,4,protein-arginine deiminase activity,MF,PADI2
6257,GO:0018101,0.0256675285367548,0.99975274739441,1,4,protein citrullination,BP,PADI2
10244,GO:0036414,0.0256675285367548,0.99975274739441,1,4,histone citrullination,BP,PADI2
8274,GO:0032286,0.0256893018101953,0.999752325425498,1,4,central nervous system myelin maintenance,BP,MYRF
17605,GO:0097444,0.0257019956364362,0.999752079249627,1,4,spine apparatus,CC,SYNPO
14732,GO:0060681,0.0257499149115194,0.999751148819855,1,4,branch elongation involved in ureteric bud branching,BP,FGF1
3959,GO:0008273,0.025844820902477,0.999749300866898,1,4,calcium, potassium:sodium antiporter activity,MF,SLC24A2
13842,GO:0051611,0.0259259693878505,0.999747715310139,1,4,regulation of serotonin uptake,BP,SNCA
7678,GO:0031133,0.0259498060985922,0.99974724860538,1,4,regulation of axon diameter,BP,CNTN2
18948,GO:1901228,0.0259636280625834,0.999746977782035,1,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
18700,GO:1900086,0.0259974854158845,0.999746313771872,1,4,positive regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
2956,GO:0006145,0.0260439489340167,0.999745401097432,1,4,purine nucleobase catabolic process,BP,GDA
17564,GO:0097360,0.0261961579470534,0.999742399676853,1,4,chorionic trophoblast cell proliferation,BP,BOK
19013,GO:1901382,0.0261961579470534,0.999742399676853,1,4,regulation of chorionic trophoblast cell proliferation,BP,BOK
531,GO:0001662,0.0263580308518831,0.997963837930441,2,39,behavioral fear response,BP,ASIC4;CCK
20176,GO:1904018,0.026387733178162,0.994569670916508,4,173,positive regulation of vasculature development,BP,FGF1;CHI3L1;S100A1;GREM1
7652,GO:0031099,0.026661299191975,0.994495689998231,4,174,regeneration,BP,MAG;SPP1;KLK6;NINJ2
7304,GO:0030323,0.0268585986337895,0.994442845628937,4,173,respiratory tube development,BP,FGF1;CHI3L1;PDGFRA;HHIP
7112,GO:0030036,0.0269610680664655,0.989733653975896,9,650,actin cytoskeleton organization,BP,GAS7;TF;RGS4;PACSIN1;PDGFRA;ERMN;CSRP1;SYNPO;LPAR1
4529,GO:0009653,0.0269840580450858,0.985097997101347,24,2472,anatomical structure morphogenesis,BP,GAS7;LRP2;DLL3;CPNE6;MAG;EPHB6;FGF1;SPP1;PACSIN1;CHI3L1;PDGFRA;ERMN;ENPP2;DOCK5;CSRP1;S100A1;HHIP;GREM1;EMX2;CNTN2;CCK;MBP;LPAR1;RYR2
7292,GO:0030308,0.0271103914536717,0.994373951296256,4,175,negative regulation of cell growth,BP,MAG;RGS4;SPP1;GREM1
12968,GO:0048518,0.0271580007769652,0.98332687466197,45,5420,positive regulation of biological process,BP,CD22;MAOB;CAMK2A;LRP2;TF;CPNE6;MAG;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ENPP2;MOG;SNCA;CXCL14;DOCK5;ST18;NKX6-2;NRGN;SLC24A2;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;GREM1;KLK6;GPR37;SYNPO;MAL;BOK;GPR62;CNTN2;CCK;MBP;LPAR1;RYR2;FXYD1
17850,GO:0098735,0.027447491516471,0.999717050014486,1,4,positive regulation of the force of heart contraction,BP,RYR2
905,GO:0002209,0.0277162396458347,0.997798510949532,2,40,behavioral defense response,BP,ASIC4;CCK
18585,GO:0140352,0.0277681718624507,0.986657299083286,15,1351,export from cell,BP,CD22;MAOB;CAMK2A;TF;SLC17A7;RARRES2;PADI2;SPP1;CHI3L1;SNCA;VSNL1;LGI3;CCK;SERPINA3;FXYD1
14230,GO:0055080,0.0279182888087621,0.989303162516372,9,661,cation homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
720,GO:0001934,0.0279815161447288,0.988149674362873,11,883,positive regulation of protein phosphorylation,BP,TF;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;LPAR1
13336,GO:0050769,0.0280730710420225,0.99071628671052,7,450,positive regulation of neurogenesis,BP,LRP2;CPNE6;MAG;PACSIN1;NKX6-2;SERPINI1;LPAR1
4608,GO:0009967,0.0286011357471923,0.985886371528774,16,1479,positive regulation of signal transduction,BP,LRP2;TF;FGF1;RGS4;CHI3L1;PDGFRA;TESPA1;ST18;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
10787,GO:0042596,0.0289128610505266,0.997648751504015,2,41,fear response,BP,ASIC4;CCK
2469,GO:0005219,0.0290423451226229,0.999682995674055,1,4,ryanodine-sensitive calcium-release channel activity,MF,RYR2
13105,GO:0048763,0.0292971736964782,0.99967737290442,1,4,calcium-induced calcium release activity,MF,RYR2
15807,GO:0070741,0.0293058580375013,0.997599481378386,2,41,response to interleukin-6,BP,CHI3L1;ST18
9037,GO:0033674,0.0295677845662841,0.989278185931472,8,560,positive regulation of kinase activity,BP,TF;EPHB6;FGF1;CHI3L1;PDGFRA;SNCA;GREM1;LPAR1
17870,GO:0098771,0.029826202639427,0.988437835645354,9,669,inorganic ion homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;SYNPO;BOK;LPAR1;RYR2
3789,GO:0007610,0.0298835318784948,0.989141885980346,8,559,behavior,BP,ASIC4;SLC17A7;NRGN;SLC24A2;GPR37;SYNPO;CNTN2;CCK
1187,GO:0002686,0.0300496270530711,0.99750308572499,2,42,negative regulation of leukocyte migration,BP,PADI2;GREM1
1365,GO:0003008,0.0300997566629585,0.984746919010579,17,1606,system process,BP,LRP2;SLC17A7;MAG;RGS4;MYRF;DOCK5;NKX6-2;NRGN;SLC24A2;S100A1;SYNPO;CNTN2;CCK;SERPINA3;MBP;RYR2;FXYD1
11999,GO:0045687,0.0302668269894172,0.997475296620255,2,42,positive regulation of glial cell differentiation,BP,MAG;NKX6-2
4763,GO:0010562,0.030498433989203,0.986400430212095,12,1010,positive regulation of phosphorus metabolic process,BP,TF;EPHB6;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;LPAR1
12134,GO:0045937,0.030498433989203,0.986400430212095,12,1010,positive regulation of phosphate metabolic process,BP,TF;EPHB6;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;LPAR1
13029,GO:0048640,0.0306045199936262,0.995223664229123,3,104,negative regulation of developmental growth,BP,MAG;RGS4;SPP1
1499,GO:0003254,0.030614510921215,0.997430584210467,2,42,regulation of membrane depolarization,BP,BOK;CCK
11019,GO:0043090,0.0306926615619603,0.997420495309831,2,42,amino acid import,BP,SLC17A7;RGS4
12037,GO:0045765,0.0311069647225063,0.991760940282218,5,269,regulation of angiogenesis,BP,FGF1;CHI3L1;ENPP2;S100A1;GREM1
17816,GO:0098662,0.0312212911028914,0.987798454084831,9,673,inorganic cation transmembrane transport,BP,ASIC4;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;S100A1;RYR2;FXYD1
1804,GO:0004090,0.0313160690928521,0.999606669631969,1,5,carbonyl reductase (NADPH) activity,MF,CBR1
14190,GO:0055007,0.0313202513511808,0.995069990366725,3,102,cardiac muscle cell differentiation,BP,RGS4;PDGFRA;GREM1
21755,GO:2000501,0.0313273890691012,0.999606383381674,1,5,regulation of natural killer cell chemotaxis,BP,CXCL14
8818,GO:0033106,0.0315253668394194,0.999601360027491,1,5,cis-Golgi network membrane,CC,BOK
4346,GO:0009153,0.0315706936214938,0.999600205396874,1,5,purine deoxyribonucleotide biosynthetic process,BP,AK5
19622,GO:1902956,0.0316001063921178,0.999599455246445,1,5,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,SNCA
21065,GO:1905867,0.0316005701982738,0.999599443411716,1,5,epididymis development,BP,GJB1
2886,GO:0006030,0.0316246253724258,0.999598829364034,1,5,chitin metabolic process,BP,CHI3L1
2887,GO:0006032,0.0316246253724258,0.999598829364034,1,5,chitin catabolic process,BP,CHI3L1
4375,GO:0009186,0.0316448658996593,0.999598312322339,1,5,deoxyribonucleoside diphosphate metabolic process,BP,AK5
3343,GO:0006710,0.0316599417760035,0.99959792699179,1,5,androgen catabolic process,BP,SPP1
15893,GO:0070915,0.0316739391776015,0.999597569058872,1,5,lysophosphatidic acid receptor activity,MF,LPAR1
9611,GO:0035239,0.0317596979123808,0.986875227710857,10,782,tube morphogenesis,BP,LRP2;FGF1;CHI3L1;PDGFRA;ENPP2;S100A1;HHIP;GREM1;EMX2;RYR2
7930,GO:0031623,0.0317760837507314,0.994966997080208,3,106,receptor internalization,BP,SNCA;GREM1;CNTN2
2970,GO:0006172,0.0317826718734802,0.999594783118848,1,5,ADP biosynthetic process,BP,AK5
19910,GO:1903522,0.0317977569003298,0.991528994906675,5,270,regulation of blood circulation,BP,RGS4;DOCK5;S100A1;RYR2;FXYD1
5134,GO:0014063,0.0318947515777729,0.999591901231007,1,5,negative regulation of serotonin secretion,BP,MAOB
14651,GO:0060537,0.0319279970675311,0.99021634156649,6,361,muscle tissue development,BP,LRP2;RGS4;PDGFRA;CSRP1;GREM1;RYR2
13325,GO:0050748,0.0319358431703496,0.999590842057271,1,5,negative regulation of lipoprotein metabolic process,BP,HHATL
3876,GO:0008131,0.0319370960531656,0.99959080974121,1,5,primary amine oxidase activity,MF,MAOB
17015,GO:0090027,0.0319496828925327,0.999590485012547,1,5,negative regulation of monocyte chemotaxis,BP,GREM1
5119,GO:0014047,0.0320475135947394,0.997241091416684,2,43,glutamate secretion,BP,SLC17A7;CCK
11766,GO:0045110,0.0320489556026443,0.999587919295836,1,5,intermediate filament bundle assembly,BP,NEFM
2836,GO:0005954,0.0321141211784355,0.999586230668704,1,5,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK2A
17593,GO:0097418,0.0321185756725427,0.999586115112223,1,5,neurofibrillary tangle,CC,NEFM
9924,GO:0035766,0.0321498641202427,0.999585302980671,1,5,cell chemotaxis to fibroblast growth factor,BP,FGF1
9926,GO:0035768,0.0321498641202427,0.999585302980671,1,5,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF1
20590,GO:1904847,0.0321498641202427,0.999585302980671,1,5,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF1
21788,GO:2000544,0.0321498641202427,0.999585302980671,1,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF1
2517,GO:0005315,0.032234646723782,0.999583098285896,1,5,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
18035,GO:0099025,0.0322562522810206,0.999582535505935,1,5,anchored component of postsynaptic membrane,CC,CNTN2
18698,GO:1900084,0.0322689020880789,0.999582205826154,1,5,regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
3710,GO:0007386,0.0322749611305177,0.999582047868439,1,5,compartment pattern specification,BP,DLL3
10354,GO:0038085,0.0323930468008945,0.999578963364044,1,5,vascular endothelial growth factor binding,MF,PDGFRA
5456,GO:0015672,0.0324076326036648,0.988955872182651,7,467,monovalent inorganic cation transport,BP,ASIC4;SLC17A7;RGS4;SLC24A2;SLC5A11;NKAIN2;FXYD1
13118,GO:0048806,0.0324347901359981,0.997189642475577,2,43,genitalia development,BP,LRP2;PDGFRA
4134,GO:0008542,0.0324389104560789,0.997189093265111,2,43,visual learning,BP,SYNPO;CCK
885,GO:0002175,0.0325460208243921,0.999574950456447,1,5,protein localization to paranode region of axon,BP,MAL
16333,GO:0071675,0.0325568788551715,0.997171145433822,2,44,regulation of mononuclear cell migration,BP,RARRES2;GREM1
3921,GO:0008202,0.0326997063835493,0.991223274999888,5,274,steroid metabolic process,BP,LRP2;FGF1;SPP1;PDGFRA;CYB5R2
12026,GO:0045744,0.0327175264900893,0.997149642866159,2,44,negative regulation of G protein-coupled receptor signaling pathway,BP,RGS4;SNCA
11287,GO:0043533,0.032734444833291,0.999569981088585,1,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ADAP1
9939,GO:0035790,0.03278172574037,0.99956872953955,1,5,platelet-derived growth factor receptor-alpha signaling pathway,BP,PDGFRA
19200,GO:1901896,0.0329836505017026,0.999563363742578,1,5,positive regulation of ATPase-coupled calcium transmembrane transporter activity,BP,RYR2
20385,GO:1904447,0.0330493441641418,0.999561610798562,1,5,folate import across plasma membrane,BP,LRP2
4970,GO:0010863,0.0331208354914587,0.997095402950385,2,44,positive regulation of phospholipase C activity,BP,PDGFRA;LPAR1
16557,GO:0072103,0.0333253762311536,0.999554206359347,1,5,glomerulus vasculature morphogenesis,BP,PDGFRA
16558,GO:0072104,0.0333253762311536,0.999554206359347,1,5,glomerular capillary formation,BP,PDGFRA
19916,GO:1903530,0.0334664131929142,0.987572262116014,8,573,regulation of secretion by cell,BP,CD22;MAOB;CAMK2A;SPP1;SNCA;VSNL1;LGI3;CCK
16955,GO:0086029,0.0334868958137482,0.999549844510476,1,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,RYR2
16982,GO:0086068,0.0334868958137482,0.999549844510476,1,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,RYR2
16023,GO:0071205,0.0335852802543153,0.999547177079305,1,5,protein localization to juxtaparanode region of axon,BP,CNTN2
5515,GO:0015798,0.0336376441528048,0.999545754114338,1,5,myo-inositol transport,BP,SLC5A11
7314,GO:0030334,0.0336608694596106,0.985953274079604,10,792,regulation of cell migration,BP,CAMK2A;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;LPAR1
13638,GO:0051247,0.0339171442005029,0.98289768777859,16,1511,positive regulation of protein metabolic process,BP,LRP2;TF;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
9498,GO:0034764,0.0339997328522945,0.992428824280829,4,187,positive regulation of transmembrane transport,BP,SNCA;S100A1;RYR2;FXYD1
17964,GO:0098910,0.0340547141556624,0.99953433960649,1,5,regulation of atrial cardiac muscle cell action potential,BP,RYR2
7315,GO:0030335,0.0341483879095142,0.988233739887979,7,471,positive regulation of cell migration,BP,RARRES2;FGF1;PDGFRA;ENPP2;CXCL14;DOCK5;LPAR1
20330,GO:1904352,0.0341778768991361,0.999530941375036,1,5,positive regulation of protein catabolic process in the vacuole,BP,LRP2
3618,GO:0007188,0.0343273746474991,0.99233216935452,4,189,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,BP,GPR37;S1PR5;LPAR1;GRM3
1186,GO:0002685,0.0344940616931189,0.992282887983734,4,190,regulation of leukocyte migration,BP,RARRES2;PADI2;CXCL14;GREM1
7658,GO:0031109,0.0345175964722803,0.994352674336743,3,109,microtubule polymerization or depolymerization,BP,SNCA;SLC39A12;TPPP3
7242,GO:0030234,0.0346767509895676,0.984810243507343,11,914,enzyme regulator activity,MF,ADAP1;RGS4;SNCA;DOCK5;SERPINI1;GREM1;PPP1R14A;MAL;RCAN2;SPOCK3;SERPINA3
11106,GO:0043235,0.0353311116215414,0.98891315362806,6,372,receptor complex,CC,LRP2;TF;EPHB6;PDGFRA;GPR37;GPR62
2822,GO:0005923,0.0354928843046921,0.994129234911936,3,110,bicellular tight junction,CC,CLDN11;CLDN10;SYNPO
14193,GO:0055010,0.0355568681253005,0.996757647751249,2,45,ventricular cardiac muscle tissue morphogenesis,BP,LRP2;RYR2
592,GO:0001763,0.0355841961678568,0.991962024099766,4,189,morphogenesis of a branching structure,BP,FGF1;ERMN;HHIP;GREM1
2462,GO:0005198,0.0357155030502253,0.986568807464617,8,580,structural molecule activity,MF,CLDN11;NEFM;CHI3L1;CLDN10;CSRP1;MOBP;MAL;MBP
3767,GO:0007566,0.0357796453723211,0.99672398102735,2,46,embryo implantation,BP,SPP1;TPPP3
7350,GO:0030425,0.0358467325762137,0.98651000272877,8,579,dendrite,CC,CAMK2A;LRP2;CPNE6;NRGN;SYNPO;CCK;LPAR1;GRM3
18813,GO:1900274,0.0359625022991523,0.996698153565534,2,46,regulation of phospholipase C activity,BP,PDGFRA;LPAR1
802,GO:0002040,0.0359869020802031,0.994014656287012,3,111,sprouting angiogenesis,BP,FGF1;S100A1;GREM1
13704,GO:0051346,0.0360146774165279,0.988646880541234,6,377,negative regulation of hydrolase activity,BP,CAMK2A;SNCA;SERPINI1;PPP1R14A;SPOCK3;SERPINA3
11408,GO:0043949,0.0360636090747227,0.996683841440955,2,46,regulation of cAMP-mediated signaling,BP,GPR62;LPAR1
17810,GO:0098656,0.036221673988931,0.990009577856354,5,280,anion transmembrane transport,BP,LRP2;SLC17A7;RGS4;SLC24A2;FXYD1
7655,GO:0031103,0.0364434789673765,0.996629869842588,2,46,axon regeneration,BP,MAG;SPP1
17606,GO:0097447,0.0364565844331065,0.986235354713228,8,581,dendritic tree,CC,CAMK2A;LRP2;CPNE6;NRGN;SYNPO;CCK;LPAR1;GRM3
5042,GO:0010951,0.0365181431769263,0.991682290239191,4,193,negative regulation of endopeptidase activity,BP,SNCA;SERPINI1;SPOCK3;SERPINA3
7381,GO:0030514,0.0367057358957575,0.996592425396452,2,46,negative regulation of BMP signaling pathway,BP,LRP2;GREM1
18137,GO:0099512,0.0372297811203777,0.984197778462305,10,800,supramolecular fiber,CC,GAS7;CLDN11;DCX;NEFM;SNCA;CSRP1;TPPP3;S100A1;SYNPO;RYR2
4177,GO:0008637,0.0373400711991009,0.993697271673984,3,114,apoptotic mitochondrial changes,BP,CAMK2A;BOK;CCK
18130,GO:0099504,0.0374116972289871,0.991414656630927,4,192,synaptic vesicle cycle,BP,SYNJ2;SLC17A7;PACSIN1;SNCA
12873,GO:0048260,0.0375312058999249,0.996471208500426,2,47,positive regulation of receptor-mediated endocytosis,BP,TF;GREM1
3473,GO:0006928,0.0375928349224198,0.979763232136031,19,1898,movement of cell or subcellular component,BP,CAMK2A;DCX;TF;MAG;EPHB6;RARRES2;FGF1;PADI2;PDGFRA;ENPP2;CXCL14;DOCK5;GREM1;EMX2;CNTN2;CCK;SPOCK3;LPAR1;RYR2
5631,GO:0016015,0.0377926901186284,0.999401940060627,1,6,morphogen activity,MF,GREM1
15389,GO:0065009,0.0378247307972448,0.978170442662191,25,2700,regulation of molecular function,BP,CAMK2A;TF;ADAP1;EPHB6;FGF1;RGS4;CHI3L1;PDGFRA;SNCA;DOCK5;ST18;S100A1;SERPINI1;GREM1;PPP1R14A;RCAN2;BOK;CCK;SPOCK3;SERPINA3;MBP;LPAR1;RYR2;GRM3;FXYD1
4329,GO:0009136,0.0379100876589897,0.999398190212226,1,6,purine nucleoside diphosphate biosynthetic process,BP,AK5
4370,GO:0009180,0.0379100876589897,0.999398190212226,1,6,purine ribonucleoside diphosphate biosynthetic process,BP,AK5
12864,GO:0048247,0.0379761314908285,0.996404181626307,2,48,lymphocyte chemotaxis,BP,PADI2;CXCL14
4710,GO:0010455,0.0379780862655064,0.999396012795628,1,6,positive regulation of cell fate commitment,BP,NKX6-2
10695,GO:0042421,0.0380028209244803,0.999395219764783,1,6,norepinephrine biosynthetic process,BP,MOXD1
6627,GO:0019800,0.0380333042714496,0.999394241695524,1,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,SPOCK3
879,GO:0002158,0.0380643749598635,0.999393243955456,1,6,osteoclast proliferation,BP,GREM1
9492,GO:0034756,0.0380650348359649,0.999393222756515,1,6,regulation of iron ion transport,BP,TF
17223,GO:0090324,0.0380717703189621,0.999393006353307,1,6,negative regulation of oxidative phosphorylation,BP,SNCA
16622,GO:0072197,0.0380774794303643,0.999392822895544,1,6,ureter morphogenesis,BP,EMX2
7910,GO:0031580,0.0380981442752358,0.999392158611831,1,6,membrane raft distribution,BP,MAL
14729,GO:0060676,0.0381757184924016,0.999389661651869,1,6,ureteric bud formation,BP,GREM1
19045,GO:1901509,0.0382592513170936,0.999386967084679,1,6,regulation of endothelial tube morphogenesis,BP,FGF1
20204,GO:1904058,0.0382888318137845,0.999386011444291,1,6,positive regulation of sensory perception of pain,BP,CCK
2033,GO:0004528,0.038302930914844,0.999385555686626,1,6,phosphodiesterase I activity,MF,ENPP2
9915,GO:0035749,0.038356602736021,0.99938381915792,1,6,myelin sheath adaxonal region,CC,MAG
5890,GO:0016530,0.0383862074664619,0.999382860244736,1,6,metallochaperone activity,MF,TF
6885,GO:0021796,0.0384022139928026,0.999382341469366,1,6,cerebral cortex regionalization,BP,EMX2
7422,GO:0030595,0.0384132982569223,0.991109220967927,4,197,leukocyte chemotaxis,BP,RARRES2;PADI2;CXCL14;GREM1
6914,GO:0021853,0.0384213439599533,0.999381721172187,1,6,cerebral cortex GABAergic interneuron migration,BP,CNTN2
20646,GO:1904936,0.0384213439599533,0.999381721172187,1,6,interneuron migration,BP,CNTN2
20168,GO:1903998,0.0384239046986065,0.999381638115173,1,6,regulation of eating behavior,BP,CCK
16462,GO:0071926,0.0384246508096111,0.999381613914155,1,6,endocannabinoid signaling pathway,BP,CAMK2A
3404,GO:0006816,0.0384310614749307,0.987698224221376,6,381,calcium ion transport,BP,CAMK2A;RGS4;SNCA;SLC24A2;S100A1;RYR2
11909,GO:0045542,0.0384536703332892,0.999380672257494,1,6,positive regulation of cholesterol biosynthetic process,BP,FGF1
18375,GO:0106120,0.0384536703332892,0.999380672257494,1,6,positive regulation of sterol biosynthetic process,BP,FGF1
12228,GO:0046113,0.0384825286150936,0.999379735111469,1,6,nucleobase catabolic process,BP,GDA
5466,GO:0015695,0.0384986281310358,0.996327611657439,2,48,organic cation transport,BP,MAOB;SNCA
11931,GO:0045597,0.0385552289488278,0.982822717708941,11,927,positive regulation of cell differentiation,BP,LRP2;CPNE6;MAG;RARRES2;PACSIN1;TESPA1;DOCK5;NKX6-2;SERPINI1;GREM1;LPAR1
17596,GO:0097427,0.0385722875563934,0.999376815673285,1,6,microtubule bundle,CC,TPPP3
3167,GO:0006498,0.0385930103302121,0.999376140669333,1,6,N-terminal protein lipidation,BP,HHATL
13711,GO:0051353,0.0385972743339912,0.996313090001292,2,48,positive regulation of oxidoreductase activity,BP,SNCA;S100A1
15445,GO:0070100,0.0388424636501105,0.99936798609234,1,6,negative regulation of chemokine-mediated signaling pathway,BP,PADI2
19654,GO:1903011,0.0388497253932645,0.999367747901873,1,6,negative regulation of bone development,BP,GREM1
4679,GO:0010269,0.038869382618128,0.999367102901879,1,6,response to selenium ion,BP,MAOB
7630,GO:0031072,0.038905322994451,0.993326336434957,3,115,heat shock protein binding,MF,FGF1;SNCA;GPR37
1500,GO:0003256,0.0390060453829901,0.999362609440094,1,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
21917,GO:2000739,0.0390819099004126,0.999360108050812,1,6,regulation of mesenchymal stem cell differentiation,BP,PDGFRA
20773,GO:1905207,0.0391275818998813,0.996234668954144,2,48,regulation of cardiocyte differentiation,BP,RGS4;GREM1
14654,GO:0060541,0.0391304636282205,0.990891532578909,4,195,respiratory system development,BP,FGF1;CHI3L1;PDGFRA;HHIP
20494,GO:1904683,0.0391348483945952,0.99935835962591,1,6,regulation of metalloendopeptidase activity,BP,MBP
18066,GO:0099081,0.0391924273496647,0.983218624097562,10,807,supramolecular polymer,CC,GAS7;CLDN11;DCX;NEFM;SNCA;CSRP1;TPPP3;S100A1;SYNPO;RYR2
17911,GO:0098838,0.0392954895039154,0.999353039221276,1,6,folate transmembrane transport,BP,LRP2
10853,GO:0042743,0.0393043424298459,0.996206048892117,2,49,hydrogen peroxide metabolic process,BP,MAOB;SNCA
11068,GO:0043177,0.0394794519537043,0.990783199313957,4,198,organic acid binding,MF,CD22;MAG;HAPLN2;RYR2
15011,GO:0061156,0.0394923329563613,0.99934648937202,1,6,pulmonary artery morphogenesis,BP,LRP2
12965,GO:0048513,0.0395430761055629,0.97653271675443,28,3112,animal organ development,BP,MAOB;DCX;SYNJ2;LRP2;DLL3;TF;SLC17A7;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;CXCL14;NKX6-2;NRGN;TPPP3;S100A1;HHIP;GREM1;EMX2;BOK;CNTN2;MBP;LPAR1;RYR2
15851,GO:0070851,0.0396371696470699,0.993150285679686,3,116,growth factor receptor binding,MF,FGF1;PDGFRA;GREM1
3792,GO:0007613,0.0398920234459799,0.993089888147071,3,115,memory,BP,SLC17A7;SLC24A2;CCK
15475,GO:0070160,0.0405132091985259,0.992938862804932,3,116,tight junction,CC,CLDN11;CLDN10;SYNPO
7098,GO:0030017,0.0405326613792826,0.990460730300919,4,194,sarcomere,CC,CSRP1;S100A1;SYNPO;RYR2
4718,GO:0010466,0.0408782657724507,0.990350627112249,4,200,negative regulation of peptidase activity,BP,SNCA;SERPINI1;SPOCK3;SERPINA3
7662,GO:0031113,0.0409112882355381,0.995964047419951,2,49,regulation of microtubule polymerization,BP,SNCA;SLC39A12
3807,GO:0007632,0.0411858134065216,0.995922164015869,2,49,visual behavior,BP,SYNPO;CCK
11140,GO:0043281,0.0413638551348198,0.990199133228449,4,201,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,SNCA;ST18;BOK;CCK
8720,GO:0032940,0.0418021867268688,0.979289534337867,14,1302,secretion by cell,BP,CD22;MAOB;CAMK2A;TF;SLC17A7;RARRES2;PADI2;SPP1;CHI3L1;SNCA;VSNL1;LGI3;CCK;SERPINA3
6692,GO:0019932,0.0419154690193228,0.986302738900482,6,390,second-messenger-mediated signaling,BP,CD22;RCAN2;S1PR5;GPR62;LPAR1;RYR2
11467,GO:0044106,0.0421262847245763,0.992540898033893,3,120,cellular amine metabolic process,BP,MAOB;MOXD1;GPR37
12542,GO:0046873,0.0432953104218559,0.985742261417012,6,391,metal ion transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2
13970,GO:0051896,0.0436153310644923,0.989490244736004,4,203,regulation of protein kinase B signaling,BP,LRP2;FGF1;CHI3L1;PDGFRA
4148,GO:0008584,0.0437012824928785,0.992149780908651,3,120,male gonad development,BP,LRP2;PDGFRA;BOK
7167,GO:0030139,0.0437511950559257,0.987301461912752,5,296,endocytic vesicle,CC,CAMK2A;LRP2;TF;CPNE6;LPAR1
1127,GO:0002576,0.0438897747025627,0.99210354633547,3,119,platelet degranulation,BP,TF;RARRES2;SERPINA3
13012,GO:0048608,0.0439211355774583,0.985485939364195,6,394,reproductive structure development,BP,LRP2;SPP1;PDGFRA;TPPP3;GJB1;BOK
20891,GO:1905446,0.043937942674345,0.999166767712733,1,7,regulation of mitochondrial ATP synthesis coupled electron transport,BP,SNCA
10668,GO:0042373,0.0439496668640197,0.999166319102715,1,7,vitamin K metabolic process,BP,CBR1
16329,GO:0071671,0.0440422392562918,0.999162772632785,1,7,regulation of smooth muscle cell chemotaxis,BP,LPAR1
13398,GO:0050859,0.0440739177780741,0.999161557262228,1,7,negative regulation of B cell receptor signaling pathway,BP,CD22
1827,GO:0004128,0.0440768212641612,0.999161445822906,1,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,CYB5R2
9913,GO:0035747,0.0441021315254272,0.999160474065194,1,7,natural killer cell chemotaxis,BP,CXCL14
4377,GO:0009188,0.0441160371255231,0.999159939932315,1,7,ribonucleoside diphosphate biosynthetic process,BP,AK5
3837,GO:0008061,0.0441233293214832,0.999159659760133,1,7,chitin binding,MF,CHI3L1
3209,GO:0006548,0.0441309849496305,0.99915936557344,1,7,histidine catabolic process,BP,CARNS1
14138,GO:0052805,0.0441309849496305,0.99915936557344,1,7,imidazole-containing compound catabolic process,BP,CARNS1
19832,GO:1903367,0.0441420210305144,0.999158941392184,1,7,positive regulation of fear response,BP,CCK
22019,GO:2000987,0.0441420210305144,0.999158941392184,1,7,positive regulation of behavioral fear response,BP,CCK
13976,GO:0051902,0.0441516976445601,0.999158569373622,1,7,negative regulation of mitochondrial depolarization,BP,BOK
15729,GO:0070573,0.044180837573353,0.99915744858008,1,7,metallodipeptidase activity,MF,CNDP1
19717,GO:1903136,0.0442233325239882,0.999155812758804,1,7,cuprous ion binding,MF,SNCA
2583,GO:0005507,0.0442287734873024,0.995439743338693,2,52,copper ion binding,MF,MOXD1;SNCA
3918,GO:0008199,0.0442474022257209,0.999154885491842,1,7,ferric iron binding,MF,TF
2560,GO:0005436,0.0442661621655026,0.99915416242026,1,7,sodium:phosphate symporter activity,MF,SLC17A7
13869,GO:0051665,0.044299325459207,0.999152883424913,1,7,membrane raft localization,BP,MAL
17822,GO:0098684,0.0443702042392493,0.999150146574971,1,7,photoreceptor ribbon synapse,CC,PACSIN1
9817,GO:0035608,0.0443714174065689,0.999150099691711,1,7,protein deglutamylation,BP,FOLH1
8601,GO:0032768,0.0444236764716757,0.995408645211423,2,52,regulation of monooxygenase activity,BP,SNCA;S100A1
21378,GO:1990791,0.0444505835557487,0.999147037444213,1,7,dorsal root ganglion development,BP,RGS4
4176,GO:0008635,0.0444554705660346,0.999146848224772,1,7,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK
16264,GO:0071578,0.0444562080662292,0.999146819667755,1,7,zinc ion import across plasma membrane,BP,SLC39A12
21334,GO:1990712,0.0444594684230051,0.999146693416448,1,7,HFE-transferrin receptor complex,CC,TF
19687,GO:1903059,0.0444667298625409,0.999146412196423,1,7,regulation of protein lipidation,BP,HHATL
6937,GO:0021894,0.0445116131698891,0.999144672915426,1,7,cerebral cortex GABAergic interneuron development,BP,CNTN2
12402,GO:0046546,0.0446158371065875,0.991919004951132,3,121,development of primary male sexual characteristics,BP,LRP2;PDGFRA;BOK
16334,GO:0071676,0.0446311693373771,0.999140031182007,1,7,negative regulation of mononuclear cell migration,BP,GREM1
3617,GO:0007187,0.0446647689153155,0.989154458044129,4,206,G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,GPR37;S1PR5;LPAR1;GRM3
11527,GO:0044300,0.044671729864838,0.999138453527011,1,7,cerebellar mossy fiber,CC,SLC17A7
16653,GO:0072239,0.0446810074163046,0.99913809245767,1,7,metanephric glomerulus vasculature development,BP,PDGFRA
7284,GO:0030297,0.0446830788669871,0.99913801182919,1,7,transmembrane receptor protein tyrosine kinase activator activity,MF,GREM1
16957,GO:0086036,0.0447063968193484,0.999137103943922,1,7,regulation of cardiac muscle cell membrane potential,BP,FXYD1
21693,GO:2000394,0.0449385428713942,0.999128038802666,1,7,positive regulation of lamellipodium morphogenesis,BP,ENPP2
2555,GO:0005412,0.0449868080283674,0.999126148027507,1,7,glucose:sodium symporter activity,MF,SLC5A11
8104,GO:0031982,0.0451432028736847,0.972513042069594,30,3437,vesicle,CC,CD22;BCAS1;CAMK2A;MOXD1;LRP2;FOLH1;TF;CPNE6;SLC17A7;RARRES2;PADI2;SPP1;PACSIN1;CHI3L1;ERMN;SNCA;SLC39A12;NRGN;CSRP1;CBR1;ICOSLG;SERPINI1;KLK6;LGI3;BOK;GPR62;SV2B;SERPINA3;LPAR1;RYR2
18939,GO:1901213,0.0451901530454398,0.999118159146015,1,7,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
2369,GO:0005021,0.0451929955172052,0.999118047210645,1,7,vascular endothelial growth factor-activated receptor activity,MF,PDGFRA
515,GO:0001640,0.0452238584432628,0.999116831375765,1,7,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,MF,GRM3
3625,GO:0007196,0.0452238584432628,0.999116831375765,1,7,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,BP,GRM3
18019,GO:0098988,0.0452238584432628,0.999116831375765,1,7,G protein-coupled glutamate receptor activity,MF,GRM3
1384,GO:0003056,0.0452541652968732,0.999115636617504,1,7,regulation of vascular associated smooth muscle contraction,BP,DOCK5
5380,GO:0015293,0.04525801582973,0.991755480465001,3,122,symporter activity,MF,SLC17A7;SLC24A2;SLC5A11
11365,GO:0043679,0.0454725825955826,0.991700949150397,3,122,axon terminus,CC,PACSIN1;SNCA;CCK
12779,GO:0048016,0.0457131273197329,0.995200972153153,2,52,inositol phosphate-mediated signaling,BP,RCAN2;GPR62
15115,GO:0061458,0.0457231165177077,0.984743700529568,6,398,reproductive system development,BP,LRP2;SPP1;PDGFRA;TPPP3;GJB1;BOK
12107,GO:0045906,0.0457694426923276,0.999095197482694,1,7,negative regulation of vasoconstriction,BP,DOCK5
15106,GO:0061438,0.0458670110909802,0.999091300534376,1,7,renal system vasculature morphogenesis,BP,PDGFRA
15107,GO:0061439,0.0458670110909802,0.999091300534376,1,7,kidney vasculature morphogenesis,BP,PDGFRA
1486,GO:0003229,0.0461234298858139,0.995134190260562,2,52,ventricular cardiac muscle tissue development,BP,LRP2;RYR2
2262,GO:0004857,0.0463040857210159,0.986350598100288,5,302,enzyme inhibitor activity,MF,SNCA;SERPINI1;PPP1R14A;SPOCK3;SERPINA3
7654,GO:0031102,0.0469644878457693,0.994993635535605,2,53,neuron projection regeneration,BP,MAG;SPP1
2641,GO:0005615,0.0469769654460112,0.972506101319271,24,2632,extracellular space,CC,CD22;BCAS1;MOXD1;LRP2;FOLH1;TF;CPNE6;RARRES2;FGF1;PADI2;SPP1;CHI3L1;ERMN;ENPP2;SNCA;CXCL14;CSRP1;CBR1;ICOSLG;SERPINI1;GREM1;KLK6;CCK;SERPINA3
6930,GO:0021885,0.0470776409163956,0.994974960451996,2,53,forebrain cell migration,BP,EMX2;CNTN2
18996,GO:1901342,0.0472105360162468,0.986009938014906,5,302,regulation of vasculature development,BP,FGF1;CHI3L1;ENPP2;S100A1;GREM1
17882,GO:0098794,0.0473575982879035,0.981171641573865,8,612,postsynapse,CC,BCAS1;CAMK2A;SLC17A7;NRGN;SYNPO;CNTN2;LPAR1;GRM3
8202,GO:0032147,0.0476958255329904,0.985826423847903,5,303,activation of protein kinase activity,BP,TF;FGF1;CHI3L1;GREM1;LPAR1
8684,GO:0032890,0.0478400666544229,0.994845881912278,2,54,regulation of organic acid transport,BP,RGS4;CCK
10675,GO:0042391,0.047848715925052,0.983858510339153,6,402,regulation of membrane potential,BP,SLC17A7;RGS4;BOK;CCK;RYR2;FXYD1
10892,GO:0042802,0.0481936635652898,0.97409063864675,17,1711,identical protein binding,MF,CLDN11;MAOB;CAMK2A;MAG;PADI2;NECAB1;PACSIN1;PDGFRA;CLDN10;SNCA;ICOSLG;S100A1;GREM1;BOK;GPR62;CNTN2;RYR2
13449,GO:0050922,0.0484083688319721,0.994750803080423,2,54,negative regulation of chemotaxis,BP,PADI2;GREM1
527,GO:0001658,0.0486788548849294,0.99470532687608,2,54,branching involved in ureteric bud morphogenesis,BP,FGF1;GREM1
5367,GO:0015267,0.048844526297895,0.983440203841113,6,404,channel activity,MF,ASIC4;SLC17A7;SLC24A2;GJB1;RYR2;FXYD1
7040,GO:0022803,0.048844526297895,0.983440203841113,6,404,passive transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC24A2;GJB1;RYR2;FXYD1
12771,GO:0048008,0.0491138356022079,0.994631893899927,2,54,platelet-derived growth factor receptor signaling pathway,BP,PDGFRA;SNCA
4446,GO:0009308,0.0493872518328886,0.990681386619485,3,128,amine metabolic process,BP,MAOB;MOXD1;GPR37
11986,GO:0045665,0.0494915142778507,0.987580515719428,4,211,negative regulation of neuron differentiation,BP,MAG;SPP1;CNTN2;LPAR1
7704,GO:0031226,0.0495048123715304,0.974296507063756,15,1458,intrinsic component of plasma membrane,CC,CD22;ASIC4;FOLH1;MAG;EPHB6;PDGFRA;SLC39A12;SLC24A2;HHIP;GPR37;NINJ2;CNTN2;LPAR1;GRM3;FXYD1
13520,GO:0051046,0.0499719816052015,0.979916252282219,8,622,regulation of secretion,BP,CD22;MAOB;CAMK2A;SPP1;SNCA;VSNL1;LGI3;CCK
13819,GO:0051584,0.0500453190530898,0.998894166248292,1,8,regulation of dopamine uptake involved in synaptic transmission,BP,SNCA
14002,GO:0051940,0.0500453190530898,0.998894166248292,1,8,regulation of catecholamine uptake involved in synaptic transmission,BP,SNCA
18899,GO:1901072,0.0500909996138319,0.998892126696007,1,8,glucosamine-containing compound catabolic process,BP,CHI3L1
21588,GO:2000252,0.0501377684267743,0.998890036570062,1,8,negative regulation of feeding behavior,BP,CCK
11343,GO:0043621,0.0501475774121954,0.99445867110805,2,53,protein self-association,MF,CNTN2;RYR2
20244,GO:1904180,0.0502256538002322,0.998886103486815,1,8,negative regulation of membrane depolarization,BP,BOK
20709,GO:1905050,0.0502639093580081,0.998884389242052,1,8,positive regulation of metallopeptidase activity,BP,MBP
12876,GO:0048263,0.0502849456060032,0.998883446027724,1,8,determination of dorsal identity,BP,GREM1
10336,GO:0038036,0.0503277464657937,0.998881525686202,1,8,sphingosine-1-phosphate receptor activity,MF,S1PR5
9899,GO:0035727,0.0503493847476778,0.998880554203385,1,8,lysophosphatidic acid binding,MF,LPAR1
20517,GO:1904714,0.0503502478873742,0.998880515442526,1,8,regulation of chaperone-mediated autophagy,BP,SNCA
10705,GO:0042439,0.0503504072167612,0.998880508287475,1,8,ethanolamine-containing compound metabolic process,BP,MOXD1
17834,GO:0098700,0.0503809095920282,0.998879138078917,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
16600,GO:0072172,0.0503996649636179,0.998878295137567,1,8,mesonephric tubule formation,BP,GREM1
5133,GO:0014062,0.0504055794426572,0.998878029250226,1,8,regulation of serotonin secretion,BP,MAOB
18025,GO:0099003,0.0504982642693951,0.987245392514525,4,212,vesicle-mediated transport in synapse,BP,SYNJ2;SLC17A7;PACSIN1;SNCA
11087,GO:0043203,0.0505417240861298,0.998871899939412,1,8,axon hillock,CC,CCK
13845,GO:0051620,0.0505788089179176,0.99887022740771,1,8,norepinephrine uptake,BP,SNCA
21654,GO:2000347,0.0506066219521908,0.998868972206293,1,8,positive regulation of hepatocyte proliferation,BP,FGF1
17132,GO:0090205,0.0507726545903708,0.998861464371055,1,8,positive regulation of cholesterol metabolic process,BP,FGF1
5372,GO:0015276,0.050776525650635,0.990314293559787,3,127,ligand-gated ion channel activity,MF,ASIC4;SLC17A7;RYR2
7046,GO:0022834,0.050776525650635,0.990314293559787,3,127,ligand-gated channel activity,MF,ASIC4;SLC17A7;RYR2
21696,GO:2000401,0.0508181732250925,0.994335265395754,2,56,regulation of lymphocyte migration,BP,PADI2;CXCL14
11090,GO:0043208,0.0509066984746544,0.998855384553338,1,8,glycosphingolipid binding,MF,MAG
9831,GO:0035630,0.0509881053739034,0.998851684126535,1,8,bone mineralization involved in bone maturation,BP,GREM1
7709,GO:0031232,0.0509930691815786,0.99885145829496,1,8,extrinsic component of external side of plasma membrane,CC,TF
16754,GO:0072497,0.0514361484635102,0.998831208860376,1,8,mesenchymal stem cell differentiation,BP,PDGFRA
19430,GO:1902475,0.0514545121209801,0.994224971517696,2,56,L-alpha-amino acid transmembrane transport,BP,SLC17A7;RGS4
5576,GO:0015884,0.0515651054930482,0.998825281396952,1,8,folic acid transport,BP,LRP2
11145,GO:0043296,0.051717560370586,0.990061504382429,3,128,apical junction complex,CC,CLDN11;CLDN10;SYNPO
13048,GO:0048671,0.0518174634482583,0.998813637592314,1,8,negative regulation of collateral sprouting,BP,SPP1
655,GO:0001836,0.0518718048300437,0.99414960787015,2,57,release of cytochrome c from mitochondria,BP,BOK;CCK
14730,GO:0060677,0.0518933644909799,0.998810124053231,1,8,ureteric bud elongation,BP,FGF1
15650,GO:0070444,0.0519881932445332,0.998805726880873,1,8,oligodendrocyte progenitor proliferation,BP,LRP2
15651,GO:0070445,0.0519881932445332,0.998805726880873,1,8,regulation of oligodendrocyte progenitor proliferation,BP,LRP2
2604,GO:0005543,0.052286657891342,0.981977142581431,6,411,phospholipid binding,MF,CPNE6;ADAP1;PACSIN1;SNCA;NRGN;LPAR1
16556,GO:0072102,0.0522873774688072,0.9987917995731,1,8,glomerulus morphogenesis,BP,PDGFRA
4742,GO:0010518,0.0528724250497318,0.993973725858869,2,57,positive regulation of phospholipase activity,BP,PDGFRA;LPAR1
17669,GO:0097553,0.0530599482216926,0.989697965452059,3,129,calcium ion transmembrane import into cytosol,BP,SNCA;SLC24A2;RYR2
1483,GO:0003223,0.0531848465171771,0.998749527029617,1,8,ventricular compact myocardium morphogenesis,BP,LRP2
7097,GO:0030016,0.0536630927293267,0.986178260490113,4,213,myofibril,CC,CSRP1;S100A1;SYNPO;RYR2
16943,GO:0086015,0.0537014248953783,0.998724858600519,1,8,SA node cell action potential,BP,RYR2
16946,GO:0086018,0.0537014248953783,0.998724858600519,1,8,SA node cell to atrial cardiac muscle cell signaling,BP,RYR2
19286,GO:1902108,0.053716289133674,0.993821256357127,2,58,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,CAMK2A;BOK
12333,GO:0046434,0.0540445177331421,0.989426426839764,3,132,organophosphate catabolic process,BP,SYNJ2;GDA;ENPP2
9552,GO:0035051,0.0541341679439911,0.989406192872725,3,128,cardiocyte differentiation,BP,RGS4;PDGFRA;GREM1
3939,GO:0008235,0.0542932656163257,0.993718005129263,2,58,metalloexopeptidase activity,MF,FOLH1;CNDP1
11890,GO:0045453,0.0545165072458703,0.993677886727594,2,58,bone resorption,BP,TF;SPP1
3415,GO:0006836,0.0545186397410943,0.9858831536961,4,218,neurotransmitter transport,BP,CAMK2A;SLC17A7;SNCA;SV2B
15693,GO:0070527,0.0547753406530026,0.993631254535341,2,58,platelet aggregation,BP,PDGFRA;CSRP1
13448,GO:0050921,0.0550808254336235,0.989140615624489,3,133,positive regulation of chemotaxis,BP,RARRES2;CXCL14;LPAR1
20701,GO:1905039,0.0550995255217382,0.989136516936628,3,132,carboxylic acid transmembrane transport,BP,LRP2;SLC17A7;RGS4
3545,GO:0007043,0.0551971158259352,0.989109580660319,3,132,cell-cell junction assembly,BP,CLDN11;CLDN10;GJB1
14667,GO:0060562,0.055219841664284,0.982914260107872,5,314,epithelial tube morphogenesis,BP,LRP2;FGF1;HHIP;GREM1;RYR2
13004,GO:0048588,0.055283431109456,0.985620640602736,4,218,developmental cell growth,BP,CPNE6;MAG;RGS4;SPP1
18065,GO:0099080,0.0554432294622676,0.972894288489035,12,1099,supramolecular complex,CC,GAS7;CLDN11;DCX;NEFM;SNCA;CSRP1;TPPP3;ICOSLG;S100A1;SYNPO;RYR2;MEX3A
13705,GO:0051347,0.0555436586467654,0.977193701424038,8,637,positive regulation of transferase activity,BP,TF;EPHB6;FGF1;CHI3L1;PDGFRA;SNCA;GREM1;LPAR1
11132,GO:0043271,0.0555747669192302,0.98900408156308,3,133,negative regulation of ion transport,BP,MAOB;RGS4;SNCA
5240,GO:0014910,0.0557365542594084,0.993456977160339,2,58,regulation of smooth muscle cell migration,BP,DOCK5;LPAR1
21518,GO:2000116,0.0559638748949898,0.985383646885361,4,222,regulation of cysteine-type endopeptidase activity,BP,SNCA;ST18;BOK;CCK
16493,GO:0072006,0.0560131362237638,0.988883563194127,3,132,nephron development,BP,FGF1;PDGFRA;GREM1
20075,GO:1903825,0.0561035557181412,0.988857346681616,3,133,organic acid transmembrane transport,BP,LRP2;SLC17A7;RGS4
18888,GO:1901029,0.0562450479318041,0.998577957411082,1,9,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
13975,GO:0051901,0.056418272954773,0.998569088158716,1,9,positive regulation of mitochondrial depolarization,BP,CCK
12875,GO:0048262,0.0564200203589549,0.99856899854673,1,9,determination of dorsal/ventral asymmetry,BP,GREM1
21650,GO:2000343,0.0564237155722147,0.998568809035964,1,9,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
3208,GO:0006547,0.0564268396384629,0.99856864880674,1,9,histidine metabolic process,BP,CARNS1
5551,GO:0015850,0.0565263495333227,0.985188930273008,4,222,organic hydroxy compound transport,BP,MAOB;SPP1;SNCA;SLC5A11
16328,GO:0071670,0.0565335086658017,0.998563172393461,1,9,smooth muscle cell chemotaxis,BP,LPAR1
19830,GO:1903365,0.0565844128521302,0.998560555193254,1,9,regulation of fear response,BP,CCK
21971,GO:2000822,0.0565844128521302,0.998560555193254,1,9,regulation of behavioral fear response,BP,CCK
10792,GO:0042609,0.0566034589292912,0.998559575327862,1,9,CD4 receptor binding,MF,CD22
17814,GO:0098660,0.0566333917962302,0.975309090371493,9,753,inorganic ion transmembrane transport,BP,ASIC4;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;S100A1;RYR2;FXYD1
1749,GO:0004017,0.0567045569526633,0.998554368422628,1,9,adenylate kinase activity,MF,AK5
16145,GO:0071394,0.0567404382397842,0.998552518100798,1,9,cellular response to testosterone stimulus,BP,SPP1
9772,GO:0035542,0.0568159210228096,0.998548621664857,1,9,regulation of SNARE complex assembly,BP,SNCA
21270,GO:1990459,0.0568537355753463,0.998546667657481,1,9,transferrin receptor binding,MF,TF
9149,GO:0034115,0.0568576719330553,0.998546464175187,1,9,negative regulation of heterotypic cell-cell adhesion,BP,MBP
15738,GO:0070587,0.0568576719330553,0.998546464175187,1,9,regulation of cell-cell adhesion involved in gastrulation,BP,MBP
20109,GO:1903897,0.0569492081714549,0.998541728282607,1,9,regulation of PERK-mediated unfolded protein response,BP,BOK
6901,GO:0021826,0.0569517706591633,0.998541595591579,1,9,substrate-independent telencephalic tangential migration,BP,CNTN2
6904,GO:0021830,0.0569517706591633,0.998541595591579,1,9,interneuron migration from the subpallium to the cortex,BP,CNTN2
6909,GO:0021843,0.0569517706591633,0.998541595591579,1,9,substrate-independent telencephalic tangential interneuron migration,BP,CNTN2
5121,GO:0014049,0.0569681294735314,0.998540748352153,1,9,positive regulation of glutamate secretion,BP,CCK
17908,GO:0098833,0.0570220960862331,0.998537951583655,1,9,presynaptic endocytic zone,CC,PACSIN1
21359,GO:1990763,0.0570483438391717,0.998536590329347,1,9,arrestin family protein binding,MF,GPR62
10409,GO:0038171,0.0570878744217573,0.998534538982297,1,9,cannabinoid signaling pathway,BP,CAMK2A
15444,GO:0070099,0.0572269472113142,0.998527310451352,1,9,regulation of chemokine-mediated signaling pathway,BP,PADI2
2559,GO:0005432,0.0573102712339499,0.998522970841518,1,9,calcium:sodium antiporter activity,MF,SLC24A2
4807,GO:0010634,0.05731193373711,0.988518737742431,3,134,positive regulation of epithelial cell migration,BP,FGF1;ENPP2;DOCK5
474,GO:0001553,0.05731576941667,0.99852268426031,1,9,luteinization,BP,PDGFRA
11073,GO:0043184,0.057414917370915,0.998517511504628,1,9,vascular endothelial growth factor receptor 2 binding,MF,GREM1
9047,GO:0033689,0.0574192380251427,0.998517285876903,1,9,negative regulation of osteoblast proliferation,BP,GREM1
1964,GO:0004439,0.0574736271733444,0.99851444413447,1,9,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,SYNJ2
695,GO:0001894,0.057512526048504,0.984845318297065,4,223,tissue homeostasis,BP,TF;SPP1;SERPINA3;MBP
19198,GO:1901894,0.0577710810466786,0.998498853451456,1,9,regulation of ATPase-coupled calcium transmembrane transporter activity,BP,RYR2
20206,GO:1904062,0.058052404286868,0.981785169119128,5,320,regulation of cation transmembrane transport,BP,RGS4;SNCA;S100A1;RYR2;FXYD1
14323,GO:0060068,0.0580784064316439,0.998482657942616,1,9,vagina development,BP,LRP2
8243,GO:0032233,0.0584171418026444,0.992956137317988,2,60,positive regulation of actin filament bundle assembly,BP,SYNPO;LPAR1
5793,GO:0016324,0.0584881460911032,0.981610337922795,5,320,apical plasma membrane,CC,LRP2;TF;MAL;TMEM235;FXYD1
5405,GO:0015370,0.0584922068377975,0.992942070003358,2,60,solute:sodium symporter activity,MF,SLC17A7;SLC5A11
14728,GO:0060675,0.0588424228753435,0.992876301864774,2,60,ureteric bud morphogenesis,BP,FGF1;GREM1
14901,GO:0060982,0.0588828329928881,0.998439845186408,1,9,coronary artery morphogenesis,BP,LRP2
20752,GO:1905165,0.059189142044068,0.998423382762589,1,9,regulation of lysosomal protein catabolic process,BP,LRP2
13573,GO:0051130,0.0595891508312953,0.970528183641946,12,1118,positive regulation of cellular component organization,BP,TF;CPNE6;PACSIN1;ENPP2;SNCA;TPPP3;SERPINI1;GREM1;SYNPO;BOK;CCK;LPAR1
5145,GO:0014701,0.0598687649879288,0.998386541026275,1,9,junctional sarcoplasmic reticulum membrane,CC,RYR2
16944,GO:0086016,0.0598764285385371,0.998386123109297,1,9,AV node cell action potential,BP,RYR2
16953,GO:0086027,0.0598764285385371,0.998386123109297,1,9,AV node cell to bundle of His cell signaling,BP,RYR2
10952,GO:0042982,0.0599706810183699,0.992660064847247,2,61,amyloid precursor protein metabolic process,BP,NECAB1;KLK6
16984,GO:0086070,0.0601494463823052,0.998371198468561,1,9,SA node cell to atrial cardiac muscle cell communication,BP,RYR2
16599,GO:0072171,0.0605406818078669,0.992551324493943,2,61,mesonephric tubule morphogenesis,BP,FGF1;GREM1
3600,GO:0007166,0.0607336319244447,0.963431824436801,24,2692,cell surface receptor signaling pathway,BP,CD22;CAMK2A;LRP2;DLL3;TF;SLC17A7;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;PDGFRA;TESPA1;MOG;SNCA;ST18;ICOSLG;HHIP;GREM1;MAL;BOK;CNTN2;GRM3
14665,GO:0060560,0.0608545298727116,0.983666490326666,4,225,developmental growth involved in morphogenesis,BP,CPNE6;MAG;FGF1;SPP1
11259,GO:0043491,0.0609645608152692,0.983626076810673,4,227,protein kinase B signaling,BP,LRP2;FGF1;CHI3L1;PDGFRA
2162,GO:0004714,0.0610049599648558,0.992462315884996,2,61,transmembrane receptor protein tyrosine kinase activity,MF,EPHB6;PDGFRA
14191,GO:0055008,0.0611416367884342,0.992441958805779,2,59,cardiac muscle tissue morphogenesis,BP,LRP2;RYR2
19727,GO:1903169,0.0611568370330268,0.98742012254009,3,138,regulation of calcium ion transmembrane transport,BP,SNCA;S100A1;RYR2
11142,GO:0043292,0.0611867096535252,0.983549459507745,4,223,contractile fiber,CC,CSRP1;S100A1;SYNPO;RYR2
14363,GO:0060135,0.0617257619740951,0.992320496906326,2,62,maternal process involved in female pregnancy,BP,SPP1;TPPP3
2734,GO:0005783,0.0619663586133541,0.968283926195496,13,1255,endoplasmic reticulum,CC,HHATL;LRP2;TF;SPP1;CHI3L1;S100A1;KLK6;GPR37;MAL;BOK;AIFM3;RYR2;TMEM235
5140,GO:0014069,0.0619834069223373,0.980192278256988,5,324,postsynaptic density,CC,BCAS1;CAMK2A;NRGN;SYNPO;GRM3
2268,GO:0004865,0.0622104341617963,0.998234888597441,1,10,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
19339,GO:1902237,0.0623379201429114,0.998227559372001,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
4326,GO:0009133,0.0623580620823572,0.998226399980248,1,10,nucleoside diphosphate biosynthetic process,BP,AK5
6044,GO:0016813,0.0624785547965444,0.998219456180895,1,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,PADI2
13732,GO:0051400,0.0624958509477014,0.998218458291308,1,10,BH domain binding,MF,BOK
11532,GO:0044306,0.0625264338542223,0.987021921826713,3,139,neuron projection terminus,CC,PACSIN1;SNCA;CCK
10596,GO:0042246,0.0625969779683372,0.99214839823572,2,63,tissue regeneration,BP,KLK6;NINJ2
1569,GO:0003376,0.0626373935322875,0.998210281328655,1,10,sphingosine-1-phosphate receptor signaling pathway,BP,S1PR5
14770,GO:0060732,0.0626965743031256,0.998206856749809,1,10,positive regulation of inositol phosphate biosynthetic process,BP,SNCA
18543,GO:0140104,0.0627695328308143,0.998202630286622,1,10,molecular carrier activity,MF,TF
15737,GO:0070586,0.062934071249988,0.998193079922345,1,10,cell-cell adhesion involved in gastrulation,BP,MBP
14952,GO:0061052,0.0629999125950385,0.998189251005939,1,10,negative regulation of cell growth involved in cardiac muscle cell development,BP,RGS4
10690,GO:0042415,0.0630733687261094,0.998184974361794,1,10,norepinephrine metabolic process,BP,MOXD1
5376,GO:0015280,0.0631443935840656,0.998180834352849,1,10,ligand-gated sodium channel activity,MF,ASIC4
13390,GO:0050851,0.06314840671559,0.982840478053701,4,232,antigen receptor-mediated signaling pathway,BP,CD22;TESPA1;MOG;ICOSLG
13034,GO:0048645,0.0632595492778979,0.99201870176235,2,63,animal organ formation,BP,LRP2;FGF1
5314,GO:0015166,0.0634366784637644,0.99816374632652,1,10,polyol transmembrane transporter activity,MF,SLC5A11
12125,GO:0045926,0.0635310034948171,0.982703014721512,4,231,negative regulation of growth,BP,MAG;RGS4;SPP1;GREM1
5403,GO:0015368,0.0635535720074861,0.998156889394405,1,10,calcium:cation antiporter activity,MF,SLC24A2
12704,GO:0047555,0.0636260024917273,0.998152634078095,1,10,3',5'-cyclic-GMP phosphodiesterase activity,MF,PDE1C
14536,GO:0060379,0.0636451164948429,0.998151510285199,1,10,cardiac muscle cell myoblast differentiation,BP,GREM1
8108,GO:0031987,0.0637077720575569,0.998147824044968,1,10,locomotion involved in locomotory behavior,BP,GPR37
3814,GO:0008016,0.0637568666025563,0.982621994528797,4,230,regulation of heart contraction,BP,RGS4;S100A1;RYR2;FXYD1
12781,GO:0048018,0.0638056765924369,0.97943996391696,5,334,receptor ligand activity,MF,FGF1;SPP1;CXCL14;GREM1;CCK
12251,GO:0046165,0.0638163326299059,0.986642221936766,3,141,alcohol biosynthetic process,BP,MOXD1;FGF1;SNCA
97,GO:0000187,0.0638711746407313,0.986626100860647,3,141,activation of MAPK activity,BP,TF;FGF1;LPAR1
17394,GO:0097050,0.0639315196739692,0.998134629495732,1,10,type B pancreatic cell apoptotic process,BP,RYR2
9795,GO:0035581,0.0640866402040822,0.998125453758897,1,10,sequestering of extracellular ligand from receptor,BP,GREM1
14509,GO:0060346,0.064155562363824,0.998121369450572,1,10,bone trabecula formation,BP,GREM1
2270,GO:0004867,0.064170050630921,0.991836351554753,2,64,serine-type endopeptidase inhibitor activity,MF,SERPINI1;SERPINA3
2800,GO:0005887,0.0642245343203117,0.966135961107215,14,1385,integral component of plasma membrane,CC,CD22;ASIC4;FOLH1;MAG;EPHB6;PDGFRA;SLC39A12;SLC24A2;HHIP;GPR37;NINJ2;LPAR1;GRM3;FXYD1
11492,GO:0044224,0.0643513701768106,0.99810974107511,1,10,juxtaparanode region of axon,CC,CNTN2
3431,GO:0006865,0.0643543875022249,0.986483802081883,3,141,amino acid transport,BP,SLC17A7;RGS4;CCK
19912,GO:1903524,0.0646030695151527,0.99175042959511,2,64,positive regulation of blood circulation,BP,RGS4;RYR2
15835,GO:0070830,0.0648819031142781,0.991694924937211,2,64,bicellular tight junction assembly,BP,CLDN11;CLDN10
6262,GO:0018108,0.0649080222809055,0.978986155824205,5,329,peptidyl-tyrosine phosphorylation,BP,EPHB6;PDGFRA;ENPP2;GREM1;CCK
5522,GO:0015807,0.0651999319074428,0.991631449131033,2,64,L-amino acid transport,BP,SLC17A7;RGS4
11354,GO:0043647,0.0652478908321968,0.991621861337532,2,64,inositol phosphate metabolic process,BP,SYNJ2;SNCA
8181,GO:0032102,0.0654032272088969,0.978778947909865,5,333,negative regulation of response to external stimulus,BP,PADI2;SPP1;PDGFRA;GREM1;CCK
13958,GO:0051881,0.0656589391206674,0.991536673261291,2,65,regulation of mitochondrial membrane potential,BP,BOK;CCK
14298,GO:0060041,0.0656771356956485,0.986091931164428,3,141,retina development in camera-type eye,BP,DCX;SLC17A7;PDGFRA
8271,GO:0032279,0.0659805456902089,0.978539968856408,5,330,asymmetric synapse,CC,BCAS1;CAMK2A;NRGN;SYNPO;GRM3
5239,GO:0014909,0.0661128264732957,0.991448245639602,2,64,smooth muscle cell migration,BP,DOCK5;LPAR1
13393,GO:0050854,0.0662501198295864,0.991417681867758,2,65,regulation of antigen receptor-mediated signaling pathway,BP,CD22;TESPA1
16981,GO:0086067,0.0662827918331034,0.997993068377387,1,10,AV node cell to bundle of His cell communication,BP,RYR2
17809,GO:0098655,0.0663117241194488,0.97020191665688,9,777,cation transmembrane transport,BP,ASIC4;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;S100A1;RYR2;FXYD1
15074,GO:0061351,0.0663786545085698,0.985881530960162,3,142,neural precursor cell proliferation,BP,LRP2;HHIP;EMX2
16086,GO:0071313,0.066573209093535,0.997975214944372,1,10,cellular response to caffeine,BP,RYR2
12465,GO:0046661,0.0667411473583059,0.985771863734474,3,143,male sex differentiation,BP,LRP2;PDGFRA;BOK
6297,GO:0018212,0.0669056540512532,0.978152832553369,5,332,peptidyl-tyrosine modification,BP,EPHB6;PDGFRA;ENPP2;GREM1;CCK
7400,GO:0030546,0.0671304102519214,0.978055807274825,5,339,signaling receptor activator activity,MF,FGF1;SPP1;CXCL14;GREM1;CCK
12966,GO:0048514,0.0673172565665233,0.973094372827712,7,548,blood vessel morphogenesis,BP,LRP2;FGF1;CHI3L1;PDGFRA;ENPP2;S100A1;GREM1
4631,GO:0010038,0.0681270847846887,0.977639009652359,5,335,response to metal ion,BP,MAOB;TF;CPNE6;SNCA;RYR2
4709,GO:0010454,0.0682206067802646,0.997851376471637,1,11,negative regulation of cell fate commitment,BP,NKX6-2
14402,GO:0060193,0.0682486680354334,0.99100793089413,2,66,positive regulation of lipase activity,BP,PDGFRA;LPAR1
7644,GO:0031089,0.0682750715700425,0.997847899169248,1,11,platelet dense granule lumen,CC,RARRES2
13818,GO:0051583,0.0682773515359228,0.997847753541983,1,11,dopamine uptake involved in synaptic transmission,BP,SNCA
13997,GO:0051934,0.0682773515359228,0.997847753541983,1,11,catecholamine uptake involved in synaptic transmission,BP,SNCA
5063,GO:0010977,0.0682853976594208,0.98530562437036,3,144,negative regulation of neuron projection development,BP,MAG;SPP1;LPAR1
4344,GO:0009151,0.0684135003435127,0.99783904820039,1,11,purine deoxyribonucleotide metabolic process,BP,AK5
18495,GO:0120192,0.06841586834258,0.990973566526907,2,66,tight junction assembly,BP,CLDN11;CLDN10
6502,GO:0019371,0.0684563782147877,0.99783630285897,1,11,cyclooxygenase pathway,BP,CBR1
14234,GO:0055085,0.0684670220903308,0.963551208111446,14,1399,transmembrane transport,BP,ASIC4;LRP2;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;SLC5A11;S100A1;TMEM144;GJB1;SV2B;RYR2;FXYD1
7246,GO:0030239,0.0686049175648285,0.990943770796336,2,63,myofibril assembly,BP,PDGFRA;CSRP1
640,GO:0001820,0.0686560137381037,0.997823497238683,1,11,serotonin secretion,BP,MAOB
2494,GO:0005254,0.0686718131086151,0.99092086790893,2,66,chloride channel activity,MF,SLC17A7;FXYD1
14549,GO:0060394,0.0687127280897589,0.997819852221789,1,11,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
755,GO:0001973,0.0687671262327299,0.997816353125358,1,11,G protein-coupled adenosine receptor signaling pathway,BP,CNTN2
9800,GO:0035588,0.0687671262327299,0.997816353125358,1,11,G protein-coupled purinergic receptor signaling pathway,BP,CNTN2
6935,GO:0021892,0.0688092011511753,0.997813644730199,1,11,cerebral cortex GABAergic interneuron differentiation,BP,CNTN2
17288,GO:0090520,0.0688303988695722,0.997812279563784,1,11,sphingolipid mediated signaling pathway,BP,S1PR5
19993,GO:1903670,0.0688612937770811,0.990881780361719,2,66,regulation of sprouting angiogenesis,BP,FGF1;S100A1
5889,GO:0016529,0.0688938404654553,0.9908780236456,2,65,sarcoplasmic reticulum,CC,S100A1;RYR2
22144,GO:2001269,0.0689003131805668,0.997807773871463,1,11,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
10560,GO:0042135,0.0689185074081382,0.997806600547323,1,11,neurotransmitter catabolic process,BP,MAOB
10710,GO:0042447,0.0689666637317894,0.997803493447716,1,11,hormone catabolic process,BP,SPP1
8602,GO:0032769,0.0690305813941935,0.997799365921545,1,11,negative regulation of monooxygenase activity,BP,SNCA
7781,GO:0031340,0.0690307981030675,0.997799351920656,1,11,positive regulation of vesicle fusion,BP,SNCA
11548,GO:0044327,0.0690614324944859,0.997797372267481,1,11,dendritic spine head,CC,NRGN
19591,GO:1902903,0.0690767557480158,0.977238107761551,5,336,regulation of supramolecular fiber organization,BP,RGS4;SNCA;SLC39A12;SYNPO;LPAR1
16069,GO:0071281,0.0691074246101813,0.997794398452781,1,11,cellular response to iron ion,BP,TF
14377,GO:0060159,0.0691499909913762,0.997791644307916,1,11,regulation of dopamine receptor signaling pathway,BP,RGS4
5529,GO:0015816,0.0691586997252191,0.997791080614951,1,11,glycine transport,BP,RGS4
20245,GO:1904181,0.0691650985147109,0.99779066639141,1,11,positive regulation of membrane depolarization,BP,CCK
8462,GO:0032536,0.0691927391148906,0.997788876628061,1,11,regulation of cell projection size,BP,CNTN2
13841,GO:0051610,0.0692004939648221,0.997788374358188,1,11,serotonin uptake,BP,SNCA
10404,GO:0038166,0.0692145244969708,0.997787465473047,1,11,angiotensin-activated signaling pathway,BP,CAMK2A
11096,GO:0043220,0.069221837974576,0.997786991636588,1,11,Schmidt-Lanterman incisure,CC,MAG
8928,GO:0033327,0.0692688284464989,0.997783945905362,1,11,Leydig cell differentiation,BP,PDGFRA
6739,GO:0021521,0.0693731442837177,0.997777176890264,1,11,ventral spinal cord interneuron specification,BP,NKX6-2
14673,GO:0060573,0.0693731442837177,0.997777176890264,1,11,cell fate specification involved in pattern specification,BP,NKX6-2
8156,GO:0032060,0.0694251947427326,0.997773795391609,1,11,bleb assembly,BP,LPAR1
21691,GO:2000392,0.0695954677206787,0.997762715034624,1,11,regulation of lamellipodium morphogenesis,BP,ENPP2
16645,GO:0072224,0.0696122025688207,0.997761624505211,1,11,metanephric glomerulus development,BP,PDGFRA
7809,GO:0031399,0.0697532720504327,0.961264663909429,16,1659,regulation of protein modification process,BP,HHATL;TF;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;PPP1R14A;GPR37;RCAN2;CCK;LPAR1;FXYD1
13101,GO:0048754,0.0698523509356426,0.984827830755407,3,145,branching morphogenesis of an epithelial tube,BP,FGF1;HHIP;GREM1
17617,GO:0097470,0.0698972031901573,0.997743010486594,1,11,ribbon synapse,CC,PACSIN1
18334,GO:0106019,0.0699211839248269,0.997741440641138,1,11,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,SYNJ2
1420,GO:0003139,0.0699727932827881,0.997738060247937,1,11,secondary heart field specification,BP,LRP2
11802,GO:0045178,0.070018832618906,0.990641634619428,2,66,basal part of cell,CC,CLDN11;TF
13609,GO:0051179,0.0700842492277219,0.953284748018796,46,5892,localization,BP,CD22;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;LRP2;TF;CPNE6;SLC17A7;MAG;RARRES2;FGF1;PADI2;RGS4;SPP1;PACSIN1;CHI3L1;PDGFRA;CLDN10;ENPP2;SNCA;CXCL14;DOCK5;SLC39A12;SLC24A2;SLC5A11;S100A1;VSNL1;TMEM144;CYB5R2;GREM1;LGI3;GJB1;EMX2;MAL;BOK;CNTN2;SV2B;CCK;NKAIN2;SPOCK3;SERPINA3;LPAR1;RYR2;FXYD1
8180,GO:0032101,0.070217927293143,0.966671603081825,10,910,regulation of response to external stimulus,BP,RARRES2;FGF1;PADI2;SPP1;PDGFRA;SNCA;CXCL14;GREM1;CCK;LPAR1
11487,GO:0044214,0.0704889218988207,0.997704111170549,1,11,spanning component of plasma membrane,CC,SLC24A2
12941,GO:0048407,0.0705248616644952,0.997701737507564,1,11,platelet-derived growth factor binding,MF,PDGFRA
17418,GO:0097090,0.0705355039332494,0.997701034390873,1,11,presynaptic membrane organization,BP,CNTN2
14557,GO:0060402,0.0709472560042587,0.984490811768457,3,146,calcium ion transport into cytosol,BP,SNCA;SLC24A2;RYR2
20328,GO:1904350,0.0712031499240794,0.997656703217569,1,11,regulation of protein catabolic process in the vacuole,BP,LRP2
20050,GO:1903779,0.0721214714197164,0.990196392787995,2,67,regulation of cardiac conduction,BP,RYR2;FXYD1
5693,GO:0016126,0.0721735959470723,0.99018234158281,2,68,sterol biosynthetic process,BP,FGF1;CYB5R2
13108,GO:0048771,0.0721876727441993,0.984105184625249,3,148,tissue remodeling,BP,TF;SPP1;GREM1
2466,GO:0005215,0.072412892297404,0.964156905801721,11,1034,transporter activity,MF,ASIC4;CPNE6;SLC17A7;SLC39A12;SLC24A2;SLC5A11;TMEM144;GJB1;SV2B;RYR2;FXYD1
12563,GO:0046902,0.0730066878855963,0.990001910458354,2,69,regulation of mitochondrial membrane permeability,BP,CAMK2A;BOK
13338,GO:0050771,0.0732178711931571,0.989959683982974,2,68,negative regulation of axonogenesis,BP,MAG;SPP1
11521,GO:0044291,0.0733252830604146,0.989936675794638,2,68,cell-cell contact zone,CC,OPALIN;FXYD1
16538,GO:0072078,0.0733943171664745,0.989921877894903,2,68,nephron tubule morphogenesis,BP,FGF1;GREM1
7060,GO:0022857,0.0734311415486423,0.964859369273224,10,914,transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC39A12;SLC24A2;SLC5A11;TMEM144;GJB1;SV2B;RYR2;FXYD1
12564,GO:0046903,0.073523471028161,0.960434999961219,14,1415,secretion,BP,CD22;MAOB;CAMK2A;TF;SLC17A7;RARRES2;PADI2;SPP1;CHI3L1;SNCA;VSNL1;LGI3;CCK;SERPINA3
1471,GO:0003208,0.0735524220120739,0.989887956379816,2,68,cardiac ventricle morphogenesis,BP,LRP2;RYR2
14186,GO:0055002,0.0737181997344022,0.983630898656941,3,146,striated muscle cell development,BP,RGS4;PDGFRA;CSRP1
2303,GO:0004930,0.0740108976978445,0.975124989471611,5,348,G protein-coupled receptor activity,MF,GPR37;S1PR5;GPR62;LPAR1;GRM3
4434,GO:0009265,0.0740705928333814,0.997440699211781,1,12,2'-deoxyribonucleotide biosynthetic process,BP,AK5
12319,GO:0046385,0.0740705928333814,0.997440699211781,1,12,deoxyribose phosphate biosynthetic process,BP,AK5
12304,GO:0046348,0.0741349843146395,0.997436184102388,1,12,amino sugar catabolic process,BP,CHI3L1
18496,GO:0120193,0.0741889582870723,0.989747930545758,2,69,tight junction organization,BP,CLDN11;CLDN10
19602,GO:1902930,0.0742144223660249,0.989742433969158,2,69,regulation of alcohol biosynthetic process,BP,FGF1;SNCA
3854,GO:0008092,0.0742981789923026,0.964368427087219,10,908,cytoskeletal protein binding,MF,GAS7;DCX;NEFM;PACSIN1;ERMN;SNCA;CSRP1;TPPP3;MOBP;SYNPO
2815,GO:0005911,0.0743726751678599,0.972016374943672,6,449,cell-cell junction,CC,CLDN11;CLDN10;GJB1;SYNPO;OPALIN;FXYD1
2802,GO:0005890,0.074454168427999,0.997413742577508,1,12,sodium:potassium-exchanging ATPase complex,CC,FXYD1
19017,GO:1901387,0.074473656019876,0.997412369165187,1,12,positive regulation of voltage-gated calcium channel activity,BP,S100A1
14404,GO:0060198,0.0745438942684245,0.997407415924874,1,12,clathrin-sculpted vesicle,CC,SLC17A7
8175,GO:0032096,0.0745640352748192,0.997405994670962,1,12,negative regulation of response to food,BP,CCK
8178,GO:0032099,0.0745640352748192,0.997405994670962,1,12,negative regulation of appetite,BP,CCK
407,GO:0001162,0.0746129908140117,0.997402538443508,1,12,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,EMX2
14137,GO:0052803,0.0746972171020845,0.997396586585038,1,12,imidazole-containing compound metabolic process,BP,CARNS1
6979,GO:0021978,0.0747601658988469,0.997392133726378,1,12,telencephalon regionalization,BP,EMX2
5516,GO:0015800,0.074819066323025,0.9896115931048,2,69,acidic amino acid transport,BP,SLC17A7;CCK
5019,GO:0010919,0.0748323772490987,0.997387020833833,1,12,regulation of inositol phosphate biosynthetic process,BP,SNCA
5759,GO:0016264,0.0749739999307838,0.997376978341497,1,12,gap junction assembly,BP,GJB1
6753,GO:0021537,0.0749810960891204,0.978430986351943,4,242,telencephalon development,BP,NRGN;EMX2;CNTN2;LPAR1
10123,GO:0036122,0.0750856874629819,0.997369044577598,1,12,BMP binding,MF,GREM1
18708,GO:1900103,0.0752064805783758,0.997360450117888,1,12,positive regulation of endoplasmic reticulum unfolded protein response,BP,BOK
5048,GO:0010958,0.0752169940624363,0.997359701398657,1,12,regulation of amino acid import across plasma membrane,BP,RGS4
20054,GO:1903789,0.0752169940624363,0.997359701398657,1,12,regulation of amino acid transmembrane transport,BP,RGS4
13081,GO:0048711,0.0752258006712873,0.997359074150688,1,12,positive regulation of astrocyte differentiation,BP,MAG
4832,GO:0010663,0.0752263515020589,0.99735903491539,1,12,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4835,GO:0010666,0.0752263515020589,0.99735903491539,1,12,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
18089,GO:0099144,0.0752294902760739,0.997358811336949,1,12,anchored component of synaptic membrane,CC,CNTN2
15678,GO:0070493,0.0752416302143595,0.997357946503669,1,12,thrombin-activated receptor signaling pathway,BP,SNCA
6738,GO:0021520,0.0752718750020844,0.997355791271051,1,12,spinal cord motor neuron cell fate specification,BP,NKX6-2
1154,GO:0002638,0.0754505254107746,0.997343042260354,1,12,negative regulation of immunoglobulin production,BP,CD22
16762,GO:0072509,0.0757715707215469,0.982980600952165,3,149,divalent inorganic cation transmembrane transporter activity,MF,SLC39A12;SLC24A2;RYR2
2814,GO:0005905,0.0757757231938953,0.989403308607586,2,69,clathrin-coated pit,CC,LRP2;TF
9392,GO:0034595,0.075829365402953,0.997315902718592,1,12,phosphatidylinositol phosphate 5-phosphatase activity,MF,SYNJ2
18719,GO:1900115,0.076013142753791,0.997302686041833,1,12,extracellular regulation of signal transduction,BP,GREM1
18720,GO:1900116,0.076013142753791,0.997302686041833,1,12,extracellular negative regulation of signal transduction,BP,GREM1
4815,GO:0010642,0.0760369681715563,0.997300970147498,1,12,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,SNCA
5148,GO:0014706,0.0760586054724407,0.974239351589786,5,343,striated muscle tissue development,BP,LRP2;RGS4;PDGFRA;GREM1;RYR2
5716,GO:0016188,0.0760764342272962,0.997298126586684,1,12,synaptic vesicle maturation,BP,SLC17A7
5512,GO:0015791,0.076128407474375,0.997294379521479,1,12,polyol transport,BP,SLC5A11
16332,GO:0071674,0.076158873523035,0.989313431651882,2,71,mononuclear cell migration,BP,RARRES2;GREM1
11792,GO:0045161,0.0768209959623655,0.997244191423573,1,12,neuronal ion channel clustering,BP,CNTN2
16544,GO:0072088,0.0771297101307524,0.989102754210628,2,70,nephron epithelium morphogenesis,BP,FGF1;GREM1
11017,GO:0043086,0.0772899282645363,0.966007847842788,8,686,negative regulation of catalytic activity,BP,CAMK2A;RGS4;SNCA;SERPINI1;PPP1R14A;SPOCK3;SERPINA3;GRM3
19454,GO:1902533,0.0775456403740029,0.962514073928706,10,926,positive regulation of intracellular signal transduction,BP,LRP2;TF;FGF1;CHI3L1;PDGFRA;GREM1;GPR37;BOK;GPR62;LPAR1
3972,GO:0008289,0.077575025543242,0.965856075904451,8,685,lipid binding,MF,CPNE6;MAG;ADAP1;PACSIN1;SNCA;NRGN;MAL;LPAR1
14566,GO:0060415,0.0775762210360324,0.989010331742769,2,68,muscle tissue morphogenesis,BP,LRP2;RYR2
18186,GO:0099572,0.0778452006985224,0.973456732162249,5,347,postsynaptic specialization,CC,BCAS1;CAMK2A;NRGN;SYNPO;GRM3
14196,GO:0055013,0.0783834532876686,0.988830972699408,2,68,cardiac muscle cell development,BP,RGS4;PDGFRA
13364,GO:0050805,0.0785344783888959,0.988787698769898,2,71,negative regulation of synaptic transmission,BP,SNCA;SLC24A2
13159,GO:0048878,0.0793541456073566,0.960086734704876,11,1052,chemical homeostasis,BP,TF;PDGFRA;SNCA;SLC39A12;SLC24A2;VSNL1;SYNPO;BOK;CCK;LPAR1;RYR2
18657,GO:1900006,0.0794295220738186,0.988587161673813,2,71,positive regulation of dendrite development,BP,PACSIN1;LPAR1
13054,GO:0048678,0.0796978528039139,0.988523693788688,2,72,response to axon injury,BP,MAG;SPP1
11146,GO:0043297,0.0797004285534188,0.988523113447164,2,72,apical junction assembly,BP,CLDN11;CLDN10
3406,GO:0006820,0.0798282101711564,0.966821431013332,7,574,anion transport,BP,LRP2;SLC17A7;RGS4;SLC24A2;CYB5R2;CCK;FXYD1
18867,GO:1900750,0.0799898749771039,0.996988113792778,1,13,oligopeptide binding,MF,FOLH1
454,GO:0001525,0.0800304403579687,0.969318835632606,6,460,angiogenesis,BP,FGF1;CHI3L1;PDGFRA;ENPP2;S100A1;GREM1
6693,GO:0019933,0.0802270576607481,0.981543434222356,3,155,cAMP-mediated signaling,BP,S1PR5;GPR62;LPAR1
9417,GO:0034638,0.0805490440084255,0.996945202063535,1,13,phosphatidylcholine catabolic process,BP,ENPP2
14013,GO:0051956,0.0805531395918039,0.996944886605863,1,13,negative regulation of amino acid transport,BP,RGS4
16800,GO:0072567,0.0805548697560503,0.996944753336875,1,13,chemokine (C-X-C motif) ligand 2 production,BP,MBP
21648,GO:2000341,0.0805548697560503,0.996944753336875,1,13,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
17366,GO:0097001,0.0806527646092428,0.996937207928775,1,13,ceramide binding,MF,MAG
1545,GO:0003337,0.0807305606607656,0.996931204826219,1,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GREM1
17456,GO:0097154,0.0807744765794315,0.996927813394901,1,13,GABAergic neuron differentiation,BP,CNTN2
8813,GO:0033089,0.0808384199053448,0.99692287188241,1,13,positive regulation of T cell differentiation in thymus,BP,TESPA1
18017,GO:0098984,0.0808749250262814,0.972117927696671,5,351,neuron to neuron synapse,CC,BCAS1;CAMK2A;NRGN;SYNPO;GRM3
13279,GO:0050665,0.0808986912460496,0.996918210390337,1,13,hydrogen peroxide biosynthetic process,BP,MAOB
7664,GO:0031115,0.080945932701181,0.996914554109076,1,13,negative regulation of microtubule polymerization,BP,SNCA
16510,GO:0072028,0.0809714383919617,0.988235393198951,2,72,nephron morphogenesis,BP,FGF1;GREM1
21652,GO:2000345,0.0809782873378042,0.996912048712447,1,13,regulation of hepatocyte proliferation,BP,FGF1
21697,GO:2000402,0.0809840499620099,0.996911602370896,1,13,negative regulation of lymphocyte migration,BP,PADI2
15064,GO:0061333,0.0810566931611382,0.988215997740187,2,72,renal tubule morphogenesis,BP,FGF1;GREM1
6336,GO:0018410,0.0810694539540171,0.996904983542114,1,13,C-terminal protein amino acid modification,BP,FOLH1
10953,GO:0042983,0.0811489063922569,0.996898819399144,1,13,amyloid precursor protein biosynthetic process,BP,NECAB1
10954,GO:0042984,0.0811489063922569,0.996898819399144,1,13,regulation of amyloid precursor protein biosynthetic process,BP,NECAB1
5085,GO:0012510,0.0811811627959833,0.996896315051806,1,13,trans-Golgi network transport vesicle membrane,CC,NRGN
5960,GO:0016653,0.0812554116375767,0.996890546501927,1,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,CYB5R2
10893,GO:0042803,0.081323492681282,0.966053737945972,7,578,protein homodimerization activity,MF,CAMK2A;MAG;PADI2;PDGFRA;S100A1;GREM1;BOK
7371,GO:0030502,0.0813306183337535,0.996884697902856,1,13,negative regulation of bone mineralization,BP,GREM1
712,GO:0001921,0.0813747717349364,0.996881261584763,1,13,positive regulation of receptor recycling,BP,SNCA
2453,GO:0005172,0.0814462447597745,0.996875694926606,1,13,vascular endothelial growth factor receptor binding,MF,GREM1
12159,GO:0045986,0.0815313095922702,0.996869063001063,1,13,negative regulation of smooth muscle contraction,BP,DOCK5
10645,GO:0042325,0.0817008022066021,0.955318005002759,14,1436,regulation of phosphorylation,BP,TF;EPHB6;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;PPP1R14A;GPR37;CCK;LPAR1
13666,GO:0051284,0.0817212142834375,0.99685423125445,1,13,positive regulation of sequestering of calcium ion,BP,RYR2
13057,GO:0048681,0.0817882007575903,0.996848990917859,1,13,negative regulation of axon regeneration,BP,SPP1
3604,GO:0007171,0.0818232278378552,0.996846248966022,1,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,GREM1
6769,GO:0021554,0.0818286133296712,0.996845827275691,1,13,optic nerve development,BP,LPAR1
2585,GO:0005513,0.081846820493109,0.99684440141806,1,13,detection of calcium ion,BP,RYR2
12809,GO:0048096,0.081910701745409,0.99683939605626,1,13,chromatin-mediated maintenance of transcription,BP,PADI2
9218,GO:0034236,0.0823098665736027,0.99680802714487,1,13,protein kinase A catalytic subunit binding,MF,RYR2
13920,GO:0051775,0.0823169116930692,0.996807472059204,1,13,response to redox state,BP,RYR2
13823,GO:0051589,0.0823953264864341,0.99680129038806,1,13,negative regulation of neurotransmitter transport,BP,SNCA
15102,GO:0061430,0.0826551950781427,0.996780760068673,1,13,bone trabecula morphogenesis,BP,GREM1
13661,GO:0051279,0.0826998485801433,0.987836654114294,2,73,regulation of release of sequestered calcium ion into cytosol,BP,SNCA;RYR2
1476,GO:0003214,0.08275626999051,0.996772756570836,1,13,cardiac left ventricle morphogenesis,BP,RYR2
13586,GO:0051146,0.0834514621858211,0.975113339294121,4,250,striated muscle cell differentiation,BP,RGS4;PDGFRA;CSRP1;GREM1
8111,GO:0031994,0.0835913164939773,0.996706241943426,1,13,insulin-like growth factor I binding,MF,LRP2
8979,GO:0033555,0.0836304104558847,0.987618448705882,2,74,multicellular organismal response to stress,BP,ASIC4;CCK
8890,GO:0033238,0.0836452142905925,0.987611961458322,2,75,regulation of cellular amine metabolic process,BP,MAOB;GPR37
7066,GO:0022898,0.0837552993307985,0.974989942358225,4,253,regulation of transmembrane transporter activity,BP,SNCA;S100A1;RYR2;FXYD1
18181,GO:0099566,0.0840039789552916,0.996673113176091,1,13,regulation of postsynaptic cytosolic calcium ion concentration,BP,SYNPO
7399,GO:0030545,0.0842630264035726,0.970598296739734,5,363,receptor regulator activity,MF,FGF1;SPP1;CXCL14;GREM1;CCK
16159,GO:0071415,0.0846659972233317,0.996619608341349,1,13,cellular response to purine-containing compound,BP,RYR2
13312,GO:0050709,0.0847655931525924,0.987350981323113,2,75,negative regulation of protein secretion,BP,CD22;VSNL1
3729,GO:0007422,0.0852623580431087,0.987237748059157,2,74,peripheral nervous system development,BP,HAPLN2;SERPINI1
13630,GO:0051234,0.0852845751487769,0.943078639654713,37,4644,establishment of localization,BP,CD22;MAOB;CAMK2A;ASIC4;SYNJ2;LRP2;TF;CPNE6;SLC17A7;RARRES2;PADI2;RGS4;SPP1;PACSIN1;CHI3L1;CLDN10;ENPP2;SNCA;SLC39A12;SLC24A2;SLC5A11;S100A1;VSNL1;TMEM144;CYB5R2;GREM1;LGI3;GJB1;MAL;BOK;CNTN2;SV2B;CCK;NKAIN2;SERPINA3;RYR2;FXYD1
2414,GO:0005125,0.0855684945798162,0.979773481039439,3,162,cytokine activity,MF,SPP1;CXCL14;GREM1
17193,GO:0090287,0.0859870958100008,0.974093425308506,4,255,regulation of cellular response to growth factor stimulus,BP,LRP2;FGF1;HHIP;GREM1
12971,GO:0048521,0.0860766872905916,0.996483896729697,1,14,negative regulation of behavior,BP,CCK
436,GO:0001501,0.0862438417725758,0.96629486858989,6,469,skeletal system development,BP,DLL3;HAPLN2;CHI3L1;PDGFRA;HHIP;GREM1
5888,GO:0016528,0.0862738105740277,0.986999606897313,2,74,sarcoplasm,CC,S100A1;RYR2
5738,GO:0016234,0.0864862935858355,0.986946157252322,2,75,inclusion body,CC,NEFM;SNCA
2483,GO:0005243,0.0865108770222314,0.99644774394337,1,14,gap junction channel activity,MF,GJB1
2821,GO:0005922,0.0865108770222314,0.99644774394337,1,14,connexin complex,CC,GJB1
406,GO:0001161,0.0865172103486181,0.996447215185282,1,14,intronic transcription regulatory region sequence-specific DNA binding,MF,EMX2
8184,GO:0032105,0.0865540073456818,0.996444142265351,1,14,negative regulation of response to extracellular stimulus,BP,CCK
8187,GO:0032108,0.0865540073456818,0.996444142265351,1,14,negative regulation of response to nutrient levels,BP,CCK
12584,GO:0046940,0.0865734354475471,0.996442519269407,1,14,nucleoside monophosphate phosphorylation,BP,AK5
13401,GO:0050862,0.0866349321827259,0.996437379396943,1,14,positive regulation of T cell receptor signaling pathway,BP,TESPA1
17486,GO:0097194,0.0867364141647536,0.986883771954427,2,76,execution phase of apoptosis,BP,BOK;AIFM3
14658,GO:0060546,0.0867820617797939,0.99642506680216,1,14,negative regulation of necroptotic process,BP,BOK
15371,GO:0062099,0.0867820617797939,0.99642506680216,1,14,negative regulation of programmed necrotic cell death,BP,BOK
6673,GO:0019888,0.086784014665679,0.986872482427504,2,76,protein phosphatase regulator activity,MF,PPP1R14A;RCAN2
12533,GO:0046851,0.0867906807292913,0.996424344841558,1,14,negative regulation of bone remodeling,BP,GREM1
5120,GO:0014048,0.0869523742585786,0.996410786725529,1,14,regulation of glutamate secretion,BP,CCK
18947,GO:1901224,0.0870149416330432,0.986817660548024,2,76,positive regulation of NIK/NF-kappaB signaling,BP,CHI3L1;GREM1
13323,GO:0050746,0.0870447061054475,0.996403032740404,1,14,regulation of lipoprotein metabolic process,BP,HHATL
7042,GO:0022821,0.087570243644192,0.996358733617238,1,14,potassium ion antiporter activity,MF,SLC24A2
15727,GO:0070571,0.0876879846178679,0.996348770445885,1,14,negative regulation of neuron projection regeneration,BP,SPP1
2443,GO:0005161,0.0878360417672418,0.996336221961647,1,14,platelet-derived growth factor receptor binding,MF,PDGFRA
13078,GO:0048708,0.0879271989191579,0.986600243447297,2,76,astrocyte differentiation,BP,MAG;CNTN2
2515,GO:0005313,0.0880032207320229,0.996322026064924,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
9143,GO:0034109,0.0880564608829655,0.986569327303113,2,76,homotypic cell-cell adhesion,BP,PDGFRA;CSRP1
14189,GO:0055006,0.0882552371101271,0.986531658980809,2,73,cardiac cell development,BP,RGS4;PDGFRA
7787,GO:0031346,0.0885431740714037,0.968658816632031,5,361,positive regulation of cell projection organization,BP,CPNE6;PACSIN1;ENPP2;SERPINI1;LPAR1
14000,GO:0051938,0.0885920504772453,0.996271799870962,1,14,L-glutamate import,BP,SLC17A7
11303,GO:0043549,0.0886159954696631,0.957833777866788,9,824,regulation of kinase activity,BP,TF;EPHB6;FGF1;RGS4;CHI3L1;PDGFRA;SNCA;GREM1;LPAR1
11800,GO:0045176,0.0887881078193106,0.996254998324197,1,14,apical protein localization,BP,MAL
17892,GO:0098805,0.0888798725292141,0.949779860480936,15,1589,whole membrane,CC,MAOB;CAMK2A;SYNJ2;MOXD1;LRP2;TF;SLC17A7;MAG;SNCA;NRGN;MAL;BOK;GPR62;SV2B;FXYD1
13033,GO:0048644,0.0891084586659034,0.986323331751549,2,74,muscle organ morphogenesis,BP,LRP2;RYR2
18413,GO:0110110,0.0891667710338963,0.9862994707667,2,77,positive regulation of animal organ morphogenesis,BP,FGF1;GREM1
2493,GO:0005253,0.0894889502926897,0.986221699949947,2,77,anion channel activity,MF,SLC17A7;FXYD1
13320,GO:0050731,0.0896978169032987,0.978376404594519,3,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,ENPP2;GREM1;CCK
5548,GO:0015844,0.0904132312392,0.985994491924128,2,78,monoamine transport,BP,MAOB;SNCA
17303,GO:0090559,0.0904433104113732,0.985987176179039,2,78,regulation of membrane permeability,BP,CAMK2A;BOK
5180,GO:0014812,0.0906643363393208,0.985936554145303,2,77,muscle cell migration,BP,DOCK5;LPAR1
14185,GO:0055001,0.0908432342257044,0.97798817932069,3,160,muscle cell development,BP,RGS4;PDGFRA;CSRP1
14556,GO:0060401,0.091460965906045,0.97777154192413,3,163,cytosolic calcium ion transport,BP,SNCA;SLC24A2;RYR2
13636,GO:0051241,0.0914618492026575,0.952818932226961,11,1081,negative regulation of multicellular organismal process,BP,DLL3;MAG;RGS4;SPP1;PDGFRA;DOCK5;NKX6-2;GREM1;CNTN2;CCK;LPAR1
11219,GO:0043410,0.0914885196918884,0.963692479507426,6,479,positive regulation of MAPK cascade,BP,TF;FGF1;CHI3L1;PDGFRA;GPR37;LPAR1
4432,GO:0009263,0.0920392248625094,0.995950643040221,1,15,deoxyribonucleotide biosynthetic process,BP,AK5
18723,GO:1900119,0.0921981375996531,0.995936400387792,1,15,positive regulation of execution phase of apoptosis,BP,BOK
22117,GO:2001235,0.092255472824048,0.97749321134321,3,166,positive regulation of apoptotic signaling pathway,BP,ST18;MAL;BOK
14304,GO:0060047,0.0923521136839395,0.971490141177836,4,260,heart contraction,BP,RGS4;S100A1;RYR2;FXYD1
5952,GO:0016641,0.0925455273218662,0.995905175184615,1,15,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,MAOB
7268,GO:0030277,0.0928672197984806,0.995876149384872,1,15,maintenance of gastrointestinal epithelium,BP,SERPINA3
4997,GO:0010893,0.0928774763312087,0.995875222207496,1,15,positive regulation of steroid biosynthetic process,BP,FGF1
11409,GO:0043950,0.0929229800441988,0.995871107428362,1,15,positive regulation of cAMP-mediated signaling,BP,GPR62
18891,GO:1901032,0.0929331967788483,0.995870183264234,1,15,negative regulation of response to reactive oxygen species,BP,GPR37
19748,GO:1903206,0.0929331967788483,0.995870183264234,1,15,negative regulation of hydrogen peroxide-induced cell death,BP,GPR37
8739,GO:0032970,0.0929706169866308,0.966616783001684,5,367,regulation of actin filament-based process,BP,RGS4;PDGFRA;SYNPO;LPAR1;RYR2
10230,GO:0036376,0.0929731321252683,0.995866569847966,1,15,sodium ion export across plasma membrane,BP,FXYD1
15147,GO:0061548,0.0930986193926305,0.995855204899034,1,15,ganglion development,BP,RGS4
14678,GO:0060579,0.0931489765565936,0.995850639679626,1,15,ventral spinal cord interneuron fate commitment,BP,NKX6-2
14680,GO:0060581,0.0931489765565936,0.995850639679626,1,15,cell fate commitment involved in pattern specification,BP,NKX6-2
19669,GO:1903035,0.0932500198449125,0.985294918224222,2,79,negative regulation of response to wounding,BP,SPP1;PDGFRA
20144,GO:1903960,0.0934751409793438,0.995821007613559,1,15,negative regulation of anion transmembrane transport,BP,RGS4
12536,GO:0046855,0.0935800699509688,0.995811451582187,1,15,inositol phosphate dephosphorylation,BP,SYNJ2
6433,GO:0019199,0.093591746046064,0.985213397571987,2,78,transmembrane receptor protein kinase activity,MF,EPHB6;PDGFRA
16677,GO:0072283,0.0936223645895289,0.995807596551355,1,15,metanephric renal vesicle morphogenesis,BP,GREM1
7283,GO:0030296,0.0937043844019439,0.995800115452074,1,15,protein tyrosine kinase activator activity,MF,GREM1
1542,GO:0003333,0.0937128454019822,0.985180063854069,2,79,amino acid transmembrane transport,BP,SLC17A7;RGS4
19259,GO:1902043,0.0937749059340901,0.99579367759581,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
9729,GO:0035461,0.0939715915897051,0.995775695316324,1,15,vitamin transmembrane transport,BP,LRP2
3399,GO:0006810,0.0941576954177065,0.936703655569832,36,4536,transport,BP,CD22;MAOB;CAMK2A;ASIC4;SYNJ2;LRP2;TF;CPNE6;SLC17A7;RARRES2;PADI2;RGS4;SPP1;PACSIN1;CHI3L1;CLDN10;ENPP2;SNCA;SLC39A12;SLC24A2;SLC5A11;S100A1;VSNL1;TMEM144;CYB5R2;GREM1;LGI3;GJB1;BOK;CNTN2;SV2B;CCK;NKAIN2;SERPINA3;RYR2;FXYD1
14205,GO:0055024,0.0942003461618253,0.985058716981057,2,79,regulation of cardiac muscle tissue development,BP,RGS4;GREM1
8361,GO:0032409,0.0942035797231446,0.970718083780694,4,264,regulation of transporter activity,BP,SNCA;S100A1;RYR2;FXYD1
20707,GO:1905048,0.0942059020603419,0.995754221245095,1,15,regulation of metallopeptidase activity,BP,MBP
3641,GO:0007216,0.0942953734333864,0.995746006490945,1,15,G protein-coupled glutamate receptor signaling pathway,BP,GRM3
7659,GO:0031110,0.0945982071111908,0.984959402636719,2,79,regulation of microtubule polymerization or depolymerization,BP,SNCA;SLC39A12
7186,GO:0030165,0.0946021560090538,0.984958415648531,2,79,PDZ domain binding,MF,LPAR1;TMEM88B
14957,GO:0061061,0.0946630150951721,0.959053351565184,7,593,muscle structure development,BP,LRP2;RGS4;PDGFRA;CXCL14;CSRP1;GREM1;RYR2
7811,GO:0031401,0.0949092636752556,0.950712623174328,11,1088,positive regulation of protein modification process,BP,TF;RARRES2;FGF1;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;LPAR1
13365,GO:0050806,0.0950567055834625,0.976517564055165,3,166,positive regulation of synaptic transmission,BP,RGS4;NRGN;SLC24A2
4804,GO:0010631,0.0954425275681751,0.970199568690111,4,265,epithelial cell migration,BP,FGF1;ENPP2;DOCK5;GREM1
8901,GO:0033268,0.0954480427329041,0.995639438704165,1,15,node of Ranvier,CC,CNTN2
7544,GO:0030900,0.0954591045137889,0.965455769042555,5,369,forebrain development,BP,LRP2;NRGN;EMX2;CNTN2;LPAR1
20743,GO:1905146,0.095486793147224,0.995635832358462,1,15,lysosomal protein catabolic process,BP,LRP2
17965,GO:0098911,0.0957468766970747,0.995611587416887,1,15,regulation of ventricular cardiac muscle cell action potential,BP,RYR2
2467,GO:0005216,0.0959499383390328,0.965224767420081,5,371,ion channel activity,MF,ASIC4;SLC17A7;SLC24A2;RYR2;FXYD1
17078,GO:0090132,0.0964078535470117,0.969793641815718,4,266,epithelium migration,BP,FGF1;ENPP2;DOCK5;GREM1
11008,GO:0043065,0.0964657019409021,0.958084498027595,7,602,positive regulation of apoptotic process,BP,CAMK2A;SNCA;ST18;MAL;BOK;CCK;LPAR1
1263,GO:0002792,0.0965082361862455,0.984472574418353,2,81,negative regulation of peptide secretion,BP,CD22;VSNL1
6451,GO:0019220,0.097252770240711,0.944291673945244,15,1608,regulation of phosphate metabolic process,BP,TF;EPHB6;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;PPP1R14A;GPR37;RCAN2;CCK;LPAR1
11887,GO:0045445,0.0973200169250197,0.984266620566984,2,81,myoblast differentiation,BP,CXCL14;GREM1
1524,GO:0003300,0.0973970958856627,0.984257096121625,2,78,cardiac muscle hypertrophy,BP,RGS4;RYR2
13503,GO:0051023,0.0975917975925382,0.995417890498327,1,16,regulation of immunoglobulin secretion,BP,CD22
13606,GO:0051174,0.0976372781945018,0.944037586981876,15,1609,regulation of phosphorus metabolic process,BP,TF;EPHB6;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;PPP1R14A;GPR37;RCAN2;CCK;LPAR1
17280,GO:0090494,0.0979927291515551,0.995379454016044,1,16,dopamine uptake,BP,SNCA
4579,GO:0009888,0.0981224503995988,0.942760947309126,16,1738,tissue development,BP,LRP2;DLL3;FGF1;RGS4;SPP1;HAPLN2;CHI3L1;PDGFRA;CSRP1;CBR1;TPPP3;HHIP;GREM1;KLK6;NINJ2;RYR2
2044,GO:0004551,0.0981748918904233,0.995361935397506,1,16,nucleotide diphosphatase activity,MF,ENPP2
14659,GO:0060547,0.0982640405930849,0.995353349413786,1,16,negative regulation of necrotic cell death,BP,BOK
8235,GO:0032225,0.0983169899486085,0.995348245917311,1,16,regulation of synaptic transmission, dopaminergic,BP,SNCA
3912,GO:0008191,0.0984307623273422,0.995337270188894,1,16,metalloendopeptidase inhibitor activity,MF,SPOCK3
4896,GO:0010759,0.0984949572442807,0.995331071320083,1,16,positive regulation of macrophage chemotaxis,BP,RARRES2
13815,GO:0051580,0.0986509455179943,0.995315990773705,1,16,regulation of neurotransmitter uptake,BP,SNCA
15216,GO:0061684,0.0986612344597139,0.995314995177773,1,16,chaperone-mediated autophagy,BP,SNCA
9560,GO:0035067,0.0986983421723174,0.99531140358632,1,16,negative regulation of histone acetylation,BP,SNCA
17122,GO:0090190,0.098701829249089,0.995311066004743,1,16,positive regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
13737,GO:0051412,0.0987112161774505,0.995310157199775,1,16,response to corticosterone,BP,MAOB
10561,GO:0042136,0.0987906053956806,0.99530246739587,1,16,neurotransmitter biosynthetic process,BP,MOXD1
6971,GO:0021954,0.0989028538621934,0.98386205811383,2,81,central nervous system neuron development,BP,EPHB6;CNTN2
5719,GO:0016192,0.099002993656536,0.941294584344683,17,1878,vesicle-mediated transport,BP,CD22;SYNJ2;LRP2;TF;CPNE6;SLC17A7;RARRES2;PADI2;PACSIN1;CHI3L1;ENPP2;SNCA;VSNL1;GREM1;LGI3;CNTN2;SERPINA3
6758,GO:0021542,0.0991829119580904,0.995264371749387,1,16,dentate gyrus development,BP,EMX2
453,GO:0001523,0.0992742131709044,0.983763282194062,2,82,retinoid metabolic process,BP,LRP2;RARRES2
14843,GO:0060850,0.0993014717735022,0.995252827345688,1,16,regulation of transcription involved in cell fate commitment,BP,NKX6-2
2554,GO:0005402,0.0993108061291401,0.995251917821284,1,16,carbohydrate:cation symporter activity,MF,SLC5A11
12527,GO:0046838,0.0994424908378457,0.995239077036615,1,16,phosphorylated carbohydrate dephosphorylation,BP,SYNJ2
12990,GO:0048557,0.0994826551934041,0.995235156962932,1,16,embryonic digestive tract morphogenesis,BP,PDGFRA
5317,GO:0015172,0.0997582953593343,0.995208209054193,1,16,acidic amino acid transmembrane transporter activity,MF,SLC17A7
7647,GO:0031092,0.0997672648928018,0.995207330823584,1,16,platelet alpha granule membrane,CC,SNCA
15741,GO:0070593,0.0998941351393564,0.995194899671731,1,16,dendrite self-avoidance,BP,CNTN2
3848,GO:0008081,0.100000067615831,0.98357598359408,2,82,phosphoric diester hydrolase activity,MF,ENPP2;PDE1C
18883,GO:1901019,0.100009531864398,0.983573535999549,2,82,regulation of calcium ion transmembrane transporter activity,BP,S100A1;RYR2
1412,GO:0003128,0.100037364060166,0.995180845546707,1,16,heart field specification,BP,LRP2
11011,GO:0043068,0.10035149492785,0.955983457321438,7,608,positive regulation of programmed cell death,BP,CAMK2A;SNCA;ST18;MAL;BOK;CCK;LPAR1
13005,GO:0048589,0.100448614661221,0.95593212489393,7,603,developmental growth,BP,CPNE6;MAG;FGF1;RGS4;SPP1;KLK6;NINJ2
7397,GO:0030540,0.100506195132166,0.995134693073853,1,16,female genitalia development,BP,LRP2
12088,GO:0045860,0.100557562291922,0.959092654299316,6,491,positive regulation of protein kinase activity,BP,TF;FGF1;CHI3L1;SNCA;GREM1;LPAR1
17760,GO:0098552,0.100598452224934,0.959070906394889,6,493,side of membrane,CC,CD22;LRP2;TF;PDGFRA;MOG;ICOSLG
17076,GO:0090130,0.101357975227307,0.967688312604345,4,271,tissue migration,BP,FGF1;ENPP2;DOCK5;GREM1
11093,GO:0043217,0.101404110261114,0.995045662754279,1,16,myelin maintenance,BP,MYRF
13649,GO:0051258,0.101436861216799,0.967653703355886,4,272,protein polymerization,BP,GAS7;SNCA;SLC39A12;TPPP3
5231,GO:0014897,0.101493311534357,0.98319495936372,2,80,striated muscle hypertrophy,BP,RGS4;RYR2
13973,GO:0051899,0.101868020402603,0.98309019046159,2,82,membrane depolarization,BP,BOK;CCK
14210,GO:0055037,0.101933990575285,0.974058522459923,3,172,recycling endosome,CC,CD22;TF;BOK
20541,GO:1904754,0.101987794810838,0.994987339086356,1,16,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK5
11078,GO:0043194,0.102146277576209,0.994971441722329,1,16,axon initial segment,CC,CCK
5381,GO:0015294,0.102202988057104,0.982999150231975,2,83,solute:cation symporter activity,MF,SLC17A7;SLC5A11
14896,GO:0060977,0.102216564421859,0.994964382891863,1,16,coronary vasculature morphogenesis,BP,LRP2
16490,GO:0072001,0.102361907185796,0.967257334362714,4,271,renal system development,BP,FGF1;PDGFRA;GREM1;EMX2
7786,GO:0031345,0.102382731158861,0.973895912153068,3,172,negative regulation of cell projection organization,BP,MAG;SPP1;LPAR1
1372,GO:0003015,0.102407457534473,0.967238559657179,4,270,heart process,BP,RGS4;S100A1;RYR2;FXYD1
13619,GO:0051219,0.102415007418162,0.982943546086441,2,83,phosphoprotein binding,MF,SHD;SNCA
2795,GO:0005882,0.102492523365745,0.982923199313912,2,83,intermediate filament,CC,CLDN11;NEFM
11403,GO:0043931,0.102527185791955,0.994933125885387,1,16,ossification involved in bone maturation,BP,GREM1
5062,GO:0010976,0.102752273895423,0.967089322647752,4,271,positive regulation of neuron projection development,BP,CPNE6;PACSIN1;SERPINI1;LPAR1
7646,GO:0031091,0.103023518435016,0.982780260486535,2,84,platelet alpha granule,CC,SNCA;SERPINA3
525,GO:0001656,0.10304465550651,0.9827780026655,2,83,metanephros development,BP,PDGFRA;GREM1
14461,GO:0060291,0.103213982994745,0.982733378963893,2,83,long-term synaptic potentiation,BP,NRGN;SLC24A2
2043,GO:0004550,0.10334794983676,0.994830546845025,1,17,nucleoside diphosphate kinase activity,MF,AK5
7377,GO:0030510,0.103484691353896,0.982661945409719,2,83,regulation of BMP signaling pathway,BP,LRP2;GREM1
2279,GO:0004888,0.10354293234118,0.951483010135546,8,734,transmembrane signaling receptor activity,MF,EPHB6;EVI2A;PDGFRA;GPR37;S1PR5;GPR62;LPAR1;GRM3
13745,GO:0051428,0.103601783834766,0.994804616194422,1,17,peptide hormone receptor binding,MF,CCK
17279,GO:0090493,0.103754380952391,0.994788995016714,1,17,catecholamine uptake,BP,SNCA
9792,GO:0035578,0.10381111122406,0.982569044825733,2,85,azurophil granule lumen,CC,PADI2;SERPINA3
22142,GO:2001267,0.104043468026107,0.994759334652854,1,17,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
5374,GO:0015278,0.104060805024564,0.994777327122611,1,16,calcium-release channel activity,MF,RYR2
16539,GO:0072079,0.104103495958536,0.99475316480193,1,17,nephron tubule formation,BP,GREM1
9740,GO:0035493,0.104178823790339,0.994745417039032,1,17,SNARE complex assembly,BP,SNCA
18547,GO:0140131,0.104380356751387,0.994724659344015,1,17,positive regulation of lymphocyte chemotaxis,BP,CXCL14
3655,GO:0007250,0.104471075379356,0.994715301519609,1,17,activation of NF-kappaB-inducing kinase activity,BP,CHI3L1
2521,GO:0005326,0.104481824195779,0.994714192184043,1,17,neurotransmitter transmembrane transporter activity,MF,SLC17A7
478,GO:0001558,0.104767603764319,0.96102279950116,5,383,regulation of cell growth,BP,CPNE6;MAG;RGS4;SPP1;GREM1
16615,GO:0072189,0.104888435362352,0.994672138755442,1,17,ureter development,BP,EMX2
6733,GO:0021514,0.104992308741589,0.99466136792931,1,17,ventral spinal cord interneuron differentiation,BP,NKX6-2
16242,GO:0071545,0.105218939109333,0.994637828910278,1,17,inositol phosphate catabolic process,BP,SYNJ2
2827,GO:0005938,0.105248194881239,0.966007747413618,4,273,cell cortex,CC,FGF1;ERMN;SNCA;MOBP
18027,GO:0099010,0.105280004782242,0.994631477092219,1,17,modification of postsynaptic structure,BP,SYNPO
4621,GO:0010002,0.105341663740558,0.994625059592404,1,17,cardioblast differentiation,BP,GREM1
7872,GO:0031498,0.105361408272775,0.994623003726753,1,17,chromatin disassembly,BP,PADI2
16837,GO:0072673,0.105413126486186,0.994617616716749,1,17,lamellipodium morphogenesis,BP,ENPP2
2358,GO:0005005,0.105484904960645,0.994610135562128,1,17,transmembrane-ephrin receptor activity,MF,EPHB6
5230,GO:0014896,0.105532315490664,0.982121463389647,2,82,muscle hypertrophy,BP,RGS4;RYR2
12915,GO:0048339,0.105550780475939,0.994603264887788,1,17,paraxial mesoderm development,BP,DLL3
21908,GO:2000726,0.105666023967055,0.994591234284124,1,17,negative regulation of cardiac muscle cell differentiation,BP,RGS4
12120,GO:0045921,0.105676181405705,0.982072691935725,2,85,positive regulation of exocytosis,BP,SNCA;VSNL1
18799,GO:1900242,0.105724419034504,0.994585132930327,1,17,regulation of synaptic vesicle endocytosis,BP,SLC17A7
1191,GO:0002690,0.105830717465495,0.982028039950655,2,86,positive regulation of leukocyte chemotaxis,BP,RARRES2;CXCL14
3592,GO:0007158,0.106048379085207,0.994551219233259,1,17,neuron cell-cell adhesion,BP,NINJ2
11801,GO:0045177,0.106198891204679,0.960330467801779,5,383,apical part of cell,CC,LRP2;TF;MAL;TMEM235;FXYD1
19431,GO:1902476,0.10620569842848,0.98193079165783,2,85,chloride transmembrane transport,BP,SLC17A7;FXYD1
791,GO:0002028,0.106207135198102,0.981930406043411,2,85,regulation of sodium ion transport,BP,NKAIN2;FXYD1
17005,GO:0089717,0.10673880191312,0.994478574579601,1,17,spanning component of membrane,CC,SLC24A2
3942,GO:0008238,0.106796855172074,0.981768534006821,2,86,exopeptidase activity,MF,FOLH1;CNDP1
13547,GO:0051093,0.106831088899801,0.947187503393715,9,859,negative regulation of developmental process,BP,DLL3;MAG;RGS4;SPP1;CXCL14;NKX6-2;GREM1;CNTN2;LPAR1
6695,GO:0019935,0.106845177171138,0.972255418064322,3,176,cyclic-nucleotide-mediated signaling,BP,S1PR5;GPR62;LPAR1
8132,GO:0032026,0.106879711123456,0.994463686887568,1,17,response to magnesium ion,BP,SNCA
14997,GO:0061138,0.107272671430762,0.972098567180019,3,175,morphogenesis of a branching epithelium,BP,FGF1;HHIP;GREM1
3495,GO:0006959,0.107711782981285,0.971929972211535,3,179,humoral immune response,BP,TF;RARRES2;CXCL14
10708,GO:0042445,0.107914006272448,0.97185624595424,3,178,hormone metabolic process,BP,SPP1;PDGFRA;KLK6
15715,GO:0070555,0.107935070224056,0.97184841672149,3,178,response to interleukin-1,BP,CHI3L1;SNCA;ST18
16052,GO:0071248,0.108460009742412,0.971654507130106,3,177,cellular response to metal ion,BP,TF;CPNE6;SNCA
7592,GO:0031000,0.108546435268758,0.994286005147841,1,17,response to caffeine,BP,RYR2
491,GO:0001578,0.109409790955036,0.98105950906493,2,86,microtubule bundle formation,BP,DCX;TPPP3
16540,GO:0072080,0.109458079481317,0.981046307419294,2,86,nephron tubule development,BP,FGF1;GREM1
4685,GO:0010310,0.109472806447316,0.994166533951287,1,18,regulation of hydrogen peroxide metabolic process,BP,SNCA
6660,GO:0019865,0.109486552934362,0.994165038027346,1,18,immunoglobulin binding,MF,CD22
8174,GO:0032095,0.109812695901686,0.994129487762423,1,18,regulation of response to food,BP,CCK
7597,GO:0031012,0.109882895605974,0.954234678540694,6,502,extracellular matrix,CC,RARRES2;FGF1;HAPLN2;CHI3L1;GREM1;SERPINA3
2955,GO:0006144,0.109889838840737,0.994121062559055,1,18,purine nucleobase metabolic process,BP,GDA
2551,GO:0005385,0.109961140861016,0.994113269672776,1,18,zinc ion transmembrane transporter activity,MF,SLC39A12
17293,GO:0090533,0.10997382627683,0.994111882668463,1,18,cation-transporting ATPase complex,CC,FXYD1
1432,GO:0003159,0.110077660196805,0.994100523219571,1,18,morphogenesis of an endothelium,BP,FGF1
15009,GO:0061154,0.110077660196805,0.994100523219571,1,18,endothelial tube morphogenesis,BP,FGF1
10906,GO:0042827,0.110140719686335,0.99409361892951,1,18,platelet dense granule,CC,RARRES2
6086,GO:0016881,0.110199176940084,0.994087214770834,1,18,acid-amino acid ligase activity,MF,CARNS1
5877,GO:0016505,0.11043741313809,0.994061077891858,1,18,peptidase activator activity involved in apoptotic process,MF,MAL
14656,GO:0060544,0.110508516478044,0.994053265501189,1,18,regulation of necroptotic process,BP,BOK
15370,GO:0062098,0.110508516478044,0.994053265501189,1,18,regulation of programmed necrotic cell death,BP,BOK
2118,GO:0004653,0.110606866708518,0.994042450565628,1,18,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT6
14439,GO:0060259,0.110678921196204,0.994034520698238,1,18,regulation of feeding behavior,BP,CCK
17542,GO:0097320,0.110680112700795,0.994034389522446,1,18,plasma membrane tubulation,BP,PACSIN1
4756,GO:0010544,0.110710668840663,0.994031025004838,1,18,negative regulation of platelet activation,BP,PDGFRA
7064,GO:0022890,0.110915482549066,0.953689080032476,6,503,inorganic cation transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2
14698,GO:0060602,0.111144361555965,0.993983164689221,1,18,branch elongation of an epithelium,BP,FGF1
16537,GO:0072077,0.111173261368724,0.993979968355177,1,18,renal vesicle morphogenesis,BP,GREM1
14950,GO:0061050,0.111220947548472,0.993974692303533,1,18,regulation of cell growth involved in cardiac muscle cell development,BP,RGS4
11765,GO:0045109,0.111241119292368,0.993972459753911,1,18,intermediate filament organization,BP,NEFM
21909,GO:2000727,0.111316665625227,0.993964094673431,1,18,positive regulation of cardiac muscle cell differentiation,BP,GREM1
5677,GO:0016101,0.111525350535575,0.980470939359291,2,88,diterpenoid metabolic process,BP,LRP2;RARRES2
10658,GO:0042359,0.111566381797597,0.993936401083804,1,18,vitamin D metabolic process,BP,LRP2
18078,GO:0099095,0.111592176778693,0.993933536645143,1,18,ligand-gated anion channel activity,MF,SLC17A7
12089,GO:0045861,0.111786280065084,0.963124301854739,4,283,negative regulation of proteolysis,BP,SNCA;SERPINI1;SPOCK3;SERPINA3
22030,GO:2001026,0.111826034148337,0.993907535431708,1,18,regulation of endothelial cell chemotaxis,BP,FGF1
17607,GO:0097449,0.111872377745728,0.993902375874188,1,18,astrocyte projection,CC,GRM3
13047,GO:0048670,0.112254348451614,0.993859763243532,1,18,regulation of collateral sprouting,BP,SPP1
4629,GO:0010035,0.112973687708077,0.95259623557018,6,507,response to inorganic substance,BP,MAOB;TF;CPNE6;SNCA;GPR37;RYR2
19918,GO:1903532,0.113108641475219,0.962535607088726,4,282,positive regulation of secretion by cell,BP,SPP1;SNCA;VSNL1;CCK
15044,GO:0061298,0.113127587742652,0.993761762857092,1,18,retina vasculature development in camera-type eye,BP,PDGFRA
14906,GO:0060993,0.113664704752237,0.979875560693508,2,88,kidney morphogenesis,BP,FGF1;GREM1
15063,GO:0061326,0.1137129302123,0.979862059598697,2,88,renal tubule development,BP,FGF1;GREM1
16942,GO:0086014,0.11390348173205,0.993674007371744,1,18,atrial cardiac muscle cell action potential,BP,RYR2
16952,GO:0086026,0.11390348173205,0.993674007371744,1,18,atrial cardiac muscle cell to AV node cell signaling,BP,RYR2
16980,GO:0086066,0.11390348173205,0.993674007371744,1,18,atrial cardiac muscle cell to AV node cell communication,BP,RYR2
11029,GO:0043112,0.114113510456049,0.969517409367433,3,181,receptor metabolic process,BP,SNCA;GREM1;CNTN2
15932,GO:0070977,0.114236379300063,0.993636159594206,1,18,bone maturation,BP,GREM1
12900,GO:0048305,0.114932004479522,0.993537512950408,1,19,immunoglobulin secretion,BP,CD22
13789,GO:0051537,0.11568385301034,0.993450790874717,1,19,2 iron, 2 sulfur cluster binding,MF,AIFM3
5950,GO:0016638,0.115687072338293,0.993450418242259,1,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,MAOB
11456,GO:0044070,0.115825889541359,0.979260138806547,2,90,regulation of anion transport,BP,RGS4;CCK
13484,GO:0051000,0.115871830893373,0.993429014151035,1,19,positive regulation of nitric-oxide synthase activity,BP,S100A1
15739,GO:0070588,0.11587788199086,0.961290745760233,4,284,calcium ion transmembrane transport,BP,SNCA;SLC24A2;S100A1;RYR2
17121,GO:0090189,0.115898434568869,0.993425929136836,1,19,regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
6440,GO:0019208,0.115920711625325,0.979233271185782,2,90,phosphatase regulator activity,MF,PPP1R14A;RCAN2
15037,GO:0061213,0.116000164361119,0.993414125372644,1,19,positive regulation of mesonephros development,BP,GREM1
9141,GO:0034104,0.116060499859807,0.993407119383935,1,19,negative regulation of tissue remodeling,BP,GREM1
9251,GO:0034329,0.116092849181013,0.955456091757762,5,392,cell junction assembly,BP,CLDN11;CLDN10;SNCA;GREM1;GJB1
2403,GO:0005104,0.116102816037942,0.993402203425795,1,19,fibroblast growth factor receptor binding,MF,FGF1
21927,GO:2000757,0.116137294319424,0.993398196596716,1,19,negative regulation of peptidyl-lysine acetylation,BP,SNCA
13593,GO:0051153,0.116180020763274,0.979159727313656,2,90,regulation of striated muscle cell differentiation,BP,RGS4;GREM1
483,GO:0001568,0.116204990207726,0.947190787166005,7,627,blood vessel development,BP,LRP2;FGF1;CHI3L1;PDGFRA;ENPP2;S100A1;GREM1
2539,GO:0005355,0.116238469810885,0.993386431337318,1,19,glucose transmembrane transporter activity,MF,SLC5A11
5307,GO:0015149,0.116238469810885,0.993386431337318,1,19,hexose transmembrane transporter activity,MF,SLC5A11
5044,GO:0010954,0.116308202475573,0.993378316054975,1,19,positive regulation of protein processing,BP,CNTN2
7071,GO:0023019,0.116388143961241,0.993369006301154,1,19,signal transduction involved in regulation of gene expression,BP,PDGFRA
16805,GO:0072574,0.116440899040409,0.993362858853371,1,19,hepatocyte proliferation,BP,FGF1
16806,GO:0072575,0.116440899040409,0.993362858853371,1,19,epithelial cell proliferation involved in liver morphogenesis,BP,FGF1
17813,GO:0098659,0.116538349790631,0.979057933204713,2,90,inorganic cation import across plasma membrane,BP,SLC39A12;SLC24A2
18194,GO:0099587,0.116538349790631,0.979057933204713,2,90,inorganic ion import across plasma membrane,BP,SLC39A12;SLC24A2
8299,GO:0032331,0.116559540936012,0.993349022864766,1,19,negative regulation of chondrocyte differentiation,BP,GREM1
3623,GO:0007194,0.116606950971276,0.993343489706813,1,19,negative regulation of adenylate cyclase activity,BP,GRM3
5283,GO:0015108,0.116644601203334,0.979027712133138,2,90,chloride transmembrane transporter activity,MF,SLC17A7;FXYD1
14014,GO:0051957,0.116708498338317,0.993331630165174,1,19,positive regulation of amino acid transport,BP,CCK
13387,GO:0050848,0.116745934138078,0.978998874189815,2,90,regulation of calcium-mediated signaling,BP,CD22;RCAN2
13337,GO:0050770,0.116816738432625,0.968480697739275,3,181,regulation of axonogenesis,BP,MAG;SPP1;CNTN2
16543,GO:0072087,0.116856454047049,0.993314330921436,1,19,renal vesicle development,BP,GREM1
2356,GO:0005003,0.11698646047623,0.993299111000889,1,19,ephrin receptor activity,MF,EPHB6
15567,GO:0070300,0.117033373273675,0.99329361445305,1,19,phosphatidic acid binding,MF,NRGN
11520,GO:0044283,0.117302672410862,0.9465668578685,7,636,small molecule biosynthetic process,BP,MOXD1;FOLH1;FGF1;GDA;SNCA;CBR1;CARNS1
13779,GO:0051493,0.117920969661154,0.949947232728408,6,511,regulation of cytoskeleton organization,BP,RGS4;PDGFRA;SNCA;SLC39A12;SYNPO;LPAR1
13429,GO:0050900,0.118196916597272,0.95439695683172,5,401,leukocyte migration,BP,MAG;RARRES2;PADI2;CXCL14;GREM1
16796,GO:0072562,0.118251677224523,0.978561709503428,2,92,blood microparticle,CC,TF;SERPINA3
3541,GO:0007039,0.118431316067754,0.993128742469483,1,19,protein catabolic process in the vacuole,BP,LRP2
11740,GO:0045056,0.118728553241667,0.993093416575238,1,19,transcytosis,BP,LRP2
6281,GO:0018193,0.11981268706316,0.935047514545244,11,1135,peptidyl-amino acid modification,BP,CAMK2A;FOLH1;EPHB6;PADI2;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;CCK;SPOCK3
13391,GO:0050852,0.120113637078976,0.967192012482904,3,187,T cell receptor signaling pathway,BP,TESPA1;MOG;ICOSLG
10680,GO:0042401,0.120570472625283,0.992853400869334,1,20,cellular biogenic amine biosynthetic process,BP,MOXD1
7816,GO:0031406,0.120781215609975,0.966930835754067,3,187,carboxylic acid binding,MF,CD22;MAG;HAPLN2
8177,GO:0032098,0.120958001071353,0.992806312617218,1,20,regulation of appetite,BP,CCK
4746,GO:0010522,0.121077124866997,0.977744796730019,2,92,regulation of calcium ion transport into cytosol,BP,SNCA;RYR2
5860,GO:0016485,0.121291379557992,0.966730788619404,3,187,protein processing,BP,MYRF;KLK6;CNTN2
10544,GO:0042104,0.121310203300833,0.992763376368441,1,20,positive regulation of activated T cell proliferation,BP,ICOSLG
14424,GO:0060231,0.121434102716072,0.99274824023371,1,20,mesenchymal to epithelial transition,BP,GREM1
10290,GO:0036499,0.121448682041231,0.992746458065842,1,20,PERK-mediated unfolded protein response,BP,BOK
18597,GO:0140467,0.121448682041231,0.992746458065842,1,20,integrated stress response signaling,BP,BOK
16263,GO:0071577,0.121545518942988,0.992734614961463,1,20,zinc ion transmembrane transport,BP,SLC39A12
8685,GO:0032891,0.121969689764019,0.992682619841639,1,20,negative regulation of organic acid transport,BP,RGS4
9661,GO:0035327,0.122212319052069,0.992652790874038,1,20,transcriptionally active chromatin,CC,PADI2
16807,GO:0072576,0.122397987856771,0.992629921722084,1,20,liver morphogenesis,BP,FGF1
17835,GO:0098703,0.122762820096358,0.992584876224522,1,20,calcium ion import across plasma membrane,BP,SLC24A2
2602,GO:0005540,0.122876097104771,0.992570860759224,1,20,hyaluronic acid binding,MF,HAPLN2
19653,GO:1903010,0.122906977489545,0.992567037605302,1,20,regulation of bone development,BP,GREM1
20774,GO:1905208,0.122919200095216,0.992565524097798,1,20,negative regulation of cardiocyte differentiation,BP,RGS4
9798,GO:0035584,0.122925370850014,0.992564759920861,1,20,calcium-mediated signaling using intracellular calcium source,BP,RYR2
5672,GO:0016082,0.12338447013503,0.992507790308186,1,20,synaptic vesicle priming,BP,SNCA
12872,GO:0048259,0.12339122412766,0.977063331644529,2,93,regulation of receptor-mediated endocytosis,BP,TF;GREM1
10047,GO:0035994,0.123447196400493,0.992542029878442,1,18,response to muscle stretch,BP,RYR2
526,GO:0001657,0.123565327570518,0.977011996273337,2,93,ureteric bud development,BP,FGF1;GREM1
7005,GO:0022038,0.123601255763983,0.992480810171942,1,20,corpus callosum development,BP,LPAR1
790,GO:0002027,0.123642127171352,0.976989337173558,2,93,regulation of heart rate,BP,RGS4;RYR2
4986,GO:0010881,0.123898520557777,0.992443731323973,1,20,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,RYR2
6970,GO:0021953,0.123942043690946,0.965685071096268,3,187,central nervous system neuron differentiation,BP,EPHB6;NKX6-2;CNTN2
15841,GO:0070840,0.124035095817701,0.992426663772718,1,20,dynein complex binding,MF,SNCA
9619,GO:0035249,0.124054841963842,0.976867419055524,2,93,synaptic transmission, glutamatergic,BP,SLC17A7;GRM3
14433,GO:0060249,0.124232883361464,0.951335780427723,5,405,anatomical structure homeostasis,BP,TF;SLC17A7;SPP1;SERPINA3;MBP
11828,GO:0045216,0.125020796659115,0.965254921904984,3,188,cell-cell junction organization,BP,CLDN11;CLDN10;GJB1
16840,GO:0072676,0.12513953319917,0.976538830522742,2,95,lymphocyte migration,BP,PADI2;CXCL14
11217,GO:0043408,0.125548874506358,0.941846962521027,7,644,regulation of MAPK cascade,BP,TF;FGF1;RGS4;CHI3L1;PDGFRA;GPR37;LPAR1
5958,GO:0016651,0.125711614001595,0.97636505675861,2,96,oxidoreductase activity, acting on NAD(P)H,MF,CBR1;CYB5R2
16591,GO:0072163,0.126053583327194,0.976269852542667,2,94,mesonephric epithelium development,BP,FGF1;GREM1
16592,GO:0072164,0.126053583327194,0.976269852542667,2,94,mesonephric tubule development,BP,FGF1;GREM1
4447,GO:0009309,0.126152890851807,0.992140611394684,1,21,amine biosynthetic process,BP,MOXD1
16068,GO:0071280,0.126371028825503,0.992112743406572,1,21,cellular response to copper ion,BP,SNCA
4406,GO:0009220,0.126411047059781,0.992107625301053,1,21,pyrimidine ribonucleotide biosynthetic process,BP,AK5
4821,GO:0010648,0.126465199299418,0.928901068737704,12,1281,negative regulation of cell communication,BP,CD22;MAOB;LRP2;PADI2;RGS4;SNCA;SLC24A2;VSNL1;HHIP;GREM1;BOK;LPAR1
2601,GO:0005539,0.126537974446501,0.964646065357443,3,190,glycosaminoglycan binding,MF,FGF1;HAPLN2;SPOCK3
17013,GO:0090025,0.126609208079833,0.99208225595804,1,21,regulation of monocyte chemotaxis,BP,GREM1
14187,GO:0055003,0.12670122633956,0.992133723650573,1,18,cardiac myofibril assembly,BP,PDGFRA
5568,GO:0015874,0.127168848370426,0.992010377895965,1,21,norepinephrine transport,BP,SNCA
12438,GO:0046625,0.12745727474646,0.99197320037417,1,21,sphingolipid binding,MF,MAG
4838,GO:0010669,0.127715758854045,0.99193980536315,1,21,epithelial structure maintenance,BP,SERPINA3
7396,GO:0030539,0.127734651942153,0.991937361604816,1,21,male genitalia development,BP,PDGFRA
19747,GO:1903205,0.127753896345322,0.991934872005243,1,21,regulation of hydrogen peroxide-induced cell death,BP,GPR37
19804,GO:1903319,0.127792148127583,0.991929922271122,1,21,positive regulation of protein maturation,BP,CNTN2
5305,GO:0015145,0.127850897532935,0.991922317065049,1,21,monosaccharide transmembrane transporter activity,MF,SLC5A11
7084,GO:0023057,0.128013967327961,0.927871424930687,12,1284,negative regulation of signaling,BP,CD22;MAOB;LRP2;PADI2;RGS4;SNCA;SLC24A2;VSNL1;HHIP;GREM1;BOK;LPAR1
6923,GO:0021871,0.128030747337384,0.991899011835141,1,21,forebrain regionalization,BP,EMX2
4908,GO:0010771,0.128033057206903,0.975672102889366,2,95,negative regulation of cell morphogenesis involved in differentiation,BP,MAG;SPP1
13699,GO:0051341,0.128056090427322,0.97566166598684,2,96,regulation of oxidoreductase activity,BP,SNCA;S100A1
13189,GO:0050145,0.128177464368516,0.991879973894867,1,21,nucleoside monophosphate kinase activity,MF,AK5
12129,GO:0045932,0.128272092165009,0.991867682584688,1,21,negative regulation of muscle contraction,BP,DOCK5
19503,GO:1902656,0.128455526055173,0.991843828347861,1,21,calcium ion import into cytosol,BP,SLC24A2
3348,GO:0006721,0.12845732815761,0.975540474001089,2,96,terpenoid metabolic process,BP,LRP2;RARRES2
4044,GO:0008406,0.128561329074231,0.963831232749797,3,191,gonad development,BP,LRP2;PDGFRA;BOK
718,GO:0001932,0.128689899176803,0.927421521632524,12,1283,regulation of protein phosphorylation,BP,TF;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;LPAR1
20096,GO:1903861,0.128961524220592,0.991777836761005,1,21,positive regulation of dendrite extension,BP,CPNE6
5205,GO:0014850,0.129155705227477,0.991752437776077,1,21,response to muscle activity,BP,RYR2
19371,GO:1902307,0.129207666701018,0.991745634207335,1,21,positive regulation of sodium ion transmembrane transport,BP,FXYD1
1818,GO:0004114,0.129275160164988,0.991736792559665,1,21,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE1C
3817,GO:0008021,0.129422989690031,0.963481485035773,3,192,synaptic vesicle,CC,SLC17A7;LGI3;SV2B
4906,GO:0010769,0.129442598328415,0.955026912344441,4,295,regulation of cell morphogenesis involved in differentiation,BP,MAG;SPP1;DOCK5;CNTN2
9390,GO:0034593,0.129442876850553,0.991714800133934,1,21,phosphatidylinositol bisphosphate phosphatase activity,MF,SYNJ2
7606,GO:0031032,0.129573374392547,0.963426887496767,3,188,actomyosin structure organization,BP,PDGFRA;CSRP1;LPAR1
1632,GO:0003779,0.130399006933249,0.948158262371183,5,405,actin binding,MF,GAS7;ERMN;SNCA;MOBP;SYNPO
9212,GO:0034220,0.130621636386447,0.930164458551145,10,1026,ion transmembrane transport,BP,ASIC4;LRP2;SLC17A7;RGS4;SNCA;SLC39A12;SLC24A2;S100A1;RYR2;FXYD1
2461,GO:0005184,0.130622378279408,0.991540936032814,1,22,neuropeptide hormone activity,MF,CCK
8241,GO:0032231,0.130767466347446,0.974838102024162,2,96,regulation of actin filament bundle assembly,BP,SYNPO;LPAR1
20529,GO:1904738,0.131046827499157,0.991502924523959,1,21,vascular associated smooth muscle cell migration,BP,DOCK5
20539,GO:1904752,0.131046827499157,0.991502924523959,1,21,regulation of vascular associated smooth muscle cell migration,BP,DOCK5
20177,GO:1904019,0.131924457435219,0.974479819230899,2,97,epithelial cell apoptotic process,BP,BOK;RYR2
14909,GO:0060996,0.132046276709971,0.974445927071583,2,96,dendritic spine development,BP,CAMK2A;LPAR1
3341,GO:0006706,0.132074577307402,0.991346943578427,1,22,steroid catabolic process,BP,SPP1
7443,GO:0030658,0.132269667020455,0.962320152454045,3,194,transport vesicle membrane,CC,SLC17A7;NRGN;SV2B
7044,GO:0022829,0.132329861429167,0.991312602314195,1,22,wide pore channel activity,MF,GJB1
18941,GO:1901215,0.132457772610327,0.962243193461241,3,194,negative regulation of neuron death,BP,MAG;SNCA;BOK
643,GO:0001823,0.132461157120923,0.974314589615951,2,97,mesonephros development,BP,FGF1;GREM1
2097,GO:0004622,0.132593865152084,0.991277012827746,1,22,lysophospholipase activity,MF,ENPP2
12137,GO:0045940,0.132654836784917,0.991268782561528,1,22,positive regulation of steroid metabolic process,BP,FGF1
20930,GO:1905523,0.132697540680724,0.991263015737937,1,22,positive regulation of macrophage migration,BP,RARRES2
9148,GO:0034114,0.132747950973405,0.991256205648876,1,22,regulation of heterotypic cell-cell adhesion,BP,MBP
15038,GO:0061217,0.132869958689433,0.991239711680608,1,22,regulation of mesonephros development,BP,GREM1
3925,GO:0008209,0.133070076356508,0.99121262278537,1,22,androgen metabolic process,BP,SPP1
18898,GO:1901071,0.133076436994007,0.991211761057281,1,22,glucosamine-containing compound metabolic process,BP,CHI3L1
19226,GO:1901984,0.133240943087591,0.991189458615408,1,22,negative regulation of protein acetylation,BP,SNCA
13396,GO:0050857,0.133256385530256,0.991187363523718,1,22,positive regulation of antigen receptor-mediated signaling pathway,BP,TESPA1
6732,GO:0021513,0.133425220111011,0.991164440469952,1,22,spinal cord dorsal/ventral patterning,BP,NKX6-2
12585,GO:0046942,0.133443933383321,0.953124621038956,4,302,carboxylic acid transport,BP,LRP2;SLC17A7;RGS4;CCK
710,GO:0001919,0.133452629895857,0.991160716025205,1,22,regulation of receptor recycling,BP,SNCA
20349,GO:1904385,0.133523343794157,0.991151103598802,1,22,cellular response to angiotensin,BP,CAMK2A
19856,GO:1903409,0.133558175424597,0.973971988574708,2,98,reactive oxygen species biosynthetic process,BP,MAOB;SNCA
7736,GO:0031280,0.13356396071281,0.991145579891158,1,22,negative regulation of cyclase activity,BP,GRM3
12970,GO:0048520,0.133658783290839,0.991132677412123,1,22,positive regulation of behavior,BP,CCK
11138,GO:0043279,0.133763530001564,0.973908319050557,2,98,response to alkaloid,BP,RGS4;RYR2
4135,GO:0008543,0.133823309103017,0.973889773168859,2,98,fibroblast growth factor receptor signaling pathway,BP,FGF1;HHIP
11542,GO:0044321,0.133991266760293,0.991087358376315,1,22,response to leptin,BP,LRP2
4596,GO:0009931,0.134060576206056,0.991077895863935,1,22,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A
9211,GO:0034219,0.134093707304313,0.973805819647236,2,98,carbohydrate transmembrane transport,BP,SLC5A11;TMEM144
15483,GO:0070168,0.13412681220503,0.99106884801757,1,22,negative regulation of biomineral tissue development,BP,GREM1
18419,GO:0110150,0.13412681220503,0.99106884801757,1,22,negative regulation of biomineralization,BP,GREM1
12256,GO:0046174,0.134404661734748,0.991030841141271,1,22,polyol catabolic process,BP,SYNJ2
8366,GO:0032414,0.134527799960555,0.973670819117488,2,98,positive regulation of ion transmembrane transporter activity,BP,S100A1;RYR2
15447,GO:0070102,0.134649442262562,0.990997287361735,1,22,interleukin-6-mediated signaling pathway,BP,ST18
9252,GO:0034330,0.135058354944517,0.936296326111364,7,650,cell junction organization,BP,CLDN11;CLDN10;SNCA;GREM1;GJB1;SYNPO;CNTN2
4813,GO:0010640,0.135063941113782,0.990940318680682,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,SNCA
18077,GO:0099094,0.135421677817272,0.973391963048338,2,98,ligand-gated cation channel activity,MF,ASIC4;RYR2
11783,GO:0045137,0.13582130251864,0.960855165232969,3,196,development of primary sexual characteristics,BP,LRP2;PDGFRA;BOK
18812,GO:1900273,0.135994306398532,0.99081176018317,1,22,positive regulation of long-term synaptic potentiation,BP,NRGN
3407,GO:0006821,0.136085947492377,0.973180396487632,2,99,chloride transport,BP,SLC17A7;FXYD1
5037,GO:0010942,0.136433914847541,0.935481288296557,7,659,positive regulation of cell death,BP,CAMK2A;SNCA;ST18;MAL;BOK;CCK;LPAR1
14333,GO:0060079,0.136484481098218,0.973055293711088,2,99,excitatory postsynaptic potential,BP,SLC17A7;RGS4
9837,GO:0035637,0.136837615913754,0.960435036641181,3,195,multicellular organismal signaling,BP,MAG;RYR2;FXYD1
2407,GO:0005112,0.136872957146718,0.990689471329047,1,22,Notch binding,MF,DLL3
5550,GO:0015849,0.136877997906861,0.951476546592197,4,305,organic acid transport,BP,LRP2;SLC17A7;RGS4;CCK
13117,GO:0048799,0.137090687171864,0.990659036384511,1,22,animal organ maturation,BP,GREM1
18945,GO:1901222,0.13729821415326,0.972795579556585,2,100,regulation of NIK/NF-kappaB signaling,BP,CHI3L1;GREM1
4404,GO:0009218,0.137648712976103,0.990562212420202,1,23,pyrimidine ribonucleotide metabolic process,BP,AK5
6283,GO:0018195,0.137833241012197,0.990536213948041,1,23,peptidyl-arginine modification,BP,PADI2
7453,GO:0030672,0.137908558435666,0.972602796228962,2,100,synaptic vesicle membrane,CC,SLC17A7;SV2B
18127,GO:0099501,0.137908558435666,0.972602796228962,2,100,exocytic vesicle membrane,CC,SLC17A7;SV2B
729,GO:0001944,0.138307182435052,0.93437234328853,7,657,vasculature development,BP,LRP2;FGF1;CHI3L1;PDGFRA;ENPP2;S100A1;GREM1
10928,GO:0042923,0.138317950066533,0.990467742872375,1,23,neuropeptide binding,MF,GPR37
13947,GO:0051861,0.138372286907462,0.990460050909637,1,23,glycolipid binding,MF,MAG
3774,GO:0007586,0.138376060535033,0.972451235472047,2,101,digestion,BP,CCK;SERPINA3
19936,GO:1903561,0.138424317040374,0.914883592689414,16,1845,extracellular vesicle,CC,CD22;BCAS1;LRP2;FOLH1;TF;CPNE6;PADI2;SPP1;CHI3L1;ERMN;SLC39A12;CSRP1;CBR1;ICOSLG;SERPINI1;SERPINA3
2820,GO:0005921,0.138457011823966,0.990448050662565,1,23,gap junction,CC,GJB1
12571,GO:0046916,0.138491877896719,0.972414509579274,2,101,cellular transition metal ion homeostasis,BP,TF;SLC39A12
7909,GO:0031579,0.13852064214287,0.990439032977619,1,23,membrane raft organization,BP,MAL
13521,GO:0051047,0.138651351363809,0.95062038961848,4,305,positive regulation of secretion,BP,SPP1;SNCA;VSNL1;CCK
7251,GO:0030247,0.138684124970683,0.990415843630402,1,23,polysaccharide binding,MF,ENPP2
590,GO:0001759,0.138749354893135,0.990406582775418,1,23,organ induction,BP,FGF1
17753,GO:0098533,0.138800226275627,0.990399357165196,1,23,ATPase dependent transmembrane transport complex,CC,FXYD1
10986,GO:0043027,0.138864492073138,0.990390224953881,1,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,SNCA
13562,GO:0051119,0.139097873196692,0.990357022842274,1,23,sugar transmembrane transporter activity,MF,SLC5A11
11998,GO:0045686,0.139118014315498,0.990354154622749,1,23,negative regulation of glial cell differentiation,BP,NKX6-2
19011,GO:1901380,0.139241240725858,0.990336596626905,1,23,negative regulation of potassium ion transmembrane transport,BP,RGS4
11102,GO:0043230,0.139331584047167,0.914237107901191,16,1847,extracellular organelle,CC,CD22;BCAS1;LRP2;FOLH1;TF;CPNE6;PADI2;SPP1;CHI3L1;ERMN;SLC39A12;CSRP1;CBR1;ICOSLG;SERPINI1;SERPINA3
9046,GO:0033688,0.139401198416177,0.990313779832768,1,23,regulation of osteoblast proliferation,BP,GREM1
5193,GO:0014829,0.13962915146219,0.99028121495585,1,23,vascular associated smooth muscle contraction,BP,DOCK5
4966,GO:0010857,0.139642235532526,0.990279344044559,1,23,calcium-dependent protein kinase activity,MF,CAMK2A
842,GO:0002092,0.139777771195981,0.990259952416633,1,23,positive regulation of receptor internalization,BP,GREM1
18178,GO:0099563,0.139793282314592,0.990257731879102,1,23,modification of synaptic structure,BP,SYNPO
16496,GO:0072009,0.139857880871362,0.971983468681769,2,100,nephron epithelium development,BP,FGF1;GREM1
16627,GO:0072202,0.139947392725578,0.990235655267063,1,23,cell differentiation involved in metanephros development,BP,GREM1
20094,GO:1903859,0.140087017767369,0.990215630950828,1,23,regulation of dendrite extension,BP,CPNE6
5528,GO:0015813,0.140221131796622,0.990196376618124,1,23,L-glutamate transmembrane transport,BP,SLC17A7
16499,GO:0072012,0.14026260532381,0.990190418350543,1,23,glomerulus vasculature development,BP,PDGFRA
1816,GO:0004112,0.14060960205435,0.990140492440401,1,23,cyclic-nucleotide phosphodiesterase activity,MF,PDE1C
7306,GO:0030325,0.140697341380587,0.990127847317184,1,23,adrenal gland development,BP,PDGFRA
538,GO:0001672,0.140941573283936,0.990092603208238,1,23,regulation of chromatin assembly or disassembly,BP,PADI2
524,GO:0001655,0.141075275285572,0.949442127571515,4,306,urogenital system development,BP,FGF1;PDGFRA;GREM1;EMX2
2590,GO:0005520,0.141252460254679,0.990047644481348,1,23,insulin-like growth factor binding,MF,LRP2
16978,GO:0086064,0.141389395489897,0.990027807592224,1,23,cell communication by electrical coupling involved in cardiac conduction,BP,RYR2
3724,GO:0007413,0.141575231165706,0.990000853475701,1,23,axonal fasciculation,BP,CNTN2
18340,GO:0106030,0.141575231165706,0.990000853475701,1,23,neuron projection fasciculation,BP,CNTN2
4511,GO:0009612,0.141832639513663,0.958335725801797,3,198,response to mechanical stimulus,BP,MAG;CHI3L1;RYR2
13892,GO:0051716,0.141967548055392,0.89858313822898,46,6196,cellular response to stimulus,BP,CD22;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NRGN;PDE1C;ICOSLG;S100A1;VSNL1;HHIP;GREM1;PPP1R14A;KLK6;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;MBP;LPAR1;RYR2;GRM3
9490,GO:0034754,0.142272965309457,0.971197725952395,2,103,cellular hormone metabolic process,BP,SPP1;PDGFRA
11773,GO:0045121,0.142392056870952,0.948796322559457,4,309,membrane raft,CC,SYNJ2;MAG;MAL;FXYD1
13427,GO:0050896,0.142890026976667,0.897628961985732,54,7419,response to stimulus,BP,CD22;MAOB;CAMK2A;ASIC4;DCX;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;ENPP2;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NRGN;PDE1C;SLC24A2;CSRP1;ICOSLG;S100A1;VSNL1;HHIP;GREM1;PPP1R14A;KLK6;EMX2;GPR37;SYNPO;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;SERPINA3;MBP;LPAR1;RYR2;GRM3
16047,GO:0071241,0.142978327799041,0.95784538041926,3,201,cellular response to inorganic substance,BP,TF;CPNE6;SNCA
3926,GO:0008210,0.143612657895607,0.989684279769076,1,24,estrogen metabolic process,BP,PDGFRA
17923,GO:0098857,0.143618720157585,0.948194222572973,4,310,membrane microdomain,CC,SYNJ2;MAG;MAL;FXYD1
98,GO:0000188,0.143894079747549,0.989642677093917,1,24,inactivation of MAPK activity,BP,RGS4
6592,GO:0019722,0.14403847757118,0.957394417371543,3,201,calcium-mediated signaling,BP,CD22;RCAN2;RYR2
3522,GO:0007009,0.14414574166504,0.97059441989144,2,102,plasma membrane organization,BP,PACSIN1;MYRF
8183,GO:0032104,0.144173414918132,0.989601295399191,1,24,regulation of response to extracellular stimulus,BP,CCK
8186,GO:0032107,0.144173414918132,0.989601295399191,1,24,regulation of response to nutrient levels,BP,CCK
3412,GO:0006829,0.144395858437409,0.98956827946734,1,24,zinc ion transport,BP,SLC39A12
4830,GO:0010661,0.144456649569292,0.989559246988331,1,24,positive regulation of muscle cell apoptotic process,BP,CAMK2A
13708,GO:0051350,0.144646682727232,0.989530984802922,1,24,negative regulation of lyase activity,BP,GRM3
8729,GO:0032958,0.144779510430051,0.989511206373561,1,24,inositol phosphate biosynthetic process,BP,SNCA
3405,GO:0006817,0.144835805471161,0.989502817925781,1,24,phosphate ion transport,BP,SLC17A7
6730,GO:0021511,0.145299914811945,0.989433526533769,1,24,spinal cord patterning,BP,NKX6-2
7059,GO:0022853,0.145312158073576,0.956848881110069,3,202,active ion transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
5430,GO:0015491,0.145459701294513,0.98940961468396,1,24,cation:cation antiporter activity,MF,SLC24A2
5026,GO:0010927,0.145528694995968,0.970150593789281,2,100,cellular component assembly involved in morphogenesis,BP,PDGFRA;CSRP1
3603,GO:0007169,0.145536040773626,0.930046433300244,7,668,transmembrane receptor protein tyrosine kinase signaling pathway,BP,EPHB6;RARRES2;FGF1;PDGFRA;SNCA;HHIP;GREM1
14507,GO:0060343,0.145536072090953,0.989398175795344,1,24,trabecula formation,BP,GREM1
3632,GO:0007205,0.145648464101424,0.989381329741425,1,24,protein kinase C-activating G protein-coupled receptor signaling pathway,BP,CCK
11410,GO:0043951,0.145659071140597,0.989379739158324,1,24,negative regulation of cAMP-mediated signaling,BP,LPAR1
9925,GO:0035767,0.145672460952641,0.989377731103458,1,24,endothelial cell chemotaxis,BP,FGF1
11692,GO:0044853,0.145771255579656,0.9700599494586,2,103,plasma membrane raft,CC,MAL;FXYD1
11214,GO:0043405,0.146685856771085,0.94667918536119,4,313,regulation of MAP kinase activity,BP,TF;FGF1;RGS4;LPAR1
8261,GO:0032269,0.146766056463727,0.922369370919387,9,925,negative regulation of cellular protein metabolic process,BP,HHATL;RGS4;SNCA;SERPINI1;GREM1;PPP1R14A;SPOCK3;SERPINA3;FXYD1
3997,GO:0008324,0.147141297411098,0.93362623185742,6,547,cation transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2
7832,GO:0031430,0.147559746959048,0.989092687366662,1,24,M band,CC,S100A1
13027,GO:0048638,0.14785116667137,0.946102207325935,4,312,regulation of developmental growth,BP,CPNE6;MAG;RGS4;SPP1
4286,GO:0009074,0.14839700720626,0.988946745540041,1,25,aromatic amino acid family catabolic process,BP,CARNS1
447,GO:0001516,0.148711462217972,0.988898491102564,1,25,prostaglandin biosynthetic process,BP,CBR1
12344,GO:0046457,0.148711462217972,0.988898491102564,1,25,prostanoid biosynthetic process,BP,CBR1
5378,GO:0015291,0.149249027600041,0.955148100899153,3,205,secondary active transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
10783,GO:0042592,0.149326421118419,0.908415432437975,15,1727,homeostatic process,BP,TF;SLC17A7;SPP1;PDGFRA;SNCA;SLC39A12;SLC24A2;VSNL1;SYNPO;BOK;CCK;SERPINA3;MBP;LPAR1;RYR2
13696,GO:0051338,0.149405217099374,0.920664260871593,9,927,regulation of transferase activity,BP,TF;EPHB6;FGF1;RGS4;CHI3L1;PDGFRA;SNCA;GREM1;LPAR1
4895,GO:0010758,0.149568831271278,0.988766358746196,1,25,regulation of macrophage chemotaxis,BP,RARRES2
10863,GO:0042755,0.149590525978436,0.988763004554216,1,25,eating behavior,BP,CCK
11983,GO:0045662,0.149630722986478,0.988756788342751,1,25,negative regulation of myoblast differentiation,BP,CXCL14
18706,GO:1900101,0.149731330200196,0.988741222096697,1,25,regulation of endoplasmic reticulum unfolded protein response,BP,BOK
3499,GO:0006972,0.149826047579837,0.988726556719371,1,25,hyperosmotic response,BP,ICOSLG
8806,GO:0033081,0.149854747473588,0.988722111032439,1,25,regulation of T cell differentiation in thymus,BP,TESPA1
10268,GO:0036474,0.149890107160994,0.988716632449994,1,25,cell death in response to hydrogen peroxide,BP,GPR37
11241,GO:0043457,0.149895302259502,0.988715827409684,1,25,regulation of cellular respiration,BP,SNCA
1862,GO:0004181,0.149910799660715,0.988713425728269,1,25,metallocarboxypeptidase activity,MF,FOLH1
14938,GO:0061037,0.15007497254223,0.988687966711882,1,25,negative regulation of cartilage development,BP,GREM1
14203,GO:0055022,0.150122733534321,0.988680554497837,1,25,negative regulation of cardiac muscle tissue growth,BP,RGS4
14992,GO:0061117,0.150122733534321,0.988680554497837,1,25,negative regulation of heart growth,BP,RGS4
4805,GO:0010632,0.150344876901183,0.954672103106933,3,205,regulation of epithelial cell migration,BP,FGF1;ENPP2;DOCK5
21369,GO:1990776,0.150633571143929,0.988601114737225,1,25,response to angiotensin,BP,CAMK2A
13001,GO:0048583,0.150669953518754,0.895913795817057,29,3708,regulation of response to stimulus,BP,CD22;CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;TESPA1;MOG;SNCA;CXCL14;ST18;ICOSLG;VSNL1;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;GPR62;CNTN2;CCK;LPAR1
19949,GO:1903579,0.150710597163472,0.988589110974222,1,25,negative regulation of ATP metabolic process,BP,SNCA
6214,GO:0017157,0.150773764712232,0.954483715886364,3,206,regulation of exocytosis,BP,SNCA;VSNL1;LGI3
8089,GO:0031954,0.150944293384929,0.988552650704091,1,25,positive regulation of protein autophosphorylation,BP,GREM1
6938,GO:0021895,0.151060365809443,0.988534518680376,1,25,cerebral cortex neuron differentiation,BP,CNTN2
4795,GO:0010614,0.151324968850624,0.988493127390799,1,25,negative regulation of cardiac muscle hypertrophy,BP,RGS4
16448,GO:0071902,0.151384535419221,0.944333815739115,4,317,positive regulation of protein serine/threonine kinase activity,BP,TF;FGF1;SNCA;LPAR1
15105,GO:0061437,0.151429836503314,0.98847670129535,1,25,renal system vasculature development,BP,PDGFRA
15108,GO:0061440,0.151429836503314,0.98847670129535,1,25,kidney vasculature development,BP,PDGFRA
12829,GO:0048169,0.151444472569723,0.988474407766543,1,25,regulation of long-term neuronal synaptic plasticity,BP,SYNPO
13055,GO:0048679,0.151551417341541,0.988457641761025,1,25,regulation of axon regeneration,BP,SPP1
16670,GO:0072273,0.15171959641158,0.988431249768405,1,25,metanephric nephron morphogenesis,BP,GREM1
789,GO:0002026,0.15179664386428,0.98841914820011,1,25,regulation of the force of heart contraction,BP,RYR2
17815,GO:0098661,0.152080479719641,0.967952388917607,2,106,inorganic anion transmembrane transport,BP,SLC17A7;FXYD1
8363,GO:0032411,0.152154869189309,0.967927325645872,2,106,positive regulation of transporter activity,BP,S100A1;RYR2
12464,GO:0046660,0.152160481756023,0.967925434342752,2,106,female sex differentiation,BP,LRP2;PDGFRA
18180,GO:0099565,0.152333035427737,0.967867265950898,2,106,chemical synaptic transmission, postsynaptic,BP,SLC17A7;RGS4
4987,GO:0010882,0.15251971092223,0.988305251751528,1,25,regulation of cardiac muscle contraction by calcium ion signaling,BP,RYR2
13045,GO:0048668,0.152664901650681,0.988282310267219,1,25,collateral sprouting,BP,SPP1
3619,GO:0007189,0.152869563072397,0.967682490708248,2,107,adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,S1PR5;LPAR1
2648,GO:0005640,0.153347060308331,0.988174203640605,1,25,nuclear outer membrane,CC,BOK
11364,GO:0043666,0.153435175982355,0.967491072961277,2,107,regulation of phosphoprotein phosphatase activity,BP,PPP1R14A;RCAN2
7810,GO:0031400,0.153664298240934,0.929833181901562,6,556,negative regulation of protein modification process,BP,HHATL;RGS4;SNCA;GREM1;PPP1R14A;FXYD1
9219,GO:0034237,0.153672004234093,0.988122522237142,1,25,protein kinase A regulatory subunit binding,MF,RYR2
6041,GO:0016810,0.15373800775389,0.967384798439336,2,108,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,PADI2;GDA
832,GO:0002082,0.154435999876985,0.987982339968737,1,26,regulation of oxidative phosphorylation,BP,SNCA
745,GO:0001963,0.154515289174962,0.987969623765266,1,26,synaptic transmission, dopaminergic,BP,SNCA
6288,GO:0018200,0.15478143672983,0.987926887556921,1,26,peptidyl-glutamic acid modification,BP,FOLH1
8603,GO:0032770,0.154893311847414,0.987908899384251,1,26,positive regulation of monooxygenase activity,BP,S100A1
7166,GO:0030137,0.154910658770998,0.987906108934945,1,26,COPI-coated vesicle,CC,PACSIN1
6463,GO:0019239,0.154913921411859,0.987905584063996,1,26,deaminase activity,MF,GDA
5034,GO:0010939,0.155055610115413,0.98788277850911,1,26,regulation of necrotic cell death,BP,BOK
3371,GO:0006760,0.15513680089106,0.987869700142648,1,26,folic acid-containing compound metabolic process,BP,FOLH1
13394,GO:0050855,0.155270983640799,0.987848069312312,1,26,regulation of B cell receptor signaling pathway,BP,CD22
5268,GO:0015077,0.155283890217463,0.94236501783827,4,320,monovalent inorganic cation transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC24A2;SLC5A11
654,GO:0001835,0.155413133672737,0.98782513180771,1,26,blastocyst hatching,BP,NECAB1
9598,GO:0035188,0.155413133672737,0.98782513180771,1,26,hatching,BP,NECAB1
16341,GO:0071684,0.155413133672737,0.98782513180771,1,26,organism emergence from protective structure,BP,NECAB1
3468,GO:0006915,0.155642917332576,0.903879420755664,15,1743,apoptotic process,BP,CAMK2A;LRP2;MAG;CHI3L1;SNCA;ST18;SLC5A11;HHIP;GREM1;MAL;BOK;AIFM3;CCK;LPAR1;RYR2
3519,GO:0007006,0.155694427580726,0.966714685234913,2,109,mitochondrial membrane organization,BP,CAMK2A;BOK
13712,GO:0051354,0.155727708919129,0.987774289919581,1,26,negative regulation of oxidoreductase activity,BP,SNCA
6261,GO:0018107,0.155750939604242,0.966702625741457,2,107,peptidyl-threonine phosphorylation,BP,CAMK2A;CHI3L1
13616,GO:0051209,0.15593733020277,0.966638834918449,2,107,release of sequestered calcium ion into cytosol,BP,SNCA;RYR2
4538,GO:0009719,0.156179049816626,0.906770681686999,13,1466,response to endogenous stimulus,BP,MAOB;CAMK2A;LRP2;RARRES2;FGF1;PADI2;RGS4;SPP1;PDGFRA;SNCA;HHIP;GREM1;RYR2
15093,GO:0061387,0.156238380304666,0.96653569884677,2,107,regulation of extent of cell growth,BP,MAG;SPP1
18200,GO:0099604,0.156364908381486,0.987689617718438,1,25,ligand-gated calcium channel activity,MF,RYR2
15614,GO:0070382,0.156593064560052,0.951917490864429,3,210,exocytic vesicle,CC,SLC17A7;LGI3;SV2B
16707,GO:0072337,0.156952406426739,0.987575281471594,1,26,modified amino acid transport,BP,LRP2
17778,GO:0098589,0.156997360080393,0.941493726607463,4,321,membrane region,CC,SYNJ2;MAG;MAL;FXYD1
1522,GO:0003298,0.157082233049377,0.987554085103135,1,26,physiological muscle hypertrophy,BP,RGS4
1525,GO:0003301,0.157082233049377,0.987554085103135,1,26,physiological cardiac muscle hypertrophy,BP,RGS4
14949,GO:0061049,0.157082233049377,0.987554085103135,1,26,cell growth involved in cardiac muscle cell development,BP,RGS4
8263,GO:0032271,0.157191027556636,0.951651773841917,3,210,regulation of protein polymerization,BP,SNCA;SLC39A12;TPPP3
13076,GO:0048705,0.15773826389052,0.951408162661876,3,210,skeletal system morphogenesis,BP,PDGFRA;HHIP;GREM1
13382,GO:0050832,0.158122285946945,0.987365923466005,1,27,defense response to fungus,BP,RARRES2
13665,GO:0051283,0.158195574492762,0.965858305622877,2,108,negative regulation of sequestering of calcium ion,BP,SNCA;RYR2
6969,GO:0021952,0.159281354985312,0.98719212311032,1,26,central nervous system projection neuron axonogenesis,BP,EPHB6
18525,GO:0140058,0.159429397423371,0.987167558018887,1,26,neuron projection arborization,BP,LRP2
5612,GO:0015949,0.159618292806204,0.987118179473488,1,27,nucleobase-containing small molecule interconversion,BP,AK5
12360,GO:0046475,0.160399194245632,0.986987842960888,1,27,glycerophospholipid catabolic process,BP,ENPP2
13664,GO:0051282,0.160470201587273,0.965064772581787,2,109,regulation of sequestering of calcium ion,BP,SNCA;RYR2
13724,GO:0051385,0.16048878028369,0.98697284595879,1,27,response to mineralocorticoid,BP,MAOB
2497,GO:0005262,0.160489957244994,0.965061647405533,2,108,calcium channel activity,MF,SLC24A2;RYR2
4708,GO:0010453,0.160824384500755,0.986916582992508,1,27,regulation of cell fate commitment,BP,NKX6-2
2468,GO:0005217,0.160933713994449,0.986916522431993,1,26,intracellular ligand-gated ion channel activity,MF,RYR2
4510,GO:0009611,0.161038105718212,0.925484181519482,6,563,response to wounding,BP,MAG;FGF1;SPP1;PDGFRA;CSRP1;KLK6
20055,GO:1903792,0.161421251937936,0.986816201298985,1,27,negative regulation of anion transport,BP,RGS4
11892,GO:0045471,0.161622941931513,0.964654304084458,2,111,response to ethanol,BP,MAOB;RGS4
18082,GO:0099106,0.161723554953355,0.964619028527719,2,111,ion channel regulator activity,MF,GRM3;FXYD1
20775,GO:1905209,0.162024359000685,0.986714355423521,1,27,positive regulation of cardiocyte differentiation,BP,GREM1
6273,GO:0018149,0.162159198257,0.98669152823784,1,27,peptide cross-linking,BP,SPOCK3
17829,GO:0098693,0.162257430510708,0.964435300079391,2,110,regulation of synaptic vesicle cycle,BP,SLC17A7;SNCA
5167,GO:0014741,0.162450329901077,0.986642170877878,1,27,negative regulation of muscle hypertrophy,BP,RGS4
17166,GO:0090257,0.162590673364028,0.949224797033503,3,213,regulation of muscle system process,BP,RGS4;DOCK5;RYR2
6602,GO:0019751,0.162609490825905,0.964307799178996,2,111,polyol metabolic process,BP,SYNJ2;SNCA
19143,GO:1901701,0.163000180265054,0.90878600767387,10,1080,cellular response to oxygen-containing compound,BP,CAMK2A;RARRES2;RGS4;SPP1;PDGFRA;SNCA;VSNL1;GPR37;LPAR1;RYR2
3805,GO:0007628,0.163257602229768,0.98650479999405,1,27,adult walking behavior,BP,CNTN2
15768,GO:0070663,0.163283937147233,0.948905928830478,3,216,regulation of leukocyte proliferation,BP,CD22;ICOSLG;GREM1
1425,GO:0003148,0.163302564723075,0.986497126868339,1,27,outflow tract septum morphogenesis,BP,LRP2
81,GO:0000165,0.163482065543398,0.914915803453244,8,820,MAPK cascade,BP,TF;FGF1;RGS4;CHI3L1;PDGFRA;GPR37;MBP;LPAR1
6596,GO:0019731,0.16374720277165,0.986403536334465,1,28,antibacterial humoral response,BP,TF
4985,GO:0010880,0.164137657918817,0.986354190729386,1,27,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,RYR2
6910,GO:0021846,0.164244425144678,0.986335858433745,1,27,cell proliferation in forebrain,BP,EMX2
3841,GO:0008066,0.164395331423127,0.986309924946833,1,27,glutamate receptor activity,MF,GRM3
8727,GO:0032956,0.164773444315205,0.937490143752904,4,326,regulation of actin cytoskeleton organization,BP,RGS4;PDGFRA;SYNPO;LPAR1
5475,GO:0015711,0.165294422302658,0.929193574349447,5,447,organic anion transport,BP,LRP2;SLC17A7;RGS4;CYB5R2;CCK
2479,GO:0005231,0.165737063548882,0.986060178424734,1,28,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7
17956,GO:0098901,0.165817198911732,0.986064287549518,1,27,regulation of cardiac muscle cell action potential,BP,RYR2
18721,GO:1900117,0.165907813344451,0.986030502236833,1,28,regulation of execution phase of apoptosis,BP,BOK
3279,GO:0006629,0.166124801742684,0.904044402903604,11,1221,lipid metabolic process,BP,SYNJ2;LRP2;CPNE6;RARRES2;FGF1;SPP1;PDGFRA;ENPP2;CBR1;CYB5R2;SERPINA3
2910,GO:0006066,0.166135674975516,0.936777502036257,4,330,alcohol metabolic process,BP,SYNJ2;MOXD1;FGF1;SNCA
8883,GO:0033218,0.166173665680394,0.936757701983191,4,330,amide binding,MF,FOLH1;MAG;GPR37;RYR2
7779,GO:0031338,0.166419352131832,0.985941395752767,1,28,regulation of vesicle fusion,BP,SNCA
9499,GO:0034765,0.166537459482502,0.928490845183222,5,446,regulation of ion transmembrane transport,BP,RGS4;SNCA;S100A1;RYR2;FXYD1
9045,GO:0033687,0.166800396681825,0.985874824082108,1,28,osteoblast proliferation,BP,GREM1
8639,GO:0032809,0.166818170118327,0.985871714819905,1,28,neuronal cell body membrane,CC,CD22
9541,GO:0035025,0.166888718086906,0.985859369649095,1,28,positive regulation of Rho protein signal transduction,BP,LPAR1
10496,GO:0040036,0.167168583056094,0.985810339487269,1,28,regulation of fibroblast growth factor receptor signaling pathway,BP,HHIP
7792,GO:0031365,0.167211359366359,0.985802837435408,1,28,N-terminal protein amino acid modification,BP,HHATL
2140,GO:0004683,0.167214386174727,0.985802306517693,1,28,calmodulin-dependent protein kinase activity,MF,CAMK2A
13615,GO:0051208,0.167359685092954,0.96261647187467,2,112,sequestering of calcium ion,BP,SNCA;RYR2
8065,GO:0031904,0.167659789893975,0.985724064958201,1,28,endosome lumen,CC,LRP2
15726,GO:0070570,0.16787152615795,0.98568678998574,1,28,regulation of neuron projection regeneration,BP,SPP1
1573,GO:0003401,0.168076565129666,0.98565064460195,1,28,axis elongation,BP,FGF1
3347,GO:0006720,0.168327729780954,0.962261211767202,2,114,isoprenoid metabolic process,BP,LRP2;RARRES2
12537,GO:0046856,0.16833117507022,0.985605692862425,1,28,phosphatidylinositol dephosphorylation,BP,SYNJ2
5650,GO:0016049,0.168355005339576,0.927457590038272,5,448,cell growth,BP,CPNE6;MAG;RGS4;SPP1;GREM1
21733,GO:2000463,0.16881476112591,0.985520108434336,1,28,positive regulation of excitatory postsynaptic potential,BP,RGS4
10825,GO:0042692,0.168942996481789,0.935312341481418,4,327,muscle cell differentiation,BP,RGS4;PDGFRA;CSRP1;GREM1
3402,GO:0006813,0.169319564363035,0.946141711354338,3,218,potassium ion transport,BP,RGS4;SLC24A2;FXYD1
7069,GO:0023014,0.169757265771765,0.910846133945825,8,828,signal transduction by protein phosphorylation,BP,TF;FGF1;RGS4;CHI3L1;PDGFRA;GPR37;MBP;LPAR1
4465,GO:0009394,0.169958894145042,0.985298907838954,1,29,2'-deoxyribonucleotide metabolic process,BP,AK5
10854,GO:0042744,0.169976218412465,0.985295810220068,1,29,hydrogen peroxide catabolic process,BP,SNCA
2998,GO:0006221,0.170146061226186,0.985265423476264,1,29,pyrimidine nucleotide biosynthetic process,BP,AK5
3145,GO:0006468,0.170904332860618,0.892771827285429,15,1764,protein phosphorylation,BP,CAMK2A;TF;EPHB6;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;GREM1;GPR37;CCK;MBP;LPAR1
13822,GO:0051588,0.170904472883801,0.961328856002213,2,114,regulation of neurotransmitter transport,BP,CAMK2A;SNCA
2740,GO:0005789,0.17102461288878,0.906408289049836,9,963,endoplasmic reticulum membrane,CC,HHATL;MOXD1;MYRF;TESPA1;CYB5R2;GJB1;GPR37;BOK;RYR2
7174,GO:0030149,0.171132617686752,0.985088254953558,1,29,sphingolipid catabolic process,BP,ENPP2
13993,GO:0051930,0.171618704251295,0.985000546064431,1,29,regulation of sensory perception of pain,BP,CCK
1036,GO:0002429,0.17190434366322,0.933744537334911,4,335,immune response-activating cell surface receptor signaling pathway,BP,CD22;TESPA1;MOG;ICOSLG
1240,GO:0002757,0.17190434366322,0.933744537334911,4,335,immune response-activating signal transduction,BP,CD22;TESPA1;MOG;ICOSLG
13003,GO:0048585,0.172300377978456,0.895285790437943,13,1498,negative regulation of response to stimulus,BP,CD22;LRP2;PADI2;RGS4;SPP1;PDGFRA;SNCA;HHIP;GREM1;GPR37;BOK;CCK;LPAR1
4917,GO:0010800,0.172360214939777,0.984866219092201,1,29,positive regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
13388,GO:0050849,0.172360966211693,0.984866082672315,1,29,negative regulation of calcium-mediated signaling,BP,CD22
22,GO:0000041,0.172716261431684,0.960660275928312,2,116,transition metal ion transport,BP,TF;SLC39A12
9398,GO:0034605,0.172829229184659,0.960622600261128,2,115,cellular response to heat,BP,CAMK2A;FGF1
1431,GO:0003158,0.172832497104914,0.960621403062765,2,115,endothelium development,BP,FGF1;HAPLN2
12555,GO:0046887,0.172944758634155,0.960576559182005,2,116,positive regulation of hormone secretion,BP,SPP1;VSNL1
14589,GO:0060441,0.173004146632881,0.984749049354986,1,29,epithelial tube branching involved in lung morphogenesis,BP,HHIP
14862,GO:0060914,0.173031792773019,0.984744008048423,1,29,heart formation,BP,LRP2
8203,GO:0032148,0.173114381881341,0.984728942519808,1,29,activation of protein kinase B activity,BP,FGF1
7168,GO:0030140,0.173164844557578,0.984719733434862,1,29,trans-Golgi network transport vesicle,CC,NRGN
13319,GO:0050730,0.173178431248819,0.94434535698724,3,221,regulation of peptidyl-tyrosine phosphorylation,BP,ENPP2;GREM1;CCK
19534,GO:1902745,0.173316806296517,0.984691983549645,1,29,positive regulation of lamellipodium organization,BP,ENPP2
5385,GO:0015298,0.173480173063537,0.984662120945517,1,29,solute:cation antiporter activity,MF,SLC24A2
17331,GO:0090659,0.174334513068552,0.984505444797482,1,29,walking behavior,BP,CNTN2
3372,GO:0006766,0.17521909547424,0.959735614004407,2,117,vitamin metabolic process,BP,LRP2;CBR1
16947,GO:0086019,0.17587506680178,0.984220770407396,1,29,cell-cell signaling involved in cardiac conduction,BP,RYR2
11767,GO:0045111,0.176003286509393,0.959448985389874,2,116,intermediate filament cytoskeleton,CC,CLDN11;NEFM
13397,GO:0050858,0.176075902195974,0.98416579294914,1,30,negative regulation of antigen receptor-mediated signaling pathway,BP,CD22
9802,GO:0035590,0.176094771678445,0.984162280696157,1,30,purinergic nucleotide receptor signaling pathway,BP,CNTN2
6295,GO:0018210,0.176446532657834,0.959284497625841,2,116,peptidyl-threonine modification,BP,CAMK2A;CHI3L1
6045,GO:0016814,0.176495901767101,0.984087518047025,1,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,GDA
19337,GO:1902235,0.176578916757067,0.984072022160928,1,30,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
5142,GO:0014072,0.176788339540732,0.984032894635034,1,30,response to isoquinoline alkaloid,BP,RGS4
11137,GO:0043278,0.176788339540732,0.984032894635034,1,30,response to morphine,BP,RGS4
13994,GO:0051931,0.176962837048608,0.984000253106899,1,30,regulation of sensory perception,BP,CCK
12119,GO:0045920,0.176967570402832,0.98399936718763,1,30,negative regulation of exocytosis,BP,SNCA
9931,GO:0035774,0.177366396077557,0.983924626511049,1,30,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
11128,GO:0043267,0.177627407399039,0.98387561147869,1,30,negative regulation of potassium ion transport,BP,RGS4
3601,GO:0007167,0.177652385390461,0.901941767849343,9,965,enzyme linked receptor protein signaling pathway,BP,LRP2;TF;EPHB6;RARRES2;FGF1;PDGFRA;SNCA;HHIP;GREM1
5443,GO:0015631,0.178310327479701,0.930330639902831,4,336,tubulin binding,MF,DCX;NEFM;SNCA;TPPP3
5390,GO:0015318,0.1784877463179,0.90955432456342,7,708,inorganic molecular entity transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2;FXYD1
20143,GO:1903959,0.178709637249449,0.983671527379056,1,30,regulation of anion transmembrane transport,BP,RGS4
17061,GO:0090101,0.178733274351513,0.958427737954535,2,117,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1
19911,GO:1903523,0.178857795915982,0.983643480926844,1,30,negative regulation of blood circulation,BP,DOCK5
2697,GO:0005737,0.17906315986529,0.871721432139549,70,10035,cytoplasm,CC,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;MOXD1;LRP2;FOLH1;TF;CPNE6;NEFM;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;GALNT6;SNCA;CXCL14;DOCK5;SLC39A12;CNDP1;AK5;NRGN;PDE1C;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;HHIP;PPP1R14A;KLK6;MOBP;LGI3;GPR37;SYNPO;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;AIFM3;SV2B;SERPINA3;OPALIN;LPAR1;RYR2;TMEM235;MEX3A
12033,GO:0045761,0.179114615599177,0.983594803802266,1,30,regulation of adenylate cyclase activity,BP,GRM3
14162,GO:0052866,0.17936173954838,0.983547891172545,1,30,phosphatidylinositol phosphate phosphatase activity,MF,SYNJ2
14491,GO:0060325,0.179779058337079,0.983468506622968,1,30,face morphogenesis,BP,PDGFRA
13639,GO:0051248,0.179792093340715,0.900488909906372,9,971,negative regulation of protein metabolic process,BP,HHATL;RGS4;SNCA;SERPINI1;GREM1;PPP1R14A;SPOCK3;SERPINA3;FXYD1
4817,GO:0010644,0.180173146175067,0.98339335303383,1,30,cell communication by electrical coupling,BP,RYR2
6585,GO:0019692,0.180606515658569,0.983293117793189,1,31,deoxyribose phosphate metabolic process,BP,AK5
9637,GO:0035270,0.181152390114342,0.957509864100983,2,119,endocrine system development,BP,PDGFRA;NKX6-2
5177,GO:0014808,0.181162752940654,0.983203826088239,1,30,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,RYR2
3442,GO:0006882,0.181173598646673,0.983184253950721,1,31,cellular zinc ion homeostasis,BP,SLC39A12
13774,GO:0051482,0.181441431938123,0.983132705643918,1,31,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,BP,LPAR1
16215,GO:0071495,0.181522559419621,0.893254945487931,11,1237,cellular response to endogenous stimulus,BP,CAMK2A;LRP2;RARRES2;FGF1;PADI2;RGS4;PDGFRA;SNCA;HHIP;GREM1;RYR2
5564,GO:0015868,0.181593098827155,0.983103477656696,1,31,purine ribonucleotide transport,BP,GJB1
14227,GO:0055076,0.181942199457996,0.957207141290405,2,120,transition metal ion homeostasis,BP,TF;SLC39A12
8686,GO:0032892,0.182530886504592,0.982922151681392,1,31,positive regulation of organic acid transport,BP,CCK
8910,GO:0033280,0.182949496863392,0.982840875757362,1,31,response to vitamin D,BP,SPP1
17895,GO:0098810,0.183009686408529,0.982829172527125,1,31,neurotransmitter reuptake,BP,SNCA
11526,GO:0044298,0.183051833630317,0.982820974888098,1,31,cell body membrane,CC,CD22
16476,GO:0071949,0.183226562074207,0.982786967775617,1,31,FAD binding,MF,CYB5R2
10594,GO:0042221,0.183505413358692,0.87004605034058,29,3796,response to chemical,BP,MAOB;CAMK2A;LRP2;TF;CPNE6;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;ENPP2;SNCA;CXCL14;ST18;VSNL1;HHIP;GREM1;PPP1R14A;EMX2;GPR37;BOK;CNTN2;CCK;MBP;LPAR1;RYR2
683,GO:0001881,0.183788321329068,0.98267738871295,1,31,receptor recycling,BP,SNCA
12528,GO:0046839,0.184244058818823,0.982588216206172,1,31,phospholipid dephosphorylation,BP,SYNJ2
14462,GO:0060292,0.184280491462122,0.982581076943915,1,31,long-term synaptic depression,BP,SLC24A2
1546,GO:0003338,0.184523679101596,0.98253338213615,1,31,metanephros morphogenesis,BP,GREM1
15871,GO:0070884,0.184621079866192,0.982514259904125,1,31,regulation of calcineurin-NFAT signaling cascade,BP,RCAN2
17983,GO:0098936,0.184893797755373,0.956082061455779,2,120,intrinsic component of postsynaptic membrane,CC,CNTN2;GRM3
1469,GO:0003206,0.185753347502591,0.95575216165091,2,120,cardiac chamber morphogenesis,BP,LRP2;RYR2
10582,GO:0042175,0.186255049560334,0.896074002000689,9,983,nuclear outer membrane-endoplasmic reticulum membrane network,CC,HHATL;MOXD1;MYRF;TESPA1;CYB5R2;GJB1;GPR37;BOK;RYR2
19903,GO:1903514,0.186400783837172,0.982162877963387,1,31,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,RYR2
3721,GO:0007409,0.18642435505285,0.916970447496238,5,461,axonogenesis,BP,MAG;EPHB6;SPP1;CNTN2;CCK
14220,GO:0055069,0.186538157764083,0.982118221740103,1,32,zinc ion homeostasis,BP,SLC39A12
1488,GO:0003231,0.186756383760801,0.955365903761128,2,120,cardiac ventricle development,BP,LRP2;RYR2
5561,GO:0015865,0.186964879403955,0.982033262473781,1,32,purine nucleotide transport,BP,GJB1
12353,GO:0046466,0.187064564081158,0.982013384280248,1,32,membrane lipid catabolic process,BP,ENPP2
3630,GO:0007202,0.187198118784844,0.981986733507574,1,32,activation of phospholipase C activity,BP,LPAR1
657,GO:0001838,0.187454243448869,0.955092515849314,2,121,embryonic epithelial tube formation,BP,LRP2;GREM1
10757,GO:0042558,0.187526515054219,0.981921111923679,1,32,pteridine-containing compound metabolic process,BP,FOLH1
13042,GO:0048665,0.187644987415859,0.981897406743673,1,32,neuron fate specification,BP,NKX6-2
1202,GO:0002701,0.187709241326652,0.981884543164051,1,32,negative regulation of production of molecular mediator of immune response,BP,CD22
3906,GO:0008180,0.187852775703555,0.981855789941783,1,32,COP9 signalosome,CC,TESPA1
3447,GO:0006887,0.188034969952041,0.898753319840914,8,850,exocytosis,BP,TF;RARRES2;PADI2;CHI3L1;SNCA;VSNL1;LGI3;SERPINA3
15348,GO:0062013,0.188037134777017,0.954863050319768,2,122,positive regulation of small molecule metabolic process,BP,FGF1;SNCA
11561,GO:0044344,0.188291112891621,0.954764563552022,2,122,cellular response to fibroblast growth factor stimulus,BP,FGF1;HHIP
16160,GO:0071417,0.188448764745647,0.908753894554254,6,591,cellular response to organonitrogen compound,BP,CAMK2A;RARRES2;RGS4;PDGFRA;SNCA;RYR2
7776,GO:0031334,0.188472887731209,0.937032179510675,3,230,positive regulation of protein-containing complex assembly,BP,SNCA;TPPP3;CCK
2582,GO:0005506,0.188636952204197,0.954626570212459,2,123,iron ion binding,MF,TF;SNCA
757,GO:0001975,0.188685477561991,0.981688496428914,1,32,response to amphetamine,BP,RGS4
15408,GO:0070050,0.188964169253576,0.9816323214133,1,32,neuron cellular homeostasis,BP,SLC17A7
4722,GO:0010470,0.189070162783727,0.981610932312428,1,32,regulation of gastrulation,BP,MBP
18414,GO:0110111,0.189394838958108,0.981545330454792,1,32,negative regulation of animal organ morphogenesis,BP,GREM1
12503,GO:0046777,0.189440058789813,0.936561920446712,3,229,protein autophosphorylation,BP,CAMK2A;PDGFRA;GREM1
12995,GO:0048565,0.189711822552987,0.954212009459317,2,122,digestive tract development,BP,RARRES2;PDGFRA
18350,GO:0106056,0.190005327236195,0.981421638636815,1,32,regulation of calcineurin-mediated signaling,BP,RCAN2
12096,GO:0045879,0.190060057340816,0.981410527962801,1,32,negative regulation of smoothened signaling pathway,BP,HHIP
16933,GO:0086005,0.191116473978638,0.981195365104297,1,32,ventricular cardiac muscle cell action potential,BP,RYR2
4431,GO:0009262,0.191283963703039,0.981143968243975,1,33,deoxyribonucleotide metabolic process,BP,AK5
12477,GO:0046688,0.191492690836891,0.981101219198511,1,33,response to copper ion,BP,SNCA
2741,GO:0005790,0.192276402506634,0.980957582221884,1,32,smooth endoplasmic reticulum,CC,RYR2
18586,GO:0140353,0.192510691106183,0.980891976274117,1,33,lipid export from cell,BP,SPP1
21698,GO:2000403,0.192585265288213,0.980876599233377,1,33,positive regulation of lymphocyte migration,BP,CXCL14
6204,GO:0017144,0.192624969107924,0.980868409667915,1,33,drug metabolic process,BP,CBR1
8173,GO:0032094,0.192694185978427,0.98085412802955,1,33,response to food,BP,CCK
4309,GO:0009112,0.192874263920931,0.980816945307361,1,33,nucleobase metabolic process,BP,GDA
18890,GO:1901031,0.192875672944943,0.98081665421691,1,33,regulation of response to reactive oxygen species,BP,GPR37
4834,GO:0010665,0.193115280865364,0.980767118940621,1,33,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
4603,GO:0009954,0.19318466640807,0.980752761676014,1,33,proximal/distal pattern formation,BP,GREM1
7275,GO:0030285,0.193230606587825,0.980743252549296,1,33,integral component of synaptic vesicle membrane,CC,SLC17A7
12469,GO:0046676,0.193405033303209,0.980707125012147,1,33,negative regulation of insulin secretion,BP,VSNL1
20836,GO:1905332,0.193743747481959,0.98063686565659,1,33,positive regulation of morphogenesis of an epithelium,BP,GREM1
4755,GO:0010543,0.193755400723247,0.980634445977519,1,33,regulation of platelet activation,BP,PDGFRA
11306,GO:0043552,0.19405238065817,0.980572726011308,1,33,positive regulation of phosphatidylinositol 3-kinase activity,BP,PDGFRA
9834,GO:0035633,0.194379359157973,0.980504649010183,1,33,maintenance of blood-brain barrier,BP,MBP
12434,GO:0046621,0.19450102000652,0.980479286390434,1,33,negative regulation of organ growth,BP,RGS4
17625,GO:0097484,0.1945077704261,0.980477878610383,1,33,dendrite extension,BP,CPNE6
20973,GO:1905606,0.194580555112162,0.980462696099247,1,33,regulation of presynapse assembly,BP,SNCA
3174,GO:0006508,0.194695470174335,0.878939359081092,13,1537,proteolysis,BP,FOLH1;MYRF;SNCA;ST18;CNDP1;SERPINI1;KLK6;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP
12087,GO:0045859,0.19483726303351,0.898937916122847,7,726,regulation of protein kinase activity,BP,TF;FGF1;RGS4;CHI3L1;SNCA;GREM1;LPAR1
4902,GO:0010765,0.194991747296883,0.980376803866988,1,33,positive regulation of sodium ion transport,BP,FXYD1
3811,GO:0008009,0.195023787837213,0.980353316389298,1,34,chemokine activity,MF,CXCL14
4607,GO:0009966,0.195075243968468,0.865802833386601,22,2802,regulation of signal transduction,BP,CD22;CAMK2A;LRP2;TF;FGF1;PADI2;RGS4;CHI3L1;PDGFRA;TESPA1;SNCA;ST18;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;GPR62;CNTN2;LPAR1
6644,GO:0019838,0.195192979716451,0.952046453386702,2,124,growth factor binding,MF,LRP2;PDGFRA
17580,GO:0097386,0.195274561848321,0.98031760985335,1,33,glial cell projection,CC,GRM3
16085,GO:0071312,0.195819389759652,0.980203304222652,1,33,cellular response to alkaloid,BP,RYR2
13623,GO:0051224,0.196100835681826,0.951677423848118,2,126,negative regulation of protein transport,BP,CD22;VSNL1
5723,GO:0016202,0.19629832721415,0.951602419408932,2,125,regulation of striated muscle tissue development,BP,RGS4;GREM1
3830,GO:0008047,0.19657016347858,0.910906586545456,5,474,enzyme activator activity,MF,ADAP1;RGS4;DOCK5;GREM1;MAL
17515,GO:0097242,0.196912698984473,0.979972847777653,1,33,amyloid-beta clearance,BP,LRP2
16446,GO:0071900,0.197144345476571,0.910558903035796,5,476,regulation of protein serine/threonine kinase activity,BP,TF;FGF1;RGS4;SNCA;LPAR1
18889,GO:1901030,0.197302450540054,0.979873164510696,1,34,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
4506,GO:0009605,0.197975261429782,0.866718947258966,19,2383,response to external stimulus,BP,MAOB;CAMK2A;TF;MAG;EPHB6;RARRES2;FGF1;PADI2;SPP1;CHI3L1;PDGFRA;ENPP2;SNCA;CXCL14;GREM1;CNTN2;CCK;LPAR1;RYR2
3934,GO:0008219,0.198053921409497,0.870830867204975,16,1961,cell death,BP,CAMK2A;LRP2;MAG;CHI3L1;SNCA;ST18;SLC5A11;HHIP;GREM1;GPR37;MAL;BOK;AIFM3;CCK;LPAR1;RYR2
12570,GO:0046915,0.198218445055284,0.979678383653191,1,34,transition metal ion transmembrane transporter activity,MF,SLC39A12
5118,GO:0014046,0.198246650397656,0.979672369861273,1,34,dopamine secretion,BP,SNCA
5130,GO:0014059,0.198246650397656,0.979672369861273,1,34,regulation of dopamine secretion,BP,SNCA
19015,GO:1901385,0.198251354888728,0.979671366701316,1,34,regulation of voltage-gated calcium channel activity,BP,S100A1
14011,GO:0051954,0.198358268433413,0.97964856182764,1,34,positive regulation of amine transport,BP,CCK
5272,GO:0015085,0.198405894337777,0.950762307092197,2,124,calcium ion transmembrane transporter activity,MF,SLC24A2;RYR2
3470,GO:0006921,0.19841874333502,0.97963565628996,1,34,cellular component disassembly involved in execution phase of apoptosis,BP,BOK
10978,GO:0043014,0.199002902320514,0.979510767161381,1,34,alpha-tubulin binding,MF,SNCA
14207,GO:0055026,0.199143860629859,0.979480569421748,1,34,negative regulation of cardiac muscle tissue development,BP,RGS4
21597,GO:2000273,0.199280606931038,0.979451251045994,1,34,positive regulation of signaling receptor activity,BP,GREM1
13356,GO:0050794,0.199428200763173,0.853570885068683,65,9292,regulation of cellular process,BP,HHATL;CD22;MAOB;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;CNDP1;NRGN;PDE1C;SLC24A2;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;KLK6;LGI3;EMX2;GPR37;SYNPO;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;FXYD1
7676,GO:0031128,0.199447953503617,0.979415341175908,1,34,developmental induction,BP,FGF1
1188,GO:0002687,0.199567543230072,0.950279176031877,2,128,positive regulation of leukocyte migration,BP,RARRES2;CXCL14
6740,GO:0021522,0.199573230212547,0.979388436625114,1,34,spinal cord motor neuron differentiation,BP,NKX6-2
10353,GO:0038084,0.199587878188324,0.979385289570222,1,34,vascular endothelial growth factor signaling pathway,BP,PDGFRA
13594,GO:0051154,0.199621969784501,0.979377964130553,1,34,negative regulation of striated muscle cell differentiation,BP,RGS4
18107,GO:0099174,0.199832126727782,0.979332775522388,1,34,regulation of presynapse organization,BP,SNCA
16375,GO:0071774,0.200181768401115,0.950034795572809,2,127,response to fibroblast growth factor,BP,FGF1;HHIP
11987,GO:0045666,0.20037560930704,0.918160116589119,4,353,positive regulation of neuron differentiation,BP,CPNE6;PACSIN1;SERPINI1;LPAR1
3794,GO:0007616,0.201084596390548,0.979062355423844,1,34,long-term memory,BP,SLC17A7
15416,GO:0070062,0.201616387292796,0.869806441324758,15,1827,extracellular exosome,CC,CD22;BCAS1;LRP2;FOLH1;TF;CPNE6;PADI2;SPP1;CHI3L1;ERMN;CSRP1;CBR1;ICOSLG;SERPINI1;SERPINA3
4284,GO:0009072,0.201817975844891,0.978886184190518,1,35,aromatic amino acid family metabolic process,BP,CARNS1
6194,GO:0017124,0.202273253320555,0.949186027686162,2,127,SH3 domain binding,MF,SYNJ2;LRP2
12863,GO:0048246,0.202304923637679,0.978780018462253,1,35,macrophage chemotaxis,BP,RARRES2
16721,GO:0072359,0.203024178500772,0.884431335803964,9,993,circulatory system development,BP,LRP2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;S100A1;GREM1;RYR2
5281,GO:0015103,0.203029047102481,0.94887399682101,2,128,inorganic anion transmembrane transporter activity,MF,SLC17A7;FXYD1
12170,GO:0046006,0.203044745853671,0.97861816838585,1,35,regulation of activated T cell proliferation,BP,ICOSLG
8989,GO:0033572,0.203126750854978,0.978600187234559,1,35,transferrin transport,BP,TF
14030,GO:0051973,0.20314673373912,0.978595804367769,1,35,positive regulation of telomerase activity,BP,GREM1
13024,GO:0048634,0.203311630478265,0.948758561552556,2,128,regulation of muscle organ development,BP,RGS4;GREM1
17116,GO:0090184,0.20331399937443,0.978559098754246,1,35,positive regulation of kidney development,BP,GREM1
6325,GO:0018345,0.20338035508329,0.978544527884654,1,35,protein palmitoylation,BP,HHATL
19185,GO:1901861,0.203508157951921,0.948678215892919,2,128,regulation of muscle tissue development,BP,RGS4;GREM1
4831,GO:0010662,0.203547794708957,0.978507736433684,1,35,regulation of striated muscle cell apoptotic process,BP,CAMK2A
12073,GO:0045834,0.203731548747322,0.948583019150798,2,129,positive regulation of lipid metabolic process,BP,FGF1;PDGFRA
4828,GO:0010659,0.203772001774573,0.978458418009061,1,35,cardiac muscle cell apoptotic process,BP,CAMK2A
18668,GO:1900026,0.203924017908036,0.978424944450689,1,35,positive regulation of substrate adhesion-dependent cell spreading,BP,DOCK5
5805,GO:0016358,0.204093778481649,0.929245331130497,3,237,dendrite development,BP,CAMK2A;PACSIN1;LPAR1
5081,GO:0012501,0.204155290966537,0.867873050429909,15,1831,programmed cell death,BP,CAMK2A;LRP2;MAG;CHI3L1;SNCA;ST18;SLC5A11;HHIP;GREM1;MAL;BOK;AIFM3;CCK;LPAR1;RYR2
9652,GO:0035304,0.204443093482269,0.948291443993509,2,129,regulation of protein dephosphorylation,BP,PPP1R14A;RCAN2
17779,GO:0098590,0.205030551457743,0.879445980220606,10,1133,plasma membrane region,CC,LRP2;TF;PACSIN1;NRGN;HHIP;MAL;CNTN2;GRM3;TMEM235;FXYD1
20651,GO:1904950,0.205540519594653,0.947836595641912,2,130,negative regulation of establishment of protein localization,BP,CD22;VSNL1
13035,GO:0048646,0.205580489112214,0.882631602143369,9,998,anatomical structure formation involved in morphogenesis,BP,LRP2;DLL3;FGF1;CHI3L1;PDGFRA;ENPP2;CSRP1;S100A1;GREM1
14489,GO:0060323,0.205773341093145,0.978015471256755,1,35,head morphogenesis,BP,PDGFRA
3764,GO:0007548,0.20611710859517,0.928209539413338,3,240,sex differentiation,BP,LRP2;PDGFRA;BOK
16603,GO:0072175,0.206251877467608,0.947547137882428,2,129,epithelial tube formation,BP,LRP2;GREM1
3750,GO:0007517,0.207007851794437,0.914386002427147,4,356,muscle organ development,BP,LRP2;RGS4;GREM1;RYR2
4179,GO:0008643,0.207173333389064,0.947162410869058,2,130,carbohydrate transport,BP,SLC5A11;TMEM144
11546,GO:0044325,0.207182073413694,0.947162631253647,2,129,ion channel binding,MF,RYR2;FXYD1
6972,GO:0021955,0.207272048396211,0.977680566101084,1,35,central nervous system neuron axonogenesis,BP,EPHB6
15566,GO:0070296,0.207461486317313,0.977638038175622,1,35,sarcoplasmic reticulum calcium ion transport,BP,RYR2
3489,GO:0006953,0.207540089841891,0.977603460379392,1,36,acute-phase response,BP,SERPINA3
3428,GO:0006862,0.207721343624144,0.97756268168668,1,36,nucleotide transport,BP,GJB1
20928,GO:1905521,0.207744937727438,0.977557370495561,1,36,regulation of macrophage migration,BP,RARRES2
7963,GO:0031672,0.208366637663399,0.977434229205269,1,35,A band,CC,S100A1
15548,GO:0070266,0.20850793078757,0.977385247729537,1,36,necroptotic process,BP,BOK
21083,GO:1905898,0.208561669774623,0.977373097895472,1,36,positive regulation of response to endoplasmic reticulum stress,BP,BOK
2888,GO:0006040,0.208608176574041,0.977362580324849,1,36,amino sugar metabolic process,BP,CHI3L1
1429,GO:0003156,0.208792023225974,0.977320977192203,1,36,regulation of animal organ formation,BP,FGF1
3491,GO:0006955,0.209286892447791,0.865888899038041,14,1706,immune response,BP,CD22;CAMK2A;TF;RARRES2;PADI2;CHI3L1;TESPA1;ENPP2;MOG;SNCA;CXCL14;ICOSLG;SERPINA3;MBP
17142,GO:0090218,0.209487895629016,0.977163130687672,1,36,positive regulation of lipid kinase activity,BP,PDGFRA
3660,GO:0007257,0.20972998130764,0.977108078339064,1,36,activation of JUN kinase activity,BP,TF
2514,GO:0005310,0.21004051106489,0.977037355785269,1,36,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7
14259,GO:0055123,0.211048760804316,0.945543845697365,2,131,digestive system development,BP,RARRES2;PDGFRA
7210,GO:0030198,0.211637554292106,0.911716450844611,4,361,extracellular matrix organization,BP,SPP1;HAPLN2;PDGFRA;GREM1
11215,GO:0043406,0.211957753480247,0.925198025805952,3,244,positive regulation of MAP kinase activity,BP,TF;FGF1;LPAR1
16775,GO:0072528,0.212461617383204,0.976465116546333,1,37,pyrimidine-containing compound biosynthetic process,BP,AK5
1250,GO:0002768,0.212612314807639,0.91114685110464,4,366,immune response-regulating cell surface receptor signaling pathway,BP,CD22;TESPA1;MOG;ICOSLG
11006,GO:0043062,0.213012261419614,0.910919282465613,4,362,extracellular structure organization,BP,SPP1;HAPLN2;PDGFRA;GREM1
8772,GO:0033017,0.213429627884518,0.976257773622645,1,36,sarcoplasmic reticulum membrane,CC,RYR2
5876,GO:0016504,0.213533988975532,0.976216605891913,1,37,peptidase activator activity,MF,MAL
8364,GO:0032412,0.213697950490974,0.924294337807263,3,244,regulation of ion transmembrane transporter activity,BP,S100A1;RYR2;FXYD1
6172,GO:0017080,0.213710526989619,0.976175558922394,1,37,sodium channel regulator activity,MF,FXYD1
4827,GO:0010658,0.214068090823261,0.976092303488179,1,37,striated muscle cell apoptotic process,BP,CAMK2A
5520,GO:0015804,0.214326739280955,0.976031981044359,1,37,neutral amino acid transport,BP,RGS4
16533,GO:0072073,0.214332373027761,0.944155764103737,2,132,kidney epithelium development,BP,FGF1;GREM1
13610,GO:0051180,0.214680099532236,0.975949435987994,1,37,vitamin transport,BP,LRP2
11082,GO:0043198,0.215672428679904,0.975716801065035,1,37,dendritic shaft,CC,LPAR1
16116,GO:0071354,0.215763356657316,0.975695423520134,1,37,cellular response to interleukin-6,BP,ST18
10894,GO:0042805,0.216172912960581,0.975634716721504,1,35,actinin binding,MF,CSRP1
10674,GO:0042383,0.216275817634646,0.943329578557536,2,132,sarcolemma,CC,RYR2;FXYD1
2458,GO:0005178,0.216399776871584,0.943272801360524,2,133,integrin binding,MF,FGF1;SPP1
1247,GO:0002764,0.216619674226203,0.908811826188732,4,369,immune response-regulating signaling pathway,BP,CD22;TESPA1;MOG;ICOSLG
7660,GO:0031111,0.216765191191875,0.975459209385145,1,37,negative regulation of microtubule polymerization or depolymerization,BP,SNCA
11060,GO:0043168,0.217355483892444,0.850237303872263,20,2551,anion binding,MF,CD22;MAOB;CAMK2A;FOLH1;CPNE6;MAG;ADAP1;EPHB6;FGF1;PACSIN1;HAPLN2;PDGFRA;SNCA;AK5;NRGN;CYB5R2;CARNS1;AIFM3;LPAR1;RYR2
13837,GO:0051604,0.218139098259058,0.921961338803324,3,249,protein maturation,BP,MYRF;KLK6;CNTN2
10476,GO:0040007,0.218225110879488,0.878030528716833,8,883,growth,BP,CPNE6;MAG;FGF1;RGS4;SPP1;GREM1;KLK6;NINJ2
16932,GO:0086004,0.218623309247213,0.975017800687757,1,37,regulation of cardiac muscle cell contraction,BP,RYR2
6447,GO:0019216,0.218815955517149,0.907525625081715,4,369,regulation of lipid metabolic process,BP,RARRES2;FGF1;PDGFRA;SERPINA3
2267,GO:0004864,0.218857735089857,0.97494495496971,1,38,protein phosphatase inhibitor activity,MF,PPP1R14A
3637,GO:0007212,0.218985939202638,0.97491428383766,1,38,dopamine receptor signaling pathway,BP,RGS4
2722,GO:0005768,0.219219781955083,0.877331119016463,8,888,endosome,CC,CD22;LRP2;TF;CPNE6;PACSIN1;BOK;GPR62;LPAR1
13663,GO:0051281,0.219364541584907,0.974823588752448,1,38,positive regulation of release of sequestered calcium ion into cytosol,BP,SNCA
5097,GO:0014014,0.219603324522153,0.974766295905834,1,38,negative regulation of gliogenesis,BP,NKX6-2
11460,GO:0044089,0.220269166427059,0.896283934032166,5,494,positive regulation of cellular component biogenesis,BP,SNCA;TPPP3;SYNPO;CCK;LPAR1
7216,GO:0030204,0.220705710141693,0.97450087115124,1,38,chondroitin sulfate metabolic process,BP,SPOCK3
17006,GO:0089718,0.2209034749067,0.974453094317397,1,38,amino acid import across plasma membrane,BP,RGS4
5784,GO:0016310,0.221112833436284,0.851359062575531,17,2136,phosphorylation,BP,CAMK2A;TF;EPHB6;RARRES2;FGF1;RGS4;CHI3L1;PDGFRA;ENPP2;SNCA;AK5;GREM1;PPP1R14A;GPR37;CCK;MBP;LPAR1
2161,GO:0004713,0.221273992806205,0.941177224085976,2,133,protein tyrosine kinase activity,MF,EPHB6;PDGFRA
7312,GO:0030331,0.221278597098257,0.974362336572432,1,38,estrogen receptor binding,MF,PADI2
4514,GO:0009620,0.221329677183498,0.974333617351182,1,39,response to fungus,BP,RARRES2
3647,GO:0007223,0.221713614523432,0.974256867543651,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
3813,GO:0008015,0.222641203950182,0.89478585261743,5,495,blood circulation,BP,RGS4;DOCK5;S100A1;RYR2;FXYD1
21533,GO:2000146,0.22318639722896,0.919287478533224,3,250,negative regulation of cell motility,BP,PADI2;GREM1;SPOCK3
22108,GO:2001222,0.223295689797408,0.973871301517084,1,38,regulation of neuron migration,BP,CAMK2A
8573,GO:0032722,0.223529313783454,0.97379742714091,1,39,positive regulation of chemokine production,BP,MBP
13359,GO:0050798,0.223671337946224,0.973762598633189,1,39,activated T cell proliferation,BP,ICOSLG
8990,GO:0033574,0.22382674681201,0.973724458824307,1,39,response to testosterone,BP,SPP1
7411,GO:0030574,0.223849000136858,0.973718995025387,1,39,collagen catabolic process,BP,KLK6
6019,GO:0016776,0.223857698736344,0.973716859112856,1,39,phosphotransferase activity, phosphate group as acceptor,MF,AK5
10987,GO:0043028,0.22409309890983,0.973659021338763,1,39,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,SNCA
17185,GO:0090278,0.224151257936614,0.973644720969577,1,39,negative regulation of peptide hormone secretion,BP,VSNL1
13083,GO:0048713,0.224544016385489,0.973548036871677,1,39,regulation of oligodendrocyte differentiation,BP,OPALIN
21585,GO:2000249,0.224830603638629,0.973477366411069,1,39,regulation of actin cytoskeleton reorganization,BP,PDGFRA
5748,GO:0016247,0.224908718722015,0.939573838385796,2,138,channel regulator activity,MF,GRM3;FXYD1
18397,GO:0110053,0.225202297296774,0.918209328144512,3,251,regulation of actin filament organization,BP,RGS4;SYNPO;LPAR1
14332,GO:0060078,0.225773327430829,0.939198248097226,2,137,regulation of postsynaptic membrane potential,BP,SLC17A7;RGS4
8855,GO:0033173,0.226153080926952,0.973149915844469,1,39,calcineurin-NFAT signaling cascade,BP,RCAN2
7700,GO:0031214,0.226244568861053,0.938987153382513,2,138,biomineral tissue development,BP,SPP1;GREM1
18417,GO:0110148,0.226244568861053,0.938987153382513,2,138,biomineralization,BP,SPP1;GREM1
5267,GO:0015075,0.226813251370863,0.877361731472205,7,761,ion transmembrane transporter activity,MF,ASIC4;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2;FXYD1
7376,GO:0030509,0.226872735327158,0.938714322265587,2,137,BMP signaling pathway,BP,LRP2;GREM1
3910,GO:0008188,0.227420543654825,0.97281763113051,1,40,neuropeptide receptor activity,MF,GPR37
535,GO:0001667,0.227884484738318,0.902148280678375,4,374,ameboidal-type cell migration,BP,FGF1;ENPP2;DOCK5;GREM1
11282,GO:0043524,0.228398008443941,0.938032448611171,2,139,negative regulation of neuron apoptotic process,BP,MAG;BOK
2401,GO:0005096,0.229180149747626,0.916068424474836,3,252,GTPase activator activity,MF,ADAP1;RGS4;DOCK5
5470,GO:0015701,0.229277963252833,0.972350775332652,1,40,bicarbonate transport,BP,CYB5R2
13826,GO:0051592,0.229447958672885,0.937574389846129,2,137,response to calcium ion,BP,CPNE6;RYR2
4760,GO:0010559,0.229799780697204,0.972218834284649,1,40,regulation of glycoprotein biosynthetic process,BP,NECAB1
7620,GO:0031057,0.230578228849024,0.97202136424707,1,40,negative regulation of histone modification,BP,SNCA
10352,GO:0038083,0.230677551267478,0.971996113816613,1,40,peptidyl-tyrosine autophosphorylation,BP,GREM1
6848,GO:0021700,0.23075795932737,0.915210698355595,3,254,developmental maturation,BP,SLC17A7;GREM1;CNTN2
15388,GO:0065008,0.230766423536119,0.832851552731142,27,3602,regulation of biological quality,BP,MAOB;CAMK2A;MOXD1;TF;SLC17A7;MAG;RGS4;SPP1;PDGFRA;ERMN;SNCA;DOCK5;SLC39A12;NRGN;SLC24A2;CSRP1;VSNL1;KLK6;SYNPO;BOK;CNTN2;CCK;SERPINA3;MBP;LPAR1;RYR2;FXYD1
6674,GO:0019894,0.231174495297933,0.971869589642081,1,40,kinesin binding,MF,SNCA
5692,GO:0016125,0.232423266247456,0.936230450827272,2,141,sterol metabolic process,BP,FGF1;CYB5R2
19141,GO:1901699,0.232581359082634,0.880054385751783,6,634,cellular response to nitrogen compound,BP,CAMK2A;RARRES2;RGS4;PDGFRA;SNCA;RYR2
3786,GO:0007605,0.233053130337607,0.935951548727807,2,140,sensory perception of sound,BP,LRP2;MBP
4466,GO:0009395,0.233371184555935,0.971290138000381,1,41,phospholipid catabolic process,BP,ENPP2
11761,GO:0045104,0.233479313324325,0.971278678174281,1,40,intermediate filament cytoskeleton organization,BP,NEFM
17537,GO:0097300,0.23359598933997,0.971232140665469,1,41,programmed necrotic cell death,BP,BOK
15152,GO:0061564,0.233784076057572,0.887662456139978,5,502,axon development,BP,MAG;EPHB6;SPP1;CNTN2;CCK
12057,GO:0045806,0.233810716483944,0.971176683241885,1,41,negative regulation of endocytosis,BP,PACSIN1
10326,GO:0038023,0.233831016888753,0.866965428540054,8,905,signaling receptor activity,MF,EPHB6;EVI2A;PDGFRA;GPR37;S1PR5;GPR62;LPAR1;GRM3
14342,GO:0060089,0.233831016888753,0.866965428540054,8,905,molecular transducer activity,MF,EPHB6;EVI2A;PDGFRA;GPR37;S1PR5;GPR62;LPAR1;GRM3
6444,GO:0019212,0.233923685806626,0.971147483189949,1,41,phosphatase inhibitor activity,MF,PPP1R14A
19095,GO:1901618,0.234249424151911,0.97106319616471,1,41,organic hydroxy compound transmembrane transporter activity,MF,SLC5A11
18833,GO:1900408,0.234452154562241,0.97101067009838,1,41,negative regulation of cellular response to oxidative stress,BP,GPR37
19744,GO:1903202,0.234452154562241,0.97101067009838,1,41,negative regulation of oxidative stress-induced cell death,BP,GPR37
439,GO:0001504,0.234525083576359,0.970991761890186,1,41,neurotransmitter uptake,BP,SNCA
7162,GO:0030133,0.235078884078896,0.897809221552474,4,381,transport vesicle,CC,SLC17A7;NRGN;LGI3;SV2B
11989,GO:0045668,0.235476388971422,0.97074449757879,1,41,negative regulation of osteoblast differentiation,BP,GREM1
691,GO:0001890,0.236211828510349,0.934517655233064,2,142,placenta development,BP,SPP1;TPPP3
5864,GO:0016491,0.236520053287568,0.877387332444585,6,646,oxidoreductase activity,MF,MAOB;MOXD1;SNCA;CBR1;CYB5R2;AIFM3
15065,GO:0061337,0.236535412814638,0.934374685881149,2,141,cardiac conduction,BP,RYR2;FXYD1
12343,GO:0046456,0.237054905629541,0.970315536244703,1,42,icosanoid biosynthetic process,BP,CBR1
13587,GO:0051147,0.238338231889293,0.933546074711026,2,143,regulation of muscle cell differentiation,BP,RGS4;GREM1
2486,GO:0005246,0.238371417568302,0.969968609593219,1,42,calcium channel regulator activity,MF,GRM3
11760,GO:0045103,0.23845976541957,0.969961564585844,1,41,intermediate filament-based process,BP,NEFM
6437,GO:0019205,0.238560328537637,0.969918645849784,1,42,nucleobase-containing compound kinase activity,MF,AK5
19706,GO:1903115,0.238576236983779,0.969930767928052,1,41,regulation of actin filament-based movement,BP,RYR2
13395,GO:0050856,0.238700655908135,0.96988150205294,1,42,regulation of T cell receptor signaling pathway,BP,TESPA1
4024,GO:0008376,0.238913015147489,0.96982524388059,1,42,acetylgalactosaminyltransferase activity,MF,GALNT6
12973,GO:0048523,0.239052591660507,0.822930044960373,32,4362,negative regulation of cellular process,BP,HHATL;CD22;MAOB;LRP2;DLL3;MAG;PADI2;RGS4;SPP1;PACSIN1;PDGFRA;SNCA;CXCL14;ST18;NKX6-2;SLC24A2;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;EMX2;GPR37;BOK;CNTN2;SPOCK3;SERPINA3;MBP;LPAR1;RYR2;FXYD1
2983,GO:0006195,0.239088083747131,0.969778821276353,1,42,purine nucleotide catabolic process,BP,GDA
602,GO:0001774,0.239653833985991,0.969628533694947,1,42,microglial cell activation,BP,SNCA
934,GO:0002269,0.239653833985991,0.969628533694947,1,42,leukocyte activation involved in inflammatory response,BP,SNCA
2720,GO:0005766,0.240484113768484,0.932555572650456,2,145,primary lysosome,CC,PADI2;SERPINA3
10774,GO:0042582,0.240484113768484,0.932555572650456,2,145,azurophil granule,CC,PADI2;SERPINA3
19532,GO:1902743,0.240531325924018,0.969394621671612,1,42,regulation of lamellipodium organization,BP,ENPP2
11907,GO:0045540,0.240536077632693,0.96939335232292,1,42,regulation of cholesterol biosynthetic process,BP,FGF1
18373,GO:0106118,0.240536077632693,0.96939335232292,1,42,regulation of sterol biosynthetic process,BP,FGF1
10716,GO:0042461,0.241117934237601,0.969237698681183,1,42,photoreceptor cell development,BP,DCX
17720,GO:0097720,0.241207008276999,0.969213831902558,1,42,calcineurin-mediated signaling,BP,RCAN2
7384,GO:0030517,0.241277847704592,0.969194843681656,1,42,negative regulation of axon extension,BP,MAG
612,GO:0001784,0.24135547223424,0.96917402933316,1,42,phosphotyrosine residue binding,MF,SHD
16927,GO:0085029,0.241514844065908,0.969131270865926,1,42,extracellular matrix assembly,BP,HAPLN2
7086,GO:0023061,0.241696804536737,0.882515725821761,5,513,signal release,BP,MAOB;CAMK2A;SPP1;SNCA;VSNL1
14206,GO:0055025,0.241735822591822,0.969071929657069,1,42,positive regulation of cardiac muscle tissue development,BP,GREM1
3330,GO:0006692,0.242287443731781,0.96890746776471,1,43,prostanoid metabolic process,BP,CBR1
3331,GO:0006693,0.242287443731781,0.96890746776471,1,43,prostaglandin metabolic process,BP,CBR1
4018,GO:0008360,0.24254291271991,0.931610598003887,2,144,regulation of cell shape,BP,ERMN;LPAR1
14912,GO:0060999,0.243022402298635,0.968725185407964,1,42,positive regulation of dendritic spine development,BP,LPAR1
17194,GO:0090288,0.243133859409502,0.931337203560698,2,144,negative regulation of cellular response to growth factor stimulus,BP,LRP2;GREM1
13483,GO:0050999,0.243518296301883,0.968574749325312,1,43,regulation of nitric-oxide synthase activity,BP,S100A1
15476,GO:0070161,0.243821966344771,0.865464043934142,7,776,anchoring junction,CC,CLDN11;CLDN10;CSRP1;GJB1;SYNPO;OPALIN;FXYD1
3987,GO:0008307,0.243869053465036,0.968530818760886,1,40,structural constituent of muscle,MF,CSRP1
19582,GO:1902883,0.244348003268641,0.968349364053321,1,43,negative regulation of response to oxidative stress,BP,GPR37
6084,GO:0016879,0.244430301463379,0.968326959751216,1,43,ligase activity, forming carbon-nitrogen bonds,MF,CARNS1
15292,GO:0061844,0.244490310533917,0.968295014353718,1,44,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,CXCL14
4916,GO:0010799,0.244497927343811,0.968308543191913,1,43,regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
9589,GO:0035148,0.244907940273764,0.930509689524951,2,145,tube formation,BP,LRP2;GREM1
7602,GO:0031018,0.245143653105644,0.968132395041181,1,43,endocrine pancreas development,BP,NKX6-2
2380,GO:0005044,0.245350599251144,0.968075827942589,1,43,scavenger receptor activity,MF,ENPP2
13269,GO:0050654,0.245391568356676,0.968064622792368,1,43,chondroitin sulfate proteoglycan metabolic process,BP,SPOCK3
10672,GO:0042379,0.24551993381938,0.968013766020494,1,44,chemokine receptor binding,MF,CXCL14
7023,GO:0022602,0.245560311888746,0.968018448137045,1,43,ovulation cycle process,BP,PDGFRA
7735,GO:0031279,0.245588201050286,0.968010813053289,1,43,regulation of cyclase activity,BP,GRM3
642,GO:0001822,0.246055051404082,0.906751955428933,3,262,kidney development,BP,FGF1;PDGFRA;GREM1
2997,GO:0006220,0.246490590895902,0.967747368309451,1,44,pyrimidine nucleotide metabolic process,BP,AK5
9965,GO:0035850,0.246785063329946,0.967682204937599,1,43,epithelial cell differentiation involved in kidney development,BP,GREM1
15874,GO:0070887,0.246828337307762,0.824038136081145,22,2911,cellular response to chemical stimulus,BP,CAMK2A;LRP2;TF;CPNE6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;SNCA;CXCL14;ST18;VSNL1;HHIP;GREM1;PPP1R14A;GPR37;BOK;LPAR1;RYR2
5796,GO:0016331,0.247228113090649,0.929422205489095,2,146,morphogenesis of embryonic epithelium,BP,LRP2;GREM1
18887,GO:1901028,0.247394865695775,0.967498090704878,1,44,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
7208,GO:0030195,0.248028842135817,0.967322692489033,1,44,negative regulation of blood coagulation,BP,PDGFRA
1370,GO:0003013,0.248095437059087,0.878307900365543,5,516,circulatory system process,BP,RGS4;DOCK5;S100A1;RYR2;FXYD1
2271,GO:0004869,0.248230045930912,0.967266917624885,1,44,cysteine-type endopeptidase inhibitor activity,MF,SNCA
2499,GO:0005272,0.249101157639095,0.967041027836721,1,43,sodium channel activity,MF,ASIC4
19659,GO:1903018,0.249320644673555,0.966963681861037,1,44,regulation of glycoprotein metabolic process,BP,NECAB1
10593,GO:0042220,0.249592938376014,0.966887730587591,1,44,response to cocaine,BP,RGS4
15608,GO:0070371,0.250170566616067,0.904420463895098,3,267,ERK1 and ERK2 cascade,BP,TF;CHI3L1;PDGFRA
778,GO:0002009,0.25026233925257,0.876872018788792,5,518,morphogenesis of an epithelium,BP,LRP2;FGF1;HHIP;GREM1;RYR2
13697,GO:0051339,0.250463605111154,0.966644226514183,1,44,regulation of lyase activity,BP,GRM3
7189,GO:0030168,0.250560856245396,0.927845144274102,2,148,platelet activation,BP,PDGFRA;CSRP1
9496,GO:0034762,0.250635348258932,0.876623828820113,5,519,regulation of transmembrane transport,BP,RGS4;SNCA;S100A1;RYR2;FXYD1
12823,GO:0048156,0.250677107845608,0.966584364286857,1,44,tau protein binding,MF,SNCA
11827,GO:0045214,0.251313922559713,0.966439210429422,1,42,sarcomere organization,BP,CSRP1
17898,GO:0098815,0.251674022057222,0.966304061247531,1,44,modulation of excitatory postsynaptic potential,BP,RGS4
13497,GO:0051017,0.25176331783228,0.927275238039834,2,148,actin filament bundle assembly,BP,SYNPO;LPAR1
15160,GO:0061572,0.25176331783228,0.927275238039834,2,148,actin filament bundle organization,BP,SYNPO;LPAR1
16155,GO:0071407,0.252009760015521,0.87570931393558,5,521,cellular response to organic cyclic compound,BP,PADI2;RGS4;SPP1;SNCA;RYR2
13340,GO:0050773,0.252011951351585,0.927161083281985,2,147,regulation of dendrite development,BP,PACSIN1;LPAR1
10679,GO:0042398,0.252456450994653,0.966067266344389,1,45,cellular modified amino acid biosynthetic process,BP,CARNS1
16295,GO:0071622,0.252460509916108,0.966066117789012,1,45,regulation of granulocyte chemotaxis,BP,RARRES2
18681,GO:1900047,0.252873479672484,0.965949146918852,1,45,negative regulation of hemostasis,BP,PDGFRA
15766,GO:0070661,0.252995164887986,0.90280878542555,3,270,leukocyte proliferation,BP,CD22;ICOSLG;GREM1
3291,GO:0006644,0.25323820009116,0.886590977526515,4,394,phospholipid metabolic process,BP,SYNJ2;CPNE6;PDGFRA;ENPP2
13546,GO:0051092,0.253276622477459,0.926547484541447,2,150,positive regulation of NF-kappaB transcription factor activity,BP,CAMK2A;GREM1
3480,GO:0006937,0.253440739688719,0.926473062728625,2,149,regulation of muscle contraction,BP,DOCK5;RYR2
2948,GO:0006120,0.254064690143891,0.965595103489411,1,46,mitochondrial electron transport, NADH to ubiquinone,BP,SNCA
12061,GO:0045815,0.254949559979297,0.965357729565819,1,45,positive regulation of gene expression, epigenetic,BP,PADI2
8087,GO:0031952,0.255191987875755,0.965288300322149,1,45,regulation of protein autophosphorylation,BP,GREM1
8298,GO:0032330,0.25555098857071,0.965185343988272,1,45,regulation of chondrocyte differentiation,BP,GREM1
16373,GO:0071772,0.255600554420903,0.925439596353387,2,149,response to BMP,BP,LRP2;GREM1
16374,GO:0071773,0.255600554420903,0.925439596353387,2,149,cellular response to BMP stimulus,BP,LRP2;GREM1
9624,GO:0035254,0.255753684757303,0.965127138858595,1,45,glutamate receptor binding,MF,CAMK2A
1116,GO:0002548,0.255761820884593,0.965109205183996,1,46,monocyte chemotaxis,BP,GREM1
12986,GO:0048546,0.256320873879117,0.964963981187797,1,45,digestive tract morphogenesis,BP,PDGFRA
18810,GO:1900271,0.256834939156948,0.964815739919136,1,45,regulation of long-term synaptic potentiation,BP,NRGN
6500,GO:0019369,0.257070547143817,0.964731926114324,1,46,arachidonic acid metabolic process,BP,CBR1
17767,GO:0098563,0.25799396419492,0.964464367853042,1,46,intrinsic component of synaptic vesicle membrane,CC,SLC17A7
9402,GO:0034614,0.258031680194558,0.924257078540669,2,152,cellular response to reactive oxygen species,BP,PDGFRA;GPR37
12250,GO:0046164,0.258097378969342,0.964434333694007,1,46,alcohol catabolic process,BP,SYNJ2
11824,GO:0045211,0.258379510803462,0.899721169838749,3,269,postsynaptic membrane,CC,NRGN;CNTN2;GRM3
14895,GO:0060976,0.259016937853604,0.96418264472956,1,45,coronary vasculature development,BP,LRP2
5144,GO:0014075,0.259675819868893,0.963974165748624,1,46,response to amine,BP,RGS4
13352,GO:0050789,0.259865853902922,0.803744445038556,67,9758,regulation of biological process,BP,HHATL;CD22;MAOB;CAMK2A;DCX;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;CNDP1;NRGN;PDE1C;SLC24A2;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;KLK6;LGI3;EMX2;GPR37;SYNPO;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;NKAIN2;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;FXYD1
6761,GO:0021545,0.259897542202489,0.96390926291584,1,46,cranial nerve development,BP,LPAR1
4473,GO:0009408,0.260059140828697,0.923274449340843,2,152,response to heat,BP,CAMK2A;FGF1
13072,GO:0048701,0.260764349893946,0.963654906445543,1,46,embryonic cranial skeleton morphogenesis,BP,PDGFRA
7178,GO:0030155,0.260795643743261,0.860627166761575,6,660,regulation of cell adhesion,BP,TESPA1;DOCK5;ICOSLG;SERPINI1;GREM1;MBP
10753,GO:0042551,0.261254508624052,0.96351063421307,1,46,neuron maturation,BP,CNTN2
14490,GO:0060324,0.261469642909894,0.963447211658281,1,46,face development,BP,PDGFRA
13420,GO:0050885,0.261780074556921,0.963355586998432,1,46,neuromuscular process controlling balance,BP,NKX6-2
13375,GO:0050819,0.262390302942213,0.96315939433036,1,47,negative regulation of coagulation,BP,PDGFRA
13572,GO:0051129,0.262565229194449,0.859381272288761,6,662,negative regulation of cellular component organization,BP,MAG;SPP1;PACSIN1;SNCA;BOK;LPAR1
926,GO:0002253,0.262702099399717,0.880590695111328,4,402,activation of immune response,BP,CD22;TESPA1;MOG;ICOSLG
14029,GO:0051972,0.262977985805259,0.962985043255221,1,47,regulation of telomerase activity,BP,GREM1
5469,GO:0015698,0.26312992188368,0.921771706620956,2,153,inorganic anion transport,BP,SLC17A7;FXYD1
16770,GO:0072523,0.263523327545282,0.962822843709274,1,47,purine-containing compound catabolic process,BP,GDA
2605,GO:0005544,0.264406415746077,0.962559351229447,1,47,calcium-dependent phospholipid binding,MF,CPNE6
12819,GO:0048146,0.264608361674277,0.962498949716367,1,47,positive regulation of fibroblast proliferation,BP,PDGFRA
10346,GO:0038061,0.264627703453549,0.921028274142879,2,155,NIK/NF-kappaB signaling,BP,CHI3L1;GREM1
6736,GO:0021517,0.264867265589334,0.96242143284905,1,47,ventral spinal cord development,BP,NKX6-2
21550,GO:2000179,0.265828316693516,0.962132909914817,1,47,positive regulation of neural precursor cell proliferation,BP,LRP2
5760,GO:0016266,0.265900706673619,0.962111127458245,1,47,O-glycan processing,BP,GALNT6
12569,GO:0046914,0.266269316978047,0.843233135824333,8,939,transition metal ion binding,MF,MOXD1;TF;GDA;ENPP2;SNCA;ST18;CSRP1;HHIP
20925,GO:1905517,0.266513936206065,0.96191079600808,1,48,macrophage migration,BP,RARRES2
15090,GO:0061383,0.266525535432217,0.961922823425637,1,47,trabecula morphogenesis,BP,GREM1
19668,GO:1903034,0.266975996309203,0.919868619578392,2,155,regulation of response to wounding,BP,SPP1;PDGFRA
7067,GO:0022900,0.267623135453585,0.919536327769708,2,158,electron transport chain,BP,MAOB;SNCA
5567,GO:0015872,0.267656708492589,0.961564937469269,1,48,dopamine transport,BP,SNCA
13498,GO:0051018,0.268143487503823,0.961432801507485,1,47,protein kinase A binding,MF,RYR2
20056,GO:1903793,0.268253803031191,0.961383533576571,1,48,positive regulation of anion transport,BP,CCK
3507,GO:0006984,0.26836485860557,0.961349741087216,1,48,ER-nucleus signaling pathway,BP,BOK
20025,GO:1903727,0.268399702995395,0.961339135079305,1,48,positive regulation of phospholipid metabolic process,BP,PDGFRA
18666,GO:1900024,0.268641260496171,0.96126556463826,1,48,regulation of substrate adhesion-dependent cell spreading,BP,DOCK5
16109,GO:0071347,0.268685822928959,0.919011882728136,2,157,cellular response to interleukin-1,BP,CHI3L1;ST18
9395,GO:0034599,0.268688170133209,0.893688297889083,3,278,cellular response to oxidative stress,BP,PDGFRA;SNCA;GPR37
19452,GO:1902531,0.268847010196112,0.821818681364463,13,1643,regulation of intracellular signal transduction,BP,CD22;LRP2;TF;FGF1;RGS4;CHI3L1;PDGFRA;GREM1;GPR37;RCAN2;BOK;GPR62;LPAR1
3747,GO:0007507,0.269808968953897,0.863694969303848,5,529,heart development,BP,LRP2;RGS4;PDGFRA;GREM1;RYR2
11119,GO:0043254,0.269863206987947,0.875985038679684,4,405,regulation of protein-containing complex assembly,BP,SNCA;SLC39A12;TPPP3;CCK
13380,GO:0050829,0.270047606341699,0.960820399117879,1,49,defense response to Gram-negative bacterium,BP,RARRES2
7950,GO:0031648,0.270107631410395,0.960817279651491,1,48,protein destabilization,BP,SNCA
20801,GO:1905268,0.270549447924633,0.960681646671785,1,48,negative regulation of chromatin organization,BP,SNCA
9778,GO:0035556,0.271037840837127,0.807860071800841,19,2507,intracellular signal transduction,BP,CD22;DCX;LRP2;TF;FGF1;RGS4;CHI3L1;PDGFRA;DOCK5;S100A1;GREM1;GPR37;RCAN2;BOK;S1PR5;GPR62;MBP;LPAR1;RYR2
4656,GO:0010171,0.271243415466734,0.960468077099022,1,48,body morphogenesis,BP,PDGFRA
110,GO:0000226,0.271364727192144,0.862625245927948,5,534,microtubule cytoskeleton organization,BP,DCX;SNCA;SLC39A12;TPPP3;CNTN2
15547,GO:0070265,0.272093699396155,0.960190000756463,1,49,necrotic cell death,BP,BOK
13230,GO:0050433,0.272228145022355,0.960148381240386,1,49,regulation of catecholamine secretion,BP,SNCA
18050,GO:0099054,0.272785667812058,0.959991129397277,1,48,presynapse assembly,BP,SNCA
5036,GO:0010941,0.273242676003974,0.821234888140027,12,1511,regulation of cell death,BP,CAMK2A;LRP2;MAG;SNCA;ST18;HHIP;GREM1;GPR37;MAL;BOK;CCK;LPAR1
17115,GO:0090183,0.273572927074388,0.959730746208031,1,49,regulation of kidney development,BP,GREM1
708,GO:0001917,0.274363732487716,0.959484015935036,1,49,photoreceptor inner segment,CC,SLC24A2
13478,GO:0050994,0.274524409936146,0.959433781645676,1,49,regulation of lipid catabolic process,BP,RARRES2
1363,GO:0003006,0.275284964614233,0.842706673074064,7,811,developmental process involved in reproduction,BP,CLDN11;LRP2;SPP1;PDGFRA;TPPP3;GJB1;BOK
4840,GO:0010676,0.275606443391918,0.959094586128311,1,49,positive regulation of cellular carbohydrate metabolic process,BP,SNCA
10482,GO:0040013,0.275712869890979,0.889509024959388,3,280,negative regulation of locomotion,BP,PADI2;GREM1;SPOCK3
5021,GO:0010921,0.275733744915238,0.915466315356035,2,158,regulation of phosphatase activity,BP,PPP1R14A;RCAN2
2728,GO:0005775,0.27727275554259,0.914676251339094,2,160,vacuolar lumen,CC,PADI2;SERPINA3
16930,GO:0086002,0.277366595150435,0.958539431492973,1,49,cardiac muscle cell action potential involved in contraction,BP,RYR2
17955,GO:0098900,0.277657735364462,0.958447200975674,1,49,regulation of action potential,BP,RYR2
743,GO:0001960,0.277662751211609,0.958430103572505,1,50,negative regulation of cytokine-mediated signaling pathway,BP,PADI2
10951,GO:0042981,0.277988255488428,0.820822537526129,11,1375,regulation of apoptotic process,BP,CAMK2A;LRP2;MAG;SNCA;ST18;HHIP;GREM1;MAL;BOK;CCK;LPAR1
11982,GO:0045661,0.27803601007985,0.958311646558342,1,50,regulation of myoblast differentiation,BP,CXCL14
22120,GO:2001238,0.278113035358911,0.958287178372665,1,50,positive regulation of extrinsic apoptotic signaling pathway,BP,MAL
1347,GO:0002931,0.27834310297594,0.95821404614387,1,50,response to ischemia,BP,CAMK2A
5646,GO:0016043,0.278443834157673,0.786147241809845,40,5635,cellular component organization,BP,GAS7;CD22;CLDN11;CAMK2A;DCX;SYNJ2;LRP2;TF;CPNE6;NEFM;SLC17A7;MAG;EPHB6;PADI2;RGS4;SPP1;PACSIN1;MYRF;HAPLN2;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;SNCA;SLC39A12;SLC24A2;CSRP1;TPPP3;SERPINI1;GREM1;KLK6;GJB1;SYNPO;MAL;BOK;CNTN2;CCK;MBP;LPAR1
12082,GO:0045843,0.278455347786643,0.958178340495456,1,50,negative regulation of striated muscle tissue development,BP,RGS4
13463,GO:0050954,0.278738681265107,0.913931939515912,2,159,sensory perception of mechanical stimulus,BP,LRP2;MBP
15317,GO:0061900,0.278995766168751,0.958006191130627,1,50,glial cell activation,BP,SNCA
14574,GO:0060425,0.279093273527874,0.957975088070673,1,50,lung morphogenesis,BP,HHIP
2880,GO:0006022,0.279094326656834,0.91374610408273,2,160,aminoglycan metabolic process,BP,CHI3L1;SPOCK3
13782,GO:0051496,0.27954713421411,0.957830144756266,1,50,positive regulation of stress fiber assembly,BP,LPAR1
7002,GO:0022029,0.280284129763158,0.957594183639692,1,50,telencephalon cell migration,BP,CNTN2
7886,GO:0031526,0.280317409806357,0.957583511048668,1,50,brush border membrane,CC,LRP2
3236,GO:0006575,0.280364806181914,0.913087028157277,2,162,cellular modified amino acid metabolic process,BP,FOLH1;CARNS1
5146,GO:0014704,0.280813071257428,0.957424378658022,1,50,intercalated disc,CC,FXYD1
13658,GO:0051271,0.281296145976519,0.886140911482366,3,283,negative regulation of cellular component movement,BP,PADI2;GREM1;SPOCK3
3825,GO:0008038,0.281496927786647,0.957204276598833,1,50,neuron recognition,BP,CNTN2
4595,GO:0009925,0.281568664905429,0.957181150759763,1,50,basal plasma membrane,CC,TF
1369,GO:0003012,0.281823859014848,0.868161293112762,4,410,muscle system process,BP,RGS4;DOCK5;RYR2;FXYD1
13229,GO:0050432,0.281878869744284,0.957065719307016,1,51,catecholamine secretion,BP,SNCA
13744,GO:0051427,0.282090945276898,0.912202299309907,2,161,hormone receptor binding,MF,PADI2;CCK
4748,GO:0010524,0.282273307385435,0.956938229734092,1,51,positive regulation of calcium ion transport into cytosol,BP,SNCA
13595,GO:0051155,0.282456899692752,0.956878816834311,1,51,positive regulation of striated muscle cell differentiation,BP,GREM1
13025,GO:0048635,0.283153257264874,0.956653047688648,1,51,negative regulation of muscle organ development,BP,RGS4
2496,GO:0005261,0.283210506036946,0.884979107036989,3,283,cation channel activity,MF,ASIC4;SLC24A2;RYR2
11305,GO:0043551,0.283637323282218,0.956495715895393,1,51,regulation of phosphatidylinositol 3-kinase activity,BP,PDGFRA
5321,GO:0015179,0.283660511294766,0.956488171250677,1,51,L-amino acid transmembrane transporter activity,MF,SLC17A7
17792,GO:0098632,0.283783817256458,0.956448039037432,1,51,cell-cell adhesion mediator activity,MF,CNTN2
3332,GO:0006694,0.284568772214612,0.910912032563945,2,163,steroid biosynthetic process,BP,FGF1;CYB5R2
7470,GO:0030695,0.285051468847591,0.883855665946816,3,284,GTPase regulator activity,MF,ADAP1;RGS4;DOCK5
3283,GO:0006636,0.285188789198307,0.955974190436479,1,52,unsaturated fatty acid biosynthetic process,BP,CBR1
3237,GO:0006576,0.285330529583342,0.955927744948651,1,52,cellular biogenic amine metabolic process,BP,MOXD1
14330,GO:0060076,0.285675368878794,0.955829788203831,1,51,excitatory synapse,CC,SLC17A7
19224,GO:1901981,0.286014501063853,0.910163716834831,2,162,phosphatidylinositol phosphate binding,MF,ADAP1;NRGN
18121,GO:0099240,0.286115642309659,0.910110990577977,2,162,intrinsic component of synaptic membrane,CC,CNTN2;GRM3
12614,GO:0046983,0.286499198141077,0.834365522400044,7,825,protein dimerization activity,MF,CAMK2A;MAG;PADI2;PDGFRA;S100A1;GREM1;BOK
18105,GO:0099172,0.286747710427659,0.955477114943063,1,51,presynapse organization,BP,SNCA
5961,GO:0016655,0.286750593338648,0.955446204857071,1,53,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,CBR1
12463,GO:0046658,0.28713437425854,0.955334251641502,1,52,anchored component of plasma membrane,CC,CNTN2
5645,GO:0016042,0.287593596921899,0.882290629141368,3,289,lipid catabolic process,BP,RARRES2;SPP1;ENPP2
6457,GO:0019229,0.287783306421233,0.955119648588515,1,52,regulation of vasoconstriction,BP,DOCK5
7387,GO:0030520,0.288029870331579,0.95503795747603,1,52,intracellular estrogen receptor signaling pathway,BP,PADI2
1468,GO:0003205,0.288158074612588,0.909043284796078,2,162,cardiac chamber development,BP,LRP2;RYR2
10009,GO:0035924,0.288386465609532,0.954919662834649,1,52,cellular response to vascular endothelial growth factor stimulus,BP,PDGFRA
840,GO:0002090,0.288451393565021,0.954898105193584,1,52,regulation of receptor internalization,BP,GREM1
803,GO:0002042,0.288722564779185,0.954808007023921,1,52,cell migration involved in sprouting angiogenesis,BP,GREM1
22126,GO:2001244,0.289156517748354,0.954648676173483,1,53,positive regulation of intrinsic apoptotic signaling pathway,BP,BOK
14918,GO:0061005,0.290077458311565,0.954356316386157,1,52,cell differentiation involved in kidney development,BP,GREM1
17556,GO:0097345,0.290138930167752,0.954320725657243,1,53,mitochondrial outer membrane permeabilization,BP,BOK
12541,GO:0046872,0.290189346425469,0.782660891460441,27,3712,metal ion binding,MF,CAMK2A;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;ADAP1;PADI2;GDA;NECAB1;ENPP2;GALNT6;SNCA;ST18;PAMR1;CNDP1;PDE1C;CSRP1;S100A1;VSNL1;HHIP;CARNS1;AIFM3;SPOCK3;RYR2;MEX3A
7211,GO:0030199,0.290518672385582,0.954208678523251,1,52,collagen fibril organization,BP,GREM1
11079,GO:0043195,0.290561207093338,0.95419443145515,1,52,terminal bouton,CC,CCK
14794,GO:0060761,0.291574552236968,0.953839084827914,1,53,negative regulation of response to cytokine stimulus,BP,PADI2
17739,GO:0097755,0.291667815057656,0.953807697161017,1,53,positive regulation of blood vessel diameter,BP,DOCK5
8452,GO:0032515,0.291689476956573,0.953800405110027,1,53,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R14A
14739,GO:0060688,0.291804841306572,0.953761559029334,1,53,regulation of morphogenesis of a branching structure,BP,GREM1
15017,GO:0061178,0.292051592519954,0.953678409791646,1,53,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
614,GO:0001786,0.292362211740593,0.953573618604368,1,53,phosphatidylserine binding,MF,CPNE6
11010,GO:0043067,0.292376629407098,0.809353290967777,11,1393,regulation of programmed cell death,BP,CAMK2A;LRP2;MAG;SNCA;ST18;HHIP;GREM1;MAL;BOK;CCK;LPAR1
19186,GO:1901862,0.292473180562944,0.953536149490519,1,53,negative regulation of muscle tissue development,BP,RGS4
14977,GO:0061098,0.292903517091972,0.953390682929479,1,53,positive regulation of protein tyrosine kinase activity,BP,GREM1
13588,GO:0051148,0.293032736762939,0.953346952678888,1,53,negative regulation of muscle cell differentiation,BP,RGS4
6734,GO:0021515,0.293263536123854,0.953268788383863,1,53,cell differentiation in spinal cord,BP,NKX6-2
13385,GO:0050840,0.29350521666019,0.953186859725879,1,53,extracellular matrix binding,MF,SPP1
6672,GO:0019887,0.293813488144883,0.906037742437648,2,167,protein kinase regulator activity,MF,SNCA;GREM1
11860,GO:0045309,0.293894640105278,0.953054676199118,1,53,protein phosphorylated amino acid binding,MF,SHD
4792,GO:0010611,0.294346506164821,0.952901033415085,1,53,regulation of cardiac muscle hypertrophy,BP,RGS4
7746,GO:0031295,0.295118632830361,0.95262286328528,1,54,T cell costimulation,BP,ICOSLG
13010,GO:0048598,0.295373237103692,0.845835401231274,5,554,embryonic morphogenesis,BP,LRP2;PDGFRA;GREM1;MBP;RYR2
6294,GO:0018209,0.295832631567957,0.877189989693259,3,291,peptidyl-serine modification,BP,CAMK2A;SNCA;SPOCK3
16979,GO:0086065,0.295866635096366,0.952382076488722,1,53,cell communication involved in cardiac conduction,BP,RYR2
3941,GO:0008237,0.295881335928413,0.904934980025692,2,167,metallopeptidase activity,MF,FOLH1;CNDP1
15747,GO:0070613,0.296455088814505,0.952165209748726,1,54,regulation of protein processing,BP,CNTN2
9558,GO:0035065,0.296536919969489,0.952137106734465,1,54,regulation of histone acetylation,BP,SNCA
11867,GO:0045334,0.296563673433653,0.952127916850574,1,54,clathrin-coated endocytic vesicle,CC,CPNE6
2748,GO:0005798,0.29757353466479,0.904024376056675,2,168,Golgi-associated vesicle,CC,PACSIN1;NRGN
3766,GO:0007565,0.297656125751036,0.903980019872191,2,168,female pregnancy,BP,SPP1;TPPP3
21167,GO:1990138,0.297768362226406,0.903927504990237,2,166,neuron projection extension,BP,CPNE6;MAG
3670,GO:0007269,0.298219452681299,0.903681107822034,2,167,neurotransmitter secretion,BP,CAMK2A;SNCA
18224,GO:0099643,0.298219452681299,0.903681107822034,2,167,signal release from synapse,BP,CAMK2A;SNCA
21865,GO:2000649,0.298559867794658,0.951439399101981,1,54,regulation of sodium ion transmembrane transporter activity,BP,FXYD1
10852,GO:0042742,0.298984960068275,0.903257450135991,2,170,defense response to bacterium,BP,TF;RARRES2
19288,GO:1902110,0.29925886422277,0.951182153695422,1,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BOK
7745,GO:0031294,0.299602892173997,0.951062559842802,1,55,lymphocyte costimulation,BP,ICOSLG
12556,GO:0046888,0.300560403157365,0.950728828185511,1,55,negative regulation of hormone secretion,BP,VSNL1
18615,GO:0150034,0.300947475780008,0.873979813417632,3,293,distal axon,CC,PACSIN1;SNCA;CCK
15611,GO:0070374,0.301112872556236,0.902107538094737,2,170,positive regulation of ERK1 and ERK2 cascade,BP,CHI3L1;PDGFRA
3482,GO:0006940,0.301152015705037,0.950521983925434,1,55,regulation of smooth muscle contraction,BP,DOCK5
7297,GO:0030315,0.301576383105681,0.950388372319401,1,54,T-tubule,CC,FXYD1
2700,GO:0005741,0.302069565145496,0.901588545108583,2,170,mitochondrial outer membrane,CC,MAOB;BOK
18940,GO:1901214,0.302590202205199,0.872937472390053,3,296,regulation of neuron death,BP,MAG;SNCA;BOK
4335,GO:0009142,0.303165688664816,0.949799584966905,1,56,nucleoside triphosphate biosynthetic process,BP,AK5
5169,GO:0014743,0.303613959342415,0.949655933771048,1,55,regulation of muscle hypertrophy,BP,RGS4
1153,GO:0002637,0.304801922561258,0.949220151052152,1,56,regulation of immunoglobulin production,BP,CD22
19802,GO:1903317,0.305618682231032,0.948929499975565,1,56,regulation of protein maturation,BP,CNTN2
13631,GO:0051235,0.305888915109851,0.870845712852881,3,296,maintenance of location,BP,SLC17A7;SNCA;RYR2
9998,GO:0035904,0.306021124734167,0.948800889816446,1,55,aorta development,BP,LRP2
4936,GO:0010823,0.306170205916394,0.948732701768189,1,56,negative regulation of mitochondrion organization,BP,BOK
17113,GO:0090181,0.306409189075196,0.948647292562753,1,56,regulation of cholesterol metabolic process,BP,FGF1
2749,GO:0005801,0.307038848224266,0.948421873899084,1,56,cis-Golgi network,CC,BOK
20834,GO:1905330,0.307189319146118,0.898782275822428,2,172,regulation of morphogenesis of an epithelium,BP,FGF1;GREM1
4559,GO:0009790,0.308230796212048,0.811109556457371,8,979,embryo development,BP,LRP2;DLL3;RARRES2;NECAB1;PDGFRA;GREM1;MBP;RYR2
19514,GO:1902686,0.308263503539165,0.947967202287688,1,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,BOK
9561,GO:0035082,0.308699458187962,0.947824676698046,1,56,axoneme assembly,BP,DCX
9260,GO:0034341,0.309009636599161,0.897770983903198,2,174,response to interferon-gamma,BP,CAMK2A;SNCA
8658,GO:0032835,0.309076866041694,0.947688405157721,1,56,glomerulus development,BP,PDGFRA
12255,GO:0046173,0.309321673156144,0.947585170630586,1,57,polyol biosynthetic process,BP,SNCA
4516,GO:0009628,0.309505693693632,0.8044461106127,9,1125,response to abiotic stimulus,BP,CAMK2A;MAG;FGF1;CHI3L1;ICOSLG;SYNPO;CCK;LPAR1;RYR2
15413,GO:0070059,0.309587035285792,0.94748911703982,1,57,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,BOK
11059,GO:0043167,0.309607559586036,0.759115185989608,39,5549,ion binding,MF,CD22;MAOB;CAMK2A;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;MAG;ADAP1;EPHB6;FGF1;PADI2;GDA;NECAB1;PACSIN1;HAPLN2;PDGFRA;ENPP2;GALNT6;SNCA;ST18;PAMR1;CNDP1;AK5;NRGN;PDE1C;CSRP1;S100A1;VSNL1;HHIP;CYB5R2;CARNS1;AIFM3;SPOCK3;LPAR1;RYR2;MEX3A
14548,GO:0060393,0.309916458610519,0.947369735672838,1,57,regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
7532,GO:0030888,0.309942592841929,0.94736025814328,1,57,regulation of B cell proliferation,BP,CD22
19257,GO:1902041,0.310006266632412,0.947337162892171,1,57,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
19359,GO:1902275,0.31021021002868,0.897114202915888,2,172,regulation of chromatin organization,BP,PADI2;SNCA
18546,GO:0140115,0.31087781444738,0.947020461377162,1,57,export across plasma membrane,BP,FXYD1
11463,GO:0044092,0.311199220937572,0.8087753122814,8,988,negative regulation of molecular function,BP,CAMK2A;RGS4;SNCA;SERPINI1;PPP1R14A;SPOCK3;SERPINA3;GRM3
4019,GO:0008361,0.311549221762422,0.896370857384128,2,172,regulation of cell size,BP,MAG;SPP1
12392,GO:0046530,0.312558360230841,0.946406728468634,1,57,photoreceptor cell differentiation,BP,DCX
9656,GO:0035308,0.314626581930711,0.945631163616399,1,58,negative regulation of protein dephosphorylation,BP,PPP1R14A
19743,GO:1903201,0.314982537114074,0.94549956425644,1,58,regulation of oxidative stress-induced cell death,BP,GPR37
9147,GO:0034113,0.315309231484067,0.945378622829048,1,58,heterotypic cell-cell adhesion,BP,MBP
13618,GO:0051216,0.315989484566142,0.893876638370808,2,175,cartilage development,BP,CHI3L1;GREM1
13614,GO:0051205,0.316794394946514,0.944812481483939,1,59,protein insertion into membrane,BP,MAL
9794,GO:0035580,0.317002429492551,0.944734924922667,1,59,specific granule lumen,CC,CHI3L1
9942,GO:0035794,0.317187413632031,0.944665909363135,1,59,positive regulation of mitochondrial membrane permeability,BP,BOK
3719,GO:0007405,0.31746813819115,0.944575545341159,1,58,neuroblast proliferation,BP,HHIP
8525,GO:0032642,0.31779683834069,0.944438191008317,1,59,regulation of chemokine production,BP,MBP
2264,GO:0004860,0.318377419811596,0.944220752343366,1,59,protein kinase inhibitor activity,MF,SNCA
11304,GO:0043550,0.319985041953621,0.943616128915583,1,59,regulation of lipid kinase activity,BP,PDGFRA
13381,GO:0050830,0.320204187976558,0.943519198075475,1,60,defense response to Gram-positive bacterium,BP,RARRES2
2883,GO:0006026,0.320260008552478,0.943512340493412,1,59,aminoglycan catabolic process,BP,CHI3L1
14202,GO:0055021,0.320939676349576,0.943255324810342,1,59,regulation of cardiac muscle tissue growth,BP,RGS4
21013,GO:1905710,0.321505147771565,0.943026647019826,1,60,positive regulation of membrane permeability,BP,BOK
3294,GO:0006650,0.321862213188936,0.860505806068021,3,307,glycerophospholipid metabolic process,BP,SYNJ2;CPNE6;ENPP2
7041,GO:0022804,0.322042550922359,0.860389394911289,3,306,active transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
17654,GO:0097529,0.32258866780373,0.890117858607147,2,180,myeloid leukocyte migration,BP,RARRES2;GREM1
13392,GO:0050853,0.322846302716568,0.94251630927468,1,60,B cell receptor signaling pathway,BP,CD22
328,GO:0000904,0.322957817640884,0.814996311771898,6,710,cell morphogenesis involved in differentiation,BP,MAG;EPHB6;SPP1;DOCK5;CNTN2;CCK
12379,GO:0046503,0.323373167745829,0.942315111462051,1,60,glycerolipid catabolic process,BP,ENPP2
4829,GO:0010660,0.323472437537474,0.942277157406625,1,60,regulation of muscle cell apoptotic process,BP,CAMK2A
8325,GO:0032370,0.323541744004686,0.942250650806309,1,60,positive regulation of lipid transport,BP,SPP1
14544,GO:0060389,0.323547300907806,0.942248525238827,1,60,pathway-restricted SMAD protein phosphorylation,BP,GREM1
9930,GO:0035773,0.323782324053906,0.942158585568025,1,60,insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
696,GO:0001895,0.323877430995242,0.942122166797843,1,60,retina homeostasis,BP,TF
21926,GO:2000756,0.324028576317437,0.942064262486282,1,60,regulation of peptidyl-lysine acetylation,BP,SNCA
13044,GO:0048667,0.324086981195185,0.824960837823058,5,573,cell morphogenesis involved in neuron differentiation,BP,MAG;EPHB6;SPP1;CNTN2;CCK
17791,GO:0098631,0.324885766534397,0.941735240714934,1,60,cell adhesion mediator activity,MF,CNTN2
3956,GO:0008270,0.324923534347756,0.813487932571288,6,717,zinc ion binding,MF,GDA;ENPP2;SNCA;ST18;CSRP1;HHIP
13357,GO:0050795,0.325060030270635,0.941668220839983,1,60,regulation of behavior,BP,CCK
14936,GO:0061035,0.325387063252817,0.941542328144421,1,60,regulation of cartilage development,BP,GREM1
12083,GO:0045844,0.325757124787174,0.941399683330873,1,60,positive regulation of striated muscle tissue development,BP,GREM1
13026,GO:0048636,0.325757124787174,0.941399683330873,1,60,positive regulation of muscle organ development,BP,GREM1
17430,GO:0097110,0.326582603204196,0.941080772273976,1,60,scaffold protein binding,MF,GRM3
13788,GO:0051536,0.327015269913727,0.940898883000186,1,61,iron-sulfur cluster binding,MF,AIFM3
13792,GO:0051540,0.327015269913727,0.940898883000186,1,61,metal cluster binding,MF,AIFM3
3440,GO:0006879,0.327524424458418,0.940701316420364,1,61,cellular iron ion homeostasis,BP,TF
10975,GO:0043010,0.32775418180565,0.856618020024464,3,308,camera-type eye development,BP,DCX;SLC17A7;PDGFRA
13135,GO:0048844,0.328714445849511,0.940252558899393,1,60,artery morphogenesis,BP,LRP2
686,GO:0001885,0.329958688207185,0.939751504805801,1,61,endothelial cell development,BP,HAPLN2
11061,GO:0043169,0.330036292922053,0.747841971740596,27,3786,cation binding,MF,CAMK2A;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;ADAP1;PADI2;GDA;NECAB1;ENPP2;GALNT6;SNCA;ST18;PAMR1;CNDP1;PDE1C;CSRP1;S100A1;VSNL1;HHIP;CARNS1;AIFM3;SPOCK3;RYR2;MEX3A
7027,GO:0022607,0.330040505924833,0.757701187575281,19,2601,cellular component assembly,BP,GAS7;CLDN11;DCX;NEFM;HAPLN2;PDGFRA;CLDN10;TESPA1;SNCA;SLC39A12;SLC24A2;CSRP1;TPPP3;GREM1;GJB1;SYNPO;BOK;CCK;LPAR1
7048,GO:0022836,0.330271078058581,0.854941193328786,3,310,gated channel activity,MF,ASIC4;SLC17A7;RYR2
19187,GO:1901863,0.330287176687319,0.939622667993596,1,61,positive regulation of muscle tissue development,BP,GREM1
3391,GO:0006796,0.330420710434843,0.754268399802776,21,2904,phosphate-containing compound metabolic process,BP,CAMK2A;SYNJ2;TF;CPNE6;EPHB6;RARRES2;FGF1;RGS4;GDA;CHI3L1;PDGFRA;ENPP2;SNCA;AK5;GREM1;PPP1R14A;GPR37;RCAN2;CCK;MBP;LPAR1
4110,GO:0008509,0.330717364830375,0.854639932652698,3,312,anion transmembrane transporter activity,MF,SLC17A7;SLC24A2;FXYD1
587,GO:0001756,0.33104877031778,0.939323352439365,1,61,somitogenesis,BP,DLL3
18138,GO:0099513,0.331219400228962,0.819639349179863,5,581,polymeric cytoskeletal fiber,CC,GAS7;CLDN11;DCX;NEFM;TPPP3
4930,GO:0010817,0.331306483041857,0.834045495374979,4,448,regulation of hormone levels,BP,SPP1;PDGFRA;VSNL1;KLK6
7648,GO:0031093,0.331616454121314,0.939085429027143,1,62,platelet alpha granule lumen,CC,SERPINA3
6442,GO:0019210,0.331840270954089,0.938997098069217,1,62,kinase inhibitor activity,MF,SNCA
13040,GO:0048663,0.332486212972301,0.938741758375495,1,62,neuron fate commitment,BP,NKX6-2
12323,GO:0046394,0.333132859216771,0.853019964545026,3,315,carboxylic acid biosynthetic process,BP,FOLH1;CBR1;CARNS1
2611,GO:0005575,0.333274574989487,0.859230658840613,98,14892,cellular_component,CC,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;NEFM;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;EVI2A;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;GALNT6;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;PAMR1;CNDP1;AK5;NRGN;PDE1C;SLC24A2;SLC5A11;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;TMEM144;HHIP;CYB5R2;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;RCAN2;CARNS1;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AIFM3;CNTN2;SV2B;MPPED1;CCK;NKAIN2;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;MEX3A;FXYD1
18630,GO:0150076,0.333796377696866,0.93822196234386,1,62,neuroinflammatory response,BP,SNCA
8182,GO:0032103,0.334096580941771,0.832038528428933,4,451,positive regulation of response to external stimulus,BP,RARRES2;SNCA;CXCL14;LPAR1
5654,GO:0016053,0.334899111255167,0.851833087022008,3,316,organic acid biosynthetic process,BP,FOLH1;CBR1;CARNS1
9465,GO:0034704,0.334985217634474,0.937762654779896,1,61,calcium channel complex,CC,RYR2
15683,GO:0070507,0.335196956515263,0.882798618514253,2,182,regulation of microtubule cytoskeleton organization,BP,SNCA;SLC39A12
568,GO:0001725,0.335798763638552,0.937422631369983,1,62,stress fiber,CC,SYNPO
17647,GO:0097517,0.335798763638552,0.937422631369983,1,62,contractile actin filament bundle,CC,SYNPO
12969,GO:0048519,0.336350860752258,0.737391220741208,34,4863,negative regulation of biological process,BP,HHATL;CD22;MAOB;LRP2;DLL3;MAG;PADI2;RGS4;SPP1;PACSIN1;PDGFRA;SNCA;CXCL14;DOCK5;ST18;NKX6-2;SLC24A2;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;EMX2;GPR37;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;RYR2;FXYD1
4826,GO:0010657,0.336745506884839,0.93702840128912,1,63,muscle cell apoptotic process,BP,CAMK2A
13967,GO:0051893,0.336928624498796,0.936968981401559,1,62,regulation of focal adhesion assembly,BP,GREM1
17066,GO:0090109,0.336928624498796,0.936968981401559,1,62,regulation of cell-substrate junction assembly,BP,GREM1
12985,GO:0048545,0.337174233162244,0.85030098771783,3,316,response to steroid hormone,BP,MAOB;PADI2;SPP1
3333,GO:0006695,0.337553329316459,0.936703043317526,1,63,cholesterol biosynthetic process,BP,FGF1
19502,GO:1902653,0.337553329316459,0.936703043317526,1,63,secondary alcohol biosynthetic process,BP,FGF1
19114,GO:1901654,0.33826380880415,0.880975512514171,2,185,response to ketone,BP,MAOB;SPP1
5795,GO:0016328,0.339094980020219,0.936079436098387,1,63,lateral plasma membrane,CC,GJB1
19369,GO:1902305,0.339116305209621,0.936070785114995,1,63,regulation of sodium ion transmembrane transport,BP,FXYD1
20619,GO:1904888,0.339388720708859,0.935960214772266,1,63,cranial skeletal system development,BP,PDGFRA
4358,GO:0009166,0.339965573701289,0.935711664067493,1,64,nucleotide catabolic process,BP,GDA
3804,GO:0007626,0.340251824379592,0.879798049814538,2,184,locomotory behavior,BP,GPR37;CNTN2
7718,GO:0031253,0.340335771537507,0.848163271794349,3,315,cell projection membrane,CC,LRP2;PACSIN1;HHIP
19002,GO:1901361,0.340388705818712,0.812716605535886,5,596,organic cyclic compound catabolic process,BP,MAOB;MOXD1;SPP1;GDA;CARNS1
7270,GO:0030279,0.342305108213076,0.934755306637908,1,64,negative regulation of ossification,BP,GREM1
16043,GO:0071230,0.342746223968885,0.934574069219671,1,64,cellular response to amino acid stimulus,BP,PDGFRA
5187,GO:0014823,0.342995750736103,0.934471419182375,1,64,response to activity,BP,RYR2
14945,GO:0061045,0.345550677879878,0.933400939971513,1,65,negative regulation of wound healing,BP,PDGFRA
508,GO:0001618,0.345836196931194,0.933282249893459,1,65,virus receptor activity,MF,MOG
18572,GO:0140272,0.345836196931194,0.933282249893459,1,65,exogenous protein binding,MF,MOG
3390,GO:0006793,0.345865793663188,0.740690143342634,21,2929,phosphorus metabolic process,BP,CAMK2A;SYNJ2;TF;CPNE6;EPHB6;RARRES2;FGF1;RGS4;GDA;CHI3L1;PDGFRA;ENPP2;SNCA;AK5;GREM1;PPP1R14A;GPR37;RCAN2;CCK;MBP;LPAR1
10828,GO:0042698,0.346266981458516,0.933102940644841,1,65,ovulation cycle,BP,PDGFRA
12412,GO:0046579,0.346979186008242,0.932805879879035,1,65,positive regulation of Ras protein signal transduction,BP,LPAR1
19195,GO:1901888,0.347379633337105,0.875506142319131,2,187,regulation of cell junction assembly,BP,SNCA;GREM1
8498,GO:0032602,0.347700188852524,0.932490571079882,1,66,chemokine production,BP,MBP
4609,GO:0009968,0.347864456732631,0.773232254085152,9,1168,negative regulation of signal transduction,BP,CD22;LRP2;PADI2;RGS4;SNCA;HHIP;GREM1;BOK;LPAR1
13999,GO:0051937,0.348317007946635,0.932231957180762,1,66,catecholamine transport,BP,SNCA
3610,GO:0007178,0.348398085068098,0.842641527117551,3,320,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;TF;GREM1
18644,GO:0150116,0.349925881530166,0.931568668152447,1,65,regulation of cell-substrate junction organization,BP,GREM1
13154,GO:0048871,0.350125021026565,0.820349972745791,4,459,multicellular organismal homeostasis,BP,TF;SPP1;SERPINA3;MBP
7369,GO:0030500,0.350950675028079,0.931121258767364,1,66,regulation of bone mineralization,BP,GREM1
14387,GO:0060170,0.351150351196883,0.931036620155057,1,66,ciliary membrane,CC,HHIP
14569,GO:0060420,0.351542539845138,0.930870203144444,1,66,regulation of heart growth,BP,RGS4
19593,GO:1902905,0.351632874184571,0.872906872105421,2,190,positive regulation of supramolecular fiber organization,BP,SYNPO;LPAR1
10771,GO:0042578,0.351755599704168,0.840316539370981,3,323,phosphoric ester hydrolase activity,MF,SYNJ2;ENPP2;PDE1C
1423,GO:0003143,0.351894811405111,0.930720524797842,1,66,embryonic heart tube morphogenesis,BP,RYR2
4316,GO:0009123,0.352440390234511,0.930474591525902,1,67,nucleoside monophosphate metabolic process,BP,AK5
8383,GO:0032432,0.352786627522738,0.930340752838548,1,66,actin filament bundle,CC,SYNPO
8130,GO:0032024,0.353563699837175,0.929995022581487,1,67,positive regulation of insulin secretion,BP,VSNL1
14687,GO:0060589,0.353948582116379,0.83879413053552,3,323,nucleoside-triphosphatase regulator activity,MF,ADAP1;RGS4;DOCK5
11934,GO:0045600,0.354156007779006,0.929741376845064,1,67,positive regulation of fat cell differentiation,BP,RARRES2
14660,GO:0060548,0.354682355447648,0.781137863250495,7,889,negative regulation of cell death,BP,LRP2;MAG;SNCA;HHIP;GREM1;GPR37;BOK
11458,GO:0044087,0.355112265852077,0.780791197009084,7,884,regulation of cellular component biogenesis,BP,SNCA;SLC39A12;TPPP3;GREM1;SYNPO;CCK;LPAR1
22139,GO:2001259,0.35526489614791,0.929265074126731,1,67,positive regulation of cation channel activity,BP,S100A1
2478,GO:0005230,0.355309021213263,0.929246082132598,1,67,extracellular ligand-gated ion channel activity,MF,SLC17A7
12901,GO:0048306,0.355372060993656,0.929205382869622,1,68,calcium-dependent protein binding,MF,S100A1
6142,GO:0017022,0.355953479721014,0.928968359482029,1,67,myosin binding,MF,MOBP
6439,GO:0019207,0.356111241500508,0.870143459023631,2,193,kinase regulator activity,MF,SNCA;GREM1
11296,GO:0043542,0.356388871369077,0.869975687283303,2,192,endothelial cell migration,BP,FGF1;GREM1
1577,GO:0003407,0.357075494050436,0.928483321625048,1,67,neural retina development,BP,SLC17A7
9868,GO:0035690,0.357162411713341,0.928431971736966,1,68,cellular response to drug,BP,PPP1R14A
9651,GO:0035303,0.357195168448517,0.869476910533146,2,192,regulation of dephosphorylation,BP,PPP1R14A;RCAN2
21814,GO:2000573,0.357561956962075,0.928258702112741,1,68,positive regulation of DNA biosynthetic process,BP,GREM1
15377,GO:0062197,0.357662481543375,0.836192815837578,3,328,cellular response to chemical stress,BP,PDGFRA;SNCA;GPR37
8099,GO:0031968,0.358028912940406,0.868956413542598,2,193,organelle outer membrane,CC,MAOB;BOK
16931,GO:0086003,0.358844861868137,0.927714513645192,1,67,cardiac muscle cell contraction,BP,RYR2
16929,GO:0086001,0.359050314749864,0.927624930570861,1,67,cardiac muscle cell action potential,BP,RYR2
11637,GO:0044706,0.359276884209437,0.868177395443292,2,194,multi-multicellular organism process,BP,SPP1;TPPP3
11268,GO:0043507,0.360261049428412,0.927081767550697,1,68,positive regulation of JUN kinase activity,BP,TF
11739,GO:0045055,0.360436194686612,0.785646715039084,6,749,regulated exocytosis,BP,TF;RARRES2;PADI2;CHI3L1;SNCA;SERPINA3
12112,GO:0045913,0.360884789969619,0.92680819072154,1,68,positive regulation of carbohydrate metabolic process,BP,SNCA
2415,GO:0005126,0.360915214826537,0.867148863378452,2,196,cytokine receptor binding,MF,CXCL14;GREM1
10327,GO:0038024,0.361086693862946,0.926719505707103,1,68,cargo receptor activity,MF,ENPP2
5441,GO:0015629,0.36157546944087,0.811823762415876,4,464,actin cytoskeleton,CC,GAS7;SNCA;MOBP;SYNPO
6454,GO:0019226,0.361642761000348,0.926474931331275,1,68,transmission of nerve impulse,BP,MAG
10335,GO:0038034,0.361670992526591,0.926448872155313,1,69,signal transduction in absence of ligand,BP,BOK
17484,GO:0097192,0.361670992526591,0.926448872155313,1,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,BOK
16408,GO:0071840,0.361810835604511,0.711884969942251,40,5809,cellular component organization or biogenesis,BP,GAS7;CD22;CLDN11;CAMK2A;DCX;SYNJ2;LRP2;TF;CPNE6;NEFM;SLC17A7;MAG;EPHB6;PADI2;RGS4;SPP1;PACSIN1;MYRF;HAPLN2;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;SNCA;SLC39A12;SLC24A2;CSRP1;TPPP3;SERPINI1;GREM1;KLK6;GJB1;SYNPO;MAL;BOK;CNTN2;CCK;MBP;LPAR1
11216,GO:0043407,0.361827013376507,0.926380145518376,1,69,negative regulation of MAP kinase activity,BP,RGS4
6662,GO:0019867,0.362905477003881,0.865907110017224,2,195,outer membrane,CC,MAOB;BOK
16042,GO:0071229,0.363886791492547,0.925469289484627,1,69,cellular response to acid chemical,BP,PDGFRA
13495,GO:0051015,0.364200643972791,0.865109089604897,2,191,actin filament binding,MF,GAS7;ERMN
13409,GO:0050870,0.364234098405332,0.865065117989172,2,197,positive regulation of T cell activation,BP,TESPA1;ICOSLG
10477,GO:0040008,0.36516944569624,0.793591788173255,5,610,regulation of growth,BP,CPNE6;MAG;RGS4;SPP1;GREM1
18969,GO:1901292,0.365303959374646,0.924825281643948,1,70,nucleoside phosphate catabolic process,BP,GDA
16388,GO:0071805,0.365346323497432,0.864368340137075,2,196,potassium ion transmembrane transport,BP,RGS4;SLC24A2
3410,GO:0006826,0.365441749988851,0.924763801376744,1,70,iron ion transport,BP,TF
10637,GO:0042310,0.366711946019451,0.924195666183253,1,70,vasoconstriction,BP,DOCK5
3479,GO:0006936,0.366761845169732,0.829768203232228,3,329,muscle contraction,BP,DOCK5;RYR2;FXYD1
5316,GO:0015171,0.367385313817448,0.923893461961054,1,70,amino acid transmembrane transporter activity,MF,SLC17A7
1515,GO:0003281,0.367429466580418,0.923887277666682,1,69,ventricular septum development,BP,LRP2
11368,GO:0043687,0.367629848085615,0.829140717548652,3,334,post-translational protein modification,BP,FOLH1;TF;SPP1
15948,GO:0070997,0.368705592927304,0.828375298563947,3,333,neuron death,BP,MAG;SNCA;BOK
19821,GO:1903350,0.369719210387691,0.922827108481262,1,71,response to dopamine,BP,RGS4
19822,GO:1903351,0.369719210387691,0.922827108481262,1,71,cellular response to dopamine,BP,RGS4
17033,GO:0090066,0.370230810183354,0.805275941489627,4,472,regulation of anatomical structure size,BP,MAG;SPP1;DOCK5;CNTN2
4923,GO:0010810,0.370490008051961,0.861102395963162,2,197,regulation of cell-substrate adhesion,BP,DOCK5;GREM1
14562,GO:0060411,0.370494312697006,0.92248897486309,1,70,cardiac septum morphogenesis,BP,LRP2
13283,GO:0050670,0.370580533370884,0.861033438977749,2,200,regulation of lymphocyte proliferation,BP,CD22;ICOSLG
2459,GO:0005179,0.370671351319852,0.92238191640138,1,72,hormone activity,MF,CCK
13861,GO:0051651,0.370768591478552,0.860924654594403,2,197,maintenance of location in cell,BP,SNCA;RYR2
19225,GO:1901983,0.371021079269282,0.922235983466851,1,71,regulation of protein acetylation,BP,SNCA
11281,GO:0043523,0.371513613204684,0.86044124274178,2,199,regulation of neuron apoptotic process,BP,MAG;BOK
15443,GO:0070098,0.371670067812126,0.921927116911962,1,72,chemokine-mediated signaling pathway,BP,PADI2
15387,GO:0065007,0.371908544470429,0.706165167717344,69,10303,biological regulation,BP,HHATL;CD22;MAOB;CAMK2A;DCX;MOXD1;LRP2;DLL3;TF;CPNE6;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;CNDP1;NRGN;PDE1C;SLC24A2;CSRP1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;KLK6;LGI3;EMX2;GPR37;SYNPO;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;NKAIN2;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;FXYD1
8264,GO:0032272,0.372049312800634,0.921767225408719,1,71,negative regulation of protein polymerization,BP,SNCA
4601,GO:0009952,0.372879215644197,0.859566917705978,2,199,anterior/posterior pattern specification,BP,DLL3;EMX2
8723,GO:0032944,0.372883551112019,0.859556712139998,2,201,regulation of mononuclear cell proliferation,BP,CD22;ICOSLG
8522,GO:0032637,0.373201625933821,0.921226624852515,1,72,interleukin-8 production,BP,CHI3L1
14023,GO:0051966,0.373439432239891,0.921130845678937,1,71,regulation of synaptic transmission, glutamatergic,BP,GRM3
13086,GO:0048729,0.3734429006475,0.787067021501682,5,612,tissue morphogenesis,BP,LRP2;FGF1;HHIP;GREM1;RYR2
17924,GO:0098858,0.373455516301129,0.859200932410841,2,198,actin-based cell projection,CC,PDGFRA;ERMN
12557,GO:0046889,0.374025731801333,0.920848173570304,1,72,positive regulation of lipid biosynthetic process,BP,FGF1
18832,GO:1900407,0.374500834717645,0.920629507052095,1,72,regulation of cellular response to oxidative stress,BP,GPR37
8802,GO:0033077,0.375588756657697,0.920127447663525,1,72,T cell differentiation in thymus,BP,TESPA1
14550,GO:0060395,0.376512831837588,0.919699531310914,1,72,SMAD protein signal transduction,BP,TF
12356,GO:0046470,0.376764818625277,0.919569428764686,1,73,phosphatidylcholine metabolic process,BP,ENPP2
13531,GO:0051057,0.377120053754441,0.91941760576433,1,72,positive regulation of small GTPase mediated signal transduction,BP,LPAR1
8362,GO:0032410,0.37864183203796,0.918695186022867,1,73,negative regulation of transporter activity,BP,SNCA
13922,GO:0051781,0.378777294908287,0.918631876053057,1,73,positive regulation of cell division,BP,FGF1
10811,GO:0042641,0.379365820079325,0.918369841844137,1,72,actomyosin,CC,SYNPO
6574,GO:0019637,0.379939446773481,0.760337762643934,7,913,organophosphate metabolic process,BP,SYNJ2;CPNE6;GDA;PDGFRA;ENPP2;SNCA;AK5
18423,GO:0110165,0.380146085862022,0.803735452402882,97,14761,cellular anatomical entity,CC,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;NEFM;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;EVI2A;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;GALNT6;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;PAMR1;CNDP1;AK5;NRGN;PDE1C;SLC24A2;SLC5A11;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;TMEM144;HHIP;CYB5R2;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;RCAN2;CARNS1;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AIFM3;CNTN2;SV2B;CCK;NKAIN2;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;TMEM235;TMEM88B;MEX3A;FXYD1
7600,GO:0031016,0.38034118141809,0.917898863603341,1,73,pancreas development,BP,NKX6-2
4008,GO:0008344,0.38068120027082,0.917738977152345,1,73,adult locomotory behavior,BP,CNTN2
17777,GO:0098588,0.380721591915865,0.724539012341056,14,1941,bounding membrane of organelle,CC,MAOB;CAMK2A;MOXD1;LRP2;TF;SLC17A7;GALNT6;SNCA;NRGN;HHIP;BOK;GPR62;SV2B;RYR2
9551,GO:0035050,0.381001033540335,0.917588414265302,1,73,embryonic heart tube development,BP,RYR2
16084,GO:0071310,0.381049918493214,0.716551290502758,17,2389,cellular response to organic substance,BP,CAMK2A;LRP2;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;SNCA;ST18;VSNL1;HHIP;GREM1;BOK;LPAR1;RYR2
18052,GO:0099056,0.381352106219525,0.91742295739138,1,73,integral component of presynaptic membrane,CC,GRM3
7206,GO:0030193,0.381609015053399,0.917288607452296,1,74,regulation of blood coagulation,BP,PDGFRA
10541,GO:0042100,0.382012516666395,0.917098005545627,1,74,B cell proliferation,BP,CD22
518,GO:0001649,0.382081085368672,0.853591713585538,2,203,osteoblast differentiation,BP,SPP1;GREM1
16705,GO:0072332,0.382657126851512,0.916792971271193,1,74,intrinsic apoptotic signaling pathway by p53 class mediator,BP,BOK
20189,GO:1904035,0.382939180092596,0.91665929254984,1,74,regulation of epithelial cell apoptotic process,BP,BOK
17740,GO:0097756,0.383177612236547,0.916546188658907,1,74,negative regulation of blood vessel diameter,BP,DOCK5
11069,GO:0043178,0.384031533419092,0.916140371105574,1,74,alcohol binding,MF,ADAP1
14911,GO:0060998,0.384192153961013,0.916077228631781,1,73,regulation of dendritic spine development,BP,LPAR1
13605,GO:0051173,0.384254996285764,0.707919421731377,20,2840,positive regulation of nitrogen compound metabolic process,BP,MAOB;LRP2;TF;RARRES2;FGF1;PADI2;SPP1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
6827,GO:0021675,0.384824888577478,0.915762289085014,1,74,nerve development,BP,LPAR1
16124,GO:0071363,0.384934617842387,0.777878857884483,5,624,cellular response to growth factor stimulus,BP,LRP2;FGF1;PDGFRA;HHIP;GREM1
16346,GO:0071695,0.385086908501271,0.851615008525837,2,204,anatomical structure maturation,BP,GREM1;CNTN2
18680,GO:1900046,0.385600825901147,0.915378471523423,1,75,regulation of hemostasis,BP,PDGFRA
2723,GO:0005769,0.385722542711363,0.816028857194304,3,342,early endosome,CC,CD22;TF;BOK
14255,GO:0055117,0.385974285406293,0.915212738326471,1,74,regulation of cardiac muscle contraction,BP,RYR2
15685,GO:0070509,0.3860897257154,0.915157426500178,1,74,calcium ion import,BP,SLC24A2
13109,GO:0048786,0.386435803029582,0.914991479219578,1,74,presynaptic active zone,CC,SLC17A7
3782,GO:0007600,0.386747052499843,0.792549625317669,4,485,sensory perception,BP,LRP2;SLC24A2;CCK;MBP
4503,GO:0009593,0.388277269753455,0.914079109688227,1,76,detection of chemical stimulus,BP,RYR2
18672,GO:1900034,0.388852282676137,0.913814099752838,1,75,regulation of cellular response to heat,BP,CAMK2A
3488,GO:0006952,0.389416826999784,0.732522867525657,10,1367,defense response,BP,CAMK2A;ASIC4;TF;RARRES2;SPP1;CHI3L1;SNCA;ICOSLG;CCK;SERPINA3
6865,GO:0021766,0.389577693724362,0.913462754290584,1,75,hippocampus development,BP,EMX2
2811,GO:0005901,0.389957615702983,0.913278403123198,1,75,caveola,CC,FXYD1
14577,GO:0060429,0.39041695907915,0.743700014401983,8,1063,epithelium development,BP,LRP2;DLL3;FGF1;HAPLN2;CBR1;HHIP;GREM1;RYR2
14223,GO:0055072,0.390629466358536,0.912938785626231,1,76,iron ion homeostasis,BP,TF
7282,GO:0030295,0.390760804035118,0.912874850121087,1,76,protein kinase activator activity,MF,GREM1
7767,GO:0031325,0.390962282474403,0.700222636886288,21,3000,positive regulation of cellular metabolic process,BP,MAOB;LRP2;TF;EPHB6;RARRES2;FGF1;PADI2;SPP1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
12818,GO:0048145,0.39179839479196,0.912368764179712,1,76,regulation of fibroblast proliferation,BP,PDGFRA
5384,GO:0015297,0.39210670827022,0.91221804696446,1,76,antiporter activity,MF,SLC24A2
17675,GO:0097581,0.392444684291409,0.91205265182829,1,76,lamellipodium organization,BP,ENPP2
9628,GO:0035258,0.393363323959892,0.911602158424694,1,76,steroid hormone receptor binding,MF,PADI2
1428,GO:0003151,0.39366848698574,0.911452204845659,1,76,outflow tract morphogenesis,BP,LRP2
8592,GO:0032755,0.393681489865966,0.911432916855483,1,77,positive regulation of interleukin-6 production,BP,MBP
4183,GO:0008652,0.394257543481525,0.911149387912141,1,77,cellular amino acid biosynthetic process,BP,FOLH1
11264,GO:0043502,0.394270353402056,0.911156009645525,1,76,regulation of muscle adaptation,BP,RGS4
148,GO:0000302,0.394324327731421,0.845448816749692,2,210,response to reactive oxygen species,BP,PDGFRA;GPR37
16059,GO:0071260,0.394384542699572,0.911086807089095,1,77,cellular response to mechanical stimulus,BP,MAG
19142,GO:1901700,0.394815040337139,0.72303167991254,11,1515,response to oxygen-containing compound,BP,MAOB;CAMK2A;RARRES2;RGS4;SPP1;PDGFRA;SNCA;VSNL1;GPR37;LPAR1;RYR2
17538,GO:0097305,0.3951062883332,0.84492675516099,2,209,response to alcohol,BP,MAOB;RGS4
12817,GO:0048144,0.39577466810078,0.910400078993439,1,77,fibroblast proliferation,BP,PDGFRA
16774,GO:0072527,0.396679008858738,0.909938882665706,1,78,pyrimidine-containing compound metabolic process,BP,AK5
2006,GO:0004497,0.397359040055138,0.909600743003207,1,78,monooxygenase activity,MF,MOXD1
15769,GO:0070664,0.397374917077944,0.909592839230374,1,78,negative regulation of leukocyte proliferation,BP,GREM1
13374,GO:0050818,0.397509342419108,0.909525904104604,1,78,regulation of coagulation,BP,PDGFRA
9539,GO:0035023,0.397565659863072,0.909510659608375,1,77,regulation of Rho protein signal transduction,BP,LPAR1
7514,GO:0030864,0.398666939166957,0.90896114395674,1,77,cortical actin cytoskeleton,CC,MOBP
10267,GO:0036473,0.398702222901323,0.908930626902986,1,78,cell death in response to oxidative stress,BP,GPR37
4161,GO:0008610,0.399023144118892,0.766427040061145,5,639,lipid biosynthetic process,BP,SYNJ2;CPNE6;FGF1;CBR1;CYB5R2
2032,GO:0004527,0.399194528987747,0.908684272039736,1,78,exonuclease activity,MF,ENPP2
18013,GO:0098978,0.399571912684446,0.805715302289652,3,348,glutamatergic synapse,CC,NRGN;SYNPO;GRM3
10878,GO:0042775,0.400493476144162,0.908007344435551,1,80,mitochondrial ATP synthesis coupled electron transport,BP,SNCA
3490,GO:0006954,0.40098820736488,0.764812613520829,5,642,inflammatory response,BP,RARRES2;SPP1;CHI3L1;SNCA;SERPINA3
4734,GO:0010507,0.401229259654974,0.907661837937009,1,78,negative regulation of autophagy,BP,SNCA
4435,GO:0009266,0.401838755152753,0.840353130274179,2,212,response to temperature stimulus,BP,CAMK2A;FGF1
14953,GO:0061053,0.401958699500843,0.907293637261389,1,78,somite development,BP,DLL3
19581,GO:1902882,0.402321223106434,0.907097543845987,1,79,regulation of response to oxidative stress,BP,GPR37
20207,GO:1904063,0.402440967727414,0.907036936883239,1,79,negative regulation of cation transmembrane transport,BP,RGS4
13781,GO:0051495,0.402672248630632,0.839783725855871,2,212,positive regulation of cytoskeleton organization,BP,SYNPO;LPAR1
7645,GO:0031090,0.402916912044743,0.68778926012743,22,3179,organelle membrane,CC,HHATL;MAOB;CAMK2A;MOXD1;LRP2;TF;SLC17A7;PACSIN1;MYRF;TESPA1;GALNT6;SNCA;NRGN;HHIP;CYB5R2;GJB1;GPR37;BOK;GPR62;AIFM3;SV2B;RYR2
4513,GO:0009617,0.402934385943086,0.779777156330293,4,498,response to bacterium,BP,MAOB;TF;RARRES2;SNCA
19864,GO:1903426,0.403034752615676,0.906736050789579,1,79,regulation of reactive oxygen species biosynthetic process,BP,SNCA
21407,GO:1990868,0.403883653736859,0.906292327297684,1,80,response to chemokine,BP,PADI2
21408,GO:1990869,0.403883653736859,0.906292327297684,1,80,cellular response to chemokine,BP,PADI2
15482,GO:0070167,0.403941841374249,0.906275277653359,1,79,regulation of biomineral tissue development,BP,GREM1
18418,GO:0110149,0.403941841374249,0.906275277653359,1,79,regulation of biomineralization,BP,GREM1
11504,GO:0044255,0.404135016110552,0.739867059681376,7,936,cellular lipid metabolic process,BP,SYNJ2;LRP2;CPNE6;RARRES2;PDGFRA;ENPP2;CBR1
3937,GO:0008233,0.404216443148893,0.778754038238551,4,498,peptidase activity,MF,FOLH1;MYRF;CNDP1;KLK6
10876,GO:0042773,0.404375815750151,0.90602950333704,1,81,ATP synthesis coupled electron transport,BP,SNCA
10723,GO:0042475,0.404950915560971,0.905761094869298,1,79,odontogenesis of dentin-containing tooth,BP,PDGFRA
11054,GO:0043154,0.405282255185676,0.905579255246051,1,80,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,SNCA
13589,GO:0051149,0.406441101782922,0.904985957127696,1,80,positive regulation of muscle cell differentiation,BP,GREM1
14211,GO:0055038,0.406660121417588,0.904873573675352,1,80,recycling endosome membrane,CC,BOK
8461,GO:0032535,0.406820779990544,0.800217257671434,3,353,regulation of cellular component size,BP,MAG;SPP1;CNTN2
17483,GO:0097191,0.407822588911171,0.836232002850741,2,215,extrinsic apoptotic signaling pathway,BP,MAL;BOK
19074,GO:1901570,0.408076331931813,0.904132468537364,1,81,fatty acid derivative biosynthetic process,BP,CBR1
19673,GO:1903039,0.408371319282353,0.835848873185359,2,216,positive regulation of leukocyte cell-cell adhesion,BP,TESPA1;ICOSLG
3146,GO:0006469,0.408539051780502,0.83573639901567,2,215,negative regulation of protein kinase activity,BP,RGS4;SNCA
12359,GO:0046474,0.408684292571325,0.835635840094758,2,215,glycerophospholipid biosynthetic process,BP,SYNJ2;CPNE6
19010,GO:1901379,0.40873343210394,0.903805749652193,1,80,regulation of potassium ion transmembrane transport,BP,RGS4
14199,GO:0055017,0.408982652084823,0.90367690935894,1,80,cardiac muscle tissue growth,BP,RGS4
4520,GO:0009636,0.409011405436217,0.835402028353426,2,217,response to toxic substance,BP,MAOB;MBP
16066,GO:0071277,0.409161966226894,0.903584144271038,1,80,cellular response to calcium ion,BP,CPNE6
9312,GO:0034401,0.409165477925424,0.903582327016758,1,80,chromatin organization involved in regulation of transcription,BP,PADI2
7022,GO:0022600,0.409230894523545,0.903535915406822,1,81,digestive system process,BP,SERPINA3
5139,GO:0014068,0.409243304980307,0.903542047317589,1,80,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PDGFRA
523,GO:0001654,0.40988008519495,0.797878998723858,3,354,eye development,BP,DCX;SLC17A7;PDGFRA
18509,GO:0140029,0.410216498139407,0.90302489593982,1,81,exocytic process,BP,SNCA
13650,GO:0051259,0.41115582348516,0.833916317008594,2,216,protein complex oligomerization,BP,SNCA;BOK
3497,GO:0006970,0.41155562901183,0.902327966610581,1,81,response to osmotic stress,BP,ICOSLG
11267,GO:0043506,0.411928317664131,0.902133470680297,1,81,regulation of JUN kinase activity,BP,TF
4334,GO:0009141,0.411969750008851,0.902099425162204,1,82,nucleoside triphosphate metabolic process,BP,AK5
339,GO:0000932,0.412380536724172,0.901897156184737,1,81,P-body,CC,MEX3A
21548,GO:2000177,0.41308045747581,0.901530722070858,1,81,regulation of neural precursor cell proliferation,BP,LRP2
4150,GO:0008589,0.413512183672627,0.901304285845962,1,81,regulation of smoothened signaling pathway,BP,HHIP
16710,GO:0072341,0.413713461189605,0.901186099285695,1,82,modified amino acid binding,MF,CPNE6
17823,GO:0098685,0.413821192432381,0.90114202065503,1,81,Schaffer collateral - CA1 synapse,CC,SYNPO
6441,GO:0019209,0.414271043287561,0.900892965219891,1,82,kinase activator activity,MF,GREM1
11009,GO:0043066,0.414278829045668,0.741105606979508,6,797,negative regulation of apoptotic process,BP,LRP2;MAG;SNCA;HHIP;GREM1;BOK
21115,GO:1905954,0.414609676196836,0.900714681565861,1,82,positive regulation of lipid localization,BP,SPP1
13561,GO:0051117,0.414611176920368,0.900713891032672,1,82,ATPase binding,MF,S100A1
12798,GO:0048041,0.41521776242965,0.900406648802309,1,81,focal adhesion assembly,BP,GREM1
10736,GO:0042493,0.415833036255664,0.793285673724788,3,361,response to drug,BP,MAOB;PPP1R14A;EMX2
17946,GO:0098889,0.416630681383495,0.899646626678199,1,82,intrinsic component of presynaptic membrane,CC,GRM3
18622,GO:0150063,0.416816031260303,0.792530542723757,3,358,visual system development,BP,DCX;SLC17A7;PDGFRA
10549,GO:0042113,0.416854867847724,0.829914917918433,2,219,B cell activation,BP,CD22;ICOSLG
11120,GO:0043255,0.417349998257442,0.899264813425985,1,82,regulation of carbohydrate biosynthetic process,BP,SNCA
8904,GO:0033273,0.417904107218143,0.898957643058106,1,83,response to vitamin,BP,SPP1
4170,GO:0008625,0.418246119240075,0.898775452960935,1,83,extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
2095,GO:0004620,0.418258993391453,0.898768591003371,1,83,phospholipase activity,MF,ENPP2
14976,GO:0061097,0.418956390550069,0.898396454851436,1,83,regulation of protein tyrosine kinase activity,BP,GREM1
10261,GO:0036464,0.419449289716689,0.828082562597201,2,219,cytoplasmic ribonucleoprotein granule,CC,ICOSLG;MEX3A
13653,GO:0051262,0.419766634898864,0.897963062048974,1,83,protein tetramerization,BP,SNCA
15849,GO:0070848,0.420263419582831,0.748779523595073,5,651,response to growth factor,BP,LRP2;FGF1;PDGFRA;HHIP;GREM1
11921,GO:0045582,0.421113750337751,0.897227686771148,1,84,positive regulation of T cell differentiation,BP,TESPA1
13368,GO:0050810,0.421935838361122,0.896784874537281,1,84,regulation of steroid biosynthetic process,BP,FGF1
20023,GO:1903725,0.422354972871164,0.896558665135996,1,84,regulation of phospholipid metabolic process,BP,PDGFRA
13362,GO:0050803,0.423175966668036,0.825429661862515,2,220,regulation of synapse structure or activity,BP,SLC17A7;SNCA
14497,GO:0060333,0.423752955669792,0.895789796400127,1,85,interferon-gamma-mediated signaling pathway,BP,CAMK2A
6556,GO:0019538,0.423856755462582,0.657013707245131,34,5028,protein metabolic process,BP,HHATL;CAMK2A;LRP2;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
2812,GO:0005902,0.423981254536005,0.895678098533006,1,84,microvillus,CC,PDGFRA
3806,GO:0007631,0.424437164723341,0.895418197033115,1,85,feeding behavior,BP,CCK
3165,GO:0006493,0.424509181461381,0.895391270401314,1,84,protein O-linked glycosylation,BP,GALNT6
17184,GO:0090277,0.424585747489345,0.895337394148849,1,85,positive regulation of peptide hormone secretion,BP,VSNL1
13778,GO:0051492,0.425116618699647,0.89506065019196,1,84,regulation of stress fiber assembly,BP,LPAR1
13404,GO:0050865,0.425209975899082,0.761716898836012,4,513,regulation of cell activation,BP,CD22;PDGFRA;TESPA1;ICOSLG
13160,GO:0048880,0.425513221243634,0.785737385262033,3,363,sensory system development,BP,DCX;SLC17A7;PDGFRA
8489,GO:0032588,0.425668764008053,0.894747275404296,1,85,trans-Golgi network membrane,CC,BOK
19135,GO:1901681,0.426590890306505,0.822973231584327,2,223,sulfur compound binding,MF,FGF1;RYR2
18966,GO:1901264,0.42702016339449,0.893995997207174,1,86,carbohydrate derivative transport,BP,GJB1
7298,GO:0030316,0.427467858544847,0.893762505034915,1,85,osteoclast differentiation,BP,TF
2463,GO:0005200,0.427968492496129,0.893487478086363,1,85,structural constituent of cytoskeleton,MF,NEFM
21519,GO:2000117,0.428044069702417,0.89343378005195,1,86,negative regulation of cysteine-type endopeptidase activity,BP,SNCA
21082,GO:1905897,0.428291024721913,0.893297907816408,1,86,regulation of response to endoplasmic reticulum stress,BP,BOK
11301,GO:0043547,0.428432760555152,0.783434726329746,3,365,positive regulation of GTPase activity,BP,ADAP1;RGS4;DOCK5
536,GO:0001669,0.428444164130366,0.893213598944813,1,86,acrosomal vesicle,CC,SV2B
3484,GO:0006942,0.428681361126036,0.893095109542443,1,85,regulation of striated muscle contraction,BP,RYR2
8832,GO:0033138,0.429161152318225,0.892818329893886,1,86,positive regulation of peptidyl-serine phosphorylation,BP,SNCA
8680,GO:0032886,0.429967944435084,0.820537837153975,2,223,regulation of microtubule-based process,BP,SNCA;SLC39A12
17262,GO:0090407,0.430303689524947,0.757507837041247,4,516,organophosphate biosynthetic process,BP,SYNJ2;CPNE6;SNCA;AK5
11012,GO:0043069,0.430663075712268,0.726994114222886,6,811,negative regulation of programmed cell death,BP,LRP2;MAG;SNCA;HHIP;GREM1;BOK
4539,GO:0009725,0.431002742939226,0.726700160350756,6,809,response to hormone,BP,MAOB;CAMK2A;LRP2;RARRES2;PADI2;SPP1
4302,GO:0009100,0.432408812736716,0.780278862231356,3,369,glycoprotein metabolic process,BP,NECAB1;GALNT6;SPOCK3
15568,GO:0070301,0.432872500846151,0.890745891946363,1,87,cellular response to hydrogen peroxide,BP,GPR37
6683,GO:0019904,0.433317805099022,0.737696800637352,5,661,protein domain specific binding,MF,SYNJ2;LRP2;BOK;LPAR1;TMEM88B
12776,GO:0048013,0.433493702649354,0.890398658575141,1,87,ephrin receptor signaling pathway,BP,EPHB6
3417,GO:0006839,0.43376861719613,0.817758900319286,2,228,mitochondrial transport,BP,CAMK2A;BOK
10550,GO:0042116,0.433773218591638,0.890242197374226,1,87,macrophage activation,BP,SNCA
11511,GO:0044267,0.434312362890788,0.649103528057288,31,4589,cellular protein metabolic process,BP,HHATL;CAMK2A;LRP2;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
4857,GO:0010717,0.434568684372646,0.889796181004394,1,87,regulation of epithelial to mesenchymal transition,BP,GREM1
12133,GO:0045936,0.435086176588916,0.753530864018055,4,517,negative regulation of phosphate metabolic process,BP,RGS4;SNCA;GREM1;PPP1R14A
3968,GO:0008284,0.436232333243191,0.722138219606405,6,815,positive regulation of cell population proliferation,BP,LRP2;FGF1;PDGFRA;ICOSLG;GREM1;CCK
2751,GO:0005811,0.436402796833017,0.888751535939806,1,88,lipid droplet,CC,CLDN11
4764,GO:0010563,0.43652249117971,0.752330522828464,4,518,negative regulation of phosphorus metabolic process,BP,RGS4;SNCA;GREM1;PPP1R14A
21680,GO:2000379,0.436617172784659,0.888630444500093,1,88,positive regulation of reactive oxygen species metabolic process,BP,SNCA
14280,GO:0060021,0.436833255231234,0.88852036371324,1,87,roof of mouth development,BP,PDGFRA
13733,GO:0051402,0.437826983274148,0.814786834518634,2,228,neuron apoptotic process,BP,MAG;BOK
14568,GO:0060419,0.439250931665099,0.887136145320524,1,88,heart growth,BP,RGS4
2885,GO:0006029,0.439429347540597,0.88703447596997,1,88,proteoglycan metabolic process,BP,SPOCK3
14835,GO:0060840,0.439483728286022,0.887015674257481,1,87,artery development,BP,LRP2
22115,GO:2001233,0.439699062235465,0.774440314038745,3,376,regulation of apoptotic signaling pathway,BP,ST18;MAL;BOK
3166,GO:0006497,0.439759372358985,0.886834326956531,1,89,protein lipidation,BP,HHATL
11297,GO:0043543,0.440446637623819,0.812851819287887,2,229,protein acylation,BP,HHATL;SNCA
6459,GO:0019233,0.441138075171276,0.886045903619659,1,89,sensory perception of pain,BP,CCK
12367,GO:0046486,0.441534919111582,0.772964203571008,3,375,glycerolipid metabolic process,BP,SYNJ2;CPNE6;ENPP2
10543,GO:0042102,0.441679975021769,0.885723320574903,1,90,positive regulation of T cell proliferation,BP,ICOSLG
9927,GO:0035770,0.441811062270537,0.811841772126371,2,229,ribonucleoprotein granule,CC,ICOSLG;MEX3A
4149,GO:0008585,0.442035635612726,0.885530814780783,1,89,female gonad development,BP,PDGFRA
17056,GO:0090092,0.442828081081579,0.811087092238688,2,229,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1
17403,GO:0097060,0.442994523029181,0.771789735593539,3,373,synaptic membrane,CC,NRGN;CNTN2;GRM3
8488,GO:0032587,0.443558915843025,0.884653363756327,1,89,ruffle membrane,CC,PACSIN1
662,GO:0001843,0.443925250171727,0.884441729107611,1,89,neural tube closure,BP,LRP2
9036,GO:0033673,0.444171157960063,0.810080983639844,2,231,negative regulation of kinase activity,BP,RGS4;SNCA
3643,GO:0007218,0.444278769358597,0.884213724403432,1,91,neuropeptide signaling pathway,BP,GPR37
9500,GO:0034766,0.444333007864229,0.88419397524799,1,90,negative regulation of ion transmembrane transport,BP,RGS4
560,GO:0001708,0.444918765419947,0.883854624338973,1,90,cell fate specification,BP,NKX6-2
11708,GO:0044877,0.446140960193933,0.694670087054438,8,1116,protein-containing complex binding,MF,GAS7;CD22;FGF1;SPP1;PDGFRA;ERMN;SNCA;BOK
9644,GO:0035282,0.446289539682374,0.883058088535988,1,90,segmentation,BP,DLL3
603,GO:0001775,0.446638895886058,0.687250030417475,9,1277,cell activation,BP,CD22;PADI2;CHI3L1;PDGFRA;TESPA1;SNCA;CSRP1;ICOSLG;SERPINA3
8733,GO:0032963,0.446902981987389,0.882688762465633,1,91,collagen metabolic process,BP,KLK6
3885,GO:0008144,0.447300116945989,0.882456908640998,1,91,drug binding,MF,LRP2
14701,GO:0060606,0.447450458562155,0.882380865910694,1,90,tube closure,BP,LRP2
18942,GO:1901216,0.448510210097278,0.881748691487269,1,91,positive regulation of neuron death,BP,SNCA
13075,GO:0048704,0.448639802380561,0.881672690567572,1,91,embryonic skeletal system morphogenesis,BP,PDGFRA
19115,GO:1901655,0.448985177657842,0.881469993665085,1,91,cellular response to ketone,BP,SPP1
3629,GO:0007200,0.449112029310737,0.88138386344577,1,92,phospholipase C-activating G protein-coupled receptor signaling pathway,BP,LPAR1
9340,GO:0034451,0.449544788541133,0.881141108590757,1,91,centriolar satellite,CC,AK5
5023,GO:0010923,0.449574293513413,0.88112375277709,1,91,negative regulation of phosphatase activity,BP,PPP1R14A
719,GO:0001933,0.450797374502325,0.765431991961219,3,380,negative regulation of protein phosphorylation,BP,RGS4;SNCA;GREM1
3461,GO:0006906,0.451092689258666,0.880216735330008,1,92,vesicle fusion,BP,SNCA
644,GO:0001824,0.45113400509564,0.880192314102842,1,92,blastocyst development,BP,NECAB1
3328,GO:0006690,0.451794787539888,0.879789806328826,1,93,icosanoid metabolic process,BP,CBR1
19068,GO:1901564,0.452487386129646,0.627496855028776,39,5851,organonitrogen compound metabolic process,BP,HHATL;MAOB;CAMK2A;MOXD1;LRP2;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;CNDP1;AK5;SERPINI1;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;CARNS1;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
20482,GO:1904659,0.45321813460932,0.878956407195054,1,92,glucose transmembrane transport,BP,SLC5A11
13871,GO:0051668,0.453557283946727,0.878754544234391,1,92,localization within membrane,BP,MAL
2813,GO:0005903,0.454470941639256,0.878209692743043,1,92,brush border,CC,LRP2
10570,GO:0042158,0.454538390805572,0.878157766075912,1,93,lipoprotein biosynthetic process,BP,HHATL
15350,GO:0062023,0.454573369543006,0.7623311872901,3,381,collagen-containing extracellular matrix,CC,RARRES2;GREM1;SERPINA3
3730,GO:0007423,0.454649880494068,0.736979033785988,4,528,sensory organ development,BP,DCX;SLC17A7;PDGFRA;CXCL14
8323,GO:0032368,0.455063430998023,0.877843886410082,1,93,regulation of lipid transport,BP,SPP1
18388,GO:0110020,0.45536281754493,0.877676366971516,1,92,regulation of actomyosin structure organization,BP,LPAR1
16820,GO:0072593,0.455401251213368,0.801600295404153,2,237,reactive oxygen species metabolic process,BP,MAOB;SNCA
21386,GO:1990823,0.455638747287858,0.877499374585818,1,93,response to leukemia inhibitory factor,BP,PADI2
21390,GO:1990830,0.455638747287858,0.877499374585818,1,93,cellular response to leukemia inhibitory factor,BP,PADI2
1103,GO:0002526,0.456020690844548,0.877258858410856,1,94,acute inflammatory response,BP,SERPINA3
12401,GO:0046545,0.456351929991277,0.877071468180133,1,93,development of primary female sexual characteristics,BP,PDGFRA
15113,GO:0061448,0.456387334835762,0.800851829438499,2,236,connective tissue development,BP,CHI3L1;GREM1
4782,GO:0010595,0.456457365057152,0.877008128914037,1,93,positive regulation of endothelial cell migration,BP,FGF1
21469,GO:2000027,0.456516860918783,0.80074946580894,2,237,regulation of animal organ morphogenesis,BP,FGF1;GREM1
5141,GO:0014070,0.45826816357036,0.702625340240316,6,833,response to organic cyclic compound,BP,MAOB;PADI2;RGS4;SPP1;SNCA;RYR2
4180,GO:0008645,0.460302057787085,0.87467289728014,1,94,hexose transmembrane transport,BP,SLC5A11
4268,GO:0009055,0.460562612338429,0.874491793773857,1,96,electron transfer activity,MF,MAOB
12433,GO:0046620,0.460565852523623,0.874512465156845,1,94,regulation of organ growth,BP,RGS4
6765,GO:0021549,0.461430203834249,0.873985895400729,1,94,cerebellum development,BP,LPAR1
7316,GO:0030336,0.461602748970735,0.796843205798927,2,238,negative regulation of cell migration,BP,PADI2;GREM1
12551,GO:0046883,0.46160477578419,0.796838167127208,2,239,regulation of hormone secretion,BP,SPP1;VSNL1
1184,GO:0002683,0.462319247135592,0.755901265389057,3,389,negative regulation of immune system process,BP,CD22;PADI2;GREM1
19085,GO:1901606,0.462659496242338,0.873211788744112,1,96,alpha-amino acid catabolic process,BP,CARNS1
15681,GO:0070498,0.462927714345256,0.873047474838165,1,96,interleukin-1-mediated signaling pathway,BP,ST18
7383,GO:0030516,0.463277163962234,0.872856097462112,1,94,regulation of axon extension,BP,MAG
16915,GO:0080135,0.463383133584905,0.711485440608743,5,687,regulation of cellular response to stress,BP,CAMK2A;TF;SPP1;GPR37;BOK
11127,GO:0043266,0.463946896491211,0.872433258319586,1,95,regulation of potassium ion transport,BP,RGS4
7013,GO:0022407,0.464458253546329,0.754115703265937,3,389,regulation of cell-cell adhesion,BP,TESPA1;ICOSLG;MBP
14020,GO:0051963,0.46558014352962,0.871426832576191,1,95,regulation of synapse assembly,BP,SNCA
7068,GO:0022904,0.466634597527671,0.870740680339464,1,98,respiratory electron transport chain,BP,SNCA
5495,GO:0015749,0.467428394962106,0.870270419961939,1,96,monosaccharide transmembrane transport,BP,SLC5A11
6110,GO:0016922,0.468183339910881,0.869800908471999,1,96,nuclear receptor binding,MF,PADI2
1364,GO:0003007,0.468224929543477,0.791702302264418,2,238,heart morphogenesis,BP,LRP2;RYR2
11948,GO:0045621,0.468670138159781,0.86948625398757,1,97,positive regulation of lymphocyte differentiation,BP,TESPA1
17107,GO:0090174,0.468843952730012,0.869377839512648,1,97,organelle membrane fusion,BP,SNCA
5101,GO:0014020,0.468844389995297,0.869388918291774,1,96,primary neural tube formation,BP,LRP2
13542,GO:0051087,0.469296223907936,0.869095476924837,1,97,chaperone binding,MF,LRP2
8982,GO:0033559,0.469471519537022,0.868974785370887,1,98,unsaturated fatty acid metabolic process,BP,CBR1
11720,GO:0045017,0.470216568451776,0.790125492005161,2,243,glycerolipid biosynthetic process,BP,SYNJ2;CPNE6
4578,GO:0009887,0.470552353518567,0.680927267984522,7,988,animal organ morphogenesis,BP,LRP2;FGF1;PDGFRA;HHIP;GREM1;EMX2;RYR2
542,GO:0001676,0.470690556759383,0.868211352685913,1,98,long-chain fatty acid metabolic process,BP,CBR1
815,GO:0002062,0.47150998203261,0.867707855361959,1,97,chondrocyte differentiation,BP,GREM1
9566,GO:0035091,0.471708426946744,0.788956860596887,2,242,phosphatidylinositol binding,MF,ADAP1;NRGN
12458,GO:0046651,0.473018858752626,0.787910780481129,2,246,lymphocyte proliferation,BP,CD22;ICOSLG
3481,GO:0006939,0.473200716751668,0.86663055893031,1,98,smooth muscle contraction,BP,DOCK5
7196,GO:0030175,0.473915372379259,0.866189680367464,1,97,filopodium,CC,ERMN
9653,GO:0035305,0.474516085991239,0.865797457065546,1,98,negative regulation of dephosphorylation,BP,PPP1R14A
11888,GO:0045446,0.475196167711329,0.865365439382009,1,98,endothelial cell differentiation,BP,HAPLN2
4174,GO:0008630,0.475873904991433,0.864922831975934,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,BOK
3546,GO:0007044,0.475965914548377,0.864886851365828,1,97,cell-substrate junction assembly,BP,GREM1
11457,GO:0044085,0.476071503710191,0.62417584619325,19,2823,cellular component biogenesis,BP,GAS7;CLDN11;DCX;NEFM;HAPLN2;PDGFRA;CLDN10;TESPA1;SNCA;SLC39A12;SLC24A2;CSRP1;TPPP3;GREM1;GJB1;SYNPO;BOK;CCK;LPAR1
3640,GO:0007215,0.476574580730655,0.864487126128058,1,98,glutamate receptor signaling pathway,BP,GRM3
12046,GO:0045785,0.476989457620433,0.743521143119006,3,396,positive regulation of cell adhesion,BP,TESPA1;DOCK5;ICOSLG
9314,GO:0034404,0.477083470476724,0.864139655139507,1,100,nucleobase-containing small molecule biosynthetic process,BP,GDA
8722,GO:0032943,0.477244684505209,0.784556603114966,2,248,mononuclear cell proliferation,BP,CD22;ICOSLG
11262,GO:0043500,0.478211597327264,0.863428036676366,1,99,muscle adaptation,BP,RGS4
9336,GO:0034446,0.478262694164274,0.863395247763986,1,99,substrate adhesion-dependent cell spreading,BP,DOCK5
1010,GO:0002377,0.478325402524085,0.863343908743708,1,100,immunoglobulin production,BP,CD22
7114,GO:0030038,0.479048213849919,0.862890553047258,1,99,contractile actin filament bundle assembly,BP,LPAR1
11051,GO:0043149,0.479048213849919,0.862890553047258,1,99,stress fiber assembly,BP,LPAR1
13367,GO:0050808,0.479062744364251,0.741755553470697,3,393,synapse organization,BP,SNCA;SYNPO;CNTN2
13433,GO:0050905,0.48001230617574,0.862269518101058,1,99,neuromuscular process,BP,NKX6-2
3815,GO:0008017,0.480264744422715,0.782157539710883,2,245,microtubule binding,MF,DCX;NEFM
13147,GO:0048863,0.480718243019661,0.781784249231832,2,248,stem cell differentiation,BP,PDGFRA;GREM1
5941,GO:0016616,0.482260232655069,0.860781445676055,1,102,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,CBR1
6862,GO:0021761,0.482288088183757,0.860785223978156,1,100,limbic system development,BP,EMX2
12576,GO:0046928,0.482437215531992,0.860688346607281,1,100,regulation of neurotransmitter secretion,BP,CAMK2A
13545,GO:0051091,0.483123626212825,0.779850015078371,2,249,positive regulation of DNA-binding transcription factor activity,BP,CAMK2A;GREM1
13640,GO:0051249,0.48363920073993,0.737810214452068,3,402,regulation of lymphocyte activation,BP,CD22;TESPA1;ICOSLG
15609,GO:0070372,0.483859507823386,0.779254122756758,2,250,regulation of ERK1 and ERK2 cascade,BP,CHI3L1;PDGFRA
18501,GO:0120254,0.484088633537542,0.859590655450643,1,102,olefinic compound metabolic process,BP,CBR1
18643,GO:0150115,0.486261780011731,0.85818918474143,1,100,cell-substrate junction organization,BP,GREM1
16294,GO:0071621,0.486270592302586,0.85815039288718,1,103,granulocyte chemotaxis,BP,RARRES2
21601,GO:2000278,0.486298247675438,0.858143000002382,1,102,regulation of DNA biosynthetic process,BP,GREM1
16118,GO:0071356,0.48675768040179,0.776902246408799,2,253,cellular response to tumor necrosis factor,BP,CHI3L1;ST18
4185,GO:0008654,0.487061108086506,0.776662964078059,2,251,phospholipid biosynthetic process,BP,SYNJ2;CPNE6
13603,GO:0051171,0.487173740642877,0.596403881684838,34,5140,regulation of nitrogen compound metabolic process,BP,HHATL;MAOB;CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
7445,GO:0030660,0.488884569434033,0.856425650132238,1,103,Golgi-associated vesicle membrane,CC,NRGN
7004,GO:0022037,0.488898387583333,0.856427392650988,1,102,metencephalon development,BP,LPAR1
11508,GO:0044262,0.489146182079689,0.774968960510811,2,251,cellular carbohydrate metabolic process,BP,SYNJ2;SNCA
8755,GO:0032993,0.489352366795435,0.856115591108001,1,103,protein-DNA complex,CC,ST18
5777,GO:0016298,0.489398662904942,0.856084882610977,1,103,lipase activity,MF,ENPP2
7513,GO:0030863,0.491501210704319,0.854696853847988,1,102,cortical cytoskeleton,CC,MOBP
6729,GO:0021510,0.492051851285092,0.854318026470628,1,103,spinal cord development,BP,NKX6-2
3504,GO:0006979,0.492329072836916,0.730262675862509,3,407,response to oxidative stress,BP,PDGFRA;SNCA;GPR37
12180,GO:0046034,0.492435249329882,0.772269413533481,2,255,ATP metabolic process,BP,SNCA;AK5
17482,GO:0097190,0.492894712425575,0.703314740228582,4,560,apoptotic signaling pathway,BP,ST18;MAL;BOK;CCK
2947,GO:0006119,0.493697848719466,0.853182941655541,1,106,oxidative phosphorylation,BP,SNCA
7015,GO:0022409,0.493914558673477,0.771055653770752,2,255,positive regulation of cell-cell adhesion,BP,TESPA1;ICOSLG
7892,GO:0031532,0.494858896516096,0.852422785774266,1,104,actin cytoskeleton reorganization,BP,PDGFRA
1185,GO:0002684,0.494868354744311,0.66914845216483,6,869,positive regulation of immune system process,BP,CD22;RARRES2;TESPA1;MOG;CXCL14;ICOSLG
1009,GO:0002376,0.495832918765599,0.609487142132424,17,2560,immune system process,BP,CD22;CAMK2A;TF;MAG;RARRES2;PADI2;CHI3L1;PDGFRA;TESPA1;ENPP2;MOG;SNCA;CXCL14;ICOSLG;GREM1;SERPINA3;MBP
660,GO:0001841,0.496400533942972,0.851381265991075,1,104,neural tube formation,BP,LRP2
11084,GO:0043200,0.497087858973346,0.850904586373112,1,105,response to amino acid,BP,PDGFRA
19605,GO:1902936,0.498437587642698,0.849986978718682,1,105,phosphatidylinositol bisphosphate binding,MF,ADAP1
2826,GO:0005930,0.498862946778206,0.849707942417375,1,104,axoneme,CC,DCX
13345,GO:0050778,0.500064582276385,0.696809726377202,4,566,positive regulation of immune response,BP,CD22;TESPA1;MOG;ICOSLG
7272,GO:0030282,0.500244234131445,0.848742345558983,1,106,bone mineralization,BP,GREM1
7385,GO:0030518,0.501522204804379,0.847865553879688,1,106,intracellular steroid hormone receptor signaling pathway,BP,PADI2
17374,GO:0097014,0.502140041990632,0.847451317295989,1,105,ciliary plasm,CC,DCX
3590,GO:0007156,0.50239510371904,0.847286666824027,1,104,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CNTN2
13642,GO:0051251,0.503120402073872,0.763407392629576,2,260,positive regulation of lymphocyte activation,BP,TESPA1;ICOSLG
13706,GO:0051348,0.503190957672549,0.763351652562295,2,259,negative regulation of transferase activity,BP,RGS4;SNCA
6528,GO:0019439,0.50328001328596,0.693871969720066,4,569,aromatic compound catabolic process,BP,MAOB;MOXD1;GDA;CARNS1
19948,GO:1903578,0.504210359750874,0.845999923418453,1,107,regulation of ATP metabolic process,BP,SNCA
1199,GO:0002698,0.505120304384552,0.845358176050697,1,108,negative regulation of immune effector process,BP,CD22
1514,GO:0003279,0.505180419355188,0.845337687803185,1,106,cardiac septum development,BP,LRP2
14254,GO:0055114,0.505416946825886,0.659249185951556,6,881,oxidation-reduction process,BP,MAOB;MOXD1;SNCA;CBR1;CYB5R2;AIFM3
10646,GO:0042326,0.507265412266962,0.717053201156097,3,414,negative regulation of phosphorylation,BP,RGS4;SNCA;GREM1
19900,GO:1903510,0.507275797833106,0.843856220173125,1,108,mucopolysaccharide metabolic process,BP,SPOCK3
6449,GO:0019218,0.509130361205866,0.842545955022848,1,109,regulation of steroid metabolic process,BP,FGF1
16823,GO:0072599,0.509435210122866,0.842311176975335,1,111,establishment of protein localization to endoplasmic reticulum,BP,RYR2
14113,GO:0052689,0.510261554318109,0.841739348071676,1,110,carboxylic ester hydrolase activity,MF,ENPP2
72,GO:0000149,0.510545490186442,0.841549423180099,1,109,SNARE binding,MF,SNCA
6985,GO:0021987,0.510603886550049,0.841518766851265,1,108,cerebral cortex development,BP,EMX2
11288,GO:0043534,0.511054076440909,0.841190284172239,1,109,blood vessel endothelial cell migration,BP,GREM1
5939,GO:0016614,0.51179784601463,0.840643496623774,1,111,oxidoreductase activity, acting on CH-OH group of donors,MF,CBR1
9497,GO:0034763,0.512127863765728,0.840419879275383,1,110,negative regulation of transmembrane transport,BP,RGS4
14619,GO:0060485,0.513760664884459,0.754406538597604,2,263,mesenchyme development,BP,DLL3;GREM1
2797,GO:0005884,0.514397557205106,0.838805649642661,1,110,actin filament,CC,GAS7
13403,GO:0050864,0.514891204651383,0.838442831614053,1,111,regulation of B cell activation,BP,CD22
12998,GO:0048568,0.514915381598762,0.71016847069242,3,418,embryonic organ development,BP,RARRES2;PDGFRA;RYR2
10616,GO:0042277,0.516847840615903,0.751753627959129,2,266,peptide binding,MF,FOLH1;GPR37
11988,GO:0045667,0.517299154141677,0.836716203457753,1,111,regulation of osteoblast differentiation,BP,GREM1
5137,GO:0014066,0.517873256287207,0.836302779820485,1,111,regulation of phosphatidylinositol 3-kinase signaling,BP,PDGFRA
21914,GO:2000736,0.518079844473681,0.836143575802247,1,112,regulation of stem cell differentiation,BP,PDGFRA
3915,GO:0008194,0.521135230647146,0.83392024465373,1,113,UDP-glycosyltransferase activity,MF,GALNT6
19069,GO:1901565,0.523131337031738,0.622449789716489,8,1201,organonitrogen compound catabolic process,BP,MAOB;MOXD1;LRP2;GDA;CHI3L1;ENPP2;SNCA;CARNS1
8790,GO:0033043,0.523539610046272,0.622054646283176,8,1196,regulation of organelle organization,BP,PADI2;RGS4;PDGFRA;SNCA;SLC39A12;SYNPO;BOK;LPAR1
12177,GO:0046031,0.523810087611775,0.831966726919354,1,113,ADP metabolic process,BP,AK5
19481,GO:1902600,0.525610620913499,0.830623151971799,1,115,proton transmembrane transport,BP,SLC17A7
3742,GO:0007498,0.52576281860182,0.830520973507382,1,114,mesoderm development,BP,DLL3
4275,GO:0009063,0.525766765682802,0.830508054417764,1,115,cellular amino acid catabolic process,BP,CARNS1
7949,GO:0031647,0.526458191344456,0.743412165835038,2,270,regulation of protein stability,BP,TF;SNCA
3303,GO:0006661,0.526972676803389,0.829627479651775,1,114,phosphatidylinositol biosynthetic process,BP,SYNJ2
15538,GO:0070252,0.52713335391443,0.829539849612463,1,111,actin-mediated cell contraction,BP,RYR2
9400,GO:0034612,0.527506323614965,0.742485054092342,2,273,response to tumor necrosis factor,BP,CHI3L1;ST18
4935,GO:0010822,0.529081485220006,0.828052606848195,1,115,positive regulation of mitochondrion organization,BP,BOK
8546,GO:0032675,0.529750133749849,0.827544506345359,1,116,regulation of interleukin-6 production,BP,MBP
735,GO:0001952,0.529767600977466,0.827551608785938,1,114,regulation of cell-matrix adhesion,BP,GREM1
4924,GO:0010811,0.530208218378073,0.827212675658868,1,115,positive regulation of cell-substrate adhesion,BP,DOCK5
7578,GO:0030968,0.530429246801348,0.827037593375527,1,116,endoplasmic reticulum unfolded protein response,BP,BOK
18051,GO:0099055,0.530747116516312,0.826809999758376,1,115,integral component of postsynaptic membrane,CC,GRM3
3143,GO:0006464,0.531045954834301,0.562303742774347,24,3675,cellular protein modification process,BP,HHATL;CAMK2A;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;GREM1;PPP1R14A;GPR37;RCAN2;CCK;SPOCK3;MBP;LPAR1;FXYD1
10158,GO:0036211,0.531045954834301,0.562303742774347,24,3675,protein modification process,BP,HHATL;CAMK2A;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;GREM1;PPP1R14A;GPR37;RCAN2;CCK;SPOCK3;MBP;LPAR1;FXYD1
12168,GO:0045995,0.531515752962607,0.826234592521744,1,115,regulation of embryonic development,BP,MBP
6259,GO:0018105,0.533107348835614,0.737553640810549,2,272,peptidyl-serine phosphorylation,BP,CAMK2A;SNCA
16545,GO:0072089,0.533197472816426,0.824961165986526,1,116,stem cell proliferation,BP,HHIP
20732,GO:1905114,0.534488834441467,0.664713869681716,4,586,cell surface receptor signaling pathway involved in cell-cell signaling,BP,CAMK2A;SLC17A7;RGS4;GREM1
5494,GO:0015748,0.534783609395661,0.823754078396613,1,117,organophosphate ester transport,BP,GJB1
4811,GO:0010638,0.534836693677193,0.66438120486457,4,587,positive regulation of organelle organization,BP,SNCA;SYNPO;BOK;LPAR1
8830,GO:0033135,0.534861961779972,0.823694801218946,1,117,regulation of peptidyl-serine phosphorylation,BP,SNCA
2739,GO:0005788,0.534919121873306,0.735939827446838,2,274,endoplasmic reticulum lumen,CC,TF;SPP1
3722,GO:0007411,0.535629185980072,0.735317960047662,2,271,axon guidance,BP,EPHB6;CNTN2
10724,GO:0042476,0.536236796168626,0.822652535705249,1,117,odontogenesis,BP,PDGFRA
6080,GO:0016874,0.536590670142073,0.822373735229355,1,118,ligase activity,MF,CARNS1
17655,GO:0097530,0.537122103998884,0.821959621632975,1,119,granulocyte migration,BP,RARRES2
7029,GO:0022612,0.537267477816562,0.821868512587619,1,117,gland morphogenesis,BP,FGF1
5669,GO:0016079,0.537528803818225,0.821669363017111,1,117,synaptic vesicle exocytosis,BP,SNCA
17626,GO:0097485,0.537578507412316,0.733576766596721,2,272,neuron projection guidance,BP,EPHB6;CNTN2
16100,GO:0071333,0.538116934347485,0.821210702723943,1,118,cellular response to glucose stimulus,BP,VSNL1
1868,GO:0004252,0.539887059148585,0.819836086059374,1,120,serine-type endopeptidase activity,MF,KLK6
12496,GO:0046718,0.539923185040532,0.819818009900926,1,119,viral entry into host cell,BP,MOG
5785,GO:0016311,0.54185244965508,0.685269961223912,3,435,dephosphorylation,BP,SYNJ2;PPP1R14A;RCAN2
10584,GO:0042177,0.542204849171003,0.818060980884889,1,119,negative regulation of protein catabolic process,BP,SNCA
16098,GO:0071331,0.544079394707334,0.816599195903053,1,120,cellular response to hexose stimulus,BP,VSNL1
13052,GO:0048675,0.545795549702328,0.815272951306936,1,119,axon extension,BP,MAG
4584,GO:0009893,0.546413770598892,0.549802369668381,22,3394,positive regulation of metabolic process,BP,MAOB;LRP2;TF;EPHB6;RARRES2;FGF1;PADI2;SPP1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;S100A1;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
7450,GO:0030667,0.546541750089405,0.7254768788757,2,280,secretory granule membrane,CC,MOXD1;SNCA
9407,GO:0034622,0.546664943127965,0.619450928966693,6,912,cellular protein-containing complex assembly,BP,GAS7;TESPA1;SNCA;SLC39A12;TPPP3;GREM1
16096,GO:0071326,0.547056441813036,0.814267606717315,1,121,cellular response to monosaccharide stimulus,BP,VSNL1
397,GO:0001101,0.547167989529497,0.814180226603364,1,121,response to acid chemical,BP,PDGFRA
2964,GO:0006165,0.547655983128316,0.813797638385357,1,121,nucleoside diphosphate phosphorylation,BP,AK5
12993,GO:0048562,0.547674562478277,0.724446606920901,2,280,embryonic organ morphogenesis,BP,PDGFRA;RYR2
7307,GO:0030326,0.547788814383107,0.813703158962514,1,120,embryonic limb morphogenesis,BP,GREM1
9580,GO:0035113,0.547788814383107,0.813703158962514,1,120,embryonic appendage morphogenesis,BP,GREM1
11018,GO:0043087,0.548276633251554,0.679183065569581,3,437,regulation of GTPase activity,BP,ADAP1;RGS4;DOCK5
6677,GO:0019898,0.549640608838235,0.72265017390909,2,281,extrinsic component of membrane,CC,TF;MAL
13284,GO:0050671,0.549731341017005,0.812145537001064,1,123,positive regulation of lymphocyte proliferation,BP,ICOSLG
3967,GO:0008283,0.550136745839807,0.576799729426796,11,1698,cell population proliferation,BP,CD22;LRP2;FGF1;PDGFRA;ST18;ICOSLG;HHIP;GREM1;EMX2;BOK;CCK
12547,GO:0046879,0.550321630934641,0.722024326636337,2,282,hormone secretion,BP,SPP1;VSNL1
13077,GO:0048706,0.550342046560834,0.811672680788809,1,122,embryonic skeletal system development,BP,PDGFRA
7932,GO:0031625,0.550638328090701,0.721731372168527,2,283,ubiquitin protein ligase binding,MF,GPR37;BOK
6699,GO:0019955,0.552010961027043,0.810340736096154,1,123,cytokine binding,MF,GREM1
8725,GO:0032946,0.552646063530378,0.809826427477131,1,124,positive regulation of mononuclear cell proliferation,BP,ICOSLG
8265,GO:0032273,0.553314886152878,0.809303211536701,1,123,positive regulation of protein polymerization,BP,TPPP3
12583,GO:0046939,0.553428942733157,0.809212277253708,1,123,nucleotide phosphorylation,BP,AK5
10974,GO:0043009,0.55512009286716,0.644766914608908,4,601,chordate embryonic development,BP,LRP2;DLL3;NECAB1;PDGFRA
1201,GO:0002700,0.556657130234655,0.806607494417582,1,125,regulation of production of molecular mediator of immune response,BP,CD22
784,GO:0002020,0.556749343804919,0.80656197755124,1,122,protease binding,MF,MBP
4573,GO:0009855,0.557271007562146,0.806122515000154,1,124,determination of bilateral symmetry,BP,GREM1
4328,GO:0009135,0.557373261892577,0.806040081882799,1,124,purine nucleoside diphosphate metabolic process,BP,AK5
4369,GO:0009179,0.557373261892577,0.806040081882799,1,124,purine ribonucleoside diphosphate metabolic process,BP,AK5
4839,GO:0010675,0.557813249803906,0.805685113580672,1,124,regulation of cellular carbohydrate metabolic process,BP,SNCA
22132,GO:2001251,0.55789017159742,0.805623010720747,1,124,negative regulation of chromosome organization,BP,SNCA
10569,GO:0042157,0.558609877187252,0.805031840758746,1,125,lipoprotein metabolic process,BP,HHATL
4479,GO:0009416,0.559362061484167,0.713665954898063,2,287,response to light stimulus,BP,SYNPO;CCK
8521,GO:0032635,0.5596962911422,0.804142146767331,1,126,interleukin-6 production,BP,MBP
4564,GO:0009799,0.560118332989721,0.803808789062978,1,125,specification of symmetry,BP,GREM1
9649,GO:0035296,0.560285567664721,0.803663509116846,1,126,regulation of tube diameter,BP,DOCK5
17733,GO:0097746,0.560285567664721,0.803663509116846,1,126,regulation of blood vessel diameter,BP,DOCK5
12886,GO:0048284,0.560577437064422,0.803426147874702,1,126,organelle fusion,BP,SNCA
3849,GO:0008083,0.56060855469354,0.803391598969615,1,127,growth factor activity,MF,FGF1
16447,GO:0071901,0.560961185001377,0.803113772832816,1,126,negative regulation of protein serine/threonine kinase activity,BP,RGS4
21113,GO:1905952,0.561513514701127,0.802663583404966,1,126,regulation of lipid localization,BP,SPP1
11932,GO:0045598,0.561788656980185,0.802439063442865,1,126,regulation of fat cell differentiation,BP,RARRES2
9590,GO:0035150,0.563104212836624,0.801353862727592,1,127,regulation of tube size,BP,DOCK5
3922,GO:0008203,0.563909281223391,0.800693486691129,1,127,cholesterol metabolic process,BP,FGF1
3526,GO:0007017,0.564060782971434,0.616548444672432,5,764,microtubule-based process,BP,DCX;SNCA;SLC39A12;TPPP3;CNTN2
14941,GO:0061041,0.564137571307093,0.800505956935947,1,127,regulation of wound healing,BP,PDGFRA
3778,GO:0007596,0.564574000449636,0.708782058836436,2,290,blood coagulation,BP,PDGFRA;CSRP1
19671,GO:1903037,0.564710444415175,0.708650793106482,2,291,regulation of leukocyte cell-cell adhesion,BP,TESPA1;ICOSLG
13318,GO:0050729,0.565121707767386,0.799686947877897,1,128,positive regulation of inflammatory response,BP,SNCA
12472,GO:0046683,0.565129355169373,0.799689867701274,1,127,response to organophosphorus,BP,LPAR1
4592,GO:0009914,0.565450184474501,0.707957849286091,2,290,hormone transport,BP,SPP1;VSNL1
4374,GO:0009185,0.565904581260162,0.799050403110251,1,127,ribonucleoside diphosphate metabolic process,BP,AK5
3667,GO:0007266,0.566673247079586,0.798414987170209,1,127,Rho protein signal transduction,BP,LPAR1
11518,GO:0044281,0.567417316755241,0.559354240602568,11,1726,small molecule metabolic process,BP,SYNJ2;MOXD1;LRP2;FOLH1;FGF1;GDA;SNCA;AK5;CBR1;CARNS1;SPOCK3
3182,GO:0006520,0.567449973753821,0.706059640959209,2,294,cellular amino acid metabolic process,BP,FOLH1;CARNS1
936,GO:0002274,0.567740553299829,0.632290672202714,4,616,myeloid leukocyte activation,BP,PADI2;CHI3L1;SNCA;SERPINA3
8097,GO:0031966,0.56808959414763,0.631939083051242,4,620,mitochondrial membrane,CC,MAOB;NRGN;BOK;AIFM3
10750,GO:0042542,0.568143972617273,0.797176946024079,1,129,response to hydrogen peroxide,BP,GPR37
13373,GO:0050817,0.568364146465296,0.705200942002236,2,292,coagulation,BP,PDGFRA;CSRP1
4125,GO:0008528,0.568735295031054,0.796676122201202,1,130,G protein-coupled peptide receptor activity,MF,GPR37
11210,GO:0043401,0.569243997155033,0.796270647940852,1,128,steroid hormone mediated signaling pathway,BP,PADI2
17871,GO:0098772,0.569540738619034,0.52803216149161,21,3282,molecular function regulator,MF,ADAP1;FGF1;RGS4;SPP1;MYRF;SNCA;CXCL14;DOCK5;ST18;NKX6-2;SERPINI1;GREM1;PPP1R14A;EMX2;MAL;RCAN2;CCK;SPOCK3;SERPINA3;GRM3;FXYD1
16094,GO:0071322,0.570177917523298,0.795481993839993,1,129,cellular response to carbohydrate stimulus,BP,VSNL1
7775,GO:0031333,0.570785437581479,0.794973868331293,1,129,negative regulation of protein-containing complex assembly,BP,SNCA
8437,GO:0032496,0.570900586545338,0.702785219631879,2,295,response to lipopolysaccharide,BP,MAOB;SNCA
12295,GO:0046330,0.570951401492223,0.79483490821403,1,129,positive regulation of JNK cascade,BP,TF
10490,GO:0040029,0.571485841729071,0.794386990993951,1,129,regulation of gene expression, epigenetic,BP,PADI2
442,GO:0001508,0.571726085755754,0.794194697009461,1,128,action potential,BP,RYR2
14305,GO:0060048,0.572601394147938,0.793468640948315,1,127,cardiac muscle contraction,BP,RYR2
10528,GO:0042060,0.572899045214949,0.655279089563152,3,455,wound healing,BP,FGF1;PDGFRA;CSRP1
3781,GO:0007599,0.573809567013578,0.700010764570077,2,295,hemostasis,BP,PDGFRA;CSRP1
522,GO:0001653,0.574357684361691,0.791941482372688,1,132,peptide receptor activity,MF,GPR37
16906,GO:0080090,0.57468475548454,0.509194898809102,34,5300,regulation of primary metabolic process,BP,HHATL;MAOB;CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
11588,GO:0044409,0.575277836731535,0.791171436687373,1,131,entry into host,BP,MOG
3824,GO:0008037,0.575771422778331,0.790752762653217,1,131,cell recognition,BP,CNTN2
11160,GO:0043312,0.576138913718223,0.652061187609357,3,461,neutrophil degranulation,BP,PADI2;CHI3L1;SERPINA3
16130,GO:0071375,0.576306620181532,0.697617093849882,2,295,cellular response to peptide hormone stimulus,BP,CAMK2A;RARRES2
3058,GO:0006333,0.576337495205011,0.790271898372664,1,131,chromatin assembly or disassembly,BP,PADI2
13723,GO:0051384,0.576929475315303,0.789759219049441,1,132,response to glucocorticoid,BP,MAOB
1197,GO:0002696,0.577070276339663,0.696873946165403,2,298,positive regulation of leukocyte activation,BP,TESPA1;ICOSLG
4561,GO:0009792,0.577418683419709,0.622592258394923,4,618,embryo development ending in birth or egg hatching,BP,LRP2;DLL3;NECAB1;PDGFRA
15770,GO:0070665,0.578182149403396,0.788681735959168,1,133,positive regulation of leukocyte proliferation,BP,ICOSLG
7394,GO:0030534,0.57845636084961,0.788465270113313,1,131,adult behavior,BP,CNTN2
945,GO:0002283,0.580531461769193,0.647681296989506,3,464,neutrophil activation involved in immune response,BP,PADI2;CHI3L1;SERPINA3
11581,GO:0044389,0.582277346586882,0.691833132661366,2,300,ubiquitin-like protein ligase binding,MF,GPR37;BOK
5977,GO:0016705,0.582927241688371,0.784591196901512,1,134,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,MOXD1
13402,GO:0050863,0.584026115211258,0.690125295022345,2,302,regulation of T cell activation,BP,TESPA1;ICOSLG
3147,GO:0006470,0.584675209055391,0.689497947312135,2,300,protein dephosphorylation,BP,PPP1R14A;RCAN2
9406,GO:0034620,0.585103877200957,0.782692027383119,1,135,cellular response to unfolded protein,BP,BOK
911,GO:0002224,0.585868542654082,0.782025215091713,1,135,toll-like receptor signaling pathway,BP,S100A1
3648,GO:0007224,0.585989100637031,0.781928804201313,1,134,smoothened signaling pathway,BP,HHIP
19437,GO:1902495,0.586253841988223,0.687957794145552,2,299,transmembrane transporter complex,CC,RYR2;FXYD1
543,GO:0001678,0.587365761911702,0.780715510437191,1,135,cellular glucose homeostasis,BP,VSNL1
4345,GO:0009152,0.58771841586272,0.780397471506498,1,136,purine ribonucleotide biosynthetic process,BP,AK5
3970,GO:0008286,0.588271540598922,0.779920542525326,1,135,insulin receptor signaling pathway,BP,RARRES2
11919,GO:0045580,0.588387230466313,0.7798100808777,1,136,regulation of T cell differentiation,BP,TESPA1
19501,GO:1902652,0.588694077973853,0.779540227303889,1,136,secondary alcohol metabolic process,BP,FGF1
3940,GO:0008236,0.588705437928332,0.779521570735416,1,137,serine-type peptidase activity,MF,KLK6
15927,GO:0070972,0.589583678257715,0.778739342564497,1,138,protein localization to endoplasmic reticulum,BP,RYR2
690,GO:0001889,0.590429132934036,0.778010049628433,1,136,liver development,BP,FGF1
4670,GO:0010243,0.59046253283855,0.57521374844928,6,951,response to organonitrogen compound,BP,CAMK2A;RARRES2;RGS4;PDGFRA;SNCA;RYR2
4622,GO:0010008,0.590644766176528,0.637488613899779,3,469,endosome membrane,CC,TF;BOK;GPR62
19453,GO:1902532,0.590822974488851,0.637309279298161,3,468,negative regulation of intracellular signal transduction,BP,CD22;RGS4;LPAR1
12586,GO:0046943,0.591829481079395,0.776760963481536,1,137,carboxylic acid transmembrane transporter activity,MF,SLC17A7
17925,GO:0098862,0.592015425278939,0.776604649862115,1,136,cluster of actin-based cell projections,CC,LRP2
656,GO:0001837,0.592911554256242,0.775799217972404,1,137,epithelial to mesenchymal transition,BP,GREM1
1052,GO:0002446,0.593611367742024,0.63446509753187,3,473,neutrophil mediated immunity,BP,PADI2;CHI3L1;SERPINA3
11245,GO:0043467,0.593716386953633,0.775082022098826,1,137,regulation of generation of precursor metabolites and energy,BP,SNCA
9627,GO:0035257,0.594004996100731,0.774824451589277,1,137,nuclear hormone receptor binding,MF,PADI2
5136,GO:0014065,0.594165998087401,0.774680675673362,1,137,phosphatidylinositol 3-kinase signaling,BP,PDGFRA
2529,GO:0005342,0.594485859970671,0.774386160644569,1,138,organic acid transmembrane transporter activity,MF,SLC17A7
917,GO:0002237,0.594663230018827,0.679634163512098,2,308,response to molecule of bacterial origin,BP,MAOB;SNCA
19592,GO:1902904,0.594879526369873,0.774042722076471,1,137,negative regulation of supramolecular fiber organization,BP,SNCA
10553,GO:0042119,0.595032221212195,0.633013570435782,3,474,neutrophil activation,BP,PADI2;CHI3L1;SERPINA3
7619,GO:0031056,0.596597623943242,0.772492706308553,1,138,regulation of histone modification,BP,SNCA
15384,GO:0065003,0.596643756128864,0.540959343413849,9,1437,protein-containing complex assembly,BP,GAS7;TESPA1;SNCA;SLC39A12;SLC24A2;TPPP3;GREM1;BOK;CCK
6222,GO:0017171,0.596701833036663,0.77238187070723,1,140,serine hydrolase activity,MF,KLK6
3920,GO:0008201,0.597476967442889,0.771692377427832,1,139,heparin binding,MF,FGF1
4303,GO:0009101,0.597706126501423,0.67660217897709,2,307,glycoprotein biosynthetic process,BP,NECAB1;GALNT6
7703,GO:0031225,0.597839097308378,0.771357253900749,1,140,anchored component of membrane,CC,CNTN2
14919,GO:0061008,0.598593782825503,0.770684092672906,1,139,hepaticobiliary system development,BP,FGF1
13406,GO:0050867,0.598694275616146,0.675604392615413,2,310,positive regulation of cell activation,BP,TESPA1;ICOSLG
7765,GO:0031323,0.598870449728865,0.483799164967365,35,5500,regulation of cellular metabolic process,BP,HHATL;MAOB;CAMK2A;LRP2;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
19072,GO:1901568,0.599259435642187,0.770064652840995,1,141,fatty acid derivative metabolic process,BP,CBR1
13311,GO:0050708,0.59945684779447,0.674848249352837,2,307,regulation of protein secretion,BP,CD22;VSNL1
1195,GO:0002694,0.600036418611995,0.627877153269292,3,477,regulation of leukocyte activation,BP,CD22;TESPA1;ICOSLG
21220,GO:1990351,0.600375021214094,0.673926092307928,2,307,transporter complex,CC,RYR2;FXYD1
10165,GO:0036230,0.602170682529293,0.625673523907993,3,479,granulocyte activation,BP,PADI2;CHI3L1;SERPINA3
3281,GO:0006633,0.603070307285244,0.766585756247202,1,142,fatty acid biosynthetic process,BP,CBR1
7546,GO:0030902,0.604622143001692,0.765170496794222,1,141,hindbrain development,BP,LPAR1
5143,GO:0014074,0.604925709387397,0.764891290613375,1,141,response to purine-containing compound,BP,RYR2
19829,GO:1903364,0.605608298546933,0.76425414894569,1,142,positive regulation of cellular protein catabolic process,BP,LRP2
4325,GO:0009132,0.605947657026826,0.763941152330029,1,142,nucleoside diphosphate metabolic process,BP,AK5
3518,GO:0007005,0.605949548551648,0.621755113770614,3,482,mitochondrion organization,BP,CAMK2A;BOK;CCK
14926,GO:0061025,0.607330092653595,0.762654686873339,1,143,membrane fusion,BP,SNCA
5651,GO:0016050,0.607498365528398,0.666700540242922,2,313,vesicle organization,BP,SLC17A7;SNCA
427,GO:0001227,0.60769886233018,0.666493449969047,2,314,DNA-binding transcription repressor activity, RNA polymerase II-specific,MF,NKX6-2;EMX2
10555,GO:0042127,0.607706806198317,0.52937560226166,9,1452,regulation of cell population proliferation,BP,CD22;LRP2;FGF1;PDGFRA;ST18;ICOSLG;GREM1;BOK;CCK
6682,GO:0019903,0.609047044580945,0.761060548497214,1,143,protein phosphatase binding,MF,CD22
420,GO:0001217,0.609446911125611,0.664706263316809,2,315,DNA-binding transcription repressor activity,MF,NKX6-2;EMX2
9577,GO:0035107,0.609815027274283,0.760353524732863,1,142,appendage morphogenesis,BP,GREM1
9578,GO:0035108,0.609815027274283,0.760353524732863,1,142,limb morphogenesis,BP,GREM1
11861,GO:0045321,0.609926228305906,0.543580544460381,7,1137,leukocyte activation,BP,CD22;PADI2;CHI3L1;TESPA1;SNCA;ICOSLG;SERPINA3
5270,GO:0015079,0.609993747242259,0.760169996478499,1,144,potassium ion transmembrane transporter activity,MF,SLC24A2
161,GO:0000323,0.610597148469613,0.588370130368389,4,648,lytic vacuole,CC,LRP2;PADI2;SNCA;SERPINA3
2718,GO:0005764,0.610597148469613,0.588370130368389,4,648,lysosome,CC,LRP2;PADI2;SNCA;SERPINA3
7120,GO:0030048,0.611426043788176,0.758865130442639,1,140,actin filament-based movement,BP,RYR2
3307,GO:0006665,0.6115068839037,0.75874687497255,1,145,sphingolipid metabolic process,BP,ENPP2
742,GO:0001959,0.612043663085404,0.758243535097331,1,145,regulation of cytokine-mediated signaling pathway,BP,PADI2
19285,GO:1902107,0.612156734449518,0.758137413076522,1,145,positive regulation of leukocyte differentiation,BP,TESPA1
16914,GO:0080134,0.612170332212959,0.532142115037434,8,1297,regulation of response to stress,BP,CAMK2A;TF;SPP1;PDGFRA;SNCA;GPR37;BOK;CCK
9105,GO:0033993,0.614471502449553,0.564607842564032,5,815,response to lipid,BP,MAOB;PADI2;SPP1;SNCA;LPAR1
8062,GO:0031901,0.616226109091801,0.75428787881269,1,146,early endosome membrane,CC,BOK
2790,GO:0005875,0.616432647635059,0.754108423484487,1,144,microtubule associated complex,CC,DCX
2699,GO:0005740,0.616514239188951,0.582103110303669,4,659,mitochondrial envelope,CC,MAOB;NRGN;BOK;AIFM3
13780,GO:0051494,0.618296046695688,0.752317406919123,1,146,negative regulation of cytoskeleton organization,BP,SNCA
3593,GO:0007159,0.618404458720536,0.655453457760728,2,321,leukocyte cell-cell adhesion,BP,TESPA1;ICOSLG
9784,GO:0035567,0.618798262149175,0.751829422753531,1,147,non-canonical Wnt signaling pathway,BP,CAMK2A
8094,GO:0031960,0.618993961342408,0.751634179795089,1,148,response to corticosteroid,BP,MAOB
8791,GO:0033044,0.61910948197764,0.654725352612545,2,319,regulation of chromosome organization,BP,PADI2;SNCA
4721,GO:0010469,0.61923735320872,0.751409402840724,1,147,regulation of signaling receptor activity,BP,GREM1
4781,GO:0010594,0.619397715148542,0.751255879820098,1,147,regulation of endothelial cell migration,BP,FGF1
7790,GO:0031349,0.61990425904604,0.653889019114878,2,322,positive regulation of defense response,BP,SNCA;CCK
21371,GO:1990778,0.62108910037612,0.652657604127448,2,320,protein localization to cell periphery,BP,PACSIN1;MAL
7215,GO:0030203,0.621209117401925,0.749508875164152,1,148,glycosaminoglycan metabolic process,BP,SPOCK3
4429,GO:0009260,0.621257800981956,0.749453972949986,1,149,ribonucleotide biosynthetic process,BP,AK5
22124,GO:2001242,0.622154411598764,0.748581958047172,1,150,regulation of intrinsic apoptotic signaling pathway,BP,BOK
10556,GO:0042129,0.622612357844208,0.748139809739391,1,150,regulation of T cell proliferation,BP,ICOSLG
7291,GO:0030307,0.62278297694795,0.747990992013228,1,148,positive regulation of cell growth,BP,CPNE6
1183,GO:0002682,0.622914100794657,0.52072182139035,8,1313,regulation of immune system process,BP,CD22;RARRES2;PADI2;TESPA1;MOG;CXCL14;ICOSLG;GREM1
5910,GO:0016573,0.624174075346847,0.746635792160261,1,149,histone acetylation,BP,SNCA
4907,GO:0010770,0.625129423301282,0.745715804655115,1,148,positive regulation of cell morphogenesis involved in differentiation,BP,DOCK5
13679,GO:0051302,0.626534998771779,0.744329663402404,1,150,regulation of cell division,BP,FGF1
22118,GO:2001236,0.62777499867064,0.743108698576934,1,151,regulation of extrinsic apoptotic signaling pathway,BP,MAL
18226,GO:0099699,0.628115191467163,0.742783174554247,1,150,integral component of synaptic membrane,CC,GRM3
4733,GO:0010506,0.628913391605966,0.644406561776881,2,325,regulation of autophagy,BP,SNCA;BOK
2464,GO:0005201,0.629284546491533,0.741642560423485,1,149,extracellular matrix structural constituent,MF,CHI3L1
1594,GO:0003674,0.629711934664619,0.550790157012536,95,14660,molecular_function,MF,GAS7;HHATL;CD22;CLDN11;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;SEC14L5;NEFM;SLC17A7;SHD;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;EVI2A;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;GALNT6;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;PAMR1;CNDP1;AK5;NRGN;PDE1C;SLC24A2;SLC5A11;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;TMEM144;HHIP;CYB5R2;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;RCAN2;CARNS1;BOK;TMEM125;S1PR5;GPR62;AIFM3;CNTN2;SV2B;MPPED1;CCK;SPOCK3;SERPINA3;MBP;LPAR1;RYR2;GRM3;TMEM88B;MEX3A;FXYD1
14054,GO:0052126,0.629841653735832,0.74106991830598,1,152,movement in host environment,BP,MOG
7449,GO:0030666,0.629987423874666,0.740926234866115,1,152,endocytic vesicle membrane,CC,CAMK2A
6330,GO:0018393,0.631456469344129,0.739475009806432,1,152,internal peptidyl-lysine acetylation,BP,SNCA
8877,GO:0033209,0.633203154981802,0.737718535954588,1,155,tumor necrosis factor-mediated signaling pathway,BP,ST18
8671,GO:0032874,0.633404215562031,0.737533967679556,1,153,positive regulation of stress-activated MAPK cascade,BP,TF
10773,GO:0042581,0.633889897078064,0.737042506531924,1,154,specific granule,CC,CHI3L1
10029,GO:0035967,0.634071228481777,0.736861760048179,1,154,cellular response to topologically incorrect protein,BP,BOK
14792,GO:0060759,0.634344201556832,0.736589498034677,1,154,regulation of response to cytokine stimulus,BP,PADI2
13314,GO:0050714,0.634420034370983,0.736529549850399,1,152,positive regulation of protein secretion,BP,VSNL1
12944,GO:0048469,0.635047753269394,0.735886839129812,1,154,cell maturation,BP,CNTN2
2963,GO:0006164,0.635708311986288,0.735218148057766,1,155,purine nucleotide biosynthetic process,BP,AK5
2778,GO:0005856,0.636247251701347,0.482768498235107,12,1955,cytoskeleton,CC,GAS7;CLDN11;DCX;SYNJ2;NEFM;PACSIN1;ERMN;SNCA;AK5;TPPP3;MOBP;SYNPO
3151,GO:0006475,0.636266338369057,0.734666589651355,1,154,internal protein amino acid acetylation,BP,SNCA
11220,GO:0043412,0.637173218043401,0.45323651544712,24,3857,macromolecule modification,BP,HHATL;CAMK2A;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;GREM1;PPP1R14A;GPR37;RCAN2;CCK;SPOCK3;MBP;LPAR1;FXYD1
11218,GO:0043409,0.638053011445336,0.732862305426426,1,155,negative regulation of MAPK cascade,BP,RGS4
12321,GO:0046390,0.638102123383532,0.732805111908192,1,156,ribose phosphate biosynthetic process,BP,AK5
15571,GO:0070304,0.638169508975746,0.732744858903334,1,155,positive regulation of stress-activated protein kinase signaling cascade,BP,TF
10849,GO:0042734,0.638396060553301,0.732524146684608,1,154,presynaptic membrane,CC,GRM3
636,GO:0001816,0.638964803583658,0.557899638423482,4,673,cytokine production,BP,CHI3L1;MOG;ICOSLG;MBP
13384,GO:0050839,0.638987540783592,0.586531337942609,3,500,cell adhesion molecule binding,MF,FGF1;SPP1;CNTN2
3772,GO:0007584,0.639187293329828,0.731709478188909,1,156,response to nutrient,BP,SPP1
16108,GO:0071346,0.639653263999878,0.731230393549106,1,157,cellular response to interferon-gamma,BP,CAMK2A
11147,GO:0043299,0.639690905636918,0.585753937988155,3,506,leukocyte degranulation,BP,PADI2;CHI3L1;SERPINA3
7917,GO:0031589,0.64016829015619,0.632328956516237,2,330,cell-substrate adhesion,BP,DOCK5;GREM1
6950,GO:0021915,0.641028377014913,0.729850915386117,1,155,neural tube development,BP,LRP2
1262,GO:0002791,0.641752511202813,0.630604842324685,2,332,regulation of peptide secretion,BP,CD22;VSNL1
4627,GO:0010033,0.642553885217201,0.457611260140606,18,2931,response to organic substance,BP,MAOB;CAMK2A;LRP2;RARRES2;FGF1;PADI2;RGS4;SPP1;CHI3L1;PDGFRA;SNCA;ST18;VSNL1;HHIP;GREM1;BOK;LPAR1;RYR2
6202,GO:0017137,0.643697449086491,0.727120740497154,1,156,Rab GTPase binding,MF,MOBP
19140,GO:1901698,0.644717294924609,0.51742482665477,6,1005,response to nitrogen compound,BP,CAMK2A;RARRES2;RGS4;PDGFRA;SNCA;RYR2
11866,GO:0045333,0.646560567465218,0.724140309775662,1,161,cellular respiration,BP,SNCA
6759,GO:0021543,0.64850127117801,0.722154883869828,1,158,pallium development,BP,EMX2
6331,GO:0018394,0.650530387924785,0.720028914019542,1,160,peptidyl-lysine acetylation,BP,SNCA
7014,GO:0022408,0.650755661220514,0.719786381344576,1,161,negative regulation of cell-cell adhesion,BP,MBP
3725,GO:0007416,0.652785316492176,0.71767690534915,1,159,synapse assembly,BP,SNCA
13028,GO:0048639,0.653384256353677,0.717040111095765,1,160,positive regulation of developmental growth,BP,CPNE6
9633,GO:0035265,0.654050613810045,0.71633134557203,1,161,organ growth,BP,RGS4
937,GO:0002275,0.65416002536393,0.569735132846631,3,517,myeloid cell activation involved in immune response,BP,PADI2;CHI3L1;SERPINA3
21678,GO:2000377,0.655023344271356,0.715290559896148,1,163,regulation of reactive oxygen species metabolic process,BP,SNCA
919,GO:0002244,0.655058023160617,0.715253930586734,1,163,hematopoietic progenitor cell differentiation,BP,PDGFRA
5779,GO:0016301,0.657406959424164,0.537471608450819,4,680,kinase activity,MF,CAMK2A;EPHB6;PDGFRA;AK5
6676,GO:0019897,0.657506400245375,0.712659009350645,1,163,extrinsic component of plasma membrane,CC,TF
11946,GO:0045619,0.657591782972518,0.712560886735646,1,164,regulation of lymphocyte differentiation,BP,TESPA1
13013,GO:0048609,0.657671768509646,0.537168391412903,4,687,multicellular organismal reproductive process,BP,CLDN11;SPP1;PDGFRA;TPPP3
16769,GO:0072522,0.658724380598469,0.71134702919449,1,165,purine-containing compound biosynthetic process,BP,AK5
3483,GO:0006941,0.660197840541004,0.709793707965447,1,162,striated muscle contraction,BP,RYR2
1050,GO:0002444,0.661937922367304,0.560974832113134,3,523,myeloid leukocyte mediated immunity,BP,PADI2;CHI3L1;SERPINA3
12369,GO:0046488,0.662302450962102,0.707510287524542,1,165,phosphatidylinositol metabolic process,BP,SYNJ2
13358,GO:0050796,0.66374310408367,0.705947538827374,1,166,regulation of insulin secretion,BP,VSNL1
14438,GO:0060255,0.663806033943805,0.415494148998294,35,5629,regulation of macromolecule metabolic process,BP,HHATL;CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;MOG;SNCA;ST18;NKX6-2;CNDP1;ICOSLG;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
6010,GO:0016758,0.666305122766663,0.70315161724897,1,168,transferase activity, transferring hexosyl groups,MF,GALNT6
8444,GO:0032504,0.666498501995089,0.527202301510291,4,695,multicellular organism reproduction,BP,CLDN11;SPP1;PDGFRA;TPPP3
7720,GO:0031256,0.666725495279214,0.702707670391259,1,166,leading edge membrane,CC,PACSIN1
22137,GO:2001257,0.666789936488908,0.702630154952871,1,167,regulation of cation channel activity,BP,S100A1
6453,GO:0019222,0.667541859559904,0.410140407763167,38,6103,regulation of metabolic process,BP,HHATL;MAOB;CAMK2A;LRP2;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;MOG;SNCA;ST18;NKX6-2;CNDP1;ICOSLG;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;BOK;S1PR5;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
16147,GO:0071396,0.668996804982079,0.552935361397382,3,526,cellular response to lipid,BP,PADI2;SPP1;LPAR1
3707,GO:0007369,0.66957609050543,0.699571549702784,1,168,gastrulation,BP,MBP
4551,GO:0009755,0.670887839716747,0.698119632271869,1,169,hormone-mediated signaling pathway,BP,PADI2
17054,GO:0090090,0.671081234920505,0.697899138401734,1,170,negative regulation of canonical Wnt signaling pathway,BP,GREM1
3508,GO:0006986,0.671924900914195,0.696959638112156,1,171,response to unfolded protein,BP,BOK
18912,GO:1901136,0.672085905855082,0.696781424548303,1,171,carbohydrate derivative catabolic process,BP,CHI3L1
4548,GO:0009749,0.672129765557573,0.696739835307863,1,170,response to glucose,BP,VSNL1
1264,GO:0002793,0.672706186578018,0.696108152446253,1,169,positive regulation of peptide secretion,BP,VSNL1
13091,GO:0048736,0.673728107345221,0.694973251463914,1,169,appendage development,BP,GREM1
14389,GO:0060173,0.673728107345221,0.694973251463914,1,169,limb development,BP,GREM1
1375,GO:0003018,0.675147827177661,0.693370176940186,1,172,vascular process in circulatory system,BP,DOCK5
12293,GO:0046328,0.67519419665204,0.693325342145805,1,171,regulation of JNK cascade,BP,TF
4785,GO:0010604,0.675515555358163,0.419885406930467,19,3138,positive regulation of macromolecule metabolic process,BP,LRP2;TF;RARRES2;FGF1;PADI2;SPP1;MYRF;CHI3L1;PDGFRA;ENPP2;SNCA;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
12778,GO:0048015,0.67603310562058,0.692387471195775,1,171,phosphatidylinositol-mediated signaling,BP,PDGFRA
554,GO:0001701,0.67723193134453,0.590665468821894,2,355,in utero embryonic development,BP,NECAB1;PDGFRA
569,GO:0001726,0.677260689753371,0.691011150540294,1,171,ruffle,CC,PACSIN1
17568,GO:0097367,0.677368186885604,0.437853545321303,12,2013,carbohydrate derivative binding,MF,CD22;CAMK2A;MAG;EPHB6;FGF1;HAPLN2;CHI3L1;PDGFRA;AK5;CARNS1;SPOCK3;LPAR1
19113,GO:1901653,0.678424559433206,0.589274875311425,2,356,cellular response to peptide,BP,CAMK2A;RARRES2
7115,GO:0030041,0.67849287158294,0.689611056848093,1,173,actin filament polymerization,BP,GAS7
2133,GO:0004672,0.68015526619878,0.54004775300478,3,528,protein kinase activity,MF,CAMK2A;EPHB6;PDGFRA
16443,GO:0071897,0.682187725073328,0.685412138442441,1,175,DNA biosynthetic process,BP,GREM1
4547,GO:0009746,0.682717180773814,0.684808885802242,1,175,response to hexose,BP,VSNL1
13291,GO:0050679,0.683400545072219,0.684028963120177,1,175,positive regulation of epithelial cell proliferation,BP,FGF1
12558,GO:0046890,0.683634760856491,0.683754550129136,1,176,regulation of lipid biosynthetic process,BP,FGF1
909,GO:0002221,0.684034795361808,0.683297002247184,1,176,pattern recognition receptor signaling pathway,BP,S100A1
12780,GO:0048017,0.684456100758545,0.682821352319296,1,175,inositol lipid-mediated signaling,BP,PDGFRA
10540,GO:0042098,0.685999871037042,0.68102865065664,1,178,T cell proliferation,BP,ICOSLG
17885,GO:0098797,0.686416017302694,0.532705225027289,3,538,plasma membrane protein complex,CC,TF;GJB1;FXYD1
7351,GO:0030426,0.686656874311176,0.680292156093021,1,175,growth cone,CC,SNCA
19070,GO:1901566,0.686910242477332,0.44293825275007,9,1556,organonitrogen compound biosynthetic process,BP,HHATL;MOXD1;FOLH1;NECAB1;GALNT6;SNCA;AK5;GPR37;CARNS1
7773,GO:0031331,0.688042341640195,0.577948237442681,2,362,positive regulation of cellular catabolic process,BP,LRP2;SNCA
15670,GO:0070482,0.688287347415082,0.57765260774058,2,364,response to oxygen levels,BP,LPAR1;RYR2
2847,GO:0005975,0.689206001348607,0.529409086026034,3,543,carbohydrate metabolic process,BP,SYNJ2;CHI3L1;SNCA
11037,GO:0043123,0.689250487748247,0.677264650624562,1,179,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
19084,GO:1901605,0.689994842943966,0.676392897379347,1,180,alpha-amino acid metabolic process,BP,CARNS1
13130,GO:0048839,0.690439358065633,0.675888566834277,1,178,inner ear development,BP,CXCL14
13528,GO:0051054,0.690713541434797,0.675562385981539,1,179,positive regulation of DNA metabolic process,BP,GREM1
2825,GO:0005929,0.690980207840626,0.527310750163472,3,542,cilium,CC,DCX;PDGFRA;HHIP
7020,GO:0022414,0.691379541014612,0.45388164934117,7,1224,reproductive process,BP,CLDN11;LRP2;SPP1;PDGFRA;TPPP3;GJB1;BOK
17890,GO:0098802,0.692111301141692,0.67392960988035,1,179,plasma membrane signaling receptor complex,CC,TF
3783,GO:0007601,0.692682476973173,0.673253967538159,1,180,visual perception,BP,SLC24A2
438,GO:0001503,0.692929919097864,0.572108871511545,2,366,ossification,BP,SPP1;GREM1
9240,GO:0034284,0.693017184626857,0.672861411131206,1,180,response to monosaccharide,BP,VSNL1
2,GO:0000003,0.693814845556108,0.451079891885353,7,1227,reproduction,BP,CLDN11;LRP2;SPP1;PDGFRA;TPPP3;GJB1;BOK
3644,GO:0007219,0.69387555365186,0.671853013466775,1,180,Notch signaling pathway,BP,DLL3
4812,GO:0010639,0.694678170933467,0.570007705735626,2,367,negative regulation of organelle organization,BP,SNCA;BOK
2939,GO:0006109,0.694680942940584,0.670904660913299,1,180,regulation of carbohydrate metabolic process,BP,SNCA
7269,GO:0030278,0.695511050745669,0.6699184030228,1,181,regulation of ossification,BP,GREM1
4934,GO:0010821,0.696640955522641,0.668574717268726,1,182,regulation of mitochondrion organization,BP,BOK
13405,GO:0050866,0.696733230769429,0.668458884145708,1,183,negative regulation of cell activation,BP,PDGFRA
10583,GO:0042176,0.696747091850027,0.567510010399284,2,369,regulation of protein catabolic process,BP,LRP2;SNCA
3888,GO:0008150,0.697445714224466,0.443060759321441,92,14293,biological_process,BP,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;NEFM;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;GALNT6;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;CNDP1;AK5;NRGN;PDE1C;SLC24A2;SLC5A11;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;TMEM144;HHIP;CYB5R2;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;RCAN2;CARNS1;BOK;TMEM125;S1PR5;GPR62;AIFM3;CNTN2;SV2B;MPPED1;CCK;NKAIN2;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;FXYD1
13462,GO:0050953,0.698762444082369,0.666046148371908,1,183,sensory perception of light stimulus,BP,SLC24A2
7352,GO:0030427,0.701243364449927,0.663084203058897,1,182,site of polarized growth,CC,SNCA
12411,GO:0046578,0.701998853519832,0.662169644946492,1,183,regulation of Ras protein signal transduction,BP,LPAR1
1046,GO:0002440,0.702706383944528,0.661298330090773,1,186,production of molecular mediator of immune response,BP,CD22
2962,GO:0006163,0.702877218965278,0.560050000494337,2,375,purine nucleotide metabolic process,BP,GDA;AK5
20010,GO:1903708,0.703787381615618,0.659993069040353,1,186,positive regulation of hemopoiesis,BP,TESPA1
7789,GO:0031348,0.704846065342061,0.658704633999617,1,187,negative regulation of defense response,BP,CCK
14511,GO:0060348,0.705039960858148,0.658482030919886,1,185,bone development,BP,GREM1
3149,GO:0006473,0.705415638323609,0.658019539453493,1,186,protein acetylation,BP,SNCA
1126,GO:0002573,0.706331462309329,0.656899248391419,1,187,myeloid leukocyte differentiation,BP,TF
2726,GO:0005773,0.707126304098706,0.479740606562225,4,734,vacuole,CC,LRP2;PADI2;SNCA;SERPINA3
2698,GO:0005739,0.708761166461288,0.42505054832975,8,1424,mitochondrion,CC,MAOB;CAMK2A;SNCA;NRGN;KLK6;MOBP;BOK;AIFM3
2024,GO:0004518,0.70952524222448,0.652979385898478,1,189,nuclease activity,MF,ENPP2
6681,GO:0019902,0.710078730996133,0.652304860892627,1,188,phosphatase binding,MF,CD22
3290,GO:0006643,0.710410887758338,0.65188345336693,1,190,membrane lipid metabolic process,BP,ENPP2
5652,GO:0016051,0.712146368205679,0.64974005325011,1,190,carbohydrate biosynthetic process,BP,SNCA
16136,GO:0071383,0.713079714981071,0.648582987384737,1,190,cellular response to steroid hormone stimulus,BP,PADI2
8668,GO:0032870,0.713138086467561,0.500555601071964,3,561,cellular response to hormone stimulus,BP,CAMK2A;RARRES2;PADI2
10028,GO:0035966,0.714480647294667,0.646828309256828,1,192,response to topologically incorrect protein,BP,BOK
17183,GO:0090276,0.714593277362737,0.646694002061158,1,191,regulation of peptide hormone secretion,BP,VSNL1
8660,GO:0032838,0.718671381642729,0.641580651016475,1,191,plasma membrane bounded cell projection cytoplasm,CC,DCX
13884,GO:0051701,0.719498477347596,0.640518139040039,1,194,interaction with host,BP,MOG
7133,GO:0030073,0.722933142247895,0.636149213031377,1,195,insulin secretion,BP,VSNL1
7506,GO:0030855,0.725464549241191,0.485249782086634,3,572,epithelial cell differentiation,BP,HAPLN2;CBR1;GREM1
15347,GO:0062012,0.727769023544866,0.528830692060886,2,393,regulation of small molecule metabolic process,BP,FGF1;SNCA
3890,GO:0008154,0.729525386181851,0.627631290350701,1,199,actin polymerization or depolymerization,BP,GAS7
3658,GO:0007254,0.729773584310877,0.627308342731987,1,199,JNK cascade,BP,TF
137,GO:0000287,0.730973595023313,0.62573790005988,1,200,magnesium ion binding,MF,SNCA
817,GO:0002064,0.732077648944661,0.624299407162503,1,199,epithelial cell development,BP,HAPLN2
16768,GO:0072521,0.733491175955414,0.521430469171149,2,398,purine-containing compound metabolic process,BP,GDA;AK5
11234,GO:0043434,0.733596993073645,0.521297109898896,2,396,response to peptide hormone,BP,CAMK2A;RARRES2
4114,GO:0008514,0.735542450875835,0.619714073816238,1,203,organic anion transmembrane transporter activity,MF,SLC17A7
7199,GO:0030178,0.737329231633488,0.617337812761602,1,204,negative regulation of Wnt signaling pathway,BP,GREM1
2702,GO:0005743,0.738378067156646,0.515033020754262,2,407,mitochondrial inner membrane,CC,BOK;AIFM3
2789,GO:0005874,0.738389825790539,0.515037692373826,2,397,microtubule,CC,DCX;TPPP3
4545,GO:0009743,0.739857086379734,0.613957442256183,1,205,response to carbohydrate,BP,VSNL1
13544,GO:0051090,0.739893323423813,0.513051973406421,2,402,regulation of DNA-binding transcription factor activity,BP,CAMK2A;GREM1
10106,GO:0036094,0.739906833415973,0.36278783284915,13,2277,small molecule binding,MF,CD22;MAOB;CAMK2A;MAG;ADAP1;EPHB6;HAPLN2;PDGFRA;AK5;CYB5R2;CARNS1;AIFM3;RYR2
14505,GO:0060341,0.740351538468308,0.42021789283889,5,939,regulation of cellular localization,BP,CAMK2A;SLC17A7;SNCA;VSNL1;RYR2
11322,GO:0043583,0.740811499928377,0.612676853228585,1,205,ear development,BP,CXCL14
2744,GO:0005794,0.741471026763031,0.386348289580434,8,1454,Golgi apparatus,CC,LRP2;SPP1;MYRF;PDGFRA;GALNT6;CXCL14;BOK;OPALIN
18913,GO:1901137,0.741481816721798,0.464886174024425,3,589,carbohydrate derivative biosynthetic process,BP,NECAB1;GALNT6;AK5
4452,GO:0009314,0.742474909783063,0.5096416509897,2,404,response to radiation,BP,SYNPO;CCK
11499,GO:0044242,0.744659497191983,0.607455730382297,1,209,cellular lipid catabolic process,BP,ENPP2
4445,GO:0009306,0.744694839822404,0.506698076086457,2,404,protein secretion,BP,CD22;VSNL1
9804,GO:0035592,0.744694839822404,0.506698076086457,2,404,establishment of protein localization to extracellular region,BP,CD22;VSNL1
8667,GO:0032869,0.745861360554545,0.605825387403849,1,208,cellular response to insulin stimulus,BP,RARRES2
6028,GO:0016787,0.746442197298322,0.358782220805635,12,2132,hydrolase activity,MF,SYNJ2;FOLH1;PADI2;RGS4;GDA;MYRF;ENPP2;CNDP1;PDE1C;KLK6;CARNS1;MPPED1
11519,GO:0044282,0.748817372354408,0.501180165970189,2,412,small molecule catabolic process,BP,SYNJ2;CARNS1
13366,GO:0050807,0.748847541958734,0.601730794038802,1,209,regulation of synapse organization,BP,SNCA
16703,GO:0072330,0.749198352895706,0.601231926927871,1,212,monocarboxylic acid biosynthetic process,BP,CBR1
22116,GO:2001234,0.749683038699938,0.600564167823607,1,212,negative regulation of apoptotic signaling pathway,BP,BOK
8669,GO:0032872,0.750182896393532,0.599879858299422,1,211,regulation of stress-activated MAPK cascade,BP,TF
9464,GO:0034703,0.750278446000649,0.599758752542706,1,209,cation channel complex,CC,RYR2
12017,GO:0045732,0.750317365780862,0.599694161492513,1,211,positive regulation of protein catabolic process,BP,LRP2
13104,GO:0048762,0.750687617101511,0.599182482871062,1,211,mesenchymal cell differentiation,BP,GREM1
16183,GO:0071453,0.750699205908013,0.599161112894562,1,212,cellular response to oxygen levels,BP,LPAR1
11886,GO:0045444,0.751474278710455,0.598088145430286,1,212,fat cell differentiation,BP,RARRES2
3594,GO:0007160,0.751476844430818,0.598095346608977,1,210,cell-matrix adhesion,BP,GREM1
10677,GO:0042393,0.751563438213596,0.597969916025948,1,211,histone binding,MF,SNCA
2391,GO:0005085,0.751632578669822,0.597884922539027,1,209,guanyl-nucleotide exchange factor activity,MF,DOCK5
16344,GO:0071692,0.753412980815561,0.49499290237401,2,411,protein localization to extracellular region,BP,CD22;VSNL1
13089,GO:0048732,0.754334037786823,0.493743391663305,2,412,gland development,BP,FGF1;PDGFRA
13604,GO:0051172,0.75445691795638,0.349287332964451,12,2143,negative regulation of nitrogen compound metabolic process,BP,HHATL;RGS4;SNCA;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;SPOCK3;SERPINA3;FXYD1
15569,GO:0070302,0.755058922054523,0.593083400213889,1,214,regulation of stress-activated protein kinase signaling cascade,BP,TF
4357,GO:0009165,0.755613540055236,0.592295567168058,1,216,nucleotide biosynthetic process,BP,AK5
13343,GO:0050776,0.75563060568304,0.419368712075242,4,788,regulation of immune response,BP,CD22;TESPA1;MOG;ICOSLG
2574,GO:0005488,0.758361359771859,0.341947144321713,86,13523,binding,MF,GAS7;HHATL;CD22;CLDN11;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;SEC14L5;NEFM;SHD;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;EVI2A;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;GALNT6;SNCA;CXCL14;DOCK5;ST18;NKX6-2;PAMR1;CNDP1;AK5;NRGN;PDE1C;SLC5A11;CSRP1;TPPP3;ICOSLG;S100A1;VSNL1;TMEM144;HHIP;CYB5R2;GREM1;KLK6;MOBP;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;AIFM3;CNTN2;SV2B;CCK;SPOCK3;SERPINA3;MBP;LPAR1;RYR2;GRM3;TMEM88B;MEX3A;FXYD1
4673,GO:0010256,0.758425957274699,0.488166002200736,2,415,endomembrane system organization,BP,PACSIN1;MYRF
6003,GO:0016746,0.758614812052406,0.588061472263809,1,217,transferase activity, transferring acyl groups,MF,HHATL
12613,GO:0046982,0.760043661180619,0.586029849225837,1,218,protein heterodimerization activity,MF,BOK
19076,GO:1901575,0.760262520565027,0.346462037302767,11,1993,organic substance catabolic process,BP,MAOB;SYNJ2;MOXD1;LRP2;RARRES2;SPP1;GDA;CHI3L1;ENPP2;SNCA;CARNS1
18970,GO:1901293,0.760327339444325,0.58562140703125,1,219,nucleoside phosphate biosynthetic process,BP,AK5
4587,GO:0009896,0.760453348935062,0.485383911075228,2,417,positive regulation of catabolic process,BP,LRP2;SNCA
8966,GO:0033500,0.760887635638181,0.584828844123329,1,218,carbohydrate homeostasis,BP,VSNL1
10784,GO:0042593,0.760887635638181,0.584828844123329,1,218,glucose homeostasis,BP,VSNL1
2750,GO:0005802,0.761700215944391,0.583669681790508,1,218,trans-Golgi network,CC,BOK
15897,GO:0070925,0.761816778094241,0.411359505711915,4,785,organelle assembly,BP,DCX;PDGFRA;CSRP1;SYNPO
637,GO:0001817,0.761877920895666,0.438144047772252,3,611,regulation of cytokine production,BP,MOG;ICOSLG;MBP
7959,GO:0031667,0.761961872938872,0.483301453510034,2,421,response to nutrient levels,BP,SPP1;CCK
3159,GO:0006486,0.769353063146115,0.572589229616739,1,223,protein glycosylation,BP,GALNT6
11221,GO:0043413,0.769353063146115,0.572589229616739,1,223,macromolecule glycosylation,BP,GALNT6
12457,GO:0046649,0.770946477198009,0.425947978032894,3,620,lymphocyte activation,BP,CD22;TESPA1;ICOSLG
5907,GO:0016570,0.771203960168301,0.470434046541388,2,426,histone modification,BP,PADI2;SNCA
10548,GO:0042110,0.772554716307396,0.468524446581463,2,431,T cell activation,BP,TESPA1;ICOSLG
16352,GO:0071702,0.773156172040177,0.32028618224422,14,2510,organic substance transport,BP,CD22;MAOB;LRP2;TF;SLC17A7;RGS4;SPP1;SNCA;SLC5A11;VSNL1;TMEM144;CYB5R2;GJB1;CCK
6680,GO:0019901,0.776365149676455,0.418572007859148,3,620,protein kinase binding,MF,DCX;MAG;RYR2
5792,GO:0016323,0.776902387236617,0.561413193130835,1,227,basolateral plasma membrane,CC,TF
532,GO:0001664,0.777788932121055,0.560067263177128,1,231,G protein-coupled receptor binding,MF,CXCL14
18911,GO:1901135,0.778009631388341,0.372255664768456,5,991,carbohydrate derivative metabolic process,BP,NECAB1;CHI3L1;GALNT6;AK5;SPOCK3
7772,GO:0031330,0.778674740714091,0.558747374105605,1,229,negative regulation of cellular catabolic process,BP,SNCA
13414,GO:0050878,0.779102208797837,0.459225886059159,2,435,regulation of body fluid levels,BP,PDGFRA;CSRP1
6009,GO:0016757,0.781231495579868,0.554876178890877,1,232,transferase activity, transferring glycosyl groups,MF,GALNT6
6015,GO:0016772,0.781614533555776,0.385184476185529,4,808,transferase activity, transferring phosphorus-containing groups,MF,CAMK2A;EPHB6;PDGFRA;AK5
7256,GO:0030258,0.781929550894811,0.553817891083332,1,232,lipid modification,BP,SYNJ2
5906,GO:0016569,0.782227768824318,0.454741932614776,2,436,covalent chromatin modification,BP,PADI2;SNCA
12126,GO:0045927,0.782851964168184,0.55242070847911,1,231,positive regulation of growth,BP,CPNE6
6016,GO:0016773,0.783091459307141,0.409311683198084,3,624,phosphotransferase activity, alcohol group as acceptor,MF,CAMK2A;EPHB6;PDGFRA
7229,GO:0030217,0.783244128270313,0.551814147136145,1,233,T cell differentiation,BP,TESPA1
11036,GO:0043122,0.783974327267297,0.550695633530804,1,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
7132,GO:0030072,0.784176420055306,0.550391534588825,1,233,peptide hormone secretion,BP,VSNL1
11405,GO:0043933,0.784340450340341,0.327065154308004,9,1694,protein-containing complex subunit organization,BP,GAS7;TESPA1;SNCA;SLC39A12;SLC24A2;TPPP3;GREM1;BOK;CCK
1261,GO:0002790,0.785931758915436,0.44938347749736,2,440,peptide secretion,BP,CD22;VSNL1
13888,GO:0051707,0.785953736137823,0.349037540459004,6,1183,response to other organism,BP,MAOB;CAMK2A;TF;RARRES2;SNCA;CXCL14
15432,GO:0070085,0.786820377493503,0.546325661147866,1,235,glycosylation,BP,GALNT6
11089,GO:0043207,0.787299887447944,0.347286547112524,6,1185,response to external biotic stimulus,BP,MAOB;CAMK2A;TF;RARRES2;SNCA;CXCL14
18183,GO:0099568,0.787965934687809,0.544567041248755,1,233,cytoplasmic region,CC,DCX
5620,GO:0015980,0.789322057217057,0.542438788625683,1,239,energy derivation by oxidation of organic compounds,BP,SNCA
6031,GO:0016791,0.791214247296388,0.539497127555758,1,238,phosphatase activity,MF,SYNJ2
2925,GO:0006091,0.79268238476812,0.439498491938117,2,451,generation of precursor metabolites and energy,BP,MAOB;SNCA
7389,GO:0030522,0.794024329954073,0.535080953479449,1,240,intracellular receptor signaling pathway,BP,PADI2
4616,GO:0009991,0.795746628107838,0.434969044640943,2,452,response to extracellular stimulus,BP,SPP1;CCK
5603,GO:0015931,0.795775231058649,0.532306555727478,1,242,nucleobase-containing compound transport,BP,GJB1
6029,GO:0016788,0.795936379591598,0.391295255418243,3,646,hydrolase activity, acting on ester bonds,MF,SYNJ2;ENPP2;PDE1C
1000,GO:0002366,0.797445198608798,0.389149515757933,3,650,leukocyte activation involved in immune response,BP,PADI2;CHI3L1;SERPINA3
19827,GO:1903362,0.797483797075237,0.529588872775498,1,243,regulation of cellular protein catabolic process,BP,LRP2
3512,GO:0006996,0.797842819263324,0.278297867740012,20,3534,organelle organization,BP,GAS7;CAMK2A;DCX;TF;NEFM;SLC17A7;PADI2;RGS4;PACSIN1;PDGFRA;ERMN;SNCA;SLC39A12;CSRP1;TPPP3;SYNPO;BOK;CNTN2;CCK;LPAR1
6661,GO:0019866,0.798387320390423,0.431029191179557,2,460,organelle inner membrane,CC,BOK;AIFM3
40,GO:0000082,0.798409941964671,0.528107685572126,1,244,G1/S transition of mitotic cell cycle,BP,CAMK2A
4313,GO:0009117,0.798983710140695,0.430145382983522,2,456,nucleotide metabolic process,BP,GDA;AK5
11795,GO:0045165,0.799539898417119,0.526300010800455,1,244,cell fate commitment,BP,NKX6-2
930,GO:0002263,0.80018884235261,0.385236018761743,3,653,cell activation involved in immune response,BP,PADI2;CHI3L1;SERPINA3
4614,GO:0009987,0.802200594839376,0.29309773386402,87,13730,cellular process,BP,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;FOLH1;DLL3;TF;CPNE6;NEFM;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;GALNT6;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;CNDP1;AK5;NRGN;PDE1C;SLC24A2;SLC5A11;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;TMEM144;HHIP;GREM1;PPP1R14A;KLK6;LGI3;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;AIFM3;CNTN2;SV2B;CCK;SPOCK3;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;FXYD1
13838,GO:0051606,0.802526439214147,0.521482590563142,1,246,detection of stimulus,BP,RYR2
2724,GO:0005770,0.804500621510694,0.518266167471102,1,249,late endosome,CC,TF
4507,GO:0009607,0.805227278613076,0.32365793584044,6,1212,response to biotic stimulus,BP,MAOB;CAMK2A;TF;RARRES2;SNCA;CXCL14
3367,GO:0006753,0.805805980204147,0.419865270927666,2,463,nucleoside phosphate metabolic process,BP,GDA;AK5
4269,GO:0009056,0.806556312312421,0.282479730074413,13,2415,catabolic process,BP,MAOB;SYNJ2;MOXD1;LRP2;RARRES2;SPP1;GDA;CHI3L1;ENPP2;SNCA;KLK6;CARNS1;BOK
16704,GO:0072331,0.808791173569117,0.511221234582586,1,252,signal transduction by p53 class mediator,BP,BOK
12100,GO:0045893,0.810374637955201,0.307449437215015,7,1389,positive regulation of transcription, DNA-templated,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1
3596,GO:0007162,0.812250316223965,0.505472625957819,1,254,negative regulation of cell adhesion,BP,MBP
15190,GO:0061629,0.815893543176189,0.499345029733225,1,257,RNA polymerase II-specific DNA-binding transcription factor binding,MF,PADI2
19283,GO:1902105,0.816025330379797,0.499118500904633,1,258,regulation of leukocyte differentiation,BP,TESPA1
11688,GO:0044843,0.816321143481219,0.49861855210246,1,258,cell cycle G1/S phase transition,BP,CAMK2A
13734,GO:0051403,0.817868567390992,0.495991490345724,1,259,stress-activated MAPK cascade,BP,TF
9137,GO:0034097,0.818183611207798,0.318145172417475,5,1051,response to cytokine,BP,CAMK2A;PADI2;CHI3L1;SNCA;ST18
6452,GO:0019221,0.818279659096022,0.358908251770084,3,677,cytokine-mediated signaling pathway,BP,CAMK2A;PADI2;ST18
19112,GO:1901652,0.819025951126919,0.39948261208288,2,474,response to peptide,BP,CAMK2A;RARRES2
5655,GO:0016054,0.819058231761779,0.49395417240315,1,262,organic acid catabolic process,BP,CARNS1
12324,GO:0046395,0.819058231761779,0.49395417240315,1,262,carboxylic acid catabolic process,BP,CARNS1
60,GO:0000122,0.819242342032313,0.333064612676709,4,862,negative regulation of transcription by RNA polymerase II,BP,SNCA;NKX6-2;S100A1;EMX2
8666,GO:0032868,0.819762382059716,0.492759179266029,1,260,response to insulin,BP,RARRES2
1098,GO:0002521,0.820225594393495,0.397598565268698,2,477,leukocyte differentiation,BP,TF;TESPA1
16828,GO:0072659,0.82386402992788,0.485686278663391,1,263,protein localization to plasma membrane,BP,PACSIN1
17485,GO:0097193,0.825959255189949,0.482027001592458,1,267,intrinsic apoptotic signaling pathway,BP,BOK
3654,GO:0007249,0.827170060155644,0.479905742188959,1,268,I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
17757,GO:0098542,0.828281194373943,0.320035325341244,4,882,defense response to other organism,BP,CAMK2A;TF;RARRES2;SNCA
74,GO:0000151,0.828332025020794,0.477865536093428,1,268,ubiquitin ligase complex,CC,GPR37
5656,GO:0016055,0.829205497412174,0.383343779792821,2,485,Wnt signaling pathway,BP,CAMK2A;GREM1
18653,GO:0198738,0.830940291930592,0.380553386935609,2,487,cell-cell signaling by wnt,BP,CAMK2A;GREM1
7651,GO:0031098,0.831825509502972,0.471672529912331,1,271,stress-activated protein kinase signaling cascade,BP,TF
3665,GO:0007264,0.832027837392085,0.378801166700846,2,486,small GTPase mediated signal transduction,BP,DOCK5;LPAR1
9519,GO:0034976,0.832037956364888,0.471290629493647,1,272,response to endoplasmic reticulum stress,BP,BOK
14827,GO:0060828,0.834412439557402,0.467040326198651,1,273,regulation of canonical Wnt signaling pathway,BP,GREM1
8096,GO:0031965,0.838212692113319,0.460161170898667,1,276,nuclear membrane,CC,BOK
17208,GO:0090305,0.840597022471062,0.455791965114701,1,280,nucleic acid phosphodiester bond hydrolysis,BP,ENPP2
3467,GO:0006914,0.840765077207516,0.364520523055023,2,500,autophagy,BP,SNCA;BOK
15322,GO:0061919,0.840765077207516,0.364520523055023,2,500,process utilizing autophagic mechanism,BP,SNCA;BOK
7766,GO:0031324,0.841847989966557,0.240655186466557,12,2317,negative regulation of cellular metabolic process,BP,HHATL;RGS4;SNCA;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;SPOCK3;SERPINA3;FXYD1
9463,GO:0034702,0.842142027261042,0.452957388343327,1,278,ion channel complex,CC,RYR2
1694,GO:0003924,0.842315163946455,0.452621025256729,1,283,GTPase activity,MF,RGS4
6679,GO:0019900,0.843405942791932,0.320738394112351,3,702,kinase binding,MF,DCX;MAG;RYR2
4586,GO:0009895,0.843819721736973,0.449844310527477,1,281,negative regulation of catabolic process,BP,SNCA
11753,GO:0045087,0.8490515423293,0.311874016274644,3,719,innate immune response,BP,CAMK2A;RARRES2;SNCA
19898,GO:1903508,0.849435502022109,0.254350686351192,7,1461,positive regulation of nucleic acid-templated transcription,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1
12963,GO:0048511,0.849839897780235,0.438538815299628,1,287,rhythmic process,BP,PDGFRA
19510,GO:1902680,0.849926558777164,0.253663677065981,7,1462,positive regulation of RNA biosynthetic process,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1
1049,GO:0002443,0.850670778646836,0.309313597089343,3,721,leukocyte mediated immunity,BP,PADI2;CHI3L1;SERPINA3
13500,GO:0051020,0.851251286089264,0.346970639459222,2,508,GTPase binding,MF,DOCK5;MOBP
18435,GO:0120031,0.852244647313516,0.345279204426449,2,512,plasma membrane bounded cell projection assembly,BP,DCX;LPAR1
7017,GO:0022411,0.858206863658928,0.335049943715328,2,523,cellular component disassembly,BP,PADI2;BOK
16216,GO:0071496,0.862921905371596,0.413111963469419,1,302,cellular response to external stimulus,BP,MAG
7107,GO:0030031,0.863260314325593,0.326257109754528,2,527,cell projection assembly,BP,DCX;LPAR1
16029,GO:0071214,0.8653766136628,0.408203389750756,1,305,cellular response to abiotic stimulus,BP,MAG
18323,GO:0104004,0.8653766136628,0.408203389750756,1,305,cellular response to environmental stimulus,BP,MAG
13290,GO:0050678,0.865660533603435,0.407636651720739,1,304,regulation of epithelial cell proliferation,BP,FGF1
14235,GO:0055086,0.866298045622906,0.320905267426658,2,536,nucleobase-containing small molecule metabolic process,BP,GDA;AK5
13859,GO:0051649,0.8672440465063,0.204369527363886,13,2552,establishment of localization in cell,BP,CAMK2A;SYNJ2;TF;SLC17A7;RARRES2;PADI2;PACSIN1;CHI3L1;SNCA;SLC24A2;VSNL1;SERPINA3;RYR2
6391,GO:0019058,0.868833976796422,0.401213642970013,1,309,viral life cycle,BP,MOG
17090,GO:0090150,0.870891149773904,0.397003914399835,1,314,establishment of protein localization to membrane,BP,MAL
4585,GO:0009894,0.871379591966063,0.254806798123742,4,946,regulation of catabolic process,BP,LRP2;RARRES2;SNCA;BOK
13530,GO:0051056,0.871429206689313,0.395917697640751,1,308,regulation of small GTPase mediated signal transduction,BP,LPAR1
14324,GO:0060070,0.87216601423118,0.394392507595652,1,312,canonical Wnt signaling pathway,BP,GREM1
21516,GO:2000113,0.873032085832423,0.228351966278881,6,1328,negative regulation of cellular macromolecule biosynthetic process,BP,HHATL;SNCA;NKX6-2;S100A1;GREM1;EMX2
13316,GO:0050727,0.873185964786159,0.392281388997216,1,315,regulation of inflammatory response,BP,SNCA
13526,GO:0051052,0.873813754579048,0.390985610076651,1,314,regulation of DNA metabolic process,BP,GREM1
3434,GO:0006869,0.875481324054698,0.387515635727628,1,316,lipid transport,BP,SPP1
3487,GO:0006950,0.875524395589414,0.184230834329483,18,3430,response to stress,BP,CAMK2A;ASIC4;TF;MAG;RARRES2;FGF1;SPP1;CHI3L1;PDGFRA;SNCA;CSRP1;ICOSLG;KLK6;GPR37;BOK;CCK;SERPINA3;RYR2
8978,GO:0033554,0.875740305367043,0.205954368300797,9,1882,cellular response to stress,BP,CAMK2A;TF;MAG;FGF1;SPP1;PDGFRA;SNCA;GPR37;BOK
12484,GO:0046700,0.876157779396626,0.303232737624934,2,552,heterocycle catabolic process,BP,GDA;CARNS1
11512,GO:0044270,0.876799190270243,0.302065775120393,2,553,cellular nitrogen compound catabolic process,BP,GDA;CARNS1
12099,GO:0045892,0.877162691737367,0.232014078962331,5,1150,negative regulation of transcription, DNA-templated,BP,SNCA;NKX6-2;S100A1;GREM1;EMX2
5852,GO:0016462,0.881207761099131,0.259207677190691,3,763,pyrophosphatase activity,MF,RGS4;ENPP2;CARNS1
16107,GO:0071345,0.881875580522505,0.238034109217041,4,973,cellular response to cytokine stimulus,BP,CAMK2A;PADI2;CHI3L1;ST18
7136,GO:0030098,0.882282144638655,0.373124785330059,1,325,lymphocyte differentiation,BP,TESPA1
17879,GO:0098791,0.882847731251721,0.371912286417208,1,325,Golgi apparatus subcompartment,CC,BOK
6047,GO:0016817,0.88288029627018,0.256355416423869,3,766,hydrolase activity, acting on acid anhydrides,MF,RGS4;ENPP2;CARNS1
6048,GO:0016818,0.88288029627018,0.256355416423869,3,766,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RGS4;ENPP2;CARNS1
3666,GO:0007265,0.885420966873286,0.366355585176614,1,327,Ras protein signal transduction,BP,LPAR1
3389,GO:0006790,0.885627750085457,0.365897052774747,1,331,sulfur compound metabolic process,BP,SPOCK3
18574,GO:0140297,0.886098867778412,0.364878361154439,1,329,DNA-binding transcription factor binding,MF,PADI2
534,GO:0001666,0.886145072757832,0.364775404530296,1,330,response to hypoxia,BP,RYR2
13621,GO:0051222,0.887658310978611,0.361473534990861,1,330,positive regulation of protein transport,BP,VSNL1
13645,GO:0051254,0.887674437347516,0.199182336060402,7,1547,positive regulation of RNA metabolic process,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1
7751,GO:0031301,0.891191636410407,0.353661359441817,1,339,integral component of organelle membrane,CC,SLC17A7
1858,GO:0004175,0.891386641492039,0.353230350493627,1,338,endopeptidase activity,MF,KLK6
14449,GO:0060271,0.891479101105033,0.353031814151125,1,335,cilium assembly,BP,DCX
2586,GO:0005515,0.892190593385673,0.155458074817605,71,11691,protein binding,MF,GAS7;HHATL;CD22;CLDN11;MAOB;CAMK2A;ASIC4;DCX;SYNJ2;MOXD1;LRP2;DLL3;TF;CPNE6;SEC14L5;NEFM;SHD;MAG;ADAP1;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;EVI2A;HAPLN2;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;ENPP2;MOG;SNCA;CXCL14;DOCK5;NRGN;PDE1C;SLC5A11;CSRP1;TPPP3;ICOSLG;S100A1;VSNL1;TMEM144;HHIP;CYB5R2;GREM1;KLK6;MOBP;GJB1;EMX2;GPR37;NINJ2;SYNPO;MAL;BOK;S1PR5;GPR62;CNTN2;SV2B;CCK;SERPINA3;MBP;LPAR1;RYR2;GRM3;TMEM88B;FXYD1
4343,GO:0009150,0.892565257249466,0.350601374400307,1,339,purine ribonucleotide metabolic process,BP,AK5
6678,GO:0019899,0.892840586906887,0.177798532212175,10,2096,enzyme binding,MF,CD22;DCX;MAG;DOCK5;S100A1;MOBP;GPR37;BOK;MBP;RYR2
19897,GO:1903507,0.893251472890324,0.206814182153874,5,1186,negative regulation of nucleic acid-templated transcription,BP,SNCA;NKX6-2;S100A1;GREM1;EMX2
13622,GO:0051223,0.893260093309363,0.271344103098448,2,574,regulation of protein transport,BP,CD22;VSNL1
3280,GO:0006631,0.893627017887804,0.348217030080617,1,342,fatty acid metabolic process,BP,CBR1
4759,GO:0010558,0.893869200088472,0.196780883947649,6,1377,negative regulation of macromolecule biosynthetic process,BP,HHATL;SNCA;NKX6-2;S100A1;GREM1;EMX2
19509,GO:1902679,0.894072075739635,0.205505728238608,5,1188,negative regulation of RNA biosynthetic process,BP,SNCA;NKX6-2;S100A1;GREM1;EMX2
10181,GO:0036293,0.894329608051291,0.346640167343176,1,341,response to decreased oxygen levels,BP,RYR2
11236,GO:0043436,0.896432701369408,0.214107820640181,4,1005,oxoacid metabolic process,BP,FOLH1;CBR1;CARNS1;SPOCK3
2719,GO:0005765,0.897831919756005,0.338685732770082,1,346,lysosomal membrane,CC,LRP2
17920,GO:0098852,0.897831919756005,0.338685732770082,1,346,lytic vacuole membrane,CC,LRP2
1198,GO:0002697,0.897903444523596,0.338517870166245,1,348,regulation of immune effector process,BP,CD22
8106,GO:0031984,0.89881249147253,0.336437921034917,1,347,organelle subcompartment,CC,BOK
20652,GO:1904951,0.898942309122391,0.336142100460106,1,346,positive regulation of establishment of protein localization,BP,VSNL1
7145,GO:0030111,0.899779318711802,0.334212144822325,1,348,regulation of Wnt signaling pathway,BP,GREM1
7771,GO:0031329,0.900068429099561,0.226309370080157,3,803,regulation of cellular catabolic process,BP,LRP2;SNCA;BOK
7770,GO:0031328,0.900345083791917,0.174820197874051,8,1767,positive regulation of cellular biosynthetic process,BP,TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;GREM1
2918,GO:0006082,0.902431635850743,0.204002954398902,4,1019,organic acid metabolic process,BP,FOLH1;CBR1;CARNS1;SPOCK3
7788,GO:0031347,0.902690589061288,0.253007982432831,2,596,regulation of defense response,BP,SNCA;CCK
4428,GO:0009259,0.902707420829323,0.32740681905165,1,354,ribonucleotide metabolic process,BP,AK5
11661,GO:0044782,0.903734425142933,0.325005419112367,1,353,cilium organization,BP,DCX
13286,GO:0050673,0.9042344375081,0.323827032484618,1,355,epithelial cell proliferation,BP,FGF1
2760,GO:0005829,0.904853728447456,0.139333387927182,25,4688,cytosol,CC,CAMK2A;DCX;SYNJ2;ADAP1;EPHB6;FGF1;PADI2;RGS4;GDA;NECAB1;PACSIN1;MYRF;SNCA;DOCK5;CNDP1;AK5;NRGN;PDE1C;CBR1;VSNL1;PPP1R14A;SYNPO;CARNS1;AIFM3;MEX3A
7135,GO:0030097,0.904975401239986,0.217468997414973,3,816,hemopoiesis,BP,TF;PDGFRA;TESPA1
4981,GO:0010876,0.905178817029641,0.321597915786131,1,357,lipid localization,BP,SPP1
923,GO:0002250,0.905432997416502,0.320991327990728,1,360,adaptive immune response,BP,ICOSLG
15508,GO:0070201,0.906110793335177,0.24622028273838,2,598,regulation of establishment of protein localization,BP,CD22;VSNL1
6291,GO:0018205,0.906929460545505,0.31744389630265,1,359,peptidyl-lysine modification,BP,SNCA
17051,GO:0090087,0.907577671378775,0.243282977133446,2,601,regulation of peptide transport,BP,CD22;VSNL1
6586,GO:0019693,0.908892246757217,0.312741243950883,1,364,ribose phosphate metabolic process,BP,AK5
11590,GO:0044419,0.908944262772031,0.161851874863239,8,1801,interspecies interaction between organisms,BP,MAOB;CAMK2A;TF;RARRES2;PDGFRA;MOG;SNCA;CXCL14
4582,GO:0009891,0.909163003771941,0.161520037280691,8,1794,positive regulation of biosynthetic process,BP,TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;GREM1
16354,GO:0071705,0.909668675298889,0.153397291958581,10,2159,nitrogen compound transport,BP,CD22;MAOB;LRP2;TF;SLC17A7;RGS4;SNCA;VSNL1;GJB1;CCK
7750,GO:0031300,0.910181276406646,0.309628301923783,1,368,intrinsic component of organelle membrane,CC,SLC17A7
11636,GO:0044703,0.910327481841426,0.207683880139721,3,828,multi-organism reproductive process,BP,CLDN11;SPP1;TPPP3
16826,GO:0072657,0.91153582587713,0.235278883701248,2,613,protein localization to membrane,BP,PACSIN1;MAL
7769,GO:0031327,0.911665262793741,0.168741628913629,6,1426,negative regulation of cellular biosynthetic process,BP,HHATL;SNCA;NKX6-2;S100A1;GREM1;EMX2
3877,GO:0008134,0.9118235729593,0.234694846476736,2,611,transcription factor binding,MF,PADI2;ENPP2
7137,GO:0030099,0.913104067730081,0.302513512051505,1,370,myeloid cell differentiation,BP,TF
1637,GO:0003824,0.915307523508472,0.124939635608013,26,4902,catalytic activity,MF,HHATL;MAOB;CAMK2A;SYNJ2;MOXD1;FOLH1;EPHB6;PADI2;RGS4;GDA;MYRF;PDGFRA;ENPP2;GALNT6;SNCA;CNDP1;AK5;PDE1C;CBR1;HHIP;CYB5R2;KLK6;LGI3;CARNS1;AIFM3;MPPED1
3969,GO:0008285,0.917306920048939,0.223408413287834,2,625,negative regulation of cell population proliferation,BP,ST18;GREM1
925,GO:0002252,0.920020041802358,0.173450988582908,4,1064,immune effector process,BP,CD22;PADI2;CHI3L1;SERPINA3
4581,GO:0009890,0.920613791140302,0.154211944582025,6,1454,negative regulation of biosynthetic process,BP,HHATL;SNCA;NKX6-2;S100A1;GREM1;EMX2
8098,GO:0031967,0.920635266735971,0.172354868447966,4,1067,organelle envelope,CC,MAOB;NRGN;BOK;AIFM3
8102,GO:0031975,0.920635266735971,0.172354868447966,4,1067,envelope,CC,MAOB;NRGN;BOK;AIFM3
639,GO:0001819,0.920902095396906,0.283013283569788,1,386,positive regulation of cytokine production,BP,MBP
12978,GO:0048534,0.921063945764642,0.187566923619668,3,855,hematopoietic or lymphoid organ development,BP,TF;PDGFRA;TESPA1
17884,GO:0098796,0.921474336436897,0.170858691459231,4,1064,membrane protein complex,CC,TF;GJB1;RYR2;FXYD1
6138,GO:0017016,0.922316053999964,0.27940603369461,1,383,Ras GTPase binding,MF,MOBP
13644,GO:0051253,0.924865737071292,0.154538606554605,5,1273,negative regulation of RNA metabolic process,BP,SNCA;NKX6-2;S100A1;GREM1;EMX2
2727,GO:0005774,0.925184152898703,0.271980875705099,1,393,vacuolar membrane,CC,LRP2
6091,GO:0016887,0.925974228604489,0.269928728955465,1,388,ATPase activity,MF,CARNS1
4802,GO:0010628,0.926525403206952,0.131096740436083,9,2037,positive regulation of gene expression,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1;CNTN2;MBP
7728,GO:0031267,0.927914742454942,0.264821866530289,1,394,small GTPase binding,MF,MOBP
7717,GO:0031252,0.930348591152998,0.258345596101374,1,399,cell leading edge,CC,PACSIN1
2823,GO:0005925,0.930765406141157,0.257223108406099,1,403,focal adhesion,CC,CSRP1
4758,GO:0010557,0.931688570196084,0.130536749634921,7,1685,positive regulation of macromolecule biosynthetic process,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1
3057,GO:0006325,0.93180868490532,0.192401382261584,2,656,chromatin organization,BP,PADI2;SNCA
12132,GO:0045935,0.93290117817888,0.128545863075037,7,1689,positive regulation of nucleobase-containing compound metabolic process,BP,TF;FGF1;PADI2;SPP1;MYRF;ST18;GREM1
7124,GO:0030055,0.933503709998261,0.2498156920999,1,409,cell-substrate junction,CC,CSRP1
3678,GO:0007283,0.934105703544956,0.248169603487779,1,412,spermatogenesis,BP,CLDN11
2135,GO:0004674,0.934287616436677,0.247681064974367,1,406,protein serine/threonine kinase activity,MF,CAMK2A
13887,GO:0051704,0.934876409453513,0.160614512503986,3,894,multi-organism process,BP,CLDN11;SPP1;TPPP3
1097,GO:0002520,0.936661836095244,0.157032140487242,3,900,immune system development,BP,TF;PDGFRA;TESPA1
4786,GO:0010605,0.938259403173047,0.106003949586931,12,2635,negative regulation of macromolecule metabolic process,BP,HHATL;RGS4;SNCA;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;SPOCK3;SERPINA3;FXYD1
20008,GO:1903706,0.940503643338025,0.230341683605787,1,428,regulation of hemopoiesis,BP,TESPA1
13852,GO:0051641,0.941064764692914,0.0975510975752757,15,3175,cellular localization,BP,CAMK2A;SYNJ2;TF;SLC17A7;RARRES2;PADI2;PACSIN1;CHI3L1;SNCA;SLC24A2;VSNL1;MAL;CNTN2;SERPINA3;RYR2
12854,GO:0048232,0.941643854160623,0.227094063987366,1,430,male gamete generation,BP,CLDN11
6603,GO:0019752,0.942526148247395,0.145089607750045,3,924,carboxylic acid metabolic process,BP,FOLH1;CBR1;CARNS1
11104,GO:0043232,0.942688833317034,0.0890599044317973,23,4543,intracellular non-membrane-bounded organelle,CC,GAS7;CLDN11;DCX;SYNJ2;NEFM;FGF1;PADI2;PACSIN1;ERMN;SNCA;ST18;NKX6-2;AK5;CSRP1;TPPP3;ICOSLG;S100A1;KLK6;MOBP;EMX2;SYNPO;RYR2;MEX3A
2644,GO:0005635,0.94292923418406,0.223405994415336,1,432,nuclear envelope,CC,BOK
11100,GO:0043228,0.944120713766344,0.0870407970877477,23,4552,non-membrane-bounded organelle,CC,GAS7;CLDN11;DCX;SYNJ2;NEFM;FGF1;PADI2;PACSIN1;ERMN;SNCA;ST18;NKX6-2;AK5;CSRP1;TPPP3;ICOSLG;S100A1;KLK6;MOBP;EMX2;SYNPO;RYR2;MEX3A
18537,GO:0140096,0.94415350016721,0.106146020891012,8,1923,catalytic activity, acting on a protein,MF,CAMK2A;FOLH1;EPHB6;MYRF;PDGFRA;GALNT6;CNDP1;KLK6
2642,GO:0005622,0.945170019379249,0.0867313619824081,75,12466,intracellular,CC,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;MOXD1;LRP2;FOLH1;TF;CPNE6;NEFM;SLC17A7;MAG;ADAP1;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;CLDN10;TESPA1;ERMN;GALNT6;SNCA;CXCL14;DOCK5;ST18;SLC39A12;NKX6-2;CNDP1;AK5;NRGN;PDE1C;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;VSNL1;SERPINI1;HHIP;CYB5R2;PPP1R14A;KLK6;MOBP;LGI3;EMX2;GPR37;SYNPO;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;AIFM3;SV2B;SERPINA3;OPALIN;MBP;LPAR1;RYR2;TMEM235;MEX3A
69,GO:0000139,0.94806716026354,0.155267135627301,2,708,Golgi membrane,CC,GALNT6;BOK
12131,GO:0045934,0.948075301825554,0.113180320847823,5,1360,negative regulation of nucleobase-containing compound metabolic process,BP,SNCA;NKX6-2;S100A1;GREM1;EMX2
82,GO:0000166,0.949203741117944,0.0977355338239523,8,1945,nucleotide binding,MF,MAOB;CAMK2A;EPHB6;PDGFRA;AK5;CYB5R2;CARNS1;AIFM3
18967,GO:1901265,0.949390230900519,0.0974225047454834,8,1946,nucleoside phosphate binding,MF,MAOB;CAMK2A;EPHB6;PDGFRA;AK5;CYB5R2;CARNS1;AIFM3
2594,GO:0005524,0.950223369875685,0.109191302929021,5,1358,ATP binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
6186,GO:0017111,0.952622562855653,0.144326964522186,2,720,nucleoside-triphosphatase activity,MF,RGS4;CARNS1
8476,GO:0032559,0.960887688674111,0.0888775150788546,5,1413,adenyl ribonucleotide binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
7408,GO:0030554,0.96290591606886,0.0849288169421584,5,1425,adenyl nucleotide binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
364,GO:0000978,0.964982253832248,0.0963921609136218,3,1015,RNA polymerase II cis-regulatory region sequence-specific DNA binding,MF,ST18;NKX6-2;EMX2
9430,GO:0034655,0.965913125624947,0.15161830924767,1,513,nucleobase-containing compound catabolic process,BP,GDA
367,GO:0000987,0.968923740145536,0.0872357619571753,3,1038,cis-regulatory region sequence-specific DNA binding,MF,ST18;NKX6-2;EMX2
4583,GO:0009892,0.97051120258489,0.0548503159150149,12,2850,negative regulation of metabolic process,BP,HHATL;RGS4;SNCA;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;SPOCK3;SERPINA3;FXYD1
11502,GO:0044248,0.970533399561317,0.0605811486993619,8,2099,cellular catabolic process,BP,MAOB;MOXD1;LRP2;GDA;ENPP2;SNCA;CARNS1;BOK
11807,GO:0045184,0.97075836716443,0.0624464711059825,7,1898,establishment of protein localization,BP,CD22;LRP2;TF;VSNL1;MAL;CNTN2;RYR2
285,GO:0000785,0.971803433157457,0.0723137946708653,4,1284,chromatin,CC,PADI2;ST18;NKX6-2;EMX2
16821,GO:0072594,0.972170641693542,0.129650035856734,1,542,establishment of protein localization to organelle,BP,RYR2
11656,GO:0044772,0.972216330219573,0.12948541540933,1,541,mitotic cell cycle phase transition,BP,CAMK2A
13678,GO:0051301,0.972924310144114,0.126913948845822,1,543,cell division,BP,FGF1
2752,GO:0005813,0.974214809638472,0.122175395727666,1,550,centrosome,CC,AK5
3676,GO:0007276,0.974692707670577,0.120403168506252,1,554,gamete generation,BP,CLDN11
2693,GO:0005730,0.976601516477214,0.0813741858537203,2,849,nucleolus,CC,FGF1;KLK6
366,GO:0000981,0.97689922217391,0.0609527235968325,4,1324,DNA-binding transcription factor activity, RNA polymerase II-specific,MF,MYRF;ST18;NKX6-2;EMX2
11314,GO:0043565,0.976949084128373,0.0562944721262243,5,1541,sequence-specific DNA binding,MF,MYRF;SNCA;ST18;NKX6-2;EMX2
5639,GO:0016032,0.977250161751641,0.0795073560890221,2,855,viral process,BP,PDGFRA;MOG
12139,GO:0045944,0.97729005857961,0.0669824191349637,3,1097,positive regulation of transcription by RNA polymerase II,BP,FGF1;ST18;GREM1
11654,GO:0044770,0.977461213961669,0.109951184294038,1,572,cell cycle phase transition,BP,CAMK2A
19003,GO:1901362,0.978204169251922,0.0388007252712133,17,3838,organic cyclic compound biosynthetic process,BP,CAMK2A;MOXD1;TF;FGF1;PADI2;SPP1;GDA;MYRF;SNCA;ST18;NKX6-2;AK5;S100A1;CYB5R2;GREM1;EMX2;GPR37
7185,GO:0030163,0.978490309225332,0.0759074085914548,2,861,protein catabolic process,BP,LRP2;SNCA
8617,GO:0032787,0.978537033123902,0.105796542380067,1,581,monocarboxylic acid metabolic process,BP,CBR1
362,GO:0000976,0.97927731593764,0.0555090532741247,4,1345,transcription regulatory region sequence-specific DNA binding,MF,SNCA;ST18;NKX6-2;EMX2
384,GO:0001067,0.979381852076495,0.0552674638076293,4,1346,regulatory region nucleic acid binding,MF,SNCA;ST18;NKX6-2;EMX2
8677,GO:0032880,0.979840690056247,0.0719371280567164,2,869,regulation of protein localization,BP,CD22;VSNL1
10998,GO:0043043,0.98165756313203,0.093421398832698,1,606,peptide biosynthetic process,BP,CARNS1
5442,GO:0015630,0.981753692608758,0.0556182961370822,3,1135,microtubule cytoskeleton,CC,DCX;AK5;TPPP3
289,GO:0000790,0.981894000668858,0.0552529285297626,3,1142,nuclear chromatin,CC,ST18;NKX6-2;EMX2
6527,GO:0019438,0.981997170466,0.0329785440616201,16,3714,aromatic compound biosynthetic process,BP,CAMK2A;MOXD1;TF;FGF1;PADI2;SPP1;GDA;MYRF;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2;GPR37
11585,GO:0044403,0.982500648737116,0.0639478946670224,2,900,symbiotic process,BP,PDGFRA;MOG
1609,GO:0003700,0.982690798128313,0.0475107671533167,4,1382,DNA-binding transcription factor activity,MF,MYRF;ST18;NKX6-2;EMX2
4271,GO:0009058,0.983162148422927,0.0285273112516145,26,5463,biosynthetic process,BP,HHATL;MAOB;CAMK2A;SYNJ2;MOXD1;FOLH1;TF;CPNE6;FGF1;PADI2;SPP1;GDA;NECAB1;MYRF;GALNT6;SNCA;ST18;NKX6-2;AK5;CBR1;S100A1;CYB5R2;GREM1;EMX2;GPR37;CARNS1
11503,GO:0044249,0.983524434694282,0.0281152470715277,25,5302,cellular biosynthetic process,BP,HHATL;MAOB;CAMK2A;SYNJ2;MOXD1;FOLH1;TF;CPNE6;FGF1;PADI2;SPP1;GDA;NECAB1;MYRF;GALNT6;SNCA;ST18;NKX6-2;AK5;CBR1;S100A1;GREM1;EMX2;GPR37;CARNS1
3072,GO:0006355,0.985548782717924,0.0287946916711595,12,3038,regulation of transcription, DNA-templated,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
21395,GO:1990837,0.987082720194806,0.0368371375625902,4,1439,sequence-specific double-stranded DNA binding,MF,SNCA;ST18;NKX6-2;EMX2
9838,GO:0035639,0.987184278263644,0.0336686193467914,5,1654,purine ribonucleoside triphosphate binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
19077,GO:1901576,0.987980673625582,0.0210013449407839,25,5395,organic substance biosynthetic process,BP,HHATL;CAMK2A;SYNJ2;MOXD1;FOLH1;TF;CPNE6;FGF1;PADI2;SPP1;GDA;NECAB1;MYRF;GALNT6;SNCA;ST18;NKX6-2;AK5;CBR1;S100A1;CYB5R2;GREM1;EMX2;GPR37;CARNS1
21515,GO:2000112,0.988210000748414,0.023056582140574,14,3462,regulation of cellular macromolecule biosynthetic process,BP,HHATL;CAMK2A;TF;FGF1;PADI2;SPP1;NECAB1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
3074,GO:0006357,0.988249882763026,0.0266842892749171,8,2311,regulation of transcription by RNA polymerase II,BP,FGF1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
19896,GO:1903506,0.98832190338318,0.0237216596427241,12,3092,regulation of nucleic acid-templated transcription,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
22068,GO:2001141,0.988550328380517,0.0232986021379308,12,3097,regulation of RNA biosynthetic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
6698,GO:0019953,0.988989194774468,0.0619650734369435,1,677,sexual reproduction,BP,CLDN11
11332,GO:0043603,0.989028104770829,0.0431967002597379,2,982,cellular amide metabolic process,BP,FOLH1;CARNS1
11507,GO:0044260,0.990152358279344,0.0167149233390804,36,7240,cellular macromolecule metabolic process,BP,HHATL;CAMK2A;LRP2;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
8472,GO:0032555,0.990362678308489,0.02617314964233,5,1712,purine ribonucleotide binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
363,GO:0000977,0.990429027507289,0.0319369098174788,3,1257,RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ST18;NKX6-2;EMX2
1604,GO:0003690,0.990963174115708,0.0269419759927404,4,1508,double-stranded DNA binding,MF,SNCA;ST18;NKX6-2;EMX2
6170,GO:0017076,0.991006186870439,0.0246180144352907,5,1726,purine nucleotide binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
8470,GO:0032553,0.991052362431852,0.0245058761358027,5,1727,ribonucleotide binding,MF,CAMK2A;EPHB6;PDGFRA;AK5;CARNS1
21194,GO:1990234,0.991642697820462,0.0494547425651229,1,717,transferase complex,CC,GPR37
2754,GO:0005815,0.991696236810402,0.0491944630572023,1,716,microtubule organizing center,CC,AK5
4757,GO:0010556,0.991778640060195,0.0165683938948737,14,3554,regulation of macromolecule biosynthetic process,BP,HHATL;CAMK2A;TF;FGF1;PADI2;SPP1;NECAB1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
3181,GO:0006518,0.991988699881458,0.0477630887963605,1,728,peptide metabolic process,BP,CARNS1
11505,GO:0044257,0.99216506213482,0.0468962300400161,1,726,cellular protein catabolic process,BP,LRP2
5998,GO:0016740,0.992388490612619,0.019860069876969,6,1986,transferase activity,MF,HHATL;CAMK2A;EPHB6;PDGFRA;GALNT6;AK5
3068,GO:0006351,0.992394007297331,0.0160358413941541,12,3198,transcription, DNA-templated,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
4270,GO:0009057,0.992529001894128,0.0257518308880784,3,1303,macromolecule catabolic process,BP,LRP2;CHI3L1;SNCA
11333,GO:0043604,0.992556289909563,0.0449553883838404,1,739,amide biosynthetic process,BP,CARNS1
13660,GO:0051276,0.993092282890036,0.0291268248508437,2,1047,chromosome organization,BP,PADI2;SNCA
3081,GO:0006366,0.993449832072458,0.0157465638465577,8,2442,transcription by RNA polymerase II,BP,FGF1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
17701,GO:0097659,0.99366898605076,0.0135542099234339,12,3242,nucleic acid-templated transcription,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
8606,GO:0032774,0.994004110972211,0.0128944604998264,12,3255,RNA biosynthetic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
111,GO:0000228,0.994142838017966,0.0208205710664871,3,1344,nuclear chromosome,CC,ST18;NKX6-2;EMX2
3500,GO:0006974,0.994226014951902,0.0364196790025567,1,771,cellular response to DNA damage stimulus,BP,BOK
9429,GO:0034654,0.99429342510628,0.0118407556314246,14,3647,nucleobase-containing compound biosynthetic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;GDA;MYRF;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2
7768,GO:0031326,0.995046509920986,0.0103917378272465,14,3679,regulation of cellular biosynthetic process,BP,HHATL;CAMK2A;TF;FGF1;PADI2;SPP1;NECAB1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
6269,GO:0018130,0.995490715393866,0.00952823456563084,14,3704,heterocycle biosynthetic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;GDA;MYRF;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2
4720,GO:0010468,0.995698483949282,0.00870646493699025,17,4265,regulation of gene expression,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;PDGFRA;MOG;SNCA;ST18;NKX6-2;ICOSLG;S100A1;GREM1;EMX2;CNTN2;MBP
19001,GO:1901360,0.995828491085838,0.00795756321489772,23,5341,organic cyclic compound metabolic process,BP,MAOB;CAMK2A;MOXD1;LRP2;FOLH1;TF;FGF1;PADI2;SPP1;GDA;MYRF;PDGFRA;ENPP2;SNCA;ST18;NKX6-2;AK5;S100A1;CYB5R2;GREM1;EMX2;GPR37;CARNS1
13643,GO:0051252,0.99589289518455,0.00910584174936754,12,3341,regulation of RNA metabolic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
19679,GO:1903047,0.995938580245129,0.0271303604966947,1,820,mitotic cell cycle process,BP,CAMK2A
3012,GO:0006259,0.995946713777147,0.0270844000247976,1,823,DNA metabolic process,BP,GREM1
3858,GO:0008104,0.995949861726273,0.0101731446082583,8,2541,protein localization,BP,CD22;LRP2;TF;PACSIN1;VSNL1;MAL;CNTN2;RYR2
4580,GO:0009889,0.996391845247057,0.00775337611991931,14,3754,regulation of biosynthetic process,BP,HHATL;CAMK2A;TF;FGF1;PADI2;SPP1;NECAB1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
4803,GO:0010629,0.996891651860095,0.00951915364086906,5,1945,negative regulation of gene expression,BP,SNCA;NKX6-2;S100A1;GREM1;EMX2
1596,GO:0003677,0.997057803243897,0.00843144395687861,6,2178,DNA binding,MF,MYRF;SNCA;ST18;NKX6-2;EMX2;SERPINA3
11101,GO:0043229,0.997194931551773,0.0052139823529549,59,10994,intracellular organelle,CC,GAS7;HHATL;CD22;CLDN11;MAOB;CAMK2A;DCX;SYNJ2;MOXD1;LRP2;TF;CPNE6;NEFM;SLC17A7;ADAP1;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ERMN;GALNT6;SNCA;CXCL14;ST18;NKX6-2;AK5;NRGN;CSRP1;TPPP3;ICOSLG;S100A1;SERPINI1;HHIP;CYB5R2;KLK6;MOBP;LGI3;EMX2;GPR37;SYNPO;MAL;BOK;GPR62;AIFM3;SV2B;SERPINA3;OPALIN;MBP;LPAR1;RYR2;TMEM235;MEX3A
11098,GO:0043226,0.997337444617513,0.00509740751680112,65,11824,organelle,CC,GAS7;HHATL;CD22;CLDN11;BCAS1;MAOB;CAMK2A;DCX;SYNJ2;MOXD1;LRP2;FOLH1;TF;CPNE6;NEFM;SLC17A7;ADAP1;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ERMN;GALNT6;SNCA;CXCL14;ST18;SLC39A12;NKX6-2;AK5;NRGN;CSRP1;CBR1;TPPP3;ICOSLG;S100A1;SERPINI1;HHIP;CYB5R2;KLK6;MOBP;LGI3;GJB1;EMX2;GPR37;SYNPO;MAL;BOK;GPR62;AIFM3;SV2B;SERPINA3;OPALIN;MBP;LPAR1;RYR2;GRM3;TMEM235;MEX3A
2684,GO:0005694,0.997372676941858,0.0089941387227113,4,1735,chromosome,CC,PADI2;ST18;NKX6-2;EMX2
8785,GO:0033036,0.997541057448615,0.00619720134701936,9,2853,macromolecule localization,BP,CD22;LRP2;TF;SPP1;PACSIN1;VSNL1;MAL;CNTN2;RYR2
11497,GO:0044238,0.997592925449718,0.00441854255009836,45,9012,primary metabolic process,BP,HHATL;MAOB;CAMK2A;SYNJ2;LRP2;FOLH1;TF;CPNE6;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;NKX6-2;CNDP1;AK5;CBR1;S100A1;SERPINI1;CYB5R2;GREM1;PPP1R14A;KLK6;EMX2;GPR37;RCAN2;CARNS1;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
1617,GO:0003723,0.997643970771512,0.0093199873781608,3,1507,RNA binding,MF,SYNJ2;CSRP1;MEX3A
8938,GO:0033365,0.997664224987416,0.0169768746395122,1,903,protein localization to organelle,BP,RYR2
16353,GO:0071704,0.99794800576139,0.00380559102160521,48,9498,organic substance metabolic process,BP,HHATL;MAOB;CAMK2A;SYNJ2;MOXD1;LRP2;FOLH1;TF;CPNE6;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;MOG;GALNT6;SNCA;ST18;NKX6-2;CNDP1;AK5;CBR1;ICOSLG;S100A1;SERPINI1;CYB5R2;GREM1;PPP1R14A;KLK6;EMX2;GPR37;RCAN2;CARNS1;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
11513,GO:0044271,0.998147452956892,0.00403413391558023,16,4289,cellular nitrogen compound biosynthetic process,BP,CAMK2A;MOXD1;TF;FGF1;PADI2;SPP1;GDA;MYRF;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2;CARNS1
3396,GO:0006807,0.998237147479984,0.003300173348325,42,8631,nitrogen compound metabolic process,BP,HHATL;MAOB;CAMK2A;MOXD1;LRP2;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;NKX6-2;CNDP1;AK5;S100A1;SERPINI1;GREM1;PPP1R14A;KLK6;EMX2;GPR37;RCAN2;CARNS1;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
18544,GO:0140110,0.998247702250041,0.00624989765098099,4,1809,transcription regulator activity,MF,MYRF;ST18;NKX6-2;EMX2
5254,GO:0015031,0.998301669848934,0.00607618354102631,4,1814,protein transport,BP,CD22;LRP2;TF;VSNL1
9401,GO:0034613,0.998406335861017,0.00573751197244462,4,1825,cellular protein localization,BP,PACSIN1;MAL;CNTN2;RYR2
133,GO:0000278,0.998414025884952,0.0121832807586195,1,956,mitotic cell cycle,BP,CAMK2A
15799,GO:0070727,0.998484867830498,0.00548180173994939,4,1834,cellular macromolecule localization,BP,PACSIN1;MAL;CNTN2;RYR2
6450,GO:0019219,0.998519947448386,0.00354234140338286,12,3567,regulation of nucleobase-containing compound metabolic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
5543,GO:0015833,0.998622878054484,0.00502886377227144,4,1851,peptide transport,BP,CD22;LRP2;TF;VSNL1
10918,GO:0042886,0.998846273592123,0.00428503152724368,4,1882,amide transport,BP,CD22;LRP2;TF;VSNL1
11062,GO:0043170,0.998880572616833,0.00215820382974848,39,8271,macromolecule metabolic process,BP,HHATL;CAMK2A;LRP2;FOLH1;TF;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;MOG;GALNT6;SNCA;ST18;NKX6-2;CNDP1;ICOSLG;S100A1;SERPINI1;GREM1;PPP1R14A;KLK6;EMX2;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
8754,GO:0032991,0.998883611268792,0.00247531252705956,17,4582,protein-containing complex,CC,CAMK2A;DCX;LRP2;TF;EPHB6;RGS4;PDGFRA;TESPA1;SNCA;ST18;S100A1;GJB1;GPR37;GPR62;MBP;RYR2;FXYD1
3350,GO:0006725,0.998998700010283,0.00215105642992054,20,5156,cellular aromatic compound metabolic process,BP,MAOB;CAMK2A;MOXD1;FOLH1;TF;FGF1;PADI2;SPP1;GDA;MYRF;ENPP2;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2;GPR37;CARNS1
3889,GO:0008152,0.99912278703554,0.00171189233774079,50,9980,metabolic process,BP,HHATL;MAOB;CAMK2A;SYNJ2;MOXD1;LRP2;FOLH1;TF;CPNE6;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;MOG;GALNT6;SNCA;ST18;NKX6-2;CNDP1;AK5;CBR1;ICOSLG;S100A1;SERPINI1;CYB5R2;GREM1;PPP1R14A;KLK6;EMX2;GPR37;RCAN2;CARNS1;BOK;S1PR5;AIFM3;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
11099,GO:0043227,0.999142162502635,0.00170321292946615,57,10968,membrane-bounded organelle,CC,HHATL;CD22;BCAS1;MAOB;CAMK2A;MOXD1;LRP2;FOLH1;TF;CPNE6;SLC17A7;ADAP1;RARRES2;FGF1;PADI2;RGS4;SPP1;NECAB1;PACSIN1;MYRF;CHI3L1;PDGFRA;TESPA1;ERMN;GALNT6;SNCA;CXCL14;ST18;SLC39A12;NKX6-2;NRGN;CSRP1;CBR1;ICOSLG;S100A1;SERPINI1;HHIP;CYB5R2;KLK6;MOBP;LGI3;GJB1;EMX2;GPR37;SYNPO;MAL;BOK;GPR62;AIFM3;SV2B;SERPINA3;OPALIN;MBP;LPAR1;RYR2;TMEM235;MEX3A
1595,GO:0003676,0.999246755740237,0.0019420649159273,11,3512,nucleic acid binding,MF,SYNJ2;MYRF;ENPP2;SNCA;ST18;NKX6-2;CSRP1;EMX2;RCAN2;SERPINA3;MEX3A
9422,GO:0034645,0.999345824484066,0.0015505468522156,15,4326,cellular macromolecule biosynthetic process,BP,HHATL;CAMK2A;TF;FGF1;PADI2;SPP1;NECAB1;MYRF;GALNT6;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
11510,GO:0044265,0.999380271993977,0.00538698862992187,1,1094,cellular macromolecule catabolic process,BP,LRP2
4719,GO:0010467,0.999412049135934,0.00131947079632809,19,5091,gene expression,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;CHI3L1;PDGFRA;MOG;SNCA;ST18;NKX6-2;ICOSLG;S100A1;GREM1;KLK6;EMX2;CNTN2;MBP
17461,GO:0097159,0.999512706176579,0.00109231223018674,20,5302,organic cyclic compound binding,MF,MAOB;CAMK2A;SYNJ2;EPHB6;MYRF;PDGFRA;ENPP2;SNCA;ST18;NKX6-2;AK5;CSRP1;CYB5R2;EMX2;RCAN2;CARNS1;AIFM3;SERPINA3;RYR2;MEX3A
4272,GO:0009059,0.999624235790557,0.000921531017347042,15,4441,macromolecule biosynthetic process,BP,HHATL;CAMK2A;TF;FGF1;PADI2;SPP1;NECAB1;MYRF;GALNT6;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
11496,GO:0044237,0.99966533031607,0.0006854346213098,44,9298,cellular metabolic process,BP,HHATL;MAOB;CAMK2A;SYNJ2;MOXD1;LRP2;FOLH1;TF;CPNE6;EPHB6;RARRES2;FGF1;PADI2;RGS4;SPP1;GDA;NECAB1;MYRF;CHI3L1;PDGFRA;ENPP2;GALNT6;SNCA;ST18;NKX6-2;CNDP1;AK5;CBR1;S100A1;SERPINI1;GREM1;PPP1R14A;EMX2;GPR37;RCAN2;CARNS1;BOK;CNTN2;CCK;SPOCK3;SERPINA3;MBP;LPAR1;FXYD1
19004,GO:1901363,0.999711001247508,0.000675559521073707,19,5231,heterocyclic compound binding,MF,MAOB;CAMK2A;SYNJ2;EPHB6;MYRF;PDGFRA;ENPP2;SNCA;ST18;NKX6-2;AK5;CSRP1;CYB5R2;EMX2;RCAN2;CARNS1;AIFM3;SERPINA3;MEX3A
7008,GO:0022402,0.999784052827407,0.00212448216948525,1,1239,cell cycle process,BP,CAMK2A
19436,GO:1902494,0.999823486730554,0.00177542707078061,1,1272,catalytic complex,CC,GPR37
9419,GO:0034641,0.999880198788437,0.000289991346695526,20,5606,cellular nitrogen compound metabolic process,BP,MAOB;CAMK2A;MOXD1;FOLH1;TF;FGF1;PADI2;SPP1;GDA;MYRF;ENPP2;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2;GPR37;CARNS1
5660,GO:0016070,0.999896888145689,0.000292775209159555,12,4103,RNA metabolic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
12365,GO:0046483,0.999913596304713,0.000222156510646477,17,5114,heterocycle metabolic process,BP,CAMK2A;FOLH1;TF;FGF1;PADI2;SPP1;GDA;MYRF;ENPP2;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2;CARNS1
17207,GO:0090304,0.999969722976668,8.95105955656734e-05,13,4529,nucleic acid metabolic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;MYRF;ENPP2;SNCA;ST18;NKX6-2;S100A1;GREM1;EMX2
2643,GO:0005634,0.999970599667016,7.30823773594402e-05,24,6572,nucleus,CC,CAMK2A;ADAP1;FGF1;PADI2;RGS4;NECAB1;MYRF;PDGFRA;TESPA1;SNCA;ST18;NKX6-2;NRGN;CSRP1;S100A1;HHIP;CYB5R2;KLK6;EMX2;SYNPO;BOK;SERPINA3;MBP;MEX3A
2953,GO:0006139,0.999975674203976,6.93552384153837e-05,15,4966,nucleobase-containing compound metabolic process,BP,CAMK2A;TF;FGF1;PADI2;SPP1;GDA;MYRF;ENPP2;SNCA;ST18;NKX6-2;AK5;S100A1;GREM1;EMX2
8101,GO:0031974,0.999985991604669,3.94700294529667e-05,17,5447,membrane-enclosed lumen,CC,CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ST18;NKX6-2;SERPINI1;KLK6;EMX2;SERPINA3
11105,GO:0043233,0.999985991604669,3.94700294529667e-05,17,5447,organelle lumen,CC,CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ST18;NKX6-2;SERPINI1;KLK6;EMX2;SERPINA3
15398,GO:0070013,0.999985991604669,3.94700294529667e-05,17,5447,intracellular organelle lumen,CC,CAMK2A;LRP2;TF;RARRES2;FGF1;PADI2;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;ST18;NKX6-2;SERPINI1;KLK6;EMX2;SERPINA3
3547,GO:0007049,0.999989410175095,0.000139591215783198,1,1658,cell cycle,BP,CAMK2A
11103,GO:0043231,0.999998875009347,2.98584842917526e-06,39,9529,intracellular membrane-bounded organelle,CC,HHATL;MAOB;CAMK2A;LRP2;TF;ADAP1;FGF1;PADI2;RGS4;SPP1;NECAB1;MYRF;CHI3L1;PDGFRA;TESPA1;GALNT6;SNCA;CXCL14;ST18;NKX6-2;NRGN;CSRP1;S100A1;HHIP;CYB5R2;KLK6;MOBP;EMX2;GPR37;SYNPO;MAL;BOK;AIFM3;SERPINA3;OPALIN;MBP;RYR2;TMEM235;MEX3A
8103,GO:0031981,0.999999754208612,1.06894232192641e-06,9,4451,nuclear lumen,CC,CAMK2A;FGF1;NECAB1;MYRF;PDGFRA;ST18;NKX6-2;KLK6;EMX2
2653,GO:0005654,0.999999927355839,4.55005674775774e-07,5,3641,nucleoplasm,CC,CAMK2A;FGF1;NECAB1;MYRF;PDGFRA
16201,GO:0071475,0.999999999999987,0.955696599336766,0,7,cellular hyperosmotic salinity response,BP,
8590,GO:0032753,0.999999999999999,0.861824806161291,0,23,positive regulation of interleukin-4 production,BP,
13240,GO:0050482,0.999999999999999,0.867591223176739,0,22,arachidonic acid secretion,BP,
17024,GO:0090042,0.999999999999999,0.91706386342713,0,13,tubulin deacetylation,BP,
20146,GO:1903963,0.999999999999999,0.867591223176739,0,22,arachidonate transport,BP,
4396,GO:0009209,0.999999999999999,0.913978054879386,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
1,GO:0000002,1,0.861032807433604,0,23,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.98720439701892,0,2,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.987186603207118,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.93692858056066,0,10,single strand break repair,BP,
6,GO:0000014,1,0.943056103216429,0,9,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.974634910117989,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000017,1,0.987054398128912,0,2,alpha-glucoside transport,BP,
9,GO:0000018,1,0.580612758927261,0,83,regulation of DNA recombination,BP,
10,GO:0000019,1,0.968070475751709,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.9492980183666,0,8,mitotic spindle elongation,BP,
12,GO:0000023,1,0.980379174951965,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.974284640577058,0,4,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.850681688043151,0,25,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.890761407225876,0,18,ribosomal small subunit assembly,BP,
17,GO:0000032,1,0.993621324578831,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.980934157669076,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.987277208215389,0,2,acyl binding,MF,
20,GO:0000036,1,0.993694965537682,0,1,acyl carrier activity,MF,
21,GO:0000038,1,0.812724214419156,0,32,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.562366494692101,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.980842216261927,0,3,peptidyltransferase activity,MF,
25,GO:0000049,1,0.704606845823161,0,54,tRNA binding,MF,
26,GO:0000050,1,0.931613626308325,0,11,urea cycle,BP,
27,GO:0000052,1,0.948750531761341,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.993617799809031,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.91375155230908,0,14,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.955904658507378,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.949870708841585,0,8,ribosomal small subunit export from nucleus,BP,
32,GO:0000062,1,0.879152290235616,0,20,fatty-acyl-CoA binding,MF,
33,GO:0000064,1,0.967560950553715,0,5,L-ornithine transmembrane transporter activity,MF,
34,GO:0000070,1,0.368922253142145,0,150,mitotic sister chromatid segregation,BP,
35,GO:0000075,1,0.262228539585804,0,204,cell cycle checkpoint,BP,
36,GO:0000076,1,0.901607126644447,0,16,DNA replication checkpoint,BP,
37,GO:0000077,1,0.404890789513325,0,138,DNA damage checkpoint,BP,
38,GO:0000079,1,0.542709156300686,0,94,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
39,GO:0000080,1,0.986954970037953,0,2,mitotic G1 phase,BP,
41,GO:0000083,1,0.802014457996824,0,34,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
42,GO:0000086,1,0.208694080079683,0,239,G2/M transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.993591022606845,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.786203254843981,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.901058447501585,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.913691452164049,0,14,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.961260779449308,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.961678493123969,0,6,sulfur amino acid transport,BP,
49,GO:0000103,1,0.980848340836207,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.974693317822604,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.987142232594978,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.92508201836641,0,12,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.980555763914436,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.993510887635227,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000112,1,0.993557585369194,0,1,nucleotide-excision repair factor 3 complex,CC,
56,GO:0000117,1,0.986952044851129,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000118,1,0.608450888750688,0,75,histone deacetylase complex,CC,
58,GO:0000120,1,0.980981060103186,0,3,RNA polymerase I transcription regulator complex,CC,
59,GO:0000121,1,0.993536670611557,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.612583421720895,0,75,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.948851797284955,0,8,SAGA complex,CC,
63,GO:0000125,1,0.979941320342288,0,3,PCAF complex,CC,
64,GO:0000126,1,0.980100877731077,0,3,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.961650040888691,0,6,transcription factor TFIIIC complex,CC,
66,GO:0000132,1,0.821945181338195,0,30,establishment of mitotic spindle orientation,BP,
67,GO:0000137,1,0.895009495126735,0,17,Golgi cis cisterna,CC,
68,GO:0000138,1,0.943622796475574,0,9,Golgi trans cisterna,CC,
70,GO:0000145,1,0.906670055144359,0,15,exocyst,CC,
71,GO:0000146,1,0.838584969505542,0,26,microfilament motor activity,MF,
73,GO:0000150,1,0.987218640787344,0,2,recombinase activity,MF,
75,GO:0000152,1,0.770623711326217,0,40,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.925402478318663,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.819239976121325,0,31,rRNA modification,BP,
78,GO:0000159,1,0.895508701081248,0,17,protein phosphatase type 2A complex,CC,
79,GO:0000160,1,0.993505885401324,0,1,phosphorelay signal transduction system,BP,
80,GO:0000164,1,0.912990272289648,0,14,protein phosphatase type 1 complex,CC,
83,GO:0000170,1,0.993646113025072,0,1,sphingosine hydroxylase activity,MF,
84,GO:0000171,1,0.980802127940013,0,3,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.949841102575873,0,8,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.993629600759913,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000175,1,0.796258873106249,0,35,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.908246233470595,0,15,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.913505244102519,0,14,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.861826284642322,0,23,exosome (RNase complex),CC,
91,GO:0000179,1,0.974631162923696,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.960945009051763,0,6,rDNA binding,MF,
93,GO:0000183,1,0.930278709661242,0,11,rDNA heterochromatin assembly,BP,
94,GO:0000184,1,0.471086064371007,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
95,GO:0000185,1,0.925289931605768,0,12,activation of MAPKKK activity,BP,
96,GO:0000186,1,0.724497285588247,0,49,activation of MAPKK activity,BP,
99,GO:0000209,1,0.122476818744979,0,319,protein polyubiquitination,BP,
100,GO:0000210,1,0.993517783031319,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000212,1,0.935587467752785,0,10,meiotic spindle organization,BP,
102,GO:0000213,1,0.987226530090558,0,2,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.974660682963245,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.987269811176736,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.806220950336165,0,33,DNA secondary structure binding,MF,
106,GO:0000220,1,0.974126011259724,0,4,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
107,GO:0000221,1,0.980619585377213,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000224,1,0.993571099749995,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.993662705067476,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000229,1,0.993666014346836,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.930559973218667,0,11,astral microtubule,CC,
114,GO:0000242,1,0.875635769386595,0,20,pericentriolar material,CC,
115,GO:0000243,1,0.968430316576174,0,5,commitment complex,CC,
116,GO:0000244,1,0.919008321836495,0,13,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.690505275794446,0,57,spliceosomal complex assembly,BP,
118,GO:0000246,1,0.993471017392034,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.993662572637293,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.987060899597149,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.993473098184963,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.993632977628268,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.981077635191997,0,3,3-keto sterol reductase activity,MF,
124,GO:0000254,1,0.980884162256979,0,3,C-4 methylsterol oxidase activity,MF,
125,GO:0000255,1,0.993643051019443,0,1,allantoin metabolic process,BP,
126,GO:0000256,1,0.993643051019443,0,1,allantoin catabolic process,BP,
127,GO:0000257,1,0.993648706748903,0,1,nitrilase activity,MF,
128,GO:0000266,1,0.784277366971863,0,37,mitochondrial fission,BP,
129,GO:0000268,1,0.968192491514469,0,5,peroxisome targeting sequence binding,MF,
130,GO:0000270,1,0.987389152388252,0,2,peptidoglycan metabolic process,BP,
131,GO:0000271,1,0.626224720828967,0,71,polysaccharide biosynthetic process,BP,
132,GO:0000272,1,0.854174815357332,0,24,polysaccharide catabolic process,BP,
134,GO:0000280,1,0.0817477711347394,0,377,nuclear division,BP,
135,GO:0000281,1,0.632031418202208,0,70,mitotic cytokinesis,BP,
136,GO:0000285,1,0.993336822914568,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
138,GO:0000288,1,0.640395790857932,0,68,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
139,GO:0000289,1,0.830697204258334,0,28,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000290,1,0.949182745428163,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.802390739304823,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.974394624918282,0,4,ferric-chelate reductase activity,MF,
143,GO:0000294,1,0.986992255930929,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
144,GO:0000295,1,0.834430066148436,0,28,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000296,1,0.987117332827918,0,2,spermine transport,BP,
146,GO:0000298,1,0.974515979575416,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.987137940243947,0,2,retrograde transport, vesicle recycling within Golgi,BP,
149,GO:0000303,1,0.845450006874846,0,26,response to superoxide,BP,
150,GO:0000304,1,0.993601019692098,0,1,response to singlet oxygen,BP,
151,GO:0000305,1,0.840036585036891,0,27,response to oxygen radical,BP,
152,GO:0000306,1,0.974224053243442,0,4,extrinsic component of vacuolar membrane,CC,
153,GO:0000307,1,0.761186369005665,0,42,cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000308,1,0.986956891634592,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000309,1,0.980617076450822,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
156,GO:0000313,1,0.584412612556091,0,84,organellar ribosome,CC,
157,GO:0000314,1,0.841850190815446,0,27,organellar small ribosomal subunit,CC,
158,GO:0000315,1,0.70357407583456,0,55,organellar large ribosomal subunit,CC,
159,GO:0000320,1,0.98698377623401,0,2,re-entry into mitotic cell cycle,BP,
160,GO:0000322,1,0.9872821770154,0,2,storage vacuole,CC,
162,GO:0000333,1,0.993488969734737,0,1,telomerase catalytic core complex,CC,
163,GO:0000334,1,0.993653755290593,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
164,GO:0000338,1,0.937819644970263,0,10,protein deneddylation,BP,
165,GO:0000339,1,0.895271775168532,0,17,RNA cap binding,MF,
166,GO:0000340,1,0.936752506004638,0,10,RNA 7-methylguanosine cap binding,MF,
167,GO:0000346,1,0.91951719751911,0,13,transcription export complex,CC,
168,GO:0000347,1,0.962078966832256,0,6,THO complex,CC,
169,GO:0000349,1,0.987187053368449,0,2,generation of catalytic spliceosome for first transesterification step,BP,
170,GO:0000350,1,0.987287930723187,0,2,generation of catalytic spliceosome for second transesterification step,BP,
171,GO:0000354,1,0.986797829310697,0,2,cis assembly of pre-catalytic spliceosome,BP,
172,GO:0000375,1,0.109988224593234,0,337,RNA splicing, via transesterification reactions,BP,
173,GO:0000377,1,0.112177294462104,0,334,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
174,GO:0000378,1,0.99355705431691,0,1,RNA exon ligation,BP,
175,GO:0000379,1,0.980917059135589,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.588856672549432,0,81,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.632613925930935,0,70,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000386,1,0.993513466388152,0,1,second spliceosomal transesterification activity,MF,
179,GO:0000387,1,0.777631627523985,0,39,spliceosomal snRNP assembly,BP,
180,GO:0000388,1,0.993225483977883,0,1,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),BP,
181,GO:0000389,1,0.961892308968919,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.98706701127485,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.96803187525185,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.908151806888316,0,15,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.962014718370406,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.112177294462104,0,334,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.894943126113919,0,17,four-way junction DNA binding,MF,
188,GO:0000403,1,0.967675551608767,0,5,Y-form DNA binding,MF,
189,GO:0000404,1,0.993510887635227,0,1,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.948935504839737,0,8,bubble DNA binding,MF,
191,GO:0000406,1,0.987107217372573,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.821797131271583,0,30,phagophore assembly site,CC,
193,GO:0000408,1,0.968454793188497,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.993256080942762,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.993256080942762,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000413,1,0.802823129048679,0,34,protein peptidyl-prolyl isomerization,BP,
197,GO:0000414,1,0.96063018428165,0,6,regulation of histone H3-K36 methylation,BP,
198,GO:0000415,1,0.993303460964053,0,1,negative regulation of histone H3-K36 methylation,BP,
199,GO:0000416,1,0.980562658895032,0,3,positive regulation of histone H3-K36 methylation,BP,
200,GO:0000417,1,0.993487343418766,0,1,HIR complex,CC,
201,GO:0000421,1,0.797062713947085,0,35,autophagosome membrane,CC,
202,GO:0000422,1,0.611022039876152,0,75,autophagy of mitochondrion,BP,
203,GO:0000423,1,0.858317967368673,0,23,mitophagy,BP,
204,GO:0000428,1,0.532089196787966,0,97,DNA-directed RNA polymerase complex,CC,
205,GO:0000429,1,0.974335877271517,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
206,GO:0000430,1,0.980952610276343,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000431,1,0.993256080942762,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000432,1,0.980952610276343,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000435,1,0.993256080942762,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000436,1,0.974335877271517,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
211,GO:0000438,1,0.980992796658017,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
212,GO:0000439,1,0.93149222042977,0,11,transcription factor TFIIH core complex,CC,
213,GO:0000444,1,0.973720105106374,0,4,MIS12/MIND type complex,CC,
214,GO:0000445,1,0.962078966832256,0,6,THO complex part of transcription export complex,CC,
215,GO:0000447,1,0.937291752639316,0,10,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000448,1,0.993273094241019,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000451,1,0.993513305733971,0,1,rRNA 2'-O-methylation,BP,
218,GO:0000453,1,0.993513305733971,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
219,GO:0000454,1,0.981107860753867,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
220,GO:0000455,1,0.96218412231476,0,6,enzyme-directed rRNA pseudouridine synthesis,BP,
221,GO:0000459,1,0.943836329460124,0,9,exonucleolytic trimming involved in rRNA processing,BP,
222,GO:0000460,1,0.801357111530918,0,34,maturation of 5.8S rRNA,BP,
223,GO:0000461,1,0.993712571412695,0,1,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000462,1,0.796941329300729,0,35,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000463,1,0.918703063547034,0,13,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000466,1,0.85563033361023,0,24,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000467,1,0.943836329460124,0,9,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000469,1,0.839411475854909,0,27,cleavage involved in rRNA processing,BP,
229,GO:0000470,1,0.850227749302756,0,25,maturation of LSU-rRNA,BP,
230,GO:0000472,1,0.967736283631542,0,5,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000478,1,0.906675422155475,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
232,GO:0000479,1,0.906675422155475,0,15,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000480,1,0.949153736913245,0,8,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000481,1,0.993511049357984,0,1,maturation of 5S rRNA,BP,
235,GO:0000491,1,0.949719349500309,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
236,GO:0000492,1,0.962024134832101,0,6,box C/D snoRNP assembly,BP,
237,GO:0000493,1,0.987214403593921,0,2,box H/ACA snoRNP assembly,BP,
238,GO:0000494,1,0.987292887275975,0,2,box C/D snoRNA 3'-end processing,BP,
239,GO:0000495,1,0.987150734602301,0,2,box H/ACA snoRNA 3'-end processing,BP,
240,GO:0000502,1,0.684126121574848,0,59,proteasome complex,CC,
241,GO:0000506,1,0.950003107114329,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
242,GO:0000578,1,0.795506282350805,0,35,embryonic axis specification,BP,
243,GO:0000700,1,0.974615659962818,0,4,mismatch base pair DNA N-glycosylase activity,MF,
244,GO:0000701,1,0.987307254564107,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.974771742287326,0,4,oxidized base lesion DNA N-glycosylase activity,MF,
246,GO:0000703,1,0.987343277976458,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
247,GO:0000706,1,0.980689201558711,0,3,meiotic DNA double-strand break processing,BP,
248,GO:0000707,1,0.98727443599786,0,2,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.974258099225041,0,4,meiotic mismatch repair,BP,
250,GO:0000711,1,0.993645081598082,0,1,meiotic DNA repair synthesis,BP,
251,GO:0000712,1,0.912640455763597,0,14,resolution of meiotic recombination intermediates,BP,
252,GO:0000715,1,0.862264121432263,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.867359658023643,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.993624477263957,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.974435679596057,0,4,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000721,1,0.99357166287299,0,1,(R,R)-butanediol dehydrogenase activity,MF,
257,GO:0000722,1,0.917512981970063,0,13,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.401405231041676,0,139,telomere maintenance,BP,
259,GO:0000724,1,0.442796487763659,0,124,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.439920313039206,0,125,recombinational repair,BP,
261,GO:0000726,1,0.615071511325376,0,74,non-recombinational repair,BP,
262,GO:0000727,1,0.925298207635047,0,12,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.865907565497341,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.962136842821306,0,6,DNA recombinase assembly,BP,
265,GO:0000731,1,0.736327443663438,0,47,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.993451019811716,0,1,strand displacement,BP,
267,GO:0000733,1,0.949254956994721,0,8,DNA strand renaturation,BP,
268,GO:0000735,1,0.993446699710237,0,1,removal of nonhomologous ends,BP,
269,GO:0000737,1,0.823158062666506,0,30,DNA catabolic process, endonucleolytic,BP,
270,GO:0000738,1,0.949833735856636,0,8,DNA catabolic process, exonucleolytic,BP,
271,GO:0000741,1,0.993623136143205,0,1,karyogamy,BP,
272,GO:0000768,1,0.744668435756171,0,45,syncytium formation by plasma membrane fusion,BP,
273,GO:0000773,1,0.993673285249299,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
274,GO:0000774,1,0.93744173875721,0,10,adenyl-nucleotide exchange factor activity,MF,
275,GO:0000775,1,0.306655362342268,0,180,chromosome, centromeric region,CC,
276,GO:0000776,1,0.438104908041266,0,126,kinetochore,CC,
277,GO:0000777,1,0.537944970766889,0,95,condensed chromosome kinetochore,CC,
278,GO:0000778,1,0.896309632393526,0,17,condensed nuclear chromosome kinetochore,CC,
279,GO:0000779,1,0.490621865868871,0,109,condensed chromosome, centromeric region,CC,
280,GO:0000780,1,0.834059692303856,0,28,condensed nuclear chromosome, centromeric region,CC,
281,GO:0000781,1,0.425791871963332,0,130,chromosome, telomeric region,CC,
282,GO:0000782,1,0.931325849007993,0,11,telomere cap complex,CC,
283,GO:0000783,1,0.931325849007993,0,11,nuclear telomere cap complex,CC,
284,GO:0000784,1,0.52927216121497,0,97,nuclear chromosome, telomeric region,CC,
286,GO:0000786,1,0.936753670288426,0,10,nucleosome,CC,
287,GO:0000788,1,0.980637809688728,0,3,nuclear nucleosome,CC,
288,GO:0000789,1,0.993666014346836,0,1,cytoplasmic chromatin,CC,
290,GO:0000791,1,0.811814598957161,0,32,euchromatin,CC,
291,GO:0000792,1,0.640454002454004,0,68,heterochromatin,CC,
292,GO:0000793,1,0.287540539617591,0,188,condensed chromosome,CC,
293,GO:0000794,1,0.570246042698714,0,84,condensed nuclear chromosome,CC,
294,GO:0000795,1,0.811980820706309,0,32,synaptonemal complex,CC,
295,GO:0000796,1,0.948728299582656,0,8,condensin complex,CC,
296,GO:0000797,1,0.980299274839601,0,3,condensin core heterodimer,CC,
297,GO:0000798,1,0.968073347099992,0,5,nuclear cohesin complex,CC,
298,GO:0000799,1,0.973913519321566,0,4,nuclear condensin complex,CC,
299,GO:0000800,1,0.918106580589811,0,13,lateral element,CC,
300,GO:0000801,1,0.96206416657046,0,6,central element,CC,
301,GO:0000803,1,0.86010798032411,0,23,sex chromosome,CC,
302,GO:0000805,1,0.960890419837076,0,6,X chromosome,CC,
303,GO:0000806,1,0.987039629192411,0,2,Y chromosome,CC,
304,GO:0000808,1,0.943454310642962,0,9,origin recognition complex,CC,
305,GO:0000811,1,0.980810581580665,0,3,GINS complex,CC,
306,GO:0000812,1,0.923561742818478,0,12,Swr1 complex,CC,
307,GO:0000813,1,0.937550643653381,0,10,ESCRT I complex,CC,
308,GO:0000814,1,0.980907892619504,0,3,ESCRT II complex,CC,
309,GO:0000815,1,0.937759022953879,0,10,ESCRT III complex,CC,
310,GO:0000818,1,0.98095154240805,0,3,nuclear MIS12/MIND complex,CC,
311,GO:0000819,1,0.312963666229574,0,175,sister chromatid segregation,BP,
312,GO:0000820,1,0.954839923030187,0,7,regulation of glutamine family amino acid metabolic process,BP,
313,GO:0000821,1,0.980406570322742,0,3,regulation of arginine metabolic process,BP,
314,GO:0000822,1,0.979862454656479,0,3,inositol hexakisphosphate binding,MF,
315,GO:0000823,1,0.993619982067935,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
316,GO:0000824,1,0.993619982067935,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
317,GO:0000825,1,0.987190958198118,0,2,inositol tetrakisphosphate 6-kinase activity,MF,
318,GO:0000827,1,0.974043538662841,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
319,GO:0000828,1,0.949067152522421,0,8,inositol hexakisphosphate kinase activity,MF,
320,GO:0000829,1,0.986804556961798,0,2,inositol heptakisphosphate kinase activity,MF,
321,GO:0000831,1,0.993557585369194,0,1,inositol hexakisphosphate 6-kinase activity,MF,
322,GO:0000832,1,0.96785745525346,0,5,inositol hexakisphosphate 5-kinase activity,MF,
323,GO:0000835,1,0.949512571414469,0,8,ER ubiquitin ligase complex,CC,
324,GO:0000836,1,0.949512571414469,0,8,Hrd1p ubiquitin ligase complex,CC,
325,GO:0000839,1,0.955672276531053,0,7,Hrd1p ubiquitin ligase ERAD-L complex,CC,
326,GO:0000900,1,0.906531043840459,0,15,translation repressor activity, mRNA regulatory element binding,MF,
329,GO:0000910,1,0.387743957464626,0,144,cytokinesis,BP,
330,GO:0000912,1,0.961559288844389,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
331,GO:0000915,1,0.961559288844389,0,6,actomyosin contractile ring assembly,BP,
332,GO:0000916,1,0.993594119272403,0,1,actomyosin contractile ring contraction,BP,
333,GO:0000917,1,0.993616288817127,0,1,division septum assembly,BP,
334,GO:0000921,1,0.993435617072509,0,1,septin ring assembly,BP,
335,GO:0000922,1,0.373486072682493,0,150,spindle pole,CC,
336,GO:0000923,1,0.974151134599317,0,4,equatorial microtubule organizing center,CC,
337,GO:0000930,1,0.882847156944287,0,19,gamma-tubulin complex,CC,
338,GO:0000931,1,0.954987084567246,0,7,gamma-tubulin large complex,CC,
340,GO:0000938,1,0.974136678305305,0,4,GARP complex,CC,
341,GO:0000939,1,0.968450301336244,0,5,condensed chromosome inner kinetochore,CC,
342,GO:0000940,1,0.918776803334295,0,13,condensed chromosome outer kinetochore,CC,
343,GO:0000941,1,0.987253659422335,0,2,condensed nuclear chromosome inner kinetochore,CC,
344,GO:0000942,1,0.974548893113956,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.279473136280641,0,196,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.961270853413567,0,6,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.980638784935324,0,3,mitochondrial mRNA catabolic process,BP,
348,GO:0000959,1,0.76087588389024,0,42,mitochondrial RNA metabolic process,BP,
349,GO:0000960,1,0.967571888228064,0,5,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.986878783427207,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.980438965062016,0,3,positive regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000963,1,0.901790180259464,0,16,mitochondrial RNA processing,BP,
353,GO:0000964,1,0.980805347817716,0,3,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.968251724000735,0,5,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.867467497543508,0,22,RNA 5'-end processing,BP,
356,GO:0000967,1,0.967736283631542,0,5,rRNA 5'-end processing,BP,
357,GO:0000968,1,0.99355705431691,0,1,tRNA exon ligation,BP,
358,GO:0000971,1,0.99355705431691,0,1,tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate,BP,
359,GO:0000972,1,0.961930967580805,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000973,1,0.987202184032186,0,2,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
361,GO:0000974,1,0.919420957839221,0,13,Prp19 complex,CC,
365,GO:0000979,1,0.878353401312216,0,20,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000992,1,0.961273838532274,0,6,RNA polymerase III cis-regulatory region sequence-specific DNA binding,MF,
369,GO:0000993,1,0.785674746581434,0,37,RNA polymerase II complex binding,MF,
370,GO:0000994,1,0.993621056111973,0,1,RNA polymerase III core binding,MF,
371,GO:0000995,1,0.968259728641454,0,5,RNA polymerase III general transcription initiation factor activity,MF,
372,GO:0001002,1,0.980115311607788,0,3,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
373,GO:0001003,1,0.980115311607788,0,3,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
374,GO:0001006,1,0.961273838532274,0,6,RNA polymerase III type 3 promoter sequence-specific DNA binding,MF,
375,GO:0001010,1,0.993547743604013,0,1,RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity,MF,
376,GO:0001016,1,0.955205081823871,0,7,RNA polymerase III transcription regulatory region sequence-specific DNA binding,MF,
377,GO:0001018,1,0.980770920190614,0,3,mitochondrial promoter sequence-specific DNA binding,MF,
378,GO:0001025,1,0.979355220106369,0,3,RNA polymerase III general transcription initiation factor binding,MF,
379,GO:0001042,1,0.96763992102113,0,5,RNA polymerase I core binding,MF,
380,GO:0001046,1,0.765947572632157,0,41,core promoter sequence-specific DNA binding,MF,
381,GO:0001054,1,0.986978957235675,0,2,RNA polymerase I activity,MF,
382,GO:0001055,1,0.974455737632354,0,4,RNA polymerase II activity,MF,
383,GO:0001056,1,0.993658962113183,0,1,RNA polymerase III activity,MF,
385,GO:0001069,1,0.986888801331724,0,2,regulatory region RNA binding,MF,
386,GO:0001079,1,0.993596235981754,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
387,GO:0001080,1,0.993596235981754,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
388,GO:0001085,1,0.706715159479697,0,53,RNA polymerase II transcription factor binding,MF,
389,GO:0001091,1,0.883332612618671,0,19,RNA polymerase II general transcription initiation factor binding,MF,
390,GO:0001093,1,0.980180679858473,0,3,TFIIB-class transcription factor binding,MF,
391,GO:0001094,1,0.937069325571732,0,10,TFIID-class transcription factor complex binding,MF,
392,GO:0001096,1,0.987118866166414,0,2,TFIIF-class transcription factor complex binding,MF,
393,GO:0001097,1,0.986893092114016,0,2,TFIIH-class transcription factor complex binding,MF,
394,GO:0001098,1,0.694081224513197,0,56,basal transcription machinery binding,MF,
395,GO:0001099,1,0.694081224513197,0,56,basal RNA polymerase II transcription machinery binding,MF,
396,GO:0001100,1,0.99355705431691,0,1,negative regulation of exit from mitosis,BP,
398,GO:0001102,1,0.749619092409811,0,44,RNA polymerase II activating transcription factor binding,MF,
399,GO:0001103,1,0.795961425867882,0,35,RNA polymerase II repressing transcription factor binding,MF,
400,GO:0001112,1,0.993542147909709,0,1,DNA-templated transcription open complex formation,BP,
401,GO:0001113,1,0.993542147909709,0,1,transcription open complex formation at RNA polymerase II promoter,BP,
402,GO:0001120,1,0.993542147909709,0,1,protein-DNA complex remodeling,BP,
403,GO:0001139,1,0.987278050940416,0,2,RNA polymerase II complex recruiting activity,MF,
404,GO:0001147,1,0.986423287837394,0,2,transcription termination site sequence-specific DNA binding,MF,
405,GO:0001156,1,0.979355220106369,0,3,TFIIIC-class transcription factor complex binding,MF,
408,GO:0001163,1,0.948945645564385,0,8,RNA polymerase I transcription regulatory region sequence-specific DNA binding,MF,
409,GO:0001164,1,0.948945645564385,0,8,RNA polymerase I core promoter sequence-specific DNA binding,MF,
410,GO:0001165,1,0.993450478728299,0,1,RNA polymerase I cis-regulatory region sequence-specific DNA binding,MF,
411,GO:0001172,1,0.986815369506144,0,2,transcription, RNA-templated,BP,
412,GO:0001173,1,0.987278050940416,0,2,DNA-templated transcriptional start site selection,BP,
413,GO:0001174,1,0.987278050940416,0,2,transcriptional start site selection at RNA polymerase II promoter,BP,
414,GO:0001179,1,0.993615482976922,0,1,RNA polymerase I general transcription initiation factor binding,MF,
415,GO:0001181,1,0.973895762101946,0,4,RNA polymerase I general transcription initiation factor activity,MF,
416,GO:0001188,1,0.942883920147713,0,9,RNA polymerase I preinitiation complex assembly,BP,
417,GO:0001192,1,0.993681269441066,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
418,GO:0001193,1,0.993681269441066,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
419,GO:0001216,1,0.0428797171174271,0,475,DNA-binding transcription activator activity,MF,
421,GO:0001221,1,0.72362945410006,0,49,transcription cofactor binding,MF,
422,GO:0001222,1,0.912313482883895,0,14,transcription corepressor binding,MF,
423,GO:0001223,1,0.830300964651945,0,28,transcription coactivator binding,MF,
424,GO:0001224,1,0.947826998576495,0,8,RNA polymerase II transcription cofactor binding,MF,
425,GO:0001225,1,0.960090861990246,0,6,RNA polymerase II transcription coactivator binding,MF,
426,GO:0001226,1,0.98723151911189,0,2,RNA polymerase II transcription corepressor binding,MF,
428,GO:0001228,1,0.0437445090710442,0,472,DNA-binding transcription activator activity, RNA polymerase II-specific,MF,
429,GO:0001300,1,0.987112967954815,0,2,chronological cell aging,BP,
430,GO:0001302,1,0.961775023994108,0,6,replicative cell aging,BP,
431,GO:0001306,1,0.993671303521141,0,1,age-dependent response to oxidative stress,BP,
432,GO:0001315,1,0.993671303521141,0,1,age-dependent response to reactive oxygen species,BP,
433,GO:0001325,1,0.912766743034244,0,14,formation of extrachromosomal circular DNA,BP,
434,GO:0001401,1,0.931418222240233,0,11,SAM complex,CC,
435,GO:0001405,1,0.968287404243352,0,5,PAM complex, Tim23 associated import motor,CC,
437,GO:0001502,1,0.893601612265291,0,17,cartilage condensation,BP,
441,GO:0001507,1,0.9871526581065,0,2,acetylcholine catabolic process in synaptic cleft,BP,
443,GO:0001510,1,0.639018355639519,0,69,RNA methylation,BP,
444,GO:0001512,1,0.993663499552189,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
445,GO:0001514,1,0.949140853421835,0,8,selenocysteine incorporation,BP,
446,GO:0001515,1,0.974733458561985,0,4,opioid peptide activity,MF,
448,GO:0001517,1,0.961358172248675,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
449,GO:0001518,1,0.890934916655901,0,17,voltage-gated sodium channel complex,CC,
450,GO:0001519,1,0.99350481307262,0,1,peptide amidation,BP,
451,GO:0001520,1,0.980632364842705,0,3,outer dense fiber,CC,
452,GO:0001522,1,0.890830300736215,0,18,pseudouridine synthesis,BP,
455,GO:0001527,1,0.935511117995663,0,10,microfibril,CC,
456,GO:0001530,1,0.851430983281981,0,25,lipopolysaccharide binding,MF,
457,GO:0001532,1,0.993529525184795,0,1,interleukin-21 receptor activity,MF,
458,GO:0001533,1,0.832158845093905,0,28,cornified envelope,CC,
459,GO:0001534,1,0.974609754152166,0,4,radial spoke,CC,
460,GO:0001535,1,0.993556848183299,0,1,radial spoke head,CC,
461,GO:0001536,1,0.99355705431691,0,1,radial spoke stalk,CC,
462,GO:0001537,1,0.968164846327113,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
463,GO:0001539,1,0.531147528703635,0,96,cilium or flagellum-dependent cell motility,BP,
464,GO:0001540,1,0.609895437311615,0,75,amyloid-beta binding,MF,
465,GO:0001541,1,0.722088705017844,0,50,ovarian follicle development,BP,
466,GO:0001542,1,0.94178269720827,0,9,ovulation from ovarian follicle,BP,
467,GO:0001543,1,0.993197515288867,0,1,ovarian follicle rupture,BP,
468,GO:0001544,1,0.986855800832228,0,2,initiation of primordial ovarian follicle growth,BP,
469,GO:0001545,1,0.993485975285673,0,1,primary ovarian follicle growth,BP,
470,GO:0001546,1,0.98094062816265,0,3,preantral ovarian follicle growth,BP,
471,GO:0001547,1,0.948948040476762,0,8,antral ovarian follicle growth,BP,
472,GO:0001550,1,0.980557520345979,0,3,ovarian cumulus expansion,BP,
473,GO:0001552,1,0.99361011378077,0,1,ovarian follicle atresia,BP,
475,GO:0001554,1,0.955107257349647,0,7,luteolysis,BP,
476,GO:0001555,1,0.980833423036582,0,3,oocyte growth,BP,
477,GO:0001556,1,0.872160587042285,0,21,oocyte maturation,BP,
479,GO:0001560,1,0.980150850778262,0,3,regulation of cell growth by extracellular stimulus,BP,
480,GO:0001561,1,0.943637059905814,0,9,fatty acid alpha-oxidation,BP,
481,GO:0001562,1,0.850332530348101,0,25,response to protozoan,BP,
482,GO:0001567,1,0.993648174873705,0,1,cholesterol 25-hydroxylase activity,MF,
484,GO:0001569,1,0.811501287538971,0,32,branching involved in blood vessel morphogenesis,BP,
485,GO:0001570,1,0.598220860134596,0,78,vasculogenesis,BP,
486,GO:0001572,1,0.993433342447335,0,1,lactosylceramide biosynthetic process,BP,
487,GO:0001573,1,0.872028164437968,0,21,ganglioside metabolic process,BP,
488,GO:0001574,1,0.918671842913557,0,13,ganglioside biosynthetic process,BP,
489,GO:0001575,1,0.993600220587304,0,1,globoside metabolic process,BP,
490,GO:0001576,1,0.993600220587304,0,1,globoside biosynthetic process,BP,
492,GO:0001579,1,0.98710216353911,0,2,medium-chain fatty acid transport,BP,
493,GO:0001580,1,0.880041408938445,0,20,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
494,GO:0001581,1,0.993540510244225,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
495,GO:0001582,1,0.993569790012993,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
496,GO:0001587,1,0.993438252987624,0,1,Gq/11-coupled serotonin receptor activity,MF,
497,GO:0001588,1,0.987146992679662,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
498,GO:0001591,1,0.980967064133537,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
499,GO:0001595,1,0.981029784742232,0,3,angiotensin receptor activity,MF,
500,GO:0001596,1,0.993584620608794,0,1,angiotensin type I receptor activity,MF,
501,GO:0001601,1,0.980808235849709,0,3,peptide YY receptor activity,MF,
502,GO:0001602,1,0.987215368772994,0,2,pancreatic polypeptide receptor activity,MF,
503,GO:0001604,1,0.987342004820623,0,2,urotensin II receptor activity,MF,
504,GO:0001605,1,0.980878171720748,0,3,adrenomedullin receptor activity,MF,
505,GO:0001607,1,0.987172254433464,0,2,neuromedin U receptor activity,MF,
506,GO:0001609,1,0.974619880959531,0,4,G protein-coupled adenosine receptor activity,MF,
507,GO:0001614,1,0.8792810868776,0,20,purinergic nucleotide receptor activity,MF,
509,GO:0001621,1,0.980922710048043,0,3,G protein-coupled ADP receptor activity,MF,
510,GO:0001626,1,0.993528942501548,0,1,nociceptin receptor activity,MF,
511,GO:0001631,1,0.987250134762074,0,2,cysteinyl leukotriene receptor activity,MF,
512,GO:0001632,1,0.987197291510389,0,2,leukotriene B4 receptor activity,MF,
513,GO:0001635,1,0.974416656888439,0,4,calcitonin gene-related peptide receptor activity,MF,
514,GO:0001637,1,0.851194217152932,0,25,G protein-coupled chemoattractant receptor activity,MF,
517,GO:0001642,1,0.974060108581234,0,4,group III metabotropic glutamate receptor activity,MF,
519,GO:0001650,1,0.453166422026352,0,121,fibrillar center,CC,
520,GO:0001651,1,0.993661711728357,0,1,dense fibrillar component,CC,
521,GO:0001652,1,0.96208700454214,0,6,granular component,CC,
528,GO:0001659,1,0.342414050382387,0,163,temperature homeostasis,BP,
529,GO:0001660,1,0.943192832783168,0,9,fever generation,BP,
530,GO:0001661,1,0.967901653921587,0,5,conditioned taste aversion,BP,
533,GO:0001665,1,0.96218010212597,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
537,GO:0001671,1,0.856690557410163,0,24,ATPase activator activity,MF,
539,GO:0001673,1,0.936862512292855,0,10,male germ cell nucleus,CC,
540,GO:0001674,1,0.987212615833328,0,2,female germ cell nucleus,CC,
541,GO:0001675,1,0.936543914157285,0,10,acrosome assembly,BP,
544,GO:0001680,1,0.993587876941037,0,1,tRNA 3'-terminal CCA addition,BP,
545,GO:0001681,1,0.993552743504316,0,1,sialate O-acetylesterase activity,MF,
546,GO:0001682,1,0.925846568939724,0,12,tRNA 5'-leader removal,BP,
547,GO:0001691,1,0.987125219746014,0,2,pseudophosphatase activity,MF,
548,GO:0001692,1,0.968190025402029,0,5,histamine metabolic process,BP,
549,GO:0001694,1,0.993579139296899,0,1,histamine biosynthetic process,BP,
550,GO:0001695,1,0.99367915923129,0,1,histamine catabolic process,BP,
551,GO:0001696,1,0.901740991682086,0,16,gastric acid secretion,BP,
552,GO:0001697,1,0.993554043534094,0,1,histamine-induced gastric acid secretion,BP,
553,GO:0001698,1,0.993554043534094,0,1,gastrin-induced gastric acid secretion,BP,
555,GO:0001702,1,0.852868165817746,0,24,gastrulation with mouth forming second,BP,
556,GO:0001704,1,0.478709409583502,0,112,formation of primary germ layer,BP,
557,GO:0001705,1,0.980711424940014,0,3,ectoderm formation,BP,
558,GO:0001706,1,0.710434303553862,0,52,endoderm formation,BP,
559,GO:0001707,1,0.662142715424125,0,63,mesoderm formation,BP,
561,GO:0001709,1,0.775317278288033,0,39,cell fate determination,BP,
562,GO:0001710,1,0.901829794535797,0,16,mesodermal cell fate commitment,BP,
563,GO:0001711,1,0.913355508465068,0,14,endodermal cell fate commitment,BP,
564,GO:0001712,1,0.980711424940014,0,3,ectodermal cell fate commitment,BP,
565,GO:0001714,1,0.956085063443683,0,7,endodermal cell fate specification,BP,
566,GO:0001715,1,0.993498240883376,0,1,ectodermal cell fate specification,BP,
567,GO:0001716,1,0.993602453027874,0,1,L-amino-acid oxidase activity,MF,
570,GO:0001727,1,0.961519933793117,0,6,lipid kinase activity,MF,
571,GO:0001729,1,0.987049232987056,0,2,ceramide kinase activity,MF,
572,GO:0001730,1,0.98055652913674,0,3,2'-5'-oligoadenylate synthetase activity,MF,
573,GO:0001731,1,0.936580181362126,0,10,formation of translation preinitiation complex,BP,
574,GO:0001732,1,0.907939635988925,0,15,formation of cytoplasmic translation initiation complex,BP,
575,GO:0001733,1,0.974604375887441,0,4,galactosylceramide sulfotransferase activity,MF,
576,GO:0001734,1,0.987206663067545,0,2,mRNA (N6-adenosine)-methyltransferase activity,MF,
577,GO:0001735,1,0.987001003788117,0,2,prenylcysteine oxidase activity,MF,
578,GO:0001736,1,0.459427993762633,0,119,establishment of planar polarity,BP,
579,GO:0001738,1,0.399378712460763,0,140,morphogenesis of a polarized epithelium,BP,
580,GO:0001739,1,0.974434430427416,0,4,sex chromatin,CC,
581,GO:0001740,1,0.98669016897325,0,2,Barr body,CC,
582,GO:0001741,1,0.931111783380316,0,11,XY body,CC,
583,GO:0001743,1,0.986843203550475,0,2,optic placode formation,BP,
584,GO:0001750,1,0.635481452251027,0,69,photoreceptor outer segment,CC,
585,GO:0001754,1,0.763969703993273,0,41,eye photoreceptor cell differentiation,BP,
586,GO:0001755,1,0.696541297413293,0,55,neural crest cell migration,BP,
588,GO:0001757,1,0.968172668783518,0,5,somite specification,BP,
589,GO:0001758,1,0.94993881292133,0,8,retinal dehydrogenase activity,MF,
591,GO:0001760,1,0.993656077753609,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
594,GO:0001765,1,0.937580441256197,0,10,membrane raft assembly,BP,
596,GO:0001767,1,0.924231541586131,0,12,establishment of lymphocyte polarity,BP,
597,GO:0001768,1,0.930526816489222,0,11,establishment of T cell polarity,BP,
598,GO:0001770,1,0.993239572028861,0,1,establishment of natural killer cell polarity,BP,
599,GO:0001771,1,0.913083604411016,0,14,immunological synapse formation,BP,
600,GO:0001772,1,0.78096981378693,0,38,immunological synapse,CC,
601,GO:0001773,1,0.839539389097667,0,27,myeloid dendritic cell activation,BP,
604,GO:0001776,1,0.585515493711507,0,82,leukocyte homeostasis,BP,
605,GO:0001777,1,0.980992667399432,0,3,T cell homeostatic proliferation,BP,
606,GO:0001778,1,0.923905455088235,0,12,plasma membrane repair,BP,
607,GO:0001779,1,0.877898721773141,0,20,natural killer cell differentiation,BP,
608,GO:0001780,1,0.900488107563168,0,16,neutrophil homeostasis,BP,
609,GO:0001781,1,0.948827808764774,0,8,neutrophil apoptotic process,BP,
610,GO:0001782,1,0.832735087115341,0,28,B cell homeostasis,BP,
611,GO:0001783,1,0.85559907307352,0,24,B cell apoptotic process,BP,
613,GO:0001785,1,0.987145566502461,0,2,prostaglandin J receptor activity,MF,
615,GO:0001787,1,0.943661047555949,0,9,natural killer cell proliferation,BP,
616,GO:0001788,1,0.987300474931701,0,2,antibody-dependent cellular cytotoxicity,BP,
618,GO:0001792,1,0.99347174644388,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001794,1,0.974611308892094,0,4,type IIa hypersensitivity,BP,
620,GO:0001796,1,0.974611308892094,0,4,regulation of type IIa hypersensitivity,BP,
621,GO:0001797,1,0.993632610050384,0,1,negative regulation of type IIa hypersensitivity,BP,
622,GO:0001798,1,0.980858017899074,0,3,positive regulation of type IIa hypersensitivity,BP,
623,GO:0001802,1,0.987305613605795,0,2,type III hypersensitivity,BP,
624,GO:0001803,1,0.987305613605795,0,2,regulation of type III hypersensitivity,BP,
625,GO:0001805,1,0.987305613605795,0,2,positive regulation of type III hypersensitivity,BP,
626,GO:0001806,1,0.97461248892493,0,4,type IV hypersensitivity,BP,
627,GO:0001807,1,0.980950436756979,0,3,regulation of type IV hypersensitivity,BP,
628,GO:0001808,1,0.993603354012658,0,1,negative regulation of type IV hypersensitivity,BP,
629,GO:0001809,1,0.993646911318008,0,1,positive regulation of type IV hypersensitivity,BP,
630,GO:0001810,1,0.981018253002993,0,3,regulation of type I hypersensitivity,BP,
631,GO:0001811,1,0.993632610050384,0,1,negative regulation of type I hypersensitivity,BP,
632,GO:0001812,1,0.987305613605795,0,2,positive regulation of type I hypersensitivity,BP,
633,GO:0001813,1,0.987300474931701,0,2,regulation of antibody-dependent cellular cytotoxicity,BP,
634,GO:0001814,1,0.993632610050384,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
635,GO:0001815,1,0.993627693156831,0,1,positive regulation of antibody-dependent cellular cytotoxicity,BP,
638,GO:0001818,1,0.219926871488535,0,232,negative regulation of cytokine production,BP,
641,GO:0001821,1,0.937777082116801,0,10,histamine secretion,BP,
645,GO:0001825,1,0.801647915218841,0,34,blastocyst formation,BP,
646,GO:0001826,1,0.967484636647015,0,5,inner cell mass cell differentiation,BP,
647,GO:0001827,1,0.993437802498607,0,1,inner cell mass cell fate commitment,BP,
648,GO:0001828,1,0.987062816053006,0,2,inner cell mass cellular morphogenesis,BP,
649,GO:0001829,1,0.924941574681367,0,12,trophectodermal cell differentiation,BP,
650,GO:0001831,1,0.986909379851723,0,2,trophectodermal cellular morphogenesis,BP,
651,GO:0001832,1,0.882485788929875,0,19,blastocyst growth,BP,
652,GO:0001833,1,0.918405731802503,0,13,inner cell mass cell proliferation,BP,
653,GO:0001834,1,0.980004947004955,0,3,trophectodermal cell proliferation,BP,
658,GO:0001839,1,0.961672276168354,0,6,neural plate morphogenesis,BP,
659,GO:0001840,1,0.942560015408755,0,9,neural plate development,BP,
661,GO:0001842,1,0.955443761114009,0,7,neural fold formation,BP,
663,GO:0001844,1,0.823719156953978,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
664,GO:0001845,1,0.91307139288926,0,14,phagolysosome assembly,BP,
665,GO:0001846,1,0.918102976781383,0,13,opsonin binding,MF,
666,GO:0001847,1,0.974057896777994,0,4,opsonin receptor activity,MF,
667,GO:0001848,1,0.894395215234634,0,17,complement binding,MF,
668,GO:0001849,1,0.961355493454428,0,6,complement component C1q complex binding,MF,
669,GO:0001850,1,0.993617699077859,0,1,complement component C3a binding,MF,
670,GO:0001851,1,0.967678589701194,0,5,complement component C3b binding,MF,
671,GO:0001855,1,0.986707664818409,0,2,complement component C4b binding,MF,
672,GO:0001856,1,0.993583842447015,0,1,complement component C5a binding,MF,
673,GO:0001861,1,0.993029719560696,0,1,complement component C4b receptor activity,MF,
674,GO:0001865,1,0.936865866109638,0,10,NK T cell differentiation,BP,
675,GO:0001866,1,0.962085506930407,0,6,NK T cell proliferation,BP,
676,GO:0001867,1,0.943785134717083,0,9,complement activation, lectin pathway,BP,
677,GO:0001868,1,0.987098144616749,0,2,regulation of complement activation, lectin pathway,BP,
678,GO:0001869,1,0.987098144616749,0,2,negative regulation of complement activation, lectin pathway,BP,
679,GO:0001872,1,0.987229447343079,0,2,(1->3)-beta-D-glucan binding,MF,
680,GO:0001875,1,0.968043513641209,0,5,lipopolysaccharide immune receptor activity,MF,
681,GO:0001878,1,0.974648371536121,0,4,response to yeast,BP,
682,GO:0001880,1,0.980489125064474,0,3,Mullerian duct regression,BP,
684,GO:0001882,1,0.108576621124181,0,339,nucleoside binding,MF,
685,GO:0001883,1,0.112993370981723,0,333,purine nucleoside binding,MF,
687,GO:0001886,1,0.923775248544403,0,12,endothelial cell morphogenesis,BP,
688,GO:0001887,1,0.974433666271785,0,4,selenium compound metabolic process,BP,
689,GO:0001888,1,0.986914668307502,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
692,GO:0001891,1,0.849618709239962,0,25,phagocytic cup,CC,
693,GO:0001892,1,0.587921817213956,0,81,embryonic placenta development,BP,
697,GO:0001905,1,0.980235125488505,0,3,activation of membrane attack complex,BP,
698,GO:0001906,1,0.437258488660249,0,128,cell killing,BP,
699,GO:0001907,1,0.980866206872695,0,3,killing by symbiont of host cells,BP,
700,GO:0001909,1,0.55157149761898,0,92,leukocyte mediated cytotoxicity,BP,
701,GO:0001910,1,0.657309239849508,0,65,regulation of leukocyte mediated cytotoxicity,BP,
702,GO:0001911,1,0.884942889123189,0,19,negative regulation of leukocyte mediated cytotoxicity,BP,
704,GO:0001913,1,0.787846417711339,0,37,T cell mediated cytotoxicity,BP,
705,GO:0001914,1,0.829735231248518,0,29,regulation of T cell mediated cytotoxicity,BP,
706,GO:0001915,1,0.955761312416198,0,7,negative regulation of T cell mediated cytotoxicity,BP,
707,GO:0001916,1,0.868011291548339,0,22,positive regulation of T cell mediated cytotoxicity,BP,
709,GO:0001918,1,0.993555820798735,0,1,farnesylated protein binding,MF,
711,GO:0001920,1,0.974447570547423,0,4,negative regulation of receptor recycling,BP,
713,GO:0001922,1,0.980444835116067,0,3,B-1 B cell homeostasis,BP,
714,GO:0001923,1,0.968103862814962,0,5,B-1 B cell differentiation,BP,
715,GO:0001927,1,0.993589054433911,0,1,exocyst assembly,BP,
716,GO:0001928,1,0.993589054433911,0,1,regulation of exocyst assembly,BP,
717,GO:0001931,1,0.918860862730488,0,13,uropod,CC,
721,GO:0001935,1,0.415102664259083,0,134,endothelial cell proliferation,BP,
722,GO:0001936,1,0.457850941414739,0,119,regulation of endothelial cell proliferation,BP,
723,GO:0001937,1,0.789961461982192,0,36,negative regulation of endothelial cell proliferation,BP,
724,GO:0001938,1,0.568608334245757,0,86,positive regulation of endothelial cell proliferation,BP,
725,GO:0001939,1,0.954660614294376,0,7,female pronucleus,CC,
726,GO:0001940,1,0.967175301988531,0,5,male pronucleus,CC,
727,GO:0001941,1,0.768240722626699,0,40,postsynaptic membrane organization,BP,
728,GO:0001942,1,0.59094990741796,0,80,hair follicle development,BP,
730,GO:0001945,1,0.841161771715484,0,26,lymph vessel development,BP,
731,GO:0001946,1,0.905479178500963,0,15,lymphangiogenesis,BP,
732,GO:0001947,1,0.675240075767909,0,60,heart looping,BP,
733,GO:0001949,1,0.993578115964395,0,1,sebaceous gland cell differentiation,BP,
734,GO:0001951,1,0.980723178265636,0,3,intestinal D-glucose absorption,BP,
736,GO:0001953,1,0.793356591323417,0,35,negative regulation of cell-matrix adhesion,BP,
737,GO:0001954,1,0.705555938880101,0,53,positive regulation of cell-matrix adhesion,BP,
738,GO:0001955,1,0.949021555585468,0,8,blood vessel maturation,BP,
739,GO:0001956,1,0.859682279202608,0,23,positive regulation of neurotransmitter secretion,BP,
740,GO:0001957,1,0.961423379033368,0,6,intramembranous ossification,BP,
741,GO:0001958,1,0.838478385827849,0,27,endochondral ossification,BP,
744,GO:0001961,1,0.736394012221941,0,47,positive regulation of cytokine-mediated signaling pathway,BP,
746,GO:0001964,1,0.835675423609929,0,27,startle response,BP,
748,GO:0001966,1,0.986774612224959,0,2,thigmotaxis,BP,
749,GO:0001967,1,0.930684680682812,0,11,suckling behavior,BP,
750,GO:0001968,1,0.84898506141058,0,25,fibronectin binding,MF,
751,GO:0001969,1,0.980235125488505,0,3,regulation of activation of membrane attack complex,BP,
752,GO:0001970,1,0.986960071855383,0,2,positive regulation of activation of membrane attack complex,BP,
753,GO:0001971,1,0.993187093316527,0,1,negative regulation of activation of membrane attack complex,BP,
754,GO:0001972,1,0.913022099834319,0,14,retinoic acid binding,MF,
756,GO:0001974,1,0.778722404783312,0,38,blood vessel remodeling,BP,
758,GO:0001976,1,0.936845767772689,0,10,nervous system process involved in regulation of systemic arterial blood pressure,BP,
759,GO:0001977,1,0.925277154389932,0,12,renal system process involved in regulation of blood volume,BP,
760,GO:0001978,1,0.993594020210193,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
761,GO:0001979,1,0.993626320181213,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
762,GO:0001980,1,0.993683246952571,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
763,GO:0001983,1,0.993594020210193,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
764,GO:0001985,1,0.993594020210193,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
765,GO:0001990,1,0.818389824935579,0,31,regulation of systemic arterial blood pressure by hormone,BP,
766,GO:0001991,1,0.913389828585951,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
767,GO:0001992,1,0.974406625020976,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
768,GO:0001993,1,0.943281455741985,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
769,GO:0001994,1,0.987216436726824,0,2,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
770,GO:0001996,1,0.961683496259496,0,6,positive regulation of heart rate by epinephrine-norepinephrine,BP,
771,GO:0001997,1,0.98718691213006,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
772,GO:0001998,1,0.993611589493306,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
773,GO:0001999,1,0.968170585821106,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
774,GO:0002001,1,0.968170585821106,0,5,renin secretion into blood stream,BP,
775,GO:0002002,1,0.943436057600448,0,9,regulation of angiotensin levels in blood,BP,
776,GO:0002003,1,0.943436057600448,0,9,angiotensin maturation,BP,
777,GO:0002007,1,0.993626320181213,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
779,GO:0002011,1,0.708105734959529,0,52,morphogenesis of an epithelial sheet,BP,
780,GO:0002016,1,0.962126214989525,0,6,regulation of blood volume by renin-angiotensin,BP,
781,GO:0002017,1,0.993614207194937,0,1,regulation of blood volume by renal aldosterone,BP,
782,GO:0002018,1,0.987194019071085,0,2,renin-angiotensin regulation of aldosterone production,BP,
783,GO:0002019,1,0.98090792701003,0,3,regulation of renal output by angiotensin,BP,
785,GO:0002021,1,0.866012621038507,0,22,response to dietary excess,BP,
786,GO:0002023,1,0.980901289460072,0,3,reduction of food intake in response to dietary excess,BP,
787,GO:0002024,1,0.942690977213885,0,9,diet induced thermogenesis,BP,
788,GO:0002025,1,0.980842831092697,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
792,GO:0002029,1,0.896348045387984,0,17,desensitization of G protein-coupled receptor signaling pathway,BP,
793,GO:0002030,1,0.993549264120569,0,1,inhibitory G protein-coupled receptor phosphorylation,BP,
794,GO:0002031,1,0.91383726190144,0,14,G protein-coupled receptor internalization,BP,
795,GO:0002032,1,0.987256667110266,0,2,desensitization of G protein-coupled receptor signaling pathway by arrestin,BP,
796,GO:0002034,1,0.974596409552985,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
797,GO:0002035,1,0.987125916975703,0,2,brain renin-angiotensin system,BP,
798,GO:0002036,1,0.961334324918842,0,6,regulation of L-glutamate import across plasma membrane,BP,
799,GO:0002037,1,0.993597893891915,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
800,GO:0002038,1,0.980545741031797,0,3,positive regulation of L-glutamate import across plasma membrane,BP,
801,GO:0002039,1,0.661008662960842,0,63,p53 binding,MF,
804,GO:0002043,1,0.883100684229767,0,19,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
805,GO:0002046,1,0.987318717539744,0,2,opsin binding,MF,
806,GO:0002051,1,0.973605346728789,0,4,osteoblast fate commitment,BP,
807,GO:0002052,1,0.859908495877061,0,23,positive regulation of neuroblast proliferation,BP,
808,GO:0002053,1,0.849506179315117,0,25,positive regulation of mesenchymal cell proliferation,BP,
809,GO:0002054,1,0.968362555327701,0,5,nucleobase binding,MF,
810,GO:0002055,1,0.993690096640088,0,1,adenine binding,MF,
811,GO:0002058,1,0.987175708540991,0,2,uracil binding,MF,
812,GO:0002059,1,0.993597694758052,0,1,thymine binding,MF,
813,GO:0002060,1,0.980944883656606,0,3,purine nucleobase binding,MF,
814,GO:0002061,1,0.987175708540991,0,2,pyrimidine nucleobase binding,MF,
816,GO:0002063,1,0.831738733053581,0,28,chondrocyte development,BP,
818,GO:0002065,1,0.502842968661369,0,105,columnar/cuboidal epithelial cell differentiation,BP,
819,GO:0002066,1,0.692934159721757,0,56,columnar/cuboidal epithelial cell development,BP,
820,GO:0002067,1,0.745204547118391,0,45,glandular epithelial cell differentiation,BP,
821,GO:0002068,1,0.848740030174135,0,25,glandular epithelial cell development,BP,
822,GO:0002069,1,0.962173211279409,0,6,columnar/cuboidal epithelial cell maturation,BP,
823,GO:0002070,1,0.906614407420019,0,15,epithelial cell maturation,BP,
824,GO:0002071,1,0.987242814320685,0,2,glandular epithelial cell maturation,BP,
825,GO:0002072,1,0.948161669626121,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
826,GO:0002074,1,0.973819525844331,0,4,extraocular skeletal muscle development,BP,
827,GO:0002076,1,0.883116995828875,0,19,osteoblast development,BP,
828,GO:0002077,1,0.993648374337151,0,1,acrosome matrix dispersal,BP,
829,GO:0002079,1,0.980503854494499,0,3,inner acrosomal membrane,CC,
830,GO:0002080,1,0.890018992911389,0,18,acrosomal membrane,CC,
831,GO:0002081,1,0.98053939222372,0,3,outer acrosomal membrane,CC,
833,GO:0002083,1,0.993630236329207,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
834,GO:0002084,1,0.943537867027684,0,9,protein depalmitoylation,BP,
835,GO:0002085,1,0.967870110726181,0,5,inhibition of neuroepithelial cell differentiation,BP,
836,GO:0002086,1,0.987244965057428,0,2,diaphragm contraction,BP,
837,GO:0002087,1,0.924711982199289,0,12,regulation of respiratory gaseous exchange by nervous system process,BP,
838,GO:0002088,1,0.630734911109312,0,70,lens development in camera-type eye,BP,
839,GO:0002089,1,0.887477062514841,0,18,lens morphogenesis in camera-type eye,BP,
841,GO:0002091,1,0.919155834084748,0,13,negative regulation of receptor internalization,BP,
843,GO:0002093,1,0.924674585884365,0,12,auditory receptor cell morphogenesis,BP,
844,GO:0002094,1,0.98719885766215,0,2,polyprenyltransferase activity,MF,
845,GO:0002095,1,0.987136995178591,0,2,caveolar macromolecular signaling complex,CC,
846,GO:0002096,1,0.986997796571923,0,2,polkadots,CC,
847,GO:0002097,1,0.884534815249544,0,19,tRNA wobble base modification,BP,
848,GO:0002098,1,0.907789664077065,0,15,tRNA wobble uridine modification,BP,
849,GO:0002100,1,0.986990748965724,0,2,tRNA wobble adenosine to inosine editing,BP,
850,GO:0002101,1,0.987252506980702,0,2,tRNA wobble cytosine modification,BP,
851,GO:0002102,1,0.826481178790987,0,29,podosome,CC,
852,GO:0002112,1,0.993564430341048,0,1,interleukin-33 receptor binding,MF,
853,GO:0002113,1,0.99358722393532,0,1,interleukin-33 binding,MF,
854,GO:0002114,1,0.987128851264058,0,2,interleukin-33 receptor activity,MF,
855,GO:0002115,1,0.889282504376997,0,18,store-operated calcium entry,BP,
856,GO:0002116,1,0.928518684624748,0,11,semaphorin receptor complex,CC,
857,GO:0002118,1,0.96194919090302,0,6,aggressive behavior,BP,
858,GO:0002121,1,0.987097255020248,0,2,inter-male aggressive behavior,BP,
859,GO:0002125,1,0.987138198940333,0,2,maternal aggressive behavior,BP,
860,GO:0002127,1,0.993643916674807,0,1,tRNA wobble base cytosine methylation,BP,
861,GO:0002128,1,0.993608907064504,0,1,tRNA nucleoside ribose methylation,BP,
862,GO:0002133,1,0.985980725709768,0,2,polycystin complex,CC,
863,GO:0002134,1,0.986980955995772,0,2,UTP binding,MF,
864,GO:0002135,1,0.99357066251008,0,1,CTP binding,MF,
865,GO:0002138,1,0.949786816526042,0,8,retinoic acid biosynthetic process,BP,
866,GO:0002139,1,0.966956171102951,0,5,stereocilia coupling link,CC,
867,GO:0002140,1,0.99321322487076,0,1,stereocilia tip link,CC,
868,GO:0002141,1,0.973565303899343,0,4,stereocilia ankle link,CC,
869,GO:0002142,1,0.973565303899343,0,4,stereocilia ankle link complex,CC,
870,GO:0002143,1,0.974652185867557,0,4,tRNA wobble position uridine thiolation,BP,
871,GO:0002144,1,0.993599222672004,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
872,GO:0002148,1,0.99353191372327,0,1,hypochlorous acid metabolic process,BP,
873,GO:0002149,1,0.99353191372327,0,1,hypochlorous acid biosynthetic process,BP,
874,GO:0002151,1,0.966573112981527,0,5,G-quadruplex RNA binding,MF,
875,GO:0002152,1,0.993521146554597,0,1,bile acid conjugation,BP,
876,GO:0002153,1,0.987278519107259,0,2,steroid receptor RNA activator RNA binding,MF,
877,GO:0002154,1,0.967210176242184,0,5,thyroid hormone mediated signaling pathway,BP,
878,GO:0002155,1,0.980555031605143,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
880,GO:0002159,1,0.973883025241033,0,4,desmosome assembly,BP,
881,GO:0002161,1,0.949475733726058,0,8,aminoacyl-tRNA editing activity,MF,
882,GO:0002162,1,0.941687241767025,0,9,dystroglycan binding,MF,
883,GO:0002169,1,0.987119229810633,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
884,GO:0002174,1,0.993547463256452,0,1,mammary stem cell proliferation,BP,
886,GO:0002176,1,0.962300466353409,0,6,male germ cell proliferation,BP,
887,GO:0002177,1,0.949427282967337,0,8,manchette,CC,
888,GO:0002178,1,0.931236127979193,0,11,palmitoyltransferase complex,CC,
889,GO:0002181,1,0.538032210805247,0,96,cytoplasmic translation,BP,
890,GO:0002182,1,0.943149673035978,0,9,cytoplasmic translational elongation,BP,
891,GO:0002183,1,0.807409146902092,0,33,cytoplasmic translational initiation,BP,
892,GO:0002184,1,0.98042105558531,0,3,cytoplasmic translational termination,BP,
893,GO:0002188,1,0.980060231385656,0,3,translation reinitiation,BP,
894,GO:0002189,1,0.974605082848927,0,4,ribose phosphate diphosphokinase complex,CC,
895,GO:0002190,1,0.968487857537534,0,5,cap-independent translational initiation,BP,
896,GO:0002191,1,0.980745126870869,0,3,cap-dependent translational initiation,BP,
897,GO:0002192,1,0.987352269734397,0,2,IRES-dependent translational initiation of linear mRNA,BP,
898,GO:0002193,1,0.980104487176896,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
899,GO:0002194,1,0.993540129524831,0,1,hepatocyte cell migration,BP,
900,GO:0002196,1,0.993612965250343,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
901,GO:0002199,1,0.962159094169654,0,6,zona pellucida receptor complex,CC,
902,GO:0002200,1,0.657416226059795,0,64,somatic diversification of immune receptors,BP,
903,GO:0002204,1,0.755882572986728,0,43,somatic recombination of immunoglobulin genes involved in immune response,BP,
904,GO:0002208,1,0.755882572986728,0,43,somatic diversification of immunoglobulins involved in immune response,BP,
906,GO:0002215,1,0.993517729948133,0,1,defense response to nematode,BP,
907,GO:0002218,1,0.444942020896573,0,124,activation of innate immune response,BP,
908,GO:0002220,1,0.521328389370624,0,100,innate immune response activating cell surface receptor signaling pathway,BP,
910,GO:0002223,1,0.531489130815365,0,97,stimulatory C-type lectin receptor signaling pathway,BP,
912,GO:0002225,1,0.987295703781533,0,2,positive regulation of antimicrobial peptide production,BP,
913,GO:0002227,1,0.926503447917104,0,12,innate immune response in mucosa,BP,
914,GO:0002228,1,0.695948654519443,0,56,natural killer cell mediated immunity,BP,
915,GO:0002230,1,0.86086202331832,0,23,positive regulation of defense response to virus by host,BP,
916,GO:0002232,1,0.962236491938742,0,6,leukocyte chemotaxis involved in inflammatory response,BP,
918,GO:0002238,1,0.974365193653196,0,4,response to molecule of fungal origin,BP,
920,GO:0002246,1,0.955941839218936,0,7,wound healing involved in inflammatory response,BP,
921,GO:0002248,1,0.962066486113314,0,6,connective tissue replacement involved in inflammatory response wound healing,BP,
922,GO:0002249,1,0.968261338528077,0,5,lymphocyte anergy,BP,
924,GO:0002251,1,0.868772180170994,0,22,organ or tissue specific immune response,BP,
927,GO:0002254,1,0.98090737319037,0,3,kinin cascade,BP,
928,GO:0002260,1,0.680775085651117,0,59,lymphocyte homeostasis,BP,
929,GO:0002262,1,0.384290546203423,0,146,myeloid cell homeostasis,BP,
931,GO:0002265,1,0.973131006068175,0,4,astrocyte activation involved in immune response,BP,
932,GO:0002266,1,0.980909536761663,0,3,follicular dendritic cell activation,BP,
933,GO:0002268,1,0.987196207567724,0,2,follicular dendritic cell differentiation,BP,
935,GO:0002270,1,0.993606629809115,0,1,plasmacytoid dendritic cell activation,BP,
938,GO:0002276,1,0.987053306032147,0,2,basophil activation involved in immune response,BP,
939,GO:0002277,1,0.980733184541431,0,3,myeloid dendritic cell activation involved in immune response,BP,
940,GO:0002278,1,0.974609841638289,0,4,eosinophil activation involved in immune response,BP,
941,GO:0002279,1,0.751249369763844,0,44,mast cell activation involved in immune response,BP,
942,GO:0002280,1,0.986758167264587,0,2,monocyte activation involved in immune response,BP,
943,GO:0002281,1,0.913159127066023,0,14,macrophage activation involved in immune response,BP,
944,GO:0002282,1,0.974761549740977,0,4,microglial cell activation involved in immune response,BP,
946,GO:0002285,1,0.375124236110605,0,150,lymphocyte activation involved in immune response,BP,
947,GO:0002286,1,0.578398999035664,0,84,T cell activation involved in immune response,BP,
948,GO:0002287,1,0.693959209994118,0,56,alpha-beta T cell activation involved in immune response,BP,
949,GO:0002290,1,0.993551538450257,0,1,gamma-delta T cell activation involved in immune response,BP,
950,GO:0002291,1,0.937490333699865,0,10,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
951,GO:0002292,1,0.662922304022316,0,63,T cell differentiation involved in immune response,BP,
952,GO:0002293,1,0.693959209994118,0,56,alpha-beta T cell differentiation involved in immune response,BP,
953,GO:0002294,1,0.698474156448055,0,55,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
954,GO:0002295,1,0.912773668926218,0,14,T-helper cell lineage commitment,BP,
955,GO:0002296,1,0.979965036259168,0,3,T-helper 1 cell lineage commitment,BP,
956,GO:0002298,1,0.99362816181609,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
957,GO:0002299,1,0.993635549330444,0,1,alpha-beta intraepithelial T cell differentiation,BP,
958,GO:0002300,1,0.993635549330444,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
959,GO:0002302,1,0.993559067926596,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
960,GO:0002304,1,0.993635549330444,0,1,gamma-delta intraepithelial T cell differentiation,BP,
961,GO:0002305,1,0.993635549330444,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
962,GO:0002309,1,0.974550543602859,0,4,T cell proliferation involved in immune response,BP,
963,GO:0002312,1,0.641910526703109,0,68,B cell activation involved in immune response,BP,
964,GO:0002313,1,0.883576001469319,0,19,mature B cell differentiation involved in immune response,BP,
965,GO:0002314,1,0.968332718272642,0,5,germinal center B cell differentiation,BP,
966,GO:0002315,1,0.942134477989011,0,9,marginal zone B cell differentiation,BP,
967,GO:0002316,1,0.987146233261635,0,2,follicular B cell differentiation,BP,
968,GO:0002317,1,0.9810627026096,0,3,plasma cell differentiation,BP,
969,GO:0002318,1,0.967992215834199,0,5,myeloid progenitor cell differentiation,BP,
970,GO:0002320,1,0.87668145537437,0,20,lymphoid progenitor cell differentiation,BP,
971,GO:0002322,1,0.961603096597573,0,6,B cell proliferation involved in immune response,BP,
972,GO:0002323,1,0.94347015916544,0,9,natural killer cell activation involved in immune response,BP,
973,GO:0002325,1,0.987345477185043,0,2,natural killer cell differentiation involved in immune response,BP,
974,GO:0002326,1,0.967092623498334,0,5,B cell lineage commitment,BP,
975,GO:0002327,1,0.941536703666493,0,9,immature B cell differentiation,BP,
976,GO:0002328,1,0.92912769194772,0,11,pro-B cell differentiation,BP,
977,GO:0002329,1,0.973202262931666,0,4,pre-B cell differentiation,BP,
978,GO:0002331,1,0.986183989422699,0,2,pre-B cell allelic exclusion,BP,
979,GO:0002332,1,0.993366850178882,0,1,transitional stage B cell differentiation,BP,
980,GO:0002333,1,0.993366850178882,0,1,transitional one stage B cell differentiation,BP,
981,GO:0002335,1,0.849753392167338,0,25,mature B cell differentiation,BP,
982,GO:0002336,1,0.993527831095836,0,1,B-1 B cell lineage commitment,BP,
983,GO:0002337,1,0.987179983880811,0,2,B-1a B cell differentiation,BP,
984,GO:0002339,1,0.980965236920794,0,3,B cell selection,BP,
985,GO:0002343,1,0.993565713879955,0,1,peripheral B cell selection,BP,
986,GO:0002344,1,0.993565713879955,0,1,B cell affinity maturation,BP,
987,GO:0002347,1,0.873425034581782,0,21,response to tumor cell,BP,
988,GO:0002349,1,0.956052320634995,0,7,histamine production involved in inflammatory response,BP,
989,GO:0002351,1,0.98079065435799,0,3,serotonin production involved in inflammatory response,BP,
990,GO:0002352,1,0.987318736454209,0,2,B cell negative selection,BP,
991,GO:0002353,1,0.98090737319037,0,3,plasma kallikrein-kinin cascade,BP,
992,GO:0002355,1,0.993578243725841,0,1,detection of tumor cell,BP,
993,GO:0002357,1,0.980809537149343,0,3,defense response to tumor cell,BP,
994,GO:0002358,1,0.993685355464975,0,1,B cell homeostatic proliferation,BP,
995,GO:0002360,1,0.854413068212445,0,24,T cell lineage commitment,BP,
996,GO:0002361,1,0.968245459317566,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
997,GO:0002362,1,0.987106491668358,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
998,GO:0002363,1,0.883668159360742,0,19,alpha-beta T cell lineage commitment,BP,
999,GO:0002364,1,0.99348104501619,0,1,NK T cell lineage commitment,BP,
1001,GO:0002367,1,0.539618732538028,0,95,cytokine production involved in immune response,BP,
1002,GO:0002368,1,0.987191848043445,0,2,B cell cytokine production,BP,
1003,GO:0002369,1,0.777134834740683,0,39,T cell cytokine production,BP,
1004,GO:0002370,1,0.949956507479464,0,8,natural killer cell cytokine production,BP,
1005,GO:0002371,1,0.917963079092966,0,13,dendritic cell cytokine production,BP,
1006,GO:0002372,1,0.96097431345299,0,6,myeloid dendritic cell cytokine production,BP,
1007,GO:0002373,1,0.993676916120149,0,1,plasmacytoid dendritic cell cytokine production,BP,
1008,GO:0002374,1,0.974246876323485,0,4,cytokine secretion involved in immune response,BP,
1011,GO:0002378,1,0.974309877189892,0,4,immunoglobulin biosynthetic process,BP,
1012,GO:0002379,1,0.993629533849245,0,1,immunoglobulin biosynthetic process involved in immune response,BP,
1013,GO:0002380,1,0.993456691965647,0,1,immunoglobulin secretion involved in immune response,BP,
1014,GO:0002381,1,0.717850553736257,0,51,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1015,GO:0002383,1,0.993629533849245,0,1,immune response in brain or nervous system,BP,
1016,GO:0002384,1,0.987182837611627,0,2,hepatic immune response,BP,
1017,GO:0002385,1,0.885715717460908,0,19,mucosal immune response,BP,
1018,GO:0002386,1,0.987124326739485,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1019,GO:0002396,1,0.956216790389705,0,7,MHC protein complex assembly,BP,
1020,GO:0002397,1,0.987270590119041,0,2,MHC class I protein complex assembly,BP,
1021,GO:0002398,1,0.993516986315932,0,1,MHC class Ib protein complex assembly,BP,
1022,GO:0002399,1,0.974871482133944,0,4,MHC class II protein complex assembly,BP,
1023,GO:0002407,1,0.861685144781245,0,23,dendritic cell chemotaxis,BP,
1024,GO:0002408,1,0.974591767783243,0,4,myeloid dendritic cell chemotaxis,BP,
1025,GO:0002413,1,0.993636984467201,0,1,tolerance induction to tumor cell,BP,
1026,GO:0002414,1,0.980827729430764,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1027,GO:0002415,1,0.987124326739485,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1028,GO:0002416,1,0.99362209630484,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1029,GO:0002418,1,0.896120183296026,0,17,immune response to tumor cell,BP,
1030,GO:0002419,1,0.980981648069767,0,3,T cell mediated cytotoxicity directed against tumor cell target,BP,
1031,GO:0002420,1,0.961861541300121,0,6,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1032,GO:0002423,1,0.955737543790599,0,7,natural killer cell mediated immune response to tumor cell,BP,
1033,GO:0002424,1,0.962047420241221,0,6,T cell mediated immune response to tumor cell,BP,
1034,GO:0002426,1,0.993658266100689,0,1,immunoglobulin production in mucosal tissue,BP,
1035,GO:0002428,1,0.962331904880949,0,6,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1037,GO:0002430,1,0.936921716908988,0,10,complement receptor mediated signaling pathway,BP,
1038,GO:0002431,1,0.589408431850905,0,81,Fc receptor mediated stimulatory signaling pathway,BP,
1039,GO:0002432,1,0.99346248594973,0,1,granuloma formation,BP,
1040,GO:0002433,1,0.61280578942735,0,75,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1041,GO:0002434,1,0.974614829027914,0,4,immune complex clearance,BP,
1042,GO:0002436,1,0.980940587308353,0,3,immune complex clearance by monocytes and macrophages,BP,
1043,GO:0002437,1,0.728191187994695,0,49,inflammatory response to antigenic stimulus,BP,
1044,GO:0002438,1,0.867867164476682,0,22,acute inflammatory response to antigenic stimulus,BP,
1045,GO:0002439,1,0.974731895720114,0,4,chronic inflammatory response to antigenic stimulus,BP,
1047,GO:0002441,1,0.956052320634995,0,7,histamine secretion involved in inflammatory response,BP,
1048,GO:0002442,1,0.98079065435799,0,3,serotonin secretion involved in inflammatory response,BP,
1051,GO:0002445,1,0.974611308892094,0,4,type II hypersensitivity,BP,
1053,GO:0002447,1,0.974609841638289,0,4,eosinophil mediated immunity,BP,
1054,GO:0002448,1,0.746401158153132,0,45,mast cell mediated immunity,BP,
1055,GO:0002449,1,0.232344814640658,0,224,lymphocyte mediated immunity,BP,
1056,GO:0002450,1,0.993632610050384,0,1,B cell antigen processing and presentation,BP,
1057,GO:0002451,1,0.993634247072194,0,1,peripheral B cell tolerance induction,BP,
1058,GO:0002455,1,0.76699266137179,0,41,humoral immune response mediated by circulating immunoglobulin,BP,
1059,GO:0002456,1,0.547450784501898,0,93,T cell mediated immunity,BP,
1060,GO:0002457,1,0.968335382525334,0,5,T cell antigen processing and presentation,BP,
1061,GO:0002458,1,0.987223225149197,0,2,peripheral T cell tolerance induction,BP,
1062,GO:0002460,1,0.217001893776491,0,234,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1063,GO:0002461,1,0.968440695359288,0,5,tolerance induction dependent upon immune response,BP,
1064,GO:0002465,1,0.974695078838373,0,4,peripheral tolerance induction,BP,
1065,GO:0002467,1,0.906617372077586,0,15,germinal center formation,BP,
1066,GO:0002468,1,0.925421016058056,0,12,dendritic cell antigen processing and presentation,BP,
1067,GO:0002470,1,0.993661380557205,0,1,plasmacytoid dendritic cell antigen processing and presentation,BP,
1068,GO:0002472,1,0.9934727364143,0,1,macrophage antigen processing and presentation,BP,
1069,GO:0002474,1,0.548629293861158,0,93,antigen processing and presentation of peptide antigen via MHC class I,BP,
1070,GO:0002475,1,0.92557516620693,0,12,antigen processing and presentation via MHC class Ib,BP,
1071,GO:0002476,1,0.96846052457873,0,5,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1072,GO:0002477,1,0.981074908960835,0,3,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1073,GO:0002478,1,0.340108732849723,0,166,antigen processing and presentation of exogenous peptide antigen,BP,
1074,GO:0002479,1,0.641882627933295,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1075,GO:0002480,1,0.950078541132778,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1076,GO:0002481,1,0.993673813558371,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1077,GO:0002483,1,0.901786136402444,0,16,antigen processing and presentation of endogenous peptide antigen,BP,
1078,GO:0002484,1,0.956313271365569,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,BP,
1079,GO:0002485,1,0.993636250300545,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,BP,
1080,GO:0002486,1,0.956313271365569,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,BP,
1081,GO:0002488,1,0.993487645841966,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1082,GO:0002489,1,0.993487645841966,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1083,GO:0002495,1,0.535011347043877,0,96,antigen processing and presentation of peptide antigen via MHC class II,BP,
1084,GO:0002501,1,0.962458804465534,0,6,peptide antigen assembly with MHC protein complex,BP,
1085,GO:0002502,1,0.987270590119041,0,2,peptide antigen assembly with MHC class I protein complex,BP,
1086,GO:0002503,1,0.974871482133944,0,4,peptide antigen assembly with MHC class II protein complex,BP,
1087,GO:0002504,1,0.53143261918725,0,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1088,GO:0002507,1,0.856149324357912,0,24,tolerance induction,BP,
1089,GO:0002508,1,0.987204349407016,0,2,central tolerance induction,BP,
1090,GO:0002509,1,0.993598524801629,0,1,central tolerance induction to self antigen,BP,
1091,GO:0002510,1,0.993565040715604,0,1,central B cell tolerance induction,BP,
1092,GO:0002513,1,0.968144684061813,0,5,tolerance induction to self antigen,BP,
1093,GO:0002514,1,0.980767308265299,0,3,B cell tolerance induction,BP,
1094,GO:0002517,1,0.925459083378295,0,12,T cell tolerance induction,BP,
1095,GO:0002518,1,0.993659525454334,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1096,GO:0002519,1,0.980961625060068,0,3,natural killer cell tolerance induction,BP,
1099,GO:0002522,1,0.98721542641913,0,2,leukocyte migration involved in immune response,BP,
1100,GO:0002523,1,0.902186864845982,0,16,leukocyte migration involved in inflammatory response,BP,
1101,GO:0002524,1,0.937698976915866,0,10,hypersensitivity,BP,
1102,GO:0002525,1,0.980888006531422,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1104,GO:0002528,1,0.974109161068478,0,4,regulation of vascular permeability involved in acute inflammatory response,BP,
1105,GO:0002532,1,0.664084249956168,0,63,production of molecular mediator involved in inflammatory response,BP,
1106,GO:0002534,1,0.755808761893257,0,43,cytokine production involved in inflammatory response,BP,
1107,GO:0002536,1,0.962286346475282,0,6,respiratory burst involved in inflammatory response,BP,
1108,GO:0002537,1,0.986606873617528,0,2,nitric oxide production involved in inflammatory response,BP,
1109,GO:0002538,1,0.987146062272731,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1110,GO:0002540,1,0.987146062272731,0,2,leukotriene production involved in inflammatory response,BP,
1111,GO:0002541,1,0.980896135955193,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1112,GO:0002542,1,0.987232078665654,0,2,Factor XII activation,BP,
1113,GO:0002543,1,0.987060334026234,0,2,activation of blood coagulation via clotting cascade,BP,
1114,GO:0002544,1,0.89617399900809,0,17,chronic inflammatory response,BP,
1115,GO:0002545,1,0.993614072915884,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1117,GO:0002551,1,0.937277638946988,0,10,mast cell chemotaxis,BP,
1118,GO:0002553,1,0.956052320634995,0,7,histamine secretion by mast cell,BP,
1119,GO:0002554,1,0.98079065435799,0,3,serotonin secretion by platelet,BP,
1120,GO:0002560,1,0.993477612420859,0,1,basophil mediated immunity,BP,
1121,GO:0002561,1,0.993477612420859,0,1,basophil degranulation,BP,
1122,GO:0002562,1,0.693097685928152,0,56,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1123,GO:0002566,1,0.912562059700372,0,14,somatic diversification of immune receptors via somatic mutation,BP,
1124,GO:0002568,1,0.96677471774948,0,5,somatic diversification of T cell receptor genes,BP,
1125,GO:0002572,1,0.987072658279835,0,2,pro-T cell differentiation,BP,
1128,GO:0002577,1,0.879022422091923,0,20,regulation of antigen processing and presentation,BP,
1129,GO:0002578,1,0.943476287724386,0,9,negative regulation of antigen processing and presentation,BP,
1130,GO:0002579,1,0.943821749277152,0,9,positive regulation of antigen processing and presentation,BP,
1131,GO:0002580,1,0.968274373645263,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1132,GO:0002581,1,0.980643788359352,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1133,GO:0002582,1,0.987388884391555,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1134,GO:0002583,1,0.962342482978496,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1135,GO:0002584,1,0.9746368800137,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1136,GO:0002585,1,0.987388884391555,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1137,GO:0002586,1,0.974755715818974,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1138,GO:0002587,1,0.987207091790477,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1139,GO:0002588,1,0.987388884391555,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1140,GO:0002589,1,0.987268523883163,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1141,GO:0002590,1,0.987268523883163,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1142,GO:0002604,1,0.931328541770733,0,11,regulation of dendritic cell antigen processing and presentation,BP,
1143,GO:0002605,1,0.974324843804821,0,4,negative regulation of dendritic cell antigen processing and presentation,BP,
1144,GO:0002606,1,0.955881893282856,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1145,GO:0002616,1,0.9934727364143,0,1,regulation of macrophage antigen processing and presentation,BP,
1146,GO:0002617,1,0.9934727364143,0,1,negative regulation of macrophage antigen processing and presentation,BP,
1147,GO:0002622,1,0.993632610050384,0,1,regulation of B cell antigen processing and presentation,BP,
1148,GO:0002625,1,0.987267389493333,0,2,regulation of T cell antigen processing and presentation,BP,
1149,GO:0002626,1,0.993609778514401,0,1,negative regulation of T cell antigen processing and presentation,BP,
1150,GO:0002634,1,0.942727625243738,0,9,regulation of germinal center formation,BP,
1151,GO:0002635,1,0.98647155616561,0,2,negative regulation of germinal center formation,BP,
1152,GO:0002636,1,0.981094872781006,0,3,positive regulation of germinal center formation,BP,
1155,GO:0002639,1,0.797266813971358,0,35,positive regulation of immunoglobulin production,BP,
1156,GO:0002640,1,0.99355705431691,0,1,regulation of immunoglobulin biosynthetic process,BP,
1157,GO:0002642,1,0.99355705431691,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1158,GO:0002643,1,0.901498163055349,0,16,regulation of tolerance induction,BP,
1159,GO:0002644,1,0.993598757362038,0,1,negative regulation of tolerance induction,BP,
1160,GO:0002645,1,0.943286788225186,0,9,positive regulation of tolerance induction,BP,
1161,GO:0002646,1,0.993565040715604,0,1,regulation of central tolerance induction,BP,
1162,GO:0002648,1,0.993565040715604,0,1,positive regulation of central tolerance induction,BP,
1163,GO:0002649,1,0.993444645315498,0,1,regulation of tolerance induction to self antigen,BP,
1164,GO:0002651,1,0.993444645315498,0,1,positive regulation of tolerance induction to self antigen,BP,
1165,GO:0002652,1,0.98092723066857,0,3,regulation of tolerance induction dependent upon immune response,BP,
1166,GO:0002654,1,0.987261440495249,0,2,positive regulation of tolerance induction dependent upon immune response,BP,
1167,GO:0002658,1,0.987261440495249,0,2,regulation of peripheral tolerance induction,BP,
1168,GO:0002660,1,0.987261440495249,0,2,positive regulation of peripheral tolerance induction,BP,
1169,GO:0002661,1,0.987051450353633,0,2,regulation of B cell tolerance induction,BP,
1170,GO:0002663,1,0.987051450353633,0,2,positive regulation of B cell tolerance induction,BP,
1171,GO:0002664,1,0.937462510895937,0,10,regulation of T cell tolerance induction,BP,
1172,GO:0002666,1,0.962090927652624,0,6,positive regulation of T cell tolerance induction,BP,
1173,GO:0002667,1,0.968261338528077,0,5,regulation of T cell anergy,BP,
1174,GO:0002669,1,0.987263031498168,0,2,positive regulation of T cell anergy,BP,
1175,GO:0002673,1,0.761975993519864,0,42,regulation of acute inflammatory response,BP,
1176,GO:0002674,1,0.942965972620394,0,9,negative regulation of acute inflammatory response,BP,
1177,GO:0002675,1,0.83474700429353,0,28,positive regulation of acute inflammatory response,BP,
1178,GO:0002676,1,0.949785491955628,0,8,regulation of chronic inflammatory response,BP,
1179,GO:0002677,1,0.974382917890109,0,4,negative regulation of chronic inflammatory response,BP,
1180,GO:0002678,1,0.974762361880665,0,4,positive regulation of chronic inflammatory response,BP,
1181,GO:0002679,1,0.937404000023055,0,10,respiratory burst involved in defense response,BP,
1182,GO:0002681,1,0.96677471774948,0,5,somatic recombination of T cell receptor gene segments,BP,
1192,GO:0002691,1,0.822301191137822,0,30,regulation of cellular extravasation,BP,
1193,GO:0002692,1,0.94310869917328,0,9,negative regulation of cellular extravasation,BP,
1194,GO:0002693,1,0.889740640577065,0,18,positive regulation of cellular extravasation,BP,
1196,GO:0002695,1,0.345953798829377,0,163,negative regulation of leukocyte activation,BP,
1200,GO:0002699,1,0.284297875541635,0,193,positive regulation of immune effector process,BP,
1203,GO:0002702,1,0.568451815155385,0,87,positive regulation of production of molecular mediator of immune response,BP,
1204,GO:0002703,1,0.297870155520426,0,186,regulation of leukocyte mediated immunity,BP,
1205,GO:0002704,1,0.733142747300348,0,48,negative regulation of leukocyte mediated immunity,BP,
1206,GO:0002705,1,0.461561621542317,0,119,positive regulation of leukocyte mediated immunity,BP,
1207,GO:0002706,1,0.427352898616765,0,131,regulation of lymphocyte mediated immunity,BP,
1208,GO:0002707,1,0.782459960321099,0,38,negative regulation of lymphocyte mediated immunity,BP,
1209,GO:0002708,1,0.565281574608883,0,88,positive regulation of lymphocyte mediated immunity,BP,
1210,GO:0002709,1,0.657100076962936,0,65,regulation of T cell mediated immunity,BP,
1211,GO:0002710,1,0.896417432244817,0,17,negative regulation of T cell mediated immunity,BP,
1212,GO:0002711,1,0.752490441652733,0,44,positive regulation of T cell mediated immunity,BP,
1213,GO:0002712,1,0.746551413644251,0,45,regulation of B cell mediated immunity,BP,
1214,GO:0002713,1,0.931037965879284,0,11,negative regulation of B cell mediated immunity,BP,
1215,GO:0002714,1,0.823211859462557,0,30,positive regulation of B cell mediated immunity,BP,
1216,GO:0002715,1,0.782343865915085,0,38,regulation of natural killer cell mediated immunity,BP,
1217,GO:0002716,1,0.902223432755517,0,16,negative regulation of natural killer cell mediated immunity,BP,
1218,GO:0002717,1,0.856315240007367,0,24,positive regulation of natural killer cell mediated immunity,BP,
1219,GO:0002718,1,0.606653266369578,0,77,regulation of cytokine production involved in immune response,BP,
1220,GO:0002719,1,0.873030848052594,0,21,negative regulation of cytokine production involved in immune response,BP,
1221,GO:0002720,1,0.709004509867943,0,53,positive regulation of cytokine production involved in immune response,BP,
1222,GO:0002721,1,0.993565713879955,0,1,regulation of B cell cytokine production,BP,
1223,GO:0002724,1,0.823814641944755,0,30,regulation of T cell cytokine production,BP,
1224,GO:0002725,1,0.956097819869387,0,7,negative regulation of T cell cytokine production,BP,
1225,GO:0002726,1,0.878654616694485,0,20,positive regulation of T cell cytokine production,BP,
1226,GO:0002727,1,0.949956507479464,0,8,regulation of natural killer cell cytokine production,BP,
1227,GO:0002728,1,0.987154097730232,0,2,negative regulation of natural killer cell cytokine production,BP,
1228,GO:0002729,1,0.956213849744446,0,7,positive regulation of natural killer cell cytokine production,BP,
1229,GO:0002730,1,0.924062536421302,0,12,regulation of dendritic cell cytokine production,BP,
1230,GO:0002731,1,0.987100882132443,0,2,negative regulation of dendritic cell cytokine production,BP,
1231,GO:0002732,1,0.948530518676899,0,8,positive regulation of dendritic cell cytokine production,BP,
1232,GO:0002733,1,0.96097431345299,0,6,regulation of myeloid dendritic cell cytokine production,BP,
1233,GO:0002735,1,0.96097431345299,0,6,positive regulation of myeloid dendritic cell cytokine production,BP,
1234,GO:0002736,1,0.993676916120149,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1235,GO:0002737,1,0.993676916120149,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1236,GO:0002752,1,0.987297364590871,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1237,GO:0002753,1,0.680141444510334,0,59,cytoplasmic pattern recognition receptor signaling pathway,BP,
1238,GO:0002755,1,0.796216348521428,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1239,GO:0002756,1,0.81260232750508,0,32,MyD88-independent toll-like receptor signaling pathway,BP,
1241,GO:0002758,1,0.517967829683465,0,101,innate immune response-activating signal transduction,BP,
1242,GO:0002759,1,0.974623226366896,0,4,regulation of antimicrobial humoral response,BP,
1243,GO:0002760,1,0.987295703781533,0,2,positive regulation of antimicrobial humoral response,BP,
1244,GO:0002761,1,0.506580040119029,0,104,regulation of myeloid leukocyte differentiation,BP,
1245,GO:0002762,1,0.749951441863519,0,44,negative regulation of myeloid leukocyte differentiation,BP,
1246,GO:0002763,1,0.726661489151855,0,49,positive regulation of myeloid leukocyte differentiation,BP,
1248,GO:0002765,1,0.949883590219406,0,8,immune response-inhibiting signal transduction,BP,
1249,GO:0002767,1,0.962108965362393,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1251,GO:0002769,1,0.98726918585936,0,2,natural killer cell inhibitory signaling pathway,BP,
1252,GO:0002774,1,0.980763067237932,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1253,GO:0002775,1,0.974683214842705,0,4,antimicrobial peptide production,BP,
1254,GO:0002777,1,0.993677971834293,0,1,antimicrobial peptide biosynthetic process,BP,
1255,GO:0002778,1,0.974683214842705,0,4,antibacterial peptide production,BP,
1256,GO:0002780,1,0.993677971834293,0,1,antibacterial peptide biosynthetic process,BP,
1257,GO:0002784,1,0.980885594502289,0,3,regulation of antimicrobial peptide production,BP,
1258,GO:0002785,1,0.993508234338811,0,1,negative regulation of antimicrobial peptide production,BP,
1259,GO:0002786,1,0.980885594502289,0,3,regulation of antibacterial peptide production,BP,
1260,GO:0002787,1,0.993508234338811,0,1,negative regulation of antibacterial peptide production,BP,
1265,GO:0002803,1,0.987295703781533,0,2,positive regulation of antibacterial peptide production,BP,
1266,GO:0002812,1,0.993677971834293,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1267,GO:0002819,1,0.382166974765829,0,148,regulation of adaptive immune response,BP,
1268,GO:0002820,1,0.756585437044967,0,43,negative regulation of adaptive immune response,BP,
1269,GO:0002821,1,0.54740787518458,0,93,positive regulation of adaptive immune response,BP,
1270,GO:0002822,1,0.421428720540105,0,133,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1271,GO:0002823,1,0.78134709444644,0,38,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1272,GO:0002824,1,0.565532635862264,0,88,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1273,GO:0002825,1,0.856514013102632,0,24,regulation of T-helper 1 type immune response,BP,
1274,GO:0002826,1,0.955730547787788,0,7,negative regulation of T-helper 1 type immune response,BP,
1275,GO:0002827,1,0.896221670582227,0,17,positive regulation of T-helper 1 type immune response,BP,
1276,GO:0002828,1,0.834639366218835,0,28,regulation of type 2 immune response,BP,
1277,GO:0002829,1,0.931350466896467,0,11,negative regulation of type 2 immune response,BP,
1278,GO:0002830,1,0.902001015748305,0,16,positive regulation of type 2 immune response,BP,
1279,GO:0002831,1,0.100359401391408,0,350,regulation of response to biotic stimulus,BP,
1280,GO:0002832,1,0.582870078309445,0,83,negative regulation of response to biotic stimulus,BP,
1281,GO:0002833,1,0.248130098035404,0,213,positive regulation of response to biotic stimulus,BP,
1282,GO:0002834,1,0.919449405106316,0,13,regulation of response to tumor cell,BP,
1283,GO:0002835,1,0.987144677703911,0,2,negative regulation of response to tumor cell,BP,
1284,GO:0002836,1,0.937509535022878,0,10,positive regulation of response to tumor cell,BP,
1285,GO:0002837,1,0.919449405106316,0,13,regulation of immune response to tumor cell,BP,
1286,GO:0002838,1,0.987144677703911,0,2,negative regulation of immune response to tumor cell,BP,
1287,GO:0002839,1,0.937509535022878,0,10,positive regulation of immune response to tumor cell,BP,
1288,GO:0002840,1,0.968210856479404,0,5,regulation of T cell mediated immune response to tumor cell,BP,
1289,GO:0002842,1,0.974526215929948,0,4,positive regulation of T cell mediated immune response to tumor cell,BP,
1290,GO:0002843,1,0.993636984467201,0,1,regulation of tolerance induction to tumor cell,BP,
1291,GO:0002845,1,0.993636984467201,0,1,positive regulation of tolerance induction to tumor cell,BP,
1292,GO:0002849,1,0.993584036860539,0,1,regulation of peripheral T cell tolerance induction,BP,
1293,GO:0002851,1,0.993584036860539,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1294,GO:0002852,1,0.987265159262682,0,2,regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1295,GO:0002854,1,0.987265159262682,0,2,positive regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1296,GO:0002855,1,0.955737543790599,0,7,regulation of natural killer cell mediated immune response to tumor cell,BP,
1297,GO:0002856,1,0.987144677703911,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1298,GO:0002857,1,0.968187910311229,0,5,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1299,GO:0002858,1,0.961861541300121,0,6,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1300,GO:0002859,1,0.987144677703911,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1301,GO:0002860,1,0.974390879465231,0,4,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1302,GO:0002861,1,0.851562696200358,0,25,regulation of inflammatory response to antigenic stimulus,BP,
1303,GO:0002862,1,0.932000019991069,0,11,negative regulation of inflammatory response to antigenic stimulus,BP,
1304,GO:0002863,1,0.925621926346164,0,12,positive regulation of inflammatory response to antigenic stimulus,BP,
1305,GO:0002864,1,0.913727845252109,0,14,regulation of acute inflammatory response to antigenic stimulus,BP,
1306,GO:0002865,1,0.97463005214074,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1307,GO:0002866,1,0.949703725312664,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1308,GO:0002870,1,0.968261338528077,0,5,T cell anergy,BP,
1309,GO:0002874,1,0.981024572293181,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1310,GO:0002875,1,0.993631038942475,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1311,GO:0002876,1,0.987313534207042,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1312,GO:0002877,1,0.980888006531422,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1313,GO:0002878,1,0.993534659899654,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1314,GO:0002879,1,0.98727187008263,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1315,GO:0002880,1,0.993614072915884,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1316,GO:0002882,1,0.993614072915884,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1317,GO:0002883,1,0.943799237162831,0,9,regulation of hypersensitivity,BP,
1318,GO:0002884,1,0.987276289234151,0,2,negative regulation of hypersensitivity,BP,
1319,GO:0002885,1,0.962148341014014,0,6,positive regulation of hypersensitivity,BP,
1320,GO:0002886,1,0.699708295573867,0,55,regulation of myeloid leukocyte mediated immunity,BP,
1321,GO:0002887,1,0.937311131231292,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1322,GO:0002888,1,0.812390800220636,0,32,positive regulation of myeloid leukocyte mediated immunity,BP,
1323,GO:0002889,1,0.746551413644251,0,45,regulation of immunoglobulin mediated immune response,BP,
1324,GO:0002890,1,0.931037965879284,0,11,negative regulation of immunoglobulin mediated immune response,BP,
1325,GO:0002891,1,0.823211859462557,0,30,positive regulation of immunoglobulin mediated immune response,BP,
1326,GO:0002892,1,0.974611308892094,0,4,regulation of type II hypersensitivity,BP,
1327,GO:0002893,1,0.993632610050384,0,1,negative regulation of type II hypersensitivity,BP,
1328,GO:0002894,1,0.980858017899074,0,3,positive regulation of type II hypersensitivity,BP,
1329,GO:0002895,1,0.993565040715604,0,1,regulation of central B cell tolerance induction,BP,
1330,GO:0002897,1,0.993565040715604,0,1,positive regulation of central B cell tolerance induction,BP,
1331,GO:0002901,1,0.974769331775353,0,4,mature B cell apoptotic process,BP,
1332,GO:0002902,1,0.889761641292811,0,18,regulation of B cell apoptotic process,BP,
1333,GO:0002903,1,0.931218139854474,0,11,negative regulation of B cell apoptotic process,BP,
1334,GO:0002904,1,0.98072509930323,0,3,positive regulation of B cell apoptotic process,BP,
1335,GO:0002905,1,0.974769331775353,0,4,regulation of mature B cell apoptotic process,BP,
1336,GO:0002906,1,0.974769331775353,0,4,negative regulation of mature B cell apoptotic process,BP,
1337,GO:0002911,1,0.968261338528077,0,5,regulation of lymphocyte anergy,BP,
1338,GO:0002913,1,0.987263031498168,0,2,positive regulation of lymphocyte anergy,BP,
1339,GO:0002920,1,0.691310587958546,0,57,regulation of humoral immune response,BP,
1340,GO:0002921,1,0.92464492740285,0,12,negative regulation of humoral immune response,BP,
1341,GO:0002922,1,0.913867556127111,0,14,positive regulation of humoral immune response,BP,
1342,GO:0002923,1,0.931188934401593,0,11,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1343,GO:0002924,1,0.961630356989851,0,6,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1344,GO:0002925,1,0.968356133337297,0,5,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1345,GO:0002926,1,0.993531647887378,0,1,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,BP,
1346,GO:0002930,1,0.987056651482107,0,2,trabecular meshwork development,BP,
1348,GO:0002933,1,0.974673035606481,0,4,lipid hydroxylation,BP,
1349,GO:0002934,1,0.942174616352128,0,9,desmosome organization,BP,
1350,GO:0002939,1,0.986995938618258,0,2,tRNA N1-guanine methylation,BP,
1351,GO:0002940,1,0.987191576987646,0,2,tRNA N2-guanine methylation,BP,
1352,GO:0002941,1,0.99362856345896,0,1,synoviocyte proliferation,BP,
1353,GO:0002943,1,0.974626614508723,0,4,tRNA dihydrouridine synthesis,BP,
1354,GO:0002944,1,0.986761418297814,0,2,cyclin K-CDK12 complex,CC,
1355,GO:0002945,1,0.98688835439695,0,2,cyclin K-CDK13 complex,CC,
1356,GO:0002946,1,0.987262127832669,0,2,tRNA C5-cytosine methylation,BP,
1357,GO:0002947,1,0.974571911428592,0,4,tumor necrosis factor receptor superfamily complex,CC,
1358,GO:0002949,1,0.98103038023871,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1359,GO:0002950,1,0.980591528656892,0,3,ceramide phosphoethanolamine synthase activity,MF,
1360,GO:0002951,1,0.987196384030129,0,2,leukotriene-C(4) hydrolase,MF,
1361,GO:0002953,1,0.993631908176109,0,1,5'-deoxynucleotidase activity,MF,
1366,GO:0003009,1,0.770716594821755,0,40,skeletal muscle contraction,BP,
1367,GO:0003010,1,0.967856217510405,0,5,voluntary skeletal muscle contraction,BP,
1368,GO:0003011,1,0.980744370369637,0,3,involuntary skeletal muscle contraction,BP,
1371,GO:0003014,1,0.493554894281434,0,108,renal system process,BP,
1373,GO:0003016,1,0.817155237315501,0,31,respiratory system process,BP,
1374,GO:0003017,1,0.985811550651518,0,2,lymph circulation,BP,
1376,GO:0003025,1,0.98015813645012,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1377,GO:0003026,1,0.99355705431691,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1378,GO:0003027,1,0.993626320181213,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1379,GO:0003029,1,0.993626320181213,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1380,GO:0003032,1,0.987164111670484,0,2,detection of oxygen,BP,
1381,GO:0003044,1,0.766986364914381,0,41,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1382,GO:0003050,1,0.993422550507093,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1383,GO:0003051,1,0.987125916975703,0,2,angiotensin-mediated drinking behavior,BP,
1385,GO:0003057,1,0.968345994583243,0,5,regulation of the force of heart contraction by chemical signal,BP,
1386,GO:0003058,1,0.993656939990299,0,1,hormonal regulation of the force of heart contraction,BP,
1387,GO:0003062,1,0.96142371724557,0,6,regulation of heart rate by chemical signal,BP,
1388,GO:0003064,1,0.98719101767625,0,2,regulation of heart rate by hormone,BP,
1389,GO:0003065,1,0.993620250602989,0,1,positive regulation of heart rate by epinephrine,BP,
1390,GO:0003068,1,0.993671303521141,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1391,GO:0003069,1,0.993671303521141,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1392,GO:0003070,1,0.993671303521141,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1393,GO:0003071,1,0.884452030248732,0,19,renal system process involved in regulation of systemic arterial blood pressure,BP,
1394,GO:0003072,1,0.974596409552985,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1395,GO:0003073,1,0.60224503235617,0,78,regulation of systemic arterial blood pressure,BP,
1396,GO:0003081,1,0.878906839379199,0,20,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1397,GO:0003083,1,0.993693386853134,0,1,negative regulation of renal output by angiotensin,BP,
1398,GO:0003084,1,0.93163764709912,0,11,positive regulation of systemic arterial blood pressure,BP,
1399,GO:0003085,1,0.895593530919312,0,17,negative regulation of systemic arterial blood pressure,BP,
1400,GO:0003091,1,0.815138446926148,0,31,renal water homeostasis,BP,
1401,GO:0003093,1,0.937207437701305,0,10,regulation of glomerular filtration,BP,
1402,GO:0003094,1,0.889320301976317,0,18,glomerular filtration,BP,
1403,GO:0003095,1,0.993624075000458,0,1,pressure natriuresis,BP,
1404,GO:0003096,1,0.961747838088699,0,6,renal sodium ion transport,BP,
1405,GO:0003097,1,0.968236928036299,0,5,renal water transport,BP,
1406,GO:0003099,1,0.98092432119745,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1407,GO:0003100,1,0.962029047416548,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1408,GO:0003104,1,0.974457360176836,0,4,positive regulation of glomerular filtration,BP,
1409,GO:0003105,1,0.980804332949828,0,3,negative regulation of glomerular filtration,BP,
1410,GO:0003106,1,0.993693386853134,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1411,GO:0003127,1,0.986515756202677,0,2,detection of nodal flow,BP,
1413,GO:0003129,1,0.943001939848194,0,9,heart induction,BP,
1414,GO:0003130,1,0.98719741231846,0,2,BMP signaling pathway involved in heart induction,BP,
1415,GO:0003131,1,0.993553580223093,0,1,mesodermal-endodermal cell signaling,BP,
1416,GO:0003133,1,0.98719741231846,0,2,endodermal-mesodermal cell signaling,BP,
1417,GO:0003134,1,0.98719741231846,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1418,GO:0003137,1,0.974036415340918,0,4,Notch signaling pathway involved in heart induction,BP,
1419,GO:0003138,1,0.980398875821651,0,3,primary heart field specification,BP,
1421,GO:0003140,1,0.949305533329169,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1422,GO:0003142,1,0.993583324430233,0,1,cardiogenic plate morphogenesis,BP,
1424,GO:0003147,1,0.993669783575295,0,1,neural crest cell migration involved in heart formation,BP,
1426,GO:0003149,1,0.943155344910285,0,9,membranous septum morphogenesis,BP,
1427,GO:0003150,1,0.967747522702009,0,5,muscular septum morphogenesis,BP,
1430,GO:0003157,1,0.930353089301242,0,11,endocardium development,BP,
1433,GO:0003160,1,0.961620579901444,0,6,endocardium morphogenesis,BP,
1434,GO:0003161,1,0.924416177434508,0,12,cardiac conduction system development,BP,
1435,GO:0003162,1,0.98013303753791,0,3,atrioventricular node development,BP,
1436,GO:0003163,1,0.980606658970722,0,3,sinoatrial node development,BP,
1437,GO:0003164,1,0.967986124032013,0,5,His-Purkinje system development,BP,
1438,GO:0003165,1,0.987018195999862,0,2,Purkinje myocyte development,BP,
1439,GO:0003166,1,0.974453512727039,0,4,bundle of His development,BP,
1440,GO:0003167,1,0.993437990272397,0,1,atrioventricular bundle cell differentiation,BP,
1441,GO:0003168,1,0.993611455304405,0,1,Purkinje myocyte differentiation,BP,
1442,GO:0003169,1,0.986591058896613,0,2,coronary vein morphogenesis,BP,
1443,GO:0003170,1,0.6812065916982,0,58,heart valve development,BP,
1444,GO:0003171,1,0.852806514495382,0,24,atrioventricular valve development,BP,
1445,GO:0003172,1,0.993309755476536,0,1,sinoatrial valve development,BP,
1446,GO:0003174,1,0.935434952348993,0,10,mitral valve development,BP,
1447,GO:0003175,1,0.961070872213013,0,6,tricuspid valve development,BP,
1448,GO:0003176,1,0.810509364765976,0,32,aortic valve development,BP,
1449,GO:0003177,1,0.875904241082977,0,20,pulmonary valve development,BP,
1450,GO:0003178,1,0.993030207644103,0,1,coronary sinus valve development,BP,
1451,GO:0003179,1,0.722742236906355,0,49,heart valve morphogenesis,BP,
1452,GO:0003180,1,0.832449078291154,0,28,aortic valve morphogenesis,BP,
1453,GO:0003181,1,0.858279501932379,0,23,atrioventricular valve morphogenesis,BP,
1454,GO:0003182,1,0.993030207644103,0,1,coronary sinus valve morphogenesis,BP,
1455,GO:0003183,1,0.935434952348993,0,10,mitral valve morphogenesis,BP,
1456,GO:0003184,1,0.89959549796637,0,16,pulmonary valve morphogenesis,BP,
1457,GO:0003185,1,0.993309755476536,0,1,sinoatrial valve morphogenesis,BP,
1458,GO:0003186,1,0.967231268672321,0,5,tricuspid valve morphogenesis,BP,
1459,GO:0003188,1,0.923956812341705,0,12,heart valve formation,BP,
1460,GO:0003190,1,0.94801517330472,0,8,atrioventricular valve formation,BP,
1461,GO:0003192,1,0.97958579240978,0,3,mitral valve formation,BP,
1462,GO:0003193,1,0.993633011042041,0,1,pulmonary valve formation,BP,
1463,GO:0003195,1,0.987134832740957,0,2,tricuspid valve formation,BP,
1464,GO:0003197,1,0.743770267852831,0,45,endocardial cushion development,BP,
1465,GO:0003198,1,0.894827625434418,0,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1466,GO:0003199,1,0.980950459014038,0,3,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1467,GO:0003203,1,0.794592347716914,0,35,endocardial cushion morphogenesis,BP,
1470,GO:0003207,1,0.930294760667701,0,11,cardiac chamber formation,BP,
1472,GO:0003209,1,0.842042637134336,0,26,cardiac atrium morphogenesis,BP,
1473,GO:0003210,1,0.993662440202503,0,1,cardiac atrium formation,BP,
1474,GO:0003211,1,0.942366633451974,0,9,cardiac ventricle formation,BP,
1475,GO:0003213,1,0.986425941192757,0,2,cardiac right atrium morphogenesis,BP,
1477,GO:0003215,1,0.888521475272171,0,18,cardiac right ventricle morphogenesis,BP,
1478,GO:0003218,1,0.993509157505027,0,1,cardiac left ventricle formation,BP,
1479,GO:0003219,1,0.980367744080548,0,3,cardiac right ventricle formation,BP,
1481,GO:0003221,1,0.98011676109549,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1482,GO:0003222,1,0.89929418119773,0,16,ventricular trabecula myocardium morphogenesis,BP,
1484,GO:0003226,1,0.992915558167278,0,1,right ventricular compact myocardium morphogenesis,BP,
1485,GO:0003228,1,0.961824387258097,0,6,atrial cardiac muscle tissue development,BP,
1487,GO:0003230,1,0.808808099197156,0,32,cardiac atrium development,BP,
1489,GO:0003235,1,0.993662440202503,0,1,sinus venosus development,BP,
1490,GO:0003236,1,0.993662440202503,0,1,sinus venosus morphogenesis,BP,
1491,GO:0003241,1,0.974116810013781,0,4,growth involved in heart morphogenesis,BP,
1492,GO:0003245,1,0.987212494947457,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1493,GO:0003247,1,0.993630437004572,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1494,GO:0003249,1,0.979009281196262,0,3,cell proliferation involved in heart valve morphogenesis,BP,
1495,GO:0003250,1,0.979009281196262,0,3,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1496,GO:0003251,1,0.993083098376319,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1497,GO:0003252,1,0.985829133800998,0,2,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003253,1,0.955834592342241,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1502,GO:0003259,1,0.993662440202503,0,1,cardioblast anterior-lateral migration,BP,
1503,GO:0003260,1,0.993662440202503,0,1,cardioblast migration,BP,
1504,GO:0003263,1,0.936889947932666,0,10,cardioblast proliferation,BP,
1505,GO:0003264,1,0.936889947932666,0,10,regulation of cardioblast proliferation,BP,
1506,GO:0003266,1,0.942965559478377,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1507,GO:0003270,1,0.993030207644103,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1508,GO:0003271,1,0.993579491715205,0,1,smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1509,GO:0003272,1,0.854127175235934,0,24,endocardial cushion formation,BP,
1510,GO:0003273,1,0.973320588087562,0,4,cell migration involved in endocardial cushion formation,BP,
1511,GO:0003274,1,0.974212224029563,0,4,endocardial cushion fusion,BP,
1512,GO:0003275,1,0.98067613533177,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1513,GO:0003278,1,0.96815453882088,0,5,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003283,1,0.875590501426595,0,20,atrial septum development,BP,
1517,GO:0003284,1,0.974152420935777,0,4,septum primum development,BP,
1518,GO:0003285,1,0.987174395245535,0,2,septum secundum development,BP,
1519,GO:0003289,1,0.974152420935777,0,4,atrial septum primum morphogenesis,BP,
1520,GO:0003290,1,0.993521965969021,0,1,atrial septum secundum morphogenesis,BP,
1521,GO:0003292,1,0.987013210655536,0,2,cardiac septum cell differentiation,BP,
1523,GO:0003299,1,0.87071519479244,0,21,muscle hypertrophy in response to stress,BP,
1526,GO:0003306,1,0.936923226256337,0,10,Wnt signaling pathway involved in heart development,BP,
1527,GO:0003307,1,0.949313804149303,0,8,regulation of Wnt signaling pathway involved in heart development,BP,
1528,GO:0003308,1,0.955448163480316,0,7,negative regulation of Wnt signaling pathway involved in heart development,BP,
1529,GO:0003309,1,0.854650388927803,0,24,type B pancreatic cell differentiation,BP,
1530,GO:0003310,1,0.961756028123509,0,6,pancreatic A cell differentiation,BP,
1531,GO:0003312,1,0.987207701233649,0,2,pancreatic PP cell differentiation,BP,
1532,GO:0003318,1,0.993662440202503,0,1,cell migration to the midline involved in heart development,BP,
1533,GO:0003321,1,0.955508727949155,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1534,GO:0003322,1,0.993257153553221,0,1,pancreatic A cell development,BP,
1535,GO:0003323,1,0.877357376043062,0,20,type B pancreatic cell development,BP,
1536,GO:0003326,1,0.987207701233649,0,2,pancreatic A cell fate commitment,BP,
1537,GO:0003327,1,0.993601286206653,0,1,type B pancreatic cell fate commitment,BP,
1538,GO:0003329,1,0.987207701233649,0,2,pancreatic PP cell fate commitment,BP,
1539,GO:0003330,1,0.955243842336807,0,7,regulation of extracellular matrix constituent secretion,BP,
1540,GO:0003331,1,0.987166628320144,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1541,GO:0003332,1,0.973943033889109,0,4,negative regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003334,1,0.942012719192361,0,9,keratinocyte development,BP,
1544,GO:0003335,1,0.987244835759656,0,2,corneocyte development,BP,
1547,GO:0003339,1,0.949656048886578,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003340,1,0.980835379177432,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1549,GO:0003341,1,0.451576648170548,0,121,cilium movement,BP,
1550,GO:0003342,1,0.987195157860844,0,2,proepicardium development,BP,
1551,GO:0003343,1,0.987195157860844,0,2,septum transversum development,BP,
1552,GO:0003344,1,0.941743638335488,0,9,pericardium morphogenesis,BP,
1553,GO:0003345,1,0.993496786067058,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1554,GO:0003348,1,0.961089638550235,0,6,cardiac endothelial cell differentiation,BP,
1555,GO:0003350,1,0.98705750737154,0,2,pulmonary myocardium development,BP,
1556,GO:0003351,1,0.836626343460197,0,27,epithelial cilium movement involved in extracellular fluid movement,BP,
1557,GO:0003352,1,0.850295984371004,0,25,regulation of cilium movement,BP,
1558,GO:0003353,1,0.937877931980531,0,10,positive regulation of cilium movement,BP,
1559,GO:0003354,1,0.993611019233983,0,1,negative regulation of cilium movement,BP,
1560,GO:0003356,1,0.930212218762521,0,11,regulation of cilium beat frequency,BP,
1561,GO:0003357,1,0.961482539225113,0,6,noradrenergic neuron differentiation,BP,
1562,GO:0003358,1,0.987170086840854,0,2,noradrenergic neuron development,BP,
1563,GO:0003359,1,0.99357512678926,0,1,noradrenergic neuron fate commitment,BP,
1564,GO:0003360,1,0.960928303808772,0,6,brainstem development,BP,
1565,GO:0003365,1,0.979887488680776,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1566,GO:0003366,1,0.986926365507085,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1567,GO:0003373,1,0.948793956381884,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1568,GO:0003374,1,0.948793956381884,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1570,GO:0003382,1,0.808763409657382,0,32,epithelial cell morphogenesis,BP,
1571,GO:0003383,1,0.973455210223822,0,4,apical constriction,BP,
1572,GO:0003400,1,0.97428368161292,0,4,regulation of COPII vesicle coating,BP,
1574,GO:0003402,1,0.961307711977533,0,6,planar cell polarity pathway involved in axis elongation,BP,
1575,GO:0003404,1,0.987141203647947,0,2,optic vesicle morphogenesis,BP,
1576,GO:0003406,1,0.967795028137156,0,5,retinal pigment epithelium development,BP,
1578,GO:0003408,1,0.980156193756705,0,3,optic cup formation involved in camera-type eye development,BP,
1579,GO:0003409,1,0.993527725306359,0,1,optic cup structural organization,BP,
1580,GO:0003413,1,0.912614637209826,0,14,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1581,GO:0003414,1,0.993499148127462,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1582,GO:0003415,1,0.967927238936675,0,5,chondrocyte hypertrophy,BP,
1583,GO:0003416,1,0.838509215733488,0,27,endochondral bone growth,BP,
1584,GO:0003417,1,0.88405822145282,0,19,growth plate cartilage development,BP,
1585,GO:0003418,1,0.943156630850127,0,9,growth plate cartilage chondrocyte differentiation,BP,
1586,GO:0003419,1,0.97473195471307,0,4,growth plate cartilage chondrocyte proliferation,BP,
1587,GO:0003420,1,0.987159114500814,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003421,1,0.993496585506695,0,1,growth plate cartilage axis specification,BP,
1589,GO:0003422,1,0.987037591319679,0,2,growth plate cartilage morphogenesis,BP,
1590,GO:0003429,1,0.993499148127462,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1591,GO:0003430,1,0.980617047674442,0,3,growth plate cartilage chondrocyte growth,BP,
1592,GO:0003431,1,0.967868199872185,0,5,growth plate cartilage chondrocyte development,BP,
1593,GO:0003433,1,0.949099668161678,0,8,chondrocyte development involved in endochondral bone morphogenesis,BP,
1597,GO:0003678,1,0.617514217891271,0,73,DNA helicase activity,MF,
1598,GO:0003680,1,0.95542843167669,0,7,minor groove of adenine-thymine-rich DNA binding,MF,
1599,GO:0003681,1,0.993538557513355,0,1,bent DNA binding,MF,
1600,GO:0003682,1,0.0293866391561252,0,529,chromatin binding,MF,
1601,GO:0003684,1,0.662387935482244,0,63,damaged DNA binding,MF,
1602,GO:0003688,1,0.861293733583189,0,23,DNA replication origin binding,MF,
1603,GO:0003689,1,0.94358312210315,0,9,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.943350188826776,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.993593888150111,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.974156977866223,0,4,satellite DNA binding,MF,
1608,GO:0003697,1,0.507522844461218,0,104,single-stranded DNA binding,MF,
1610,GO:0003707,1,0.847787156456315,0,25,steroid hormone receptor activity,MF,
1611,GO:0003711,1,0.987036189938744,0,2,transcription elongation regulator activity,MF,
1612,GO:0003712,1,0.0460504085712815,0,464,transcription coregulator activity,MF,
1613,GO:0003713,1,0.188726005403781,0,253,transcription coactivator activity,MF,
1614,GO:0003714,1,0.303931206611602,0,181,transcription corepressor activity,MF,
1615,GO:0003720,1,0.961287613370863,0,6,telomerase activity,MF,
1616,GO:0003721,1,0.993488969734737,0,1,telomerase RNA reverse transcriptase activity,MF,
1618,GO:0003724,1,0.624605572492574,0,72,RNA helicase activity,MF,
1619,GO:0003725,1,0.61176610483253,0,75,double-stranded RNA binding,MF,
1620,GO:0003726,1,0.974067827499745,0,4,double-stranded RNA adenosine deaminase activity,MF,
1621,GO:0003727,1,0.589908500238731,0,81,single-stranded RNA binding,MF,
1622,GO:0003729,1,0.165025205113616,0,274,mRNA binding,MF,
1623,GO:0003730,1,0.56958078804155,0,86,mRNA 3'-UTR binding,MF,
1624,GO:0003735,1,0.376273871867447,0,153,structural constituent of ribosome,MF,
1625,GO:0003743,1,0.727898080256903,0,49,translation initiation factor activity,MF,
1626,GO:0003746,1,0.895720055135517,0,17,translation elongation factor activity,MF,
1627,GO:0003747,1,0.961641030282619,0,6,translation release factor activity,MF,
1628,GO:0003755,1,0.824569835282112,0,30,peptidyl-prolyl cis-trans isomerase activity,MF,
1629,GO:0003756,1,0.901486447569157,0,16,protein disulfide isomerase activity,MF,
1630,GO:0003774,1,0.433167635241085,0,124,motor activity,MF,
1631,GO:0003777,1,0.606066888833231,0,74,microtubule motor activity,MF,
1633,GO:0003785,1,0.855868264027758,0,24,actin monomer binding,MF,
1634,GO:0003796,1,0.987351915276899,0,2,lysozyme activity,MF,
1635,GO:0003810,1,0.955701468911898,0,7,protein-glutamine gamma-glutamyltransferase activity,MF,
1636,GO:0003823,1,0.714780498522364,0,52,antigen binding,MF,
1638,GO:0003826,1,0.987226873523804,0,2,alpha-ketoacid dehydrogenase activity,MF,
1639,GO:0003827,1,0.993548305437112,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1640,GO:0003828,1,0.960658540788562,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1641,GO:0003829,1,0.986933996686022,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003830,1,0.99341736789544,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003831,1,0.968164566653037,0,5,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1644,GO:0003834,1,0.987150068329575,0,2,beta-carotene 15,15'-monooxygenase activity,MF,
1645,GO:0003835,1,0.986782095967082,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1646,GO:0003836,1,0.980469467958875,0,3,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1647,GO:0003837,1,0.993601419490681,0,1,beta-ureidopropionase activity,MF,
1648,GO:0003839,1,0.981076540059567,0,3,gamma-glutamylcyclotransferase activity,MF,
1649,GO:0003841,1,0.912265978858791,0,14,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1650,GO:0003842,1,0.993530373480267,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1651,GO:0003844,1,0.993537909365421,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1652,GO:0003845,1,0.987299995711113,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1653,GO:0003846,1,0.987123137050372,0,2,2-acylglycerol O-acyltransferase activity,MF,
1654,GO:0003847,1,0.956101431357051,0,7,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1655,GO:0003851,1,0.993549348930523,0,1,2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity,MF,
1656,GO:0003854,1,0.980905363462327,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.949912951393099,0,8,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.987112270366269,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.99361088507242,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.987226873523804,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.987193226125423,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.993425585143341,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.993628362645024,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.98722869527992,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.98075565819342,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.974249334154165,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.993677246056371,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.987181696246034,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.987013372953963,0,2,AMP deaminase activity,MF,
1670,GO:0003878,1,0.993466352008072,0,1,ATP citrate synthase activity,MF,
1671,GO:0003880,1,0.987128362669805,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1672,GO:0003881,1,0.993614610049831,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1673,GO:0003882,1,0.993576586363069,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1674,GO:0003883,1,0.987090975174982,0,2,CTP synthase activity,MF,
1675,GO:0003884,1,0.987304762926478,0,2,D-amino-acid oxidase activity,MF,
1676,GO:0003886,1,0.980476417838515,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1677,GO:0003887,1,0.859885441779215,0,23,DNA-directed DNA polymerase activity,MF,
1678,GO:0003896,1,0.980907583509208,0,3,DNA primase activity,MF,
1679,GO:0003899,1,0.787398450901668,0,37,DNA-directed 5'-3' RNA polymerase activity,MF,
1680,GO:0003905,1,0.993667138868627,0,1,alkylbase DNA N-glycosylase activity,MF,
1681,GO:0003906,1,0.919969272629843,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1682,GO:0003908,1,0.99365528165529,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1683,GO:0003909,1,0.980671564416421,0,3,DNA ligase activity,MF,
1684,GO:0003910,1,0.980671564416421,0,3,DNA ligase (ATP) activity,MF,
1685,GO:0003912,1,0.993603320630034,0,1,DNA nucleotidylexotransferase activity,MF,
1686,GO:0003916,1,0.96152093287597,0,6,DNA topoisomerase activity,MF,
1687,GO:0003917,1,0.974381826900776,0,4,DNA topoisomerase type I (single strand cut, ATP-independent) activity,MF,
1688,GO:0003918,1,0.986804373287233,0,2,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity,MF,
1689,GO:0003919,1,0.99360800250412,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.987292812091904,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.993575697177987,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.993575697177987,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.980723216548039,0,3,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.993609275710424,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.993609275710424,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.99359962170577,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.987239844976311,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.99357166287299,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.993593261226275,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.980974362712847,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.98710492839429,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.993592404321181,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.96812216895097,0,5,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.993543025542769,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.993600220587304,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.866428256362361,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.900401902977628,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.993577031815251,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.90100967510994,0,16,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.785292262745526,0,38,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.980879370176901,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.981035478081144,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.993443834564564,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.961445208638276,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.974709352765481,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003963,1,0.99355705431691,0,1,RNA-3'-phosphate cyclase activity,MF,
1718,GO:0003964,1,0.961287613370863,0,6,RNA-directed DNA polymerase activity,MF,
1719,GO:0003968,1,0.986815369506144,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1720,GO:0003972,1,0.99355705431691,0,1,RNA ligase (ATP) activity,MF,
1721,GO:0003973,1,0.980708161631508,0,3,(S)-2-hydroxy-acid oxidase activity,MF,
1722,GO:0003974,1,0.993632108729713,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1723,GO:0003975,1,0.993596501007589,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1724,GO:0003976,1,0.980743926300254,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003977,1,0.987149615136021,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1726,GO:0003978,1,0.993632108729713,0,1,UDP-glucose 4-epimerase activity,MF,
1727,GO:0003979,1,0.993533298185381,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1728,GO:0003980,1,0.98634188627115,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1729,GO:0003983,1,0.993596567278639,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1730,GO:0003984,1,0.993585855414673,0,1,acetolactate synthase activity,MF,
1731,GO:0003985,1,0.974627033546247,0,4,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.968574414845518,0,5,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.980668459789134,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.956081507798059,0,7,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.993033036880822,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.987186447827457,0,2,acetylcholinesterase activity,MF,
1737,GO:0003993,1,0.962374942741506,0,6,acid phosphatase activity,MF,
1738,GO:0003994,1,0.980501171008818,0,3,aconitate hydratase activity,MF,
1739,GO:0003995,1,0.931143893226394,0,11,acyl-CoA dehydrogenase activity,MF,
1740,GO:0003996,1,0.919212439403649,0,13,acyl-CoA ligase activity,MF,
1741,GO:0003997,1,0.961703031333841,0,6,acyl-CoA oxidase activity,MF,
1742,GO:0003998,1,0.987394257320509,0,2,acylphosphatase activity,MF,
1743,GO:0003999,1,0.993690096640088,0,1,adenine phosphoribosyltransferase activity,MF,
1744,GO:0004000,1,0.93693128269213,0,10,adenosine deaminase activity,MF,
1745,GO:0004001,1,0.993602486384613,0,1,adenosine kinase activity,MF,
1746,GO:0004013,1,0.993586832538947,0,1,adenosylhomocysteinase activity,MF,
1747,GO:0004014,1,0.993529657669243,0,1,adenosylmethionine decarboxylase activity,MF,
1748,GO:0004016,1,0.935133467240886,0,10,adenylate cyclase activity,MF,
1750,GO:0004018,1,0.993640985774167,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1751,GO:0004020,1,0.987109595128248,0,2,adenylylsulfate kinase activity,MF,
1752,GO:0004021,1,0.987148535899793,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1753,GO:0004022,1,0.96836801023382,0,5,alcohol dehydrogenase (NAD+) activity,MF,
1754,GO:0004024,1,0.980856228510659,0,3,alcohol dehydrogenase activity, zinc-dependent,MF,
1755,GO:0004027,1,0.993657802017862,0,1,alcohol sulfotransferase activity,MF,
1756,GO:0004028,1,0.974452748770284,0,4,3-chloroallyl aldehyde dehydrogenase activity,MF,
1757,GO:0004029,1,0.913045105289361,0,14,aldehyde dehydrogenase (NAD+) activity,MF,
1758,GO:0004030,1,0.907203107961674,0,15,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1759,GO:0004031,1,0.987037512133835,0,2,aldehyde oxidase activity,MF,
1760,GO:0004032,1,0.932206766829501,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1761,GO:0004033,1,0.851960520144448,0,25,aldo-keto reductase (NADP) activity,MF,
1762,GO:0004034,1,0.993574494173141,0,1,aldose 1-epimerase activity,MF,
1763,GO:0004035,1,0.98716050406878,0,2,alkaline phosphatase activity,MF,
1764,GO:0004037,1,0.993643051019443,0,1,allantoicase activity,MF,
1765,GO:0004040,1,0.98728778224901,0,2,amidase activity,MF,
1766,GO:0004042,1,0.993601286206653,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1767,GO:0004043,1,0.99351378750625,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1768,GO:0004044,1,0.993503735944501,0,1,amidophosphoribosyltransferase activity,MF,
1769,GO:0004045,1,0.981048336005619,0,3,aminoacyl-tRNA hydrolase activity,MF,
1770,GO:0004046,1,0.974770544591321,0,4,aminoacylase activity,MF,
1771,GO:0004047,1,0.987280934220258,0,2,aminomethyltransferase activity,MF,
1772,GO:0004051,1,0.993569790012993,0,1,arachidonate 5-lipoxygenase activity,MF,
1773,GO:0004052,1,0.980839224198107,0,3,arachidonate 12(S)-lipoxygenase activity,MF,
1774,GO:0004053,1,0.987290651409777,0,2,arginase activity,MF,
1775,GO:0004055,1,0.993617799809031,0,1,argininosuccinate synthase activity,MF,
1776,GO:0004056,1,0.993606629809115,0,1,argininosuccinate lyase activity,MF,
1777,GO:0004057,1,0.993591877580252,0,1,arginyltransferase activity,MF,
1778,GO:0004058,1,0.993604790345139,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1779,GO:0004059,1,0.993641718764055,0,1,aralkylamine N-acetyltransferase activity,MF,
1780,GO:0004060,1,0.98101893132797,0,3,arylamine N-acetyltransferase activity,MF,
1781,GO:0004061,1,0.993626487655239,0,1,arylformamidase activity,MF,
1782,GO:0004062,1,0.968633391185651,0,5,aryl sulfotransferase activity,MF,
1783,GO:0004063,1,0.987322752279399,0,2,aryldialkylphosphatase activity,MF,
1784,GO:0004064,1,0.962352151890404,0,6,arylesterase activity,MF,
1785,GO:0004065,1,0.924694582393649,0,12,arylsulfatase activity,MF,
1786,GO:0004066,1,0.987200615663076,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1787,GO:0004067,1,0.98723755534997,0,2,asparaginase activity,MF,
1788,GO:0004068,1,0.993560801035551,0,1,aspartate 1-decarboxylase activity,MF,
1789,GO:0004069,1,0.987214736105641,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1790,GO:0004070,1,0.993234704873342,0,1,aspartate carbamoyltransferase activity,MF,
1791,GO:0004074,1,0.987389534443695,0,2,biliverdin reductase (NAD(P)+) activity,MF,
1792,GO:0004075,1,0.993570537705107,0,1,biotin carboxylase activity,MF,
1793,GO:0004077,1,0.993334450818515,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1794,GO:0004078,1,0.993334450818515,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1795,GO:0004079,1,0.993334450818515,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1796,GO:0004080,1,0.993334450818515,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1797,GO:0004081,1,0.993673615449867,0,1,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1798,GO:0004082,1,0.97478523434614,0,4,bisphosphoglycerate mutase activity,MF,
1799,GO:0004084,1,0.986806044626505,0,2,branched-chain-amino-acid transaminase activity,MF,
1800,GO:0004085,1,0.98710043961143,0,2,butyryl-CoA dehydrogenase activity,MF,
1801,GO:0004087,1,0.993356941546488,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1802,GO:0004088,1,0.986636142325274,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1803,GO:0004089,1,0.913831001026678,0,14,carbonate dehydratase activity,MF,
1805,GO:0004092,1,0.993553898620515,0,1,carnitine O-acetyltransferase activity,MF,
1806,GO:0004095,1,0.974395878234102,0,4,carnitine O-palmitoyltransferase activity,MF,
1807,GO:0004096,1,0.974640468888645,0,4,catalase activity,MF,
1808,GO:0004098,1,0.993612596091886,0,1,cerebroside-sulfatase activity,MF,
1809,GO:0004102,1,0.993575506940464,0,1,choline O-acetyltransferase activity,MF,
1810,GO:0004103,1,0.987232731503218,0,2,choline kinase activity,MF,
1811,GO:0004104,1,0.980829622984004,0,3,cholinesterase activity,MF,
1812,GO:0004105,1,0.987054787347506,0,2,choline-phosphate cytidylyltransferase activity,MF,
1813,GO:0004108,1,0.99354490102801,0,1,citrate (Si)-synthase activity,MF,
1814,GO:0004109,1,0.987174889457047,0,2,coproporphyrinogen oxidase activity,MF,
1815,GO:0004111,1,0.962004824317024,0,6,creatine kinase activity,MF,
1817,GO:0004113,1,0.99340149531635,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1819,GO:0004115,1,0.923991518187006,0,12,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1821,GO:0004118,1,0.979893813833233,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004119,1,0.986851387481575,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004122,1,0.993567127228303,0,1,cystathionine beta-synthase activity,MF,
1824,GO:0004123,1,0.993623303821261,0,1,cystathionine gamma-lyase activity,MF,
1825,GO:0004126,1,0.937907515958905,0,10,cytidine deaminase activity,MF,
1826,GO:0004127,1,0.974462960331974,0,4,cytidylate kinase activity,MF,
1828,GO:0004129,1,0.87496583004443,0,21,cytochrome-c oxidase activity,MF,
1829,GO:0004132,1,0.993604122074002,0,1,dCMP deaminase activity,MF,
1830,GO:0004133,1,0.993228923395904,0,1,glycogen debranching enzyme activity,MF,
1831,GO:0004134,1,0.993228923395904,0,1,4-alpha-glucanotransferase activity,MF,
1832,GO:0004135,1,0.993228923395904,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1833,GO:0004136,1,0.987279341978086,0,2,deoxyadenosine kinase activity,MF,
1834,GO:0004137,1,0.98702391604782,0,2,deoxycytidine kinase activity,MF,
1835,GO:0004138,1,0.987279341978086,0,2,deoxyguanosine kinase activity,MF,
1836,GO:0004139,1,0.993624477263957,0,1,deoxyribose-phosphate aldolase activity,MF,
1837,GO:0004140,1,0.987230346704666,0,2,dephospho-CoA kinase activity,MF,
1838,GO:0004142,1,0.980801833459981,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1839,GO:0004143,1,0.936129554983836,0,10,diacylglycerol kinase activity,MF,
1840,GO:0004144,1,0.987123137050372,0,2,diacylglycerol O-acyltransferase activity,MF,
1841,GO:0004145,1,0.980893897746943,0,3,diamine N-acetyltransferase activity,MF,
1842,GO:0004146,1,0.993494161434535,0,1,dihydrofolate reductase activity,MF,
1843,GO:0004148,1,0.993512555144168,0,1,dihydrolipoyl dehydrogenase activity,MF,
1844,GO:0004149,1,0.993552226090051,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1845,GO:0004151,1,0.993234704873342,0,1,dihydroorotase activity,MF,
1846,GO:0004152,1,0.993601552792331,0,1,dihydroorotate dehydrogenase activity,MF,
1847,GO:0004155,1,0.99362956730479,0,1,6,7-dihydropteridine reductase activity,MF,
1848,GO:0004157,1,0.993597694758052,0,1,dihydropyrimidinase activity,MF,
1849,GO:0004161,1,0.98723569659904,0,2,dimethylallyltranstransferase activity,MF,
1850,GO:0004163,1,0.993619579239474,0,1,diphosphomevalonate decarboxylase activity,MF,
1851,GO:0004164,1,0.993620116337282,0,1,diphthine synthase activity,MF,
1852,GO:0004165,1,0.980732480122549,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1853,GO:0004167,1,0.981100432722266,0,3,dopachrome isomerase activity,MF,
1854,GO:0004168,1,0.993592931510071,0,1,dolichol kinase activity,MF,
1855,GO:0004169,1,0.942728771454897,0,9,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1856,GO:0004170,1,0.993614677194696,0,1,dUTP diphosphatase activity,MF,
1857,GO:0004174,1,0.987154653898441,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1859,GO:0004176,1,0.968150882845328,0,5,ATP-dependent peptidase activity,MF,
1860,GO:0004177,1,0.756231104296603,0,43,aminopeptidase activity,MF,
1863,GO:0004185,1,0.967983382634408,0,5,serine-type carboxypeptidase activity,MF,
1864,GO:0004190,1,0.890131150414247,0,18,aspartic-type endopeptidase activity,MF,
1865,GO:0004197,1,0.564980482958564,0,87,cysteine-type endopeptidase activity,MF,
1866,GO:0004198,1,0.931192279080218,0,11,calcium-dependent cysteine-type endopeptidase activity,MF,
1867,GO:0004222,1,0.546569517277643,0,92,metalloendopeptidase activity,MF,
1869,GO:0004298,1,0.891822735363484,0,18,threonine-type endopeptidase activity,MF,
1870,GO:0004300,1,0.937719810446272,0,10,enoyl-CoA hydratase activity,MF,
1871,GO:0004301,1,0.962265300066073,0,6,epoxide hydrolase activity,MF,
1872,GO:0004303,1,0.932019835315886,0,11,estradiol 17-beta-dehydrogenase activity,MF,
1873,GO:0004304,1,0.99362078762623,0,1,estrone sulfotransferase activity,MF,
1874,GO:0004305,1,0.974492883767517,0,4,ethanolamine kinase activity,MF,
1875,GO:0004306,1,0.993615684432828,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1876,GO:0004307,1,0.987298151640666,0,2,ethanolaminephosphotransferase activity,MF,
1877,GO:0004308,1,0.980865206977092,0,3,exo-alpha-sialidase activity,MF,
1878,GO:0004309,1,0.973531786001792,0,4,exopolyphosphatase activity,MF,
1879,GO:0004310,1,0.993598956749965,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1880,GO:0004311,1,0.980820160917624,0,3,farnesyltranstransferase activity,MF,
1881,GO:0004312,1,0.937071937687716,0,10,fatty acid synthase activity,MF,
1882,GO:0004313,1,0.993109877834153,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1883,GO:0004314,1,0.986763081946851,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1884,GO:0004315,1,0.986807716193671,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1885,GO:0004316,1,0.993109877834153,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1886,GO:0004317,1,0.993109877834153,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1887,GO:0004320,1,0.986775782043092,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1888,GO:0004321,1,0.974585008110862,0,4,fatty-acyl-CoA synthase activity,MF,
1889,GO:0004322,1,0.961421918924624,0,6,ferroxidase activity,MF,
1890,GO:0004324,1,0.993612998811935,0,1,ferredoxin-NADP+ reductase activity,MF,
1891,GO:0004325,1,0.993223127831834,0,1,ferrochelatase activity,MF,
1892,GO:0004326,1,0.993574052071418,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1893,GO:0004329,1,0.987071159884228,0,2,formate-tetrahydrofolate ligase activity,MF,
1894,GO:0004331,1,0.974249334154165,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1895,GO:0004332,1,0.980965317863819,0,3,fructose-bisphosphate aldolase activity,MF,
1896,GO:0004333,1,0.993620116337282,0,1,fumarate hydratase activity,MF,
1897,GO:0004334,1,0.993642584796253,0,1,fumarylacetoacetase activity,MF,
1898,GO:0004335,1,0.987224141063316,0,2,galactokinase activity,MF,
1899,GO:0004336,1,0.987216952184729,0,2,galactosylceramidase activity,MF,
1900,GO:0004337,1,0.98723569659904,0,2,geranyltranstransferase activity,MF,
1901,GO:0004339,1,0.993289981237472,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1902,GO:0004340,1,0.967772838107429,0,5,glucokinase activity,MF,
1903,GO:0004341,1,0.993611019233983,0,1,gluconolactonase activity,MF,
1904,GO:0004342,1,0.987238790495732,0,2,glucosamine-6-phosphate deaminase activity,MF,
1905,GO:0004343,1,0.993493579386938,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1906,GO:0004344,1,0.993050631663841,0,1,glucose dehydrogenase activity,MF,
1907,GO:0004345,1,0.986678458669127,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1908,GO:0004346,1,0.980834410601425,0,3,glucose-6-phosphatase activity,MF,
1909,GO:0004347,1,0.993600287153707,0,1,glucose-6-phosphate isomerase activity,MF,
1910,GO:0004348,1,0.980840029204895,0,3,glucosylceramidase activity,MF,
1911,GO:0004349,1,0.993518684820754,0,1,glutamate 5-kinase activity,MF,
1912,GO:0004350,1,0.993518684820754,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1913,GO:0004351,1,0.987187887699155,0,2,glutamate decarboxylase activity,MF,
1914,GO:0004352,1,0.987143646551886,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1915,GO:0004353,1,0.987143646551886,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1916,GO:0004356,1,0.993465978515376,0,1,glutamate-ammonia ligase activity,MF,
1917,GO:0004357,1,0.987086242861852,0,2,glutamate-cysteine ligase activity,MF,
1918,GO:0004359,1,0.980732886810121,0,3,glutaminase activity,MF,
1919,GO:0004360,1,0.986681342008797,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1920,GO:0004361,1,0.993625482651768,0,1,glutaryl-CoA dehydrogenase activity,MF,
1921,GO:0004362,1,0.993588269144815,0,1,glutathione-disulfide reductase activity,MF,
1922,GO:0004363,1,0.993612394748107,0,1,glutathione synthase activity,MF,
1923,GO:0004364,1,0.88019356249011,0,20,glutathione transferase activity,MF,
1924,GO:0004365,1,0.993652029015428,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1925,GO:0004366,1,0.986897772763483,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1926,GO:0004367,1,0.99355079633967,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1927,GO:0004368,1,0.986935426023332,0,2,glycerol-3-phosphate dehydrogenase (quinone) activity,MF,
1928,GO:0004370,1,0.986478689313179,0,2,glycerol kinase activity,MF,
1929,GO:0004372,1,0.987207013938763,0,2,glycine hydroxymethyltransferase activity,MF,
1930,GO:0004373,1,0.98709782397572,0,2,glycogen (starch) synthase activity,MF,
1931,GO:0004375,1,0.993499374287033,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1932,GO:0004376,1,0.968173406277944,0,5,glycolipid mannosyltransferase activity,MF,
1933,GO:0004377,1,0.993571287338555,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1934,GO:0004378,1,0.993549151096788,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1935,GO:0004379,1,0.986888968507763,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1936,GO:0004380,1,0.993634247072194,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1937,GO:0004381,1,0.993634247072194,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1938,GO:0004382,1,0.987161722088901,0,2,guanosine-diphosphatase activity,MF,
1939,GO:0004383,1,0.974301900011995,0,4,guanylate cyclase activity,MF,
1940,GO:0004385,1,0.942298337249867,0,9,guanylate kinase activity,MF,
1941,GO:0004386,1,0.366199537754451,0,152,helicase activity,MF,
1942,GO:0004392,1,0.987299963474816,0,2,heme oxygenase (decyclizing) activity,MF,
1943,GO:0004394,1,0.993478955219004,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1944,GO:0004395,1,0.993655215305584,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1945,GO:0004396,1,0.967772838107429,0,5,hexokinase activity,MF,
1946,GO:0004397,1,0.993535489730704,0,1,histidine ammonia-lyase activity,MF,
1947,GO:0004398,1,0.993579139296899,0,1,histidine decarboxylase activity,MF,
1948,GO:0004402,1,0.729197240258711,0,48,histone acetyltransferase activity,MF,
1949,GO:0004407,1,0.84917103852296,0,25,histone deacetylase activity,MF,
1950,GO:0004408,1,0.993587093435636,0,1,holocytochrome-c synthase activity,MF,
1951,GO:0004411,1,0.993610985692955,0,1,homogentisate 1,2-dioxygenase activity,MF,
1952,GO:0004415,1,0.96835047308195,0,5,hyalurononglucosaminidase activity,MF,
1953,GO:0004416,1,0.987220486394866,0,2,hydroxyacylglutathione hydrolase activity,MF,
1954,GO:0004418,1,0.993641718764055,0,1,hydroxymethylbilane synthase activity,MF,
1955,GO:0004419,1,0.987252217917792,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1956,GO:0004420,1,0.993455559841101,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1957,GO:0004421,1,0.987138627578934,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1958,GO:0004422,1,0.993645181428393,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1959,GO:0004423,1,0.993351984414862,0,1,iduronate-2-sulfatase activity,MF,
1960,GO:0004427,1,0.981036282084797,0,3,inorganic diphosphatase activity,MF,
1961,GO:0004430,1,0.974184753915507,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1962,GO:0004435,1,0.854146814166414,0,24,phosphatidylinositol phospholipase C activity,MF,
1963,GO:0004438,1,0.893783856083825,0,17,phosphatidylinositol-3-phosphatase activity,MF,
1965,GO:0004441,1,0.993600054192142,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1966,GO:0004445,1,0.961651076524134,0,6,inositol-polyphosphate 5-phosphatase activity,MF,
1967,GO:0004446,1,0.993552513362211,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1968,GO:0004447,1,0.993546178401606,0,1,iodide peroxidase activity,MF,
1969,GO:0004448,1,0.968443816142399,0,5,isocitrate dehydrogenase activity,MF,
1970,GO:0004449,1,0.980954744483781,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1971,GO:0004450,1,0.987248608625349,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1972,GO:0004452,1,0.993597230304888,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1973,GO:0004454,1,0.993578691241332,0,1,ketohexokinase activity,MF,
1974,GO:0004457,1,0.968491546937353,0,5,lactate dehydrogenase activity,MF,
1975,GO:0004458,1,0.993603654499301,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1976,GO:0004459,1,0.974727834130371,0,4,L-lactate dehydrogenase activity,MF,
1977,GO:0004461,1,0.980888890115407,0,3,lactose synthase activity,MF,
1978,GO:0004462,1,0.993603153731468,0,1,lactoylglutathione lyase activity,MF,
1979,GO:0004463,1,0.993601219571296,0,1,leukotriene-A4 hydrolase activity,MF,
1980,GO:0004464,1,0.968798265131175,0,5,leukotriene-C4 synthase activity,MF,
1981,GO:0004465,1,0.974437735983073,0,4,lipoprotein lipase activity,MF,
1982,GO:0004466,1,0.97448906306038,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1983,GO:0004467,1,0.919072963830637,0,13,long-chain fatty acid-CoA ligase activity,MF,
1984,GO:0004468,1,0.973853332100991,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1985,GO:0004470,1,0.974468018273785,0,4,malic enzyme activity,MF,
1986,GO:0004471,1,0.980691897275247,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1987,GO:0004473,1,0.980691897275247,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1988,GO:0004474,1,0.993355319229239,0,1,malate synthase activity,MF,
1989,GO:0004475,1,0.993632643468557,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1990,GO:0004476,1,0.993621324578831,0,1,mannose-6-phosphate isomerase activity,MF,
1991,GO:0004477,1,0.980814228057593,0,3,methenyltetrahydrofolate cyclohydrolase activity,MF,
1992,GO:0004478,1,0.987117480450955,0,2,methionine adenosyltransferase activity,MF,
1993,GO:0004479,1,0.993558236361319,0,1,methionyl-tRNA formyltransferase activity,MF,
1994,GO:0004482,1,0.993317641726585,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1995,GO:0004483,1,0.987155207697788,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1996,GO:0004484,1,0.993458451180492,0,1,mRNA guanylyltransferase activity,MF,
1997,GO:0004485,1,0.987119229810633,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1998,GO:0004486,1,0.980814228057593,0,3,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1999,GO:0004487,1,0.980814228057593,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2000,GO:0004488,1,0.980814228057593,0,3,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2001,GO:0004489,1,0.993233712184945,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2002,GO:0004490,1,0.993633579015231,0,1,methylglutaconyl-CoA hydratase activity,MF,
2003,GO:0004491,1,0.9935938551392,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2004,GO:0004493,1,0.99368153315395,0,1,methylmalonyl-CoA epimerase activity,MF,
2005,GO:0004496,1,0.993601252888419,0,1,mevalonate kinase activity,MF,
2007,GO:0004498,1,0.993574052071418,0,1,calcidiol 1-monooxygenase activity,MF,
2008,GO:0004499,1,0.968181508712529,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2010,GO:0004502,1,0.993417288929514,0,1,kynurenine 3-monooxygenase activity,MF,
2011,GO:0004503,1,0.993550739374143,0,1,monophenol monooxygenase activity,MF,
2012,GO:0004504,1,0.99350481307262,0,1,peptidylglycine monooxygenase activity,MF,
2013,GO:0004505,1,0.980936906348173,0,3,phenylalanine 4-monooxygenase activity,MF,
2014,GO:0004506,1,0.99354429263137,0,1,squalene monooxygenase activity,MF,
2015,GO:0004509,1,0.993604289108459,0,1,steroid 21-monooxygenase activity,MF,
2016,GO:0004510,1,0.987240819349756,0,2,tryptophan 5-monooxygenase activity,MF,
2017,GO:0004511,1,0.993612461861447,0,1,tyrosine 3-monooxygenase activity,MF,
2018,GO:0004512,1,0.993588727088719,0,1,inositol-3-phosphate synthase activity,MF,
2019,GO:0004513,1,0.993585660228222,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2020,GO:0004514,1,0.980767429890391,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2021,GO:0004515,1,0.974111227472695,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2022,GO:0004516,1,0.99355705431691,0,1,nicotinate phosphoribosyltransferase activity,MF,
2023,GO:0004517,1,0.980413163645653,0,3,nitric-oxide synthase activity,MF,
2025,GO:0004519,1,0.482291475945856,0,112,endonuclease activity,MF,
2026,GO:0004520,1,0.786134451631324,0,37,endodeoxyribonuclease activity,MF,
2027,GO:0004521,1,0.681182478890648,0,59,endoribonuclease activity,MF,
2028,GO:0004522,1,0.98112496660748,0,3,ribonuclease A activity,MF,
2029,GO:0004523,1,0.962292132252924,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2030,GO:0004525,1,0.973834682691033,0,4,ribonuclease III activity,MF,
2031,GO:0004526,1,0.937832466966942,0,10,ribonuclease P activity,MF,
2034,GO:0004529,1,0.867341383366304,0,22,exodeoxyribonuclease activity,MF,
2035,GO:0004530,1,0.967738030583021,0,5,deoxyribonuclease I activity,MF,
2036,GO:0004531,1,0.987309634970666,0,2,deoxyribonuclease II activity,MF,
2037,GO:0004532,1,0.775098627857922,0,39,exoribonuclease activity,MF,
2038,GO:0004534,1,0.979675950710351,0,3,5'-3' exoribonuclease activity,MF,
2039,GO:0004535,1,0.918126260793945,0,13,poly(A)-specific ribonuclease activity,MF,
2040,GO:0004536,1,0.694977476158054,0,56,deoxyribonuclease activity,MF,
2041,GO:0004540,1,0.504251110693917,0,105,ribonuclease activity,MF,
2042,GO:0004549,1,0.919822668527861,0,13,tRNA-specific ribonuclease activity,MF,
2045,GO:0004553,1,0.634211459116072,0,70,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2046,GO:0004556,1,0.987265288259839,0,2,alpha-amylase activity,MF,
2047,GO:0004557,1,0.98719068907982,0,2,alpha-galactosidase activity,MF,
2048,GO:0004558,1,0.980379174951965,0,3,alpha-1,4-glucosidase activity,MF,
2049,GO:0004559,1,0.912201059317352,0,14,alpha-mannosidase activity,MF,
2050,GO:0004560,1,0.987238612398019,0,2,alpha-L-fucosidase activity,MF,
2051,GO:0004561,1,0.993556348481526,0,1,alpha-N-acetylglucosaminidase activity,MF,
2052,GO:0004563,1,0.980824866799288,0,3,beta-N-acetylhexosaminidase activity,MF,
2053,GO:0004565,1,0.962016676829272,0,6,beta-galactosidase activity,MF,
2054,GO:0004566,1,0.980750421959977,0,3,beta-glucuronidase activity,MF,
2055,GO:0004567,1,0.993526615009978,0,1,beta-mannosidase activity,MF,
2056,GO:0004568,1,0.980836026336262,0,3,chitinase activity,MF,
2057,GO:0004569,1,0.993451343975067,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2058,GO:0004571,1,0.955054750384355,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2059,GO:0004572,1,0.986762407850406,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2060,GO:0004573,1,0.99355933592829,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2061,GO:0004576,1,0.962217579191614,0,6,oligosaccharyl transferase activity,MF,
2062,GO:0004577,1,0.993541273247875,0,1,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2063,GO:0004578,1,0.993492878350646,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2064,GO:0004579,1,0.968357436029728,0,5,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2065,GO:0004581,1,0.993661546146423,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2066,GO:0004582,1,0.981134122904285,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2067,GO:0004583,1,0.987189774484054,0,2,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2068,GO:0004585,1,0.99362956730479,0,1,ornithine carbamoyltransferase activity,MF,
2069,GO:0004586,1,0.987114490460907,0,2,ornithine decarboxylase activity,MF,
2070,GO:0004587,1,0.993607332753872,0,1,ornithine-oxo-acid transaminase activity,MF,
2071,GO:0004588,1,0.99356376070488,0,1,orotate phosphoribosyltransferase activity,MF,
2072,GO:0004590,1,0.99356376070488,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2073,GO:0004591,1,0.980510712238513,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2074,GO:0004594,1,0.980830045231949,0,3,pantothenate kinase activity,MF,
2075,GO:0004595,1,0.99358644145289,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2076,GO:0004596,1,0.93721126424823,0,10,peptide alpha-N-acetyltransferase activity,MF,
2077,GO:0004597,1,0.993510104848315,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2078,GO:0004598,1,0.99350481307262,0,1,peptidylamidoglycolate lyase activity,MF,
2079,GO:0004601,1,0.748885319427732,0,45,peroxidase activity,MF,
2080,GO:0004602,1,0.897322156237351,0,17,glutathione peroxidase activity,MF,
2081,GO:0004603,1,0.993662572637293,0,1,phenylethanolamine N-methyltransferase activity,MF,
2082,GO:0004605,1,0.980695350368103,0,3,phosphatidate cytidylyltransferase activity,MF,
2083,GO:0004607,1,0.993649305004385,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2084,GO:0004608,1,0.993673285249299,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2085,GO:0004609,1,0.987200489688133,0,2,phosphatidylserine decarboxylase activity,MF,
2086,GO:0004610,1,0.993606161356718,0,1,phosphoacetylglucosamine mutase activity,MF,
2087,GO:0004611,1,0.987211202392378,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2088,GO:0004613,1,0.987211202392378,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2089,GO:0004614,1,0.980834267843893,0,3,phosphoglucomutase activity,MF,
2090,GO:0004615,1,0.987278881270876,0,2,phosphomannomutase activity,MF,
2091,GO:0004616,1,0.993609912615018,0,1,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2092,GO:0004617,1,0.993604756923246,0,1,phosphoglycerate dehydrogenase activity,MF,
2093,GO:0004618,1,0.993578115964395,0,1,phosphoglycerate kinase activity,MF,
2094,GO:0004619,1,0.97478523434614,0,4,phosphoglycerate mutase activity,MF,
2096,GO:0004621,1,0.993586995583296,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2098,GO:0004623,1,0.890164995419793,0,18,phospholipase A2 activity,MF,
2099,GO:0004629,1,0.843173468246304,0,26,phospholipase C activity,MF,
2100,GO:0004630,1,0.96811175658564,0,5,phospholipase D activity,MF,
2101,GO:0004631,1,0.993653091442398,0,1,phosphomevalonate kinase activity,MF,
2102,GO:0004632,1,0.993655381177487,0,1,phosphopantothenate--cysteine ligase activity,MF,
2103,GO:0004633,1,0.993591614380833,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2104,GO:0004634,1,0.974634910117989,0,4,phosphopyruvate hydratase activity,MF,
2105,GO:0004637,1,0.993520035565342,0,1,phosphoribosylamine-glycine ligase activity,MF,
2106,GO:0004638,1,0.993525452561765,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2107,GO:0004639,1,0.993525452561765,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2108,GO:0004641,1,0.993520035565342,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2109,GO:0004642,1,0.993386202518017,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2110,GO:0004643,1,0.99359962170577,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2111,GO:0004644,1,0.993520035565342,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2112,GO:0004645,1,0.961780685893795,0,6,1,4-alpha-oligoglucan phosphorylase activity,MF,
2113,GO:0004647,1,0.98095532653472,0,3,phosphoserine phosphatase activity,MF,
2114,GO:0004648,1,0.993598126276326,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2115,GO:0004649,1,0.9934727364143,0,1,poly(ADP-ribose) glycohydrolase activity,MF,
2116,GO:0004651,1,0.987129875137122,0,2,polynucleotide 5'-phosphatase activity,MF,
2117,GO:0004652,1,0.96153592588266,0,6,polynucleotide adenylyltransferase activity,MF,
2119,GO:0004654,1,0.993449321048369,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2120,GO:0004655,1,0.993533671582301,0,1,porphobilinogen synthase activity,MF,
2121,GO:0004656,1,0.968297279748454,0,5,procollagen-proline 4-dioxygenase activity,MF,
2122,GO:0004657,1,0.993591614380833,0,1,proline dehydrogenase activity,MF,
2123,GO:0004658,1,0.987233911060271,0,2,propionyl-CoA carboxylase activity,MF,
2124,GO:0004659,1,0.895471397049293,0,17,prenyltransferase activity,MF,
2125,GO:0004660,1,0.98722719653886,0,2,protein farnesyltransferase activity,MF,
2126,GO:0004661,1,0.968318096077461,0,5,protein geranylgeranyltransferase activity,MF,
2127,GO:0004662,1,0.987232744295453,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2128,GO:0004663,1,0.974596727481524,0,4,Rab geranylgeranyltransferase activity,MF,
2129,GO:0004666,1,0.986915233549909,0,2,prostaglandin-endoperoxide synthase activity,MF,
2130,GO:0004667,1,0.981057389005443,0,3,prostaglandin-D synthase activity,MF,
2132,GO:0004671,1,0.993433646532901,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2134,GO:0004673,1,0.99369062319473,0,1,protein histidine kinase activity,MF,
2136,GO:0004675,1,0.892906931529629,0,17,transmembrane receptor protein serine/threonine kinase activity,MF,
2137,GO:0004676,1,0.993243170853743,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2138,GO:0004677,1,0.985492621187397,0,2,DNA-dependent protein kinase activity,MF,
2139,GO:0004679,1,0.948763523899601,0,8,AMP-activated protein kinase activity,MF,
2141,GO:0004686,1,0.993209489350032,0,1,elongation factor-2 kinase activity,MF,
2142,GO:0004687,1,0.973526663768022,0,4,myosin light chain kinase activity,MF,
2143,GO:0004689,1,0.96764606202954,0,5,phosphorylase kinase activity,MF,
2144,GO:0004690,1,0.948228090181491,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2145,GO:0004691,1,0.960657233783341,0,6,cAMP-dependent protein kinase activity,MF,
2146,GO:0004692,1,0.987066991330167,0,2,cGMP-dependent protein kinase activity,MF,
2147,GO:0004693,1,0.83338043143075,0,28,cyclin-dependent protein serine/threonine kinase activity,MF,
2148,GO:0004694,1,0.974092123077346,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2149,GO:0004697,1,0.906116615250079,0,15,protein kinase C activity,MF,
2150,GO:0004698,1,0.906116615250079,0,15,calcium-dependent protein kinase C activity,MF,
2151,GO:0004699,1,0.98697406092106,0,2,calcium-independent protein kinase C activity,MF,
2152,GO:0004703,1,0.968334158062335,0,5,G protein-coupled receptor kinase activity,MF,
2153,GO:0004704,1,0.967967217932592,0,5,NF-kappaB-inducing kinase activity,MF,
2154,GO:0004705,1,0.980728006957003,0,3,JUN kinase activity,MF,
2155,GO:0004706,1,0.949250813451423,0,8,JUN kinase kinase kinase activity,MF,
2156,GO:0004707,1,0.884056253700323,0,19,MAP kinase activity,MF,
2157,GO:0004708,1,0.895343237593064,0,17,MAP kinase kinase activity,MF,
2158,GO:0004709,1,0.871445486109998,0,21,MAP kinase kinase kinase activity,MF,
2159,GO:0004711,1,0.961005456869532,0,6,ribosomal protein S6 kinase activity,MF,
2160,GO:0004712,1,0.750084100834975,0,44,protein serine/threonine/tyrosine kinase activity,MF,
2163,GO:0004715,1,0.745492125025141,0,45,non-membrane spanning protein tyrosine kinase activity,MF,
2164,GO:0004719,1,0.980722479093551,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2165,GO:0004720,1,0.96803451396888,0,5,protein-lysine 6-oxidase activity,MF,
2166,GO:0004721,1,0.333266543905734,0,167,phosphoprotein phosphatase activity,MF,
2167,GO:0004722,1,0.632366925853078,0,70,protein serine/threonine phosphatase activity,MF,
2168,GO:0004723,1,0.955061457050713,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2169,GO:0004724,1,0.930820543242918,0,11,magnesium-dependent protein serine/threonine phosphatase activity,MF,
2170,GO:0004725,1,0.538903709480317,0,94,protein tyrosine phosphatase activity,MF,
2171,GO:0004726,1,0.943263694597461,0,9,non-membrane spanning protein tyrosine phosphatase activity,MF,
2172,GO:0004727,1,0.987296042604508,0,2,prenylated protein tyrosine phosphatase activity,MF,
2173,GO:0004729,1,0.993623236751341,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2174,GO:0004731,1,0.98068570879888,0,3,purine-nucleoside phosphorylase activity,MF,
2175,GO:0004733,1,0.993519002836817,0,1,pyridoxamine-phosphate oxidase activity,MF,
2176,GO:0004735,1,0.980918716296427,0,3,pyrroline-5-carboxylate reductase activity,MF,
2177,GO:0004736,1,0.99348806826988,0,1,pyruvate carboxylase activity,MF,
2178,GO:0004738,1,0.968113941468826,0,5,pyruvate dehydrogenase activity,MF,
2179,GO:0004739,1,0.987201591213676,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2180,GO:0004740,1,0.974019432893248,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2181,GO:0004741,1,0.987016331945296,0,2,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2182,GO:0004742,1,0.993466792606792,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2183,GO:0004743,1,0.987140070139458,0,2,pyruvate kinase activity,MF,
2184,GO:0004744,1,0.993566204593089,0,1,retinal isomerase activity,MF,
2185,GO:0004745,1,0.913981213551072,0,14,retinol dehydrogenase activity,MF,
2186,GO:0004747,1,0.993659657992585,0,1,ribokinase activity,MF,
2187,GO:0004748,1,0.98060873536916,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2188,GO:0004749,1,0.974605082848927,0,4,ribose phosphate diphosphokinase activity,MF,
2189,GO:0004750,1,0.993586376302338,0,1,ribulose-phosphate 3-epimerase activity,MF,
2190,GO:0004751,1,0.993617094682346,0,1,ribose-5-phosphate isomerase activity,MF,
2191,GO:0004753,1,0.993345469353142,0,1,saccharopine dehydrogenase activity,MF,
2192,GO:0004756,1,0.987196813657943,0,2,selenide, water dikinase activity,MF,
2193,GO:0004757,1,0.993642518187136,0,1,sepiapterin reductase activity,MF,
2194,GO:0004758,1,0.967869414342266,0,5,serine C-palmitoyltransferase activity,MF,
2195,GO:0004760,1,0.993632777137238,0,1,serine-pyruvate transaminase activity,MF,
2196,GO:0004766,1,0.993654551738843,0,1,spermidine synthase activity,MF,
2197,GO:0004767,1,0.968083141739899,0,5,sphingomyelin phosphodiesterase activity,MF,
2198,GO:0004768,1,0.9806098070163,0,3,stearoyl-CoA 9-desaturase activity,MF,
2199,GO:0004769,1,0.987357993505916,0,2,steroid delta-isomerase activity,MF,
2200,GO:0004771,1,0.943292820711997,0,9,sterol esterase activity,MF,
2201,GO:0004772,1,0.993522335899357,0,1,sterol O-acyltransferase activity,MF,
2202,GO:0004773,1,0.993302804248433,0,1,steryl-sulfatase activity,MF,
2203,GO:0004774,1,0.980940994783307,0,3,succinate-CoA ligase activity,MF,
2204,GO:0004775,1,0.980940994783307,0,3,succinate-CoA ligase (ADP-forming) activity,MF,
2205,GO:0004776,1,0.980940994783307,0,3,succinate-CoA ligase (GDP-forming) activity,MF,
2206,GO:0004777,1,0.993406836997533,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2207,GO:0004778,1,0.987333442317422,0,2,succinyl-CoA hydrolase activity,MF,
2208,GO:0004779,1,0.987109595128248,0,2,sulfate adenylyltransferase activity,MF,
2209,GO:0004781,1,0.987109595128248,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2210,GO:0004782,1,0.993560801035551,0,1,sulfinoalanine decarboxylase activity,MF,
2211,GO:0004784,1,0.968626624131526,0,5,superoxide dismutase activity,MF,
2212,GO:0004788,1,0.993582419392773,0,1,thiamine diphosphokinase activity,MF,
2213,GO:0004790,1,0.993569914492127,0,1,thioether S-methyltransferase activity,MF,
2214,GO:0004791,1,0.962125610026565,0,6,thioredoxin-disulfide reductase activity,MF,
2215,GO:0004792,1,0.981002671348832,0,3,thiosulfate sulfurtransferase activity,MF,
2216,GO:0004793,1,0.987207013938763,0,2,threonine aldolase activity,MF,
2217,GO:0004794,1,0.987318943796952,0,2,L-threonine ammonia-lyase activity,MF,
2218,GO:0004796,1,0.987205211240471,0,2,thromboxane-A synthase activity,MF,
2219,GO:0004797,1,0.987089719860921,0,2,thymidine kinase activity,MF,
2220,GO:0004798,1,0.987248884937554,0,2,thymidylate kinase activity,MF,
2221,GO:0004799,1,0.993633979868395,0,1,thymidylate synthase activity,MF,
2222,GO:0004800,1,0.98694451659087,0,2,thyroxine 5'-deiodinase activity,MF,
2223,GO:0004801,1,0.993656608385667,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2224,GO:0004802,1,0.987204343077046,0,2,transketolase activity,MF,
2225,GO:0004803,1,0.987048834114702,0,2,transposase activity,MF,
2226,GO:0004806,1,0.861653812038698,0,23,triglyceride lipase activity,MF,
2227,GO:0004807,1,0.993642318351066,0,1,triose-phosphate isomerase activity,MF,
2228,GO:0004809,1,0.980881665346382,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2229,GO:0004810,1,0.993587876941037,0,1,tRNA adenylyltransferase activity,MF,
2230,GO:0004812,1,0.867481502453136,0,22,aminoacyl-tRNA ligase activity,MF,
2231,GO:0004813,1,0.987089190243977,0,2,alanine-tRNA ligase activity,MF,
2232,GO:0004814,1,0.987246845392515,0,2,arginine-tRNA ligase activity,MF,
2233,GO:0004815,1,0.993524607399594,0,1,aspartate-tRNA ligase activity,MF,
2234,GO:0004816,1,0.993587778936705,0,1,asparagine-tRNA ligase activity,MF,
2235,GO:0004817,1,0.9936147443402,0,1,cysteine-tRNA ligase activity,MF,
2236,GO:0004818,1,0.993494103316609,0,1,glutamate-tRNA ligase activity,MF,
2237,GO:0004821,1,0.993573673610986,0,1,histidine-tRNA ligase activity,MF,
2238,GO:0004822,1,0.993514001447054,0,1,isoleucine-tRNA ligase activity,MF,
2239,GO:0004823,1,0.99347561208118,0,1,leucine-tRNA ligase activity,MF,
2240,GO:0004825,1,0.993542641203597,0,1,methionine-tRNA ligase activity,MF,
2241,GO:0004826,1,0.974628828206859,0,4,phenylalanine-tRNA ligase activity,MF,
2242,GO:0004827,1,0.993583583362043,0,1,proline-tRNA ligase activity,MF,
2243,GO:0004828,1,0.993601252888419,0,1,serine-tRNA ligase activity,MF,
2244,GO:0004829,1,0.993580872450883,0,1,threonine-tRNA ligase activity,MF,
2245,GO:0004830,1,0.993554101532261,0,1,tryptophan-tRNA ligase activity,MF,
2246,GO:0004831,1,0.993595573832411,0,1,tyrosine-tRNA ligase activity,MF,
2247,GO:0004832,1,0.993510239947417,0,1,valine-tRNA ligase activity,MF,
2248,GO:0004833,1,0.987301301340907,0,2,tryptophan 2,3-dioxygenase activity,MF,
2249,GO:0004835,1,0.993406353395107,0,1,tubulin-tyrosine ligase activity,MF,
2250,GO:0004838,1,0.993557349169712,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2251,GO:0004839,1,0.980509794501295,0,3,ubiquitin activating enzyme activity,MF,
2252,GO:0004842,1,0.0797401847601427,0,382,ubiquitin-protein transferase activity,MF,
2253,GO:0004843,1,0.589373520579877,0,80,thiol-dependent ubiquitin-specific protease activity,MF,
2254,GO:0004844,1,0.97465069020277,0,4,uracil DNA N-glycosylase activity,MF,
2255,GO:0004849,1,0.974664795237928,0,4,uridine kinase activity,MF,
2256,GO:0004850,1,0.98723844987102,0,2,uridine phosphorylase activity,MF,
2257,GO:0004852,1,0.993649105598105,0,1,uroporphyrinogen-III synthase activity,MF,
2258,GO:0004853,1,0.993647110859941,0,1,uroporphyrinogen decarboxylase activity,MF,
2259,GO:0004854,1,0.986822950665227,0,2,xanthine dehydrogenase activity,MF,
2260,GO:0004855,1,0.993357453520874,0,1,xanthine oxidase activity,MF,
2261,GO:0004856,1,0.993506597747951,0,1,xylulokinase activity,MF,
2263,GO:0004859,1,0.950160710195738,0,8,phospholipase inhibitor activity,MF,
2265,GO:0004861,1,0.925608705508576,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2266,GO:0004862,1,0.949702229504664,0,8,cAMP-dependent protein kinase inhibitor activity,MF,
2272,GO:0004873,1,0.987324122958311,0,2,asialoglycoprotein receptor activity,MF,
2273,GO:0004875,1,0.942972544706165,0,9,complement receptor activity,MF,
2274,GO:0004876,1,0.993609376261734,0,1,complement component C3a receptor activity,MF,
2275,GO:0004877,1,0.993029719560696,0,1,complement component C3b receptor activity,MF,
2276,GO:0004878,1,0.987181824937369,0,2,complement component C5a receptor activity,MF,
2277,GO:0004879,1,0.724274869995894,0,49,nuclear receptor activity,MF,
2278,GO:0004883,1,0.993281951373687,0,1,glucocorticoid receptor activity,MF,
2280,GO:0004890,1,0.894572778007846,0,17,GABA-A receptor activity,MF,
2281,GO:0004896,1,0.567632573331404,0,87,cytokine receptor activity,MF,
2282,GO:0004897,1,0.954256312671685,0,7,ciliary neurotrophic factor receptor activity,MF,
2283,GO:0004900,1,0.993616154507802,0,1,erythropoietin receptor activity,MF,
2284,GO:0004903,1,0.993466046469306,0,1,growth hormone receptor activity,MF,
2285,GO:0004904,1,0.968127512786466,0,5,interferon receptor activity,MF,
2286,GO:0004905,1,0.987014723848397,0,2,type I interferon receptor activity,MF,
2287,GO:0004906,1,0.987230063602119,0,2,interferon-gamma receptor activity,MF,
2288,GO:0004908,1,0.955683105878295,0,7,interleukin-1 receptor activity,MF,
2289,GO:0004909,1,0.987075822170856,0,2,interleukin-1, type I, activating receptor activity,MF,
2290,GO:0004910,1,0.987229208968125,0,2,interleukin-1, type II, blocking receptor activity,MF,
2291,GO:0004911,1,0.980778919242181,0,3,interleukin-2 receptor activity,MF,
2292,GO:0004912,1,0.99343059475148,0,1,interleukin-3 receptor activity,MF,
2293,GO:0004913,1,0.987258175434008,0,2,interleukin-4 receptor activity,MF,
2294,GO:0004914,1,0.987076880776844,0,2,interleukin-5 receptor activity,MF,
2295,GO:0004915,1,0.987056121307749,0,2,interleukin-6 receptor activity,MF,
2296,GO:0004917,1,0.987296624284201,0,2,interleukin-7 receptor activity,MF,
2297,GO:0004918,1,0.987173047044945,0,2,interleukin-8 receptor activity,MF,
2298,GO:0004920,1,0.987156722184795,0,2,interleukin-10 receptor activity,MF,
2299,GO:0004921,1,0.980763165374046,0,3,interleukin-11 receptor activity,MF,
2300,GO:0004923,1,0.966702510122552,0,5,leukemia inhibitory factor receptor activity,MF,
2301,GO:0004924,1,0.966702510122552,0,5,oncostatin-M receptor activity,MF,
2302,GO:0004925,1,0.992779042421936,0,1,prolactin receptor activity,MF,
2304,GO:0004931,1,0.955971731707472,0,7,extracellularly ATP-gated cation channel activity,MF,
2305,GO:0004935,1,0.949705036564385,0,8,adrenergic receptor activity,MF,
2306,GO:0004936,1,0.968260085704129,0,5,alpha-adrenergic receptor activity,MF,
2307,GO:0004937,1,0.98086900514441,0,3,alpha1-adrenergic receptor activity,MF,
2308,GO:0004938,1,0.987147621702769,0,2,alpha2-adrenergic receptor activity,MF,
2309,GO:0004939,1,0.980842831092697,0,3,beta-adrenergic receptor activity,MF,
2310,GO:0004940,1,0.993551996593999,0,1,beta1-adrenergic receptor activity,MF,
2311,GO:0004941,1,0.99360368789145,0,1,beta2-adrenergic receptor activity,MF,
2312,GO:0004945,1,0.981029784742232,0,3,angiotensin type II receptor activity,MF,
2313,GO:0004946,1,0.99364558071789,0,1,bombesin receptor activity,MF,
2314,GO:0004947,1,0.98717216384844,0,2,bradykinin receptor activity,MF,
2315,GO:0004948,1,0.98697203485957,0,2,calcitonin receptor activity,MF,
2316,GO:0004949,1,0.980598521801392,0,3,cannabinoid receptor activity,MF,
2317,GO:0004950,1,0.851194217152932,0,25,chemokine receptor activity,MF,
2318,GO:0004951,1,0.987266108108302,0,2,cholecystokinin receptor activity,MF,
2319,GO:0004952,1,0.968356279477817,0,5,dopamine neurotransmitter receptor activity,MF,
2320,GO:0004953,1,0.907749869494145,0,15,icosanoid receptor activity,MF,
2321,GO:0004954,1,0.931416005919215,0,11,prostanoid receptor activity,MF,
2322,GO:0004955,1,0.937430399387522,0,10,prostaglandin receptor activity,MF,
2323,GO:0004956,1,0.987145566502461,0,2,prostaglandin D receptor activity,MF,
2324,GO:0004957,1,0.968311455408931,0,5,prostaglandin E receptor activity,MF,
2325,GO:0004958,1,0.986986600657329,0,2,prostaglandin F receptor activity,MF,
2326,GO:0004960,1,0.993588301841849,0,1,thromboxane receptor activity,MF,
2327,GO:0004961,1,0.993588301841849,0,1,thromboxane A2 receptor activity,MF,
2328,GO:0004962,1,0.987012910405857,0,2,endothelin receptor activity,MF,
2329,GO:0004965,1,0.98042418399094,0,3,G protein-coupled GABA receptor activity,MF,
2330,GO:0004966,1,0.974799029675679,0,4,galanin receptor activity,MF,
2331,GO:0004967,1,0.987205899809993,0,2,glucagon receptor activity,MF,
2332,GO:0004968,1,0.993473917945218,0,1,gonadotropin-releasing hormone receptor activity,MF,
2333,GO:0004969,1,0.968146535941254,0,5,histamine receptor activity,MF,
2334,GO:0004970,1,0.881074673075375,0,19,ionotropic glutamate receptor activity,MF,
2335,GO:0004971,1,0.973837740674638,0,4,AMPA glutamate receptor activity,MF,
2336,GO:0004972,1,0.947586248579753,0,8,NMDA glutamate receptor activity,MF,
2337,GO:0004974,1,0.974609047292856,0,4,leukotriene receptor activity,MF,
2338,GO:0004977,1,0.974713635179622,0,4,melanocortin receptor activity,MF,
2339,GO:0004979,1,0.993615214374777,0,1,beta-endorphin receptor activity,MF,
2340,GO:0004980,1,0.987223482821655,0,2,melanocyte-stimulating hormone receptor activity,MF,
2341,GO:0004982,1,0.980954717351441,0,3,N-formyl peptide receptor activity,MF,
2342,GO:0004983,1,0.949798762788049,0,8,neuropeptide Y receptor activity,MF,
2343,GO:0004984,1,0.902862876355641,0,16,olfactory receptor activity,MF,
2344,GO:0004985,1,0.943809949698308,0,9,opioid receptor activity,MF,
2345,GO:0004990,1,0.993466521572054,0,1,oxytocin receptor activity,MF,
2346,GO:0004991,1,0.987198242084792,0,2,parathyroid hormone receptor activity,MF,
2347,GO:0004992,1,0.980604465569856,0,3,platelet activating factor receptor activity,MF,
2348,GO:0004993,1,0.86775258951518,0,22,G protein-coupled serotonin receptor activity,MF,
2349,GO:0004994,1,0.97453180448356,0,4,somatostatin receptor activity,MF,
2350,GO:0004995,1,0.980854033189696,0,3,tachykinin receptor activity,MF,
2351,GO:0004996,1,0.987194256409864,0,2,thyroid-stimulating hormone receptor activity,MF,
2352,GO:0004998,1,0.986997456532364,0,2,transferrin receptor activity,MF,
2353,GO:0004999,1,0.980799912152667,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2354,GO:0005000,1,0.961924787329584,0,6,vasopressin receptor activity,MF,
2355,GO:0005001,1,0.89206978787856,0,17,transmembrane receptor protein tyrosine phosphatase activity,MF,
2357,GO:0005004,1,0.954758368568772,0,7,GPI-linked ephrin receptor activity,MF,
2359,GO:0005006,1,0.987170032648898,0,2,epidermal growth factor-activated receptor activity,MF,
2360,GO:0005007,1,0.967818785699886,0,5,fibroblast growth factor-activated receptor activity,MF,
2361,GO:0005008,1,0.993277792836378,0,1,hepatocyte growth factor-activated receptor activity,MF,
2362,GO:0005009,1,0.979510549590879,0,3,insulin-activated receptor activity,MF,
2363,GO:0005010,1,0.979396120467711,0,3,insulin-like growth factor-activated receptor activity,MF,
2364,GO:0005011,1,0.98696718784363,0,2,macrophage colony-stimulating factor receptor activity,MF,
2367,GO:0005019,1,0.98704017711159,0,2,platelet-derived growth factor beta-receptor activity,MF,
2368,GO:0005020,1,0.993404495823808,0,1,stem cell factor receptor activity,MF,
2370,GO:0005024,1,0.923414461420547,0,12,transforming growth factor beta-activated receptor activity,MF,
2371,GO:0005025,1,0.967634792127989,0,5,transforming growth factor beta receptor activity, type I,MF,
2372,GO:0005026,1,0.993444645315498,0,1,transforming growth factor beta receptor activity, type II,MF,
2373,GO:0005030,1,0.973854947144704,0,4,neurotrophin receptor activity,MF,
2374,GO:0005031,1,0.937676634321741,0,10,tumor necrosis factor-activated receptor activity,MF,
2375,GO:0005034,1,0.974162782224304,0,4,osmosensor activity,MF,
2376,GO:0005035,1,0.925653419273623,0,12,death receptor activity,MF,
2377,GO:0005041,1,0.922464167951577,0,12,low-density lipoprotein particle receptor activity,MF,
2378,GO:0005042,1,0.960786146304538,0,6,netrin receptor activity,MF,
2379,GO:0005043,1,0.99350877773261,0,1,netrin receptor activity involved in chemorepulsion,MF,
2381,GO:0005046,1,0.980967899988832,0,3,KDEL sequence binding,MF,
2382,GO:0005047,1,0.98082639130275,0,3,signal recognition particle binding,MF,
2383,GO:0005048,1,0.765167743323028,0,41,signal sequence binding,MF,
2384,GO:0005049,1,0.936009899624003,0,10,nuclear export signal receptor activity,MF,
2385,GO:0005052,1,0.987088184228163,0,2,peroxisome matrix targeting signal-1 binding,MF,
2386,GO:0005053,1,0.993640585886275,0,1,peroxisome matrix targeting signal-2 binding,MF,
2387,GO:0005055,1,0.987282397041931,0,2,laminin receptor activity,MF,
2388,GO:0005068,1,0.918446453411382,0,13,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2389,GO:0005078,1,0.92921022790288,0,11,MAP-kinase scaffold activity,MF,
2390,GO:0005080,1,0.730428573183974,0,48,protein kinase C binding,MF,
2392,GO:0005086,1,0.8809749623279,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2393,GO:0005087,1,0.974673511881997,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2394,GO:0005088,1,0.47208256022704,0,113,Ras guanyl-nucleotide exchange factor activity,MF,
2395,GO:0005089,1,0.675040632602973,0,59,Rho guanyl-nucleotide exchange factor activity,MF,
2396,GO:0005090,1,0.993594978417679,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2397,GO:0005092,1,0.900961357529718,0,16,GDP-dissociation inhibitor activity,MF,
2398,GO:0005093,1,0.987198383624733,0,2,Rab GDP-dissociation inhibitor activity,MF,
2399,GO:0005094,1,0.981069976936795,0,3,Rho GDP-dissociation inhibitor activity,MF,
2400,GO:0005095,1,0.912657597623194,0,14,GTPase inhibitor activity,MF,
2404,GO:0005105,1,0.974794098062078,0,4,type 1 fibroblast growth factor receptor binding,MF,
2405,GO:0005109,1,0.801414440138153,0,34,frizzled binding,MF,
2406,GO:0005111,1,0.968556660045371,0,5,type 2 fibroblast growth factor receptor binding,MF,
2408,GO:0005113,1,0.949356597990868,0,8,patched binding,MF,
2409,GO:0005114,1,0.949014542096724,0,8,type II transforming growth factor beta receptor binding,MF,
2410,GO:0005115,1,0.993349843576017,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2411,GO:0005119,1,0.980310699631741,0,3,smoothened binding,MF,
2412,GO:0005123,1,0.884339891787419,0,19,death receptor binding,MF,
2413,GO:0005124,1,0.974680971728974,0,4,scavenger receptor binding,MF,
2416,GO:0005127,1,0.948303214549089,0,8,ciliary neurotrophic factor receptor binding,MF,
2417,GO:0005128,1,0.987221138522379,0,2,erythropoietin receptor binding,MF,
2418,GO:0005130,1,0.993638518943644,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2419,GO:0005131,1,0.974125341432274,0,4,growth hormone receptor binding,MF,
2420,GO:0005134,1,0.980840107138199,0,3,interleukin-2 receptor binding,MF,
2421,GO:0005135,1,0.993529366231814,0,1,interleukin-3 receptor binding,MF,
2422,GO:0005136,1,0.98720022758434,0,2,interleukin-4 receptor binding,MF,
2423,GO:0005137,1,0.993595044550104,0,1,interleukin-5 receptor binding,MF,
2424,GO:0005138,1,0.955728518368069,0,7,interleukin-6 receptor binding,MF,
2425,GO:0005139,1,0.98721446467763,0,2,interleukin-7 receptor binding,MF,
2426,GO:0005141,1,0.993631038942475,0,1,interleukin-10 receptor binding,MF,
2427,GO:0005142,1,0.993582807031021,0,1,interleukin-11 receptor binding,MF,
2428,GO:0005143,1,0.974421689377421,0,4,interleukin-12 receptor binding,MF,
2429,GO:0005144,1,0.993654219907791,0,1,interleukin-13 receptor binding,MF,
2430,GO:0005146,1,0.987164254513865,0,2,leukemia inhibitory factor receptor binding,MF,
2431,GO:0005147,1,0.993615550128517,0,1,oncostatin-M receptor binding,MF,
2432,GO:0005148,1,0.993660154968469,0,1,prolactin receptor binding,MF,
2433,GO:0005149,1,0.93107401199409,0,11,interleukin-1 receptor binding,MF,
2434,GO:0005150,1,0.987173408633606,0,2,interleukin-1, type I receptor binding,MF,
2435,GO:0005151,1,0.987053658299183,0,2,interleukin-1, type II receptor binding,MF,
2436,GO:0005152,1,0.986925672482646,0,2,interleukin-1 receptor antagonist activity,MF,
2437,GO:0005153,1,0.987127748887329,0,2,interleukin-8 receptor binding,MF,
2438,GO:0005154,1,0.82074141379925,0,30,epidermal growth factor receptor binding,MF,
2439,GO:0005157,1,0.980958558597146,0,3,macrophage colony-stimulating factor receptor binding,MF,
2440,GO:0005158,1,0.862832695227562,0,22,insulin receptor binding,MF,
2441,GO:0005159,1,0.918059683647717,0,13,insulin-like growth factor receptor binding,MF,
2442,GO:0005160,1,0.855020578373923,0,24,transforming growth factor beta receptor binding,MF,
2444,GO:0005163,1,0.974728422392662,0,4,nerve growth factor receptor binding,MF,
2445,GO:0005164,1,0.829877957942123,0,29,tumor necrosis factor receptor binding,MF,
2446,GO:0005165,1,0.930770515353311,0,11,neurotrophin receptor binding,MF,
2447,GO:0005166,1,0.993564308449953,0,1,neurotrophin p75 receptor binding,MF,
2448,GO:0005167,1,0.961101485446189,0,6,neurotrophin TRK receptor binding,MF,
2449,GO:0005168,1,0.961101485446189,0,6,neurotrophin TRKA receptor binding,MF,
2450,GO:0005169,1,0.993392243759699,0,1,neurotrophin TRKB receptor binding,MF,
2451,GO:0005170,1,0.993392243759699,0,1,neurotrophin TRKC receptor binding,MF,
2452,GO:0005171,1,0.987249177426272,0,2,hepatocyte growth factor receptor binding,MF,
2454,GO:0005173,1,0.973730914081061,0,4,stem cell factor receptor binding,MF,
2455,GO:0005174,1,0.987245437091365,0,2,CD40 receptor binding,MF,
2456,GO:0005175,1,0.993694505128082,0,1,CD27 receptor binding,MF,
2457,GO:0005176,1,0.980828998911547,0,3,ErbB-2 class receptor binding,MF,
2460,GO:0005183,1,0.987377408966258,0,2,gonadotropin hormone-releasing hormone activity,MF,
2465,GO:0005212,1,0.902968248363907,0,16,structural constituent of eye lens,MF,
2470,GO:0005220,1,0.978842641431325,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2471,GO:0005221,1,0.942888504538469,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2472,GO:0005222,1,0.949005187023432,0,8,intracellular cAMP-activated cation channel activity,MF,
2473,GO:0005223,1,0.961875335918202,0,6,intracellular cGMP-activated cation channel activity,MF,
2474,GO:0005225,1,0.942451789778998,0,9,volume-sensitive anion channel activity,MF,
2475,GO:0005227,1,0.866734264747819,0,22,calcium activated cation channel activity,MF,
2476,GO:0005228,1,0.986820127997415,0,2,intracellular sodium activated potassium channel activity,MF,
2477,GO:0005229,1,0.900925869740894,0,16,intracellular calcium activated chloride channel activity,MF,
2481,GO:0005237,1,0.912080754335924,0,14,inhibitory extracellular ligand-gated ion channel activity,MF,
2482,GO:0005242,1,0.872474322939927,0,21,inward rectifier potassium channel activity,MF,
2484,GO:0005244,1,0.300568617827603,0,182,voltage-gated ion channel activity,MF,
2485,GO:0005245,1,0.756396818301133,0,42,voltage-gated calcium channel activity,MF,
2487,GO:0005247,1,0.9424130466522,0,9,voltage-gated chloride channel activity,MF,
2488,GO:0005248,1,0.856229779903489,0,23,voltage-gated sodium channel activity,MF,
2489,GO:0005249,1,0.58925866147843,0,81,voltage-gated potassium channel activity,MF,
2490,GO:0005250,1,0.97422511372048,0,4,A-type (transient outward) potassium channel activity,MF,
2491,GO:0005251,1,0.827813288164094,0,29,delayed rectifier potassium channel activity,MF,
2492,GO:0005252,1,0.993490817047684,0,1,open rectifier potassium channel activity,MF,
2495,GO:0005260,1,0.993322767667789,0,1,intracellularly ATP-gated chloride channel activity,MF,
2498,GO:0005267,1,0.484809984767997,0,111,potassium channel activity,MF,
2500,GO:0005275,1,0.980845581625191,0,3,amine transmembrane transporter activity,MF,
2501,GO:0005277,1,0.987235488320197,0,2,acetylcholine transmembrane transporter activity,MF,
2502,GO:0005280,1,0.986966184530463,0,2,amino acid:proton symporter activity,MF,
2503,GO:0005283,1,0.905928267898921,0,15,amino acid:sodium symporter activity,MF,
2504,GO:0005287,1,0.993581967599629,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2505,GO:0005289,1,0.993581967599629,0,1,high-affinity arginine transmembrane transporter activity,MF,
2506,GO:0005290,1,0.967925655777981,0,5,L-histidine transmembrane transporter activity,MF,
2507,GO:0005292,1,0.993581967599629,0,1,high-affinity lysine transmembrane transporter activity,MF,
2508,GO:0005294,1,0.992997617862815,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2509,GO:0005295,1,0.973893421877381,0,4,neutral amino acid:sodium symporter activity,MF,
2510,GO:0005298,1,0.980485767776825,0,3,proline:sodium symporter activity,MF,
2511,GO:0005302,1,0.993535489730704,0,1,L-tyrosine transmembrane transporter activity,MF,
2512,GO:0005308,1,0.980680258340544,0,3,creatine transmembrane transporter activity,MF,
2513,GO:0005309,1,0.993514909520236,0,1,creatine:sodium symporter activity,MF,
2516,GO:0005314,1,0.973655828465509,0,4,high-affinity glutamate transmembrane transporter activity,MF,
2518,GO:0005316,1,0.99352841311213,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2519,GO:0005319,1,0.470448345125854,0,115,lipid transporter activity,MF,
2520,GO:0005324,1,0.896224507544624,0,17,long-chain fatty acid transporter activity,MF,
2522,GO:0005328,1,0.993524607399594,0,1,neurotransmitter:sodium symporter activity,MF,
2523,GO:0005330,1,0.974250727297457,0,4,dopamine:sodium symporter activity,MF,
2524,GO:0005332,1,0.974431773066886,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2525,GO:0005334,1,0.980756787645488,0,3,norepinephrine:sodium symporter activity,MF,
2526,GO:0005335,1,0.980742167455478,0,3,serotonin:sodium symporter activity,MF,
2527,GO:0005337,1,0.96209888136636,0,6,nucleoside transmembrane transporter activity,MF,
2528,GO:0005338,1,0.925168227909049,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2530,GO:0005343,1,0.843117164867248,0,26,organic acid:sodium symporter activity,MF,
2531,GO:0005344,1,0.920482694997389,0,13,oxygen carrier activity,MF,
2532,GO:0005345,1,0.968256258171234,0,5,purine nucleobase transmembrane transporter activity,MF,
2533,GO:0005346,1,0.834430066148436,0,28,purine ribonucleotide transmembrane transporter activity,MF,
2534,GO:0005347,1,0.856280242012963,0,24,ATP transmembrane transporter activity,MF,
2535,GO:0005350,1,0.98085956405763,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2536,GO:0005351,1,0.955690240802519,0,7,carbohydrate:proton symporter activity,MF,
2537,GO:0005353,1,0.974524234557096,0,4,fructose transmembrane transporter activity,MF,
2538,GO:0005354,1,0.993425236077443,0,1,galactose transmembrane transporter activity,MF,
2540,GO:0005362,1,0.987159131596528,0,2,low-affinity glucose:sodium symporter activity,MF,
2541,GO:0005365,1,0.979613486488885,0,3,myo-inositol transmembrane transporter activity,MF,
2542,GO:0005366,1,0.993247302685017,0,1,myo-inositol:proton symporter activity,MF,
2543,GO:0005367,1,0.986274416241217,0,2,myo-inositol:sodium symporter activity,MF,
2544,GO:0005368,1,0.980367867847474,0,3,taurine transmembrane transporter activity,MF,
2545,GO:0005369,1,0.993291214050799,0,1,taurine:sodium symporter activity,MF,
2546,GO:0005371,1,0.993632777137238,0,1,tricarboxylate secondary active transmembrane transporter activity,MF,
2547,GO:0005372,1,0.925394006470062,0,12,water transmembrane transporter activity,MF,
2548,GO:0005375,1,0.967380988546808,0,5,copper ion transmembrane transporter activity,MF,
2549,GO:0005381,1,0.937265879647763,0,10,iron ion transmembrane transporter activity,MF,
2550,GO:0005384,1,0.94312248653641,0,9,manganese ion transmembrane transporter activity,MF,
2552,GO:0005388,1,0.941390623440053,0,9,calcium transmembrane transporter activity, phosphorylative mechanism,MF,
2553,GO:0005391,1,0.931322038974612,0,11,sodium:potassium-exchanging ATPase activity,MF,
2556,GO:0005415,1,0.987235258621901,0,2,nucleoside:sodium symporter activity,MF,
2557,GO:0005416,1,0.894108971227604,0,17,amino acid:cation symporter activity,MF,
2558,GO:0005427,1,0.993505803079024,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2561,GO:0005451,1,0.924450166748045,0,12,monovalent cation:proton antiporter activity,MF,
2562,GO:0005452,1,0.92399733075657,0,12,inorganic anion exchanger activity,MF,
2563,GO:0005456,1,0.993618639207036,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2564,GO:0005457,1,0.993532499008885,0,1,GDP-fucose transmembrane transporter activity,MF,
2565,GO:0005459,1,0.974740031870329,0,4,UDP-galactose transmembrane transporter activity,MF,
2566,GO:0005460,1,0.9936602543556,0,1,UDP-glucose transmembrane transporter activity,MF,
2567,GO:0005461,1,0.980633959859824,0,3,UDP-glucuronic acid transmembrane transporter activity,MF,
2568,GO:0005462,1,0.967787875852904,0,5,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2569,GO:0005463,1,0.980633959859824,0,3,UDP-N-acetylgalactosamine transmembrane transporter activity,MF,
2570,GO:0005464,1,0.9932640242992,0,1,UDP-xylose transmembrane transporter activity,MF,
2571,GO:0005477,1,0.993515069579258,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2572,GO:0005483,1,0.980742092920355,0,3,soluble NSF attachment protein activity,MF,
2573,GO:0005484,1,0.802506039084356,0,34,SNAP receptor activity,MF,
2575,GO:0005496,1,0.552182445830947,0,91,steroid binding,MF,
2576,GO:0005497,1,0.974729749679787,0,4,androgen binding,MF,
2577,GO:0005499,1,0.968076407202772,0,5,vitamin D binding,MF,
2578,GO:0005501,1,0.850915574253706,0,25,retinoid binding,MF,
2579,GO:0005502,1,0.974449177723761,0,4,11-cis retinal binding,MF,
2580,GO:0005503,1,0.987091954411856,0,2,all-trans retinal binding,MF,
2581,GO:0005504,1,0.814003522070143,0,32,fatty acid binding,MF,
2588,GO:0005518,1,0.64831148535027,0,66,collagen binding,MF,
2589,GO:0005519,1,0.993490639180229,0,1,cytoskeletal regulatory protein binding,MF,
2591,GO:0005521,1,0.899745134310483,0,16,lamin binding,MF,
2592,GO:0005522,1,0.927926579134877,0,11,profilin binding,MF,
2593,GO:0005523,1,0.907299932854252,0,15,tropomyosin binding,MF,
2595,GO:0005525,1,0.118320930934818,0,326,GTP binding,MF,
2596,GO:0005527,1,0.937766298211057,0,10,macrolide binding,MF,
2597,GO:0005528,1,0.949822127271055,0,8,FK506 binding,MF,
2598,GO:0005534,1,0.974593064967231,0,4,galactose binding,MF,
2599,GO:0005536,1,0.930944426090006,0,11,glucose binding,MF,
2600,GO:0005537,1,0.907415115903848,0,15,mannose binding,MF,
2603,GO:0005542,1,0.937751152426157,0,10,folic acid binding,MF,
2606,GO:0005545,1,0.911984642230825,0,14,1-phosphatidylinositol binding,MF,
2607,GO:0005546,1,0.631645440317323,0,70,phosphatidylinositol-4,5-bisphosphate binding,MF,
2609,GO:0005548,1,0.764772184852472,0,41,phospholipid transporter activity,MF,
2610,GO:0005549,1,0.93852571779336,0,10,odorant binding,MF,
2613,GO:0005577,1,0.961435461817021,0,6,fibrinogen complex,CC,
2614,GO:0005579,1,0.974188359000951,0,4,membrane attack complex,CC,
2615,GO:0005581,1,0.598288989478527,0,78,collagen trimer,CC,
2616,GO:0005582,1,0.993394219246824,0,1,collagen type XV trimer,CC,
2617,GO:0005583,1,0.922899205893344,0,12,fibrillar collagen trimer,CC,
2618,GO:0005584,1,0.986763935091198,0,2,collagen type I trimer,CC,
2619,GO:0005585,1,0.993416735806892,0,1,collagen type II trimer,CC,
2620,GO:0005586,1,0.993375418689938,0,1,collagen type III trimer,CC,
2621,GO:0005587,1,0.959942962382903,0,6,collagen type IV trimer,CC,
2622,GO:0005588,1,0.97330931265846,0,4,collagen type V trimer,CC,
2623,GO:0005589,1,0.980323622773481,0,3,collagen type VI trimer,CC,
2624,GO:0005590,1,0.99303420677743,0,1,collagen type VII trimer,CC,
2625,GO:0005591,1,0.9935656219776,0,1,collagen type VIII trimer,CC,
2626,GO:0005592,1,0.986588036629984,0,2,collagen type XI trimer,CC,
2627,GO:0005593,1,0.960923236445505,0,6,FACIT collagen trimer,CC,
2628,GO:0005594,1,0.980768161832,0,3,collagen type IX trimer,CC,
2629,GO:0005595,1,0.992974775869522,0,1,collagen type XII trimer,CC,
2630,GO:0005596,1,0.993292710123616,0,1,collagen type XIV trimer,CC,
2631,GO:0005597,1,0.993365790516823,0,1,collagen type XVI trimer,CC,
2632,GO:0005598,1,0.9935656219776,0,1,short-chain collagen trimer,CC,
2633,GO:0005600,1,0.993540619115763,0,1,collagen type XIII trimer,CC,
2634,GO:0005602,1,0.987376349224664,0,2,complement component C1 complex,CC,
2635,GO:0005604,1,0.518675063305641,0,98,basement membrane,CC,
2636,GO:0005606,1,0.979655382036098,0,3,laminin-1 complex,CC,
2637,GO:0005607,1,0.986802348357276,0,2,laminin-2 complex,CC,
2638,GO:0005608,1,0.986402144814177,0,2,laminin-3 complex,CC,
2639,GO:0005610,1,0.979587583944073,0,3,laminin-5 complex,CC,
2640,GO:0005614,1,0.917847294438923,0,13,interstitial matrix,CC,
2645,GO:0005637,1,0.707528764844558,0,53,nuclear inner membrane,CC,
2646,GO:0005638,1,0.968234028636144,0,5,lamin filament,CC,
2647,GO:0005639,1,0.913305626819021,0,14,integral component of nuclear inner membrane,CC,
2649,GO:0005641,1,0.942335003494953,0,9,nuclear envelope lumen,CC,
2650,GO:0005642,1,0.960923902770035,0,6,annulate lamellae,CC,
2651,GO:0005643,1,0.610742419360474,0,75,nuclear pore,CC,
2652,GO:0005652,1,0.930975512066741,0,11,nuclear lamina,CC,
2654,GO:0005655,1,0.968429135680266,0,5,nucleolar ribonuclease P complex,CC,
2655,GO:0005656,1,0.980925640645653,0,3,nuclear pre-replicative complex,CC,
2656,GO:0005657,1,0.65496598056696,0,65,replication fork,CC,
2657,GO:0005658,1,0.968131373572627,0,5,alpha DNA polymerase:primase complex,CC,
2658,GO:0005662,1,0.91315023932714,0,14,DNA replication factor A complex,CC,
2659,GO:0005663,1,0.968310253511023,0,5,DNA replication factor C complex,CC,
2660,GO:0005664,1,0.943454310642962,0,9,nuclear origin of replication recognition complex,CC,
2661,GO:0005665,1,0.908171646943408,0,15,RNA polymerase II, core complex,CC,
2662,GO:0005666,1,0.890655351691924,0,18,RNA polymerase III complex,CC,
2663,GO:0005667,1,0.0806152122927987,0,381,transcription regulator complex,CC,
2664,GO:0005668,1,0.987281032989356,0,2,RNA polymerase transcription factor SL1 complex,CC,
2665,GO:0005669,1,0.812772391618604,0,32,transcription factor TFIID complex,CC,
2666,GO:0005671,1,0.91864576277212,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2667,GO:0005672,1,0.968569096165101,0,5,transcription factor TFIIA complex,CC,
2668,GO:0005673,1,0.98721994806429,0,2,transcription factor TFIIE complex,CC,
2669,GO:0005674,1,0.987252980444626,0,2,transcription factor TFIIF complex,CC,
2670,GO:0005675,1,0.925438722430377,0,12,transcription factor TFIIH holo complex,CC,
2671,GO:0005677,1,0.955189085594198,0,7,chromatin silencing complex,CC,
2672,GO:0005680,1,0.873150121388708,0,21,anaphase-promoting complex,CC,
2673,GO:0005681,1,0.314477103562872,0,178,spliceosomal complex,CC,
2674,GO:0005682,1,0.901881289400572,0,16,U5 snRNP,CC,
2675,GO:0005683,1,0.956419794314866,0,7,U7 snRNP,CC,
2676,GO:0005684,1,0.569437737813612,0,87,U2-type spliceosomal complex,CC,
2677,GO:0005685,1,0.890858573399927,0,18,U1 snRNP,CC,
2678,GO:0005686,1,0.88541099317453,0,19,U2 snRNP,CC,
2679,GO:0005687,1,0.938209725790644,0,10,U4 snRNP,CC,
2680,GO:0005688,1,0.95023516279492,0,8,U6 snRNP,CC,
2681,GO:0005689,1,0.840729732432341,0,27,U12-type spliceosomal complex,CC,
2682,GO:0005690,1,0.993593393160155,0,1,U4atac snRNP,CC,
2683,GO:0005691,1,0.993464683510922,0,1,U6atac snRNP,CC,
2685,GO:0005697,1,0.877622756745516,0,20,telomerase holoenzyme complex,CC,
2686,GO:0005712,1,0.986787609793848,0,2,chiasma,CC,
2687,GO:0005713,1,0.993575443551876,0,1,recombination nodule,CC,
2688,GO:0005715,1,0.993575443551876,0,1,late recombination nodule,CC,
2689,GO:0005719,1,0.849523456268497,0,25,nuclear euchromatin,CC,
2690,GO:0005720,1,0.837550414011455,0,27,nuclear heterochromatin,CC,
2691,GO:0005721,1,0.888103154000178,0,18,pericentric heterochromatin,CC,
2692,GO:0005726,1,0.967637051528482,0,5,perichromatin fibrils,CC,
2694,GO:0005731,1,0.993625080542958,0,1,nucleolus organizer region,CC,
2695,GO:0005732,1,0.868485659272548,0,22,small nucleolar ribonucleoprotein complex,CC,
2696,GO:0005736,1,0.93759441300776,0,10,RNA polymerase I complex,CC,
2701,GO:0005742,1,0.956251148085976,0,7,mitochondrial outer membrane translocase complex,CC,
2703,GO:0005744,1,0.925884007049664,0,12,TIM23 mitochondrial import inner membrane translocase complex,CC,
2704,GO:0005745,1,0.987147628118467,0,2,m-AAA complex,CC,
2705,GO:0005746,1,0.635591590548118,0,71,mitochondrial respirasome,CC,
2706,GO:0005747,1,0.770374502425089,0,41,mitochondrial respiratory chain complex I,CC,
2707,GO:0005749,1,0.974693317822604,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2708,GO:0005750,1,0.938027286257774,0,10,mitochondrial respiratory chain complex III,CC,
2709,GO:0005751,1,0.932641238958911,0,11,mitochondrial respiratory chain complex IV,CC,
2710,GO:0005753,1,0.993593129319401,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2711,GO:0005757,1,0.974699776264265,0,4,mitochondrial permeability transition pore complex,CC,
2712,GO:0005758,1,0.633119012226314,0,71,mitochondrial intermembrane space,CC,
2713,GO:0005759,1,0.0598130075532368,0,431,mitochondrial matrix,CC,
2714,GO:0005760,1,0.980678780641073,0,3,gamma DNA polymerase complex,CC,
2715,GO:0005761,1,0.584412612556091,0,84,mitochondrial ribosome,CC,
2716,GO:0005762,1,0.70357407583456,0,55,mitochondrial large ribosomal subunit,CC,
2717,GO:0005763,1,0.841850190815446,0,27,mitochondrial small ribosomal subunit,CC,
2721,GO:0005767,1,0.907633993960476,0,15,secondary lysosome,CC,
2725,GO:0005771,1,0.704489605505784,0,54,multivesicular body,CC,
2729,GO:0005776,1,0.555695383372805,0,90,autophagosome,CC,
2730,GO:0005777,1,0.440593458421391,0,126,peroxisome,CC,
2731,GO:0005778,1,0.685481746705188,0,58,peroxisomal membrane,CC,
2732,GO:0005779,1,0.90773802668173,0,15,integral component of peroxisomal membrane,CC,
2733,GO:0005782,1,0.719529354933618,0,51,peroxisomal matrix,CC,
2735,GO:0005784,1,0.968479264942722,0,5,Sec61 translocon complex,CC,
2736,GO:0005785,1,0.962197553122216,0,6,signal recognition particle receptor complex,CC,
2737,GO:0005786,1,0.962240691847473,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2738,GO:0005787,1,0.968415414089831,0,5,signal peptidase complex,CC,
2742,GO:0005791,1,0.60319050475568,0,78,rough endoplasmic reticulum,CC,
2743,GO:0005793,1,0.458946247903851,0,119,endoplasmic reticulum-Golgi intermediate compartment,CC,
2745,GO:0005795,1,0.424085797016033,0,131,Golgi stack,CC,
2746,GO:0005796,1,0.607490450274894,0,76,Golgi lumen,CC,
2747,GO:0005797,1,0.937472460637103,0,10,Golgi medial cisterna,CC,
2753,GO:0005814,1,0.435561390861141,0,126,centriole,CC,
2755,GO:0005818,1,0.930559973218667,0,11,aster,CC,
2756,GO:0005819,1,0.109992959497402,0,334,spindle,CC,
2757,GO:0005826,1,0.974078104402819,0,4,actomyosin contractile ring,CC,
2758,GO:0005827,1,0.967815164906964,0,5,polar microtubule,CC,
2759,GO:0005828,1,0.954284559833698,0,7,kinetochore microtubule,CC,
2761,GO:0005832,1,0.943750318046365,0,9,chaperonin-containing T-complex,CC,
2762,GO:0005833,1,0.93266914919118,0,11,hemoglobin complex,CC,
2763,GO:0005834,1,0.813053767890289,0,32,heterotrimeric G-protein complex,CC,
2764,GO:0005838,1,0.874114681068828,0,21,proteasome regulatory particle,CC,
2765,GO:0005839,1,0.897460070677203,0,17,proteasome core complex,CC,
2766,GO:0005840,1,0.248968803759301,0,216,ribosome,CC,
2767,GO:0005844,1,0.656355868300508,0,65,polysome,CC,
2768,GO:0005845,1,0.93684463304742,0,10,mRNA cap binding complex,CC,
2769,GO:0005846,1,0.980669000686441,0,3,nuclear cap binding complex,CC,
2770,GO:0005847,1,0.895255484654937,0,17,mRNA cleavage and polyadenylation specificity factor complex,CC,
2771,GO:0005848,1,0.993586571780172,0,1,mRNA cleavage stimulating factor complex,CC,
2772,GO:0005849,1,0.872273534083106,0,21,mRNA cleavage factor complex,CC,
2773,GO:0005850,1,0.974310122778065,0,4,eukaryotic translation initiation factor 2 complex,CC,
2774,GO:0005851,1,0.962127631665166,0,6,eukaryotic translation initiation factor 2B complex,CC,
2775,GO:0005852,1,0.902105984663348,0,16,eukaryotic translation initiation factor 3 complex,CC,
2776,GO:0005853,1,0.97469932296302,0,4,eukaryotic translation elongation factor 1 complex,CC,
2777,GO:0005854,1,0.980889824229282,0,3,nascent polypeptide-associated complex,CC,
2779,GO:0005858,1,0.883017797827959,0,18,axonemal dynein complex,CC,
2780,GO:0005859,1,0.924385949683135,0,12,muscle myosin complex,CC,
2781,GO:0005861,1,0.950188625298131,0,8,troponin complex,CC,
2782,GO:0005862,1,0.974543342866761,0,4,muscle thin filament tropomyosin,CC,
2783,GO:0005863,1,0.980465529120608,0,3,striated muscle myosin thick filament,CC,
2784,GO:0005865,1,0.873116098993102,0,21,striated muscle thin filament,CC,
2785,GO:0005868,1,0.888135092053331,0,18,cytoplasmic dynein complex,CC,
2786,GO:0005869,1,0.925798479982874,0,12,dynactin complex,CC,
2787,GO:0005871,1,0.72824293003628,0,48,kinesin complex,CC,
2788,GO:0005873,1,0.986800098289814,0,2,plus-end kinesin complex,CC,
2791,GO:0005876,1,0.666300184968432,0,62,spindle microtubule,CC,
2792,GO:0005879,1,0.961236814480945,0,6,axonemal microtubule,CC,
2793,GO:0005880,1,0.987191081696202,0,2,nuclear microtubule,CC,
2794,GO:0005881,1,0.635928264145671,0,69,cytoplasmic microtubule,CC,
2798,GO:0005885,1,0.931996181585842,0,11,Arp2/3 protein complex,CC,
2801,GO:0005889,1,0.993512823379632,0,1,potassium:proton exchanging ATPase complex,CC,
2803,GO:0005891,1,0.766239866892738,0,40,voltage-gated calcium channel complex,CC,
2804,GO:0005892,1,0.907218585285997,0,15,acetylcholine-gated channel complex,CC,
2805,GO:0005893,1,0.987060216634915,0,2,interleukin-2 receptor complex,CC,
2806,GO:0005895,1,0.993595044550104,0,1,interleukin-5 receptor complex,CC,
2807,GO:0005896,1,0.980798146964705,0,3,interleukin-6 receptor complex,CC,
2808,GO:0005898,1,0.993488669807864,0,1,interleukin-13 receptor complex,CC,
2809,GO:0005899,1,0.972738099437114,0,4,insulin receptor complex,CC,
2810,GO:0005900,1,0.987084175410681,0,2,oncostatin-M receptor complex,CC,
2816,GO:0005912,1,0.356334030356017,0,156,adherens junction,CC,
2817,GO:0005914,1,0.993525505389455,0,1,spot adherens junction,CC,
2818,GO:0005915,1,0.95510332904878,0,7,zonula adherens,CC,
2819,GO:0005916,1,0.936393190993535,0,10,fascia adherens,CC,
2824,GO:0005927,1,0.980818753063616,0,3,muscle tendon junction,CC,
2828,GO:0005942,1,0.848637770778067,0,25,phosphatidylinositol 3-kinase complex,CC,
2829,GO:0005943,1,0.980374433659406,0,3,phosphatidylinositol 3-kinase complex, class IA,CC,
2830,GO:0005944,1,0.980479285074436,0,3,phosphatidylinositol 3-kinase complex, class IB,CC,
2831,GO:0005945,1,0.98075565819342,0,3,6-phosphofructokinase complex,CC,
2832,GO:0005947,1,0.967735363116966,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2833,GO:0005948,1,0.993585855414673,0,1,acetolactate synthase complex,CC,
2834,GO:0005952,1,0.94936747388494,0,8,cAMP-dependent protein kinase complex,CC,
2835,GO:0005953,1,0.987232744295453,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2837,GO:0005955,1,0.967492459059695,0,5,calcineurin complex,CC,
2838,GO:0005956,1,0.980973407602104,0,3,protein kinase CK2 complex,CC,
2839,GO:0005958,1,0.979839795153078,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2840,GO:0005960,1,0.987179597913016,0,2,glycine cleavage complex,CC,
2841,GO:0005964,1,0.96764606202954,0,5,phosphorylase kinase complex,CC,
2842,GO:0005965,1,0.98722719653886,0,2,protein farnesyltransferase complex,CC,
2843,GO:0005967,1,0.968076567409157,0,5,mitochondrial pyruvate dehydrogenase complex,CC,
2844,GO:0005968,1,0.974213805930334,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2845,GO:0005969,1,0.993153978976421,0,1,serine-pyruvate aminotransferase complex,CC,
2846,GO:0005971,1,0.9870990977436,0,2,ribonucleoside-diphosphate reductase complex,CC,
2848,GO:0005976,1,0.517970134162574,0,100,polysaccharide metabolic process,BP,
2849,GO:0005977,1,0.656460122357267,0,64,glycogen metabolic process,BP,
2850,GO:0005978,1,0.762887311938484,0,41,glycogen biosynthetic process,BP,
2851,GO:0005979,1,0.841570249126294,0,26,regulation of glycogen biosynthetic process,BP,
2852,GO:0005980,1,0.871113605068575,0,21,glycogen catabolic process,BP,
2853,GO:0005981,1,0.967873365855979,0,5,regulation of glycogen catabolic process,BP,
2854,GO:0005982,1,0.993289981237472,0,1,starch metabolic process,BP,
2855,GO:0005983,1,0.993289981237472,0,1,starch catabolic process,BP,
2856,GO:0005984,1,0.943176334794829,0,9,disaccharide metabolic process,BP,
2857,GO:0005985,1,0.987189447954469,0,2,sucrose metabolic process,BP,
2858,GO:0005986,1,0.993636984467201,0,1,sucrose biosynthetic process,BP,
2859,GO:0005988,1,0.980798558600785,0,3,lactose metabolic process,BP,
2860,GO:0005989,1,0.980798558600785,0,3,lactose biosynthetic process,BP,
2861,GO:0005991,1,0.993546289825048,0,1,trehalose metabolic process,BP,
2862,GO:0005996,1,0.191285567198261,0,252,monosaccharide metabolic process,BP,
2863,GO:0005997,1,0.974687426338603,0,4,xylulose metabolic process,BP,
2864,GO:0005998,1,0.993506597747951,0,1,xylulose catabolic process,BP,
2865,GO:0005999,1,0.98729563383622,0,2,xylulose biosynthetic process,BP,
2866,GO:0006000,1,0.919528051574619,0,13,fructose metabolic process,BP,
2867,GO:0006001,1,0.974531408893151,0,4,fructose catabolic process,BP,
2868,GO:0006002,1,0.930541063045074,0,11,fructose 6-phosphate metabolic process,BP,
2869,GO:0006003,1,0.974249334154165,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2870,GO:0006004,1,0.912331809797361,0,14,fucose metabolic process,BP,
2871,GO:0006006,1,0.2894653789317,0,189,glucose metabolic process,BP,
2872,GO:0006007,1,0.812021463650405,0,32,glucose catabolic process,BP,
2873,GO:0006011,1,0.967561100145691,0,5,UDP-glucose metabolic process,BP,
2874,GO:0006012,1,0.918962205976328,0,13,galactose metabolic process,BP,
2875,GO:0006013,1,0.94308927645711,0,9,mannose metabolic process,BP,
2876,GO:0006014,1,0.981055508313464,0,3,D-ribose metabolic process,BP,
2877,GO:0006015,1,0.968321889467719,0,5,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2878,GO:0006020,1,0.936159523600413,0,10,inositol metabolic process,BP,
2879,GO:0006021,1,0.980872699181099,0,3,inositol biosynthetic process,BP,
2881,GO:0006023,1,0.482523773010945,0,111,aminoglycan biosynthetic process,BP,
2882,GO:0006024,1,0.50172852641932,0,105,glycosaminoglycan biosynthetic process,BP,
2884,GO:0006027,1,0.702018501703635,0,54,glycosaminoglycan catabolic process,BP,
2889,GO:0006041,1,0.974542195941054,0,4,glucosamine metabolic process,BP,
2890,GO:0006043,1,0.987238790495732,0,2,glucosamine catabolic process,BP,
2891,GO:0006044,1,0.901033941998248,0,16,N-acetylglucosamine metabolic process,BP,
2892,GO:0006045,1,0.986938687374885,0,2,N-acetylglucosamine biosynthetic process,BP,
2893,GO:0006046,1,0.980936631346023,0,3,N-acetylglucosamine catabolic process,BP,
2894,GO:0006047,1,0.907296114364741,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2895,GO:0006048,1,0.931166507057437,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2896,GO:0006049,1,0.993548305437112,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2897,GO:0006050,1,0.98731584083892,0,2,mannosamine metabolic process,BP,
2898,GO:0006051,1,0.98731584083892,0,2,N-acetylmannosamine metabolic process,BP,
2899,GO:0006054,1,0.931204648533456,0,11,N-acetylneuraminate metabolic process,BP,
2900,GO:0006055,1,0.993656939990299,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2901,GO:0006056,1,0.993621324578831,0,1,mannoprotein metabolic process,BP,
2902,GO:0006057,1,0.993621324578831,0,1,mannoprotein biosynthetic process,BP,
2903,GO:0006059,1,0.980987112420262,0,3,hexitol metabolic process,BP,
2904,GO:0006060,1,0.987258214922006,0,2,sorbitol metabolic process,BP,
2905,GO:0006061,1,0.993646113025072,0,1,sorbitol biosynthetic process,BP,
2906,GO:0006062,1,0.99357166287299,0,1,sorbitol catabolic process,BP,
2907,GO:0006063,1,0.949715763478264,0,8,uronic acid metabolic process,BP,
2908,GO:0006064,1,0.96844507163844,0,5,glucuronate catabolic process,BP,
2909,GO:0006065,1,0.98055120051536,0,3,UDP-glucuronate biosynthetic process,BP,
2911,GO:0006067,1,0.902214147263741,0,16,ethanol metabolic process,BP,
2912,GO:0006068,1,0.937927439861393,0,10,ethanol catabolic process,BP,
2913,GO:0006069,1,0.949594187588143,0,8,ethanol oxidation,BP,
2914,GO:0006071,1,0.900672338682201,0,16,glycerol metabolic process,BP,
2915,GO:0006072,1,0.954576233618735,0,7,glycerol-3-phosphate metabolic process,BP,
2916,GO:0006073,1,0.65203674835373,0,65,cellular glucan metabolic process,BP,
2917,GO:0006081,1,0.687057011889336,0,58,cellular aldehyde metabolic process,BP,
2919,GO:0006083,1,0.987044121206429,0,2,acetate metabolic process,BP,
2920,GO:0006084,1,0.790867500020529,0,36,acetyl-CoA metabolic process,BP,
2921,GO:0006085,1,0.872095040353277,0,21,acetyl-CoA biosynthetic process,BP,
2922,GO:0006086,1,0.906647524692501,0,15,acetyl-CoA biosynthetic process from pyruvate,BP,
2923,GO:0006089,1,0.925156232987653,0,12,lactate metabolic process,BP,
2924,GO:0006090,1,0.401657342860283,0,139,pyruvate metabolic process,BP,
2926,GO:0006094,1,0.609705223811721,0,76,gluconeogenesis,BP,
2927,GO:0006096,1,0.50485888717093,0,104,glycolytic process,BP,
2928,GO:0006097,1,0.987248608625349,0,2,glyoxylate cycle,BP,
2929,GO:0006098,1,0.913520709049989,0,14,pentose-phosphate shunt,BP,
2930,GO:0006099,1,0.807903600661665,0,33,tricarboxylic acid cycle,BP,
2931,GO:0006101,1,0.967804147691012,0,5,citrate metabolic process,BP,
2932,GO:0006102,1,0.96220310598863,0,6,isocitrate metabolic process,BP,
2933,GO:0006103,1,0.907547287988545,0,15,2-oxoglutarate metabolic process,BP,
2934,GO:0006104,1,0.968238053585334,0,5,succinyl-CoA metabolic process,BP,
2935,GO:0006105,1,0.96823494841296,0,5,succinate metabolic process,BP,
2936,GO:0006106,1,0.980915612928714,0,3,fumarate metabolic process,BP,
2937,GO:0006107,1,0.949871978246622,0,8,oxaloacetate metabolic process,BP,
2938,GO:0006108,1,0.955926228143191,0,7,malate metabolic process,BP,
2940,GO:0006110,1,0.626365559346774,0,71,regulation of glycolytic process,BP,
2941,GO:0006111,1,0.784429596308335,0,37,regulation of gluconeogenesis,BP,
2942,GO:0006112,1,0.611026772916292,0,75,energy reserve metabolic process,BP,
2943,GO:0006113,1,0.987098243375882,0,2,fermentation,BP,
2944,GO:0006114,1,0.962040329685771,0,6,glycerol biosynthetic process,BP,
2945,GO:0006116,1,0.980596421198701,0,3,NADH oxidation,BP,
2946,GO:0006117,1,0.993568579238729,0,1,acetaldehyde metabolic process,BP,
2949,GO:0006121,1,0.974689418499767,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2950,GO:0006122,1,0.925614610296198,0,12,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2951,GO:0006123,1,0.902907544948173,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2952,GO:0006127,1,0.986935426023332,0,2,glycerophosphate shuttle,BP,
2954,GO:0006140,1,0.501841647231756,0,105,regulation of nucleotide metabolic process,BP,
2958,GO:0006148,1,0.993578947207367,0,1,inosine catabolic process,BP,
2959,GO:0006152,1,0.962068522657836,0,6,purine nucleoside catabolic process,BP,
2960,GO:0006154,1,0.987246736676818,0,2,adenosine catabolic process,BP,
2961,GO:0006157,1,0.993637117932028,0,1,deoxyadenosine catabolic process,BP,
2965,GO:0006166,1,0.968377520650855,0,5,purine ribonucleoside salvage,BP,
2966,GO:0006167,1,0.974845585608697,0,4,AMP biosynthetic process,BP,
2967,GO:0006168,1,0.987374977828253,0,2,adenine salvage,BP,
2968,GO:0006170,1,0.987279341978086,0,2,dAMP biosynthetic process,BP,
2969,GO:0006171,1,0.935133467240886,0,10,cAMP biosynthetic process,BP,
2972,GO:0006174,1,0.99355705431691,0,1,dADP phosphorylation,BP,
2973,GO:0006175,1,0.993602486384613,0,1,dATP biosynthetic process,BP,
2974,GO:0006177,1,0.974662085872847,0,4,GMP biosynthetic process,BP,
2975,GO:0006178,1,0.993645181428393,0,1,guanine salvage,BP,
2976,GO:0006182,1,0.955987290876757,0,7,cGMP biosynthetic process,BP,
2977,GO:0006183,1,0.938192542161294,0,10,GTP biosynthetic process,BP,
2978,GO:0006185,1,0.993673483372605,0,1,dGDP biosynthetic process,BP,
2979,GO:0006186,1,0.99355705431691,0,1,dGDP phosphorylation,BP,
2980,GO:0006188,1,0.943261564468011,0,9,IMP biosynthetic process,BP,
2981,GO:0006189,1,0.96179258363519,0,6,'de novo' IMP biosynthetic process,BP,
2982,GO:0006193,1,0.993666179737523,0,1,ITP catabolic process,BP,
2984,GO:0006196,1,0.98699529473509,0,2,AMP catabolic process,BP,
2985,GO:0006198,1,0.942087051522523,0,9,cAMP catabolic process,BP,
2986,GO:0006203,1,0.980950674659092,0,3,dGTP catabolic process,BP,
2987,GO:0006206,1,0.901007118256551,0,16,pyrimidine nucleobase metabolic process,BP,
2988,GO:0006207,1,0.961033468751433,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2989,GO:0006208,1,0.980850904181618,0,3,pyrimidine nucleobase catabolic process,BP,
2990,GO:0006210,1,0.980850904181618,0,3,thymine catabolic process,BP,
2991,GO:0006211,1,0.979032302319157,0,3,5-methylcytosine catabolic process,BP,
2992,GO:0006212,1,0.987175708540991,0,2,uracil catabolic process,BP,
2993,GO:0006213,1,0.813891861896269,0,32,pyrimidine nucleoside metabolic process,BP,
2994,GO:0006214,1,0.993537047150672,0,1,thymidine catabolic process,BP,
2995,GO:0006216,1,0.937907515958905,0,10,cytidine catabolic process,BP,
2996,GO:0006218,1,0.98723844987102,0,2,uridine catabolic process,BP,
2999,GO:0006222,1,0.937409120148856,0,10,UMP biosynthetic process,BP,
3000,GO:0006225,1,0.993551996593999,0,1,UDP biosynthetic process,BP,
3001,GO:0006226,1,0.987259233161437,0,2,dUMP biosynthetic process,BP,
3002,GO:0006227,1,0.987248884937554,0,2,dUDP biosynthetic process,BP,
3003,GO:0006228,1,0.94389248341872,0,9,UTP biosynthetic process,BP,
3004,GO:0006231,1,0.980935404510993,0,3,dTMP biosynthetic process,BP,
3005,GO:0006233,1,0.987248884937554,0,2,dTDP biosynthetic process,BP,
3006,GO:0006235,1,0.974734589195674,0,4,dTTP biosynthetic process,BP,
3007,GO:0006241,1,0.920208699473888,0,13,CTP biosynthetic process,BP,
3008,GO:0006244,1,0.920051345510794,0,13,pyrimidine nucleotide catabolic process,BP,
3009,GO:0006253,1,0.993665154203989,0,1,dCTP catabolic process,BP,
3010,GO:0006256,1,0.993547687504412,0,1,UDP catabolic process,BP,
3011,GO:0006258,1,0.987284561880311,0,2,UDP-glucose catabolic process,BP,
3013,GO:0006260,1,0.184756117018537,0,257,DNA replication,BP,
3014,GO:0006261,1,0.392915277828124,0,143,DNA-dependent DNA replication,BP,
3015,GO:0006264,1,0.925132461086405,0,12,mitochondrial DNA replication,BP,
3016,GO:0006265,1,0.94309398187014,0,9,DNA topological change,BP,
3017,GO:0006266,1,0.901807793824196,0,16,DNA ligation,BP,
3018,GO:0006267,1,0.949456670626831,0,8,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3019,GO:0006268,1,0.907138192978532,0,15,DNA unwinding involved in DNA replication,BP,
3020,GO:0006269,1,0.968101681035454,0,5,DNA replication, synthesis of RNA primer,BP,
3021,GO:0006270,1,0.78169524726218,0,38,DNA replication initiation,BP,
3022,GO:0006271,1,0.88397762921463,0,19,DNA strand elongation involved in DNA replication,BP,
3023,GO:0006272,1,0.974036980282656,0,4,leading strand elongation,BP,
3024,GO:0006273,1,0.974155187124971,0,4,lagging strand elongation,BP,
3025,GO:0006275,1,0.506161545941842,0,104,regulation of DNA replication,BP,
3026,GO:0006278,1,0.644984036526652,0,67,RNA-dependent DNA biosynthetic process,BP,
3027,GO:0006281,1,0.0394730748811603,0,488,DNA repair,BP,
3028,GO:0006282,1,0.479847043257175,0,112,regulation of DNA repair,BP,
3029,GO:0006283,1,0.623422022262051,0,73,transcription-coupled nucleotide-excision repair,BP,
3030,GO:0006284,1,0.770617049408535,0,40,base-excision repair,BP,
3031,GO:0006285,1,0.937906221777528,0,10,base-excision repair, AP site formation,BP,
3032,GO:0006286,1,0.987335286242623,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3033,GO:0006287,1,0.961640047857447,0,6,base-excision repair, gap-filling,BP,
3034,GO:0006288,1,0.980898149906948,0,3,base-excision repair, DNA ligation,BP,
3035,GO:0006289,1,0.502207483410787,0,106,nucleotide-excision repair,BP,
3036,GO:0006290,1,0.942786451347597,0,9,pyrimidine dimer repair,BP,
3037,GO:0006293,1,0.872472547832993,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3038,GO:0006294,1,0.829130530941414,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3039,GO:0006295,1,0.872472547832993,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3040,GO:0006296,1,0.78707486105762,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3041,GO:0006297,1,0.861824168247818,0,23,nucleotide-excision repair, DNA gap filling,BP,
3042,GO:0006298,1,0.812146609286634,0,32,mismatch repair,BP,
3043,GO:0006301,1,0.727044833924798,0,49,postreplication repair,BP,
3044,GO:0006302,1,0.238051841368726,0,218,double-strand break repair,BP,
3045,GO:0006303,1,0.643653512894151,0,67,double-strand break repair via nonhomologous end joining,BP,
3046,GO:0006304,1,0.50678026426617,0,104,DNA modification,BP,
3047,GO:0006305,1,0.675103702027307,0,60,DNA alkylation,BP,
3048,GO:0006306,1,0.675103702027307,0,60,DNA methylation,BP,
3049,GO:0006307,1,0.937534255396789,0,10,DNA dealkylation involved in DNA repair,BP,
3050,GO:0006308,1,0.77620447903846,0,39,DNA catabolic process,BP,
3051,GO:0006309,1,0.855632826984218,0,24,apoptotic DNA fragmentation,BP,
3052,GO:0006310,1,0.194345336016402,0,249,DNA recombination,BP,
3053,GO:0006311,1,0.980736279533803,0,3,meiotic gene conversion,BP,
3054,GO:0006312,1,0.871006712716219,0,21,mitotic recombination,BP,
3055,GO:0006313,1,0.987048834114702,0,2,transposition, DNA-mediated,BP,
3056,GO:0006323,1,0.39139477090436,0,141,DNA packaging,BP,
3059,GO:0006334,1,0.668011791175992,0,62,nucleosome assembly,BP,
3060,GO:0006335,1,0.949293623512054,0,8,DNA replication-dependent nucleosome assembly,BP,
3061,GO:0006336,1,0.801786813819775,0,34,DNA replication-independent nucleosome assembly,BP,
3062,GO:0006337,1,0.906400425830719,0,15,nucleosome disassembly,BP,
3063,GO:0006338,1,0.319306820372136,0,173,chromatin remodeling,BP,
3064,GO:0006342,1,0.800171693344285,0,34,chromatin silencing,BP,
3065,GO:0006346,1,0.894618903772539,0,17,DNA methylation-dependent heterochromatin assembly,BP,
3066,GO:0006348,1,0.936962870607422,0,10,chromatin silencing at telomere,BP,
3067,GO:0006349,1,0.894423511476818,0,17,regulation of gene expression by genetic imprinting,BP,
3069,GO:0006352,1,0.235487457355327,0,220,DNA-templated transcription, initiation,BP,
3070,GO:0006353,1,0.630985590822349,0,71,DNA-templated transcription, termination,BP,
3071,GO:0006354,1,0.507964184412064,0,104,DNA-templated transcription, elongation,BP,
3073,GO:0006356,1,0.838404252105586,0,27,regulation of transcription by RNA polymerase I,BP,
3075,GO:0006359,1,0.860672781851535,0,23,regulation of transcription by RNA polymerase III,BP,
3076,GO:0006360,1,0.693951293482301,0,56,transcription by RNA polymerase I,BP,
3077,GO:0006361,1,0.812543622296956,0,32,transcription initiation from RNA polymerase I promoter,BP,
3078,GO:0006362,1,0.839698650504469,0,27,transcription elongation from RNA polymerase I promoter,BP,
3079,GO:0006363,1,0.839974151025711,0,27,termination of RNA polymerase I transcription,BP,
3080,GO:0006364,1,0.263435436329125,0,205,rRNA processing,BP,
3082,GO:0006367,1,0.306979099388462,0,180,transcription initiation from RNA polymerase II promoter,BP,
3083,GO:0006368,1,0.601861840858265,0,78,transcription elongation from RNA polymerase II promoter,BP,
3084,GO:0006369,1,0.796800422403851,0,35,termination of RNA polymerase II transcription,BP,
3085,GO:0006370,1,0.818453719840832,0,31,7-methylguanosine mRNA capping,BP,
3086,GO:0006376,1,0.817080831374547,0,31,mRNA splice site selection,BP,
3087,GO:0006378,1,0.760348247242606,0,42,mRNA polyadenylation,BP,
3088,GO:0006379,1,0.878050601881287,0,20,mRNA cleavage,BP,
3089,GO:0006382,1,0.948874707607673,0,8,adenosine to inosine editing,BP,
3090,GO:0006383,1,0.741293378023018,0,46,transcription by RNA polymerase III,BP,
3091,GO:0006384,1,0.948567797379916,0,8,transcription initiation from RNA polymerase III promoter,BP,
3092,GO:0006386,1,0.993686409408619,0,1,termination of RNA polymerase III transcription,BP,
3093,GO:0006388,1,0.914109813775991,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3094,GO:0006390,1,0.912722890239342,0,14,mitochondrial transcription,BP,
3095,GO:0006391,1,0.980853303329356,0,3,transcription initiation from mitochondrial promoter,BP,
3096,GO:0006392,1,0.99355705431691,0,1,transcription elongation from mitochondrial promoter,BP,
3097,GO:0006393,1,0.987155207697788,0,2,termination of mitochondrial transcription,BP,
3098,GO:0006396,1,0.00323662765313824,0,859,RNA processing,BP,
3099,GO:0006397,1,0.0436998926090932,0,475,mRNA processing,BP,
3100,GO:0006398,1,0.968062431732783,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3101,GO:0006399,1,0.361236583123173,0,157,tRNA metabolic process,BP,
3102,GO:0006400,1,0.591579006604536,0,81,tRNA modification,BP,
3103,GO:0006401,1,0.0816663199981262,0,382,RNA catabolic process,BP,
3104,GO:0006402,1,0.103063944494295,0,347,mRNA catabolic process,BP,
3105,GO:0006403,1,0.237300307972545,0,219,RNA localization,BP,
3106,GO:0006404,1,0.980410528154827,0,3,RNA import into nucleus,BP,
3107,GO:0006405,1,0.418638888570666,0,133,RNA export from nucleus,BP,
3108,GO:0006406,1,0.502861188847561,0,105,mRNA export from nucleus,BP,
3109,GO:0006407,1,0.986788932701909,0,2,rRNA export from nucleus,BP,
3110,GO:0006408,1,0.987263462010014,0,2,snRNA export from nucleus,BP,
3111,GO:0006409,1,0.815746545716061,0,31,tRNA export from nucleus,BP,
3112,GO:0006412,1,0.0210015591164371,0,586,translation,BP,
3113,GO:0006413,1,0.300374971029097,0,186,translational initiation,BP,
3114,GO:0006414,1,0.446779076952975,0,125,translational elongation,BP,
3115,GO:0006415,1,0.522746569399558,0,101,translational termination,BP,
3116,GO:0006417,1,0.106321648791938,0,340,regulation of translation,BP,
3117,GO:0006418,1,0.845650620249829,0,26,tRNA aminoacylation for protein translation,BP,
3118,GO:0006419,1,0.987089190243977,0,2,alanyl-tRNA aminoacylation,BP,
3119,GO:0006420,1,0.987246845392515,0,2,arginyl-tRNA aminoacylation,BP,
3120,GO:0006421,1,0.987153495400304,0,2,asparaginyl-tRNA aminoacylation,BP,
3121,GO:0006423,1,0.9936147443402,0,1,cysteinyl-tRNA aminoacylation,BP,
3122,GO:0006424,1,0.993494103316609,0,1,glutamyl-tRNA aminoacylation,BP,
3123,GO:0006427,1,0.993573673610986,0,1,histidyl-tRNA aminoacylation,BP,
3124,GO:0006428,1,0.993514001447054,0,1,isoleucyl-tRNA aminoacylation,BP,
3125,GO:0006429,1,0.99347561208118,0,1,leucyl-tRNA aminoacylation,BP,
3126,GO:0006431,1,0.993542641203597,0,1,methionyl-tRNA aminoacylation,BP,
3127,GO:0006432,1,0.98094320664817,0,3,phenylalanyl-tRNA aminoacylation,BP,
3128,GO:0006433,1,0.993583583362043,0,1,prolyl-tRNA aminoacylation,BP,
3129,GO:0006434,1,0.993601252888419,0,1,seryl-tRNA aminoacylation,BP,
3130,GO:0006435,1,0.993580872450883,0,1,threonyl-tRNA aminoacylation,BP,
3131,GO:0006436,1,0.993554101532261,0,1,tryptophanyl-tRNA aminoacylation,BP,
3132,GO:0006437,1,0.993595573832411,0,1,tyrosyl-tRNA aminoacylation,BP,
3133,GO:0006438,1,0.993510239947417,0,1,valyl-tRNA aminoacylation,BP,
3134,GO:0006446,1,0.609461500784357,0,76,regulation of translational initiation,BP,
3135,GO:0006447,1,0.980589043418436,0,3,regulation of translational initiation by iron,BP,
3136,GO:0006448,1,0.889587153962786,0,18,regulation of translational elongation,BP,
3137,GO:0006449,1,0.936772856777268,0,10,regulation of translational termination,BP,
3138,GO:0006450,1,0.913785639183078,0,14,regulation of translational fidelity,BP,
3139,GO:0006451,1,0.949140853421835,0,8,translational readthrough,BP,
3140,GO:0006457,1,0.270548940066588,0,201,protein folding,BP,
3141,GO:0006458,1,0.792209564473375,0,36,'de novo' protein folding,BP,
3142,GO:0006463,1,0.993504012603006,0,1,steroid hormone receptor complex assembly,BP,
3144,GO:0006465,1,0.931555669877038,0,11,signal peptide processing,BP,
3148,GO:0006471,1,0.827911904808077,0,29,protein ADP-ribosylation,BP,
3150,GO:0006474,1,0.900398436091289,0,16,N-terminal protein amino acid acetylation,BP,
3152,GO:0006476,1,0.545756897016482,0,92,protein deacetylation,BP,
3153,GO:0006477,1,0.955391084282675,0,7,protein sulfation,BP,
3154,GO:0006478,1,0.987252872121761,0,2,peptidyl-tyrosine sulfation,BP,
3155,GO:0006479,1,0.362720807576619,0,154,protein methylation,BP,
3156,GO:0006480,1,0.987274370430642,0,2,N-terminal protein amino acid methylation,BP,
3157,GO:0006481,1,0.987128362669805,0,2,C-terminal protein methylation,BP,
3158,GO:0006482,1,0.825129355313288,0,29,protein demethylation,BP,
3160,GO:0006487,1,0.630367054818983,0,71,protein N-linked glycosylation,BP,
3161,GO:0006488,1,0.87800640844266,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3162,GO:0006489,1,0.955786038226416,0,7,dolichyl diphosphate biosynthetic process,BP,
3163,GO:0006490,1,0.872354632449609,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3164,GO:0006491,1,0.887893821258619,0,18,N-glycan processing,BP,
3168,GO:0006499,1,0.973820444092252,0,4,N-terminal protein myristoylation,BP,
3170,GO:0006501,1,0.961708714576479,0,6,C-terminal protein lipidation,BP,
3171,GO:0006505,1,0.818355665517698,0,31,GPI anchor metabolic process,BP,
3172,GO:0006506,1,0.823647949178671,0,30,GPI anchor biosynthetic process,BP,
3173,GO:0006507,1,0.993586995583296,0,1,GPI anchor release,BP,
3175,GO:0006509,1,0.770384467440615,0,40,membrane protein ectodomain proteolysis,BP,
3176,GO:0006511,1,0.0211607138579525,0,580,ubiquitin-dependent protein catabolic process,BP,
3177,GO:0006513,1,0.656836639745693,0,64,protein monoubiquitination,BP,
3178,GO:0006515,1,0.832503484397833,0,28,protein quality control for misfolded or incompletely synthesized proteins,BP,
3179,GO:0006516,1,0.87817800103138,0,20,glycoprotein catabolic process,BP,
3180,GO:0006517,1,0.843150091836509,0,26,protein deglycosylation,BP,
3183,GO:0006521,1,0.688546972919738,0,58,regulation of cellular amino acid metabolic process,BP,
3184,GO:0006522,1,0.974615889470712,0,4,alanine metabolic process,BP,
3185,GO:0006524,1,0.974615889470712,0,4,alanine catabolic process,BP,
3186,GO:0006525,1,0.884231031477615,0,19,arginine metabolic process,BP,
3187,GO:0006526,1,0.968469137324277,0,5,arginine biosynthetic process,BP,
3188,GO:0006527,1,0.936853616365726,0,10,arginine catabolic process,BP,
3189,GO:0006528,1,0.968423110820249,0,5,asparagine metabolic process,BP,
3190,GO:0006529,1,0.987200615663076,0,2,asparagine biosynthetic process,BP,
3191,GO:0006530,1,0.993581097680666,0,1,asparagine catabolic process,BP,
3192,GO:0006531,1,0.968472051700043,0,5,aspartate metabolic process,BP,
3193,GO:0006532,1,0.987214736105641,0,2,aspartate biosynthetic process,BP,
3194,GO:0006533,1,0.974694335847405,0,4,aspartate catabolic process,BP,
3195,GO:0006534,1,0.931175716334163,0,11,cysteine metabolic process,BP,
3196,GO:0006535,1,0.993567127228303,0,1,cysteine biosynthetic process from serine,BP,
3197,GO:0006536,1,0.817701131748033,0,31,glutamate metabolic process,BP,
3198,GO:0006537,1,0.968035855501854,0,5,glutamate biosynthetic process,BP,
3199,GO:0006538,1,0.94963654048187,0,8,glutamate catabolic process,BP,
3200,GO:0006539,1,0.993612730327216,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3201,GO:0006540,1,0.987187887699155,0,2,glutamate decarboxylation to succinate,BP,
3202,GO:0006541,1,0.871831806735403,0,21,glutamine metabolic process,BP,
3203,GO:0006542,1,0.993465978515376,0,1,glutamine biosynthetic process,BP,
3204,GO:0006543,1,0.98066052906439,0,3,glutamine catabolic process,BP,
3205,GO:0006544,1,0.925726105562023,0,12,glycine metabolic process,BP,
3206,GO:0006545,1,0.980920439969665,0,3,glycine biosynthetic process,BP,
3207,GO:0006546,1,0.980862171411792,0,3,glycine catabolic process,BP,
3210,GO:0006549,1,0.968493904971449,0,5,isoleucine metabolic process,BP,
3211,GO:0006550,1,0.987268878264795,0,2,isoleucine catabolic process,BP,
3212,GO:0006551,1,0.949283945784958,0,8,leucine metabolic process,BP,
3213,GO:0006552,1,0.961981170496145,0,6,leucine catabolic process,BP,
3214,GO:0006553,1,0.919201360080834,0,13,lysine metabolic process,BP,
3215,GO:0006554,1,0.925171816179213,0,12,lysine catabolic process,BP,
3216,GO:0006555,1,0.901106849015406,0,16,methionine metabolic process,BP,
3217,GO:0006556,1,0.974479100063486,0,4,S-adenosylmethionine biosynthetic process,BP,
3218,GO:0006557,1,0.993529657669243,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3219,GO:0006558,1,0.937924211363937,0,10,L-phenylalanine metabolic process,BP,
3220,GO:0006559,1,0.937924211363937,0,10,L-phenylalanine catabolic process,BP,
3221,GO:0006560,1,0.949804844691483,0,8,proline metabolic process,BP,
3222,GO:0006561,1,0.968328214319694,0,5,proline biosynthetic process,BP,
3223,GO:0006562,1,0.980876871014133,0,3,proline catabolic process,BP,
3224,GO:0006563,1,0.937744694342087,0,10,L-serine metabolic process,BP,
3225,GO:0006564,1,0.956015120494948,0,7,L-serine biosynthetic process,BP,
3226,GO:0006565,1,0.974608894970601,0,4,L-serine catabolic process,BP,
3227,GO:0006566,1,0.974757775905641,0,4,threonine metabolic process,BP,
3228,GO:0006567,1,0.981032917731119,0,3,threonine catabolic process,BP,
3229,GO:0006568,1,0.937398904170215,0,10,tryptophan metabolic process,BP,
3230,GO:0006569,1,0.949965851152255,0,8,tryptophan catabolic process,BP,
3231,GO:0006570,1,0.94392080520124,0,9,tyrosine metabolic process,BP,
3232,GO:0006571,1,0.993561823482235,0,1,tyrosine biosynthetic process,BP,
3233,GO:0006572,1,0.968490458427019,0,5,tyrosine catabolic process,BP,
3234,GO:0006573,1,0.955612902514721,0,7,valine metabolic process,BP,
3235,GO:0006574,1,0.974647053625402,0,4,valine catabolic process,BP,
3238,GO:0006577,1,0.895869187108129,0,17,amino-acid betaine metabolic process,BP,
3239,GO:0006578,1,0.955758074781938,0,7,amino-acid betaine biosynthetic process,BP,
3240,GO:0006579,1,0.980808897324889,0,3,amino-acid betaine catabolic process,BP,
3241,GO:0006580,1,0.987150087326475,0,2,ethanolamine metabolic process,BP,
3242,GO:0006581,1,0.9871526581065,0,2,acetylcholine catabolic process,BP,
3243,GO:0006582,1,0.870850216684631,0,21,melanin metabolic process,BP,
3244,GO:0006583,1,0.99358309799152,0,1,melanin biosynthetic process from tyrosine,BP,
3246,GO:0006585,1,0.993612461861447,0,1,dopamine biosynthetic process from tyrosine,BP,
3247,GO:0006586,1,0.913656495537475,0,14,indolalkylamine metabolic process,BP,
3249,GO:0006590,1,0.882849359417636,0,19,thyroid hormone generation,BP,
3250,GO:0006591,1,0.943720822773215,0,9,ornithine metabolic process,BP,
3251,GO:0006592,1,0.993518684820754,0,1,ornithine biosynthetic process,BP,
3252,GO:0006593,1,0.99362956730479,0,1,ornithine catabolic process,BP,
3253,GO:0006595,1,0.902491177057899,0,16,polyamine metabolic process,BP,
3254,GO:0006596,1,0.919968756183705,0,13,polyamine biosynthetic process,BP,
3255,GO:0006597,1,0.987197240558703,0,2,spermine biosynthetic process,BP,
3256,GO:0006598,1,0.974807067395148,0,4,polyamine catabolic process,BP,
3257,GO:0006599,1,0.968560734015304,0,5,phosphagen metabolic process,BP,
3258,GO:0006600,1,0.95003336696587,0,8,creatine metabolic process,BP,
3259,GO:0006601,1,0.987280712461114,0,2,creatine biosynthetic process,BP,
3260,GO:0006603,1,0.968560734015304,0,5,phosphocreatine metabolic process,BP,
3261,GO:0006605,1,0.0657828551315296,0,415,protein targeting,BP,
3262,GO:0006606,1,0.410779509860902,0,135,protein import into nucleus,BP,
3263,GO:0006607,1,0.899146076387785,0,16,NLS-bearing protein import into nucleus,BP,
3264,GO:0006610,1,0.974221161783666,0,4,ribosomal protein import into nucleus,BP,
3265,GO:0006611,1,0.315316321991999,0,176,protein export from nucleus,BP,
3266,GO:0006612,1,0.290815643039045,0,191,protein targeting to membrane,BP,
3267,GO:0006613,1,0.534504270273591,0,98,cotranslational protein targeting to membrane,BP,
3268,GO:0006614,1,0.548985045883029,0,94,SRP-dependent cotranslational protein targeting to membrane,BP,
3269,GO:0006616,1,0.949559934859229,0,8,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3270,GO:0006617,1,0.987310523075677,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3271,GO:0006620,1,0.931046031648192,0,11,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3272,GO:0006621,1,0.943503338172244,0,9,protein retention in ER lumen,BP,
3273,GO:0006622,1,0.876337394506981,0,20,protein targeting to lysosome,BP,
3274,GO:0006623,1,0.782379942616757,0,37,protein targeting to vacuole,BP,
3275,GO:0006624,1,0.987326800115694,0,2,vacuolar protein processing,BP,
3276,GO:0006625,1,0.643682364566445,0,68,protein targeting to peroxisome,BP,
3277,GO:0006626,1,0.550690772760047,0,92,protein targeting to mitochondrion,BP,
3278,GO:0006627,1,0.955556377462351,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3282,GO:0006635,1,0.629988323934743,0,71,fatty acid beta-oxidation,BP,
3284,GO:0006637,1,0.54659557424951,0,93,acyl-CoA metabolic process,BP,
3285,GO:0006638,1,0.500117593812553,0,106,neutral lipid metabolic process,BP,
3286,GO:0006639,1,0.500117593812553,0,106,acylglycerol metabolic process,BP,
3287,GO:0006640,1,0.980753031807962,0,3,monoacylglycerol biosynthetic process,BP,
3288,GO:0006641,1,0.585839986303783,0,82,triglyceride metabolic process,BP,
3289,GO:0006642,1,0.973260547578367,0,4,triglyceride mobilization,BP,
3292,GO:0006646,1,0.913095314935748,0,14,phosphatidylethanolamine biosynthetic process,BP,
3293,GO:0006649,1,0.986794147786739,0,2,phospholipid transfer to membrane,BP,
3295,GO:0006651,1,0.955367940174463,0,7,diacylglycerol biosynthetic process,BP,
3296,GO:0006654,1,0.764109547244571,0,41,phosphatidic acid biosynthetic process,BP,
3297,GO:0006655,1,0.937199907899383,0,10,phosphatidylglycerol biosynthetic process,BP,
3298,GO:0006656,1,0.787232992325164,0,37,phosphatidylcholine biosynthetic process,BP,
3299,GO:0006657,1,0.955738690184342,0,7,CDP-choline pathway,BP,
3300,GO:0006658,1,0.84514007007145,0,26,phosphatidylserine metabolic process,BP,
3301,GO:0006659,1,0.974500681971728,0,4,phosphatidylserine biosynthetic process,BP,
3302,GO:0006660,1,0.980936437220288,0,3,phosphatidylserine catabolic process,BP,
3304,GO:0006662,1,0.883561673817679,0,19,glycerol ether metabolic process,BP,
3305,GO:0006663,1,0.968163517571865,0,5,platelet activating factor biosynthetic process,BP,
3306,GO:0006664,1,0.511732375632426,0,103,glycolipid metabolic process,BP,
3308,GO:0006666,1,0.993403037976352,0,1,3-keto-sphinganine metabolic process,BP,
3309,GO:0006667,1,0.980611994565801,0,3,sphinganine metabolic process,BP,
3310,GO:0006668,1,0.987114825387047,0,2,sphinganine-1-phosphate metabolic process,BP,
3311,GO:0006669,1,0.993545900089888,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3312,GO:0006670,1,0.90706188287914,0,15,sphingosine metabolic process,BP,
3313,GO:0006671,1,0.9934640675287,0,1,phytosphingosine metabolic process,BP,
3314,GO:0006672,1,0.5606883966413,0,89,ceramide metabolic process,BP,
3315,GO:0006677,1,0.890268883384269,0,18,glycosylceramide metabolic process,BP,
3316,GO:0006678,1,0.949582584155573,0,8,glucosylceramide metabolic process,BP,
3317,GO:0006679,1,0.980742943746571,0,3,glucosylceramide biosynthetic process,BP,
3318,GO:0006680,1,0.974518072500141,0,4,glucosylceramide catabolic process,BP,
3319,GO:0006681,1,0.943645361629203,0,9,galactosylceramide metabolic process,BP,
3320,GO:0006682,1,0.962074516017893,0,6,galactosylceramide biosynthetic process,BP,
3321,GO:0006683,1,0.980851693272584,0,3,galactosylceramide catabolic process,BP,
3322,GO:0006684,1,0.924896080103844,0,12,sphingomyelin metabolic process,BP,
3323,GO:0006685,1,0.96184259461854,0,6,sphingomyelin catabolic process,BP,
3324,GO:0006686,1,0.961602428159607,0,6,sphingomyelin biosynthetic process,BP,
3325,GO:0006687,1,0.667808548012139,0,62,glycosphingolipid metabolic process,BP,
3326,GO:0006688,1,0.849633104873842,0,25,glycosphingolipid biosynthetic process,BP,
3327,GO:0006689,1,0.962053386335138,0,6,ganglioside catabolic process,BP,
3329,GO:0006691,1,0.86221342266864,0,23,leukotriene metabolic process,BP,
3334,GO:0006699,1,0.807613738040579,0,33,bile acid biosynthetic process,BP,
3335,GO:0006700,1,0.878252836608931,0,20,C21-steroid hormone biosynthetic process,BP,
3336,GO:0006701,1,0.967901669925904,0,5,progesterone biosynthetic process,BP,
3337,GO:0006702,1,0.955516836333452,0,7,androgen biosynthetic process,BP,
3338,GO:0006703,1,0.931852333021003,0,11,estrogen biosynthetic process,BP,
3339,GO:0006704,1,0.912679093680338,0,14,glucocorticoid biosynthetic process,BP,
3340,GO:0006705,1,0.942998068670825,0,9,mineralocorticoid biosynthetic process,BP,
3342,GO:0006707,1,0.943841926872538,0,9,cholesterol catabolic process,BP,
3344,GO:0006711,1,0.99362078762623,0,1,estrogen catabolic process,BP,
3345,GO:0006713,1,0.993620317734421,0,1,glucocorticoid catabolic process,BP,
3346,GO:0006714,1,0.987330825123749,0,2,sesquiterpenoid metabolic process,BP,
3349,GO:0006722,1,0.987094015861735,0,2,triterpenoid metabolic process,BP,
3351,GO:0006726,1,0.987202636475676,0,2,eye pigment biosynthetic process,BP,
3352,GO:0006729,1,0.956145414137528,0,7,tetrahydrobiopterin biosynthetic process,BP,
3353,GO:0006730,1,0.781929403252255,0,38,one-carbon metabolic process,BP,
3354,GO:0006734,1,0.786336073605518,0,37,NADH metabolic process,BP,
3355,GO:0006735,1,0.844407981674876,0,26,NADH regeneration,BP,
3356,GO:0006738,1,0.993578947207367,0,1,nicotinamide riboside catabolic process,BP,
3357,GO:0006739,1,0.818361984957838,0,31,NADP metabolic process,BP,
3358,GO:0006740,1,0.901697942929431,0,16,NADPH regeneration,BP,
3359,GO:0006741,1,0.980834731816794,0,3,NADP biosynthetic process,BP,
3360,GO:0006742,1,0.980905089929376,0,3,NADP catabolic process,BP,
3361,GO:0006743,1,0.896412430174509,0,17,ubiquinone metabolic process,BP,
3362,GO:0006744,1,0.908204736650977,0,15,ubiquinone biosynthetic process,BP,
3363,GO:0006747,1,0.99360800250412,0,1,FAD biosynthetic process,BP,
3364,GO:0006749,1,0.763178648193561,0,42,glutathione metabolic process,BP,
3365,GO:0006750,1,0.907337154811015,0,15,glutathione biosynthetic process,BP,
3366,GO:0006751,1,0.962243223262172,0,6,glutathione catabolic process,BP,
3368,GO:0006754,1,0.829285612958661,0,29,ATP biosynthetic process,BP,
3369,GO:0006756,1,0.99355705431691,0,1,AMP phosphorylation,BP,
3370,GO:0006757,1,0.50158387237413,0,105,ATP generation from ADP,BP,
3373,GO:0006767,1,0.601600578202776,0,78,water-soluble vitamin metabolic process,BP,
3374,GO:0006768,1,0.943344261997568,0,9,biotin metabolic process,BP,
3375,GO:0006771,1,0.955542616711834,0,7,riboflavin metabolic process,BP,
3376,GO:0006772,1,0.980888889774802,0,3,thiamine metabolic process,BP,
3378,GO:0006776,1,0.955753037424456,0,7,vitamin A metabolic process,BP,
3379,GO:0006777,1,0.961925229714383,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3380,GO:0006778,1,0.80205858039234,0,34,porphyrin-containing compound metabolic process,BP,
3381,GO:0006779,1,0.844403401710573,0,26,porphyrin-containing compound biosynthetic process,BP,
3382,GO:0006780,1,0.987284291669493,0,2,uroporphyrinogen III biosynthetic process,BP,
3383,GO:0006781,1,0.993594912291517,0,1,succinyl-CoA pathway,BP,
3384,GO:0006782,1,0.943597302084008,0,9,protoporphyrinogen IX biosynthetic process,BP,
3385,GO:0006783,1,0.866873387631309,0,22,heme biosynthetic process,BP,
3386,GO:0006784,1,0.986828524013289,0,2,heme A biosynthetic process,BP,
3387,GO:0006787,1,0.97484806961936,0,4,porphyrin-containing compound catabolic process,BP,
3388,GO:0006788,1,0.987299963474816,0,2,heme oxidation,BP,
3392,GO:0006797,1,0.967253274356027,0,5,polyphosphate metabolic process,BP,
3393,GO:0006798,1,0.973531786001792,0,4,polyphosphate catabolic process,BP,
3394,GO:0006801,1,0.664454823144509,0,63,superoxide metabolic process,BP,
3395,GO:0006805,1,0.573397146048082,0,86,xenobiotic metabolic process,BP,
3397,GO:0006808,1,0.980901511200292,0,3,regulation of nitrogen utilization,BP,
3398,GO:0006809,1,0.658108553189697,0,64,nitric oxide biosynthetic process,BP,
3408,GO:0006824,1,0.961969606042119,0,6,cobalt ion transport,BP,
3409,GO:0006825,1,0.889005358424858,0,18,copper ion transport,BP,
3411,GO:0006828,1,0.906813603345588,0,15,manganese ion transport,BP,
3413,GO:0006833,1,0.890071887870073,0,18,water transport,BP,
3418,GO:0006842,1,0.974378020525168,0,4,tricarboxylic acid transport,BP,
3419,GO:0006843,1,0.993632777137238,0,1,mitochondrial citrate transmembrane transport,BP,
3420,GO:0006844,1,0.968305323352594,0,5,acyl carnitine transport,BP,
3421,GO:0006848,1,0.974493790403254,0,4,pyruvate transport,BP,
3422,GO:0006850,1,0.987155207697788,0,2,mitochondrial pyruvate transmembrane transport,BP,
3423,GO:0006851,1,0.861630168657833,0,23,mitochondrial calcium ion transmembrane transport,BP,
3424,GO:0006853,1,0.942313122497153,0,9,carnitine shuttle,BP,
3425,GO:0006855,1,0.948894579435585,0,8,drug transmembrane transport,BP,
3426,GO:0006857,1,0.936434651322345,0,10,oligopeptide transport,BP,
3427,GO:0006858,1,0.820618220333058,0,30,extracellular transport,BP,
3429,GO:0006863,1,0.955913454439633,0,7,purine nucleobase transport,BP,
3430,GO:0006864,1,0.987128423034646,0,2,pyrimidine nucleotide transport,BP,
3432,GO:0006867,1,0.980860576088632,0,3,asparagine transport,BP,
3433,GO:0006868,1,0.942999042970064,0,9,glutamine transport,BP,
3438,GO:0006876,1,0.987070338383916,0,2,cellular cadmium ion homeostasis,BP,
3439,GO:0006878,1,0.913032200432691,0,14,cellular copper ion homeostasis,BP,
3441,GO:0006880,1,0.981064804422583,0,3,intracellular sequestering of iron ion,BP,
3443,GO:0006883,1,0.894754406799464,0,17,cellular sodium ion homeostasis,BP,
3444,GO:0006884,1,0.837773063452007,0,27,cell volume homeostasis,BP,
3445,GO:0006885,1,0.534824346758076,0,96,regulation of pH,BP,
3446,GO:0006886,1,0.000612566028975337,0,1096,intracellular protein transport,BP,
3448,GO:0006888,1,0.290631111049002,0,188,endoplasmic reticulum to Golgi vesicle-mediated transport,BP,
3449,GO:0006890,1,0.589193146128165,0,81,retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum,BP,
3450,GO:0006891,1,0.812184924347522,0,32,intra-Golgi vesicle-mediated transport,BP,
3451,GO:0006892,1,0.523477983346673,0,98,post-Golgi vesicle-mediated transport,BP,
3452,GO:0006893,1,0.691571077024276,0,56,Golgi to plasma membrane transport,BP,
3453,GO:0006895,1,0.904733056174817,0,15,Golgi to endosome transport,BP,
3454,GO:0006896,1,0.895377999564504,0,17,Golgi to vacuole transport,BP,
3457,GO:0006900,1,0.500090546647397,0,106,vesicle budding from membrane,BP,
3458,GO:0006901,1,0.641326422884149,0,68,vesicle coating,BP,
3459,GO:0006903,1,0.554804146850875,0,90,vesicle targeting,BP,
3460,GO:0006904,1,0.750951628438085,0,44,vesicle docking involved in exocytosis,BP,
3462,GO:0006907,1,0.866864578892779,0,22,pinocytosis,BP,
3463,GO:0006909,1,0.19512657666834,0,249,phagocytosis,BP,
3464,GO:0006910,1,0.913161009047744,0,14,phagocytosis, recognition,BP,
3465,GO:0006911,1,0.717174295522357,0,51,phagocytosis, engulfment,BP,
3466,GO:0006913,1,0.111641611960358,0,332,nucleocytoplasmic transport,BP,
3471,GO:0006924,1,0.949496050908025,0,8,activation-induced cell death of T cells,BP,
3472,GO:0006925,1,0.88351321723147,0,19,inflammatory cell apoptotic process,BP,
3474,GO:0006929,1,0.842119772987959,0,26,substrate-dependent cell migration,BP,
3475,GO:0006930,1,0.942571084722509,0,9,substrate-dependent cell migration, cell extension,BP,
3476,GO:0006931,1,0.973645758845626,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3477,GO:0006933,1,0.980755560783803,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3485,GO:0006948,1,0.993538017299483,0,1,induction by virus of host cell-cell fusion,BP,
3486,GO:0006949,1,0.739834039394749,0,46,syncytium formation,BP,
3492,GO:0006956,1,0.709490138552851,0,53,complement activation,BP,
3493,GO:0006957,1,0.930751844208787,0,11,complement activation, alternative pathway,BP,
3494,GO:0006958,1,0.839213135825036,0,27,complement activation, classical pathway,BP,
3496,GO:0006968,1,0.733269013472073,0,48,cellular defense response,BP,
3498,GO:0006971,1,0.93611329088102,0,10,hypotonic response,BP,
3501,GO:0006975,1,0.94894197964229,0,8,DNA damage induced protein phosphorylation,BP,
3502,GO:0006977,1,0.70322579157006,0,54,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3503,GO:0006978,1,0.894017408145624,0,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3505,GO:0006982,1,0.987340614268841,0,2,response to lipid hydroperoxide,BP,
3506,GO:0006983,1,0.93058724995318,0,11,ER overload response,BP,
3509,GO:0006990,1,0.980444722431379,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3510,GO:0006991,1,0.906929979161763,0,15,response to sterol depletion,BP,
3511,GO:0006995,1,0.931864974054781,0,11,cellular response to nitrogen starvation,BP,
3513,GO:0006997,1,0.466701290552275,0,116,nucleus organization,BP,
3514,GO:0006998,1,0.722647907317098,0,50,nuclear envelope organization,BP,
3515,GO:0006999,1,0.912070484185347,0,14,nuclear pore organization,BP,
3516,GO:0007000,1,0.955588507185945,0,7,nucleolus organization,BP,
3517,GO:0007004,1,0.653834106244396,0,65,telomere maintenance via telomerase,BP,
3520,GO:0007007,1,0.829494128862692,0,29,inner mitochondrial membrane organization,BP,
3521,GO:0007008,1,0.962133526480798,0,6,outer mitochondrial membrane organization,BP,
3524,GO:0007014,1,0.993505638353356,0,1,actin ubiquitination,BP,
3527,GO:0007018,1,0.118396700362249,0,321,microtubule-based movement,BP,
3528,GO:0007019,1,0.752529282603401,0,43,microtubule depolymerization,BP,
3529,GO:0007020,1,0.831296365978339,0,28,microtubule nucleation,BP,
3530,GO:0007021,1,0.943897525349605,0,9,tubulin complex assembly,BP,
3531,GO:0007023,1,0.968290084369605,0,5,post-chaperonin tubulin folding pathway,BP,
3532,GO:0007026,1,0.846948585601858,0,25,negative regulation of microtubule depolymerization,BP,
3533,GO:0007028,1,0.93574791834548,0,10,cytoplasm organization,BP,
3534,GO:0007029,1,0.666345532695025,0,62,endoplasmic reticulum organization,BP,
3535,GO:0007030,1,0.409849424956898,0,135,Golgi organization,BP,
3536,GO:0007031,1,0.590858978632329,0,81,peroxisome organization,BP,
3537,GO:0007032,1,0.629080249503051,0,71,endosome organization,BP,
3538,GO:0007033,1,0.347965859070469,0,161,vacuole organization,BP,
3539,GO:0007034,1,0.394808510665514,0,141,vacuolar transport,BP,
3540,GO:0007035,1,0.860834720159804,0,23,vacuolar acidification,BP,
3542,GO:0007040,1,0.666261896921106,0,62,lysosome organization,BP,
3543,GO:0007041,1,0.510313354315464,0,102,lysosomal transport,BP,
3544,GO:0007042,1,0.943908783724038,0,9,lysosomal lumen acidification,BP,
3548,GO:0007050,1,0.237614217420901,0,219,cell cycle arrest,BP,
3549,GO:0007051,1,0.330269199476111,0,168,spindle organization,BP,
3550,GO:0007052,1,0.488291554310301,0,109,mitotic spindle organization,BP,
3551,GO:0007056,1,0.987225923451612,0,2,spindle assembly involved in female meiosis,BP,
3552,GO:0007057,1,0.987225923451612,0,2,spindle assembly involved in female meiosis I,BP,
3553,GO:0007059,1,0.146152467024601,0,290,chromosome segregation,BP,
3554,GO:0007060,1,0.97447337768978,0,4,male meiosis chromosome segregation,BP,
3555,GO:0007062,1,0.734485934256309,0,47,sister chromatid cohesion,BP,
3556,GO:0007063,1,0.887850300123544,0,18,regulation of sister chromatid cohesion,BP,
3557,GO:0007064,1,0.870090812029438,0,21,mitotic sister chromatid cohesion,BP,
3558,GO:0007066,1,0.993677048097434,0,1,female meiosis sister chromatid cohesion,BP,
3559,GO:0007072,1,0.993625080542958,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3560,GO:0007076,1,0.893837171508731,0,15,mitotic chromosome condensation,BP,
3561,GO:0007077,1,0.924701542376619,0,12,mitotic nuclear envelope disassembly,BP,
3562,GO:0007079,1,0.973931057599331,0,4,mitotic chromosome movement towards spindle pole,BP,
3563,GO:0007080,1,0.737467060613621,0,47,mitotic metaphase plate congression,BP,
3564,GO:0007084,1,0.937678699973768,0,10,mitotic nuclear envelope reassembly,BP,
3565,GO:0007088,1,0.366182836986198,0,153,regulation of mitotic nuclear division,BP,
3566,GO:0007089,1,0.974169908630952,0,4,traversing start control point of mitotic cell cycle,BP,
3567,GO:0007091,1,0.688739389347173,0,57,metaphase/anaphase transition of mitotic cell cycle,BP,
3568,GO:0007093,1,0.357797072722944,0,157,mitotic cell cycle checkpoint,BP,
3569,GO:0007094,1,0.800645592591424,0,34,mitotic spindle assembly checkpoint,BP,
3570,GO:0007095,1,0.877128812369579,0,20,mitotic G2 DNA damage checkpoint,BP,
3571,GO:0007096,1,0.907377037975222,0,15,regulation of exit from mitosis,BP,
3572,GO:0007097,1,0.855701237428477,0,23,nuclear migration,BP,
3573,GO:0007098,1,0.454089737629498,0,120,centrosome cycle,BP,
3574,GO:0007099,1,0.799740054667678,0,34,centriole replication,BP,
3575,GO:0007100,1,0.912836099831489,0,14,mitotic centrosome separation,BP,
3576,GO:0007113,1,0.980975807415039,0,3,endomitotic cell cycle,BP,
3577,GO:0007127,1,0.545109346337601,0,93,meiosis I,BP,
3578,GO:0007129,1,0.791379224684669,0,36,homologous chromosome pairing at meiosis,BP,
3579,GO:0007130,1,0.901479257453921,0,16,synaptonemal complex assembly,BP,
3580,GO:0007131,1,0.735814039134233,0,47,reciprocal meiotic recombination,BP,
3581,GO:0007135,1,0.937479872134406,0,10,meiosis II,BP,
3582,GO:0007140,1,0.784773086535968,0,37,male meiotic nuclear division,BP,
3583,GO:0007141,1,0.889545253196171,0,18,male meiosis I,BP,
3584,GO:0007143,1,0.843684843410612,0,26,female meiotic nuclear division,BP,
3585,GO:0007144,1,0.955567023744936,0,7,female meiosis I,BP,
3586,GO:0007146,1,0.99355705431691,0,1,meiotic recombination nodule assembly,BP,
3587,GO:0007147,1,0.993510239947417,0,1,female meiosis II,BP,
3591,GO:0007157,1,0.772899614387287,0,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3595,GO:0007161,1,0.972961831500028,0,4,calcium-independent cell-matrix adhesion,BP,
3597,GO:0007163,1,0.249515372481904,0,210,establishment or maintenance of cell polarity,BP,
3598,GO:0007164,1,0.459427993762633,0,119,establishment of tissue polarity,BP,
3602,GO:0007168,1,0.949893846629787,0,8,receptor guanylyl cyclase signaling pathway,BP,
3605,GO:0007172,1,0.949423817567114,0,8,signal complex assembly,BP,
3606,GO:0007173,1,0.483040185225044,0,111,epidermal growth factor receptor signaling pathway,BP,
3607,GO:0007174,1,0.98723003826349,0,2,epidermal growth factor catabolic process,BP,
3608,GO:0007175,1,0.912462133589319,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3609,GO:0007176,1,0.827856790297907,0,29,regulation of epidermal growth factor-activated receptor activity,BP,
3611,GO:0007179,1,0.30244032069115,0,181,transforming growth factor beta receptor signaling pathway,BP,
3612,GO:0007181,1,0.980615998291091,0,3,transforming growth factor beta receptor complex assembly,BP,
3613,GO:0007182,1,0.960770040717306,0,6,common-partner SMAD protein phosphorylation,BP,
3614,GO:0007183,1,0.917873442903948,0,13,SMAD protein complex assembly,BP,
3615,GO:0007185,1,0.960183084027873,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3620,GO:0007190,1,0.800904203287779,0,34,activation of adenylate cyclase activity,BP,
3621,GO:0007191,1,0.931461073430971,0,11,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3624,GO:0007195,1,0.961647938358688,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3626,GO:0007197,1,0.955896239939179,0,7,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,BP,
3627,GO:0007198,1,0.95606606457194,0,7,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3628,GO:0007199,1,0.99356854826303,0,1,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3633,GO:0007206,1,0.986686204986142,0,2,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,BP,
3634,GO:0007207,1,0.980847138584665,0,3,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway,BP,
3635,GO:0007208,1,0.987013747903075,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3636,GO:0007210,1,0.85667229894213,0,24,serotonin receptor signaling pathway,BP,
3638,GO:0007213,1,0.895777600870796,0,17,G protein-coupled acetylcholine receptor signaling pathway,BP,
3639,GO:0007214,1,0.84837828760896,0,25,gamma-aminobutyric acid signaling pathway,BP,
3642,GO:0007217,1,0.956184596620682,0,7,tachykinin receptor signaling pathway,BP,
3645,GO:0007220,1,0.937168717187369,0,10,Notch receptor processing,BP,
3646,GO:0007221,1,0.886433272744544,0,18,positive regulation of transcription of Notch receptor target,BP,
3649,GO:0007225,1,0.993438702899051,0,1,patched ligand maturation,BP,
3650,GO:0007227,1,0.974303628030597,0,4,signal transduction downstream of smoothened,BP,
3651,GO:0007228,1,0.980686892725175,0,3,positive regulation of hh target transcription factor activity,BP,
3652,GO:0007229,1,0.514487805307948,0,101,integrin-mediated signaling pathway,BP,
3653,GO:0007231,1,0.974059016388267,0,4,osmosensory signaling pathway,BP,
3656,GO:0007252,1,0.889226871318073,0,18,I-kappaB phosphorylation,BP,
3657,GO:0007253,1,0.949945871240272,0,8,cytoplasmic sequestering of NF-kappaB,BP,
3659,GO:0007256,1,0.930155388499262,0,11,activation of JNKK activity,BP,
3661,GO:0007258,1,0.974392095949968,0,4,JUN phosphorylation,BP,
3662,GO:0007259,1,0.487450626394607,0,110,receptor signaling pathway via JAK-STAT,BP,
3663,GO:0007260,1,0.681627563625193,0,59,tyrosine phosphorylation of STAT protein,BP,
3664,GO:0007263,1,0.849998110423044,0,25,nitric oxide mediated signal transduction,BP,
3671,GO:0007270,1,0.947623578298453,0,8,neuron-neuron synaptic transmission,BP,
3672,GO:0007271,1,0.84461650025905,0,26,synaptic transmission, cholinergic,BP,
3674,GO:0007274,1,0.866390898213182,0,22,neuromuscular synaptic transmission,BP,
3677,GO:0007281,1,0.265957024286674,0,202,germ cell development,BP,
3679,GO:0007284,1,0.986979115530434,0,2,spermatogonial cell division,BP,
3680,GO:0007286,1,0.497038671140918,0,107,spermatid development,BP,
3681,GO:0007288,1,0.912648799102686,0,14,sperm axoneme assembly,BP,
3682,GO:0007289,1,0.911884602522114,0,14,spermatid nucleus differentiation,BP,
3683,GO:0007290,1,0.99343648529655,0,1,spermatid nucleus elongation,BP,
3684,GO:0007291,1,0.993674209748855,0,1,sperm individualization,BP,
3685,GO:0007292,1,0.464709888174575,0,117,female gamete generation,BP,
3686,GO:0007296,1,0.973550632306346,0,4,vitellogenesis,BP,
3687,GO:0007308,1,0.980786897379998,0,3,oocyte construction,BP,
3688,GO:0007309,1,0.980786897379998,0,3,oocyte axis specification,BP,
3689,GO:0007314,1,0.980786897379998,0,3,oocyte anterior/posterior axis specification,BP,
3690,GO:0007315,1,0.980786897379998,0,3,pole plasm assembly,BP,
3691,GO:0007320,1,0.943362661177062,0,9,insemination,BP,
3692,GO:0007338,1,0.476313468330358,0,114,single fertilization,BP,
3693,GO:0007339,1,0.829243538095391,0,29,binding of sperm to zona pellucida,BP,
3694,GO:0007340,1,0.817035655369785,0,31,acrosome reaction,BP,
3695,GO:0007341,1,0.962307204686508,0,6,penetration of zona pellucida,BP,
3696,GO:0007342,1,0.944198665874855,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3697,GO:0007343,1,0.986894749366708,0,2,egg activation,BP,
3698,GO:0007344,1,0.993623136143205,0,1,pronuclear fusion,BP,
3699,GO:0007346,1,0.0186446933008057,0,599,regulation of mitotic cell cycle,BP,
3700,GO:0007349,1,0.993674209748855,0,1,cellularization,BP,
3701,GO:0007350,1,0.889159501366213,0,18,blastoderm segmentation,BP,
3702,GO:0007351,1,0.912826612705475,0,14,tripartite regional subdivision,BP,
3703,GO:0007352,1,0.980288444859992,0,3,zygotic specification of dorsal/ventral axis,BP,
3704,GO:0007354,1,0.968309391240651,0,5,zygotic determination of anterior/posterior axis, embryo,BP,
3705,GO:0007356,1,0.974619113764489,0,4,thorax and anterior abdomen determination,BP,
3706,GO:0007368,1,0.466417580130771,0,116,determination of left/right symmetry,BP,
3708,GO:0007371,1,0.993504123174293,0,1,ventral midline determination,BP,
3709,GO:0007379,1,0.907634624651282,0,15,segment specification,BP,
3711,GO:0007387,1,0.993560471261178,0,1,anterior compartment pattern formation,BP,
3712,GO:0007388,1,0.993560471261178,0,1,posterior compartment specification,BP,
3716,GO:0007400,1,0.99357512678926,0,1,neuroblast fate determination,BP,
3717,GO:0007402,1,0.987301261073998,0,2,ganglion mother cell fate determination,BP,
3718,GO:0007403,1,0.993521120114323,0,1,glial cell fate determination,BP,
3720,GO:0007406,1,0.961079504984765,0,6,negative regulation of neuroblast proliferation,BP,
3723,GO:0007412,1,0.980770204776576,0,3,axon target recognition,BP,
3727,GO:0007418,1,0.974176118827583,0,4,ventral midline development,BP,
3731,GO:0007431,1,0.773832534586926,0,39,salivary gland development,BP,
3732,GO:0007435,1,0.794434522792996,0,35,salivary gland morphogenesis,BP,
3733,GO:0007439,1,0.987156785506307,0,2,ectodermal digestive tract development,BP,
3734,GO:0007440,1,0.9351844552915,0,10,foregut morphogenesis,BP,
3735,GO:0007442,1,0.9549135715683,0,7,hindgut morphogenesis,BP,
3736,GO:0007468,1,0.980889676071801,0,3,regulation of rhodopsin gene expression,BP,
3737,GO:0007492,1,0.610244915187169,0,75,endoderm development,BP,
3738,GO:0007493,1,0.987141919130419,0,2,endodermal cell fate determination,BP,
3739,GO:0007494,1,0.918976481762672,0,13,midgut development,BP,
3740,GO:0007495,1,0.993533885086564,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3741,GO:0007497,1,0.986940775884692,0,2,posterior midgut development,BP,
3743,GO:0007499,1,0.993446663143167,0,1,ectoderm and mesoderm interaction,BP,
3744,GO:0007500,1,0.987209215831194,0,2,mesodermal cell fate determination,BP,
3745,GO:0007501,1,0.925365362474786,0,12,mesodermal cell fate specification,BP,
3746,GO:0007506,1,0.987104338203057,0,2,gonadal mesoderm development,BP,
3748,GO:0007509,1,0.993287072628792,0,1,mesoderm migration involved in gastrulation,BP,
3749,GO:0007512,1,0.924029867090567,0,12,adult heart development,BP,
3751,GO:0007518,1,0.987241729285917,0,2,myoblast fate determination,BP,
3752,GO:0007519,1,0.388708750686959,0,144,skeletal muscle tissue development,BP,
3753,GO:0007520,1,0.800797823015874,0,34,myoblast fusion,BP,
3754,GO:0007521,1,0.986876205085198,0,2,muscle cell fate determination,BP,
3755,GO:0007522,1,0.993337986430601,0,1,visceral muscle development,BP,
3756,GO:0007525,1,0.9845441092957,0,2,somatic muscle development,BP,
3757,GO:0007528,1,0.722272156446928,0,49,neuromuscular junction development,BP,
3758,GO:0007529,1,0.987015034153209,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3759,GO:0007530,1,0.866178910893307,0,22,sex determination,BP,
3760,GO:0007531,1,0.992938094261375,0,1,mating type determination,BP,
3761,GO:0007533,1,0.992938094261375,0,1,mating type switching,BP,
3762,GO:0007538,1,0.986920758750871,0,2,primary sex determination,BP,
3763,GO:0007542,1,0.986920758750871,0,2,primary sex determination, germ-line,BP,
3765,GO:0007549,1,0.911072175666375,0,14,dosage compensation,BP,
3768,GO:0007567,1,0.901115754616106,0,16,parturition,BP,
3769,GO:0007568,1,0.155662715679393,0,283,aging,BP,
3770,GO:0007569,1,0.519614124264438,0,100,cell aging,BP,
3771,GO:0007571,1,0.993671303521141,0,1,age-dependent general metabolic decline,BP,
3773,GO:0007585,1,0.671550995855969,0,61,respiratory gaseous exchange by respiratory system,BP,
3775,GO:0007588,1,0.712788897212648,0,52,excretion,BP,
3776,GO:0007589,1,0.58825303236054,0,81,body fluid secretion,BP,
3777,GO:0007595,1,0.758002999510342,0,42,lactation,BP,
3779,GO:0007597,1,0.913293922110984,0,14,blood coagulation, intrinsic pathway,BP,
3780,GO:0007598,1,0.97457386781087,0,4,blood coagulation, extrinsic pathway,BP,
3784,GO:0007602,1,0.747275204393224,0,45,phototransduction,BP,
3785,GO:0007603,1,0.839259768872135,0,27,phototransduction, visible light,BP,
3787,GO:0007606,1,0.577172499597904,0,85,sensory perception of chemical stimulus,BP,
3788,GO:0007608,1,0.787094532080221,0,37,sensory perception of smell,BP,
3793,GO:0007614,1,0.931034342082561,0,11,short-term memory,BP,
3795,GO:0007617,1,0.871600429177982,0,21,mating behavior,BP,
3796,GO:0007618,1,0.790779549809607,0,36,mating,BP,
3797,GO:0007619,1,0.980522750569862,0,3,courtship behavior,BP,
3798,GO:0007620,1,0.901472416547319,0,16,copulation,BP,
3799,GO:0007621,1,0.980441260776458,0,3,negative regulation of female receptivity,BP,
3800,GO:0007622,1,0.740594154002081,0,46,rhythmic behavior,BP,
3801,GO:0007623,1,0.258898261744341,0,205,circadian rhythm,BP,
3802,GO:0007624,1,0.987074310946348,0,2,ultradian rhythm,BP,
3803,GO:0007625,1,0.901392579235308,0,16,grooming behavior,BP,
3808,GO:0007634,1,0.98719840321929,0,2,optokinetic behavior,BP,
3809,GO:0007635,1,0.906153763854358,0,15,chemosensory behavior,BP,
3810,GO:0007638,1,0.910467893469049,0,14,mechanosensory behavior,BP,
3812,GO:0008013,1,0.580882151232057,0,82,beta-catenin binding,MF,
3816,GO:0008020,1,0.937792619772881,0,10,G protein-coupled photoreceptor activity,MF,
3818,GO:0008022,1,0.297530496523187,0,184,protein C-terminus binding,MF,
3819,GO:0008023,1,0.734850417025367,0,47,transcription elongation factor complex,CC,
3820,GO:0008024,1,0.948779293348737,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3821,GO:0008028,1,0.713439725238782,0,52,monocarboxylic acid transmembrane transporter activity,MF,
3822,GO:0008033,1,0.465630292910152,0,118,tRNA processing,BP,
3823,GO:0008035,1,0.937160828677293,0,10,high-density lipoprotein particle binding,MF,
3826,GO:0008039,1,0.993543217935102,0,1,synaptic target recognition,BP,
3827,GO:0008043,1,0.987379010231755,0,2,intracellular ferritin complex,CC,
3828,GO:0008045,1,0.821324855914141,0,30,motor neuron axon guidance,BP,
3829,GO:0008046,1,0.942327849278782,0,9,axon guidance receptor activity,MF,
3831,GO:0008048,1,0.980983059225986,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3832,GO:0008049,1,0.993612327636041,0,1,male courtship behavior,BP,
3833,GO:0008050,1,0.986827112116753,0,2,female courtship behavior,BP,
3834,GO:0008052,1,0.993673219206214,0,1,sensory organ boundary specification,BP,
3835,GO:0008053,1,0.855237517301457,0,24,mitochondrial fusion,BP,
3836,GO:0008057,1,0.993207117496243,0,1,eye pigment granule organization,BP,
3838,GO:0008063,1,0.955541543646955,0,7,Toll signaling pathway,BP,
3839,GO:0008064,1,0.327767596826994,0,170,regulation of actin polymerization or depolymerization,BP,
3843,GO:0008073,1,0.981075959446611,0,3,ornithine decarboxylase inhibitor activity,MF,
3844,GO:0008076,1,0.58153360397335,0,83,voltage-gated potassium channel complex,CC,
3845,GO:0008078,1,0.980743045338666,0,3,mesodermal cell migration,BP,
3846,GO:0008079,1,0.961641030282619,0,6,translation termination factor activity,MF,
3847,GO:0008080,1,0.615946909528455,0,74,N-acetyltransferase activity,MF,
3850,GO:0008088,1,0.638292449659488,0,68,axo-dendritic transport,BP,
3851,GO:0008089,1,0.739341434329631,0,46,anterograde axonal transport,BP,
3852,GO:0008090,1,0.879650678637468,0,19,retrograde axonal transport,BP,
3853,GO:0008091,1,0.940283495136969,0,9,spectrin,CC,
3855,GO:0008093,1,0.870417969669395,0,21,cytoskeletal anchor activity,MF,
3856,GO:0008094,1,0.512999133095959,0,101,DNA-dependent ATPase activity,MF,
3857,GO:0008097,1,0.937851934583179,0,10,5S rRNA binding,MF,
3859,GO:0008106,1,0.879825752880737,0,20,alcohol dehydrogenase (NADP+) activity,MF,
3860,GO:0008107,1,0.993474114180346,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3861,GO:0008108,1,0.993650434744294,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3862,GO:0008109,1,0.987018044116094,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3863,GO:0008111,1,0.993607868533236,0,1,alpha-methylacyl-CoA racemase activity,MF,
3864,GO:0008112,1,0.993634581041459,0,1,nicotinamide N-methyltransferase activity,MF,
3865,GO:0008113,1,0.987331395601432,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3866,GO:0008115,1,0.993578883199393,0,1,sarcosine oxidase activity,MF,
3867,GO:0008116,1,0.993369516407457,0,1,prostaglandin-I synthase activity,MF,
3868,GO:0008117,1,0.986885528197904,0,2,sphinganine-1-phosphate aldolase activity,MF,
3869,GO:0008118,1,0.99359125267072,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3870,GO:0008119,1,0.993530426531246,0,1,thiopurine S-methyltransferase activity,MF,
3871,GO:0008120,1,0.993630771430821,0,1,ceramide glucosyltransferase activity,MF,
3872,GO:0008121,1,0.962547403165447,0,6,ubiquinol-cytochrome-c reductase activity,MF,
3873,GO:0008124,1,0.987294090310122,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3874,GO:0008126,1,0.967862056798414,0,5,acetylesterase activity,MF,
3875,GO:0008127,1,0.993653025050466,0,1,quercetin 2,3-dioxygenase activity,MF,
3878,GO:0008135,1,0.601988979516245,0,78,translation factor activity, RNA binding,MF,
3879,GO:0008137,1,0.785292262745526,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3880,GO:0008138,1,0.776121486346668,0,39,protein tyrosine/serine/threonine phosphatase activity,MF,
3881,GO:0008139,1,0.870792231998371,0,21,nuclear localization sequence binding,MF,
3882,GO:0008140,1,0.943242324427639,0,9,cAMP response element binding protein binding,MF,
3883,GO:0008142,1,0.954965355007211,0,7,oxysterol binding,MF,
3884,GO:0008143,1,0.860367097220786,0,23,poly(A) binding,MF,
3886,GO:0008146,1,0.736316175549434,0,47,sulfotransferase activity,MF,
3887,GO:0008147,1,0.987438107707395,0,2,structural constituent of bone,MF,
3891,GO:0008156,1,0.827408663453618,0,29,negative regulation of DNA replication,BP,
3892,GO:0008157,1,0.832851688507851,0,28,protein phosphatase 1 binding,MF,
3893,GO:0008158,1,0.980462735660128,0,3,hedgehog receptor activity,MF,
3894,GO:0008160,1,0.993566265999097,0,1,protein tyrosine phosphatase activator activity,MF,
3895,GO:0008168,1,0.306431004171826,0,181,methyltransferase activity,MF,
3896,GO:0008169,1,0.968302827319631,0,5,C-methyltransferase activity,MF,
3897,GO:0008170,1,0.58895767412875,0,81,N-methyltransferase activity,MF,
3898,GO:0008171,1,0.895989688216361,0,17,O-methyltransferase activity,MF,
3899,GO:0008172,1,0.961466978770383,0,6,S-methyltransferase activity,MF,
3900,GO:0008173,1,0.682148545956131,0,59,RNA methyltransferase activity,MF,
3901,GO:0008174,1,0.93085610559927,0,11,mRNA methyltransferase activity,MF,
3902,GO:0008175,1,0.812414677075155,0,32,tRNA methyltransferase activity,MF,
3903,GO:0008176,1,0.987316499739963,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3904,GO:0008177,1,0.987283483465467,0,2,succinate dehydrogenase (ubiquinone) activity,MF,
3905,GO:0008179,1,0.917949982839543,0,13,adenylate cyclase binding,MF,
3907,GO:0008184,1,0.98067706331546,0,3,glycogen phosphorylase activity,MF,
3908,GO:0008186,1,0.967743451113789,0,5,RNA-dependent ATPase activity,MF,
3909,GO:0008187,1,0.82758233767454,0,29,poly-pyrimidine tract binding,MF,
3911,GO:0008190,1,0.936761085954251,0,10,eukaryotic initiation factor 4E binding,MF,
3913,GO:0008192,1,0.98715218691978,0,2,RNA guanylyltransferase activity,MF,
3914,GO:0008193,1,0.993652626671644,0,1,tRNA guanylyltransferase activity,MF,
3916,GO:0008195,1,0.980298781875677,0,3,phosphatidate phosphatase activity,MF,
3919,GO:0008200,1,0.795619988263603,0,35,ion channel inhibitor activity,MF,
3923,GO:0008206,1,0.751787467935216,0,44,bile acid metabolic process,BP,
3924,GO:0008207,1,0.82359637607385,0,30,C21-steroid hormone metabolic process,BP,
3927,GO:0008211,1,0.872491143235385,0,21,glucocorticoid metabolic process,BP,
3928,GO:0008212,1,0.942998068670825,0,9,mineralocorticoid metabolic process,BP,
3929,GO:0008213,1,0.362720807576619,0,154,protein alkylation,BP,
3930,GO:0008214,1,0.825129355313288,0,29,protein dealkylation,BP,
3931,GO:0008215,1,0.968460853076464,0,5,spermine metabolic process,BP,
3932,GO:0008216,1,0.950080305096811,0,8,spermidine metabolic process,BP,
3933,GO:0008217,1,0.356861225339145,0,158,regulation of blood pressure,BP,
3935,GO:0008227,1,0.818720686845044,0,31,G protein-coupled amine receptor activity,MF,
3936,GO:0008228,1,0.949174131285123,0,8,opsonization,BP,
3938,GO:0008234,1,0.495873890337685,0,107,cysteine-type peptidase activity,MF,
3943,GO:0008239,1,0.949542521347724,0,8,dipeptidyl-peptidase activity,MF,
3944,GO:0008240,1,0.980604678418746,0,3,tripeptidyl-peptidase activity,MF,
3945,GO:0008241,1,0.987082074528409,0,2,peptidyl-dipeptidase activity,MF,
3946,GO:0008242,1,0.559307750094844,0,88,omega peptidase activity,MF,
3947,GO:0008250,1,0.920043000133424,0,13,oligosaccharyltransferase complex,CC,
3948,GO:0008251,1,0.955198045598808,0,7,tRNA-specific adenosine deaminase activity,MF,
3949,GO:0008252,1,0.925145313075676,0,12,nucleotidase activity,MF,
3950,GO:0008253,1,0.931131320876844,0,11,5'-nucleotidase activity,MF,
3951,GO:0008260,1,0.98717274007544,0,2,3-oxoacid CoA-transferase activity,MF,
3952,GO:0008263,1,0.987146874847055,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3953,GO:0008265,1,0.993559008417533,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3954,GO:0008266,1,0.844105196009105,0,26,poly(U) RNA binding,MF,
3955,GO:0008269,1,0.99359233845386,0,1,JAK pathway signal transduction adaptor activity,MF,
3957,GO:0008271,1,0.936665613874857,0,10,secondary active sulfate transmembrane transporter activity,MF,
3958,GO:0008272,1,0.906961170276168,0,15,sulfate transport,BP,
3960,GO:0008274,1,0.954987084567246,0,7,gamma-tubulin ring complex,CC,
3961,GO:0008275,1,0.97401878663413,0,4,gamma-tubulin small complex,CC,
3962,GO:0008276,1,0.612115832396938,0,75,protein methyltransferase activity,MF,
3964,GO:0008278,1,0.942368297110148,0,9,cohesin complex,CC,
3965,GO:0008281,1,0.986902959110496,0,2,sulfonylurea receptor activity,MF,
3966,GO:0008282,1,0.980526373578904,0,3,inward rectifying potassium channel,CC,
3971,GO:0008287,1,0.740994680011661,0,46,protein serine/threonine phosphatase complex,CC,
3973,GO:0008290,1,0.955750928006173,0,7,F-actin capping protein complex,CC,
3974,GO:0008291,1,0.974496535693293,0,4,acetylcholine metabolic process,BP,
3975,GO:0008292,1,0.987180811145068,0,2,acetylcholine biosynthetic process,BP,
3976,GO:0008294,1,0.986231824623827,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3977,GO:0008295,1,0.974645922294825,0,4,spermidine biosynthetic process,BP,
3978,GO:0008296,1,0.931444513994737,0,11,3'-5'-exodeoxyribonuclease activity,MF,
3979,GO:0008297,1,0.943265703107811,0,9,single-stranded DNA exodeoxyribonuclease activity,MF,
3980,GO:0008298,1,0.925523708216638,0,12,intracellular mRNA localization,BP,
3981,GO:0008299,1,0.845439172039185,0,26,isoprenoid biosynthetic process,BP,
3982,GO:0008300,1,0.943776771791162,0,9,isoprenoid catabolic process,BP,
3983,GO:0008301,1,0.895622614676751,0,17,DNA binding, bending,MF,
3984,GO:0008303,1,0.968214707990303,0,5,caspase complex,CC,
3985,GO:0008305,1,0.815434591760273,0,31,integrin complex,CC,
3988,GO:0008308,1,0.906894634629078,0,15,voltage-gated anion channel activity,MF,
3989,GO:0008309,1,0.974613869582152,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3990,GO:0008310,1,0.967925714227117,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3991,GO:0008311,1,0.987288203083438,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3992,GO:0008312,1,0.956073247169555,0,7,7S RNA binding,MF,
3993,GO:0008315,1,0.98074743380276,0,3,G2/MI transition of meiotic cell cycle,BP,
3994,GO:0008318,1,0.955296631657127,0,7,protein prenyltransferase activity,MF,
3995,GO:0008320,1,0.895700673025455,0,17,protein transmembrane transporter activity,MF,
3996,GO:0008321,1,0.980411947401217,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
3998,GO:0008327,1,0.871376972126243,0,21,methyl-CpG binding,MF,
3999,GO:0008328,1,0.723653009161078,0,49,ionotropic glutamate receptor complex,CC,
4000,GO:0008330,1,0.937411116680006,0,10,protein tyrosine/threonine phosphatase activity,MF,
4001,GO:0008331,1,0.934303965353714,0,10,high voltage-gated calcium channel activity,MF,
4002,GO:0008332,1,0.97944830656068,0,3,low voltage-gated calcium channel activity,MF,
4003,GO:0008333,1,0.729544834697495,0,48,endosome to lysosome transport,BP,
4004,GO:0008334,1,0.866116984282435,0,22,histone mRNA metabolic process,BP,
4005,GO:0008336,1,0.993613535833335,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4006,GO:0008340,1,0.905442272999404,0,15,determination of adult lifespan,BP,
4007,GO:0008343,1,0.937533767198529,0,10,adult feeding behavior,BP,
4009,GO:0008347,1,0.729479248698936,0,48,glial cell migration,BP,
4010,GO:0008348,1,0.993508234338811,0,1,negative regulation of antimicrobial humoral response,BP,
4011,GO:0008349,1,0.974295881089863,0,4,MAP kinase kinase kinase kinase activity,MF,
4012,GO:0008352,1,0.993563517666836,0,1,katanin complex,CC,
4013,GO:0008353,1,0.923885903188434,0,12,RNA polymerase II CTD heptapeptide repeat kinase activity,MF,
4014,GO:0008354,1,0.961524257324018,0,6,germ cell migration,BP,
4015,GO:0008355,1,0.986976963591537,0,2,olfactory learning,BP,
4016,GO:0008356,1,0.883051546018971,0,19,asymmetric cell division,BP,
4017,GO:0008358,1,0.980786897379998,0,3,maternal determination of anterior/posterior axis, embryo,BP,
4021,GO:0008373,1,0.877154673817659,0,20,sialyltransferase activity,MF,
4022,GO:0008374,1,0.790792312330582,0,36,O-acyltransferase activity,MF,
4023,GO:0008375,1,0.756550371252364,0,43,acetylglucosaminyltransferase activity,MF,
4025,GO:0008378,1,0.850764106328539,0,25,galactosyltransferase activity,MF,
4026,GO:0008379,1,0.968738188697305,0,5,thioredoxin peroxidase activity,MF,
4027,GO:0008380,1,0.0627386506664962,0,421,RNA splicing,BP,
4028,GO:0008381,1,0.895406103477287,0,17,mechanosensitive ion channel activity,MF,
4029,GO:0008384,1,0.987050186549168,0,2,IkappaB kinase activity,MF,
4030,GO:0008385,1,0.955332859165454,0,7,IkappaB kinase complex,CC,
4031,GO:0008386,1,0.993608069493367,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4032,GO:0008387,1,0.993587680951148,0,1,steroid 7-alpha-hydroxylase activity,MF,
4033,GO:0008389,1,0.99362179434674,0,1,coumarin 7-hydroxylase activity,MF,
4034,GO:0008391,1,0.931719730274351,0,11,arachidonic acid monooxygenase activity,MF,
4035,GO:0008392,1,0.949999602782181,0,8,arachidonic acid epoxygenase activity,MF,
4036,GO:0008395,1,0.856645021542357,0,24,steroid hydroxylase activity,MF,
4037,GO:0008396,1,0.987208539516795,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4038,GO:0008397,1,0.993492585408494,0,1,sterol 12-alpha-hydroxylase activity,MF,
4039,GO:0008398,1,0.993539803596889,0,1,sterol 14-demethylase activity,MF,
4040,GO:0008401,1,0.962092512505067,0,6,retinoic acid 4-hydroxylase activity,MF,
4041,GO:0008403,1,0.993534499479782,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4042,GO:0008404,1,0.993615550128517,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4043,GO:0008405,1,0.993615550128517,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4045,GO:0008408,1,0.708160857498899,0,53,3'-5' exonuclease activity,MF,
4046,GO:0008409,1,0.894397852503564,0,17,5'-3' exonuclease activity,MF,
4047,GO:0008410,1,0.962135673835688,0,6,CoA-transferase activity,MF,
4048,GO:0008413,1,0.987336507216861,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4049,GO:0008417,1,0.92424277122659,0,12,fucosyltransferase activity,MF,
4050,GO:0008418,1,0.993665286545864,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4051,GO:0008419,1,0.993564064852802,0,1,RNA lariat debranching enzyme activity,MF,
4052,GO:0008420,1,0.955494491051918,0,7,RNA polymerase II CTD heptapeptide repeat phosphatase activity,MF,
4053,GO:0008422,1,0.968143363601805,0,5,beta-glucosidase activity,MF,
4054,GO:0008424,1,0.993528307267913,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4055,GO:0008425,1,0.987334159261577,0,2,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4056,GO:0008426,1,0.980957000177402,0,3,protein kinase C inhibitor activity,MF,
4057,GO:0008427,1,0.981026765498445,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4058,GO:0008428,1,0.980753101791639,0,3,ribonuclease inhibitor activity,MF,
4059,GO:0008429,1,0.930664368997174,0,11,phosphatidylethanolamine binding,MF,
4060,GO:0008430,1,0.968087592107133,0,5,selenium binding,MF,
4061,GO:0008431,1,0.987147515905657,0,2,vitamin E binding,MF,
4062,GO:0008432,1,0.942810906281132,0,9,JUN kinase binding,MF,
4063,GO:0008437,1,0.993605826839084,0,1,thyrotropin-releasing hormone activity,MF,
4064,GO:0008440,1,0.974334534918453,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4065,GO:0008441,1,0.993575824062632,0,1,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4066,GO:0008442,1,0.993607567136502,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4067,GO:0008443,1,0.955495702000633,0,7,phosphofructokinase activity,MF,
4068,GO:0008444,1,0.993593261226275,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4069,GO:0008445,1,0.993631707608,0,1,D-aspartate oxidase activity,MF,
4070,GO:0008446,1,0.993627827067832,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4071,GO:0008448,1,0.993617195415608,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4072,GO:0008449,1,0.974059036508692,0,4,N-acetylglucosamine-6-sulfatase activity,MF,
4073,GO:0008452,1,0.99355705431691,0,1,RNA ligase activity,MF,
4074,GO:0008453,1,0.993632777137238,0,1,alanine-glyoxylate transaminase activity,MF,
4075,GO:0008454,1,0.980628642536915,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4076,GO:0008455,1,0.993560801035551,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4077,GO:0008456,1,0.993504840627077,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4078,GO:0008457,1,0.980803085148409,0,3,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4079,GO:0008458,1,0.98712550887706,0,2,carnitine O-octanoyltransferase activity,MF,
4080,GO:0008459,1,0.986879248624868,0,2,chondroitin 6-sulfotransferase activity,MF,
4081,GO:0008460,1,0.993612327636041,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4082,GO:0008465,1,0.99365700630751,0,1,glycerate dehydrogenase activity,MF,
4083,GO:0008466,1,0.987184887261202,0,2,glycogenin glucosyltransferase activity,MF,
4084,GO:0008467,1,0.962093373389878,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4085,GO:0008469,1,0.955935413329221,0,7,histone-arginine N-methyltransferase activity,MF,
4086,GO:0008470,1,0.993447539552435,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4087,GO:0008474,1,0.925541816603852,0,12,palmitoyl-(protein) hydrolase activity,MF,
4088,GO:0008475,1,0.980698499145116,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4089,GO:0008476,1,0.987252872121761,0,2,protein-tyrosine sulfotransferase activity,MF,
4090,GO:0008478,1,0.993212951735508,0,1,pyridoxal kinase activity,MF,
4091,GO:0008479,1,0.993650434744294,0,1,queuine tRNA-ribosyltransferase activity,MF,
4092,GO:0008480,1,0.993527170053586,0,1,sarcosine dehydrogenase activity,MF,
4093,GO:0008481,1,0.987201913020278,0,2,sphinganine kinase activity,MF,
4094,GO:0008482,1,0.993584101683949,0,1,sulfite oxidase activity,MF,
4095,GO:0008483,1,0.895290350025287,0,17,transaminase activity,MF,
4096,GO:0008484,1,0.906598202785365,0,15,sulfuric ester hydrolase activity,MF,
4097,GO:0008486,1,0.974515979575416,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4098,GO:0008488,1,0.993534633158787,0,1,gamma-glutamyl carboxylase activity,MF,
4099,GO:0008489,1,0.98054888008476,0,3,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4100,GO:0008493,1,0.993615315099758,0,1,tetracycline transmembrane transporter activity,MF,
4101,GO:0008494,1,0.925082300519194,0,12,translation activator activity,MF,
4102,GO:0008495,1,0.993543906289336,0,1,protoheme IX farnesyltransferase activity,MF,
4103,GO:0008499,1,0.955744900616874,0,7,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4104,GO:0008502,1,0.974653693068166,0,4,melatonin receptor activity,MF,
4105,GO:0008503,1,0.936463499712564,0,10,benzodiazepine receptor activity,MF,
4106,GO:0008504,1,0.943213249537796,0,9,monoamine transmembrane transporter activity,MF,
4107,GO:0008506,1,0.974462931665959,0,4,sucrose:proton symporter activity,MF,
4108,GO:0008507,1,0.993512662461134,0,1,sodium:iodide symporter activity,MF,
4109,GO:0008508,1,0.974743988756758,0,4,bile acid:sodium symporter activity,MF,
4111,GO:0008510,1,0.960786825934242,0,6,sodium:bicarbonate symporter activity,MF,
4112,GO:0008511,1,0.986742253298152,0,2,sodium:potassium:chloride symporter activity,MF,
4113,GO:0008513,1,0.987249709924394,0,2,secondary active organic cation transmembrane transporter activity,MF,
4115,GO:0008515,1,0.974462931665959,0,4,sucrose transmembrane transporter activity,MF,
4116,GO:0008517,1,0.974150641352956,0,4,folic acid transmembrane transporter activity,MF,
4117,GO:0008518,1,0.993552973937176,0,1,folate:anion antiporter activity,MF,
4118,GO:0008519,1,0.948847178051162,0,8,ammonium transmembrane transporter activity,MF,
4119,GO:0008520,1,0.986876344920053,0,2,L-ascorbate:sodium symporter activity,MF,
4120,GO:0008521,1,0.993563578402913,0,1,acetyl-CoA transmembrane transporter activity,MF,
4121,GO:0008523,1,0.993527540196377,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4122,GO:0008525,1,0.929974016585068,0,11,phosphatidylcholine transporter activity,MF,
4123,GO:0008526,1,0.943114135702318,0,9,phosphatidylinositol transfer activity,MF,
4124,GO:0008527,1,0.926170684451981,0,12,taste receptor activity,MF,
4126,GO:0008531,1,0.993560801035551,0,1,riboflavin kinase activity,MF,
4127,GO:0008532,1,0.943534036183227,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4128,GO:0008534,1,0.981017061469418,0,3,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4129,GO:0008535,1,0.856476376006927,0,24,respiratory chain complex IV assembly,BP,
4130,GO:0008536,1,0.777557605923423,0,38,Ran GTPase binding,MF,
4131,GO:0008537,1,0.981004455798868,0,3,proteasome activator complex,CC,
4132,GO:0008540,1,0.925924192601692,0,12,proteasome regulatory particle, base subcomplex,CC,
4133,GO:0008541,1,0.956216630812224,0,7,proteasome regulatory particle, lid subcomplex,CC,
4136,GO:0008544,1,0.143809930336234,0,294,epidermis development,BP,
4137,GO:0008545,1,0.987069154097376,0,2,JUN kinase kinase activity,MF,
4138,GO:0008553,1,0.901257697157975,0,16,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4139,GO:0008554,1,0.925203371587488,0,12,sodium transmembrane transporter activity, phosphorylative mechanism,MF,
4140,GO:0008555,1,0.99338869096963,0,1,ATPase-coupled chloride transmembrane transporter activity,MF,
4141,GO:0008556,1,0.931322038974612,0,11,potassium transmembrane transporter activity, phosphorylative mechanism,MF,
4142,GO:0008559,1,0.96118761762789,0,6,ATPase-coupled xenobiotic transmembrane transporter activity,MF,
4143,GO:0008568,1,0.949018014166243,0,8,microtubule-severing ATPase activity,MF,
4144,GO:0008569,1,0.878847567544168,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4145,GO:0008574,1,0.898553713934966,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4146,GO:0008579,1,0.993396271142847,0,1,JUN kinase phosphatase activity,MF,
4147,GO:0008582,1,0.967635019252565,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4151,GO:0008591,1,0.993619377814711,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4152,GO:0008592,1,0.974206968373817,0,4,regulation of Toll signaling pathway,BP,
4153,GO:0008593,1,0.532463403206154,0,96,regulation of Notch signaling pathway,BP,
4154,GO:0008594,1,0.974403131648263,0,4,photoreceptor cell morphogenesis,BP,
4155,GO:0008595,1,0.912826612705475,0,14,anterior/posterior axis specification, embryo,BP,
4157,GO:0008603,1,0.937659750886831,0,10,cAMP-dependent protein kinase regulator activity,MF,
4158,GO:0008607,1,0.98082518379594,0,3,phosphorylase kinase regulator activity,MF,
4159,GO:0008608,1,0.822545869811627,0,30,attachment of spindle microtubules to kinetochore,BP,
4160,GO:0008609,1,0.993186034888142,0,1,alkylglycerone-phosphate synthase activity,MF,
4162,GO:0008611,1,0.936519728128069,0,10,ether lipid biosynthetic process,BP,
4163,GO:0008612,1,0.98091397881398,0,3,peptidyl-lysine modification to peptidyl-hypusine,BP,
4164,GO:0008613,1,0.99369292632955,0,1,diuretic hormone activity,MF,
4165,GO:0008614,1,0.987158207361031,0,2,pyridoxine metabolic process,BP,
4166,GO:0008615,1,0.987158207361031,0,2,pyridoxine biosynthetic process,BP,
4167,GO:0008617,1,0.993672096321179,0,1,guanosine metabolic process,BP,
4168,GO:0008622,1,0.968060356817316,0,5,epsilon DNA polymerase complex,CC,
4169,GO:0008623,1,0.980624502598797,0,3,CHRAC,CC,
4171,GO:0008626,1,0.968306383188903,0,5,granzyme-mediated apoptotic signaling pathway,BP,
4172,GO:0008627,1,0.949092554463965,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4173,GO:0008628,1,0.981029030812959,0,3,hormone-mediated apoptotic signaling pathway,BP,
4175,GO:0008631,1,0.771780072216708,0,40,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4178,GO:0008641,1,0.937070283879293,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4181,GO:0008649,1,0.896402864569946,0,17,rRNA methyltransferase activity,MF,
4182,GO:0008650,1,0.993513305733971,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4184,GO:0008653,1,0.993580358118446,0,1,lipopolysaccharide metabolic process,BP,
4186,GO:0008655,1,0.937783895226189,0,10,pyrimidine-containing compound salvage,BP,
4187,GO:0008656,1,0.907025102688337,0,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4188,GO:0008659,1,0.993109877834153,0,1,(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,MF,
4189,GO:0008663,1,0.99355705431691,0,1,2',3'-cyclic-nucleotide 2'-phosphodiesterase activity,MF,
4190,GO:0008670,1,0.987329777652544,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4191,GO:0008682,1,0.993568176830251,0,1,2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity,MF,
4192,GO:0008689,1,0.993655215305584,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4193,GO:0008693,1,0.993109877834153,0,1,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,MF,
4194,GO:0008700,1,0.99355705431691,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4195,GO:0008705,1,0.992904381480759,0,1,methionine synthase activity,MF,
4196,GO:0008709,1,0.993676091176895,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4197,GO:0008720,1,0.993603654499301,0,1,D-lactate dehydrogenase activity,MF,
4198,GO:0008721,1,0.993574747073295,0,1,D-serine ammonia-lyase activity,MF,
4199,GO:0008725,1,0.993667138868627,0,1,DNA-3-methyladenine glycosylase activity,MF,
4200,GO:0008732,1,0.987207013938763,0,2,L-allo-threonine aldolase activity,MF,
4201,GO:0008745,1,0.993676124177465,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4202,GO:0008746,1,0.987152277281337,0,2,NAD(P)+ transhydrogenase activity,MF,
4203,GO:0008747,1,0.99363571624362,0,1,N-acetylneuraminate lyase activity,MF,
4204,GO:0008753,1,0.993519691453182,0,1,NADPH dehydrogenase (quinone) activity,MF,
4205,GO:0008757,1,0.419789990472861,0,133,S-adenosylmethionine-dependent methyltransferase activity,MF,
4206,GO:0008761,1,0.993394958632404,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4207,GO:0008768,1,0.987393017226266,0,2,UDP-sugar diphosphatase activity,MF,
4208,GO:0008775,1,0.993617900539627,0,1,acetate CoA-transferase activity,MF,
4209,GO:0008781,1,0.987320389565741,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4210,GO:0008783,1,0.993592997439697,0,1,agmatinase activity,MF,
4211,GO:0008785,1,0.99363531563562,0,1,alkyl hydroperoxide reductase activity,MF,
4212,GO:0008792,1,0.99355705431691,0,1,arginine decarboxylase activity,MF,
4213,GO:0008794,1,0.993678763465064,0,1,arsenate reductase (glutaredoxin) activity,MF,
4214,GO:0008796,1,0.993673615449867,0,1,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4215,GO:0008798,1,0.986982078881531,0,2,beta-aspartyl-peptidase activity,MF,
4216,GO:0008800,1,0.993626487655239,0,1,beta-lactamase activity,MF,
4217,GO:0008802,1,0.99351378750625,0,1,betaine-aldehyde dehydrogenase activity,MF,
4218,GO:0008803,1,0.993673615449867,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4219,GO:0008808,1,0.993500810126899,0,1,cardiolipin synthase activity,MF,
4220,GO:0008812,1,0.993509428474531,0,1,choline dehydrogenase activity,MF,
4221,GO:0008817,1,0.99348072998934,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4222,GO:0008821,1,0.968078710324364,0,5,crossover junction endodeoxyribonuclease activity,MF,
4223,GO:0008823,1,0.980357057853239,0,3,cupric reductase activity,MF,
4224,GO:0008828,1,0.993691741969084,0,1,dATP pyrophosphohydrolase activity,MF,
4225,GO:0008832,1,0.993533084946483,0,1,dGTPase activity,MF,
4226,GO:0008843,1,0.993585465122445,0,1,endochitinase activity,MF,
4227,GO:0008852,1,0.993553320136503,0,1,exodeoxyribonuclease I activity,MF,
4228,GO:0008853,1,0.974576285722187,0,4,exodeoxyribonuclease III activity,MF,
4229,GO:0008859,1,0.99367579416113,0,1,exoribonuclease II activity,MF,
4230,GO:0008865,1,0.967772838107429,0,5,fructokinase activity,MF,
4231,GO:0008887,1,0.993531063467569,0,1,glycerate kinase activity,MF,
4232,GO:0008889,1,0.987082028154844,0,2,glycerophosphodiester phosphodiesterase activity,MF,
4233,GO:0008890,1,0.993634046671714,0,1,glycine C-acetyltransferase activity,MF,
4234,GO:0008891,1,0.993623001992913,0,1,glycolate oxidase activity,MF,
4236,GO:0008893,1,0.993670047953032,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4237,GO:0008894,1,0.993558948925545,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4238,GO:0008897,1,0.993551652880839,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4239,GO:0008900,1,0.980789645219065,0,3,potassium:proton exchanging ATPase activity,MF,
4240,GO:0008903,1,0.993665617381083,0,1,hydroxypyruvate isomerase activity,MF,
4241,GO:0008905,1,0.993632643468557,0,1,mannose-phosphate guanylyltransferase activity,MF,
4242,GO:0008929,1,0.993642318351066,0,1,methylglyoxal synthase activity,MF,
4243,GO:0008934,1,0.980820612932707,0,3,inositol monophosphate 1-phosphatase activity,MF,
4244,GO:0008937,1,0.993612998811935,0,1,ferredoxin-NAD(P) reductase activity,MF,
4245,GO:0008940,1,0.993472472896888,0,1,nitrate reductase activity,MF,
4246,GO:0008941,1,0.993572918047278,0,1,nitric oxide dioxygenase activity,MF,
4247,GO:0008946,1,0.993489925788297,0,1,oligonucleotidase activity,MF,
4248,GO:0008948,1,0.974441347148088,0,4,oxaloacetate decarboxylase activity,MF,
4249,GO:0008955,1,0.993491998011845,0,1,peptidoglycan glycosyltransferase activity,MF,
4250,GO:0008962,1,0.99356808405181,0,1,phosphatidylglycerophosphatase activity,MF,
4251,GO:0008963,1,0.993596501007589,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4252,GO:0008967,1,0.987182351359527,0,2,phosphoglycolate phosphatase activity,MF,
4253,GO:0008970,1,0.955823143797903,0,7,phospholipase A1 activity,MF,
4254,GO:0008973,1,0.993530585708529,0,1,phosphopentomutase activity,MF,
4255,GO:0008988,1,0.974589402010789,0,4,rRNA (adenine-N6-)-methyltransferase activity,MF,
4256,GO:0008995,1,0.993567805908878,0,1,ribonuclease E activity,MF,
4257,GO:0009000,1,0.993575633753531,0,1,selenocysteine lyase activity,MF,
4258,GO:0009007,1,0.986982750090081,0,2,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4259,GO:0009008,1,0.961568949147775,0,6,DNA-methyltransferase activity,MF,
4260,GO:0009013,1,0.993406836997533,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4261,GO:0009019,1,0.974316531826986,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4262,GO:0009020,1,0.993608907064504,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4263,GO:0009032,1,0.993628898115626,0,1,thymidine phosphorylase activity,MF,
4264,GO:0009041,1,0.98088228634309,0,3,uridylate kinase activity,MF,
4265,GO:0009048,1,0.911072175666375,0,14,dosage compensation by inactivation of X chromosome,BP,
4266,GO:0009051,1,0.974166363905848,0,4,pentose-phosphate shunt, oxidative branch,BP,
4267,GO:0009052,1,0.968361595414652,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4273,GO:0009060,1,0.616530837801568,0,75,aerobic respiration,BP,
4274,GO:0009062,1,0.495146034039157,0,108,fatty acid catabolic process,BP,
4276,GO:0009064,1,0.638359155359519,0,69,glutamine family amino acid metabolic process,BP,
4277,GO:0009065,1,0.850208174325529,0,25,glutamine family amino acid catabolic process,BP,
4278,GO:0009066,1,0.747215885217305,0,45,aspartate family amino acid metabolic process,BP,
4279,GO:0009067,1,0.877706210945594,0,20,aspartate family amino acid biosynthetic process,BP,
4280,GO:0009068,1,0.873234597196868,0,21,aspartate family amino acid catabolic process,BP,
4281,GO:0009069,1,0.807956632526387,0,33,serine family amino acid metabolic process,BP,
4282,GO:0009070,1,0.907986414683539,0,15,serine family amino acid biosynthetic process,BP,
4283,GO:0009071,1,0.925786909078687,0,12,serine family amino acid catabolic process,BP,
4285,GO:0009073,1,0.974583548497974,0,4,aromatic amino acid family biosynthetic process,BP,
4287,GO:0009078,1,0.974615889470712,0,4,pyruvate family amino acid metabolic process,BP,
4288,GO:0009080,1,0.974615889470712,0,4,pyruvate family amino acid catabolic process,BP,
4289,GO:0009081,1,0.850063401248788,0,25,branched-chain amino acid metabolic process,BP,
4290,GO:0009082,1,0.968039786190626,0,5,branched-chain amino acid biosynthetic process,BP,
4291,GO:0009083,1,0.866564225730865,0,22,branched-chain amino acid catabolic process,BP,
4292,GO:0009084,1,0.901854572354161,0,16,glutamine family amino acid biosynthetic process,BP,
4293,GO:0009085,1,0.986939606660676,0,2,lysine biosynthetic process,BP,
4294,GO:0009086,1,0.924515980225576,0,12,methionine biosynthetic process,BP,
4295,GO:0009087,1,0.993522124519047,0,1,methionine catabolic process,BP,
4296,GO:0009092,1,0.974736824605422,0,4,homoserine metabolic process,BP,
4297,GO:0009093,1,0.974635315001332,0,4,cysteine catabolic process,BP,
4298,GO:0009095,1,0.993561823482235,0,1,aromatic amino acid family biosynthetic process, prephenate pathway,BP,
4299,GO:0009097,1,0.980985331575164,0,3,isoleucine biosynthetic process,BP,
4300,GO:0009098,1,0.986806044626505,0,2,leucine biosynthetic process,BP,
4301,GO:0009099,1,0.980475689947823,0,3,valine biosynthetic process,BP,
4304,GO:0009104,1,0.993580358118446,0,1,lipopolysaccharide catabolic process,BP,
4305,GO:0009106,1,0.987181410333477,0,2,lipoate metabolic process,BP,
4306,GO:0009107,1,0.9936279274967,0,1,lipoate biosynthetic process,BP,
4307,GO:0009110,1,0.884389594890316,0,19,vitamin biosynthetic process,BP,
4308,GO:0009111,1,0.931665490324252,0,11,vitamin catabolic process,BP,
4310,GO:0009113,1,0.937661777964317,0,10,purine nucleobase biosynthetic process,BP,
4311,GO:0009115,1,0.986822950665227,0,2,xanthine catabolic process,BP,
4312,GO:0009116,1,0.543843275973285,0,94,nucleoside metabolic process,BP,
4314,GO:0009119,1,0.656195152173287,0,65,ribonucleoside metabolic process,BP,
4315,GO:0009120,1,0.956026100981025,0,7,deoxyribonucleoside metabolic process,BP,
4317,GO:0009124,1,0.777489298218739,0,39,nucleoside monophosphate biosynthetic process,BP,
4318,GO:0009125,1,0.962062753315643,0,6,nucleoside monophosphate catabolic process,BP,
4319,GO:0009126,1,0.786450358016574,0,37,purine nucleoside monophosphate metabolic process,BP,
4320,GO:0009127,1,0.884773244003689,0,19,purine nucleoside monophosphate biosynthetic process,BP,
4321,GO:0009128,1,0.974508889077822,0,4,purine nucleoside monophosphate catabolic process,BP,
4322,GO:0009129,1,0.907828349159953,0,15,pyrimidine nucleoside monophosphate metabolic process,BP,
4323,GO:0009130,1,0.913649963144734,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4324,GO:0009131,1,0.993633913063494,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4327,GO:0009134,1,0.961945965968965,0,6,nucleoside diphosphate catabolic process,BP,
4330,GO:0009137,1,0.980696599745052,0,3,purine nucleoside diphosphate catabolic process,BP,
4331,GO:0009138,1,0.974552109367374,0,4,pyrimidine nucleoside diphosphate metabolic process,BP,
4332,GO:0009139,1,0.98088228634309,0,3,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4333,GO:0009140,1,0.993547687504412,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4336,GO:0009143,1,0.92529444028986,0,12,nucleoside triphosphate catabolic process,BP,
4337,GO:0009144,1,0.678492598233858,0,60,purine nucleoside triphosphate metabolic process,BP,
4338,GO:0009145,1,0.772947204818616,0,40,purine nucleoside triphosphate biosynthetic process,BP,
4339,GO:0009146,1,0.962073782175794,0,6,purine nucleoside triphosphate catabolic process,BP,
4340,GO:0009147,1,0.873888763978579,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4341,GO:0009148,1,0.890865503810432,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4342,GO:0009149,1,0.987319879429479,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4347,GO:0009154,1,0.827718910093036,0,29,purine ribonucleotide catabolic process,BP,
4348,GO:0009155,1,0.96820821456167,0,5,purine deoxyribonucleotide catabolic process,BP,
4349,GO:0009156,1,0.823918648170131,0,30,ribonucleoside monophosphate biosynthetic process,BP,
4350,GO:0009157,1,0.949841089184117,0,8,deoxyribonucleoside monophosphate biosynthetic process,BP,
4351,GO:0009158,1,0.980722300170849,0,3,ribonucleoside monophosphate catabolic process,BP,
4352,GO:0009159,1,0.987231576136616,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4353,GO:0009161,1,0.736979350058236,0,47,ribonucleoside monophosphate metabolic process,BP,
4354,GO:0009162,1,0.931770688276839,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4355,GO:0009163,1,0.79847782785525,0,35,nucleoside biosynthetic process,BP,
4356,GO:0009164,1,0.835316128869167,0,28,nucleoside catabolic process,BP,
4359,GO:0009167,1,0.801696041430353,0,34,purine ribonucleoside monophosphate metabolic process,BP,
4360,GO:0009168,1,0.896185740471556,0,17,purine ribonucleoside monophosphate biosynthetic process,BP,
4361,GO:0009169,1,0.980722300170849,0,3,purine ribonucleoside monophosphate catabolic process,BP,
4362,GO:0009170,1,0.981032505520042,0,3,purine deoxyribonucleoside monophosphate metabolic process,BP,
4363,GO:0009171,1,0.987279341978086,0,2,purine deoxyribonucleoside monophosphate biosynthetic process,BP,
4364,GO:0009173,1,0.937409120148856,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4365,GO:0009174,1,0.937409120148856,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4366,GO:0009176,1,0.968464188124792,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4367,GO:0009177,1,0.974670613228687,0,4,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4368,GO:0009178,1,0.993633913063494,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4371,GO:0009181,1,0.980696599745052,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4376,GO:0009187,1,0.793507175471585,0,35,cyclic nucleotide metabolic process,BP,
4379,GO:0009190,1,0.888135088794265,0,18,cyclic nucleotide biosynthetic process,BP,
4380,GO:0009191,1,0.968187604528635,0,5,ribonucleoside diphosphate catabolic process,BP,
4381,GO:0009193,1,0.987140875228273,0,2,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4382,GO:0009194,1,0.993551996593999,0,1,pyrimidine ribonucleoside diphosphate biosynthetic process,BP,
4383,GO:0009195,1,0.993547687504412,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4384,GO:0009196,1,0.987248884937554,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4385,GO:0009197,1,0.987248884937554,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4386,GO:0009199,1,0.687021894181331,0,58,ribonucleoside triphosphate metabolic process,BP,
4387,GO:0009200,1,0.896519741471926,0,17,deoxyribonucleoside triphosphate metabolic process,BP,
4388,GO:0009201,1,0.748124457366978,0,45,ribonucleoside triphosphate biosynthetic process,BP,
4389,GO:0009202,1,0.962255154493323,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4390,GO:0009203,1,0.993666179737523,0,1,ribonucleoside triphosphate catabolic process,BP,
4391,GO:0009204,1,0.949869882273939,0,8,deoxyribonucleoside triphosphate catabolic process,BP,
4392,GO:0009205,1,0.71442288461406,0,52,purine ribonucleoside triphosphate metabolic process,BP,
4393,GO:0009206,1,0.777936538793448,0,39,purine ribonucleoside triphosphate biosynthetic process,BP,
4394,GO:0009207,1,0.993666179737523,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4395,GO:0009208,1,0.908091032022151,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4397,GO:0009211,1,0.962371693367877,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4398,GO:0009212,1,0.974734589195674,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4399,GO:0009213,1,0.987319879429479,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4400,GO:0009214,1,0.911706042502211,0,14,cyclic nucleotide catabolic process,BP,
4401,GO:0009215,1,0.943748735765733,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4402,GO:0009216,1,0.987200349939021,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4403,GO:0009217,1,0.96820821456167,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4405,GO:0009219,1,0.891070253414352,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4407,GO:0009221,1,0.956128375687391,0,7,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4408,GO:0009222,1,0.993547687504412,0,1,pyrimidine ribonucleotide catabolic process,BP,
4409,GO:0009223,1,0.926030965742988,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4410,GO:0009225,1,0.796728758152918,0,35,nucleotide-sugar metabolic process,BP,
4411,GO:0009226,1,0.873028980334572,0,21,nucleotide-sugar biosynthetic process,BP,
4412,GO:0009227,1,0.980914090813329,0,3,nucleotide-sugar catabolic process,BP,
4413,GO:0009229,1,0.993582419392773,0,1,thiamine diphosphate biosynthetic process,BP,
4414,GO:0009231,1,0.993560801035551,0,1,riboflavin biosynthetic process,BP,
4415,GO:0009233,1,0.974456835544079,0,4,menaquinone metabolic process,BP,
4416,GO:0009234,1,0.993509157505027,0,1,menaquinone biosynthetic process,BP,
4417,GO:0009235,1,0.888797966399044,0,18,cobalamin metabolic process,BP,
4418,GO:0009237,1,0.993548136726401,0,1,siderophore metabolic process,BP,
4419,GO:0009240,1,0.974712112402508,0,4,isopentenyl diphosphate biosynthetic process,BP,
4420,GO:0009247,1,0.664213193523776,0,63,glycolipid biosynthetic process,BP,
4421,GO:0009249,1,0.956428702677261,0,7,protein lipoylation,BP,
4422,GO:0009250,1,0.762887311938484,0,41,glucan biosynthetic process,BP,
4423,GO:0009251,1,0.865260373490167,0,22,glucan catabolic process,BP,
4424,GO:0009253,1,0.987389152388252,0,2,peptidoglycan catabolic process,BP,
4425,GO:0009256,1,0.967767275859722,0,5,10-formyltetrahydrofolate metabolic process,BP,
4426,GO:0009257,1,0.987071159884228,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4427,GO:0009258,1,0.986779366323023,0,2,10-formyltetrahydrofolate catabolic process,BP,
4430,GO:0009261,1,0.822368133436125,0,30,ribonucleotide catabolic process,BP,
4433,GO:0009264,1,0.890846195671128,0,18,deoxyribonucleotide catabolic process,BP,
4436,GO:0009267,1,0.381751242923219,0,147,cellular response to starvation,BP,
4437,GO:0009268,1,0.792351106295998,0,36,response to pH,BP,
4438,GO:0009295,1,0.770998416264528,0,40,nucleoid,CC,
4439,GO:0009298,1,0.974733097095188,0,4,GDP-mannose biosynthetic process,BP,
4440,GO:0009299,1,0.894368501199088,0,17,mRNA transcription,BP,
4441,GO:0009301,1,0.634787056225803,0,70,snRNA transcription,BP,
4442,GO:0009303,1,0.839044506990101,0,27,rRNA transcription,BP,
4443,GO:0009304,1,0.949367258258475,0,8,tRNA transcription,BP,
4444,GO:0009305,1,0.993334450818515,0,1,protein biotinylation,BP,
4448,GO:0009310,1,0.878790821986996,0,20,amine catabolic process,BP,
4449,GO:0009311,1,0.722101075318729,0,50,oligosaccharide metabolic process,BP,
4450,GO:0009312,1,0.901872603564216,0,16,oligosaccharide biosynthetic process,BP,
4451,GO:0009313,1,0.931314150063742,0,11,oligosaccharide catabolic process,BP,
4453,GO:0009328,1,0.987245908088761,0,2,phenylalanine-tRNA ligase complex,CC,
4454,GO:0009330,1,0.993359414532482,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex,CC,
4455,GO:0009331,1,0.980514028334925,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4456,GO:0009353,1,0.99365123197514,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4457,GO:0009360,1,0.993561161358993,0,1,DNA polymerase III complex,CC,
4458,GO:0009361,1,0.99364225173612,0,1,succinate-CoA ligase complex (ADP-forming),CC,
4459,GO:0009368,1,0.987285520352958,0,2,endopeptidase Clp complex,CC,
4460,GO:0009374,1,0.967429796581806,0,5,biotin binding,MF,
4461,GO:0009378,1,0.961192372110996,0,6,four-way junction helicase activity,MF,
4462,GO:0009383,1,0.980726961441056,0,3,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4463,GO:0009384,1,0.993394958632404,0,1,N-acylmannosamine kinase activity,MF,
4464,GO:0009386,1,0.987260064651239,0,2,translational attenuation,BP,
4467,GO:0009396,1,0.949641388413503,0,8,folic acid-containing compound biosynthetic process,BP,
4468,GO:0009397,1,0.980542695376376,0,3,folic acid-containing compound catabolic process,BP,
4469,GO:0009398,1,0.993560801035551,0,1,FMN biosynthetic process,BP,
4470,GO:0009404,1,0.919167349098082,0,13,toxin metabolic process,BP,
4471,GO:0009405,1,0.986768543000801,0,2,pathogenesis,BP,
4472,GO:0009407,1,0.987256023000812,0,2,toxin catabolic process,BP,
4474,GO:0009409,1,0.755704958745588,0,43,response to cold,BP,
4475,GO:0009410,1,0.537380147015382,0,96,response to xenobiotic stimulus,BP,
4476,GO:0009411,1,0.424683399327651,0,131,response to UV,BP,
4477,GO:0009414,1,0.949643583945849,0,8,response to water deprivation,BP,
4478,GO:0009415,1,0.912773250023939,0,14,response to water,BP,
4480,GO:0009435,1,0.850643656121067,0,25,NAD biosynthetic process,BP,
4481,GO:0009436,1,0.987230447456813,0,2,glyoxylate catabolic process,BP,
4482,GO:0009437,1,0.919442329810875,0,13,carnitine metabolic process,BP,
4483,GO:0009438,1,0.968502944088756,0,5,methylglyoxal metabolic process,BP,
4484,GO:0009439,1,0.987345795368234,0,2,cyanate metabolic process,BP,
4485,GO:0009440,1,0.987345795368234,0,2,cyanate catabolic process,BP,
4486,GO:0009441,1,0.980649358645729,0,3,glycolate metabolic process,BP,
4487,GO:0009443,1,0.993212951735508,0,1,pyridoxal 5'-phosphate salvage,BP,
4488,GO:0009444,1,0.993394178146891,0,1,pyruvate oxidation,BP,
4489,GO:0009445,1,0.956032991574389,0,7,putrescine metabolic process,BP,
4490,GO:0009446,1,0.968256443240892,0,5,putrescine biosynthetic process,BP,
4491,GO:0009447,1,0.981085983691911,0,3,putrescine catabolic process,BP,
4492,GO:0009448,1,0.967942760185595,0,5,gamma-aminobutyric acid metabolic process,BP,
4493,GO:0009449,1,0.980641255375092,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4494,GO:0009450,1,0.986875337734799,0,2,gamma-aminobutyric acid catabolic process,BP,
4495,GO:0009451,1,0.39258553824461,0,144,RNA modification,BP,
4496,GO:0009452,1,0.813128502113964,0,32,7-methylguanosine RNA capping,BP,
4497,GO:0009566,1,0.398941300365152,0,141,fertilization,BP,
4498,GO:0009581,1,0.458848679527013,0,117,detection of external stimulus,BP,
4499,GO:0009582,1,0.449950465562537,0,120,detection of abiotic stimulus,BP,
4500,GO:0009583,1,0.676952882987951,0,60,detection of light stimulus,BP,
4501,GO:0009584,1,0.722261114262101,0,50,detection of visible light,BP,
4502,GO:0009590,1,0.993602686546463,0,1,detection of gravity,BP,
4504,GO:0009595,1,0.811962017436016,0,32,detection of biotic stimulus,BP,
4505,GO:0009597,1,0.968115355134125,0,5,detection of virus,BP,
4508,GO:0009608,1,0.974514656179254,0,4,response to symbiont,BP,
4509,GO:0009609,1,0.974514656179254,0,4,response to symbiotic bacterium,BP,
4512,GO:0009615,1,0.149598050368185,0,290,response to virus,BP,
4515,GO:0009624,1,0.987267791619736,0,2,response to nematode,BP,
4517,GO:0009629,1,0.937683036663627,0,10,response to gravity,BP,
4518,GO:0009631,1,0.98698321663493,0,2,cold acclimation,BP,
4519,GO:0009635,1,0.956026023145744,0,7,response to herbicide,BP,
4521,GO:0009637,1,0.987052092804469,0,2,response to blue light,BP,
4522,GO:0009642,1,0.943074179376992,0,9,response to light intensity,BP,
4523,GO:0009644,1,0.987039671749209,0,2,response to high light intensity,BP,
4524,GO:0009645,1,0.993517995321724,0,1,response to low light intensity stimulus,BP,
4525,GO:0009648,1,0.822938139575776,0,30,photoperiodism,BP,
4526,GO:0009649,1,0.81754588280245,0,31,entrainment of circadian clock,BP,
4527,GO:0009650,1,0.91936591923405,0,13,UV protection,BP,
4528,GO:0009651,1,0.855820336954379,0,24,response to salt stress,BP,
4530,GO:0009669,1,0.974462931665959,0,4,sucrose:cation symporter activity,MF,
4531,GO:0009673,1,0.99350834310007,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4532,GO:0009674,1,0.986742253298152,0,2,potassium:sodium symporter activity,MF,
4533,GO:0009678,1,0.82863035059325,0,29,pyrophosphate hydrolysis-driven proton transmembrane transporter activity,MF,
4534,GO:0009692,1,0.993566696254439,0,1,ethylene metabolic process,BP,
4535,GO:0009698,1,0.962298034889861,0,6,phenylpropanoid metabolic process,BP,
4540,GO:0009726,1,0.980230340478818,0,3,detection of endogenous stimulus,BP,
4541,GO:0009730,1,0.974625505293096,0,4,detection of carbohydrate stimulus,BP,
4542,GO:0009732,1,0.974625505293096,0,4,detection of hexose stimulus,BP,
4543,GO:0009737,1,0.993466657130638,0,1,response to abscisic acid,BP,
4544,GO:0009738,1,0.993466657130638,0,1,abscisic acid-activated signaling pathway,BP,
4546,GO:0009744,1,0.974231209085574,0,4,response to sucrose,BP,
4549,GO:0009750,1,0.949410744557797,0,8,response to fructose,BP,
4550,GO:0009753,1,0.974843726608518,0,4,response to jasmonic acid,BP,
4552,GO:0009756,1,0.949587961989861,0,8,carbohydrate mediated signaling,BP,
4553,GO:0009757,1,0.961948176386361,0,6,hexose mediated signaling,BP,
4554,GO:0009758,1,0.99308300260054,0,1,carbohydrate utilization,BP,
4555,GO:0009785,1,0.987052092804469,0,2,blue light signaling pathway,BP,
4556,GO:0009786,1,0.96739414695022,0,5,regulation of asymmetric cell division,BP,
4557,GO:0009787,1,0.993466657130638,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4558,GO:0009789,1,0.993466657130638,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4560,GO:0009791,1,0.59887267335667,0,77,post-embryonic development,BP,
4562,GO:0009794,1,0.974472425169823,0,4,regulation of mitotic cell cycle, embryonic,BP,
4563,GO:0009798,1,0.592000287356471,0,80,axis specification,BP,
4565,GO:0009804,1,0.962298034889861,0,6,coumarin metabolic process,BP,
4566,GO:0009810,1,0.99359233845386,0,1,stilbene metabolic process,BP,
4567,GO:0009812,1,0.962004253651634,0,6,flavonoid metabolic process,BP,
4568,GO:0009820,1,0.968455260185534,0,5,alkaloid metabolic process,BP,
4569,GO:0009822,1,0.987299506350496,0,2,alkaloid catabolic process,BP,
4570,GO:0009826,1,0.986945789104525,0,2,unidimensional cell growth,BP,
4571,GO:0009838,1,0.968415228468303,0,5,abscission,BP,
4572,GO:0009841,1,0.993582483974472,0,1,mitochondrial endopeptidase Clp complex,CC,
4574,GO:0009880,1,0.661306196230754,0,63,embryonic pattern specification,BP,
4575,GO:0009881,1,0.925642416719321,0,12,photoreceptor activity,MF,
4576,GO:0009882,1,0.987052092804469,0,2,blue light photoreceptor activity,MF,
4577,GO:0009886,1,0.923490972608432,0,12,post-embryonic animal morphogenesis,BP,
4589,GO:0009898,1,0.360120392935102,0,156,cytoplasmic side of plasma membrane,CC,
4590,GO:0009912,1,0.973794474510474,0,4,auditory receptor cell fate commitment,BP,
4591,GO:0009913,1,0.285560290325826,0,191,epidermal cell differentiation,BP,
4593,GO:0009918,1,0.993563851908475,0,1,sterol delta7 reductase activity,MF,
4594,GO:0009922,1,0.961852691979628,0,6,fatty acid elongase activity,MF,
4597,GO:0009946,1,0.980990886162628,0,3,proximal/distal axis specification,BP,
4598,GO:0009948,1,0.745779949662938,0,45,anterior/posterior axis specification,BP,
4599,GO:0009949,1,0.993634714618148,0,1,polarity specification of anterior/posterior axis,BP,
4600,GO:0009950,1,0.930639905193904,0,11,dorsal/ventral axis specification,BP,
4604,GO:0009955,1,0.993592601965037,0,1,adaxial/abaxial pattern specification,BP,
4605,GO:0009956,1,0.993494538735368,0,1,radial pattern formation,BP,
4606,GO:0009957,1,0.980368992740905,0,3,epidermal cell fate specification,BP,
4610,GO:0009972,1,0.937907515958905,0,10,cytidine deamination,BP,
4611,GO:0009975,1,0.899448721937336,0,16,cyclase activity,MF,
4612,GO:0009982,1,0.919706074519074,0,13,pseudouridine synthase activity,MF,
4615,GO:0009988,1,0.678462748754788,0,60,cell-cell recognition,BP,
4617,GO:0009992,1,0.968222478006772,0,5,cellular water homeostasis,BP,
4618,GO:0009994,1,0.750534719024807,0,44,oocyte differentiation,BP,
4619,GO:0009996,1,0.97462956328023,0,4,negative regulation of cell fate specification,BP,
4623,GO:0010009,1,0.97450974017025,0,4,cytoplasmic side of endosome membrane,CC,
4624,GO:0010021,1,0.993535543327298,0,1,amylopectin biosynthetic process,BP,
4625,GO:0010025,1,0.987037948085173,0,2,wax biosynthetic process,BP,
4626,GO:0010032,1,0.954980604952528,0,7,meiotic chromosome condensation,BP,
4628,GO:0010034,1,0.993515122920151,0,1,response to acetate,BP,
4630,GO:0010037,1,0.993538746806461,0,1,response to carbon dioxide,BP,
4634,GO:0010041,1,0.967947907326028,0,5,response to iron(III) ion,BP,
4635,GO:0010042,1,0.883146429975193,0,19,response to manganese ion,BP,
4636,GO:0010043,1,0.73847188316506,0,47,response to zinc ion,BP,
4638,GO:0010045,1,0.993195498614027,0,1,response to nickel cation,BP,
4639,GO:0010046,1,0.974693919059603,0,4,response to mycotoxin,BP,
4640,GO:0010070,1,0.993578883199393,0,1,zygote asymmetric cell division,BP,
4641,GO:0010085,1,0.993600553466401,0,1,polarity specification of proximal/distal axis,BP,
4643,GO:0010106,1,0.993609778514401,0,1,cellular response to iron ion starvation,BP,
4644,GO:0010121,1,0.993607332753872,0,1,arginine catabolic process to proline via ornithine,BP,
4645,GO:0010124,1,0.987318016149939,0,2,phenylacetate catabolic process,BP,
4646,GO:0010133,1,0.987163035747824,0,2,proline catabolic process to glutamate,BP,
4647,GO:0010138,1,0.968470082401636,0,5,pyrimidine ribonucleotide salvage,BP,
4648,GO:0010142,1,0.987138627578934,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4649,GO:0010155,1,0.87928526356586,0,20,regulation of proton transport,BP,
4650,GO:0010157,1,0.986784399137193,0,2,response to chlorate,BP,
4651,GO:0010159,1,0.980713002719647,0,3,specification of animal organ position,BP,
4652,GO:0010160,1,0.993673219206214,0,1,formation of animal organ boundary,BP,
4653,GO:0010164,1,0.993631908176109,0,1,response to cesium ion,BP,
4654,GO:0010165,1,0.815806860593677,0,31,response to X-ray,BP,
4655,GO:0010166,1,0.987037948085173,0,2,wax metabolic process,BP,
4657,GO:0010172,1,0.929619280814757,0,11,embryonic body morphogenesis,BP,
4658,GO:0010181,1,0.913171325623756,0,14,FMN binding,MF,
4659,GO:0010182,1,0.961948176386361,0,6,sugar mediated signaling pathway,BP,
4660,GO:0010185,1,0.993564430341048,0,1,regulation of cellular defense response,BP,
4661,GO:0010186,1,0.993564430341048,0,1,positive regulation of cellular defense response,BP,
4662,GO:0010189,1,0.993627793590708,0,1,vitamin E biosynthetic process,BP,
4663,GO:0010193,1,0.980934969666351,0,3,response to ozone,BP,
4664,GO:0010212,1,0.415649693421586,0,134,response to ionizing radiation,BP,
4665,GO:0010216,1,0.960902657420834,0,6,maintenance of DNA methylation,BP,
4666,GO:0010224,1,0.901667188821135,0,16,response to UV-B,BP,
4667,GO:0010225,1,0.90041399791211,0,16,response to UV-C,BP,
4668,GO:0010226,1,0.860965777386641,0,23,response to lithium ion,BP,
4669,GO:0010232,1,0.925297960247533,0,12,vascular transport,BP,
4671,GO:0010248,1,0.913628341086584,0,14,establishment or maintenance of transmembrane electrochemical gradient,BP,
4672,GO:0010255,1,0.961948176386361,0,6,glucose mediated signaling pathway,BP,
4674,GO:0010257,1,0.699431445040552,0,56,NADH dehydrogenase complex assembly,BP,
4675,GO:0010259,1,0.815490771455785,0,31,multicellular organism aging,BP,
4676,GO:0010260,1,0.987185707013359,0,2,animal organ senescence,BP,
4677,GO:0010265,1,0.961695723065346,0,6,SCF complex assembly,BP,
4678,GO:0010266,1,0.980562927641475,0,3,response to vitamin B1,BP,
4680,GO:0010272,1,0.993568331531998,0,1,response to silver ion,BP,
4681,GO:0010273,1,0.932327372650389,0,11,detoxification of copper ion,BP,
4682,GO:0010286,1,0.968459908108966,0,5,heat acclimation,BP,
4683,GO:0010288,1,0.872064665403563,0,21,response to lead ion,BP,
4684,GO:0010309,1,0.993628027921804,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4686,GO:0010314,1,0.903945175407367,0,15,phosphatidylinositol-5-phosphate binding,MF,
4687,GO:0010324,1,0.641950014803989,0,68,membrane invagination,BP,
4688,GO:0010332,1,0.710505399380134,0,52,response to gamma radiation,BP,
4689,GO:0010335,1,0.99345683314107,0,1,response to non-ionic osmotic stress,BP,
4690,GO:0010340,1,0.96809653318423,0,5,carboxyl-O-methyltransferase activity,MF,
4691,GO:0010348,1,0.99355705431691,0,1,lithium:proton antiporter activity,MF,
4692,GO:0010359,1,0.94257561974549,0,9,regulation of anion channel activity,BP,
4693,GO:0010360,1,0.980681441209426,0,3,negative regulation of anion channel activity,BP,
4694,GO:0010369,1,0.906456832457131,0,15,chromocenter,CC,
4695,GO:0010370,1,0.987145334596348,0,2,perinucleolar chromocenter,CC,
4696,GO:0010385,1,0.967326689849403,0,5,double-stranded methylated DNA binding,MF,
4698,GO:0010389,1,0.294080160941443,0,187,regulation of G2/M transition of mitotic cell cycle,BP,
4699,GO:0010390,1,0.838099267707317,0,27,histone monoubiquitination,BP,
4700,GO:0010420,1,0.993655215305584,0,1,3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity,MF,
4701,GO:0010421,1,0.931163115576486,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4702,GO:0010428,1,0.993344266992794,0,1,methyl-CpNpG binding,MF,
4703,GO:0010430,1,0.974394969044716,0,4,fatty acid omega-oxidation,BP,
4704,GO:0010436,1,0.987150068329575,0,2,carotenoid dioxygenase activity,MF,
4705,GO:0010446,1,0.987139310450451,0,2,response to alkaline pH,BP,
4706,GO:0010447,1,0.873069523577036,0,21,response to acidic pH,BP,
4707,GO:0010452,1,0.910855603893079,0,14,histone H3-K36 methylation,BP,
4711,GO:0010457,1,0.923277457109389,0,12,centriole-centriole cohesion,BP,
4712,GO:0010458,1,0.844498878587705,0,26,exit from mitosis,BP,
4713,GO:0010459,1,0.937663138053053,0,10,negative regulation of heart rate,BP,
4715,GO:0010463,1,0.754165465886136,0,43,mesenchymal cell proliferation,BP,
4716,GO:0010464,1,0.806185353718415,0,33,regulation of mesenchymal cell proliferation,BP,
4717,GO:0010465,1,0.986852228838096,0,2,nerve growth factor receptor activity,MF,
4723,GO:0010477,1,0.99353053264535,0,1,response to sulfur dioxide,BP,
4724,GO:0010481,1,0.987140077126388,0,2,epidermal cell division,BP,
4725,GO:0010482,1,0.987140077126388,0,2,regulation of epidermal cell division,BP,
4726,GO:0010484,1,0.948198078360429,0,8,H3 histone acetyltransferase activity,MF,
4727,GO:0010485,1,0.894769521098393,0,17,H4 histone acetyltransferase activity,MF,
4728,GO:0010494,1,0.627107240093271,0,71,cytoplasmic stress granule,CC,
4729,GO:0010496,1,0.968153164886917,0,5,intercellular transport,BP,
4730,GO:0010498,1,0.0503691273845134,0,453,proteasomal protein catabolic process,BP,
4731,GO:0010499,1,0.885518500248169,0,19,proteasomal ubiquitin-independent protein catabolic process,BP,
4732,GO:0010501,1,0.94928117013451,0,8,RNA secondary structure unwinding,BP,
4735,GO:0010508,1,0.455862336454166,0,119,positive regulation of autophagy,BP,
4736,GO:0010509,1,0.993375418689938,0,1,polyamine homeostasis,BP,
4737,GO:0010510,1,0.948721525782828,0,8,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4738,GO:0010511,1,0.949526338203276,0,8,regulation of phosphatidylinositol biosynthetic process,BP,
4739,GO:0010512,1,0.987148729174502,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4740,GO:0010513,1,0.96189265438602,0,6,positive regulation of phosphatidylinositol biosynthetic process,BP,
4743,GO:0010519,1,0.968011798825188,0,5,negative regulation of phospholipase activity,BP,
4744,GO:0010520,1,0.974352268625298,0,4,regulation of reciprocal meiotic recombination,BP,
4745,GO:0010521,1,0.974518207926352,0,4,telomerase inhibitor activity,MF,
4747,GO:0010523,1,0.901537661213185,0,16,negative regulation of calcium ion transport into cytosol,BP,
4749,GO:0010525,1,0.993512206150665,0,1,regulation of transposition, RNA-mediated,BP,
4750,GO:0010526,1,0.993512206150665,0,1,negative regulation of transposition, RNA-mediated,BP,
4751,GO:0010528,1,0.884149299280469,0,19,regulation of transposition,BP,
4752,GO:0010529,1,0.884149299280469,0,19,negative regulation of transposition,BP,
4753,GO:0010533,1,0.968395378949453,0,5,regulation of activation of Janus kinase activity,BP,
4754,GO:0010536,1,0.980842277990434,0,3,positive regulation of activation of Janus kinase activity,BP,
4761,GO:0010560,1,0.86570505751886,0,22,positive regulation of glycoprotein biosynthetic process,BP,
4762,GO:0010561,1,0.925163873716399,0,12,negative regulation of glycoprotein biosynthetic process,BP,
4765,GO:0010564,1,0.00972575578633298,0,694,regulation of cell cycle process,BP,
4766,GO:0010565,1,0.343033207098225,0,164,regulation of cellular ketone metabolic process,BP,
4767,GO:0010566,1,0.895256434118391,0,17,regulation of ketone biosynthetic process,BP,
4768,GO:0010569,1,0.773852893417893,0,39,regulation of double-strand break repair via homologous recombination,BP,
4769,GO:0010571,1,0.954489803253591,0,7,positive regulation of nuclear cell cycle DNA replication,BP,
4770,GO:0010572,1,0.955416185220966,0,7,positive regulation of platelet activation,BP,
4771,GO:0010573,1,0.811247045186299,0,32,vascular endothelial growth factor production,BP,
4772,GO:0010574,1,0.827339872471026,0,29,regulation of vascular endothelial growth factor production,BP,
4773,GO:0010575,1,0.843411731796724,0,26,positive regulation of vascular endothelial growth factor production,BP,
4774,GO:0010578,1,0.993569541219392,0,1,regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway,BP,
4775,GO:0010585,1,0.99361105277542,0,1,glutamine secretion,BP,
4776,GO:0010586,1,0.849072155553244,0,25,miRNA metabolic process,BP,
4777,GO:0010587,1,0.961584290849623,0,6,miRNA catabolic process,BP,
4778,GO:0010591,1,0.816397532648246,0,31,regulation of lamellipodium assembly,BP,
4779,GO:0010592,1,0.865638628200725,0,22,positive regulation of lamellipodium assembly,BP,
4780,GO:0010593,1,0.986771760994658,0,2,negative regulation of lamellipodium assembly,BP,
4783,GO:0010596,1,0.739741865337873,0,46,negative regulation of endothelial cell migration,BP,
4784,GO:0010603,1,0.942043029546442,0,9,regulation of cytoplasmic mRNA processing body assembly,BP,
4787,GO:0010606,1,0.960614690539757,0,6,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4788,GO:0010607,1,0.993608773028313,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4789,GO:0010608,1,0.0266214183671448,0,547,posttranscriptional regulation of gene expression,BP,
4790,GO:0010609,1,0.987182699637192,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4791,GO:0010610,1,0.980194152756096,0,3,regulation of mRNA stability involved in response to stress,BP,
4793,GO:0010612,1,0.948560039460722,0,8,regulation of cardiac muscle adaptation,BP,
4794,GO:0010613,1,0.8370751607395,0,27,positive regulation of cardiac muscle hypertrophy,BP,
4796,GO:0010615,1,0.987007666347042,0,2,positive regulation of cardiac muscle adaptation,BP,
4797,GO:0010616,1,0.961051267271737,0,6,negative regulation of cardiac muscle adaptation,BP,
4798,GO:0010621,1,0.980972471825366,0,3,negative regulation of transcription by transcription factor localization,BP,
4799,GO:0010623,1,0.918376492998102,0,13,programmed cell death involved in cell development,BP,
4800,GO:0010624,1,0.961157269454475,0,6,regulation of Schwann cell proliferation,BP,
4801,GO:0010626,1,0.961157269454475,0,6,negative regulation of Schwann cell proliferation,BP,
4806,GO:0010633,1,0.670517551830952,0,61,negative regulation of epithelial cell migration,BP,
4808,GO:0010635,1,0.924062335698129,0,12,regulation of mitochondrial fusion,BP,
4809,GO:0010636,1,0.980591998632568,0,3,positive regulation of mitochondrial fusion,BP,
4810,GO:0010637,1,0.948473549062092,0,8,negative regulation of mitochondrial fusion,BP,
4814,GO:0010641,1,0.967709248813189,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4816,GO:0010643,1,0.987121744294695,0,2,cell communication by chemical coupling,BP,
4818,GO:0010645,1,0.993537047150672,0,1,regulation of cell communication by chemical coupling,BP,
4822,GO:0010649,1,0.918174490273495,0,13,regulation of cell communication by electrical coupling,BP,
4823,GO:0010650,1,0.98646995319467,0,2,positive regulation of cell communication by electrical coupling,BP,
4824,GO:0010652,1,0.993537047150672,0,1,positive regulation of cell communication by chemical coupling,BP,
4825,GO:0010656,1,0.796126837226212,0,35,negative regulation of muscle cell apoptotic process,BP,
4833,GO:0010664,1,0.855695431954507,0,24,negative regulation of striated muscle cell apoptotic process,BP,
4836,GO:0010667,1,0.872614400253726,0,21,negative regulation of cardiac muscle cell apoptotic process,BP,
4837,GO:0010668,1,0.955321455499726,0,7,ectodermal cell differentiation,BP,
4841,GO:0010677,1,0.789861968543977,0,36,negative regulation of cellular carbohydrate metabolic process,BP,
4842,GO:0010692,1,0.941798944750045,0,9,regulation of alkaline phosphatase activity,BP,
4843,GO:0010693,1,0.980611949992931,0,3,negative regulation of alkaline phosphatase activity,BP,
4844,GO:0010694,1,0.960427201918945,0,6,positive regulation of alkaline phosphatase activity,BP,
4845,GO:0010698,1,0.981014209132114,0,3,acetyltransferase activator activity,MF,
4846,GO:0010700,1,0.968344482338692,0,5,negative regulation of norepinephrine secretion,BP,
4847,GO:0010701,1,0.980693394245435,0,3,positive regulation of norepinephrine secretion,BP,
4848,GO:0010705,1,0.987049534481141,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4849,GO:0010706,1,0.98691596643586,0,2,ganglioside biosynthetic process via lactosylceramide,BP,
4850,GO:0010710,1,0.980867957294759,0,3,regulation of collagen catabolic process,BP,
4851,GO:0010711,1,0.993687792402336,0,1,negative regulation of collagen catabolic process,BP,
4852,GO:0010712,1,0.7972906555855,0,35,regulation of collagen metabolic process,BP,
4853,GO:0010713,1,0.931687235509122,0,11,negative regulation of collagen metabolic process,BP,
4854,GO:0010714,1,0.872620729846599,0,21,positive regulation of collagen metabolic process,BP,
4855,GO:0010715,1,0.91169819966607,0,14,regulation of extracellular matrix disassembly,BP,
4856,GO:0010716,1,0.974573549254914,0,4,negative regulation of extracellular matrix disassembly,BP,
4858,GO:0010718,1,0.739253177969724,0,46,positive regulation of epithelial to mesenchymal transition,BP,
4859,GO:0010719,1,0.807274779942256,0,33,negative regulation of epithelial to mesenchymal transition,BP,
4862,GO:0010722,1,0.993232719080104,0,1,regulation of ferrochelatase activity,BP,
4863,GO:0010723,1,0.993320336531158,0,1,positive regulation of transcription from RNA polymerase II promoter in response to iron,BP,
4864,GO:0010724,1,0.974414858152391,0,4,regulation of definitive erythrocyte differentiation,BP,
4865,GO:0010725,1,0.987205706234572,0,2,regulation of primitive erythrocyte differentiation,BP,
4867,GO:0010727,1,0.949667588194048,0,8,negative regulation of hydrogen peroxide metabolic process,BP,
4868,GO:0010728,1,0.961915997657541,0,6,regulation of hydrogen peroxide biosynthetic process,BP,
4869,GO:0010729,1,0.987258864773203,0,2,positive regulation of hydrogen peroxide biosynthetic process,BP,
4870,GO:0010730,1,0.974333318258027,0,4,negative regulation of hydrogen peroxide biosynthetic process,BP,
4874,GO:0010735,1,0.980698502075765,0,3,positive regulation of transcription via serum response element binding,BP,
4875,GO:0010736,1,0.993469083002281,0,1,serum response element binding,MF,
4876,GO:0010737,1,0.810283251080609,0,30,protein kinase A signaling,BP,
4877,GO:0010738,1,0.876642338812882,0,20,regulation of protein kinase A signaling,BP,
4878,GO:0010739,1,0.955549945548716,0,7,positive regulation of protein kinase A signaling,BP,
4879,GO:0010742,1,0.815688841312508,0,31,macrophage derived foam cell differentiation,BP,
4880,GO:0010743,1,0.837531270518934,0,27,regulation of macrophage derived foam cell differentiation,BP,
4881,GO:0010744,1,0.900993716590844,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4882,GO:0010745,1,0.929634714292397,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4883,GO:0010746,1,0.96750054596143,0,5,regulation of long-chain fatty acid import across plasma membrane,BP,
4884,GO:0010747,1,0.993524132028894,0,1,positive regulation of long-chain fatty acid import across plasma membrane,BP,
4885,GO:0010748,1,0.973808469512884,0,4,negative regulation of long-chain fatty acid import across plasma membrane,BP,
4886,GO:0010749,1,0.948672161797831,0,8,regulation of nitric oxide mediated signal transduction,BP,
4887,GO:0010750,1,0.980698959078781,0,3,positive regulation of nitric oxide mediated signal transduction,BP,
4888,GO:0010751,1,0.980269651730473,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4889,GO:0010752,1,0.918610757791063,0,13,regulation of cGMP-mediated signaling,BP,
4890,GO:0010753,1,0.962225293857895,0,6,positive regulation of cGMP-mediated signaling,BP,
4891,GO:0010754,1,0.960970830610655,0,6,negative regulation of cGMP-mediated signaling,BP,
4892,GO:0010755,1,0.937573350899191,0,10,regulation of plasminogen activation,BP,
4893,GO:0010756,1,0.968462605248221,0,5,positive regulation of plasminogen activation,BP,
4894,GO:0010757,1,0.968114912805297,0,5,negative regulation of plasminogen activation,BP,
4897,GO:0010760,1,0.962011777702875,0,6,negative regulation of macrophage chemotaxis,BP,
4898,GO:0010761,1,0.754219108685904,0,43,fibroblast migration,BP,
4899,GO:0010762,1,0.811316498184607,0,32,regulation of fibroblast migration,BP,
4900,GO:0010763,1,0.91221751044243,0,14,positive regulation of fibroblast migration,BP,
4901,GO:0010764,1,0.96182840694471,0,6,negative regulation of fibroblast migration,BP,
4903,GO:0010766,1,0.887570655870048,0,18,negative regulation of sodium ion transport,BP,
4904,GO:0010767,1,0.986905902833831,0,2,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4905,GO:0010768,1,0.993301139693358,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4909,GO:0010780,1,0.993331082223326,0,1,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,BP,
4910,GO:0010789,1,0.99355705431691,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4911,GO:0010792,1,0.968147539004864,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4912,GO:0010793,1,0.961144027884959,0,6,regulation of mRNA export from nucleus,BP,
4913,GO:0010795,1,0.987199759065777,0,2,regulation of ubiquinone biosynthetic process,BP,
4914,GO:0010796,1,0.98097979528796,0,3,regulation of multivesicular body size,BP,
4915,GO:0010797,1,0.993658663838475,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4918,GO:0010801,1,0.89548633547524,0,17,negative regulation of peptidyl-threonine phosphorylation,BP,
4919,GO:0010803,1,0.718356250840249,0,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4920,GO:0010804,1,0.902308143024567,0,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4921,GO:0010807,1,0.955464954785018,0,7,regulation of synaptic vesicle priming,BP,
4922,GO:0010808,1,0.993300789100768,0,1,positive regulation of synaptic vesicle priming,BP,
4925,GO:0010812,1,0.686595507459492,0,57,negative regulation of cell-substrate adhesion,BP,
4926,GO:0010813,1,0.987091694237475,0,2,neuropeptide catabolic process,BP,
4927,GO:0010814,1,0.993408847556443,0,1,substance P catabolic process,BP,
4928,GO:0010815,1,0.974277140712001,0,4,bradykinin catabolic process,BP,
4929,GO:0010816,1,0.993408847556443,0,1,calcitonin catabolic process,BP,
4931,GO:0010818,1,0.850501679266972,0,25,T cell chemotaxis,BP,
4932,GO:0010819,1,0.907298067777613,0,15,regulation of T cell chemotaxis,BP,
4933,GO:0010820,1,0.913090992028171,0,14,positive regulation of T cell chemotaxis,BP,
4937,GO:0010824,1,0.754110720698038,0,43,regulation of centrosome duplication,BP,
4938,GO:0010825,1,0.949009253694704,0,8,positive regulation of centrosome duplication,BP,
4939,GO:0010826,1,0.918614655751798,0,13,negative regulation of centrosome duplication,BP,
4940,GO:0010827,1,0.65694646739572,0,64,regulation of glucose transmembrane transport,BP,
4941,GO:0010828,1,0.788307563544312,0,36,positive regulation of glucose transmembrane transport,BP,
4942,GO:0010829,1,0.90163831542894,0,16,negative regulation of glucose transmembrane transport,BP,
4943,GO:0010830,1,0.736499910218967,0,47,regulation of myotube differentiation,BP,
4944,GO:0010831,1,0.839430873599145,0,27,positive regulation of myotube differentiation,BP,
4945,GO:0010832,1,0.91246717471616,0,14,negative regulation of myotube differentiation,BP,
4946,GO:0010833,1,0.608445140297868,0,76,telomere maintenance via telomere lengthening,BP,
4947,GO:0010835,1,0.968118225063337,0,5,regulation of protein ADP-ribosylation,BP,
4948,GO:0010836,1,0.980949307740436,0,3,negative regulation of protein ADP-ribosylation,BP,
4949,GO:0010837,1,0.826034243722345,0,29,regulation of keratinocyte proliferation,BP,
4950,GO:0010838,1,0.930328148504608,0,11,positive regulation of keratinocyte proliferation,BP,
4951,GO:0010839,1,0.929536165316881,0,11,negative regulation of keratinocyte proliferation,BP,
4952,GO:0010840,1,0.980821162137212,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4953,GO:0010841,1,0.987121285841492,0,2,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4954,GO:0010842,1,0.863155252144989,0,22,retina layer formation,BP,
4955,GO:0010844,1,0.993506707165435,0,1,recombination hotspot binding,MF,
4956,GO:0010845,1,0.974352268625298,0,4,positive regulation of reciprocal meiotic recombination,BP,
4957,GO:0010847,1,0.887842286197873,0,18,regulation of chromatin assembly,BP,
4959,GO:0010849,1,0.993593129319401,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4960,GO:0010851,1,0.968331052447768,0,5,cyclase regulator activity,MF,
4961,GO:0010852,1,0.993586767336276,0,1,cyclase inhibitor activity,MF,
4962,GO:0010853,1,0.980983059225986,0,3,cyclase activator activity,MF,
4963,GO:0010854,1,0.993477001696749,0,1,adenylate cyclase regulator activity,MF,
4964,GO:0010855,1,0.993477001696749,0,1,adenylate cyclase inhibitor activity,MF,
4965,GO:0010856,1,0.96826436488245,0,5,adenylate cyclase activator activity,MF,
4967,GO:0010858,1,0.981026765498445,0,3,calcium-dependent protein kinase regulator activity,MF,
4968,GO:0010859,1,0.993465093254032,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4969,GO:0010862,1,0.750768311129602,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4971,GO:0010866,1,0.895662063070985,0,17,regulation of triglyceride biosynthetic process,BP,
4972,GO:0010867,1,0.91932776896335,0,13,positive regulation of triglyceride biosynthetic process,BP,
4973,GO:0010868,1,0.986987655953346,0,2,negative regulation of triglyceride biosynthetic process,BP,
4974,GO:0010869,1,0.877160598150737,0,20,regulation of receptor biosynthetic process,BP,
4975,GO:0010870,1,0.92515774073745,0,12,positive regulation of receptor biosynthetic process,BP,
4976,GO:0010871,1,0.967247686928526,0,5,negative regulation of receptor biosynthetic process,BP,
4977,GO:0010872,1,0.943487536104739,0,9,regulation of cholesterol esterification,BP,
4978,GO:0010873,1,0.962388136286175,0,6,positive regulation of cholesterol esterification,BP,
4979,GO:0010874,1,0.837356888707569,0,27,regulation of cholesterol efflux,BP,
4980,GO:0010875,1,0.88221996455547,0,19,positive regulation of cholesterol efflux,BP,
4982,GO:0010877,1,0.987289883240203,0,2,lipid transport involved in lipid storage,BP,
4983,GO:0010878,1,0.88805112526937,0,18,cholesterol storage,BP,
4984,GO:0010879,1,0.993588596206985,0,1,cholesterol transport involved in cholesterol storage,BP,
4988,GO:0010883,1,0.735046315100185,0,47,regulation of lipid storage,BP,
4989,GO:0010884,1,0.860315752799895,0,23,positive regulation of lipid storage,BP,
4990,GO:0010885,1,0.89962157236243,0,16,regulation of cholesterol storage,BP,
4991,GO:0010886,1,0.954590396360095,0,7,positive regulation of cholesterol storage,BP,
4992,GO:0010887,1,0.942442298670561,0,9,negative regulation of cholesterol storage,BP,
4993,GO:0010888,1,0.87710803787902,0,20,negative regulation of lipid storage,BP,
4994,GO:0010889,1,0.912916873291257,0,14,regulation of sequestering of triglyceride,BP,
4995,GO:0010890,1,0.943865028652622,0,9,positive regulation of sequestering of triglyceride,BP,
4996,GO:0010891,1,0.967229875182438,0,5,negative regulation of sequestering of triglyceride,BP,
4998,GO:0010894,1,0.867601082058155,0,22,negative regulation of steroid biosynthetic process,BP,
4999,GO:0010896,1,0.936870260048593,0,10,regulation of triglyceride catabolic process,BP,
5000,GO:0010897,1,0.973679060984944,0,4,negative regulation of triglyceride catabolic process,BP,
5001,GO:0010898,1,0.962206057575165,0,6,positive regulation of triglyceride catabolic process,BP,
5002,GO:0010899,1,0.980790644897263,0,3,regulation of phosphatidylcholine catabolic process,BP,
5003,GO:0010900,1,0.993708370328509,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5004,GO:0010901,1,0.98741051035869,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5005,GO:0010902,1,0.993691347131295,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5006,GO:0010903,1,0.993679686869083,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5007,GO:0010904,1,0.9935938551392,0,1,regulation of UDP-glucose catabolic process,BP,
5008,GO:0010905,1,0.9935938551392,0,1,negative regulation of UDP-glucose catabolic process,BP,
5009,GO:0010906,1,0.517677771496014,0,100,regulation of glucose metabolic process,BP,
5010,GO:0010907,1,0.804299723022045,0,33,positive regulation of glucose metabolic process,BP,
5011,GO:0010908,1,0.980692803569018,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5012,GO:0010909,1,0.980692803569018,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5013,GO:0010911,1,0.948961524334803,0,8,regulation of isomerase activity,BP,
5014,GO:0010912,1,0.948961524334803,0,8,positive regulation of isomerase activity,BP,
5015,GO:0010915,1,0.981152957313728,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5016,GO:0010916,1,0.981152957313728,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5017,GO:0010917,1,0.925645658700846,0,12,negative regulation of mitochondrial membrane potential,BP,
5018,GO:0010918,1,0.937266351815875,0,10,positive regulation of mitochondrial membrane potential,BP,
5020,GO:0010920,1,0.99355205394135,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5022,GO:0010922,1,0.820709774387363,0,30,positive regulation of phosphatase activity,BP,
5024,GO:0010924,1,0.99355205394135,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5025,GO:0010925,1,0.99355205394135,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5027,GO:0010931,1,0.993133102768264,0,1,macrophage tolerance induction,BP,
5028,GO:0010932,1,0.993133102768264,0,1,regulation of macrophage tolerance induction,BP,
5029,GO:0010933,1,0.993133102768264,0,1,positive regulation of macrophage tolerance induction,BP,
5030,GO:0010934,1,0.901096734726942,0,16,macrophage cytokine production,BP,
5031,GO:0010935,1,0.912871706610652,0,14,regulation of macrophage cytokine production,BP,
5032,GO:0010936,1,0.967742874750767,0,5,negative regulation of macrophage cytokine production,BP,
5033,GO:0010938,1,0.99350877773261,0,1,cytoplasmic microtubule depolymerization,BP,
5035,GO:0010940,1,0.943712714420573,0,9,positive regulation of necrotic cell death,BP,
5038,GO:0010944,1,0.942857572666653,0,9,negative regulation of transcription by competitive promoter binding,BP,
5039,GO:0010948,1,0.134196064552381,0,306,negative regulation of cell cycle process,BP,
5040,GO:0010949,1,0.993562850607424,0,1,negative regulation of intestinal phytosterol absorption,BP,
5045,GO:0010955,1,0.838831390497341,0,27,negative regulation of protein processing,BP,
5046,GO:0010956,1,0.980741943332899,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5047,GO:0010957,1,0.968251966507537,0,5,negative regulation of vitamin D biosynthetic process,BP,
5050,GO:0010960,1,0.929519710752907,0,11,magnesium ion homeostasis,BP,
5051,GO:0010961,1,0.967625809767226,0,5,cellular magnesium ion homeostasis,BP,
5052,GO:0010962,1,0.841570249126294,0,26,regulation of glucan biosynthetic process,BP,
5053,GO:0010963,1,0.987252011224745,0,2,regulation of L-arginine import,BP,
5054,GO:0010965,1,0.684378507223626,0,58,regulation of mitotic sister chromatid separation,BP,
5055,GO:0010966,1,0.961473157810066,0,6,regulation of phosphate transport,BP,
5056,GO:0010967,1,0.993626487655239,0,1,regulation of polyamine biosynthetic process,BP,
5057,GO:0010968,1,0.955380242726371,0,7,regulation of microtubule nucleation,BP,
5058,GO:0010970,1,0.368959477133884,0,151,transport along microtubule,BP,
5059,GO:0010971,1,0.844512816332134,0,26,positive regulation of G2/M transition of mitotic cell cycle,BP,
5060,GO:0010972,1,0.577065293394496,0,85,negative regulation of G2/M transition of mitotic cell cycle,BP,
5064,GO:0010979,1,0.98705661418122,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5065,GO:0010980,1,0.98705661418122,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5066,GO:0010982,1,0.98710886743322,0,2,regulation of high-density lipoprotein particle clearance,BP,
5067,GO:0010983,1,0.98710886743322,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5068,GO:0010984,1,0.908067104618945,0,15,regulation of lipoprotein particle clearance,BP,
5069,GO:0010985,1,0.956031167649138,0,7,negative regulation of lipoprotein particle clearance,BP,
5070,GO:0010986,1,0.974490577001237,0,4,positive regulation of lipoprotein particle clearance,BP,
5071,GO:0010988,1,0.937618576569889,0,10,regulation of low-density lipoprotein particle clearance,BP,
5072,GO:0010989,1,0.974400453408606,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5073,GO:0010990,1,0.961461044281762,0,6,regulation of SMAD protein complex assembly,BP,
5074,GO:0010991,1,0.967764011451575,0,5,negative regulation of SMAD protein complex assembly,BP,
5075,GO:0010992,1,0.943248663890208,0,9,ubiquitin recycling,BP,
5076,GO:0010994,1,0.962057578741365,0,6,free ubiquitin chain polymerization,BP,
5077,GO:0010996,1,0.847967325473097,0,25,response to auditory stimulus,BP,
5078,GO:0010997,1,0.955691498081244,0,7,anaphase-promoting complex binding,MF,
5079,GO:0010998,1,0.936810714260208,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5080,GO:0010999,1,0.993458626443647,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5084,GO:0012507,1,0.690446313011438,0,57,ER to Golgi transport vesicle membrane,CC,
5086,GO:0014002,1,0.769180242457218,0,40,astrocyte development,BP,
5088,GO:0014004,1,0.968133288338789,0,5,microglia differentiation,BP,
5089,GO:0014005,1,0.974377938572469,0,4,microglia development,BP,
5090,GO:0014006,1,0.993592799671384,0,1,regulation of microglia differentiation,BP,
5091,GO:0014008,1,0.993592799671384,0,1,positive regulation of microglia differentiation,BP,
5092,GO:0014009,1,0.744974008137084,0,45,glial cell proliferation,BP,
5093,GO:0014010,1,0.954753319959634,0,7,Schwann cell proliferation,BP,
5094,GO:0014011,1,0.99355705431691,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5095,GO:0014012,1,0.961176920276931,0,6,peripheral nervous system axon regeneration,BP,
5099,GO:0014016,1,0.980846809293286,0,3,neuroblast differentiation,BP,
5100,GO:0014017,1,0.99357512678926,0,1,neuroblast fate commitment,BP,
5102,GO:0014022,1,0.980606654751864,0,3,neural plate elongation,BP,
5103,GO:0014028,1,0.980620581195337,0,3,notochord formation,BP,
5104,GO:0014029,1,0.930641751663599,0,11,neural crest formation,BP,
5105,GO:0014031,1,0.57979159042697,0,83,mesenchymal cell development,BP,
5106,GO:0014032,1,0.59545340524226,0,79,neural crest cell development,BP,
5107,GO:0014033,1,0.564484489724979,0,87,neural crest cell differentiation,BP,
5108,GO:0014034,1,0.980737175200618,0,3,neural crest cell fate commitment,BP,
5109,GO:0014036,1,0.987195167801154,0,2,neural crest cell fate specification,BP,
5110,GO:0014037,1,0.776750295518398,0,38,Schwann cell differentiation,BP,
5111,GO:0014038,1,0.973935588357447,0,4,regulation of Schwann cell differentiation,BP,
5112,GO:0014040,1,0.980187356652705,0,3,positive regulation of Schwann cell differentiation,BP,
5113,GO:0014041,1,0.936012907786824,0,10,regulation of neuron maturation,BP,
5114,GO:0014042,1,0.967257885254822,0,5,positive regulation of neuron maturation,BP,
5115,GO:0014043,1,0.980706701111368,0,3,negative regulation of neuron maturation,BP,
5116,GO:0014044,1,0.81862042630014,0,30,Schwann cell development,BP,
5117,GO:0014045,1,0.968239800666352,0,5,establishment of endothelial blood-brain barrier,BP,
5122,GO:0014050,1,0.968222768789831,0,5,negative regulation of glutamate secretion,BP,
5123,GO:0014051,1,0.936062462982455,0,10,gamma-aminobutyric acid secretion,BP,
5124,GO:0014052,1,0.955493476417797,0,7,regulation of gamma-aminobutyric acid secretion,BP,
5125,GO:0014053,1,0.987128487552837,0,2,negative regulation of gamma-aminobutyric acid secretion,BP,
5126,GO:0014054,1,0.974328043103198,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5127,GO:0014055,1,0.980833650138042,0,3,acetylcholine secretion, neurotransmission,BP,
5128,GO:0014056,1,0.980833650138042,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5129,GO:0014057,1,0.98718924125113,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5131,GO:0014060,1,0.96847487575383,0,5,regulation of epinephrine secretion,BP,
5132,GO:0014061,1,0.925483913516651,0,12,regulation of norepinephrine secretion,BP,
5135,GO:0014064,1,0.993453709913066,0,1,positive regulation of serotonin secretion,BP,
5138,GO:0014067,1,0.924794042940279,0,12,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5147,GO:0014705,1,0.993473983378802,0,1,C zone,CC,
5149,GO:0014707,1,0.987224272985807,0,2,branchiomeric skeletal muscle development,BP,
5150,GO:0014717,1,0.987218294830893,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5151,GO:0014718,1,0.987218294830893,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5152,GO:0014719,1,0.961578900185437,0,6,skeletal muscle satellite cell activation,BP,
5153,GO:0014721,1,0.967856217510405,0,5,twitch skeletal muscle contraction,BP,
5154,GO:0014722,1,0.968120415489153,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5155,GO:0014724,1,0.986888593794247,0,2,regulation of twitch skeletal muscle contraction,BP,
5156,GO:0014728,1,0.993330304100628,0,1,regulation of the force of skeletal muscle contraction,BP,
5157,GO:0014731,1,0.946735034224321,0,8,spectrin-associated cytoskeleton,CC,
5158,GO:0014732,1,0.961953075921643,0,6,skeletal muscle atrophy,BP,
5159,GO:0014733,1,0.929831801637377,0,11,regulation of skeletal muscle adaptation,BP,
5160,GO:0014734,1,0.980133347376011,0,3,skeletal muscle hypertrophy,BP,
5161,GO:0014735,1,0.980057648992228,0,3,regulation of muscle atrophy,BP,
5162,GO:0014736,1,0.99308300260054,0,1,negative regulation of muscle atrophy,BP,
5163,GO:0014737,1,0.986884826720443,0,2,positive regulation of muscle atrophy,BP,
5164,GO:0014738,1,0.980941260454337,0,3,regulation of muscle hyperplasia,BP,
5165,GO:0014739,1,0.993696675348725,0,1,positive regulation of muscle hyperplasia,BP,
5166,GO:0014740,1,0.98716448014117,0,2,negative regulation of muscle hyperplasia,BP,
5168,GO:0014742,1,0.8370751607395,0,27,positive regulation of muscle hypertrophy,BP,
5170,GO:0014744,1,0.961222501052355,0,6,positive regulation of muscle adaptation,BP,
5171,GO:0014745,1,0.935843424352937,0,10,negative regulation of muscle adaptation,BP,
5172,GO:0014802,1,0.973497324086305,0,4,terminal cisterna,CC,
5173,GO:0014804,1,0.993608706013666,0,1,terminal cisterna lumen,CC,
5174,GO:0014805,1,0.974784619559233,0,4,smooth muscle adaptation,BP,
5175,GO:0014806,1,0.987252490183138,0,2,smooth muscle hyperplasia,BP,
5176,GO:0014807,1,0.961502304286294,0,6,regulation of somitogenesis,BP,
5178,GO:0014809,1,0.974405652077393,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5179,GO:0014810,1,0.993687199732952,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5181,GO:0014813,1,0.993588792541698,0,1,skeletal muscle satellite cell commitment,BP,
5182,GO:0014816,1,0.942397514608323,0,9,skeletal muscle satellite cell differentiation,BP,
5183,GO:0014819,1,0.924579093819438,0,12,regulation of skeletal muscle contraction,BP,
5184,GO:0014820,1,0.931244636295608,0,11,tonic smooth muscle contraction,BP,
5185,GO:0014821,1,0.884696899952741,0,19,phasic smooth muscle contraction,BP,
5186,GO:0014822,1,0.993569852245708,0,1,detection of wounding,BP,
5188,GO:0014824,1,0.943591056501756,0,9,artery smooth muscle contraction,BP,
5189,GO:0014825,1,0.993685091946878,0,1,stomach fundus smooth muscle contraction,BP,
5190,GO:0014826,1,0.97453968322972,0,4,vein smooth muscle contraction,BP,
5191,GO:0014827,1,0.962034474275287,0,6,intestine smooth muscle contraction,BP,
5192,GO:0014828,1,0.993404495823808,0,1,distal stomach smooth muscle contraction,BP,
5194,GO:0014831,1,0.931215206393761,0,11,gastro-intestinal system smooth muscle contraction,BP,
5195,GO:0014832,1,0.955095261367651,0,7,urinary bladder smooth muscle contraction,BP,
5196,GO:0014834,1,0.97416465172037,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5197,GO:0014835,1,0.993588269144815,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
5198,GO:0014839,1,0.97462293395002,0,4,myoblast migration involved in skeletal muscle regeneration,BP,
5199,GO:0014841,1,0.912427860255612,0,14,skeletal muscle satellite cell proliferation,BP,
5200,GO:0014842,1,0.918695141181345,0,13,regulation of skeletal muscle satellite cell proliferation,BP,
5201,GO:0014843,1,0.993268208057769,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5202,GO:0014846,1,0.986882745879586,0,2,esophagus smooth muscle contraction,BP,
5203,GO:0014847,1,0.993685091946878,0,1,proximal stomach smooth muscle contraction,BP,
5204,GO:0014848,1,0.955095261367651,0,7,urinary tract smooth muscle contraction,BP,
5206,GO:0014852,1,0.993551338364449,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5207,GO:0014853,1,0.993551338364449,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5208,GO:0014854,1,0.917726714833559,0,13,response to inactivity,BP,
5209,GO:0014855,1,0.657314584066758,0,64,striated muscle cell proliferation,BP,
5210,GO:0014856,1,0.906614687988802,0,15,skeletal muscle cell proliferation,BP,
5211,GO:0014857,1,0.91284243876602,0,14,regulation of skeletal muscle cell proliferation,BP,
5212,GO:0014858,1,0.980577030044522,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5213,GO:0014859,1,0.974335973841114,0,4,negative regulation of skeletal muscle cell proliferation,BP,
5214,GO:0014861,1,0.99338835963025,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5215,GO:0014862,1,0.993330304100628,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5216,GO:0014866,1,0.936420971102299,0,8,skeletal myofibril assembly,BP,
5217,GO:0014870,1,0.935606426257648,0,10,response to muscle inactivity,BP,
5218,GO:0014873,1,0.987232755821936,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5219,GO:0014874,1,0.923419603376101,0,12,response to stimulus involved in regulation of muscle adaptation,BP,
5220,GO:0014877,1,0.941677236700891,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5221,GO:0014878,1,0.980677461659229,0,3,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5222,GO:0014883,1,0.961232548922286,0,6,transition between fast and slow fiber,BP,
5223,GO:0014886,1,0.993529684168764,0,1,transition between slow and fast fiber,BP,
5224,GO:0014887,1,0.87071519479244,0,21,cardiac muscle adaptation,BP,
5225,GO:0014888,1,0.764487650192778,0,41,striated muscle adaptation,BP,
5226,GO:0014889,1,0.936633780153102,0,10,muscle atrophy,BP,
5227,GO:0014891,1,0.955754776615414,0,7,striated muscle atrophy,BP,
5228,GO:0014894,1,0.941677236700891,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5229,GO:0014895,1,0.993693386853134,0,1,smooth muscle hypertrophy,BP,
5232,GO:0014898,1,0.87071519479244,0,21,cardiac muscle hypertrophy in response to stress,BP,
5233,GO:0014900,1,0.974697663618316,0,4,muscle hyperplasia,BP,
5234,GO:0014901,1,0.980825474824392,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5235,GO:0014902,1,0.543242263216709,0,93,myotube differentiation,BP,
5236,GO:0014904,1,0.827064563020149,0,29,myotube cell development,BP,
5237,GO:0014905,1,0.980742301332008,0,3,myoblast fusion involved in skeletal muscle regeneration,BP,
5238,GO:0014908,1,0.961694591686034,0,6,myotube differentiation involved in skeletal muscle regeneration,BP,
5242,GO:0014912,1,0.871035335481641,0,21,negative regulation of smooth muscle cell migration,BP,
5243,GO:0014916,1,0.973418658199894,0,4,regulation of lung blood pressure,BP,
5244,GO:0015002,1,0.87496583004443,0,21,heme-copper terminal oxidase activity,MF,
5245,GO:0015012,1,0.842909449489834,0,26,heparan sulfate proteoglycan biosynthetic process,BP,
5246,GO:0015014,1,0.948685568862921,0,8,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5247,GO:0015015,1,0.961395373861707,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5248,GO:0015016,1,0.973766283673341,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5249,GO:0015018,1,0.980889138891881,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5250,GO:0015019,1,0.993401088710608,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5251,GO:0015020,1,0.913198234761775,0,14,glucuronosyltransferase activity,MF,
5252,GO:0015026,1,0.759283634887439,0,42,coreceptor activity,MF,
5253,GO:0015030,1,0.699990512042806,0,55,Cajal body,CC,
5255,GO:0015035,1,0.890709749895951,0,18,protein disulfide oxidoreductase activity,MF,
5256,GO:0015036,1,0.793286083097808,0,36,disulfide oxidoreductase activity,MF,
5257,GO:0015037,1,0.920136797585654,0,13,peptide disulfide oxidoreductase activity,MF,
5258,GO:0015038,1,0.968640098201109,0,5,glutathione disulfide oxidoreductase activity,MF,
5259,GO:0015039,1,0.993612998811935,0,1,NADPH-adrenodoxin reductase activity,MF,
5260,GO:0015052,1,0.993564735337408,0,1,beta3-adrenergic receptor activity,MF,
5261,GO:0015054,1,0.993598225889756,0,1,gastrin receptor activity,MF,
5262,GO:0015056,1,0.987236406509795,0,2,corticotrophin-releasing factor receptor activity,MF,
5263,GO:0015057,1,0.968117085378556,0,5,thrombin-activated receptor activity,MF,
5264,GO:0015067,1,0.993567991305384,0,1,amidinotransferase activity,MF,
5265,GO:0015068,1,0.993567991305384,0,1,glycine amidinotransferase activity,MF,
5266,GO:0015074,1,0.936677306505343,0,10,DNA integration,BP,
5269,GO:0015078,1,0.557397349980589,0,90,proton transmembrane transporter activity,MF,
5273,GO:0015086,1,0.974200783873519,0,4,cadmium ion transmembrane transporter activity,MF,
5274,GO:0015087,1,0.980644183077389,0,3,cobalt ion transmembrane transporter activity,MF,
5275,GO:0015093,1,0.974206125174811,0,4,ferrous iron transmembrane transporter activity,MF,
5276,GO:0015094,1,0.993478636411314,0,1,lead ion transmembrane transporter activity,MF,
5277,GO:0015095,1,0.906776100363004,0,15,magnesium ion transmembrane transporter activity,MF,
5278,GO:0015098,1,0.993612965250343,0,1,molybdate ion transmembrane transporter activity,MF,
5279,GO:0015099,1,0.993478636411314,0,1,nickel cation transmembrane transporter activity,MF,
5280,GO:0015101,1,0.861529507697962,0,23,organic cation transmembrane transporter activity,MF,
5282,GO:0015106,1,0.882181155608966,0,19,bicarbonate transmembrane transporter activity,MF,
5284,GO:0015111,1,0.980538412668424,0,3,iodide transmembrane transporter activity,MF,
5285,GO:0015112,1,0.993564003992181,0,1,nitrate transmembrane transporter activity,MF,
5286,GO:0015114,1,0.961020254838234,0,6,phosphate ion transmembrane transporter activity,MF,
5287,GO:0015116,1,0.912876279780284,0,14,sulfate transmembrane transporter activity,MF,
5288,GO:0015117,1,0.974618507925107,0,4,thiosulfate transmembrane transporter activity,MF,
5289,GO:0015119,1,0.980738922838941,0,3,hexose phosphate transmembrane transporter activity,MF,
5290,GO:0015125,1,0.913194566836509,0,14,bile acid transmembrane transporter activity,MF,
5291,GO:0015126,1,0.993434784661427,0,1,canalicular bile acid transmembrane transporter activity,MF,
5292,GO:0015127,1,0.99341300588565,0,1,bilirubin transmembrane transporter activity,MF,
5293,GO:0015129,1,0.967940779051765,0,5,lactate transmembrane transporter activity,MF,
5294,GO:0015130,1,0.99348063536873,0,1,mevalonate transmembrane transporter activity,MF,
5295,GO:0015131,1,0.974618507925107,0,4,oxaloacetate transmembrane transporter activity,MF,
5296,GO:0015132,1,0.993474962251865,0,1,prostaglandin transmembrane transporter activity,MF,
5297,GO:0015136,1,0.987194141723599,0,2,sialic acid transmembrane transporter activity,MF,
5298,GO:0015137,1,0.974378020525168,0,4,citrate transmembrane transporter activity,MF,
5299,GO:0015139,1,0.980781117309098,0,3,alpha-ketoglutarate transmembrane transporter activity,MF,
5300,GO:0015140,1,0.974618507925107,0,4,malate transmembrane transporter activity,MF,
5301,GO:0015141,1,0.962003064218483,0,6,succinate transmembrane transporter activity,MF,
5302,GO:0015142,1,0.974378020525168,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5303,GO:0015143,1,0.980824922652278,0,3,urate transmembrane transporter activity,MF,
5306,GO:0015146,1,0.986274416241217,0,2,pentose transmembrane transporter activity,MF,
5308,GO:0015150,1,0.986274416241217,0,2,fucose transmembrane transporter activity,MF,
5309,GO:0015151,1,0.987054398128912,0,2,alpha-glucoside transmembrane transporter activity,MF,
5310,GO:0015152,1,0.993599023222853,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5311,GO:0015154,1,0.974462931665959,0,4,disaccharide transmembrane transporter activity,MF,
5312,GO:0015157,1,0.974462931665959,0,4,oligosaccharide transmembrane transporter activity,MF,
5313,GO:0015165,1,0.937212631055234,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5315,GO:0015168,1,0.962240403042951,0,6,glycerol transmembrane transporter activity,MF,
5318,GO:0015173,1,0.937051909379018,0,10,aromatic amino acid transmembrane transporter activity,MF,
5319,GO:0015174,1,0.912741263965049,0,14,basic amino acid transmembrane transporter activity,MF,
5320,GO:0015175,1,0.822144619799096,0,30,neutral amino acid transmembrane transporter activity,MF,
5322,GO:0015180,1,0.95549340543377,0,7,L-alanine transmembrane transporter activity,MF,
5323,GO:0015181,1,0.955134396148662,0,7,arginine transmembrane transporter activity,MF,
5324,GO:0015182,1,0.980860576088632,0,3,L-asparagine transmembrane transporter activity,MF,
5325,GO:0015183,1,0.94340788323488,0,9,L-aspartate transmembrane transporter activity,MF,
5326,GO:0015184,1,0.980692319395235,0,3,L-cystine transmembrane transporter activity,MF,
5327,GO:0015185,1,0.955514877279977,0,7,gamma-aminobutyric acid transmembrane transporter activity,MF,
5328,GO:0015186,1,0.949151631872141,0,8,L-glutamine transmembrane transporter activity,MF,
5329,GO:0015187,1,0.955579629027911,0,7,glycine transmembrane transporter activity,MF,
5330,GO:0015188,1,0.99338835963025,0,1,L-isoleucine transmembrane transporter activity,MF,
5331,GO:0015189,1,0.973842385170511,0,4,L-lysine transmembrane transporter activity,MF,
5332,GO:0015190,1,0.968088095541935,0,5,L-leucine transmembrane transporter activity,MF,
5333,GO:0015191,1,0.993556407202904,0,1,L-methionine transmembrane transporter activity,MF,
5334,GO:0015193,1,0.967713529921252,0,5,L-proline transmembrane transporter activity,MF,
5335,GO:0015194,1,0.955681422813079,0,7,L-serine transmembrane transporter activity,MF,
5336,GO:0015195,1,0.993470052424229,0,1,L-threonine transmembrane transporter activity,MF,
5337,GO:0015196,1,0.987070366645416,0,2,L-tryptophan transmembrane transporter activity,MF,
5338,GO:0015199,1,0.99338835963025,0,1,amino-acid betaine transmembrane transporter activity,MF,
5339,GO:0015204,1,0.96200859660048,0,6,urea transmembrane transporter activity,MF,
5340,GO:0015205,1,0.955545124069436,0,7,nucleobase transmembrane transporter activity,MF,
5341,GO:0015207,1,0.987153221227735,0,2,adenine transmembrane transporter activity,MF,
5342,GO:0015211,1,0.987197289825744,0,2,purine nucleoside transmembrane transporter activity,MF,
5343,GO:0015212,1,0.993603320630034,0,1,cytidine transmembrane transporter activity,MF,
5344,GO:0015213,1,0.974594358081872,0,4,uridine transmembrane transporter activity,MF,
5345,GO:0015214,1,0.974594358081872,0,4,pyrimidine nucleoside transmembrane transporter activity,MF,
5346,GO:0015215,1,0.818344826388947,0,31,nucleotide transmembrane transporter activity,MF,
5347,GO:0015216,1,0.82895417264261,0,29,purine nucleotide transmembrane transporter activity,MF,
5348,GO:0015217,1,0.987166187237356,0,2,ADP transmembrane transporter activity,MF,
5349,GO:0015218,1,0.987128423034646,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5350,GO:0015220,1,0.9743592383669,0,4,choline transmembrane transporter activity,MF,
5351,GO:0015225,1,0.980627806630077,0,3,biotin transmembrane transporter activity,MF,
5352,GO:0015226,1,0.980852237328591,0,3,carnitine transmembrane transporter activity,MF,
5353,GO:0015227,1,0.974561698792962,0,4,acyl carnitine transmembrane transporter activity,MF,
5354,GO:0015228,1,0.987166187237356,0,2,coenzyme A transmembrane transporter activity,MF,
5355,GO:0015229,1,0.986876344920053,0,2,L-ascorbic acid transmembrane transporter activity,MF,
5356,GO:0015230,1,0.987172117747167,0,2,FAD transmembrane transporter activity,MF,
5357,GO:0015232,1,0.943280873215097,0,9,heme transmembrane transporter activity,MF,
5358,GO:0015233,1,0.993527540196377,0,1,pantothenate transmembrane transporter activity,MF,
5359,GO:0015234,1,0.980766136873752,0,3,thiamine transmembrane transporter activity,MF,
5360,GO:0015245,1,0.955789533227365,0,7,fatty acid transmembrane transporter activity,MF,
5361,GO:0015247,1,0.973940431688119,0,4,aminophospholipid flippase activity,MF,
5362,GO:0015248,1,0.821552339943705,0,30,sterol transporter activity,MF,
5363,GO:0015250,1,0.937637078539502,0,10,water channel activity,MF,
5364,GO:0015252,1,0.974638952824153,0,4,proton channel activity,MF,
5365,GO:0015254,1,0.968481352680927,0,5,glycerol channel activity,MF,
5366,GO:0015265,1,0.987067685213315,0,2,urea channel activity,MF,
5368,GO:0015269,1,0.93747085373733,0,10,calcium-activated potassium channel activity,MF,
5369,GO:0015271,1,0.924609726631772,0,12,outward rectifier potassium channel activity,MF,
5370,GO:0015272,1,0.961632621769364,0,6,ATP-activated inward rectifier potassium channel activity,MF,
5371,GO:0015275,1,0.980646461611439,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5373,GO:0015277,1,0.967498313171783,0,5,kainate selective glutamate receptor activity,MF,
5375,GO:0015279,1,0.942307341822384,0,9,store-operated calcium channel activity,MF,
5377,GO:0015288,1,0.968491224150519,0,5,porin activity,MF,
5379,GO:0015292,1,0.99355705431691,0,1,uniporter activity,MF,
5382,GO:0015295,1,0.901080350203444,0,16,solute:proton symporter activity,MF,
5383,GO:0015296,1,0.876964729952182,0,20,anion:cation symporter activity,MF,
5386,GO:0015299,1,0.888339959248385,0,18,solute:proton antiporter activity,MF,
5387,GO:0015301,1,0.848951115119936,0,25,anion:anion antiporter activity,MF,
5388,GO:0015315,1,0.980738922838941,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5389,GO:0015317,1,0.993627425314698,0,1,phosphate:proton symporter activity,MF,
5392,GO:0015322,1,0.993505803079024,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5393,GO:0015327,1,0.992997617862815,0,1,cystine:glutamate antiporter activity,MF,
5394,GO:0015328,1,0.992997617862815,0,1,cystine secondary active transmembrane transporter activity,MF,
5395,GO:0015333,1,0.993379027530122,0,1,peptide:proton symporter activity,MF,
5396,GO:0015343,1,0.99355705431691,0,1,siderophore transmembrane transporter activity,MF,
5397,GO:0015347,1,0.924658975601609,0,12,sodium-independent organic anion transmembrane transporter activity,MF,
5398,GO:0015349,1,0.961681239227484,0,6,thyroid hormone transmembrane transporter activity,MF,
5399,GO:0015350,1,0.986889108373994,0,2,methotrexate transmembrane transporter activity,MF,
5400,GO:0015355,1,0.931496212782486,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5401,GO:0015362,1,0.993485455304034,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5402,GO:0015367,1,0.993620921871391,0,1,oxoglutarate:malate antiporter activity,MF,
5404,GO:0015369,1,0.993381035769376,0,1,calcium:proton antiporter activity,MF,
5406,GO:0015373,1,0.924550496957467,0,12,anion:sodium symporter activity,MF,
5407,GO:0015375,1,0.987124398532198,0,2,glycine:sodium symporter activity,MF,
5408,GO:0015377,1,0.900135533313334,0,16,cation:chloride symporter activity,MF,
5409,GO:0015378,1,0.93663757106684,0,10,sodium:chloride symporter activity,MF,
5410,GO:0015379,1,0.948307210000153,0,8,potassium:chloride symporter activity,MF,
5411,GO:0015382,1,0.99354954696155,0,1,sodium:sulfate symporter activity,MF,
5412,GO:0015385,1,0.930614285580952,0,11,sodium:proton antiporter activity,MF,
5413,GO:0015386,1,0.936653028170355,0,10,potassium:proton antiporter activity,MF,
5414,GO:0015389,1,0.987235258621901,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5415,GO:0015390,1,0.993591351297065,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5416,GO:0015391,1,0.987235258621901,0,2,nucleobase:cation symporter activity,MF,
5417,GO:0015399,1,0.517280421721148,0,100,primary active transmembrane transporter activity,MF,
5418,GO:0015410,1,0.980660328124717,0,3,manganese transmembrane transporter activity, phosphorylative mechanism,MF,
5419,GO:0015420,1,0.980670424651463,0,3,ATPase-coupled vitamin B12 transmembrane transporter activity,MF,
5420,GO:0015431,1,0.993300263107567,0,1,ATPase-coupled glutathione S-conjugate transmembrane transporter activity,MF,
5421,GO:0015432,1,0.98699197972332,0,2,ATPase-coupled bile acid transmembrane transporter activity,MF,
5422,GO:0015433,1,0.974314852588397,0,4,ATPase-coupled peptide antigen transmembrane transporter activity,MF,
5423,GO:0015439,1,0.99354467960849,0,1,ATPase-coupled heme transmembrane transporter activity,MF,
5424,GO:0015440,1,0.974314852588397,0,4,ATPase-coupled peptide transmembrane transporter activity,MF,
5425,GO:0015450,1,0.968489611066937,0,5,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5426,GO:0015459,1,0.716121227629562,0,51,potassium channel regulator activity,MF,
5427,GO:0015464,1,0.889978694145559,0,18,acetylcholine receptor activity,MF,
5428,GO:0015467,1,0.974462695796026,0,4,G-protein activated inward rectifier potassium channel activity,MF,
5429,GO:0015485,1,0.760692919873254,0,42,cholesterol binding,MF,
5431,GO:0015495,1,0.993568982242165,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5432,GO:0015499,1,0.993563851908475,0,1,formate transmembrane transporter activity,MF,
5433,GO:0015501,1,0.973655828465509,0,4,glutamate:sodium symporter activity,MF,
5434,GO:0015526,1,0.980738922838941,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5435,GO:0015538,1,0.993526773574863,0,1,sialic acid:proton symporter activity,MF,
5436,GO:0015556,1,0.90754078268403,0,15,C4-dicarboxylate transmembrane transporter activity,MF,
5437,GO:0015562,1,0.918380401337901,0,13,efflux transmembrane transporter activity,MF,
5438,GO:0015605,1,0.792255154338802,0,36,organophosphate ester transmembrane transporter activity,MF,
5439,GO:0015607,1,0.993508125535763,0,1,ATPase-coupled fatty-acyl-CoA transmembrane transporter activity,MF,
5440,GO:0015616,1,0.967051413309443,0,5,DNA translocase activity,MF,
5444,GO:0015633,1,0.993599821289346,0,1,ATPase-coupled zinc transmembrane transporter activity,MF,
5445,GO:0015636,1,0.987227583679254,0,2,short-chain fatty acid transmembrane transporter activity,MF,
5446,GO:0015643,1,0.93747395166988,0,10,toxic substance binding,MF,
5447,GO:0015645,1,0.88423332515923,0,19,fatty acid ligase activity,MF,
5448,GO:0015651,1,0.937246810393244,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5449,GO:0015658,1,0.955441837682949,0,7,branched-chain amino acid transmembrane transporter activity,MF,
5450,GO:0015660,1,0.993563851908475,0,1,formate efflux transmembrane transporter activity,MF,
5451,GO:0015662,1,0.810556321550927,0,32,ion transmembrane transporter activity, phosphorylative mechanism,MF,
5452,GO:0015665,1,0.980966110212822,0,3,alcohol transmembrane transporter activity,MF,
5453,GO:0015669,1,0.891330424074061,0,18,gas transport,BP,
5454,GO:0015670,1,0.974611561401618,0,4,carbon dioxide transport,BP,
5455,GO:0015671,1,0.914570422603779,0,14,oxygen transport,BP,
5457,GO:0015675,1,0.993478636411314,0,1,nickel cation transport,BP,
5458,GO:0015677,1,0.960731232643754,0,6,copper ion import,BP,
5459,GO:0015679,1,0.993436372167868,0,1,plasma membrane copper ion transport,BP,
5460,GO:0015680,1,0.987018436398764,0,2,protein maturation by copper ion transfer,BP,
5461,GO:0015689,1,0.993612965250343,0,1,molybdate ion transport,BP,
5462,GO:0015691,1,0.967969300370395,0,5,cadmium ion transport,BP,
5463,GO:0015692,1,0.993478636411314,0,1,lead ion transport,BP,
5464,GO:0015693,1,0.900774972712189,0,16,magnesium ion transport,BP,
5465,GO:0015694,1,0.99341300588565,0,1,mercury ion transport,BP,
5467,GO:0015696,1,0.948847178051162,0,8,ammonium transport,BP,
5468,GO:0015697,1,0.919176280393735,0,13,quaternary ammonium group transport,BP,
5471,GO:0015705,1,0.967043728206282,0,5,iodide transport,BP,
5472,GO:0015706,1,0.993564003992181,0,1,nitrate transport,BP,
5473,GO:0015707,1,0.993497443542082,0,1,nitrite transport,BP,
5474,GO:0015709,1,0.974618507925107,0,4,thiosulfate transport,BP,
5476,GO:0015712,1,0.962020020267144,0,6,hexose phosphate transport,BP,
5477,GO:0015718,1,0.382860549906079,0,147,monocarboxylic acid transport,BP,
5478,GO:0015721,1,0.855248823317094,0,24,bile acid and bile salt transport,BP,
5479,GO:0015722,1,0.974157256561494,0,4,canalicular bile acid transport,BP,
5480,GO:0015723,1,0.99341300588565,0,1,bilirubin transport,BP,
5481,GO:0015724,1,0.993563851908475,0,1,formate transport,BP,
5482,GO:0015727,1,0.96161770312529,0,6,lactate transport,BP,
5483,GO:0015728,1,0.99348063536873,0,1,mevalonate transport,BP,
5484,GO:0015729,1,0.974618507925107,0,4,oxaloacetate transport,BP,
5485,GO:0015732,1,0.919211772765901,0,13,prostaglandin transport,BP,
5486,GO:0015734,1,0.961077992317961,0,6,taurine transport,BP,
5487,GO:0015739,1,0.97463897469447,0,4,sialic acid transport,BP,
5488,GO:0015740,1,0.854575234533019,0,24,C4-dicarboxylate transport,BP,
5489,GO:0015742,1,0.974501456591535,0,4,alpha-ketoglutarate transport,BP,
5490,GO:0015743,1,0.974618507925107,0,4,malate transport,BP,
5491,GO:0015744,1,0.962003064218483,0,6,succinate transport,BP,
5492,GO:0015746,1,0.974378020525168,0,4,citrate transport,BP,
5493,GO:0015747,1,0.974516429023135,0,4,urate transport,BP,
5496,GO:0015750,1,0.986274416241217,0,2,pentose transmembrane transport,BP,
5497,GO:0015755,1,0.974524234557096,0,4,fructose transmembrane transport,BP,
5498,GO:0015756,1,0.986274416241217,0,2,fucose transmembrane transport,BP,
5499,GO:0015757,1,0.986942478608109,0,2,galactose transmembrane transport,BP,
5500,GO:0015760,1,0.962020020267144,0,6,glucose-6-phosphate transport,BP,
5501,GO:0015766,1,0.974462931665959,0,4,disaccharide transport,BP,
5502,GO:0015770,1,0.974462931665959,0,4,sucrose transport,BP,
5503,GO:0015772,1,0.974462931665959,0,4,oligosaccharide transport,BP,
5504,GO:0015774,1,0.993397417507683,0,1,polysaccharide transport,BP,
5505,GO:0015780,1,0.925172775115818,0,12,nucleotide-sugar transmembrane transport,BP,
5506,GO:0015782,1,0.993618639207036,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5507,GO:0015783,1,0.993532499008885,0,1,GDP-fucose transmembrane transport,BP,
5508,GO:0015786,1,0.987288768276619,0,2,UDP-glucose transmembrane transport,BP,
5509,GO:0015787,1,0.980633959859824,0,3,UDP-glucuronic acid transmembrane transport,BP,
5510,GO:0015789,1,0.980633959859824,0,3,UDP-N-acetylgalactosamine transmembrane transport,BP,
5511,GO:0015790,1,0.9932640242992,0,1,UDP-xylose transmembrane transport,BP,
5513,GO:0015793,1,0.962240403042951,0,6,glycerol transport,BP,
5514,GO:0015797,1,0.993563851908475,0,1,mannitol transport,BP,
5517,GO:0015801,1,0.918983097810495,0,13,aromatic amino acid transport,BP,
5518,GO:0015802,1,0.901047369004532,0,16,basic amino acid transport,BP,
5519,GO:0015803,1,0.924679567253297,0,12,branched-chain amino acid transport,BP,
5521,GO:0015805,1,0.993591022606845,0,1,S-adenosyl-L-methionine transport,BP,
5523,GO:0015808,1,0.949381361432678,0,8,L-alanine transport,BP,
5524,GO:0015809,1,0.930829845191773,0,11,arginine transport,BP,
5525,GO:0015810,1,0.94299751252239,0,9,aspartate transmembrane transport,BP,
5526,GO:0015811,1,0.980692319395235,0,3,L-cystine transport,BP,
5527,GO:0015812,1,0.900292080952708,0,16,gamma-aminobutyric acid transport,BP,
5530,GO:0015817,1,0.987172515713419,0,2,histidine transport,BP,
5531,GO:0015818,1,0.99338835963025,0,1,isoleucine transport,BP,
5532,GO:0015819,1,0.993216227320241,0,1,lysine transport,BP,
5533,GO:0015820,1,0.949107820277572,0,8,leucine transport,BP,
5534,GO:0015821,1,0.993556407202904,0,1,methionine transport,BP,
5535,GO:0015822,1,0.954914002341886,0,7,ornithine transport,BP,
5536,GO:0015823,1,0.987083499056468,0,2,phenylalanine transport,BP,
5537,GO:0015824,1,0.942588244815409,0,9,proline transport,BP,
5538,GO:0015825,1,0.955681422813079,0,7,L-serine transport,BP,
5539,GO:0015826,1,0.993470052424229,0,1,threonine transport,BP,
5540,GO:0015827,1,0.968053392508452,0,5,tryptophan transport,BP,
5541,GO:0015828,1,0.993535489730704,0,1,tyrosine transport,BP,
5542,GO:0015829,1,0.993507880574595,0,1,valine transport,BP,
5545,GO:0015838,1,0.961761986576966,0,6,amino-acid betaine transport,BP,
5546,GO:0015840,1,0.955928115047138,0,7,urea transport,BP,
5547,GO:0015842,1,0.974624647879509,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5549,GO:0015846,1,0.955909103822849,0,7,polyamine transport,BP,
5552,GO:0015851,1,0.943362755384756,0,9,nucleobase transport,BP,
5553,GO:0015853,1,0.974571946091286,0,4,adenine transport,BP,
5554,GO:0015854,1,0.993572164320609,0,1,guanine transport,BP,
5555,GO:0015855,1,0.974553545179502,0,4,pyrimidine nucleobase transport,BP,
5556,GO:0015858,1,0.949788865399005,0,8,nucleoside transport,BP,
5557,GO:0015860,1,0.980869876468046,0,3,purine nucleoside transmembrane transport,BP,
5558,GO:0015861,1,0.993603320630034,0,1,cytidine transport,BP,
5559,GO:0015862,1,0.974594358081872,0,4,uridine transport,BP,
5560,GO:0015864,1,0.974594358081872,0,4,pyrimidine nucleoside transport,BP,
5562,GO:0015866,1,0.980711607187463,0,3,ADP transport,BP,
5563,GO:0015867,1,0.845233802011823,0,26,ATP transport,BP,
5565,GO:0015870,1,0.97452014920907,0,4,acetylcholine transport,BP,
5566,GO:0015871,1,0.961445795190418,0,6,choline transport,BP,
5569,GO:0015876,1,0.993563578402913,0,1,acetyl-CoA transport,BP,
5570,GO:0015878,1,0.980627806630077,0,3,biotin transport,BP,
5571,GO:0015879,1,0.974572288733496,0,4,carnitine transport,BP,
5572,GO:0015880,1,0.987166187237356,0,2,coenzyme A transport,BP,
5573,GO:0015881,1,0.980680258340544,0,3,creatine transmembrane transport,BP,
5574,GO:0015882,1,0.986876344920053,0,2,L-ascorbic acid transmembrane transport,BP,
5575,GO:0015883,1,0.987172117747167,0,2,FAD transport,BP,
5577,GO:0015886,1,0.943280873215097,0,9,heme transport,BP,
5578,GO:0015887,1,0.993527540196377,0,1,pantothenate transmembrane transport,BP,
5579,GO:0015888,1,0.974438803923061,0,4,thiamine transport,BP,
5580,GO:0015889,1,0.955062094290103,0,7,cobalamin transport,BP,
5581,GO:0015891,1,0.980956785817154,0,3,siderophore transport,BP,
5582,GO:0015893,1,0.936447240558213,0,10,drug transport,BP,
5583,GO:0015904,1,0.993615315099758,0,1,tetracycline transmembrane transport,BP,
5584,GO:0015908,1,0.590296012757834,0,81,fatty acid transport,BP,
5585,GO:0015909,1,0.668524119310224,0,62,long-chain fatty acid transport,BP,
5586,GO:0015910,1,0.974273143925571,0,4,long-chain fatty acid import into peroxisome,BP,
5587,GO:0015911,1,0.948848568421911,0,8,long-chain fatty acid import across plasma membrane,BP,
5588,GO:0015912,1,0.987227583679254,0,2,short-chain fatty acid transport,BP,
5589,GO:0015913,1,0.993585595183978,0,1,short-chain fatty acid import,BP,
5590,GO:0015914,1,0.611227283249991,0,75,phospholipid transport,BP,
5591,GO:0015916,1,0.987113073200532,0,2,fatty-acyl-CoA transport,BP,
5592,GO:0015917,1,0.97383136579432,0,4,aminophospholipid transport,BP,
5593,GO:0015918,1,0.56538474322728,0,87,sterol transport,BP,
5594,GO:0015919,1,0.878126077105402,0,20,peroxisomal membrane transport,BP,
5595,GO:0015920,1,0.987220170687612,0,2,lipopolysaccharide transport,BP,
5596,GO:0015922,1,0.993631707608,0,1,aspartate oxidase activity,MF,
5597,GO:0015923,1,0.906290619303649,0,15,mannosidase activity,MF,
5598,GO:0015924,1,0.942406348749975,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5599,GO:0015925,1,0.949689163491218,0,8,galactosidase activity,MF,
5600,GO:0015926,1,0.93053925980509,0,11,glucosidase activity,MF,
5601,GO:0015928,1,0.987238612398019,0,2,fucosidase activity,MF,
5602,GO:0015929,1,0.931509297160444,0,11,hexosaminidase activity,MF,
5604,GO:0015932,1,0.718688045333855,0,51,nucleobase-containing compound transmembrane transporter activity,MF,
5605,GO:0015934,1,0.495263213732675,0,110,large ribosomal subunit,CC,
5606,GO:0015935,1,0.639345263946894,0,70,small ribosomal subunit,CC,
5607,GO:0015936,1,0.90775499085876,0,15,coenzyme A metabolic process,BP,
5608,GO:0015937,1,0.937740412373784,0,10,coenzyme A biosynthetic process,BP,
5609,GO:0015938,1,0.993672096321179,0,1,coenzyme A catabolic process,BP,
5610,GO:0015939,1,0.955934335342266,0,7,pantothenate metabolic process,BP,
5611,GO:0015942,1,0.962068451822429,0,6,formate metabolic process,BP,
5613,GO:0015959,1,0.96205238019927,0,6,diadenosine polyphosphate metabolic process,BP,
5614,GO:0015960,1,0.993505995122584,0,1,diadenosine polyphosphate biosynthetic process,BP,
5615,GO:0015961,1,0.968342820002704,0,5,diadenosine polyphosphate catabolic process,BP,
5616,GO:0015962,1,0.993667039658787,0,1,diadenosine triphosphate metabolic process,BP,
5617,GO:0015964,1,0.993667039658787,0,1,diadenosine triphosphate catabolic process,BP,
5618,GO:0015965,1,0.993505995122584,0,1,diadenosine tetraphosphate metabolic process,BP,
5619,GO:0015966,1,0.993505995122584,0,1,diadenosine tetraphosphate biosynthetic process,BP,
5621,GO:0015985,1,0.968546774132351,0,5,energy coupled proton transport, down electrochemical gradient,BP,
5622,GO:0015986,1,0.968546774132351,0,5,ATP synthesis coupled proton transport,BP,
5623,GO:0015988,1,0.993686804584947,0,1,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5624,GO:0015990,1,0.993686804584947,0,1,electron transport coupled proton transport,BP,
5625,GO:0016004,1,0.93718510009106,0,10,phospholipase activator activity,MF,
5626,GO:0016005,1,0.987031916799431,0,2,phospholipase A2 activator activity,MF,
5627,GO:0016010,1,0.882382672203219,0,19,dystrophin-associated glycoprotein complex,CC,
5628,GO:0016011,1,0.955202542889528,0,7,dystroglycan complex,CC,
5629,GO:0016012,1,0.961588499022305,0,6,sarcoglycan complex,CC,
5630,GO:0016013,1,0.97427145609715,0,4,syntrophin complex,CC,
5632,GO:0016018,1,0.919574517021746,0,13,cyclosporin A binding,MF,
5633,GO:0016019,1,0.987349696303231,0,2,peptidoglycan immune receptor activity,MF,
5636,GO:0016024,1,0.9302166057262,0,11,CDP-diacylglycerol biosynthetic process,BP,
5637,GO:0016028,1,0.993509699201877,0,1,rhabdomere,CC,
5638,GO:0016031,1,0.993523392537954,0,1,tRNA import into mitochondrion,BP,
5640,GO:0016034,1,0.993650434744294,0,1,maleylacetoacetate isomerase activity,MF,
5641,GO:0016035,1,0.973956317559259,0,4,zeta DNA polymerase complex,CC,
5642,GO:0016036,1,0.986750290930517,0,2,cellular response to phosphate starvation,BP,
5643,GO:0016037,1,0.993557172205026,0,1,light absorption,BP,
5644,GO:0016038,1,0.993557172205026,0,1,absorption of visible light,BP,
5647,GO:0016045,1,0.912616993200884,0,14,detection of bacterium,BP,
5648,GO:0016046,1,0.986986530518428,0,2,detection of fungus,BP,
5649,GO:0016048,1,0.866633911421454,0,22,detection of temperature stimulus,BP,
5653,GO:0016052,1,0.308517094175954,0,179,carbohydrate catabolic process,BP,
5657,GO:0016056,1,0.855916806838088,0,24,rhodopsin mediated signaling pathway,BP,
5658,GO:0016064,1,0.51565158458374,0,102,immunoglobulin mediated immune response,BP,
5659,GO:0016068,1,0.981018253002993,0,3,type I hypersensitivity,BP,
5661,GO:0016071,1,0.00524220856958543,0,789,mRNA metabolic process,BP,
5662,GO:0016072,1,0.247992848655494,0,214,rRNA metabolic process,BP,
5663,GO:0016073,1,0.807786600718777,0,33,snRNA metabolic process,BP,
5664,GO:0016074,1,0.919737762055882,0,13,snoRNA metabolic process,BP,
5665,GO:0016075,1,0.883660206339059,0,19,rRNA catabolic process,BP,
5666,GO:0016076,1,0.980841431779898,0,3,snRNA catabolic process,BP,
5667,GO:0016077,1,0.986931987041807,0,2,snoRNA catabolic process,BP,
5668,GO:0016078,1,0.930743933612885,0,11,tRNA catabolic process,BP,
5670,GO:0016080,1,0.980285389143149,0,3,synaptic vesicle targeting,BP,
5671,GO:0016081,1,0.929871687189087,0,11,synaptic vesicle docking,BP,
5673,GO:0016093,1,0.949843939524877,0,8,polyprenol metabolic process,BP,
5674,GO:0016094,1,0.980650528087594,0,3,polyprenol biosynthetic process,BP,
5675,GO:0016095,1,0.980975139882866,0,3,polyprenol catabolic process,BP,
5676,GO:0016098,1,0.987302368334911,0,2,monoterpenoid metabolic process,BP,
5678,GO:0016102,1,0.943664248154491,0,9,diterpenoid biosynthetic process,BP,
5679,GO:0016103,1,0.974614285742773,0,4,diterpenoid catabolic process,BP,
5680,GO:0016104,1,0.993473098184963,0,1,triterpenoid biosynthetic process,BP,
5681,GO:0016107,1,0.987330825123749,0,2,sesquiterpenoid catabolic process,BP,
5682,GO:0016108,1,0.980798127878863,0,3,tetraterpenoid metabolic process,BP,
5683,GO:0016109,1,0.993566204593089,0,1,tetraterpenoid biosynthetic process,BP,
5684,GO:0016114,1,0.907731239645743,0,15,terpenoid biosynthetic process,BP,
5685,GO:0016115,1,0.96226357118173,0,6,terpenoid catabolic process,BP,
5686,GO:0016116,1,0.980798127878863,0,3,carotenoid metabolic process,BP,
5687,GO:0016117,1,0.993566204593089,0,1,carotenoid biosynthetic process,BP,
5688,GO:0016119,1,0.987150068329575,0,2,carotene metabolic process,BP,
5689,GO:0016121,1,0.987150068329575,0,2,carotene catabolic process,BP,
5690,GO:0016122,1,0.987159160186186,0,2,xanthophyll metabolic process,BP,
5691,GO:0016123,1,0.993566204593089,0,1,xanthophyll biosynthetic process,BP,
5694,GO:0016127,1,0.943841926872538,0,9,sterol catabolic process,BP,
5695,GO:0016128,1,0.993563851908475,0,1,phytosteroid metabolic process,BP,
5696,GO:0016129,1,0.993563851908475,0,1,phytosteroid biosynthetic process,BP,
5697,GO:0016131,1,0.993563851908475,0,1,brassinosteroid metabolic process,BP,
5698,GO:0016132,1,0.993563851908475,0,1,brassinosteroid biosynthetic process,BP,
5699,GO:0016137,1,0.885203605515551,0,19,glycoside metabolic process,BP,
5700,GO:0016139,1,0.943664099742386,0,9,glycoside catabolic process,BP,
5701,GO:0016149,1,0.993506925863602,0,1,translation release factor activity, codon specific,MF,
5702,GO:0016151,1,0.993622867835704,0,1,nickel cation binding,MF,
5703,GO:0016153,1,0.99352405280035,0,1,urocanate hydratase activity,MF,
5704,GO:0016154,1,0.993628898115626,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5705,GO:0016155,1,0.986779366323023,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5706,GO:0016160,1,0.980639873433738,0,3,amylase activity,MF,
5707,GO:0016165,1,0.980832176681796,0,3,linoleate 13S-lipoxygenase activity,MF,
5708,GO:0016167,1,0.980322867734232,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5709,GO:0016170,1,0.993416459009427,0,1,interleukin-15 receptor binding,MF,
5710,GO:0016174,1,0.942810991074801,0,9,NAD(P)H oxidase H2O2-forming activity,MF,
5711,GO:0016175,1,0.937169108454019,0,10,superoxide-generating NAD(P)H oxidase activity,MF,
5712,GO:0016176,1,0.948892306917018,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5713,GO:0016180,1,0.861545156406705,0,23,snRNA processing,BP,
5714,GO:0016182,1,0.986963827195048,0,2,synaptic vesicle budding from endosome,BP,
5715,GO:0016185,1,0.948958326185794,0,8,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5717,GO:0016189,1,0.980334657465408,0,3,synaptic vesicle to endosome fusion,BP,
5718,GO:0016191,1,0.967608227390061,0,5,synaptic vesicle uncoating,BP,
5720,GO:0016197,1,0.242255883557948,0,215,endosomal transport,BP,
5721,GO:0016198,1,0.955114518189777,0,7,axon choice point recognition,BP,
5722,GO:0016199,1,0.967516689707864,0,5,axon midline choice point recognition,BP,
5724,GO:0016203,1,0.993361543141894,0,1,muscle attachment,BP,
5725,GO:0016206,1,0.98717019565669,0,2,catechol O-methyltransferase activity,MF,
5726,GO:0016208,1,0.925362605960664,0,12,AMP binding,MF,
5727,GO:0016209,1,0.629325714733222,0,72,antioxidant activity,MF,
5728,GO:0016211,1,0.993465978515376,0,1,ammonia ligase activity,MF,
5729,GO:0016212,1,0.987208532808745,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5730,GO:0016213,1,0.987039421363074,0,2,linoleoyl-CoA desaturase activity,MF,
5731,GO:0016215,1,0.974197466756536,0,4,acyl-CoA desaturase activity,MF,
5732,GO:0016222,1,0.987161409200159,0,2,procollagen-proline 4-dioxygenase complex,CC,
5733,GO:0016226,1,0.879164333210133,0,20,iron-sulfur cluster assembly,BP,
5734,GO:0016229,1,0.835885906252856,0,28,steroid dehydrogenase activity,MF,
5735,GO:0016230,1,0.987201549983177,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5736,GO:0016232,1,0.993554304672796,0,1,HNK-1 sulfotransferase activity,MF,
5737,GO:0016233,1,0.779112462624896,0,38,telomere capping,BP,
5739,GO:0016235,1,0.779971314886723,0,38,aggresome,CC,
5740,GO:0016236,1,0.149376678142597,0,289,macroautophagy,BP,
5741,GO:0016237,1,0.966846659396249,0,5,lysosomal microautophagy,BP,
5742,GO:0016239,1,0.667756916981942,0,61,positive regulation of macroautophagy,BP,
5743,GO:0016240,1,0.97422638063328,0,4,autophagosome membrane docking,BP,
5744,GO:0016241,1,0.337859822272001,0,165,regulation of macroautophagy,BP,
5745,GO:0016242,1,0.815154848696092,0,31,negative regulation of macroautophagy,BP,
5746,GO:0016243,1,0.993489029653295,0,1,regulation of autophagosome size,BP,
5747,GO:0016246,1,0.900702579541325,0,16,RNA interference,BP,
5749,GO:0016248,1,0.790435279264805,0,36,channel inhibitor activity,MF,
5750,GO:0016250,1,0.99355705431691,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5751,GO:0016251,1,0.792637043098301,0,36,RNA polymerase II general transcription initiation factor activity,MF,
5752,GO:0016254,1,0.902113106878315,0,16,preassembly of GPI anchor in ER membrane,BP,
5753,GO:0016255,1,0.961287814871375,0,6,attachment of GPI anchor to protein,BP,
5754,GO:0016256,1,0.993367485537145,0,1,N-glycan processing to lysosome,BP,
5755,GO:0016259,1,0.980646702020455,0,3,selenocysteine metabolic process,BP,
5756,GO:0016260,1,0.987196813657943,0,2,selenocysteine biosynthetic process,BP,
5757,GO:0016262,1,0.980676194574596,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5758,GO:0016263,1,0.987269890749614,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5761,GO:0016267,1,0.987269890749614,0,2,O-glycan processing, core 1,BP,
5762,GO:0016272,1,0.956500026932572,0,7,prefoldin complex,CC,
5763,GO:0016273,1,0.931543249814155,0,11,arginine N-methyltransferase activity,MF,
5764,GO:0016274,1,0.931543249814155,0,11,protein-arginine N-methyltransferase activity,MF,
5765,GO:0016277,1,0.993579587886027,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5766,GO:0016278,1,0.729080753281709,0,48,lysine N-methyltransferase activity,MF,
5767,GO:0016279,1,0.733823345283773,0,47,protein-lysine N-methyltransferase activity,MF,
5768,GO:0016281,1,0.918933103692238,0,13,eukaryotic translation initiation factor 4F complex,CC,
5769,GO:0016282,1,0.902358089759101,0,16,eukaryotic 43S preinitiation complex,CC,
5770,GO:0016286,1,0.974577099557814,0,4,small conductance calcium-activated potassium channel activity,MF,
5771,GO:0016287,1,0.993561763207888,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5772,GO:0016289,1,0.879360087742596,0,20,CoA hydrolase activity,MF,
5773,GO:0016290,1,0.925786678893007,0,12,palmitoyl-CoA hydrolase activity,MF,
5774,GO:0016295,1,0.986775782043092,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5775,GO:0016296,1,0.986775782043092,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5776,GO:0016297,1,0.986775782043092,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5778,GO:0016300,1,0.980701281396161,0,3,tRNA (uracil) methyltransferase activity,MF,
5780,GO:0016303,1,0.935276707658836,0,10,1-phosphatidylinositol-3-kinase activity,MF,
5781,GO:0016307,1,0.911849519063982,0,14,phosphatidylinositol phosphate kinase activity,MF,
5782,GO:0016308,1,0.961592096392478,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5783,GO:0016309,1,0.987077588684932,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5786,GO:0016312,1,0.98717305767374,0,2,inositol bisphosphate phosphatase activity,MF,
5787,GO:0016314,1,0.974196894344354,0,4,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5788,GO:0016316,1,0.986801175593692,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5789,GO:0016320,1,0.986838339760974,0,2,endoplasmic reticulum membrane fusion,BP,
5790,GO:0016321,1,0.961959695468835,0,6,female meiosis chromosome segregation,BP,
5791,GO:0016322,1,0.92491746159524,0,12,neuron remodeling,BP,
5794,GO:0016327,1,0.901507542932776,0,16,apicolateral plasma membrane,CC,
5797,GO:0016332,1,0.993494567725236,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5798,GO:0016333,1,0.993547211263135,0,1,morphogenesis of follicular epithelium,BP,
5799,GO:0016334,1,0.993547211263135,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5801,GO:0016339,1,0.827121906755378,0,29,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5802,GO:0016340,1,0.986628671670714,0,2,calcium-dependent cell-matrix adhesion,BP,
5803,GO:0016342,1,0.815341656463904,0,31,catenin complex,CC,
5804,GO:0016344,1,0.980478557348869,0,3,meiotic chromosome movement towards spindle pole,BP,
5806,GO:0016361,1,0.967465949182788,0,5,activin receptor activity, type I,MF,
5807,GO:0016362,1,0.985623156685578,0,2,activin receptor activity, type II,MF,
5808,GO:0016363,1,0.502042433954028,0,105,nuclear matrix,CC,
5809,GO:0016401,1,0.974227733912663,0,4,palmitoyl-CoA oxidase activity,MF,
5810,GO:0016402,1,0.993552254797103,0,1,pristanoyl-CoA oxidase activity,MF,
5811,GO:0016403,1,0.987180940246863,0,2,dimethylargininase activity,MF,
5812,GO:0016404,1,0.987057854746741,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5813,GO:0016405,1,0.861497117320911,0,23,CoA-ligase activity,MF,
5814,GO:0016406,1,0.961847793634793,0,6,carnitine O-acyltransferase activity,MF,
5815,GO:0016407,1,0.543935648449264,0,93,acetyltransferase activity,MF,
5816,GO:0016408,1,0.896065908519665,0,17,C-acyltransferase activity,MF,
5817,GO:0016409,1,0.775711738250738,0,39,palmitoyltransferase activity,MF,
5818,GO:0016410,1,0.566000230561509,0,87,N-acyltransferase activity,MF,
5819,GO:0016411,1,0.89470265750073,0,17,acylglycerol O-acyltransferase activity,MF,
5820,GO:0016413,1,0.955540371455659,0,7,O-acetyltransferase activity,MF,
5821,GO:0016414,1,0.98712550887706,0,2,O-octanoyltransferase activity,MF,
5822,GO:0016415,1,0.98088185226551,0,3,octanoyltransferase activity,MF,
5823,GO:0016416,1,0.967990550370175,0,5,O-palmitoyltransferase activity,MF,
5824,GO:0016417,1,0.811776727882789,0,32,S-acyltransferase activity,MF,
5825,GO:0016418,1,0.986621237978702,0,2,S-acetyltransferase activity,MF,
5826,GO:0016419,1,0.986763081946851,0,2,S-malonyltransferase activity,MF,
5827,GO:0016420,1,0.986763081946851,0,2,malonyltransferase activity,MF,
5828,GO:0016421,1,0.967724791178109,0,5,CoA carboxylase activity,MF,
5829,GO:0016422,1,0.980890142650836,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5830,GO:0016423,1,0.91933868238977,0,13,tRNA (guanine) methyltransferase activity,MF,
5831,GO:0016426,1,0.974534396687308,0,4,tRNA (adenine) methyltransferase activity,MF,
5832,GO:0016427,1,0.942966969485082,0,9,tRNA (cytosine) methyltransferase activity,MF,
5833,GO:0016428,1,0.974240651231004,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5834,GO:0016429,1,0.974534396687308,0,4,tRNA (adenine-N1-)-methyltransferase activity,MF,
5835,GO:0016432,1,0.987025266686611,0,2,tRNA-uridine aminocarboxypropyltransferase activity,MF,
5836,GO:0016433,1,0.949915957848724,0,8,rRNA (adenine) methyltransferase activity,MF,
5837,GO:0016434,1,0.974406964960169,0,4,rRNA (cytosine) methyltransferase activity,MF,
5838,GO:0016435,1,0.9872544465627,0,2,rRNA (guanine) methyltransferase activity,MF,
5839,GO:0016436,1,0.987096710001197,0,2,rRNA (uridine) methyltransferase activity,MF,
5840,GO:0016441,1,0.450712991437756,0,121,posttranscriptional gene silencing,BP,
5841,GO:0016442,1,0.911245018980258,0,14,RISC complex,CC,
5842,GO:0016444,1,0.693097685928152,0,56,somatic cell DNA recombination,BP,
5843,GO:0016445,1,0.698127972180841,0,55,somatic diversification of immunoglobulins,BP,
5844,GO:0016446,1,0.918733446132901,0,13,somatic hypermutation of immunoglobulin genes,BP,
5845,GO:0016447,1,0.731040891121915,0,48,somatic recombination of immunoglobulin gene segments,BP,
5846,GO:0016453,1,0.968421013439231,0,5,C-acetyltransferase activity,MF,
5847,GO:0016454,1,0.967869414342266,0,5,C-palmitoyltransferase activity,MF,
5848,GO:0016458,1,0.299034696364505,0,183,gene silencing,BP,
5849,GO:0016459,1,0.711437549252401,0,51,myosin complex,CC,
5850,GO:0016460,1,0.893938559923601,0,17,myosin II complex,CC,
5851,GO:0016461,1,0.935127774727169,0,10,unconventional myosin complex,CC,
5853,GO:0016469,1,0.834968987888141,0,28,proton-transporting two-sector ATPase complex,CC,
5854,GO:0016471,1,0.901807448301205,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5855,GO:0016476,1,0.986960943755914,0,2,regulation of embryonic cell shape,BP,
5857,GO:0016479,1,0.980355684535437,0,3,negative regulation of transcription by RNA polymerase I,BP,
5858,GO:0016480,1,0.980991246664623,0,3,negative regulation of transcription by RNA polymerase III,BP,
5859,GO:0016482,1,0.373595482562939,0,149,cytosolic transport,BP,
5861,GO:0016486,1,0.844716374304793,0,26,peptide hormone processing,BP,
5862,GO:0016487,1,0.987330825123749,0,2,farnesol metabolic process,BP,
5863,GO:0016488,1,0.987330825123749,0,2,farnesol catabolic process,BP,
5865,GO:0016492,1,0.987155030600972,0,2,G protein-coupled neurotensin receptor activity,MF,
5866,GO:0016493,1,0.867963579256002,0,22,C-C chemokine receptor activity,MF,
5867,GO:0016494,1,0.949835705894646,0,8,C-X-C chemokine receptor activity,MF,
5868,GO:0016495,1,0.993534152108704,0,1,C-X3-C chemokine receptor activity,MF,
5869,GO:0016496,1,0.99353021435118,0,1,substance P receptor activity,MF,
5870,GO:0016497,1,0.993578819202381,0,1,substance K receptor activity,MF,
5871,GO:0016499,1,0.987264730627994,0,2,orexin receptor activity,MF,
5872,GO:0016500,1,0.92390050512531,0,12,protein-hormone receptor activity,MF,
5873,GO:0016501,1,0.993600620056264,0,1,prostacyclin receptor activity,MF,
5874,GO:0016502,1,0.8792810868776,0,20,nucleotide receptor activity,MF,
5875,GO:0016503,1,0.993652361059728,0,1,pheromone receptor activity,MF,
5878,GO:0016507,1,0.99354110956801,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5879,GO:0016508,1,0.980721328296818,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5880,GO:0016509,1,0.987077248879484,0,2,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5881,GO:0016513,1,0.980473225874109,0,3,core-binding factor complex,CC,
5882,GO:0016514,1,0.894664141453957,0,17,SWI/SNF complex,CC,
5883,GO:0016517,1,0.993607064928852,0,1,interleukin-12 receptor activity,MF,
5884,GO:0016519,1,0.993603955062257,0,1,gastric inhibitory peptide receptor activity,MF,
5885,GO:0016520,1,0.98713911728976,0,2,growth hormone-releasing hormone receptor activity,MF,
5886,GO:0016521,1,0.993534659899654,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5887,GO:0016525,1,0.518747195202759,0,100,negative regulation of angiogenesis,BP,
5891,GO:0016531,1,0.974449600079445,0,4,copper chaperone activity,MF,
5892,GO:0016532,1,0.986829313192305,0,2,superoxide dismutase copper chaperone activity,MF,
5893,GO:0016533,1,0.980858277407411,0,3,protein kinase 5 complex,CC,
5894,GO:0016538,1,0.742808270581435,0,46,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5895,GO:0016539,1,0.987276590604405,0,2,intein-mediated protein splicing,BP,
5897,GO:0016553,1,0.895516940566571,0,17,base conversion or substitution editing,BP,
5898,GO:0016554,1,0.943795986890259,0,9,cytidine to uridine editing,BP,
5899,GO:0016556,1,0.878236167474007,0,20,mRNA modification,BP,
5900,GO:0016557,1,0.980956565956312,0,3,peroxisome membrane biogenesis,BP,
5901,GO:0016558,1,0.919165255128795,0,13,protein import into peroxisome matrix,BP,
5902,GO:0016559,1,0.943812186714463,0,9,peroxisome fission,BP,
5903,GO:0016560,1,0.974361082439335,0,4,protein import into peroxisome matrix, docking,BP,
5904,GO:0016561,1,0.987168769204642,0,2,protein import into peroxisome matrix, translocation,BP,
5905,GO:0016567,1,0.00581168463240628,0,770,protein ubiquitination,BP,
5908,GO:0016571,1,0.441158739554325,0,124,histone methylation,BP,
5909,GO:0016572,1,0.790658300811575,0,36,histone phosphorylation,BP,
5911,GO:0016574,1,0.744059420678798,0,45,histone ubiquitination,BP,
5912,GO:0016575,1,0.611283298065418,0,75,histone deacetylation,BP,
5913,GO:0016576,1,0.961654083151838,0,6,histone dephosphorylation,BP,
5914,GO:0016577,1,0.83583111398551,0,27,histone demethylation,BP,
5915,GO:0016578,1,0.865795234779339,0,22,histone deubiquitination,BP,
5916,GO:0016579,1,0.207301757458809,0,239,protein deubiquitination,BP,
5917,GO:0016580,1,0.923985252302195,0,12,Sin3 complex,CC,
5918,GO:0016581,1,0.90541242071573,0,15,NuRD complex,CC,
5919,GO:0016584,1,0.9679249935724,0,5,nucleosome positioning,BP,
5920,GO:0016586,1,0.993197515288867,0,1,RSC-type complex,CC,
5921,GO:0016589,1,0.960819997460865,0,6,NURF complex,CC,
5922,GO:0016590,1,0.993336909122794,0,1,ACF complex,CC,
5923,GO:0016591,1,0.6140732866074,0,75,RNA polymerase II, holoenzyme,CC,
5924,GO:0016592,1,0.769292787509558,0,40,mediator complex,CC,
5925,GO:0016593,1,0.948971263976624,0,8,Cdc73/Paf1 complex,CC,
5926,GO:0016594,1,0.912925774544072,0,14,glycine binding,MF,
5927,GO:0016595,1,0.936716435944446,0,10,glutamate binding,MF,
5928,GO:0016596,1,0.99355705431691,0,1,thienylcyclohexylpiperidine binding,MF,
5929,GO:0016597,1,0.703741425508565,0,54,amino acid binding,MF,
5930,GO:0016598,1,0.987249668417907,0,2,protein arginylation,BP,
5931,GO:0016600,1,0.948648084080598,0,8,flotillin complex,CC,
5932,GO:0016601,1,0.784772491819682,0,37,Rac protein signal transduction,BP,
5933,GO:0016602,1,0.974351604046887,0,4,CCAAT-binding factor complex,CC,
5934,GO:0016603,1,0.987261712661474,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5935,GO:0016604,1,0.00743026385717128,0,733,nuclear body,CC,
5936,GO:0016605,1,0.528999875716713,0,97,PML body,CC,
5937,GO:0016607,1,0.086009867379329,0,372,nuclear speck,CC,
5938,GO:0016608,1,0.987440059465361,0,2,growth hormone-releasing hormone activity,MF,
5940,GO:0016615,1,0.955911445704927,0,7,malate dehydrogenase activity,MF,
5942,GO:0016618,1,0.99365700630751,0,1,hydroxypyruvate reductase activity,MF,
5943,GO:0016620,1,0.812758723361682,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5944,GO:0016623,1,0.987037512133835,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5945,GO:0016624,1,0.95559141304036,0,7,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5946,GO:0016627,1,0.70047506049976,0,55,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5947,GO:0016628,1,0.856602776503864,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5948,GO:0016634,1,0.943307288763787,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5949,GO:0016635,1,0.980965596186374,0,3,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5951,GO:0016639,1,0.987143646551886,0,2,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5953,GO:0016642,1,0.993499374287033,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5954,GO:0016645,1,0.855858180973972,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5955,GO:0016646,1,0.907036415015867,0,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5956,GO:0016647,1,0.974651206593276,0,4,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5957,GO:0016649,1,0.987154653898441,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5959,GO:0016652,1,0.987152277281337,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5962,GO:0016657,1,0.987292812091904,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5963,GO:0016661,1,0.980825722508392,0,3,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5964,GO:0016662,1,0.993567127228303,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5965,GO:0016667,1,0.710463515169372,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5966,GO:0016668,1,0.93163451651752,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5967,GO:0016670,1,0.943255347087119,0,9,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5968,GO:0016671,1,0.955896546747018,0,7,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5969,GO:0016672,1,0.987366936148646,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5970,GO:0016675,1,0.869334859805495,0,22,oxidoreductase activity, acting on a heme group of donors,MF,
5971,GO:0016676,1,0.87496583004443,0,21,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5972,GO:0016679,1,0.956352686458995,0,7,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5973,GO:0016681,1,0.962547403165447,0,6,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5974,GO:0016684,1,0.729810940527914,0,49,oxidoreductase activity, acting on peroxide as acceptor,MF,
5975,GO:0016701,1,0.856783571679472,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5976,GO:0016702,1,0.856783571679472,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5978,GO:0016706,1,0.754604874265094,0,43,2-oxoglutarate-dependent dioxygenase activity,MF,
5979,GO:0016708,1,0.993572918047278,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5980,GO:0016709,1,0.786667846681205,0,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
5981,GO:0016711,1,0.993566696254439,0,1,flavonoid 3'-monooxygenase activity,MF,
5982,GO:0016712,1,0.873350493337423,0,21,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5983,GO:0016713,1,0.98079358258413,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
5984,GO:0016714,1,0.956028790735547,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5986,GO:0016716,1,0.993550739374143,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
5987,GO:0016717,1,0.967919129598788,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5988,GO:0016721,1,0.968626624131526,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5989,GO:0016722,1,0.900721367970723,0,16,oxidoreductase activity, oxidizing metal ions,MF,
5990,GO:0016723,1,0.942942403431407,0,9,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5991,GO:0016724,1,0.961421918924624,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5992,GO:0016725,1,0.955329877390682,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
5993,GO:0016726,1,0.986822950665227,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5994,GO:0016727,1,0.993357453520874,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5995,GO:0016728,1,0.98060873536916,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5996,GO:0016730,1,0.993612998811935,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5997,GO:0016731,1,0.993612998811935,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5999,GO:0016741,1,0.285005716459986,0,192,transferase activity, transferring one-carbon groups,MF,
6000,GO:0016742,1,0.949340786837971,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6001,GO:0016743,1,0.986906941891555,0,2,carboxyl- or carbamoyltransferase activity,MF,
6002,GO:0016744,1,0.974648208739887,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6004,GO:0016747,1,0.284514595994159,0,192,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6005,GO:0016748,1,0.980862452185344,0,3,succinyltransferase activity,MF,
6006,GO:0016749,1,0.98722869527992,0,2,N-succinyltransferase activity,MF,
6007,GO:0016751,1,0.993552226090051,0,1,S-succinyltransferase activity,MF,
6008,GO:0016755,1,0.919500895720418,0,13,transferase activity, transferring amino-acyl groups,MF,
6011,GO:0016763,1,0.760729390185004,0,42,transferase activity, transferring pentosyl groups,MF,
6012,GO:0016765,1,0.71967600757518,0,51,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6013,GO:0016768,1,0.99362675559169,0,1,spermine synthase activity,MF,
6014,GO:0016769,1,0.883872206122795,0,19,transferase activity, transferring nitrogenous groups,MF,
6017,GO:0016774,1,0.987138009461597,0,2,phosphotransferase activity, carboxyl group as acceptor,MF,
6018,GO:0016775,1,0.955932828890592,0,7,phosphotransferase activity, nitrogenous group as acceptor,MF,
6020,GO:0016778,1,0.968348872096317,0,5,diphosphotransferase activity,MF,
6021,GO:0016779,1,0.48845481337819,0,110,nucleotidyltransferase activity,MF,
6022,GO:0016780,1,0.889868855040292,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6023,GO:0016781,1,0.987196813657943,0,2,phosphotransferase activity, paired acceptors,MF,
6024,GO:0016782,1,0.655741080863271,0,65,transferase activity, transferring sulfur-containing groups,MF,
6025,GO:0016783,1,0.938011813883647,0,10,sulfurtransferase activity,MF,
6026,GO:0016784,1,0.993641352291369,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6027,GO:0016785,1,0.993365790516823,0,1,transferase activity, transferring selenium-containing groups,MF,
6030,GO:0016790,1,0.787696120031134,0,37,thiolester hydrolase activity,MF,
6032,GO:0016793,1,0.993533084946483,0,1,triphosphoric monoester hydrolase activity,MF,
6033,GO:0016794,1,0.993670047953032,0,1,diphosphoric monoester hydrolase activity,MF,
6034,GO:0016796,1,0.689560206270435,0,57,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6035,GO:0016798,1,0.498668071326761,0,107,hydrolase activity, acting on glycosyl bonds,MF,
6036,GO:0016799,1,0.802204291279304,0,34,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6037,GO:0016801,1,0.931724150145162,0,11,hydrolase activity, acting on ether bonds,MF,
6038,GO:0016802,1,0.993586832538947,0,1,trialkylsulfonium hydrolase activity,MF,
6039,GO:0016803,1,0.937741900997282,0,10,ether hydrolase activity,MF,
6042,GO:0016811,1,0.669245738168811,0,62,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6043,GO:0016812,1,0.961677880685353,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6046,GO:0016815,1,0.993648706748903,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6049,GO:0016822,1,0.981030772642562,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6050,GO:0016823,1,0.981030772642562,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6051,GO:0016826,1,0.99355705431691,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6052,GO:0016829,1,0.336016786971022,0,168,lyase activity,MF,
6053,GO:0016830,1,0.747757636897335,0,45,carbon-carbon lyase activity,MF,
6054,GO:0016831,1,0.818591268086406,0,31,carboxy-lyase activity,MF,
6055,GO:0016832,1,0.943491805525654,0,9,aldehyde-lyase activity,MF,
6056,GO:0016833,1,0.961898629841901,0,6,oxo-acid-lyase activity,MF,
6057,GO:0016835,1,0.640357994660819,0,69,carbon-oxygen lyase activity,MF,
6058,GO:0016836,1,0.705710105993557,0,54,hydro-lyase activity,MF,
6059,GO:0016838,1,0.980997053398296,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6060,GO:0016840,1,0.919915299798778,0,13,carbon-nitrogen lyase activity,MF,
6061,GO:0016841,1,0.968404995792483,0,5,ammonia-lyase activity,MF,
6062,GO:0016842,1,0.956106858799677,0,7,amidine-lyase activity,MF,
6063,GO:0016843,1,0.99355705431691,0,1,amine-lyase activity,MF,
6064,GO:0016844,1,0.99355705431691,0,1,strictosidine synthase activity,MF,
6065,GO:0016846,1,0.938225984185885,0,10,carbon-sulfur lyase activity,MF,
6066,GO:0016849,1,0.893652132700099,0,17,phosphorus-oxygen lyase activity,MF,
6067,GO:0016853,1,0.411546541434756,0,137,isomerase activity,MF,
6068,GO:0016854,1,0.913152590301959,0,14,racemase and epimerase activity,MF,
6069,GO:0016855,1,0.993574747073295,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6070,GO:0016857,1,0.942817113741211,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6071,GO:0016859,1,0.808834751831005,0,33,cis-trans isomerase activity,MF,
6072,GO:0016860,1,0.753077934309955,0,44,intramolecular oxidoreductase activity,MF,
6073,GO:0016861,1,0.950000700859289,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6074,GO:0016862,1,0.981122284405232,0,3,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6075,GO:0016863,1,0.932009480526174,0,11,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6076,GO:0016864,1,0.901486447569157,0,16,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6077,GO:0016866,1,0.850917034434257,0,25,intramolecular transferase activity,MF,
6078,GO:0016868,1,0.937421093547045,0,10,intramolecular transferase activity, phosphotransferases,MF,
6079,GO:0016872,1,0.993588727088719,0,1,intramolecular lyase activity,MF,
6081,GO:0016875,1,0.867481502453136,0,22,ligase activity, forming carbon-oxygen bonds,MF,
6082,GO:0016877,1,0.786639960176155,0,37,ligase activity, forming carbon-sulfur bonds,MF,
6083,GO:0016878,1,0.839562944311956,0,27,acid-thiol ligase activity,MF,
6085,GO:0016880,1,0.98706471289987,0,2,acid-ammonia (or amide) ligase activity,MF,
6087,GO:0016882,1,0.987241188149644,0,2,cyclo-ligase activity,MF,
6088,GO:0016884,1,0.936889352125849,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6089,GO:0016885,1,0.961420972370161,0,6,ligase activity, forming carbon-carbon bonds,MF,
6090,GO:0016886,1,0.968072598709243,0,5,ligase activity, forming phosphoric ester bonds,MF,
6092,GO:0016888,1,0.900957860708033,0,16,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6093,GO:0016889,1,0.949649841220244,0,8,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6094,GO:0016890,1,0.987142871747566,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6095,GO:0016891,1,0.834203775950203,0,28,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6096,GO:0016892,1,0.962443799272825,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6097,GO:0016893,1,0.771652420571329,0,40,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6098,GO:0016894,1,0.913966516574118,0,14,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6099,GO:0016895,1,0.867341383366304,0,22,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6100,GO:0016896,1,0.785139658062512,0,37,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6101,GO:0016898,1,0.993603654499301,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6102,GO:0016899,1,0.974334978293154,0,4,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6103,GO:0016900,1,0.98737985374338,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6104,GO:0016901,1,0.986935426023332,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6105,GO:0016903,1,0.776462639466125,0,39,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6106,GO:0016907,1,0.962041035846917,0,6,G protein-coupled acetylcholine receptor activity,MF,
6107,GO:0016917,1,0.877041456844295,0,20,GABA receptor activity,MF,
6108,GO:0016918,1,0.920063069324587,0,13,retinal binding,MF,
6109,GO:0016920,1,0.993240292234838,0,1,pyroglutamyl-peptidase activity,MF,
6111,GO:0016925,1,0.616053216478223,0,74,protein sumoylation,BP,
6112,GO:0016926,1,0.954945752005593,0,7,protein desumoylation,BP,
6113,GO:0016929,1,0.954945752005593,0,7,SUMO-specific protease activity,MF,
6114,GO:0016933,1,0.974443974989987,0,4,extracellularly glycine-gated ion channel activity,MF,
6115,GO:0016934,1,0.974443974989987,0,4,extracellularly glycine-gated chloride channel activity,MF,
6116,GO:0016935,1,0.987093710747665,0,2,glycine-gated chloride channel complex,CC,
6117,GO:0016936,1,0.950296032904675,0,8,galactoside binding,MF,
6118,GO:0016938,1,0.993546540736066,0,1,kinesin I complex,CC,
6119,GO:0016939,1,0.980312356439714,0,3,kinesin II complex,CC,
6120,GO:0016941,1,0.980685829786118,0,3,natriuretic peptide receptor activity,MF,
6121,GO:0016942,1,0.967800299468445,0,5,insulin-like growth factor binding protein complex,CC,
6122,GO:0016964,1,0.992427154022935,0,1,alpha-2 macroglobulin receptor activity,MF,
6123,GO:0016971,1,0.980704328245029,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6124,GO:0016972,1,0.974267797475126,0,4,thiol oxidase activity,MF,
6125,GO:0016973,1,0.890162981090327,0,18,poly(A)+ mRNA export from nucleus,BP,
6126,GO:0016979,1,0.993645447627033,0,1,lipoate-protein ligase activity,MF,
6127,GO:0016992,1,0.9936279274967,0,1,lipoate synthase activity,MF,
6128,GO:0016997,1,0.980865206977092,0,3,alpha-sialidase activity,MF,
6129,GO:0016998,1,0.993673417332495,0,1,cell wall macromolecule catabolic process,BP,
6130,GO:0016999,1,0.987081058696925,0,2,antibiotic metabolic process,BP,
6131,GO:0017002,1,0.941042151330636,0,9,activin-activated receptor activity,MF,
6132,GO:0017003,1,0.993587093435636,0,1,protein-heme linkage,BP,
6133,GO:0017004,1,0.797672685151766,0,35,cytochrome complex assembly,BP,
6134,GO:0017005,1,0.993509428474531,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6135,GO:0017006,1,0.993587093435636,0,1,protein-tetrapyrrole linkage,BP,
6136,GO:0017014,1,0.912471928637697,0,14,protein nitrosylation,BP,
6137,GO:0017015,1,0.468064202925991,0,115,regulation of transforming growth factor beta receptor signaling pathway,BP,
6139,GO:0017017,1,0.931385916103117,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6140,GO:0017018,1,0.973687941396128,0,4,myosin phosphatase activity,MF,
6141,GO:0017020,1,0.980584116335948,0,3,myosin phosphatase regulator activity,MF,
6143,GO:0017024,1,0.99367981876957,0,1,myosin I binding,MF,
6144,GO:0017025,1,0.844749252603281,0,26,TBP-class protein binding,MF,
6145,GO:0017034,1,0.967249475011783,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6146,GO:0017038,1,0.302393918959171,0,182,protein import,BP,
6147,GO:0017040,1,0.968270751525122,0,5,N-acylsphingosine amidohydrolase activity,MF,
6148,GO:0017041,1,0.993644981764571,0,1,galactosylgalactosylglucosylceramidase activity,MF,
6149,GO:0017042,1,0.993627324866982,0,1,glycosylceramidase activity,MF,
6150,GO:0017045,1,0.993654551738843,0,1,corticotropin-releasing hormone activity,MF,
6151,GO:0017046,1,0.750652084847239,0,44,peptide hormone binding,MF,
6152,GO:0017048,1,0.367758969704823,0,151,Rho GTPase binding,MF,
6153,GO:0017049,1,0.877776166863033,0,20,GTP-Rho binding,MF,
6154,GO:0017050,1,0.980831138439451,0,3,D-erythro-sphingosine kinase activity,MF,
6155,GO:0017053,1,0.617617769945934,0,73,transcription repressor complex,CC,
6156,GO:0017054,1,0.987245812982787,0,2,negative cofactor 2 complex,CC,
6157,GO:0017055,1,0.987140947078961,0,2,negative regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
6158,GO:0017056,1,0.860150305144267,0,23,structural constituent of nuclear pore,MF,
6159,GO:0017057,1,0.98676488816921,0,2,6-phosphogluconolactonase activity,MF,
6160,GO:0017059,1,0.949443275468926,0,8,serine C-palmitoyltransferase complex,CC,
6161,GO:0017060,1,0.987239799246545,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6162,GO:0017061,1,0.9870242689237,0,2,S-methyl-5-thioadenosine phosphorylase activity,MF,
6163,GO:0017062,1,0.937406063548693,0,10,respiratory chain complex III assembly,BP,
6164,GO:0017064,1,0.980944830720272,0,3,fatty acid amide hydrolase activity,MF,
6165,GO:0017065,1,0.993635048532407,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6166,GO:0017069,1,0.762251000409171,0,42,snRNA binding,MF,
6167,GO:0017070,1,0.913663355484597,0,14,U6 snRNA binding,MF,
6168,GO:0017071,1,0.993508804875487,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6169,GO:0017075,1,0.842900520700865,0,26,syntaxin-1 binding,MF,
6171,GO:0017077,1,0.987254428910982,0,2,oxidative phosphorylation uncoupler activity,MF,
6173,GO:0017081,1,0.906312851834299,0,15,chloride channel regulator activity,MF,
6174,GO:0017083,1,0.960965686646781,0,6,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity,MF,
6175,GO:0017085,1,0.93040537839572,0,11,response to insecticide,BP,
6176,GO:0017089,1,0.987230724149212,0,2,glycolipid transfer activity,MF,
6177,GO:0017090,1,0.993547351222257,0,1,meprin A complex,CC,
6178,GO:0017091,1,0.844548388382374,0,26,AU-rich element binding,MF,
6179,GO:0017095,1,0.980253936183116,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6180,GO:0017098,1,0.99357066251008,0,1,sulfonylurea receptor binding,MF,
6181,GO:0017099,1,0.980792992032537,0,3,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6182,GO:0017101,1,0.981029738625208,0,3,aminoacyl-tRNA synthetase multienzyme complex,CC,
6183,GO:0017108,1,0.949273077889316,0,8,5'-flap endonuclease activity,MF,
6184,GO:0017109,1,0.987086242861852,0,2,glutamate-cysteine ligase complex,CC,
6185,GO:0017110,1,0.937586436104521,0,10,nucleoside-diphosphatase activity,MF,
6187,GO:0017112,1,0.809392107112503,0,32,Rab guanyl-nucleotide exchange factor activity,MF,
6188,GO:0017113,1,0.993537047150672,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6189,GO:0017116,1,0.889664887784188,0,18,single-stranded DNA helicase activity,MF,
6190,GO:0017118,1,0.993645447627033,0,1,lipoyltransferase activity,MF,
6191,GO:0017119,1,0.919030770694149,0,13,Golgi transport complex,CC,
6192,GO:0017121,1,0.907004875605664,0,15,plasma membrane phospholipid scrambling,BP,
6193,GO:0017122,1,0.993379781136771,0,1,protein N-acetylglucosaminyltransferase complex,CC,
6195,GO:0017125,1,0.993438440521058,0,1,deoxycytidyl transferase activity,MF,
6196,GO:0017126,1,0.987103136627555,0,2,nucleologenesis,BP,
6197,GO:0017128,1,0.949269270696576,0,8,phospholipid scramblase activity,MF,
6198,GO:0017129,1,0.987169042069706,0,2,triglyceride binding,MF,
6199,GO:0017130,1,0.993263355971432,0,1,poly(C) RNA binding,MF,
6200,GO:0017134,1,0.871376659753544,0,21,fibroblast growth factor binding,MF,
6201,GO:0017136,1,0.906729326860646,0,15,NAD-dependent histone deacetylase activity,MF,
6203,GO:0017143,1,0.987170637766985,0,2,insecticide metabolic process,BP,
6205,GO:0017145,1,0.763762682818752,0,41,stem cell division,BP,
6206,GO:0017146,1,0.928924178788975,0,11,NMDA selective glutamate receptor complex,CC,
6207,GO:0017147,1,0.822264260247396,0,30,Wnt-protein binding,MF,
6208,GO:0017148,1,0.430819071024899,0,128,negative regulation of translation,BP,
6209,GO:0017150,1,0.974626614508723,0,4,tRNA dihydrouridine synthase activity,MF,
6210,GO:0017151,1,0.949104624840726,0,8,DEAD/H-box RNA helicase binding,MF,
6211,GO:0017153,1,0.961052722315409,0,6,sodium:dicarboxylate symporter activity,MF,
6212,GO:0017154,1,0.922272375294515,0,12,semaphorin receptor activity,MF,
6213,GO:0017156,1,0.674106718046006,0,60,calcium-ion regulated exocytosis,BP,
6215,GO:0017158,1,0.764358793840148,0,41,regulation of calcium ion-dependent exocytosis,BP,
6216,GO:0017159,1,0.980852050687883,0,3,pantetheine hydrolase activity,MF,
6217,GO:0017160,1,0.906139641060898,0,15,Ral GTPase binding,MF,
6218,GO:0017162,1,0.942646772108272,0,9,aryl hydrocarbon receptor binding,MF,
6219,GO:0017166,1,0.929171721130936,0,11,vinculin binding,MF,
6220,GO:0017168,1,0.993487343418766,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6221,GO:0017169,1,0.955976171941859,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6223,GO:0017172,1,0.993632175577685,0,1,cysteine dioxygenase activity,MF,
6224,GO:0017174,1,0.993668329197426,0,1,glycine N-methyltransferase activity,MF,
6225,GO:0017176,1,0.962292136447704,0,6,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6226,GO:0017177,1,0.98712458374887,0,2,glucosidase II complex,CC,
6227,GO:0017178,1,0.99355705431691,0,1,diphthine-ammonia ligase activity,MF,
6228,GO:0017182,1,0.955806517350843,0,7,peptidyl-diphthamide metabolic process,BP,
6229,GO:0017183,1,0.955806517350843,0,7,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6230,GO:0017185,1,0.949462114726316,0,8,peptidyl-lysine hydroxylation,BP,
6231,GO:0017186,1,0.987261712661474,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6232,GO:0017187,1,0.980995272483281,0,3,peptidyl-glutamic acid carboxylation,BP,
6233,GO:0017188,1,0.993347185820484,0,1,aspartate N-acetyltransferase activity,MF,
6234,GO:0017196,1,0.955452438891063,0,7,N-terminal peptidyl-methionine acetylation,BP,
6235,GO:0017198,1,0.987359064993001,0,2,N-terminal peptidyl-serine acetylation,BP,
6236,GO:0018002,1,0.987359064993001,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6237,GO:0018008,1,0.986888968507763,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6238,GO:0018009,1,0.993597097654161,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6239,GO:0018011,1,0.99355705431691,0,1,N-terminal peptidyl-alanine methylation,BP,
6240,GO:0018012,1,0.99355705431691,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6241,GO:0018013,1,0.99355705431691,0,1,N-terminal peptidyl-glycine methylation,BP,
6242,GO:0018016,1,0.99355705431691,0,1,N-terminal peptidyl-proline dimethylation,BP,
6243,GO:0018021,1,0.9871931198819,0,2,peptidyl-histidine methylation,BP,
6244,GO:0018022,1,0.496698098555578,0,106,peptidyl-lysine methylation,BP,
6245,GO:0018023,1,0.763128275718348,0,41,peptidyl-lysine trimethylation,BP,
6246,GO:0018024,1,0.772852347644821,0,39,histone-lysine N-methyltransferase activity,MF,
6247,GO:0018025,1,0.99355705431691,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6248,GO:0018026,1,0.955106030323904,0,7,peptidyl-lysine monomethylation,BP,
6249,GO:0018027,1,0.876724218761033,0,20,peptidyl-lysine dimethylation,BP,
6250,GO:0018032,1,0.99350481307262,0,1,protein amidation,BP,
6251,GO:0018057,1,0.96803451396888,0,5,peptidyl-lysine oxidation,BP,
6252,GO:0018063,1,0.993587093435636,0,1,cytochrome c-heme linkage,BP,
6253,GO:0018064,1,0.9871931198819,0,2,protein-histidine N-methyltransferase activity,MF,
6254,GO:0018076,1,0.973161909211972,0,4,N-terminal peptidyl-lysine acetylation,BP,
6255,GO:0018094,1,0.987156468695129,0,2,protein polyglycylation,BP,
6256,GO:0018095,1,0.931178563052641,0,11,protein polyglutamylation,BP,
6258,GO:0018103,1,0.967691913584831,0,5,protein C-linked glycosylation,BP,
6260,GO:0018106,1,0.99369062319473,0,1,peptidyl-histidine phosphorylation,BP,
6263,GO:0018114,1,0.993574747073295,0,1,threonine racemase activity,MF,
6264,GO:0018117,1,0.993629701122825,0,1,protein adenylylation,BP,
6265,GO:0018119,1,0.912471928637697,0,14,peptidyl-cysteine S-nitrosylation,BP,
6266,GO:0018120,1,0.987325107364343,0,2,peptidyl-arginine ADP-ribosylation,BP,
6267,GO:0018125,1,0.980894882274803,0,3,peptidyl-cysteine methylation,BP,
6268,GO:0018126,1,0.850057687752717,0,25,protein hydroxylation,BP,
6270,GO:0018142,1,0.99355705431691,0,1,protein-DNA covalent cross-linking,BP,
6271,GO:0018143,1,0.99355705431691,0,1,nucleic acid-protein covalent cross-linking,BP,
6272,GO:0018146,1,0.844071618066231,0,26,keratan sulfate biosynthetic process,BP,
6274,GO:0018153,1,0.987187556243805,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6275,GO:0018158,1,0.91369964535331,0,14,protein oxidation,BP,
6276,GO:0018160,1,0.993641718764055,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6277,GO:0018166,1,0.993406353395107,0,1,C-terminal protein-tyrosinylation,BP,
6278,GO:0018171,1,0.974631705392969,0,4,peptidyl-cysteine oxidation,BP,
6279,GO:0018175,1,0.993629701122825,0,1,protein nucleotidylation,BP,
6280,GO:0018192,1,0.993576395629378,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6282,GO:0018194,1,0.99355705431691,0,1,peptidyl-alanine modification,BP,
6284,GO:0018196,1,0.823400260942731,0,30,peptidyl-asparagine modification,BP,
6285,GO:0018197,1,0.980383050870569,0,3,peptidyl-aspartic acid modification,BP,
6286,GO:0018198,1,0.73660714609153,0,47,peptidyl-cysteine modification,BP,
6287,GO:0018199,1,0.974610865944663,0,4,peptidyl-glutamine modification,BP,
6289,GO:0018201,1,0.97430556363204,0,4,peptidyl-glycine modification,BP,
6290,GO:0018202,1,0.931275707280227,0,11,peptidyl-histidine modification,BP,
6292,GO:0018206,1,0.925224091732307,0,12,peptidyl-methionine modification,BP,
6293,GO:0018208,1,0.728201338542766,0,49,peptidyl-proline modification,BP,
6296,GO:0018211,1,0.967691913584831,0,5,peptidyl-tryptophan modification,BP,
6298,GO:0018214,1,0.980995272483281,0,3,protein carboxylation,BP,
6299,GO:0018216,1,0.913602354223055,0,14,peptidyl-arginine methylation,BP,
6300,GO:0018217,1,0.993489029653295,0,1,peptidyl-aspartic acid phosphorylation,BP,
6301,GO:0018230,1,0.86108389715683,0,23,peptidyl-L-cysteine S-palmitoylation,BP,
6302,GO:0018231,1,0.86108389715683,0,23,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6303,GO:0018242,1,0.948999461275963,0,8,protein O-linked glycosylation via serine,BP,
6304,GO:0018243,1,0.942953068003868,0,9,protein O-linked glycosylation via threonine,BP,
6305,GO:0018262,1,0.980921620353553,0,3,isopeptide cross-linking,BP,
6306,GO:0018271,1,0.993334450818515,0,1,biotin-protein ligase activity,MF,
6307,GO:0018272,1,0.993623303821261,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6308,GO:0018276,1,0.993653556149668,0,1,isopeptide cross-linking via N6-glycyl-L-lysine,BP,
6309,GO:0018277,1,0.993582225707261,0,1,protein deamination,BP,
6310,GO:0018279,1,0.829001886219843,0,29,protein N-linked glycosylation via asparagine,BP,
6311,GO:0018282,1,0.986856919688642,0,2,metal incorporation into metallo-sulfur cluster,BP,
6312,GO:0018283,1,0.986856919688642,0,2,iron incorporation into metallo-sulfur cluster,BP,
6313,GO:0018293,1,0.993659194087702,0,1,protein-FAD linkage,BP,
6314,GO:0018298,1,0.949785186618182,0,8,protein-chromophore linkage,BP,
6315,GO:0018307,1,0.987293852923509,0,2,enzyme active site formation,BP,
6316,GO:0018312,1,0.987144746675562,0,2,peptidyl-serine ADP-ribosylation,BP,
6317,GO:0018315,1,0.993472472896888,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6318,GO:0018317,1,0.967691913584831,0,5,protein C-linked glycosylation via tryptophan,BP,
6319,GO:0018322,1,0.993406353395107,0,1,protein tyrosinylation,BP,
6320,GO:0018323,1,0.993677246056371,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6321,GO:0018335,1,0.974320308010017,0,4,protein succinylation,BP,
6322,GO:0018342,1,0.936658331444028,0,10,protein prenylation,BP,
6323,GO:0018343,1,0.980864512259067,0,3,protein farnesylation,BP,
6324,GO:0018344,1,0.955589049425745,0,7,protein geranylgeranylation,BP,
6326,GO:0018350,1,0.993580486638777,0,1,protein esterification,BP,
6327,GO:0018352,1,0.987245598307358,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6328,GO:0018364,1,0.967786262524553,0,5,peptidyl-glutamine methylation,BP,
6329,GO:0018377,1,0.973820444092252,0,4,protein myristoylation,BP,
6332,GO:0018395,1,0.99351061792185,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6333,GO:0018400,1,0.993278855318345,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6334,GO:0018401,1,0.943427208356847,0,9,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6335,GO:0018406,1,0.967691913584831,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6337,GO:0018423,1,0.993653456574864,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6338,GO:0018424,1,0.99348920927597,0,1,peptidyl-glutamic acid poly-ADP-ribosylation,BP,
6339,GO:0018444,1,0.98042105558531,0,3,translation release factor complex,CC,
6340,GO:0018455,1,0.962221118840565,0,6,alcohol dehydrogenase [NAD(P)+] activity,MF,
6341,GO:0018467,1,0.993564491309667,0,1,formaldehyde dehydrogenase activity,MF,
6342,GO:0018477,1,0.993554188564519,0,1,benzaldehyde dehydrogenase (NADP+) activity,MF,
6343,GO:0018478,1,0.9935938551392,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6344,GO:0018479,1,0.980895994065125,0,3,benzaldehyde dehydrogenase (NAD+) activity,MF,
6345,GO:0018549,1,0.993625549663926,0,1,methanethiol oxidase activity,MF,
6346,GO:0018585,1,0.993595342222919,0,1,fluorene oxygenase activity,MF,
6347,GO:0018601,1,0.993628228760742,0,1,4-nitrophenol 2-monooxygenase activity,MF,
6348,GO:0018636,1,0.981065004849759,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6349,GO:0018685,1,0.993624075000458,0,1,alkane 1-monooxygenase activity,MF,
6350,GO:0018729,1,0.993615684432828,0,1,propionate CoA-transferase activity,MF,
6351,GO:0018733,1,0.993660055578653,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6352,GO:0018738,1,0.993659856790988,0,1,S-formylglutathione hydrolase activity,MF,
6353,GO:0018773,1,0.993627626198812,0,1,acetylpyruvate hydrolase activity,MF,
6354,GO:0018812,1,0.974473775128644,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6355,GO:0018858,1,0.98718855948895,0,2,benzoate-CoA ligase activity,MF,
6356,GO:0018871,1,0.993603821469413,0,1,1-aminocyclopropane-1-carboxylate metabolic process,BP,
6357,GO:0018872,1,0.987050000221097,0,2,arsonoacetate metabolic process,BP,
6358,GO:0018874,1,0.993602219559638,0,1,benzoate metabolic process,BP,
6359,GO:0018879,1,0.987199101160153,0,2,biphenyl metabolic process,BP,
6360,GO:0018885,1,0.993628228760742,0,1,carbon tetrachloride metabolic process,BP,
6361,GO:0018894,1,0.987170637766985,0,2,dibenzo-p-dioxin metabolic process,BP,
6362,GO:0018904,1,0.855598762135323,0,24,ether metabolic process,BP,
6363,GO:0018910,1,0.993628228760742,0,1,benzene metabolic process,BP,
6364,GO:0018916,1,0.974687427876145,0,4,nitrobenzene metabolic process,BP,
6365,GO:0018917,1,0.993595342222919,0,1,fluorene metabolic process,BP,
6366,GO:0018931,1,0.993646113025072,0,1,naphthalene metabolic process,BP,
6368,GO:0018960,1,0.993628228760742,0,1,4-nitrophenol metabolic process,BP,
6369,GO:0018963,1,0.987216111686571,0,2,phthalate metabolic process,BP,
6370,GO:0018964,1,0.993471812592686,0,1,propylene metabolic process,BP,
6371,GO:0018969,1,0.993549660211287,0,1,thiocyanate metabolic process,BP,
6372,GO:0018992,1,0.986920758750871,0,2,germ-line sex determination,BP,
6373,GO:0018993,1,0.987131636519589,0,2,somatic sex determination,BP,
6374,GO:0018995,1,0.675674413639115,0,60,host cellular component,CC,
6375,GO:0019001,1,0.105622486645745,0,343,guanyl nucleotide binding,MF,
6376,GO:0019002,1,0.980632824545206,0,3,GMP binding,MF,
6377,GO:0019003,1,0.627456539931725,0,72,GDP binding,MF,
6378,GO:0019005,1,0.681583103012424,0,59,SCF ubiquitin ligase complex,CC,
6379,GO:0019008,1,0.987164955064998,0,2,molybdopterin synthase complex,CC,
6380,GO:0019034,1,0.980530016988269,0,3,viral replication complex,CC,
6381,GO:0019035,1,0.986804373287233,0,2,viral integration complex,CC,
6382,GO:0019042,1,0.930883214872319,0,11,viral latency,BP,
6383,GO:0019043,1,0.943671147631598,0,9,establishment of viral latency,BP,
6384,GO:0019045,1,0.986456540987353,0,2,latent virus replication,BP,
6385,GO:0019046,1,0.986456540987353,0,2,release from viral latency,BP,
6386,GO:0019048,1,0.837302974561289,0,27,modulation by virus of host process,BP,
6387,GO:0019049,1,0.987004970665312,0,2,mitigation of host defenses by virus,BP,
6388,GO:0019050,1,0.980921485741858,0,3,suppression by virus of host apoptotic process,BP,
6389,GO:0019054,1,0.889370087146928,0,18,modulation by virus of host cellular process,BP,
6390,GO:0019056,1,0.99355096733832,0,1,modulation by virus of host transcription,BP,
6392,GO:0019060,1,0.987348677121156,0,2,intracellular transport of viral protein in host cell,BP,
6393,GO:0019061,1,0.993587942287656,0,1,uncoating of virus,BP,
6394,GO:0019062,1,0.955512530461513,0,7,virion attachment to host cell,BP,
6395,GO:0019064,1,0.96203622693941,0,6,fusion of virus membrane with host plasma membrane,BP,
6396,GO:0019065,1,0.954995418783049,0,7,receptor-mediated endocytosis of virus by host cell,BP,
6397,GO:0019068,1,0.772087868154703,0,40,virion assembly,BP,
6398,GO:0019072,1,0.98684663115417,0,2,viral genome packaging,BP,
6399,GO:0019074,1,0.98684663115417,0,2,viral RNA genome packaging,BP,
6400,GO:0019075,1,0.987155207697788,0,2,virus maturation,BP,
6401,GO:0019076,1,0.812067650700145,0,32,viral release from host cell,BP,
6402,GO:0019079,1,0.47200913096488,0,115,viral genome replication,BP,
6403,GO:0019080,1,0.297663849321492,0,187,viral gene expression,BP,
6404,GO:0019081,1,0.912786053514161,0,14,viral translation,BP,
6405,GO:0019082,1,0.980718850314496,0,3,viral protein processing,BP,
6406,GO:0019083,1,0.330724115733979,0,171,viral transcription,BP,
6407,GO:0019085,1,0.987022574377681,0,2,early viral transcription,BP,
6408,GO:0019086,1,0.974478667398241,0,4,late viral transcription,BP,
6409,GO:0019087,1,0.986692363365161,0,2,transformation of host cell by virus,BP,
6410,GO:0019098,1,0.832791648013554,0,28,reproductive behavior,BP,
6411,GO:0019100,1,0.986920758750871,0,2,male germ-line sex determination,BP,
6412,GO:0019101,1,0.993548812407926,0,1,female somatic sex determination,BP,
6413,GO:0019102,1,0.993541573586608,0,1,male somatic sex determination,BP,
6414,GO:0019103,1,0.961872206543471,0,6,pyrimidine nucleotide binding,MF,
6415,GO:0019104,1,0.920065894157483,0,13,DNA N-glycosylase activity,MF,
6416,GO:0019107,1,0.968112444498323,0,5,myristoyltransferase activity,MF,
6417,GO:0019115,1,0.974624345015026,0,4,benzaldehyde dehydrogenase [NAD(P)+] activity,MF,
6418,GO:0019118,1,0.993648706748903,0,1,phenanthrene-epoxide hydrolase activity,MF,
6419,GO:0019119,1,0.993648706748903,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6420,GO:0019135,1,0.987173013942184,0,2,deoxyhypusine monooxygenase activity,MF,
6421,GO:0019136,1,0.974531667586567,0,4,deoxynucleoside kinase activity,MF,
6422,GO:0019144,1,0.987336357207097,0,2,ADP-sugar diphosphatase activity,MF,
6423,GO:0019145,1,0.993573106767278,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6424,GO:0019150,1,0.9936021862112,0,1,D-ribulokinase activity,MF,
6425,GO:0019153,1,0.993633111280964,0,1,protein-disulfide reductase (glutathione) activity,MF,
6426,GO:0019158,1,0.967772838107429,0,5,mannokinase activity,MF,
6427,GO:0019166,1,0.980950769688733,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6428,GO:0019171,1,0.993109877834153,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6429,GO:0019184,1,0.895623998067277,0,17,nonribosomal peptide biosynthetic process,BP,
6430,GO:0019185,1,0.980671329346298,0,3,snRNA-activating protein complex,CC,
6431,GO:0019187,1,0.993492878350646,0,1,beta-1,4-mannosyltransferase activity,MF,
6432,GO:0019198,1,0.89206978787856,0,17,transmembrane receptor protein phosphatase activity,MF,
6434,GO:0019200,1,0.872469009318306,0,21,carbohydrate kinase activity,MF,
6435,GO:0019202,1,0.987117082973668,0,2,amino acid kinase activity,MF,
6436,GO:0019203,1,0.949489368447425,0,8,carbohydrate phosphatase activity,MF,
6438,GO:0019206,1,0.943755714380903,0,9,nucleoside kinase activity,MF,
6443,GO:0019211,1,0.907068150821471,0,15,phosphatase activator activity,MF,
6445,GO:0019213,1,0.77523710945687,0,39,deacetylase activity,MF,
6446,GO:0019215,1,0.912630514018128,0,14,intermediate filament binding,MF,
6448,GO:0019217,1,0.588387465571362,0,81,regulation of fatty acid metabolic process,BP,
6455,GO:0019227,1,0.948662290710223,0,8,neuronal action potential propagation,BP,
6456,GO:0019228,1,0.797369118341166,0,34,neuronal action potential,BP,
6458,GO:0019230,1,0.967756761809114,0,5,proprioception,BP,
6460,GO:0019236,1,0.974731895244296,0,4,response to pheromone,BP,
6461,GO:0019237,1,0.961539003994662,0,6,centromeric DNA binding,MF,
6462,GO:0019238,1,0.968305844534059,0,5,cyclohydrolase activity,MF,
6464,GO:0019240,1,0.967250713765152,0,5,citrulline biosynthetic process,BP,
6465,GO:0019242,1,0.993642318351066,0,1,methylglyoxal biosynthetic process,BP,
6466,GO:0019243,1,0.987220486394866,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6467,GO:0019244,1,0.993655679727065,0,1,lactate biosynthetic process from pyruvate,BP,
6468,GO:0019249,1,0.980760990588784,0,3,lactate biosynthetic process,BP,
6469,GO:0019254,1,0.980816895628382,0,3,carnitine metabolic process, CoA-linked,BP,
6470,GO:0019255,1,0.987243264283812,0,2,glucose 1-phosphate metabolic process,BP,
6471,GO:0019262,1,0.962326169877991,0,6,N-acetylneuraminate catabolic process,BP,
6472,GO:0019264,1,0.987207013938763,0,2,glycine biosynthetic process from serine,BP,
6473,GO:0019265,1,0.993632777137238,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6474,GO:0019276,1,0.987084802154888,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6475,GO:0019284,1,0.980920351082139,0,3,L-methionine salvage from S-adenosylmethionine,BP,
6476,GO:0019285,1,0.987064896920279,0,2,glycine betaine biosynthetic process from choline,BP,
6477,GO:0019287,1,0.980994395242572,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6478,GO:0019290,1,0.993548136726401,0,1,siderophore biosynthetic process,BP,
6479,GO:0019303,1,0.987358523671409,0,2,D-ribose catabolic process,BP,
6480,GO:0019317,1,0.948436977946192,0,8,fucose catabolic process,BP,
6481,GO:0019318,1,0.226800525006486,0,226,hexose metabolic process,BP,
6482,GO:0019319,1,0.597931904395624,0,79,hexose biosynthetic process,BP,
6483,GO:0019320,1,0.721964763407982,0,50,hexose catabolic process,BP,
6484,GO:0019321,1,0.914133159427397,0,14,pentose metabolic process,BP,
6485,GO:0019322,1,0.974690400412709,0,4,pentose biosynthetic process,BP,
6486,GO:0019323,1,0.968480033182249,0,5,pentose catabolic process,BP,
6488,GO:0019341,1,0.993566696254439,0,1,dibenzo-p-dioxin catabolic process,BP,
6489,GO:0019343,1,0.987231043887942,0,2,cysteine biosynthetic process via cystathionine,BP,
6490,GO:0019344,1,0.980894246825733,0,3,cysteine biosynthetic process,BP,
6491,GO:0019346,1,0.974736824605422,0,4,transsulfuration,BP,
6492,GO:0019348,1,0.968305918742615,0,5,dolichol metabolic process,BP,
6493,GO:0019359,1,0.834314700282091,0,28,nicotinamide nucleotide biosynthetic process,BP,
6494,GO:0019362,1,0.818131848832238,0,31,pyridine nucleotide metabolic process,BP,
6495,GO:0019363,1,0.834314700282091,0,28,pyridine nucleotide biosynthetic process,BP,
6496,GO:0019364,1,0.974280238079737,0,4,pyridine nucleotide catabolic process,BP,
6497,GO:0019365,1,0.99355705431691,0,1,pyridine nucleotide salvage,BP,
6498,GO:0019367,1,0.961852691979628,0,6,fatty acid elongation, saturated fatty acid,BP,
6499,GO:0019368,1,0.961852691979628,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6501,GO:0019370,1,0.925845183388018,0,12,leukotriene biosynthetic process,BP,
6503,GO:0019372,1,0.902324925655481,0,16,lipoxygenase pathway,BP,
6504,GO:0019373,1,0.931646321085064,0,11,epoxygenase P450 pathway,BP,
6505,GO:0019374,1,0.943645361629203,0,9,galactolipid metabolic process,BP,
6506,GO:0019375,1,0.962074516017893,0,6,galactolipid biosynthetic process,BP,
6507,GO:0019376,1,0.980851693272584,0,3,galactolipid catabolic process,BP,
6508,GO:0019377,1,0.90775011115742,0,15,glycolipid catabolic process,BP,
6509,GO:0019388,1,0.949436079159137,0,8,galactose catabolic process,BP,
6510,GO:0019389,1,0.987191655375207,0,2,glucuronoside metabolic process,BP,
6511,GO:0019391,1,0.987191655375207,0,2,glucuronoside catabolic process,BP,
6512,GO:0019395,1,0.514866556483008,0,102,fatty acid oxidation,BP,
6513,GO:0019400,1,0.883530202101532,0,19,alditol metabolic process,BP,
6514,GO:0019401,1,0.955925275387637,0,7,alditol biosynthetic process,BP,
6515,GO:0019402,1,0.993648773227165,0,1,galactitol metabolic process,BP,
6516,GO:0019405,1,0.967417924463613,0,5,alditol catabolic process,BP,
6517,GO:0019406,1,0.993646113025072,0,1,hexitol biosynthetic process,BP,
6518,GO:0019407,1,0.99357166287299,0,1,hexitol catabolic process,BP,
6519,GO:0019408,1,0.987039672406538,0,2,dolichol biosynthetic process,BP,
6520,GO:0019413,1,0.987044121206429,0,2,acetate biosynthetic process,BP,
6521,GO:0019417,1,0.987050936583712,0,2,sulfur oxidation,BP,
6522,GO:0019418,1,0.97481216638499,0,4,sulfide oxidation,BP,
6523,GO:0019427,1,0.987044121206429,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6524,GO:0019430,1,0.862171322171545,0,23,removal of superoxide radicals,BP,
6525,GO:0019432,1,0.817174528979701,0,31,triglyceride biosynthetic process,BP,
6526,GO:0019433,1,0.827877562174477,0,29,triglyceride catabolic process,BP,
6529,GO:0019441,1,0.974768061452744,0,4,tryptophan catabolic process to kynurenine,BP,
6530,GO:0019442,1,0.98730696971319,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6531,GO:0019448,1,0.974635315001332,0,4,L-cysteine catabolic process,BP,
6532,GO:0019449,1,0.993560801035551,0,1,L-cysteine catabolic process to hypotaurine,BP,
6533,GO:0019452,1,0.993560801035551,0,1,L-cysteine catabolic process to taurine,BP,
6534,GO:0019464,1,0.980862171411792,0,3,glycine decarboxylation via glycine cleavage system,BP,
6535,GO:0019470,1,0.974500601979184,0,4,4-hydroxyproline catabolic process,BP,
6536,GO:0019471,1,0.974500601979184,0,4,4-hydroxyproline metabolic process,BP,
6537,GO:0019474,1,0.974316429176893,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6538,GO:0019477,1,0.974316429176893,0,4,L-lysine catabolic process,BP,
6539,GO:0019478,1,0.987304762926478,0,2,D-amino acid catabolic process,BP,
6540,GO:0019482,1,0.974494828329006,0,4,beta-alanine metabolic process,BP,
6541,GO:0019483,1,0.987179409438511,0,2,beta-alanine biosynthetic process,BP,
6542,GO:0019493,1,0.993607332753872,0,1,arginine catabolic process to proline,BP,
6543,GO:0019509,1,0.968258935300786,0,5,L-methionine salvage from methylthioadenosine,BP,
6544,GO:0019510,1,0.993586832538947,0,1,S-adenosylhomocysteine catabolic process,BP,
6545,GO:0019511,1,0.91313362387436,0,14,peptidyl-proline hydroxylation,BP,
6546,GO:0019516,1,0.993655679727065,0,1,lactate oxidation,BP,
6547,GO:0019518,1,0.981032917731119,0,3,L-threonine catabolic process to glycine,BP,
6548,GO:0019519,1,0.99357166287299,0,1,pentitol metabolic process,BP,
6549,GO:0019520,1,0.987207728795018,0,2,aldonic acid metabolic process,BP,
6550,GO:0019521,1,0.987207728795018,0,2,D-gluconate metabolic process,BP,
6551,GO:0019527,1,0.99357166287299,0,1,pentitol catabolic process,BP,
6552,GO:0019530,1,0.955527986023648,0,7,taurine metabolic process,BP,
6553,GO:0019531,1,0.948874118463775,0,8,oxalate transmembrane transporter activity,MF,
6554,GO:0019532,1,0.94282926392444,0,9,oxalate transport,BP,
6555,GO:0019534,1,0.955069576039963,0,7,toxin transmembrane transporter activity,MF,
6557,GO:0019541,1,0.974419377896754,0,4,propionate metabolic process,BP,
6558,GO:0019542,1,0.987044121206429,0,2,propionate biosynthetic process,BP,
6559,GO:0019543,1,0.987211202392378,0,2,propionate catabolic process,BP,
6560,GO:0019544,1,0.993607332753872,0,1,arginine catabolic process to glutamate,BP,
6561,GO:0019547,1,0.987290651409777,0,2,arginine catabolic process to ornithine,BP,
6562,GO:0019550,1,0.987214736105641,0,2,glutamate catabolic process to aspartate,BP,
6563,GO:0019551,1,0.987214736105641,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6564,GO:0019556,1,0.974514145893851,0,4,histidine catabolic process to glutamate and formamide,BP,
6565,GO:0019557,1,0.974514145893851,0,4,histidine catabolic process to glutamate and formate,BP,
6566,GO:0019563,1,0.973678723929339,0,4,glycerol catabolic process,BP,
6567,GO:0019566,1,0.987155207697788,0,2,arabinose metabolic process,BP,
6568,GO:0019585,1,0.949715763478264,0,8,glucuronate metabolic process,BP,
6569,GO:0019605,1,0.987254141194442,0,2,butyrate metabolic process,BP,
6570,GO:0019606,1,0.993628630393618,0,1,2-oxobutyrate catabolic process,BP,
6572,GO:0019626,1,0.949754950761545,0,8,short-chain fatty acid catabolic process,BP,
6573,GO:0019627,1,0.925643578072641,0,12,urea metabolic process,BP,
6575,GO:0019640,1,0.96844507163844,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6576,GO:0019646,1,0.902907544948173,0,16,aerobic electron transport chain,BP,
6577,GO:0019659,1,0.987098243375882,0,2,glucose catabolic process to lactate,BP,
6578,GO:0019660,1,0.987098243375882,0,2,glycolytic fermentation,BP,
6579,GO:0019661,1,0.987098243375882,0,2,glucose catabolic process to lactate via pyruvate,BP,
6580,GO:0019673,1,0.962391029959613,0,6,GDP-mannose metabolic process,BP,
6581,GO:0019674,1,0.741524077548411,0,46,NAD metabolic process,BP,
6582,GO:0019676,1,0.987103641078168,0,2,ammonia assimilation cycle,BP,
6583,GO:0019677,1,0.980557995580484,0,3,NAD catabolic process,BP,
6584,GO:0019682,1,0.956028049721771,0,7,glyceraldehyde-3-phosphate metabolic process,BP,
6587,GO:0019694,1,0.955527986023648,0,7,alkanesulfonate metabolic process,BP,
6588,GO:0019695,1,0.943218514008865,0,9,choline metabolic process,BP,
6589,GO:0019706,1,0.833492027824531,0,28,protein-cysteine S-palmitoyltransferase activity,MF,
6590,GO:0019707,1,0.833492027824531,0,28,protein-cysteine S-acyltransferase activity,MF,
6591,GO:0019720,1,0.961925229714383,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6593,GO:0019724,1,0.505794185657658,0,105,B cell mediated immunity,BP,
6598,GO:0019740,1,0.974491047609951,0,4,nitrogen utilization,BP,
6599,GO:0019742,1,0.993579427614789,0,1,pentacyclic triterpenoid metabolic process,BP,
6600,GO:0019747,1,0.97464185973566,0,4,regulation of isoprenoid metabolic process,BP,
6601,GO:0019748,1,0.717563691668829,0,51,secondary metabolic process,BP,
6604,GO:0019755,1,0.931647789354559,0,11,one-carbon compound transport,BP,
6605,GO:0019763,1,0.968510359141181,0,5,immunoglobulin receptor activity,MF,
6606,GO:0019767,1,0.993699765080044,0,1,IgE receptor activity,MF,
6607,GO:0019770,1,0.993632610050384,0,1,IgG receptor activity,MF,
6608,GO:0019772,1,0.993632610050384,0,1,low-affinity IgG receptor activity,MF,
6609,GO:0019773,1,0.956484884086309,0,7,proteasome core complex, alpha-subunit complex,CC,
6610,GO:0019774,1,0.944452353507774,0,9,proteasome core complex, beta-subunit complex,CC,
6611,GO:0019776,1,0.993656409407995,0,1,Atg8 ligase activity,MF,
6612,GO:0019777,1,0.987279327286034,0,2,Atg12 transferase activity,MF,
6613,GO:0019778,1,0.993421064509849,0,1,Atg12 activating enzyme activity,MF,
6614,GO:0019779,1,0.993421064509849,0,1,Atg8 activating enzyme activity,MF,
6615,GO:0019780,1,0.993294556828004,0,1,FAT10 activating enzyme activity,MF,
6616,GO:0019781,1,0.987257070883801,0,2,NEDD8 activating enzyme activity,MF,
6617,GO:0019782,1,0.993526139394331,0,1,ISG15 activating enzyme activity,MF,
6618,GO:0019783,1,0.895267683880751,0,17,ubiquitin-like protein-specific protease activity,MF,
6619,GO:0019784,1,0.956079061648541,0,7,NEDD8-specific protease activity,MF,
6620,GO:0019785,1,0.993484718268421,0,1,ISG15-specific protease activity,MF,
6621,GO:0019787,1,0.0697741428789394,0,402,ubiquitin-like protein transferase activity,MF,
6622,GO:0019788,1,0.962047156111231,0,6,NEDD8 transferase activity,MF,
6623,GO:0019789,1,0.894539640737439,0,17,SUMO transferase activity,MF,
6624,GO:0019797,1,0.980794200606343,0,3,procollagen-proline 3-dioxygenase activity,MF,
6625,GO:0019798,1,0.949694421284728,0,8,procollagen-proline dioxygenase activity,MF,
6626,GO:0019799,1,0.99355705431691,0,1,tubulin N-acetyltransferase activity,MF,
6628,GO:0019805,1,0.974610567465587,0,4,quinolinate biosynthetic process,BP,
6629,GO:0019806,1,0.993262330824517,0,1,bromide peroxidase activity,MF,
6630,GO:0019807,1,0.993647310389401,0,1,aspartoacylase activity,MF,
6631,GO:0019808,1,0.980990363686198,0,3,polyamine binding,MF,
6632,GO:0019809,1,0.987379858291577,0,2,spermidine binding,MF,
6633,GO:0019810,1,0.993529657669243,0,1,putrescine binding,MF,
6634,GO:0019811,1,0.993453709913066,0,1,cocaine binding,MF,
6635,GO:0019814,1,0.962233998145039,0,6,immunoglobulin complex,CC,
6636,GO:0019815,1,0.974633636276589,0,4,B cell receptor complex,CC,
6637,GO:0019825,1,0.829976038815042,0,29,oxygen binding,MF,
6638,GO:0019826,1,0.980445917465444,0,3,oxygen sensor activity,MF,
6639,GO:0019827,1,0.360140549942177,0,155,stem cell population maintenance,BP,
6640,GO:0019828,1,0.961758224598667,0,6,aspartic-type endopeptidase inhibitor activity,MF,
6641,GO:0019829,1,0.711629955432023,0,52,ATPase-coupled cation transmembrane transporter activity,MF,
6642,GO:0019834,1,0.981027804335133,0,3,phospholipase A2 inhibitor activity,MF,
6643,GO:0019835,1,0.885132332270276,0,19,cytolysis,BP,
6645,GO:0019840,1,0.845426311221163,0,26,isoprenoid binding,MF,
6646,GO:0019841,1,0.931926515237487,0,11,retinol binding,MF,
6647,GO:0019842,1,0.460985105337998,0,119,vitamin binding,MF,
6648,GO:0019843,1,0.693515218266316,0,57,rRNA binding,MF,
6649,GO:0019852,1,0.931364711238778,0,11,L-ascorbic acid metabolic process,BP,
6650,GO:0019853,1,0.987292593068382,0,2,L-ascorbic acid biosynthetic process,BP,
6651,GO:0019855,1,0.943375384846495,0,9,calcium channel inhibitor activity,MF,
6652,GO:0019856,1,0.948622563869908,0,8,pyrimidine nucleobase biosynthetic process,BP,
6653,GO:0019857,1,0.979032302319157,0,3,5-methylcytosine metabolic process,BP,
6654,GO:0019858,1,0.987222385005463,0,2,cytosine metabolic process,BP,
6655,GO:0019859,1,0.980850904181618,0,3,thymine metabolic process,BP,
6656,GO:0019860,1,0.980890519403768,0,3,uracil metabolic process,BP,
6657,GO:0019862,1,0.993635115310551,0,1,IgA binding,MF,
6658,GO:0019863,1,0.974876966208138,0,4,IgE binding,MF,
6659,GO:0019864,1,0.944049375404753,0,9,IgG binding,MF,
6663,GO:0019869,1,0.936156050544998,0,10,chloride channel inhibitor activity,MF,
6664,GO:0019870,1,0.941868816701024,0,9,potassium channel inhibitor activity,MF,
6665,GO:0019871,1,0.948887465157587,0,8,sodium channel inhibitor activity,MF,
6666,GO:0019878,1,0.986939606660676,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6667,GO:0019882,1,0.243612339203169,0,217,antigen processing and presentation,BP,
6668,GO:0019883,1,0.867548452573654,0,22,antigen processing and presentation of endogenous antigen,BP,
6669,GO:0019884,1,0.32488706270961,0,173,antigen processing and presentation of exogenous antigen,BP,
6670,GO:0019885,1,0.901786136402444,0,16,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6671,GO:0019886,1,0.541886883093155,0,94,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6675,GO:0019896,1,0.918495491058375,0,13,axonal transport of mitochondrion,BP,
6684,GO:0019905,1,0.615660254504127,0,74,syntaxin binding,MF,
6685,GO:0019907,1,0.981053523401411,0,3,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6686,GO:0019908,1,0.924872848301536,0,12,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6688,GO:0019912,1,0.993592700810439,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
6689,GO:0019915,1,0.620123945566787,0,73,lipid storage,BP,
6690,GO:0019918,1,0.974515759401507,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6691,GO:0019919,1,0.96833627737269,0,5,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6694,GO:0019934,1,0.849887687272218,0,25,cGMP-mediated signaling,BP,
6696,GO:0019941,1,0.0203227029425686,0,586,modification-dependent protein catabolic process,BP,
6697,GO:0019948,1,0.987179313530264,0,2,SUMO activating enzyme activity,MF,
6700,GO:0019956,1,0.812711439162367,0,32,chemokine binding,MF,
6701,GO:0019957,1,0.8623849753328,0,23,C-C chemokine binding,MF,
6702,GO:0019958,1,0.961876977897034,0,6,C-X-C chemokine binding,MF,
6703,GO:0019959,1,0.980699633932044,0,3,interleukin-8 binding,MF,
6704,GO:0019960,1,0.967471206555797,0,5,C-X3-C chemokine binding,MF,
6705,GO:0019961,1,0.986889022616965,0,2,interferon binding,MF,
6706,GO:0019962,1,0.993327361973143,0,1,type I interferon binding,MF,
6707,GO:0019964,1,0.993518843844864,0,1,interferon-gamma binding,MF,
6708,GO:0019966,1,0.955476802498496,0,7,interleukin-1 binding,MF,
6709,GO:0019969,1,0.993505253568292,0,1,interleukin-10 binding,MF,
6710,GO:0019970,1,0.980763165374046,0,3,interleukin-11 binding,MF,
6711,GO:0019972,1,0.993643783512876,0,1,interleukin-12 binding,MF,
6712,GO:0019975,1,0.993643783512876,0,1,interleukin-17 binding,MF,
6713,GO:0019976,1,0.980778919242181,0,3,interleukin-2 binding,MF,
6714,GO:0019981,1,0.987056121307749,0,2,interleukin-6 binding,MF,
6715,GO:0019985,1,0.775953383080891,0,39,translesion synthesis,BP,
6716,GO:0019988,1,0.993558236361319,0,1,charged-tRNA amino acid modification,BP,
6717,GO:0019992,1,0.923641429973487,0,12,diacylglycerol binding,MF,
6718,GO:0020003,1,0.980943617781594,0,3,symbiont-containing vacuole,CC,
6719,GO:0020005,1,0.987305584236948,0,2,symbiont-containing vacuole membrane,CC,
6720,GO:0020016,1,0.98061278765741,0,3,ciliary pocket,CC,
6721,GO:0020018,1,0.98061278765741,0,3,ciliary pocket membrane,CC,
6722,GO:0020027,1,0.907957803194395,0,15,hemoglobin metabolic process,BP,
6723,GO:0020037,1,0.495839209900455,0,108,heme binding,MF,
6724,GO:0021501,1,0.993600420300672,0,1,prechordal plate formation,BP,
6725,GO:0021502,1,0.980695527567329,0,3,neural fold elevation formation,BP,
6726,GO:0021503,1,0.993113810219607,0,1,neural fold bending,BP,
6727,GO:0021508,1,0.993267852290662,0,1,floor plate formation,BP,
6728,GO:0021509,1,0.993606763679216,0,1,roof plate formation,BP,
6731,GO:0021512,1,0.993473196735768,0,1,spinal cord anterior/posterior patterning,BP,
6735,GO:0021516,1,0.884227529783702,0,19,dorsal spinal cord development,BP,
6737,GO:0021519,1,0.993654219907791,0,1,spinal cord association neuron specification,BP,
6741,GO:0021523,1,0.968096594917329,0,5,somatic motor neuron differentiation,BP,
6742,GO:0021524,1,0.98093433632961,0,3,visceral motor neuron differentiation,BP,
6743,GO:0021526,1,0.987236295931546,0,2,medial motor column neuron differentiation,BP,
6744,GO:0021527,1,0.93106045862825,0,11,spinal cord association neuron differentiation,BP,
6745,GO:0021528,1,0.99355705431691,0,1,commissural neuron differentiation in spinal cord,BP,
6746,GO:0021529,1,0.967722552705458,0,5,spinal cord oligodendrocyte cell differentiation,BP,
6747,GO:0021530,1,0.980872870067999,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6748,GO:0021532,1,0.780063200358499,0,38,neural tube patterning,BP,
6749,GO:0021533,1,0.87595695716142,0,20,cell differentiation in hindbrain,BP,
6750,GO:0021534,1,0.906434044321674,0,15,cell proliferation in hindbrain,BP,
6751,GO:0021535,1,0.911583737488194,0,14,cell migration in hindbrain,BP,
6752,GO:0021536,1,0.636959623707627,0,69,diencephalon development,BP,
6754,GO:0021538,1,0.980401171024129,0,3,epithalamus development,BP,
6755,GO:0021539,1,0.99363411347346,0,1,subthalamus development,BP,
6756,GO:0021540,1,0.961148688792891,0,6,corpus callosum morphogenesis,BP,
6757,GO:0021541,1,0.993475254948498,0,1,ammon gyrus development,BP,
6760,GO:0021544,1,0.853808526237237,0,24,subpallium development,BP,
6762,GO:0021546,1,0.962099624456947,0,6,rhombomere development,BP,
6763,GO:0021547,1,0.993600420300672,0,1,midbrain-hindbrain boundary initiation,BP,
6764,GO:0021548,1,0.943202039114668,0,9,pons development,BP,
6766,GO:0021550,1,0.99357512678926,0,1,medulla oblongata development,BP,
6767,GO:0021551,1,0.992765431201216,0,1,central nervous system morphogenesis,BP,
6768,GO:0021553,1,0.980016539045106,0,3,olfactory nerve development,BP,
6770,GO:0021555,1,0.980813057517601,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6771,GO:0021557,1,0.98091856809553,0,3,oculomotor nerve development,BP,
6772,GO:0021558,1,0.987309520135339,0,2,trochlear nerve development,BP,
6773,GO:0021559,1,0.930973838540414,0,11,trigeminal nerve development,BP,
6774,GO:0021560,1,0.987143321946142,0,2,abducens nerve development,BP,
6775,GO:0021561,1,0.936665778783786,0,10,facial nerve development,BP,
6776,GO:0021562,1,0.949009059429094,0,8,vestibulocochlear nerve development,BP,
6777,GO:0021563,1,0.967453351752582,0,5,glossopharyngeal nerve development,BP,
6778,GO:0021564,1,0.980166258101606,0,3,vagus nerve development,BP,
6779,GO:0021566,1,0.993423486490551,0,1,hypoglossal nerve development,BP,
6780,GO:0021568,1,0.987312254744808,0,2,rhombomere 2 development,BP,
6781,GO:0021569,1,0.980927621736066,0,3,rhombomere 3 development,BP,
6782,GO:0021570,1,0.993633178104923,0,1,rhombomere 4 development,BP,
6783,GO:0021571,1,0.987118058082868,0,2,rhombomere 5 development,BP,
6784,GO:0021572,1,0.993524924321381,0,1,rhombomere 6 development,BP,
6785,GO:0021575,1,0.77293739323103,0,39,hindbrain morphogenesis,BP,
6786,GO:0021577,1,0.987100425552305,0,2,hindbrain structural organization,BP,
6787,GO:0021578,1,0.961452810477083,0,6,hindbrain maturation,BP,
6788,GO:0021586,1,0.980669591688469,0,3,pons maturation,BP,
6789,GO:0021587,1,0.788130847089545,0,36,cerebellum morphogenesis,BP,
6790,GO:0021589,1,0.987100425552305,0,2,cerebellum structural organization,BP,
6791,GO:0021590,1,0.98040821552155,0,3,cerebellum maturation,BP,
6792,GO:0021591,1,0.808311196260478,0,32,ventricular system development,BP,
6793,GO:0021592,1,0.986629650286789,0,2,fourth ventricle development,BP,
6794,GO:0021593,1,0.987213842868633,0,2,rhombomere morphogenesis,BP,
6795,GO:0021594,1,0.993551796017618,0,1,rhombomere formation,BP,
6796,GO:0021595,1,0.993551796017618,0,1,rhombomere structural organization,BP,
6797,GO:0021598,1,0.987143321946142,0,2,abducens nerve morphogenesis,BP,
6798,GO:0021599,1,0.987143321946142,0,2,abducens nerve formation,BP,
6799,GO:0021602,1,0.83829251696266,0,27,cranial nerve morphogenesis,BP,
6800,GO:0021603,1,0.94944404302058,0,8,cranial nerve formation,BP,
6801,GO:0021604,1,0.936755313962358,0,10,cranial nerve structural organization,BP,
6802,GO:0021610,1,0.936665778783786,0,10,facial nerve morphogenesis,BP,
6803,GO:0021612,1,0.948982779087213,0,8,facial nerve structural organization,BP,
6804,GO:0021615,1,0.974396889910537,0,4,glossopharyngeal nerve morphogenesis,BP,
6805,GO:0021618,1,0.993423486490551,0,1,hypoglossal nerve morphogenesis,BP,
6806,GO:0021622,1,0.987195120727611,0,2,oculomotor nerve morphogenesis,BP,
6807,GO:0021623,1,0.987195120727611,0,2,oculomotor nerve formation,BP,
6808,GO:0021626,1,0.955233766497045,0,7,central nervous system maturation,BP,
6809,GO:0021631,1,0.961088086649908,0,6,optic nerve morphogenesis,BP,
6810,GO:0021633,1,0.987121889669537,0,2,optic nerve structural organization,BP,
6811,GO:0021634,1,0.993482486668847,0,1,optic nerve formation,BP,
6812,GO:0021636,1,0.967666993577037,0,5,trigeminal nerve morphogenesis,BP,
6813,GO:0021637,1,0.967666993577037,0,5,trigeminal nerve structural organization,BP,
6814,GO:0021639,1,0.993626554641888,0,1,trochlear nerve morphogenesis,BP,
6815,GO:0021642,1,0.993626554641888,0,1,trochlear nerve formation,BP,
6816,GO:0021644,1,0.987200117124322,0,2,vagus nerve morphogenesis,BP,
6817,GO:0021648,1,0.961629303419698,0,6,vestibulocochlear nerve morphogenesis,BP,
6818,GO:0021649,1,0.987005016713402,0,2,vestibulocochlear nerve structural organization,BP,
6819,GO:0021650,1,0.974293507582208,0,4,vestibulocochlear nerve formation,BP,
6820,GO:0021658,1,0.987213842868633,0,2,rhombomere 3 morphogenesis,BP,
6821,GO:0021659,1,0.993551796017618,0,1,rhombomere 3 structural organization,BP,
6822,GO:0021660,1,0.993551796017618,0,1,rhombomere 3 formation,BP,
6823,GO:0021664,1,0.993551796017618,0,1,rhombomere 5 morphogenesis,BP,
6824,GO:0021665,1,0.993551796017618,0,1,rhombomere 5 structural organization,BP,
6825,GO:0021666,1,0.993551796017618,0,1,rhombomere 5 formation,BP,
6826,GO:0021670,1,0.922768873222322,0,12,lateral ventricle development,BP,
6828,GO:0021678,1,0.967915844002103,0,5,third ventricle development,BP,
6829,GO:0021679,1,0.98710921522178,0,2,cerebellar molecular layer development,BP,
6830,GO:0021680,1,0.852609797552542,0,24,cerebellar Purkinje cell layer development,BP,
6831,GO:0021681,1,0.918397301015645,0,13,cerebellar granular layer development,BP,
6832,GO:0021682,1,0.993361543141894,0,1,nerve maturation,BP,
6833,GO:0021683,1,0.942573469506708,0,9,cerebellar granular layer morphogenesis,BP,
6834,GO:0021684,1,0.95513691149887,0,7,cerebellar granular layer formation,BP,
6835,GO:0021685,1,0.993220587846093,0,1,cerebellar granular layer structural organization,BP,
6836,GO:0021686,1,0.993630102537454,0,1,cerebellar granular layer maturation,BP,
6837,GO:0021687,1,0.98710921522178,0,2,cerebellar molecular layer morphogenesis,BP,
6838,GO:0021688,1,0.993527037882868,0,1,cerebellar molecular layer formation,BP,
6839,GO:0021691,1,0.986694195647619,0,2,cerebellar Purkinje cell layer maturation,BP,
6840,GO:0021692,1,0.91050644266577,0,14,cerebellar Purkinje cell layer morphogenesis,BP,
6841,GO:0021693,1,0.98679107271547,0,2,cerebellar Purkinje cell layer structural organization,BP,
6842,GO:0021694,1,0.92905806303471,0,11,cerebellar Purkinje cell layer formation,BP,
6843,GO:0021695,1,0.743341683643756,0,45,cerebellar cortex development,BP,
6844,GO:0021696,1,0.820029393369818,0,30,cerebellar cortex morphogenesis,BP,
6845,GO:0021697,1,0.864530804855257,0,22,cerebellar cortex formation,BP,
6846,GO:0021698,1,0.98679107271547,0,2,cerebellar cortex structural organization,BP,
6847,GO:0021699,1,0.98040821552155,0,3,cerebellar cortex maturation,BP,
6849,GO:0021702,1,0.92905806303471,0,11,cerebellar Purkinje cell differentiation,BP,
6850,GO:0021703,1,0.993626554641888,0,1,locus ceruleus development,BP,
6851,GO:0021707,1,0.95513691149887,0,7,cerebellar granule cell differentiation,BP,
6852,GO:0021718,1,0.987114493181028,0,2,superior olivary nucleus development,BP,
6853,GO:0021722,1,0.987114493181028,0,2,superior olivary nucleus maturation,BP,
6854,GO:0021730,1,0.986720096567798,0,2,trigeminal sensory nucleus development,BP,
6855,GO:0021740,1,0.986720096567798,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6856,GO:0021747,1,0.980476328390064,0,3,cochlear nucleus development,BP,
6857,GO:0021750,1,0.99357512678926,0,1,vestibular nucleus development,BP,
6858,GO:0021756,1,0.887733859981199,0,18,striatum development,BP,
6859,GO:0021757,1,0.993509428474531,0,1,caudate nucleus development,BP,
6860,GO:0021758,1,0.993509428474531,0,1,putamen development,BP,
6861,GO:0021759,1,0.974336387602342,0,4,globus pallidus development,BP,
6864,GO:0021764,1,0.966894338263986,0,5,amygdala development,BP,
6866,GO:0021767,1,0.993044617066839,0,1,mammillary body development,BP,
6867,GO:0021768,1,0.99351714574147,0,1,nucleus accumbens development,BP,
6868,GO:0021769,1,0.974270584048141,0,4,orbitofrontal cortex development,BP,
6869,GO:0021771,1,0.993360096027058,0,1,lateral geniculate nucleus development,BP,
6870,GO:0021772,1,0.815078077600442,0,31,olfactory bulb development,BP,
6871,GO:0021773,1,0.97365092353731,0,4,striatal medium spiny neuron differentiation,BP,
6872,GO:0021775,1,0.979964029566696,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6873,GO:0021776,1,0.979964029566696,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6874,GO:0021778,1,0.967501071005916,0,5,oligodendrocyte cell fate specification,BP,
6875,GO:0021779,1,0.967501071005916,0,5,oligodendrocyte cell fate commitment,BP,
6876,GO:0021780,1,0.967501071005916,0,5,glial cell fate specification,BP,
6877,GO:0021781,1,0.918490102640724,0,13,glial cell fate commitment,BP,
6879,GO:0021783,1,0.906420541094755,0,15,preganglionic parasympathetic fiber development,BP,
6880,GO:0021784,1,0.987256612452285,0,2,postganglionic parasympathetic fiber development,BP,
6881,GO:0021785,1,0.96032178903069,0,6,branchiomotor neuron axon guidance,BP,
6882,GO:0021793,1,0.993522124519047,0,1,chemorepulsion of branchiomotor axon,BP,
6883,GO:0021794,1,0.924332101689518,0,12,thalamus development,BP,
6884,GO:0021795,1,0.778765831942993,0,38,cerebral cortex cell migration,BP,
6886,GO:0021797,1,0.980898661198864,0,3,forebrain anterior/posterior pattern specification,BP,
6887,GO:0021798,1,0.955185108664377,0,7,forebrain dorsal/ventral pattern formation,BP,
6888,GO:0021799,1,0.836973843309053,0,27,cerebral cortex radially oriented cell migration,BP,
6889,GO:0021800,1,0.960521716731381,0,6,cerebral cortex tangential migration,BP,
6890,GO:0021801,1,0.87615342538249,0,20,cerebral cortex radial glia guided migration,BP,
6891,GO:0021806,1,0.993640619212295,0,1,initiation of movement involved in cerebral cortex radial glia guided migration,BP,
6892,GO:0021808,1,0.993640619212295,0,1,cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration,BP,
6893,GO:0021812,1,0.986956700652058,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6894,GO:0021813,1,0.993567744138669,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6895,GO:0021814,1,0.967254344609529,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6896,GO:0021815,1,0.979858405797604,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6897,GO:0021817,1,0.979858405797604,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6898,GO:0021819,1,0.936023454205353,0,10,layer formation in cerebral cortex,BP,
6899,GO:0021823,1,0.986673275404256,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6900,GO:0021825,1,0.986673275404256,0,2,substrate-dependent cerebral cortex tangential migration,BP,
6902,GO:0021827,1,0.986673275404256,0,2,postnatal olfactory bulb interneuron migration,BP,
6903,GO:0021828,1,0.980454908622329,0,3,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6905,GO:0021831,1,0.993551081422835,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6906,GO:0021836,1,0.986673275404256,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6907,GO:0021840,1,0.987129147212438,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6908,GO:0021842,1,0.987129147212438,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6911,GO:0021847,1,0.980558999652175,0,3,ventricular zone neuroblast division,BP,
6912,GO:0021849,1,0.980367998607113,0,3,neuroblast division in subventricular zone,BP,
6913,GO:0021852,1,0.980454069205996,0,3,pyramidal neuron migration,BP,
6915,GO:0021854,1,0.889767813586524,0,18,hypothalamus development,BP,
6916,GO:0021855,1,0.980454908622329,0,3,hypothalamus cell migration,BP,
6917,GO:0021856,1,0.980454908622329,0,3,hypothalamic tangential migration using cell-axon interactions,BP,
6918,GO:0021859,1,0.935835097703134,0,10,pyramidal neuron differentiation,BP,
6919,GO:0021860,1,0.94222654315577,0,9,pyramidal neuron development,BP,
6920,GO:0021861,1,0.955626410213189,0,7,forebrain radial glial cell differentiation,BP,
6921,GO:0021869,1,0.961545532106636,0,6,forebrain ventricular zone progenitor cell division,BP,
6922,GO:0021870,1,0.993328054601569,0,1,Cajal-Retzius cell differentiation,BP,
6924,GO:0021872,1,0.674256198907092,0,60,forebrain generation of neurons,BP,
6925,GO:0021873,1,0.967254068425966,0,5,forebrain neuroblast division,BP,
6926,GO:0021877,1,0.93669003424534,0,10,forebrain neuron fate commitment,BP,
6927,GO:0021879,1,0.71565497727694,0,51,forebrain neuron differentiation,BP,
6928,GO:0021882,1,0.987214742689817,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6929,GO:0021884,1,0.842888475199224,0,26,forebrain neuron development,BP,
6931,GO:0021886,1,0.974252312904025,0,4,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6932,GO:0021888,1,0.974252312904025,0,4,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6933,GO:0021889,1,0.923777583401955,0,12,olfactory bulb interneuron differentiation,BP,
6934,GO:0021891,1,0.954792036083419,0,7,olfactory bulb interneuron development,BP,
6936,GO:0021893,1,0.987214742689817,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6939,GO:0021896,1,0.98615070759072,0,2,forebrain astrocyte differentiation,BP,
6940,GO:0021897,1,0.98615070759072,0,2,forebrain astrocyte development,BP,
6941,GO:0021898,1,0.987214742689817,0,2,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6942,GO:0021902,1,0.954952078839135,0,7,commitment of neuronal cell to specific neuron type in forebrain,BP,
6943,GO:0021903,1,0.936760294925346,0,10,rostrocaudal neural tube patterning,BP,
6944,GO:0021904,1,0.860536698852535,0,23,dorsal/ventral neural tube patterning,BP,
6945,GO:0021905,1,0.993257153553221,0,1,forebrain-midbrain boundary formation,BP,
6946,GO:0021910,1,0.954811366464587,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6949,GO:0021914,1,0.980710010803063,0,3,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6951,GO:0021917,1,0.993257153553221,0,1,somatic motor neuron fate commitment,BP,
6952,GO:0021918,1,0.993257153553221,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6953,GO:0021919,1,0.99351501623234,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6954,GO:0021920,1,0.993654219907791,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6955,GO:0021924,1,0.912292817293644,0,14,cell proliferation in external granule layer,BP,
6956,GO:0021930,1,0.912292817293644,0,14,cerebellar granule cell precursor proliferation,BP,
6957,GO:0021932,1,0.936453241307792,0,10,hindbrain radial glia guided cell migration,BP,
6958,GO:0021933,1,0.993630102537454,0,1,radial glia guided migration of cerebellar granule cell,BP,
6959,GO:0021934,1,0.986227487948056,0,2,hindbrain tangential cell migration,BP,
6960,GO:0021935,1,0.986227487948056,0,2,cerebellar granule cell precursor tangential migration,BP,
6961,GO:0021936,1,0.943090837548205,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6962,GO:0021937,1,0.967940304696603,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6963,GO:0021938,1,0.974176118827583,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6964,GO:0021940,1,0.955397059690025,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6965,GO:0021941,1,0.987125097309519,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6966,GO:0021942,1,0.974026523976054,0,4,radial glia guided migration of Purkinje cell,BP,
6967,GO:0021943,1,0.973907031543962,0,4,formation of radial glial scaffolds,BP,
6968,GO:0021944,1,0.99352598087898,0,1,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration,BP,
6973,GO:0021956,1,0.993606295185282,0,1,central nervous system interneuron axonogenesis,BP,
6974,GO:0021957,1,0.954474049437451,0,7,corticospinal tract morphogenesis,BP,
6975,GO:0021960,1,0.967538618674421,0,5,anterior commissure morphogenesis,BP,
6976,GO:0021965,1,0.979767803429367,0,3,spinal cord ventral commissure morphogenesis,BP,
6977,GO:0021966,1,0.987116282621428,0,2,corticospinal neuron axon guidance,BP,
6978,GO:0021972,1,0.99342059423354,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6980,GO:0021979,1,0.955412797664283,0,7,hypothalamus cell differentiation,BP,
6981,GO:0021983,1,0.771247960167528,0,40,pituitary gland development,BP,
6982,GO:0021984,1,0.931793357201891,0,11,adenohypophysis development,BP,
6983,GO:0021985,1,0.987088544134932,0,2,neurohypophysis development,BP,
6984,GO:0021986,1,0.980401171024129,0,3,habenula development,BP,
6986,GO:0021988,1,0.804418653325031,0,33,olfactory lobe development,BP,
6987,GO:0021989,1,0.993380701370849,0,1,olfactory cortex development,BP,
6988,GO:0021993,1,0.993396598875455,0,1,initiation of neural tube closure,BP,
6989,GO:0021997,1,0.986526151263043,0,2,neural plate axis specification,BP,
6990,GO:0021998,1,0.99351061792185,0,1,neural plate mediolateral regionalization,BP,
6991,GO:0021999,1,0.967656144292201,0,5,neural plate anterior/posterior regionalization,BP,
6992,GO:0022007,1,0.980606654751864,0,3,convergent extension involved in neural plate elongation,BP,
6994,GO:0022009,1,0.974424102928794,0,4,central nervous system vasculogenesis,BP,
6996,GO:0022011,1,0.835025848902177,0,27,myelination in peripheral nervous system,BP,
6997,GO:0022012,1,0.99313563936281,0,1,subpallium cell proliferation in forebrain,BP,
6998,GO:0022013,1,0.993102994041828,0,1,pallium cell proliferation in forebrain,BP,
6999,GO:0022018,1,0.99313563936281,0,1,lateral ganglionic eminence cell proliferation,BP,
7000,GO:0022027,1,0.965796203053385,0,5,interkinetic nuclear migration,BP,
7001,GO:0022028,1,0.967121374963378,0,5,tangential migration from the subventricular zone to the olfactory bulb,BP,
7003,GO:0022030,1,0.87615342538249,0,20,telencephalon glial cell migration,BP,
7006,GO:0022400,1,0.861493249003665,0,23,regulation of rhodopsin mediated signaling pathway,BP,
7007,GO:0022401,1,0.896348045387984,0,17,negative adaptation of signaling pathway,BP,
7009,GO:0022403,1,0.986954970037953,0,2,cell cycle phase,BP,
7010,GO:0022404,1,0.583207719675944,0,82,molting cycle process,BP,
7011,GO:0022405,1,0.583207719675944,0,82,hair cycle process,BP,
7012,GO:0022406,1,0.310655545258345,0,178,membrane docking,BP,
7016,GO:0022410,1,0.861903505467667,0,23,circadian sleep/wake cycle process,BP,
7018,GO:0022412,1,0.158696440798201,0,280,cellular process involved in reproduction in multicellular organism,BP,
7019,GO:0022413,1,0.992938094261375,0,1,reproductive process in single-celled organism,BP,
7021,GO:0022417,1,0.956259998995688,0,7,protein maturation by protein folding,BP,
7026,GO:0022605,1,0.961865074980106,0,6,mammalian oogenesis stage,BP,
7030,GO:0022613,1,0.0707073769630371,0,404,ribonucleoprotein complex biogenesis,BP,
7031,GO:0022614,1,0.967798955287943,0,5,membrane to membrane docking,BP,
7032,GO:0022615,1,0.974667429985186,0,4,protein to membrane docking,BP,
7033,GO:0022616,1,0.849646273048052,0,25,DNA strand elongation,BP,
7034,GO:0022617,1,0.636978268702807,0,69,extracellular matrix disassembly,BP,
7035,GO:0022618,1,0.313386064298401,0,178,ribonucleoprotein complex assembly,BP,
7036,GO:0022624,1,0.857488251281546,0,24,proteasome accessory complex,CC,
7037,GO:0022625,1,0.709325614505206,0,54,cytosolic large ribosomal subunit,CC,
7038,GO:0022626,1,0.517645011872249,0,103,cytosolic ribosome,CC,
7039,GO:0022627,1,0.754987746706574,0,44,cytosolic small ribosomal subunit,CC,
7043,GO:0022824,1,0.701240607205105,0,54,transmitter-gated ion channel activity,MF,
7045,GO:0022832,1,0.300568617827603,0,182,voltage-gated channel activity,MF,
7047,GO:0022835,1,0.701240607205105,0,54,transmitter-gated channel activity,MF,
7049,GO:0022839,1,0.775597343921376,0,39,ion gated channel activity,MF,
7050,GO:0022840,1,0.901535105179269,0,16,leak channel activity,MF,
7051,GO:0022841,1,0.913557787556925,0,14,potassium ion leak channel activity,MF,
7052,GO:0022842,1,0.901535105179269,0,16,narrow pore channel activity,MF,
7053,GO:0022843,1,0.421631730454642,0,131,voltage-gated cation channel activity,MF,
7054,GO:0022848,1,0.913394564225622,0,14,acetylcholine-gated cation-selective channel activity,MF,
7055,GO:0022849,1,0.966631648959449,0,5,glutamate-gated calcium ion channel activity,MF,
7056,GO:0022850,1,0.987249035137505,0,2,serotonin-gated cation-selective channel activity,MF,
7057,GO:0022851,1,0.923831423445331,0,12,GABA-gated chloride ion channel activity,MF,
7058,GO:0022852,1,0.987079274541434,0,2,glycine-gated chloride ion channel activity,MF,
7061,GO:0022858,1,0.943008867113691,0,9,alanine transmembrane transporter activity,MF,
7062,GO:0022884,1,0.884001501825373,0,19,macromolecule transmembrane transporter activity,MF,
7063,GO:0022889,1,0.943394401860927,0,9,serine transmembrane transporter activity,MF,
7065,GO:0022894,1,0.993590103266034,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7070,GO:0023016,1,0.980044855574608,0,3,signal transduction by trans-phosphorylation,BP,
7072,GO:0023021,1,0.980842417096519,0,3,termination of signal transduction,BP,
7073,GO:0023023,1,0.857087080812061,0,24,MHC protein complex binding,MF,
7074,GO:0023024,1,0.962240388893998,0,6,MHC class I protein complex binding,MF,
7075,GO:0023025,1,0.98075608130823,0,3,MHC class Ib protein complex binding,MF,
7076,GO:0023026,1,0.902376032420312,0,16,MHC class II protein complex binding,MF,
7077,GO:0023029,1,0.955769301676927,0,7,MHC class Ib protein binding,MF,
7078,GO:0023030,1,0.993533298185381,0,1,MHC class Ib protein binding, via antigen binding groove,MF,
7079,GO:0023035,1,0.907642417655158,0,15,CD40 signaling pathway,BP,
7080,GO:0023041,1,0.961584216405129,0,6,neuronal signal transduction,BP,
7085,GO:0023058,1,0.896348045387984,0,17,adaptation of signaling pathway,BP,
7088,GO:0030002,1,0.936160597030901,0,10,cellular anion homeostasis,BP,
7090,GO:0030004,1,0.500216229170541,0,106,cellular monovalent inorganic cation homeostasis,BP,
7091,GO:0030007,1,0.91255647045231,0,14,cellular potassium ion homeostasis,BP,
7092,GO:0030008,1,0.913719687871913,0,14,TRAPP complex,CC,
7093,GO:0030010,1,0.40727403440514,0,136,establishment of cell polarity,BP,
7094,GO:0030011,1,0.887755690938544,0,18,maintenance of cell polarity,BP,
7095,GO:0030014,1,0.906306794443737,0,15,CCR4-NOT complex,CC,
7096,GO:0030015,1,0.967926344013908,0,5,CCR4-NOT core complex,CC,
7100,GO:0030020,1,0.765466224278514,0,40,extracellular matrix structural constituent conferring tensile strength,MF,
7101,GO:0030021,1,0.899747089779095,0,16,extracellular matrix structural constituent conferring compression resistance,MF,
7102,GO:0030023,1,0.941433331234687,0,9,extracellular matrix constituent conferring elasticity,MF,
7103,GO:0030026,1,0.993531249358711,0,1,cellular manganese ion homeostasis,BP,
7104,GO:0030027,1,0.286109949117059,0,189,lamellipodium,CC,
7108,GO:0030032,1,0.679247493880976,0,59,lamellipodium assembly,BP,
7109,GO:0030033,1,0.894356191345842,0,17,microvillus assembly,BP,
7110,GO:0030034,1,0.993515176255024,0,1,microvillar actin bundle assembly,BP,
7111,GO:0030035,1,0.974048766062796,0,4,microspike assembly,BP,
7113,GO:0030037,1,0.993421142842156,0,1,actin filament reorganization involved in cell cycle,BP,
7116,GO:0030042,1,0.709689322637585,0,52,actin filament depolymerization,BP,
7117,GO:0030043,1,0.974611056624589,0,4,actin filament fragmentation,BP,
7118,GO:0030046,1,0.955407603139833,0,7,parallel actin filament bundle assembly,BP,
7119,GO:0030047,1,0.974329166967607,0,4,actin modification,BP,
7121,GO:0030049,1,0.784016773382783,0,35,muscle filament sliding,BP,
7122,GO:0030050,1,0.886031424181919,0,18,vesicle transport along actin filament,BP,
7125,GO:0030056,1,0.965118021003622,0,5,hemidesmosome,CC,
7126,GO:0030057,1,0.864703490310238,0,22,desmosome,CC,
7127,GO:0030060,1,0.974736529062985,0,4,L-malate dehydrogenase activity,MF,
7128,GO:0030061,1,0.955565767475723,0,7,mitochondrial crista,CC,
7129,GO:0030062,1,0.961523062836803,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7130,GO:0030070,1,0.987058058921323,0,2,insulin processing,BP,
7131,GO:0030071,1,0.697912067596426,0,55,regulation of mitotic metaphase/anaphase transition,BP,
7134,GO:0030091,1,0.956074899828445,0,7,protein repair,BP,
7139,GO:0030101,1,0.682398894262587,0,59,natural killer cell activation,BP,
7140,GO:0030103,1,0.987275510175506,0,2,vasopressin secretion,BP,
7141,GO:0030104,1,0.648366694123108,0,66,water homeostasis,BP,
7142,GO:0030107,1,0.993551538450257,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7143,GO:0030108,1,0.993641352291369,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7144,GO:0030109,1,0.987204914170652,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7146,GO:0030116,1,0.97492510267027,0,4,glial cell-derived neurotrophic factor receptor binding,MF,
7147,GO:0030117,1,0.559135893337973,0,89,membrane coat,CC,
7148,GO:0030118,1,0.754621778240414,0,43,clathrin coat,CC,
7149,GO:0030119,1,0.785519533263668,0,37,AP-type membrane coat adaptor complex,CC,
7150,GO:0030120,1,0.712416134238331,0,52,vesicle coat,CC,
7151,GO:0030121,1,0.967945902357965,0,5,AP-1 adaptor complex,CC,
7152,GO:0030122,1,0.936711231570819,0,10,AP-2 adaptor complex,CC,
7153,GO:0030123,1,0.942830086202347,0,9,AP-3 adaptor complex,CC,
7154,GO:0030124,1,0.974351088682605,0,4,AP-4 adaptor complex,CC,
7155,GO:0030125,1,0.843830652058552,0,26,clathrin vesicle coat,CC,
7156,GO:0030126,1,0.92540914182024,0,12,COPI vesicle coat,CC,
7157,GO:0030127,1,0.906691000316284,0,15,COPII vesicle coat,CC,
7158,GO:0030128,1,0.930566616466594,0,11,clathrin coat of endocytic vesicle,CC,
7159,GO:0030130,1,0.930628884277145,0,11,clathrin coat of trans-Golgi network vesicle,CC,
7160,GO:0030131,1,0.866332264649678,0,22,clathrin adaptor complex,CC,
7161,GO:0030132,1,0.90638189538385,0,15,clathrin coat of coated pit,CC,
7163,GO:0030134,1,0.563764087697659,0,88,COPII-coated ER to Golgi transport vesicle,CC,
7170,GO:0030142,1,0.992983269287457,0,1,COPI-coated Golgi to ER transport vesicle,CC,
7171,GO:0030144,1,0.987098752562451,0,2,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7172,GO:0030145,1,0.6759470826759,0,60,manganese ion binding,MF,
7173,GO:0030148,1,0.541879914661949,0,94,sphingolipid biosynthetic process,BP,
7175,GO:0030150,1,0.896611296782263,0,17,protein import into mitochondrial matrix,BP,
7176,GO:0030151,1,0.98718402420763,0,2,molybdenum ion binding,MF,
7179,GO:0030156,1,0.993690162461986,0,1,benzodiazepine receptor binding,MF,
7180,GO:0030157,1,0.931050164038502,0,11,pancreatic juice secretion,BP,
7181,GO:0030158,1,0.986586582279483,0,2,protein xylosyltransferase activity,MF,
7182,GO:0030159,1,0.763570913671414,0,41,signaling receptor complex adaptor activity,MF,
7183,GO:0030160,1,0.97338907278871,0,4,synaptic receptor adaptor activity,MF,
7187,GO:0030166,1,0.655830147610803,0,64,proteoglycan biosynthetic process,BP,
7188,GO:0030167,1,0.974355169401499,0,4,proteoglycan catabolic process,BP,
7190,GO:0030169,1,0.91220134327415,0,14,low-density lipoprotein particle binding,MF,
7191,GO:0030170,1,0.75197952693975,0,44,pyridoxal phosphate binding,MF,
7192,GO:0030171,1,0.993624510783113,0,1,voltage-gated proton channel activity,MF,
7193,GO:0030172,1,0.981125574769891,0,3,troponin C binding,MF,
7194,GO:0030173,1,0.686041383693627,0,58,integral component of Golgi membrane,CC,
7195,GO:0030174,1,0.955769376958777,0,7,regulation of DNA-dependent DNA replication initiation,BP,
7197,GO:0030176,1,0.387446481379596,0,146,integral component of endoplasmic reticulum membrane,CC,
7198,GO:0030177,1,0.325300911085815,0,171,positive regulation of Wnt signaling pathway,BP,
7201,GO:0030183,1,0.483091937277852,0,111,B cell differentiation,BP,
7202,GO:0030184,1,0.993557999392919,0,1,nitric oxide transmembrane transporter activity,MF,
7203,GO:0030185,1,0.98097595262134,0,3,nitric oxide transport,BP,
7204,GO:0030186,1,0.993641718764055,0,1,melatonin metabolic process,BP,
7205,GO:0030187,1,0.993641718764055,0,1,melatonin biosynthetic process,BP,
7207,GO:0030194,1,0.850339870902156,0,25,positive regulation of blood coagulation,BP,
7209,GO:0030197,1,0.987061174050527,0,2,extracellular matrix constituent, lubricant activity,MF,
7212,GO:0030200,1,0.980808863546386,0,3,heparan sulfate proteoglycan catabolic process,BP,
7213,GO:0030201,1,0.810554381607479,0,32,heparan sulfate proteoglycan metabolic process,BP,
7214,GO:0030202,1,0.936420817653148,0,10,heparin metabolic process,BP,
7217,GO:0030205,1,0.917927420228704,0,13,dermatan sulfate metabolic process,BP,
7218,GO:0030206,1,0.842883901339192,0,26,chondroitin sulfate biosynthetic process,BP,
7219,GO:0030207,1,0.912440826037585,0,14,chondroitin sulfate catabolic process,BP,
7220,GO:0030208,1,0.923850966987088,0,12,dermatan sulfate biosynthetic process,BP,
7221,GO:0030209,1,0.993593261226275,0,1,dermatan sulfate catabolic process,BP,
7222,GO:0030210,1,0.94246249650557,0,9,heparin biosynthetic process,BP,
7223,GO:0030211,1,0.993593261226275,0,1,heparin catabolic process,BP,
7224,GO:0030212,1,0.796353998461184,0,35,hyaluronan metabolic process,BP,
7225,GO:0030213,1,0.912764956860219,0,14,hyaluronan biosynthetic process,BP,
7226,GO:0030214,1,0.913209240083037,0,14,hyaluronan catabolic process,BP,
7227,GO:0030215,1,0.858992951080986,0,23,semaphorin receptor binding,MF,
7228,GO:0030216,1,0.399889353619687,0,140,keratinocyte differentiation,BP,
7230,GO:0030218,1,0.477018638856474,0,113,erythrocyte differentiation,BP,
7231,GO:0030219,1,0.63599037676021,0,69,megakaryocyte differentiation,BP,
7232,GO:0030220,1,0.876295957257271,0,20,platelet formation,BP,
7233,GO:0030221,1,0.987101652262094,0,2,basophil differentiation,BP,
7234,GO:0030222,1,0.980798262337535,0,3,eosinophil differentiation,BP,
7235,GO:0030223,1,0.949111786844382,0,8,neutrophil differentiation,BP,
7236,GO:0030224,1,0.800696271544685,0,34,monocyte differentiation,BP,
7237,GO:0030225,1,0.766686385403324,0,41,macrophage differentiation,BP,
7238,GO:0030226,1,0.978755826234481,0,3,apolipoprotein receptor activity,MF,
7239,GO:0030228,1,0.904743908163783,0,15,lipoprotein particle receptor activity,MF,
7240,GO:0030229,1,0.974191899130179,0,4,very-low-density lipoprotein particle receptor activity,MF,
7241,GO:0030233,1,0.993630035639127,0,1,deoxynucleotide transmembrane transporter activity,MF,
7243,GO:0030235,1,0.955056134335191,0,7,nitric-oxide synthase regulator activity,MF,
7244,GO:0030237,1,0.987085391146965,0,2,female sex determination,BP,
7245,GO:0030238,1,0.91267540073771,0,14,male sex determination,BP,
7247,GO:0030240,1,0.948853513669635,0,6,skeletal muscle thin filament assembly,BP,
7248,GO:0030241,1,0.967199782444305,0,3,skeletal muscle myosin thick filament assembly,BP,
7249,GO:0030242,1,0.967705867596812,0,5,autophagy of peroxisome,BP,
7252,GO:0030249,1,0.974690582313291,0,4,guanylate cyclase regulator activity,MF,
7253,GO:0030250,1,0.980983059225986,0,3,guanylate cyclase activator activity,MF,
7254,GO:0030251,1,0.993586767336276,0,1,guanylate cyclase inhibitor activity,MF,
7255,GO:0030252,1,0.912510600197349,0,14,growth hormone secretion,BP,
7257,GO:0030259,1,0.93745944031693,0,10,lipid glycosylation,BP,
7258,GO:0030261,1,0.826800642400481,0,27,chromosome condensation,BP,
7259,GO:0030262,1,0.81197005672076,0,32,apoptotic nuclear changes,BP,
7260,GO:0030263,1,0.974143280171655,0,4,apoptotic chromosome condensation,BP,
7261,GO:0030264,1,0.99355705431691,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7262,GO:0030267,1,0.99365700630751,0,1,glyoxylate reductase (NADP) activity,MF,
7263,GO:0030272,1,0.993680610097799,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7264,GO:0030273,1,0.993578627277328,0,1,melanin-concentrating hormone receptor activity,MF,
7265,GO:0030274,1,0.961485714449623,0,6,LIM domain binding,MF,
7266,GO:0030275,1,0.912589933404177,0,14,LRR domain binding,MF,
7267,GO:0030276,1,0.656648706688001,0,64,clathrin binding,MF,
7271,GO:0030280,1,0.967367353420601,0,5,structural constituent of skin epidermis,MF,
7273,GO:0030283,1,0.962501252931845,0,6,testosterone dehydrogenase [NAD(P)] activity,MF,
7274,GO:0030284,1,0.967901185750942,0,5,estrogen receptor activity,MF,
7276,GO:0030286,1,0.727888240027343,0,47,dynein complex,CC,
7277,GO:0030289,1,0.980906572746405,0,3,protein phosphatase 4 complex,CC,
7278,GO:0030290,1,0.99351293062108,0,1,sphingolipid activator protein activity,MF,
7279,GO:0030291,1,0.834341469069231,0,28,protein serine/threonine kinase inhibitor activity,MF,
7280,GO:0030292,1,0.98698757041116,0,2,protein tyrosine kinase inhibitor activity,MF,
7281,GO:0030294,1,0.993592305522835,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7285,GO:0030299,1,0.9373206124697,0,10,intestinal cholesterol absorption,BP,
7286,GO:0030300,1,0.974593006378662,0,4,regulation of intestinal cholesterol absorption,BP,
7287,GO:0030301,1,0.611835642625589,0,75,cholesterol transport,BP,
7288,GO:0030302,1,0.993630035639127,0,1,deoxynucleotide transport,BP,
7289,GO:0030305,1,0.987135653551042,0,2,heparanase activity,MF,
7290,GO:0030306,1,0.954372792858888,0,7,ADP-ribosylation factor binding,MF,
7293,GO:0030309,1,0.931269406596835,0,11,poly-N-acetyllactosamine metabolic process,BP,
7294,GO:0030311,1,0.937340841962142,0,10,poly-N-acetyllactosamine biosynthetic process,BP,
7295,GO:0030312,1,0.980965165080472,0,3,external encapsulating structure,CC,
7296,GO:0030314,1,0.954233065835751,0,7,junctional membrane complex,CC,
7299,GO:0030317,1,0.61960863231068,0,73,flagellated sperm motility,BP,
7300,GO:0030318,1,0.85293074885045,0,24,melanocyte differentiation,BP,
7301,GO:0030320,1,0.936160597030901,0,10,cellular monovalent inorganic anion homeostasis,BP,
7302,GO:0030321,1,0.968045006580306,0,5,transepithelial chloride transport,BP,
7303,GO:0030322,1,0.907763190344133,0,15,stabilization of membrane potential,BP,
7308,GO:0030327,1,0.980619534776319,0,3,prenylated protein catabolic process,BP,
7309,GO:0030328,1,0.987001003788117,0,2,prenylcysteine catabolic process,BP,
7310,GO:0030329,1,0.987001003788117,0,2,prenylcysteine metabolic process,BP,
7311,GO:0030330,1,0.512480157048112,0,102,DNA damage response, signal transduction by p53 class mediator,BP,
7313,GO:0030332,1,0.827562517681754,0,29,cyclin binding,MF,
7317,GO:0030337,1,0.980961720753819,0,3,DNA polymerase processivity factor activity,MF,
7318,GO:0030342,1,0.993534499479782,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7319,GO:0030343,1,0.98725891538831,0,2,vitamin D3 25-hydroxylase activity,MF,
7320,GO:0030345,1,0.993539532268693,0,1,structural constituent of tooth enamel,MF,
7321,GO:0030346,1,0.955145645315805,0,7,protein phosphatase 2B binding,MF,
7322,GO:0030348,1,0.980654957523045,0,3,syntaxin-3 binding,MF,
7323,GO:0030350,1,0.986859357870397,0,2,iron-responsive element binding,MF,
7324,GO:0030351,1,0.993552513362211,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7325,GO:0030354,1,0.993689109222643,0,1,melanin-concentrating hormone activity,MF,
7326,GO:0030366,1,0.993644715526298,0,1,molybdopterin synthase activity,MF,
7327,GO:0030368,1,0.94908179186981,0,8,interleukin-17 receptor activity,MF,
7328,GO:0030369,1,0.98699966572757,0,2,ICAM-3 receptor activity,MF,
7329,GO:0030371,1,0.848917957645455,0,25,translation repressor activity,MF,
7330,GO:0030374,1,0.700672747646315,0,54,nuclear receptor transcription coactivator activity,MF,
7331,GO:0030375,1,0.973723613976346,0,4,thyroid hormone receptor coactivator activity,MF,
7332,GO:0030377,1,0.993643716929759,0,1,urokinase plasminogen activator receptor activity,MF,
7333,GO:0030378,1,0.993574747073295,0,1,serine racemase activity,MF,
7334,GO:0030379,1,0.993244878363986,0,1,neurotensin receptor activity, non-G protein-coupled,MF,
7335,GO:0030382,1,0.992890508145322,0,1,sperm mitochondrion organization,BP,
7336,GO:0030387,1,0.993644049831006,0,1,fructosamine-3-kinase activity,MF,
7337,GO:0030388,1,0.955959579187396,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7338,GO:0030389,1,0.987377515031459,0,2,fructosamine metabolic process,BP,
7339,GO:0030393,1,0.993644049831006,0,1,fructoselysine metabolic process,BP,
7340,GO:0030395,1,0.987365494989778,0,2,lactose binding,MF,
7341,GO:0030397,1,0.90088705242338,0,16,membrane disassembly,BP,
7342,GO:0030407,1,0.993612931689035,0,1,formimidoyltransferase activity,MF,
7343,GO:0030409,1,0.993612931689035,0,1,glutamate formimidoyltransferase activity,MF,
7344,GO:0030412,1,0.993612931689035,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7346,GO:0030421,1,0.993679686869083,0,1,defecation,BP,
7347,GO:0030422,1,0.936913552404883,0,10,production of siRNA involved in RNA interference,BP,
7348,GO:0030423,1,0.973906412869706,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7353,GO:0030429,1,0.993640552559868,0,1,kynureninase activity,MF,
7354,GO:0030430,1,0.962006752800934,0,6,host cell cytoplasm,CC,
7355,GO:0030431,1,0.82235519656672,0,30,sleep,BP,
7356,GO:0030432,1,0.943680387192977,0,9,peristalsis,BP,
7357,GO:0030433,1,0.630055792474411,0,71,ubiquitin-dependent ERAD pathway,BP,
7358,GO:0030449,1,0.766439467979115,0,41,regulation of complement activation,BP,
7359,GO:0030450,1,0.980350554551774,0,3,regulation of complement activation, classical pathway,BP,
7360,GO:0030451,1,0.980385303226424,0,3,regulation of complement activation, alternative pathway,BP,
7361,GO:0030473,1,0.967064262468125,0,5,nuclear migration along microtubule,BP,
7362,GO:0030478,1,0.974223308198262,0,4,actin cap,CC,
7363,GO:0030485,1,0.980841667258366,0,3,smooth muscle contractile fiber,CC,
7364,GO:0030488,1,0.786536049583556,0,37,tRNA methylation,BP,
7365,GO:0030490,1,0.742252755924807,0,46,maturation of SSU-rRNA,BP,
7366,GO:0030492,1,0.950323450729654,0,8,hemoglobin binding,MF,
7367,GO:0030496,1,0.335751789370555,0,166,midbody,CC,
7368,GO:0030497,1,0.92529554418025,0,12,fatty acid elongation,BP,
7370,GO:0030501,1,0.784326400805488,0,37,positive regulation of bone mineralization,BP,
7372,GO:0030504,1,0.993136484344882,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7373,GO:0030505,1,0.986388855303187,0,2,inorganic diphosphate transport,BP,
7374,GO:0030506,1,0.884268966563433,0,18,ankyrin binding,MF,
7375,GO:0030507,1,0.835884952907308,0,27,spectrin binding,MF,
7378,GO:0030511,1,0.825946289962055,0,29,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7379,GO:0030512,1,0.602044567026444,0,77,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7380,GO:0030513,1,0.814299986453031,0,31,positive regulation of BMP signaling pathway,BP,
7382,GO:0030515,1,0.822676408907907,0,30,snoRNA binding,MF,
7386,GO:0030519,1,0.993492644036998,0,1,snoRNP binding,MF,
7388,GO:0030521,1,0.779323574773176,0,38,androgen receptor signaling pathway,BP,
7390,GO:0030523,1,0.993466792606792,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7391,GO:0030526,1,0.99343059475148,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7392,GO:0030527,1,0.993607734572613,0,1,structural constituent of chromatin,MF,
7393,GO:0030532,1,0.674401841815846,0,61,small nuclear ribonucleoprotein complex,CC,
7395,GO:0030538,1,0.980856161952572,0,3,embryonic genitalia morphogenesis,BP,
7401,GO:0030547,1,0.862051153817402,0,23,receptor inhibitor activity,MF,
7402,GO:0030548,1,0.943964651429143,0,9,acetylcholine receptor regulator activity,MF,
7403,GO:0030549,1,0.993662936809219,0,1,acetylcholine receptor activator activity,MF,
7404,GO:0030550,1,0.962205282389979,0,6,acetylcholine receptor inhibitor activity,MF,
7405,GO:0030551,1,0.805153297845661,0,33,cyclic nucleotide binding,MF,
7406,GO:0030552,1,0.859683573703127,0,23,cAMP binding,MF,
7407,GO:0030553,1,0.924170752147432,0,12,cGMP binding,MF,
7409,GO:0030572,1,0.993500810126899,0,1,phosphatidyltransferase activity,MF,
7410,GO:0030573,1,0.993606964505936,0,1,bile acid catabolic process,BP,
7412,GO:0030575,1,0.905139179153799,0,15,nuclear body organization,BP,
7413,GO:0030576,1,0.974512210666545,0,4,Cajal body organization,BP,
7414,GO:0030578,1,0.960491991286328,0,6,PML body organization,BP,
7415,GO:0030579,1,0.967899454450118,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7416,GO:0030580,1,0.987334159261577,0,2,quinone cofactor methyltransferase activity,MF,
7417,GO:0030581,1,0.987348677121156,0,2,symbiont intracellular protein transport in host,BP,
7418,GO:0030586,1,0.993528148521336,0,1,[methionine synthase] reductase activity,MF,
7419,GO:0030592,1,0.980808752911954,0,3,DNA ADP-ribosylation,BP,
7420,GO:0030593,1,0.58146941217395,0,84,neutrophil chemotaxis,BP,
7421,GO:0030594,1,0.55148443622452,0,91,neurotransmitter receptor activity,MF,
7423,GO:0030611,1,0.993678763465064,0,1,arsenate reductase activity,MF,
7424,GO:0030613,1,0.981124765007104,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7425,GO:0030614,1,0.981124765007104,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7426,GO:0030619,1,0.955604335459257,0,7,U1 snRNA binding,MF,
7427,GO:0030620,1,0.974375079355697,0,4,U2 snRNA binding,MF,
7428,GO:0030621,1,0.96797246766343,0,5,U4 snRNA binding,MF,
7429,GO:0030622,1,0.987019894002955,0,2,U4atac snRNA binding,MF,
7430,GO:0030623,1,0.986742681759716,0,2,U5 snRNA binding,MF,
7431,GO:0030624,1,0.993464683510922,0,1,U6atac snRNA binding,MF,
7432,GO:0030626,1,0.987153644986792,0,2,U12 snRNA binding,MF,
7433,GO:0030627,1,0.993659923054731,0,1,pre-mRNA 5'-splice site binding,MF,
7434,GO:0030628,1,0.968455431326311,0,5,pre-mRNA 3'-splice site binding,MF,
7435,GO:0030629,1,0.987290278308935,0,2,U6 snRNA 3'-end binding,MF,
7436,GO:0030638,1,0.944118307211244,0,9,polyketide metabolic process,BP,
7437,GO:0030641,1,0.567093142867239,0,87,regulation of cellular pH,BP,
7438,GO:0030643,1,0.967435620578228,0,5,cellular phosphate ion homeostasis,BP,
7439,GO:0030644,1,0.967682769952863,0,5,cellular chloride ion homeostasis,BP,
7440,GO:0030647,1,0.944118307211244,0,9,aminoglycoside antibiotic metabolic process,BP,
7441,GO:0030653,1,0.99341300588565,0,1,beta-lactam antibiotic metabolic process,BP,
7442,GO:0030656,1,0.925395537029859,0,12,regulation of vitamin metabolic process,BP,
7447,GO:0030663,1,0.89622650881946,0,17,COPI-coated vesicle membrane,CC,
7451,GO:0030669,1,0.785531260185233,0,37,clathrin-coated endocytic vesicle membrane,CC,
7452,GO:0030670,1,0.630388177585907,0,71,phagocytic vesicle membrane,CC,
7454,GO:0030673,1,0.904294330426479,0,15,axolemma,CC,
7455,GO:0030674,1,0.213840833957057,0,234,protein-macromolecule adaptor activity,MF,
7456,GO:0030676,1,0.881826461730104,0,19,Rac guanyl-nucleotide exchange factor activity,MF,
7457,GO:0030677,1,0.925889512896667,0,12,ribonuclease P complex,CC,
7458,GO:0030678,1,0.987273485181826,0,2,mitochondrial ribonuclease P complex,CC,
7459,GO:0030681,1,0.937832466966942,0,10,multimeric ribonuclease P complex,CC,
7460,GO:0030682,1,0.980305876166821,0,3,mitigation of host defenses by symbiont,BP,
7461,GO:0030683,1,0.987004970665312,0,2,mitigation of host immune response by virus,BP,
7462,GO:0030684,1,0.633260320699736,0,70,preribosome,CC,
7463,GO:0030686,1,0.849607571606648,0,25,90S preribosome,CC,
7464,GO:0030687,1,0.866291991360076,0,22,preribosome, large subunit precursor,CC,
7465,GO:0030688,1,0.907039567524324,0,15,preribosome, small subunit precursor,CC,
7466,GO:0030689,1,0.980854650102331,0,3,Noc complex,CC,
7467,GO:0030690,1,0.993554478974729,0,1,Noc1p-Noc2p complex,CC,
7468,GO:0030691,1,0.993554478974729,0,1,Noc2p-Noc3p complex,CC,
7469,GO:0030692,1,0.987218604398355,0,2,Noc4p-Nop14p complex,CC,
7471,GO:0030696,1,0.993535087987529,0,1,tRNA (m5U54) methyltransferase activity,MF,
7472,GO:0030697,1,0.993535087987529,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7473,GO:0030704,1,0.993601552792331,0,1,vitelline membrane formation,BP,
7474,GO:0030705,1,0.291038288281387,0,186,cytoskeleton-dependent intracellular transport,BP,
7475,GO:0030718,1,0.987175695996792,0,2,germ-line stem cell population maintenance,BP,
7476,GO:0030719,1,0.98712597776074,0,2,P granule organization,BP,
7477,GO:0030728,1,0.871565443486536,0,21,ovulation,BP,
7478,GO:0030729,1,0.993525928042811,0,1,acetoacetate-CoA ligase activity,MF,
7479,GO:0030730,1,0.895190219403844,0,17,sequestering of triglyceride,BP,
7480,GO:0030731,1,0.993672426611534,0,1,guanidinoacetate N-methyltransferase activity,MF,
7481,GO:0030742,1,0.860914361161019,0,23,GTP-dependent protein binding,MF,
7482,GO:0030748,1,0.993569914492127,0,1,amine N-methyltransferase activity,MF,
7483,GO:0030760,1,0.993634581041459,0,1,pyridine N-methyltransferase activity,MF,
7484,GO:0030791,1,0.993575380175285,0,1,arsenite methyltransferase activity,MF,
7485,GO:0030792,1,0.987050000221097,0,2,methylarsonite methyltransferase activity,MF,
7486,GO:0030808,1,0.801619126220786,0,34,regulation of nucleotide biosynthetic process,BP,
7487,GO:0030809,1,0.961927424330101,0,6,negative regulation of nucleotide biosynthetic process,BP,
7488,GO:0030810,1,0.895643982862098,0,17,positive regulation of nucleotide biosynthetic process,BP,
7489,GO:0030832,1,0.324757759739712,0,171,regulation of actin filament length,BP,
7490,GO:0030833,1,0.361928473470286,0,155,regulation of actin filament polymerization,BP,
7491,GO:0030834,1,0.728769674391291,0,48,regulation of actin filament depolymerization,BP,
7492,GO:0030835,1,0.778119805359707,0,38,negative regulation of actin filament depolymerization,BP,
7493,GO:0030836,1,0.936722223992945,0,10,positive regulation of actin filament depolymerization,BP,
7494,GO:0030837,1,0.687869354853552,0,57,negative regulation of actin filament polymerization,BP,
7495,GO:0030838,1,0.563664038232775,0,88,positive regulation of actin filament polymerization,BP,
7496,GO:0030842,1,0.993373819886646,0,1,regulation of intermediate filament depolymerization,BP,
7497,GO:0030844,1,0.993373819886646,0,1,positive regulation of intermediate filament depolymerization,BP,
7498,GO:0030845,1,0.99355205394135,0,1,phospholipase C-inhibiting G protein-coupled receptor signaling pathway,BP,
7499,GO:0030846,1,0.980104177957859,0,3,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7500,GO:0030849,1,0.98707307869969,0,2,autosome,CC,
7501,GO:0030850,1,0.734271743476562,0,47,prostate gland development,BP,
7502,GO:0030851,1,0.823006237603685,0,30,granulocyte differentiation,BP,
7503,GO:0030852,1,0.919167596518692,0,13,regulation of granulocyte differentiation,BP,
7504,GO:0030853,1,0.955480156579181,0,7,negative regulation of granulocyte differentiation,BP,
7505,GO:0030854,1,0.955766922911045,0,7,positive regulation of granulocyte differentiation,BP,
7507,GO:0030856,1,0.420071465722557,0,132,regulation of epithelial cell differentiation,BP,
7508,GO:0030857,1,0.765290916144938,0,41,negative regulation of epithelial cell differentiation,BP,
7509,GO:0030858,1,0.711645185745859,0,52,positive regulation of epithelial cell differentiation,BP,
7510,GO:0030859,1,0.865431216195148,0,22,polarized epithelial cell differentiation,BP,
7511,GO:0030860,1,0.986989861613383,0,2,regulation of polarized epithelial cell differentiation,BP,
7512,GO:0030862,1,0.99337403039786,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7515,GO:0030865,1,0.679560430173059,0,59,cortical cytoskeleton organization,BP,
7516,GO:0030866,1,0.778741378649373,0,38,cortical actin cytoskeleton organization,BP,
7517,GO:0030867,1,0.840321342531095,0,27,rough endoplasmic reticulum membrane,CC,
7518,GO:0030868,1,0.968143058839119,0,5,smooth endoplasmic reticulum membrane,CC,
7519,GO:0030870,1,0.967812978606024,0,5,Mre11 complex,CC,
7520,GO:0030874,1,0.993625080542958,0,1,nucleolar chromatin,CC,
7521,GO:0030877,1,0.923676845862752,0,12,beta-catenin destruction complex,CC,
7522,GO:0030878,1,0.872744844987917,0,21,thyroid gland development,BP,
7523,GO:0030879,1,0.426942911049051,0,129,mammary gland development,BP,
7524,GO:0030880,1,0.524992857961819,0,99,RNA polymerase complex,CC,
7525,GO:0030881,1,0.956145723289725,0,7,beta-2-microglobulin binding,MF,
7526,GO:0030882,1,0.96824199896289,0,5,lipid antigen binding,MF,
7527,GO:0030883,1,0.974526242702554,0,4,endogenous lipid antigen binding,MF,
7528,GO:0030884,1,0.974526242702554,0,4,exogenous lipid antigen binding,MF,
7529,GO:0030885,1,0.962379589580417,0,6,regulation of myeloid dendritic cell activation,BP,
7530,GO:0030886,1,0.980984098234455,0,3,negative regulation of myeloid dendritic cell activation,BP,
7531,GO:0030887,1,0.987288549312743,0,2,positive regulation of myeloid dendritic cell activation,BP,
7533,GO:0030889,1,0.895023889861837,0,17,negative regulation of B cell proliferation,BP,
7534,GO:0030890,1,0.791659221741039,0,36,positive regulation of B cell proliferation,BP,
7535,GO:0030891,1,0.980844185730543,0,3,VCB complex,CC,
7536,GO:0030892,1,0.980830938341138,0,3,mitotic cohesin complex,CC,
7537,GO:0030893,1,0.955008777698433,0,7,meiotic cohesin complex,CC,
7538,GO:0030894,1,0.850558831900078,0,25,replisome,CC,
7539,GO:0030895,1,0.987217284019527,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7540,GO:0030896,1,0.974501953169471,0,4,checkpoint clamp complex,CC,
7541,GO:0030897,1,0.923618339446287,0,12,HOPS complex,CC,
7542,GO:0030898,1,0.856050035315847,0,23,actin-dependent ATPase activity,MF,
7543,GO:0030899,1,0.98073344120284,0,3,calcium-dependent ATPase activity,MF,
7547,GO:0030903,1,0.888985000573853,0,18,notochord development,BP,
7548,GO:0030904,1,0.877497207450245,0,20,retromer complex,CC,
7549,GO:0030905,1,0.974142261394353,0,4,retromer, tubulation complex,CC,
7550,GO:0030906,1,0.974513002480093,0,4,retromer, cargo-selective complex,CC,
7551,GO:0030908,1,0.987276590604405,0,2,protein splicing,BP,
7552,GO:0030910,1,0.980545934366415,0,3,olfactory placode formation,BP,
7553,GO:0030911,1,0.948996813975842,0,8,TPR domain binding,MF,
7554,GO:0030913,1,0.954610674568671,0,7,paranodal junction assembly,BP,
7555,GO:0030914,1,0.930678850912872,0,11,STAGA complex,CC,
7556,GO:0030915,1,0.961965839583046,0,6,Smc5-Smc6 complex,CC,
7557,GO:0030916,1,0.949517694536679,0,8,otic vesicle formation,BP,
7558,GO:0030917,1,0.955330769621303,0,7,midbrain-hindbrain boundary development,BP,
7559,GO:0030920,1,0.987359064993001,0,2,peptidyl-serine acetylation,BP,
7560,GO:0030934,1,0.979442734842809,0,3,anchoring collagen complex,CC,
7561,GO:0030935,1,0.9935656219776,0,1,sheet-forming collagen trimer,CC,
7562,GO:0030936,1,0.993540619115763,0,1,transmembrane collagen trimer,CC,
7563,GO:0030942,1,0.980947417577509,0,3,endoplasmic reticulum signal peptide binding,MF,
7564,GO:0030943,1,0.98083648524216,0,3,mitochondrion targeting sequence binding,MF,
7565,GO:0030947,1,0.833365807550037,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7566,GO:0030948,1,0.931019703385591,0,11,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7567,GO:0030949,1,0.919093376244151,0,13,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7568,GO:0030950,1,0.967719940262461,0,5,establishment or maintenance of actin cytoskeleton polarity,BP,
7569,GO:0030951,1,0.974173847610748,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7570,GO:0030952,1,0.942719361736557,0,9,establishment or maintenance of cytoskeleton polarity,BP,
7571,GO:0030953,1,0.935991033331835,0,10,astral microtubule organization,BP,
7572,GO:0030954,1,0.993404576710679,0,1,astral microtubule nucleation,BP,
7573,GO:0030955,1,0.924407705954721,0,12,potassium ion binding,MF,
7574,GO:0030956,1,0.980872649372175,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7575,GO:0030957,1,0.937296087093926,0,10,Tat protein binding,MF,
7576,GO:0030961,1,0.99355705431691,0,1,peptidyl-arginine hydroxylation,BP,
7577,GO:0030964,1,0.770374502425089,0,41,NADH dehydrogenase complex,CC,
7579,GO:0030970,1,0.844593723501548,0,26,retrograde protein transport, ER to cytosol,BP,
7580,GO:0030971,1,0.645363361453689,0,67,receptor tyrosine kinase binding,MF,
7581,GO:0030974,1,0.98723499238184,0,2,thiamine pyrophosphate transmembrane transport,BP,
7582,GO:0030975,1,0.993582419392773,0,1,thiamine binding,MF,
7583,GO:0030976,1,0.955597133751157,0,7,thiamine pyrophosphate binding,MF,
7584,GO:0030977,1,0.993618773504528,0,1,taurine binding,MF,
7585,GO:0030981,1,0.980088822637815,0,3,cortical microtubule cytoskeleton,CC,
7586,GO:0030983,1,0.918918053926319,0,13,mismatched DNA binding,MF,
7587,GO:0030984,1,0.987259460690505,0,2,kininogen binding,MF,
7588,GO:0030990,1,0.839030029193727,0,27,intraciliary transport particle,CC,
7589,GO:0030991,1,0.954938683024987,0,7,intraciliary transport particle A,CC,
7590,GO:0030992,1,0.884299848895585,0,19,intraciliary transport particle B,CC,
7591,GO:0030997,1,0.980370222001153,0,3,regulation of centriole-centriole cohesion,BP,
7593,GO:0031004,1,0.98056745173748,0,3,potassium ion-transporting ATPase complex,CC,
7594,GO:0031005,1,0.936529611621855,0,10,filamin binding,MF,
7595,GO:0031010,1,0.929767843882628,0,11,ISWI-type complex,CC,
7596,GO:0031011,1,0.907883793739286,0,15,Ino80 complex,CC,
7598,GO:0031013,1,0.968576827726128,0,5,troponin I binding,MF,
7599,GO:0031014,1,0.974974770588628,0,4,troponin T binding,MF,
7601,GO:0031017,1,0.961448607549892,0,6,exocrine pancreas development,BP,
7603,GO:0031021,1,0.99355705431691,0,1,interphase microtubule organizing center,CC,
7604,GO:0031022,1,0.986265238684018,0,2,nuclear migration along microfilament,BP,
7605,GO:0031023,1,0.422000197956158,0,131,microtubule organizing center organization,BP,
7607,GO:0031033,1,0.954764148601516,0,5,myosin filament organization,BP,
7608,GO:0031034,1,0.960917465088031,0,4,myosin filament assembly,BP,
7609,GO:0031038,1,0.993598956749965,0,1,myosin II filament organization,BP,
7610,GO:0031045,1,0.836617731822526,0,27,dense core granule,CC,
7611,GO:0031047,1,0.397872706862047,0,140,gene silencing by RNA,BP,
7612,GO:0031048,1,0.980355203859531,0,3,heterochromatin assembly by small RNA,BP,
7613,GO:0031049,1,0.987017955272666,0,2,programmed DNA elimination,BP,
7615,GO:0031052,1,0.987017955272666,0,2,chromosome breakage,BP,
7616,GO:0031053,1,0.918287386912732,0,13,primary miRNA processing,BP,
7617,GO:0031054,1,0.924519031613176,0,12,pre-miRNA processing,BP,
7618,GO:0031055,1,0.834675656768769,0,28,chromatin remodeling at centromere,BP,
7621,GO:0031058,1,0.569094455001559,0,86,positive regulation of histone modification,BP,
7622,GO:0031060,1,0.67802047750854,0,59,regulation of histone methylation,BP,
7623,GO:0031061,1,0.888794252847453,0,18,negative regulation of histone methylation,BP,
7624,GO:0031062,1,0.789464749522706,0,36,positive regulation of histone methylation,BP,
7625,GO:0031063,1,0.837819100280621,0,27,regulation of histone deacetylation,BP,
7626,GO:0031064,1,0.961259486122856,0,6,negative regulation of histone deacetylation,BP,
7627,GO:0031065,1,0.89436586218848,0,17,positive regulation of histone deacetylation,BP,
7628,GO:0031069,1,0.84937185047387,0,25,hair follicle morphogenesis,BP,
7629,GO:0031071,1,0.993581194246427,0,1,cysteine desulfurase activity,MF,
7631,GO:0031073,1,0.993586571780172,0,1,cholesterol 26-hydroxylase activity,MF,
7632,GO:0031074,1,0.980647184077467,0,3,nucleocytoplasmic transport complex,CC,
7633,GO:0031076,1,0.772490142138791,0,39,embryonic camera-type eye development,BP,
7634,GO:0031077,1,0.955336707152291,0,7,post-embryonic camera-type eye development,BP,
7635,GO:0031078,1,0.936411953261762,0,10,histone deacetylase activity (H3-K14 specific),MF,
7636,GO:0031080,1,0.936698299112654,0,10,nuclear pore outer ring,CC,
7637,GO:0031082,1,0.884533379397283,0,19,BLOC complex,CC,
7638,GO:0031083,1,0.913884972180334,0,14,BLOC-1 complex,CC,
7639,GO:0031084,1,0.98058874225091,0,3,BLOC-2 complex,CC,
7640,GO:0031085,1,0.987073877906004,0,2,BLOC-3 complex,CC,
7641,GO:0031086,1,0.961894649770862,0,6,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7642,GO:0031087,1,0.968148134609336,0,5,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7643,GO:0031088,1,0.96137819484378,0,6,platelet dense granule membrane,CC,
7649,GO:0031094,1,0.934907597177899,0,10,platelet dense tubular network,CC,
7650,GO:0031095,1,0.947105993359331,0,8,platelet dense tubular network membrane,CC,
7653,GO:0031100,1,0.633900413507985,0,70,animal organ regeneration,BP,
7656,GO:0031104,1,0.987161465047142,0,2,dendrite regeneration,BP,
7657,GO:0031106,1,0.987070123655157,0,2,septin ring organization,BP,
7661,GO:0031112,1,0.804124737673065,0,33,positive regulation of microtubule polymerization or depolymerization,BP,
7663,GO:0031114,1,0.824608961839438,0,29,regulation of microtubule depolymerization,BP,
7665,GO:0031116,1,0.825256332959661,0,29,positive regulation of microtubule polymerization,BP,
7666,GO:0031117,1,0.97444240469882,0,4,positive regulation of microtubule depolymerization,BP,
7667,GO:0031118,1,0.938035668523175,0,10,rRNA pseudouridine synthesis,BP,
7668,GO:0031119,1,0.968324396308568,0,5,tRNA pseudouridine synthesis,BP,
7669,GO:0031120,1,0.981077676094798,0,3,snRNA pseudouridine synthesis,BP,
7670,GO:0031122,1,0.671704127126081,0,60,cytoplasmic microtubule organization,BP,
7671,GO:0031123,1,0.426291529186341,0,131,RNA 3'-end processing,BP,
7672,GO:0031124,1,0.542270353191129,0,94,mRNA 3'-end processing,BP,
7673,GO:0031125,1,0.937898604973008,0,10,rRNA 3'-end processing,BP,
7674,GO:0031126,1,0.937940554487318,0,10,snoRNA 3'-end processing,BP,
7675,GO:0031127,1,0.993474114180346,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7677,GO:0031129,1,0.993403524320284,0,1,inductive cell-cell signaling,BP,
7679,GO:0031134,1,0.980733402955749,0,3,sister chromatid biorientation,BP,
7680,GO:0031143,1,0.907147770651202,0,15,pseudopodium,CC,
7681,GO:0031145,1,0.609401600764992,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7682,GO:0031146,1,0.569686861581443,0,87,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7683,GO:0031151,1,0.993206387228838,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7684,GO:0031161,1,0.993535972368311,0,1,phosphatidylinositol catabolic process,BP,
7685,GO:0031163,1,0.879164333210133,0,20,metallo-sulfur cluster assembly,BP,
7686,GO:0031166,1,0.967939244868433,0,5,integral component of vacuolar membrane,CC,
7687,GO:0031167,1,0.884953686631476,0,19,rRNA methylation,BP,
7689,GO:0031177,1,0.993109877834153,0,1,phosphopantetheine binding,MF,
7690,GO:0031179,1,0.987128148931137,0,2,peptide modification,BP,
7691,GO:0031201,1,0.737109595701122,0,47,SNARE complex,CC,
7692,GO:0031204,1,0.955438335956236,0,7,posttranslational protein targeting to membrane, translocation,BP,
7693,GO:0031205,1,0.987034674795493,0,2,endoplasmic reticulum Sec complex,CC,
7694,GO:0031207,1,0.993291037976274,0,1,Sec62/Sec63 complex,CC,
7695,GO:0031208,1,0.9805190867969,0,3,POZ domain binding,MF,
7696,GO:0031209,1,0.942846429950214,0,9,SCAR complex,CC,
7697,GO:0031210,1,0.859872819422674,0,23,phosphatidylcholine binding,MF,
7698,GO:0031211,1,0.949443275468926,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7699,GO:0031213,1,0.986947152723243,0,2,RSF complex,CC,
7701,GO:0031223,1,0.922792265286209,0,12,auditory behavior,BP,
7705,GO:0031227,1,0.370051883656734,0,153,intrinsic component of endoplasmic reticulum membrane,CC,
7706,GO:0031228,1,0.668467453590526,0,62,intrinsic component of Golgi membrane,CC,
7707,GO:0031229,1,0.913305626819021,0,14,intrinsic component of nuclear inner membrane,CC,
7708,GO:0031231,1,0.90773802668173,0,15,intrinsic component of peroxisomal membrane,CC,
7710,GO:0031233,1,0.878086792210168,0,20,intrinsic component of external side of plasma membrane,CC,
7711,GO:0031234,1,0.541831835037733,0,94,extrinsic component of cytoplasmic side of plasma membrane,CC,
7712,GO:0031235,1,0.961077997257661,0,6,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7713,GO:0031247,1,0.987202468338206,0,2,actin rod assembly,BP,
7714,GO:0031248,1,0.573461735763073,0,85,protein acetyltransferase complex,CC,
7715,GO:0031249,1,0.993578371531918,0,1,denatured protein binding,MF,
7716,GO:0031251,1,0.986803000252732,0,2,PAN complex,CC,
7719,GO:0031254,1,0.918860862730488,0,13,cell trailing edge,CC,
7721,GO:0031257,1,0.99355705431691,0,1,cell trailing edge membrane,CC,
7722,GO:0031258,1,0.864707329798999,0,22,lamellipodium membrane,CC,
7723,GO:0031259,1,0.99355705431691,0,1,uropod membrane,CC,
7724,GO:0031261,1,0.968262743568722,0,5,DNA replication preinitiation complex,CC,
7725,GO:0031262,1,0.974790095501801,0,4,Ndc80 complex,CC,
7726,GO:0031264,1,0.943438594869287,0,9,death-inducing signaling complex,CC,
7727,GO:0031265,1,0.961886586228601,0,6,CD95 death-inducing signaling complex,CC,
7729,GO:0031268,1,0.918917897187183,0,13,pseudopodium organization,BP,
7730,GO:0031269,1,0.918917897187183,0,13,pseudopodium assembly,BP,
7731,GO:0031271,1,0.99355705431691,0,1,lateral pseudopodium assembly,BP,
7732,GO:0031272,1,0.918917897187183,0,13,regulation of pseudopodium assembly,BP,
7733,GO:0031274,1,0.924881498825754,0,12,positive regulation of pseudopodium assembly,BP,
7734,GO:0031275,1,0.99355705431691,0,1,regulation of lateral pseudopodium assembly,BP,
7737,GO:0031281,1,0.887830938569401,0,18,positive regulation of cyclase activity,BP,
7738,GO:0031282,1,0.937291728956441,0,10,regulation of guanylate cyclase activity,BP,
7739,GO:0031283,1,0.980828240786768,0,3,negative regulation of guanylate cyclase activity,BP,
7740,GO:0031284,1,0.955620902136229,0,7,positive regulation of guanylate cyclase activity,BP,
7741,GO:0031289,1,0.993541327829881,0,1,actin phosphorylation,BP,
7742,GO:0031290,1,0.882242949310126,0,19,retinal ganglion cell axon guidance,BP,
7743,GO:0031291,1,0.974519902016933,0,4,Ran protein signal transduction,BP,
7744,GO:0031293,1,0.889575752740416,0,18,membrane protein intracellular domain proteolysis,BP,
7747,GO:0031296,1,0.9811178836259,0,3,B cell costimulation,BP,
7748,GO:0031297,1,0.816063230454134,0,31,replication fork processing,BP,
7749,GO:0031298,1,0.94937711418951,0,8,replication fork protection complex,CC,
7752,GO:0031302,1,0.980647878798519,0,3,intrinsic component of endosome membrane,CC,
7753,GO:0031304,1,0.757974279037664,0,43,intrinsic component of mitochondrial inner membrane,CC,
7754,GO:0031305,1,0.757974279037664,0,43,integral component of mitochondrial inner membrane,CC,
7755,GO:0031306,1,0.867041941909078,0,22,intrinsic component of mitochondrial outer membrane,CC,
7756,GO:0031307,1,0.872767876367017,0,21,integral component of mitochondrial outer membrane,CC,
7757,GO:0031308,1,0.99355705431691,0,1,intrinsic component of nuclear outer membrane,CC,
7758,GO:0031309,1,0.99355705431691,0,1,integral component of nuclear outer membrane,CC,
7759,GO:0031310,1,0.967939244868433,0,5,intrinsic component of vacuolar membrane,CC,
7760,GO:0031312,1,0.765921169736484,0,41,extrinsic component of organelle membrane,CC,
7761,GO:0031313,1,0.943155590025561,0,9,extrinsic component of endosome membrane,CC,
7762,GO:0031314,1,0.937476526173453,0,10,extrinsic component of mitochondrial inner membrane,CC,
7763,GO:0031315,1,0.986842301949856,0,2,extrinsic component of mitochondrial outer membrane,CC,
7764,GO:0031320,1,0.99357166287299,0,1,hexitol dehydrogenase activity,MF,
7774,GO:0031332,1,0.911245018980258,0,14,RNAi effector complex,CC,
7777,GO:0031335,1,0.980288800626313,0,3,regulation of sulfur amino acid metabolic process,BP,
7778,GO:0031337,1,0.993588301841849,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7780,GO:0031339,1,0.961517558128481,0,6,negative regulation of vesicle fusion,BP,
7782,GO:0031341,1,0.603977460562755,0,78,regulation of cell killing,BP,
7783,GO:0031342,1,0.873659688517719,0,21,negative regulation of cell killing,BP,
7784,GO:0031343,1,0.71469181105811,0,52,positive regulation of cell killing,BP,
7791,GO:0031362,1,0.900974302524113,0,16,anchored component of external side of plasma membrane,CC,
7793,GO:0031369,1,0.823019465857749,0,30,translation initiation factor binding,MF,
7794,GO:0031370,1,0.99343832801304,0,1,eukaryotic initiation factor 4G binding,MF,
7795,GO:0031371,1,0.949708908539886,0,8,ubiquitin conjugating enzyme complex,CC,
7796,GO:0031372,1,0.987249162020693,0,2,UBC13-MMS2 complex,CC,
7797,GO:0031379,1,0.986746577679867,0,2,RNA-directed RNA polymerase complex,CC,
7798,GO:0031380,1,0.993213862066267,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7799,GO:0031386,1,0.926431469694764,0,12,protein tag,MF,
7800,GO:0031389,1,0.993549603578293,0,1,Rad17 RFC-like complex,CC,
7801,GO:0031390,1,0.949775320485938,0,8,Ctf18 RFC-like complex,CC,
7802,GO:0031391,1,0.980511396872691,0,3,Elg1 RFC-like complex,CC,
7803,GO:0031392,1,0.943624019802513,0,9,regulation of prostaglandin biosynthetic process,BP,
7804,GO:0031393,1,0.987077195598476,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7805,GO:0031394,1,0.962051325243642,0,6,positive regulation of prostaglandin biosynthetic process,BP,
7806,GO:0031396,1,0.286087059240467,0,191,regulation of protein ubiquitination,BP,
7807,GO:0031397,1,0.625531528924558,0,72,negative regulation of protein ubiquitination,BP,
7808,GO:0031398,1,0.490230093910601,0,109,positive regulation of protein ubiquitination,BP,
7812,GO:0031402,1,0.948428038668376,0,8,sodium ion binding,MF,
7813,GO:0031403,1,0.986778972615872,0,2,lithium ion binding,MF,
7814,GO:0031404,1,0.918185045197472,0,13,chloride ion binding,MF,
7815,GO:0031405,1,0.992880371068028,0,1,lipoic acid binding,MF,
7817,GO:0031407,1,0.980808216845216,0,3,oxylipin metabolic process,BP,
7818,GO:0031408,1,0.987144495744695,0,2,oxylipin biosynthetic process,BP,
7820,GO:0031414,1,0.936438717674753,0,10,N-terminal protein acetyltransferase complex,CC,
7821,GO:0031415,1,0.968229979540552,0,5,NatA complex,CC,
7822,GO:0031416,1,0.987060058063603,0,2,NatB complex,CC,
7823,GO:0031417,1,0.979857879946874,0,3,NatC complex,CC,
7824,GO:0031418,1,0.878529265735386,0,20,L-ascorbic acid binding,MF,
7825,GO:0031419,1,0.948375399395577,0,8,cobalamin binding,MF,
7826,GO:0031420,1,0.894319230665339,0,17,alkali metal ion binding,MF,
7827,GO:0031422,1,0.993517889184918,0,1,RecQ family helicase-topoisomerase III complex,CC,
7828,GO:0031424,1,0.618259192067434,0,74,keratinization,BP,
7829,GO:0031427,1,0.974338361890115,0,4,response to methotrexate,BP,
7830,GO:0031428,1,0.968405322024944,0,5,box C/D snoRNP complex,CC,
7831,GO:0031429,1,0.968514748047333,0,5,box H/ACA snoRNP complex,CC,
7833,GO:0031431,1,0.987090474727509,0,2,Dbf4-dependent protein kinase complex,CC,
7834,GO:0031432,1,0.911577656157125,0,14,titin binding,MF,
7835,GO:0031433,1,0.948901589849287,0,6,telethonin binding,MF,
7836,GO:0031434,1,0.918908145416974,0,13,mitogen-activated protein kinase kinase binding,MF,
7837,GO:0031435,1,0.895028095347779,0,17,mitogen-activated protein kinase kinase kinase binding,MF,
7838,GO:0031436,1,0.980608909454036,0,3,BRCA1-BARD1 complex,CC,
7839,GO:0031437,1,0.993463037265516,0,1,regulation of mRNA cleavage,BP,
7840,GO:0031439,1,0.993463037265516,0,1,positive regulation of mRNA cleavage,BP,
7841,GO:0031440,1,0.838612859705158,0,27,regulation of mRNA 3'-end processing,BP,
7842,GO:0031441,1,0.943173109961072,0,9,negative regulation of mRNA 3'-end processing,BP,
7843,GO:0031442,1,0.930828452153256,0,11,positive regulation of mRNA 3'-end processing,BP,
7844,GO:0031443,1,0.986816933767171,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7845,GO:0031444,1,0.980788509268778,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7846,GO:0031445,1,0.899624211750596,0,16,regulation of heterochromatin assembly,BP,
7847,GO:0031446,1,0.993515469491067,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7848,GO:0031448,1,0.993515469491067,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7849,GO:0031449,1,0.993330304100628,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7850,GO:0031452,1,0.973542685132645,0,4,negative regulation of heterochromatin assembly,BP,
7851,GO:0031453,1,0.930118363749858,0,11,positive regulation of heterochromatin assembly,BP,
7852,GO:0031455,1,0.987064896920279,0,2,glycine betaine metabolic process,BP,
7853,GO:0031456,1,0.987064896920279,0,2,glycine betaine biosynthetic process,BP,
7854,GO:0031460,1,0.99342744196779,0,1,glycine betaine transport,BP,
7855,GO:0031461,1,0.370239804262565,0,152,cullin-RING ubiquitin ligase complex,CC,
7856,GO:0031462,1,0.918624280193466,0,13,Cul2-RING ubiquitin ligase complex,CC,
7857,GO:0031463,1,0.7903759061377,0,36,Cul3-RING ubiquitin ligase complex,CC,
7858,GO:0031464,1,0.931235209033035,0,11,Cul4A-RING E3 ubiquitin ligase complex,CC,
7859,GO:0031465,1,0.968057670397898,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7860,GO:0031466,1,0.968180905807557,0,5,Cul5-RING ubiquitin ligase complex,CC,
7861,GO:0031467,1,0.974349188134264,0,4,Cul7-RING ubiquitin ligase complex,CC,
7862,GO:0031468,1,0.89030691707779,0,18,nuclear envelope reassembly,BP,
7863,GO:0031475,1,0.993638318840217,0,1,myosin V complex,CC,
7864,GO:0031477,1,0.99321322487076,0,1,myosin VII complex,CC,
7865,GO:0031489,1,0.901584746341482,0,16,myosin V binding,MF,
7866,GO:0031490,1,0.56762692790712,0,86,chromatin DNA binding,MF,
7867,GO:0031491,1,0.716342140318707,0,51,nucleosome binding,MF,
7868,GO:0031492,1,0.855183087087581,0,24,nucleosomal DNA binding,MF,
7869,GO:0031493,1,0.96824329372576,0,5,nucleosomal histone binding,MF,
7870,GO:0031494,1,0.992938094261375,0,1,regulation of mating type switching,BP,
7871,GO:0031497,1,0.493363333220587,0,108,chromatin assembly,BP,
7873,GO:0031499,1,0.993551081422835,0,1,TRAMP complex,CC,
7874,GO:0031501,1,0.968468103066865,0,5,mannosyltransferase complex,CC,
7875,GO:0031503,1,0.166352228826651,0,272,protein-containing complex localization,BP,
7876,GO:0031506,1,0.993621324578831,0,1,cell wall glycoprotein biosynthetic process,BP,
7877,GO:0031507,1,0.773904196672328,0,39,heterochromatin assembly,BP,
7878,GO:0031508,1,0.987240233696719,0,2,pericentric heterochromatin assembly,BP,
7879,GO:0031509,1,0.993630437004572,0,1,subtelomeric heterochromatin assembly,BP,
7880,GO:0031510,1,0.987179313530264,0,2,SUMO activating enzyme complex,CC,
7881,GO:0031511,1,0.993631105816331,0,1,Mis6-Sim4 complex,CC,
7882,GO:0031514,1,0.376332282434702,0,149,motile cilium,CC,
7883,GO:0031515,1,0.980855211423697,0,3,tRNA (m1A) methyltransferase complex,CC,
7884,GO:0031519,1,0.75429373803525,0,43,PcG protein complex,CC,
7885,GO:0031523,1,0.980471763505609,0,3,Myb complex,CC,
7887,GO:0031527,1,0.887158492874475,0,18,filopodium membrane,CC,
7888,GO:0031528,1,0.854746479772892,0,24,microvillus membrane,CC,
7889,GO:0031529,1,0.722542339341224,0,50,ruffle organization,BP,
7890,GO:0031530,1,0.987377408966258,0,2,gonadotropin-releasing hormone receptor binding,MF,
7891,GO:0031531,1,0.99365123197514,0,1,thyrotropin-releasing hormone receptor binding,MF,
7893,GO:0031533,1,0.993317641726585,0,1,mRNA cap methyltransferase complex,CC,
7894,GO:0031536,1,0.981020162194352,0,3,positive regulation of exit from mitosis,BP,
7895,GO:0031543,1,0.925171168452984,0,12,peptidyl-proline dioxygenase activity,MF,
7896,GO:0031544,1,0.974459420927592,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7897,GO:0031545,1,0.949432654330663,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7898,GO:0031547,1,0.954646473914424,0,7,brain-derived neurotrophic factor receptor signaling pathway,BP,
7899,GO:0031548,1,0.980537577524517,0,3,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7900,GO:0031549,1,0.99338736476851,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7901,GO:0031550,1,0.987065528786302,0,2,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7902,GO:0031554,1,0.973766857624031,0,4,regulation of DNA-templated transcription, termination,BP,
7903,GO:0031559,1,0.993473098184963,0,1,oxidosqualene cyclase activity,MF,
7904,GO:0031570,1,0.379141314271057,0,148,DNA integrity checkpoint,BP,
7905,GO:0031571,1,0.671024763790376,0,61,mitotic G1 DNA damage checkpoint,BP,
7906,GO:0031572,1,0.826995093416942,0,29,G2 DNA damage checkpoint,BP,
7907,GO:0031573,1,0.913362600757387,0,14,intra-S DNA damage checkpoint,BP,
7908,GO:0031577,1,0.800645592591424,0,34,spindle checkpoint,BP,
7911,GO:0031581,1,0.921630189642146,0,12,hemidesmosome assembly,BP,
7912,GO:0031583,1,0.993599654966631,0,1,phospholipase D-activating G protein-coupled receptor signaling pathway,BP,
7913,GO:0031584,1,0.968120672719221,0,5,activation of phospholipase D activity,BP,
7914,GO:0031585,1,0.966314013593722,0,5,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7915,GO:0031587,1,0.973388939472073,0,4,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7916,GO:0031588,1,0.949293289520306,0,8,nucleotide-activated protein kinase complex,CC,
7918,GO:0031590,1,0.980755124730954,0,3,wybutosine metabolic process,BP,
7919,GO:0031591,1,0.980755124730954,0,3,wybutosine biosynthetic process,BP,
7920,GO:0031592,1,0.993161334039552,0,1,centrosomal corona,CC,
7921,GO:0031593,1,0.770525502404306,0,40,polyubiquitin modification-dependent protein binding,MF,
7922,GO:0031594,1,0.613390317432262,0,74,neuromuscular junction,CC,
7923,GO:0031595,1,0.980910820285232,0,3,nuclear proteasome complex,CC,
7924,GO:0031597,1,0.949685312270297,0,8,cytosolic proteasome complex,CC,
7925,GO:0031616,1,0.919315202628678,0,13,spindle pole centrosome,CC,
7926,GO:0031617,1,0.974790095501801,0,4,NMS complex,CC,
7927,GO:0031618,1,0.941784416904325,0,9,nuclear pericentric heterochromatin,CC,
7928,GO:0031620,1,0.955553349401687,0,7,regulation of fever generation,BP,
7929,GO:0031622,1,0.961835272135624,0,6,positive regulation of fever generation,BP,
7931,GO:0031624,1,0.821134825567665,0,30,ubiquitin conjugating enzyme binding,MF,
7933,GO:0031626,1,0.993402956880897,0,1,beta-endorphin binding,MF,
7934,GO:0031627,1,0.987100265053303,0,2,telomeric loop formation,BP,
7935,GO:0031628,1,0.949368369155056,0,8,opioid receptor binding,MF,
7936,GO:0031629,1,0.861519706282972,0,23,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7937,GO:0031630,1,0.931039727060626,0,11,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7938,GO:0031632,1,0.9741997886268,0,4,positive regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7939,GO:0031635,1,0.987079265628911,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7940,GO:0031638,1,0.737465714446501,0,47,zymogen activation,BP,
7941,GO:0031639,1,0.896183278218341,0,17,plasminogen activation,BP,
7942,GO:0031640,1,0.784324992703005,0,38,killing of cells of other organism,BP,
7944,GO:0031642,1,0.949044651080141,0,8,negative regulation of myelination,BP,
7947,GO:0031645,1,0.86074561587821,0,23,negative regulation of nervous system process,BP,
7951,GO:0031649,1,0.901338304351026,0,16,heat generation,BP,
7952,GO:0031650,1,0.92500821928695,0,12,regulation of heat generation,BP,
7953,GO:0031651,1,0.993479209855665,0,1,negative regulation of heat generation,BP,
7954,GO:0031652,1,0.937206596275085,0,10,positive regulation of heat generation,BP,
7955,GO:0031663,1,0.704487137110335,0,54,lipopolysaccharide-mediated signaling pathway,BP,
7956,GO:0031664,1,0.861544867484445,0,23,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7957,GO:0031665,1,0.937587079581353,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7958,GO:0031666,1,0.943053963188186,0,9,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7960,GO:0031668,1,0.219189170086284,0,231,cellular response to extracellular stimulus,BP,
7961,GO:0031669,1,0.267200213239969,0,201,cellular response to nutrient levels,BP,
7962,GO:0031670,1,0.765128594700379,0,41,cellular response to nutrient,BP,
7964,GO:0031673,1,0.99209656558817,0,1,H zone,CC,
7966,GO:0031680,1,0.937747366520935,0,10,G-protein beta/gamma-subunit complex,CC,
7967,GO:0031681,1,0.890546669154933,0,18,G-protein beta-subunit binding,MF,
7968,GO:0031682,1,0.961234131258476,0,6,G-protein gamma-subunit binding,MF,
7969,GO:0031683,1,0.884162229707587,0,19,G-protein beta/gamma-subunit complex binding,MF,
7970,GO:0031685,1,0.974465863738272,0,4,adenosine receptor binding,MF,
7971,GO:0031686,1,0.993538341317984,0,1,A1 adenosine receptor binding,MF,
7972,GO:0031687,1,0.987237058130886,0,2,A2A adenosine receptor binding,MF,
7973,GO:0031690,1,0.883256511259128,0,19,adrenergic receptor binding,MF,
7974,GO:0031691,1,0.987245749516002,0,2,alpha-1A adrenergic receptor binding,MF,
7975,GO:0031692,1,0.980824968409405,0,3,alpha-1B adrenergic receptor binding,MF,
7976,GO:0031694,1,0.974644108806596,0,4,alpha-2A adrenergic receptor binding,MF,
7977,GO:0031695,1,0.993576046225,0,1,alpha-2B adrenergic receptor binding,MF,
7978,GO:0031696,1,0.987114506268197,0,2,alpha-2C adrenergic receptor binding,MF,
7979,GO:0031697,1,0.96755895000181,0,5,beta-1 adrenergic receptor binding,MF,
7980,GO:0031698,1,0.967387915317681,0,5,beta-2 adrenergic receptor binding,MF,
7981,GO:0031699,1,0.993479209855665,0,1,beta-3 adrenergic receptor binding,MF,
7982,GO:0031700,1,0.993643117616969,0,1,adrenomedullin receptor binding,MF,
7983,GO:0031701,1,0.949166691134938,0,8,angiotensin receptor binding,MF,
7984,GO:0031702,1,0.955290313472969,0,7,type 1 angiotensin receptor binding,MF,
7985,GO:0031703,1,0.99356854826303,0,1,type 2 angiotensin receptor binding,MF,
7986,GO:0031704,1,0.993532020092422,0,1,apelin receptor binding,MF,
7987,GO:0031705,1,0.974735832516463,0,4,bombesin receptor binding,MF,
7988,GO:0031707,1,0.993599654966631,0,1,endothelin A receptor binding,MF,
7989,GO:0031708,1,0.980945159989557,0,3,endothelin B receptor binding,MF,
7990,GO:0031710,1,0.993671270484629,0,1,neuromedin B receptor binding,MF,
7991,GO:0031711,1,0.98715017362915,0,2,bradykinin receptor binding,MF,
7992,GO:0031714,1,0.993408365682519,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7993,GO:0031715,1,0.993408365682519,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7994,GO:0031716,1,0.993670774906219,0,1,calcitonin receptor binding,MF,
7995,GO:0031717,1,0.993630102537454,0,1,cannabinoid receptor binding,MF,
7996,GO:0031718,1,0.993630102537454,0,1,type 1 cannabinoid receptor binding,MF,
7997,GO:0031720,1,0.944682477673876,0,9,haptoglobin binding,MF,
7998,GO:0031721,1,0.975021292947648,0,4,hemoglobin alpha binding,MF,
7999,GO:0031724,1,0.993659525454334,0,1,CXCR5 chemokine receptor binding,MF,
8000,GO:0031726,1,0.993685882462423,0,1,CCR1 chemokine receptor binding,MF,
8001,GO:0031727,1,0.974881420089056,0,4,CCR2 chemokine receptor binding,MF,
8002,GO:0031728,1,0.987450383246288,0,2,CCR3 chemokine receptor binding,MF,
8003,GO:0031729,1,0.993698253253194,0,1,CCR4 chemokine receptor binding,MF,
8004,GO:0031730,1,0.974256627972397,0,4,CCR5 chemokine receptor binding,MF,
8005,GO:0031731,1,0.987431128664135,0,2,CCR6 chemokine receptor binding,MF,
8006,GO:0031732,1,0.987414371056172,0,2,CCR7 chemokine receptor binding,MF,
8007,GO:0031735,1,0.981151927997118,0,3,CCR10 chemokine receptor binding,MF,
8008,GO:0031737,1,0.993529419212751,0,1,CX3C chemokine receptor binding,MF,
8009,GO:0031739,1,0.993598225889756,0,1,cholecystokinin receptor binding,MF,
8010,GO:0031741,1,0.993598225889756,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8011,GO:0031748,1,0.943520587462758,0,9,D1 dopamine receptor binding,MF,
8012,GO:0031749,1,0.968066969173802,0,5,D2 dopamine receptor binding,MF,
8013,GO:0031750,1,0.980806541255646,0,3,D3 dopamine receptor binding,MF,
8014,GO:0031751,1,0.987170099875706,0,2,D4 dopamine receptor binding,MF,
8015,GO:0031752,1,0.980528707786224,0,3,D5 dopamine receptor binding,MF,
8016,GO:0031753,1,0.993555703734651,0,1,endothelial differentiation G protein-coupled receptor binding,MF,
8017,GO:0031755,1,0.993555703734651,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8018,GO:0031762,1,0.987245749516002,0,2,follicle-stimulating hormone receptor binding,MF,
8019,GO:0031763,1,0.993687463149324,0,1,galanin receptor binding,MF,
8020,GO:0031764,1,0.993687463149324,0,1,type 1 galanin receptor binding,MF,
8021,GO:0031765,1,0.993687463149324,0,1,type 2 galanin receptor binding,MF,
8022,GO:0031766,1,0.993687463149324,0,1,type 3 galanin receptor binding,MF,
8023,GO:0031768,1,0.993691741969084,0,1,ghrelin receptor binding,MF,
8024,GO:0031770,1,0.993709026865349,0,1,growth hormone-releasing hormone receptor binding,MF,
8025,GO:0031773,1,0.993691873575978,0,1,kisspeptin receptor binding,MF,
8026,GO:0031775,1,0.993133478716038,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8027,GO:0031776,1,0.993689109222643,0,1,melanin-concentrating hormone receptor binding,MF,
8028,GO:0031777,1,0.993689109222643,0,1,type 1 melanin-concentrating hormone receptor binding,MF,
8029,GO:0031779,1,0.974870885468323,0,4,melanocortin receptor binding,MF,
8030,GO:0031780,1,0.987317623010051,0,2,corticotropin hormone receptor binding,MF,
8031,GO:0031781,1,0.974870885468323,0,4,type 3 melanocortin receptor binding,MF,
8032,GO:0031782,1,0.974870885468323,0,4,type 4 melanocortin receptor binding,MF,
8033,GO:0031783,1,0.987317623010051,0,2,type 5 melanocortin receptor binding,MF,
8034,GO:0031798,1,0.993188565160649,0,1,type 1 metabotropic glutamate receptor binding,MF,
8035,GO:0031799,1,0.987241978321359,0,2,type 2 metabotropic glutamate receptor binding,MF,
8036,GO:0031800,1,0.980911948874243,0,3,type 3 metabotropic glutamate receptor binding,MF,
8037,GO:0031802,1,0.967964899720021,0,5,type 5 metabotropic glutamate receptor binding,MF,
8038,GO:0031811,1,0.993495348677466,0,1,G protein-coupled nucleotide receptor binding,MF,
8039,GO:0031812,1,0.993495348677466,0,1,P2Y1 nucleotide receptor binding,MF,
8040,GO:0031821,1,0.943409030256246,0,9,G protein-coupled serotonin receptor binding,MF,
8041,GO:0031826,1,0.968414855280011,0,5,type 2A serotonin receptor binding,MF,
8042,GO:0031834,1,0.987400929234933,0,2,neurokinin receptor binding,MF,
8043,GO:0031835,1,0.987400929234933,0,2,substance P receptor binding,MF,
8044,GO:0031838,1,0.93868027936231,0,10,haptoglobin-hemoglobin complex,CC,
8045,GO:0031839,1,0.993685091946878,0,1,type 1 neuromedin U receptor binding,MF,
8046,GO:0031840,1,0.993685091946878,0,1,type 2 neuromedin U receptor binding,MF,
8047,GO:0031848,1,0.93700680676015,0,10,protection from non-homologous end joining at telomere,BP,
8048,GO:0031849,1,0.974568510379621,0,4,olfactory receptor binding,MF,
8049,GO:0031852,1,0.973988898495569,0,4,mu-type opioid receptor binding,MF,
8050,GO:0031858,1,0.993534659899654,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8051,GO:0031859,1,0.993612528976046,0,1,platelet activating factor receptor binding,MF,
8052,GO:0031860,1,0.980432821687723,0,3,telomeric 3' overhang formation,BP,
8053,GO:0031862,1,0.986870783250044,0,2,prostanoid receptor binding,MF,
8054,GO:0031867,1,0.993498751725196,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8055,GO:0031870,1,0.993329093125224,0,1,thromboxane A2 receptor binding,MF,
8056,GO:0031871,1,0.980631469301002,0,3,proteinase activated receptor binding,MF,
8057,GO:0031877,1,0.993278058503644,0,1,somatostatin receptor binding,MF,
8058,GO:0031883,1,0.993599422166483,0,1,taste receptor binding,MF,
8059,GO:0031893,1,0.987114095989639,0,2,vasopressin receptor binding,MF,
8060,GO:0031894,1,0.993480034901692,0,1,V1A vasopressin receptor binding,MF,
8061,GO:0031896,1,0.993592700810439,0,1,V2 vasopressin receptor binding,MF,
8063,GO:0031902,1,0.444003047059787,0,125,late endosome membrane,CC,
8064,GO:0031903,1,0.685481746705188,0,58,microbody membrane,CC,
8066,GO:0031905,1,0.980851656109699,0,3,early endosome lumen,CC,
8067,GO:0031906,1,0.962494988622951,0,6,late endosome lumen,CC,
8068,GO:0031907,1,0.719529354933618,0,51,microbody lumen,CC,
8069,GO:0031914,1,0.967667487837963,0,5,negative regulation of synaptic plasticity,BP,
8070,GO:0031915,1,0.929722735673547,0,11,positive regulation of synaptic plasticity,BP,
8071,GO:0031929,1,0.494753915094544,0,107,TOR signaling,BP,
8072,GO:0031930,1,0.993642185119733,0,1,mitochondria-nucleus signaling pathway,BP,
8073,GO:0031931,1,0.947489310382634,0,8,TORC1 complex,CC,
8074,GO:0031932,1,0.923239160990239,0,12,TORC2 complex,CC,
8075,GO:0031935,1,0.942653268377634,0,9,regulation of chromatin silencing,BP,
8076,GO:0031936,1,0.973957759535938,0,4,negative regulation of chromatin silencing,BP,
8077,GO:0031937,1,0.980478375726465,0,3,positive regulation of chromatin silencing,BP,
8078,GO:0031938,1,0.987282046814369,0,2,regulation of chromatin silencing at telomere,BP,
8079,GO:0031940,1,0.993630437004572,0,1,positive regulation of chromatin silencing at telomere,BP,
8080,GO:0031941,1,0.816348416667187,0,31,filamentous actin,CC,
8081,GO:0031943,1,0.936862325119267,0,10,regulation of glucocorticoid metabolic process,BP,
8082,GO:0031944,1,0.968111454799014,0,5,negative regulation of glucocorticoid metabolic process,BP,
8083,GO:0031945,1,0.993495030922634,0,1,positive regulation of glucocorticoid metabolic process,BP,
8084,GO:0031946,1,0.948862168555527,0,8,regulation of glucocorticoid biosynthetic process,BP,
8085,GO:0031947,1,0.968111454799014,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8086,GO:0031948,1,0.993495030922634,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8088,GO:0031953,1,0.924745109116593,0,12,negative regulation of protein autophosphorylation,BP,
8090,GO:0031956,1,0.937159754569413,0,10,medium-chain fatty acid-CoA ligase activity,MF,
8091,GO:0031957,1,0.943373080295137,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8092,GO:0031958,1,0.912186398154186,0,14,corticosteroid receptor signaling pathway,BP,
8093,GO:0031959,1,0.993394712257761,0,1,mineralocorticoid receptor signaling pathway,BP,
8095,GO:0031962,1,0.993343708520855,0,1,mineralocorticoid receptor binding,MF,
8100,GO:0031970,1,0.596447835576438,0,80,organelle envelope lumen,CC,
8107,GO:0031985,1,0.517243416781534,0,101,Golgi cisterna,CC,
8109,GO:0031989,1,0.99364558071789,0,1,bombesin receptor signaling pathway,BP,
8110,GO:0031990,1,0.98661757541472,0,2,mRNA export from nucleus in response to heat stress,BP,
8112,GO:0031995,1,0.94870369602004,0,8,insulin-like growth factor II binding,MF,
8113,GO:0031996,1,0.931238839631717,0,11,thioesterase binding,MF,
8114,GO:0031997,1,0.980838324338711,0,3,N-terminal myristoylation domain binding,MF,
8115,GO:0031998,1,0.881726007952422,0,19,regulation of fatty acid beta-oxidation,BP,
8116,GO:0031999,1,0.967532747425041,0,5,negative regulation of fatty acid beta-oxidation,BP,
8117,GO:0032000,1,0.935906806764845,0,10,positive regulation of fatty acid beta-oxidation,BP,
8118,GO:0032002,1,0.987208195214142,0,2,interleukin-28 receptor complex,CC,
8119,GO:0032006,1,0.568839872508152,0,86,regulation of TOR signaling,BP,
8120,GO:0032007,1,0.789895848128875,0,36,negative regulation of TOR signaling,BP,
8121,GO:0032008,1,0.780124613861189,0,38,positive regulation of TOR signaling,BP,
8122,GO:0032009,1,0.918459229951655,0,13,early phagosome,CC,
8123,GO:0032010,1,0.962191620096662,0,6,phagolysosome,CC,
8124,GO:0032011,1,0.881490411141381,0,19,ARF protein signal transduction,BP,
8125,GO:0032012,1,0.881490411141381,0,19,regulation of ARF protein signal transduction,BP,
8126,GO:0032014,1,0.986811627375238,0,2,positive regulation of ARF protein signal transduction,BP,
8127,GO:0032020,1,0.962260331727999,0,6,ISG15-protein conjugation,BP,
8128,GO:0032021,1,0.974473775128644,0,4,NELF complex,CC,
8129,GO:0032023,1,0.993587680951148,0,1,trypsinogen activation,BP,
8131,GO:0032025,1,0.943277205580196,0,9,response to cobalt ion,BP,
8133,GO:0032027,1,0.955482455447268,0,7,myosin light chain binding,MF,
8134,GO:0032028,1,0.986968242005707,0,2,myosin head/neck binding,MF,
8135,GO:0032029,1,0.992779888053238,0,1,myosin tail binding,MF,
8136,GO:0032034,1,0.993326928966921,0,1,myosin II head/neck binding,MF,
8137,GO:0032036,1,0.930820745896467,0,11,myosin heavy chain binding,MF,
8138,GO:0032038,1,0.980807674129194,0,3,myosin II heavy chain binding,MF,
8139,GO:0032039,1,0.905660413277397,0,15,integrator complex,CC,
8140,GO:0032040,1,0.80637514280066,0,33,small-subunit processome,CC,
8141,GO:0032041,1,0.936411953261762,0,10,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8142,GO:0032042,1,0.913081843453624,0,14,mitochondrial DNA metabolic process,BP,
8143,GO:0032044,1,0.987186150171421,0,2,DSIF complex,CC,
8144,GO:0032045,1,0.912201051390897,0,14,guanyl-nucleotide exchange factor complex,CC,
8145,GO:0032048,1,0.895920602414742,0,17,cardiolipin metabolic process,BP,
8146,GO:0032049,1,0.949641499981937,0,8,cardiolipin biosynthetic process,BP,
8147,GO:0032050,1,0.948107885616467,0,8,clathrin heavy chain binding,MF,
8148,GO:0032051,1,0.967269087348438,0,5,clathrin light chain binding,MF,
8149,GO:0032052,1,0.943986912973614,0,9,bile acid binding,MF,
8150,GO:0032053,1,0.973890234001299,0,4,ciliary basal body organization,BP,
8151,GO:0032055,1,0.961691673592609,0,6,negative regulation of translation in response to stress,BP,
8152,GO:0032056,1,0.948979472039844,0,8,positive regulation of translation in response to stress,BP,
8153,GO:0032057,1,0.974175306132254,0,4,negative regulation of translational initiation in response to stress,BP,
8154,GO:0032058,1,0.974083020683913,0,4,positive regulation of translational initiation in response to stress,BP,
8155,GO:0032059,1,0.94291735485654,0,9,bleb,CC,
8157,GO:0032069,1,0.867491078366424,0,22,regulation of nuclease activity,BP,
8158,GO:0032070,1,0.937645535091751,0,10,regulation of deoxyribonuclease activity,BP,
8159,GO:0032071,1,0.94975997035913,0,8,regulation of endodeoxyribonuclease activity,BP,
8160,GO:0032072,1,0.993521225872363,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8161,GO:0032074,1,0.955818343197749,0,7,negative regulation of nuclease activity,BP,
8162,GO:0032075,1,0.94983738182733,0,8,positive regulation of nuclease activity,BP,
8163,GO:0032076,1,0.98728037023297,0,2,negative regulation of deoxyribonuclease activity,BP,
8164,GO:0032077,1,0.968338410243118,0,5,positive regulation of deoxyribonuclease activity,BP,
8165,GO:0032078,1,0.993679752819776,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8166,GO:0032079,1,0.974527797637629,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8167,GO:0032088,1,0.597777025723082,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8168,GO:0032089,1,0.986991608008749,0,2,NACHT domain binding,MF,
8169,GO:0032090,1,0.987235890880089,0,2,Pyrin domain binding,MF,
8170,GO:0032091,1,0.537771178366326,0,95,negative regulation of protein binding,BP,
8171,GO:0032092,1,0.591004754459577,0,80,positive regulation of protein binding,BP,
8172,GO:0032093,1,0.99355705431691,0,1,SAM domain binding,MF,
8176,GO:0032097,1,0.981127602655165,0,3,positive regulation of response to food,BP,
8179,GO:0032100,1,0.981127602655165,0,3,positive regulation of appetite,BP,
8185,GO:0032106,1,0.968578713507175,0,5,positive regulation of response to extracellular stimulus,BP,
8188,GO:0032109,1,0.968578713507175,0,5,positive regulation of response to nutrient levels,BP,
8189,GO:0032116,1,0.986549835690528,0,2,SMC loading complex,CC,
8190,GO:0032119,1,0.955510361721842,0,7,sequestering of zinc ion,BP,
8191,GO:0032127,1,0.960486661391507,0,6,dense core granule membrane,CC,
8192,GO:0032129,1,0.987169877302622,0,2,histone deacetylase activity (H3-K9 specific),MF,
8193,GO:0032133,1,0.962148899799283,0,6,chromosome passenger complex,CC,
8194,GO:0032135,1,0.961781850760619,0,6,DNA insertion or deletion binding,MF,
8195,GO:0032137,1,0.980703762845288,0,3,guanine/thymine mispair binding,MF,
8196,GO:0032138,1,0.974253433084551,0,4,single base insertion or deletion binding,MF,
8197,GO:0032139,1,0.980756122102289,0,3,dinucleotide insertion or deletion binding,MF,
8198,GO:0032142,1,0.980576670351766,0,3,single guanine insertion binding,MF,
8199,GO:0032143,1,0.987045919340616,0,2,single thymine insertion binding,MF,
8200,GO:0032144,1,0.993425585143341,0,1,4-aminobutyrate transaminase complex,CC,
8201,GO:0032145,1,0.993425585143341,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8204,GO:0032153,1,0.692673034768389,0,56,cell division site,CC,
8205,GO:0032154,1,0.72511991536579,0,49,cleavage furrow,CC,
8206,GO:0032156,1,0.993475287442748,0,1,septin cytoskeleton,CC,
8207,GO:0032181,1,0.987024079177312,0,2,dinucleotide repeat insertion binding,MF,
8208,GO:0032182,1,0.558628450230917,0,89,ubiquitin-like protein binding,MF,
8209,GO:0032183,1,0.905318398468256,0,15,SUMO binding,MF,
8210,GO:0032184,1,0.967493486202594,0,5,SUMO polymer binding,MF,
8211,GO:0032185,1,0.974420263607764,0,4,septin cytoskeleton organization,BP,
8212,GO:0032190,1,0.980996668725588,0,3,acrosin binding,MF,
8213,GO:0032194,1,0.993509157505027,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8214,GO:0032196,1,0.867117558078445,0,22,transposition,BP,
8215,GO:0032197,1,0.987182659575597,0,2,transposition, RNA-mediated,BP,
8216,GO:0032200,1,0.398653322876227,0,140,telomere organization,BP,
8217,GO:0032201,1,0.83958712020275,0,27,telomere maintenance via semi-conservative replication,BP,
8218,GO:0032202,1,0.96834145046476,0,5,telomere assembly,BP,
8219,GO:0032203,1,0.993615718009131,0,1,telomere formation via telomerase,BP,
8220,GO:0032204,1,0.60679581724734,0,76,regulation of telomere maintenance,BP,
8221,GO:0032205,1,0.804336905055323,0,33,negative regulation of telomere maintenance,BP,
8222,GO:0032206,1,0.72612400903969,0,49,positive regulation of telomere maintenance,BP,
8223,GO:0032207,1,0.99354954696155,0,1,regulation of telomere maintenance via recombination,BP,
8224,GO:0032208,1,0.99354954696155,0,1,negative regulation of telomere maintenance via recombination,BP,
8225,GO:0032210,1,0.716172726437481,0,51,regulation of telomere maintenance via telomerase,BP,
8226,GO:0032211,1,0.888615511375605,0,18,negative regulation of telomere maintenance via telomerase,BP,
8227,GO:0032212,1,0.801243021379394,0,34,positive regulation of telomere maintenance via telomerase,BP,
8228,GO:0032213,1,0.987138301957793,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8229,GO:0032214,1,0.987138301957793,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8230,GO:0032217,1,0.968200617521467,0,5,riboflavin transmembrane transporter activity,MF,
8231,GO:0032218,1,0.968200617521467,0,5,riboflavin transport,BP,
8232,GO:0032222,1,0.961556392647555,0,6,regulation of synaptic transmission, cholinergic,BP,
8233,GO:0032223,1,0.993568517290874,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8234,GO:0032224,1,0.974054569013488,0,4,positive regulation of synaptic transmission, cholinergic,BP,
8236,GO:0032226,1,0.955852702712544,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8238,GO:0032228,1,0.804593200015667,0,33,regulation of synaptic transmission, GABAergic,BP,
8239,GO:0032229,1,0.955746083402018,0,7,negative regulation of synaptic transmission, GABAergic,BP,
8240,GO:0032230,1,0.924081754008057,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8242,GO:0032232,1,0.830990093675551,0,28,negative regulation of actin filament bundle assembly,BP,
8244,GO:0032237,1,0.974171915730122,0,4,activation of store-operated calcium channel activity,BP,
8245,GO:0032238,1,0.987197289825744,0,2,adenosine transport,BP,
8246,GO:0032239,1,0.882339100142053,0,19,regulation of nucleobase-containing compound transport,BP,
8247,GO:0032240,1,0.980097791429324,0,3,negative regulation of nucleobase-containing compound transport,BP,
8248,GO:0032241,1,0.942829461629981,0,9,positive regulation of nucleobase-containing compound transport,BP,
8249,GO:0032242,1,0.98720995246097,0,2,regulation of nucleoside transport,BP,
8250,GO:0032243,1,0.993616288817127,0,1,negative regulation of nucleoside transport,BP,
8251,GO:0032244,1,0.993552916301587,0,1,positive regulation of nucleoside transport,BP,
8252,GO:0032252,1,0.903918581162303,0,15,secretory granule localization,BP,
8253,GO:0032253,1,0.928724799872283,0,11,dense core granule localization,BP,
8254,GO:0032259,1,0.133454790903256,0,306,methylation,BP,
8255,GO:0032261,1,0.962151136296876,0,6,purine nucleotide salvage,BP,
8256,GO:0032262,1,0.968470082401636,0,5,pyrimidine nucleotide salvage,BP,
8257,GO:0032263,1,0.993645181428393,0,1,GMP salvage,BP,
8258,GO:0032264,1,0.980740264632699,0,3,IMP salvage,BP,
8259,GO:0032266,1,0.756990242304371,0,42,phosphatidylinositol-3-phosphate binding,MF,
8266,GO:0032274,1,0.918847480520086,0,13,gonadotropin secretion,BP,
8267,GO:0032275,1,0.942853367451001,0,9,luteinizing hormone secretion,BP,
8268,GO:0032276,1,0.937216972420427,0,10,regulation of gonadotropin secretion,BP,
8269,GO:0032277,1,0.962148265316702,0,6,negative regulation of gonadotropin secretion,BP,
8270,GO:0032278,1,0.955482382427173,0,7,positive regulation of gonadotropin secretion,BP,
8272,GO:0032280,1,0.929884439905637,0,11,symmetric synapse,CC,
8273,GO:0032281,1,0.844519119835122,0,26,AMPA glutamate receptor complex,CC,
8275,GO:0032287,1,0.946682497404931,0,8,peripheral nervous system myelin maintenance,BP,
8276,GO:0032288,1,0.870447292570126,0,21,myelin assembly,BP,
8277,GO:0032289,1,0.974066309725798,0,4,central nervous system myelin formation,BP,
8278,GO:0032290,1,0.986538244629182,0,2,peripheral nervous system myelin formation,BP,
8280,GO:0032292,1,0.835025848902177,0,27,peripheral nervous system axon ensheathment,BP,
8281,GO:0032296,1,0.973834682691033,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8282,GO:0032298,1,0.993590070459919,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8283,GO:0032299,1,0.9809748903912,0,3,ribonuclease H2 complex,CC,
8284,GO:0032300,1,0.955147596694423,0,7,mismatch repair complex,CC,
8285,GO:0032301,1,0.987045919340616,0,2,MutSalpha complex,CC,
8286,GO:0032302,1,0.987024079177312,0,2,MutSbeta complex,CC,
8287,GO:0032303,1,0.925391039328015,0,12,regulation of icosanoid secretion,BP,
8288,GO:0032304,1,0.993415944541412,0,1,negative regulation of icosanoid secretion,BP,
8289,GO:0032305,1,0.931528130109425,0,11,positive regulation of icosanoid secretion,BP,
8290,GO:0032306,1,0.956074676136703,0,7,regulation of prostaglandin secretion,BP,
8291,GO:0032308,1,0.956074676136703,0,7,positive regulation of prostaglandin secretion,BP,
8292,GO:0032309,1,0.818457225128518,0,31,icosanoid secretion,BP,
8293,GO:0032310,1,0.937500037614025,0,10,prostaglandin secretion,BP,
8294,GO:0032311,1,0.987327407776341,0,2,angiogenin-PRI complex,CC,
8295,GO:0032324,1,0.961925229714383,0,6,molybdopterin cofactor biosynthetic process,BP,
8296,GO:0032328,1,0.924576060775221,0,12,alanine transport,BP,
8297,GO:0032329,1,0.949532048161989,0,8,serine transport,BP,
8300,GO:0032332,1,0.877162765663877,0,20,positive regulation of chondrocyte differentiation,BP,
8301,GO:0032341,1,0.949071217531438,0,8,aldosterone metabolic process,BP,
8302,GO:0032342,1,0.949071217531438,0,8,aldosterone biosynthetic process,BP,
8303,GO:0032344,1,0.95562367261606,0,7,regulation of aldosterone metabolic process,BP,
8304,GO:0032345,1,0.974443764686646,0,4,negative regulation of aldosterone metabolic process,BP,
8305,GO:0032346,1,0.987074772841688,0,2,positive regulation of aldosterone metabolic process,BP,
8306,GO:0032347,1,0.95562367261606,0,7,regulation of aldosterone biosynthetic process,BP,
8307,GO:0032348,1,0.974443764686646,0,4,negative regulation of aldosterone biosynthetic process,BP,
8308,GO:0032349,1,0.987074772841688,0,2,positive regulation of aldosterone biosynthetic process,BP,
8309,GO:0032350,1,0.817401710647182,0,31,regulation of hormone metabolic process,BP,
8310,GO:0032351,1,0.949539027195708,0,8,negative regulation of hormone metabolic process,BP,
8311,GO:0032352,1,0.918871935730356,0,13,positive regulation of hormone metabolic process,BP,
8312,GO:0032353,1,0.961811885058096,0,6,negative regulation of hormone biosynthetic process,BP,
8313,GO:0032354,1,0.911681372718575,0,14,response to follicle-stimulating hormone,BP,
8314,GO:0032355,1,0.433728702962564,0,128,response to estradiol,BP,
8315,GO:0032356,1,0.937139354913179,0,10,oxidized DNA binding,MF,
8316,GO:0032357,1,0.943180592650695,0,9,oxidized purine DNA binding,MF,
8317,GO:0032358,1,0.993683378759476,0,1,oxidized pyrimidine DNA binding,MF,
8318,GO:0032361,1,0.993606027540371,0,1,pyridoxal phosphate catabolic process,BP,
8319,GO:0032364,1,0.955451578148029,0,7,oxygen homeostasis,BP,
8320,GO:0032365,1,0.784436708925004,0,37,intracellular lipid transport,BP,
8321,GO:0032366,1,0.871211913481975,0,21,intracellular sterol transport,BP,
8322,GO:0032367,1,0.871211913481975,0,21,intracellular cholesterol transport,BP,
8324,GO:0032369,1,0.877074079204175,0,20,negative regulation of lipid transport,BP,
8327,GO:0032372,1,0.943101711654643,0,9,negative regulation of sterol transport,BP,
8328,GO:0032373,1,0.843225530558081,0,26,positive regulation of sterol transport,BP,
8329,GO:0032374,1,0.755073766288232,0,43,regulation of cholesterol transport,BP,
8330,GO:0032375,1,0.943101711654643,0,9,negative regulation of cholesterol transport,BP,
8331,GO:0032376,1,0.843225530558081,0,26,positive regulation of cholesterol transport,BP,
8332,GO:0032377,1,0.955415498085579,0,7,regulation of intracellular lipid transport,BP,
8333,GO:0032378,1,0.986691524732186,0,2,negative regulation of intracellular lipid transport,BP,
8334,GO:0032379,1,0.98094390687185,0,3,positive regulation of intracellular lipid transport,BP,
8335,GO:0032380,1,0.955415498085579,0,7,regulation of intracellular sterol transport,BP,
8336,GO:0032381,1,0.986691524732186,0,2,negative regulation of intracellular sterol transport,BP,
8337,GO:0032382,1,0.98094390687185,0,3,positive regulation of intracellular sterol transport,BP,
8338,GO:0032383,1,0.955415498085579,0,7,regulation of intracellular cholesterol transport,BP,
8339,GO:0032384,1,0.986691524732186,0,2,negative regulation of intracellular cholesterol transport,BP,
8340,GO:0032385,1,0.98094390687185,0,3,positive regulation of intracellular cholesterol transport,BP,
8341,GO:0032386,1,0.110108859713365,0,334,regulation of intracellular transport,BP,
8342,GO:0032387,1,0.702983694545296,0,54,negative regulation of intracellular transport,BP,
8343,GO:0032388,1,0.247847625483638,0,212,positive regulation of intracellular transport,BP,
8344,GO:0032389,1,0.98716922483569,0,2,MutLalpha complex,CC,
8345,GO:0032391,1,0.804331268074148,0,33,photoreceptor connecting cilium,CC,
8346,GO:0032392,1,0.482127296099885,0,111,DNA geometric change,BP,
8347,GO:0032393,1,0.956140116119144,0,7,MHC class I receptor activity,MF,
8348,GO:0032394,1,0.974697127185108,0,4,MHC class Ib receptor activity,MF,
8349,GO:0032395,1,0.944156372937694,0,9,MHC class II receptor activity,MF,
8350,GO:0032396,1,0.980834369514242,0,3,inhibitory MHC class I receptor activity,MF,
8351,GO:0032397,1,0.987317068245266,0,2,activating MHC class I receptor activity,MF,
8352,GO:0032398,1,0.987321684631369,0,2,MHC class Ib protein complex,CC,
8353,GO:0032400,1,0.850078246573819,0,25,melanosome localization,BP,
8354,GO:0032401,1,0.861141869031219,0,23,establishment of melanosome localization,BP,
8355,GO:0032402,1,0.867039948908779,0,22,melanosome transport,BP,
8356,GO:0032404,1,0.930845983769716,0,11,mismatch repair complex binding,MF,
8357,GO:0032405,1,0.961397763475846,0,6,MutLalpha complex binding,MF,
8358,GO:0032406,1,0.987122879694448,0,2,MutLbeta complex binding,MF,
8359,GO:0032407,1,0.955450890007563,0,7,MutSalpha complex binding,MF,
8360,GO:0032408,1,0.987122879694448,0,2,MutSbeta complex binding,MF,
8365,GO:0032413,1,0.65046810474031,0,66,negative regulation of ion transmembrane transporter activity,BP,
8367,GO:0032415,1,0.962214474492422,0,6,regulation of sodium:proton antiporter activity,BP,
8368,GO:0032416,1,0.987279642992093,0,2,negative regulation of sodium:proton antiporter activity,BP,
8369,GO:0032417,1,0.974615094706333,0,4,positive regulation of sodium:proton antiporter activity,BP,
8370,GO:0032418,1,0.642065325802729,0,68,lysosome localization,BP,
8371,GO:0032419,1,0.99359069410163,0,1,extrinsic component of lysosome membrane,CC,
8372,GO:0032420,1,0.739244510039507,0,46,stereocilium,CC,
8373,GO:0032421,1,0.720314864755991,0,50,stereocilium bundle,CC,
8374,GO:0032422,1,0.974056790331806,0,4,purine-rich negative regulatory element binding,MF,
8375,GO:0032423,1,0.974342008591999,0,4,regulation of mismatch repair,BP,
8376,GO:0032425,1,0.980743017741603,0,3,positive regulation of mismatch repair,BP,
8377,GO:0032426,1,0.90107513972126,0,16,stereocilium tip,CC,
8378,GO:0032427,1,0.987090271783055,0,2,GBD domain binding,MF,
8379,GO:0032428,1,0.99351293062108,0,1,beta-N-acetylgalactosaminidase activity,MF,
8380,GO:0032429,1,0.94243681604154,0,9,regulation of phospholipase A2 activity,BP,
8381,GO:0032430,1,0.968259363364,0,5,positive regulation of phospholipase A2 activity,BP,
8382,GO:0032431,1,0.980966720495539,0,3,activation of phospholipase A2 activity,BP,
8384,GO:0032433,1,0.899206820225124,0,16,filopodium tip,CC,
8385,GO:0032434,1,0.445029601911352,0,124,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8386,GO:0032435,1,0.806503851029764,0,33,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8387,GO:0032436,1,0.585997771656881,0,82,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8388,GO:0032437,1,0.942721610133973,0,9,cuticular plate,CC,
8389,GO:0032438,1,0.838148063440312,0,27,melanosome organization,BP,
8390,GO:0032440,1,0.99365614408698,0,1,2-alkenal reductase [NAD(P)+] activity,MF,
8391,GO:0032444,1,0.979732618931116,0,3,activin responsive factor complex,CC,
8392,GO:0032445,1,0.99358494523866,0,1,fructose import,BP,
8393,GO:0032446,1,0.00349327381089022,0,844,protein modification by small protein conjugation,BP,
8394,GO:0032447,1,0.974679899235323,0,4,protein urmylation,BP,
8395,GO:0032448,1,0.993634247072194,0,1,DNA hairpin binding,MF,
8396,GO:0032449,1,0.974165832683882,0,4,CBM complex,CC,
8397,GO:0032450,1,0.980379174951965,0,3,maltose alpha-glucosidase activity,MF,
8398,GO:0032451,1,0.798862950121128,0,34,demethylase activity,MF,
8399,GO:0032452,1,0.84670769803748,0,25,histone demethylase activity,MF,
8400,GO:0032453,1,0.960535640609987,0,6,histone demethylase activity (H3-K4 specific),MF,
8401,GO:0032454,1,0.923625814657485,0,12,histone demethylase activity (H3-K9 specific),MF,
8402,GO:0032455,1,0.974445213050606,0,4,nerve growth factor processing,BP,
8403,GO:0032456,1,0.743995140246842,0,45,endocytic recycling,BP,
8404,GO:0032458,1,0.993496642831731,0,1,slow endocytic recycling,BP,
8405,GO:0032459,1,0.987174243068975,0,2,regulation of protein oligomerization,BP,
8406,GO:0032460,1,0.993528042703053,0,1,negative regulation of protein oligomerization,BP,
8407,GO:0032461,1,0.993605224907254,0,1,positive regulation of protein oligomerization,BP,
8408,GO:0032462,1,0.993528042703053,0,1,regulation of protein homooligomerization,BP,
8409,GO:0032463,1,0.993528042703053,0,1,negative regulation of protein homooligomerization,BP,
8410,GO:0032465,1,0.594585984334842,0,79,regulation of cytokinesis,BP,
8411,GO:0032466,1,0.955605457245446,0,7,negative regulation of cytokinesis,BP,
8412,GO:0032467,1,0.816276382272644,0,31,positive regulation of cytokinesis,BP,
8413,GO:0032468,1,0.987166660346313,0,2,Golgi calcium ion homeostasis,BP,
8414,GO:0032469,1,0.860293236198351,0,23,endoplasmic reticulum calcium ion homeostasis,BP,
8415,GO:0032470,1,0.986693032134152,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8416,GO:0032471,1,0.949626658717731,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8417,GO:0032472,1,0.987166660346313,0,2,Golgi calcium ion transport,BP,
8418,GO:0032473,1,0.986681044216117,0,2,cytoplasmic side of mitochondrial outer membrane,CC,
8419,GO:0032474,1,0.974177374824677,0,4,otolith morphogenesis,BP,
8420,GO:0032475,1,0.993564369387814,0,1,otolith formation,BP,
8421,GO:0032479,1,0.474247561361496,0,114,regulation of type I interferon production,BP,
8422,GO:0032480,1,0.764922543483082,0,41,negative regulation of type I interferon production,BP,
8423,GO:0032481,1,0.63682165192606,0,69,positive regulation of type I interferon production,BP,
8424,GO:0032482,1,0.872152964771431,0,21,Rab protein signal transduction,BP,
8425,GO:0032483,1,0.954515209217504,0,7,regulation of Rab protein signal transduction,BP,
8426,GO:0032484,1,0.980313350766905,0,3,Ral protein signal transduction,BP,
8427,GO:0032485,1,0.980313350766905,0,3,regulation of Ral protein signal transduction,BP,
8428,GO:0032486,1,0.911364570139803,0,14,Rap protein signal transduction,BP,
8429,GO:0032487,1,0.973292701799875,0,4,regulation of Rap protein signal transduction,BP,
8430,GO:0032488,1,0.924820261182872,0,12,Cdc42 protein signal transduction,BP,
8431,GO:0032489,1,0.961492532725313,0,6,regulation of Cdc42 protein signal transduction,BP,
8432,GO:0032490,1,0.924502342038146,0,12,detection of molecule of bacterial origin,BP,
8433,GO:0032491,1,0.99357830762331,0,1,detection of molecule of fungal origin,BP,
8434,GO:0032493,1,0.94904814291563,0,8,response to bacterial lipoprotein,BP,
8435,GO:0032494,1,0.931223603144807,0,11,response to peptidoglycan,BP,
8436,GO:0032495,1,0.88915245978732,0,18,response to muramyl dipeptide,BP,
8438,GO:0032497,1,0.974541663415586,0,4,detection of lipopolysaccharide,BP,
8439,GO:0032498,1,0.993457185747408,0,1,detection of muramyl dipeptide,BP,
8440,GO:0032499,1,0.98716764684237,0,2,detection of peptidoglycan,BP,
8441,GO:0032500,1,0.993457185747408,0,1,muramyl dipeptide binding,MF,
8445,GO:0032505,1,0.992938094261375,0,1,reproduction of a single-celled organism,BP,
8446,GO:0032506,1,0.776336698979859,0,39,cytokinetic process,BP,
8447,GO:0032507,1,0.661087701674005,0,63,maintenance of protein location in cell,BP,
8448,GO:0032508,1,0.507955871348935,0,103,DNA duplex unwinding,BP,
8449,GO:0032509,1,0.807272367790592,0,33,endosome transport via multivesicular body sorting pathway,BP,
8450,GO:0032510,1,0.954797653679404,0,7,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8451,GO:0032511,1,0.902189697257898,0,16,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8453,GO:0032516,1,0.888634769263434,0,18,positive regulation of phosphoprotein phosphatase activity,BP,
8454,GO:0032525,1,0.931058559974465,0,11,somite rostral/caudal axis specification,BP,
8455,GO:0032526,1,0.516381145886746,0,101,response to retinoic acid,BP,
8456,GO:0032527,1,0.745079204795477,0,45,protein exit from endoplasmic reticulum,BP,
8457,GO:0032528,1,0.854352707809925,0,24,microvillus organization,BP,
8458,GO:0032530,1,0.924641769951973,0,12,regulation of microvillus organization,BP,
8459,GO:0032532,1,0.961876282349588,0,6,regulation of microvillus length,BP,
8460,GO:0032534,1,0.961304458672263,0,6,regulation of microvillus assembly,BP,
8463,GO:0032541,1,0.968223584363105,0,5,cortical endoplasmic reticulum,CC,
8464,GO:0032542,1,0.987128779072902,0,2,sulfiredoxin activity,MF,
8465,GO:0032543,1,0.436115017329593,0,129,mitochondrial translation,BP,
8466,GO:0032545,1,0.987177473212687,0,2,CURI complex,CC,
8467,GO:0032549,1,0.112949629881463,0,333,ribonucleoside binding,MF,
8468,GO:0032550,1,0.115245809834786,0,330,purine ribonucleoside binding,MF,
8469,GO:0032552,1,0.968336280633573,0,5,deoxyribonucleotide binding,MF,
8471,GO:0032554,1,0.974511248400913,0,4,purine deoxyribonucleotide binding,MF,
8473,GO:0032556,1,0.993665154203989,0,1,pyrimidine deoxyribonucleotide binding,MF,
8474,GO:0032557,1,0.98066006419,0,3,pyrimidine ribonucleotide binding,MF,
8475,GO:0032558,1,0.980855580484128,0,3,adenyl deoxyribonucleotide binding,MF,
8477,GO:0032560,1,0.993533084946483,0,1,guanyl deoxyribonucleotide binding,MF,
8478,GO:0032561,1,0.105622486645745,0,343,guanyl ribonucleotide binding,MF,
8479,GO:0032564,1,0.987144965256702,0,2,dATP binding,MF,
8480,GO:0032567,1,0.993533084946483,0,1,dGTP binding,MF,
8481,GO:0032570,1,0.760803285685072,0,42,response to progesterone,BP,
8482,GO:0032571,1,0.974590309139645,0,4,response to vitamin K,BP,
8483,GO:0032574,1,0.98704548023592,0,2,5'-3' RNA helicase activity,MF,
8484,GO:0032580,1,0.605459901115933,0,77,Golgi cisterna membrane,CC,
8485,GO:0032581,1,0.993616523860029,0,1,ER-dependent peroxisome organization,BP,
8486,GO:0032584,1,0.955615754789778,0,7,growth cone membrane,CC,
8487,GO:0032585,1,0.930888919930933,0,11,multivesicular body membrane,CC,
8490,GO:0032589,1,0.68150297529554,0,58,neuron projection membrane,CC,
8491,GO:0032590,1,0.759515115687626,0,42,dendrite membrane,CC,
8492,GO:0032591,1,0.906052651163804,0,15,dendritic spine membrane,CC,
8493,GO:0032592,1,0.627664691350172,0,72,integral component of mitochondrial membrane,CC,
8494,GO:0032593,1,0.93543946934784,0,10,insulin-responsive compartment,CC,
8495,GO:0032594,1,0.955815560222616,0,7,protein transport within lipid bilayer,BP,
8496,GO:0032596,1,0.974354086555536,0,4,protein transport into membrane raft,BP,
8497,GO:0032601,1,0.980553620739771,0,3,connective tissue growth factor production,BP,
8499,GO:0032603,1,0.987347070904678,0,2,fractalkine production,BP,
8500,GO:0032604,1,0.925291757766108,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8501,GO:0032605,1,0.993533084946483,0,1,hepatocyte growth factor production,BP,
8502,GO:0032606,1,0.468149973605274,0,116,type I interferon production,BP,
8503,GO:0032607,1,0.837766037083148,0,27,interferon-alpha production,BP,
8504,GO:0032608,1,0.730958972141935,0,48,interferon-beta production,BP,
8505,GO:0032609,1,0.526488792584467,0,99,interferon-gamma production,BP,
8506,GO:0032610,1,0.974188888599031,0,4,interleukin-1 alpha production,BP,
8507,GO:0032611,1,0.591360882904384,0,81,interleukin-1 beta production,BP,
8508,GO:0032612,1,0.550424864399559,0,92,interleukin-1 production,BP,
8509,GO:0032613,1,0.719220714568603,0,51,interleukin-10 production,BP,
8510,GO:0032615,1,0.71332428753881,0,52,interleukin-12 production,BP,
8511,GO:0032616,1,0.901641909166932,0,16,interleukin-13 production,BP,
8512,GO:0032618,1,0.98728852716219,0,2,interleukin-15 production,BP,
8513,GO:0032620,1,0.845637148044889,0,26,interleukin-17 production,BP,
8514,GO:0032621,1,0.94927062924143,0,8,interleukin-18 production,BP,
8515,GO:0032623,1,0.713165604106701,0,52,interleukin-2 production,BP,
8516,GO:0032625,1,0.987215254203963,0,2,interleukin-21 production,BP,
8517,GO:0032627,1,0.974279142027375,0,4,interleukin-23 production,BP,
8518,GO:0032632,1,0.987123624023955,0,2,interleukin-3 production,BP,
8519,GO:0032633,1,0.818470762426116,0,31,interleukin-4 production,BP,
8520,GO:0032634,1,0.918892246647768,0,13,interleukin-5 production,BP,
8523,GO:0032639,1,0.993627693156831,0,1,TRAIL production,BP,
8524,GO:0032640,1,0.518333847074526,0,101,tumor necrosis factor production,BP,
8526,GO:0032643,1,0.980553620739771,0,3,regulation of connective tissue growth factor production,BP,
8527,GO:0032645,1,0.93123326237507,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032646,1,0.993533084946483,0,1,regulation of hepatocyte growth factor production,BP,
8529,GO:0032647,1,0.84854932594274,0,25,regulation of interferon-alpha production,BP,
8530,GO:0032648,1,0.735744170077793,0,47,regulation of interferon-beta production,BP,
8531,GO:0032649,1,0.562058859748072,0,89,regulation of interferon-gamma production,BP,
8532,GO:0032650,1,0.980367622717995,0,3,regulation of interleukin-1 alpha production,BP,
8533,GO:0032651,1,0.627361737754898,0,72,regulation of interleukin-1 beta production,BP,
8534,GO:0032652,1,0.587681160599708,0,82,regulation of interleukin-1 production,BP,
8535,GO:0032653,1,0.733251912405985,0,48,regulation of interleukin-10 production,BP,
8536,GO:0032655,1,0.722663514202073,0,50,regulation of interleukin-12 production,BP,
8537,GO:0032656,1,0.913297351242405,0,14,regulation of interleukin-13 production,BP,
8538,GO:0032658,1,0.993620653376666,0,1,regulation of interleukin-15 production,BP,
8539,GO:0032660,1,0.873333509746475,0,21,regulation of interleukin-17 production,BP,
8540,GO:0032661,1,0.961776116526161,0,6,regulation of interleukin-18 production,BP,
8541,GO:0032663,1,0.736463995323719,0,47,regulation of interleukin-2 production,BP,
8542,GO:0032667,1,0.974279142027375,0,4,regulation of interleukin-23 production,BP,
8543,GO:0032672,1,0.993584880294264,0,1,regulation of interleukin-3 production,BP,
8544,GO:0032673,1,0.829100532757471,0,29,regulation of interleukin-4 production,BP,
8545,GO:0032674,1,0.918892246647768,0,13,regulation of interleukin-5 production,BP,
8547,GO:0032677,1,0.651748105432925,0,66,regulation of interleukin-8 production,BP,
8548,GO:0032679,1,0.993627693156831,0,1,regulation of TRAIL production,BP,
8549,GO:0032680,1,0.535404497789624,0,96,regulation of tumor necrosis factor production,BP,
8550,GO:0032682,1,0.913601578429598,0,14,negative regulation of chemokine production,BP,
8551,GO:0032683,1,0.993474766872755,0,1,negative regulation of connective tissue growth factor production,BP,
8552,GO:0032685,1,0.993529578175962,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8553,GO:0032686,1,0.993533084946483,0,1,negative regulation of hepatocyte growth factor production,BP,
8554,GO:0032687,1,0.967838093578309,0,5,negative regulation of interferon-alpha production,BP,
8555,GO:0032688,1,0.918918835522153,0,13,negative regulation of interferon-beta production,BP,
8556,GO:0032689,1,0.819011280881533,0,31,negative regulation of interferon-gamma production,BP,
8557,GO:0032690,1,0.993529419212751,0,1,negative regulation of interleukin-1 alpha production,BP,
8558,GO:0032691,1,0.867747370383673,0,22,negative regulation of interleukin-1 beta production,BP,
8559,GO:0032692,1,0.84016374613739,0,27,negative regulation of interleukin-1 production,BP,
8560,GO:0032693,1,0.913734393291938,0,14,negative regulation of interleukin-10 production,BP,
8561,GO:0032695,1,0.901142666979024,0,16,negative regulation of interleukin-12 production,BP,
8562,GO:0032696,1,0.980819027960569,0,3,negative regulation of interleukin-13 production,BP,
8563,GO:0032700,1,0.949607240047693,0,8,negative regulation of interleukin-17 production,BP,
8564,GO:0032701,1,0.98720141747638,0,2,negative regulation of interleukin-18 production,BP,
8565,GO:0032703,1,0.867098777757207,0,22,negative regulation of interleukin-2 production,BP,
8566,GO:0032707,1,0.986989974249861,0,2,negative regulation of interleukin-23 production,BP,
8567,GO:0032712,1,0.993584880294264,0,1,negative regulation of interleukin-3 production,BP,
8568,GO:0032713,1,0.962007350788568,0,6,negative regulation of interleukin-4 production,BP,
8569,GO:0032714,1,0.980734901183764,0,3,negative regulation of interleukin-5 production,BP,
8570,GO:0032715,1,0.791750912279942,0,36,negative regulation of interleukin-6 production,BP,
8571,GO:0032717,1,0.895868974160691,0,17,negative regulation of interleukin-8 production,BP,
8572,GO:0032720,1,0.747020750442669,0,45,negative regulation of tumor necrosis factor production,BP,
8574,GO:0032723,1,0.986994832488472,0,2,positive regulation of connective tissue growth factor production,BP,
8575,GO:0032725,1,0.937301916824794,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8576,GO:0032727,1,0.876784904810552,0,20,positive regulation of interferon-alpha production,BP,
8577,GO:0032728,1,0.821951153224782,0,30,positive regulation of interferon-beta production,BP,
8578,GO:0032729,1,0.69116544553398,0,57,positive regulation of interferon-gamma production,BP,
8579,GO:0032730,1,0.986753338612813,0,2,positive regulation of interleukin-1 alpha production,BP,
8580,GO:0032731,1,0.742251743419146,0,46,positive regulation of interleukin-1 beta production,BP,
8581,GO:0032732,1,0.718171607121268,0,51,positive regulation of interleukin-1 production,BP,
8582,GO:0032733,1,0.80284001597134,0,34,positive regulation of interleukin-10 production,BP,
8583,GO:0032735,1,0.818168161843541,0,31,positive regulation of interleukin-12 production,BP,
8584,GO:0032736,1,0.931170731200835,0,11,positive regulation of interleukin-13 production,BP,
8585,GO:0032738,1,0.993620653376666,0,1,positive regulation of interleukin-15 production,BP,
8586,GO:0032740,1,0.919718482280005,0,13,positive regulation of interleukin-17 production,BP,
8587,GO:0032741,1,0.980593032717228,0,3,positive regulation of interleukin-18 production,BP,
8588,GO:0032743,1,0.843937877316447,0,26,positive regulation of interleukin-2 production,BP,
8589,GO:0032747,1,0.9871232952818,0,2,positive regulation of interleukin-23 production,BP,
8591,GO:0032754,1,0.94298864630708,0,9,positive regulation of interleukin-5 production,BP,
8593,GO:0032757,1,0.727907305824959,0,49,positive regulation of interleukin-8 production,BP,
8594,GO:0032759,1,0.993627693156831,0,1,positive regulation of TRAIL production,BP,
8595,GO:0032760,1,0.741177020659862,0,46,positive regulation of tumor necrosis factor production,BP,
8596,GO:0032762,1,0.955649836224842,0,7,mast cell cytokine production,BP,
8597,GO:0032763,1,0.96819245270667,0,5,regulation of mast cell cytokine production,BP,
8598,GO:0032764,1,0.987192562529967,0,2,negative regulation of mast cell cytokine production,BP,
8599,GO:0032765,1,0.980755847521801,0,3,positive regulation of mast cell cytokine production,BP,
8600,GO:0032767,1,0.980446998853947,0,3,copper-dependent protein binding,MF,
8604,GO:0032771,1,0.993471216481218,0,1,regulation of monophenol monooxygenase activity,BP,
8605,GO:0032773,1,0.993471216481218,0,1,positive regulation of monophenol monooxygenase activity,BP,
8607,GO:0032775,1,0.986982750090081,0,2,DNA methylation on adenine,BP,
8608,GO:0032776,1,0.980476417838515,0,3,DNA methylation on cytosine,BP,
8609,GO:0032777,1,0.974518918284315,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8610,GO:0032780,1,0.896049225235247,0,17,negative regulation of ATPase activity,BP,
8611,GO:0032781,1,0.71055981711732,0,53,positive regulation of ATPase activity,BP,
8612,GO:0032782,1,0.955585989545079,0,7,bile acid secretion,BP,
8613,GO:0032783,1,0.966749829438182,0,5,super elongation complex,CC,
8614,GO:0032784,1,0.74559722704529,0,45,regulation of DNA-templated transcription, elongation,BP,
8615,GO:0032785,1,0.907168239681634,0,15,negative regulation of DNA-templated transcription, elongation,BP,
8616,GO:0032786,1,0.849342225333356,0,25,positive regulation of DNA-templated transcription, elongation,BP,
8618,GO:0032788,1,0.993631105816331,0,1,saturated monocarboxylic acid metabolic process,BP,
8619,GO:0032789,1,0.993631105816331,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8620,GO:0032790,1,0.949185032911793,0,8,ribosome disassembly,BP,
8621,GO:0032791,1,0.993623001992913,0,1,lead ion binding,MF,
8622,GO:0032792,1,0.968082611408049,0,5,negative regulation of CREB transcription factor activity,BP,
8623,GO:0032793,1,0.887852692598446,0,18,positive regulation of CREB transcription factor activity,BP,
8624,GO:0032794,1,0.911548530398635,0,14,GTPase activating protein binding,MF,
8625,GO:0032795,1,0.980840124285943,0,3,heterotrimeric G-protein binding,MF,
8626,GO:0032796,1,0.986873079683434,0,2,uropod organization,BP,
8627,GO:0032797,1,0.931389760207576,0,11,SMN complex,CC,
8628,GO:0032798,1,0.987155207697788,0,2,Swi5-Sfr1 complex,CC,
8629,GO:0032799,1,0.86608942472495,0,22,low-density lipoprotein receptor particle metabolic process,BP,
8630,GO:0032800,1,0.854840938427859,0,24,receptor biosynthetic process,BP,
8631,GO:0032801,1,0.799995793870296,0,34,receptor catabolic process,BP,
8632,GO:0032802,1,0.912569386379129,0,14,low-density lipoprotein particle receptor catabolic process,BP,
8633,GO:0032803,1,0.961579901558531,0,6,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8634,GO:0032804,1,0.987149087004314,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8635,GO:0032805,1,0.980436100469043,0,3,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8636,GO:0032806,1,0.878001301524932,0,20,carboxy-terminal domain protein kinase complex,CC,
8637,GO:0032807,1,0.980837008017066,0,3,DNA ligase IV complex,CC,
8638,GO:0032808,1,0.955110286205784,0,7,lacrimal gland development,BP,
8640,GO:0032810,1,0.987098752073798,0,2,sterol response element binding,MF,
8641,GO:0032811,1,0.980882919688063,0,3,negative regulation of epinephrine secretion,BP,
8642,GO:0032812,1,0.987352553822903,0,2,positive regulation of epinephrine secretion,BP,
8643,GO:0032813,1,0.748068022548174,0,45,tumor necrosis factor receptor superfamily binding,MF,
8644,GO:0032814,1,0.823830390675929,0,30,regulation of natural killer cell activation,BP,
8645,GO:0032815,1,0.950043546546951,0,8,negative regulation of natural killer cell activation,BP,
8646,GO:0032816,1,0.890112816643471,0,18,positive regulation of natural killer cell activation,BP,
8647,GO:0032817,1,0.949856595382597,0,8,regulation of natural killer cell proliferation,BP,
8648,GO:0032819,1,0.962268753429666,0,6,positive regulation of natural killer cell proliferation,BP,
8649,GO:0032823,1,0.931078370472836,0,11,regulation of natural killer cell differentiation,BP,
8650,GO:0032824,1,0.993676124177465,0,1,negative regulation of natural killer cell differentiation,BP,
8651,GO:0032825,1,0.949262907543121,0,8,positive regulation of natural killer cell differentiation,BP,
8652,GO:0032826,1,0.987345477185043,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8653,GO:0032827,1,0.993676124177465,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8654,GO:0032829,1,0.987252673891063,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8655,GO:0032831,1,0.987252673891063,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8656,GO:0032832,1,0.99362816181609,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8657,GO:0032834,1,0.99362816181609,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8659,GO:0032836,1,0.935629267345263,0,10,glomerular basement membrane development,BP,
8661,GO:0032839,1,0.800280527678459,0,34,dendrite cytoplasm,CC,
8662,GO:0032841,1,0.993510887635227,0,1,calcitonin binding,MF,
8663,GO:0032847,1,0.961898288098244,0,6,regulation of cellular pH reduction,BP,
8664,GO:0032848,1,0.993498269298743,0,1,negative regulation of cellular pH reduction,BP,
8665,GO:0032849,1,0.974441018133364,0,4,positive regulation of cellular pH reduction,BP,
8670,GO:0032873,1,0.76004661355865,0,42,negative regulation of stress-activated MAPK cascade,BP,
8672,GO:0032875,1,0.974240473125231,0,4,regulation of DNA endoreduplication,BP,
8673,GO:0032876,1,0.993594780058018,0,1,negative regulation of DNA endoreduplication,BP,
8674,GO:0032877,1,0.986905447491721,0,2,positive regulation of DNA endoreduplication,BP,
8675,GO:0032878,1,0.870506584944621,0,21,regulation of establishment or maintenance of cell polarity,BP,
8678,GO:0032881,1,0.778100135886714,0,38,regulation of polysaccharide metabolic process,BP,
8679,GO:0032885,1,0.798386301396163,0,34,regulation of polysaccharide biosynthetic process,BP,
8681,GO:0032887,1,0.993229466008014,0,1,regulation of spindle elongation,BP,
8682,GO:0032888,1,0.993229466008014,0,1,regulation of mitotic spindle elongation,BP,
8683,GO:0032889,1,0.968368206676346,0,5,regulation of vacuole fusion, non-autophagic,BP,
8687,GO:0032896,1,0.99338111934952,0,1,palmitoyl-CoA 9-desaturase activity,MF,
8688,GO:0032897,1,0.86100207406174,0,23,negative regulation of viral transcription,BP,
8689,GO:0032898,1,0.974302798173246,0,4,neurotrophin production,BP,
8690,GO:0032899,1,0.987090328377263,0,2,regulation of neurotrophin production,BP,
8691,GO:0032900,1,0.993552916301587,0,1,negative regulation of neurotrophin production,BP,
8692,GO:0032901,1,0.993495896214987,0,1,positive regulation of neurotrophin production,BP,
8693,GO:0032902,1,0.987046900305514,0,2,nerve growth factor production,BP,
8694,GO:0032905,1,0.925165797344041,0,12,transforming growth factor beta1 production,BP,
8695,GO:0032906,1,0.948695055819952,0,8,transforming growth factor beta2 production,BP,
8696,GO:0032907,1,0.97993847007366,0,3,transforming growth factor beta3 production,BP,
8697,GO:0032908,1,0.931169538560046,0,11,regulation of transforming growth factor beta1 production,BP,
8698,GO:0032909,1,0.948695055819952,0,8,regulation of transforming growth factor beta2 production,BP,
8699,GO:0032910,1,0.97993847007366,0,3,regulation of transforming growth factor beta3 production,BP,
8700,GO:0032911,1,0.968083744537394,0,5,negative regulation of transforming growth factor beta1 production,BP,
8701,GO:0032912,1,0.987030530756844,0,2,negative regulation of transforming growth factor beta2 production,BP,
8702,GO:0032914,1,0.955604604410586,0,7,positive regulation of transforming growth factor beta1 production,BP,
8703,GO:0032915,1,0.98724990546324,0,2,positive regulation of transforming growth factor beta2 production,BP,
8704,GO:0032916,1,0.986377207746172,0,2,positive regulation of transforming growth factor beta3 production,BP,
8705,GO:0032917,1,0.987379858291577,0,2,polyamine acetylation,BP,
8706,GO:0032918,1,0.987379858291577,0,2,spermidine acetylation,BP,
8707,GO:0032919,1,0.993675200071609,0,1,spermine acetylation,BP,
8708,GO:0032920,1,0.993675200071609,0,1,putrescine acetylation,BP,
8709,GO:0032922,1,0.667545483682234,0,61,circadian regulation of gene expression,BP,
8710,GO:0032924,1,0.774382226422231,0,39,activin receptor signaling pathway,BP,
8711,GO:0032925,1,0.854846767382004,0,24,regulation of activin receptor signaling pathway,BP,
8712,GO:0032926,1,0.93695604507495,0,10,negative regulation of activin receptor signaling pathway,BP,
8713,GO:0032927,1,0.948209183822945,0,8,positive regulation of activin receptor signaling pathway,BP,
8714,GO:0032928,1,0.878924362890745,0,20,regulation of superoxide anion generation,BP,
8715,GO:0032929,1,0.987334193690448,0,2,negative regulation of superoxide anion generation,BP,
8716,GO:0032930,1,0.89021266277324,0,18,positive regulation of superoxide anion generation,BP,
8717,GO:0032933,1,0.918885463930813,0,13,SREBP signaling pathway,BP,
8718,GO:0032934,1,0.716876071285653,0,51,sterol binding,MF,
8719,GO:0032937,1,0.980721741965664,0,3,SREBP-SCAP-Insig complex,CC,
8721,GO:0032941,1,0.817637495604891,0,31,secretion by tissue,BP,
8724,GO:0032945,1,0.626553993390386,0,72,negative regulation of mononuclear cell proliferation,BP,
8726,GO:0032954,1,0.98045424282562,0,3,regulation of cytokinetic process,BP,
8728,GO:0032957,1,0.936922070005932,0,10,inositol trisphosphate metabolic process,BP,
8730,GO:0032959,1,0.955469121764292,0,7,inositol trisphosphate biosynthetic process,BP,
8731,GO:0032960,1,0.968062603344406,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8732,GO:0032962,1,0.97443020388434,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8734,GO:0032964,1,0.770984489030164,0,40,collagen biosynthetic process,BP,
8735,GO:0032965,1,0.818105529327082,0,31,regulation of collagen biosynthetic process,BP,
8736,GO:0032966,1,0.937609423320725,0,10,negative regulation of collagen biosynthetic process,BP,
8737,GO:0032967,1,0.872620729846599,0,21,positive regulation of collagen biosynthetic process,BP,
8738,GO:0032968,1,0.930025031853125,0,11,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8740,GO:0032971,1,0.980844401380907,0,3,regulation of muscle filament sliding,BP,
8741,GO:0032972,1,0.993692860537692,0,1,regulation of muscle filament sliding speed,BP,
8742,GO:0032976,1,0.993685355464975,0,1,release of matrix enzymes from mitochondria,BP,
8743,GO:0032977,1,0.98712091165157,0,2,membrane insertase activity,MF,
8744,GO:0032978,1,0.980837650336018,0,3,protein insertion into membrane from inner side,BP,
8745,GO:0032979,1,0.980837650336018,0,3,protein insertion into mitochondrial inner membrane from matrix,BP,
8746,GO:0032981,1,0.699431445040552,0,56,mitochondrial respiratory chain complex I assembly,BP,
8747,GO:0032982,1,0.875397649455405,0,20,myosin filament,CC,
8748,GO:0032983,1,0.973806041078251,0,4,kainate selective glutamate receptor complex,CC,
8749,GO:0032984,1,0.133960337898069,0,306,protein-containing complex disassembly,BP,
8750,GO:0032986,1,0.89489876144054,0,17,protein-DNA complex disassembly,BP,
8751,GO:0032988,1,0.955490380607591,0,7,ribonucleoprotein complex disassembly,BP,
8756,GO:0032994,1,0.807800567661105,0,33,protein-lipid complex,CC,
8757,GO:0032996,1,0.993615080076501,0,1,Bcl3-Bcl10 complex,CC,
8758,GO:0032997,1,0.987365142725081,0,2,Fc receptor complex,CC,
8759,GO:0032998,1,0.987365142725081,0,2,Fc-epsilon receptor I complex,CC,
8760,GO:0033002,1,0.301290499381404,0,183,muscle cell proliferation,BP,
8761,GO:0033003,1,0.776923150694939,0,39,regulation of mast cell activation,BP,
8762,GO:0033004,1,0.925502316078819,0,12,negative regulation of mast cell activation,BP,
8763,GO:0033005,1,0.890190170016498,0,18,positive regulation of mast cell activation,BP,
8764,GO:0033006,1,0.823646550794634,0,30,regulation of mast cell activation involved in immune response,BP,
8765,GO:0033007,1,0.949830610553477,0,8,negative regulation of mast cell activation involved in immune response,BP,
8766,GO:0033008,1,0.913581903369308,0,14,positive regulation of mast cell activation involved in immune response,BP,
8767,GO:0033010,1,0.948457546288387,0,8,paranodal junction,CC,
8768,GO:0033011,1,0.98092253253941,0,3,perinuclear theca,CC,
8769,GO:0033013,1,0.712682382847485,0,52,tetrapyrrole metabolic process,BP,
8770,GO:0033014,1,0.844403401710573,0,26,tetrapyrrole biosynthetic process,BP,
8771,GO:0033015,1,0.97484806961936,0,4,tetrapyrrole catabolic process,BP,
8773,GO:0033018,1,0.943505745102748,0,9,sarcoplasmic reticulum lumen,CC,
8774,GO:0033023,1,0.98072465005065,0,3,mast cell homeostasis,BP,
8775,GO:0033024,1,0.98072465005065,0,3,mast cell apoptotic process,BP,
8776,GO:0033025,1,0.98072465005065,0,3,regulation of mast cell apoptotic process,BP,
8777,GO:0033026,1,0.987128253372165,0,2,negative regulation of mast cell apoptotic process,BP,
8778,GO:0033028,1,0.828087244502581,0,29,myeloid cell apoptotic process,BP,
8779,GO:0033029,1,0.954883809583979,0,7,regulation of neutrophil apoptotic process,BP,
8780,GO:0033030,1,0.98692161665825,0,2,negative regulation of neutrophil apoptotic process,BP,
8781,GO:0033031,1,0.974366493185113,0,4,positive regulation of neutrophil apoptotic process,BP,
8782,GO:0033032,1,0.849716440936015,0,25,regulation of myeloid cell apoptotic process,BP,
8783,GO:0033033,1,0.919308713855461,0,13,negative regulation of myeloid cell apoptotic process,BP,
8784,GO:0033034,1,0.955455223725096,0,7,positive regulation of myeloid cell apoptotic process,BP,
8786,GO:0033037,1,0.986798166202444,0,2,polysaccharide localization,BP,
8787,GO:0033038,1,0.950410292625612,0,8,bitter taste receptor activity,MF,
8788,GO:0033040,1,0.993540510244225,0,1,sour taste receptor activity,MF,
8789,GO:0033041,1,0.993569790012993,0,1,sweet taste receptor activity,MF,
8792,GO:0033045,1,0.607269169030804,0,76,regulation of sister chromatid segregation,BP,
8793,GO:0033046,1,0.764136940327649,0,41,negative regulation of sister chromatid segregation,BP,
8794,GO:0033047,1,0.648076817879445,0,66,regulation of mitotic sister chromatid segregation,BP,
8795,GO:0033048,1,0.769320983838519,0,40,negative regulation of mitotic sister chromatid segregation,BP,
8796,GO:0033058,1,0.979653656975128,0,3,directional locomotion,BP,
8797,GO:0033059,1,0.711668723460454,0,52,cellular pigmentation,BP,
8798,GO:0033061,1,0.955862283719493,0,7,DNA recombinase mediator complex,CC,
8799,GO:0033063,1,0.974575095408888,0,4,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8800,GO:0033065,1,0.987284201031532,0,2,Rad51C-XRCC3 complex,CC,
8801,GO:0033076,1,0.980971989951713,0,3,isoquinoline alkaloid metabolic process,BP,
8803,GO:0033078,1,0.980803600031043,0,3,extrathymic T cell differentiation,BP,
8804,GO:0033079,1,0.937564151548895,0,10,immature T cell proliferation,BP,
8805,GO:0033080,1,0.949694220626884,0,8,immature T cell proliferation in thymus,BP,
8807,GO:0033082,1,0.987096479933615,0,2,regulation of extrathymic T cell differentiation,BP,
8808,GO:0033083,1,0.943706479477807,0,9,regulation of immature T cell proliferation,BP,
8809,GO:0033084,1,0.955915214735435,0,7,regulation of immature T cell proliferation in thymus,BP,
8810,GO:0033085,1,0.955948005496949,0,7,negative regulation of T cell differentiation in thymus,BP,
8811,GO:0033087,1,0.974531155915904,0,4,negative regulation of immature T cell proliferation,BP,
8812,GO:0033088,1,0.980784392474815,0,3,negative regulation of immature T cell proliferation in thymus,BP,
8814,GO:0033091,1,0.968377767992889,0,5,positive regulation of immature T cell proliferation,BP,
8815,GO:0033092,1,0.974648440702442,0,4,positive regulation of immature T cell proliferation in thymus,BP,
8816,GO:0033093,1,0.967525042509487,0,5,Weibel-Palade body,CC,
8817,GO:0033100,1,0.993596169739984,0,1,NuA3 histone acetyltransferase complex,CC,
8819,GO:0033108,1,0.561440406534295,0,90,mitochondrial respiratory chain complex assembly,BP,
8820,GO:0033116,1,0.642018720805092,0,68,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8821,GO:0033119,1,0.845414870739077,0,26,negative regulation of RNA splicing,BP,
8822,GO:0033120,1,0.795746369910631,0,35,positive regulation of RNA splicing,BP,
8823,GO:0033127,1,0.924821895722319,0,12,regulation of histone phosphorylation,BP,
8824,GO:0033128,1,0.987234833028548,0,2,negative regulation of histone phosphorylation,BP,
8825,GO:0033129,1,0.948984481330945,0,8,positive regulation of histone phosphorylation,BP,
8826,GO:0033130,1,0.930714347043722,0,11,acetylcholine receptor binding,MF,
8827,GO:0033131,1,0.942949545033786,0,9,regulation of glucokinase activity,BP,
8828,GO:0033132,1,0.974581909240641,0,4,negative regulation of glucokinase activity,BP,
8829,GO:0033133,1,0.967550851339432,0,5,positive regulation of glucokinase activity,BP,
8831,GO:0033137,1,0.849861163501279,0,25,negative regulation of peptidyl-serine phosphorylation,BP,
8833,GO:0033139,1,0.974432227429294,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8834,GO:0033140,1,0.987304863736772,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8835,GO:0033141,1,0.986963497472635,0,2,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8836,GO:0033142,1,0.980174674334845,0,3,progesterone receptor binding,MF,
8837,GO:0033143,1,0.632631025849397,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8838,GO:0033144,1,0.805791010139683,0,33,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8839,GO:0033145,1,0.930798603342771,0,11,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8840,GO:0033146,1,0.795569667355659,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8841,GO:0033147,1,0.924572561024342,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8842,GO:0033148,1,0.942917219850567,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8843,GO:0033149,1,0.980552132770843,0,3,FFAT motif binding,MF,
8844,GO:0033150,1,0.987256260397247,0,2,cytoskeletal calyx,CC,
8845,GO:0033151,1,0.917196951482545,0,13,V(D)J recombination,BP,
8846,GO:0033152,1,0.96726414250541,0,5,immunoglobulin V(D)J recombination,BP,
8847,GO:0033153,1,0.96677471774948,0,5,T cell receptor V(D)J recombination,BP,
8848,GO:0033157,1,0.191282188434167,0,251,regulation of intracellular protein transport,BP,
8849,GO:0033162,1,0.919783820845889,0,13,melanosome membrane,CC,
8850,GO:0033165,1,0.967582107604213,0,5,interphotoreceptor matrix,CC,
8851,GO:0033167,1,0.992936130150715,0,1,ARC complex,CC,
8852,GO:0033168,1,0.992936130150715,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8853,GO:0033169,1,0.917681426955323,0,13,histone H3-K9 demethylation,BP,
8854,GO:0033170,1,0.94358312210315,0,9,protein-DNA loading ATPase activity,MF,
8856,GO:0033176,1,0.851191363853356,0,25,proton-transporting V-type ATPase complex,CC,
8857,GO:0033177,1,0.937481476748759,0,10,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8858,GO:0033178,1,0.931542406841458,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8859,GO:0033179,1,0.937481476748759,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8860,GO:0033180,1,0.943533856380187,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8861,GO:0033181,1,0.974738264311496,0,4,plasma membrane proton-transporting V-type ATPase complex,CC,
8862,GO:0033182,1,0.924501466262789,0,12,regulation of histone ubiquitination,BP,
8863,GO:0033183,1,0.973651769841182,0,4,negative regulation of histone ubiquitination,BP,
8864,GO:0033184,1,0.967963118927196,0,5,positive regulation of histone ubiquitination,BP,
8865,GO:0033185,1,0.981134122904285,0,3,dolichol-phosphate-mannose synthase complex,CC,
8866,GO:0033186,1,0.980401801057761,0,3,CAF-1 complex,CC,
8867,GO:0033188,1,0.980591528656892,0,3,sphingomyelin synthase activity,MF,
8868,GO:0033189,1,0.895192116595903,0,17,response to vitamin A,BP,
8869,GO:0033192,1,0.967556235911506,0,5,calmodulin-dependent protein phosphatase activity,MF,
8870,GO:0033193,1,0.99341910185417,0,1,Lsd1/2 complex,CC,
8871,GO:0033194,1,0.901205122419118,0,16,response to hydroperoxide,BP,
8872,GO:0033197,1,0.931315906509208,0,11,response to vitamin E,BP,
8873,GO:0033198,1,0.801174883562506,0,34,response to ATP,BP,
8874,GO:0033202,1,0.907883793739286,0,15,DNA helicase complex,CC,
8875,GO:0033204,1,0.937832466966942,0,10,ribonuclease P RNA binding,MF,
8876,GO:0033206,1,0.967689012929008,0,5,meiotic cytokinesis,BP,
8878,GO:0033210,1,0.931415007627626,0,11,leptin-mediated signaling pathway,BP,
8879,GO:0033211,1,0.955491194466742,0,7,adiponectin-activated signaling pathway,BP,
8880,GO:0033212,1,0.95573107684355,0,7,iron import into cell,BP,
8881,GO:0033214,1,0.993581645191367,0,1,siderophore-dependent iron import into cell,BP,
8882,GO:0033215,1,0.993567620641266,0,1,reductive iron assimilation,BP,
8884,GO:0033220,1,0.967988082115413,0,5,ATPase-coupled amide-transporter activity,MF,
8885,GO:0033227,1,0.980821013779275,0,3,dsRNA transport,BP,
8886,GO:0033229,1,0.993504840627077,0,1,cysteine transmembrane transporter activity,MF,
8887,GO:0033233,1,0.855499858190782,0,24,regulation of protein sumoylation,BP,
8888,GO:0033234,1,0.93724486479655,0,10,negative regulation of protein sumoylation,BP,
8889,GO:0033235,1,0.919105951712604,0,13,positive regulation of protein sumoylation,BP,
8891,GO:0033239,1,0.967492597590293,0,5,negative regulation of cellular amine metabolic process,BP,
8893,GO:0033241,1,0.99307768176836,0,1,regulation of cellular amine catabolic process,BP,
8894,GO:0033242,1,0.99307768176836,0,1,negative regulation of cellular amine catabolic process,BP,
8895,GO:0033256,1,0.974518382056746,0,4,I-kappaB/NF-kappaB complex,CC,
8896,GO:0033257,1,0.987196207567724,0,2,Bcl3/NF-kappaB2 complex,CC,
8897,GO:0033260,1,0.685312049754336,0,58,nuclear DNA replication,BP,
8898,GO:0033262,1,0.90058067366424,0,16,regulation of nuclear cell cycle DNA replication,BP,
8899,GO:0033263,1,0.967997415191442,0,5,CORVET complex,CC,
8900,GO:0033265,1,0.987179467387381,0,2,choline binding,MF,
8905,GO:0033274,1,0.993233712184945,0,1,response to vitamin B2,BP,
8906,GO:0033275,1,0.784016773382783,0,35,actin-myosin filament sliding,BP,
8907,GO:0033276,1,0.918584575470072,0,13,transcription factor TFTC complex,CC,
8908,GO:0033277,1,0.986941990148331,0,2,abortive mitotic cell cycle,BP,
8909,GO:0033278,1,0.967862026473427,0,5,cell proliferation in midbrain,BP,
8911,GO:0033283,1,0.98699197972332,0,2,ATPase-coupled organic acid transmembrane transporter activity,MF,
8912,GO:0033284,1,0.98699197972332,0,2,ATPase-coupled carboxylic acid transmembrane transporter activity,MF,
8913,GO:0033285,1,0.98699197972332,0,2,ATPase-coupled monocarboxylic acid transmembrane transporter activity,MF,
8914,GO:0033290,1,0.913937494936544,0,14,eukaryotic 48S preinitiation complex,CC,
8915,GO:0033291,1,0.993714113577592,0,1,eukaryotic 80S initiation complex,CC,
8916,GO:0033292,1,0.942167021299275,0,9,T-tubule organization,BP,
8917,GO:0033293,1,0.682615167715707,0,59,monocarboxylic acid binding,MF,
8918,GO:0033299,1,0.961952133940936,0,6,secretion of lysosomal enzymes,BP,
8919,GO:0033300,1,0.955708371095422,0,7,dehydroascorbic acid transmembrane transporter activity,MF,
8920,GO:0033301,1,0.993505281072859,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8921,GO:0033306,1,0.987158194782415,0,2,phytol metabolic process,BP,
8922,GO:0033313,1,0.968147766578204,0,5,meiotic cell cycle checkpoint,BP,
8923,GO:0033314,1,0.943364879735769,0,9,mitotic DNA replication checkpoint,BP,
8924,GO:0033316,1,0.993542175290034,0,1,meiotic spindle assembly checkpoint,BP,
8925,GO:0033319,1,0.993599954369409,0,1,UDP-D-xylose metabolic process,BP,
8926,GO:0033320,1,0.993599954369409,0,1,UDP-D-xylose biosynthetic process,BP,
8927,GO:0033326,1,0.980022488236536,0,3,cerebrospinal fluid secretion,BP,
8929,GO:0033328,1,0.987086607748149,0,2,peroxisome membrane targeting sequence binding,MF,
8930,GO:0033341,1,0.986781753786206,0,2,regulation of collagen binding,BP,
8931,GO:0033342,1,0.993571913492292,0,1,negative regulation of collagen binding,BP,
8932,GO:0033343,1,0.993166349326095,0,1,positive regulation of collagen binding,BP,
8933,GO:0033344,1,0.77380705798277,0,39,cholesterol efflux,BP,
8934,GO:0033345,1,0.993581097680666,0,1,asparagine catabolic process via L-aspartate,BP,
8935,GO:0033353,1,0.955672698044026,0,7,S-adenosylmethionine cycle,BP,
8936,GO:0033363,1,0.826339822073334,0,29,secretory granule organization,BP,
8937,GO:0033364,1,0.98629406440836,0,2,mast cell secretory granule organization,BP,
8939,GO:0033366,1,0.974608663731374,0,4,protein localization to secretory granule,BP,
8940,GO:0033367,1,0.993656276749981,0,1,protein localization to mast cell secretory granule,BP,
8941,GO:0033368,1,0.993656276749981,0,1,protease localization to mast cell secretory granule,BP,
8942,GO:0033370,1,0.993656276749981,0,1,maintenance of protein location in mast cell secretory granule,BP,
8943,GO:0033371,1,0.993656276749981,0,1,T cell secretory granule organization,BP,
8944,GO:0033373,1,0.993656276749981,0,1,maintenance of protease location in mast cell secretory granule,BP,
8945,GO:0033374,1,0.993656276749981,0,1,protein localization to T cell secretory granule,BP,
8946,GO:0033375,1,0.993656276749981,0,1,protease localization to T cell secretory granule,BP,
8947,GO:0033377,1,0.993656276749981,0,1,maintenance of protein location in T cell secretory granule,BP,
8948,GO:0033379,1,0.993656276749981,0,1,maintenance of protease location in T cell secretory granule,BP,
8949,GO:0033380,1,0.993656276749981,0,1,granzyme B localization to T cell secretory granule,BP,
8950,GO:0033382,1,0.993656276749981,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8951,GO:0033383,1,0.98723569659904,0,2,geranyl diphosphate metabolic process,BP,
8952,GO:0033384,1,0.98723569659904,0,2,geranyl diphosphate biosynthetic process,BP,
8953,GO:0033385,1,0.993554595268817,0,1,geranylgeranyl diphosphate metabolic process,BP,
8954,GO:0033386,1,0.993554595268817,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8955,GO:0033387,1,0.980753743135303,0,3,putrescine biosynthetic process from ornithine,BP,
8956,GO:0033388,1,0.993592997439697,0,1,putrescine biosynthetic process from arginine,BP,
8957,GO:0033389,1,0.993592997439697,0,1,putrescine biosynthetic process from arginine, using agmatinase,BP,
8958,GO:0033391,1,0.924220218380888,0,12,chromatoid body,CC,
8959,GO:0033396,1,0.993601419490681,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8960,GO:0033477,1,0.993606562878433,0,1,S-methylmethionine metabolic process,BP,
8961,GO:0033483,1,0.937107128821892,0,10,gas homeostasis,BP,
8962,GO:0033484,1,0.980808895434471,0,3,nitric oxide homeostasis,BP,
8963,GO:0033489,1,0.974499545612541,0,4,cholesterol biosynthetic process via desmosterol,BP,
8964,GO:0033490,1,0.974499545612541,0,4,cholesterol biosynthetic process via lathosterol,BP,
8965,GO:0033499,1,0.980977721063442,0,3,galactose catabolic process via UDP-galactose,BP,
8967,GO:0033503,1,0.974398317713513,0,4,HULC complex,CC,
8968,GO:0033504,1,0.961378558909198,0,6,floor plate development,BP,
8969,GO:0033505,1,0.986911059788852,0,2,floor plate morphogenesis,BP,
8970,GO:0033512,1,0.980614296974735,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8971,GO:0033514,1,0.993578883199393,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
8972,GO:0033522,1,0.848620331045055,0,25,histone H2A ubiquitination,BP,
8973,GO:0033523,1,0.924737433465618,0,12,histone H2B ubiquitination,BP,
8974,GO:0033539,1,0.937633125029657,0,10,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8975,GO:0033540,1,0.913364664117221,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8976,GO:0033549,1,0.925310885753429,0,12,MAP kinase phosphatase activity,MF,
8977,GO:0033553,1,0.974006175823475,0,4,rDNA heterochromatin,CC,
8980,GO:0033557,1,0.987155207697788,0,2,Slx1-Slx4 complex,CC,
8981,GO:0033558,1,0.843672792519632,0,26,protein deacetylase activity,MF,
8983,GO:0033561,1,0.854967338275503,0,24,regulation of water loss via skin,BP,
8984,GO:0033563,1,0.979904267304898,0,3,dorsal/ventral axon guidance,BP,
8985,GO:0033564,1,0.960942008002237,0,6,anterior/posterior axon guidance,BP,
8986,GO:0033565,1,0.980579948615348,0,3,ESCRT-0 complex,CC,
8987,GO:0033566,1,0.987176643037008,0,2,gamma-tubulin complex localization,BP,
8988,GO:0033567,1,0.987041405584169,0,2,DNA replication, Okazaki fragment processing,BP,
8991,GO:0033577,1,0.987233331659777,0,2,protein glycosylation in endoplasmic reticulum,BP,
8992,GO:0033578,1,0.967914819864582,0,5,protein glycosylation in Golgi,BP,
8993,GO:0033588,1,0.962087328786542,0,6,Elongator holoenzyme complex,CC,
8994,GO:0033590,1,0.980893686717397,0,3,response to cobalamin,BP,
8995,GO:0033591,1,0.967901413777065,0,5,response to L-ascorbic acid,BP,
8996,GO:0033592,1,0.967884628167279,0,5,RNA strand annealing activity,MF,
8997,GO:0033593,1,0.992819503931928,0,1,BRCA2-MAGE-D1 complex,CC,
8998,GO:0033594,1,0.974641716727829,0,4,response to hydroxyisoflavone,BP,
8999,GO:0033595,1,0.987167253017376,0,2,response to genistein,BP,
9000,GO:0033596,1,0.986512454204878,0,2,TSC1-TSC2 complex,CC,
9001,GO:0033597,1,0.993595937940486,0,1,mitotic checkpoint complex,CC,
9002,GO:0033598,1,0.842914856635582,0,26,mammary gland epithelial cell proliferation,BP,
9003,GO:0033599,1,0.900213376154054,0,16,regulation of mammary gland epithelial cell proliferation,BP,
9004,GO:0033600,1,0.973477358544722,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9005,GO:0033601,1,0.954849619912481,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9006,GO:0033602,1,0.973995448441475,0,4,negative regulation of dopamine secretion,BP,
9007,GO:0033603,1,0.961789308910437,0,6,positive regulation of dopamine secretion,BP,
9008,GO:0033604,1,0.931007916777356,0,11,negative regulation of catecholamine secretion,BP,
9009,GO:0033605,1,0.93127708382666,0,11,positive regulation of catecholamine secretion,BP,
9010,GO:0033609,1,0.99355705431691,0,1,oxalate metabolic process,BP,
9011,GO:0033612,1,0.855689385799336,0,24,receptor serine/threonine kinase binding,MF,
9012,GO:0033613,1,0.615165636220435,0,74,activating transcription factor binding,MF,
9013,GO:0033615,1,0.980834985738297,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9014,GO:0033617,1,0.873560208963095,0,21,mitochondrial cytochrome c oxidase assembly,BP,
9015,GO:0033619,1,0.685365488995977,0,58,membrane protein proteolysis,BP,
9016,GO:0033622,1,0.855019228747974,0,24,integrin activation,BP,
9017,GO:0033623,1,0.907221566747032,0,15,regulation of integrin activation,BP,
9018,GO:0033624,1,0.980378990068473,0,3,negative regulation of integrin activation,BP,
9019,GO:0033625,1,0.943612032928738,0,9,positive regulation of integrin activation,BP,
9020,GO:0033626,1,0.987187310975056,0,2,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9021,GO:0033627,1,0.653307221850862,0,65,cell adhesion mediated by integrin,BP,
9022,GO:0033628,1,0.746130500136862,0,45,regulation of cell adhesion mediated by integrin,BP,
9023,GO:0033629,1,0.936165435536641,0,10,negative regulation of cell adhesion mediated by integrin,BP,
9024,GO:0033630,1,0.878578426416757,0,20,positive regulation of cell adhesion mediated by integrin,BP,
9025,GO:0033631,1,0.906439121743782,0,15,cell-cell adhesion mediated by integrin,BP,
9026,GO:0033632,1,0.936748455430084,0,10,regulation of cell-cell adhesion mediated by integrin,BP,
9027,GO:0033633,1,0.986406081681747,0,2,negative regulation of cell-cell adhesion mediated by integrin,BP,
9028,GO:0033634,1,0.968237753978942,0,5,positive regulation of cell-cell adhesion mediated by integrin,BP,
9029,GO:0033643,1,0.918768844105754,0,13,host cell part,CC,
9030,GO:0033646,1,0.924841105238282,0,12,host intracellular part,CC,
9031,GO:0033647,1,0.949055327866542,0,8,host intracellular organelle,CC,
9032,GO:0033648,1,0.949055327866542,0,8,host intracellular membrane-bounded organelle,CC,
9033,GO:0033650,1,0.993622733671697,0,1,host cell mitochondrion,CC,
9034,GO:0033655,1,0.962006752800934,0,6,host cell cytoplasm part,CC,
9035,GO:0033668,1,0.974525056066214,0,4,negative regulation by symbiont of host apoptotic process,BP,
9038,GO:0033677,1,0.980694832631377,0,3,DNA/RNA helicase activity,MF,
9039,GO:0033678,1,0.99356333555262,0,1,5'-3' DNA/RNA helicase activity,MF,
9040,GO:0033679,1,0.993447576014988,0,1,3'-5' DNA/RNA helicase activity,MF,
9041,GO:0033683,1,0.776983953575876,0,39,nucleotide-excision repair, DNA incision,BP,
9042,GO:0033684,1,0.961697873759884,0,6,regulation of luteinizing hormone secretion,BP,
9043,GO:0033685,1,0.987273711292113,0,2,negative regulation of luteinizing hormone secretion,BP,
9044,GO:0033686,1,0.974097756294612,0,4,positive regulation of luteinizing hormone secretion,BP,
9048,GO:0033690,1,0.930976685605192,0,11,positive regulation of osteoblast proliferation,BP,
9050,GO:0033692,1,0.655891502700004,0,64,cellular polysaccharide biosynthetic process,BP,
9052,GO:0033695,1,0.99361105277542,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9053,GO:0033699,1,0.993604756923246,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9054,GO:0033700,1,0.948735469793172,0,8,phospholipid efflux,BP,
9055,GO:0033721,1,0.993554188564519,0,1,aldehyde dehydrogenase (NADP+) activity,MF,
9056,GO:0033735,1,0.993676388173438,0,1,aspartate dehydrogenase activity,MF,
9057,GO:0033737,1,0.993573106767278,0,1,1-pyrroline dehydrogenase activity,MF,
9058,GO:0033743,1,0.974542299771543,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9059,GO:0033744,1,0.993640785836875,0,1,L-methionine:thioredoxin-disulfide S-oxidoreductase activity,MF,
9060,GO:0033745,1,0.980770777869199,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9061,GO:0033746,1,0.99351061792185,0,1,histone demethylase activity (H3-R2 specific),MF,
9062,GO:0033749,1,0.99351061792185,0,1,histone demethylase activity (H4-R3 specific),MF,
9063,GO:0033750,1,0.91375155230908,0,14,ribosome localization,BP,
9064,GO:0033754,1,0.993634848188552,0,1,indoleamine 2,3-dioxygenase activity,MF,
9065,GO:0033762,1,0.810694793142946,0,32,response to glucagon,BP,
9066,GO:0033764,1,0.852224938610693,0,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9067,GO:0033765,1,0.987193226125423,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9068,GO:0033781,1,0.993600420300672,0,1,cholesterol 24-hydroxylase activity,MF,
9069,GO:0033783,1,0.993580101204257,0,1,25-hydroxycholesterol 7alpha-hydroxylase activity,MF,
9070,GO:0033787,1,0.993552513362211,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9071,GO:0033791,1,0.993585140126802,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9072,GO:0033798,1,0.98694451659087,0,2,thyroxine 5-deiodinase activity,MF,
9073,GO:0033814,1,0.993644915207127,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9074,GO:0033819,1,0.993675728155016,0,1,lipoyl(octanoyl) transferase activity,MF,
9075,GO:0033823,1,0.993544458400251,0,1,procollagen glucosyltransferase activity,MF,
9076,GO:0033829,1,0.980934597717748,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9077,GO:0033842,1,0.987080170544404,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9078,GO:0033857,1,0.986804556961798,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9079,GO:0033858,1,0.993534713386497,0,1,N-acetylgalactosamine kinase activity,MF,
9080,GO:0033860,1,0.93768365448395,0,10,regulation of NAD(P)H oxidase activity,BP,
9081,GO:0033861,1,0.987276253860133,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9082,GO:0033862,1,0.987137831567233,0,2,UMP kinase activity,MF,
9083,GO:0033864,1,0.9559644763329,0,7,positive regulation of NAD(P)H oxidase activity,BP,
9084,GO:0033865,1,0.446741788488472,0,124,nucleoside bisphosphate metabolic process,BP,
9085,GO:0033866,1,0.663402746574773,0,63,nucleoside bisphosphate biosynthetic process,BP,
9086,GO:0033867,1,0.993629968739144,0,1,Fas-activated serine/threonine kinase activity,MF,
9087,GO:0033869,1,0.968410849979955,0,5,nucleoside bisphosphate catabolic process,BP,
9088,GO:0033871,1,0.993609711467124,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9089,GO:0033872,1,0.987216902140692,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9090,GO:0033875,1,0.446741788488472,0,124,ribonucleoside bisphosphate metabolic process,BP,
9091,GO:0033878,1,0.986612099845395,0,2,hormone-sensitive lipase activity,MF,
9092,GO:0033882,1,0.987224173055619,0,2,choloyl-CoA hydrolase activity,MF,
9093,GO:0033883,1,0.987310889489669,0,2,pyridoxal phosphatase activity,MF,
9094,GO:0033885,1,0.99359233845386,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9095,GO:0033897,1,0.993656276749981,0,1,ribonuclease T2 activity,MF,
9096,GO:0033906,1,0.987242956856132,0,2,hyaluronoglucuronidase activity,MF,
9097,GO:0033919,1,0.993494857364421,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9098,GO:0033925,1,0.99345683314107,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9099,GO:0033961,1,0.993623035531141,0,1,cis-stilbene-oxide hydrolase activity,MF,
9100,GO:0033962,1,0.881100059555399,0,19,P-body assembly,BP,
9101,GO:0033967,1,0.987292887275975,0,2,box C/D snoRNA metabolic process,BP,
9102,GO:0033979,1,0.980726165248751,0,3,box H/ACA snoRNA metabolic process,BP,
9103,GO:0033981,1,0.993696346572902,0,1,D-dopachrome decarboxylase activity,MF,
9104,GO:0033989,1,0.993561702949748,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9106,GO:0034014,1,0.993586995583296,0,1,response to triglyceride,BP,
9107,GO:0034030,1,0.663402746574773,0,63,ribonucleoside bisphosphate biosynthetic process,BP,
9108,GO:0034031,1,0.968410849979955,0,5,ribonucleoside bisphosphate catabolic process,BP,
9109,GO:0034032,1,0.446741788488472,0,124,purine nucleoside bisphosphate metabolic process,BP,
9110,GO:0034033,1,0.663402746574773,0,63,purine nucleoside bisphosphate biosynthetic process,BP,
9111,GO:0034034,1,0.968410849979955,0,5,purine nucleoside bisphosphate catabolic process,BP,
9112,GO:0034035,1,0.873067146703779,0,21,purine ribonucleoside bisphosphate metabolic process,BP,
9113,GO:0034036,1,0.96156963794011,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9114,GO:0034038,1,0.993660453121866,0,1,deoxyhypusine synthase activity,MF,
9115,GO:0034039,1,0.987268921853977,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9116,GO:0034040,1,0.967322563789566,0,5,ATPase-coupled lipid transmembrane transporter activity,MF,
9117,GO:0034041,1,0.993544707274335,0,1,ATPase-coupled sterol transmembrane transporter activity,MF,
9118,GO:0034045,1,0.900157668191876,0,16,phagophore assembly site membrane,CC,
9119,GO:0034046,1,0.948510196291111,0,8,poly(G) binding,MF,
9120,GO:0034056,1,0.97416224614821,0,4,estrogen response element binding,MF,
9121,GO:0034057,1,0.987100931494068,0,2,RNA strand-exchange activity,MF,
9122,GO:0034058,1,0.942740855720929,0,9,endosomal vesicle fusion,BP,
9123,GO:0034059,1,0.9867199359211,0,2,response to anoxia,BP,
9124,GO:0034061,1,0.826547916322551,0,29,DNA polymerase activity,MF,
9125,GO:0034062,1,0.777231208481685,0,39,5'-3' RNA polymerase activity,MF,
9126,GO:0034063,1,0.859100441697288,0,23,stress granule assembly,BP,
9127,GO:0034066,1,0.987250500232175,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9128,GO:0034067,1,0.846293408336296,0,25,protein localization to Golgi apparatus,BP,
9129,GO:0034080,1,0.845481816317924,0,26,CENP-A containing nucleosome assembly,BP,
9130,GO:0034085,1,0.955011843391912,0,7,establishment of sister chromatid cohesion,BP,
9131,GO:0034086,1,0.941608554776598,0,9,maintenance of sister chromatid cohesion,BP,
9132,GO:0034087,1,0.986506232990893,0,2,establishment of mitotic sister chromatid cohesion,BP,
9133,GO:0034088,1,0.941608554776598,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9134,GO:0034091,1,0.966963838868991,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9135,GO:0034092,1,0.979665288835441,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9136,GO:0034093,1,0.987037554359669,0,2,positive regulation of maintenance of sister chromatid cohesion,BP,
9138,GO:0034098,1,0.955294209162371,0,7,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9139,GO:0034101,1,0.452835067955197,0,121,erythrocyte homeostasis,BP,
9144,GO:0034110,1,0.838024660200451,0,27,regulation of homotypic cell-cell adhesion,BP,
9145,GO:0034111,1,0.906869952519871,0,15,negative regulation of homotypic cell-cell adhesion,BP,
9146,GO:0034112,1,0.955154364031562,0,7,positive regulation of homotypic cell-cell adhesion,BP,
9150,GO:0034116,1,0.913718146427828,0,14,positive regulation of heterotypic cell-cell adhesion,BP,
9151,GO:0034117,1,0.993702130795493,0,1,erythrocyte aggregation,BP,
9152,GO:0034118,1,0.993702130795493,0,1,regulation of erythrocyte aggregation,BP,
9153,GO:0034120,1,0.993702130795493,0,1,positive regulation of erythrocyte aggregation,BP,
9154,GO:0034121,1,0.654268443744249,0,65,regulation of toll-like receptor signaling pathway,BP,
9155,GO:0034122,1,0.790251654348995,0,36,negative regulation of toll-like receptor signaling pathway,BP,
9156,GO:0034123,1,0.855830154221739,0,24,positive regulation of toll-like receptor signaling pathway,BP,
9157,GO:0034124,1,0.97460072229851,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9158,GO:0034125,1,0.98727619298972,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9159,GO:0034127,1,0.949349873792295,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9160,GO:0034128,1,0.955460235912559,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9161,GO:0034130,1,0.993552455871846,0,1,toll-like receptor 1 signaling pathway,BP,
9162,GO:0034134,1,0.912942927616196,0,14,toll-like receptor 2 signaling pathway,BP,
9163,GO:0034135,1,0.943072348349016,0,9,regulation of toll-like receptor 2 signaling pathway,BP,
9164,GO:0034136,1,0.974001922915902,0,4,negative regulation of toll-like receptor 2 signaling pathway,BP,
9165,GO:0034137,1,0.961859481463767,0,6,positive regulation of toll-like receptor 2 signaling pathway,BP,
9166,GO:0034138,1,0.878525263550426,0,20,toll-like receptor 3 signaling pathway,BP,
9167,GO:0034139,1,0.943258028031706,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9168,GO:0034140,1,0.980618696819731,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9169,GO:0034141,1,0.955702181155177,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9170,GO:0034142,1,0.806970294771798,0,33,toll-like receptor 4 signaling pathway,BP,
9171,GO:0034143,1,0.889637543031112,0,18,regulation of toll-like receptor 4 signaling pathway,BP,
9172,GO:0034144,1,0.955462149203928,0,7,negative regulation of toll-like receptor 4 signaling pathway,BP,
9173,GO:0034145,1,0.943501786684236,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9174,GO:0034146,1,0.986976109392286,0,2,toll-like receptor 5 signaling pathway,BP,
9175,GO:0034147,1,0.993461379502464,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9176,GO:0034148,1,0.993461379502464,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9177,GO:0034150,1,0.993346499401612,0,1,toll-like receptor 6 signaling pathway,BP,
9178,GO:0034154,1,0.937089774529861,0,10,toll-like receptor 7 signaling pathway,BP,
9179,GO:0034155,1,0.968084608402085,0,5,regulation of toll-like receptor 7 signaling pathway,BP,
9180,GO:0034156,1,0.993625616674369,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9181,GO:0034157,1,0.974296761807816,0,4,positive regulation of toll-like receptor 7 signaling pathway,BP,
9182,GO:0034158,1,0.986905198583323,0,2,toll-like receptor 8 signaling pathway,BP,
9183,GO:0034159,1,0.993386285591659,0,1,regulation of toll-like receptor 8 signaling pathway,BP,
9184,GO:0034161,1,0.993386285591659,0,1,positive regulation of toll-like receptor 8 signaling pathway,BP,
9185,GO:0034162,1,0.855402482195103,0,24,toll-like receptor 9 signaling pathway,BP,
9186,GO:0034163,1,0.943051051199996,0,9,regulation of toll-like receptor 9 signaling pathway,BP,
9187,GO:0034164,1,0.980499868390565,0,3,negative regulation of toll-like receptor 9 signaling pathway,BP,
9188,GO:0034165,1,0.974405209944585,0,4,positive regulation of toll-like receptor 9 signaling pathway,BP,
9189,GO:0034166,1,0.993527249361668,0,1,toll-like receptor 10 signaling pathway,BP,
9190,GO:0034182,1,0.966963838868991,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9191,GO:0034183,1,0.979665288835441,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9192,GO:0034184,1,0.987037554359669,0,2,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9193,GO:0034185,1,0.892942682987225,0,17,apolipoprotein binding,MF,
9194,GO:0034186,1,0.96780216111365,0,5,apolipoprotein A-I binding,MF,
9195,GO:0034188,1,0.98622539062671,0,2,apolipoprotein A-I receptor activity,MF,
9196,GO:0034189,1,0.974562075935058,0,4,very-low-density lipoprotein particle binding,MF,
9197,GO:0034190,1,0.96789813999345,0,5,apolipoprotein receptor binding,MF,
9198,GO:0034191,1,0.97422294434831,0,4,apolipoprotein A-I receptor binding,MF,
9199,GO:0034196,1,0.968358388724801,0,5,acylglycerol transport,BP,
9200,GO:0034197,1,0.968358388724801,0,5,triglyceride transport,BP,
9201,GO:0034198,1,0.761324785894584,0,42,cellular response to amino acid starvation,BP,
9202,GO:0034199,1,0.893763648131559,0,17,activation of protein kinase A activity,BP,
9203,GO:0034201,1,0.961857705515083,0,6,response to oleic acid,BP,
9204,GO:0034203,1,0.993410930777097,0,1,glycolipid translocation,BP,
9205,GO:0034204,1,0.756966067229252,0,42,lipid translocation,BP,
9206,GO:0034205,1,0.789187788354596,0,36,amyloid-beta formation,BP,
9207,GO:0034211,1,0.993035571048495,0,1,GTP-dependent protein kinase activity,MF,
9208,GO:0034212,1,0.687701295148215,0,57,peptide N-acetyltransferase activity,MF,
9209,GO:0034213,1,0.993636450546327,0,1,quinolinate catabolic process,BP,
9210,GO:0034214,1,0.9549478386656,0,7,protein hexamerization,BP,
9213,GO:0034224,1,0.99358967693686,0,1,cellular response to zinc ion starvation,BP,
9214,GO:0034227,1,0.968448383265369,0,5,tRNA thio-modification,BP,
9215,GO:0034230,1,0.987037387835347,0,2,enkephalin processing,BP,
9216,GO:0034231,1,0.993438478015697,0,1,islet amyloid polypeptide processing,BP,
9217,GO:0034235,1,0.962035735853147,0,6,GPI anchor binding,MF,
9220,GO:0034238,1,0.968459915357652,0,5,macrophage fusion,BP,
9221,GO:0034239,1,0.974660682323466,0,4,regulation of macrophage fusion,BP,
9222,GO:0034241,1,0.974660682323466,0,4,positive regulation of macrophage fusion,BP,
9223,GO:0034242,1,0.980729698840775,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9224,GO:0034243,1,0.849111872653436,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9225,GO:0034244,1,0.919083058107929,0,13,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9226,GO:0034245,1,0.99349999491189,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9227,GO:0034246,1,0.986881894306009,0,2,mitochondrial transcription factor activity,MF,
9228,GO:0034247,1,0.993653556149668,0,1,snoRNA splicing,BP,
9229,GO:0034248,1,0.0745211750197809,0,393,regulation of cellular amide metabolic process,BP,
9230,GO:0034249,1,0.385061323367021,0,145,negative regulation of cellular amide metabolic process,BP,
9231,GO:0034250,1,0.375410327782194,0,150,positive regulation of cellular amide metabolic process,BP,
9232,GO:0034255,1,0.993596235981754,0,1,regulation of urea metabolic process,BP,
9233,GO:0034260,1,0.744231749877937,0,45,negative regulation of GTPase activity,BP,
9234,GO:0034263,1,0.993425507597842,0,1,positive regulation of autophagy in response to ER overload,BP,
9235,GO:0034271,1,0.980674993866621,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9236,GO:0034272,1,0.980674993866621,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9237,GO:0034274,1,0.98056258295205,0,3,Atg12-Atg5-Atg16 complex,CC,
9238,GO:0034275,1,0.987093620753865,0,2,kynurenic acid metabolic process,BP,
9239,GO:0034276,1,0.987093620753865,0,2,kynurenic acid biosynthetic process,BP,
9241,GO:0034285,1,0.974231209085574,0,4,response to disaccharide,BP,
9242,GO:0034287,1,0.974625505293096,0,4,detection of monosaccharide stimulus,BP,
9243,GO:0034308,1,0.587902164063847,0,82,primary alcohol metabolic process,BP,
9244,GO:0034309,1,0.930367521398251,0,11,primary alcohol biosynthetic process,BP,
9245,GO:0034310,1,0.920127240604679,0,13,primary alcohol catabolic process,BP,
9246,GO:0034311,1,0.861726885279393,0,23,diol metabolic process,BP,
9247,GO:0034312,1,0.878479617211094,0,20,diol biosynthetic process,BP,
9248,GO:0034314,1,0.796609058016055,0,35,Arp2/3 complex-mediated actin nucleation,BP,
9249,GO:0034315,1,0.883742634479185,0,19,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9250,GO:0034316,1,0.961948806121649,0,6,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9253,GO:0034331,1,0.819666456149407,0,30,cell junction maintenance,BP,
9254,GO:0034332,1,0.669473722693282,0,61,adherens junction organization,BP,
9255,GO:0034333,1,0.924247997697678,0,12,adherens junction assembly,BP,
9256,GO:0034334,1,0.967553127101469,0,5,adherens junction maintenance,BP,
9257,GO:0034337,1,0.993615718009131,0,1,RNA folding,BP,
9258,GO:0034338,1,0.961593240398509,0,6,short-chain carboxylesterase activity,MF,
9259,GO:0034340,1,0.598468813954836,0,79,response to type I interferon,BP,
9261,GO:0034342,1,0.99355705431691,0,1,response to type III interferon,BP,
9262,GO:0034343,1,0.980624896359301,0,3,type III interferon production,BP,
9263,GO:0034344,1,0.980624896359301,0,3,regulation of type III interferon production,BP,
9264,GO:0034346,1,0.993541764887949,0,1,positive regulation of type III interferon production,BP,
9265,GO:0034349,1,0.906728211783831,0,15,glial cell apoptotic process,BP,
9266,GO:0034350,1,0.936612737192356,0,10,regulation of glial cell apoptotic process,BP,
9267,GO:0034351,1,0.949117543995256,0,8,negative regulation of glial cell apoptotic process,BP,
9268,GO:0034352,1,0.986831640174105,0,2,positive regulation of glial cell apoptotic process,BP,
9269,GO:0034353,1,0.99355705431691,0,1,RNA pyrophosphohydrolase activity,MF,
9270,GO:0034354,1,0.962231312765198,0,6,'de novo' NAD biosynthetic process from tryptophan,BP,
9271,GO:0034355,1,0.99355705431691,0,1,NAD salvage,BP,
9272,GO:0034356,1,0.931001277721937,0,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9273,GO:0034358,1,0.823516541127653,0,30,plasma lipoprotein particle,CC,
9274,GO:0034359,1,0.992521690588248,0,1,mature chylomicron,CC,
9275,GO:0034360,1,0.992521690588248,0,1,chylomicron remnant,CC,
9276,GO:0034361,1,0.907303118948391,0,15,very-low-density lipoprotein particle,CC,
9277,GO:0034362,1,0.930841062280559,0,11,low-density lipoprotein particle,CC,
9278,GO:0034363,1,0.973811834896199,0,4,intermediate-density lipoprotein particle,CC,
9279,GO:0034364,1,0.867910583374281,0,22,high-density lipoprotein particle,CC,
9280,GO:0034365,1,0.981147843129428,0,3,discoidal high-density lipoprotein particle,CC,
9281,GO:0034366,1,0.962485857542007,0,6,spherical high-density lipoprotein particle,CC,
9282,GO:0034367,1,0.850095646945428,0,25,protein-containing complex remodeling,BP,
9283,GO:0034368,1,0.85562977199483,0,24,protein-lipid complex remodeling,BP,
9284,GO:0034369,1,0.85562977199483,0,24,plasma lipoprotein particle remodeling,BP,
9285,GO:0034370,1,0.949121144680373,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9286,GO:0034371,1,0.967483914709054,0,5,chylomicron remodeling,BP,
9287,GO:0034372,1,0.956275654881872,0,7,very-low-density lipoprotein particle remodeling,BP,
9288,GO:0034373,1,0.993632509793473,0,1,intermediate-density lipoprotein particle remodeling,BP,
9289,GO:0034374,1,0.918629642435065,0,13,low-density lipoprotein particle remodeling,BP,
9290,GO:0034375,1,0.907956112493288,0,15,high-density lipoprotein particle remodeling,BP,
9291,GO:0034377,1,0.854905476578299,0,24,plasma lipoprotein particle assembly,BP,
9292,GO:0034378,1,0.948732179268381,0,8,chylomicron assembly,BP,
9293,GO:0034379,1,0.930535550881994,0,11,very-low-density lipoprotein particle assembly,BP,
9294,GO:0034380,1,0.930797707562846,0,11,high-density lipoprotein particle assembly,BP,
9295,GO:0034381,1,0.736401797974101,0,47,plasma lipoprotein particle clearance,BP,
9296,GO:0034382,1,0.955059534579159,0,7,chylomicron remnant clearance,BP,
9297,GO:0034383,1,0.822300357397033,0,30,low-density lipoprotein particle clearance,BP,
9298,GO:0034384,1,0.930696610811439,0,11,high-density lipoprotein particle clearance,BP,
9299,GO:0034385,1,0.907303118948391,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9300,GO:0034386,1,0.993425585143341,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9301,GO:0034388,1,0.96793633598377,0,5,Pwp2p-containing subcomplex of 90S preribosome,CC,
9302,GO:0034389,1,0.85610462591543,0,24,lipid droplet organization,BP,
9303,GO:0034390,1,0.877698401990977,0,20,smooth muscle cell apoptotic process,BP,
9304,GO:0034391,1,0.877698401990977,0,20,regulation of smooth muscle cell apoptotic process,BP,
9305,GO:0034392,1,0.961075247597244,0,6,negative regulation of smooth muscle cell apoptotic process,BP,
9306,GO:0034393,1,0.92519441628572,0,12,positive regulation of smooth muscle cell apoptotic process,BP,
9307,GO:0034394,1,0.665571459073402,0,62,protein localization to cell surface,BP,
9308,GO:0034395,1,0.980606909014148,0,3,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9309,GO:0034397,1,0.955032141155432,0,7,telomere localization,BP,
9310,GO:0034398,1,0.987164315777841,0,2,telomere tethering at nuclear periphery,BP,
9311,GO:0034399,1,0.434287201361099,0,127,nuclear periphery,CC,
9313,GO:0034402,1,0.986967340072208,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9315,GO:0034405,1,0.810776098919189,0,32,response to fluid shear stress,BP,
9316,GO:0034414,1,0.987131898113914,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9317,GO:0034416,1,0.993552513362211,0,1,bisphosphoglycerate phosphatase activity,MF,
9318,GO:0034417,1,0.993552513362211,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9319,GO:0034418,1,0.987215367087838,0,2,urate biosynthetic process,BP,
9320,GO:0034421,1,0.98069317561646,0,3,post-translational protein acetylation,BP,
9321,GO:0034423,1,0.993565162973259,0,1,autophagosome lumen,CC,
9322,GO:0034427,1,0.937955028463469,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9323,GO:0034431,1,0.974515979575416,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9324,GO:0034432,1,0.974515979575416,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9325,GO:0034433,1,0.925447416058325,0,12,steroid esterification,BP,
9326,GO:0034434,1,0.925447416058325,0,12,sterol esterification,BP,
9327,GO:0034435,1,0.925447416058325,0,12,cholesterol esterification,BP,
9328,GO:0034436,1,0.974529583499569,0,4,glycoprotein transport,BP,
9329,GO:0034439,1,0.987226041140597,0,2,lipoprotein lipid oxidation,BP,
9330,GO:0034440,1,0.498487609603469,0,107,lipid oxidation,BP,
9331,GO:0034441,1,0.987348064408043,0,2,plasma lipoprotein particle oxidation,BP,
9332,GO:0034442,1,0.987226041140597,0,2,regulation of lipoprotein oxidation,BP,
9333,GO:0034443,1,0.993664227685745,0,1,negative regulation of lipoprotein oxidation,BP,
9334,GO:0034444,1,0.993688582531049,0,1,regulation of plasma lipoprotein oxidation,BP,
9335,GO:0034445,1,0.993688582531049,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9337,GO:0034447,1,0.94914079966747,0,8,very-low-density lipoprotein particle clearance,BP,
9338,GO:0034448,1,0.974538223858191,0,4,EGO complex,CC,
9339,GO:0034450,1,0.918331021863218,0,13,ubiquitin-ubiquitin ligase activity,MF,
9341,GO:0034452,1,0.927882201306738,0,11,dynactin binding,MF,
9342,GO:0034453,1,0.868864880814271,0,21,microtubule anchoring,BP,
9343,GO:0034454,1,0.935116446795708,0,10,microtubule anchoring at centrosome,BP,
9344,GO:0034455,1,0.986881376936845,0,2,t-UTP complex,CC,
9345,GO:0034456,1,0.987177473212687,0,2,UTP-C complex,CC,
9346,GO:0034457,1,0.981020902828647,0,3,Mpp10 complex,CC,
9347,GO:0034458,1,0.980456396991755,0,3,3'-5' RNA helicase activity,MF,
9348,GO:0034462,1,0.9798345140301,0,3,small-subunit processome assembly,BP,
9349,GO:0034463,1,0.993714113577592,0,1,90S preribosome assembly,BP,
9350,GO:0034464,1,0.94950292016784,0,8,BBSome,CC,
9351,GO:0034465,1,0.974375409252319,0,4,response to carbon monoxide,BP,
9352,GO:0034466,1,0.993557113252117,0,1,chromaffin granule lumen,CC,
9353,GO:0034470,1,0.102554454712509,0,348,ncRNA processing,BP,
9354,GO:0034471,1,0.878916491225836,0,20,ncRNA 5'-end processing,BP,
9355,GO:0034472,1,0.884232421818874,0,19,snRNA 3'-end processing,BP,
9356,GO:0034473,1,0.981059597505267,0,3,U1 snRNA 3'-end processing,BP,
9357,GO:0034474,1,0.993246315302102,0,1,U2 snRNA 3'-end processing,BP,
9358,GO:0034475,1,0.950281172864088,0,8,U4 snRNA 3'-end processing,BP,
9359,GO:0034476,1,0.981059597505267,0,3,U5 snRNA 3'-end processing,BP,
9360,GO:0034477,1,0.987151669582325,0,2,U6 snRNA 3'-end processing,BP,
9361,GO:0034478,1,0.993547631419887,0,1,phosphatidylglycerol catabolic process,BP,
9362,GO:0034481,1,0.967837118140996,0,5,chondroitin sulfotransferase activity,MF,
9363,GO:0034483,1,0.91233993716428,0,14,heparan sulfate sulfotransferase activity,MF,
9364,GO:0034485,1,0.987163170474599,0,2,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9365,GO:0034497,1,0.924580022893694,0,12,protein localization to phagophore assembly site,BP,
9366,GO:0034498,1,0.948996275515097,0,8,early endosome to Golgi transport,BP,
9367,GO:0034499,1,0.967678784004938,0,5,late endosome to Golgi transport,BP,
9368,GO:0034501,1,0.901975403565252,0,16,protein localization to kinetochore,BP,
9369,GO:0034502,1,0.620561083975832,0,73,protein localization to chromosome,BP,
9370,GO:0034504,1,0.189973596396645,0,252,protein localization to nucleus,BP,
9371,GO:0034505,1,0.888619994589021,0,18,tooth mineralization,BP,
9372,GO:0034506,1,0.993487645841966,0,1,chromosome, centromeric core domain,CC,
9373,GO:0034508,1,0.786013636502023,0,37,centromere complex assembly,BP,
9374,GO:0034511,1,0.948218395379943,0,8,U3 snoRNA binding,MF,
9375,GO:0034512,1,0.993492644036998,0,1,box C/D snoRNA binding,MF,
9376,GO:0034513,1,0.968514748047333,0,5,box H/ACA snoRNA binding,MF,
9377,GO:0034514,1,0.993585270097841,0,1,mitochondrial unfolded protein response,BP,
9378,GO:0034515,1,0.98711926700061,0,2,proteasome storage granule,CC,
9379,GO:0034516,1,0.993640552559868,0,1,response to vitamin B6,BP,
9380,GO:0034518,1,0.930804667428077,0,11,RNA cap binding complex,CC,
9381,GO:0034545,1,0.993627626198812,0,1,fumarylpyruvate hydrolase activity,MF,
9382,GO:0034551,1,0.937406063548693,0,10,mitochondrial respiratory chain complex III assembly,BP,
9383,GO:0034552,1,0.987363327940237,0,2,respiratory chain complex II assembly,BP,
9384,GO:0034553,1,0.987363327940237,0,2,mitochondrial respiratory chain complex II assembly,BP,
9385,GO:0034584,1,0.987072971047839,0,2,piRNA binding,MF,
9386,GO:0034587,1,0.913107452989437,0,14,piRNA metabolic process,BP,
9387,GO:0034589,1,0.993470052424229,0,1,hydroxyproline transport,BP,
9388,GO:0034590,1,0.993470052424229,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9389,GO:0034592,1,0.993655115778651,0,1,synaptic vesicle lumen,CC,
9391,GO:0034594,1,0.961688046095163,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9393,GO:0034596,1,0.96121124313222,0,6,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9394,GO:0034597,1,0.986801175593692,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9396,GO:0034603,1,0.968113941468826,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9397,GO:0034604,1,0.968113941468826,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9399,GO:0034611,1,0.993489925788297,0,1,oligoribonucleotidase activity,MF,
9403,GO:0034616,1,0.918589849223188,0,13,response to laminar fluid shear stress,BP,
9404,GO:0034617,1,0.974149502178825,0,4,tetrahydrobiopterin binding,MF,
9405,GO:0034618,1,0.967890615380634,0,5,arginine binding,MF,
9408,GO:0034625,1,0.961852691979628,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9409,GO:0034626,1,0.961852691979628,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9410,GO:0034627,1,0.962231312765198,0,6,'de novo' NAD biosynthetic process,BP,
9411,GO:0034629,1,0.877874915997763,0,20,cellular protein-containing complex localization,BP,
9412,GO:0034632,1,0.987270325283949,0,2,retinol transmembrane transporter activity,MF,
9413,GO:0034633,1,0.987270325283949,0,2,retinol transport,BP,
9414,GO:0034634,1,0.980450258830931,0,3,glutathione transmembrane transporter activity,MF,
9415,GO:0034635,1,0.967356563603445,0,5,glutathione transport,BP,
9416,GO:0034637,1,0.599099580216677,0,78,cellular carbohydrate biosynthetic process,BP,
9418,GO:0034640,1,0.993531647887378,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9420,GO:0034643,1,0.865322373752666,0,22,establishment of mitochondrion localization, microtubule-mediated,BP,
9421,GO:0034644,1,0.604413148102417,0,77,cellular response to UV,BP,
9423,GO:0034647,1,0.973114894432071,0,4,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9424,GO:0034648,1,0.973472460818586,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9425,GO:0034649,1,0.993495896214987,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9426,GO:0034650,1,0.942455050203049,0,9,cortisol metabolic process,BP,
9427,GO:0034651,1,0.948521126320791,0,8,cortisol biosynthetic process,BP,
9428,GO:0034653,1,0.974614285742773,0,4,retinoic acid catabolic process,BP,
9431,GO:0034656,1,0.747493394530137,0,45,nucleobase-containing small molecule catabolic process,BP,
9432,GO:0034657,1,0.9743162443257,0,4,GID complex,CC,
9433,GO:0034660,1,0.0647735797055217,0,417,ncRNA metabolic process,BP,
9434,GO:0034661,1,0.816771096787749,0,31,ncRNA catabolic process,BP,
9435,GO:0034663,1,0.943493822631039,0,9,endoplasmic reticulum chaperone complex,CC,
9436,GO:0034665,1,0.986978280375601,0,2,integrin alpha1-beta1 complex,CC,
9437,GO:0034666,1,0.980338508421774,0,3,integrin alpha2-beta1 complex,CC,
9438,GO:0034667,1,0.986966271494157,0,2,integrin alpha3-beta1 complex,CC,
9439,GO:0034668,1,0.980451072927787,0,3,integrin alpha4-beta1 complex,CC,
9440,GO:0034669,1,0.986926365507085,0,2,integrin alpha4-beta7 complex,CC,
9441,GO:0034670,1,0.992987284020826,0,1,chemotaxis to arachidonic acid,BP,
9442,GO:0034673,1,0.98047001145653,0,3,inhibin-betaglycan-ActRII complex,CC,
9443,GO:0034674,1,0.987016982493537,0,2,integrin alpha5-beta1 complex,CC,
9444,GO:0034676,1,0.993355959808134,0,1,integrin alpha6-beta4 complex,CC,
9445,GO:0034677,1,0.99350284838165,0,1,integrin alpha7-beta1 complex,CC,
9446,GO:0034678,1,0.980607016445747,0,3,integrin alpha8-beta1 complex,CC,
9447,GO:0034679,1,0.993490342308954,0,1,integrin alpha9-beta1 complex,CC,
9448,GO:0034680,1,0.986948966210039,0,2,integrin alpha10-beta1 complex,CC,
9449,GO:0034681,1,0.986962324331963,0,2,integrin alpha11-beta1 complex,CC,
9450,GO:0034683,1,0.986723339003217,0,2,integrin alphav-beta3 complex,CC,
9451,GO:0034684,1,0.98681944419337,0,2,integrin alphav-beta5 complex,CC,
9452,GO:0034685,1,0.986874968142504,0,2,integrin alphav-beta6 complex,CC,
9453,GO:0034686,1,0.986381415717764,0,2,integrin alphav-beta8 complex,CC,
9454,GO:0034687,1,0.98699966572757,0,2,integrin alphaL-beta2 complex,CC,
9455,GO:0034688,1,0.987025969089797,0,2,integrin alphaM-beta2 complex,CC,
9456,GO:0034689,1,0.987032817610284,0,2,integrin alphaX-beta2 complex,CC,
9457,GO:0034693,1,0.993575824062632,0,1,U11/U12 snRNP,CC,
9458,GO:0034694,1,0.821584207039392,0,30,response to prostaglandin,BP,
9459,GO:0034695,1,0.86643391353043,0,22,response to prostaglandin E,BP,
9460,GO:0034696,1,0.98720815866231,0,2,response to prostaglandin F,BP,
9461,GO:0034698,1,0.854295618087699,0,24,response to gonadotropin,BP,
9462,GO:0034699,1,0.980543046328753,0,3,response to luteinizing hormone,BP,
9466,GO:0034705,1,0.551567390684866,0,91,potassium channel complex,CC,
9467,GO:0034706,1,0.83983373168066,0,26,sodium channel complex,CC,
9468,GO:0034707,1,0.760252923352902,0,42,chloride channel complex,CC,
9469,GO:0034708,1,0.532824289433566,0,96,methyltransferase complex,CC,
9470,GO:0034709,1,0.926373996653107,0,12,methylosome,CC,
9471,GO:0034711,1,0.968121589551828,0,5,inhibin binding,MF,
9472,GO:0034713,1,0.942797249199832,0,9,type I transforming growth factor beta receptor binding,MF,
9473,GO:0034714,1,0.980654916722351,0,3,type III transforming growth factor beta receptor binding,MF,
9474,GO:0034715,1,0.962529995963961,0,6,pICln-Sm protein complex,CC,
9475,GO:0034718,1,0.993384539271311,0,1,SMN-Gemin2 complex,CC,
9476,GO:0034719,1,0.890830505594385,0,18,SMN-Sm protein complex,CC,
9477,GO:0034720,1,0.954151036853078,0,7,histone H3-K4 demethylation,BP,
9478,GO:0034721,1,0.966647516073062,0,5,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9479,GO:0034722,1,0.993640185944994,0,1,gamma-glutamyl-peptidase activity,MF,
9480,GO:0034723,1,0.949293623512054,0,8,DNA replication-dependent nucleosome organization,BP,
9481,GO:0034724,1,0.796516913877921,0,35,DNA replication-independent nucleosome organization,BP,
9482,GO:0034727,1,0.966846659396249,0,5,piecemeal microautophagy of the nucleus,BP,
9483,GO:0034728,1,0.53675135132121,0,95,nucleosome organization,BP,
9484,GO:0034729,1,0.980462023947365,0,3,histone H3-K79 methylation,BP,
9485,GO:0034736,1,0.993522335899357,0,1,cholesterol O-acyltransferase activity,MF,
9486,GO:0034739,1,0.980831328335763,0,3,histone deacetylase activity (H4-K16 specific),MF,
9487,GO:0034750,1,0.986965668157756,0,2,Scrib-APC-beta-catenin complex,CC,
9488,GO:0034751,1,0.980666619850808,0,3,aryl hydrocarbon receptor complex,CC,
9489,GO:0034752,1,0.993313898226276,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9491,GO:0034755,1,0.901408103813505,0,16,iron ion transmembrane transport,BP,
9493,GO:0034757,1,0.980609765559023,0,3,negative regulation of iron ion transport,BP,
9494,GO:0034759,1,0.980609765559023,0,3,regulation of iron ion transmembrane transport,BP,
9495,GO:0034760,1,0.980609765559023,0,3,negative regulation of iron ion transmembrane transport,BP,
9502,GO:0034769,1,0.987125242120492,0,2,basement membrane disassembly,BP,
9503,GO:0034770,1,0.960198524884562,0,6,histone H4-K20 methylation,BP,
9504,GO:0034773,1,0.973858584142219,0,4,histone H4-K20 trimethylation,BP,
9506,GO:0034775,1,0.973583420917017,0,4,glutathione transmembrane transport,BP,
9507,GO:0034776,1,0.936657687641269,0,10,response to histamine,BP,
9508,GO:0034777,1,0.993590529919135,0,1,recycling endosome lumen,CC,
9509,GO:0034875,1,0.99361105277542,0,1,caffeine oxidase activity,MF,
9510,GO:0034899,1,0.993600786551147,0,1,trimethylamine monooxygenase activity,MF,
9511,GO:0034959,1,0.993408847556443,0,1,endothelin maturation,BP,
9512,GO:0034963,1,0.987292887275975,0,2,box C/D snoRNA processing,BP,
9513,GO:0034964,1,0.987150734602301,0,2,box H/ACA snoRNA processing,BP,
9514,GO:0034968,1,0.519823130806218,0,99,histone lysine methylation,BP,
9515,GO:0034969,1,0.937529453775798,0,10,histone arginine methylation,BP,
9516,GO:0034970,1,0.987151226798836,0,2,histone H3-R2 methylation,BP,
9517,GO:0034971,1,0.987182283406852,0,2,histone H3-R17 methylation,BP,
9518,GO:0034975,1,0.949247438762152,0,8,protein folding in endoplasmic reticulum,BP,
9520,GO:0034979,1,0.900862236895816,0,16,NAD-dependent protein deacetylase activity,MF,
9521,GO:0034982,1,0.925224341639729,0,12,mitochondrial protein processing,BP,
9522,GO:0034983,1,0.949063404188653,0,8,peptidyl-lysine deacetylation,BP,
9524,GO:0034987,1,0.961725412902307,0,6,immunoglobulin receptor binding,MF,
9525,GO:0034988,1,0.9867261816079,0,2,Fc-gamma receptor I complex binding,MF,
9526,GO:0034990,1,0.980830938341138,0,3,nuclear mitotic cohesin complex,CC,
9527,GO:0034991,1,0.968073347099992,0,5,nuclear meiotic cohesin complex,CC,
9528,GO:0034992,1,0.946350287273187,0,8,microtubule organizing center attachment site,CC,
9529,GO:0034993,1,0.946350287273187,0,8,meiotic nuclear membrane microtubule tethering complex,CC,
9530,GO:0034998,1,0.987172159735512,0,2,oligosaccharyltransferase I complex,CC,
9531,GO:0035000,1,0.993554304672796,0,1,oligosaccharyltransferase III complex,CC,
9532,GO:0035004,1,0.929305644184591,0,11,phosphatidylinositol 3-kinase activity,MF,
9533,GO:0035005,1,0.95446171064447,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9534,GO:0035014,1,0.894827012977281,0,17,phosphatidylinositol 3-kinase regulator activity,MF,
9535,GO:0035019,1,0.633163235671212,0,70,somatic stem cell population maintenance,BP,
9536,GO:0035020,1,0.894079430464972,0,17,regulation of Rac protein signal transduction,BP,
9537,GO:0035021,1,0.973573525969248,0,4,negative regulation of Rac protein signal transduction,BP,
9538,GO:0035022,1,0.974101870948292,0,4,positive regulation of Rac protein signal transduction,BP,
9540,GO:0035024,1,0.870131789250253,0,21,negative regulation of Rho protein signal transduction,BP,
9542,GO:0035026,1,0.987017769486007,0,2,leading edge cell differentiation,BP,
9543,GO:0035032,1,0.96187270567215,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9544,GO:0035033,1,0.974516881703521,0,4,histone deacetylase regulator activity,MF,
9545,GO:0035034,1,0.987175633069935,0,2,histone acetyltransferase regulator activity,MF,
9546,GO:0035035,1,0.831939798142482,0,28,histone acetyltransferase binding,MF,
9547,GO:0035036,1,0.757859829305714,0,43,sperm-egg recognition,BP,
9548,GO:0035037,1,0.993455134053272,0,1,sperm entry,BP,
9549,GO:0035038,1,0.987166544780185,0,2,female pronucleus assembly,BP,
9550,GO:0035039,1,0.993585335096994,0,1,male pronucleus assembly,BP,
9553,GO:0035054,1,0.98077536141139,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9554,GO:0035060,1,0.980035712612693,0,3,brahma complex,CC,
9555,GO:0035061,1,0.967478992183751,0,5,interchromatin granule,CC,
9556,GO:0035063,1,0.97981132155151,0,3,nuclear speck organization,BP,
9557,GO:0035064,1,0.665506089787848,0,62,methylated histone binding,MF,
9559,GO:0035066,1,0.827872880331734,0,29,positive regulation of histone acetylation,BP,
9562,GO:0035087,1,0.974013758982778,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9563,GO:0035088,1,0.743337687234799,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9564,GO:0035089,1,0.882924077243698,0,19,establishment of apical/basal cell polarity,BP,
9565,GO:0035090,1,0.930915396253754,0,11,maintenance of apical/basal cell polarity,BP,
9567,GO:0035092,1,0.961021758186195,0,6,sperm chromatin condensation,BP,
9568,GO:0035093,1,0.973534483102858,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9569,GO:0035094,1,0.765339327995708,0,41,response to nicotine,BP,
9570,GO:0035095,1,0.95488485954747,0,7,behavioral response to nicotine,BP,
9571,GO:0035097,1,0.626339863405681,0,71,histone methyltransferase complex,CC,
9572,GO:0035098,1,0.912225572573028,0,14,ESC/E(Z) complex,CC,
9573,GO:0035101,1,0.974357182308466,0,4,FACT complex,CC,
9574,GO:0035102,1,0.912165617409054,0,14,PRC1 complex,CC,
9575,GO:0035103,1,0.993586050681278,0,1,sterol regulatory element binding protein cleavage,BP,
9576,GO:0035106,1,0.98079453203852,0,3,operant conditioning,BP,
9579,GO:0035112,1,0.918240350762259,0,13,genitalia morphogenesis,BP,
9581,GO:0035115,1,0.811487581452148,0,32,embryonic forelimb morphogenesis,BP,
9582,GO:0035116,1,0.832821013081579,0,28,embryonic hindlimb morphogenesis,BP,
9583,GO:0035120,1,0.992845986822309,0,1,post-embryonic appendage morphogenesis,BP,
9584,GO:0035127,1,0.992845986822309,0,1,post-embryonic limb morphogenesis,BP,
9585,GO:0035128,1,0.992845986822309,0,1,post-embryonic forelimb morphogenesis,BP,
9586,GO:0035136,1,0.769008966095276,0,40,forelimb morphogenesis,BP,
9587,GO:0035137,1,0.789610564475529,0,36,hindlimb morphogenesis,BP,
9588,GO:0035145,1,0.88977819508997,0,18,exon-exon junction complex,CC,
9591,GO:0035162,1,0.865837864068267,0,22,embryonic hemopoiesis,BP,
9592,GO:0035166,1,0.980639197497764,0,3,post-embryonic hemopoiesis,BP,
9593,GO:0035173,1,0.906393265375804,0,15,histone kinase activity,MF,
9594,GO:0035174,1,0.961598563202927,0,6,histone serine kinase activity,MF,
9595,GO:0035175,1,0.993625616674369,0,1,histone kinase activity (H3-S10 specific),MF,
9596,GO:0035176,1,0.727584898335888,0,48,social behavior,BP,
9597,GO:0035184,1,0.967624751348132,0,5,histone threonine kinase activity,MF,
9599,GO:0035189,1,0.987038190062483,0,2,Rb-E2F complex,CC,
9600,GO:0035194,1,0.453839326204445,0,120,post-transcriptional gene silencing by RNA,BP,
9601,GO:0035195,1,0.481827888749401,0,111,gene silencing by miRNA,BP,
9602,GO:0035196,1,0.744554121777745,0,45,production of miRNAs involved in gene silencing by miRNA,BP,
9603,GO:0035197,1,0.936255243614396,0,10,siRNA binding,MF,
9604,GO:0035198,1,0.838266917679833,0,27,miRNA binding,MF,
9605,GO:0035226,1,0.993539749311169,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9606,GO:0035227,1,0.993539749311169,0,1,regulation of glutamate-cysteine ligase activity,BP,
9607,GO:0035229,1,0.993539749311169,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9608,GO:0035234,1,0.954639758601771,0,7,ectopic germ cell programmed cell death,BP,
9609,GO:0035235,1,0.846940099825215,0,25,ionotropic glutamate receptor signaling pathway,BP,
9610,GO:0035238,1,0.99355705431691,0,1,vitamin A biosynthetic process,BP,
9612,GO:0035240,1,0.94980995884153,0,8,dopamine binding,MF,
9613,GO:0035241,1,0.968334386996252,0,5,protein-arginine omega-N monomethyltransferase activity,MF,
9614,GO:0035242,1,0.96833627737269,0,5,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9615,GO:0035243,1,0.974515759401507,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9616,GO:0035246,1,0.931543249814155,0,11,peptidyl-arginine N-methylation,BP,
9617,GO:0035247,1,0.943651121845052,0,9,peptidyl-arginine omega-N-methylation,BP,
9618,GO:0035248,1,0.993551252678424,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9620,GO:0035250,1,0.861750516868916,0,23,UDP-galactosyltransferase activity,MF,
9621,GO:0035251,1,0.942836483325095,0,9,UDP-glucosyltransferase activity,MF,
9622,GO:0035252,1,0.961138462045635,0,6,UDP-xylosyltransferase activity,MF,
9623,GO:0035253,1,0.930168942735462,0,11,ciliary rootlet,CC,
9625,GO:0035255,1,0.837347025622767,0,27,ionotropic glutamate receptor binding,MF,
9626,GO:0035256,1,0.931286859010472,0,11,G protein-coupled glutamate receptor binding,MF,
9629,GO:0035259,1,0.905664103309048,0,15,glucocorticoid receptor binding,MF,
9630,GO:0035261,1,0.985950457486956,0,2,external genitalia morphogenesis,BP,
9631,GO:0035262,1,0.986713525876574,0,2,gonad morphogenesis,BP,
9632,GO:0035264,1,0.399463822645105,0,139,multicellular organism growth,BP,
9634,GO:0035267,1,0.883480648712272,0,19,NuA4 histone acetyltransferase complex,CC,
9635,GO:0035268,1,0.877136605675592,0,20,protein mannosylation,BP,
9636,GO:0035269,1,0.906701814251999,0,15,protein O-linked mannosylation,BP,
9638,GO:0035272,1,0.724570206030847,0,49,exocrine system development,BP,
9639,GO:0035276,1,0.987025363897186,0,2,ethanol binding,MF,
9640,GO:0035278,1,0.910825242060597,0,14,miRNA mediated inhibition of translation,BP,
9641,GO:0035279,1,0.987110645633239,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9642,GO:0035280,1,0.954980210031684,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9643,GO:0035281,1,0.987097197189291,0,2,pre-miRNA export from nucleus,BP,
9645,GO:0035283,1,0.980820738480352,0,3,central nervous system segmentation,BP,
9646,GO:0035284,1,0.980820738480352,0,3,brain segmentation,BP,
9647,GO:0035290,1,0.974096050771965,0,4,trunk segmentation,BP,
9650,GO:0035299,1,0.993462968420911,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9654,GO:0035306,1,0.7017708394251,0,54,positive regulation of dephosphorylation,BP,
9655,GO:0035307,1,0.764942822276782,0,41,positive regulation of protein dephosphorylation,BP,
9657,GO:0035312,1,0.949503319244212,0,8,5'-3' exodeoxyribonuclease activity,MF,
9658,GO:0035313,1,0.90509660097614,0,15,wound healing, spreading of epidermal cells,BP,
9659,GO:0035315,1,0.779067580136672,0,38,hair cell differentiation,BP,
9660,GO:0035325,1,0.925476113166235,0,12,Toll-like receptor binding,MF,
9662,GO:0035329,1,0.75646781815217,0,42,hippo signaling,BP,
9663,GO:0035330,1,0.899546016792321,0,16,regulation of hippo signaling,BP,
9664,GO:0035331,1,0.929726901342641,0,11,negative regulation of hippo signaling,BP,
9665,GO:0035332,1,0.980023205158211,0,3,positive regulation of hippo signaling,BP,
9666,GO:0035333,1,0.955595177962667,0,7,Notch receptor processing, ligand-dependent,BP,
9667,GO:0035335,1,0.531913207608722,0,96,peptidyl-tyrosine dephosphorylation,BP,
9668,GO:0035336,1,0.861439280367871,0,23,long-chain fatty-acyl-CoA metabolic process,BP,
9669,GO:0035337,1,0.786450454257288,0,37,fatty-acyl-CoA metabolic process,BP,
9670,GO:0035338,1,0.889834732065223,0,18,long-chain fatty-acyl-CoA biosynthetic process,BP,
9671,GO:0035339,1,0.974702894392483,0,4,SPOTS complex,CC,
9672,GO:0035344,1,0.993572164320609,0,1,hypoxanthine transport,BP,
9673,GO:0035349,1,0.987166187237356,0,2,coenzyme A transmembrane transport,BP,
9674,GO:0035350,1,0.987172117747167,0,2,FAD transmembrane transport,BP,
9675,GO:0035351,1,0.99354467960849,0,1,heme transmembrane transport,BP,
9676,GO:0035352,1,0.993588596206985,0,1,NAD transmembrane transport,BP,
9677,GO:0035354,1,0.987116404319094,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9678,GO:0035355,1,0.993346499401612,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9679,GO:0035356,1,0.955869975531185,0,7,cellular triglyceride homeostasis,BP,
9680,GO:0035357,1,0.871890189829935,0,21,peroxisome proliferator activated receptor signaling pathway,BP,
9681,GO:0035358,1,0.913205318182223,0,14,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9682,GO:0035359,1,0.980814769657565,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9683,GO:0035360,1,0.943254224904006,0,9,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9684,GO:0035363,1,0.974479399138086,0,4,histone locus body,CC,
9685,GO:0035364,1,0.993572164320609,0,1,thymine transport,BP,
9686,GO:0035368,1,0.968116027404019,0,5,selenocysteine insertion sequence binding,MF,
9687,GO:0035370,1,0.987196388128204,0,2,UBC13-UEV1A complex,CC,
9688,GO:0035371,1,0.863298981187141,0,22,microtubule plus-end,CC,
9689,GO:0035372,1,0.894059161187991,0,17,protein localization to microtubule,BP,
9690,GO:0035373,1,0.979729023645953,0,3,chondroitin sulfate proteoglycan binding,MF,
9691,GO:0035374,1,0.942936191270548,0,9,chondroitin sulfate binding,MF,
9692,GO:0035375,1,0.993183916675647,0,1,zymogen binding,MF,
9693,GO:0035376,1,0.948644969054232,0,8,sterol import,BP,
9694,GO:0035377,1,0.980433715089759,0,3,transepithelial water transport,BP,
9695,GO:0035378,1,0.993557999392919,0,1,carbon dioxide transmembrane transport,BP,
9696,GO:0035379,1,0.993557999392919,0,1,carbon dioxide transmembrane transporter activity,MF,
9697,GO:0035381,1,0.949585621199895,0,8,ATP-gated ion channel activity,MF,
9698,GO:0035383,1,0.54659557424951,0,93,thioester metabolic process,BP,
9699,GO:0035384,1,0.726593816824502,0,49,thioester biosynthetic process,BP,
9700,GO:0035385,1,0.967248509507175,0,5,Roundabout signaling pathway,BP,
9701,GO:0035397,1,0.993538017299483,0,1,helper T cell enhancement of adaptive immune response,BP,
9702,GO:0035400,1,0.993394712257761,0,1,histone tyrosine kinase activity,MF,
9703,GO:0035401,1,0.993394712257761,0,1,histone kinase activity (H3-Y41 specific),MF,
9704,GO:0035402,1,0.987145510828723,0,2,histone kinase activity (H3-T11 specific),MF,
9705,GO:0035403,1,0.986516864096528,0,2,histone kinase activity (H3-T6 specific),MF,
9706,GO:0035404,1,0.924993651845016,0,12,histone-serine phosphorylation,BP,
9707,GO:0035405,1,0.967624751348132,0,5,histone-threonine phosphorylation,BP,
9708,GO:0035406,1,0.993394712257761,0,1,histone-tyrosine phosphorylation,BP,
9709,GO:0035407,1,0.987145510828723,0,2,histone H3-T11 phosphorylation,BP,
9710,GO:0035408,1,0.986516864096528,0,2,histone H3-T6 phosphorylation,BP,
9711,GO:0035409,1,0.993394712257761,0,1,histone H3-Y41 phosphorylation,BP,
9712,GO:0035410,1,0.987373667940552,0,2,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9713,GO:0035418,1,0.581280391112201,0,82,protein localization to synapse,BP,
9714,GO:0035425,1,0.955965153661614,0,7,autocrine signaling,BP,
9715,GO:0035426,1,0.967705429425134,0,5,extracellular matrix-cell signaling,BP,
9716,GO:0035434,1,0.96129085745676,0,6,copper ion transmembrane transport,BP,
9717,GO:0035435,1,0.918612159777673,0,13,phosphate ion transmembrane transport,BP,
9718,GO:0035437,1,0.913312368294684,0,14,maintenance of protein localization in endoplasmic reticulum,BP,
9719,GO:0035441,1,0.980114399341062,0,3,cell migration involved in vasculogenesis,BP,
9720,GO:0035442,1,0.973827064264287,0,4,dipeptide transmembrane transport,BP,
9721,GO:0035443,1,0.973583420917017,0,4,tripeptide transmembrane transport,BP,
9722,GO:0035444,1,0.993478636411314,0,1,nickel cation transmembrane transport,BP,
9723,GO:0035445,1,0.99353758577563,0,1,borate transmembrane transport,BP,
9724,GO:0035455,1,0.878056171807023,0,20,response to interferon-alpha,BP,
9725,GO:0035456,1,0.851381406844133,0,25,response to interferon-beta,BP,
9726,GO:0035457,1,0.936490487425305,0,10,cellular response to interferon-alpha,BP,
9727,GO:0035458,1,0.890300245087124,0,18,cellular response to interferon-beta,BP,
9728,GO:0035459,1,0.877244149178864,0,20,vesicle cargo loading,BP,
9730,GO:0035469,1,0.967822676468481,0,5,determination of pancreatic left/right asymmetry,BP,
9731,GO:0035470,1,0.974646511233574,0,4,positive regulation of vascular wound healing,BP,
9732,GO:0035473,1,0.973454156402075,0,4,lipase binding,MF,
9733,GO:0035480,1,0.974036415340918,0,4,regulation of Notch signaling pathway involved in heart induction,BP,
9734,GO:0035481,1,0.974036415340918,0,4,positive regulation of Notch signaling pathway involved in heart induction,BP,
9735,GO:0035482,1,0.962573990424031,0,6,gastric motility,BP,
9736,GO:0035483,1,0.968747936275571,0,5,gastric emptying,BP,
9737,GO:0035485,1,0.993616658170895,0,1,adenine/guanine mispair binding,MF,
9738,GO:0035490,1,0.993535114757867,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9739,GO:0035491,1,0.993535114757867,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9741,GO:0035494,1,0.98079176914289,0,3,SNARE complex disassembly,BP,
9742,GO:0035497,1,0.912512195881193,0,14,cAMP response element binding,MF,
9745,GO:0035500,1,0.98709778533358,0,2,MH2 domain binding,MF,
9746,GO:0035501,1,0.993553580223093,0,1,MH1 domain binding,MF,
9747,GO:0035502,1,0.968124658981556,0,5,metanephric part of ureteric bud development,BP,
9748,GO:0035504,1,0.993639652606539,0,1,regulation of myosin light chain kinase activity,BP,
9749,GO:0035505,1,0.993639652606539,0,1,positive regulation of myosin light chain kinase activity,BP,
9750,GO:0035507,1,0.954719904613054,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9751,GO:0035508,1,0.993369854541022,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9752,GO:0035509,1,0.967614936556798,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9753,GO:0035510,1,0.821501733226994,0,30,DNA dealkylation,BP,
9754,GO:0035511,1,0.962089935097685,0,6,oxidative DNA demethylation,BP,
9755,GO:0035513,1,0.968115467403294,0,5,oxidative RNA demethylation,BP,
9756,GO:0035514,1,0.968356695499481,0,5,DNA demethylase activity,MF,
9757,GO:0035515,1,0.968115467403294,0,5,oxidative RNA demethylase activity,MF,
9758,GO:0035516,1,0.980764633979803,0,3,oxidative DNA demethylase activity,MF,
9759,GO:0035517,1,0.973679710403992,0,4,PR-DUB complex,CC,
9760,GO:0035518,1,0.900711112863084,0,16,histone H2A monoubiquitination,BP,
9761,GO:0035519,1,0.974530938180356,0,4,protein K29-linked ubiquitination,BP,
9762,GO:0035520,1,0.942419782759013,0,9,monoubiquitinated protein deubiquitination,BP,
9763,GO:0035521,1,0.974357729212651,0,4,monoubiquitinated histone deubiquitination,BP,
9764,GO:0035522,1,0.974357729212651,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9765,GO:0035523,1,0.973621646308796,0,4,protein K29-linked deubiquitination,BP,
9766,GO:0035524,1,0.955192691518707,0,7,proline transmembrane transport,BP,
9767,GO:0035525,1,0.993568579238729,0,1,NF-kappaB p50/p65 complex,CC,
9768,GO:0035526,1,0.986949824104025,0,2,retrograde transport, plasma membrane to Golgi,BP,
9769,GO:0035529,1,0.949596290023249,0,8,NADH pyrophosphatase activity,MF,
9770,GO:0035538,1,0.993529975722969,0,1,carbohydrate response element binding,MF,
9771,GO:0035539,1,0.987336507216861,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9774,GO:0035544,1,0.980599689556785,0,3,negative regulation of SNARE complex assembly,BP,
9775,GO:0035545,1,0.986049523292089,0,2,determination of left/right asymmetry in nervous system,BP,
9776,GO:0035552,1,0.987146547747524,0,2,oxidative single-stranded DNA demethylation,BP,
9777,GO:0035553,1,0.980749910186184,0,3,oxidative single-stranded RNA demethylation,BP,
9779,GO:0035561,1,0.872148357224138,0,21,regulation of chromatin binding,BP,
9780,GO:0035562,1,0.955048412297785,0,7,negative regulation of chromatin binding,BP,
9781,GO:0035563,1,0.919196574585251,0,13,positive regulation of chromatin binding,BP,
9782,GO:0035564,1,0.980135605306884,0,3,regulation of kidney size,BP,
9783,GO:0035566,1,0.993482486668847,0,1,regulation of metanephros size,BP,
9785,GO:0035568,1,0.99355705431691,0,1,N-terminal peptidyl-proline methylation,BP,
9786,GO:0035570,1,0.99355705431691,0,1,N-terminal peptidyl-serine methylation,BP,
9787,GO:0035572,1,0.99355705431691,0,1,N-terminal peptidyl-serine dimethylation,BP,
9788,GO:0035573,1,0.99355705431691,0,1,N-terminal peptidyl-serine trimethylation,BP,
9789,GO:0035574,1,0.986929044604478,0,2,histone H4-K20 demethylation,BP,
9790,GO:0035575,1,0.986929044604478,0,2,histone demethylase activity (H4-K20 specific),MF,
9791,GO:0035577,1,0.703005332369939,0,54,azurophil granule membrane,CC,
9793,GO:0035579,1,0.562236369428954,0,88,specific granule membrane,CC,
9796,GO:0035582,1,0.973926724367923,0,4,sequestering of BMP in extracellular matrix,BP,
9797,GO:0035583,1,0.972905154093491,0,4,sequestering of TGFbeta in extracellular matrix,BP,
9799,GO:0035585,1,0.973582384308944,0,4,calcium-mediated signaling using extracellular calcium source,BP,
9801,GO:0035589,1,0.919811930784403,0,13,G protein-coupled purinergic nucleotide receptor signaling pathway,BP,
9803,GO:0035591,1,0.642608877977787,0,67,signaling adaptor activity,MF,
9806,GO:0035596,1,0.987174301323115,0,2,methylthiotransferase activity,MF,
9807,GO:0035597,1,0.993604489579372,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9808,GO:0035598,1,0.993528836600293,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9809,GO:0035600,1,0.987174301323115,0,2,tRNA methylthiolation,BP,
9810,GO:0035601,1,0.511439695369045,0,102,protein deacylation,BP,
9811,GO:0035602,1,0.993483358145713,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,BP,
9812,GO:0035603,1,0.993483358145713,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9813,GO:0035604,1,0.993483358145713,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9814,GO:0035605,1,0.993652029015428,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9815,GO:0035606,1,0.987392500519108,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9816,GO:0035607,1,0.986892625866021,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9819,GO:0035610,1,0.974291473616199,0,4,protein side chain deglutamylation,BP,
9820,GO:0035611,1,0.993552714720699,0,1,protein branching point deglutamylation,BP,
9821,GO:0035612,1,0.940851526449132,0,9,AP-2 adaptor complex binding,MF,
9822,GO:0035613,1,0.923942630803969,0,12,RNA stem-loop binding,MF,
9823,GO:0035615,1,0.900692640001122,0,16,clathrin adaptor activity,MF,
9824,GO:0035616,1,0.980492336815325,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9825,GO:0035617,1,0.968013735742543,0,5,stress granule disassembly,BP,
9826,GO:0035621,1,0.987175897624279,0,2,ER to Golgi ceramide transport,BP,
9827,GO:0035622,1,0.986354999902453,0,2,intrahepatic bile duct development,BP,
9828,GO:0035623,1,0.99353090417575,0,1,renal glucose absorption,BP,
9829,GO:0035624,1,0.97403027387661,0,4,receptor transactivation,BP,
9830,GO:0035627,1,0.930453203470301,0,11,ceramide transport,BP,
9832,GO:0035631,1,0.931280121615592,0,11,CD40 receptor complex,CC,
9833,GO:0035632,1,0.987302010582328,0,2,mitochondrial prohibitin complex,CC,
9835,GO:0035634,1,0.974357621512948,0,4,response to stilbenoid,BP,
9836,GO:0035635,1,0.911577457534342,0,14,entry of bacterium into host cell,BP,
9839,GO:0035640,1,0.859260924338425,0,23,exploration behavior,BP,
9840,GO:0035641,1,0.92428702099808,0,12,locomotory exploration behavior,BP,
9841,GO:0035642,1,0.993545122661012,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9842,GO:0035643,1,0.993626353676866,0,1,L-DOPA receptor activity,MF,
9843,GO:0035644,1,0.993543493042677,0,1,phosphoanandamide dephosphorylation,BP,
9844,GO:0035645,1,0.993471349100425,0,1,enteric smooth muscle cell differentiation,BP,
9845,GO:0035646,1,0.937219743213343,0,10,endosome to melanosome transport,BP,
9846,GO:0035650,1,0.968302997972566,0,5,AP-1 adaptor complex binding,MF,
9847,GO:0035651,1,0.98090465991632,0,3,AP-3 adaptor complex binding,MF,
9848,GO:0035655,1,0.949733553839499,0,8,interleukin-18-mediated signaling pathway,BP,
9849,GO:0035657,1,0.993432847786582,0,1,eRF1 methyltransferase complex,CC,
9850,GO:0035658,1,0.974493543199534,0,4,Mon1-Ccz1 complex,CC,
9851,GO:0035662,1,0.974969389796548,0,4,Toll-like receptor 4 binding,MF,
9852,GO:0035663,1,0.980644561324337,0,3,Toll-like receptor 2 binding,MF,
9853,GO:0035664,1,0.993620653376666,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9854,GO:0035665,1,0.993620653376666,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9855,GO:0035666,1,0.834512385911103,0,28,TRIF-dependent toll-like receptor signaling pathway,BP,
9856,GO:0035668,1,0.980379844472055,0,3,TRAM-dependent toll-like receptor signaling pathway,BP,
9857,GO:0035669,1,0.980379844472055,0,3,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9858,GO:0035671,1,0.980931512092529,0,3,enone reductase activity,MF,
9859,GO:0035672,1,0.94858058145459,0,8,oligopeptide transmembrane transport,BP,
9860,GO:0035673,1,0.967630711962107,0,5,oligopeptide transmembrane transporter activity,MF,
9861,GO:0035674,1,0.987205703208671,0,2,tricarboxylic acid transmembrane transport,BP,
9862,GO:0035675,1,0.987071439746508,0,2,neuromast hair cell development,BP,
9863,GO:0035677,1,0.993465434147348,0,1,posterior lateral line neuromast hair cell development,BP,
9864,GO:0035683,1,0.986885586523744,0,2,memory T cell extravasation,BP,
9865,GO:0035684,1,0.980791754332587,0,3,helper T cell extravasation,BP,
9866,GO:0035685,1,0.987020896899734,0,2,helper T cell diapedesis,BP,
9867,GO:0035686,1,0.968268135256808,0,5,sperm fibrous sheath,CC,
9869,GO:0035691,1,0.980862767274081,0,3,macrophage migration inhibitory factor signaling pathway,BP,
9870,GO:0035692,1,0.987113494295794,0,2,macrophage migration inhibitory factor receptor complex,CC,
9871,GO:0035693,1,0.993652095426906,0,1,NOS2-CD74 complex,CC,
9872,GO:0035694,1,0.974364086923217,0,4,mitochondrial protein catabolic process,BP,
9873,GO:0035695,1,0.993469885599314,0,1,mitophagy by induced vacuole formation,BP,
9874,GO:0035696,1,0.961483370839438,0,6,monocyte extravasation,BP,
9875,GO:0035697,1,0.980922285837238,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9876,GO:0035698,1,0.987267788064455,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9877,GO:0035700,1,0.987234927582536,0,2,astrocyte chemotaxis,BP,
9878,GO:0035701,1,0.949034151909013,0,8,hematopoietic stem cell migration,BP,
9879,GO:0035702,1,0.986937726245932,0,2,monocyte homeostasis,BP,
9880,GO:0035704,1,0.993573484549642,0,1,helper T cell chemotaxis,BP,
9881,GO:0035705,1,0.993573484549642,0,1,T-helper 17 cell chemotaxis,BP,
9882,GO:0035708,1,0.993517729948133,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9883,GO:0035709,1,0.980844696284158,0,3,memory T cell activation,BP,
9884,GO:0035710,1,0.567544249451911,0,87,CD4-positive, alpha-beta T cell activation,BP,
9885,GO:0035711,1,0.974634061307553,0,4,T-helper 1 cell activation,BP,
9886,GO:0035712,1,0.987088465914308,0,2,T-helper 2 cell activation,BP,
9887,GO:0035713,1,0.993517729948133,0,1,response to nitrogen dioxide,BP,
9888,GO:0035715,1,0.993573484549642,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9889,GO:0035716,1,0.993573484549642,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9890,GO:0035717,1,0.987177232363129,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9891,GO:0035718,1,0.987332450356044,0,2,macrophage migration inhibitory factor binding,MF,
9892,GO:0035720,1,0.980843600400689,0,3,intraciliary anterograde transport,BP,
9893,GO:0035721,1,0.941808462478217,0,9,intraciliary retrograde transport,BP,
9894,GO:0035722,1,0.752641911021918,0,44,interleukin-12-mediated signaling pathway,BP,
9895,GO:0035723,1,0.918533472842969,0,13,interleukin-15-mediated signaling pathway,BP,
9896,GO:0035724,1,0.993266651168057,0,1,CD24 biosynthetic process,BP,
9898,GO:0035726,1,0.95553548937895,0,7,common myeloid progenitor cell proliferation,BP,
9900,GO:0035728,1,0.882885398725643,0,19,response to hepatocyte growth factor,BP,
9901,GO:0035729,1,0.894710697174007,0,17,cellular response to hepatocyte growth factor stimulus,BP,
9902,GO:0035730,1,0.993675530130927,0,1,S-nitrosoglutathione binding,MF,
9903,GO:0035731,1,0.993675530130927,0,1,dinitrosyl-iron complex binding,MF,
9904,GO:0035732,1,0.993675530130927,0,1,nitric oxide storage,BP,
9905,GO:0035733,1,0.948889851574746,0,8,hepatic stellate cell activation,BP,
9906,GO:0035735,1,0.779359213360095,0,38,intraciliary transport involved in cilium assembly,BP,
9907,GO:0035739,1,0.931843375984512,0,11,CD4-positive, alpha-beta T cell proliferation,BP,
9908,GO:0035740,1,0.955771260955037,0,7,CD8-positive, alpha-beta T cell proliferation,BP,
9909,GO:0035743,1,0.884714835156127,0,19,CD4-positive, alpha-beta T cell cytokine production,BP,
9910,GO:0035744,1,0.955955817999503,0,7,T-helper 1 cell cytokine production,BP,
9911,GO:0035745,1,0.925608187543804,0,12,T-helper 2 cell cytokine production,BP,
9912,GO:0035746,1,0.993658266100689,0,1,granzyme A production,BP,
9914,GO:0035748,1,0.961497529267169,0,6,myelin sheath abaxonal region,CC,
9916,GO:0035750,1,0.993389601419398,0,1,protein localization to myelin sheath abaxonal region,BP,
9917,GO:0035751,1,0.919433380420898,0,13,regulation of lysosomal lumen pH,BP,
9918,GO:0035752,1,0.993612562533813,0,1,lysosomal lumen pH elevation,BP,
9919,GO:0035754,1,0.949695806181839,0,8,B cell chemotaxis,BP,
9920,GO:0035755,1,0.993568982242165,0,1,cardiolipin hydrolase activity,MF,
9921,GO:0035757,1,0.993594912291517,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9922,GO:0035758,1,0.993594912291517,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9923,GO:0035759,1,0.987281531960349,0,2,mesangial cell-matrix adhesion,BP,
9928,GO:0035771,1,0.955389099605182,0,7,interleukin-4-mediated signaling pathway,BP,
9929,GO:0035772,1,0.993622264046537,0,1,interleukin-13-mediated signaling pathway,BP,
9932,GO:0035780,1,0.993555294583176,0,1,CD80 biosynthetic process,BP,
9933,GO:0035781,1,0.987225476224745,0,2,CD86 biosynthetic process,BP,
9934,GO:0035782,1,0.993658266100689,0,1,mature natural killer cell chemotaxis,BP,
9935,GO:0035783,1,0.980914519862607,0,3,CD4-positive, alpha-beta T cell costimulation,BP,
9936,GO:0035787,1,0.974110221505091,0,4,cell migration involved in kidney development,BP,
9937,GO:0035788,1,0.980592133740928,0,3,cell migration involved in metanephros development,BP,
9938,GO:0035789,1,0.980592133740928,0,3,metanephric mesenchymal cell migration,BP,
9940,GO:0035791,1,0.91134709463694,0,14,platelet-derived growth factor receptor-beta signaling pathway,BP,
9941,GO:0035793,1,0.980592133740928,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9943,GO:0035795,1,0.968104113966155,0,5,negative regulation of mitochondrial membrane permeability,BP,
9944,GO:0035799,1,0.974229060203841,0,4,ureter maturation,BP,
9945,GO:0035800,1,0.987185348487347,0,2,deubiquitinase activator activity,MF,
9946,GO:0035801,1,0.987204810843351,0,2,adrenal cortex development,BP,
9947,GO:0035802,1,0.987204810843351,0,2,adrenal cortex formation,BP,
9948,GO:0035803,1,0.981012554582707,0,3,egg coat formation,BP,
9949,GO:0035804,1,0.9873307412719,0,2,structural constituent of egg coat,MF,
9950,GO:0035805,1,0.980965165080472,0,3,egg coat,CC,
9951,GO:0035809,1,0.878495898410551,0,20,regulation of urine volume,BP,
9952,GO:0035810,1,0.913375538126394,0,14,positive regulation of urine volume,BP,
9953,GO:0035811,1,0.98049545869339,0,3,negative regulation of urine volume,BP,
9954,GO:0035812,1,0.884612307524896,0,19,renal sodium excretion,BP,
9955,GO:0035813,1,0.890308227645423,0,18,regulation of renal sodium excretion,BP,
9956,GO:0035814,1,0.974573407744534,0,4,negative regulation of renal sodium excretion,BP,
9957,GO:0035815,1,0.925553741081389,0,12,positive regulation of renal sodium excretion,BP,
9958,GO:0035821,1,0.534351445405431,0,96,modulation of process of other organism,BP,
9959,GO:0035822,1,0.974160370859717,0,4,gene conversion,BP,
9960,GO:0035825,1,0.731062251719616,0,48,homologous recombination,BP,
9961,GO:0035838,1,0.980314236970965,0,3,growing cell tip,CC,
9962,GO:0035841,1,0.986751065460651,0,2,new growing cell tip,CC,
9963,GO:0035844,1,0.974301422156317,0,4,cloaca development,BP,
9964,GO:0035845,1,0.936781390515447,0,10,photoreceptor cell outer segment organization,BP,
9966,GO:0035851,1,0.987185901228156,0,2,Krueppel-associated box domain binding,MF,
9967,GO:0035853,1,0.993457678596647,0,1,chromosome passenger complex localization to spindle midzone,BP,
9968,GO:0035854,1,0.987205706234572,0,2,eosinophil fate commitment,BP,
9969,GO:0035855,1,0.900006898307378,0,16,megakaryocyte development,BP,
9970,GO:0035859,1,0.919312490365181,0,13,Seh1-associated complex,CC,
9971,GO:0035860,1,0.948831966333386,0,8,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9972,GO:0035861,1,0.721375987811365,0,50,site of double-strand break,CC,
9973,GO:0035862,1,0.993333458067306,0,1,dITP metabolic process,BP,
9974,GO:0035863,1,0.993333458067306,0,1,dITP catabolic process,BP,
9975,GO:0035864,1,0.924097186924255,0,12,response to potassium ion,BP,
9976,GO:0035865,1,0.942378627843453,0,9,cellular response to potassium ion,BP,
9977,GO:0035866,1,0.97989679470441,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
9978,GO:0035867,1,0.973013532732172,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9979,GO:0035868,1,0.980329729689869,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
9980,GO:0035869,1,0.683588372234828,0,58,ciliary transition zone,CC,
9981,GO:0035870,1,0.987041442958185,0,2,dITP diphosphatase activity,MF,
9982,GO:0035871,1,0.948105027586627,0,8,protein K11-linked deubiquitination,BP,
9983,GO:0035872,1,0.796075932041191,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9984,GO:0035873,1,0.96161770312529,0,6,lactate transmembrane transport,BP,
9985,GO:0035877,1,0.980653309740539,0,3,death effector domain binding,MF,
9986,GO:0035878,1,0.949296360650771,0,8,nail development,BP,
9987,GO:0035879,1,0.980678667035357,0,3,plasma membrane lactate transport,BP,
9988,GO:0035880,1,0.980828592595567,0,3,embryonic nail plate morphogenesis,BP,
9989,GO:0035881,1,0.955662230163976,0,7,amacrine cell differentiation,BP,
9990,GO:0035883,1,0.843735721652272,0,26,enteroendocrine cell differentiation,BP,
9991,GO:0035886,1,0.849699211132968,0,25,vascular associated smooth muscle cell differentiation,BP,
9992,GO:0035887,1,0.993623303821261,0,1,aortic smooth muscle cell differentiation,BP,
9993,GO:0035890,1,0.812067650700145,0,32,exit from host,BP,
9994,GO:0035891,1,0.812067650700145,0,32,exit from host cell,BP,
9995,GO:0035898,1,0.980644999140446,0,3,parathyroid hormone secretion,BP,
9996,GO:0035900,1,0.961939451553379,0,6,response to isolation stress,BP,
9997,GO:0035902,1,0.872533243296393,0,21,response to immobilization stress,BP,
9999,GO:0035905,1,0.967947941216223,0,5,ascending aorta development,BP,
10000,GO:0035906,1,0.993494857364421,0,1,descending aorta development,BP,
10001,GO:0035907,1,0.937133294107015,0,10,dorsal aorta development,BP,
10002,GO:0035909,1,0.820029119173155,0,30,aorta morphogenesis,BP,
10003,GO:0035910,1,0.974287465967717,0,4,ascending aorta morphogenesis,BP,
10004,GO:0035912,1,0.949393652080305,0,8,dorsal aorta morphogenesis,BP,
10005,GO:0035914,1,0.670736593341649,0,61,skeletal muscle cell differentiation,BP,
10006,GO:0035915,1,0.974713512180671,0,4,pore formation in membrane of other organism,BP,
10007,GO:0035921,1,0.993599754756595,0,1,desmosome disassembly,BP,
10008,GO:0035922,1,0.993633011042041,0,1,foramen ovale closure,BP,
10010,GO:0035925,1,0.84994292963393,0,25,mRNA 3'-UTR AU-rich region binding,MF,
10011,GO:0035927,1,0.974555700208912,0,4,RNA import into mitochondrion,BP,
10012,GO:0035928,1,0.980909889274233,0,3,rRNA import into mitochondrion,BP,
10013,GO:0035929,1,0.890280996408252,0,18,steroid hormone secretion,BP,
10014,GO:0035930,1,0.919678438561329,0,13,corticosteroid hormone secretion,BP,
10015,GO:0035931,1,0.974496728206376,0,4,mineralocorticoid secretion,BP,
10016,GO:0035932,1,0.974496728206376,0,4,aldosterone secretion,BP,
10017,GO:0035933,1,0.943761195881859,0,9,glucocorticoid secretion,BP,
10018,GO:0035934,1,0.974782480968429,0,4,corticosterone secretion,BP,
10019,GO:0035935,1,0.993528995456759,0,1,androgen secretion,BP,
10020,GO:0035936,1,0.98682768422265,0,2,testosterone secretion,BP,
10022,GO:0035945,1,0.993574494173141,0,1,mitochondrial ncRNA surveillance,BP,
10023,GO:0035946,1,0.993574494173141,0,1,mitochondrial mRNA surveillance,BP,
10024,GO:0035962,1,0.980805791347907,0,3,response to interleukin-13,BP,
10025,GO:0035963,1,0.980805791347907,0,3,cellular response to interleukin-13,BP,
10026,GO:0035964,1,0.961756955358935,0,6,COPI-coated vesicle budding,BP,
10027,GO:0035965,1,0.955723642640369,0,7,cardiolipin acyl-chain remodeling,BP,
10030,GO:0035970,1,0.86679394088422,0,22,peptidyl-threonine dephosphorylation,BP,
10031,GO:0035971,1,0.993658266100689,0,1,peptidyl-histidine dephosphorylation,BP,
10032,GO:0035973,1,0.942456849337256,0,9,aggrephagy,BP,
10033,GO:0035976,1,0.974599771646044,0,4,transcription factor AP-1 complex,CC,
10034,GO:0035977,1,0.974026237899482,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10035,GO:0035978,1,0.987178051148436,0,2,histone H2A-S139 phosphorylation,BP,
10036,GO:0035981,1,0.987132983517839,0,2,tongue muscle cell differentiation,BP,
10037,GO:0035983,1,0.980495370494482,0,3,response to trichostatin A,BP,
10038,GO:0035984,1,0.980495370494482,0,3,cellular response to trichostatin A,BP,
10039,GO:0035985,1,0.974682838693175,0,4,senescence-associated heterochromatin focus,CC,
10040,GO:0035986,1,0.980944856651352,0,3,senescence-associated heterochromatin focus assembly,BP,
10041,GO:0035987,1,0.74856672093335,0,44,endodermal cell differentiation,BP,
10042,GO:0035988,1,0.900770258194316,0,16,chondrocyte proliferation,BP,
10043,GO:0035989,1,0.961412939727859,0,6,tendon development,BP,
10044,GO:0035990,1,0.980997684381878,0,3,tendon cell differentiation,BP,
10045,GO:0035992,1,0.980997684381878,0,3,tendon formation,BP,
10046,GO:0035993,1,0.987251764520654,0,2,deltoid tuberosity development,BP,
10048,GO:0035995,1,0.961441131435451,0,4,detection of muscle stretch,BP,
10049,GO:0035998,1,0.993609275710424,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10050,GO:0035999,1,0.937350686770236,0,10,tetrahydrofolate interconversion,BP,
10051,GO:0036002,1,0.791137501784178,0,36,pre-mRNA binding,MF,
10052,GO:0036003,1,0.861122620512992,0,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10053,GO:0036004,1,0.993657404184838,0,1,GAF domain binding,MF,
10054,GO:0036005,1,0.92505315230929,0,12,response to macrophage colony-stimulating factor,BP,
10055,GO:0036006,1,0.92505315230929,0,12,cellular response to macrophage colony-stimulating factor stimulus,BP,
10056,GO:0036009,1,0.987135770418553,0,2,protein-glutamine N-methyltransferase activity,MF,
10057,GO:0036010,1,0.859500096520572,0,23,protein localization to endosome,BP,
10058,GO:0036015,1,0.967779556213184,0,5,response to interleukin-3,BP,
10059,GO:0036016,1,0.967779556213184,0,5,cellular response to interleukin-3,BP,
10060,GO:0036017,1,0.956273637920439,0,7,response to erythropoietin,BP,
10061,GO:0036018,1,0.962328167337791,0,6,cellular response to erythropoietin,BP,
10062,GO:0036019,1,0.883169062710487,0,19,endolysosome,CC,
10063,GO:0036020,1,0.912229447634626,0,14,endolysosome membrane,CC,
10064,GO:0036021,1,0.968172342653662,0,5,endolysosome lumen,CC,
10065,GO:0036022,1,0.98087435930056,0,3,limb joint morphogenesis,BP,
10066,GO:0036023,1,0.98087435930056,0,3,embryonic skeletal limb joint morphogenesis,BP,
10067,GO:0036024,1,0.993585465122445,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10068,GO:0036025,1,0.993585465122445,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10069,GO:0036026,1,0.993585465122445,0,1,protein C inhibitor-PLAT complex,CC,
10070,GO:0036027,1,0.993585465122445,0,1,protein C inhibitor-PLAU complex,CC,
10071,GO:0036028,1,0.993585465122445,0,1,protein C inhibitor-thrombin complex,CC,
10072,GO:0036029,1,0.993585465122445,0,1,protein C inhibitor-KLK3 complex,CC,
10073,GO:0036030,1,0.993585465122445,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10074,GO:0036033,1,0.966157950780118,0,5,mediator complex binding,MF,
10075,GO:0036034,1,0.993583324430233,0,1,mediator complex assembly,BP,
10076,GO:0036035,1,0.89999491436363,0,16,osteoclast development,BP,
10077,GO:0036037,1,0.850523322519607,0,25,CD8-positive, alpha-beta T cell activation,BP,
10078,GO:0036038,1,0.919259608334696,0,13,MKS complex,CC,
10079,GO:0036041,1,0.932199508536892,0,11,long-chain fatty acid binding,MF,
10080,GO:0036042,1,0.96230627021222,0,6,long-chain fatty acyl-CoA binding,MF,
10081,GO:0036046,1,0.993535704161469,0,1,protein demalonylation,BP,
10082,GO:0036047,1,0.993535704161469,0,1,peptidyl-lysine demalonylation,BP,
10083,GO:0036048,1,0.987201584567984,0,2,protein desuccinylation,BP,
10084,GO:0036049,1,0.987201584567984,0,2,peptidyl-lysine desuccinylation,BP,
10085,GO:0036053,1,0.993560171902411,0,1,glomerular endothelium fenestra,CC,
10086,GO:0036054,1,0.993535704161469,0,1,protein-malonyllysine demalonylase activity,MF,
10087,GO:0036055,1,0.987201584567984,0,2,protein-succinyllysine desuccinylase activity,MF,
10088,GO:0036056,1,0.948319899426837,0,8,filtration diaphragm,CC,
10089,GO:0036057,1,0.948319899426837,0,8,slit diaphragm,CC,
10090,GO:0036058,1,0.993487494702479,0,1,filtration diaphragm assembly,BP,
10091,GO:0036060,1,0.993487494702479,0,1,slit diaphragm assembly,BP,
10092,GO:0036064,1,0.409960986085838,0,136,ciliary basal body,CC,
10093,GO:0036065,1,0.906484174998802,0,15,fucosylation,BP,
10094,GO:0036066,1,0.974431186567851,0,4,protein O-linked fucosylation,BP,
10095,GO:0036071,1,0.987109746700454,0,2,N-glycan fucosylation,BP,
10096,GO:0036072,1,0.961423379033368,0,6,direct ossification,BP,
10097,GO:0036075,1,0.838478385827849,0,27,replacement ossification,BP,
10098,GO:0036080,1,0.993532499008885,0,1,purine nucleotide-sugar transmembrane transporter activity,MF,
10099,GO:0036085,1,0.993532499008885,0,1,GDP-fucose import into Golgi lumen,BP,
10100,GO:0036088,1,0.993632910799513,0,1,D-serine catabolic process,BP,
10101,GO:0036089,1,0.955459799311912,0,7,cleavage furrow formation,BP,
10102,GO:0036090,1,0.987250543050768,0,2,cleavage furrow ingression,BP,
10103,GO:0036091,1,0.967743285558597,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10104,GO:0036092,1,0.910839400688871,0,14,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10105,GO:0036093,1,0.962300466353409,0,6,germ cell proliferation,BP,
10107,GO:0036100,1,0.980824441335495,0,3,leukotriene catabolic process,BP,
10108,GO:0036101,1,0.980824441335495,0,3,leukotriene B4 catabolic process,BP,
10109,GO:0036102,1,0.980824441335495,0,3,leukotriene B4 metabolic process,BP,
10110,GO:0036105,1,0.993510968506391,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10111,GO:0036109,1,0.925042020348959,0,12,alpha-linolenic acid metabolic process,BP,
10112,GO:0036111,1,0.987111209802376,0,2,very long-chain fatty-acyl-CoA metabolic process,BP,
10113,GO:0036112,1,0.980866877637975,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10114,GO:0036113,1,0.993508125535763,0,1,very long-chain fatty-acyl-CoA catabolic process,BP,
10115,GO:0036114,1,0.993637618370531,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10116,GO:0036115,1,0.987186637255195,0,2,fatty-acyl-CoA catabolic process,BP,
10117,GO:0036116,1,0.993637618370531,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10118,GO:0036117,1,0.987209788054955,0,2,hyaluranon cable,CC,
10119,GO:0036118,1,0.98077960469934,0,3,hyaluranon cable assembly,BP,
10120,GO:0036119,1,0.882186624811925,0,19,response to platelet-derived growth factor,BP,
10121,GO:0036120,1,0.887924219986634,0,18,cellular response to platelet-derived growth factor stimulus,BP,
10122,GO:0036121,1,0.986903847400842,0,2,double-stranded DNA helicase activity,MF,
10124,GO:0036123,1,0.962002544346313,0,6,histone H3-K9 dimethylation,BP,
10125,GO:0036124,1,0.905977748784282,0,15,histone H3-K9 trimethylation,BP,
10126,GO:0036125,1,0.99354110956801,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10127,GO:0036126,1,0.58486991648108,0,82,sperm flagellum,CC,
10128,GO:0036128,1,0.955807133006207,0,7,CatSper complex,CC,
10129,GO:0036130,1,0.993657868319067,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10130,GO:0036131,1,0.993657868319067,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10131,GO:0036132,1,0.980729234151434,0,3,13-prostaglandin reductase activity,MF,
10132,GO:0036134,1,0.993598657685488,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10133,GO:0036135,1,0.979354007508479,0,3,Schwann cell migration,BP,
10134,GO:0036137,1,0.987208532808745,0,2,kynurenine aminotransferase activity,MF,
10135,GO:0036138,1,0.993255544451043,0,1,peptidyl-histidine hydroxylation,BP,
10136,GO:0036139,1,0.993255544451043,0,1,peptidyl-histidine dioxygenase activity,MF,
10137,GO:0036140,1,0.993255544451043,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10138,GO:0036143,1,0.993682785601875,0,1,kringle domain binding,MF,
10139,GO:0036145,1,0.993620854749373,0,1,dendritic cell homeostasis,BP,
10140,GO:0036146,1,0.99355705431691,0,1,cellular response to mycotoxin,BP,
10141,GO:0036148,1,0.918886149667605,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10142,GO:0036149,1,0.930920450188182,0,11,phosphatidylinositol acyl-chain remodeling,BP,
10143,GO:0036150,1,0.913113898568353,0,14,phosphatidylserine acyl-chain remodeling,BP,
10144,GO:0036151,1,0.867319329065825,0,22,phosphatidylcholine acyl-chain remodeling,BP,
10145,GO:0036152,1,0.895891536886294,0,17,phosphatidylethanolamine acyl-chain remodeling,BP,
10146,GO:0036153,1,0.993554711636952,0,1,triglyceride acyl-chain remodeling,BP,
10147,GO:0036155,1,0.96811157565336,0,5,acylglycerol acyl-chain remodeling,BP,
10148,GO:0036156,1,0.978547148530458,0,3,inner dynein arm,CC,
10149,GO:0036157,1,0.927691882344029,0,11,outer dynein arm,CC,
10150,GO:0036158,1,0.898726273781864,0,16,outer dynein arm assembly,BP,
10151,GO:0036159,1,0.935877083988059,0,10,inner dynein arm assembly,BP,
10152,GO:0036164,1,0.993666278968631,0,1,cell-abiotic substrate adhesion,BP,
10153,GO:0036166,1,0.96156643605454,0,6,phenotypic switching,BP,
10154,GO:0036179,1,0.993557821849349,0,1,osteoclast maturation,BP,
10155,GO:0036186,1,0.987061906563312,0,2,early phagosome membrane,CC,
10156,GO:0036194,1,0.981029726611446,0,3,muscle cell projection,CC,
10157,GO:0036195,1,0.981029726611446,0,3,muscle cell projection membrane,CC,
10159,GO:0036213,1,0.993594119272403,0,1,contractile ring contraction,BP,
10160,GO:0036215,1,0.980463783500519,0,3,response to stem cell factor,BP,
10161,GO:0036216,1,0.980463783500519,0,3,cellular response to stem cell factor stimulus,BP,
10162,GO:0036218,1,0.974260788265181,0,4,dTTP diphosphatase activity,MF,
10163,GO:0036219,1,0.993691741969084,0,1,GTP diphosphatase activity,MF,
10164,GO:0036228,1,0.987093762964551,0,2,protein localization to nuclear inner membrane,BP,
10166,GO:0036245,1,0.987113424988583,0,2,cellular response to menadione,BP,
10167,GO:0036250,1,0.993610985692955,0,1,peroxisome transport along microtubule,BP,
10168,GO:0036255,1,0.993499374287033,0,1,response to methylamine,BP,
10169,GO:0036257,1,0.818554415478854,0,31,multivesicular body organization,BP,
10170,GO:0036258,1,0.823874476608025,0,30,multivesicular body assembly,BP,
10171,GO:0036260,1,0.813128502113964,0,32,RNA capping,BP,
10172,GO:0036261,1,0.993506543021991,0,1,7-methylguanosine cap hypermethylation,BP,
10173,GO:0036265,1,0.974539006626661,0,4,RNA (guanine-N7)-methylation,BP,
10174,GO:0036266,1,0.993570319426232,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10175,GO:0036268,1,0.993082140467003,0,1,swimming,BP,
10176,GO:0036269,1,0.986991747317992,0,2,swimming behavior,BP,
10177,GO:0036284,1,0.986870911814607,0,2,tubulobulbar complex,CC,
10178,GO:0036289,1,0.948649808582743,0,8,peptidyl-serine autophosphorylation,BP,
10179,GO:0036290,1,0.993488007991549,0,1,protein trans-autophosphorylation,BP,
10180,GO:0036292,1,0.987081293391287,0,2,DNA rewinding,BP,
10182,GO:0036294,1,0.276946641595821,0,196,cellular response to decreased oxygen levels,BP,
10183,GO:0036295,1,0.91903120812795,0,13,cellular response to increased oxygen levels,BP,
10184,GO:0036296,1,0.844565054481558,0,26,response to increased oxygen levels,BP,
10185,GO:0036297,1,0.73158050605944,0,48,interstrand cross-link repair,BP,
10186,GO:0036298,1,0.987122879694448,0,2,recombinational interstrand cross-link repair,BP,
10187,GO:0036301,1,0.968200277292267,0,5,macrophage colony-stimulating factor production,BP,
10188,GO:0036302,1,0.95437769333557,0,7,atrioventricular canal development,BP,
10189,GO:0036303,1,0.875007741810933,0,20,lymph vessel morphogenesis,BP,
10190,GO:0036304,1,0.987190227024227,0,2,umbilical cord morphogenesis,BP,
10191,GO:0036306,1,0.993633011042041,0,1,embryonic heart tube elongation,BP,
10192,GO:0036309,1,0.984701526462825,0,2,protein localization to M-band,BP,
10193,GO:0036310,1,0.95540297160707,0,7,annealing helicase activity,MF,
10194,GO:0036312,1,0.947762913599489,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10195,GO:0036313,1,0.993577732949299,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10196,GO:0036314,1,0.825406403352816,0,29,response to sterol,BP,
10197,GO:0036315,1,0.870469198415352,0,21,cellular response to sterol,BP,
10198,GO:0036316,1,0.987169628628222,0,2,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10199,GO:0036317,1,0.99355705431691,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10200,GO:0036321,1,0.99355705431691,0,1,ghrelin secretion,BP,
10201,GO:0036323,1,0.993438965079672,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10202,GO:0036324,1,0.967970223030918,0,5,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10203,GO:0036325,1,0.993589447510989,0,1,vascular endothelial growth factor receptor-3 signaling pathway,BP,
10204,GO:0036326,1,0.993438965079672,0,1,VEGF-A-activated receptor activity,MF,
10205,GO:0036327,1,0.993438965079672,0,1,VEGF-B-activated receptor activity,MF,
10206,GO:0036328,1,0.993402835217355,0,1,VEGF-C-activated receptor activity,MF,
10207,GO:0036331,1,0.993590431432257,0,1,avascular cornea development in camera-type eye,BP,
10208,GO:0036332,1,0.993438965079672,0,1,placental growth factor-activated receptor activity,MF,
10209,GO:0036333,1,0.99356519354714,0,1,hepatocyte homeostasis,BP,
10210,GO:0036335,1,0.980784099854248,0,3,intestinal stem cell homeostasis,BP,
10211,GO:0036336,1,0.833898915179952,0,28,dendritic cell migration,BP,
10212,GO:0036337,1,0.967823874411741,0,5,Fas signaling pathway,BP,
10213,GO:0036342,1,0.894409576135111,0,17,post-anal tail morphogenesis,BP,
10214,GO:0036343,1,0.974685594318823,0,4,psychomotor behavior,BP,
10215,GO:0036344,1,0.870696954841591,0,21,platelet morphogenesis,BP,
10216,GO:0036345,1,0.987216588234831,0,2,platelet maturation,BP,
10217,GO:0036351,1,0.993585270097841,0,1,histone H2A-K13 ubiquitination,BP,
10218,GO:0036352,1,0.993585270097841,0,1,histone H2A-K15 ubiquitination,BP,
10219,GO:0036353,1,0.955262941931706,0,7,histone H2A-K119 monoubiquitination,BP,
10220,GO:0036359,1,0.993612562533813,0,1,renal potassium excretion,BP,
10221,GO:0036361,1,0.993574747073295,0,1,racemase activity, acting on amino acids and derivatives,MF,
10222,GO:0036363,1,0.942364591949165,0,9,transforming growth factor beta activation,BP,
10223,GO:0036364,1,0.987076145002817,0,2,transforming growth factor beta1 activation,BP,
10224,GO:0036366,1,0.993473229575174,0,1,transforming growth factor beta3 activation,BP,
10225,GO:0036369,1,0.967365102103044,0,5,transcription factor catabolic process,BP,
10226,GO:0036371,1,0.986787016555477,0,2,protein localization to T-tubule,BP,
10227,GO:0036372,1,0.993674473856274,0,1,opsin transport,BP,
10228,GO:0036373,1,0.99355705431691,0,1,L-fucose mutarotase activity,MF,
10229,GO:0036374,1,0.980842216261927,0,3,glutathione hydrolase activity,MF,
10231,GO:0036378,1,0.980914029984237,0,3,calcitriol biosynthetic process from calciol,BP,
10232,GO:0036379,1,0.850591245687987,0,25,myofilament,CC,
10233,GO:0036387,1,0.980925640645653,0,3,pre-replicative complex,CC,
10234,GO:0036388,1,0.949456670626831,0,8,pre-replicative complex assembly,BP,
10235,GO:0036392,1,0.993505638353356,0,1,chemokine (C-C motif) ligand 20 production,BP,
10236,GO:0036393,1,0.993549660211287,0,1,thiocyanate peroxidase activity,MF,
10237,GO:0036396,1,0.961740693297603,0,6,RNA N6-methyladenosine methyltransferase complex,CC,
10238,GO:0036398,1,0.993577414080855,0,1,TCR signalosome,CC,
10239,GO:0036402,1,0.981037828307026,0,3,proteasome-activating ATPase activity,MF,
10240,GO:0036403,1,0.993565591350976,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10241,GO:0036404,1,0.992936130150715,0,1,conversion of ds siRNA to ss siRNA,BP,
10242,GO:0036409,1,0.987047296007172,0,2,histone H3-K14 acetyltransferase complex,CC,
10245,GO:0036415,1,0.986812197093363,0,2,regulation of tRNA stability,BP,
10246,GO:0036416,1,0.986812197093363,0,2,tRNA stabilization,BP,
10247,GO:0036435,1,0.974564339737395,0,4,K48-linked polyubiquitin modification-dependent protein binding,MF,
10248,GO:0036438,1,0.974381129230337,0,4,maintenance of lens transparency,BP,
10249,GO:0036440,1,0.99354490102801,0,1,citrate synthase activity,MF,
10250,GO:0036444,1,0.937129547474142,0,10,calcium import into the mitochondrion,BP,
10251,GO:0036446,1,0.974056325603175,0,4,myofibroblast differentiation,BP,
10252,GO:0036449,1,0.953811939085098,0,7,microtubule minus-end,CC,
10253,GO:0036451,1,0.987155207697788,0,2,cap mRNA methylation,BP,
10255,GO:0036454,1,0.967800299468445,0,5,growth factor complex,CC,
10256,GO:0036456,1,0.993640785836875,0,1,L-methionine-(S)-S-oxide reductase activity,MF,
10257,GO:0036457,1,0.992676945284198,0,1,keratohyalin granule,CC,
10258,GO:0036458,1,0.993593261226275,0,1,hepatocyte growth factor binding,MF,
10259,GO:0036461,1,0.987345326395144,0,2,BLOC-2 complex binding,MF,
10260,GO:0036462,1,0.936525381964136,0,10,TRAIL-activated apoptotic signaling pathway,BP,
10263,GO:0036466,1,0.961214478143804,0,6,synaptic vesicle recycling via endosome,BP,
10264,GO:0036468,1,0.993604790345139,0,1,L-dopa decarboxylase activity,MF,
10265,GO:0036470,1,0.993677246056371,0,1,tyrosine 3-monooxygenase activator activity,MF,
10266,GO:0036471,1,0.993677246056371,0,1,cellular response to glyoxal,BP,
10269,GO:0036475,1,0.843272758227002,0,26,neuron death in response to oxidative stress,BP,
10270,GO:0036476,1,0.974510738914181,0,4,neuron death in response to hydrogen peroxide,BP,
10272,GO:0036478,1,0.993677246056371,0,1,L-dopa decarboxylase activator activity,MF,
10273,GO:0036479,1,0.993035571048495,0,1,peroxidase inhibitor activity,MF,
10274,GO:0036480,1,0.955618922538196,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10275,GO:0036481,1,0.968477620056256,0,5,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10276,GO:0036482,1,0.987280995240913,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10277,GO:0036483,1,0.993452278385691,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10278,GO:0036484,1,0.974096050771965,0,4,trunk neural crest cell migration,BP,
10279,GO:0036486,1,0.974096050771965,0,4,ventral trunk neural crest cell migration,BP,
10280,GO:0036487,1,0.99307768176836,0,1,nitric-oxide synthase inhibitor activity,MF,
10281,GO:0036488,1,0.987336203038433,0,2,CHOP-C/EBP complex,CC,
10282,GO:0036490,1,0.936541610621291,0,10,regulation of translation in response to endoplasmic reticulum stress,BP,
10283,GO:0036491,1,0.955242028677965,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10284,GO:0036492,1,0.961415651934777,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10285,GO:0036493,1,0.967775444885687,0,5,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10286,GO:0036494,1,0.993371121641015,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10287,GO:0036496,1,0.98726305740578,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10288,GO:0036497,1,0.993581129866679,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10289,GO:0036498,1,0.667407454046013,0,62,IRE1-mediated unfolded protein response,BP,
10291,GO:0036500,1,0.937347714980267,0,10,ATF6-mediated unfolded protein response,BP,
10292,GO:0036501,1,0.993464204555109,0,1,UFD1-NPL4 complex,CC,
10293,GO:0036502,1,0.993536616852926,0,1,Derlin-1-VIMP complex,CC,
10294,GO:0036503,1,0.548930082680774,0,92,ERAD pathway,BP,
10296,GO:0036506,1,0.980445916667657,0,3,maintenance of unfolded protein,BP,
10297,GO:0036507,1,0.882539991512439,0,19,protein demannosylation,BP,
10298,GO:0036508,1,0.882539991512439,0,19,protein alpha-1,2-demannosylation,BP,
10299,GO:0036509,1,0.987211159420195,0,2,trimming of terminal mannose on B branch,BP,
10300,GO:0036510,1,0.980617789953903,0,3,trimming of terminal mannose on C branch,BP,
10301,GO:0036511,1,0.987211159420195,0,2,trimming of first mannose on A branch,BP,
10302,GO:0036512,1,0.987211159420195,0,2,trimming of second mannose on A branch,BP,
10303,GO:0036513,1,0.955386836459962,0,7,Derlin-1 retrotranslocation complex,CC,
10304,GO:0036514,1,0.966981158273491,0,5,dopaminergic neuron axon guidance,BP,
10305,GO:0036515,1,0.973263390136216,0,4,serotonergic neuron axon guidance,BP,
10306,GO:0036517,1,0.993349843576017,0,1,chemoattraction of serotonergic neuron axon,BP,
10307,GO:0036518,1,0.986939262783382,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10308,GO:0036520,1,0.98703035765109,0,2,astrocyte-dopaminergic neuron signaling,BP,
10309,GO:0036524,1,0.993677246056371,0,1,protein deglycase activity,MF,
10310,GO:0036525,1,0.98736108358804,0,2,protein deglycation,BP,
10311,GO:0036526,1,0.993677246056371,0,1,peptidyl-cysteine deglycation,BP,
10312,GO:0036527,1,0.993677246056371,0,1,peptidyl-arginine deglycation,BP,
10313,GO:0036528,1,0.993677246056371,0,1,peptidyl-lysine deglycation,BP,
10314,GO:0036529,1,0.993677246056371,0,1,protein deglycation, glyoxal removal,BP,
10315,GO:0036530,1,0.993677246056371,0,1,protein deglycation, methylglyoxal removal,BP,
10316,GO:0036531,1,0.993677246056371,0,1,glutathione deglycation,BP,
10317,GO:0038001,1,0.973292536035977,0,4,paracrine signaling,BP,
10318,GO:0038002,1,0.993390138902082,0,1,endocrine signaling,BP,
10319,GO:0038003,1,0.925556451393735,0,12,opioid receptor signaling pathway,BP,
10320,GO:0038007,1,0.923730396722407,0,12,netrin-activated signaling pathway,BP,
10321,GO:0038009,1,0.993648341094093,0,1,regulation of signal transduction by receptor internalization,BP,
10322,GO:0038016,1,0.987122819475131,0,2,insulin receptor internalization,BP,
10323,GO:0038018,1,0.986784166484378,0,2,Wnt receptor catabolic process,BP,
10324,GO:0038020,1,0.992865259922889,0,1,insulin receptor recycling,BP,
10325,GO:0038021,1,0.993472802239549,0,1,leptin receptor activity,MF,
10328,GO:0038025,1,0.987028623762814,0,2,reelin receptor activity,MF,
10329,GO:0038026,1,0.954589518479511,0,7,reelin-mediated signaling pathway,BP,
10330,GO:0038027,1,0.966911365968017,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10331,GO:0038028,1,0.974265872997183,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10332,GO:0038030,1,0.95532911111791,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10333,GO:0038031,1,0.961586645195729,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10334,GO:0038033,1,0.967975596682048,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10337,GO:0038037,1,0.955185640489033,0,7,G protein-coupled receptor dimeric complex,CC,
10338,GO:0038038,1,0.99325670669263,0,1,G protein-coupled receptor homodimeric complex,CC,
10339,GO:0038039,1,0.98042418399094,0,3,G protein-coupled receptor heterodimeric complex,CC,
10340,GO:0038041,1,0.987201851904031,0,2,cross-receptor inhibition within G protein-coupled receptor heterodimer,BP,
10341,GO:0038043,1,0.987076880776844,0,2,interleukin-5-mediated signaling pathway,BP,
10342,GO:0038046,1,0.993621458804803,0,1,enkephalin receptor activity,MF,
10343,GO:0038047,1,0.993615214374777,0,1,morphine receptor activity,MF,
10344,GO:0038048,1,0.993422472419224,0,1,dynorphin receptor activity,MF,
10345,GO:0038060,1,0.993525452561765,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10347,GO:0038062,1,0.980728665061173,0,3,protein tyrosine kinase collagen receptor activity,MF,
10348,GO:0038063,1,0.929309171156036,0,11,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10349,GO:0038064,1,0.961460989329972,0,6,collagen receptor activity,MF,
10350,GO:0038065,1,0.911041960249628,0,14,collagen-activated signaling pathway,BP,
10351,GO:0038066,1,0.755715199076857,0,43,p38MAPK cascade,BP,
10356,GO:0038089,1,0.955049420078819,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10358,GO:0038092,1,0.906908495092225,0,15,nodal signaling pathway,BP,
10359,GO:0038093,1,0.327784383298628,0,171,Fc receptor signaling pathway,BP,
10360,GO:0038094,1,0.6011219053408,0,78,Fc-gamma receptor signaling pathway,BP,
10361,GO:0038095,1,0.502217823711876,0,106,Fc-epsilon receptor signaling pathway,BP,
10362,GO:0038096,1,0.61280578942735,0,75,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10363,GO:0038097,1,0.993394178146891,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10365,GO:0038100,1,0.980497592429337,0,3,nodal binding,MF,
10366,GO:0038101,1,0.993624343183029,0,1,sequestering of nodal from receptor via nodal binding,BP,
10367,GO:0038102,1,0.987150233974064,0,2,activin receptor antagonist activity,MF,
10368,GO:0038107,1,0.955515258721162,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10369,GO:0038108,1,0.974461366262675,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10370,GO:0038109,1,0.980463783500519,0,3,Kit signaling pathway,BP,
10371,GO:0038110,1,0.930632977361649,0,11,interleukin-2-mediated signaling pathway,BP,
10372,GO:0038111,1,0.900139388970808,0,16,interleukin-7-mediated signaling pathway,BP,
10373,GO:0038112,1,0.987173047044945,0,2,interleukin-8-mediated signaling pathway,BP,
10374,GO:0038113,1,0.955127162252501,0,7,interleukin-9-mediated signaling pathway,BP,
10375,GO:0038114,1,0.955325072315124,0,7,interleukin-21-mediated signaling pathway,BP,
10376,GO:0038115,1,0.993594912291517,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10377,GO:0038116,1,0.973915869189839,0,4,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10378,GO:0038117,1,0.993594912291517,0,1,C-C motif chemokine 19 receptor activity,MF,
10379,GO:0038118,1,0.993669453079625,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10380,GO:0038121,1,0.993594912291517,0,1,C-C motif chemokine 21 receptor activity,MF,
10381,GO:0038123,1,0.974510662851842,0,4,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10382,GO:0038124,1,0.97435206343983,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10383,GO:0038127,1,0.41945562030564,0,132,ERBB signaling pathway,BP,
10384,GO:0038128,1,0.815872511052292,0,31,ERBB2 signaling pathway,BP,
10385,GO:0038129,1,0.980883471932787,0,3,ERBB3 signaling pathway,BP,
10386,GO:0038131,1,0.987181163110285,0,2,neuregulin receptor activity,MF,
10387,GO:0038132,1,0.967352162397012,0,5,neuregulin binding,MF,
10388,GO:0038133,1,0.993603420780784,0,1,ERBB2-ERBB3 signaling pathway,BP,
10389,GO:0038143,1,0.987009311491787,0,2,ERBB3:ERBB2 complex,CC,
10390,GO:0038145,1,0.961991152363261,0,6,macrophage colony-stimulating factor signaling pathway,BP,
10391,GO:0038146,1,0.974460241469486,0,4,chemokine (C-X-C motif) ligand 12 signaling pathway,BP,
10392,GO:0038147,1,0.993620921871391,0,1,C-X-C motif chemokine 12 receptor activity,MF,
10393,GO:0038154,1,0.980763165374046,0,3,interleukin-11-mediated signaling pathway,BP,
10394,GO:0038155,1,0.955552807246994,0,7,interleukin-23-mediated signaling pathway,BP,
10395,GO:0038156,1,0.980671417953976,0,3,interleukin-3-mediated signaling pathway,BP,
10396,GO:0038158,1,0.987188944975069,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10397,GO:0038159,1,0.993620921871391,0,1,C-X-C chemokine receptor CXCR4 signaling pathway,BP,
10398,GO:0038160,1,0.993620921871391,0,1,CXCL12-activated CXCR4 signaling pathway,BP,
10399,GO:0038161,1,0.986382159023175,0,2,prolactin signaling pathway,BP,
10400,GO:0038162,1,0.980794762126446,0,3,erythropoietin-mediated signaling pathway,BP,
10401,GO:0038163,1,0.968119929815695,0,5,thrombopoietin-mediated signaling pathway,BP,
10402,GO:0038164,1,0.993509103281684,0,1,thrombopoietin receptor activity,MF,
10403,GO:0038165,1,0.960528562754855,0,6,oncostatin-M-mediated signaling pathway,BP,
10405,GO:0038167,1,0.993390056237292,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10406,GO:0038168,1,0.993390056237292,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10407,GO:0038169,1,0.97453180448356,0,4,somatostatin receptor signaling pathway,BP,
10408,GO:0038170,1,0.97453180448356,0,4,somatostatin signaling pathway,BP,
10410,GO:0038172,1,0.980775294340567,0,3,interleukin-33-mediated signaling pathway,BP,
10411,GO:0038177,1,0.993660685002361,0,1,death receptor agonist activity,MF,
10412,GO:0038178,1,0.987181824937369,0,2,complement component C5a signaling pathway,BP,
10413,GO:0038179,1,0.784859236660685,0,37,neurotrophin signaling pathway,BP,
10414,GO:0038180,1,0.924329678972516,0,12,nerve growth factor signaling pathway,BP,
10415,GO:0038181,1,0.980800203348092,0,3,bile acid receptor activity,MF,
10416,GO:0038182,1,0.993640185944994,0,1,G protein-coupled bile acid receptor activity,MF,
10417,GO:0038183,1,0.980800203348092,0,3,bile acid signaling pathway,BP,
10418,GO:0038184,1,0.993640185944994,0,1,cell surface bile acid receptor signaling pathway,BP,
10419,GO:0038185,1,0.993596235981754,0,1,intracellular bile acid receptor signaling pathway,BP,
10420,GO:0038186,1,0.993440832014577,0,1,lithocholic acid receptor activity,MF,
10421,GO:0038187,1,0.878126512937384,0,20,pattern recognition receptor activity,MF,
10422,GO:0038188,1,0.987266108108302,0,2,cholecystokinin signaling pathway,BP,
10423,GO:0038189,1,0.974301266072852,0,4,neuropilin signaling pathway,BP,
10424,GO:0038190,1,0.987131788372622,0,2,VEGF-activated neuropilin signaling pathway,BP,
10425,GO:0038191,1,0.973925799948471,0,4,neuropilin binding,MF,
10426,GO:0038192,1,0.993603955062257,0,1,gastric inhibitory peptide signaling pathway,BP,
10427,GO:0038193,1,0.993588301841849,0,1,thromboxane A2 signaling pathway,BP,
10428,GO:0038194,1,0.987194256409864,0,2,thyroid-stimulating hormone signaling pathway,BP,
10429,GO:0038195,1,0.993643716929759,0,1,urokinase plasminogen activator signaling pathway,BP,
10430,GO:0038201,1,0.905034334768178,0,15,TOR complex,CC,
10431,GO:0038202,1,0.77392303198638,0,39,TORC1 signaling,BP,
10432,GO:0038203,1,0.949340982171197,0,8,TORC2 signaling,BP,
10433,GO:0039003,1,0.987021321748086,0,2,pronephric field specification,BP,
10434,GO:0039007,1,0.99337403039786,0,1,pronephric nephron morphogenesis,BP,
10435,GO:0039008,1,0.99337403039786,0,1,pronephric nephron tubule morphogenesis,BP,
10436,GO:0039017,1,0.987021321748086,0,2,pattern specification involved in pronephros development,BP,
10437,GO:0039019,1,0.986926199360857,0,2,pronephric nephron development,BP,
10438,GO:0039020,1,0.99337403039786,0,1,pronephric nephron tubule development,BP,
10439,GO:0039022,1,0.99337403039786,0,1,pronephric duct development,BP,
10440,GO:0039023,1,0.99337403039786,0,1,pronephric duct morphogenesis,BP,
10441,GO:0039506,1,0.987001836507624,0,2,modulation by virus of host molecular function,BP,
10442,GO:0039507,1,0.987001836507624,0,2,suppression by virus of host molecular function,BP,
10443,GO:0039513,1,0.993557526292956,0,1,suppression by virus of host catalytic activity,BP,
10444,GO:0039514,1,0.99340222653439,0,1,suppression by virus of host JAK-STAT cascade,BP,
10445,GO:0039516,1,0.993557526292956,0,1,modulation by virus of host catalytic activity,BP,
10446,GO:0039519,1,0.980565769186139,0,3,modulation by virus of host autophagy,BP,
10447,GO:0039520,1,0.987060419019193,0,2,induction by virus of host autophagy,BP,
10448,GO:0039521,1,0.993421064509849,0,1,suppression by virus of host autophagy,BP,
10449,GO:0039526,1,0.974471186542949,0,4,modulation by virus of host apoptotic process,BP,
10450,GO:0039528,1,0.849257523235164,0,25,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10451,GO:0039529,1,0.877137686998447,0,20,RIG-I signaling pathway,BP,
10452,GO:0039530,1,0.949023341825765,0,8,MDA-5 signaling pathway,BP,
10453,GO:0039531,1,0.900116233336092,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10454,GO:0039532,1,0.943101561674079,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10455,GO:0039533,1,0.967526202664978,0,5,regulation of MDA-5 signaling pathway,BP,
10456,GO:0039534,1,0.980837087151799,0,3,negative regulation of MDA-5 signaling pathway,BP,
10457,GO:0039535,1,0.911863045551548,0,14,regulation of RIG-I signaling pathway,BP,
10458,GO:0039536,1,0.955403569695452,0,7,negative regulation of RIG-I signaling pathway,BP,
10459,GO:0039552,1,0.98046474926062,0,3,RIG-I binding,MF,
10460,GO:0039562,1,0.99340222653439,0,1,suppression by virus of host STAT activity,BP,
10461,GO:0039563,1,0.99340222653439,0,1,suppression by virus of host STAT1 activity,BP,
10462,GO:0039564,1,0.99340222653439,0,1,suppression by virus of host STAT2 activity,BP,
10463,GO:0039650,1,0.993557526292956,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10464,GO:0039654,1,0.99355705431691,0,1,fusion of virus membrane with host endosome membrane,BP,
10465,GO:0039656,1,0.980833476860635,0,3,modulation by virus of host gene expression,BP,
10466,GO:0039663,1,0.955835487907172,0,7,membrane fusion involved in viral entry into host cell,BP,
10467,GO:0039689,1,0.980772903251002,0,3,negative stranded viral RNA replication,BP,
10468,GO:0039692,1,0.889981911762307,0,18,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10469,GO:0039694,1,0.806896488791726,0,33,viral RNA genome replication,BP,
10470,GO:0039695,1,0.993447576014988,0,1,DNA-templated viral transcription,BP,
10471,GO:0039702,1,0.873416491030149,0,21,viral budding via host ESCRT complex,BP,
10472,GO:0039706,1,0.930844184092342,0,11,co-receptor binding,MF,
10473,GO:0039713,1,0.993520353102423,0,1,viral factory,CC,
10474,GO:0039714,1,0.993520353102423,0,1,cytoplasmic viral factory,CC,
10475,GO:0040001,1,0.794893906366381,0,35,establishment of mitotic spindle localization,BP,
10478,GO:0040009,1,0.960675777584662,0,6,regulation of growth rate,BP,
10479,GO:0040010,1,0.987275641638481,0,2,positive regulation of growth rate,BP,
10483,GO:0040014,1,0.661799621848385,0,63,regulation of multicellular organism growth,BP,
10484,GO:0040015,1,0.930469304715974,0,11,negative regulation of multicellular organism growth,BP,
10485,GO:0040016,1,0.967761470446122,0,5,embryonic cleavage,BP,
10487,GO:0040018,1,0.821375034899153,0,30,positive regulation of multicellular organism growth,BP,
10488,GO:0040019,1,0.815818917056429,0,31,positive regulation of embryonic development,BP,
10489,GO:0040020,1,0.83393439851128,0,28,regulation of meiotic nuclear division,BP,
10491,GO:0040030,1,0.987242175844806,0,2,regulation of molecular function, epigenetic,BP,
10492,GO:0040031,1,0.956016223670925,0,7,snRNA modification,BP,
10493,GO:0040032,1,0.993613368007114,0,1,post-embryonic body morphogenesis,BP,
10494,GO:0040033,1,0.910825242060597,0,14,negative regulation of translation, ncRNA-mediated,BP,
10495,GO:0040034,1,0.918806403745192,0,13,regulation of development, heterochronic,BP,
10497,GO:0040037,1,0.90064542065375,0,16,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10498,GO:0040038,1,0.980342804362872,0,3,polar body extrusion after meiotic divisions,BP,
10499,GO:0040040,1,0.993329698698484,0,1,thermosensory behavior,BP,
10500,GO:0042000,1,0.993578851199516,0,1,translocation of peptides or proteins into host,BP,
10501,GO:0042007,1,0.987201767184576,0,2,interleukin-18 binding,MF,
10502,GO:0042008,1,0.987120097185966,0,2,interleukin-18 receptor activity,MF,
10503,GO:0042010,1,0.980870115762465,0,3,interleukin-15 receptor activity,MF,
10504,GO:0042011,1,0.993538017299483,0,1,interleukin-16 binding,MF,
10505,GO:0042012,1,0.993538017299483,0,1,interleukin-16 receptor activity,MF,
10506,GO:0042015,1,0.980789054600299,0,3,interleukin-20 binding,MF,
10507,GO:0042019,1,0.987177597053249,0,2,interleukin-23 binding,MF,
10508,GO:0042020,1,0.993607064928852,0,1,interleukin-23 receptor activity,MF,
10509,GO:0042022,1,0.987177597053249,0,2,interleukin-12 receptor complex,CC,
10510,GO:0042023,1,0.96796186156155,0,5,DNA endoreduplication,BP,
10511,GO:0042025,1,0.961381213455198,0,6,host cell nucleus,CC,
10512,GO:0042026,1,0.867562779434912,0,22,protein refolding,BP,
10513,GO:0042030,1,0.973623087073331,0,4,ATPase inhibitor activity,MF,
10514,GO:0042033,1,0.993663168536915,0,1,chemokine biosynthetic process,BP,
10515,GO:0042035,1,0.912254979366129,0,14,regulation of cytokine biosynthetic process,BP,
10516,GO:0042036,1,0.967802571301589,0,5,negative regulation of cytokine biosynthetic process,BP,
10517,GO:0042038,1,0.99355705431691,0,1,peptidyl-histidine methylation, to form tele-methylhistidine,BP,
10518,GO:0042040,1,0.993472472896888,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10519,GO:0042043,1,0.912168230832937,0,14,neurexin family protein binding,MF,
10520,GO:0042044,1,0.855535648115334,0,24,fluid transport,BP,
10521,GO:0042045,1,0.948560559524288,0,8,epithelial fluid transport,BP,
10522,GO:0042048,1,0.942036537627548,0,9,olfactory behavior,BP,
10524,GO:0042054,1,0.705996408473324,0,53,histone methyltransferase activity,MF,
10525,GO:0042056,1,0.862288742411904,0,23,chemoattractant activity,MF,
10526,GO:0042058,1,0.585470922167894,0,82,regulation of epidermal growth factor receptor signaling pathway,BP,
10527,GO:0042059,1,0.745604899440319,0,45,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10531,GO:0042073,1,0.725302041789319,0,49,intraciliary transport,BP,
10532,GO:0042074,1,0.912259552384258,0,14,cell migration involved in gastrulation,BP,
10533,GO:0042078,1,0.980854861232935,0,3,germ-line stem cell division,BP,
10534,GO:0042083,1,0.993633979868395,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10535,GO:0042084,1,0.992904381480759,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10536,GO:0042088,1,0.766849510816521,0,41,T-helper 1 type immune response,BP,
10537,GO:0042089,1,0.889054534300103,0,18,cytokine biosynthetic process,BP,
10538,GO:0042092,1,0.797816813583462,0,35,type 2 immune response,BP,
10539,GO:0042093,1,0.702969127176557,0,54,T-helper cell differentiation,BP,
10542,GO:0042101,1,0.896318773768574,0,17,T cell receptor complex,CC,
10545,GO:0042105,1,0.96859954615412,0,5,alpha-beta T cell receptor complex,CC,
10546,GO:0042107,1,0.883363991066546,0,19,cytokine metabolic process,BP,
10547,GO:0042108,1,0.980547877878644,0,3,positive regulation of cytokine biosynthetic process,BP,
10551,GO:0042117,1,0.943242852066379,0,9,monocyte activation,BP,
10552,GO:0042118,1,0.942805064693062,0,9,endothelial cell activation,BP,
10554,GO:0042126,1,0.987252645372152,0,2,nitrate metabolic process,BP,
10557,GO:0042130,1,0.686576266487568,0,58,negative regulation of T cell proliferation,BP,
10558,GO:0042132,1,0.993636984467201,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10563,GO:0042138,1,0.980597735886824,0,3,meiotic DNA double-strand break formation,BP,
10564,GO:0042140,1,0.99355705431691,0,1,late meiotic recombination nodule assembly,BP,
10565,GO:0042144,1,0.968368206676346,0,5,vacuole fusion, non-autophagic,BP,
10566,GO:0042147,1,0.59539696575725,0,79,retrograde transport, endosome to Golgi,BP,
10567,GO:0042148,1,0.96804280392284,0,5,strand invasion,BP,
10568,GO:0042149,1,0.735711199116766,0,47,cellular response to glucose starvation,BP,
10571,GO:0042159,1,0.906045013854004,0,15,lipoprotein catabolic process,BP,
10572,GO:0042160,1,0.987226041140597,0,2,lipoprotein modification,BP,
10573,GO:0042161,1,0.987226041140597,0,2,lipoprotein oxidation,BP,
10574,GO:0042162,1,0.795092195292837,0,35,telomeric DNA binding,MF,
10575,GO:0042163,1,0.993643783512876,0,1,interleukin-12 beta subunit binding,MF,
10576,GO:0042165,1,0.878216128503299,0,20,neurotransmitter binding,MF,
10577,GO:0042166,1,0.925117729340116,0,12,acetylcholine binding,MF,
10578,GO:0042167,1,0.97484806961936,0,4,heme catabolic process,BP,
10579,GO:0042168,1,0.834221320165476,0,28,heme metabolic process,BP,
10580,GO:0042169,1,0.768596099196473,0,40,SH2 domain binding,MF,
10581,GO:0042171,1,0.900591314986076,0,16,lysophosphatidic acid acyltransferase activity,MF,
10585,GO:0042178,1,0.931678714032301,0,11,xenobiotic catabolic process,BP,
10586,GO:0042180,1,0.236465041280594,0,221,cellular ketone metabolic process,BP,
10587,GO:0042181,1,0.791906590950735,0,36,ketone biosynthetic process,BP,
10588,GO:0042182,1,0.937751726095409,0,10,ketone catabolic process,BP,
10589,GO:0042197,1,0.993628228760742,0,1,halogenated hydrocarbon metabolic process,BP,
10590,GO:0042214,1,0.98084379659406,0,3,terpene metabolic process,BP,
10591,GO:0042218,1,0.993603821469413,0,1,1-aminocyclopropane-1-carboxylate biosynthetic process,BP,
10592,GO:0042219,1,0.845072771682656,0,26,cellular modified amino acid catabolic process,BP,
10595,GO:0042245,1,0.98708037866097,0,2,RNA repair,BP,
10597,GO:0042247,1,0.993547211263135,0,1,establishment of planar polarity of follicular epithelium,BP,
10598,GO:0042249,1,0.894293355720924,0,17,establishment of planar polarity of embryonic epithelium,BP,
10599,GO:0042253,1,0.987016213064463,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10600,GO:0042254,1,0.164285377238844,0,277,ribosome biogenesis,BP,
10601,GO:0042255,1,0.69178264602923,0,57,ribosome assembly,BP,
10602,GO:0042256,1,0.968216846550851,0,5,mature ribosome assembly,BP,
10603,GO:0042262,1,0.968605402518414,0,5,DNA protection,BP,
10604,GO:0042264,1,0.986808985323165,0,2,peptidyl-aspartic acid hydroxylation,BP,
10605,GO:0042265,1,0.993255544451043,0,1,peptidyl-asparagine hydroxylation,BP,
10606,GO:0042267,1,0.718841757439784,0,51,natural killer cell mediated cytotoxicity,BP,
10607,GO:0042268,1,0.98725065141094,0,2,regulation of cytolysis,BP,
10608,GO:0042269,1,0.797709760331236,0,35,regulation of natural killer cell mediated cytotoxicity,BP,
10609,GO:0042270,1,0.968416034852355,0,5,protection from natural killer cell mediated cytotoxicity,BP,
10610,GO:0042271,1,0.986872101690115,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
10611,GO:0042272,1,0.993612327636041,0,1,nuclear RNA export factor complex,CC,
10612,GO:0042273,1,0.652535251319461,0,66,ribosomal large subunit biogenesis,BP,
10613,GO:0042274,1,0.644056987276348,0,68,ribosomal small subunit biogenesis,BP,
10614,GO:0042275,1,0.993638252136038,0,1,error-free postreplication DNA repair,BP,
10615,GO:0042276,1,0.872245968374675,0,21,error-prone translesion synthesis,BP,
10617,GO:0042278,1,0.695205098595402,0,56,purine nucleoside metabolic process,BP,
10618,GO:0042281,1,0.993523551006735,0,1,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10619,GO:0042282,1,0.993455559841101,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10620,GO:0042283,1,0.993625348622338,0,1,dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10621,GO:0042284,1,0.987302293189697,0,2,sphingolipid delta-4 desaturase activity,MF,
10622,GO:0042285,1,0.961138462045635,0,6,xylosyltransferase activity,MF,
10623,GO:0042287,1,0.834701422797015,0,28,MHC protein binding,MF,
10624,GO:0042288,1,0.890293029593101,0,18,MHC class I protein binding,MF,
10625,GO:0042289,1,0.962070353254699,0,6,MHC class II protein binding,MF,
10626,GO:0042292,1,0.993576395629378,0,1,URM1 activating enzyme activity,MF,
10627,GO:0042296,1,0.974679111131661,0,4,ISG15 transferase activity,MF,
10628,GO:0042297,1,0.953143180957942,0,7,vocal learning,BP,
10629,GO:0042300,1,0.993473098184963,0,1,beta-amyrin synthase activity,MF,
10630,GO:0042301,1,0.93719907497585,0,10,phosphate ion binding,MF,
10631,GO:0042303,1,0.528579800722181,0,97,molting cycle,BP,
10632,GO:0042304,1,0.771128925859357,0,40,regulation of fatty acid biosynthetic process,BP,
10633,GO:0042306,1,0.692411105618904,0,56,regulation of protein import into nucleus,BP,
10634,GO:0042307,1,0.773865329472466,0,39,positive regulation of protein import into nucleus,BP,
10635,GO:0042308,1,0.918468428311674,0,13,negative regulation of protein import into nucleus,BP,
10636,GO:0042309,1,0.993557113252117,0,1,homoiothermy,BP,
10638,GO:0042311,1,0.828589977589191,0,29,vasodilation,BP,
10639,GO:0042313,1,0.993599654966631,0,1,protein kinase C deactivation,BP,
10640,GO:0042316,1,0.99341300588565,0,1,penicillin metabolic process,BP,
10641,GO:0042320,1,0.974657387778434,0,4,regulation of circadian sleep/wake cycle, REM sleep,BP,
10642,GO:0042321,1,0.968500566085434,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10643,GO:0042322,1,0.98738592458853,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10644,GO:0042323,1,0.987230648614645,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10648,GO:0042328,1,0.987071136121334,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10650,GO:0042335,1,0.980392684073681,0,3,cuticle development,BP,
10651,GO:0042339,1,0.817152750212743,0,31,keratan sulfate metabolic process,BP,
10652,GO:0042340,1,0.930716781607639,0,11,keratan sulfate catabolic process,BP,
10653,GO:0042350,1,0.993627827067832,0,1,GDP-L-fucose biosynthetic process,BP,
10654,GO:0042351,1,0.993627827067832,0,1,'de novo' GDP-L-fucose biosynthetic process,BP,
10655,GO:0042354,1,0.948436977946192,0,8,L-fucose metabolic process,BP,
10656,GO:0042355,1,0.948436977946192,0,8,L-fucose catabolic process,BP,
10657,GO:0042357,1,0.987242872146107,0,2,thiamine diphosphate metabolic process,BP,
10659,GO:0042360,1,0.980938340549969,0,3,vitamin E metabolic process,BP,
10660,GO:0042361,1,0.980824441335495,0,3,menaquinone catabolic process,BP,
10661,GO:0042362,1,0.919582627574278,0,13,fat-soluble vitamin biosynthetic process,BP,
10662,GO:0042363,1,0.943631365886106,0,9,fat-soluble vitamin catabolic process,BP,
10663,GO:0042364,1,0.961760798607678,0,6,water-soluble vitamin biosynthetic process,BP,
10664,GO:0042365,1,0.987326642073396,0,2,water-soluble vitamin catabolic process,BP,
10665,GO:0042368,1,0.937579944764103,0,10,vitamin D biosynthetic process,BP,
10666,GO:0042369,1,0.987149685686083,0,2,vitamin D catabolic process,BP,
10667,GO:0042371,1,0.993509157505027,0,1,vitamin K biosynthetic process,BP,
10669,GO:0042374,1,0.974610389553405,0,4,phylloquinone metabolic process,BP,
10670,GO:0042376,1,0.974610389553405,0,4,phylloquinone catabolic process,BP,
10671,GO:0042377,1,0.980824441335495,0,3,vitamin K catabolic process,BP,
10673,GO:0042382,1,0.961635124699905,0,6,paraspeckles,CC,
10676,GO:0042392,1,0.987227854268378,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10678,GO:0042396,1,0.968560734015304,0,5,phosphagen biosynthetic process,BP,
10681,GO:0042402,1,0.884924014136613,0,19,cellular biogenic amine catabolic process,BP,
10682,GO:0042403,1,0.866003552724729,0,22,thyroid hormone metabolic process,BP,
10683,GO:0042404,1,0.98694451659087,0,2,thyroid hormone catabolic process,BP,
10684,GO:0042405,1,0.928618252100258,0,11,nuclear inclusion body,CC,
10685,GO:0042406,1,0.968254742166828,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10686,GO:0042407,1,0.902086867389481,0,16,cristae formation,BP,
10687,GO:0042412,1,0.987233572830557,0,2,taurine biosynthetic process,BP,
10688,GO:0042413,1,0.993573862785088,0,1,carnitine catabolic process,BP,
10689,GO:0042414,1,0.980510589071759,0,3,epinephrine metabolic process,BP,
10693,GO:0042418,1,0.98731511275179,0,2,epinephrine biosynthetic process,BP,
10698,GO:0042426,1,0.961734184670538,0,6,choline catabolic process,BP,
10699,GO:0042427,1,0.9809263990276,0,3,serotonin biosynthetic process,BP,
10700,GO:0042428,1,0.935714651245996,0,10,serotonin metabolic process,BP,
10701,GO:0042430,1,0.877571325065603,0,20,indole-containing compound metabolic process,BP,
10702,GO:0042435,1,0.974688195537251,0,4,indole-containing compound biosynthetic process,BP,
10703,GO:0042436,1,0.949965851152255,0,8,indole-containing compound catabolic process,BP,
10704,GO:0042438,1,0.876556842408473,0,20,melanin biosynthetic process,BP,
10706,GO:0042440,1,0.667640636496412,0,62,pigment metabolic process,BP,
10707,GO:0042441,1,0.987202636475676,0,2,eye pigment metabolic process,BP,
10709,GO:0042446,1,0.699113558478377,0,55,hormone biosynthetic process,BP,
10711,GO:0042448,1,0.91354970427865,0,14,progesterone metabolic process,BP,
10712,GO:0042450,1,0.987276520894005,0,2,arginine biosynthetic process via ornithine,BP,
10713,GO:0042451,1,0.87402120492575,0,21,purine nucleoside biosynthetic process,BP,
10714,GO:0042454,1,0.890782288024222,0,18,ribonucleoside catabolic process,BP,
10715,GO:0042455,1,0.87402120492575,0,21,ribonucleoside biosynthetic process,BP,
10717,GO:0042462,1,0.821373255956788,0,30,eye photoreceptor cell development,BP,
10718,GO:0042470,1,0.518191788670629,0,101,melanosome,CC,
10719,GO:0042471,1,0.476958387391567,0,113,ear morphogenesis,BP,
10720,GO:0042472,1,0.543336962534771,0,93,inner ear morphogenesis,BP,
10721,GO:0042473,1,0.943311096061424,0,9,outer ear morphogenesis,BP,
10722,GO:0042474,1,0.878987634080148,0,20,middle ear morphogenesis,BP,
10725,GO:0042478,1,0.986848060583889,0,2,regulation of eye photoreceptor cell development,BP,
10726,GO:0042480,1,0.986848060583889,0,2,negative regulation of eye photoreceptor cell development,BP,
10727,GO:0042481,1,0.867318173745426,0,22,regulation of odontogenesis,BP,
10728,GO:0042482,1,0.955802183221188,0,7,positive regulation of odontogenesis,BP,
10729,GO:0042483,1,0.974247908512418,0,4,negative regulation of odontogenesis,BP,
10730,GO:0042487,1,0.925381752109282,0,12,regulation of odontogenesis of dentin-containing tooth,BP,
10731,GO:0042488,1,0.987141457920268,0,2,positive regulation of odontogenesis of dentin-containing tooth,BP,
10732,GO:0042489,1,0.987160266597181,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10733,GO:0042490,1,0.687030918760227,0,57,mechanoreceptor differentiation,BP,
10734,GO:0042491,1,0.821306401111653,0,30,inner ear auditory receptor cell differentiation,BP,
10735,GO:0042492,1,0.930514007464833,0,11,gamma-delta T cell differentiation,BP,
10737,GO:0042494,1,0.96745870275129,0,5,detection of bacterial lipoprotein,BP,
10738,GO:0042495,1,0.987116404319094,0,2,detection of triacyl bacterial lipopeptide,BP,
10739,GO:0042496,1,0.986911768742732,0,2,detection of diacyl bacterial lipopeptide,BP,
10740,GO:0042497,1,0.993522600096194,0,1,triacyl lipopeptide binding,MF,
10741,GO:0042500,1,0.961780982189456,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10742,GO:0042501,1,0.955717293795933,0,7,serine phosphorylation of STAT protein,BP,
10743,GO:0042509,1,0.690659545142332,0,57,regulation of tyrosine phosphorylation of STAT protein,BP,
10744,GO:0042531,1,0.732300442796076,0,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,
10745,GO:0042532,1,0.930789498669565,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10746,GO:0042537,1,0.873884463880365,0,21,benzene-containing compound metabolic process,BP,
10747,GO:0042538,1,0.93734143423504,0,10,hyperosmotic salinity response,BP,
10748,GO:0042539,1,0.986781593814355,0,2,hypotonic salinity response,BP,
10749,GO:0042541,1,0.937616679744938,0,10,hemoglobin biosynthetic process,BP,
10751,GO:0042543,1,0.993702722110288,0,1,protein N-linked glycosylation via arginine,BP,
10752,GO:0042546,1,0.993621324578831,0,1,cell wall biogenesis,BP,
10755,GO:0042554,1,0.818251646936271,0,31,superoxide anion generation,BP,
10756,GO:0042555,1,0.925177893740319,0,12,MCM complex,CC,
10758,GO:0042559,1,0.919808538318039,0,13,pteridine-containing compound biosynthetic process,BP,
10759,GO:0042560,1,0.980542695376376,0,3,pteridine-containing compound catabolic process,BP,
10760,GO:0042562,1,0.62170019388496,0,73,hormone binding,MF,
10761,GO:0042564,1,0.993466521572054,0,1,NLS-dependent protein nuclear import complex,CC,
10762,GO:0042565,1,0.987097197189291,0,2,RNA nuclear export complex,CC,
10763,GO:0042567,1,0.973962099597299,0,4,insulin-like growth factor ternary complex,CC,
10764,GO:0042568,1,0.993675134056867,0,1,insulin-like growth factor binary complex,CC,
10765,GO:0042571,1,0.987280889977395,0,2,immunoglobulin complex, circulating,CC,
10766,GO:0042572,1,0.777522116705874,0,39,retinol metabolic process,BP,
10767,GO:0042573,1,0.879134393822461,0,20,retinoic acid metabolic process,BP,
10768,GO:0042574,1,0.907496574379656,0,15,retinal metabolic process,BP,
10769,GO:0042575,1,0.872264824110481,0,21,DNA polymerase complex,CC,
10770,GO:0042577,1,0.974555552547796,0,4,lipid phosphatase activity,MF,
10772,GO:0042579,1,0.440593458421391,0,126,microbody,CC,
10775,GO:0042583,1,0.936621787366237,0,10,chromaffin granule,CC,
10776,GO:0042584,1,0.954931065065666,0,7,chromaffin granule membrane,CC,
10777,GO:0042585,1,0.99359049708829,0,1,germinal vesicle,CC,
10778,GO:0042586,1,0.993662572637293,0,1,peptide deformylase activity,MF,
10779,GO:0042587,1,0.955045087599183,0,7,glycogen granule,CC,
10780,GO:0042588,1,0.913109192114712,0,14,zymogen granule,CC,
10781,GO:0042589,1,0.936952901232234,0,10,zymogen granule membrane,CC,
10782,GO:0042590,1,0.62146922064093,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10785,GO:0042594,1,0.300942227754816,0,183,response to starvation,BP,
10786,GO:0042595,1,0.98721763050401,0,2,behavioral response to starvation,BP,
10788,GO:0042599,1,0.913224153482676,0,14,lamellar body,CC,
10789,GO:0042602,1,0.993682324209646,0,1,riboflavin reductase (NADPH) activity,MF,
10790,GO:0042605,1,0.873574691540416,0,21,peptide antigen binding,MF,
10791,GO:0042608,1,0.943755560553584,0,9,T cell receptor binding,MF,
10793,GO:0042610,1,0.974710956493269,0,4,CD8 receptor binding,MF,
10794,GO:0042611,1,0.869024440031312,0,22,MHC protein complex,CC,
10795,GO:0042612,1,0.950260633405145,0,8,MHC class I protein complex,CC,
10796,GO:0042613,1,0.914553381327129,0,14,MHC class II protein complex,CC,
10797,GO:0042622,1,0.901140516115787,0,16,photoreceptor outer segment membrane,CC,
10798,GO:0042625,1,0.693152991635436,0,56,ATPase-coupled ion transmembrane transporter activity,MF,
10799,GO:0042626,1,0.53421803112274,0,95,ATPase-coupled transmembrane transporter activity,MF,
10800,GO:0042627,1,0.943053043148092,0,9,chylomicron,CC,
10801,GO:0042628,1,0.993588825271203,0,1,mating plug formation,BP,
10802,GO:0042629,1,0.872213372239029,0,21,mast cell granule,CC,
10803,GO:0042631,1,0.987035027155043,0,2,cellular response to water deprivation,BP,
10804,GO:0042632,1,0.633215557549365,0,70,cholesterol homeostasis,BP,
10805,GO:0042633,1,0.528579800722181,0,97,hair cycle,BP,
10806,GO:0042634,1,0.843500530402154,0,26,regulation of hair cycle,BP,
10807,GO:0042635,1,0.925190331126342,0,12,positive regulation of hair cycle,BP,
10808,GO:0042636,1,0.967842367281223,0,5,negative regulation of hair cycle,BP,
10809,GO:0042637,1,0.974401619206679,0,4,catagen,BP,
10810,GO:0042640,1,0.96779275071189,0,5,anagen,BP,
10812,GO:0042645,1,0.770998416264528,0,40,mitochondrial nucleoid,CC,
10813,GO:0042658,1,0.993652095426906,0,1,MHC class II protein binding, via antigen binding groove,MF,
10814,GO:0042659,1,0.918698444058104,0,13,regulation of cell fate specification,BP,
10815,GO:0042660,1,0.993268208057769,0,1,positive regulation of cell fate specification,BP,
10816,GO:0042661,1,0.968174736058682,0,5,regulation of mesodermal cell fate specification,BP,
10817,GO:0042662,1,0.981009067108271,0,3,negative regulation of mesodermal cell fate specification,BP,
10818,GO:0042663,1,0.987321853710363,0,2,regulation of endodermal cell fate specification,BP,
10819,GO:0042664,1,0.993662440202503,0,1,negative regulation of endodermal cell fate specification,BP,
10820,GO:0042665,1,0.993498240883376,0,1,regulation of ectodermal cell fate specification,BP,
10821,GO:0042666,1,0.993498240883376,0,1,negative regulation of ectodermal cell fate specification,BP,
10822,GO:0042667,1,0.993506871206079,0,1,auditory receptor cell fate specification,BP,
10823,GO:0042669,1,0.993506871206079,0,1,regulation of inner ear auditory receptor cell fate specification,BP,
10824,GO:0042670,1,0.942946195851125,0,9,retinal cone cell differentiation,BP,
10826,GO:0042693,1,0.92540374501995,0,12,muscle cell fate commitment,BP,
10827,GO:0042695,1,0.97404665700272,0,4,thelarche,BP,
10829,GO:0042699,1,0.987245749516002,0,2,follicle-stimulating hormone signaling pathway,BP,
10830,GO:0042700,1,0.993447430138573,0,1,luteinizing hormone signaling pathway,BP,
10831,GO:0042701,1,0.974368186198279,0,4,progesterone secretion,BP,
10832,GO:0042704,1,0.986979518447059,0,2,uterine wall breakdown,BP,
10833,GO:0042706,1,0.993601552792331,0,1,eye photoreceptor cell fate commitment,BP,
10834,GO:0042709,1,0.980940994783307,0,3,succinate-CoA ligase complex,CC,
10835,GO:0042710,1,0.993581645191367,0,1,biofilm formation,BP,
10836,GO:0042711,1,0.936897551518228,0,10,maternal behavior,BP,
10837,GO:0042713,1,0.974053258179527,0,4,sperm ejaculation,BP,
10838,GO:0042719,1,0.968601173197064,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10839,GO:0042720,1,0.987364297754429,0,2,mitochondrial inner membrane peptidase complex,CC,
10840,GO:0042721,1,0.980855066167876,0,3,TIM22 mitochondrial import inner membrane insertion complex,CC,
10841,GO:0042723,1,0.96201900100981,0,6,thiamine-containing compound metabolic process,BP,
10842,GO:0042726,1,0.949325783321791,0,8,flavin-containing compound metabolic process,BP,
10843,GO:0042727,1,0.987209553875425,0,2,flavin-containing compound biosynthetic process,BP,
10844,GO:0042728,1,0.993496871955458,0,1,flavin-containing compound catabolic process,BP,
10845,GO:0042730,1,0.878944845659104,0,20,fibrinolysis,BP,
10846,GO:0042731,1,0.974282572988441,0,4,PH domain binding,MF,
10847,GO:0042732,1,0.980978571448972,0,3,D-xylose metabolic process,BP,
10848,GO:0042733,1,0.692149340820035,0,56,embryonic digit morphogenesis,BP,
10850,GO:0042737,1,0.896044975875092,0,17,drug catabolic process,BP,
10851,GO:0042738,1,0.907616983300327,0,15,exogenous drug catabolic process,BP,
10855,GO:0042745,1,0.845398170414793,0,26,circadian sleep/wake cycle,BP,
10856,GO:0042746,1,0.980821162137212,0,3,circadian sleep/wake cycle, wakefulness,BP,
10857,GO:0042747,1,0.956095608708626,0,7,circadian sleep/wake cycle, REM sleep,BP,
10858,GO:0042748,1,0.943191842249306,0,9,circadian sleep/wake cycle, non-REM sleep,BP,
10859,GO:0042749,1,0.879066723542183,0,20,regulation of circadian sleep/wake cycle,BP,
10860,GO:0042752,1,0.469582039502581,0,115,regulation of circadian rhythm,BP,
10861,GO:0042753,1,0.901099094383875,0,16,positive regulation of circadian rhythm,BP,
10862,GO:0042754,1,0.913065319821666,0,14,negative regulation of circadian rhythm,BP,
10864,GO:0042756,1,0.949792875086794,0,8,drinking behavior,BP,
10865,GO:0042758,1,0.943588217191144,0,9,long-chain fatty acid catabolic process,BP,
10866,GO:0042759,1,0.82280582585554,0,30,long-chain fatty acid biosynthetic process,BP,
10867,GO:0042760,1,0.961772635194505,0,6,very long-chain fatty acid catabolic process,BP,
10868,GO:0042761,1,0.925338745691329,0,12,very long-chain fatty acid biosynthetic process,BP,
10869,GO:0042762,1,0.917720185401836,0,13,regulation of sulfur metabolic process,BP,
10870,GO:0042765,1,0.968214707990303,0,5,GPI-anchor transamidase complex,CC,
10871,GO:0042766,1,0.97317100406653,0,4,nucleosome mobilization,BP,
10872,GO:0042769,1,0.787355316100526,0,37,DNA damage response, detection of DNA damage,BP,
10873,GO:0042770,1,0.443333390996135,0,124,signal transduction in response to DNA damage,BP,
10874,GO:0042771,1,0.755404931566146,0,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10875,GO:0042772,1,0.888346284294035,0,18,DNA damage response, signal transduction resulting in transcription,BP,
10877,GO:0042774,1,0.99355705431691,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10879,GO:0042776,1,0.974829141736017,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10880,GO:0042779,1,0.980898746650352,0,3,tRNA 3'-trailer cleavage,BP,
10881,GO:0042780,1,0.949890600721382,0,8,tRNA 3'-end processing,BP,
10882,GO:0042781,1,0.987131898113914,0,2,3'-tRNA processing endoribonuclease activity,MF,
10883,GO:0042788,1,0.814348764055559,0,32,polysomal ribosome,CC,
10884,GO:0042789,1,0.930022709728337,0,11,mRNA transcription by RNA polymerase II,BP,
10885,GO:0042790,1,0.918884891769625,0,13,nucleolar large rRNA transcription by RNA polymerase I,BP,
10886,GO:0042791,1,0.961650040888691,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10887,GO:0042795,1,0.638962270239348,0,69,snRNA transcription by RNA polymerase II,BP,
10888,GO:0042796,1,0.949603569712069,0,8,snRNA transcription by RNA polymerase III,BP,
10889,GO:0042797,1,0.955571264017554,0,7,tRNA transcription by RNA polymerase III,BP,
10890,GO:0042799,1,0.992691816345791,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10891,GO:0042800,1,0.894376734017819,0,17,histone methyltransferase activity (H3-K4 specific),MF,
10895,GO:0042806,1,0.968398689530433,0,5,fucose binding,MF,
10896,GO:0042809,1,0.905886786585675,0,15,vitamin D receptor binding,MF,
10897,GO:0042813,1,0.90512852635774,0,15,Wnt-activated receptor activity,MF,
10898,GO:0042816,1,0.96777756059569,0,5,vitamin B6 metabolic process,BP,
10899,GO:0042819,1,0.980457453966977,0,3,vitamin B6 biosynthetic process,BP,
10900,GO:0042820,1,0.993606027540371,0,1,vitamin B6 catabolic process,BP,
10901,GO:0042822,1,0.980465251768816,0,3,pyridoxal phosphate metabolic process,BP,
10902,GO:0042823,1,0.986775504495358,0,2,pyridoxal phosphate biosynthetic process,BP,
10903,GO:0042824,1,0.949661865418658,0,8,MHC class I peptide loading complex,CC,
10904,GO:0042825,1,0.987075546921429,0,2,TAP complex,CC,
10905,GO:0042826,1,0.489279020922883,0,109,histone deacetylase binding,MF,
10907,GO:0042832,1,0.855846792055029,0,24,defense response to protozoan,BP,
10908,GO:0042834,1,0.943532266221927,0,9,peptidoglycan binding,MF,
10909,GO:0042835,1,0.986969616351384,0,2,BRE binding,MF,
10910,GO:0042839,1,0.993641352291369,0,1,D-glucuronate metabolic process,BP,
10911,GO:0042840,1,0.993641352291369,0,1,D-glucuronate catabolic process,BP,
10912,GO:0042843,1,0.993667337280991,0,1,D-xylose catabolic process,BP,
10913,GO:0042851,1,0.98086233062088,0,3,L-alanine metabolic process,BP,
10914,GO:0042853,1,0.98086233062088,0,3,L-alanine catabolic process,BP,
10915,GO:0042866,1,0.962102513092654,0,6,pyruvate biosynthetic process,BP,
10916,GO:0042868,1,0.993555996530659,0,1,antisense RNA metabolic process,BP,
10917,GO:0042883,1,0.986976079399005,0,2,cysteine transport,BP,
10919,GO:0042887,1,0.74134336394762,0,46,amide transmembrane transporter activity,MF,
10920,GO:0042903,1,0.987132749489009,0,2,tubulin deacetylase activity,MF,
10921,GO:0042904,1,0.974533512969203,0,4,9-cis-retinoic acid biosynthetic process,BP,
10922,GO:0042905,1,0.974533512969203,0,4,9-cis-retinoic acid metabolic process,BP,
10923,GO:0042908,1,0.80080220273383,0,34,xenobiotic transport,BP,
10924,GO:0042910,1,0.838177794206409,0,27,xenobiotic transmembrane transporter activity,MF,
10925,GO:0042918,1,0.961077992317961,0,6,alkanesulfonate transport,BP,
10926,GO:0042921,1,0.918256906479836,0,13,glucocorticoid receptor signaling pathway,BP,
10927,GO:0042922,1,0.993685091946878,0,1,neuromedin U receptor binding,MF,
10929,GO:0042924,1,0.987172254433464,0,2,neuromedin U binding,MF,
10930,GO:0042930,1,0.99355705431691,0,1,enterobactin transport,BP,
10931,GO:0042931,1,0.99355705431691,0,1,enterobactin transmembrane transporter activity,MF,
10932,GO:0042937,1,0.980450258830931,0,3,tripeptide transmembrane transporter activity,MF,
10933,GO:0042938,1,0.973827064264287,0,4,dipeptide transport,BP,
10934,GO:0042939,1,0.967356563603445,0,5,tripeptide transport,BP,
10935,GO:0042940,1,0.954861876992617,0,7,D-amino acid transport,BP,
10936,GO:0042941,1,0.993609376261734,0,1,D-alanine transport,BP,
10937,GO:0042942,1,0.980844203801704,0,3,D-serine transport,BP,
10938,GO:0042943,1,0.987090428058592,0,2,D-amino acid transmembrane transporter activity,MF,
10939,GO:0042945,1,0.993544071787492,0,1,D-serine transmembrane transporter activity,MF,
10940,GO:0042946,1,0.980694034177578,0,3,glucoside transport,BP,
10941,GO:0042947,1,0.980694034177578,0,3,glucoside transmembrane transporter activity,MF,
10942,GO:0042953,1,0.928092824371713,0,11,lipoprotein transport,BP,
10943,GO:0042959,1,0.980367867847474,0,3,alkanesulfonate transmembrane transporter activity,MF,
10944,GO:0042969,1,0.99355705431691,0,1,lactone transport,BP,
10945,GO:0042971,1,0.99355705431691,0,1,lactone transmembrane transporter activity,MF,
10946,GO:0042974,1,0.836855845547725,0,27,retinoic acid receptor binding,MF,
10947,GO:0042975,1,0.929352167828122,0,11,peroxisome proliferator activated receptor binding,MF,
10948,GO:0042976,1,0.936507206519623,0,10,activation of Janus kinase activity,BP,
10949,GO:0042978,1,0.987070279622378,0,2,ornithine decarboxylase activator activity,MF,
10950,GO:0042979,1,0.968388513270588,0,5,ornithine decarboxylase regulator activity,MF,
10955,GO:0042985,1,0.961829221710004,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10956,GO:0042986,1,0.974069956125554,0,4,positive regulation of amyloid precursor protein biosynthetic process,BP,
10957,GO:0042987,1,0.739264001847198,0,46,amyloid precursor protein catabolic process,BP,
10958,GO:0042988,1,0.993404050748242,0,1,X11-like protein binding,MF,
10959,GO:0042989,1,0.938164328182019,0,10,sequestering of actin monomers,BP,
10960,GO:0042994,1,0.900978168729333,0,16,cytoplasmic sequestering of transcription factor,BP,
10962,GO:0042996,1,0.94950046379772,0,8,regulation of Golgi to plasma membrane protein transport,BP,
10963,GO:0042997,1,0.968191033920541,0,5,negative regulation of Golgi to plasma membrane protein transport,BP,
10964,GO:0042998,1,0.9807015491139,0,3,positive regulation of Golgi to plasma membrane protein transport,BP,
10965,GO:0042999,1,0.993450008972402,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10966,GO:0043000,1,0.980277971188855,0,3,Golgi to plasma membrane CFTR protein transport,BP,
10967,GO:0043001,1,0.778801878328716,0,38,Golgi to plasma membrane protein transport,BP,
10968,GO:0043002,1,0.993450008972402,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10969,GO:0043004,1,0.993450008972402,0,1,cytoplasmic sequestering of CFTR protein,BP,
10971,GO:0043006,1,0.987212289343165,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10972,GO:0043007,1,0.987133620958887,0,2,maintenance of rDNA,BP,
10973,GO:0043008,1,0.94961917988441,0,8,ATP-dependent protein binding,MF,
10976,GO:0043011,1,0.901212472278534,0,16,myeloid dendritic cell differentiation,BP,
10977,GO:0043012,1,0.993567620641266,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
10979,GO:0043015,1,0.838150623633948,0,27,gamma-tubulin binding,MF,
10980,GO:0043020,1,0.931285059034056,0,11,NADPH oxidase complex,CC,
10981,GO:0043021,1,0.456799191718782,0,120,ribonucleoprotein complex binding,MF,
10982,GO:0043022,1,0.721774044847811,0,50,ribosome binding,MF,
10983,GO:0043023,1,0.925079300001747,0,12,ribosomal large subunit binding,MF,
10984,GO:0043024,1,0.895428539793765,0,17,ribosomal small subunit binding,MF,
10988,GO:0043029,1,0.791286800204222,0,36,T cell homeostasis,BP,
10989,GO:0043030,1,0.730425862841162,0,48,regulation of macrophage activation,BP,
10990,GO:0043031,1,0.907509300372502,0,15,negative regulation of macrophage activation,BP,
10991,GO:0043032,1,0.871852382415893,0,21,positive regulation of macrophage activation,BP,
10992,GO:0043033,1,0.993228923395904,0,1,isoamylase complex,CC,
10993,GO:0043034,1,0.879144150632102,0,19,costamere,CC,
10994,GO:0043035,1,0.967780664540029,0,5,chromatin insulator sequence binding,MF,
10995,GO:0043038,1,0.824058441137344,0,30,amino acid activation,BP,
10996,GO:0043039,1,0.829448681442518,0,29,tRNA aminoacylation,BP,
10997,GO:0043041,1,0.993513519925344,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10999,GO:0043044,1,0.636234213260329,0,69,ATP-dependent chromatin remodeling,BP,
11000,GO:0043045,1,0.961138133218685,0,6,DNA methylation involved in embryo development,BP,
11001,GO:0043046,1,0.89552128930863,0,17,DNA methylation involved in gamete generation,BP,
11002,GO:0043047,1,0.931091363209861,0,11,single-stranded telomeric DNA binding,MF,
11003,GO:0043048,1,0.993592931510071,0,1,dolichyl monophosphate biosynthetic process,BP,
11004,GO:0043049,1,0.993540129524831,0,1,otic placode formation,BP,
11005,GO:0043060,1,0.993575443551876,0,1,meiotic metaphase I plate congression,BP,
11007,GO:0043063,1,0.993427403368067,0,1,intercellular bridge organization,BP,
11013,GO:0043073,1,0.924874725132644,0,12,germ cell nucleus,CC,
11014,GO:0043083,1,0.8998941020551,0,16,synaptic cleft,CC,
11015,GO:0043084,1,0.949135975514763,0,8,penile erection,BP,
11020,GO:0043094,1,0.818883082886879,0,31,cellular metabolic compound salvage,BP,
11021,GO:0043095,1,0.993691873575978,0,1,regulation of GTP cyclohydrolase I activity,BP,
11022,GO:0043096,1,0.981091631419423,0,3,purine nucleobase salvage,BP,
11023,GO:0043097,1,0.937783895226189,0,10,pyrimidine nucleoside salvage,BP,
11024,GO:0043101,1,0.913835436625784,0,14,purine-containing compound salvage,BP,
11025,GO:0043102,1,0.955881201687723,0,7,amino acid salvage,BP,
11026,GO:0043103,1,0.987322332465864,0,2,hypoxanthine salvage,BP,
11027,GO:0043105,1,0.993691873575978,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11028,GO:0043111,1,0.974168599427584,0,4,replication fork arrest,BP,
11030,GO:0043113,1,0.695529392999487,0,55,receptor clustering,BP,
11031,GO:0043114,1,0.75055153398817,0,44,regulation of vascular permeability,BP,
11032,GO:0043116,1,0.906767637724111,0,15,negative regulation of vascular permeability,BP,
11033,GO:0043117,1,0.895589765983528,0,17,positive regulation of vascular permeability,BP,
11034,GO:0043120,1,0.968005527735346,0,5,tumor necrosis factor binding,MF,
11035,GO:0043121,1,0.942516472246591,0,9,neurotrophin binding,MF,
11038,GO:0043124,1,0.754471212847458,0,43,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11039,GO:0043125,1,0.96797743163681,0,5,ErbB-3 class receptor binding,MF,
11040,GO:0043126,1,0.993639652606539,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11041,GO:0043128,1,0.993639652606539,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11042,GO:0043129,1,0.949221041433572,0,8,surfactant homeostasis,BP,
11043,GO:0043130,1,0.630016417846008,0,71,ubiquitin binding,MF,
11044,GO:0043131,1,0.993406836997533,0,1,erythrocyte enucleation,BP,
11045,GO:0043132,1,0.987165760246799,0,2,NAD transport,BP,
11046,GO:0043136,1,0.987183613845316,0,2,glycerol-3-phosphatase activity,MF,
11047,GO:0043137,1,0.974588616933743,0,4,DNA replication, removal of RNA primer,BP,
11048,GO:0043138,1,0.888868407190267,0,18,3'-5' DNA helicase activity,MF,
11049,GO:0043139,1,0.955750751366167,0,7,5'-3' DNA helicase activity,MF,
11050,GO:0043144,1,0.931984163996903,0,11,snoRNA processing,BP,
11052,GO:0043152,1,0.974395116797778,0,4,induction of bacterial agglutination,BP,
11053,GO:0043153,1,0.839075475046401,0,27,entrainment of circadian clock by photoperiod,BP,
11055,GO:0043159,1,0.980888180199992,0,3,acrosomal matrix,CC,
11056,GO:0043161,1,0.0713895675134971,0,401,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11057,GO:0043162,1,0.867142513526702,0,22,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11058,GO:0043163,1,0.987159311583059,0,2,cell envelope organization,BP,
11063,GO:0043171,1,0.855391225159756,0,24,peptide catabolic process,BP,
11064,GO:0043173,1,0.925795281410877,0,12,nucleotide salvage,BP,
11065,GO:0043174,1,0.908110088170489,0,15,nucleoside salvage,BP,
11066,GO:0043175,1,0.750432292759845,0,44,RNA polymerase core enzyme binding,MF,
11067,GO:0043176,1,0.925477191390581,0,12,amine binding,MF,
11070,GO:0043179,1,0.993599654966631,0,1,rhythmic excitation,BP,
11071,GO:0043181,1,0.993511587877193,0,1,vacuolar sequestering,BP,
11072,GO:0043183,1,0.980896961624632,0,3,vascular endothelial growth factor receptor 1 binding,MF,
11074,GO:0043185,1,0.993600753249866,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11075,GO:0043186,1,0.894505129934126,0,17,P granule,CC,
11076,GO:0043189,1,0.883480648712272,0,19,H4/H2A histone acetyltransferase complex,CC,
11077,GO:0043190,1,0.967648839754198,0,5,ATP-binding cassette (ABC) transporter complex,CC,
11080,GO:0043196,1,0.948923685287139,0,8,varicosity,CC,
11083,GO:0043199,1,0.974108812712816,0,4,sulfate binding,MF,
11085,GO:0043201,1,0.923795482138599,0,12,response to leucine,BP,
11086,GO:0043202,1,0.558780874701452,0,89,lysosomal lumen,CC,
11092,GO:0043210,1,0.993618773504528,0,1,alkanesulfonate binding,MF,
11095,GO:0043219,1,0.974312420297601,0,4,lateral loop,CC,
11097,GO:0043225,1,0.99338869096963,0,1,ATPase-coupled inorganic anion transmembrane transporter activity,MF,
11107,GO:0043236,1,0.83796843533882,0,27,laminin binding,MF,
11108,GO:0043237,1,0.967694660763747,0,5,laminin-1 binding,MF,
11109,GO:0043240,1,0.943180644789933,0,9,Fanconi anaemia nuclear complex,CC,
11110,GO:0043242,1,0.621033600812837,0,72,negative regulation of protein-containing complex disassembly,BP,
11111,GO:0043243,1,0.804552509335817,0,33,positive regulation of protein-containing complex disassembly,BP,
11112,GO:0043244,1,0.476282420711166,0,112,regulation of protein-containing complex disassembly,BP,
11113,GO:0043247,1,0.918571349045439,0,13,telomere maintenance in response to DNA damage,BP,
11114,GO:0043248,1,0.926097294317479,0,12,proteasome assembly,BP,
11115,GO:0043249,1,0.907393965788664,0,15,erythrocyte maturation,BP,
11116,GO:0043250,1,0.993639452579957,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11117,GO:0043251,1,0.993639452579957,0,1,sodium-dependent organic anion transport,BP,
11118,GO:0043252,1,0.918654192412674,0,13,sodium-independent organic anion transport,BP,
11121,GO:0043256,1,0.922523708862973,0,12,laminin complex,CC,
11122,GO:0043257,1,0.993346585216228,0,1,laminin-8 complex,CC,
11123,GO:0043259,1,0.979461978256228,0,3,laminin-10 complex,CC,
11124,GO:0043260,1,0.979465444988025,0,3,laminin-11 complex,CC,
11125,GO:0043262,1,0.987096354446886,0,2,adenosine-diphosphatase activity,MF,
11126,GO:0043265,1,0.993536240766316,0,1,ectoplasm,CC,
11129,GO:0043268,1,0.748146759868486,0,44,positive regulation of potassium ion transport,BP,
11133,GO:0043273,1,0.993386285591659,0,1,CTPase activity,MF,
11134,GO:0043274,1,0.918483777214175,0,13,phospholipase binding,MF,
11135,GO:0043276,1,0.82163928780038,0,30,anoikis,BP,
11136,GO:0043277,1,0.730782315078628,0,48,apoptotic cell clearance,BP,
11141,GO:0043291,1,0.979521319095778,0,3,RAVE complex,CC,
11143,GO:0043293,1,0.986905688476771,0,2,apoptosome,CC,
11144,GO:0043295,1,0.925971292304803,0,12,glutathione binding,MF,
11148,GO:0043300,1,0.751748142697633,0,44,regulation of leukocyte degranulation,BP,
11149,GO:0043301,1,0.9253183102694,0,12,negative regulation of leukocyte degranulation,BP,
11150,GO:0043302,1,0.861646170710114,0,23,positive regulation of leukocyte degranulation,BP,
11151,GO:0043303,1,0.756152338965601,0,43,mast cell degranulation,BP,
11152,GO:0043304,1,0.829017055209983,0,29,regulation of mast cell degranulation,BP,
11153,GO:0043305,1,0.962227787036173,0,6,negative regulation of mast cell degranulation,BP,
11154,GO:0043306,1,0.913581903369308,0,14,positive regulation of mast cell degranulation,BP,
11155,GO:0043307,1,0.96838400020099,0,5,eosinophil activation,BP,
11156,GO:0043308,1,0.974609841638289,0,4,eosinophil degranulation,BP,
11157,GO:0043309,1,0.980892845973445,0,3,regulation of eosinophil degranulation,BP,
11158,GO:0043310,1,0.993573484549642,0,1,negative regulation of eosinophil degranulation,BP,
11159,GO:0043311,1,0.987238159661105,0,2,positive regulation of eosinophil degranulation,BP,
11161,GO:0043313,1,0.948883660271428,0,8,regulation of neutrophil degranulation,BP,
11162,GO:0043314,1,0.986700534664971,0,2,negative regulation of neutrophil degranulation,BP,
11163,GO:0043315,1,0.974295658862264,0,4,positive regulation of neutrophil degranulation,BP,
11164,GO:0043316,1,0.980828919630549,0,3,cytotoxic T cell degranulation,BP,
11165,GO:0043317,1,0.987192101160039,0,2,regulation of cytotoxic T cell degranulation,BP,
11166,GO:0043318,1,0.987192101160039,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11167,GO:0043320,1,0.961751780563584,0,6,natural killer cell degranulation,BP,
11168,GO:0043321,1,0.980610421525357,0,3,regulation of natural killer cell degranulation,BP,
11169,GO:0043322,1,0.993653954419938,0,1,negative regulation of natural killer cell degranulation,BP,
11170,GO:0043323,1,0.980610421525357,0,3,positive regulation of natural killer cell degranulation,BP,
11171,GO:0043324,1,0.987202636475676,0,2,pigment metabolic process involved in developmental pigmentation,BP,
11172,GO:0043325,1,0.852352024311825,0,24,phosphatidylinositol-3,4-bisphosphate binding,MF,
11173,GO:0043328,1,0.968406822664938,0,5,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11174,GO:0043330,1,0.844248587781859,0,26,response to exogenous dsRNA,BP,
11175,GO:0043331,1,0.806716658412962,0,33,response to dsRNA,BP,
11176,GO:0043333,1,0.993638985798715,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
11177,GO:0043335,1,0.980894737014265,0,3,protein unfolding,BP,
11178,GO:0043337,1,0.993500810126899,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11179,GO:0043353,1,0.948872535509927,0,8,enucleate erythrocyte differentiation,BP,
11180,GO:0043354,1,0.993406836997533,0,1,enucleate erythrocyte maturation,BP,
11181,GO:0043366,1,0.980761475223068,0,3,beta selection,BP,
11182,GO:0043367,1,0.633281941916642,0,70,CD4-positive, alpha-beta T cell differentiation,BP,
11183,GO:0043368,1,0.806227301303006,0,33,positive T cell selection,BP,
11184,GO:0043369,1,0.877583357268105,0,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11185,GO:0043370,1,0.760990134233213,0,42,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11186,GO:0043371,1,0.883151085473256,0,19,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11187,GO:0043372,1,0.845441380276248,0,26,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11188,GO:0043373,1,0.895183044514188,0,17,CD4-positive, alpha-beta T cell lineage commitment,BP,
11189,GO:0043374,1,0.912989726217779,0,14,CD8-positive, alpha-beta T cell differentiation,BP,
11190,GO:0043375,1,0.987021277702127,0,2,CD8-positive, alpha-beta T cell lineage commitment,BP,
11191,GO:0043376,1,0.961631827563144,0,6,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11192,GO:0043377,1,0.987210572323209,0,2,negative regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11193,GO:0043378,1,0.974093171439044,0,4,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11194,GO:0043379,1,0.949130509317221,0,8,memory T cell differentiation,BP,
11195,GO:0043380,1,0.955730944791316,0,7,regulation of memory T cell differentiation,BP,
11196,GO:0043381,1,0.9934727364143,0,1,negative regulation of memory T cell differentiation,BP,
11197,GO:0043382,1,0.968293704025397,0,5,positive regulation of memory T cell differentiation,BP,
11198,GO:0043383,1,0.924826092875959,0,12,negative T cell selection,BP,
11199,GO:0043385,1,0.987256023000812,0,2,mycotoxin metabolic process,BP,
11200,GO:0043387,1,0.987256023000812,0,2,mycotoxin catabolic process,BP,
11201,GO:0043388,1,0.702908261480611,0,54,positive regulation of DNA binding,BP,
11202,GO:0043392,1,0.721967467497697,0,50,negative regulation of DNA binding,BP,
11203,GO:0043393,1,0.279258882640778,0,194,regulation of protein binding,BP,
11204,GO:0043394,1,0.803479790732948,0,33,proteoglycan binding,MF,
11205,GO:0043395,1,0.905048758303839,0,15,heparan sulfate proteoglycan binding,MF,
11206,GO:0043396,1,0.987012292665064,0,2,corticotropin-releasing hormone secretion,BP,
11207,GO:0043397,1,0.987012292665064,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11208,GO:0043398,1,0.974460648335905,0,4,HLH domain binding,MF,
11209,GO:0043400,1,0.968305961070776,0,5,cortisol secretion,BP,
11211,GO:0043402,1,0.979591455496905,0,3,glucocorticoid mediated signaling pathway,BP,
11212,GO:0043403,1,0.801955421204538,0,34,skeletal muscle tissue regeneration,BP,
11213,GO:0043404,1,0.987236406509795,0,2,corticotropin-releasing hormone receptor activity,MF,
11222,GO:0043414,1,0.17954031340292,0,261,macromolecule methylation,BP,
11223,GO:0043415,1,0.968167055102366,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11224,GO:0043416,1,0.962004670577627,0,6,regulation of skeletal muscle tissue regeneration,BP,
11225,GO:0043417,1,0.993637051200376,0,1,negative regulation of skeletal muscle tissue regeneration,BP,
11226,GO:0043418,1,0.980796589564465,0,3,homocysteine catabolic process,BP,
11227,GO:0043420,1,0.980834103347186,0,3,anthranilate metabolic process,BP,
11228,GO:0043422,1,0.930590547242609,0,11,protein kinase B binding,MF,
11229,GO:0043423,1,0.993466995666296,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11230,GO:0043425,1,0.843407947281994,0,26,bHLH transcription factor binding,MF,
11231,GO:0043426,1,0.967482730933133,0,5,MRF binding,MF,
11232,GO:0043430,1,0.993638985798715,0,1,2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
11233,GO:0043433,1,0.369847556143574,0,152,negative regulation of DNA-binding transcription factor activity,BP,
11235,GO:0043435,1,0.968084260650155,0,5,response to corticotropin-releasing hormone,BP,
11237,GO:0043438,1,0.993550739374143,0,1,acetoacetic acid metabolic process,BP,
11238,GO:0043449,1,0.987080089374105,0,2,cellular alkene metabolic process,BP,
11239,GO:0043455,1,0.935803258409353,0,10,regulation of secondary metabolic process,BP,
11240,GO:0043456,1,0.987233606493143,0,2,regulation of pentose-phosphate shunt,BP,
11242,GO:0043461,1,0.974591731177015,0,4,proton-transporting ATP synthase complex assembly,BP,
11243,GO:0043462,1,0.611974103965639,0,76,regulation of ATPase activity,BP,
11244,GO:0043465,1,0.987098243375882,0,2,regulation of fermentation,BP,
11246,GO:0043470,1,0.590516949129132,0,80,regulation of carbohydrate catabolic process,BP,
11247,GO:0043471,1,0.943156079691729,0,9,regulation of cellular carbohydrate catabolic process,BP,
11248,GO:0043473,1,0.539338721132802,0,94,pigmentation,BP,
11249,GO:0043474,1,0.987202636475676,0,2,pigment metabolic process involved in pigmentation,BP,
11250,GO:0043476,1,0.92419771562311,0,12,pigment accumulation,BP,
11251,GO:0043482,1,0.92419771562311,0,12,cellular pigment accumulation,BP,
11252,GO:0043484,1,0.385888725975842,0,145,regulation of RNA splicing,BP,
11253,GO:0043485,1,0.937219743213343,0,10,endosome to pigment granule transport,BP,
11254,GO:0043486,1,0.78116056359123,0,38,histone exchange,BP,
11255,GO:0043487,1,0.318570414324384,0,175,regulation of RNA stability,BP,
11256,GO:0043488,1,0.335820940824505,0,167,regulation of mRNA stability,BP,
11257,GO:0043489,1,0.750023519994879,0,44,RNA stabilization,BP,
11258,GO:0043490,1,0.974425968441259,0,4,malate-aspartate shuttle,BP,
11260,GO:0043495,1,0.88897742685007,0,18,protein-membrane adaptor activity,MF,
11261,GO:0043496,1,0.993327448563918,0,1,regulation of protein homodimerization activity,BP,
11263,GO:0043501,1,0.866196296334463,0,22,skeletal muscle adaptation,BP,
11265,GO:0043503,1,0.974705626825542,0,4,skeletal muscle fiber adaptation,BP,
11266,GO:0043504,1,0.96177272082925,0,6,mitochondrial DNA repair,BP,
11269,GO:0043508,1,0.919353186023162,0,13,negative regulation of JUN kinase activity,BP,
11270,GO:0043509,1,0.993594780058018,0,1,activin A complex,CC,
11271,GO:0043511,1,0.987280062587245,0,2,inhibin complex,CC,
11272,GO:0043512,1,0.987280062587245,0,2,inhibin A complex,CC,
11273,GO:0043513,1,0.993644981764571,0,1,inhibin B complex,CC,
11274,GO:0043514,1,0.993643783512876,0,1,interleukin-12 complex,CC,
11275,GO:0043515,1,0.961198237551816,0,6,kinetochore binding,MF,
11276,GO:0043516,1,0.81723036462044,0,31,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11277,GO:0043517,1,0.906511152961057,0,15,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11278,GO:0043518,1,0.919218957037895,0,13,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11279,GO:0043519,1,0.993598956749965,0,1,regulation of myosin II filament organization,BP,
11280,GO:0043522,1,0.949503279334306,0,8,leucine zipper domain binding,MF,
11283,GO:0043525,1,0.703217765991395,0,54,positive regulation of neuron apoptotic process,BP,
11284,GO:0043527,1,0.968412143959736,0,5,tRNA methyltransferase complex,CC,
11285,GO:0043531,1,0.805296855876099,0,33,ADP binding,MF,
11286,GO:0043532,1,0.993271496279011,0,1,angiostatin binding,MF,
11289,GO:0043535,1,0.576438942615398,0,84,regulation of blood vessel endothelial cell migration,BP,
11290,GO:0043536,1,0.720991641161511,0,50,positive regulation of blood vessel endothelial cell migration,BP,
11291,GO:0043537,1,0.810871235117162,0,32,negative regulation of blood vessel endothelial cell migration,BP,
11292,GO:0043538,1,0.993541327829881,0,1,regulation of actin phosphorylation,BP,
11293,GO:0043539,1,0.786552927458028,0,37,protein serine/threonine kinase activator activity,MF,
11294,GO:0043540,1,0.993623471488449,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11295,GO:0043541,1,0.987215194285745,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11298,GO:0043544,1,0.993512555144168,0,1,lipoamide binding,MF,
11299,GO:0043545,1,0.961925229714383,0,6,molybdopterin cofactor metabolic process,BP,
11300,GO:0043546,1,0.974089320819206,0,4,molybdopterin cofactor binding,MF,
11302,GO:0043548,1,0.83074409375366,0,28,phosphatidylinositol 3-kinase binding,MF,
11307,GO:0043553,1,0.98707697566193,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11308,GO:0043555,1,0.877594664369569,0,20,regulation of translation in response to stress,BP,
11309,GO:0043558,1,0.912972691649899,0,14,regulation of translational initiation in response to stress,BP,
11310,GO:0043559,1,0.960418730004212,0,6,insulin binding,MF,
11311,GO:0043560,1,0.935547013330934,0,10,insulin receptor substrate binding,MF,
11312,GO:0043562,1,0.931864974054781,0,11,cellular response to nitrogen levels,BP,
11313,GO:0043564,1,0.987158013600301,0,2,Ku70:Ku80 complex,CC,
11315,GO:0043567,1,0.889313437062847,0,18,regulation of insulin-like growth factor receptor signaling pathway,BP,
11316,GO:0043568,1,0.942341232720202,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11317,GO:0043569,1,0.961650679715129,0,6,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11318,GO:0043570,1,0.96166026725877,0,6,maintenance of DNA repeat elements,BP,
11319,GO:0043574,1,0.627050267278175,0,72,peroxisomal transport,BP,
11320,GO:0043576,1,0.86587331019862,0,22,regulation of respiratory gaseous exchange,BP,
11321,GO:0043578,1,0.979050973549502,0,3,nuclear matrix organization,BP,
11323,GO:0043584,1,0.905806492254327,0,15,nose development,BP,
11324,GO:0043585,1,0.980179992827501,0,3,nose morphogenesis,BP,
11325,GO:0043586,1,0.865401488217286,0,22,tongue development,BP,
11326,GO:0043587,1,0.936887076770171,0,10,tongue morphogenesis,BP,
11327,GO:0043588,1,0.183385768940799,0,257,skin development,BP,
11328,GO:0043589,1,0.93587074491127,0,10,skin morphogenesis,BP,
11329,GO:0043596,1,0.771143102606938,0,40,nuclear replication fork,CC,
11330,GO:0043601,1,0.861529138431034,0,23,nuclear replisome,CC,
11331,GO:0043602,1,0.993572918047278,0,1,nitrate catabolic process,BP,
11334,GO:0043605,1,0.980983607080786,0,3,cellular amide catabolic process,BP,
11335,GO:0043606,1,0.974514145893851,0,4,formamide metabolic process,BP,
11336,GO:0043610,1,0.99308300260054,0,1,regulation of carbohydrate utilization,BP,
11337,GO:0043614,1,0.986914987489947,0,2,multi-eIF complex,CC,
11338,GO:0043615,1,0.955834160140413,0,7,astrocyte cell migration,BP,
11339,GO:0043616,1,0.778754231333811,0,38,keratinocyte proliferation,BP,
11340,GO:0043618,1,0.512529140286174,0,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11341,GO:0043619,1,0.930485082060578,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11342,GO:0043620,1,0.495775974663245,0,108,regulation of DNA-templated transcription in response to stress,BP,
11344,GO:0043622,1,0.974110265129312,0,4,cortical microtubule organization,BP,
11345,GO:0043624,1,0.251618768331315,0,211,cellular protein complex disassembly,BP,
11346,GO:0043625,1,0.974585665765109,0,4,delta DNA polymerase complex,CC,
11347,GO:0043626,1,0.993650467966065,0,1,PCNA complex,CC,
11348,GO:0043627,1,0.634534380100767,0,70,response to estrogen,BP,
11349,GO:0043628,1,0.792523514665426,0,36,ncRNA 3'-end processing,BP,
11350,GO:0043631,1,0.760348247242606,0,42,RNA polyadenylation,BP,
11351,GO:0043632,1,0.0192639375165799,0,594,modification-dependent macromolecule catabolic process,BP,
11352,GO:0043633,1,0.956044290825641,0,7,polyadenylation-dependent RNA catabolic process,BP,
11353,GO:0043634,1,0.962350753576027,0,6,polyadenylation-dependent ncRNA catabolic process,BP,
11355,GO:0043648,1,0.568729230144947,0,87,dicarboxylic acid metabolic process,BP,
11356,GO:0043649,1,0.896107531145007,0,17,dicarboxylic acid catabolic process,BP,
11357,GO:0043650,1,0.919330669444774,0,13,dicarboxylic acid biosynthetic process,BP,
11358,GO:0043651,1,0.890234045718733,0,18,linoleic acid metabolic process,BP,
11359,GO:0043652,1,0.900915252693755,0,16,engulfment of apoptotic cell,BP,
11360,GO:0043653,1,0.94305760525749,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11361,GO:0043654,1,0.961632430710787,0,6,recognition of apoptotic cell,BP,
11362,GO:0043656,1,0.924841105238282,0,12,host intracellular region,CC,
11363,GO:0043657,1,0.675674413639115,0,60,host cell,CC,
11366,GO:0043682,1,0.986460511755922,0,2,copper transmembrane transporter activity, phosphorylative mechanism,MF,
11367,GO:0043686,1,0.980912507558976,0,3,co-translational protein modification,BP,
11369,GO:0043691,1,0.913056083189112,0,14,reverse cholesterol transport,BP,
11370,GO:0043696,1,0.94863803662327,0,8,dedifferentiation,BP,
11371,GO:0043697,1,0.94863803662327,0,8,cell dedifferentiation,BP,
11372,GO:0043715,1,0.993605224907254,0,1,2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity,MF,
11373,GO:0043716,1,0.993605224907254,0,1,2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity,MF,
11374,GO:0043727,1,0.993525452561765,0,1,5-amino-4-imidazole carboxylate lyase activity,MF,
11375,GO:0043733,1,0.993667138868627,0,1,DNA-3-methylbase glycosylase activity,MF,
11376,GO:0043734,1,0.980903606471364,0,3,DNA-N1-methyladenine dioxygenase activity,MF,
11377,GO:0043739,1,0.99353053264535,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11378,GO:0043754,1,0.992880371068028,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11379,GO:0043783,1,0.993582807031021,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11380,GO:0043795,1,0.993646113025072,0,1,glyceraldehyde oxidoreductase activity,MF,
11381,GO:0043812,1,0.974071193272379,0,4,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11382,GO:0043813,1,0.986916666489709,0,2,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11383,GO:0043843,1,0.993569790012993,0,1,ADP-specific glucokinase activity,MF,
11384,GO:0043849,1,0.993548446135624,0,1,Ras palmitoyltransferase activity,MF,
11385,GO:0043855,1,0.942888504538469,0,9,cyclic nucleotide-gated ion channel activity,MF,
11386,GO:0043865,1,0.993556407202904,0,1,methionine transmembrane transporter activity,MF,
11387,GO:0043874,1,0.993605224907254,0,1,acireductone synthase activity,MF,
11388,GO:0043878,1,0.968122181233949,0,5,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity,MF,
11389,GO:0043890,1,0.993581709652802,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11390,GO:0043891,1,0.993652029015428,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11391,GO:0043900,1,0.672370185309669,0,61,regulation of multi-organism process,BP,
11392,GO:0043901,1,0.884500537656616,0,19,negative regulation of multi-organism process,BP,
11393,GO:0043902,1,0.800935173705146,0,34,positive regulation of multi-organism process,BP,
11394,GO:0043903,1,0.263930604942823,0,204,regulation of symbiotic process,BP,
11395,GO:0043914,1,0.993493695951471,0,1,NADPH:sulfur oxidoreductase activity,MF,
11396,GO:0043915,1,0.993625951701016,0,1,L-seryl-tRNA(Sec) kinase activity,MF,
11397,GO:0043916,1,0.993667138868627,0,1,DNA-7-methylguanine glycosylase activity,MF,
11398,GO:0043921,1,0.986972325854346,0,2,modulation by host of viral transcription,BP,
11399,GO:0043922,1,0.931049358042855,0,11,negative regulation by host of viral transcription,BP,
11400,GO:0043923,1,0.894577081389641,0,17,positive regulation by host of viral transcription,BP,
11402,GO:0043928,1,0.812782947654308,0,32,exonucleolytic catabolism of deadenylated mRNA,BP,
11404,GO:0043932,1,0.96840584585446,0,5,ossification involved in bone remodeling,BP,
11406,GO:0043946,1,0.993623169679685,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11407,GO:0043947,1,0.993623169679685,0,1,positive regulation by host of symbiont catalytic activity,BP,
11411,GO:0043954,1,0.69479526628346,0,55,cellular component maintenance,BP,
11412,GO:0043966,1,0.693777467596612,0,56,histone H3 acetylation,BP,
11413,GO:0043967,1,0.636288020904646,0,69,histone H4 acetylation,BP,
11414,GO:0043968,1,0.900644117791126,0,16,histone H2A acetylation,BP,
11415,GO:0043969,1,0.980292881128251,0,3,histone H2B acetylation,BP,
11416,GO:0043970,1,0.91848682839593,0,13,histone H3-K9 acetylation,BP,
11417,GO:0043972,1,0.967736736835538,0,5,histone H3-K23 acetylation,BP,
11418,GO:0043973,1,0.993592569020044,0,1,histone H3-K4 acetylation,BP,
11419,GO:0043974,1,0.986812581800602,0,2,histone H3-K27 acetylation,BP,
11420,GO:0043977,1,0.993545900089888,0,1,histone H2A-K5 acetylation,BP,
11421,GO:0043979,1,0.993535328984749,0,1,histone H2B-K5 acetylation,BP,
11422,GO:0043980,1,0.993545900089888,0,1,histone H2B-K12 acetylation,BP,
11423,GO:0043981,1,0.901096016693536,0,16,histone H4-K5 acetylation,BP,
11424,GO:0043982,1,0.901096016693536,0,16,histone H4-K8 acetylation,BP,
11425,GO:0043983,1,0.955855239736109,0,7,histone H4-K12 acetylation,BP,
11426,GO:0043984,1,0.877375092772363,0,20,histone H4-K16 acetylation,BP,
11427,GO:0043985,1,0.962010380186201,0,6,histone H4-R3 methylation,BP,
11428,GO:0043987,1,0.968232302394083,0,5,histone H3-S10 phosphorylation,BP,
11429,GO:0043988,1,0.98085433374189,0,3,histone H3-S28 phosphorylation,BP,
11430,GO:0043990,1,0.993538719757544,0,1,histone H2A-S1 phosphorylation,BP,
11431,GO:0043994,1,0.967736736835538,0,5,histone acetyltransferase activity (H3-K23 specific),MF,
11432,GO:0043995,1,0.943138177899264,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11433,GO:0043996,1,0.943138177899264,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11434,GO:0043997,1,0.993537100975057,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11435,GO:0043998,1,0.993525822373687,0,1,H2A histone acetyltransferase activity,MF,
11436,GO:0044003,1,0.789817279412282,0,36,modulation by symbiont of host process,BP,
11437,GO:0044010,1,0.993581645191367,0,1,single-species biofilm formation,BP,
11438,GO:0044020,1,0.974609434824821,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11439,GO:0044026,1,0.980863443514543,0,3,DNA hypermethylation,BP,
11440,GO:0044027,1,0.987280036177048,0,2,hypermethylation of CpG island,BP,
11441,GO:0044028,1,0.987082069775253,0,2,DNA hypomethylation,BP,
11442,GO:0044029,1,0.987082069775253,0,2,hypomethylation of CpG island,BP,
11443,GO:0044030,1,0.883544797829265,0,19,regulation of DNA methylation,BP,
11444,GO:0044033,1,0.993630470449032,0,1,multi-organism metabolic process,BP,
11445,GO:0044035,1,0.993630470449032,0,1,multi-organism catabolic process,BP,
11446,GO:0044036,1,0.98733469606039,0,2,cell wall macromolecule metabolic process,BP,
11447,GO:0044038,1,0.993621324578831,0,1,cell wall macromolecule biosynthetic process,BP,
11448,GO:0044042,1,0.65203674835373,0,65,glucan metabolic process,BP,
11449,GO:0044053,1,0.993578851199516,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11451,GO:0044058,1,0.813237910622873,0,32,regulation of digestive system process,BP,
11452,GO:0044060,1,0.771652147568236,0,40,regulation of endocrine process,BP,
11453,GO:0044062,1,0.873054560062619,0,21,regulation of excretion,BP,
11454,GO:0044065,1,0.906927665629598,0,15,regulation of respiratory system process,BP,
11455,GO:0044068,1,0.849639560005381,0,25,modulation by symbiont of host cellular process,BP,
11459,GO:0044088,1,0.750629957272936,0,44,regulation of vacuole organization,BP,
11461,GO:0044090,1,0.936585607169313,0,10,positive regulation of vacuole organization,BP,
11462,GO:0044091,1,0.75891873326408,0,42,membrane biogenesis,BP,
11465,GO:0044094,1,0.974240257401015,0,4,host cell nuclear part,CC,
11466,GO:0044105,1,0.993683971849142,0,1,L-xylulose reductase (NAD+) activity,MF,
11468,GO:0044107,1,0.980914029984237,0,3,cellular alcohol metabolic process,BP,
11469,GO:0044108,1,0.980914029984237,0,3,cellular alcohol biosynthetic process,BP,
11470,GO:0044110,1,0.993676124177465,0,1,growth involved in symbiotic interaction,BP,
11471,GO:0044111,1,0.986973854824237,0,2,development involved in symbiotic interaction,BP,
11472,GO:0044115,1,0.993630470449032,0,1,development of symbiont involved in interaction with host,BP,
11473,GO:0044117,1,0.993676124177465,0,1,growth of symbiont in host,BP,
11474,GO:0044145,1,0.993630470449032,0,1,modulation of development of symbiont involved in interaction with host,BP,
11475,GO:0044147,1,0.993630470449032,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11476,GO:0044154,1,0.912794349856227,0,14,histone H3-K14 acetylation,BP,
11477,GO:0044183,1,0.851357523090577,0,25,protein folding chaperone,MF,
11478,GO:0044190,1,0.993622733671697,0,1,host cell mitochondrial envelope,CC,
11479,GO:0044194,1,0.968408969248543,0,5,cytolytic granule,CC,
11480,GO:0044205,1,0.98052648860793,0,3,'de novo' UMP biosynthetic process,BP,
11481,GO:0044206,1,0.968470082401636,0,5,UMP salvage,BP,
11482,GO:0044207,1,0.993479018912325,0,1,translation initiation ternary complex,CC,
11483,GO:0044208,1,0.993640985774167,0,1,'de novo' AMP biosynthetic process,BP,
11484,GO:0044209,1,0.98733254952588,0,2,AMP salvage,BP,
11485,GO:0044210,1,0.987090975174982,0,2,'de novo' CTP biosynthetic process,BP,
11486,GO:0044211,1,0.980991441670111,0,3,CTP salvage,BP,
11488,GO:0044216,1,0.986985152527941,0,2,other organism cell,CC,
11489,GO:0044217,1,0.986985152527941,0,2,other organism part,CC,
11490,GO:0044218,1,0.993561341742343,0,1,other organism cell membrane,CC,
11491,GO:0044220,1,0.99343158922812,0,1,host cell perinuclear region of cytoplasm,CC,
11493,GO:0044228,1,0.993439376677822,0,1,host cell surface,CC,
11494,GO:0044232,1,0.84988996396099,0,25,organelle membrane contact site,CC,
11495,GO:0044233,1,0.901281301581712,0,16,mitochondria-associated endoplasmic reticulum membrane,CC,
11498,GO:0044241,1,0.925290167928283,0,12,lipid digestion,BP,
11500,GO:0044245,1,0.980631526547934,0,3,polysaccharide digestion,BP,
11501,GO:0044247,1,0.859697692591445,0,23,cellular polysaccharide catabolic process,BP,
11506,GO:0044258,1,0.993580486638777,0,1,intestinal lipid catabolic process,BP,
11509,GO:0044264,1,0.553210355121091,0,90,cellular polysaccharide metabolic process,BP,
11514,GO:0044272,1,0.320174951113162,0,174,sulfur compound biosynthetic process,BP,
11515,GO:0044273,1,0.727421997918209,0,49,sulfur compound catabolic process,BP,
11516,GO:0044275,1,0.779651234943627,0,38,cellular carbohydrate catabolic process,BP,
11517,GO:0044278,1,0.993685289586667,0,1,cell wall disruption in other organism,BP,
11522,GO:0044292,1,0.924620568049088,0,12,dendrite terminus,CC,
11523,GO:0044294,1,0.948686292610835,0,8,dendritic growth cone,CC,
11524,GO:0044295,1,0.836050827134726,0,27,axonal growth cone,CC,
11528,GO:0044301,1,0.9871387591715,0,2,climbing fiber,CC,
11529,GO:0044302,1,0.967117069911821,0,5,dentate gyrus mossy fiber,CC,
11531,GO:0044305,1,0.859604711303508,0,23,calyx of Held,CC,
11533,GO:0044307,1,0.979149286558161,0,3,dendritic branch,CC,
11534,GO:0044308,1,0.980087427437141,0,3,axonal spine,CC,
11536,GO:0044313,1,0.980088703358411,0,3,protein K6-linked deubiquitination,BP,
11537,GO:0044314,1,0.974747943914109,0,4,protein K27-linked ubiquitination,BP,
11538,GO:0044316,1,0.987115670604026,0,2,cone cell pedicle,CC,
11539,GO:0044317,1,0.993648174873705,0,1,rod spherule,CC,
11540,GO:0044319,1,0.837245349248462,0,27,wound healing, spreading of cells,BP,
11541,GO:0044320,1,0.895632219427087,0,17,cellular response to leptin stimulus,BP,
11543,GO:0044322,1,0.865747994224132,0,22,endoplasmic reticulum quality control compartment,CC,
11544,GO:0044323,1,0.961688984968975,0,6,retinoic acid-responsive element binding,MF,
11545,GO:0044324,1,0.993678895390759,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11547,GO:0044326,1,0.955118995789821,0,7,dendritic spine neck,CC,
11549,GO:0044331,1,0.848631048256613,0,25,cell-cell adhesion mediated by cadherin,BP,
11550,GO:0044332,1,0.993459081563851,0,1,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11551,GO:0044333,1,0.99361427433561,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11552,GO:0044334,1,0.987053159618953,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11553,GO:0044335,1,0.992953461439198,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11554,GO:0044336,1,0.980648865928675,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11555,GO:0044338,1,0.987148388410357,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11556,GO:0044339,1,0.980649593881886,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11557,GO:0044340,1,0.967541409785462,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11558,GO:0044341,1,0.961956799444446,0,6,sodium-dependent phosphate transport,BP,
11559,GO:0044342,1,0.88449420723061,0,19,type B pancreatic cell proliferation,BP,
11560,GO:0044343,1,0.993459081563851,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11562,GO:0044345,1,0.993459081563851,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11563,GO:0044346,1,0.877499878834728,0,20,fibroblast apoptotic process,BP,
11564,GO:0044349,1,0.993624477263957,0,1,DNA excision,BP,
11565,GO:0044351,1,0.942943013127642,0,9,macropinocytosis,BP,
11566,GO:0044352,1,0.961407090259829,0,6,pinosome,CC,
11567,GO:0044354,1,0.961407090259829,0,6,macropinosome,CC,
11568,GO:0044355,1,0.993643383992613,0,1,clearance of foreign intracellular DNA,BP,
11569,GO:0044357,1,0.993617699077859,0,1,regulation of rRNA stability,BP,
11570,GO:0044359,1,0.94957882032466,0,8,modulation of molecular function in other organism,BP,
11571,GO:0044362,1,0.962128128844782,0,6,negative regulation of molecular function in other organism,BP,
11572,GO:0044374,1,0.993504675252892,0,1,sequence-specific DNA binding, bending,MF,
11573,GO:0044375,1,0.981082954330351,0,3,regulation of peroxisome size,BP,
11574,GO:0044377,1,0.993504675252892,0,1,RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending,MF,
11575,GO:0044378,1,0.987005790232945,0,2,non-sequence-specific DNA binding, bending,MF,
11576,GO:0044379,1,0.993486188892521,0,1,protein localization to actin cortical patch,BP,
11577,GO:0044380,1,0.690390213096941,0,56,protein localization to cytoskeleton,BP,
11578,GO:0044381,1,0.987108907097958,0,2,glucose import in response to insulin stimulus,BP,
11579,GO:0044387,1,0.949252846255144,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11580,GO:0044388,1,0.968518088025672,0,5,small protein activating enzyme binding,MF,
11582,GO:0044390,1,0.790041296951342,0,36,ubiquitin-like protein conjugating enzyme binding,MF,
11583,GO:0044391,1,0.321845075899204,0,177,ribosomal subunit,CC,
11584,GO:0044393,1,0.974251059861559,0,4,microspike,CC,
11586,GO:0044406,1,0.931207210720372,0,11,adhesion of symbiont to host,BP,
11587,GO:0044407,1,0.993581645191367,0,1,single-species biofilm formation in or on host organism,BP,
11589,GO:0044417,1,0.943615106072985,0,9,translocation of molecules into host,BP,
11591,GO:0044458,1,0.878652491452798,0,20,motile cilium assembly,BP,
11592,GO:0044466,1,0.987333442317422,0,2,glutaryl-CoA hydrolase activity,MF,
11593,GO:0044467,1,0.980120897114814,0,3,glial cell-derived neurotrophic factor secretion,BP,
11594,GO:0044501,1,0.986973386837848,0,2,modulation of signal transduction in other organism,BP,
11595,GO:0044508,1,0.993536831936185,0,1,glucagon-like peptide 1 receptor activity,MF,
11596,GO:0044524,1,0.993623303821261,0,1,protein sulfhydration,BP,
11597,GO:0044528,1,0.955523088640868,0,7,regulation of mitochondrial mRNA stability,BP,
11598,GO:0044530,1,0.980407837837916,0,3,supraspliceosomal complex,CC,
11599,GO:0044531,1,0.961968839971322,0,6,modulation of programmed cell death in other organism,BP,
11600,GO:0044532,1,0.961968839971322,0,6,modulation of apoptotic process in other organism,BP,
11601,GO:0044533,1,0.993652029015428,0,1,positive regulation of apoptotic process in other organism,BP,
11602,GO:0044539,1,0.900869951079809,0,16,long-chain fatty acid import into cell,BP,
11603,GO:0044540,1,0.993623303821261,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11604,GO:0044545,1,0.955580253133113,0,7,NSL complex,CC,
11605,GO:0044546,1,0.912608381729363,0,14,NLRP3 inflammasome complex assembly,BP,
11606,GO:0044547,1,0.968060906937556,0,5,DNA topoisomerase binding,MF,
11608,GO:0044549,1,0.993691873575978,0,1,GTP cyclohydrolase binding,MF,
11609,GO:0044550,1,0.87089398539037,0,21,secondary metabolite biosynthetic process,BP,
11610,GO:0044557,1,0.955500306343531,0,7,relaxation of smooth muscle,BP,
11611,GO:0044565,1,0.987227832494207,0,2,dendritic cell proliferation,BP,
11612,GO:0044571,1,0.968646150046081,0,5,[2Fe-2S] cluster assembly,BP,
11613,GO:0044594,1,0.993561702949748,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11614,GO:0044595,1,0.993655215305584,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11615,GO:0044596,1,0.993655215305584,0,1,3-demethylubiquinol-10 3-O-methyltransferase activity,MF,
11616,GO:0044597,1,0.944118307211244,0,9,daunorubicin metabolic process,BP,
11617,GO:0044598,1,0.944118307211244,0,9,doxorubicin metabolic process,BP,
11618,GO:0044599,1,0.99355705431691,0,1,AP-5 adaptor complex,CC,
11619,GO:0044601,1,0.993629701122825,0,1,protein denucleotidylation,BP,
11620,GO:0044602,1,0.993629701122825,0,1,protein deadenylylation,BP,
11621,GO:0044603,1,0.993629701122825,0,1,protein adenylylhydrolase activity,MF,
11622,GO:0044609,1,0.987194995585092,0,2,DBIRD complex,CC,
11623,GO:0044610,1,0.993588596206985,0,1,FMN transmembrane transporter activity,MF,
11624,GO:0044611,1,0.980269307951617,0,3,nuclear pore inner ring,CC,
11625,GO:0044613,1,0.949758976924871,0,8,nuclear pore central transport channel,CC,
11626,GO:0044614,1,0.980015331105625,0,3,nuclear pore cytoplasmic filaments,CC,
11627,GO:0044615,1,0.92410847286172,0,12,nuclear pore nuclear basket,CC,
11628,GO:0044620,1,0.993694965537682,0,1,ACP phosphopantetheine attachment site binding,MF,
11629,GO:0044648,1,0.961245212534382,0,6,histone H3-K4 dimethylation,BP,
11630,GO:0044650,1,0.94330295297694,0,9,adhesion of symbiont to host cell,BP,
11631,GO:0044651,1,0.99365402079382,0,1,adhesion of symbiont to host epithelial cell,BP,
11632,GO:0044657,1,0.987452081814542,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11633,GO:0044665,1,0.832588018518638,0,28,MLL1/2 complex,CC,
11634,GO:0044666,1,0.930834040683131,0,11,MLL3/4 complex,CC,
11635,GO:0044691,1,0.967391598579498,0,5,tooth eruption,BP,
11638,GO:0044715,1,0.99365906153264,0,1,8-oxo-dGDP phosphatase activity,MF,
11639,GO:0044721,1,0.993610985692955,0,1,protein import into peroxisome matrix, substrate release,BP,
11640,GO:0044722,1,0.993496585506695,0,1,renal phosphate excretion,BP,
11641,GO:0044725,1,0.992863507823101,0,1,chromatin reprogramming in the zygote,BP,
11642,GO:0044727,1,0.992863507823101,0,1,DNA demethylation of male pronucleus,BP,
11643,GO:0044728,1,0.58414725536228,0,82,DNA methylation or demethylation,BP,
11644,GO:0044729,1,0.98712169843865,0,2,hemi-methylated DNA-binding,MF,
11645,GO:0044730,1,0.993630470449032,0,1,bone sialoprotein binding,MF,
11646,GO:0044736,1,0.987155207697788,0,2,acid-sensing ion channel activity,MF,
11647,GO:0044743,1,0.808319042958352,0,33,protein transmembrane import into intracellular organelle,BP,
11648,GO:0044752,1,0.980752825491043,0,3,response to human chorionic gonadotropin,BP,
11649,GO:0044753,1,0.9866293708249,0,2,amphisome,CC,
11650,GO:0044754,1,0.943275893129976,0,9,autolysosome,CC,
11651,GO:0044764,1,0.90077306590891,0,16,multi-organism cellular process,BP,
11652,GO:0044766,1,0.670781444628742,0,61,multi-organism transport,BP,
11653,GO:0044769,1,0.88450195253151,0,19,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11655,GO:0044771,1,0.961935533382829,0,6,meiotic cell cycle phase transition,BP,
11657,GO:0044773,1,0.540830273794101,0,94,mitotic DNA damage checkpoint,BP,
11658,GO:0044774,1,0.516610893500442,0,101,mitotic DNA integrity checkpoint,BP,
11659,GO:0044778,1,0.993596434742361,0,1,meiotic DNA integrity checkpoint,BP,
11660,GO:0044779,1,0.993542175290034,0,1,meiotic spindle checkpoint,BP,
11662,GO:0044783,1,0.666660023414723,0,62,G1 DNA damage checkpoint,BP,
11663,GO:0044784,1,0.684324166756536,0,58,metaphase/anaphase transition of cell cycle,BP,
11664,GO:0044785,1,0.987196210458918,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11665,GO:0044786,1,0.663274139942998,0,63,cell cycle DNA replication,BP,
11666,GO:0044788,1,0.849788411099035,0,25,modulation by host of viral process,BP,
11667,GO:0044789,1,0.974061046870963,0,4,modulation by host of viral release from host cell,BP,
11668,GO:0044791,1,0.974061046870963,0,4,positive regulation by host of viral release from host cell,BP,
11669,GO:0044793,1,0.943036840064217,0,9,negative regulation by host of viral process,BP,
11670,GO:0044794,1,0.912300908810022,0,14,positive regulation by host of viral process,BP,
11671,GO:0044795,1,0.993662506420478,0,1,trans-Golgi network to recycling endosome transport,BP,
11672,GO:0044796,1,0.993650467966065,0,1,DNA polymerase processivity factor complex,CC,
11673,GO:0044800,1,0.955835487907172,0,7,multi-organism membrane fusion,BP,
11674,GO:0044803,1,0.937166950013738,0,10,multi-organism membrane organization,BP,
11675,GO:0044804,1,0.912026217486078,0,14,autophagy of nucleus,BP,
11676,GO:0044805,1,0.96696434376733,0,5,late nucleophagy,BP,
11677,GO:0044806,1,0.95510826114543,0,7,G-quadruplex DNA unwinding,BP,
11678,GO:0044815,1,0.888694139437448,0,18,DNA packaging complex,CC,
11679,GO:0044818,1,0.838123575032173,0,27,mitotic G2/M transition checkpoint,BP,
11680,GO:0044819,1,0.666684160364009,0,62,mitotic G1/S transition checkpoint,BP,
11681,GO:0044821,1,0.987164315777841,0,2,meiotic telomere tethering at nuclear periphery,BP,
11682,GO:0044827,1,0.906913238346443,0,15,modulation by host of viral genome replication,BP,
11683,GO:0044828,1,0.967851084592126,0,5,negative regulation by host of viral genome replication,BP,
11684,GO:0044829,1,0.95502852764378,0,7,positive regulation by host of viral genome replication,BP,
11685,GO:0044830,1,0.98075573243947,0,3,modulation by host of viral RNA genome replication,BP,
11686,GO:0044837,1,0.95539724733841,0,7,actomyosin contractile ring organization,BP,
11687,GO:0044839,1,0.187805911202101,0,255,cell cycle G2/M phase transition,BP,
11689,GO:0044848,1,0.93070203779293,0,11,biological phase,BP,
11690,GO:0044849,1,0.906991969701572,0,15,estrous cycle,BP,
11691,GO:0044851,1,0.943010815451538,0,9,hair cycle phase,BP,
11693,GO:0044854,1,0.968363903783776,0,5,plasma membrane raft assembly,BP,
11694,GO:0044855,1,0.987016850987852,0,2,plasma membrane raft distribution,BP,
11695,GO:0044856,1,0.987016850987852,0,2,plasma membrane raft localization,BP,
11696,GO:0044857,1,0.949549420518141,0,8,plasma membrane raft organization,BP,
11697,GO:0044858,1,0.993559038169924,0,1,plasma membrane raft polarization,BP,
11698,GO:0044860,1,0.974339239958663,0,4,protein localization to plasma membrane raft,BP,
11699,GO:0044861,1,0.987005277174998,0,2,protein transport into plasma membrane raft,BP,
11700,GO:0044866,1,0.993610516163832,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11701,GO:0044867,1,0.993610516163832,0,1,modulation by host of viral catalytic activity,BP,
11702,GO:0044868,1,0.98694915061708,0,2,modulation by host of viral molecular function,BP,
11703,GO:0044869,1,0.993610516163832,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11704,GO:0044870,1,0.993610516163832,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11705,GO:0044871,1,0.993610516163832,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11706,GO:0044872,1,0.921305612090924,0,12,lipoprotein localization,BP,
11707,GO:0044873,1,0.992692357954619,0,1,lipoprotein localization to membrane,BP,
11709,GO:0044878,1,0.97469675134809,0,4,mitotic cytokinesis checkpoint,BP,
11710,GO:0045002,1,0.961960911294736,0,6,double-strand break repair via single-strand annealing,BP,
11711,GO:0045003,1,0.943349198057333,0,9,double-strand break repair via synthesis-dependent strand annealing,BP,
11712,GO:0045004,1,0.986729925419074,0,2,DNA replication proofreading,BP,
11713,GO:0045005,1,0.769366990877461,0,40,DNA-dependent DNA replication maintenance of fidelity,BP,
11714,GO:0045006,1,0.920157376705825,0,13,DNA deamination,BP,
11715,GO:0045007,1,0.981015886145631,0,3,depurination,BP,
11716,GO:0045008,1,0.949954157308721,0,8,depyrimidination,BP,
11717,GO:0045009,1,0.919783820845889,0,13,chitosome,CC,
11718,GO:0045010,1,0.736253932339366,0,47,actin nucleation,BP,
11719,GO:0045016,1,0.993525294083166,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11721,GO:0045019,1,0.912622580222315,0,14,negative regulation of nitric oxide biosynthetic process,BP,
11722,GO:0045022,1,0.784594286284002,0,37,early endosome to late endosome transport,BP,
11723,GO:0045023,1,0.763943816596277,0,41,G0 to G1 transition,BP,
11724,GO:0045025,1,0.987065488437658,0,2,mitochondrial degradosome,CC,
11725,GO:0045026,1,0.932004490738534,0,11,plasma membrane fusion,BP,
11726,GO:0045027,1,0.987160652599506,0,2,DNA end binding,MF,
11727,GO:0045028,1,0.919811930784403,0,13,G protein-coupled purinergic nucleotide receptor activity,MF,
11728,GO:0045029,1,0.987231399711428,0,2,G protein-coupled UDP receptor activity,MF,
11729,GO:0045030,1,0.987293220125095,0,2,G protein-coupled UTP receptor activity,MF,
11730,GO:0045031,1,0.987187336144873,0,2,G protein-coupled ATP receptor activity,MF,
11731,GO:0045039,1,0.956387979638461,0,7,protein insertion into mitochondrial inner membrane,BP,
11732,GO:0045040,1,0.968407529319534,0,5,protein insertion into mitochondrial outer membrane,BP,
11733,GO:0045041,1,0.980937165364342,0,3,protein import into mitochondrial intermembrane space,BP,
11734,GO:0045046,1,0.96182862132981,0,6,protein import into peroxisome membrane,BP,
11735,GO:0045047,1,0.504443256041822,0,107,protein targeting to ER,BP,
11736,GO:0045048,1,0.955574820579758,0,7,protein insertion into ER membrane,BP,
11737,GO:0045053,1,0.964809953429696,0,5,protein retention in Golgi apparatus,BP,
11738,GO:0045054,1,0.955743918058085,0,7,constitutive secretory pathway,BP,
11741,GO:0045058,1,0.740516419471455,0,46,T cell selection,BP,
11742,GO:0045059,1,0.919194607936785,0,13,positive thymic T cell selection,BP,
11743,GO:0045060,1,0.930883806232541,0,11,negative thymic T cell selection,BP,
11744,GO:0045061,1,0.87222830427578,0,21,thymic T cell selection,BP,
11745,GO:0045062,1,0.993625683683103,0,1,extrathymic T cell selection,BP,
11746,GO:0045063,1,0.88365938686579,0,19,T-helper 1 cell differentiation,BP,
11747,GO:0045064,1,0.913593160227024,0,14,T-helper 2 cell differentiation,BP,
11748,GO:0045065,1,0.980814581892205,0,3,cytotoxic T cell differentiation,BP,
11749,GO:0045066,1,0.822955919497589,0,30,regulatory T cell differentiation,BP,
11750,GO:0045069,1,0.556300255728574,0,90,regulation of viral genome replication,BP,
11751,GO:0045070,1,0.795096050004492,0,35,positive regulation of viral genome replication,BP,
11752,GO:0045071,1,0.713728092716459,0,52,negative regulation of viral genome replication,BP,
11754,GO:0045088,1,0.178555768863778,0,263,regulation of innate immune response,BP,
11755,GO:0045089,1,0.306415534784738,0,181,positive regulation of innate immune response,BP,
11756,GO:0045091,1,0.895696647513221,0,17,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11757,GO:0045092,1,0.987120097185966,0,2,interleukin-18 receptor complex,CC,
11758,GO:0045095,1,0.867744928694057,0,22,keratin filament,CC,
11759,GO:0045098,1,0.980945925742951,0,3,type III intermediate filament,CC,
11762,GO:0045105,1,0.993373819886646,0,1,intermediate filament polymerization or depolymerization,BP,
11763,GO:0045106,1,0.993373819886646,0,1,intermediate filament depolymerization,BP,
11764,GO:0045108,1,0.993373819886646,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11768,GO:0045112,1,0.967793072567996,0,5,integrin biosynthetic process,BP,
11769,GO:0045113,1,0.974509474540344,0,4,regulation of integrin biosynthetic process,BP,
11770,GO:0045116,1,0.913347810094685,0,14,protein neddylation,BP,
11771,GO:0045117,1,0.931134785946396,0,11,azole transmembrane transport,BP,
11772,GO:0045120,1,0.917896874990795,0,13,pronucleus,CC,
11774,GO:0045123,1,0.667302661525866,0,62,cellular extravasation,BP,
11777,GO:0045127,1,0.993634514250758,0,1,N-acetylglucosamine kinase activity,MF,
11778,GO:0045130,1,0.993560141989477,0,1,keratan sulfotransferase activity,MF,
11779,GO:0045131,1,0.9935448456532,0,1,pre-mRNA branch point binding,MF,
11780,GO:0045132,1,0.629195712421459,0,71,meiotic chromosome segregation,BP,
11781,GO:0045134,1,0.974472876494697,0,4,uridine-diphosphatase activity,MF,
11782,GO:0045136,1,0.949082583486223,0,8,development of secondary sexual characteristics,BP,
11784,GO:0045141,1,0.955032141155432,0,7,meiotic telomere clustering,BP,
11785,GO:0045142,1,0.986982435392916,0,2,triplex DNA binding,MF,
11786,GO:0045143,1,0.74567543467929,0,45,homologous chromosome segregation,BP,
11787,GO:0045144,1,0.943607200707066,0,9,meiotic sister chromatid segregation,BP,
11788,GO:0045145,1,0.97453102554567,0,4,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11789,GO:0045153,1,0.993658862690994,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11790,GO:0045155,1,0.98707854144836,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11791,GO:0045159,1,0.91808004302701,0,13,myosin II binding,MF,
11793,GO:0045162,1,0.954321987591543,0,7,clustering of voltage-gated sodium channels,BP,
11796,GO:0045167,1,0.99362541563791,0,1,asymmetric protein localization involved in cell fate determination,BP,
11797,GO:0045168,1,0.987210629772786,0,2,cell-cell signaling involved in cell fate commitment,BP,
11798,GO:0045171,1,0.650566218643927,0,66,intercellular bridge,CC,
11799,GO:0045174,1,0.987366936148646,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11803,GO:0045179,1,0.94936838672428,0,8,apical cortex,CC,
11804,GO:0045180,1,0.966955072906562,0,5,basal cortex,CC,
11805,GO:0045182,1,0.436525590306205,0,127,translation regulator activity,MF,
11806,GO:0045183,1,0.99355705431691,0,1,translation factor activity, non-nucleic acid binding,MF,
11808,GO:0045185,1,0.545706220817288,0,92,maintenance of protein location,BP,
11809,GO:0045186,1,0.993202183935,0,1,zonula adherens assembly,BP,
11810,GO:0045187,1,0.896362931120143,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11811,GO:0045188,1,0.949756776691632,0,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11812,GO:0045190,1,0.755882572986728,0,43,isotype switching,BP,
11813,GO:0045191,1,0.827966762000338,0,29,regulation of isotype switching,BP,
11814,GO:0045196,1,0.980459446208975,0,3,establishment or maintenance of neuroblast polarity,BP,
11815,GO:0045197,1,0.75800199145273,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11816,GO:0045198,1,0.906328276352053,0,15,establishment of epithelial cell apical/basal polarity,BP,
11817,GO:0045199,1,0.930915396253754,0,11,maintenance of epithelial cell apical/basal polarity,BP,
11818,GO:0045200,1,0.980459446208975,0,3,establishment of neuroblast polarity,BP,
11820,GO:0045204,1,0.980509634202244,0,3,MAPK export from nucleus,BP,
11821,GO:0045208,1,0.993513573455483,0,1,MAPK phosphatase export from nucleus,BP,
11822,GO:0045209,1,0.993513573455483,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11823,GO:0045210,1,0.986769815073693,0,2,FasL biosynthetic process,BP,
11825,GO:0045212,1,0.993568517290874,0,1,neurotransmitter receptor biosynthetic process,BP,
11826,GO:0045213,1,0.980903986248877,0,3,neurotransmitter receptor metabolic process,BP,
11829,GO:0045217,1,0.92472614661534,0,12,cell-cell junction maintenance,BP,
11830,GO:0045218,1,0.980638792866812,0,3,zonula adherens maintenance,BP,
11831,GO:0045219,1,0.993382539006241,0,1,regulation of FasL production,BP,
11832,GO:0045221,1,0.993382539006241,0,1,negative regulation of FasL production,BP,
11833,GO:0045222,1,0.99366237398337,0,1,CD4 biosynthetic process,BP,
11834,GO:0045223,1,0.99366237398337,0,1,regulation of CD4 production,BP,
11835,GO:0045225,1,0.99366237398337,0,1,negative regulation of CD4 production,BP,
11836,GO:0045226,1,0.980814260417026,0,3,extracellular polysaccharide biosynthetic process,BP,
11837,GO:0045229,1,0.987159311583059,0,2,external encapsulating structure organization,BP,
11838,GO:0045234,1,0.993620519122829,0,1,protein palmitoleylation,BP,
11839,GO:0045236,1,0.902523002913945,0,16,CXCR chemokine receptor binding,MF,
11840,GO:0045237,1,0.993529419212751,0,1,CXCR1 chemokine receptor binding,MF,
11841,GO:0045239,1,0.913022186706319,0,14,tricarboxylic acid cycle enzyme complex,CC,
11842,GO:0045240,1,0.936754711481311,0,10,dihydrolipoyl dehydrogenase complex,CC,
11843,GO:0045244,1,0.993582677778861,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11844,GO:0045252,1,0.961849191789657,0,6,oxoglutarate dehydrogenase complex,CC,
11845,GO:0045254,1,0.955601041739229,0,7,pyruvate dehydrogenase complex,CC,
11846,GO:0045257,1,0.974693317822604,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11847,GO:0045259,1,0.993593129319401,0,1,proton-transporting ATP synthase complex,CC,
11848,GO:0045271,1,0.770374502425089,0,41,respiratory chain complex I,CC,
11849,GO:0045273,1,0.974693317822604,0,4,respiratory chain complex II,CC,
11850,GO:0045275,1,0.938027286257774,0,10,respiratory chain complex III,CC,
11851,GO:0045277,1,0.915125086638265,0,14,respiratory chain complex IV,CC,
11852,GO:0045281,1,0.974693317822604,0,4,succinate dehydrogenase complex,CC,
11853,GO:0045283,1,0.974693317822604,0,4,fumarate reductase complex,CC,
11854,GO:0045292,1,0.817781425762545,0,31,mRNA cis splicing, via spliceosome,BP,
11855,GO:0045293,1,0.961740693297603,0,6,mRNA editing complex,CC,
11856,GO:0045294,1,0.936158688407376,0,10,alpha-catenin binding,MF,
11857,GO:0045295,1,0.922142377485375,0,12,gamma-catenin binding,MF,
11858,GO:0045296,1,0.130668363769938,0,308,cadherin binding,MF,
11859,GO:0045298,1,0.986918766561989,0,2,tubulin complex,CC,
11862,GO:0045322,1,0.948990345063685,0,8,unmethylated CpG binding,MF,
11863,GO:0045324,1,0.86226362840773,0,23,late endosome to vacuole transport,BP,
11864,GO:0045329,1,0.968286977832313,0,5,carnitine biosynthetic process,BP,
11865,GO:0045332,1,0.772277768478491,0,39,phospholipid translocation,BP,
11868,GO:0045335,1,0.419638007967802,0,133,phagocytic vesicle,CC,
11869,GO:0045337,1,0.974536869720911,0,4,farnesyl diphosphate biosynthetic process,BP,
11870,GO:0045338,1,0.968297212875028,0,5,farnesyl diphosphate metabolic process,BP,
11871,GO:0045340,1,0.987340167516166,0,2,mercury ion binding,MF,
11872,GO:0045341,1,0.967749902039765,0,5,MHC class I biosynthetic process,BP,
11873,GO:0045342,1,0.913096051954149,0,14,MHC class II biosynthetic process,BP,
11874,GO:0045343,1,0.967749902039765,0,5,regulation of MHC class I biosynthetic process,BP,
11875,GO:0045344,1,0.993586962970126,0,1,negative regulation of MHC class I biosynthetic process,BP,
11876,GO:0045345,1,0.973997826810476,0,4,positive regulation of MHC class I biosynthetic process,BP,
11877,GO:0045346,1,0.919077433856155,0,13,regulation of MHC class II biosynthetic process,BP,
11878,GO:0045347,1,0.961974938103547,0,6,negative regulation of MHC class II biosynthetic process,BP,
11879,GO:0045348,1,0.949335911806497,0,8,positive regulation of MHC class II biosynthetic process,BP,
11880,GO:0045352,1,0.99362078762623,0,1,interleukin-1 type I receptor antagonist activity,MF,
11881,GO:0045353,1,0.99362078762623,0,1,interleukin-1 type II receptor antagonist activity,MF,
11882,GO:0045423,1,0.987016213064463,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11883,GO:0045425,1,0.987016213064463,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11884,GO:0045428,1,0.707683326120972,0,53,regulation of nitric oxide biosynthetic process,BP,
11885,GO:0045429,1,0.790972820788072,0,36,positive regulation of nitric oxide biosynthetic process,BP,
11889,GO:0045448,1,0.974472425169823,0,4,mitotic cell cycle, embryonic,BP,
11891,GO:0045454,1,0.701067829111765,0,55,cell redox homeostasis,BP,
11893,GO:0045472,1,0.918319712085197,0,13,response to ether,BP,
11894,GO:0045475,1,0.917046287454771,0,13,locomotor rhythm,BP,
11895,GO:0045485,1,0.993462140730111,0,1,omega-6 fatty acid desaturase activity,MF,
11896,GO:0045494,1,0.784162028388667,0,37,photoreceptor cell maintenance,BP,
11897,GO:0045495,1,0.888755193414995,0,18,pole plasm,CC,
11898,GO:0045499,1,0.831142056243139,0,28,chemorepellent activity,MF,
11899,GO:0045503,1,0.960868490760906,0,6,dynein light chain binding,MF,
11900,GO:0045504,1,0.937038701238621,0,10,dynein heavy chain binding,MF,
11901,GO:0045505,1,0.821481774772978,0,28,dynein intermediate chain binding,MF,
11902,GO:0045509,1,0.987104249922763,0,2,interleukin-27 receptor activity,MF,
11903,GO:0045513,1,0.993643783512876,0,1,interleukin-27 binding,MF,
11904,GO:0045515,1,0.993663168536915,0,1,interleukin-18 receptor binding,MF,
11905,GO:0045519,1,0.99367018013566,0,1,interleukin-23 receptor binding,MF,
11906,GO:0045523,1,0.98737391649658,0,2,interleukin-27 receptor binding,MF,
11908,GO:0045541,1,0.968361885403268,0,5,negative regulation of cholesterol biosynthetic process,BP,
11910,GO:0045545,1,0.954785719205347,0,7,syndecan binding,MF,
11911,GO:0045547,1,0.987004131214085,0,2,dehydrodolichyl diphosphate synthase activity,MF,
11912,GO:0045550,1,0.987330825123749,0,2,geranylgeranyl reductase activity,MF,
11913,GO:0045569,1,0.968298426263531,0,5,TRAIL binding,MF,
11914,GO:0045575,1,0.987053306032147,0,2,basophil activation,BP,
11915,GO:0045576,1,0.699712532757562,0,55,mast cell activation,BP,
11916,GO:0045577,1,0.833417310606761,0,28,regulation of B cell differentiation,BP,
11917,GO:0045578,1,0.96826858741824,0,5,negative regulation of B cell differentiation,BP,
11918,GO:0045579,1,0.919096210794823,0,13,positive regulation of B cell differentiation,BP,
11920,GO:0045581,1,0.781114661288838,0,38,negative regulation of T cell differentiation,BP,
11922,GO:0045583,1,0.98718074543269,0,2,regulation of cytotoxic T cell differentiation,BP,
11923,GO:0045585,1,0.98718074543269,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11924,GO:0045586,1,0.942688328902658,0,9,regulation of gamma-delta T cell differentiation,BP,
11925,GO:0045588,1,0.955049616661591,0,7,positive regulation of gamma-delta T cell differentiation,BP,
11926,GO:0045589,1,0.839137558521843,0,27,regulation of regulatory T cell differentiation,BP,
11927,GO:0045590,1,0.968334344409471,0,5,negative regulation of regulatory T cell differentiation,BP,
11928,GO:0045591,1,0.931470197306435,0,11,positive regulation of regulatory T cell differentiation,BP,
11933,GO:0045599,1,0.754643918355089,0,43,negative regulation of fat cell differentiation,BP,
11935,GO:0045601,1,0.805327174658032,0,33,regulation of endothelial cell differentiation,BP,
11936,GO:0045602,1,0.942331831955167,0,9,negative regulation of endothelial cell differentiation,BP,
11937,GO:0045603,1,0.900704099368338,0,16,positive regulation of endothelial cell differentiation,BP,
11938,GO:0045604,1,0.721387172456506,0,50,regulation of epidermal cell differentiation,BP,
11939,GO:0045605,1,0.937113039374261,0,10,negative regulation of epidermal cell differentiation,BP,
11940,GO:0045606,1,0.877088050466262,0,20,positive regulation of epidermal cell differentiation,BP,
11941,GO:0045607,1,0.955349500323375,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
11942,GO:0045608,1,0.974105477164743,0,4,negative regulation of inner ear auditory receptor cell differentiation,BP,
11943,GO:0045616,1,0.810667372532426,0,32,regulation of keratinocyte differentiation,BP,
11944,GO:0045617,1,0.974447864469287,0,4,negative regulation of keratinocyte differentiation,BP,
11945,GO:0045618,1,0.912001909726637,0,14,positive regulation of keratinocyte differentiation,BP,
11947,GO:0045620,1,0.746656166898035,0,45,negative regulation of lymphocyte differentiation,BP,
11949,GO:0045622,1,0.817538010054066,0,31,regulation of T-helper cell differentiation,BP,
11950,GO:0045623,1,0.906637843983062,0,15,negative regulation of T-helper cell differentiation,BP,
11951,GO:0045624,1,0.884529020992165,0,19,positive regulation of T-helper cell differentiation,BP,
11952,GO:0045625,1,0.937476780593982,0,10,regulation of T-helper 1 cell differentiation,BP,
11953,GO:0045626,1,0.980606280192951,0,3,negative regulation of T-helper 1 cell differentiation,BP,
11954,GO:0045627,1,0.962118512092223,0,6,positive regulation of T-helper 1 cell differentiation,BP,
11955,GO:0045628,1,0.93134436725719,0,11,regulation of T-helper 2 cell differentiation,BP,
11956,GO:0045629,1,0.974454393802312,0,4,negative regulation of T-helper 2 cell differentiation,BP,
11957,GO:0045630,1,0.955771024406487,0,7,positive regulation of T-helper 2 cell differentiation,BP,
11958,GO:0045631,1,0.955349500323375,0,7,regulation of mechanoreceptor differentiation,BP,
11959,GO:0045632,1,0.974105477164743,0,4,negative regulation of mechanoreceptor differentiation,BP,
11960,GO:0045634,1,0.960785573874867,0,6,regulation of melanocyte differentiation,BP,
11961,GO:0045636,1,0.966944127351993,0,5,positive regulation of melanocyte differentiation,BP,
11962,GO:0045637,1,0.251400018759633,0,210,regulation of myeloid cell differentiation,BP,
11963,GO:0045638,1,0.616916574721819,0,74,negative regulation of myeloid cell differentiation,BP,
11964,GO:0045639,1,0.562555208014963,0,88,positive regulation of myeloid cell differentiation,BP,
11965,GO:0045643,1,0.993510347985418,0,1,regulation of eosinophil differentiation,BP,
11966,GO:0045645,1,0.993510347985418,0,1,positive regulation of eosinophil differentiation,BP,
11967,GO:0045646,1,0.735077880205836,0,47,regulation of erythrocyte differentiation,BP,
11968,GO:0045647,1,0.936920905604435,0,10,negative regulation of erythrocyte differentiation,BP,
11969,GO:0045648,1,0.816120477666189,0,31,positive regulation of erythrocyte differentiation,BP,
11970,GO:0045649,1,0.87848744740752,0,20,regulation of macrophage differentiation,BP,
11971,GO:0045650,1,0.962121822269408,0,6,negative regulation of macrophage differentiation,BP,
11972,GO:0045651,1,0.913105061872848,0,14,positive regulation of macrophage differentiation,BP,
11973,GO:0045652,1,0.711408421593221,0,52,regulation of megakaryocyte differentiation,BP,
11974,GO:0045653,1,0.974672530086113,0,4,negative regulation of megakaryocyte differentiation,BP,
11975,GO:0045654,1,0.943691672292032,0,9,positive regulation of megakaryocyte differentiation,BP,
11976,GO:0045655,1,0.883652492174136,0,19,regulation of monocyte differentiation,BP,
11977,GO:0045656,1,0.961071003217619,0,6,negative regulation of monocyte differentiation,BP,
11978,GO:0045657,1,0.931442072453975,0,11,positive regulation of monocyte differentiation,BP,
11979,GO:0045658,1,0.980672358925128,0,3,regulation of neutrophil differentiation,BP,
11980,GO:0045659,1,0.986983266471813,0,2,negative regulation of neutrophil differentiation,BP,
11981,GO:0045660,1,0.993606696742716,0,1,positive regulation of neutrophil differentiation,BP,
11984,GO:0045663,1,0.883104124176527,0,19,positive regulation of myoblast differentiation,BP,
11990,GO:0045669,1,0.683482876327657,0,58,positive regulation of osteoblast differentiation,BP,
11991,GO:0045670,1,0.697317156810859,0,55,regulation of osteoclast differentiation,BP,
11992,GO:0045671,1,0.843114257364777,0,26,negative regulation of osteoclast differentiation,BP,
11993,GO:0045672,1,0.877347939990615,0,20,positive regulation of osteoclast differentiation,BP,
11994,GO:0045682,1,0.624946621561128,0,72,regulation of epidermis development,BP,
11995,GO:0045683,1,0.912878583404241,0,14,negative regulation of epidermis development,BP,
12000,GO:0045703,1,0.993657868319067,0,1,ketoreductase activity,MF,
12001,GO:0045713,1,0.942918488074188,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12002,GO:0045714,1,0.948980208925968,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12003,GO:0045715,1,0.986723339003217,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12004,GO:0045716,1,0.974601153687831,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12005,GO:0045717,1,0.919103763500341,0,13,negative regulation of fatty acid biosynthetic process,BP,
12006,GO:0045719,1,0.967452034471022,0,5,negative regulation of glycogen biosynthetic process,BP,
12007,GO:0045720,1,0.987201150238386,0,2,negative regulation of integrin biosynthetic process,BP,
12008,GO:0045721,1,0.918775457501993,0,13,negative regulation of gluconeogenesis,BP,
12009,GO:0045722,1,0.924071609371462,0,12,positive regulation of gluconeogenesis,BP,
12010,GO:0045723,1,0.890032921484978,0,18,positive regulation of fatty acid biosynthetic process,BP,
12011,GO:0045724,1,0.881878637018329,0,19,positive regulation of cilium assembly,BP,
12012,GO:0045725,1,0.910910741195044,0,14,positive regulation of glycogen biosynthetic process,BP,
12013,GO:0045726,1,0.986987156729784,0,2,positive regulation of integrin biosynthetic process,BP,
12014,GO:0045727,1,0.445603327096599,0,124,positive regulation of translation,BP,
12015,GO:0045728,1,0.993595573832411,0,1,respiratory burst after phagocytosis,BP,
12016,GO:0045730,1,0.839711759580465,0,27,respiratory burst,BP,
12018,GO:0045736,1,0.827631461982213,0,29,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12019,GO:0045737,1,0.827967100001785,0,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12020,GO:0045738,1,0.831800249495172,0,28,negative regulation of DNA repair,BP,
12021,GO:0045739,1,0.684042768562744,0,58,positive regulation of DNA repair,BP,
12022,GO:0045740,1,0.775350823364195,0,39,positive regulation of DNA replication,BP,
12023,GO:0045741,1,0.925178122440507,0,12,positive regulation of epidermal growth factor-activated receptor activity,BP,
12024,GO:0045742,1,0.810950093483715,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12025,GO:0045743,1,0.961539798949666,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12028,GO:0045746,1,0.786406048797033,0,37,negative regulation of Notch signaling pathway,BP,
12029,GO:0045747,1,0.723518786274194,0,49,positive regulation of Notch signaling pathway,BP,
12030,GO:0045751,1,0.9935310103659,0,1,negative regulation of Toll signaling pathway,BP,
12031,GO:0045759,1,0.949505149686669,0,8,negative regulation of action potential,BP,
12032,GO:0045760,1,0.942320005995692,0,9,positive regulation of action potential,BP,
12034,GO:0045762,1,0.947241678593425,0,8,positive regulation of adenylate cyclase activity,BP,
12035,GO:0045763,1,0.98653867197531,0,2,negative regulation of cellular amino acid metabolic process,BP,
12036,GO:0045764,1,0.980982406679374,0,3,positive regulation of cellular amino acid metabolic process,BP,
12039,GO:0045769,1,0.992871127726004,0,1,negative regulation of asymmetric cell division,BP,
12040,GO:0045773,1,0.760664309910252,0,41,positive regulation of axon extension,BP,
12041,GO:0045776,1,0.770993724830863,0,40,negative regulation of blood pressure,BP,
12042,GO:0045777,1,0.818378991002838,0,31,positive regulation of blood pressure,BP,
12043,GO:0045778,1,0.580058343424801,0,83,positive regulation of ossification,BP,
12044,GO:0045779,1,0.925263145166576,0,12,negative regulation of bone resorption,BP,
12047,GO:0045786,1,0.023956775239411,0,563,negative regulation of cell cycle,BP,
12048,GO:0045787,1,0.0978695690794798,0,352,positive regulation of cell cycle,BP,
12049,GO:0045792,1,0.936551440395627,0,10,negative regulation of cell size,BP,
12050,GO:0045793,1,0.942793623838889,0,9,positive regulation of cell size,BP,
12051,GO:0045794,1,0.967433532865754,0,5,negative regulation of cell volume,BP,
12052,GO:0045795,1,0.993258493616895,0,1,positive regulation of cell volume,BP,
12053,GO:0045796,1,0.993562850607424,0,1,negative regulation of intestinal cholesterol absorption,BP,
12054,GO:0045797,1,0.993586050681278,0,1,positive regulation of intestinal cholesterol absorption,BP,
12055,GO:0045798,1,0.973542685132645,0,4,negative regulation of chromatin assembly or disassembly,BP,
12056,GO:0045799,1,0.923992928506009,0,12,positive regulation of chromatin assembly or disassembly,BP,
12059,GO:0045813,1,0.993619377814711,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12060,GO:0045814,1,0.70642375891081,0,53,negative regulation of gene expression, epigenetic,BP,
12062,GO:0045819,1,0.993493229223831,0,1,positive regulation of glycogen catabolic process,BP,
12063,GO:0045820,1,0.917885945132638,0,13,negative regulation of glycolytic process,BP,
12064,GO:0045821,1,0.876314039184595,0,20,positive regulation of glycolytic process,BP,
12065,GO:0045822,1,0.871769848050932,0,21,negative regulation of heart contraction,BP,
12067,GO:0045824,1,0.708684881412749,0,53,negative regulation of innate immune response,BP,
12068,GO:0045827,1,0.987244792457811,0,2,negative regulation of isoprenoid metabolic process,BP,
12069,GO:0045828,1,0.993515602722042,0,1,positive regulation of isoprenoid metabolic process,BP,
12070,GO:0045829,1,0.968199200331329,0,5,negative regulation of isotype switching,BP,
12071,GO:0045830,1,0.877836368878556,0,20,positive regulation of isotype switching,BP,
12072,GO:0045833,1,0.609395206449893,0,76,negative regulation of lipid metabolic process,BP,
12074,GO:0045835,1,0.943419084348075,0,9,negative regulation of meiotic nuclear division,BP,
12075,GO:0045836,1,0.918971870902312,0,13,positive regulation of meiotic nuclear division,BP,
12076,GO:0045837,1,0.919750913289623,0,13,negative regulation of membrane potential,BP,
12077,GO:0045838,1,0.918786418912981,0,13,positive regulation of membrane potential,BP,
12078,GO:0045839,1,0.721119470617396,0,50,negative regulation of mitotic nuclear division,BP,
12079,GO:0045840,1,0.71593647506193,0,51,positive regulation of mitotic nuclear division,BP,
12080,GO:0045841,1,0.790325890611194,0,36,negative regulation of mitotic metaphase/anaphase transition,BP,
12081,GO:0045842,1,0.918795610259732,0,13,positive regulation of mitotic metaphase/anaphase transition,BP,
12084,GO:0045848,1,0.993596235981754,0,1,positive regulation of nitrogen utilization,BP,
12085,GO:0045851,1,0.695738291940765,0,56,pH reduction,BP,
12086,GO:0045852,1,0.967836902691834,0,5,pH elevation,BP,
12091,GO:0045869,1,0.913577092224348,0,14,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12092,GO:0045870,1,0.986804373287233,0,2,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12093,GO:0045872,1,0.987242203486632,0,2,positive regulation of rhodopsin gene expression,BP,
12094,GO:0045875,1,0.97307972888823,0,4,negative regulation of sister chromatid cohesion,BP,
12095,GO:0045876,1,0.954954638525974,0,7,positive regulation of sister chromatid cohesion,BP,
12097,GO:0045880,1,0.794966684328676,0,35,positive regulation of smoothened signaling pathway,BP,
12098,GO:0045887,1,0.993216227320241,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12101,GO:0045898,1,0.918723327605327,0,13,regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12102,GO:0045899,1,0.936845413471043,0,10,positive regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12103,GO:0045900,1,0.974230193087544,0,4,negative regulation of translational elongation,BP,
12104,GO:0045901,1,0.96818569948837,0,5,positive regulation of translational elongation,BP,
12105,GO:0045903,1,0.980936359749208,0,3,positive regulation of translational fidelity,BP,
12106,GO:0045905,1,0.974343956493899,0,4,positive regulation of translational termination,BP,
12108,GO:0045907,1,0.839503825937293,0,27,positive regulation of vasoconstriction,BP,
12109,GO:0045910,1,0.832450851461208,0,28,negative regulation of DNA recombination,BP,
12110,GO:0045911,1,0.790309673646949,0,36,positive regulation of DNA recombination,BP,
12111,GO:0045912,1,0.759221624570545,0,42,negative regulation of carbohydrate metabolic process,BP,
12113,GO:0045914,1,0.980696632616608,0,3,negative regulation of catecholamine metabolic process,BP,
12115,GO:0045916,1,0.948814964232789,0,8,negative regulation of complement activation,BP,
12116,GO:0045917,1,0.974421617594211,0,4,positive regulation of complement activation,BP,
12117,GO:0045918,1,0.993592799671384,0,1,negative regulation of cytolysis,BP,
12118,GO:0045919,1,0.993617363303949,0,1,positive regulation of cytolysis,BP,
12121,GO:0045922,1,0.855065266447899,0,24,negative regulation of fatty acid metabolic process,BP,
12122,GO:0045923,1,0.816779468161692,0,31,positive regulation of fatty acid metabolic process,BP,
12123,GO:0045924,1,0.961360679080555,0,6,regulation of female receptivity,BP,
12124,GO:0045925,1,0.986877487962718,0,2,positive regulation of female receptivity,BP,
12127,GO:0045930,1,0.141655051782349,0,298,negative regulation of mitotic cell cycle,BP,
12128,GO:0045931,1,0.378422069791963,0,148,positive regulation of mitotic cell cycle,BP,
12130,GO:0045933,1,0.771511002795841,0,40,positive regulation of muscle contraction,BP,
12135,GO:0045938,1,0.962356582787652,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12136,GO:0045939,1,0.867601082058155,0,22,negative regulation of steroid metabolic process,BP,
12138,GO:0045943,1,0.877408050754707,0,20,positive regulation of transcription by RNA polymerase I,BP,
12140,GO:0045945,1,0.930222920318823,0,11,positive regulation of transcription by RNA polymerase III,BP,
12141,GO:0045947,1,0.883155368132765,0,19,negative regulation of translational initiation,BP,
12142,GO:0045948,1,0.832896974639495,0,28,positive regulation of translational initiation,BP,
12143,GO:0045950,1,0.980837378616915,0,3,negative regulation of mitotic recombination,BP,
12144,GO:0045951,1,0.99359530914198,0,1,positive regulation of mitotic recombination,BP,
12145,GO:0045953,1,0.908169432936528,0,15,negative regulation of natural killer cell mediated cytotoxicity,BP,
12146,GO:0045954,1,0.878564457337649,0,20,positive regulation of natural killer cell mediated cytotoxicity,BP,
12147,GO:0045955,1,0.948900587681873,0,8,negative regulation of calcium ion-dependent exocytosis,BP,
12148,GO:0045956,1,0.888819599280729,0,18,positive regulation of calcium ion-dependent exocytosis,BP,
12149,GO:0045957,1,0.980385303226424,0,3,negative regulation of complement activation, alternative pathway,BP,
12150,GO:0045959,1,0.980350554551774,0,3,negative regulation of complement activation, classical pathway,BP,
12151,GO:0045963,1,0.980696632616608,0,3,negative regulation of dopamine metabolic process,BP,
12153,GO:0045967,1,0.985894693300788,0,2,negative regulation of growth rate,BP,
12154,GO:0045974,1,0.910825242060597,0,14,regulation of translation, ncRNA-mediated,BP,
12155,GO:0045976,1,0.987057301742758,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12156,GO:0045977,1,0.993642851218205,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12157,GO:0045980,1,0.877319579282241,0,20,negative regulation of nucleotide metabolic process,BP,
12158,GO:0045981,1,0.784751060255565,0,37,positive regulation of nucleotide metabolic process,BP,
12160,GO:0045987,1,0.839121257823256,0,27,positive regulation of smooth muscle contraction,BP,
12161,GO:0045988,1,0.955199232214169,0,7,negative regulation of striated muscle contraction,BP,
12162,GO:0045989,1,0.919540246794191,0,13,positive regulation of striated muscle contraction,BP,
12163,GO:0045990,1,0.967970921293134,0,5,carbon catabolite regulation of transcription,BP,
12164,GO:0045991,1,0.967970921293134,0,5,carbon catabolite activation of transcription,BP,
12165,GO:0045992,1,0.849261131258172,0,25,negative regulation of embryonic development,BP,
12166,GO:0045993,1,0.993458626443647,0,1,negative regulation of translational initiation by iron,BP,
12167,GO:0045994,1,0.98704652256081,0,2,positive regulation of translational initiation by iron,BP,
12169,GO:0046005,1,0.993709026865349,0,1,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12171,GO:0046007,1,0.918729056549654,0,13,negative regulation of activated T cell proliferation,BP,
12172,GO:0046010,1,0.974720530077392,0,4,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12173,GO:0046013,1,0.987227456877859,0,2,regulation of T cell homeostatic proliferation,BP,
12174,GO:0046015,1,0.968333492880022,0,5,regulation of transcription by glucose,BP,
12175,GO:0046016,1,0.974544861991886,0,4,positive regulation of transcription by glucose,BP,
12176,GO:0046030,1,0.955358004208571,0,7,inositol trisphosphate phosphatase activity,MF,
12178,GO:0046032,1,0.993637351480717,0,1,ADP catabolic process,BP,
12179,GO:0046033,1,0.925559212020917,0,12,AMP metabolic process,BP,
12181,GO:0046036,1,0.920208699473888,0,13,CTP metabolic process,BP,
12182,GO:0046037,1,0.912538580449024,0,14,GMP metabolic process,BP,
12183,GO:0046038,1,0.993645181428393,0,1,GMP catabolic process,BP,
12184,GO:0046039,1,0.861637611852141,0,23,GTP metabolic process,BP,
12185,GO:0046040,1,0.937025753251471,0,10,IMP metabolic process,BP,
12186,GO:0046041,1,0.987271209174294,0,2,ITP metabolic process,BP,
12187,GO:0046048,1,0.987140875228273,0,2,UDP metabolic process,BP,
12188,GO:0046049,1,0.937409120148856,0,10,UMP metabolic process,BP,
12189,GO:0046051,1,0.937814730342403,0,10,UTP metabolic process,BP,
12190,GO:0046053,1,0.987279341978086,0,2,dAMP metabolic process,BP,
12191,GO:0046054,1,0.993673483372605,0,1,dGMP metabolic process,BP,
12193,GO:0046058,1,0.869622012072773,0,21,cAMP metabolic process,BP,
12194,GO:0046060,1,0.968537444977742,0,5,dATP metabolic process,BP,
12195,GO:0046061,1,0.98098256161175,0,3,dATP catabolic process,BP,
12196,GO:0046065,1,0.993665154203989,0,1,dCTP metabolic process,BP,
12197,GO:0046066,1,0.987270894013581,0,2,dGDP metabolic process,BP,
12198,GO:0046068,1,0.918312306930379,0,13,cGMP metabolic process,BP,
12199,GO:0046069,1,0.967506885448121,0,5,cGMP catabolic process,BP,
12200,GO:0046070,1,0.9747421228846,0,4,dGTP metabolic process,BP,
12201,GO:0046072,1,0.987248884937554,0,2,dTDP metabolic process,BP,
12202,GO:0046073,1,0.980935404510993,0,3,dTMP metabolic process,BP,
12203,GO:0046075,1,0.974734589195674,0,4,dTTP metabolic process,BP,
12204,GO:0046077,1,0.987248884937554,0,2,dUDP metabolic process,BP,
12205,GO:0046078,1,0.974727358715502,0,4,dUMP metabolic process,BP,
12206,GO:0046079,1,0.993633913063494,0,1,dUMP catabolic process,BP,
12207,GO:0046080,1,0.993614677194696,0,1,dUTP metabolic process,BP,
12208,GO:0046081,1,0.993614677194696,0,1,dUTP catabolic process,BP,
12209,GO:0046083,1,0.980976012671089,0,3,adenine metabolic process,BP,
12210,GO:0046084,1,0.980976012671089,0,3,adenine biosynthetic process,BP,
12211,GO:0046085,1,0.955710351872108,0,7,adenosine metabolic process,BP,
12212,GO:0046086,1,0.993485761385536,0,1,adenosine biosynthetic process,BP,
12213,GO:0046087,1,0.937907515958905,0,10,cytidine metabolic process,BP,
12214,GO:0046090,1,0.993637117932028,0,1,deoxyadenosine metabolic process,BP,
12215,GO:0046092,1,0.993415033013829,0,1,deoxycytidine metabolic process,BP,
12217,GO:0046099,1,0.993645181428393,0,1,guanine biosynthetic process,BP,
12218,GO:0046100,1,0.980998425865451,0,3,hypoxanthine metabolic process,BP,
12219,GO:0046101,1,0.980998425865451,0,3,hypoxanthine biosynthetic process,BP,
12220,GO:0046102,1,0.98090676208619,0,3,inosine metabolic process,BP,
12221,GO:0046103,1,0.987246736676818,0,2,inosine biosynthetic process,BP,
12222,GO:0046104,1,0.97449416656946,0,4,thymidine metabolic process,BP,
12223,GO:0046105,1,0.993663764343901,0,1,thymidine biosynthetic process,BP,
12224,GO:0046108,1,0.98723844987102,0,2,uridine metabolic process,BP,
12225,GO:0046110,1,0.980543082286748,0,3,xanthine metabolic process,BP,
12226,GO:0046111,1,0.993637117932028,0,1,xanthine biosynthetic process,BP,
12227,GO:0046112,1,0.889456905208292,0,18,nucleobase biosynthetic process,BP,
12229,GO:0046120,1,0.993663764343901,0,1,deoxyribonucleoside biosynthetic process,BP,
12230,GO:0046121,1,0.980920061078358,0,3,deoxyribonucleoside catabolic process,BP,
12231,GO:0046122,1,0.987349077793377,0,2,purine deoxyribonucleoside metabolic process,BP,
12232,GO:0046124,1,0.993637117932028,0,1,purine deoxyribonucleoside catabolic process,BP,
12233,GO:0046125,1,0.97449416656946,0,4,pyrimidine deoxyribonucleoside metabolic process,BP,
12234,GO:0046126,1,0.993663764343901,0,1,pyrimidine deoxyribonucleoside biosynthetic process,BP,
12235,GO:0046127,1,0.993537047150672,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12236,GO:0046128,1,0.708875167231989,0,53,purine ribonucleoside metabolic process,BP,
12237,GO:0046129,1,0.87402120492575,0,21,purine ribonucleoside biosynthetic process,BP,
12238,GO:0046130,1,0.962068522657836,0,6,purine ribonucleoside catabolic process,BP,
12239,GO:0046131,1,0.92593073501611,0,12,pyrimidine ribonucleoside metabolic process,BP,
12240,GO:0046133,1,0.92593073501611,0,12,pyrimidine ribonucleoside catabolic process,BP,
12241,GO:0046134,1,0.913679218722167,0,14,pyrimidine nucleoside biosynthetic process,BP,
12242,GO:0046135,1,0.873876514713427,0,21,pyrimidine nucleoside catabolic process,BP,
12243,GO:0046136,1,0.974386367247814,0,4,positive regulation of vitamin metabolic process,BP,
12244,GO:0046137,1,0.962109209550741,0,6,negative regulation of vitamin metabolic process,BP,
12245,GO:0046144,1,0.993632910799513,0,1,D-alanine family amino acid metabolic process,BP,
12246,GO:0046146,1,0.956145414137528,0,7,tetrahydrobiopterin metabolic process,BP,
12247,GO:0046148,1,0.703111050841041,0,54,pigment biosynthetic process,BP,
12248,GO:0046149,1,0.97484806961936,0,4,pigment catabolic process,BP,
12249,GO:0046160,1,0.986828524013289,0,2,heme a metabolic process,BP,
12252,GO:0046166,1,0.987281434371451,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12253,GO:0046167,1,0.986478689313179,0,2,glycerol-3-phosphate biosynthetic process,BP,
12254,GO:0046168,1,0.987086786813789,0,2,glycerol-3-phosphate catabolic process,BP,
12257,GO:0046176,1,0.987207728795018,0,2,aldonic acid catabolic process,BP,
12258,GO:0046177,1,0.987207728795018,0,2,D-gluconate catabolic process,BP,
12259,GO:0046184,1,0.91852149812146,0,13,aldehyde biosynthetic process,BP,
12260,GO:0046185,1,0.931864241071473,0,11,aldehyde catabolic process,BP,
12262,GO:0046203,1,0.993626487655239,0,1,spermidine catabolic process,BP,
12263,GO:0046204,1,0.993675200071609,0,1,nor-spermidine metabolic process,BP,
12264,GO:0046208,1,0.987268117750204,0,2,spermine catabolic process,BP,
12265,GO:0046209,1,0.641097088174374,0,68,nitric oxide metabolic process,BP,
12266,GO:0046210,1,0.993572918047278,0,1,nitric oxide catabolic process,BP,
12267,GO:0046218,1,0.949965851152255,0,8,indolalkylamine catabolic process,BP,
12268,GO:0046219,1,0.974688195537251,0,4,indolalkylamine biosynthetic process,BP,
12269,GO:0046222,1,0.987256023000812,0,2,aflatoxin metabolic process,BP,
12270,GO:0046223,1,0.987256023000812,0,2,aflatoxin catabolic process,BP,
12271,GO:0046226,1,0.987321885514288,0,2,coumarin catabolic process,BP,
12272,GO:0046247,1,0.987150068329575,0,2,terpene catabolic process,BP,
12273,GO:0046271,1,0.987321885514288,0,2,phenylpropanoid catabolic process,BP,
12274,GO:0046272,1,0.99359233845386,0,1,stilbene catabolic process,BP,
12275,GO:0046292,1,0.974513050068726,0,4,formaldehyde metabolic process,BP,
12276,GO:0046293,1,0.99343648529655,0,1,formaldehyde biosynthetic process,BP,
12277,GO:0046294,1,0.98095278236682,0,3,formaldehyde catabolic process,BP,
12278,GO:0046295,1,0.993677246056371,0,1,glycolate biosynthetic process,BP,
12279,GO:0046296,1,0.993623001992913,0,1,glycolate catabolic process,BP,
12280,GO:0046305,1,0.987233572830557,0,2,alkanesulfonate biosynthetic process,BP,
12281,GO:0046314,1,0.968560734015304,0,5,phosphocreatine biosynthetic process,BP,
12282,GO:0046316,1,0.99355705431691,0,1,gluconokinase activity,MF,
12283,GO:0046317,1,0.9934103706996,0,1,regulation of glucosylceramide biosynthetic process,BP,
12284,GO:0046318,1,0.9934103706996,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12285,GO:0046320,1,0.815625104484167,0,31,regulation of fatty acid oxidation,BP,
12286,GO:0046321,1,0.911709439797417,0,14,positive regulation of fatty acid oxidation,BP,
12287,GO:0046322,1,0.930786904035309,0,11,negative regulation of fatty acid oxidation,BP,
12288,GO:0046323,1,0.669554528004394,0,61,glucose import,BP,
12289,GO:0046324,1,0.729281908311433,0,48,regulation of glucose import,BP,
12290,GO:0046325,1,0.931198046491031,0,11,negative regulation of glucose import,BP,
12291,GO:0046326,1,0.809291028710498,0,32,positive regulation of glucose import,BP,
12292,GO:0046327,1,0.987211202392378,0,2,glycerol biosynthetic process from pyruvate,BP,
12294,GO:0046329,1,0.800642416915822,0,34,negative regulation of JNK cascade,BP,
12296,GO:0046331,1,0.987210629772786,0,2,lateral inhibition,BP,
12297,GO:0046332,1,0.592517028513401,0,79,SMAD binding,MF,
12299,GO:0046337,1,0.866976197915255,0,22,phosphatidylethanolamine metabolic process,BP,
12300,GO:0046338,1,0.980734450887719,0,3,phosphatidylethanolamine catabolic process,BP,
12301,GO:0046339,1,0.876893033459101,0,20,diacylglycerol metabolic process,BP,
12302,GO:0046340,1,0.986899005076561,0,2,diacylglycerol catabolic process,BP,
12303,GO:0046341,1,0.924272525222168,0,12,CDP-diacylglycerol metabolic process,BP,
12305,GO:0046349,1,0.918995629862157,0,13,amino sugar biosynthetic process,BP,
12306,GO:0046351,1,0.974556515750263,0,4,disaccharide biosynthetic process,BP,
12307,GO:0046356,1,0.98730911057212,0,2,acetyl-CoA catabolic process,BP,
12308,GO:0046359,1,0.993611455304405,0,1,butyrate catabolic process,BP,
12309,GO:0046360,1,0.993598491583926,0,1,2-oxobutyrate biosynthetic process,BP,
12310,GO:0046361,1,0.987267503028215,0,2,2-oxobutyrate metabolic process,BP,
12311,GO:0046364,1,0.575276720832784,0,85,monosaccharide biosynthetic process,BP,
12312,GO:0046365,1,0.681438155478998,0,59,monosaccharide catabolic process,BP,
12313,GO:0046368,1,0.987196963289183,0,2,GDP-L-fucose metabolic process,BP,
12314,GO:0046370,1,0.987258214922006,0,2,fructose biosynthetic process,BP,
12315,GO:0046373,1,0.987155207697788,0,2,L-arabinose metabolic process,BP,
12316,GO:0046379,1,0.980814260417026,0,3,extracellular polysaccharide metabolic process,BP,
12317,GO:0046380,1,0.99350123053554,0,1,N-acetylneuraminate biosynthetic process,BP,
12318,GO:0046381,1,0.993656939990299,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12320,GO:0046386,1,0.885076298383607,0,19,deoxyribose phosphate catabolic process,BP,
12322,GO:0046391,1,0.968321889467719,0,5,5-phosphoribose 1-diphosphate metabolic process,BP,
12325,GO:0046398,1,0.974168521972203,0,4,UDP-glucuronate metabolic process,BP,
12326,GO:0046403,1,0.993624477263957,0,1,polynucleotide 3'-phosphatase activity,MF,
12327,GO:0046404,1,0.980636230239808,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12328,GO:0046415,1,0.949633015953925,0,8,urate metabolic process,BP,
12329,GO:0046416,1,0.980960272064183,0,3,D-amino acid metabolic process,BP,
12330,GO:0046425,1,0.552638191218957,0,91,regulation of receptor signaling pathway via JAK-STAT,BP,
12331,GO:0046426,1,0.883861828531739,0,19,negative regulation of receptor signaling pathway via JAK-STAT,BP,
12332,GO:0046427,1,0.659245991305113,0,64,positive regulation of receptor signaling pathway via JAK-STAT,BP,
12334,GO:0046436,1,0.993632910799513,0,1,D-alanine metabolic process,BP,
12335,GO:0046437,1,0.993574747073295,0,1,D-amino acid biosynthetic process,BP,
12336,GO:0046439,1,0.974635315001332,0,4,L-cysteine metabolic process,BP,
12337,GO:0046440,1,0.974316429176893,0,4,L-lysine metabolic process,BP,
12338,GO:0046443,1,0.99360800250412,0,1,FAD metabolic process,BP,
12339,GO:0046444,1,0.993560801035551,0,1,FMN metabolic process,BP,
12340,GO:0046448,1,0.993577031815251,0,1,tropane alkaloid metabolic process,BP,
12341,GO:0046449,1,0.993363923351374,0,1,creatinine metabolic process,BP,
12342,GO:0046452,1,0.98713500921672,0,2,dihydrofolate metabolic process,BP,
12345,GO:0046458,1,0.99350270938318,0,1,hexadecanal metabolic process,BP,
12346,GO:0046459,1,0.901980752220513,0,16,short-chain fatty acid metabolic process,BP,
12347,GO:0046460,1,0.785884112249453,0,37,neutral lipid biosynthetic process,BP,
12348,GO:0046461,1,0.785746346679657,0,37,neutral lipid catabolic process,BP,
12349,GO:0046462,1,0.943541696623053,0,9,monoacylglycerol metabolic process,BP,
12350,GO:0046463,1,0.785884112249453,0,37,acylglycerol biosynthetic process,BP,
12351,GO:0046464,1,0.785746346679657,0,37,acylglycerol catabolic process,BP,
12352,GO:0046465,1,0.955786038226416,0,7,dolichyl diphosphate metabolic process,BP,
12354,GO:0046467,1,0.423152127641385,0,132,membrane lipid biosynthetic process,BP,
12355,GO:0046469,1,0.949422101976779,0,8,platelet activating factor metabolic process,BP,
12357,GO:0046471,1,0.828318338519534,0,29,phosphatidylglycerol metabolic process,BP,
12358,GO:0046473,1,0.754260982583411,0,43,phosphatidic acid metabolic process,BP,
12361,GO:0046476,1,0.949642331898383,0,8,glycosylceramide biosynthetic process,BP,
12362,GO:0046477,1,0.949658600855199,0,8,glycosylceramide catabolic process,BP,
12363,GO:0046478,1,0.993433342447335,0,1,lactosylceramide metabolic process,BP,
12364,GO:0046479,1,0.913604007637185,0,14,glycosphingolipid catabolic process,BP,
12366,GO:0046485,1,0.894853382155435,0,17,ether lipid metabolic process,BP,
12368,GO:0046487,1,0.949947603505569,0,8,glyoxylate metabolic process,BP,
12370,GO:0046490,1,0.974712112402508,0,4,isopentenyl diphosphate metabolic process,BP,
12371,GO:0046491,1,0.99368153315395,0,1,L-methylmalonyl-CoA metabolic process,BP,
12372,GO:0046495,1,0.993578947207367,0,1,nicotinamide riboside metabolic process,BP,
12373,GO:0046496,1,0.818131848832238,0,31,nicotinamide nucleotide metabolic process,BP,
12374,GO:0046498,1,0.981048231796624,0,3,S-adenosylhomocysteine metabolic process,BP,
12375,GO:0046499,1,0.993529657669243,0,1,S-adenosylmethioninamine metabolic process,BP,
12376,GO:0046500,1,0.901564016644511,0,16,S-adenosylmethionine metabolic process,BP,
12377,GO:0046501,1,0.931064430036899,0,11,protoporphyrinogen IX metabolic process,BP,
12378,GO:0046502,1,0.987284291669493,0,2,uroporphyrinogen III metabolic process,BP,
12380,GO:0046504,1,0.936519728128069,0,10,glycerol ether biosynthetic process,BP,
12381,GO:0046511,1,0.986883365317259,0,2,sphinganine biosynthetic process,BP,
12382,GO:0046512,1,0.918806897137363,0,13,sphingosine biosynthetic process,BP,
12383,GO:0046513,1,0.668439488206544,0,62,ceramide biosynthetic process,BP,
12384,GO:0046514,1,0.884590249122371,0,19,ceramide catabolic process,BP,
12385,GO:0046519,1,0.895340949997391,0,17,sphingoid metabolic process,BP,
12386,GO:0046520,1,0.918806897137363,0,13,sphingoid biosynthetic process,BP,
12387,GO:0046521,1,0.993615214374777,0,1,sphingoid catabolic process,BP,
12388,GO:0046523,1,0.993538098273556,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12389,GO:0046525,1,0.993624544301834,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12390,GO:0046526,1,0.99357166287299,0,1,D-xylulose reductase activity,MF,
12391,GO:0046527,1,0.900530270161907,0,16,glucosyltransferase activity,MF,
12393,GO:0046532,1,0.94882954355821,0,8,regulation of photoreceptor cell differentiation,BP,
12394,GO:0046533,1,0.94882954355821,0,8,negative regulation of photoreceptor cell differentiation,BP,
12395,GO:0046538,1,0.993682456040252,0,1,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12396,GO:0046539,1,0.99367915923129,0,1,histamine N-methyltransferase activity,MF,
12397,GO:0046540,1,0.82452720113608,0,30,U4/U6 x U5 tri-snRNP complex,CC,
12398,GO:0046541,1,0.937676556722166,0,10,saliva secretion,BP,
12399,GO:0046543,1,0.961390268534638,0,6,development of secondary female sexual characteristics,BP,
12400,GO:0046544,1,0.993410690815657,0,1,development of secondary male sexual characteristics,BP,
12403,GO:0046548,1,0.94267166689594,0,9,retinal rod cell development,BP,
12404,GO:0046549,1,0.942946195851125,0,9,retinal cone cell development,BP,
12405,GO:0046552,1,0.993601552792331,0,1,photoreceptor cell fate commitment,BP,
12406,GO:0046554,1,0.993652493868292,0,1,malate dehydrogenase (NADP+) activity,MF,
12407,GO:0046556,1,0.987155207697788,0,2,alpha-L-arabinofuranosidase activity,MF,
12408,GO:0046570,1,0.993655613384918,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12409,GO:0046573,1,0.981033071799383,0,3,lactonohydrolase activity,MF,
12410,GO:0046577,1,0.99350270938318,0,1,long-chain-alcohol oxidase activity,MF,
12413,GO:0046580,1,0.719071707441505,0,50,negative regulation of Ras protein signal transduction,BP,
12414,GO:0046581,1,0.961259455953792,0,6,intercellular canaliculus,CC,
12415,GO:0046586,1,0.98726278945571,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12416,GO:0046587,1,0.993543355450236,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12417,GO:0046588,1,0.993679027312827,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12418,GO:0046592,1,0.980951216709984,0,3,polyamine oxidase activity,MF,
12419,GO:0046596,1,0.81333588122347,0,32,regulation of viral entry into host cell,BP,
12420,GO:0046597,1,0.907674027883114,0,15,negative regulation of viral entry into host cell,BP,
12421,GO:0046598,1,0.937781045580802,0,10,positive regulation of viral entry into host cell,BP,
12422,GO:0046599,1,0.865461424286585,0,22,regulation of centriole replication,BP,
12423,GO:0046600,1,0.942700173427383,0,9,negative regulation of centriole replication,BP,
12424,GO:0046601,1,0.961578300357467,0,6,positive regulation of centriole replication,BP,
12425,GO:0046602,1,0.943076683575426,0,9,regulation of mitotic centrosome separation,BP,
12426,GO:0046603,1,0.993643949964391,0,1,negative regulation of mitotic centrosome separation,BP,
12427,GO:0046604,1,0.980732302270899,0,3,positive regulation of mitotic centrosome separation,BP,
12428,GO:0046605,1,0.683519219333717,0,58,regulation of centrosome cycle,BP,
12429,GO:0046606,1,0.906921430500975,0,15,negative regulation of centrosome cycle,BP,
12430,GO:0046607,1,0.930714549824859,0,11,positive regulation of centrosome cycle,BP,
12431,GO:0046618,1,0.986890605985369,0,2,drug export,BP,
12432,GO:0046619,1,0.986843203550475,0,2,optic placode formation involved in camera-type eye formation,BP,
12435,GO:0046622,1,0.739110913533003,0,46,positive regulation of organ growth,BP,
12436,GO:0046623,1,0.979621316672031,0,3,sphingolipid floppase activity,MF,
12437,GO:0046624,1,0.930308420123321,0,11,sphingolipid transporter activity,MF,
12439,GO:0046626,1,0.679446921427443,0,59,regulation of insulin receptor signaling pathway,BP,
12440,GO:0046627,1,0.822063426893374,0,30,negative regulation of insulin receptor signaling pathway,BP,
12441,GO:0046628,1,0.8763634706236,0,20,positive regulation of insulin receptor signaling pathway,BP,
12442,GO:0046629,1,0.895023004344434,0,17,gamma-delta T cell activation,BP,
12443,GO:0046631,1,0.417498809578323,0,134,alpha-beta T cell activation,BP,
12444,GO:0046632,1,0.530680419752408,0,97,alpha-beta T cell differentiation,BP,
12445,GO:0046633,1,0.802767105544901,0,34,alpha-beta T cell proliferation,BP,
12446,GO:0046634,1,0.561060429475419,0,89,regulation of alpha-beta T cell activation,BP,
12447,GO:0046635,1,0.682223239746059,0,59,positive regulation of alpha-beta T cell activation,BP,
12448,GO:0046636,1,0.791536329594642,0,36,negative regulation of alpha-beta T cell activation,BP,
12449,GO:0046637,1,0.685489872236738,0,58,regulation of alpha-beta T cell differentiation,BP,
12450,GO:0046638,1,0.756522441552816,0,43,positive regulation of alpha-beta T cell differentiation,BP,
12451,GO:0046639,1,0.860408450536731,0,23,negative regulation of alpha-beta T cell differentiation,BP,
12452,GO:0046640,1,0.81871776489323,0,31,regulation of alpha-beta T cell proliferation,BP,
12453,GO:0046641,1,0.878975780429724,0,20,positive regulation of alpha-beta T cell proliferation,BP,
12454,GO:0046642,1,0.93794463749311,0,10,negative regulation of alpha-beta T cell proliferation,BP,
12455,GO:0046643,1,0.930473822463768,0,11,regulation of gamma-delta T cell activation,BP,
12456,GO:0046645,1,0.942676545413917,0,9,positive regulation of gamma-delta T cell activation,BP,
12459,GO:0046653,1,0.895523551287544,0,17,tetrahydrofolate metabolic process,BP,
12460,GO:0046654,1,0.961866756349387,0,6,tetrahydrofolate biosynthetic process,BP,
12461,GO:0046655,1,0.889490864287862,0,18,folic acid metabolic process,BP,
12462,GO:0046657,1,0.993680610097799,0,1,folic acid catabolic process,BP,
12466,GO:0046666,1,0.968306881576006,0,5,retinal cell programmed cell death,BP,
12467,GO:0046668,1,0.980724184998926,0,3,regulation of retinal cell programmed cell death,BP,
12468,GO:0046671,1,0.993498269298743,0,1,negative regulation of retinal cell programmed cell death,BP,
12470,GO:0046677,1,0.74600981793502,0,45,response to antibiotic,BP,
12471,GO:0046680,1,0.993600087468788,0,1,response to DDT,BP,
12473,GO:0046684,1,0.97454119450816,0,4,response to pyrethroid,BP,
12474,GO:0046685,1,0.807518001248449,0,33,response to arsenic-containing substance,BP,
12475,GO:0046686,1,0.697031486623525,0,56,response to cadmium ion,BP,
12476,GO:0046687,1,0.993666576647194,0,1,response to chromate,BP,
12478,GO:0046689,1,0.943633960088752,0,9,response to mercury ion,BP,
12479,GO:0046690,1,0.993517995321724,0,1,response to tellurium ion,BP,
12480,GO:0046691,1,0.987028465474076,0,2,intracellular canaliculus,CC,
12481,GO:0046695,1,0.980949051063605,0,3,SLIK (SAGA-like) complex,CC,
12482,GO:0046696,1,0.974529309660455,0,4,lipopolysaccharide receptor complex,CC,
12485,GO:0046703,1,0.94993135363048,0,8,natural killer cell lectin-like receptor binding,MF,
12486,GO:0046704,1,0.993551996593999,0,1,CDP metabolic process,BP,
12487,GO:0046705,1,0.993551996593999,0,1,CDP biosynthetic process,BP,
12488,GO:0046707,1,0.98701280498906,0,2,IDP metabolic process,BP,
12489,GO:0046709,1,0.98701280498906,0,2,IDP catabolic process,BP,
12490,GO:0046710,1,0.942298337249867,0,9,GDP metabolic process,BP,
12491,GO:0046711,1,0.993673483372605,0,1,GDP biosynthetic process,BP,
12492,GO:0046713,1,0.99353758577563,0,1,borate transport,BP,
12493,GO:0046715,1,0.99353758577563,0,1,active borate transmembrane transporter activity,MF,
12494,GO:0046716,1,0.883982481278689,0,19,muscle cell cellular homeostasis,BP,
12495,GO:0046717,1,0.780944380637305,0,38,acid secretion,BP,
12497,GO:0046719,1,0.955678105317459,0,7,regulation by virus of viral protein levels in host cell,BP,
12498,GO:0046724,1,0.987237202193924,0,2,oxalic acid secretion,BP,
12499,GO:0046725,1,0.993513359292508,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12500,GO:0046726,1,0.974248884057187,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12501,GO:0046745,1,0.99355705431691,0,1,viral capsid secondary envelopment,BP,
12502,GO:0046755,1,0.845410326861896,0,26,viral budding,BP,
12504,GO:0046778,1,0.987200784557703,0,2,modification by virus of host mRNA processing,BP,
12505,GO:0046782,1,0.672473030683192,0,61,regulation of viral transcription,BP,
12506,GO:0046784,1,0.949716514321608,0,8,viral mRNA export from host cell nucleus,BP,
12508,GO:0046786,1,0.993426050119044,0,1,viral replication complex formation and maintenance,BP,
12509,GO:0046789,1,0.993533084946483,0,1,host cell surface receptor binding,MF,
12510,GO:0046790,1,0.954516806165037,0,7,virion binding,MF,
12511,GO:0046794,1,0.679480130462092,0,59,transport of virus,BP,
12512,GO:0046811,1,0.987100668648337,0,2,histone deacetylase inhibitor activity,MF,
12513,GO:0046812,1,0.993533084946483,0,1,host cell surface binding,MF,
12514,GO:0046813,1,0.968016061093372,0,5,receptor-mediated virion attachment to host cell,BP,
12515,GO:0046822,1,0.488615689165429,0,109,regulation of nucleocytoplasmic transport,BP,
12516,GO:0046823,1,0.871691815789671,0,21,negative regulation of nucleocytoplasmic transport,BP,
12517,GO:0046824,1,0.652137666882654,0,65,positive regulation of nucleocytoplasmic transport,BP,
12518,GO:0046825,1,0.764437233373825,0,41,regulation of protein export from nucleus,BP,
12519,GO:0046826,1,0.96220861834558,0,6,negative regulation of protein export from nucleus,BP,
12520,GO:0046827,1,0.871138463871264,0,21,positive regulation of protein export from nucleus,BP,
12521,GO:0046831,1,0.899639831651643,0,16,regulation of RNA export from nucleus,BP,
12522,GO:0046832,1,0.98639551528363,0,2,negative regulation of RNA export from nucleus,BP,
12523,GO:0046833,1,0.948950622024591,0,8,positive regulation of RNA export from nucleus,BP,
12524,GO:0046834,1,0.660274092058703,0,63,lipid phosphorylation,BP,
12525,GO:0046835,1,0.866689514441565,0,22,carbohydrate phosphorylation,BP,
12526,GO:0046836,1,0.955921686558725,0,7,glycolipid transport,BP,
12529,GO:0046847,1,0.691761931559119,0,56,filopodium assembly,BP,
12530,GO:0046848,1,0.993703576153858,0,1,hydroxyapatite binding,MF,
12535,GO:0046854,1,0.72407909665554,0,49,phosphatidylinositol phosphorylation,BP,
12538,GO:0046864,1,0.987270325283949,0,2,isoprenoid transport,BP,
12539,GO:0046865,1,0.987270325283949,0,2,terpenoid transport,BP,
12540,GO:0046870,1,0.97423929780468,0,4,cadmium ion binding,MF,
12543,GO:0046874,1,0.96840699460433,0,5,quinolinate metabolic process,BP,
12544,GO:0046875,1,0.838026544399992,0,27,ephrin receptor binding,MF,
12545,GO:0046877,1,0.962158519919775,0,6,regulation of saliva secretion,BP,
12546,GO:0046878,1,0.987262143245837,0,2,positive regulation of saliva secretion,BP,
12548,GO:0046880,1,0.961550334930315,0,6,regulation of follicle-stimulating hormone secretion,BP,
12549,GO:0046881,1,0.961550334930315,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12550,GO:0046882,1,0.980894591471267,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12552,GO:0046884,1,0.95523816603799,0,7,follicle-stimulating hormone secretion,BP,
12553,GO:0046885,1,0.888980082054849,0,18,regulation of hormone biosynthetic process,BP,
12554,GO:0046886,1,0.949173151814127,0,8,positive regulation of hormone biosynthetic process,BP,
12559,GO:0046898,1,0.973961789025472,0,4,response to cycloheximide,BP,
12560,GO:0046899,1,0.98716277907789,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12561,GO:0046900,1,0.987254699720602,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12562,GO:0046901,1,0.993574052071418,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12565,GO:0046906,1,0.470066235933193,0,116,tetrapyrrole binding,MF,
12566,GO:0046907,1,1.72145865517662e-05,0,1593,intracellular transport,BP,
12567,GO:0046911,1,0.993661049356776,0,1,metal chelating activity,MF,
12568,GO:0046912,1,0.967880544690845,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12572,GO:0046920,1,0.948620689053908,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12573,GO:0046921,1,0.993528307267913,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12574,GO:0046922,1,0.987105454518051,0,2,peptide-O-fucosyltransferase activity,MF,
12575,GO:0046923,1,0.968386320970417,0,5,ER retention sequence binding,MF,
12577,GO:0046929,1,0.935846463525642,0,10,negative regulation of neurotransmitter secretion,BP,
12578,GO:0046930,1,0.884432506657476,0,19,pore complex,CC,
12579,GO:0046931,1,0.88353945758961,0,19,pore complex assembly,BP,
12580,GO:0046933,1,0.993666874303623,0,1,proton-transporting ATP synthase activity, rotational mechanism,MF,
12581,GO:0046934,1,0.967847148655553,0,5,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12582,GO:0046935,1,0.918526993619477,0,13,1-phosphatidylinositol-3-kinase regulator activity,MF,
12587,GO:0046946,1,0.987072884480478,0,2,hydroxylysine metabolic process,BP,
12588,GO:0046947,1,0.987072884480478,0,2,hydroxylysine biosynthetic process,BP,
12589,GO:0046949,1,0.828383311708888,0,29,fatty-acyl-CoA biosynthetic process,BP,
12590,GO:0046950,1,0.931451100825959,0,11,cellular ketone body metabolic process,BP,
12591,GO:0046951,1,0.943561396951758,0,9,ketone body biosynthetic process,BP,
12592,GO:0046952,1,0.974496526434058,0,4,ketone body catabolic process,BP,
12593,GO:0046958,1,0.961302414609313,0,6,nonassociative learning,BP,
12594,GO:0046959,1,0.973817075172464,0,4,habituation,BP,
12595,GO:0046960,1,0.987146992679662,0,2,sensitization,BP,
12596,GO:0046961,1,0.88450195253151,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12597,GO:0046963,1,0.987245694080208,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12598,GO:0046964,1,0.987245694080208,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12599,GO:0046965,1,0.887737096979488,0,18,retinoid X receptor binding,MF,
12600,GO:0046966,1,0.825543670693309,0,29,thyroid hormone receptor binding,MF,
12601,GO:0046967,1,0.97385938472,0,4,cytosol to endoplasmic reticulum transport,BP,
12602,GO:0046968,1,0.98700503464663,0,2,peptide antigen transport,BP,
12603,GO:0046969,1,0.987169877302622,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12604,GO:0046970,1,0.993609711467124,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12605,GO:0046972,1,0.937084271028247,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12606,GO:0046974,1,0.935386803218322,0,10,histone methyltransferase activity (H3-K9 specific),MF,
12607,GO:0046975,1,0.935156774688885,0,10,histone methyltransferase activity (H3-K36 specific),MF,
12608,GO:0046976,1,0.968018136544972,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12609,GO:0046977,1,0.949758530764088,0,8,TAP binding,MF,
12610,GO:0046978,1,0.968130201984524,0,5,TAP1 binding,MF,
12611,GO:0046979,1,0.980839677889322,0,3,TAP2 binding,MF,
12612,GO:0046980,1,0.993487645841966,0,1,tapasin binding,MF,
12615,GO:0046984,1,0.974488811904085,0,4,regulation of hemoglobin biosynthetic process,BP,
12616,GO:0046985,1,0.980906520981514,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12617,GO:0046986,1,0.993458626443647,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12618,GO:0046997,1,0.987107404538174,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12619,GO:0047006,1,0.987331600730539,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12620,GO:0047012,1,0.993632977628268,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12621,GO:0047015,1,0.993676091176895,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12622,GO:0047016,1,0.993593723111995,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12623,GO:0047017,1,0.993657868319067,0,1,prostaglandin-F synthase activity,MF,
12626,GO:0047023,1,0.95632983696536,0,7,androsterone dehydrogenase activity,MF,
12627,GO:0047024,1,0.993638185430346,0,1,5alpha-androstane-3beta,17beta-diol dehydrogenase activity,MF,
12628,GO:0047025,1,0.987233568340713,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12629,GO:0047035,1,0.968628719561099,0,5,testosterone dehydrogenase (NAD+) activity,MF,
12630,GO:0047042,1,0.993647509906438,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12631,GO:0047044,1,0.981013144212972,0,3,androstan-3-alpha,17-beta-diol dehydrogenase activity,MF,
12632,GO:0047045,1,0.974847643787456,0,4,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12633,GO:0047057,1,0.98737985374338,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12634,GO:0047058,1,0.993676817134721,0,1,vitamin-K-epoxide reductase (warfarin-insensitive) activity,MF,
12635,GO:0047066,1,0.987386722637299,0,2,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12636,GO:0047086,1,0.974843726608518,0,4,ketosteroid monooxygenase activity,MF,
12637,GO:0047092,1,0.993580101204257,0,1,27-hydroxycholesterol 7-alpha-monooxygenase activity,MF,
12638,GO:0047102,1,0.993575919257305,0,1,aminomuconate-semialdehyde dehydrogenase activity,MF,
12639,GO:0047105,1,0.993573106767278,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12640,GO:0047115,1,0.974851066845284,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12641,GO:0047117,1,0.993109877834153,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12642,GO:0047127,1,0.993648075137372,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12643,GO:0047130,1,0.993345469353142,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12644,GO:0047131,1,0.993345469353142,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12645,GO:0047134,1,0.974669958442349,0,4,protein-disulfide reductase activity,MF,
12646,GO:0047144,1,0.98711986787335,0,2,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12647,GO:0047150,1,0.993573358571638,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12648,GO:0047159,1,0.986921839863664,0,2,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12649,GO:0047166,1,0.993611790787931,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12650,GO:0047173,1,0.993428059072322,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12651,GO:0047179,1,0.981096402703506,0,3,platelet-activating factor acetyltransferase activity,MF,
12652,GO:0047184,1,0.96810309112514,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12653,GO:0047186,1,0.993495781080878,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12654,GO:0047191,1,0.993492115653698,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12655,GO:0047192,1,0.980616349264486,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12656,GO:0047220,1,0.993556055144106,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12657,GO:0047223,1,0.993552197387467,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12658,GO:0047237,1,0.980672970108544,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12659,GO:0047238,1,0.961625887812974,0,6,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12660,GO:0047256,1,0.993482049208774,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12661,GO:0047263,1,0.993549348930523,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12662,GO:0047273,1,0.993526932154482,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12663,GO:0047275,1,0.987151156459693,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12664,GO:0047276,1,0.99355705431691,0,1,N-acetyllactosaminide 3-alpha-galactosyltransferase activity,MF,
12665,GO:0047277,1,0.993609577378704,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12666,GO:0047280,1,0.993450550931208,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12667,GO:0047288,1,0.987124415857863,0,2,monosialoganglioside sialyltransferase activity,MF,
12668,GO:0047290,1,0.987262978428673,0,2,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12669,GO:0047291,1,0.993585660228222,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12670,GO:0047293,1,0.993630236329207,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12671,GO:0047298,1,0.993425585143341,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12672,GO:0047322,1,0.986482945830729,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12673,GO:0047323,1,0.993597362978043,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12674,GO:0047325,1,0.993530108284653,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12675,GO:0047326,1,0.993619982067935,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12676,GO:0047341,1,0.993521172994364,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12677,GO:0047369,1,0.99355705431691,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12678,GO:0047372,1,0.931034006052968,0,11,acylglycerol lipase activity,MF,
12679,GO:0047374,1,0.980880966662577,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12680,GO:0047381,1,0.993622398233068,0,1,dodecanoyl-[acyl-carrier-protein] hydrolase activity,MF,
12681,GO:0047389,1,0.986956962387724,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12682,GO:0047390,1,0.993492995387735,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12684,GO:0047394,1,0.993590332962404,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12685,GO:0047395,1,0.993547463256452,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12686,GO:0047408,1,0.987176956219485,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12687,GO:0047409,1,0.987176956219485,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12688,GO:0047412,1,0.993619478527912,0,1,N-(long-chain-acyl)ethanolamine deacylase activity,MF,
12689,GO:0047419,1,0.993617195415608,0,1,N-acetylgalactosamine-6-phosphate deacetylase activity,MF,
12690,GO:0047429,1,0.943234108670687,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12691,GO:0047444,1,0.993656939990299,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12692,GO:0047451,1,0.993109877834153,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12693,GO:0047464,1,0.993415786135267,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12694,GO:0047484,1,0.913115905998377,0,14,regulation of response to osmotic stress,BP,
12695,GO:0047485,1,0.510034829915218,0,103,protein N-terminus binding,MF,
12696,GO:0047493,1,0.980591528656892,0,3,ceramide cholinephosphotransferase activity,MF,
12697,GO:0047496,1,0.742785684096545,0,45,vesicle transport along microtubule,BP,
12698,GO:0047497,1,0.865322373752666,0,22,mitochondrion transport along microtubule,BP,
12699,GO:0047498,1,0.943472063150695,0,9,calcium-dependent phospholipase A2 activity,MF,
12700,GO:0047499,1,0.94972127106088,0,8,calcium-independent phospholipase A2 activity,MF,
12701,GO:0047522,1,0.980729234151434,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12702,GO:0047536,1,0.99359125267072,0,1,2-aminoadipate transaminase activity,MF,
12703,GO:0047545,1,0.993327361973143,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12705,GO:0047560,1,0.993403037976352,0,1,3-dehydrosphinganine reductase activity,MF,
12706,GO:0047598,1,0.993563851908475,0,1,7-dehydrocholesterol reductase activity,MF,
12707,GO:0047603,1,0.99366237398337,0,1,acetoacetyl-CoA hydrolase activity,MF,
12708,GO:0047609,1,0.993561853625484,0,1,acetylputrescine deacetylase activity,MF,
12709,GO:0047611,1,0.993561853625484,0,1,acetylspermidine deacetylase activity,MF,
12710,GO:0047617,1,0.890664027320978,0,18,acyl-CoA hydrolase activity,MF,
12711,GO:0047620,1,0.993547463256452,0,1,acylglycerol kinase activity,MF,
12712,GO:0047621,1,0.993627626198812,0,1,acylpyruvate hydrolase activity,MF,
12713,GO:0047623,1,0.987013372953963,0,2,adenosine-phosphate deaminase activity,MF,
12714,GO:0047631,1,0.96859877765631,0,5,ADP-ribose diphosphatase activity,MF,
12715,GO:0047635,1,0.987148535899793,0,2,alanine-oxo-acid transaminase activity,MF,
12716,GO:0047655,1,0.974790864719604,0,4,allyl-alcohol dehydrogenase activity,MF,
12717,GO:0047658,1,0.993626487655239,0,1,alpha-amino-acid esterase activity,MF,
12718,GO:0047661,1,0.993574747073295,0,1,amino-acid racemase activity,MF,
12719,GO:0047676,1,0.931021018194376,0,11,arachidonate-CoA ligase activity,MF,
12720,GO:0047677,1,0.99357272944211,0,1,arachidonate 8(R)-lipoxygenase activity,MF,
12721,GO:0047685,1,0.993639219198546,0,1,amine sulfotransferase activity,MF,
12722,GO:0047693,1,0.993691741969084,0,1,ATP diphosphatase activity,MF,
12723,GO:0047696,1,0.987156499577097,0,2,beta-adrenergic receptor kinase activity,MF,
12724,GO:0047704,1,0.993606964505936,0,1,bile-salt sulfotransferase activity,MF,
12725,GO:0047708,1,0.987303748367137,0,2,biotinidase activity,MF,
12726,GO:0047710,1,0.987151908247631,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12727,GO:0047718,1,0.981058018509555,0,3,indanol dehydrogenase activity,MF,
12728,GO:0047726,1,0.993572918047278,0,1,iron-cytochrome-c reductase activity,MF,
12730,GO:0047734,1,0.99355705431691,0,1,CDP-glycerol diphosphatase activity,MF,
12731,GO:0047743,1,0.993659856790988,0,1,chlordecone reductase activity,MF,
12732,GO:0047747,1,0.987207870868935,0,2,cholate-CoA ligase activity,MF,
12733,GO:0047749,1,0.993586571780172,0,1,cholestanetriol 26-monooxygenase activity,MF,
12734,GO:0047750,1,0.987376670019592,0,2,cholestenol delta-isomerase activity,MF,
12735,GO:0047751,1,0.987193226125423,0,2,cholestenone 5-alpha-reductase activity,MF,
12736,GO:0047756,1,0.980707224377515,0,3,chondroitin 4-sulfotransferase activity,MF,
12737,GO:0047757,1,0.986567572687206,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12738,GO:0047760,1,0.955848917057534,0,7,butyrate-CoA ligase activity,MF,
12739,GO:0047777,1,0.993355319229239,0,1,(S)-citramalyl-CoA lyase activity,MF,
12740,GO:0047780,1,0.987113262208991,0,2,citrate dehydratase activity,MF,
12741,GO:0047787,1,0.993657868319067,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12742,GO:0047800,1,0.993505391060352,0,1,cysteamine dioxygenase activity,MF,
12743,GO:0047801,1,0.993597495673468,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12744,GO:0047837,1,0.993667337280991,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12745,GO:0047840,1,0.993665154203989,0,1,dCTP diphosphatase activity,MF,
12746,GO:0047844,1,0.950037529150668,0,8,deoxycytidine deaminase activity,MF,
12747,GO:0047860,1,0.993654817180767,0,1,diiodophenylpyruvate reductase activity,MF,
12748,GO:0047865,1,0.993538827967378,0,1,dimethylglycine dehydrogenase activity,MF,
12749,GO:0047874,1,0.993598624462572,0,1,dolichyldiphosphatase activity,MF,
12750,GO:0047886,1,0.993630972067005,0,1,farnesol dehydrogenase activity,MF,
12751,GO:0047888,1,0.993609510337612,0,1,fatty acid peroxidase activity,MF,
12752,GO:0047894,1,0.981056699214881,0,3,flavonol 3-sulfotransferase activity,MF,
12753,GO:0047915,1,0.993627492277748,0,1,ganglioside galactosyltransferase activity,MF,
12754,GO:0047933,1,0.993108455057932,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12755,GO:0047936,1,0.993050631663841,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12756,GO:0047939,1,0.993641352291369,0,1,L-glucuronate reductase activity,MF,
12757,GO:0047941,1,0.993641352291369,0,1,glucuronolactone reductase activity,MF,
12758,GO:0047946,1,0.993601486139316,0,1,glutamine N-acyltransferase activity,MF,
12759,GO:0047952,1,0.99355079633967,0,1,glycerol-3-phosphate dehydrogenase [NAD(P)+] activity,MF,
12760,GO:0047961,1,0.987289568991595,0,2,glycine N-acyltransferase activity,MF,
12761,GO:0047963,1,0.993521146554597,0,1,glycine N-choloyltransferase activity,MF,
12762,GO:0047975,1,0.99355705431691,0,1,guanosine phosphorylase activity,MF,
12763,GO:0047977,1,0.987184944780185,0,2,hepoxilin-epoxide hydrolase activity,MF,
12764,GO:0047988,1,0.993612730327216,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12765,GO:0047992,1,0.99355705431691,0,1,hydroxylysine kinase activity,MF,
12766,GO:0047994,1,0.99366237398337,0,1,hydroxymethylglutaryl-CoA hydrolase activity,MF,
12767,GO:0048002,1,0.310338739481424,0,180,antigen processing and presentation of peptide antigen,BP,
12768,GO:0048003,1,0.961818892872827,0,6,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12769,GO:0048006,1,0.974526242702554,0,4,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12770,GO:0048007,1,0.961818892872827,0,6,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12772,GO:0048009,1,0.820009556520748,0,30,insulin-like growth factor receptor signaling pathway,BP,
12773,GO:0048010,1,0.559115975531831,0,89,vascular endothelial growth factor receptor signaling pathway,BP,
12774,GO:0048011,1,0.816822109719588,0,31,neurotrophin TRK receptor signaling pathway,BP,
12775,GO:0048012,1,0.901270582414057,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12777,GO:0048014,1,0.97328680221816,0,4,Tie signaling pathway,BP,
12782,GO:0048019,1,0.907627187935941,0,15,receptor antagonist activity,MF,
12783,GO:0048020,1,0.857849686667863,0,24,CCR chemokine receptor binding,MF,
12784,GO:0048021,1,0.935803258409353,0,10,regulation of melanin biosynthetic process,BP,
12785,GO:0048022,1,0.980298798274441,0,3,negative regulation of melanin biosynthetic process,BP,
12786,GO:0048023,1,0.961353458757579,0,6,positive regulation of melanin biosynthetic process,BP,
12787,GO:0048024,1,0.503755736957685,0,105,regulation of mRNA splicing, via spliceosome,BP,
12788,GO:0048025,1,0.867393645526015,0,22,negative regulation of mRNA splicing, via spliceosome,BP,
12789,GO:0048026,1,0.87286610952415,0,21,positive regulation of mRNA splicing, via spliceosome,BP,
12790,GO:0048027,1,0.844474445430882,0,26,mRNA 5'-UTR binding,MF,
12791,GO:0048029,1,0.660323469172111,0,64,monosaccharide binding,MF,
12792,GO:0048030,1,0.98107336425347,0,3,disaccharide binding,MF,
12793,GO:0048033,1,0.993543906289336,0,1,heme o metabolic process,BP,
12794,GO:0048034,1,0.993543906289336,0,1,heme O biosynthetic process,BP,
12795,GO:0048038,1,0.908383761589015,0,15,quinone binding,MF,
12796,GO:0048039,1,0.962340653046437,0,6,ubiquinone binding,MF,
12797,GO:0048040,1,0.993599954369409,0,1,UDP-glucuronate decarboxylase activity,MF,
12799,GO:0048048,1,0.781963574526605,0,37,embryonic eye morphogenesis,BP,
12800,GO:0048050,1,0.961564600114507,0,6,post-embryonic eye morphogenesis,BP,
12801,GO:0048066,1,0.754122489224524,0,43,developmental pigmentation,BP,
12802,GO:0048069,1,0.961915699013622,0,6,eye pigmentation,BP,
12803,GO:0048070,1,0.906346106700882,0,15,regulation of developmental pigmentation,BP,
12804,GO:0048073,1,0.980662427948203,0,3,regulation of eye pigmentation,BP,
12805,GO:0048074,1,0.993601552792331,0,1,negative regulation of eye pigmentation,BP,
12806,GO:0048075,1,0.993469618404483,0,1,positive regulation of eye pigmentation,BP,
12807,GO:0048086,1,0.993601552792331,0,1,negative regulation of developmental pigmentation,BP,
12808,GO:0048087,1,0.942292267261409,0,9,positive regulation of developmental pigmentation,BP,
12811,GO:0048102,1,0.93101878204813,0,11,autophagic cell death,BP,
12812,GO:0048103,1,0.942519859723001,0,9,somatic stem cell division,BP,
12813,GO:0048104,1,0.973422038468419,0,4,establishment of body hair or bristle planar orientation,BP,
12814,GO:0048105,1,0.973422038468419,0,4,establishment of body hair planar orientation,BP,
12815,GO:0048133,1,0.980854861232935,0,3,male germ-line stem cell asymmetric division,BP,
12816,GO:0048143,1,0.866194097825587,0,22,astrocyte activation,BP,
12820,GO:0048147,1,0.838865839685501,0,27,negative regulation of fibroblast proliferation,BP,
12821,GO:0048148,1,0.925256416301088,0,12,behavioral response to cocaine,BP,
12822,GO:0048149,1,0.942962015868408,0,9,behavioral response to ethanol,BP,
12824,GO:0048160,1,0.993447430138573,0,1,primary follicle stage,BP,
12825,GO:0048162,1,0.98094062816265,0,3,multi-layer follicle stage,BP,
12826,GO:0048165,1,0.980557520345979,0,3,fused antrum stage,BP,
12830,GO:0048170,1,0.96763428000683,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12831,GO:0048172,1,0.899798072934405,0,16,regulation of short-term neuronal synaptic plasticity,BP,
12832,GO:0048174,1,0.993483668270107,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12833,GO:0048175,1,0.993533084946483,0,1,hepatocyte growth factor biosynthetic process,BP,
12834,GO:0048176,1,0.993533084946483,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12835,GO:0048178,1,0.993533084946483,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12836,GO:0048179,1,0.960444644735732,0,6,activin receptor complex,CC,
12837,GO:0048180,1,0.993594780058018,0,1,activin complex,CC,
12838,GO:0048185,1,0.912008089419657,0,14,activin binding,MF,
12839,GO:0048188,1,0.930246010343053,0,11,Set1C/COMPASS complex,CC,
12840,GO:0048193,1,0.10180873148589,0,345,Golgi vesicle transport,BP,
12841,GO:0048194,1,0.596201270239197,0,79,Golgi vesicle budding,BP,
12842,GO:0048199,1,0.624816261047189,0,72,vesicle targeting, to, from or within Golgi,BP,
12843,GO:0048200,1,0.961756955358935,0,6,Golgi transport vesicle coating,BP,
12844,GO:0048203,1,0.987203284687533,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12845,GO:0048205,1,0.961756955358935,0,6,COPI coating of Golgi vesicle,BP,
12846,GO:0048207,1,0.658308836766422,0,64,vesicle targeting, rough ER to cis-Golgi,BP,
12847,GO:0048208,1,0.658308836766422,0,64,COPII vesicle coating,BP,
12848,GO:0048209,1,0.96785343427699,0,5,regulation of vesicle targeting, to, from or within Golgi,BP,
12849,GO:0048210,1,0.974549114723924,0,4,Golgi vesicle fusion to target membrane,BP,
12850,GO:0048211,1,0.987095542177556,0,2,Golgi vesicle docking,BP,
12851,GO:0048213,1,0.987216409411823,0,2,Golgi vesicle prefusion complex stabilization,BP,
12852,GO:0048219,1,0.993427210315475,0,1,inter-Golgi cisterna vesicle-mediated transport,BP,
12853,GO:0048227,1,0.949359071869006,0,8,plasma membrane to endosome transport,BP,
12855,GO:0048237,1,0.980982816131035,0,3,rough endoplasmic reticulum lumen,CC,
12856,GO:0048239,1,0.987188986863482,0,2,negative regulation of DNA recombination at telomere,BP,
12857,GO:0048240,1,0.895904103532577,0,17,sperm capacitation,BP,
12858,GO:0048241,1,0.949736911788174,0,8,epinephrine transport,BP,
12859,GO:0048242,1,0.96847487575383,0,5,epinephrine secretion,BP,
12860,GO:0048243,1,0.919369898305549,0,13,norepinephrine secretion,BP,
12861,GO:0048244,1,0.993628630393618,0,1,phytanoyl-CoA dioxygenase activity,MF,
12862,GO:0048245,1,0.932051439125161,0,11,eosinophil chemotaxis,BP,
12865,GO:0048248,1,0.968637050680412,0,5,CXCR3 chemokine receptor binding,MF,
12866,GO:0048250,1,0.987291693247685,0,2,iron import into the mitochondrion,BP,
12867,GO:0048251,1,0.936070337781354,0,10,elastic fiber assembly,BP,
12868,GO:0048254,1,0.974494536031966,0,4,snoRNA localization,BP,
12869,GO:0048255,1,0.780023635256492,0,38,mRNA stabilization,BP,
12870,GO:0048256,1,0.943174885478366,0,9,flap endonuclease activity,MF,
12871,GO:0048257,1,0.987177279087119,0,2,3'-flap endonuclease activity,MF,
12874,GO:0048261,1,0.861314017841605,0,23,negative regulation of receptor-mediated endocytosis,BP,
12877,GO:0048264,1,0.993543410477906,0,1,determination of ventral identity,BP,
12878,GO:0048265,1,0.832814711414315,0,28,response to pain,BP,
12879,GO:0048266,1,0.918726072306517,0,13,behavioral response to pain,BP,
12880,GO:0048268,1,0.900192159937556,0,16,clathrin coat assembly,BP,
12881,GO:0048269,1,0.987195309598871,0,2,methionine adenosyltransferase complex,CC,
12882,GO:0048270,1,0.993600453590349,0,1,methionine adenosyltransferase regulator activity,MF,
12883,GO:0048273,1,0.968149936513308,0,5,mitogen-activated protein kinase p38 binding,MF,
12884,GO:0048278,1,0.654888748885671,0,65,vesicle docking,BP,
12885,GO:0048280,1,0.961975992053857,0,6,vesicle fusion with Golgi apparatus,BP,
12887,GO:0048285,1,0.0616651925223159,0,419,organelle fission,BP,
12888,GO:0048286,1,0.767584533091274,0,40,lung alveolus development,BP,
12889,GO:0048289,1,0.961853256707569,0,6,isotype switching to IgE isotypes,BP,
12890,GO:0048290,1,0.962026365747041,0,6,isotype switching to IgA isotypes,BP,
12891,GO:0048291,1,0.924944287057944,0,12,isotype switching to IgG isotypes,BP,
12892,GO:0048293,1,0.961853256707569,0,6,regulation of isotype switching to IgE isotypes,BP,
12893,GO:0048294,1,0.980735188148,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12894,GO:0048295,1,0.980750875383017,0,3,positive regulation of isotype switching to IgE isotypes,BP,
12895,GO:0048296,1,0.968297642802024,0,5,regulation of isotype switching to IgA isotypes,BP,
12896,GO:0048297,1,0.993597230304888,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12897,GO:0048298,1,0.974538996044714,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12898,GO:0048302,1,0.93092015104845,0,11,regulation of isotype switching to IgG isotypes,BP,
12899,GO:0048304,1,0.949202499653366,0,8,positive regulation of isotype switching to IgG isotypes,BP,
12902,GO:0048308,1,0.907252914645874,0,15,organelle inheritance,BP,
12903,GO:0048311,1,0.899702898212447,0,16,mitochondrion distribution,BP,
12904,GO:0048312,1,0.948369683645141,0,8,intracellular distribution of mitochondria,BP,
12905,GO:0048313,1,0.907252914645874,0,15,Golgi inheritance,BP,
12906,GO:0048318,1,0.955714077724104,0,7,axial mesoderm development,BP,
12907,GO:0048319,1,0.980506198284353,0,3,axial mesoderm morphogenesis,BP,
12908,GO:0048320,1,0.987133609763484,0,2,axial mesoderm formation,BP,
12909,GO:0048321,1,0.993600553466401,0,1,axial mesodermal cell differentiation,BP,
12910,GO:0048322,1,0.993600553466401,0,1,axial mesodermal cell fate commitment,BP,
12911,GO:0048327,1,0.993600553466401,0,1,axial mesodermal cell fate specification,BP,
12912,GO:0048332,1,0.653231702807454,0,65,mesoderm morphogenesis,BP,
12913,GO:0048333,1,0.822358380470778,0,30,mesodermal cell differentiation,BP,
12914,GO:0048338,1,0.99351061792185,0,1,mesoderm structural organization,BP,
12916,GO:0048340,1,0.942459441381799,0,9,paraxial mesoderm morphogenesis,BP,
12917,GO:0048341,1,0.961791929662631,0,6,paraxial mesoderm formation,BP,
12918,GO:0048342,1,0.993627960972156,0,1,paraxial mesodermal cell differentiation,BP,
12919,GO:0048343,1,0.993627960972156,0,1,paraxial mesodermal cell fate commitment,BP,
12920,GO:0048352,1,0.99351061792185,0,1,paraxial mesoderm structural organization,BP,
12921,GO:0048365,1,0.651761840858571,0,65,Rac GTPase binding,MF,
12922,GO:0048368,1,0.907128436509382,0,15,lateral mesoderm development,BP,
12923,GO:0048369,1,0.974328316573926,0,4,lateral mesoderm morphogenesis,BP,
12924,GO:0048370,1,0.974328316573926,0,4,lateral mesoderm formation,BP,
12925,GO:0048371,1,0.980572834121907,0,3,lateral mesodermal cell differentiation,BP,
12926,GO:0048372,1,0.986919706598356,0,2,lateral mesodermal cell fate commitment,BP,
12927,GO:0048377,1,0.986919706598356,0,2,lateral mesodermal cell fate specification,BP,
12928,GO:0048378,1,0.986919706598356,0,2,regulation of lateral mesodermal cell fate specification,BP,
12929,GO:0048382,1,0.955433032790927,0,7,mesendoderm development,BP,
12930,GO:0048384,1,0.812725511611047,0,32,retinoic acid receptor signaling pathway,BP,
12931,GO:0048385,1,0.895897904544815,0,17,regulation of retinoic acid receptor signaling pathway,BP,
12932,GO:0048386,1,0.968191843273788,0,5,positive regulation of retinoic acid receptor signaling pathway,BP,
12933,GO:0048387,1,0.943238551324559,0,9,negative regulation of retinoic acid receptor signaling pathway,BP,
12934,GO:0048388,1,0.980869562804037,0,3,endosomal lumen acidification,BP,
12935,GO:0048389,1,0.987274525790186,0,2,intermediate mesoderm development,BP,
12936,GO:0048390,1,0.993620720501988,0,1,intermediate mesoderm morphogenesis,BP,
12937,GO:0048391,1,0.993620720501988,0,1,intermediate mesoderm formation,BP,
12938,GO:0048392,1,0.993620720501988,0,1,intermediate mesodermal cell differentiation,BP,
12939,GO:0048403,1,0.980250526036044,0,3,brain-derived neurotrophic factor binding,MF,
12940,GO:0048406,1,0.967756364732737,0,5,nerve growth factor binding,MF,
12942,GO:0048408,1,0.980919024519069,0,3,epidermal growth factor binding,MF,
12946,GO:0048475,1,0.559135893337973,0,89,coated membrane,CC,
12947,GO:0048476,1,0.96844947324566,0,5,Holliday junction resolvase complex,CC,
12948,GO:0048477,1,0.62108816356409,0,73,oogenesis,BP,
12949,GO:0048478,1,0.948771364617141,0,8,replication fork protection,BP,
12950,GO:0048483,1,0.759048097755549,0,42,autonomic nervous system development,BP,
12951,GO:0048484,1,0.919010636254636,0,13,enteric nervous system development,BP,
12952,GO:0048485,1,0.876909771815035,0,20,sympathetic nervous system development,BP,
12953,GO:0048486,1,0.900699092147326,0,16,parasympathetic nervous system development,BP,
12954,GO:0048487,1,0.785962490168773,0,37,beta-tubulin binding,MF,
12956,GO:0048489,1,0.760041267686244,0,42,synaptic vesicle transport,BP,
12957,GO:0048490,1,0.889852330470373,0,18,anterograde synaptic vesicle transport,BP,
12958,GO:0048495,1,0.954687189427876,0,7,Roundabout binding,MF,
12959,GO:0048496,1,0.973387276327442,0,4,maintenance of animal organ identity,BP,
12960,GO:0048499,1,0.974531992489512,0,4,synaptic vesicle membrane organization,BP,
12961,GO:0048500,1,0.943818040038044,0,9,signal recognition particle,CC,
12962,GO:0048505,1,0.924679907381711,0,12,regulation of timing of cell differentiation,BP,
12964,GO:0048512,1,0.745414838993658,0,45,circadian behavior,BP,
12967,GO:0048515,1,0.477783458617731,0,113,spermatid differentiation,BP,
12974,GO:0048524,1,0.507478778593658,0,104,positive regulation of viral process,BP,
12975,GO:0048525,1,0.575461567403708,0,85,negative regulation of viral process,BP,
12976,GO:0048531,1,0.943572689654667,0,9,beta-1,3-galactosyltransferase activity,MF,
12977,GO:0048532,1,0.900640865653484,0,16,anatomical structure arrangement,BP,
12979,GO:0048535,1,0.901396245346619,0,16,lymph node development,BP,
12980,GO:0048536,1,0.81138048009621,0,32,spleen development,BP,
12981,GO:0048537,1,0.955618033142843,0,7,mucosa-associated lymphoid tissue development,BP,
12982,GO:0048538,1,0.749269412927077,0,44,thymus development,BP,
12983,GO:0048539,1,0.943294140392333,0,9,bone marrow development,BP,
12984,GO:0048541,1,0.955618033142843,0,7,Peyer's patch development,BP,
12987,GO:0048548,1,0.918928082695929,0,13,regulation of pinocytosis,BP,
12988,GO:0048549,1,0.949164068544567,0,8,positive regulation of pinocytosis,BP,
12989,GO:0048550,1,0.96816096732258,0,5,negative regulation of pinocytosis,BP,
12991,GO:0048560,1,0.98722624634346,0,2,establishment of anatomical structure orientation,BP,
12992,GO:0048561,1,0.993591482824417,0,1,establishment of animal organ orientation,BP,
12994,GO:0048563,1,0.948754370699749,0,8,post-embryonic animal organ morphogenesis,BP,
12997,GO:0048567,1,0.993569852245708,0,1,ectodermal digestive tract morphogenesis,BP,
12999,GO:0048569,1,0.906024809101329,0,15,post-embryonic animal organ development,BP,
13000,GO:0048570,1,0.942707897445898,0,9,notochord morphogenesis,BP,
13006,GO:0048592,1,0.385317117522072,0,144,eye morphogenesis,BP,
13007,GO:0048593,1,0.464301452742307,0,116,camera-type eye morphogenesis,BP,
13008,GO:0048596,1,0.829956514925308,0,28,embryonic camera-type eye morphogenesis,BP,
13009,GO:0048597,1,0.981051451773173,0,3,post-embryonic camera-type eye morphogenesis,BP,
13011,GO:0048599,1,0.775092485959227,0,39,oocyte development,BP,
13014,GO:0048611,1,0.987156785506307,0,2,embryonic ectodermal digestive tract development,BP,
13015,GO:0048613,1,0.993569852245708,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13016,GO:0048617,1,0.941752198090276,0,9,embryonic foregut morphogenesis,BP,
13017,GO:0048619,1,0.98076181652643,0,3,embryonic hindgut morphogenesis,BP,
13018,GO:0048625,1,0.968088771960008,0,5,myoblast fate commitment,BP,
13019,GO:0048627,1,0.980488248108245,0,3,myoblast development,BP,
13020,GO:0048630,1,0.961716751989622,0,6,skeletal muscle tissue growth,BP,
13021,GO:0048631,1,0.974122376712737,0,4,regulation of skeletal muscle tissue growth,BP,
13022,GO:0048632,1,0.98686573785886,0,2,negative regulation of skeletal muscle tissue growth,BP,
13023,GO:0048633,1,0.987088732723503,0,2,positive regulation of skeletal muscle tissue growth,BP,
13030,GO:0048641,1,0.759720246694849,0,42,regulation of skeletal muscle tissue development,BP,
13031,GO:0048642,1,0.930585249748278,0,11,negative regulation of skeletal muscle tissue development,BP,
13032,GO:0048643,1,0.883523560456292,0,19,positive regulation of skeletal muscle tissue development,BP,
13036,GO:0048659,1,0.427491953874569,0,130,smooth muscle cell proliferation,BP,
13037,GO:0048660,1,0.430285198361576,0,129,regulation of smooth muscle cell proliferation,BP,
13038,GO:0048661,1,0.577313823115874,0,84,positive regulation of smooth muscle cell proliferation,BP,
13039,GO:0048662,1,0.756729772157791,0,43,negative regulation of smooth muscle cell proliferation,BP,
13041,GO:0048664,1,0.962112850023176,0,6,neuron fate determination,BP,
13046,GO:0048669,1,0.980676578153697,0,3,collateral sprouting in absence of injury,BP,
13049,GO:0048672,1,0.936293094124773,0,10,positive regulation of collateral sprouting,BP,
13051,GO:0048674,1,0.992427154022935,0,1,collateral sprouting of injured axon,BP,
13053,GO:0048677,1,0.966451314614516,0,5,axon extension involved in regeneration,BP,
13056,GO:0048680,1,0.948765219124878,0,8,positive regulation of axon regeneration,BP,
13058,GO:0048682,1,0.966451314614516,0,5,sprouting of injured axon,BP,
13061,GO:0048686,1,0.972922924135382,0,4,regulation of sprouting of injured axon,BP,
13062,GO:0048687,1,0.986026474123296,0,2,positive regulation of sprouting of injured axon,BP,
13063,GO:0048688,1,0.986712609348032,0,2,negative regulation of sprouting of injured axon,BP,
13064,GO:0048690,1,0.972922924135382,0,4,regulation of axon extension involved in regeneration,BP,
13065,GO:0048691,1,0.986026474123296,0,2,positive regulation of axon extension involved in regeneration,BP,
13066,GO:0048692,1,0.986712609348032,0,2,negative regulation of axon extension involved in regeneration,BP,
13067,GO:0048693,1,0.992427154022935,0,1,regulation of collateral sprouting of injured axon,BP,
13068,GO:0048694,1,0.992427154022935,0,1,positive regulation of collateral sprouting of injured axon,BP,
13069,GO:0048696,1,0.993639919287708,0,1,regulation of collateral sprouting in absence of injury,BP,
13070,GO:0048697,1,0.993639919287708,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13073,GO:0048702,1,0.942428890012946,0,9,embryonic neurocranium morphogenesis,BP,
13074,GO:0048703,1,0.936095235607687,0,10,embryonic viscerocranium morphogenesis,BP,
13082,GO:0048712,1,0.930551009205818,0,11,negative regulation of astrocyte differentiation,BP,
13084,GO:0048714,1,0.866801788203141,0,22,positive regulation of oligodendrocyte differentiation,BP,
13085,GO:0048715,1,0.918343071325825,0,13,negative regulation of oligodendrocyte differentiation,BP,
13087,GO:0048730,1,0.833103922750258,0,28,epidermis morphogenesis,BP,
13090,GO:0048733,1,0.960786586019684,0,6,sebaceous gland development,BP,
13093,GO:0048739,1,0.923249860736977,0,10,cardiac muscle fiber development,BP,
13094,GO:0048741,1,0.843522922820176,0,26,skeletal muscle fiber development,BP,
13095,GO:0048742,1,0.949042827411901,0,8,regulation of skeletal muscle fiber development,BP,
13096,GO:0048743,1,0.968169453735809,0,5,positive regulation of skeletal muscle fiber development,BP,
13097,GO:0048745,1,0.865104007953813,0,22,smooth muscle tissue development,BP,
13098,GO:0048747,1,0.694103424332561,0,53,muscle fiber development,BP,
13099,GO:0048752,1,0.954937830037317,0,7,semicircular canal morphogenesis,BP,
13100,GO:0048753,1,0.832689051721584,0,28,pigment granule organization,BP,
13102,GO:0048755,1,0.936115336099631,0,10,branching morphogenesis of a nerve,BP,
13103,GO:0048757,1,0.937219743213343,0,10,pigment granule maturation,BP,
13106,GO:0048769,1,0.96710572820662,0,3,sarcomerogenesis,BP,
13107,GO:0048770,1,0.518191788670629,0,101,pigment granule,CC,
13110,GO:0048787,1,0.821202849923723,0,30,presynaptic active zone membrane,CC,
13111,GO:0048788,1,0.964792737736256,0,5,cytoskeleton of presynaptic active zone,CC,
13112,GO:0048789,1,0.993425430038218,0,1,cytoskeletal matrix organization at active zone,BP,
13113,GO:0048790,1,0.965253987231258,0,5,maintenance of presynaptic active zone structure,BP,
13114,GO:0048791,1,0.858974189527639,0,23,calcium ion-regulated exocytosis of neurotransmitter,BP,
13115,GO:0048792,1,0.993520696996191,0,1,spontaneous exocytosis of neurotransmitter,BP,
13116,GO:0048793,1,0.961266387723938,0,6,pronephros development,BP,
13119,GO:0048807,1,0.980942814557827,0,3,female genitalia morphogenesis,BP,
13120,GO:0048808,1,0.974467382254126,0,4,male genitalia morphogenesis,BP,
13122,GO:0048813,1,0.395444736813323,0,140,dendrite morphogenesis,BP,
13123,GO:0048814,1,0.55112364202161,0,90,regulation of dendrite morphogenesis,BP,
13124,GO:0048817,1,0.986920270818589,0,2,negative regulation of hair follicle maturation,BP,
13125,GO:0048818,1,0.968034092897161,0,5,positive regulation of hair follicle maturation,BP,
13126,GO:0048819,1,0.943010815451538,0,9,regulation of hair follicle maturation,BP,
13127,GO:0048820,1,0.899563896583601,0,16,hair follicle maturation,BP,
13128,GO:0048821,1,0.811700179611343,0,32,erythrocyte development,BP,
13129,GO:0048822,1,0.980275730933497,0,3,enucleate erythrocyte development,BP,
13131,GO:0048840,1,0.961679671624634,0,6,otolith development,BP,
13132,GO:0048841,1,0.813951627010153,0,31,regulation of axon extension involved in axon guidance,BP,
13133,GO:0048842,1,0.953276515556256,0,7,positive regulation of axon extension involved in axon guidance,BP,
13134,GO:0048843,1,0.847776837839325,0,25,negative regulation of axon extension involved in axon guidance,BP,
13136,GO:0048845,1,0.942224725896072,0,9,venous blood vessel morphogenesis,BP,
13137,GO:0048846,1,0.78722199923146,0,36,axon extension involved in axon guidance,BP,
13138,GO:0048850,1,0.993349843576017,0,1,hypophysis morphogenesis,BP,
13139,GO:0048852,1,0.9869871903241,0,2,diencephalon morphogenesis,BP,
13140,GO:0048853,1,0.936183853153717,0,10,forebrain morphogenesis,BP,
13141,GO:0048854,1,0.803864329391597,0,33,brain morphogenesis,BP,
13145,GO:0048859,1,0.968061562525108,0,5,formation of anatomical boundary,BP,
13146,GO:0048861,1,0.954289987250282,0,7,leukemia inhibitory factor signaling pathway,BP,
13148,GO:0048864,1,0.579907101237756,0,83,stem cell development,BP,
13149,GO:0048865,1,0.949786711691874,0,8,stem cell fate commitment,BP,
13150,GO:0048866,1,0.974606918777627,0,4,stem cell fate specification,BP,
13151,GO:0048867,1,0.980957167432762,0,3,stem cell fate determination,BP,
13155,GO:0048872,1,0.206808406722887,0,240,homeostasis of number of cells,BP,
13156,GO:0048873,1,0.838921825485821,0,27,homeostasis of number of cells within a tissue,BP,
13157,GO:0048874,1,0.993402145330824,0,1,host-mediated regulation of intestinal microbiota composition,BP,
13158,GO:0048875,1,0.936999120949315,0,10,chemical homeostasis within a tissue,BP,
13161,GO:0048881,1,0.993465434147348,0,1,mechanosensory lateral line system development,BP,
13162,GO:0048882,1,0.987071439746508,0,2,lateral line development,BP,
13163,GO:0048884,1,0.987071439746508,0,2,neuromast development,BP,
13164,GO:0048886,1,0.987071439746508,0,2,neuromast hair cell differentiation,BP,
13165,GO:0048915,1,0.993465434147348,0,1,posterior lateral line system development,BP,
13166,GO:0048916,1,0.993465434147348,0,1,posterior lateral line development,BP,
13167,GO:0048919,1,0.993465434147348,0,1,posterior lateral line neuromast development,BP,
13168,GO:0048923,1,0.993465434147348,0,1,posterior lateral line neuromast hair cell differentiation,BP,
13169,GO:0048925,1,0.987071439746508,0,2,lateral line system development,BP,
13170,GO:0048934,1,0.917517021722537,0,13,peripheral nervous system neuron differentiation,BP,
13171,GO:0048935,1,0.917517021722537,0,13,peripheral nervous system neuron development,BP,
13172,GO:0048936,1,0.98077385127497,0,3,peripheral nervous system neuron axonogenesis,BP,
13173,GO:0050000,1,0.624965294887046,0,72,chromosome localization,BP,
13174,GO:0050011,1,0.993633579015231,0,1,itaconyl-CoA hydratase activity,MF,
13175,GO:0050023,1,0.993615415825736,0,1,L-fuconate dehydratase activity,MF,
13176,GO:0050031,1,0.993578883199393,0,1,L-pipecolate oxidase activity,MF,
13177,GO:0050038,1,0.993683971849142,0,1,L-xylulose reductase (NADP+) activity,MF,
13178,GO:0050051,1,0.980824441335495,0,3,leukotriene-B4 20-monooxygenase activity,MF,
13179,GO:0050061,1,0.99350270938318,0,1,long-chain-aldehyde dehydrogenase activity,MF,
13180,GO:0050072,1,0.955188148141139,0,7,m7G(5')pppN diphosphatase activity,MF,
13181,GO:0050080,1,0.993593327189849,0,1,malonyl-CoA decarboxylase activity,MF,
13182,GO:0050104,1,0.993639585932517,0,1,L-gulonate 3-dehydrogenase activity,MF,
13183,GO:0050115,1,0.993428059072322,0,1,myosin-light-chain-phosphatase activity,MF,
13184,GO:0050121,1,0.993641252336557,0,1,N-acylglucosamine 2-epimerase activity,MF,
13185,GO:0050124,1,0.99350123053554,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13186,GO:0050129,1,0.993533031651275,0,1,N-formylglutamate deformylase activity,MF,
13187,GO:0050135,1,0.90100967510994,0,16,NAD(P)+ nucleosidase activity,MF,
13188,GO:0050136,1,0.785292262745526,0,38,NADH dehydrogenase (quinone) activity,MF,
13190,GO:0050152,1,0.99365461810124,0,1,omega-amidase activity,MF,
13191,GO:0050155,1,0.993607332753872,0,1,ornithine(lysine) transaminase activity,MF,
13192,GO:0050178,1,0.987437521178517,0,2,phenylpyruvate tautomerase activity,MF,
13193,GO:0050185,1,0.992848007277361,0,1,phosphatidylinositol deacylase activity,MF,
13194,GO:0050196,1,0.986872943087472,0,2,[phosphorylase] phosphatase activity,MF,
13195,GO:0050197,1,0.98712633098888,0,2,phytanate-CoA ligase activity,MF,
13196,GO:0050200,1,0.986921839863664,0,2,plasmalogen synthase activity,MF,
13197,GO:0050211,1,0.980781764889468,0,3,procollagen galactosyltransferase activity,MF,
13198,GO:0050218,1,0.974406344381339,0,4,propionate-CoA ligase activity,MF,
13199,GO:0050220,1,0.980986726516025,0,3,prostaglandin-E synthase activity,MF,
13201,GO:0050251,1,0.987222889854729,0,2,retinol isomerase activity,MF,
13202,GO:0050252,1,0.987123137050372,0,2,retinol O-fatty-acyltransferase activity,MF,
13203,GO:0050253,1,0.974312775893263,0,4,retinyl-palmitate esterase activity,MF,
13204,GO:0050254,1,0.980935209855357,0,3,rhodopsin kinase activity,MF,
13205,GO:0050255,1,0.99357166287299,0,1,ribitol 2-dehydrogenase activity,MF,
13206,GO:0050262,1,0.987155207697788,0,2,ribosylnicotinamide kinase activity,MF,
13207,GO:0050265,1,0.993553493485706,0,1,RNA uridylyltransferase activity,MF,
13208,GO:0050277,1,0.993498638320409,0,1,sedoheptulokinase activity,MF,
13209,GO:0050290,1,0.993438552992901,0,1,sphingomyelin phosphodiesterase D activity,MF,
13210,GO:0050291,1,0.961953645410098,0,6,sphingosine N-acyltransferase activity,MF,
13211,GO:0050294,1,0.974781069232404,0,4,steroid sulfotransferase activity,MF,
13212,GO:0050295,1,0.987131509937383,0,2,steryl-beta-glucosidase activity,MF,
13213,GO:0050308,1,0.949489368447425,0,8,sugar-phosphatase activity,MF,
13214,GO:0050309,1,0.980834410601425,0,3,sugar-terminal-phosphatase activity,MF,
13215,GO:0050313,1,0.993675200071609,0,1,sulfur dioxygenase activity,MF,
13216,GO:0050321,1,0.865292387572157,0,22,tau-protein kinase activity,MF,
13217,GO:0050333,1,0.993619914931929,0,1,thiamin-triphosphatase activity,MF,
13218,GO:0050337,1,0.993700290859053,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13219,GO:0050346,1,0.99355705431691,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13220,GO:0050347,1,0.987186603207118,0,2,trans-octaprenyltranstransferase activity,MF,
13221,GO:0050353,1,0.993551881952435,0,1,trimethyllysine dioxygenase activity,MF,
13222,GO:0050355,1,0.993458451180492,0,1,triphosphatase activity,MF,
13223,GO:0050405,1,0.986482945830729,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13224,GO:0050421,1,0.993567127228303,0,1,nitrite reductase (NO-forming) activity,MF,
13225,GO:0050427,1,0.873067146703779,0,21,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13226,GO:0050428,1,0.96156963794011,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13227,GO:0050429,1,0.993295523538054,0,1,calcium-dependent phospholipase C activity,MF,
13228,GO:0050431,1,0.865381620301126,0,22,transforming growth factor beta binding,MF,
13231,GO:0050434,1,0.766010079854557,0,41,positive regulation of viral transcription,BP,
13232,GO:0050435,1,0.743515973141876,0,45,amyloid-beta metabolic process,BP,
13233,GO:0050436,1,0.980132087412033,0,3,microfibril binding,MF,
13234,GO:0050444,1,0.993528148521336,0,1,aquacobalamin reductase (NADPH) activity,MF,
13235,GO:0050459,1,0.99355705431691,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13236,GO:0050462,1,0.993656939990299,0,1,N-acetylneuraminate synthase activity,MF,
13237,GO:0050473,1,0.980832176681796,0,3,arachidonate 15-lipoxygenase activity,MF,
13238,GO:0050479,1,0.99355705431691,0,1,glyceryl-ether monooxygenase activity,MF,
13239,GO:0050480,1,0.993596898720476,0,1,imidazolonepropionase activity,MF,
13241,GO:0050486,1,0.993526456458889,0,1,intramolecular transferase activity, transferring hydroxy groups,MF,
13242,GO:0050497,1,0.987174301323115,0,2,transferase activity, transferring alkylthio groups,MF,
13243,GO:0050501,1,0.974542767488175,0,4,hyaluronan synthase activity,MF,
13244,GO:0050508,1,0.980642740859026,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13245,GO:0050509,1,0.987071136121334,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13246,GO:0050510,1,0.974256535504962,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13247,GO:0050512,1,0.993600220587304,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13248,GO:0050528,1,0.993580358118446,0,1,acyloxyacyl hydrolase activity,MF,
13249,GO:0050542,1,0.962473725486414,0,6,icosanoid binding,MF,
13250,GO:0050543,1,0.96251637140363,0,6,icosatetraenoic acid binding,MF,
13251,GO:0050544,1,0.968653307360017,0,5,arachidonic acid binding,MF,
13252,GO:0050560,1,0.993524607399594,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13253,GO:0050561,1,0.993494103316609,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13254,GO:0050567,1,0.980872649372175,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13255,GO:0050571,1,0.993632309268821,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13256,GO:0050610,1,0.987366936148646,0,2,methylarsonate reductase activity,MF,
13257,GO:0050613,1,0.987175977777327,0,2,delta14-sterol reductase activity,MF,
13258,GO:0050614,1,0.993471017392034,0,1,delta24-sterol reductase activity,MF,
13259,GO:0050632,1,0.993644915207127,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13260,GO:0050633,1,0.980976512908801,0,3,acetyl-CoA C-myristoyltransferase activity,MF,
13261,GO:0050646,1,0.993622465323995,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13262,GO:0050647,1,0.993622465323995,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13263,GO:0050648,1,0.993622465323995,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13264,GO:0050649,1,0.987260488267917,0,2,testosterone 6-beta-hydroxylase activity,MF,
13265,GO:0050650,1,0.816204307280218,0,31,chondroitin sulfate proteoglycan biosynthetic process,BP,
13266,GO:0050651,1,0.906065931517861,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13267,GO:0050652,1,0.993505115999098,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13268,GO:0050653,1,0.987038962769175,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13270,GO:0050655,1,0.90025529295619,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13271,GO:0050656,1,0.961533462091436,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13272,GO:0050657,1,0.298651775606913,0,184,nucleic acid transport,BP,
13273,GO:0050658,1,0.298651775606913,0,184,RNA transport,BP,
13274,GO:0050659,1,0.986844057955993,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13276,GO:0050661,1,0.722729362864521,0,50,NADP binding,MF,
13277,GO:0050663,1,0.668453629662891,0,62,cytokine secretion,BP,
13278,GO:0050664,1,0.90134420021419,0,16,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13280,GO:0050666,1,0.987202456633064,0,2,regulation of homocysteine metabolic process,BP,
13281,GO:0050667,1,0.925118477338426,0,12,homocysteine metabolic process,BP,
13282,GO:0050668,1,0.993588301841849,0,1,positive regulation of homocysteine metabolic process,BP,
13285,GO:0050672,1,0.626553993390386,0,72,negative regulation of lymphocyte proliferation,BP,
13287,GO:0050674,1,0.993697530091657,0,1,urothelial cell proliferation,BP,
13288,GO:0050675,1,0.993697530091657,0,1,regulation of urothelial cell proliferation,BP,
13289,GO:0050677,1,0.993697530091657,0,1,positive regulation of urothelial cell proliferation,BP,
13292,GO:0050680,1,0.466760723689393,0,116,negative regulation of epithelial cell proliferation,BP,
13293,GO:0050681,1,0.837812157780075,0,27,androgen receptor binding,MF,
13294,GO:0050682,1,0.98002521722479,0,3,AF-2 domain binding,MF,
13295,GO:0050683,1,0.993482424244643,0,1,AF-1 domain binding,MF,
13296,GO:0050684,1,0.392684687296393,0,143,regulation of mRNA processing,BP,
13297,GO:0050685,1,0.817828395016565,0,31,positive regulation of mRNA processing,BP,
13298,GO:0050686,1,0.81803420294596,0,31,negative regulation of mRNA processing,BP,
13299,GO:0050687,1,0.872372784427868,0,21,negative regulation of defense response to virus,BP,
13300,GO:0050688,1,0.662838635621695,0,63,regulation of defense response to virus,BP,
13301,GO:0050689,1,0.980915607342741,0,3,negative regulation of defense response to virus by host,BP,
13302,GO:0050690,1,0.828417160993005,0,29,regulation of defense response to virus by virus,BP,
13303,GO:0050691,1,0.812024154581952,0,32,regulation of defense response to virus by host,BP,
13304,GO:0050692,1,0.98065682156279,0,3,DNA binding domain binding,MF,
13305,GO:0050693,1,0.961595310726621,0,6,LBD domain binding,MF,
13306,GO:0050694,1,0.974604375887441,0,4,galactose 3-O-sulfotransferase activity,MF,
13307,GO:0050698,1,0.987139180583363,0,2,proteoglycan sulfotransferase activity,MF,
13308,GO:0050699,1,0.822866739157184,0,30,WW domain binding,MF,
13309,GO:0050700,1,0.912677918341649,0,14,CARD domain binding,MF,
13310,GO:0050707,1,0.722744195624553,0,50,regulation of cytokine secretion,BP,
13313,GO:0050710,1,0.907474532693352,0,15,negative regulation of cytokine secretion,BP,
13315,GO:0050715,1,0.839514681956696,0,27,positive regulation of cytokine secretion,BP,
13317,GO:0050728,1,0.449138029871255,0,123,negative regulation of inflammatory response,BP,
13321,GO:0050732,1,0.736246562597714,0,47,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13322,GO:0050733,1,0.967972691635844,0,5,RS domain binding,MF,
13324,GO:0050747,1,0.967953593685682,0,5,positive regulation of lipoprotein metabolic process,BP,
13326,GO:0050750,1,0.887894582099415,0,18,low-density lipoprotein particle receptor binding,MF,
13327,GO:0050755,1,0.993663168536915,0,1,chemokine metabolic process,BP,
13328,GO:0050757,1,0.98727001305548,0,2,thymidylate synthase biosynthetic process,BP,
13329,GO:0050758,1,0.98727001305548,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13330,GO:0050760,1,0.993564826910877,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13331,GO:0050764,1,0.574414747939933,0,85,regulation of phagocytosis,BP,
13332,GO:0050765,1,0.895178584947516,0,17,negative regulation of phagocytosis,BP,
13333,GO:0050766,1,0.667698754633475,0,62,positive regulation of phagocytosis,BP,
13339,GO:0050772,1,0.579887609564279,0,82,positive regulation of axonogenesis,BP,
13341,GO:0050774,1,0.900390725616818,0,16,negative regulation of dendrite morphogenesis,BP,
13342,GO:0050775,1,0.783766026728308,0,37,positive regulation of dendrite morphogenesis,BP,
13344,GO:0050777,1,0.423872907136032,0,132,negative regulation of immune response,BP,
13346,GO:0050779,1,0.79990790986263,0,34,RNA destabilization,BP,
13347,GO:0050780,1,0.895486665811315,0,17,dopamine receptor binding,MF,
13348,GO:0050783,1,0.993577031815251,0,1,cocaine metabolic process,BP,
13349,GO:0050785,1,0.993650235406605,0,1,advanced glycation end-product receptor activity,MF,
13350,GO:0050786,1,0.938463203952793,0,10,RAGE receptor binding,MF,
13351,GO:0050787,1,0.987131486053405,0,2,detoxification of mercury ion,BP,
13354,GO:0050792,1,0.285550149328309,0,192,regulation of viral process,BP,
13361,GO:0050802,1,0.8731956167706,0,21,circadian sleep/wake cycle, sleep,BP,
13369,GO:0050811,1,0.89431034289746,0,17,GABA receptor binding,MF,
13370,GO:0050812,1,0.948721525782828,0,8,regulation of acyl-CoA biosynthetic process,BP,
13371,GO:0050815,1,0.949403370856717,0,8,phosphoserine residue binding,MF,
13372,GO:0050816,1,0.980603927083235,0,3,phosphothreonine residue binding,MF,
13376,GO:0050820,1,0.844657275743393,0,26,positive regulation of coagulation,BP,
13377,GO:0050821,1,0.334510273395661,0,167,protein stabilization,BP,
13378,GO:0050822,1,0.993516986315932,0,1,peptide stabilization,BP,
13379,GO:0050823,1,0.993516986315932,0,1,peptide antigen stabilization,BP,
13383,GO:0050833,1,0.974493790403254,0,4,pyruvate transmembrane transporter activity,MF,
13386,GO:0050847,1,0.941296036730626,0,9,progesterone receptor signaling pathway,BP,
13389,GO:0050850,1,0.780552616656932,0,38,positive regulation of calcium-mediated signaling,BP,
13399,GO:0050860,1,0.861969701588304,0,23,negative regulation of T cell receptor signaling pathway,BP,
13400,GO:0050861,1,0.949215351074447,0,8,positive regulation of B cell receptor signaling pathway,BP,
13407,GO:0050868,1,0.515345229656797,0,102,negative regulation of T cell activation,BP,
13408,GO:0050869,1,0.812273721414135,0,32,negative regulation of B cell activation,BP,
13410,GO:0050871,1,0.64281293918589,0,68,positive regulation of B cell activation,BP,
13411,GO:0050872,1,0.912910030313115,0,14,white fat cell differentiation,BP,
13412,GO:0050873,1,0.740760301862684,0,46,brown fat cell differentiation,BP,
13415,GO:0050879,1,0.710668058967198,0,52,multicellular organismal movement,BP,
13416,GO:0050881,1,0.710668058967198,0,52,musculoskeletal movement,BP,
13417,GO:0050882,1,0.952926939942013,0,7,voluntary musculoskeletal movement,BP,
13418,GO:0050883,1,0.987249069990403,0,2,musculoskeletal movement, spinal reflex action,BP,
13419,GO:0050884,1,0.906512147421351,0,15,neuromuscular process controlling posture,BP,
13421,GO:0050886,1,0.626534446252073,0,72,endocrine process,BP,
13423,GO:0050891,1,0.674238715013417,0,60,multicellular organismal water homeostasis,BP,
13424,GO:0050892,1,0.82267821363103,0,30,intestinal absorption,BP,
13425,GO:0050893,1,0.974290138965924,0,4,sensory processing,BP,
13426,GO:0050894,1,0.993278058503644,0,1,determination of affect,BP,
13428,GO:0050897,1,0.980624912403425,0,3,cobalt ion binding,MF,
13430,GO:0050901,1,0.827641756562826,0,29,leukocyte tethering or rolling,BP,
13431,GO:0050902,1,0.987142201629914,0,2,leukocyte adhesive activation,BP,
13432,GO:0050904,1,0.967790406469735,0,5,diapedesis,BP,
13434,GO:0050906,1,0.539786130921863,0,95,detection of stimulus involved in sensory perception,BP,
13435,GO:0050907,1,0.764127015874226,0,42,detection of chemical stimulus involved in sensory perception,BP,
13436,GO:0050908,1,0.894544660943579,0,17,detection of light stimulus involved in visual perception,BP,
13437,GO:0050909,1,0.753156505918057,0,44,sensory perception of taste,BP,
13438,GO:0050910,1,0.930906525047329,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13439,GO:0050911,1,0.902862876355641,0,16,detection of chemical stimulus involved in sensory perception of smell,BP,
13440,GO:0050912,1,0.857579460659301,0,24,detection of chemical stimulus involved in sensory perception of taste,BP,
13441,GO:0050913,1,0.857037439764752,0,24,sensory perception of bitter taste,BP,
13442,GO:0050915,1,0.974457545681314,0,4,sensory perception of sour taste,BP,
13443,GO:0050916,1,0.967850035494463,0,5,sensory perception of sweet taste,BP,
13444,GO:0050917,1,0.961594438262539,0,6,sensory perception of umami taste,BP,
13445,GO:0050918,1,0.706938758093588,0,53,positive chemotaxis,BP,
13446,GO:0050919,1,0.737619060717696,0,46,negative chemotaxis,BP,
13450,GO:0050923,1,0.97375488061626,0,4,regulation of negative chemotaxis,BP,
13451,GO:0050924,1,0.99342059423354,0,1,positive regulation of negative chemotaxis,BP,
13452,GO:0050925,1,0.986597248094362,0,2,negative regulation of negative chemotaxis,BP,
13453,GO:0050926,1,0.850019607615721,0,25,regulation of positive chemotaxis,BP,
13454,GO:0050927,1,0.855677723145398,0,24,positive regulation of positive chemotaxis,BP,
13455,GO:0050928,1,0.993397826446438,0,1,negative regulation of positive chemotaxis,BP,
13456,GO:0050929,1,0.99342059423354,0,1,induction of negative chemotaxis,BP,
13457,GO:0050930,1,0.919707509296472,0,13,induction of positive chemotaxis,BP,
13458,GO:0050931,1,0.799301003021206,0,34,pigment cell differentiation,BP,
13459,GO:0050932,1,0.948439576612548,0,8,regulation of pigment cell differentiation,BP,
13460,GO:0050942,1,0.954519782170729,0,7,positive regulation of pigment cell differentiation,BP,
13461,GO:0050951,1,0.872015199621206,0,21,sensory perception of temperature stimulus,BP,
13464,GO:0050955,1,0.974011170346199,0,4,thermoception,BP,
13465,GO:0050957,1,0.961160208521324,0,6,equilibrioception,BP,
13466,GO:0050960,1,0.980516650564524,0,3,detection of temperature stimulus involved in thermoception,BP,
13467,GO:0050961,1,0.895614995167969,0,17,detection of temperature stimulus involved in sensory perception,BP,
13468,GO:0050962,1,0.894544660943579,0,17,detection of light stimulus involved in sensory perception,BP,
13469,GO:0050965,1,0.907467475506524,0,15,detection of temperature stimulus involved in sensory perception of pain,BP,
13470,GO:0050966,1,0.924254322870081,0,12,detection of mechanical stimulus involved in sensory perception of pain,BP,
13471,GO:0050968,1,0.98707952684944,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13472,GO:0050974,1,0.838430883255128,0,27,detection of mechanical stimulus involved in sensory perception,BP,
13473,GO:0050975,1,0.967995120504725,0,5,sensory perception of touch,BP,
13474,GO:0050976,1,0.980465340411565,0,3,detection of mechanical stimulus involved in sensory perception of touch,BP,
13475,GO:0050982,1,0.758468414982403,0,40,detection of mechanical stimulus,BP,
13476,GO:0050992,1,0.993597230304888,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13477,GO:0050993,1,0.993597230304888,0,1,dimethylallyl diphosphate metabolic process,BP,
13479,GO:0050995,1,0.882903501971051,0,19,negative regulation of lipid catabolic process,BP,
13480,GO:0050996,1,0.87740988974041,0,20,positive regulation of lipid catabolic process,BP,
13481,GO:0050997,1,0.859872819422674,0,23,quaternary ammonium group binding,MF,
13482,GO:0050998,1,0.911971993561582,0,14,nitric-oxide synthase binding,MF,
13485,GO:0051001,1,0.955439694962624,0,7,negative regulation of nitric-oxide synthase activity,BP,
13486,GO:0051004,1,0.901721249302463,0,16,regulation of lipoprotein lipase activity,BP,
13487,GO:0051005,1,0.974292642755043,0,4,negative regulation of lipoprotein lipase activity,BP,
13488,GO:0051006,1,0.956066472730294,0,7,positive regulation of lipoprotein lipase activity,BP,
13489,GO:0051008,1,0.993609610900034,0,1,Hsp27 protein binding,MF,
13490,GO:0051010,1,0.874819631729116,0,20,microtubule plus-end binding,MF,
13491,GO:0051011,1,0.929034359070157,0,11,microtubule minus-end binding,MF,
13492,GO:0051012,1,0.986818142252478,0,2,microtubule sliding,BP,
13493,GO:0051013,1,0.930778680996921,0,11,microtubule severing,BP,
13494,GO:0051014,1,0.907036142553304,0,15,actin filament severing,BP,
13496,GO:0051016,1,0.877981283548209,0,20,barbed-end actin filament capping,BP,
13499,GO:0051019,1,0.806298400343456,0,33,mitogen-activated protein kinase binding,MF,
13501,GO:0051021,1,0.974387715338644,0,4,GDP-dissociation inhibitor binding,MF,
13502,GO:0051022,1,0.980626120093283,0,3,Rho GDP-dissociation inhibitor binding,MF,
13504,GO:0051024,1,0.94401242860963,0,9,positive regulation of immunoglobulin secretion,BP,
13506,GO:0051026,1,0.968167026147119,0,5,chiasma assembly,BP,
13507,GO:0051028,1,0.398705702312159,0,140,mRNA transport,BP,
13508,GO:0051029,1,0.96794854116549,0,5,rRNA transport,BP,
13509,GO:0051030,1,0.974757559138598,0,4,snRNA transport,BP,
13510,GO:0051031,1,0.805284477285753,0,33,tRNA transport,BP,
13511,GO:0051032,1,0.986952811570306,0,2,nucleic acid transmembrane transporter activity,MF,
13512,GO:0051033,1,0.986952811570306,0,2,RNA transmembrane transporter activity,MF,
13513,GO:0051036,1,0.968263138815369,0,5,regulation of endosome size,BP,
13514,GO:0051040,1,0.987106695386556,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13515,GO:0051041,1,0.993529419212751,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13516,GO:0051042,1,0.993535865062877,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13517,GO:0051043,1,0.872328372803528,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13518,GO:0051044,1,0.919198115553571,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13519,GO:0051045,1,0.949052024788094,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13527,GO:0051053,1,0.525352648860122,0,98,negative regulation of DNA metabolic process,BP,
13529,GO:0051055,1,0.736970873064281,0,47,negative regulation of lipid biosynthetic process,BP,
13532,GO:0051058,1,0.69112504977051,0,56,negative regulation of small GTPase mediated signal transduction,BP,
13533,GO:0051059,1,0.816895254282776,0,31,NF-kappaB binding,MF,
13534,GO:0051066,1,0.987279150106209,0,2,dihydrobiopterin metabolic process,BP,
13535,GO:0051068,1,0.993512555144168,0,1,dihydrolipoamide metabolic process,BP,
13536,GO:0051081,1,0.90088705242338,0,16,nuclear envelope disassembly,BP,
13537,GO:0051082,1,0.516347221577737,0,102,unfolded protein binding,MF,
13538,GO:0051083,1,0.987255828534506,0,2,'de novo' cotranslational protein folding,BP,
13539,GO:0051084,1,0.812772237626577,0,32,'de novo' posttranslational protein folding,BP,
13540,GO:0051085,1,0.83452735708875,0,28,chaperone cofactor-dependent protein refolding,BP,
13541,GO:0051086,1,0.993608504983777,0,1,chaperone mediated protein folding independent of cofactor,BP,
13543,GO:0051089,1,0.993492995387735,0,1,constitutive protein ectodomain proteolysis,BP,
13549,GO:0051095,1,0.925306834738979,0,12,regulation of helicase activity,BP,
13550,GO:0051096,1,0.955655331612556,0,7,positive regulation of helicase activity,BP,
13551,GO:0051097,1,0.968257433923809,0,5,negative regulation of helicase activity,BP,
13552,GO:0051098,1,0.106223481552889,0,340,regulation of binding,BP,
13553,GO:0051099,1,0.34356225784311,0,163,positive regulation of binding,BP,
13554,GO:0051100,1,0.370047953068778,0,152,negative regulation of binding,BP,
13555,GO:0051101,1,0.471408270047289,0,115,regulation of DNA binding,BP,
13556,GO:0051102,1,0.993486005818868,0,1,DNA ligation involved in DNA recombination,BP,
13557,GO:0051103,1,0.955902834910866,0,7,DNA ligation involved in DNA repair,BP,
13558,GO:0051105,1,0.961951205986846,0,6,regulation of DNA ligation,BP,
13559,GO:0051106,1,0.968198482318591,0,5,positive regulation of DNA ligation,BP,
13560,GO:0051107,1,0.993549603578293,0,1,negative regulation of DNA ligation,BP,
13563,GO:0051120,1,0.987129723391051,0,2,hepoxilin A3 synthase activity,MF,
13564,GO:0051121,1,0.943808754689052,0,9,hepoxilin metabolic process,BP,
13565,GO:0051122,1,0.943808754689052,0,9,hepoxilin biosynthetic process,BP,
13566,GO:0051123,1,0.855481237845946,0,24,RNA polymerase II preinitiation complex assembly,BP,
13567,GO:0051124,1,0.935336400711768,0,10,synaptic growth at neuromuscular junction,BP,
13568,GO:0051125,1,0.832925429066754,0,28,regulation of actin nucleation,BP,
13569,GO:0051126,1,0.949659007749353,0,8,negative regulation of actin nucleation,BP,
13570,GO:0051127,1,0.905940953419692,0,15,positive regulation of actin nucleation,BP,
13574,GO:0051131,1,0.879307084748597,0,20,chaperone-mediated protein complex assembly,BP,
13575,GO:0051132,1,0.943689993788013,0,9,NK T cell activation,BP,
13576,GO:0051133,1,0.955982198043408,0,7,regulation of NK T cell activation,BP,
13577,GO:0051134,1,0.987165735099337,0,2,negative regulation of NK T cell activation,BP,
13578,GO:0051135,1,0.968415057883609,0,5,positive regulation of NK T cell activation,BP,
13579,GO:0051136,1,0.961627623345632,0,6,regulation of NK T cell differentiation,BP,
13580,GO:0051138,1,0.97420151710089,0,4,positive regulation of NK T cell differentiation,BP,
13581,GO:0051139,1,0.91843416861545,0,13,metal ion:proton antiporter activity,MF,
13582,GO:0051140,1,0.974614890476487,0,4,regulation of NK T cell proliferation,BP,
13583,GO:0051141,1,0.993511103248229,0,1,negative regulation of NK T cell proliferation,BP,
13584,GO:0051142,1,0.980981597300175,0,3,positive regulation of NK T cell proliferation,BP,
13585,GO:0051145,1,0.703222920866024,0,54,smooth muscle cell differentiation,BP,
13590,GO:0051150,1,0.8222165165271,0,30,regulation of smooth muscle cell differentiation,BP,
13591,GO:0051151,1,0.900669032661305,0,16,negative regulation of smooth muscle cell differentiation,BP,
13592,GO:0051152,1,0.931244636181174,0,11,positive regulation of smooth muscle cell differentiation,BP,
13596,GO:0051156,1,0.855863613887797,0,24,glucose 6-phosphate metabolic process,BP,
13597,GO:0051160,1,0.99357166287299,0,1,L-xylitol catabolic process,BP,
13598,GO:0051164,1,0.99357166287299,0,1,L-xylitol metabolic process,BP,
13599,GO:0051167,1,0.96844507163844,0,5,xylulose 5-phosphate metabolic process,BP,
13600,GO:0051168,1,0.281468238920198,0,193,nuclear export,BP,
13601,GO:0051169,1,0.109464436601267,0,335,nuclear transport,BP,
13602,GO:0051170,1,0.358370614250361,0,156,import into nucleus,BP,
13607,GO:0051176,1,0.980465530300039,0,3,positive regulation of sulfur metabolic process,BP,
13608,GO:0051177,1,0.943607200707066,0,9,meiotic sister chromatid cohesion,BP,
13611,GO:0051189,1,0.961925229714383,0,6,prosthetic group metabolic process,BP,
13612,GO:0051192,1,0.993694965537682,0,1,prosthetic group binding,MF,
13613,GO:0051204,1,0.757776176658456,0,43,protein insertion into mitochondrial membrane,BP,
13617,GO:0051213,1,0.569387129621531,0,86,dioxygenase activity,MF,
13620,GO:0051220,1,0.860189842662042,0,23,cytoplasmic sequestering of protein,BP,
13624,GO:0051225,1,0.504347435179433,0,104,spindle assembly,BP,
13625,GO:0051228,1,0.986944515840558,0,2,mitotic spindle disassembly,BP,
13626,GO:0051230,1,0.986944515840558,0,2,spindle disassembly,BP,
13627,GO:0051231,1,0.943201742097979,0,9,spindle elongation,BP,
13628,GO:0051232,1,0.99358145186799,0,1,meiotic spindle elongation,BP,
13629,GO:0051233,1,0.795393872812075,0,35,spindle midzone,CC,
13632,GO:0051236,1,0.292505715280939,0,187,establishment of RNA localization,BP,
13633,GO:0051238,1,0.931485339224509,0,11,sequestering of metal ion,BP,
13641,GO:0051250,1,0.412831393267654,0,136,negative regulation of lymphocyte activation,BP,
13646,GO:0051255,1,0.9312778782788,0,11,spindle midzone assembly,BP,
13647,GO:0051256,1,0.955772023092178,0,7,mitotic spindle midzone assembly,BP,
13648,GO:0051257,1,0.987096792782129,0,2,meiotic spindle midzone assembly,BP,
13651,GO:0051260,1,0.334876468633548,0,167,protein homooligomerization,BP,
13652,GO:0051261,1,0.496362113790865,0,106,protein depolymerization,BP,
13654,GO:0051264,1,0.993554711636952,0,1,mono-olein transacylation activity,MF,
13655,GO:0051265,1,0.993554711636952,0,1,diolein transacylation activity,MF,
13656,GO:0051267,1,0.993530691847354,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13662,GO:0051280,1,0.925455927196864,0,12,negative regulation of release of sequestered calcium ion into cytosol,BP,
13667,GO:0051286,1,0.955057415279731,0,7,cell tip,CC,
13668,GO:0051287,1,0.705667734991774,0,54,NAD binding,MF,
13669,GO:0051289,1,0.697924593054214,0,55,protein homotetramerization,BP,
13670,GO:0051290,1,0.905977082962583,0,15,protein heterotetramerization,BP,
13671,GO:0051291,1,0.870943242007626,0,21,protein heterooligomerization,BP,
13672,GO:0051292,1,0.94256870178818,0,9,nuclear pore complex assembly,BP,
13673,GO:0051293,1,0.74829462205168,0,44,establishment of spindle localization,BP,
13674,GO:0051294,1,0.795283465853605,0,35,establishment of spindle orientation,BP,
13675,GO:0051295,1,0.973674065389801,0,4,establishment of meiotic spindle localization,BP,
13676,GO:0051298,1,0.651813788153883,0,65,centrosome duplication,BP,
13677,GO:0051299,1,0.906900581183484,0,15,centrosome separation,BP,
13680,GO:0051303,1,0.624965294887046,0,72,establishment of chromosome localization,BP,
13681,GO:0051304,1,0.569606267035726,0,86,chromosome separation,BP,
13683,GO:0051306,1,0.671218816120115,0,61,mitotic sister chromatid separation,BP,
13684,GO:0051307,1,0.877646511183975,0,20,meiotic chromosome separation,BP,
13685,GO:0051308,1,0.99355705431691,0,1,male meiosis chromosome separation,BP,
13686,GO:0051309,1,0.987120640358365,0,2,female meiosis chromosome separation,BP,
13687,GO:0051310,1,0.680761758007699,0,59,metaphase plate congression,BP,
13688,GO:0051311,1,0.993575443551876,0,1,meiotic metaphase plate congression,BP,
13689,GO:0051315,1,0.907149790364216,0,15,attachment of mitotic spindle microtubules to kinetochore,BP,
13690,GO:0051316,1,0.99355705431691,0,1,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13691,GO:0051318,1,0.986954970037953,0,2,G1 phase,BP,
13692,GO:0051321,1,0.260560299169556,0,205,meiotic cell cycle,BP,
13693,GO:0051325,1,0.986954970037953,0,2,interphase,BP,
13694,GO:0051329,1,0.986954970037953,0,2,mitotic interphase,BP,
13698,GO:0051340,1,0.937889555547799,0,10,regulation of ligase activity,BP,
13700,GO:0051342,1,0.943228334797563,0,9,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13701,GO:0051343,1,0.974502778982841,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13702,GO:0051344,1,0.961662536673497,0,6,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13707,GO:0051349,1,0.887693356200833,0,18,positive regulation of lyase activity,BP,
13709,GO:0051351,1,0.950055099589142,0,8,positive regulation of ligase activity,BP,
13710,GO:0051352,1,0.987201424748515,0,2,negative regulation of ligase activity,BP,
13713,GO:0051355,1,0.993500388867616,0,1,proprioception involved in equilibrioception,BP,
13714,GO:0051365,1,0.980787893869288,0,3,cellular response to potassium ion starvation,BP,
13715,GO:0051371,1,0.900079571266019,0,14,muscle alpha-actinin binding,MF,
13716,GO:0051373,1,0.968249613282591,0,5,FATZ binding,MF,
13717,GO:0051377,1,0.974405020688012,0,4,mannose-ethanolamine phosphotransferase activity,MF,
13718,GO:0051378,1,0.925477191390581,0,12,serotonin binding,MF,
13719,GO:0051379,1,0.968311963251082,0,5,epinephrine binding,MF,
13720,GO:0051380,1,0.974558475600796,0,4,norepinephrine binding,MF,
13721,GO:0051382,1,0.906337237221697,0,15,kinetochore assembly,BP,
13722,GO:0051383,1,0.877234462269381,0,20,kinetochore organization,BP,
13725,GO:0051386,1,0.931127015476514,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
13726,GO:0051387,1,0.980868825662214,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13727,GO:0051388,1,0.96170676352276,0,6,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13728,GO:0051389,1,0.986310570109458,0,2,inactivation of MAPKK activity,BP,
13729,GO:0051391,1,0.993491968588613,0,1,tRNA acetylation,BP,
13730,GO:0051393,1,0.831041651698868,0,26,alpha-actinin binding,MF,
13731,GO:0051394,1,0.993648341094093,0,1,regulation of nerve growth factor receptor activity,BP,
13735,GO:0051409,1,0.936934517644901,0,10,response to nitrosative stress,BP,
13736,GO:0051410,1,0.980919449183031,0,3,detoxification of nitrogen compound,BP,
13738,GO:0051413,1,0.993572792297707,0,1,response to cortisone,BP,
13739,GO:0051414,1,0.967535498049647,0,5,response to cortisol,BP,
13740,GO:0051415,1,0.967873093068122,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13741,GO:0051418,1,0.942155079819939,0,9,microtubule nucleation by microtubule organizing center,BP,
13742,GO:0051424,1,0.987227139576147,0,2,corticotropin-releasing hormone binding,MF,
13743,GO:0051425,1,0.980231598295865,0,3,PTB domain binding,MF,
13746,GO:0051429,1,0.968445631267238,0,5,corticotropin-releasing hormone receptor binding,MF,
13747,GO:0051430,1,0.974645130523699,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13748,GO:0051431,1,0.98111275657798,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13749,GO:0051433,1,0.993453209714063,0,1,BH2 domain binding,MF,
13750,GO:0051434,1,0.968291725884839,0,5,BH3 domain binding,MF,
13751,GO:0051438,1,0.713182330136733,0,52,regulation of ubiquitin-protein transferase activity,BP,
13752,GO:0051443,1,0.806686275364979,0,33,positive regulation of ubiquitin-protein transferase activity,BP,
13753,GO:0051444,1,0.901793075415939,0,16,negative regulation of ubiquitin-protein transferase activity,BP,
13754,GO:0051445,1,0.745863979013167,0,45,regulation of meiotic cell cycle,BP,
13755,GO:0051446,1,0.871732584027224,0,21,positive regulation of meiotic cell cycle,BP,
13756,GO:0051447,1,0.913446111745724,0,14,negative regulation of meiotic cell cycle,BP,
13757,GO:0051450,1,0.889183203085489,0,18,myoblast proliferation,BP,
13758,GO:0051451,1,0.918715696071637,0,13,myoblast migration,BP,
13759,GO:0051452,1,0.709289942592851,0,53,intracellular pH reduction,BP,
13760,GO:0051453,1,0.593448674868746,0,80,regulation of intracellular pH,BP,
13761,GO:0051454,1,0.974247393825341,0,4,intracellular pH elevation,BP,
13762,GO:0051455,1,0.99355705431691,0,1,monopolar spindle attachment to meiosis I kinetochore,BP,
13763,GO:0051457,1,0.865836999699009,0,22,maintenance of protein location in nucleus,BP,
13764,GO:0051458,1,0.956035064615008,0,7,corticotropin secretion,BP,
13765,GO:0051459,1,0.962224988413549,0,6,regulation of corticotropin secretion,BP,
13766,GO:0051460,1,0.993616960371134,0,1,negative regulation of corticotropin secretion,BP,
13767,GO:0051461,1,0.968408355868299,0,5,positive regulation of corticotropin secretion,BP,
13768,GO:0051462,1,0.968305961070776,0,5,regulation of cortisol secretion,BP,
13769,GO:0051463,1,0.993310410117274,0,1,negative regulation of cortisol secretion,BP,
13770,GO:0051464,1,0.974828823227229,0,4,positive regulation of cortisol secretion,BP,
13771,GO:0051466,1,0.993532020092422,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13773,GO:0051481,1,0.922429001297298,0,12,negative regulation of cytosolic calcium ion concentration,BP,
13775,GO:0051489,1,0.759048365498133,0,42,regulation of filopodium assembly,BP,
13776,GO:0051490,1,0.980860379503344,0,3,negative regulation of filopodium assembly,BP,
13777,GO:0051491,1,0.832523962281395,0,28,positive regulation of filopodium assembly,BP,
13783,GO:0051497,1,0.842333516587454,0,26,negative regulation of stress fiber assembly,BP,
13784,GO:0051499,1,0.987246143335771,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13785,GO:0051500,1,0.987246143335771,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13786,GO:0051503,1,0.823662739124037,0,30,adenine nucleotide transport,BP,
13787,GO:0051525,1,0.967606896378832,0,5,NFAT protein binding,MF,
13790,GO:0051538,1,0.98085728293047,0,3,3 iron, 4 sulfur cluster binding,MF,
13791,GO:0051539,1,0.771276268944929,0,40,4 iron, 4 sulfur cluster binding,MF,
13793,GO:0051541,1,0.961570280347948,0,6,elastin metabolic process,BP,
13794,GO:0051542,1,0.986735261828999,0,2,elastin biosynthetic process,BP,
13795,GO:0051543,1,0.993582548566064,0,1,regulation of elastin biosynthetic process,BP,
13796,GO:0051545,1,0.993582548566064,0,1,negative regulation of elastin biosynthetic process,BP,
13797,GO:0051546,1,0.894603495420545,0,17,keratinocyte migration,BP,
13798,GO:0051547,1,0.918095551783687,0,13,regulation of keratinocyte migration,BP,
13799,GO:0051548,1,0.993374240866269,0,1,negative regulation of keratinocyte migration,BP,
13800,GO:0051549,1,0.9242240488004,0,12,positive regulation of keratinocyte migration,BP,
13801,GO:0051552,1,0.99330761561877,0,1,flavone metabolic process,BP,
13802,GO:0051560,1,0.855972390735208,0,24,mitochondrial calcium ion homeostasis,BP,
13803,GO:0051561,1,0.93149229519131,0,11,positive regulation of mitochondrial calcium ion concentration,BP,
13804,GO:0051562,1,0.974399530784927,0,4,negative regulation of mitochondrial calcium ion concentration,BP,
13805,GO:0051563,1,0.986889342144314,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13806,GO:0051567,1,0.787724345823445,0,36,histone H3-K9 methylation,BP,
13807,GO:0051568,1,0.719314803336826,0,50,histone H3-K4 methylation,BP,
13808,GO:0051569,1,0.838145449283561,0,27,regulation of histone H3-K4 methylation,BP,
13809,GO:0051570,1,0.870572361514805,0,21,regulation of histone H3-K9 methylation,BP,
13810,GO:0051571,1,0.894495308558241,0,17,positive regulation of histone H3-K4 methylation,BP,
13811,GO:0051572,1,0.967604978570946,0,5,negative regulation of histone H3-K4 methylation,BP,
13812,GO:0051573,1,0.930644892009102,0,11,negative regulation of histone H3-K9 methylation,BP,
13813,GO:0051574,1,0.942173417109609,0,9,positive regulation of histone H3-K9 methylation,BP,
13814,GO:0051575,1,0.967738564404767,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13817,GO:0051582,1,0.974595365022389,0,4,positive regulation of neurotransmitter uptake,BP,
13821,GO:0051586,1,0.980970097269164,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13824,GO:0051590,1,0.837809738891677,0,27,positive regulation of neurotransmitter transport,BP,
13825,GO:0051591,1,0.564936876026101,0,87,response to cAMP,BP,
13827,GO:0051593,1,0.943515804366373,0,9,response to folic acid,BP,
13828,GO:0051594,1,0.974625505293096,0,4,detection of glucose,BP,
13829,GO:0051595,1,0.98072232035816,0,3,response to methylglyoxal,BP,
13830,GO:0051596,1,0.980977733706401,0,3,methylglyoxal catabolic process,BP,
13831,GO:0051597,1,0.955129772757761,0,7,response to methylmercury,BP,
13832,GO:0051598,1,0.987100774372108,0,2,meiotic recombination checkpoint,BP,
13833,GO:0051599,1,0.967445486638247,0,5,response to hydrostatic pressure,BP,
13834,GO:0051601,1,0.955723123833141,0,7,exocyst localization,BP,
13835,GO:0051602,1,0.785817079427543,0,37,response to electrical stimulus,BP,
13836,GO:0051603,1,0.0116586867325175,0,668,proteolysis involved in cellular protein catabolic process,BP,
13839,GO:0051607,1,0.248629645615598,0,213,defense response to virus,BP,
13840,GO:0051608,1,0.919586994599493,0,13,histamine transport,BP,
13844,GO:0051615,1,0.980615310222337,0,3,histamine uptake,BP,
13848,GO:0051623,1,0.993618974946725,0,1,positive regulation of norepinephrine uptake,BP,
13849,GO:0051625,1,0.986959783884245,0,2,epinephrine uptake,BP,
13850,GO:0051639,1,0.93673012167913,0,10,actin filament network formation,BP,
13851,GO:0051640,1,0.0167912449070167,0,612,organelle localization,BP,
13853,GO:0051642,1,0.830104440490663,0,28,centrosome localization,BP,
13854,GO:0051643,1,0.95463475124333,0,7,endoplasmic reticulum localization,BP,
13855,GO:0051645,1,0.918054619738411,0,13,Golgi localization,BP,
13856,GO:0051646,1,0.753939525344975,0,43,mitochondrion localization,BP,
13857,GO:0051647,1,0.828252114755205,0,28,nucleus localization,BP,
13858,GO:0051648,1,0.242759991097082,0,214,vesicle localization,BP,
13860,GO:0051650,1,0.272203381132371,0,197,establishment of vesicle localization,BP,
13862,GO:0051653,1,0.728519272687187,0,48,spindle localization,BP,
13863,GO:0051654,1,0.859599562202542,0,23,establishment of mitochondrion localization,BP,
13864,GO:0051656,1,0.0695864370352623,0,402,establishment of organelle localization,BP,
13865,GO:0051657,1,0.935278801084222,0,10,maintenance of organelle location,BP,
13866,GO:0051659,1,0.987145878056736,0,2,maintenance of mitochondrion location,BP,
13867,GO:0051660,1,0.943051209714046,0,9,establishment of centrosome localization,BP,
13868,GO:0051661,1,0.966488793999805,0,5,maintenance of centrosome location,BP,
13870,GO:0051666,1,0.993616288817127,0,1,actin cortical patch localization,BP,
13872,GO:0051673,1,0.950212326992249,0,8,membrane disruption in other organism,BP,
13874,GO:0051683,1,0.955640533962472,0,7,establishment of Golgi localization,BP,
13875,GO:0051684,1,0.980315478595506,0,3,maintenance of Golgi location,BP,
13876,GO:0051685,1,0.99355705431691,0,1,maintenance of ER location,BP,
13877,GO:0051686,1,0.992733607935975,0,1,establishment of ER localization,BP,
13878,GO:0051691,1,0.993627324866982,0,1,cellular oligosaccharide metabolic process,BP,
13879,GO:0051692,1,0.993627324866982,0,1,cellular oligosaccharide catabolic process,BP,
13880,GO:0051693,1,0.793782053767124,0,35,actin filament capping,BP,
13881,GO:0051694,1,0.955270001242871,0,7,pointed-end actin filament capping,BP,
13882,GO:0051695,1,0.993453495652635,0,1,actin filament uncapping,BP,
13883,GO:0051697,1,0.993550170645785,0,1,protein delipidation,BP,
13885,GO:0051702,1,0.622512502731035,0,73,interaction with symbiont,BP,
13886,GO:0051703,1,0.722900172985812,0,49,intraspecies interaction between organisms,BP,
13889,GO:0051709,1,0.925426855416189,0,12,regulation of killing of cells of other organism,BP,
13890,GO:0051712,1,0.937427945956871,0,10,positive regulation of killing of cells of other organism,BP,
13891,GO:0051715,1,0.981032259322261,0,3,cytolysis in other organism,BP,
13893,GO:0051717,1,0.986969049312636,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13894,GO:0051721,1,0.821994663917258,0,30,protein phosphatase 2A binding,MF,
13895,GO:0051722,1,0.993575950994789,0,1,protein C-terminal methylesterase activity,MF,
13896,GO:0051723,1,0.993575950994789,0,1,protein methylesterase activity,MF,
13897,GO:0051724,1,0.993588596206985,0,1,NAD transmembrane transporter activity,MF,
13898,GO:0051725,1,0.968207058200376,0,5,protein de-ADP-ribosylation,BP,
13899,GO:0051726,1,0.000594254384029698,0,1098,regulation of cell cycle,BP,
13900,GO:0051728,1,0.98689415309101,0,2,cell cycle switching, mitotic to meiotic cell cycle,BP,
13901,GO:0051729,1,0.98689415309101,0,2,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13902,GO:0051731,1,0.97403829717758,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13903,GO:0051732,1,0.993623136143205,0,1,polyribonucleotide kinase activity,MF,
13904,GO:0051733,1,0.980636230239808,0,3,polydeoxyribonucleotide kinase activity,MF,
13905,GO:0051734,1,0.980636230239808,0,3,ATP-dependent polynucleotide kinase activity,MF,
13906,GO:0051736,1,0.993623136143205,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13907,GO:0051747,1,0.987351151079693,0,2,cytosine C-5 DNA demethylase activity,MF,
13908,GO:0051748,1,0.993596567278639,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13909,GO:0051750,1,0.993655215305584,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13910,GO:0051751,1,0.993469150001234,0,1,alpha-1,4-mannosyltransferase activity,MF,
13911,GO:0051754,1,0.974404774012619,0,4,meiotic sister chromatid cohesion, centromeric,BP,
13912,GO:0051758,1,0.993297894589529,0,1,homologous chromosome movement towards spindle pole in meiosis I anaphase,BP,
13913,GO:0051764,1,0.930839882357624,0,11,actin crosslink formation,BP,
13914,GO:0051765,1,0.987190958198118,0,2,inositol tetrakisphosphate kinase activity,MF,
13915,GO:0051766,1,0.968029061974332,0,5,inositol trisphosphate kinase activity,MF,
13916,GO:0051767,1,0.888767208858293,0,18,nitric-oxide synthase biosynthetic process,BP,
13917,GO:0051769,1,0.888767208858293,0,18,regulation of nitric-oxide synthase biosynthetic process,BP,
13918,GO:0051770,1,0.90603912974184,0,15,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13919,GO:0051771,1,0.980955515783555,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13921,GO:0051780,1,0.99348063536873,0,1,behavioral response to nutrient,BP,
13923,GO:0051782,1,0.90639442488486,0,15,negative regulation of cell division,BP,
13924,GO:0051783,1,0.321079024653769,0,173,regulation of nuclear division,BP,
13925,GO:0051784,1,0.693503626625388,0,56,negative regulation of nuclear division,BP,
13926,GO:0051785,1,0.65773934344621,0,64,positive regulation of nuclear division,BP,
13927,GO:0051786,1,0.993526932154482,0,1,all-trans-retinol 13,14-reductase activity,MF,
13928,GO:0051787,1,0.845142840020175,0,26,misfolded protein binding,MF,
13929,GO:0051788,1,0.854861272015676,0,24,response to misfolded protein,BP,
13930,GO:0051790,1,0.974500382845678,0,4,short-chain fatty acid biosynthetic process,BP,
13931,GO:0051791,1,0.925353247171587,0,12,medium-chain fatty acid metabolic process,BP,
13932,GO:0051792,1,0.961841304168197,0,6,medium-chain fatty acid biosynthetic process,BP,
13933,GO:0051793,1,0.967940983126347,0,5,medium-chain fatty acid catabolic process,BP,
13934,GO:0051794,1,0.974401619206679,0,4,regulation of timing of catagen,BP,
13935,GO:0051795,1,0.980806328515505,0,3,positive regulation of timing of catagen,BP,
13936,GO:0051796,1,0.993471216481218,0,1,negative regulation of timing of catagen,BP,
13937,GO:0051797,1,0.883505771062061,0,19,regulation of hair follicle development,BP,
13938,GO:0051798,1,0.93125808663981,0,11,positive regulation of hair follicle development,BP,
13939,GO:0051799,1,0.974155814006707,0,4,negative regulation of hair follicle development,BP,
13940,GO:0051800,1,0.993374240866269,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13941,GO:0051801,1,0.981032259322261,0,3,cytolysis in other organism involved in symbiotic interaction,BP,
13942,GO:0051817,1,0.562463478539918,0,88,modulation of process of other organism involved in symbiotic interaction,BP,
13943,GO:0051823,1,0.942151752813693,0,9,regulation of synapse structural plasticity,BP,
13944,GO:0051835,1,0.973838677990997,0,4,positive regulation of synapse structural plasticity,BP,
13945,GO:0051838,1,0.981032259322261,0,3,cytolysis by host of symbiont cells,BP,
13946,GO:0051851,1,0.707976742646668,0,53,modulation by host of symbiont process,BP,
13948,GO:0051864,1,0.948556043814569,0,8,histone demethylase activity (H3-K36 specific),MF,
13949,GO:0051865,1,0.64882530546289,0,66,protein autoubiquitination,BP,
13950,GO:0051866,1,0.987211346494261,0,2,general adaptation syndrome,BP,
13951,GO:0051867,1,0.993655115778651,0,1,general adaptation syndrome, behavioral process,BP,
13952,GO:0051870,1,0.980949799818225,0,3,methotrexate binding,MF,
13953,GO:0051873,1,0.908932702490171,0,15,killing by host of symbiont cells,BP,
13954,GO:0051875,1,0.844299611050689,0,26,pigment granule localization,BP,
13955,GO:0051877,1,0.987143414108319,0,2,pigment granule aggregation in cell center,BP,
13956,GO:0051879,1,0.780480060943382,0,38,Hsp90 protein binding,MF,
13957,GO:0051880,1,0.936312276791397,0,10,G-quadruplex DNA binding,MF,
13960,GO:0051883,1,0.897226645102574,0,17,killing of cells in other organism involved in symbiotic interaction,BP,
13961,GO:0051884,1,0.96779275071189,0,5,regulation of timing of anagen,BP,
13962,GO:0051885,1,0.986980328119045,0,2,positive regulation of timing of anagen,BP,
13963,GO:0051886,1,0.993406434023935,0,1,negative regulation of timing of anagen,BP,
13964,GO:0051890,1,0.955415390084269,0,7,regulation of cardioblast differentiation,BP,
13965,GO:0051891,1,0.961694530426651,0,6,positive regulation of cardioblast differentiation,BP,
13966,GO:0051892,1,0.993473295237682,0,1,negative regulation of cardioblast differentiation,BP,
13968,GO:0051894,1,0.853097005229142,0,24,positive regulation of focal adhesion assembly,BP,
13969,GO:0051895,1,0.88786648183999,0,18,negative regulation of focal adhesion assembly,BP,
13972,GO:0051898,1,0.759471547858957,0,42,negative regulation of protein kinase B signaling,BP,
13977,GO:0051903,1,0.987212655117218,0,2,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13978,GO:0051904,1,0.861147171853879,0,23,pigment granule transport,BP,
13979,GO:0051905,1,0.855288779823484,0,24,establishment of pigment granule localization,BP,
13980,GO:0051908,1,0.993533031651275,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13981,GO:0051913,1,0.992759217039765,0,1,regulation of synaptic plasticity by chemical substance,BP,
13982,GO:0051914,1,0.992759217039765,0,1,positive regulation of synaptic plasticity by chemical substance,BP,
13983,GO:0051915,1,0.992759217039765,0,1,induction of synaptic plasticity by chemical substance,BP,
13984,GO:0051916,1,0.987166448271045,0,2,granulocyte colony-stimulating factor binding,MF,
13985,GO:0051917,1,0.937390493015011,0,10,regulation of fibrinolysis,BP,
13986,GO:0051918,1,0.955682062146725,0,7,negative regulation of fibrinolysis,BP,
13987,GO:0051919,1,0.980894797510503,0,3,positive regulation of fibrinolysis,BP,
13988,GO:0051920,1,0.956475351362716,0,7,peroxiredoxin activity,MF,
13989,GO:0051923,1,0.901776492314482,0,16,sulfation,BP,
13991,GO:0051926,1,0.713492700458533,0,52,negative regulation of calcium ion transport,BP,
13995,GO:0051932,1,0.74333770461183,0,45,synaptic transmission, GABAergic,BP,
13996,GO:0051933,1,0.973905905392567,0,4,amino acid neurotransmitter reuptake,BP,
13998,GO:0051935,1,0.973905905392567,0,4,glutamate reuptake,BP,
14001,GO:0051939,1,0.974197551905759,0,4,gamma-aminobutyric acid import,BP,
14003,GO:0051941,1,0.980317439246561,0,3,regulation of amino acid uptake involved in synaptic transmission,BP,
14004,GO:0051943,1,0.99350284838165,0,1,positive regulation of amino acid uptake involved in synaptic transmission,BP,
14005,GO:0051944,1,0.980970097269164,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14007,GO:0051946,1,0.980317439246561,0,3,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14008,GO:0051951,1,0.99350284838165,0,1,positive regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14015,GO:0051958,1,0.986889108373994,0,2,methotrexate transport,BP,
14016,GO:0051959,1,0.827142663273722,0,27,dynein light intermediate chain binding,MF,
14021,GO:0051964,1,0.94852349311876,0,8,negative regulation of synapse assembly,BP,
14022,GO:0051965,1,0.682979704373349,0,58,positive regulation of synapse assembly,BP,
14024,GO:0051967,1,0.936865189328323,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14025,GO:0051968,1,0.815494094413025,0,31,positive regulation of synaptic transmission, glutamatergic,BP,
14026,GO:0051969,1,0.913289826700105,0,14,regulation of transmission of nerve impulse,BP,
14027,GO:0051970,1,0.974586030948571,0,4,negative regulation of transmission of nerve impulse,BP,
14028,GO:0051971,1,0.961653819032529,0,6,positive regulation of transmission of nerve impulse,BP,
14031,GO:0051974,1,0.931401353316713,0,11,negative regulation of telomerase activity,BP,
14032,GO:0051977,1,0.993593558115241,0,1,lysophospholipid transport,BP,
14033,GO:0051978,1,0.993593558115241,0,1,lysophospholipid:sodium symporter activity,MF,
14034,GO:0051983,1,0.538693466506128,0,94,regulation of chromosome segregation,BP,
14035,GO:0051984,1,0.821646588978023,0,30,positive regulation of chromosome segregation,BP,
14036,GO:0051985,1,0.764136940327649,0,41,negative regulation of chromosome segregation,BP,
14037,GO:0051987,1,0.961829295041535,0,6,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14038,GO:0051988,1,0.918557896574144,0,13,regulation of attachment of spindle microtubules to kinetochore,BP,
14039,GO:0051990,1,0.993567805908878,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14040,GO:0051996,1,0.993598956749965,0,1,squalene synthase activity,MF,
14041,GO:0051998,1,0.96809653318423,0,5,protein carboxyl O-methyltransferase activity,MF,
14042,GO:0052025,1,0.987452081814542,0,2,modification by symbiont of host cell membrane,BP,
14043,GO:0052026,1,0.99355096733832,0,1,modulation by symbiont of host transcription,BP,
14044,GO:0052027,1,0.986973386837848,0,2,modulation by symbiont of host signal transduction pathway,BP,
14045,GO:0052029,1,0.99340222653439,0,1,suppression by symbiont of host signal transduction pathway,BP,
14046,GO:0052040,1,0.943266535560871,0,9,modulation by symbiont of host programmed cell death,BP,
14047,GO:0052041,1,0.974525056066214,0,4,negative regulation by symbiont of host programmed cell death,BP,
14048,GO:0052042,1,0.980866206872695,0,3,positive regulation by symbiont of host programmed cell death,BP,
14049,GO:0052043,1,0.987452081814542,0,2,modification by symbiont of host cellular component,BP,
14050,GO:0052053,1,0.993557526292956,0,1,negative regulation by symbiont of host catalytic activity,BP,
14051,GO:0052055,1,0.987001836507624,0,2,modulation by symbiont of host molecular function,BP,
14052,GO:0052056,1,0.987001836507624,0,2,negative regulation by symbiont of host molecular function,BP,
14053,GO:0052111,1,0.987452081814542,0,2,modification by symbiont of host structure,BP,
14055,GO:0052148,1,0.993557526292956,0,1,modulation by symbiont of host catalytic activity,BP,
14056,GO:0052150,1,0.961968839971322,0,6,modulation by symbiont of host apoptotic process,BP,
14057,GO:0052151,1,0.980866206872695,0,3,positive regulation by symbiont of host apoptotic process,BP,
14058,GO:0052173,1,0.980305876166821,0,3,response to defenses of other organism,BP,
14059,GO:0052185,1,0.987452081814542,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14060,GO:0052188,1,0.987452081814542,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14061,GO:0052199,1,0.987208797483737,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14062,GO:0052200,1,0.980305876166821,0,3,response to host defenses,BP,
14063,GO:0052203,1,0.980912726493705,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14064,GO:0052204,1,0.962128128844782,0,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14065,GO:0052205,1,0.94957882032466,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14066,GO:0052214,1,0.993630470449032,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14067,GO:0052227,1,0.993630470449032,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14068,GO:0052229,1,0.993630470449032,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14069,GO:0052248,1,0.961968839971322,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14070,GO:0052312,1,0.99355096733832,0,1,modulation of transcription in other organism involved in symbiotic interaction,BP,
14071,GO:0052314,1,0.987257695901969,0,2,phytoalexin metabolic process,BP,
14072,GO:0052330,1,0.980866206872695,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14073,GO:0052332,1,0.987452081814542,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14074,GO:0052360,1,0.993630470449032,0,1,catabolism by host of symbiont macromolecule,BP,
14075,GO:0052361,1,0.993630470449032,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14076,GO:0052362,1,0.993630470449032,0,1,catabolism by host of symbiont protein,BP,
14077,GO:0052363,1,0.993630470449032,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14078,GO:0052364,1,0.993630470449032,0,1,catabolism by host of substance in symbiont,BP,
14079,GO:0052372,1,0.781951617733052,0,38,modulation by symbiont of entry into host,BP,
14080,GO:0052381,1,0.993597362978043,0,1,tRNA dimethylallyltransferase activity,MF,
14081,GO:0052403,1,0.993610516163832,0,1,negative regulation by host of symbiont catalytic activity,BP,
14082,GO:0052405,1,0.974801977656394,0,4,negative regulation by host of symbiont molecular function,BP,
14083,GO:0052416,1,0.993630470449032,0,1,metabolism by host of symbiont macromolecule,BP,
14084,GO:0052417,1,0.993630470449032,0,1,metabolism by host of symbiont protein,BP,
14085,GO:0052418,1,0.993630470449032,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14086,GO:0052419,1,0.993630470449032,0,1,metabolism by host of substance in symbiont,BP,
14087,GO:0052422,1,0.987274025584221,0,2,modulation by host of symbiont catalytic activity,BP,
14088,GO:0052428,1,0.962089013513718,0,6,modulation by host of symbiont molecular function,BP,
14089,GO:0052433,1,0.961968839971322,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14090,GO:0052501,1,0.993652029015428,0,1,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14093,GO:0052590,1,0.993342118214506,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14094,GO:0052591,1,0.993342118214506,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14095,GO:0052593,1,0.987095418757374,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14096,GO:0052594,1,0.987095418757374,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14097,GO:0052595,1,0.987095418757374,0,2,aliphatic-amine oxidase activity,MF,
14098,GO:0052596,1,0.987095418757374,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14099,GO:0052629,1,0.954793213473144,0,7,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14100,GO:0052630,1,0.993584296210633,0,1,UDP-N-acetylgalactosamine diphosphorylase activity,MF,
14101,GO:0052642,1,0.98725152763937,0,2,lysophosphatidic acid phosphatase activity,MF,
14102,GO:0052646,1,0.942389670303903,0,9,alditol phosphate metabolic process,BP,
14103,GO:0052650,1,0.925967585827242,0,12,NADP-retinol dehydrogenase activity,MF,
14104,GO:0052651,1,0.962065637311195,0,6,monoacylglycerol catabolic process,BP,
14105,GO:0052652,1,0.888135088794265,0,18,cyclic purine nucleotide metabolic process,BP,
14106,GO:0052654,1,0.986806044626505,0,2,L-leucine transaminase activity,MF,
14107,GO:0052655,1,0.986806044626505,0,2,L-valine transaminase activity,MF,
14108,GO:0052656,1,0.986806044626505,0,2,L-isoleucine transaminase activity,MF,
14109,GO:0052657,1,0.993645181428393,0,1,guanine phosphoribosyltransferase activity,MF,
14110,GO:0052658,1,0.961587959105504,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14111,GO:0052659,1,0.967921655947524,0,5,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14112,GO:0052666,1,0.993608907064504,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14114,GO:0052692,1,0.993644981764571,0,1,raffinose alpha-galactosidase activity,MF,
14115,GO:0052695,1,0.980666573733398,0,3,cellular glucuronidation,BP,
14116,GO:0052717,1,0.986990748965724,0,2,tRNA-specific adenosine-34 deaminase activity,MF,
14117,GO:0052718,1,0.986990748965724,0,2,tRNA-specific adenosine-34 deaminase complex,CC,
14118,GO:0052723,1,0.974043538662841,0,4,inositol hexakisphosphate 1-kinase activity,MF,
14119,GO:0052724,1,0.974043538662841,0,4,inositol hexakisphosphate 3-kinase activity,MF,
14120,GO:0052725,1,0.993530108284653,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14121,GO:0052726,1,0.993530108284653,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14122,GO:0052731,1,0.993598989985766,0,1,phosphocholine phosphatase activity,MF,
14123,GO:0052732,1,0.993598989985766,0,1,phosphoethanolamine phosphatase activity,MF,
14124,GO:0052735,1,0.974135084407154,0,4,tRNA (cytosine-3-)-methyltransferase activity,MF,
14125,GO:0052739,1,0.962010018018112,0,6,phosphatidylserine 1-acylhydrolase activity,MF,
14126,GO:0052740,1,0.968186652413975,0,5,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14127,GO:0052742,1,0.911116358247809,0,14,phosphatidylinositol kinase activity,MF,
14128,GO:0052743,1,0.955304630341929,0,7,inositol tetrakisphosphate phosphatase activity,MF,
14129,GO:0052744,1,0.887999942378033,0,18,phosphatidylinositol monophosphate phosphatase activity,MF,
14130,GO:0052745,1,0.918884956756505,0,13,inositol phosphate phosphatase activity,MF,
14131,GO:0052746,1,0.987034950383818,0,2,inositol phosphorylation,BP,
14132,GO:0052751,1,0.993671633872263,0,1,GDP-mannose hydrolase activity,MF,
14133,GO:0052794,1,0.980865206977092,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14134,GO:0052795,1,0.980865206977092,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14135,GO:0052796,1,0.980865206977092,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14136,GO:0052798,1,0.99359962170577,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14139,GO:0052812,1,0.967847148655553,0,5,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14140,GO:0052813,1,0.967847148655553,0,5,phosphatidylinositol bisphosphate kinase activity,MF,
14141,GO:0052814,1,0.99350270938318,0,1,medium-chain-aldehyde dehydrogenase activity,MF,
14142,GO:0052815,1,0.987224173055619,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14143,GO:0052816,1,0.993521146554597,0,1,long-chain acyl-CoA hydrolase activity,MF,
14144,GO:0052817,1,0.993521146554597,0,1,very long chain acyl-CoA hydrolase activity,MF,
14145,GO:0052821,1,0.993667138868627,0,1,DNA-7-methyladenine glycosylase activity,MF,
14146,GO:0052822,1,0.993667138868627,0,1,DNA-3-methylguanine glycosylase activity,MF,
14147,GO:0052824,1,0.993581387447247,0,1,dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity,MF,
14148,GO:0052826,1,0.993552513362211,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14149,GO:0052827,1,0.993552513362211,0,1,inositol pentakisphosphate phosphatase activity,MF,
14150,GO:0052832,1,0.980820612932707,0,3,inositol monophosphate 3-phosphatase activity,MF,
14151,GO:0052833,1,0.980820612932707,0,3,inositol monophosphate 4-phosphatase activity,MF,
14152,GO:0052834,1,0.980820612932707,0,3,inositol monophosphate phosphatase activity,MF,
14153,GO:0052840,1,0.974515979575416,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14154,GO:0052842,1,0.974515979575416,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14155,GO:0052851,1,0.980357057853239,0,3,ferric-chelate reductase (NADPH) activity,MF,
14156,GO:0052852,1,0.987296875775944,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14157,GO:0052853,1,0.987296875775944,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14158,GO:0052854,1,0.987296875775944,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14159,GO:0052856,1,0.993673879592571,0,1,NADHX epimerase activity,MF,
14160,GO:0052857,1,0.993673879592571,0,1,NADPHX epimerase activity,MF,
14161,GO:0052858,1,0.99351314501512,0,1,peptidyl-lysine acetyltransferase activity,MF,
14163,GO:0052869,1,0.993438403022402,0,1,arachidonic acid omega-hydroxylase activity,MF,
14164,GO:0052884,1,0.993566204593089,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14165,GO:0052885,1,0.993566204593089,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14166,GO:0052890,1,0.98710043961143,0,2,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14167,GO:0052894,1,0.993601252888419,0,1,norspermine:oxygen oxidoreductase activity,MF,
14168,GO:0052895,1,0.993601252888419,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14169,GO:0052899,1,0.993626487655239,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14170,GO:0052901,1,0.987268117750204,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14171,GO:0052902,1,0.993626487655239,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14172,GO:0052903,1,0.993626487655239,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14173,GO:0052904,1,0.993626487655239,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14174,GO:0052905,1,0.980794200606343,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14175,GO:0052906,1,0.993396762681996,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14176,GO:0052907,1,0.99355705431691,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14177,GO:0052909,1,0.99355705431691,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14178,GO:0052917,1,0.993581387447247,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14179,GO:0052918,1,0.993310191925463,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14180,GO:0052925,1,0.99363841889363,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14181,GO:0052926,1,0.993310191925463,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14182,GO:0052927,1,0.993587876941037,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14183,GO:0052928,1,0.993587876941037,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14184,GO:0052929,1,0.993587876941037,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14188,GO:0055005,1,0.980657412895596,0,3,ventricular cardiac myofibril assembly,BP,
14192,GO:0055009,1,0.967992953725993,0,5,atrial cardiac muscle tissue morphogenesis,BP,
14194,GO:0055011,1,0.987278122652091,0,2,atrial cardiac muscle cell differentiation,BP,
14195,GO:0055012,1,0.906523176733028,0,15,ventricular cardiac muscle cell differentiation,BP,
14197,GO:0055014,1,0.987278122652091,0,2,atrial cardiac muscle cell development,BP,
14198,GO:0055015,1,0.937039904596524,0,10,ventricular cardiac muscle cell development,BP,
14200,GO:0055018,1,0.993620720501988,0,1,regulation of cardiac muscle fiber development,BP,
14201,GO:0055020,1,0.993620720501988,0,1,positive regulation of cardiac muscle fiber development,BP,
14204,GO:0055023,1,0.809753111515114,0,32,positive regulation of cardiac muscle tissue growth,BP,
14208,GO:0055028,1,0.993229466008014,0,1,cortical microtubule,CC,
14209,GO:0055029,1,0.535592283717682,0,96,nuclear DNA-directed RNA polymerase complex,CC,
14212,GO:0055048,1,0.993229466008014,0,1,anastral spindle assembly,BP,
14213,GO:0055056,1,0.961671405697377,0,6,D-glucose transmembrane transporter activity,MF,
14214,GO:0055057,1,0.911684051554329,0,14,neuroblast division,BP,
14215,GO:0055059,1,0.961449786912556,0,6,asymmetric neuroblast division,BP,
14216,GO:0055062,1,0.948630989185476,0,8,phosphate ion homeostasis,BP,
14217,GO:0055064,1,0.918118947024275,0,13,chloride ion homeostasis,BP,
14219,GO:0055067,1,0.390120448399844,0,144,monovalent inorganic cation homeostasis,BP,
14221,GO:0055070,1,0.895288234172488,0,17,copper ion homeostasis,BP,
14222,GO:0055071,1,0.987015823820488,0,2,manganese ion homeostasis,BP,
14224,GO:0055073,1,0.980851535015176,0,3,cadmium ion homeostasis,BP,
14226,GO:0055075,1,0.837905593168117,0,27,potassium ion homeostasis,BP,
14228,GO:0055077,1,0.98698229739778,0,2,gap junction hemi-channel activity,MF,
14229,GO:0055078,1,0.756000942901631,0,43,sodium ion homeostasis,BP,
14231,GO:0055081,1,0.710820996226021,0,52,anion homeostasis,BP,
14233,GO:0055083,1,0.870916823919688,0,21,monovalent inorganic anion homeostasis,BP,
14236,GO:0055087,1,0.980665952207159,0,3,Ski complex,CC,
14237,GO:0055088,1,0.447632664936319,0,123,lipid homeostasis,BP,
14238,GO:0055089,1,0.912622483315872,0,14,fatty acid homeostasis,BP,
14239,GO:0055090,1,0.839420224255384,0,27,acylglycerol homeostasis,BP,
14240,GO:0055091,1,0.92463477765312,0,12,phospholipid homeostasis,BP,
14241,GO:0055092,1,0.629086035754431,0,71,sterol homeostasis,BP,
14242,GO:0055093,1,0.883737246871635,0,19,response to hyperoxia,BP,
14243,GO:0055094,1,0.827422513191492,0,29,response to lipoprotein particle,BP,
14244,GO:0055095,1,0.980727902873706,0,3,lipoprotein particle mediated signaling,BP,
14245,GO:0055096,1,0.980727902873706,0,3,low-density lipoprotein particle mediated signaling,BP,
14246,GO:0055100,1,0.980711753780967,0,3,adiponectin binding,MF,
14247,GO:0055102,1,0.932048407817567,0,11,lipase inhibitor activity,MF,
14248,GO:0055103,1,0.993530691847354,0,1,ligase regulator activity,MF,
14249,GO:0055105,1,0.962550719424648,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14250,GO:0055106,1,0.896348130497778,0,17,ubiquitin-protein transferase regulator activity,MF,
14251,GO:0055108,1,0.993607634108975,0,1,Golgi to transport vesicle transport,BP,
14252,GO:0055111,1,0.993365875323033,0,1,ingression involved in gastrulation with mouth forming second,BP,
14253,GO:0055113,1,0.992861754780332,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14256,GO:0055118,1,0.961566615396741,0,6,negative regulation of cardiac muscle contraction,BP,
14257,GO:0055119,1,0.900352432426674,0,16,relaxation of cardiac muscle,BP,
14258,GO:0055120,1,0.993669783575295,0,1,striated muscle dense body,CC,
14260,GO:0055129,1,0.968328214319694,0,5,L-proline biosynthetic process,BP,
14261,GO:0055130,1,0.993632910799513,0,1,D-alanine catabolic process,BP,
14262,GO:0055131,1,0.962095164235745,0,6,C3HC4-type RING finger domain binding,MF,
14263,GO:0060001,1,0.993091131520974,0,1,minus-end directed microfilament motor activity,MF,
14264,GO:0060002,1,0.98621265960611,0,2,plus-end directed microfilament motor activity,MF,
14265,GO:0060003,1,0.980251474974555,0,3,copper ion export,BP,
14266,GO:0060004,1,0.889222200876962,0,18,reflex,BP,
14267,GO:0060005,1,0.974189546646268,0,4,vestibular reflex,BP,
14268,GO:0060007,1,0.993478317036219,0,1,linear vestibuloocular reflex,BP,
14270,GO:0060009,1,0.911929046747351,0,14,Sertoli cell development,BP,
14271,GO:0060010,1,0.993526747146384,0,1,Sertoli cell fate commitment,BP,
14272,GO:0060011,1,0.980722461278999,0,3,Sertoli cell proliferation,BP,
14273,GO:0060012,1,0.961894194899901,0,6,synaptic transmission, glycinergic,BP,
14274,GO:0060013,1,0.955047837498111,0,7,righting reflex,BP,
14275,GO:0060014,1,0.993548812407926,0,1,granulosa cell differentiation,BP,
14276,GO:0060017,1,0.961581783894019,0,6,parathyroid gland development,BP,
14277,GO:0060018,1,0.980580104248186,0,3,astrocyte fate commitment,BP,
14278,GO:0060019,1,0.925269728523509,0,12,radial glial cell differentiation,BP,
14279,GO:0060020,1,0.949177727546854,0,8,Bergmann glial cell differentiation,BP,
14281,GO:0060022,1,0.96125017482469,0,6,hard palate development,BP,
14282,GO:0060023,1,0.967418833320286,0,5,soft palate development,BP,
14283,GO:0060024,1,0.974109330393231,0,4,rhythmic synaptic transmission,BP,
14284,GO:0060025,1,0.980447477811345,0,3,regulation of synaptic activity,BP,
14285,GO:0060026,1,0.906570195998564,0,15,convergent extension,BP,
14286,GO:0060027,1,0.94901878280892,0,8,convergent extension involved in gastrulation,BP,
14287,GO:0060028,1,0.955399356040563,0,7,convergent extension involved in axis elongation,BP,
14288,GO:0060029,1,0.961716262826019,0,6,convergent extension involved in organogenesis,BP,
14289,GO:0060031,1,0.987003028372917,0,2,mediolateral intercalation,BP,
14290,GO:0060032,1,0.98682915736524,0,2,notochord regression,BP,
14291,GO:0060033,1,0.900986950234925,0,16,anatomical structure regression,BP,
14292,GO:0060034,1,0.993491821395586,0,1,notochord cell differentiation,BP,
14293,GO:0060035,1,0.993491821395586,0,1,notochord cell development,BP,
14294,GO:0060037,1,0.854173955752491,0,24,pharyngeal system development,BP,
14295,GO:0060038,1,0.720351845408543,0,50,cardiac muscle cell proliferation,BP,
14296,GO:0060039,1,0.880940378923829,0,19,pericardium development,BP,
14297,GO:0060040,1,0.968244956189179,0,5,retinal bipolar neuron differentiation,BP,
14299,GO:0060042,1,0.699927574858991,0,54,retina morphogenesis in camera-type eye,BP,
14300,GO:0060043,1,0.764279939551709,0,41,regulation of cardiac muscle cell proliferation,BP,
14301,GO:0060044,1,0.907077021565181,0,15,negative regulation of cardiac muscle cell proliferation,BP,
14302,GO:0060045,1,0.853728570715759,0,24,positive regulation of cardiac muscle cell proliferation,BP,
14303,GO:0060046,1,0.918937493687182,0,13,regulation of acrosome reaction,BP,
14306,GO:0060049,1,0.912036687860466,0,14,regulation of protein glycosylation,BP,
14307,GO:0060050,1,0.942545841433597,0,9,positive regulation of protein glycosylation,BP,
14308,GO:0060051,1,0.987219343301116,0,2,negative regulation of protein glycosylation,BP,
14309,GO:0060052,1,0.961814975902264,0,6,neurofilament cytoskeleton organization,BP,
14310,GO:0060053,1,0.986881708478854,0,2,neurofilament cytoskeleton,CC,
14311,GO:0060054,1,0.962080246710599,0,6,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14312,GO:0060055,1,0.844317665077326,0,26,angiogenesis involved in wound healing,BP,
14313,GO:0060056,1,0.955584452433561,0,7,mammary gland involution,BP,
14314,GO:0060057,1,0.987167194724238,0,2,apoptotic process involved in mammary gland involution,BP,
14315,GO:0060058,1,0.987167194724238,0,2,positive regulation of apoptotic process involved in mammary gland involution,BP,
14316,GO:0060059,1,0.959666867408993,0,6,embryonic retina morphogenesis in camera-type eye,BP,
14317,GO:0060060,1,0.98670358954002,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14318,GO:0060061,1,0.980663140782318,0,3,Spemann organizer formation,BP,
14319,GO:0060064,1,0.993639919287708,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14320,GO:0060065,1,0.875921924291828,0,20,uterus development,BP,
14321,GO:0060066,1,0.987187425520416,0,2,oviduct development,BP,
14322,GO:0060067,1,0.993349843576017,0,1,cervix development,BP,
14325,GO:0060071,1,0.507183924730443,0,104,Wnt signaling pathway, planar cell polarity pathway,BP,
14326,GO:0060072,1,0.99331211126655,0,1,large conductance calcium-activated potassium channel activity,MF,
14327,GO:0060073,1,0.955311156789098,0,7,micturition,BP,
14328,GO:0060074,1,0.853803569233827,0,24,synapse maturation,BP,
14329,GO:0060075,1,0.942768686153139,0,9,regulation of resting membrane potential,BP,
14331,GO:0060077,1,0.894902074873807,0,17,inhibitory synapse,CC,
14334,GO:0060080,1,0.90012832449232,0,16,inhibitory postsynaptic potential,BP,
14335,GO:0060081,1,0.930718327831788,0,11,membrane hyperpolarization,BP,
14336,GO:0060082,1,0.993636517291837,0,1,eye blink reflex,BP,
14337,GO:0060083,1,0.986836164849115,0,2,smooth muscle contraction involved in micturition,BP,
14338,GO:0060084,1,0.980624784643614,0,3,synaptic transmission involved in micturition,BP,
14339,GO:0060086,1,0.98075416447592,0,3,circadian temperature homeostasis,BP,
14340,GO:0060087,1,0.961916274566887,0,6,relaxation of vascular associated smooth muscle,BP,
14341,GO:0060088,1,0.936788587089657,0,10,auditory receptor cell stereocilium organization,BP,
14343,GO:0060090,1,0.154947212327269,0,282,molecular adaptor activity,MF,
14344,GO:0060091,1,0.955640091285791,0,7,kinocilium,CC,
14345,GO:0060099,1,0.90682836197484,0,15,regulation of phagocytosis, engulfment,BP,
14346,GO:0060100,1,0.918581128010104,0,13,positive regulation of phagocytosis, engulfment,BP,
14347,GO:0060101,1,0.993613602965508,0,1,negative regulation of phagocytosis, engulfment,BP,
14348,GO:0060112,1,0.987348632054188,0,2,generation of ovulation cycle rhythm,BP,
14349,GO:0060113,1,0.719202801092471,0,50,inner ear receptor cell differentiation,BP,
14350,GO:0060117,1,0.894519750684606,0,17,auditory receptor cell development,BP,
14351,GO:0060119,1,0.784093180517965,0,37,inner ear receptor cell development,BP,
14352,GO:0060120,1,0.973794474510474,0,4,inner ear receptor cell fate commitment,BP,
14353,GO:0060122,1,0.854331954758763,0,24,inner ear receptor cell stereocilium organization,BP,
14354,GO:0060123,1,0.93053284439617,0,11,regulation of growth hormone secretion,BP,
14355,GO:0060124,1,0.949837612748625,0,8,positive regulation of growth hormone secretion,BP,
14356,GO:0060125,1,0.986677057253561,0,2,negative regulation of growth hormone secretion,BP,
14357,GO:0060126,1,0.980856071002334,0,3,somatotropin secreting cell differentiation,BP,
14358,GO:0060127,1,0.993590562751877,0,1,prolactin secreting cell differentiation,BP,
14359,GO:0060128,1,0.987246259881743,0,2,corticotropin hormone secreting cell differentiation,BP,
14360,GO:0060129,1,0.980823431751758,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14361,GO:0060133,1,0.993648241362892,0,1,somatotropin secreting cell development,BP,
14362,GO:0060134,1,0.905952250328945,0,15,prepulse inhibition,BP,
14364,GO:0060136,1,0.961749673689416,0,6,embryonic process involved in female pregnancy,BP,
14365,GO:0060137,1,0.949385590036647,0,8,maternal process involved in parturition,BP,
14366,GO:0060139,1,0.987133309544964,0,2,positive regulation of apoptotic process by virus,BP,
14367,GO:0060142,1,0.862328695131516,0,23,regulation of syncytium formation by plasma membrane fusion,BP,
14368,GO:0060143,1,0.873427055616568,0,21,positive regulation of syncytium formation by plasma membrane fusion,BP,
14369,GO:0060147,1,0.576838916529225,0,84,regulation of posttranscriptional gene silencing,BP,
14370,GO:0060148,1,0.855316244345427,0,24,positive regulation of posttranscriptional gene silencing,BP,
14371,GO:0060149,1,0.877195557711431,0,20,negative regulation of posttranscriptional gene silencing,BP,
14372,GO:0060151,1,0.986961640187573,0,2,peroxisome localization,BP,
14373,GO:0060152,1,0.986961640187573,0,2,microtubule-based peroxisome localization,BP,
14374,GO:0060155,1,0.943108354915884,0,9,platelet dense granule organization,BP,
14375,GO:0060157,1,0.974224006290567,0,4,urinary bladder development,BP,
14376,GO:0060158,1,0.949838329816386,0,8,phospholipase C-activating dopamine receptor signaling pathway,BP,
14379,GO:0060161,1,0.967727736742785,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14380,GO:0060163,1,0.987274457324989,0,2,subpallium neuron fate commitment,BP,
14381,GO:0060164,1,0.980869882623557,0,3,regulation of timing of neuron differentiation,BP,
14382,GO:0060165,1,0.99357512678926,0,1,regulation of timing of subpallium neuron differentiation,BP,
14383,GO:0060166,1,0.980859448777211,0,3,olfactory pit development,BP,
14386,GO:0060169,1,0.993637117932028,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14388,GO:0060171,1,0.97971477917173,0,3,stereocilium membrane,CC,
14390,GO:0060174,1,0.92995918134391,0,11,limb bud formation,BP,
14391,GO:0060175,1,0.993237139706207,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14392,GO:0060177,1,0.98719503158041,0,2,regulation of angiotensin metabolic process,BP,
14393,GO:0060178,1,0.993589054433911,0,1,regulation of exocyst localization,BP,
14394,GO:0060179,1,0.948322842947935,0,8,male mating behavior,BP,
14395,GO:0060180,1,0.955164250996985,0,7,female mating behavior,BP,
14396,GO:0060182,1,0.993549264120569,0,1,apelin receptor activity,MF,
14397,GO:0060183,1,0.987122592868171,0,2,apelin receptor signaling pathway,BP,
14398,GO:0060184,1,0.98689415309101,0,2,cell cycle switching,BP,
14399,GO:0060187,1,0.942519115712479,0,9,cell pole,CC,
14401,GO:0060192,1,0.925142692448996,0,12,negative regulation of lipase activity,BP,
14403,GO:0060197,1,0.980801438400208,0,3,cloacal septation,BP,
14406,GO:0060200,1,0.980775234578628,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14407,GO:0060201,1,0.980775234578628,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14410,GO:0060211,1,0.922814927001527,0,12,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14411,GO:0060212,1,0.993618169151267,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14412,GO:0060213,1,0.922814927001527,0,12,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14413,GO:0060214,1,0.974628358172755,0,4,endocardium formation,BP,
14414,GO:0060215,1,0.949214071812951,0,8,primitive hemopoiesis,BP,
14415,GO:0060216,1,0.871548786986239,0,21,definitive hemopoiesis,BP,
14416,GO:0060217,1,0.99341910185417,0,1,hemangioblast cell differentiation,BP,
14417,GO:0060218,1,0.579973423721497,0,84,hematopoietic stem cell differentiation,BP,
14418,GO:0060219,1,0.854284989860164,0,24,camera-type eye photoreceptor cell differentiation,BP,
14419,GO:0060220,1,0.993601552792331,0,1,camera-type eye photoreceptor cell fate commitment,BP,
14420,GO:0060221,1,0.924556945456362,0,12,retinal rod cell differentiation,BP,
14421,GO:0060228,1,0.981167383670995,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14422,GO:0060229,1,0.93123893310055,0,11,lipase activator activity,MF,
14423,GO:0060230,1,0.98739034316417,0,2,lipoprotein lipase activator activity,MF,
14425,GO:0060232,1,0.974161204355114,0,4,delamination,BP,
14426,GO:0060234,1,0.99321167669606,0,1,neuroblast delamination,BP,
14427,GO:0060235,1,0.973122469818698,0,4,lens induction in camera-type eye,BP,
14428,GO:0060236,1,0.799567850054372,0,34,regulation of mitotic spindle organization,BP,
14429,GO:0060242,1,0.94928285346333,0,8,contact inhibition,BP,
14430,GO:0060243,1,0.993474506059225,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14431,GO:0060244,1,0.980815675717063,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14432,GO:0060245,1,0.94928285346333,0,8,detection of cell density,BP,
14434,GO:0060251,1,0.821218932863383,0,30,regulation of glial cell proliferation,BP,
14435,GO:0060252,1,0.90700950579401,0,15,positive regulation of glial cell proliferation,BP,
14436,GO:0060253,1,0.912026099312322,0,14,negative regulation of glial cell proliferation,BP,
14440,GO:0060260,1,0.795048124898594,0,35,regulation of transcription initiation from RNA polymerase II promoter,BP,
14441,GO:0060261,1,0.826792124877105,0,29,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14443,GO:0060263,1,0.919169468844669,0,13,regulation of respiratory burst,BP,
14444,GO:0060264,1,0.968406511079109,0,5,regulation of respiratory burst involved in inflammatory response,BP,
14445,GO:0060265,1,0.98734013415817,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14446,GO:0060266,1,0.97462880659421,0,4,negative regulation of respiratory burst involved in inflammatory response,BP,
14447,GO:0060267,1,0.967956181427843,0,5,positive regulation of respiratory burst,BP,
14448,GO:0060268,1,0.968056962036505,0,5,negative regulation of respiratory burst,BP,
14450,GO:0060272,1,0.931415445662303,0,11,embryonic skeletal joint morphogenesis,BP,
14451,GO:0060278,1,0.980835317700232,0,3,regulation of ovulation,BP,
14452,GO:0060279,1,0.987168875416592,0,2,positive regulation of ovulation,BP,
14453,GO:0060280,1,0.99358494523866,0,1,negative regulation of ovulation,BP,
14454,GO:0060281,1,0.93078148966224,0,11,regulation of oocyte development,BP,
14455,GO:0060282,1,0.967810889051027,0,5,positive regulation of oocyte development,BP,
14456,GO:0060283,1,0.974248149435666,0,4,negative regulation of oocyte development,BP,
14458,GO:0060285,1,0.531147528703635,0,96,cilium-dependent cell motility,BP,
14459,GO:0060287,1,0.930205644281599,0,11,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14460,GO:0060290,1,0.949440719650331,0,8,transdifferentiation,BP,
14463,GO:0060293,1,0.894505129934126,0,17,germ plasm,CC,
14464,GO:0060294,1,0.57337595559387,0,85,cilium movement involved in cell motility,BP,
14465,GO:0060295,1,0.896560489756075,0,17,regulation of cilium movement involved in cell motility,BP,
14466,GO:0060296,1,0.961984533405437,0,6,regulation of cilium beat frequency involved in ciliary motility,BP,
14467,GO:0060297,1,0.960525846934739,0,6,regulation of sarcomere organization,BP,
14468,GO:0060298,1,0.980423614508216,0,3,positive regulation of sarcomere organization,BP,
14469,GO:0060299,1,0.993648341094093,0,1,negative regulation of sarcomere organization,BP,
14470,GO:0060300,1,0.974541693079526,0,4,regulation of cytokine activity,BP,
14471,GO:0060301,1,0.993574430978759,0,1,positive regulation of cytokine activity,BP,
14472,GO:0060302,1,0.987284979108769,0,2,negative regulation of cytokine activity,BP,
14473,GO:0060304,1,0.960818083211557,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14474,GO:0060305,1,0.99355205394135,0,1,regulation of cell diameter,BP,
14475,GO:0060306,1,0.8151033478692,0,31,regulation of membrane repolarization,BP,
14476,GO:0060307,1,0.876929493464085,0,20,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14477,GO:0060309,1,0.987285111761278,0,2,elastin catabolic process,BP,
14478,GO:0060310,1,0.993687792402336,0,1,regulation of elastin catabolic process,BP,
14479,GO:0060311,1,0.993687792402336,0,1,negative regulation of elastin catabolic process,BP,
14480,GO:0060312,1,0.955312546251283,0,7,regulation of blood vessel remodeling,BP,
14481,GO:0060313,1,0.980471444724939,0,3,negative regulation of blood vessel remodeling,BP,
14482,GO:0060314,1,0.849328981349158,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14483,GO:0060315,1,0.931532547427077,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14484,GO:0060316,1,0.949103538219908,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14485,GO:0060317,1,0.817021169152257,0,31,cardiac epithelial to mesenchymal transition,BP,
14486,GO:0060318,1,0.961699730889298,0,6,definitive erythrocyte differentiation,BP,
14487,GO:0060319,1,0.974457600994284,0,4,primitive erythrocyte differentiation,BP,
14493,GO:0060327,1,0.986927606895486,0,2,cytoplasmic actin-based contraction involved in cell motility,BP,
14494,GO:0060330,1,0.861235487845019,0,23,regulation of response to interferon-gamma,BP,
14495,GO:0060331,1,0.961916673012316,0,6,negative regulation of response to interferon-gamma,BP,
14496,GO:0060332,1,0.961371374054765,0,6,positive regulation of response to interferon-gamma,BP,
14498,GO:0060334,1,0.861235487845019,0,23,regulation of interferon-gamma-mediated signaling pathway,BP,
14499,GO:0060335,1,0.961371374054765,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14500,GO:0060336,1,0.961916673012316,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14501,GO:0060337,1,0.61052478748078,0,76,type I interferon signaling pathway,BP,
14502,GO:0060338,1,0.816843978143056,0,31,regulation of type I interferon-mediated signaling pathway,BP,
14503,GO:0060339,1,0.924843463452631,0,12,negative regulation of type I interferon-mediated signaling pathway,BP,
14504,GO:0060340,1,0.930126071498743,0,11,positive regulation of type I interferon-mediated signaling pathway,BP,
14506,GO:0060342,1,0.974434546970766,0,4,photoreceptor inner segment membrane,CC,
14508,GO:0060345,1,0.993524818679468,0,1,spleen trabecula formation,BP,
14510,GO:0060347,1,0.919051676237378,0,13,heart trabecula formation,BP,
14512,GO:0060349,1,0.565329949021561,0,87,bone morphogenesis,BP,
14513,GO:0060350,1,0.707245630128641,0,53,endochondral bone morphogenesis,BP,
14514,GO:0060351,1,0.827832737388988,0,29,cartilage development involved in endochondral bone morphogenesis,BP,
14515,GO:0060352,1,0.930667021647866,0,11,cell adhesion molecule production,BP,
14516,GO:0060353,1,0.942955683229456,0,9,regulation of cell adhesion molecule production,BP,
14517,GO:0060354,1,0.973794207607664,0,4,negative regulation of cell adhesion molecule production,BP,
14518,GO:0060355,1,0.974599225814878,0,4,positive regulation of cell adhesion molecule production,BP,
14519,GO:0060357,1,0.987157538209783,0,2,regulation of leucine import,BP,
14520,GO:0060358,1,0.987157538209783,0,2,negative regulation of leucine import,BP,
14521,GO:0060359,1,0.980625398399603,0,3,response to ammonium ion,BP,
14522,GO:0060363,1,0.95550412073601,0,7,cranial suture morphogenesis,BP,
14523,GO:0060364,1,0.980390360424506,0,3,frontal suture morphogenesis,BP,
14524,GO:0060366,1,0.99313563936281,0,1,lambdoid suture morphogenesis,BP,
14525,GO:0060367,1,0.99313563936281,0,1,sagittal suture morphogenesis,BP,
14526,GO:0060368,1,0.930528503018488,0,11,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14527,GO:0060369,1,0.955241130631593,0,7,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14528,GO:0060370,1,0.993356728175516,0,1,susceptibility to T cell mediated cytotoxicity,BP,
14529,GO:0060371,1,0.96072867753198,0,6,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14530,GO:0060372,1,0.954621474331207,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14531,GO:0060373,1,0.967563747035605,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14532,GO:0060374,1,0.967700165836663,0,5,mast cell differentiation,BP,
14533,GO:0060375,1,0.986991944587747,0,2,regulation of mast cell differentiation,BP,
14534,GO:0060377,1,0.993530691847354,0,1,negative regulation of mast cell differentiation,BP,
14535,GO:0060378,1,0.986840151786646,0,2,regulation of brood size,BP,
14537,GO:0060380,1,0.993601952801517,0,1,regulation of single-stranded telomeric DNA binding,BP,
14538,GO:0060381,1,0.993601952801517,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14539,GO:0060382,1,0.986823021533998,0,2,regulation of DNA strand elongation,BP,
14540,GO:0060383,1,0.993483544291113,0,1,positive regulation of DNA strand elongation,BP,
14541,GO:0060384,1,0.842057810187802,0,26,innervation,BP,
14542,GO:0060385,1,0.961406798381451,0,6,axonogenesis involved in innervation,BP,
14543,GO:0060386,1,0.993359073668008,0,1,synapse assembly involved in innervation,BP,
14545,GO:0060390,1,0.849040725062749,0,25,regulation of SMAD protein signal transduction,BP,
14546,GO:0060391,1,0.906338558980951,0,15,positive regulation of SMAD protein signal transduction,BP,
14547,GO:0060392,1,0.968151951082276,0,5,negative regulation of SMAD protein signal transduction,BP,
14551,GO:0060396,1,0.882580499008929,0,19,growth hormone receptor signaling pathway,BP,
14552,GO:0060397,1,0.929858744125708,0,11,growth hormone receptor signaling pathway via JAK-STAT,BP,
14553,GO:0060398,1,0.967941405531979,0,5,regulation of growth hormone receptor signaling pathway,BP,
14554,GO:0060399,1,0.98054642837298,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14555,GO:0060400,1,0.987147408585407,0,2,negative regulation of growth hormone receptor signaling pathway,BP,
14558,GO:0060404,1,0.99350877773261,0,1,axonemal microtubule depolymerization,BP,
14559,GO:0060405,1,0.961718341727916,0,6,regulation of penile erection,BP,
14560,GO:0060406,1,0.97435815420515,0,4,positive regulation of penile erection,BP,
14561,GO:0060407,1,0.993637117932028,0,1,negative regulation of penile erection,BP,
14563,GO:0060412,1,0.76823288263215,0,40,ventricular septum morphogenesis,BP,
14564,GO:0060413,1,0.917647808084804,0,13,atrial septum morphogenesis,BP,
14565,GO:0060414,1,0.980241191408869,0,3,aorta smooth muscle tissue morphogenesis,BP,
14567,GO:0060416,1,0.810712815327475,0,32,response to growth hormone,BP,
14570,GO:0060421,1,0.788649366726212,0,36,positive regulation of heart growth,BP,
14571,GO:0060422,1,0.993586636956867,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14572,GO:0060423,1,0.980785421581249,0,3,foregut regionalization,BP,
14573,GO:0060424,1,0.980785421581249,0,3,lung field specification,BP,
14575,GO:0060426,1,0.968227323154331,0,5,lung vasculature development,BP,
14576,GO:0060428,1,0.79568197612142,0,35,lung epithelium development,BP,
14578,GO:0060430,1,0.948983198486264,0,8,lung saccule development,BP,
14579,GO:0060431,1,0.974424389182551,0,4,primary lung bud formation,BP,
14580,GO:0060432,1,0.993697530091657,0,1,lung pattern specification process,BP,
14581,GO:0060433,1,0.937327895583475,0,10,bronchus development,BP,
14582,GO:0060434,1,0.987056107009854,0,2,bronchus morphogenesis,BP,
14583,GO:0060435,1,0.987388179251786,0,2,bronchiole development,BP,
14584,GO:0060436,1,0.993697530091657,0,1,bronchiole morphogenesis,BP,
14585,GO:0060437,1,0.961898723526868,0,6,lung growth,BP,
14586,GO:0060438,1,0.883245923773047,0,19,trachea development,BP,
14587,GO:0060439,1,0.930798453559555,0,11,trachea morphogenesis,BP,
14588,GO:0060440,1,0.961888005790408,0,6,trachea formation,BP,
14590,GO:0060442,1,0.924566288785931,0,12,branching involved in prostate gland morphogenesis,BP,
14591,GO:0060443,1,0.753287375400244,0,43,mammary gland morphogenesis,BP,
14592,GO:0060444,1,0.858927867152415,0,23,branching involved in mammary gland duct morphogenesis,BP,
14593,GO:0060445,1,0.859298101831691,0,23,branching involved in salivary gland morphogenesis,BP,
14594,GO:0060447,1,0.980648550361053,0,3,bud outgrowth involved in lung branching,BP,
14595,GO:0060448,1,0.979984312776372,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14596,GO:0060449,1,0.955745128707886,0,7,bud elongation involved in lung branching,BP,
14597,GO:0060452,1,0.931442137741233,0,11,positive regulation of cardiac muscle contraction,BP,
14598,GO:0060453,1,0.943486707883783,0,9,regulation of gastric acid secretion,BP,
14599,GO:0060454,1,0.98705159648907,0,2,positive regulation of gastric acid secretion,BP,
14600,GO:0060455,1,0.974697516339177,0,4,negative regulation of gastric acid secretion,BP,
14601,GO:0060456,1,0.943738081946267,0,9,positive regulation of digestive system process,BP,
14602,GO:0060457,1,0.91953518124104,0,13,negative regulation of digestive system process,BP,
14603,GO:0060458,1,0.987245089848517,0,2,right lung development,BP,
14604,GO:0060459,1,0.987275597576666,0,2,left lung development,BP,
14605,GO:0060460,1,0.993600553466401,0,1,left lung morphogenesis,BP,
14606,GO:0060461,1,0.993569852245708,0,1,right lung morphogenesis,BP,
14607,GO:0060462,1,0.961695197683751,0,6,lung lobe development,BP,
14608,GO:0060463,1,0.961695197683751,0,6,lung lobe morphogenesis,BP,
14609,GO:0060465,1,0.980562794343864,0,3,pharynx development,BP,
14610,GO:0060466,1,0.993266651168057,0,1,activation of meiosis involved in egg activation,BP,
14611,GO:0060467,1,0.980915222481189,0,3,negative regulation of fertilization,BP,
14612,GO:0060474,1,0.987274179771518,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14613,GO:0060478,1,0.955420515443335,0,7,acrosomal vesicle exocytosis,BP,
14614,GO:0060479,1,0.872148637276448,0,21,lung cell differentiation,BP,
14615,GO:0060480,1,0.981038364853865,0,3,lung goblet cell differentiation,BP,
14616,GO:0060481,1,0.974655125080411,0,4,lobar bronchus epithelium development,BP,
14617,GO:0060482,1,0.968312949436056,0,5,lobar bronchus development,BP,
14618,GO:0060484,1,0.943229370987452,0,9,lung-associated mesenchyme development,BP,
14620,GO:0060486,1,0.974083623891112,0,4,club cell differentiation,BP,
14621,GO:0060487,1,0.877843470681944,0,20,lung epithelial cell differentiation,BP,
14622,GO:0060488,1,0.98625643508405,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14623,GO:0060489,1,0.98625643508405,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14624,GO:0060490,1,0.98625643508405,0,2,lateral sprouting involved in lung morphogenesis,BP,
14625,GO:0060491,1,0.344823710217002,0,162,regulation of cell projection assembly,BP,
14626,GO:0060492,1,0.980785421581249,0,3,lung induction,BP,
14627,GO:0060495,1,0.993697530091657,0,1,cell-cell signaling involved in lung development,BP,
14628,GO:0060496,1,0.993697530091657,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14629,GO:0060501,1,0.96180527955484,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14630,GO:0060502,1,0.936862671610237,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14631,GO:0060503,1,0.993620720501988,0,1,bud dilation involved in lung branching,BP,
14632,GO:0060509,1,0.966982698208375,0,5,type I pneumocyte differentiation,BP,
14633,GO:0060510,1,0.968016891977249,0,5,type II pneumocyte differentiation,BP,
14634,GO:0060512,1,0.83785174758554,0,27,prostate gland morphogenesis,BP,
14635,GO:0060513,1,0.936874935628725,0,10,prostatic bud formation,BP,
14636,GO:0060514,1,0.993541573586608,0,1,prostate induction,BP,
14637,GO:0060515,1,0.993541573586608,0,1,prostate field specification,BP,
14638,GO:0060516,1,0.987169529277445,0,2,primary prostatic bud elongation,BP,
14639,GO:0060517,1,0.993493812438227,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14640,GO:0060520,1,0.993541573586608,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14641,GO:0060523,1,0.980550201679082,0,3,prostate epithelial cord elongation,BP,
14642,GO:0060525,1,0.929919002932011,0,11,prostate glandular acinus development,BP,
14643,GO:0060526,1,0.961269062611008,0,6,prostate glandular acinus morphogenesis,BP,
14644,GO:0060527,1,0.961269062611008,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14645,GO:0060528,1,0.973782685066797,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14646,GO:0060529,1,0.986972302764466,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14647,GO:0060532,1,0.98700496465385,0,2,bronchus cartilage development,BP,
14648,GO:0060534,1,0.948848353336257,0,8,trachea cartilage development,BP,
14649,GO:0060535,1,0.973891702590624,0,4,trachea cartilage morphogenesis,BP,
14650,GO:0060536,1,0.93062583753571,0,11,cartilage morphogenesis,BP,
14652,GO:0060538,1,0.368867696784339,0,152,skeletal muscle organ development,BP,
14653,GO:0060539,1,0.949550853738773,0,8,diaphragm development,BP,
14655,GO:0060542,1,0.993355148367012,0,1,regulation of strand invasion,BP,
14657,GO:0060545,1,0.980824815711062,0,3,positive regulation of necroptotic process,BP,
14661,GO:0060556,1,0.949686185800257,0,8,regulation of vitamin D biosynthetic process,BP,
14662,GO:0060557,1,0.987308337875004,0,2,positive regulation of vitamin D biosynthetic process,BP,
14663,GO:0060558,1,0.961939060427825,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14664,GO:0060559,1,0.987308337875004,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14666,GO:0060561,1,0.860497491031212,0,23,apoptotic process involved in morphogenesis,BP,
14668,GO:0060563,1,0.721071639473773,0,50,neuroepithelial cell differentiation,BP,
14669,GO:0060566,1,0.992858142606386,0,1,positive regulation of DNA-templated transcription, termination,BP,
14670,GO:0060567,1,0.987155207697788,0,2,negative regulation of DNA-templated transcription, termination,BP,
14671,GO:0060571,1,0.850016616161813,0,25,morphogenesis of an epithelial fold,BP,
14672,GO:0060572,1,0.90114769678612,0,16,morphogenesis of an epithelial bud,BP,
14674,GO:0060574,1,0.9746096657668,0,4,intestinal epithelial cell maturation,BP,
14675,GO:0060575,1,0.878392009037775,0,20,intestinal epithelial cell differentiation,BP,
14676,GO:0060576,1,0.91934136274341,0,13,intestinal epithelial cell development,BP,
14677,GO:0060577,1,0.993633011042041,0,1,pulmonary vein morphogenesis,BP,
14679,GO:0060580,1,0.993601286206653,0,1,ventral spinal cord interneuron fate determination,BP,
14681,GO:0060582,1,0.993601286206653,0,1,cell fate determination involved in pattern specification,BP,
14682,GO:0060584,1,0.974525787109754,0,4,regulation of prostaglandin-endoperoxide synthase activity,BP,
14683,GO:0060585,1,0.974525787109754,0,4,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14684,GO:0060586,1,0.949197710648804,0,8,multicellular organismal iron ion homeostasis,BP,
14685,GO:0060587,1,0.987226041140597,0,2,regulation of lipoprotein lipid oxidation,BP,
14686,GO:0060588,1,0.993664227685745,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14688,GO:0060590,1,0.776708867022986,0,39,ATPase regulator activity,MF,
14689,GO:0060591,1,0.980502876700454,0,3,chondroblast differentiation,BP,
14690,GO:0060592,1,0.955278272117404,0,7,mammary gland formation,BP,
14691,GO:0060594,1,0.980444037787106,0,3,mammary gland specification,BP,
14692,GO:0060595,1,0.987221551041485,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14693,GO:0060596,1,0.980593986294027,0,3,mammary placode formation,BP,
14694,GO:0060598,1,0.99365720525173,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14695,GO:0060599,1,0.986933940028498,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14696,GO:0060600,1,0.935662112387939,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14697,GO:0060601,1,0.91796453252625,0,13,lateral sprouting from an epithelium,BP,
14699,GO:0060603,1,0.814753814080106,0,31,mammary gland duct morphogenesis,BP,
14700,GO:0060605,1,0.967878246923589,0,5,tube lumen cavitation,BP,
14702,GO:0060611,1,0.99357798824772,0,1,mammary gland fat development,BP,
14703,GO:0060612,1,0.764573506117756,0,41,adipose tissue development,BP,
14704,GO:0060613,1,0.955097910568471,0,7,fat pad development,BP,
14705,GO:0060615,1,0.987221551041485,0,2,mammary gland bud formation,BP,
14706,GO:0060620,1,0.986032515460747,0,2,regulation of cholesterol import,BP,
14707,GO:0060623,1,0.987151448607149,0,2,regulation of chromosome condensation,BP,
14709,GO:0060628,1,0.900289198362155,0,16,regulation of ER to Golgi vesicle-mediated transport,BP,
14710,GO:0060631,1,0.961761081187383,0,6,regulation of meiosis I,BP,
14711,GO:0060632,1,0.781248382088318,0,38,regulation of microtubule-based movement,BP,
14712,GO:0060633,1,0.968025471508024,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14713,GO:0060638,1,0.949103954715229,0,8,mesenchymal-epithelial cell signaling,BP,
14714,GO:0060644,1,0.899876243341775,0,16,mammary gland epithelial cell differentiation,BP,
14715,GO:0060648,1,0.98091761117329,0,3,mammary gland bud morphogenesis,BP,
14716,GO:0060661,1,0.987332474775983,0,2,submandibular salivary gland formation,BP,
14717,GO:0060662,1,0.967878246923589,0,5,salivary gland cavitation,BP,
14718,GO:0060664,1,0.968376815050166,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14719,GO:0060665,1,0.974409561123218,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14720,GO:0060666,1,0.967080780224673,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14721,GO:0060667,1,0.987221551041485,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14722,GO:0060668,1,0.993510833710189,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14723,GO:0060669,1,0.866465654398571,0,22,embryonic placenta morphogenesis,BP,
14724,GO:0060670,1,0.937286468899788,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14725,GO:0060671,1,0.987193092116845,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14726,GO:0060672,1,0.987193092116845,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14727,GO:0060674,1,0.820870893857421,0,30,placenta blood vessel development,BP,
14731,GO:0060678,1,0.993588792541698,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14733,GO:0060682,1,0.993558829992923,0,1,primary ureteric bud growth,BP,
14734,GO:0060683,1,0.993556877617643,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14735,GO:0060684,1,0.962087922192026,0,6,epithelial-mesenchymal cell signaling,BP,
14736,GO:0060685,1,0.961622140108968,0,6,regulation of prostatic bud formation,BP,
14737,GO:0060686,1,0.974077027143958,0,4,negative regulation of prostatic bud formation,BP,
14738,GO:0060687,1,0.961461424049078,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
14740,GO:0060689,1,0.980421977054485,0,3,cell differentiation involved in salivary gland development,BP,
14741,GO:0060690,1,0.993619142811206,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14742,GO:0060691,1,0.993619142811206,0,1,epithelial cell maturation involved in salivary gland development,BP,
14743,GO:0060693,1,0.94330331246295,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14744,GO:0060694,1,0.993615718009131,0,1,regulation of cholesterol transporter activity,BP,
14745,GO:0060696,1,0.962105258425757,0,6,regulation of phospholipid catabolic process,BP,
14746,GO:0060697,1,0.987287388910313,0,2,positive regulation of phospholipid catabolic process,BP,
14747,GO:0060698,1,0.987058196112342,0,2,endoribonuclease inhibitor activity,MF,
14748,GO:0060699,1,0.97448867941646,0,4,regulation of endoribonuclease activity,BP,
14749,GO:0060700,1,0.943324089056816,0,9,regulation of ribonuclease activity,BP,
14750,GO:0060701,1,0.987058196112342,0,2,negative regulation of ribonuclease activity,BP,
14751,GO:0060702,1,0.987058196112342,0,2,negative regulation of endoribonuclease activity,BP,
14752,GO:0060703,1,0.993560321529714,0,1,deoxyribonuclease inhibitor activity,MF,
14753,GO:0060706,1,0.861313574929036,0,23,cell differentiation involved in embryonic placenta development,BP,
14754,GO:0060707,1,0.919160371174485,0,13,trophoblast giant cell differentiation,BP,
14755,GO:0060710,1,0.961855942697664,0,6,chorio-allantoic fusion,BP,
14756,GO:0060711,1,0.755392966470771,0,43,labyrinthine layer development,BP,
14757,GO:0060712,1,0.980569662276516,0,3,spongiotrophoblast layer development,BP,
14758,GO:0060713,1,0.889737515186074,0,18,labyrinthine layer morphogenesis,BP,
14759,GO:0060715,1,0.980575234747196,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14760,GO:0060716,1,0.883968636197675,0,19,labyrinthine layer blood vessel development,BP,
14761,GO:0060717,1,0.955120737606828,0,7,chorion development,BP,
14762,GO:0060718,1,0.967557083248776,0,5,chorionic trophoblast cell differentiation,BP,
14763,GO:0060720,1,0.986870121045008,0,2,spongiotrophoblast cell proliferation,BP,
14764,GO:0060721,1,0.986870121045008,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14765,GO:0060722,1,0.986870121045008,0,2,cell proliferation involved in embryonic placenta development,BP,
14766,GO:0060723,1,0.986870121045008,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14767,GO:0060729,1,0.967997352353726,0,5,intestinal epithelial structure maintenance,BP,
14768,GO:0060730,1,0.987135660582146,0,2,regulation of intestinal epithelial structure maintenance,BP,
14769,GO:0060731,1,0.993528783654157,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14771,GO:0060733,1,0.986920210236958,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14772,GO:0060734,1,0.993445233658993,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14773,GO:0060735,1,0.993648573788288,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14774,GO:0060736,1,0.929639348639309,0,11,prostate gland growth,BP,
14775,GO:0060737,1,0.974169309055279,0,4,prostate gland morphogenetic growth,BP,
14776,GO:0060738,1,0.987213616487764,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14777,GO:0060739,1,0.993191460296112,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14778,GO:0060740,1,0.843166612183393,0,26,prostate gland epithelium morphogenesis,BP,
14779,GO:0060741,1,0.980950111331136,0,3,prostate gland stromal morphogenesis,BP,
14780,GO:0060742,1,0.930458813430938,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14781,GO:0060743,1,0.980773722272346,0,3,epithelial cell maturation involved in prostate gland development,BP,
14782,GO:0060744,1,0.97404665700272,0,4,mammary gland branching involved in thelarche,BP,
14783,GO:0060745,1,0.960237896110668,0,6,mammary gland branching involved in pregnancy,BP,
14784,GO:0060746,1,0.936897551518228,0,10,parental behavior,BP,
14785,GO:0060748,1,0.979817023017092,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14786,GO:0060749,1,0.894301812761303,0,17,mammary gland alveolus development,BP,
14787,GO:0060750,1,0.973715066357321,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14788,GO:0060751,1,0.973715066357321,0,4,branch elongation involved in mammary gland duct branching,BP,
14789,GO:0060752,1,0.993562850607424,0,1,intestinal phytosterol absorption,BP,
14790,GO:0060753,1,0.962085567671278,0,6,regulation of mast cell chemotaxis,BP,
14791,GO:0060754,1,0.968243850827361,0,5,positive regulation of mast cell chemotaxis,BP,
14793,GO:0060760,1,0.707964874868361,0,53,positive regulation of response to cytokine stimulus,BP,
14795,GO:0060762,1,0.974372563676496,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14796,GO:0060763,1,0.986921285260943,0,2,mammary duct terminal end bud growth,BP,
14797,GO:0060764,1,0.987100353350807,0,2,cell-cell signaling involved in mammary gland development,BP,
14798,GO:0060765,1,0.84900128743802,0,25,regulation of androgen receptor signaling pathway,BP,
14799,GO:0060766,1,0.912268534813686,0,14,negative regulation of androgen receptor signaling pathway,BP,
14800,GO:0060767,1,0.930987405163527,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14801,GO:0060768,1,0.937088227028893,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14802,GO:0060769,1,0.980820108795004,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14803,GO:0060770,1,0.96212980900465,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14804,GO:0060775,1,0.987003028372917,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14805,GO:0060781,1,0.993634714618148,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14806,GO:0060782,1,0.993634714618148,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14807,GO:0060783,1,0.993634714618148,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14808,GO:0060784,1,0.993493812438227,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14809,GO:0060788,1,0.930483532418992,0,11,ectodermal placode formation,BP,
14810,GO:0060789,1,0.974308785564201,0,4,hair follicle placode formation,BP,
14811,GO:0060795,1,0.818089673284282,0,31,cell fate commitment involved in formation of primary germ layer,BP,
14812,GO:0060796,1,0.993583324430233,0,1,regulation of transcription involved in primary germ layer cell fate commitment,BP,
14813,GO:0060800,1,0.980612713979069,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
14814,GO:0060802,1,0.993600553466401,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
14815,GO:0060803,1,0.993640385922323,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
14816,GO:0060804,1,0.993535865062877,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14817,GO:0060806,1,0.993627090474246,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
14818,GO:0060807,1,0.993583324430233,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
14819,GO:0060809,1,0.986951319176699,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
14820,GO:0060816,1,0.986473155209594,0,2,random inactivation of X chromosome,BP,
14821,GO:0060819,1,0.986644674533058,0,2,inactivation of X chromosome by genetic imprinting,BP,
14822,GO:0060820,1,0.99308902989931,0,1,inactivation of X chromosome by heterochromatin assembly,BP,
14823,GO:0060821,1,0.99308902989931,0,1,inactivation of X chromosome by DNA methylation,BP,
14824,GO:0060823,1,0.993484902849537,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14825,GO:0060825,1,0.987282718807681,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14826,GO:0060827,1,0.993484902849537,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14828,GO:0060829,1,0.993484902849537,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14829,GO:0060830,1,0.980745785079729,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14830,GO:0060831,1,0.912062811264527,0,14,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14831,GO:0060836,1,0.954185734998308,0,7,lymphatic endothelial cell differentiation,BP,
14832,GO:0060837,1,0.942951796936831,0,9,blood vessel endothelial cell differentiation,BP,
14833,GO:0060838,1,0.980718642694478,0,3,lymphatic endothelial cell fate commitment,BP,
14834,GO:0060839,1,0.955681577017558,0,7,endothelial cell fate commitment,BP,
14836,GO:0060841,1,0.904796808565429,0,15,venous blood vessel development,BP,
14837,GO:0060842,1,0.961520635906939,0,6,arterial endothelial cell differentiation,BP,
14838,GO:0060843,1,0.993030207644103,0,1,venous endothelial cell differentiation,BP,
14839,GO:0060844,1,0.987150681513712,0,2,arterial endothelial cell fate commitment,BP,
14840,GO:0060846,1,0.980806858879045,0,3,blood vessel endothelial cell fate commitment,BP,
14841,GO:0060847,1,0.980806858879045,0,3,endothelial cell fate specification,BP,
14842,GO:0060849,1,0.987076275149004,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14844,GO:0060853,1,0.993527037882868,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14845,GO:0060856,1,0.931332251333313,0,11,establishment of blood-brain barrier,BP,
14846,GO:0060857,1,0.993587811602735,0,1,establishment of glial blood-brain barrier,BP,
14847,GO:0060872,1,0.942234651916075,0,9,semicircular canal development,BP,
14848,GO:0060873,1,0.99313563936281,0,1,anterior semicircular canal development,BP,
14849,GO:0060875,1,0.99313563936281,0,1,lateral semicircular canal development,BP,
14850,GO:0060876,1,0.987314830053471,0,2,semicircular canal formation,BP,
14851,GO:0060879,1,0.993697530091657,0,1,semicircular canal fusion,BP,
14852,GO:0060896,1,0.948416111237041,0,8,neural plate pattern specification,BP,
14853,GO:0060897,1,0.96137459562658,0,6,neural plate regionalization,BP,
14854,GO:0060900,1,0.923716300543015,0,12,embryonic camera-type eye formation,BP,
14855,GO:0060901,1,0.993471216481218,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14856,GO:0060903,1,0.968016315123648,0,5,positive regulation of meiosis I,BP,
14857,GO:0060904,1,0.993491231333169,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14858,GO:0060907,1,0.9433179042841,0,9,positive regulation of macrophage cytokine production,BP,
14859,GO:0060911,1,0.937515557999215,0,10,cardiac cell fate commitment,BP,
14860,GO:0060912,1,0.987181310225188,0,2,cardiac cell fate specification,BP,
14861,GO:0060913,1,0.980927529229184,0,3,cardiac cell fate determination,BP,
14863,GO:0060915,1,0.987221551041485,0,2,mesenchymal cell differentiation involved in lung development,BP,
14864,GO:0060916,1,0.967700052462127,0,5,mesenchymal cell proliferation involved in lung development,BP,
14865,GO:0060920,1,0.967869248785602,0,5,cardiac pacemaker cell differentiation,BP,
14866,GO:0060921,1,0.980606658970722,0,3,sinoatrial node cell differentiation,BP,
14867,GO:0060922,1,0.987013210655536,0,2,atrioventricular node cell differentiation,BP,
14868,GO:0060923,1,0.961952493896753,0,6,cardiac muscle cell fate commitment,BP,
14869,GO:0060926,1,0.974043929059089,0,4,cardiac pacemaker cell development,BP,
14870,GO:0060927,1,0.993611455304405,0,1,cardiac pacemaker cell fate commitment,BP,
14871,GO:0060928,1,0.987013210655536,0,2,atrioventricular node cell development,BP,
14872,GO:0060929,1,0.993611455304405,0,1,atrioventricular node cell fate commitment,BP,
14873,GO:0060931,1,0.986861779132999,0,2,sinoatrial node cell development,BP,
14874,GO:0060932,1,0.987090950735152,0,2,His-Purkinje system cell differentiation,BP,
14875,GO:0060935,1,0.980515085146141,0,3,cardiac fibroblast cell differentiation,BP,
14876,GO:0060936,1,0.980515085146141,0,3,cardiac fibroblast cell development,BP,
14877,GO:0060938,1,0.980515085146141,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14878,GO:0060939,1,0.980515085146141,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14879,GO:0060940,1,0.987131102795449,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14880,GO:0060947,1,0.948754639135801,0,8,cardiac vascular smooth muscle cell differentiation,BP,
14881,GO:0060948,1,0.980239430035021,0,3,cardiac vascular smooth muscle cell development,BP,
14882,GO:0060956,1,0.961089638550235,0,6,endocardial cell differentiation,BP,
14883,GO:0060957,1,0.99354609487117,0,1,endocardial cell fate commitment,BP,
14884,GO:0060964,1,0.588496552629094,0,81,regulation of gene silencing by miRNA,BP,
14885,GO:0060965,1,0.888924736114694,0,18,negative regulation of gene silencing by miRNA,BP,
14886,GO:0060966,1,0.576838916529225,0,84,regulation of gene silencing by RNA,BP,
14887,GO:0060967,1,0.877195557711431,0,20,negative regulation of gene silencing by RNA,BP,
14888,GO:0060968,1,0.540076345779056,0,94,regulation of gene silencing,BP,
14889,GO:0060969,1,0.854321860654918,0,24,negative regulation of gene silencing,BP,
14890,GO:0060971,1,0.973843554376836,0,4,embryonic heart tube left/right pattern formation,BP,
14891,GO:0060972,1,0.864776510075977,0,22,left/right pattern formation,BP,
14892,GO:0060973,1,0.894530303331016,0,17,cell migration involved in heart development,BP,
14893,GO:0060974,1,0.987371943175768,0,2,cell migration involved in heart formation,BP,
14894,GO:0060975,1,0.993662440202503,0,1,cardioblast migration to the midline involved in heart field formation,BP,
14897,GO:0060978,1,0.980366478971948,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
14898,GO:0060979,1,0.973330884210588,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
14899,GO:0060980,1,0.993509157505027,0,1,cell migration involved in coronary vasculogenesis,BP,
14900,GO:0060981,1,0.993358903206799,0,1,cell migration involved in coronary angiogenesis,BP,
14902,GO:0060986,1,0.761189741960422,0,42,endocrine hormone secretion,BP,
14903,GO:0060987,1,0.99358494523866,0,1,lipid tube,CC,
14904,GO:0060988,1,0.980744057843462,0,3,lipid tube assembly,BP,
14905,GO:0060992,1,0.961388115714775,0,6,response to fungicide,BP,
14907,GO:0060994,1,0.993506104796352,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14908,GO:0060995,1,0.986980912041294,0,2,cell-cell signaling involved in kidney development,BP,
14910,GO:0060997,1,0.675901681172164,0,59,dendritic spine morphogenesis,BP,
14913,GO:0061000,1,0.923724611473627,0,12,negative regulation of dendritic spine development,BP,
14914,GO:0061001,1,0.741527007138888,0,45,regulation of dendritic spine morphogenesis,BP,
14915,GO:0061002,1,0.955001939447096,0,7,negative regulation of dendritic spine morphogenesis,BP,
14916,GO:0061003,1,0.876036998178249,0,20,positive regulation of dendritic spine morphogenesis,BP,
14917,GO:0061004,1,0.94978435268492,0,8,pattern specification involved in kidney development,BP,
14920,GO:0061009,1,0.967539690061644,0,5,common bile duct development,BP,
14921,GO:0061010,1,0.986575922369579,0,2,gall bladder development,BP,
14922,GO:0061013,1,0.289769962062028,0,189,regulation of mRNA catabolic process,BP,
14923,GO:0061014,1,0.723831873996188,0,49,positive regulation of mRNA catabolic process,BP,
14924,GO:0061015,1,0.98733437394636,0,2,snRNA import into nucleus,BP,
14927,GO:0061026,1,0.967286636066434,0,5,cardiac muscle tissue regeneration,BP,
14928,GO:0061027,1,0.987190227024227,0,2,umbilical cord development,BP,
14929,GO:0061028,1,0.749377127149215,0,44,establishment of endothelial barrier,BP,
14930,GO:0061029,1,0.918354522488902,0,13,eyelid development in camera-type eye,BP,
14931,GO:0061030,1,0.980830419699712,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14932,GO:0061031,1,0.987272644575207,0,2,endodermal digestive tract morphogenesis,BP,
14933,GO:0061032,1,0.987166834072487,0,2,visceral serous pericardium development,BP,
14934,GO:0061033,1,0.980913277116493,0,3,secretion by lung epithelial cell involved in lung growth,BP,
14935,GO:0061034,1,0.993403524320284,0,1,olfactory bulb mitral cell layer development,BP,
14937,GO:0061036,1,0.832062113297535,0,28,positive regulation of cartilage development,BP,
14939,GO:0061038,1,0.960506192541674,0,6,uterus morphogenesis,BP,
14940,GO:0061040,1,0.993083098376319,0,1,female gonad morphogenesis,BP,
14942,GO:0061042,1,0.895446836727535,0,17,vascular wound healing,BP,
14943,GO:0061043,1,0.943323339284435,0,9,regulation of vascular wound healing,BP,
14944,GO:0061044,1,0.974241993577565,0,4,negative regulation of vascular wound healing,BP,
14946,GO:0061046,1,0.962014696696148,0,6,regulation of branching involved in lung morphogenesis,BP,
14947,GO:0061047,1,0.974527506981506,0,4,positive regulation of branching involved in lung morphogenesis,BP,
14948,GO:0061048,1,0.99362856345896,0,1,negative regulation of branching involved in lung morphogenesis,BP,
14951,GO:0061051,1,0.948569395583275,0,8,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14954,GO:0061054,1,0.987143168701725,0,2,dermatome development,BP,
14955,GO:0061055,1,0.974173916294574,0,4,myotome development,BP,
14956,GO:0061056,1,0.974632833188728,0,4,sclerotome development,BP,
14958,GO:0061072,1,0.941939157625858,0,9,iris morphogenesis,BP,
14959,GO:0061073,1,0.973581580382231,0,4,ciliary body morphogenesis,BP,
14960,GO:0061074,1,0.961961477912597,0,6,regulation of neural retina development,BP,
14961,GO:0061075,1,0.987214742689817,0,2,positive regulation of neural retina development,BP,
14962,GO:0061076,1,0.99353645562527,0,1,negative regulation of neural retina development,BP,
14963,GO:0061077,1,0.705278503335401,0,54,chaperone-mediated protein folding,BP,
14964,GO:0061078,1,0.993701867974549,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14965,GO:0061081,1,0.883415990389291,0,19,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14966,GO:0061082,1,0.822217046948878,0,30,myeloid leukocyte cytokine production,BP,
14967,GO:0061083,1,0.974381468368776,0,4,regulation of protein refolding,BP,
14968,GO:0061084,1,0.974381468368776,0,4,negative regulation of protein refolding,BP,
14969,GO:0061085,1,0.94911746089819,0,8,regulation of histone H3-K27 methylation,BP,
14970,GO:0061086,1,0.980545466743951,0,3,negative regulation of histone H3-K27 methylation,BP,
14971,GO:0061087,1,0.961695028261955,0,6,positive regulation of histone H3-K27 methylation,BP,
14972,GO:0061088,1,0.974331841276021,0,4,regulation of sequestering of zinc ion,BP,
14973,GO:0061090,1,0.993579716151439,0,1,positive regulation of sequestering of zinc ion,BP,
14974,GO:0061091,1,0.973850193430001,0,4,regulation of phospholipid translocation,BP,
14975,GO:0061092,1,0.973850193430001,0,4,positive regulation of phospholipid translocation,BP,
14978,GO:0061099,1,0.849644212636799,0,25,negative regulation of protein tyrosine kinase activity,BP,
14979,GO:0061100,1,0.99357512678926,0,1,lung neuroendocrine cell differentiation,BP,
14980,GO:0061101,1,0.949851595574019,0,8,neuroendocrine cell differentiation,BP,
14981,GO:0061102,1,0.987258415989157,0,2,stomach neuroendocrine cell differentiation,BP,
14982,GO:0061103,1,0.99357512678926,0,1,carotid body glomus cell differentiation,BP,
14983,GO:0061104,1,0.987170086840854,0,2,adrenal chromaffin cell differentiation,BP,
14984,GO:0061105,1,0.993642851218205,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14985,GO:0061106,1,0.993642851218205,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14986,GO:0061107,1,0.980879874985956,0,3,seminal vesicle development,BP,
14987,GO:0061108,1,0.993588825271203,0,1,seminal vesicle epithelium development,BP,
14988,GO:0061110,1,0.980323406081898,0,3,dense core granule biogenesis,BP,
14989,GO:0061113,1,0.980591021787647,0,3,pancreas morphogenesis,BP,
14990,GO:0061114,1,0.993540129524831,0,1,branching involved in pancreas morphogenesis,BP,
14991,GO:0061115,1,0.993697530091657,0,1,lung proximal/distal axis specification,BP,
14993,GO:0061133,1,0.956125581512724,0,7,endopeptidase activator activity,MF,
14996,GO:0061136,1,0.30998897411865,0,179,regulation of proteasomal protein catabolic process,BP,
14998,GO:0061140,1,0.943551236604256,0,9,lung secretory cell differentiation,BP,
14999,GO:0061141,1,0.980487474196605,0,3,lung ciliated cell differentiation,BP,
15000,GO:0061143,1,0.993552455871846,0,1,alveolar primary septum development,BP,
15001,GO:0061144,1,0.993538179267919,0,1,alveolar secondary septum development,BP,
15002,GO:0061145,1,0.98700496465385,0,2,lung smooth muscle development,BP,
15003,GO:0061146,1,0.980705053630639,0,3,Peyer's patch morphogenesis,BP,
15004,GO:0061149,1,0.993620720501988,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15005,GO:0061150,1,0.993620720501988,0,1,renal system segmentation,BP,
15006,GO:0061151,1,0.993620720501988,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15007,GO:0061152,1,0.987218413596245,0,2,trachea submucosa development,BP,
15008,GO:0061153,1,0.987218413596245,0,2,trachea gland development,BP,
15010,GO:0061155,1,0.993620720501988,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15012,GO:0061157,1,0.815791734395144,0,31,mRNA destabilization,BP,
15013,GO:0061158,1,0.894753462727989,0,17,3'-UTR-mediated mRNA destabilization,BP,
15014,GO:0061159,1,0.993424031562691,0,1,establishment of bipolar cell polarity involved in cell morphogenesis,BP,
15015,GO:0061162,1,0.870642736096161,0,21,establishment of monopolar cell polarity,BP,
15016,GO:0061171,1,0.993424031562691,0,1,establishment of bipolar cell polarity,BP,
15018,GO:0061179,1,0.949979907145142,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15019,GO:0061180,1,0.64705075645056,0,66,mammary gland epithelium development,BP,
15020,GO:0061181,1,0.980770778108662,0,3,regulation of chondrocyte development,BP,
15021,GO:0061182,1,0.993633612421849,0,1,negative regulation of chondrocyte development,BP,
15022,GO:0061183,1,0.987143168701725,0,2,regulation of dermatome development,BP,
15023,GO:0061184,1,0.993495030922634,0,1,positive regulation of dermatome development,BP,
15024,GO:0061185,1,0.993606964505936,0,1,negative regulation of dermatome development,BP,
15025,GO:0061187,1,0.980373535406713,0,3,regulation of ribosomal DNA heterochromatin assembly,BP,
15026,GO:0061188,1,0.986762862014905,0,2,negative regulation of ribosomal DNA heterochromatin assembly,BP,
15027,GO:0061189,1,0.993634714618148,0,1,positive regulation of sclerotome development,BP,
15028,GO:0061190,1,0.993634714618148,0,1,regulation of sclerotome development,BP,
15029,GO:0061193,1,0.987202317012902,0,2,taste bud development,BP,
15030,GO:0061196,1,0.961493536745916,0,6,fungiform papilla development,BP,
15031,GO:0061197,1,0.96770020102296,0,5,fungiform papilla morphogenesis,BP,
15032,GO:0061198,1,0.980525866664552,0,3,fungiform papilla formation,BP,
15033,GO:0061200,1,0.949653312625373,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15034,GO:0061202,1,0.949653312625373,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15035,GO:0061205,1,0.98050337942431,0,3,paramesonephric duct development,BP,
15036,GO:0061209,1,0.974527940099687,0,4,cell proliferation involved in mesonephros development,BP,
15039,GO:0061218,1,0.980884558999557,0,3,negative regulation of mesonephros development,BP,
15040,GO:0061227,1,0.987274525790186,0,2,pattern specification involved in mesonephros development,BP,
15041,GO:0061245,1,0.743337687234799,0,45,establishment or maintenance of bipolar cell polarity,BP,
15042,GO:0061289,1,0.986980912041294,0,2,Wnt signaling pathway involved in kidney development,BP,
15043,GO:0061290,1,0.986980912041294,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15045,GO:0061299,1,0.929930587861949,0,11,retina vasculature morphogenesis in camera-type eye,BP,
15046,GO:0061300,1,0.986894651940943,0,2,cerebellum vasculature development,BP,
15047,GO:0061301,1,0.993213589003073,0,1,cerebellum vasculature morphogenesis,BP,
15048,GO:0061302,1,0.968303556500808,0,5,smooth muscle cell-matrix adhesion,BP,
15049,GO:0061303,1,0.943046068499867,0,9,cornea development in camera-type eye,BP,
15050,GO:0061304,1,0.960543195025004,0,6,retinal blood vessel morphogenesis,BP,
15051,GO:0061307,1,0.931302931632441,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15052,GO:0061308,1,0.931302931632441,0,11,cardiac neural crest cell development involved in heart development,BP,
15053,GO:0061309,1,0.943422233487387,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15054,GO:0061311,1,0.827503447034077,0,29,cell surface receptor signaling pathway involved in heart development,BP,
15055,GO:0061312,1,0.962100956321415,0,6,BMP signaling pathway involved in heart development,BP,
15056,GO:0061314,1,0.930010863085521,0,11,Notch signaling involved in heart development,BP,
15057,GO:0061316,1,0.980845390847221,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15058,GO:0061317,1,0.987242434706085,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15059,GO:0061318,1,0.899631459625709,0,16,renal filtration cell differentiation,BP,
15060,GO:0061323,1,0.900112002369543,0,16,cell proliferation involved in heart morphogenesis,BP,
15061,GO:0061324,1,0.993521120114323,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15062,GO:0061325,1,0.974558417160706,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15066,GO:0061339,1,0.870642736096161,0,21,establishment or maintenance of monopolar cell polarity,BP,
15067,GO:0061341,1,0.986784446204537,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15068,GO:0061343,1,0.967617123556668,0,5,cell adhesion involved in heart morphogenesis,BP,
15069,GO:0061346,1,0.986784446204537,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15070,GO:0061347,1,0.993349843576017,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15071,GO:0061348,1,0.993349843576017,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15072,GO:0061349,1,0.993349843576017,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15073,GO:0061350,1,0.993349843576017,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15075,GO:0061354,1,0.993349843576017,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15076,GO:0061355,1,0.968148181726099,0,5,Wnt protein secretion,BP,
15077,GO:0061356,1,0.974365738718089,0,4,regulation of Wnt protein secretion,BP,
15078,GO:0061357,1,0.980628059753946,0,3,positive regulation of Wnt protein secretion,BP,
15079,GO:0061358,1,0.993615214374777,0,1,negative regulation of Wnt protein secretion,BP,
15080,GO:0061360,1,0.993482486668847,0,1,optic chiasma development,BP,
15081,GO:0061364,1,0.980280345508201,0,3,apoptotic process involved in luteolysis,BP,
15082,GO:0061365,1,0.956066472730294,0,7,positive regulation of triglyceride lipase activity,BP,
15083,GO:0061366,1,0.987254078406311,0,2,behavioral response to chemical pain,BP,
15084,GO:0061368,1,0.987254078406311,0,2,behavioral response to formalin induced pain,BP,
15085,GO:0061369,1,0.993495030922634,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15086,GO:0061370,1,0.962115510617415,0,6,testosterone biosynthetic process,BP,
15087,GO:0061371,1,0.661869285133837,0,63,determination of heart left/right asymmetry,BP,
15088,GO:0061373,1,0.993044617066839,0,1,mammillary axonal complex development,BP,
15089,GO:0061377,1,0.894301812761303,0,17,mammary gland lobule development,BP,
15091,GO:0061384,1,0.81012657917795,0,32,heart trabecula morphogenesis,BP,
15092,GO:0061386,1,0.986452394630932,0,2,closure of optic fissure,BP,
15094,GO:0061394,1,0.987268641696912,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15095,GO:0061395,1,0.993625114054372,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15096,GO:0061400,1,0.99355705431691,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15097,GO:0061402,1,0.987178896230494,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15098,GO:0061408,1,0.993595573832411,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15099,GO:0061418,1,0.627395173382954,0,72,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15100,GO:0061419,1,0.961374801820131,0,6,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15101,GO:0061428,1,0.974285044268102,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15103,GO:0061433,1,0.993609711467124,0,1,cellular response to caloric restriction,BP,
15104,GO:0061436,1,0.86616534675274,0,22,establishment of skin barrier,BP,
15109,GO:0061441,1,0.987030369400433,0,2,renal artery morphogenesis,BP,
15110,GO:0061443,1,0.986923823073498,0,2,endocardial cushion cell differentiation,BP,
15111,GO:0061444,1,0.993335141155463,0,1,endocardial cushion cell development,BP,
15112,GO:0061445,1,0.99354609487117,0,1,endocardial cushion cell fate commitment,BP,
15114,GO:0061450,1,0.925223382428476,0,12,trophoblast cell migration,BP,
15116,GO:0061459,1,0.96130651995656,0,6,L-arginine transmembrane transporter activity,MF,
15117,GO:0061462,1,0.769799278894104,0,40,protein localization to lysosome,BP,
15118,GO:0061463,1,0.99355705431691,0,1,O-acetyl-ADP-ribose deacetylase activity,MF,
15119,GO:0061469,1,0.931417357561898,0,11,regulation of type B pancreatic cell proliferation,BP,
15120,GO:0061470,1,0.967581985815824,0,5,T follicular helper cell differentiation,BP,
15121,GO:0061474,1,0.993570724932747,0,1,phagolysosome membrane,CC,
15122,GO:0061476,1,0.993538746806461,0,1,response to anticoagulant,BP,
15123,GO:0061481,1,0.993683378759476,0,1,response to TNF agonist,BP,
15124,GO:0061484,1,0.974177671486216,0,4,hematopoietic stem cell homeostasis,BP,
15125,GO:0061485,1,0.99320300688905,0,1,memory T cell proliferation,BP,
15126,GO:0061502,1,0.973360965128147,0,4,early endosome to recycling endosome transport,BP,
15127,GO:0061507,1,0.993552973937176,0,1,cyclic-GMP-AMP binding,MF,
15128,GO:0061508,1,0.99355705431691,0,1,CDP phosphorylation,BP,
15129,GO:0061511,1,0.955343760501879,0,7,centriole elongation,BP,
15130,GO:0061512,1,0.693009809073969,0,56,protein localization to cilium,BP,
15131,GO:0061513,1,0.980738922838941,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15132,GO:0061514,1,0.993621056111973,0,1,interleukin-34-mediated signaling pathway,BP,
15133,GO:0061515,1,0.649126659997205,0,66,myeloid cell development,BP,
15134,GO:0061517,1,0.937400656226547,0,10,macrophage proliferation,BP,
15135,GO:0061518,1,0.95585405529967,0,7,microglial cell proliferation,BP,
15136,GO:0061519,1,0.993512179291318,0,1,macrophage homeostasis,BP,
15137,GO:0061523,1,0.99350877773261,0,1,cilium disassembly,BP,
15138,GO:0061525,1,0.948595458847999,0,8,hindgut development,BP,
15139,GO:0061526,1,0.97452014920907,0,4,acetylcholine secretion,BP,
15140,GO:0061528,1,0.986727960000236,0,2,aspartate secretion,BP,
15141,GO:0061534,1,0.992712879993245,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15142,GO:0061535,1,0.973316107001393,0,4,glutamate secretion, neurotransmission,BP,
15143,GO:0061536,1,0.993532020092422,0,1,glycine secretion,BP,
15144,GO:0061537,1,0.993532020092422,0,1,glycine secretion, neurotransmission,BP,
15145,GO:0061542,1,0.993655215305584,0,1,3-demethylubiquinol-n 3-O-methyltransferase activity,MF,
15146,GO:0061547,1,0.98709782397572,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15148,GO:0061549,1,0.949144743219181,0,8,sympathetic ganglion development,BP,
15149,GO:0061550,1,0.961358945822492,0,6,cranial ganglion development,BP,
15150,GO:0061551,1,0.967630161949031,0,5,trigeminal ganglion development,BP,
15151,GO:0061552,1,0.987005016713402,0,2,ganglion morphogenesis,BP,
15153,GO:0061565,1,0.99355705431691,0,1,dAMP phosphorylation,BP,
15154,GO:0061566,1,0.99355705431691,0,1,CMP phosphorylation,BP,
15155,GO:0061567,1,0.99355705431691,0,1,dCMP phosphorylation,BP,
15156,GO:0061568,1,0.99355705431691,0,1,GDP phosphorylation,BP,
15157,GO:0061569,1,0.99355705431691,0,1,UDP phosphorylation,BP,
15158,GO:0061570,1,0.99355705431691,0,1,dCDP phosphorylation,BP,
15159,GO:0061571,1,0.99355705431691,0,1,TDP phosphorylation,BP,
15161,GO:0061574,1,0.974339325381497,0,4,ASAP complex,CC,
15162,GO:0061575,1,0.94375497676407,0,9,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15163,GO:0061577,1,0.911756671743551,0,14,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15164,GO:0061578,1,0.930177412185587,0,11,Lys63-specific deubiquitinase activity,MF,
15165,GO:0061580,1,0.993481798718386,0,1,colon epithelial cell migration,BP,
15166,GO:0061582,1,0.98683537978877,0,2,intestinal epithelial cell migration,BP,
15167,GO:0061586,1,0.993525241258344,0,1,positive regulation of transcription by transcription factor localization,BP,
15168,GO:0061588,1,0.967796724454962,0,5,calcium activated phospholipid scrambling,BP,
15169,GO:0061589,1,0.974287616121293,0,4,calcium activated phosphatidylserine scrambling,BP,
15170,GO:0061590,1,0.967796724454962,0,5,calcium activated phosphatidylcholine scrambling,BP,
15171,GO:0061591,1,0.967796724454962,0,5,calcium activated galactosylceramide scrambling,BP,
15172,GO:0061598,1,0.993472472896888,0,1,molybdopterin adenylyltransferase activity,MF,
15173,GO:0061599,1,0.993472472896888,0,1,molybdopterin molybdotransferase activity,MF,
15174,GO:0061604,1,0.993576395629378,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15175,GO:0061605,1,0.993576395629378,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15176,GO:0061608,1,0.888012121031044,0,18,nuclear import signal receptor activity,MF,
15177,GO:0061609,1,0.993577924406225,0,1,fructose-1-phosphate aldolase activity,MF,
15178,GO:0061611,1,0.993621324578831,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15179,GO:0061614,1,0.706116037430345,0,53,pri-miRNA transcription by RNA polymerase II,BP,
15180,GO:0061615,1,0.833506870411999,0,28,glycolytic process through fructose-6-phosphate,BP,
15181,GO:0061617,1,0.956121461845489,0,7,MICOS complex,CC,
15182,GO:0061620,1,0.839035905460999,0,27,glycolytic process through glucose-6-phosphate,BP,
15183,GO:0061621,1,0.844407981674876,0,26,canonical glycolysis,BP,
15184,GO:0061622,1,0.993648773227165,0,1,glycolytic process through glucose-1-phosphate,BP,
15185,GO:0061623,1,0.993648773227165,0,1,glycolytic process from galactose,BP,
15186,GO:0061624,1,0.974531408893151,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15187,GO:0061626,1,0.95508985363131,0,7,pharyngeal arch artery morphogenesis,BP,
15188,GO:0061627,1,0.993606562878433,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15189,GO:0061628,1,0.979901418812977,0,3,H3K27me3 modified histone binding,MF,
15191,GO:0061630,1,0.187246803606564,0,254,ubiquitin protein ligase activity,MF,
15192,GO:0061631,1,0.780983271215836,0,38,ubiquitin conjugating enzyme activity,MF,
15193,GO:0061632,1,0.99356467430751,0,1,RNA lariat debranching enzyme activator activity,MF,
15194,GO:0061635,1,0.931650438414807,0,11,regulation of protein complex stability,BP,
15195,GO:0061640,1,0.58069934957209,0,83,cytoskeleton-dependent cytokinesis,BP,
15196,GO:0061641,1,0.845481816317924,0,26,CENP-A containing chromatin organization,BP,
15197,GO:0061642,1,0.973192739945974,0,4,chemoattraction of axon,BP,
15198,GO:0061643,1,0.9614428988623,0,6,chemorepulsion of axon,BP,
15199,GO:0061646,1,0.993423486490551,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15200,GO:0061647,1,0.732976065057151,0,47,histone H3-K9 modification,BP,
15201,GO:0061649,1,0.980486390091606,0,3,ubiquitin modification-dependent histone binding,MF,
15202,GO:0061650,1,0.771090533684271,0,40,ubiquitin-like protein conjugating enzyme activity,MF,
15203,GO:0061654,1,0.993649570860514,0,1,NEDD8 conjugating enzyme activity,MF,
15204,GO:0061656,1,0.993659525454334,0,1,SUMO conjugating enzyme activity,MF,
15205,GO:0061657,1,0.993664757151642,0,1,UFM1 conjugating enzyme activity,MF,
15206,GO:0061659,1,0.176500164870915,0,263,ubiquitin-like protein ligase activity,MF,
15207,GO:0061663,1,0.980676956508948,0,3,NEDD8 ligase activity,MF,
15208,GO:0061665,1,0.949655162114407,0,8,SUMO ligase activity,MF,
15209,GO:0061666,1,0.99355705431691,0,1,UFM1 ligase activity,MF,
15210,GO:0061668,1,0.961767043386561,0,6,mitochondrial ribosome assembly,BP,
15211,GO:0061669,1,0.954834118249019,0,7,spontaneous neurotransmitter secretion,BP,
15212,GO:0061670,1,0.993639585932517,0,1,evoked neurotransmitter secretion,BP,
15213,GO:0061673,1,0.949344690833536,0,8,mitotic spindle astral microtubule,CC,
15214,GO:0061676,1,0.955289677005793,0,7,importin-alpha family protein binding,MF,
15215,GO:0061682,1,0.993583648118973,0,1,seminal vesicle morphogenesis,BP,
15217,GO:0061685,1,0.99355705431691,0,1,diphthine methylesterase activity,MF,
15218,GO:0061687,1,0.920254530742555,0,13,detoxification of inorganic compound,BP,
15219,GO:0061689,1,0.974158662435595,0,4,tricellular tight junction,CC,
15220,GO:0061690,1,0.993661645496463,0,1,lipoamidase activity,MF,
15221,GO:0061695,1,0.216416190992324,0,233,transferase complex, transferring phosphorus-containing groups,CC,
15222,GO:0061697,1,0.987201584567984,0,2,protein-glutaryllysine deglutarylase activity,MF,
15223,GO:0061698,1,0.987201584567984,0,2,protein deglutarylation,BP,
15224,GO:0061699,1,0.987201584567984,0,2,peptidyl-lysine deglutarylation,BP,
15225,GO:0061700,1,0.943469129195935,0,9,GATOR2 complex,CC,
15226,GO:0061702,1,0.913102685651256,0,14,inflammasome complex,CC,
15227,GO:0061709,1,0.942570576913387,0,9,reticulophagy,BP,
15228,GO:0061711,1,0.987261611863574,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15229,GO:0061712,1,0.993528836600293,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15230,GO:0061713,1,0.987277963419866,0,2,anterior neural tube closure,BP,
15231,GO:0061714,1,0.987374311366355,0,2,folic acid receptor activity,MF,
15232,GO:0061715,1,0.993530691847354,0,1,miRNA 2'-O-methylation,BP,
15233,GO:0061718,1,0.844407981674876,0,26,glucose catabolic process to pyruvate,BP,
15234,GO:0061723,1,0.986895803703265,0,2,glycophagy,BP,
15235,GO:0061724,1,0.954671516185998,0,7,lipophagy,BP,
15236,GO:0061726,1,0.611022039876152,0,75,mitochondrion disassembly,BP,
15237,GO:0061727,1,0.980977733706401,0,3,methylglyoxal catabolic process to lactate,BP,
15238,GO:0061731,1,0.98060873536916,0,3,ribonucleoside-diphosphate reductase activity,MF,
15239,GO:0061732,1,0.961961840227993,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15240,GO:0061733,1,0.71972811334468,0,50,peptide-lysine-N-acetyltransferase activity,MF,
15241,GO:0061734,1,0.96697160885743,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15242,GO:0061736,1,0.993360564370827,0,1,engulfment of target by autophagosome,BP,
15243,GO:0061737,1,0.968414903550125,0,5,leukotriene signaling pathway,BP,
15244,GO:0061738,1,0.980843849880105,0,3,late endosomal microautophagy,BP,
15245,GO:0061739,1,0.980744485110495,0,3,protein lipidation involved in autophagosome assembly,BP,
15246,GO:0061740,1,0.980764532411995,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15247,GO:0061741,1,0.987197287822521,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15248,GO:0061743,1,0.968370411266895,0,5,motor learning,BP,
15249,GO:0061744,1,0.943332331987439,0,9,motor behavior,BP,
15250,GO:0061749,1,0.986851783419988,0,2,forked DNA-dependent helicase activity,MF,
15251,GO:0061750,1,0.993584620608794,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15252,GO:0061751,1,0.993397417507683,0,1,neutral sphingomyelin phosphodiesterase activity,MF,
15253,GO:0061752,1,0.987196229726313,0,2,telomeric repeat-containing RNA binding,MF,
15254,GO:0061753,1,0.993360564370827,0,1,substrate localization to autophagosome,BP,
15255,GO:0061756,1,0.760039691512093,0,42,leukocyte adhesion to vascular endothelial cell,BP,
15256,GO:0061757,1,0.974521968219944,0,4,leukocyte adhesion to arterial endothelial cell,BP,
15258,GO:0061762,1,0.954170219765036,0,7,CAMKK-AMPK signaling cascade,BP,
15259,GO:0061763,1,0.987163629419928,0,2,multivesicular body-lysosome fusion,BP,
15260,GO:0061767,1,0.993343708520855,0,1,negative regulation of lung blood pressure,BP,
15261,GO:0061768,1,0.993430058220605,0,1,magnesium:sodium antiporter activity,MF,
15262,GO:0061769,1,0.987155207697788,0,2,ribosylnicotinate kinase activity,MF,
15263,GO:0061770,1,0.993595573832411,0,1,translation elongation factor binding,MF,
15264,GO:0061771,1,0.980790911510844,0,3,response to caloric restriction,BP,
15265,GO:0061772,1,0.993521543099334,0,1,xenobiotic transport across blood-nerve barrier,BP,
15266,GO:0061778,1,0.900925869740894,0,16,intracellular chloride channel activity,MF,
15267,GO:0061780,1,0.992947795630555,0,1,mitotic cohesin loading,BP,
15268,GO:0061782,1,0.993483668270107,0,1,vesicle fusion with vesicle,BP,
15269,GO:0061783,1,0.981107231919941,0,3,peptidoglycan muralytic activity,MF,
15270,GO:0061789,1,0.979557164123262,0,3,dense core granule priming,BP,
15271,GO:0061792,1,0.974028770263041,0,4,secretory granule maturation,BP,
15272,GO:0061795,1,0.987088731412983,0,2,Golgi lumen acidification,BP,
15273,GO:0061798,1,0.993479209855665,0,1,GTP 3',8'-cyclase activity,MF,
15274,GO:0061799,1,0.993479209855665,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15275,GO:0061809,1,0.90100967510994,0,16,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15276,GO:0061811,1,0.993640785836875,0,1,ADP-ribosyl cyclase activity,MF,
15277,GO:0061812,1,0.993640785836875,0,1,cyclic ADP-ribose hydrolase,MF,
15278,GO:0061817,1,0.967862938772014,0,5,endoplasmic reticulum-plasma membrane tethering,BP,
15279,GO:0061819,1,0.980520803672759,0,3,telomeric DNA-containing double minutes formation,BP,
15280,GO:0061820,1,0.949158810464641,0,8,telomeric D-loop disassembly,BP,
15281,GO:0061821,1,0.974045225568805,0,4,telomeric D-loop binding,MF,
15282,GO:0061825,1,0.993493521075413,0,1,podosome core,CC,
15283,GO:0061827,1,0.937299671441844,0,10,sperm head,CC,
15284,GO:0061828,1,0.993188565160649,0,1,apical tubulobulbar complex,CC,
15285,GO:0061829,1,0.993188565160649,0,1,basal tubulobulbar complex,CC,
15286,GO:0061830,1,0.993315466056991,0,1,concave side of sperm head,CC,
15287,GO:0061831,1,0.993133478716038,0,1,apical ectoplasmic specialization,CC,
15288,GO:0061832,1,0.993172002791072,0,1,basal ectoplasmic specialization,CC,
15289,GO:0061833,1,0.987100469925506,0,2,protein localization to tricellular tight junction,BP,
15290,GO:0061837,1,0.993363923351374,0,1,neuropeptide processing,BP,
15291,GO:0061842,1,0.824788139574143,0,29,microtubule organizing center localization,BP,
15293,GO:0061845,1,0.993530108284653,0,1,neuron projection branch point,CC,
15294,GO:0061846,1,0.993530108284653,0,1,dendritic spine cytoplasm,CC,
15295,GO:0061847,1,0.987142095312388,0,2,response to cholecystokinin,BP,
15296,GO:0061849,1,0.986851783419988,0,2,telomeric G-quadruplex DNA binding,MF,
15297,GO:0061850,1,0.993680412277699,0,1,growth cone leading edge,CC,
15298,GO:0061851,1,0.987241361259596,0,2,leading edge of lamellipodium,CC,
15299,GO:0061857,1,0.987095409260079,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15300,GO:0061860,1,0.986783551695246,0,2,DNA clamp unloader activity,MF,
15301,GO:0061863,1,0.99327934212249,0,1,microtubule plus end polymerase,MF,
15302,GO:0061868,1,0.993125572424245,0,1,hepatic stellate cell migration,BP,
15303,GO:0061869,1,0.993125572424245,0,1,regulation of hepatic stellate cell migration,BP,
15304,GO:0061870,1,0.993125572424245,0,1,positive regulation of hepatic stellate cell migration,BP,
15305,GO:0061880,1,0.993626152696582,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15306,GO:0061881,1,0.993626152696582,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15307,GO:0061884,1,0.987162072718749,0,2,regulation of mini excitatory postsynaptic potential,BP,
15308,GO:0061885,1,0.987162072718749,0,2,positive regulation of mini excitatory postsynaptic potential,BP,
15309,GO:0061888,1,0.974103100725021,0,4,regulation of astrocyte activation,BP,
15310,GO:0061889,1,0.986996264022194,0,2,negative regulation of astrocyte activation,BP,
15311,GO:0061890,1,0.993235426566939,0,1,positive regulation of astrocyte activation,BP,
15312,GO:0061891,1,0.980729221828055,0,3,calcium ion sensor activity,MF,
15313,GO:0061896,1,0.993443021768063,0,1,all-trans retinol 3,4-desaturase activity,MF,
15314,GO:0061897,1,0.993443021768063,0,1,all-trans retinal 3,4-desaturase activity,MF,
15315,GO:0061898,1,0.993443021768063,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15316,GO:0061899,1,0.993443021768063,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15318,GO:0061901,1,0.987111138279784,0,2,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15319,GO:0061903,1,0.987111138279784,0,2,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15320,GO:0061909,1,0.987142767359067,0,2,autophagosome-lysosome fusion,BP,
15321,GO:0061912,1,0.691219594434446,0,56,selective autophagy,BP,
15323,GO:0061920,1,0.993082140467003,0,1,protein propionyltransferase activity,MF,
15324,GO:0061921,1,0.993082140467003,0,1,peptidyl-lysine propionylation,BP,
15325,GO:0061928,1,0.98733495655164,0,2,glutathione specific gamma-glutamylcyclotransferase activity,MF,
15326,GO:0061929,1,0.99355705431691,0,1,gamma-glutamylaminecyclotransferase activity,MF,
15327,GO:0061930,1,0.993406836997533,0,1,regulation of erythrocyte enucleation,BP,
15328,GO:0061931,1,0.993406836997533,0,1,positive regulation of erythrocyte enucleation,BP,
15329,GO:0061944,1,0.993467873437937,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15330,GO:0061945,1,0.980736730451794,0,3,regulation of protein K48-linked ubiquitination,BP,
15331,GO:0061951,1,0.706298251261057,0,53,establishment of protein localization to plasma membrane,BP,
15332,GO:0061952,1,0.896231286868494,0,17,midbody abscission,BP,
15333,GO:0061953,1,0.980827417733577,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15334,GO:0061966,1,0.987065494051978,0,2,establishment of left/right asymmetry,BP,
15335,GO:0061975,1,0.980806647854434,0,3,articular cartilage development,BP,
15336,GO:0061980,1,0.789780033556089,0,36,regulatory RNA binding,MF,
15337,GO:0061981,1,0.993640552559868,0,1,3-hydroxykynureninase activity,MF,
15338,GO:0061982,1,0.52763433995481,0,98,meiosis I cell cycle process,BP,
15339,GO:0061983,1,0.937479872134406,0,10,meiosis II cell cycle process,BP,
15340,GO:0061986,1,0.993579011226295,0,1,negative regulation of transcription by glucose,BP,
15341,GO:0061987,1,0.993579011226295,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15342,GO:0061999,1,0.993567435503044,0,1,regulation of cardiac endothelial to mesenchymal transition,BP,
15343,GO:0062000,1,0.993567435503044,0,1,positive regulation of cardiac endothelial to mesenchymal transition,BP,
15344,GO:0062002,1,0.993546401305344,0,1,regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15345,GO:0062003,1,0.993546401305344,0,1,negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15346,GO:0062009,1,0.86415966340907,0,22,secondary palate development,BP,
15349,GO:0062014,1,0.57411209428507,0,85,negative regulation of small molecule metabolic process,BP,
15351,GO:0062025,1,0.993438890191099,0,1,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
15352,GO:0062026,1,0.993438890191099,0,1,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process,BP,
15353,GO:0062028,1,0.967531315669792,0,5,regulation of stress granule assembly,BP,
15354,GO:0062029,1,0.987064842121785,0,2,positive regulation of stress granule assembly,BP,
15355,GO:0062030,1,0.993645048320597,0,1,negative regulation of stress granule assembly,BP,
15356,GO:0062033,1,0.882642307637226,0,19,positive regulation of mitotic sister chromatid segregation,BP,
15357,GO:0062035,1,0.993442873768306,0,1,sensory perception of cold stimulus,BP,
15358,GO:0062036,1,0.993466250207999,0,1,sensory perception of hot stimulus,BP,
15359,GO:0062037,1,0.974045225568805,0,4,D-loop DNA binding,MF,
15360,GO:0062042,1,0.942359935065904,0,9,regulation of cardiac epithelial to mesenchymal transition,BP,
15361,GO:0062043,1,0.948420056722806,0,8,positive regulation of cardiac epithelial to mesenchymal transition,BP,
15362,GO:0062044,1,0.987058782344764,0,2,negative regulation of cardiac epithelial to mesenchymal transition,BP,
15363,GO:0062050,1,0.993554769848748,0,1,GPI-mannose ethanolamine phosphate phosphodiesterase activity,MF,
15364,GO:0062061,1,0.987194082927958,0,2,TAP complex binding,MF,
15365,GO:0062064,1,0.993492644036998,0,1,box C/D snoRNP complex binding,MF,
15366,GO:0062065,1,0.993492644036998,0,1,box H/ACA snoRNP complex binding,MF,
15367,GO:0062069,1,0.993510914594462,0,1,GARP complex binding,MF,
15368,GO:0062072,1,0.993578947207367,0,1,H3K9me3 modified histone binding,MF,
15369,GO:0062094,1,0.980729283650049,0,3,stomach development,BP,
15372,GO:0062100,1,0.980824815711062,0,3,positive regulation of programmed necrotic cell death,BP,
15373,GO:0062105,1,0.974481722955617,0,4,RNA 2'-O-methyltransferase activity,MF,
15374,GO:0062111,1,0.987253491919789,0,2,zinc ion import into organelle,BP,
15375,GO:0062125,1,0.834491713585773,0,28,regulation of mitochondrial gene expression,BP,
15376,GO:0062149,1,0.86616949730668,0,22,detection of stimulus involved in sensory perception of pain,BP,
15378,GO:0062207,1,0.580895050596198,0,83,regulation of pattern recognition receptor signaling pathway,BP,
15379,GO:0062208,1,0.801057660431368,0,34,positive regulation of pattern recognition receptor signaling pathway,BP,
15380,GO:0062232,1,0.980867958995444,0,3,prostanoid catabolic process,BP,
15382,GO:0065001,1,0.974164313471174,0,4,specification of axis polarity,BP,
15383,GO:0065002,1,0.728042787184218,0,49,intracellular protein transmembrane transport,BP,
15385,GO:0065004,1,0.358487929198969,0,157,protein-DNA complex assembly,BP,
15386,GO:0065005,1,0.838417887376084,0,27,protein-lipid complex assembly,BP,
15390,GO:0065010,1,0.968393037504072,0,5,extracellular membrane-bounded organelle,CC,
15391,GO:0070001,1,0.890131150414247,0,18,aspartic-type peptidase activity,MF,
15392,GO:0070003,1,0.863315837315932,0,23,threonine-type peptidase activity,MF,
15393,GO:0070004,1,0.980725459437801,0,3,cysteine-type exopeptidase activity,MF,
15394,GO:0070006,1,0.866434851790541,0,22,metalloaminopeptidase activity,MF,
15395,GO:0070008,1,0.9431256092639,0,9,serine-type exopeptidase activity,MF,
15396,GO:0070009,1,0.980604678418746,0,3,serine-type aminopeptidase activity,MF,
15397,GO:0070012,1,0.980621740457596,0,3,oligopeptidase activity,MF,
15399,GO:0070016,1,0.936465751861183,0,10,armadillo repeat domain binding,MF,
15400,GO:0070025,1,0.993567127228303,0,1,carbon monoxide binding,MF,
15401,GO:0070026,1,0.981002278765426,0,3,nitric oxide binding,MF,
15402,GO:0070032,1,0.974636657051993,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15403,GO:0070033,1,0.980760422677101,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15404,GO:0070034,1,0.871291709773438,0,21,telomerase RNA binding,MF,
15405,GO:0070037,1,0.993669519180857,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15406,GO:0070042,1,0.993541928971256,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15407,GO:0070044,1,0.974551845656663,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15409,GO:0070051,1,0.967772663622157,0,5,fibrinogen binding,MF,
15410,GO:0070052,1,0.986929842010291,0,2,collagen V binding,MF,
15411,GO:0070053,1,0.980685972472655,0,3,thrombospondin receptor activity,MF,
15412,GO:0070054,1,0.993488007991549,0,1,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15414,GO:0070060,1,0.993048692877836,0,1,'de novo' actin filament nucleation,BP,
15415,GO:0070061,1,0.968273232125067,0,5,fructose binding,MF,
15417,GO:0070063,1,0.671435928219257,0,61,RNA polymerase binding,MF,
15418,GO:0070064,1,0.894116961522037,0,17,proline-rich region binding,MF,
15419,GO:0070069,1,0.857930648855098,0,24,cytochrome complex,CC,
15420,GO:0070070,1,0.96818906036395,0,5,proton-transporting V-type ATPase complex assembly,BP,
15421,GO:0070071,1,0.943581198953002,0,9,proton-transporting two-sector ATPase complex assembly,BP,
15422,GO:0070072,1,0.96818906036395,0,5,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15423,GO:0070075,1,0.993697530091657,0,1,tear secretion,BP,
15424,GO:0070076,1,0.841300042936281,0,26,histone lysine demethylation,BP,
15425,GO:0070077,1,0.99351061792185,0,1,histone arginine demethylation,BP,
15426,GO:0070078,1,0.99351061792185,0,1,histone H3-R2 demethylation,BP,
15427,GO:0070079,1,0.99351061792185,0,1,histone H4-R3 demethylation,BP,
15428,GO:0070080,1,0.987170017537923,0,2,titin Z domain binding,MF,
15429,GO:0070081,1,0.968240842242689,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15430,GO:0070083,1,0.968240842242689,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15431,GO:0070084,1,0.980754083543714,0,3,protein initiator methionine removal,BP,
15433,GO:0070086,1,0.968063524637669,0,5,ubiquitin-dependent endocytosis,BP,
15434,GO:0070087,1,0.960476498278272,0,6,chromo shadow domain binding,MF,
15435,GO:0070089,1,0.993341688196393,0,1,chloride-activated potassium channel activity,MF,
15436,GO:0070091,1,0.943649000846263,0,9,glucagon secretion,BP,
15437,GO:0070092,1,0.943649000846263,0,9,regulation of glucagon secretion,BP,
15438,GO:0070093,1,0.974746739627798,0,4,negative regulation of glucagon secretion,BP,
15439,GO:0070094,1,0.987166320732228,0,2,positive regulation of glucagon secretion,BP,
15440,GO:0070095,1,0.968255265695662,0,5,fructose-6-phosphate binding,MF,
15441,GO:0070096,1,0.993523392537954,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15442,GO:0070097,1,0.954590130004502,0,7,delta-catenin binding,MF,
15446,GO:0070101,1,0.980880063514291,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15448,GO:0070103,1,0.974573365657335,0,4,regulation of interleukin-6-mediated signaling pathway,BP,
15449,GO:0070104,1,0.993626018701236,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15450,GO:0070105,1,0.980826341140479,0,3,positive regulation of interleukin-6-mediated signaling pathway,BP,
15451,GO:0070106,1,0.930903943396949,0,11,interleukin-27-mediated signaling pathway,BP,
15452,GO:0070110,1,0.98074508296758,0,3,ciliary neurotrophic factor receptor complex,CC,
15453,GO:0070119,1,0.993481139411545,0,1,ciliary neurotrophic factor binding,MF,
15454,GO:0070120,1,0.967603222064583,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15455,GO:0070121,1,0.99337403039786,0,1,Kupffer's vesicle development,BP,
15456,GO:0070122,1,0.896048659143392,0,17,isopeptidase activity,MF,
15457,GO:0070123,1,0.993298596636808,0,1,transforming growth factor beta receptor activity, type III,MF,
15458,GO:0070124,1,0.987267991617968,0,2,mitochondrial translational initiation,BP,
15459,GO:0070125,1,0.580475985097786,0,85,mitochondrial translational elongation,BP,
15460,GO:0070126,1,0.576700602441846,0,86,mitochondrial translational termination,BP,
15461,GO:0070127,1,0.955643569376673,0,7,tRNA aminoacylation for mitochondrial protein translation,BP,
15462,GO:0070129,1,0.850910095502716,0,25,regulation of mitochondrial translation,BP,
15463,GO:0070130,1,0.99355705431691,0,1,negative regulation of mitochondrial translation,BP,
15464,GO:0070131,1,0.901891033082761,0,16,positive regulation of mitochondrial translation,BP,
15465,GO:0070137,1,0.980371195659474,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15466,GO:0070138,1,0.980592562105921,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15467,GO:0070139,1,0.980371195659474,0,3,SUMO-specific endopeptidase activity,MF,
15468,GO:0070140,1,0.980592562105921,0,3,SUMO-specific isopeptidase activity,MF,
15469,GO:0070141,1,0.961748237755484,0,6,response to UV-A,BP,
15470,GO:0070142,1,0.930590220331982,0,11,synaptic vesicle budding,BP,
15471,GO:0070143,1,0.993434708894376,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15472,GO:0070145,1,0.993524607399594,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15473,GO:0070158,1,0.993601252888419,0,1,mitochondrial seryl-tRNA aminoacylation,BP,
15474,GO:0070159,1,0.993580872450883,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15477,GO:0070162,1,0.961557857112268,0,6,adiponectin secretion,BP,
15478,GO:0070163,1,0.961557857112268,0,6,regulation of adiponectin secretion,BP,
15479,GO:0070164,1,0.974120521633308,0,4,negative regulation of adiponectin secretion,BP,
15480,GO:0070165,1,0.987106942252648,0,2,positive regulation of adiponectin secretion,BP,
15481,GO:0070166,1,0.930166632877004,0,11,enamel mineralization,BP,
15484,GO:0070169,1,0.764438993062809,0,41,positive regulation of biomineral tissue development,BP,
15485,GO:0070170,1,0.968009565249927,0,5,regulation of tooth mineralization,BP,
15486,GO:0070171,1,0.986921373510123,0,2,negative regulation of tooth mineralization,BP,
15487,GO:0070172,1,0.987194921050445,0,2,positive regulation of tooth mineralization,BP,
15488,GO:0070173,1,0.993563548032922,0,1,regulation of enamel mineralization,BP,
15489,GO:0070176,1,0.993619646379563,0,1,DRM complex,CC,
15490,GO:0070178,1,0.987248161483678,0,2,D-serine metabolic process,BP,
15491,GO:0070179,1,0.993574747073295,0,1,D-serine biosynthetic process,BP,
15492,GO:0070180,1,0.97492574509784,0,4,large ribosomal subunit rRNA binding,MF,
15493,GO:0070181,1,0.938036560865435,0,10,small ribosomal subunit rRNA binding,MF,
15494,GO:0070182,1,0.889618812126551,0,18,DNA polymerase binding,MF,
15495,GO:0070183,1,0.993554101532261,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15496,GO:0070184,1,0.993595573832411,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15497,GO:0070187,1,0.961996301783356,0,6,shelterin complex,CC,
15498,GO:0070189,1,0.949815318764553,0,8,kynurenine metabolic process,BP,
15499,GO:0070191,1,0.99355705431691,0,1,methionine-R-sulfoxide reductase activity,MF,
15500,GO:0070192,1,0.697995024375207,0,55,chromosome organization involved in meiotic cell cycle,BP,
15501,GO:0070193,1,0.884188969394394,0,19,synaptonemal complex organization,BP,
15502,GO:0070194,1,0.987192847367817,0,2,synaptonemal complex disassembly,BP,
15503,GO:0070195,1,0.993466046469306,0,1,growth hormone receptor complex,CC,
15504,GO:0070197,1,0.987164315777841,0,2,meiotic attachment of telomere to nuclear envelope,BP,
15505,GO:0070198,1,0.826156683008336,0,29,protein localization to chromosome, telomeric region,BP,
15506,GO:0070199,1,0.859970307784911,0,23,establishment of protein localization to chromosome,BP,
15507,GO:0070200,1,0.888606399792438,0,18,establishment of protein localization to telomere,BP,
15509,GO:0070202,1,0.92561416342626,0,12,regulation of establishment of protein localization to chromosome,BP,
15510,GO:0070203,1,0.931620785151612,0,11,regulation of establishment of protein localization to telomere,BP,
15511,GO:0070206,1,0.895214028056924,0,17,protein trimerization,BP,
15512,GO:0070207,1,0.906947116652186,0,15,protein homotrimerization,BP,
15513,GO:0070208,1,0.99338195471899,0,1,protein heterotrimerization,BP,
15514,GO:0070209,1,0.980763052930498,0,3,ASTRA complex,CC,
15515,GO:0070212,1,0.948468367427157,0,8,protein poly-ADP-ribosylation,BP,
15516,GO:0070213,1,0.930323545774824,0,11,protein auto-ADP-ribosylation,BP,
15517,GO:0070221,1,0.97481216638499,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15518,GO:0070227,1,0.651532870893423,0,66,lymphocyte apoptotic process,BP,
15519,GO:0070228,1,0.727872903567234,0,49,regulation of lymphocyte apoptotic process,BP,
15520,GO:0070229,1,0.839211139511984,0,27,negative regulation of lymphocyte apoptotic process,BP,
15521,GO:0070230,1,0.913630236664943,0,14,positive regulation of lymphocyte apoptotic process,BP,
15522,GO:0070231,1,0.751947592195552,0,44,T cell apoptotic process,BP,
15523,GO:0070232,1,0.828837495236971,0,29,regulation of T cell apoptotic process,BP,
15524,GO:0070233,1,0.895523398427283,0,17,negative regulation of T cell apoptotic process,BP,
15525,GO:0070234,1,0.937664152543972,0,10,positive regulation of T cell apoptotic process,BP,
15526,GO:0070235,1,0.97438677033581,0,4,regulation of activation-induced cell death of T cells,BP,
15527,GO:0070236,1,0.980653200602414,0,3,negative regulation of activation-induced cell death of T cells,BP,
15528,GO:0070238,1,0.99362816181609,0,1,activated T cell autonomous cell death,BP,
15529,GO:0070239,1,0.99362816181609,0,1,regulation of activated T cell autonomous cell death,BP,
15530,GO:0070241,1,0.99362816181609,0,1,positive regulation of activated T cell autonomous cell death,BP,
15531,GO:0070242,1,0.895303003716982,0,17,thymocyte apoptotic process,BP,
15532,GO:0070243,1,0.925097052632868,0,12,regulation of thymocyte apoptotic process,BP,
15533,GO:0070244,1,0.955581038319234,0,7,negative regulation of thymocyte apoptotic process,BP,
15534,GO:0070245,1,0.968113265533761,0,5,positive regulation of thymocyte apoptotic process,BP,
15535,GO:0070246,1,0.993653224222364,0,1,natural killer cell apoptotic process,BP,
15536,GO:0070247,1,0.993653224222364,0,1,regulation of natural killer cell apoptotic process,BP,
15537,GO:0070251,1,0.993585335096994,0,1,pristanate-CoA ligase activity,MF,
15539,GO:0070253,1,0.974711079447365,0,4,somatostatin secretion,BP,
15540,GO:0070254,1,0.937481818301588,0,10,mucus secretion,BP,
15541,GO:0070255,1,0.943438341834014,0,9,regulation of mucus secretion,BP,
15542,GO:0070256,1,0.987230648614645,0,2,negative regulation of mucus secretion,BP,
15543,GO:0070257,1,0.961841276075141,0,6,positive regulation of mucus secretion,BP,
15544,GO:0070259,1,0.987107885676839,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15545,GO:0070260,1,0.99355705431691,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15546,GO:0070262,1,0.87837966896611,0,20,peptidyl-serine dephosphorylation,BP,
15549,GO:0070267,1,0.993512501474192,0,1,oncosis,BP,
15550,GO:0070268,1,0.663883004479623,0,63,cornification,BP,
15551,GO:0070269,1,0.937388696200397,0,10,pyroptosis,BP,
15552,GO:0070273,1,0.841608672093838,0,26,phosphatidylinositol-4-phosphate binding,MF,
15553,GO:0070274,1,0.993605626166114,0,1,RES complex,CC,
15554,GO:0070278,1,0.93691661065034,0,10,extracellular matrix constituent secretion,BP,
15555,GO:0070279,1,0.75197952693975,0,44,vitamin B6 binding,MF,
15556,GO:0070280,1,0.993499374287033,0,1,pyridoxal binding,MF,
15557,GO:0070286,1,0.840838409293359,0,26,axonemal dynein complex assembly,BP,
15558,GO:0070287,1,0.993510239947417,0,1,ferritin receptor activity,MF,
15559,GO:0070288,1,0.987379010231755,0,2,ferritin complex,CC,
15560,GO:0070290,1,0.980421646905112,0,3,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15561,GO:0070291,1,0.968262422210055,0,5,N-acylethanolamine metabolic process,BP,
15562,GO:0070292,1,0.98701742211405,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15563,GO:0070293,1,0.901610567002535,0,16,renal absorption,BP,
15564,GO:0070294,1,0.974165778303738,0,4,renal sodium ion absorption,BP,
15565,GO:0070295,1,0.980861795367409,0,3,renal water absorption,BP,
15570,GO:0070303,1,0.76004661355865,0,42,negative regulation of stress-activated protein kinase signaling cascade,BP,
15572,GO:0070305,1,0.961063470488845,0,6,response to cGMP,BP,
15573,GO:0070306,1,0.810615763558482,0,32,lens fiber cell differentiation,BP,
15574,GO:0070307,1,0.924800231959539,0,12,lens fiber cell development,BP,
15575,GO:0070309,1,0.967828288016106,0,5,lens fiber cell morphogenesis,BP,
15576,GO:0070314,1,0.95517962266621,0,7,G1 to G0 transition,BP,
15577,GO:0070315,1,0.987106470258768,0,2,G1 to G0 transition involved in cell differentiation,BP,
15578,GO:0070316,1,0.768850610943757,0,40,regulation of G0 to G1 transition,BP,
15579,GO:0070317,1,0.784200801386288,0,37,negative regulation of G0 to G1 transition,BP,
15580,GO:0070318,1,0.980472749263522,0,3,positive regulation of G0 to G1 transition,BP,
15581,GO:0070319,1,0.986658836804715,0,2,Golgi to plasma membrane transport vesicle,CC,
15582,GO:0070320,1,0.993562880886849,0,1,inward rectifier potassium channel inhibitor activity,MF,
15583,GO:0070324,1,0.955682087133725,0,7,thyroid hormone binding,MF,
15584,GO:0070325,1,0.869271015124013,0,21,lipoprotein particle receptor binding,MF,
15585,GO:0070326,1,0.973859437526132,0,4,very-low-density lipoprotein particle receptor binding,MF,
15586,GO:0070327,1,0.943268509450347,0,9,thyroid hormone transport,BP,
15587,GO:0070328,1,0.839420224255384,0,27,triglyceride homeostasis,BP,
15588,GO:0070330,1,0.913595988356784,0,14,aromatase activity,MF,
15589,GO:0070335,1,0.993234704873342,0,1,aspartate binding,MF,
15590,GO:0070336,1,0.980568526378617,0,3,flap-structured DNA binding,MF,
15591,GO:0070337,1,0.993355148367012,0,1,3'-flap-structured DNA binding,MF,
15592,GO:0070339,1,0.961890616960487,0,6,response to bacterial lipopeptide,BP,
15593,GO:0070340,1,0.98054777588101,0,3,detection of bacterial lipopeptide,BP,
15594,GO:0070341,1,0.943232105631112,0,9,fat cell proliferation,BP,
15595,GO:0070343,1,0.980943279976947,0,3,white fat cell proliferation,BP,
15596,GO:0070344,1,0.943232105631112,0,9,regulation of fat cell proliferation,BP,
15597,GO:0070345,1,0.967797807489646,0,5,negative regulation of fat cell proliferation,BP,
15598,GO:0070346,1,0.981031797262923,0,3,positive regulation of fat cell proliferation,BP,
15599,GO:0070350,1,0.980943279976947,0,3,regulation of white fat cell proliferation,BP,
15600,GO:0070352,1,0.987391082754058,0,2,positive regulation of white fat cell proliferation,BP,
15601,GO:0070358,1,0.954448900977072,0,7,actin polymerization-dependent cell motility,BP,
15602,GO:0070365,1,0.919061841888202,0,13,hepatocyte differentiation,BP,
15603,GO:0070366,1,0.987306328609117,0,2,regulation of hepatocyte differentiation,BP,
15604,GO:0070367,1,0.993603754678565,0,1,negative regulation of hepatocyte differentiation,BP,
15605,GO:0070368,1,0.993662440202503,0,1,positive regulation of hepatocyte differentiation,BP,
15606,GO:0070369,1,0.98026573612816,0,3,beta-catenin-TCF7L2 complex,CC,
15607,GO:0070370,1,0.968459908108966,0,5,cellular heat acclimation,BP,
15610,GO:0070373,1,0.641694860647931,0,68,negative regulation of ERK1 and ERK2 cascade,BP,
15612,GO:0070375,1,0.987005222284797,0,2,ERK5 cascade,BP,
15613,GO:0070381,1,0.987064858411731,0,2,endosome to plasma membrane transport vesicle,CC,
15615,GO:0070383,1,0.943880309906324,0,9,DNA cytosine deamination,BP,
15616,GO:0070384,1,0.974506658969483,0,4,Harderian gland development,BP,
15617,GO:0070390,1,0.968395770233712,0,5,transcription export complex 2,CC,
15618,GO:0070391,1,0.937451624891322,0,10,response to lipoteichoic acid,BP,
15619,GO:0070392,1,0.993669453079625,0,1,detection of lipoteichoic acid,BP,
15620,GO:0070401,1,0.980930179684651,0,3,NADP+ binding,MF,
15621,GO:0070402,1,0.907318500260984,0,15,NADPH binding,MF,
15622,GO:0070403,1,0.91376291376309,0,14,NAD+ binding,MF,
15623,GO:0070404,1,0.981009506804815,0,3,NADH binding,MF,
15624,GO:0070407,1,0.993537208649004,0,1,oxidation-dependent protein catabolic process,BP,
15625,GO:0070408,1,0.993356941546488,0,1,carbamoyl phosphate metabolic process,BP,
15626,GO:0070409,1,0.993356941546488,0,1,carbamoyl phosphate biosynthetic process,BP,
15627,GO:0070410,1,0.922697965564714,0,12,co-SMAD binding,MF,
15628,GO:0070411,1,0.911245833659568,0,14,I-SMAD binding,MF,
15629,GO:0070412,1,0.858587165510141,0,23,R-SMAD binding,MF,
15630,GO:0070413,1,0.993546289825048,0,1,trehalose metabolism in response to stress,BP,
15631,GO:0070417,1,0.942822481168735,0,9,cellular response to cold,BP,
15632,GO:0070418,1,0.98690895074172,0,2,DNA-dependent protein kinase complex,CC,
15633,GO:0070419,1,0.954815286947393,0,7,nonhomologous end joining complex,CC,
15634,GO:0070421,1,0.993522811433526,0,1,DNA ligase III-XRCC1 complex,CC,
15635,GO:0070423,1,0.801212420278824,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15636,GO:0070424,1,0.942707428109329,0,9,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15637,GO:0070425,1,0.98704666974811,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15638,GO:0070426,1,0.974338487729313,0,4,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15639,GO:0070427,1,0.968016935761794,0,5,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15640,GO:0070428,1,0.980527397171042,0,3,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15641,GO:0070429,1,0.993461379502464,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15642,GO:0070430,1,0.986981739124982,0,2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15643,GO:0070431,1,0.925163179320829,0,12,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15644,GO:0070432,1,0.967936780980204,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15645,GO:0070433,1,0.98704666974811,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15646,GO:0070434,1,0.980641825737078,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15647,GO:0070435,1,0.987137011137665,0,2,Shc-EGFR complex,CC,
15648,GO:0070436,1,0.987039110370703,0,2,Grb2-EGFR complex,CC,
15649,GO:0070442,1,0.993647576409349,0,1,integrin alphaIIb-beta3 complex,CC,
15652,GO:0070446,1,0.993609711467124,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15654,GO:0070453,1,0.987354303394558,0,2,regulation of heme biosynthetic process,BP,
15655,GO:0070458,1,0.980919449183031,0,3,cellular detoxification of nitrogen compound,BP,
15656,GO:0070459,1,0.955918124231796,0,7,prolactin secretion,BP,
15657,GO:0070460,1,0.980637427007134,0,3,thyroid-stimulating hormone secretion,BP,
15658,GO:0070461,1,0.860402923377895,0,23,SAGA-type complex,CC,
15659,GO:0070462,1,0.99350877773261,0,1,plus-end specific microtubule depolymerization,BP,
15660,GO:0070463,1,0.993518525763532,0,1,tubulin-dependent ATPase activity,MF,
15661,GO:0070469,1,0.6075562064388,0,78,respirasome,CC,
15662,GO:0070471,1,0.943414982648517,0,9,uterine smooth muscle contraction,BP,
15663,GO:0070472,1,0.949524960409996,0,8,regulation of uterine smooth muscle contraction,BP,
15664,GO:0070473,1,0.993609376261734,0,1,negative regulation of uterine smooth muscle contraction,BP,
15665,GO:0070474,1,0.968062512546537,0,5,positive regulation of uterine smooth muscle contraction,BP,
15666,GO:0070475,1,0.956012210035861,0,7,rRNA base methylation,BP,
15667,GO:0070476,1,0.993700685168828,0,1,rRNA (guanine-N7)-methylation,BP,
15668,GO:0070478,1,0.99347735552092,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15669,GO:0070481,1,0.99354858693132,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15671,GO:0070483,1,0.993533885086564,0,1,detection of hypoxia,BP,
15672,GO:0070486,1,0.91310956755296,0,14,leukocyte aggregation,BP,
15673,GO:0070487,1,0.961490391609931,0,6,monocyte aggregation,BP,
15674,GO:0070488,1,0.987452078329143,0,2,neutrophil aggregation,BP,
15675,GO:0070489,1,0.98714185942317,0,2,T cell aggregation,BP,
15676,GO:0070491,1,0.628791492156443,0,71,repressing transcription factor binding,MF,
15677,GO:0070492,1,0.931776540772845,0,11,oligosaccharide binding,MF,
15682,GO:0070506,1,0.987166728628488,0,2,high-density lipoprotein particle receptor activity,MF,
15684,GO:0070508,1,0.948644969054232,0,8,cholesterol import,BP,
15686,GO:0070510,1,0.993236193124982,0,1,regulation of histone H4-K20 methylation,BP,
15687,GO:0070512,1,0.993236193124982,0,1,positive regulation of histone H4-K20 methylation,BP,
15688,GO:0070513,1,0.937767565420876,0,10,death domain binding,MF,
15689,GO:0070516,1,0.974768980546837,0,4,CAK-ERCC2 complex,CC,
15690,GO:0070522,1,0.974202122513801,0,4,ERCC4-ERCC1 complex,CC,
15691,GO:0070524,1,0.993645613989723,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15692,GO:0070525,1,0.913958572360065,0,14,tRNA threonylcarbamoyladenosine metabolic process,BP,
15694,GO:0070528,1,0.828085636899655,0,29,protein kinase C signaling,BP,
15695,GO:0070530,1,0.894819213156223,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15696,GO:0070531,1,0.961774581872628,0,6,BRCA1-A complex,CC,
15697,GO:0070534,1,0.712202995456699,0,52,protein K63-linked ubiquitination,BP,
15698,GO:0070535,1,0.960994116333675,0,6,histone H2A K63-linked ubiquitination,BP,
15699,GO:0070536,1,0.837483698905679,0,27,protein K63-linked deubiquitination,BP,
15700,GO:0070537,1,0.980784848860472,0,3,histone H2A K63-linked deubiquitination,BP,
15701,GO:0070538,1,0.98735124267355,0,2,oleic acid binding,MF,
15702,GO:0070539,1,0.993516348173392,0,1,linoleic acid binding,MF,
15703,GO:0070541,1,0.980532291650068,0,3,response to platinum ion,BP,
15704,GO:0070542,1,0.581177515045263,0,83,response to fatty acid,BP,
15705,GO:0070543,1,0.99360135284646,0,1,response to linoleic acid,BP,
15706,GO:0070544,1,0.948556043814569,0,8,histone H3-K36 demethylation,BP,
15707,GO:0070545,1,0.987215877053142,0,2,PeBoW complex,CC,
15708,GO:0070547,1,0.993557349169712,0,1,L-tyrosine aminotransferase activity,MF,
15709,GO:0070548,1,0.986681342008797,0,2,L-glutamine aminotransferase activity,MF,
15710,GO:0070550,1,0.992947795630555,0,1,rDNA condensation,BP,
15711,GO:0070551,1,0.99355705431691,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15712,GO:0070552,1,0.980820434372561,0,3,BRISC complex,CC,
15713,GO:0070553,1,0.99355705431691,0,1,nicotinic acid receptor activity,MF,
15714,GO:0070554,1,0.987080633975662,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15716,GO:0070557,1,0.987283447819687,0,2,PCNA-p21 complex,CC,
15717,GO:0070560,1,0.987150239221311,0,2,protein secretion by platelet,BP,
15718,GO:0070561,1,0.942843742230129,0,9,vitamin D receptor signaling pathway,BP,
15719,GO:0070562,1,0.96144458046249,0,6,regulation of vitamin D receptor signaling pathway,BP,
15720,GO:0070563,1,0.98705394581112,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15721,GO:0070564,1,0.987212149214921,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15722,GO:0070566,1,0.877776763634967,0,20,adenylyltransferase activity,MF,
15723,GO:0070567,1,0.949615409111218,0,8,cytidylyltransferase activity,MF,
15724,GO:0070568,1,0.974509742692627,0,4,guanylyltransferase activity,MF,
15725,GO:0070569,1,0.968314254649257,0,5,uridylyltransferase activity,MF,
15728,GO:0070572,1,0.94269521463173,0,9,positive regulation of neuron projection regeneration,BP,
15730,GO:0070574,1,0.967969300370395,0,5,cadmium ion transmembrane transport,BP,
15731,GO:0070576,1,0.987142376958624,0,2,vitamin D 24-hydroxylase activity,MF,
15732,GO:0070577,1,0.86985957048656,0,21,lysine-acetylated histone binding,MF,
15733,GO:0070578,1,0.942979870823478,0,9,RISC-loading complex,CC,
15734,GO:0070579,1,0.972733949149052,0,4,methylcytosine dioxygenase activity,MF,
15735,GO:0070584,1,0.867248420609847,0,22,mitochondrion morphogenesis,BP,
15736,GO:0070585,1,0.418787386682102,0,134,protein localization to mitochondrion,BP,
15740,GO:0070589,1,0.993621324578831,0,1,cellular component macromolecule biosynthetic process,BP,
15742,GO:0070601,1,0.937290218426871,0,10,centromeric sister chromatid cohesion,BP,
15743,GO:0070602,1,0.974423903023505,0,4,regulation of centromeric sister chromatid cohesion,BP,
15744,GO:0070603,1,0.622755358748396,0,72,SWI/SNF superfamily-type complex,CC,
15745,GO:0070611,1,0.993564979609524,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15746,GO:0070612,1,0.993564979609524,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15748,GO:0070615,1,0.986743219220825,0,2,nucleosome-dependent ATPase activity,MF,
15749,GO:0070618,1,0.993561883772767,0,1,Grb2-Sos complex,CC,
15750,GO:0070625,1,0.993600753249866,0,1,zymogen granule exocytosis,BP,
15751,GO:0070626,1,0.993640985774167,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15752,GO:0070628,1,0.900329149101197,0,16,proteasome binding,MF,
15753,GO:0070633,1,0.853663782713589,0,24,transepithelial transport,BP,
15754,GO:0070634,1,0.986911123696616,0,2,transepithelial ammonium transport,BP,
15755,GO:0070637,1,0.993578947207367,0,1,pyridine nucleoside metabolic process,BP,
15756,GO:0070638,1,0.993578947207367,0,1,pyridine nucleoside catabolic process,BP,
15757,GO:0070640,1,0.974405856293007,0,4,vitamin D3 metabolic process,BP,
15758,GO:0070643,1,0.980874976375921,0,3,vitamin D 25-hydroxylase activity,MF,
15759,GO:0070644,1,0.980417059327391,0,3,vitamin D response element binding,MF,
15760,GO:0070646,1,0.185306538744571,0,256,protein modification by small protein removal,BP,
15761,GO:0070647,1,0.0011264812706795,0,1006,protein modification by small protein conjugation or removal,BP,
15762,GO:0070649,1,0.980342804362872,0,3,formin-nucleated actin cable assembly,BP,
15763,GO:0070651,1,0.99354858693132,0,1,nonfunctional rRNA decay,BP,
15764,GO:0070652,1,0.949339439125007,0,8,HAUS complex,CC,
15765,GO:0070653,1,0.993679686869083,0,1,high-density lipoprotein particle receptor binding,MF,
15767,GO:0070662,1,0.967850814079069,0,5,mast cell proliferation,BP,
15771,GO:0070666,1,0.974278340052348,0,4,regulation of mast cell proliferation,BP,
15772,GO:0070667,1,0.980765159932404,0,3,negative regulation of mast cell proliferation,BP,
15773,GO:0070668,1,0.986969906115258,0,2,positive regulation of mast cell proliferation,BP,
15774,GO:0070669,1,0.918770258299031,0,13,response to interleukin-2,BP,
15775,GO:0070670,1,0.812560689040266,0,32,response to interleukin-4,BP,
15776,GO:0070671,1,0.737976802641786,0,47,response to interleukin-12,BP,
15777,GO:0070672,1,0.912469664841205,0,14,response to interleukin-15,BP,
15778,GO:0070673,1,0.931467877125204,0,11,response to interleukin-18,BP,
15779,GO:0070676,1,0.980976919255115,0,3,intralumenal vesicle formation,BP,
15780,GO:0070678,1,0.993562306258195,0,1,preprotein binding,MF,
15781,GO:0070679,1,0.916615047054292,0,13,inositol 1,4,5 trisphosphate binding,MF,
15782,GO:0070681,1,0.980872649372175,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15783,GO:0070682,1,0.980867900127257,0,3,proteasome regulatory particle assembly,BP,
15784,GO:0070684,1,0.993663896732946,0,1,seminal clot liquefaction,BP,
15785,GO:0070685,1,0.993598724135227,0,1,macropinocytic cup,CC,
15786,GO:0070694,1,0.99355705431691,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15787,GO:0070695,1,0.966950127170715,0,5,FHF complex,CC,
15788,GO:0070696,1,0.878310057781782,0,20,transmembrane receptor protein serine/threonine kinase binding,MF,
15789,GO:0070697,1,0.949568565177785,0,8,activin receptor binding,MF,
15790,GO:0070698,1,0.980878442067969,0,3,type I activin receptor binding,MF,
15791,GO:0070699,1,0.980520689977933,0,3,type II activin receptor binding,MF,
15792,GO:0070700,1,0.92499430936802,0,12,BMP receptor binding,MF,
15793,GO:0070704,1,0.987060899597149,0,2,sterol desaturase activity,MF,
15794,GO:0070715,1,0.993528783654157,0,1,sodium-dependent organic cation transport,BP,
15795,GO:0070716,1,0.993575633753531,0,1,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,BP,
15796,GO:0070717,1,0.826885027838992,0,29,poly-purine tract binding,MF,
15797,GO:0070723,1,0.847651329627337,0,25,response to cholesterol,BP,
15798,GO:0070724,1,0.980683460851009,0,3,BMP receptor complex,CC,
15800,GO:0070728,1,0.955230036431276,0,7,leucine binding,MF,
15801,GO:0070733,1,0.993629701122825,0,1,protein adenylyltransferase activity,MF,
15802,GO:0070734,1,0.906033193297385,0,15,histone H3-K27 methylation,BP,
15803,GO:0070735,1,0.993522018820499,0,1,protein-glycine ligase activity,MF,
15804,GO:0070736,1,0.993522018820499,0,1,protein-glycine ligase activity, initiating,MF,
15805,GO:0070739,1,0.949422354426105,0,8,protein-glutamic acid ligase activity,MF,
15806,GO:0070740,1,0.949422354426105,0,8,tubulin-glutamic acid ligase activity,MF,
15808,GO:0070742,1,0.912305478926439,0,14,C2H2 zinc finger domain binding,MF,
15809,GO:0070743,1,0.99367018013566,0,1,interleukin-23 complex,CC,
15810,GO:0070757,1,0.930833451796182,0,11,interleukin-35-mediated signaling pathway,BP,
15811,GO:0070761,1,0.968119578836762,0,5,pre-snoRNP complex,CC,
15812,GO:0070762,1,0.99355705431691,0,1,nuclear pore transmembrane ring,CC,
15813,GO:0070765,1,0.961754205474451,0,6,gamma-secretase complex,CC,
15814,GO:0070772,1,0.993538017299483,0,1,PAS complex,CC,
15815,GO:0070774,1,0.987086861787436,0,2,phytoceramidase activity,MF,
15816,GO:0070775,1,0.942880351408072,0,9,H3 histone acetyltransferase complex,CC,
15817,GO:0070776,1,0.948997884634383,0,8,MOZ/MORF histone acetyltransferase complex,CC,
15818,GO:0070777,1,0.973515295727738,0,4,D-aspartate transport,BP,
15819,GO:0070778,1,0.930486440476176,0,11,L-aspartate transmembrane transport,BP,
15820,GO:0070779,1,0.973515295727738,0,4,D-aspartate import across plasma membrane,BP,
15821,GO:0070781,1,0.987006058683818,0,2,response to biotin,BP,
15822,GO:0070782,1,0.968088781403565,0,5,phosphatidylserine exposure on apoptotic cell surface,BP,
15823,GO:0070813,1,0.968108654660959,0,5,hydrogen sulfide metabolic process,BP,
15824,GO:0070814,1,0.97427233365461,0,4,hydrogen sulfide biosynthetic process,BP,
15825,GO:0070815,1,0.97433313536425,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15827,GO:0070818,1,0.993623236751341,0,1,protoporphyrinogen oxidase activity,MF,
15828,GO:0070820,1,0.363803635119309,0,155,tertiary granule,CC,
15829,GO:0070821,1,0.632339091957814,0,70,tertiary granule membrane,CC,
15830,GO:0070822,1,0.906247432289653,0,15,Sin3-type complex,CC,
15831,GO:0070826,1,0.993478636411314,0,1,paraferritin complex,CC,
15832,GO:0070827,1,0.967359450942158,0,5,chromatin maintenance,BP,
15833,GO:0070828,1,0.733639380458889,0,47,heterochromatin organization,BP,
15834,GO:0070829,1,0.980142476826278,0,3,heterochromatin maintenance,BP,
15836,GO:0070831,1,0.905464328019663,0,15,basement membrane assembly,BP,
15837,GO:0070836,1,0.9745861259175,0,4,caveola assembly,BP,
15838,GO:0070837,1,0.955708371095422,0,7,dehydroascorbic acid transport,BP,
15840,GO:0070839,1,0.929930735954597,0,11,divalent metal ion export,BP,
15842,GO:0070841,1,0.865592471205912,0,22,inclusion body assembly,BP,
15843,GO:0070842,1,0.968116334198531,0,5,aggresome assembly,BP,
15844,GO:0070843,1,0.993481798718386,0,1,misfolded protein transport,BP,
15845,GO:0070844,1,0.993481798718386,0,1,polyubiquitinated protein transport,BP,
15846,GO:0070845,1,0.993481798718386,0,1,polyubiquitinated misfolded protein transport,BP,
15847,GO:0070846,1,0.993481798718386,0,1,Hsp90 deacetylation,BP,
15848,GO:0070847,1,0.949605002590224,0,8,core mediator complex,CC,
15850,GO:0070849,1,0.743933309462992,0,45,response to epidermal growth factor,BP,
15852,GO:0070852,1,0.954556770493914,0,7,cell body fiber,CC,
15853,GO:0070853,1,0.986440563039512,0,2,myosin VI binding,MF,
15854,GO:0070856,1,0.993328573926243,0,1,myosin VI light chain binding,MF,
15855,GO:0070857,1,0.943503739995403,0,9,regulation of bile acid biosynthetic process,BP,
15856,GO:0070858,1,0.98713839087469,0,2,negative regulation of bile acid biosynthetic process,BP,
15857,GO:0070859,1,0.980831153782908,0,3,positive regulation of bile acid biosynthetic process,BP,
15858,GO:0070860,1,0.993585855414673,0,1,RNA polymerase I core factor complex,CC,
15859,GO:0070861,1,0.837491355994671,0,27,regulation of protein exit from endoplasmic reticulum,BP,
15860,GO:0070862,1,0.937225690518563,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
15861,GO:0070863,1,0.91178466503932,0,14,positive regulation of protein exit from endoplasmic reticulum,BP,
15862,GO:0070868,1,0.9733673877485,0,4,heterochromatin organization involved in chromatin silencing,BP,
15863,GO:0070873,1,0.820197942965539,0,30,regulation of glycogen metabolic process,BP,
15864,GO:0070874,1,0.967452034471022,0,5,negative regulation of glycogen metabolic process,BP,
15865,GO:0070875,1,0.904978138967594,0,15,positive regulation of glycogen metabolic process,BP,
15866,GO:0070876,1,0.974374627842978,0,4,SOSS complex,CC,
15867,GO:0070877,1,0.987059038820619,0,2,microprocessor complex,CC,
15868,GO:0070878,1,0.94917713638897,0,8,primary miRNA binding,MF,
15869,GO:0070881,1,0.993516082062855,0,1,regulation of proline transport,BP,
15870,GO:0070883,1,0.961393481248922,0,6,pre-miRNA binding,MF,
15872,GO:0070885,1,0.912415763054599,0,14,negative regulation of calcineurin-NFAT signaling cascade,BP,
15873,GO:0070886,1,0.918101056327368,0,13,positive regulation of calcineurin-NFAT signaling cascade,BP,
15875,GO:0070888,1,0.755980074067727,0,43,E-box binding,MF,
15876,GO:0070889,1,0.987188424348237,0,2,platelet alpha granule organization,BP,
15877,GO:0070890,1,0.986876344920053,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
15878,GO:0070891,1,0.974690003432675,0,4,lipoteichoic acid binding,MF,
15879,GO:0070892,1,0.99360135284646,0,1,lipoteichoic acid immune receptor activity,MF,
15880,GO:0070893,1,0.986985118363577,0,2,transposon integration,BP,
15881,GO:0070894,1,0.986985118363577,0,2,regulation of transposon integration,BP,
15882,GO:0070895,1,0.986985118363577,0,2,negative regulation of transposon integration,BP,
15883,GO:0070897,1,0.795558586891665,0,35,transcription preinitiation complex assembly,BP,
15884,GO:0070898,1,0.986407014265285,0,2,RNA polymerase III preinitiation complex assembly,BP,
15885,GO:0070899,1,0.993543630712982,0,1,mitochondrial tRNA wobble uridine modification,BP,
15886,GO:0070900,1,0.94974972773971,0,8,mitochondrial tRNA modification,BP,
15887,GO:0070901,1,0.974491787136977,0,4,mitochondrial tRNA methylation,BP,
15888,GO:0070902,1,0.993628496522646,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
15889,GO:0070904,1,0.986876344920053,0,2,transepithelial L-ascorbic acid transport,BP,
15890,GO:0070905,1,0.974487036235003,0,4,serine binding,MF,
15891,GO:0070911,1,0.84454358890137,0,26,global genome nucleotide-excision repair,BP,
15892,GO:0070914,1,0.924914025779074,0,12,UV-damage excision repair,BP,
15895,GO:0070920,1,0.860679577413912,0,23,regulation of production of small RNA involved in gene silencing by RNA,BP,
15896,GO:0070922,1,0.942666868006453,0,9,small RNA loading onto RISC,BP,
15898,GO:0070926,1,0.993497100798592,0,1,regulation of ATP:ADP antiporter activity,BP,
15899,GO:0070931,1,0.993358775348292,0,1,Golgi-associated vesicle lumen,CC,
15900,GO:0070932,1,0.877130451093617,0,20,histone H3 deacetylation,BP,
15901,GO:0070933,1,0.930445376310155,0,11,histone H4 deacetylation,BP,
15902,GO:0070934,1,0.967153575135593,0,5,CRD-mediated mRNA stabilization,BP,
15903,GO:0070935,1,0.883822925509439,0,19,3'-UTR-mediated mRNA stabilization,BP,
15904,GO:0070936,1,0.703105480470849,0,54,protein K48-linked ubiquitination,BP,
15905,GO:0070937,1,0.96084694971442,0,6,CRD-mediated mRNA stability complex,CC,
15906,GO:0070938,1,0.935855353548766,0,10,contractile ring,CC,
15907,GO:0070939,1,0.980440305844792,0,3,Dsl1/NZR complex,CC,
15908,GO:0070940,1,0.968078675154208,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15909,GO:0070942,1,0.944090754367386,0,9,neutrophil mediated cytotoxicity,BP,
15910,GO:0070943,1,0.956317093148588,0,7,neutrophil-mediated killing of symbiont cell,BP,
15911,GO:0070944,1,0.962437660140832,0,6,neutrophil-mediated killing of bacterium,BP,
15912,GO:0070945,1,0.974726132507717,0,4,neutrophil-mediated killing of gram-negative bacterium,BP,
15913,GO:0070946,1,0.993677905859105,0,1,neutrophil-mediated killing of gram-positive bacterium,BP,
15914,GO:0070947,1,0.98736074605703,0,2,neutrophil-mediated killing of fungus,BP,
15915,GO:0070948,1,0.968405926243523,0,5,regulation of neutrophil mediated cytotoxicity,BP,
15916,GO:0070949,1,0.980943946425395,0,3,regulation of neutrophil mediated killing of symbiont cell,BP,
15917,GO:0070950,1,0.987220527470697,0,2,regulation of neutrophil mediated killing of bacterium,BP,
15918,GO:0070951,1,0.987220527470697,0,2,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15919,GO:0070953,1,0.993642984420479,0,1,regulation of neutrophil mediated killing of fungus,BP,
15920,GO:0070960,1,0.987234257839345,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15921,GO:0070961,1,0.987234257839345,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15922,GO:0070962,1,0.993550682425573,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15923,GO:0070963,1,0.993550682425573,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15924,GO:0070965,1,0.993642984420479,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15925,GO:0070966,1,0.974146680635564,0,4,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15926,GO:0070971,1,0.85293126222712,0,24,endoplasmic reticulum exit site,CC,
15928,GO:0070973,1,0.953927776827273,0,7,protein localization to endoplasmic reticulum exit site,BP,
15929,GO:0070974,1,0.993541573586608,0,1,POU domain binding,MF,
15930,GO:0070975,1,0.993213771048639,0,1,FHA domain binding,MF,
15931,GO:0070976,1,0.993560501219935,0,1,TIR domain binding,MF,
15933,GO:0070979,1,0.840279051724646,0,27,protein K11-linked ubiquitination,BP,
15934,GO:0070981,1,0.99358449082159,0,1,L-asparagine biosynthetic process,BP,
15935,GO:0070982,1,0.987250096586273,0,2,L-asparagine metabolic process,BP,
15936,GO:0070984,1,0.993478827764107,0,1,SET domain binding,MF,
15937,GO:0070985,1,0.981053523401411,0,3,transcription factor TFIIK complex,CC,
15938,GO:0070986,1,0.911205681475801,0,14,left/right axis specification,BP,
15939,GO:0070987,1,0.872724319257619,0,21,error-free translesion synthesis,BP,
15940,GO:0070988,1,0.668937409463506,0,61,demethylation,BP,
15941,GO:0070989,1,0.906192986145985,0,15,oxidative demethylation,BP,
15942,GO:0070990,1,0.956323086593114,0,7,snRNP binding,MF,
15943,GO:0070991,1,0.980771293879217,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15944,GO:0070992,1,0.993714113577592,0,1,translation initiation complex,CC,
15945,GO:0070993,1,0.896467800305218,0,17,translation preinitiation complex,CC,
15946,GO:0070995,1,0.974358368272876,0,4,NADPH oxidation,BP,
15947,GO:0070996,1,0.981052344280813,0,3,type 1 melanocortin receptor binding,MF,
15949,GO:0071000,1,0.987239292815035,0,2,response to magnetism,BP,
15950,GO:0071001,1,0.980831629649353,0,3,U4/U6 snRNP,CC,
15951,GO:0071004,1,0.901915357379299,0,16,U2-type prespliceosome,CC,
15952,GO:0071005,1,0.728374344427324,0,49,U2-type precatalytic spliceosome,CC,
15953,GO:0071006,1,0.942916390559192,0,9,U2-type catalytic step 1 spliceosome,CC,
15954,GO:0071007,1,0.823871982555925,0,30,U2-type catalytic step 2 spliceosome,CC,
15955,GO:0071008,1,0.980772614933067,0,3,U2-type post-mRNA release spliceosomal complex,CC,
15956,GO:0071010,1,0.901915357379299,0,16,prespliceosome,CC,
15957,GO:0071011,1,0.718952187060419,0,51,precatalytic spliceosome,CC,
15958,GO:0071012,1,0.942916390559192,0,9,catalytic step 1 spliceosome,CC,
15959,GO:0071013,1,0.58351018301825,0,83,catalytic step 2 spliceosome,CC,
15960,GO:0071014,1,0.919416150137444,0,13,post-mRNA release spliceosomal complex,CC,
15961,GO:0071020,1,0.987287930723187,0,2,post-spliceosomal complex,CC,
15962,GO:0071021,1,0.993625683683103,0,1,U2-type post-spliceosomal complex,CC,
15963,GO:0071025,1,0.907793049448803,0,15,RNA surveillance,BP,
15964,GO:0071026,1,0.993574494173141,0,1,cytoplasmic RNA surveillance,BP,
15965,GO:0071027,1,0.919606844286563,0,13,nuclear RNA surveillance,BP,
15966,GO:0071028,1,0.919606844286563,0,13,nuclear mRNA surveillance,BP,
15967,GO:0071029,1,0.962350753576027,0,6,nuclear ncRNA surveillance,BP,
15968,GO:0071030,1,0.987222348144026,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15969,GO:0071031,1,0.987296527047039,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15970,GO:0071033,1,0.968464826791902,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15971,GO:0071034,1,0.974254288233466,0,4,CUT catabolic process,BP,
15972,GO:0071035,1,0.962350753576027,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15973,GO:0071036,1,0.993555996530659,0,1,nuclear polyadenylation-dependent snoRNA catabolic process,BP,
15974,GO:0071037,1,0.993555996530659,0,1,nuclear polyadenylation-dependent snRNA catabolic process,BP,
15975,GO:0071038,1,0.962350753576027,0,6,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15976,GO:0071039,1,0.993555996530659,0,1,nuclear polyadenylation-dependent CUT catabolic process,BP,
15977,GO:0071040,1,0.993555996530659,0,1,nuclear polyadenylation-dependent antisense transcript catabolic process,BP,
15978,GO:0071041,1,0.993555996530659,0,1,antisense RNA transcript catabolic process,BP,
15979,GO:0071042,1,0.974631765979459,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15980,GO:0071043,1,0.974254288233466,0,4,CUT metabolic process,BP,
15981,GO:0071044,1,0.9417228672964,0,9,histone mRNA catabolic process,BP,
15982,GO:0071045,1,0.993630035639127,0,1,nuclear histone mRNA catabolic process,BP,
15983,GO:0071046,1,0.962350753576027,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15984,GO:0071047,1,0.974631765979459,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15985,GO:0071048,1,0.987222348144026,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15986,GO:0071049,1,0.987296527047039,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15987,GO:0071051,1,0.956170988229608,0,7,polyadenylation-dependent snoRNA 3'-end processing,BP,
15988,GO:0071062,1,0.980651521297646,0,3,alphav-beta3 integrin-vitronectin complex,CC,
15989,GO:0071065,1,0.987122881299922,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15990,GO:0071071,1,0.895477148185799,0,17,regulation of phospholipid biosynthetic process,BP,
15991,GO:0071072,1,0.967673853019643,0,5,negative regulation of phospholipid biosynthetic process,BP,
15992,GO:0071073,1,0.931394983647692,0,11,positive regulation of phospholipid biosynthetic process,BP,
15993,GO:0071074,1,0.987008723321378,0,2,eukaryotic initiation factor eIF2 binding,MF,
15994,GO:0071077,1,0.974443015979272,0,4,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15995,GO:0071103,1,0.188818554347074,0,251,DNA conformation change,BP,
15996,GO:0071104,1,0.949086466833,0,8,response to interleukin-9,BP,
15997,GO:0071105,1,0.987155365583146,0,2,response to interleukin-11,BP,
15998,GO:0071106,1,0.987166187237356,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15999,GO:0071107,1,0.942554130850764,0,9,response to parathyroid hormone,BP,
16000,GO:0071108,1,0.83529352637283,0,27,protein K48-linked deubiquitination,BP,
16001,GO:0071109,1,0.986258063115606,0,2,superior temporal gyrus development,BP,
16002,GO:0071110,1,0.993334450818515,0,1,histone biotinylation,BP,
16003,GO:0071133,1,0.993535757787753,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16004,GO:0071139,1,0.98691881416678,0,2,resolution of recombination intermediates,BP,
16005,GO:0071140,1,0.98691881416678,0,2,resolution of mitotic recombination intermediates,BP,
16006,GO:0071141,1,0.941708532488667,0,9,SMAD protein complex,CC,
16007,GO:0071144,1,0.947821854512305,0,8,heteromeric SMAD protein complex,CC,
16008,GO:0071148,1,0.986459979020445,0,2,TEAD-1-YAP complex,CC,
16009,GO:0071149,1,0.987032361393165,0,2,TEAD-2-YAP complex,CC,
16010,GO:0071156,1,0.521530163593251,0,100,regulation of cell cycle arrest,BP,
16011,GO:0071157,1,0.878358125194151,0,20,negative regulation of cell cycle arrest,BP,
16012,GO:0071158,1,0.605382375401465,0,77,positive regulation of cell cycle arrest,BP,
16013,GO:0071159,1,0.987292179116542,0,2,NF-kappaB complex,CC,
16014,GO:0071163,1,0.980953339702566,0,3,DNA replication preinitiation complex assembly,BP,
16015,GO:0071164,1,0.993506543021991,0,1,RNA trimethylguanosine synthase activity,MF,
16016,GO:0071166,1,0.44715768304568,0,123,ribonucleoprotein complex localization,BP,
16017,GO:0071168,1,0.871937362771014,0,21,protein localization to chromatin,BP,
16018,GO:0071169,1,0.974089223964059,0,4,establishment of protein localization to chromatin,BP,
16019,GO:0071173,1,0.800645592591424,0,34,spindle assembly checkpoint,BP,
16020,GO:0071174,1,0.800645592591424,0,34,mitotic spindle checkpoint,BP,
16021,GO:0071203,1,0.967542720874343,0,5,WASH complex,CC,
16022,GO:0071204,1,0.961828997689836,0,6,histone pre-mRNA 3'end processing complex,CC,
16025,GO:0071207,1,0.987113998153442,0,2,histone pre-mRNA stem-loop binding,MF,
16026,GO:0071208,1,0.974860230991058,0,4,histone pre-mRNA DCP binding,MF,
16027,GO:0071209,1,0.981020162929946,0,3,U7 snRNA binding,MF,
16028,GO:0071211,1,0.974251548781531,0,4,protein targeting to vacuole involved in autophagy,BP,
16030,GO:0071215,1,0.993466657130638,0,1,cellular response to abscisic acid stimulus,BP,
16031,GO:0071216,1,0.255893354059347,0,209,cellular response to biotic stimulus,BP,
16032,GO:0071218,1,0.865965220849805,0,22,cellular response to misfolded protein,BP,
16033,GO:0071219,1,0.294112591356622,0,188,cellular response to molecule of bacterial origin,BP,
16034,GO:0071220,1,0.961890616960487,0,6,cellular response to bacterial lipoprotein,BP,
16035,GO:0071221,1,0.961890616960487,0,6,cellular response to bacterial lipopeptide,BP,
16036,GO:0071222,1,0.30991810191822,0,180,cellular response to lipopolysaccharide,BP,
16037,GO:0071223,1,0.937451624891322,0,10,cellular response to lipoteichoic acid,BP,
16038,GO:0071224,1,0.962066505050494,0,6,cellular response to peptidoglycan,BP,
16039,GO:0071225,1,0.94338384490202,0,9,cellular response to muramyl dipeptide,BP,
16040,GO:0071226,1,0.974365193653196,0,4,cellular response to molecule of fungal origin,BP,
16041,GO:0071228,1,0.993666742014599,0,1,cellular response to tumor cell,BP,
16044,GO:0071231,1,0.987374311366355,0,2,cellular response to folic acid,BP,
16045,GO:0071233,1,0.942138177616939,0,9,cellular response to leucine,BP,
16046,GO:0071236,1,0.918502273120388,0,13,cellular response to antibiotic,BP,
16048,GO:0071242,1,0.980625398399603,0,3,cellular response to ammonium ion,BP,
16049,GO:0071243,1,0.878901981578353,0,20,cellular response to arsenic-containing substance,BP,
16050,GO:0071245,1,0.993509563868202,0,1,cellular response to carbon monoxide,BP,
16051,GO:0071247,1,0.993666576647194,0,1,cellular response to chromate,BP,
16053,GO:0071250,1,0.99330761561877,0,1,cellular response to nitrite,BP,
16054,GO:0071253,1,0.96815170888817,0,5,connexin binding,MF,
16055,GO:0071256,1,0.962383878751382,0,6,translocon complex,CC,
16056,GO:0071257,1,0.936849481238214,0,10,cellular response to electrical stimulus,BP,
16057,GO:0071258,1,0.99348063536873,0,1,cellular response to gravity,BP,
16058,GO:0071259,1,0.987239292815035,0,2,cellular response to magnetism,BP,
16060,GO:0071261,1,0.993708239015662,0,1,Ssh1 translocon complex,CC,
16061,GO:0071262,1,0.986920210236958,0,2,regulation of translational initiation in response to starvation,BP,
16062,GO:0071264,1,0.986920210236958,0,2,positive regulation of translational initiation in response to starvation,BP,
16063,GO:0071265,1,0.955881201687723,0,7,L-methionine biosynthetic process,BP,
16064,GO:0071267,1,0.955881201687723,0,7,L-methionine salvage,BP,
16065,GO:0071276,1,0.808959313367475,0,33,cellular response to cadmium ion,BP,
16067,GO:0071279,1,0.980509603892647,0,3,cellular response to cobalt ion,BP,
16070,GO:0071283,1,0.987313985697107,0,2,cellular response to iron(III) ion,BP,
16071,GO:0071284,1,0.973878159529355,0,4,cellular response to lead ion,BP,
16072,GO:0071285,1,0.913438337299303,0,14,cellular response to lithium ion,BP,
16073,GO:0071286,1,0.953435646096951,0,7,cellular response to magnesium ion,BP,
16074,GO:0071287,1,0.924437219288153,0,12,cellular response to manganese ion,BP,
16075,GO:0071288,1,0.987189963675497,0,2,cellular response to mercury ion,BP,
16076,GO:0071294,1,0.884795273951949,0,19,cellular response to zinc ion,BP,
16077,GO:0071295,1,0.827559590183692,0,29,cellular response to vitamin,BP,
16078,GO:0071298,1,0.993521172994364,0,1,cellular response to L-ascorbic acid,BP,
16079,GO:0071300,1,0.661647172921327,0,63,cellular response to retinoic acid,BP,
16080,GO:0071301,1,0.993214499093636,0,1,cellular response to vitamin B1,BP,
16081,GO:0071305,1,0.87759346050423,0,20,cellular response to vitamin D,BP,
16082,GO:0071306,1,0.986996156497311,0,2,cellular response to vitamin E,BP,
16083,GO:0071307,1,0.987145850470592,0,2,cellular response to vitamin K,BP,
16087,GO:0071314,1,0.980947812642453,0,3,cellular response to cocaine,BP,
16088,GO:0071315,1,0.968112064680222,0,5,cellular response to morphine,BP,
16089,GO:0071316,1,0.943789114095419,0,9,cellular response to nicotine,BP,
16090,GO:0071317,1,0.968112064680222,0,5,cellular response to isoquinoline alkaloid,BP,
16091,GO:0071318,1,0.88898975593859,0,18,cellular response to ATP,BP,
16092,GO:0071320,1,0.724013511965412,0,49,cellular response to cAMP,BP,
16093,GO:0071321,1,0.961063470488845,0,6,cellular response to cGMP,BP,
16095,GO:0071324,1,0.993418865778257,0,1,cellular response to disaccharide stimulus,BP,
16097,GO:0071329,1,0.993418865778257,0,1,cellular response to sucrose stimulus,BP,
16099,GO:0071332,1,0.968049792732637,0,5,cellular response to fructose stimulus,BP,
16101,GO:0071335,1,0.993697530091657,0,1,hair follicle cell proliferation,BP,
16102,GO:0071336,1,0.993697530091657,0,1,regulation of hair follicle cell proliferation,BP,
16103,GO:0071338,1,0.993697530091657,0,1,positive regulation of hair follicle cell proliferation,BP,
16104,GO:0071339,1,0.832588018518638,0,28,MLL1 complex,CC,
16105,GO:0071340,1,0.930898304177709,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16106,GO:0071344,1,0.987326016176636,0,2,diphosphate metabolic process,BP,
16110,GO:0071348,1,0.993435881534396,0,1,cellular response to interleukin-11,BP,
16111,GO:0071349,1,0.742768571919715,0,46,cellular response to interleukin-12,BP,
16112,GO:0071350,1,0.918533472842969,0,13,cellular response to interleukin-15,BP,
16113,GO:0071351,1,0.949733553839499,0,8,cellular response to interleukin-18,BP,
16114,GO:0071352,1,0.924619903577432,0,12,cellular response to interleukin-2,BP,
16115,GO:0071353,1,0.823175182795016,0,30,cellular response to interleukin-4,BP,
16117,GO:0071355,1,0.955127162252501,0,7,cellular response to interleukin-9,BP,
16119,GO:0071357,1,0.61052478748078,0,76,cellular response to type I interferon,BP,
16120,GO:0071359,1,0.889347125799305,0,18,cellular response to dsRNA,BP,
16121,GO:0071360,1,0.918718512144449,0,13,cellular response to exogenous dsRNA,BP,
16122,GO:0071361,1,0.917870761953897,0,13,cellular response to ethanol,BP,
16123,GO:0071362,1,0.955111814810281,0,7,cellular response to ether,BP,
16125,GO:0071364,1,0.763893731039739,0,41,cellular response to epidermal growth factor stimulus,BP,
16126,GO:0071371,1,0.900625941783017,0,16,cellular response to gonadotropin stimulus,BP,
16127,GO:0071372,1,0.936420934528496,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16128,GO:0071373,1,0.987159250759207,0,2,cellular response to luteinizing hormone stimulus,BP,
16129,GO:0071374,1,0.955083360666475,0,7,cellular response to parathyroid hormone stimulus,BP,
16131,GO:0071376,1,0.968084260650155,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16132,GO:0071377,1,0.859831447923769,0,23,cellular response to glucagon stimulus,BP,
16133,GO:0071378,1,0.876892198813973,0,20,cellular response to growth hormone stimulus,BP,
16134,GO:0071379,1,0.870725775353974,0,21,cellular response to prostaglandin stimulus,BP,
16135,GO:0071380,1,0.906473939517267,0,15,cellular response to prostaglandin E stimulus,BP,
16137,GO:0071384,1,0.685366291770522,0,58,cellular response to corticosteroid stimulus,BP,
16138,GO:0071385,1,0.698739796955025,0,55,cellular response to glucocorticoid stimulus,BP,
16139,GO:0071386,1,0.980137064984338,0,3,cellular response to corticosterone stimulus,BP,
16140,GO:0071387,1,0.993402956880897,0,1,cellular response to cortisol stimulus,BP,
16141,GO:0071389,1,0.961384200330728,0,6,cellular response to mineralocorticoid stimulus,BP,
16142,GO:0071391,1,0.91273359108229,0,14,cellular response to estrogen stimulus,BP,
16143,GO:0071392,1,0.796119999543754,0,35,cellular response to estradiol stimulus,BP,
16144,GO:0071393,1,0.980360370698308,0,3,cellular response to progesterone stimulus,BP,
16146,GO:0071395,1,0.974843726608518,0,4,cellular response to jasmonic acid stimulus,BP,
16148,GO:0071397,1,0.893915949156943,0,17,cellular response to cholesterol,BP,
16149,GO:0071398,1,0.706341365574344,0,53,cellular response to fatty acid,BP,
16150,GO:0071400,1,0.980675623829579,0,3,cellular response to oleic acid,BP,
16151,GO:0071401,1,0.993586995583296,0,1,cellular response to triglyceride,BP,
16152,GO:0071402,1,0.816728567081793,0,31,cellular response to lipoprotein particle stimulus,BP,
16153,GO:0071403,1,0.987099895992843,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16154,GO:0071404,1,0.883478601423589,0,19,cellular response to low-density lipoprotein particle stimulus,BP,
16156,GO:0071409,1,0.980260249359335,0,3,cellular response to cycloheximide,BP,
16157,GO:0071412,1,0.993587485036605,0,1,cellular response to genistein,BP,
16158,GO:0071413,1,0.993587485036605,0,1,cellular response to hydroxyisoflavone,BP,
16161,GO:0071418,1,0.987307035266026,0,2,cellular response to amine stimulus,BP,
16162,GO:0071420,1,0.954839405443253,0,7,cellular response to histamine,BP,
16163,GO:0071421,1,0.94312248653641,0,9,manganese ion transmembrane transport,BP,
16164,GO:0071422,1,0.962003064218483,0,6,succinate transmembrane transport,BP,
16165,GO:0071423,1,0.974618507925107,0,4,malate transmembrane transport,BP,
16166,GO:0071424,1,0.99355705431691,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16167,GO:0071425,1,0.861098780671385,0,23,hematopoietic stem cell proliferation,BP,
16168,GO:0071426,1,0.450064105726164,0,122,ribonucleoprotein complex export from nucleus,BP,
16169,GO:0071427,1,0.502861188847561,0,105,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16170,GO:0071428,1,0.907438208390299,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16171,GO:0071431,1,0.815746545716061,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16172,GO:0071437,1,0.912641357370067,0,14,invadopodium,CC,
16173,GO:0071438,1,0.968029662792313,0,5,invadopodium membrane,CC,
16174,GO:0071439,1,0.948793797088263,0,8,clathrin complex,CC,
16175,GO:0071440,1,0.961889681249703,0,6,regulation of histone H3-K14 acetylation,BP,
16176,GO:0071441,1,0.993498439703457,0,1,negative regulation of histone H3-K14 acetylation,BP,
16177,GO:0071442,1,0.974466486295581,0,4,positive regulation of histone H3-K14 acetylation,BP,
16178,GO:0071444,1,0.993724838128259,0,1,cellular response to pheromone,BP,
16179,GO:0071447,1,0.949349634516166,0,8,cellular response to hydroperoxide,BP,
16180,GO:0071449,1,0.993678433634904,0,1,cellular response to lipid hydroperoxide,BP,
16181,GO:0071450,1,0.856713269349864,0,24,cellular response to oxygen radical,BP,
16182,GO:0071451,1,0.856713269349864,0,24,cellular response to superoxide,BP,
16184,GO:0071454,1,0.993209489350032,0,1,cellular response to anoxia,BP,
16185,GO:0071455,1,0.961620434807667,0,6,cellular response to hyperoxia,BP,
16186,GO:0071456,1,0.296272886535418,0,186,cellular response to hypoxia,BP,
16187,GO:0071458,1,0.968075491147483,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16188,GO:0071459,1,0.878903792537105,0,20,protein localization to chromosome, centromeric region,BP,
16189,GO:0071460,1,0.98735351763901,0,2,cellular response to cell-matrix adhesion,BP,
16190,GO:0071461,1,0.980734731402462,0,3,cellular response to redox state,BP,
16191,GO:0071462,1,0.980533608732498,0,3,cellular response to water stimulus,BP,
16192,GO:0071464,1,0.993414040334807,0,1,cellular response to hydrostatic pressure,BP,
16193,GO:0071466,1,0.555090920694573,0,91,cellular response to xenobiotic stimulus,BP,
16194,GO:0071467,1,0.884425437936996,0,19,cellular response to pH,BP,
16195,GO:0071468,1,0.937218283867768,0,10,cellular response to acidic pH,BP,
16196,GO:0071469,1,0.987139310450451,0,2,cellular response to alkaline pH,BP,
16197,GO:0071470,1,0.759901114907316,0,42,cellular response to osmotic stress,BP,
16198,GO:0071471,1,0.99345683314107,0,1,cellular response to non-ionic osmotic stress,BP,
16199,GO:0071472,1,0.924898518931787,0,12,cellular response to salt stress,BP,
16200,GO:0071474,1,0.907380143660617,0,15,cellular hyperosmotic response,BP,
16202,GO:0071476,1,0.948890900454541,0,8,cellular hypotonic response,BP,
16203,GO:0071477,1,0.986781593814355,0,2,cellular hypotonic salinity response,BP,
16204,GO:0071478,1,0.328563999156085,0,170,cellular response to radiation,BP,
16205,GO:0071479,1,0.649656310978907,0,66,cellular response to ionizing radiation,BP,
16206,GO:0071480,1,0.832744002662641,0,28,cellular response to gamma radiation,BP,
16207,GO:0071481,1,0.923685312201455,0,12,cellular response to X-ray,BP,
16208,GO:0071482,1,0.47797677780385,0,113,cellular response to light stimulus,BP,
16209,GO:0071483,1,0.987052092804469,0,2,cellular response to blue light,BP,
16210,GO:0071484,1,0.993397417507683,0,1,cellular response to light intensity,BP,
16211,GO:0071486,1,0.993397417507683,0,1,cellular response to high light intensity,BP,
16212,GO:0071492,1,0.980662725008751,0,3,cellular response to UV-A,BP,
16213,GO:0071493,1,0.949750043446227,0,8,cellular response to UV-B,BP,
16214,GO:0071494,1,0.955341536165163,0,7,cellular response to UV-C,BP,
16217,GO:0071498,1,0.889541078365566,0,18,cellular response to fluid shear stress,BP,
16218,GO:0071499,1,0.955807275854722,0,7,cellular response to laminar fluid shear stress,BP,
16219,GO:0071500,1,0.961537087948266,0,6,cellular response to nitrosative stress,BP,
16220,GO:0071501,1,0.912831894742626,0,14,cellular response to sterol depletion,BP,
16221,GO:0071502,1,0.968107129905718,0,5,cellular response to temperature stimulus,BP,
16222,GO:0071503,1,0.974161798855265,0,4,response to heparin,BP,
16223,GO:0071504,1,0.974161798855265,0,4,cellular response to heparin,BP,
16224,GO:0071505,1,0.987128651202677,0,2,response to mycophenolic acid,BP,
16225,GO:0071506,1,0.987128651202677,0,2,cellular response to mycophenolic acid,BP,
16226,GO:0071513,1,0.993591614380833,0,1,phosphopantothenoylcysteine decarboxylase complex,CC,
16227,GO:0071514,1,0.854361623811114,0,24,genetic imprinting,BP,
16228,GO:0071515,1,0.992938094261375,0,1,genetic imprinting at mating-type locus,BP,
16229,GO:0071517,1,0.992938094261375,0,1,maintenance of imprinting at mating-type locus,BP,
16231,GO:0071527,1,0.993582096633424,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16232,GO:0071528,1,0.993496068780281,0,1,tRNA re-export from nucleus,BP,
16233,GO:0071529,1,0.993568300584555,0,1,cementum mineralization,BP,
16234,GO:0071532,1,0.967428951142474,0,5,ankyrin repeat binding,MF,
16235,GO:0071535,1,0.974458455349398,0,4,RING-like zinc finger domain binding,MF,
16236,GO:0071539,1,0.814086620741838,0,31,protein localization to centrosome,BP,
16237,GO:0071540,1,0.987073576678388,0,2,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16238,GO:0071541,1,0.95599696030844,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16239,GO:0071542,1,0.812031952354393,0,32,dopaminergic neuron differentiation,BP,
16240,GO:0071543,1,0.974515979575416,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16241,GO:0071544,1,0.993649703780491,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16243,GO:0071546,1,0.961706310650156,0,6,pi-body,CC,
16244,GO:0071547,1,0.968124161368096,0,5,piP-body,CC,
16245,GO:0071548,1,0.776328799713947,0,39,response to dexamethasone,BP,
16246,GO:0071549,1,0.8232777069789,0,30,cellular response to dexamethasone stimulus,BP,
16247,GO:0071550,1,0.943768307350313,0,9,death-inducing signaling complex assembly,BP,
16248,GO:0071553,1,0.980942559573044,0,3,G protein-coupled pyrimidinergic nucleotide receptor activity,MF,
16249,GO:0071554,1,0.98733469606039,0,2,cell wall organization or biogenesis,BP,
16250,GO:0071556,1,0.851773827028746,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16251,GO:0071557,1,0.96736683450071,0,5,histone H3-K27 demethylation,BP,
16252,GO:0071558,1,0.96736683450071,0,5,histone demethylase activity (H3-K27 specific),MF,
16253,GO:0071559,1,0.211219585220036,0,235,response to transforming growth factor beta,BP,
16254,GO:0071560,1,0.220197020928116,0,229,cellular response to transforming growth factor beta stimulus,BP,
16255,GO:0071561,1,0.993414993344295,0,1,nucleus-vacuole junction,CC,
16256,GO:0071564,1,0.924460576100854,0,12,npBAF complex,CC,
16257,GO:0071565,1,0.906280969268401,0,15,nBAF complex,CC,
16258,GO:0071566,1,0.993546791938033,0,1,UFM1 activating enzyme activity,MF,
16259,GO:0071567,1,0.993581548518238,0,1,UFM1 hydrolase activity,MF,
16260,GO:0071568,1,0.987262223460066,0,2,UFM1 transferase activity,MF,
16261,GO:0071569,1,0.962208394939433,0,6,protein ufmylation,BP,
16262,GO:0071573,1,0.993547547321298,0,1,shelterin complex assembly,BP,
16265,GO:0071579,1,0.987198206897346,0,2,regulation of zinc ion transport,BP,
16266,GO:0071580,1,0.993605158042286,0,1,regulation of zinc ion transmembrane transport,BP,
16267,GO:0071581,1,0.993605158042286,0,1,regulation of zinc ion transmembrane import,BP,
16268,GO:0071582,1,0.993605158042286,0,1,negative regulation of zinc ion transport,BP,
16269,GO:0071583,1,0.993605158042286,0,1,negative regulation of zinc ion transmembrane transport,BP,
16270,GO:0071584,1,0.993605158042286,0,1,negative regulation of zinc ion transmembrane import,BP,
16271,GO:0071585,1,0.993605158042286,0,1,detoxification of cadmium ion,BP,
16272,GO:0071586,1,0.987217544872559,0,2,CAAX-box protein processing,BP,
16273,GO:0071593,1,0.968112348556706,0,5,lymphocyte aggregation,BP,
16274,GO:0071595,1,0.987155207697788,0,2,Nem1-Spo7 phosphatase complex,CC,
16275,GO:0071596,1,0.979864106860987,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16276,GO:0071598,1,0.980811695651085,0,3,neuronal ribonucleoprotein granule,CC,
16277,GO:0071599,1,0.907046627066621,0,15,otic vesicle development,BP,
16278,GO:0071600,1,0.937236960309054,0,10,otic vesicle morphogenesis,BP,
16279,GO:0071602,1,0.9934640675287,0,1,phytosphingosine biosynthetic process,BP,
16280,GO:0071603,1,0.980588214837168,0,3,endothelial cell-cell adhesion,BP,
16281,GO:0071604,1,0.790138791925177,0,36,transforming growth factor beta production,BP,
16282,GO:0071605,1,0.919633814077638,0,13,monocyte chemotactic protein-1 production,BP,
16283,GO:0071606,1,0.993607433199545,0,1,chemokine (C-C motif) ligand 4 production,BP,
16284,GO:0071608,1,0.961963809984803,0,6,macrophage inflammatory protein-1 alpha production,BP,
16285,GO:0071609,1,0.930690702035646,0,11,chemokine (C-C motif) ligand 5 production,BP,
16286,GO:0071610,1,0.993572792297707,0,1,chemokine (C-C motif) ligand 1 production,BP,
16287,GO:0071611,1,0.968308004595665,0,5,granulocyte colony-stimulating factor production,BP,
16288,GO:0071612,1,0.992782423708489,0,1,IP-10 production,BP,
16289,GO:0071613,1,0.980896150058519,0,3,granzyme B production,BP,
16290,GO:0071614,1,0.993615550128517,0,1,linoleic acid epoxygenase activity,MF,
16291,GO:0071616,1,0.726593816824502,0,49,acyl-CoA biosynthetic process,BP,
16292,GO:0071617,1,0.889086372251323,0,18,lysophospholipid acyltransferase activity,MF,
16293,GO:0071619,1,0.99358804032313,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16296,GO:0071623,1,0.980597334164188,0,3,negative regulation of granulocyte chemotaxis,BP,
16297,GO:0071624,1,0.845914229224256,0,26,positive regulation of granulocyte chemotaxis,BP,
16298,GO:0071625,1,0.886737417010334,0,18,vocalization behavior,BP,
16299,GO:0071626,1,0.987252610627966,0,2,mastication,BP,
16300,GO:0071629,1,0.993630035639127,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16301,GO:0071630,1,0.980278468473547,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16302,GO:0071633,1,0.980721467566323,0,3,dihydroceramidase activity,MF,
16303,GO:0071634,1,0.800528903809454,0,34,regulation of transforming growth factor beta production,BP,
16304,GO:0071635,1,0.949508780822289,0,8,negative regulation of transforming growth factor beta production,BP,
16305,GO:0071636,1,0.883689400839841,0,19,positive regulation of transforming growth factor beta production,BP,
16306,GO:0071637,1,0.919633814077638,0,13,regulation of monocyte chemotactic protein-1 production,BP,
16307,GO:0071638,1,0.96830916031222,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16308,GO:0071639,1,0.949747383380833,0,8,positive regulation of monocyte chemotactic protein-1 production,BP,
16309,GO:0071640,1,0.961963809984803,0,6,regulation of macrophage inflammatory protein 1 alpha production,BP,
16310,GO:0071641,1,0.980730819948387,0,3,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16311,GO:0071642,1,0.987117750696167,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16312,GO:0071643,1,0.993607433199545,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16313,GO:0071644,1,0.993607433199545,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16314,GO:0071649,1,0.936663365663576,0,10,regulation of chemokine (C-C motif) ligand 5 production,BP,
16315,GO:0071650,1,0.974541591885517,0,4,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16316,GO:0071651,1,0.961142089540186,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16317,GO:0071652,1,0.993572792297707,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16318,GO:0071654,1,0.993572792297707,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16319,GO:0071655,1,0.974522892204058,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16320,GO:0071656,1,0.993584880294264,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16321,GO:0071657,1,0.980816160383956,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16322,GO:0071658,1,0.992782423708489,0,1,regulation of IP-10 production,BP,
16323,GO:0071660,1,0.992782423708489,0,1,positive regulation of IP-10 production,BP,
16324,GO:0071661,1,0.980896150058519,0,3,regulation of granzyme B production,BP,
16325,GO:0071663,1,0.980896150058519,0,3,positive regulation of granzyme B production,BP,
16326,GO:0071664,1,0.973916403386123,0,4,catenin-TCF7L2 complex,CC,
16327,GO:0071665,1,0.993524132028894,0,1,gamma-catenin-TCF7L2 complex,CC,
16330,GO:0071672,1,0.974646979953876,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16335,GO:0071677,1,0.879507358984685,0,20,positive regulation of mononuclear cell migration,BP,
16336,GO:0071678,1,0.993183732397853,0,1,olfactory bulb axon guidance,BP,
16337,GO:0071679,1,0.92398114525955,0,12,commissural neuron axon guidance,BP,
16338,GO:0071680,1,0.967639382789317,0,5,response to indole-3-methanol,BP,
16339,GO:0071681,1,0.967639382789317,0,5,cellular response to indole-3-methanol,BP,
16340,GO:0071682,1,0.878791086636944,0,20,endocytic vesicle lumen,CC,
16342,GO:0071688,1,0.967199782444305,0,3,striated muscle myosin thick filament assembly,BP,
16343,GO:0071691,1,0.977714908304381,0,3,cardiac muscle thin filament assembly,BP,
16345,GO:0071694,1,0.954422667986796,0,7,maintenance of protein location in extracellular region,BP,
16347,GO:0071696,1,0.92450035055373,0,12,ectodermal placode development,BP,
16348,GO:0071697,1,0.930483532418992,0,11,ectodermal placode morphogenesis,BP,
16349,GO:0071698,1,0.980545934366415,0,3,olfactory placode development,BP,
16350,GO:0071699,1,0.980545934366415,0,3,olfactory placode morphogenesis,BP,
16351,GO:0071701,1,0.993430441531184,0,1,regulation of MAPK export from nucleus,BP,
16355,GO:0071706,1,0.511662734530624,0,103,tumor necrosis factor superfamily cytokine production,BP,
16356,GO:0071707,1,0.993655082602374,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16357,GO:0071709,1,0.783823547788298,0,37,membrane assembly,BP,
16358,GO:0071711,1,0.826132065238175,0,29,basement membrane organization,BP,
16359,GO:0071712,1,0.930690484352306,0,11,ER-associated misfolded protein catabolic process,BP,
16360,GO:0071714,1,0.993474962251865,0,1,icosanoid transmembrane transporter activity,MF,
16361,GO:0071715,1,0.797081561289959,0,35,icosanoid transport,BP,
16362,GO:0071716,1,0.986756961779233,0,2,leukotriene transport,BP,
16363,GO:0071723,1,0.943415229028013,0,9,lipopeptide binding,MF,
16364,GO:0071724,1,0.97435206343983,0,4,response to diacyl bacterial lipopeptide,BP,
16365,GO:0071725,1,0.98083132519031,0,3,response to triacyl bacterial lipopeptide,BP,
16366,GO:0071726,1,0.97435206343983,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16367,GO:0071727,1,0.98083132519031,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16368,GO:0071731,1,0.883978557309974,0,19,response to nitric oxide,BP,
16369,GO:0071732,1,0.907152744899965,0,15,cellular response to nitric oxide,BP,
16370,GO:0071733,1,0.974013785058424,0,4,transcriptional activation by promoter-enhancer looping,BP,
16371,GO:0071763,1,0.96182977345613,0,6,nuclear membrane organization,BP,
16372,GO:0071765,1,0.993475806598455,0,1,nuclear inner membrane organization,BP,
16376,GO:0071782,1,0.878543949220753,0,20,endoplasmic reticulum tubular network,CC,
16377,GO:0071786,1,0.89532776917063,0,17,endoplasmic reticulum tubular network organization,BP,
16378,GO:0071787,1,0.974528641213981,0,4,endoplasmic reticulum tubular network formation,BP,
16379,GO:0071791,1,0.987119481141535,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16380,GO:0071796,1,0.993653556149668,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16381,GO:0071797,1,0.974495441727807,0,4,LUBAC complex,CC,
16382,GO:0071798,1,0.967841606028119,0,5,response to prostaglandin D,BP,
16383,GO:0071799,1,0.967841606028119,0,5,cellular response to prostaglandin D stimulus,BP,
16384,GO:0071800,1,0.894971744560939,0,17,podosome assembly,BP,
16385,GO:0071801,1,0.918786347577681,0,13,regulation of podosome assembly,BP,
16386,GO:0071802,1,0.993477162610047,0,1,negative regulation of podosome assembly,BP,
16387,GO:0071803,1,0.942937010215927,0,9,positive regulation of podosome assembly,BP,
16389,GO:0071806,1,0.690960694781783,0,57,protein transmembrane transport,BP,
16390,GO:0071812,1,0.993536885727411,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16391,GO:0071813,1,0.854458919937358,0,24,lipoprotein particle binding,MF,
16392,GO:0071814,1,0.854458919937358,0,24,protein-lipid complex binding,MF,
16393,GO:0071816,1,0.974571797274358,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16394,GO:0071817,1,0.974483843721403,0,4,MMXD complex,CC,
16395,GO:0071818,1,0.980865378114858,0,3,BAT3 complex,CC,
16396,GO:0071819,1,0.987253086328484,0,2,DUBm complex,CC,
16397,GO:0071820,1,0.993642851218205,0,1,N-box binding,MF,
16398,GO:0071821,1,0.986954587549581,0,2,FANCM-MHF complex,CC,
16399,GO:0071824,1,0.285849937959124,0,191,protein-DNA complex subunit organization,BP,
16400,GO:0071825,1,0.750704465639261,0,44,protein-lipid complex subunit organization,BP,
16401,GO:0071826,1,0.29927825842866,0,185,ribonucleoprotein complex subunit organization,BP,
16402,GO:0071827,1,0.765483640726277,0,41,plasma lipoprotein particle organization,BP,
16403,GO:0071830,1,0.955059534579159,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16404,GO:0071831,1,0.993661049356776,0,1,intermediate-density lipoprotein particle clearance,BP,
16405,GO:0071837,1,0.900711262769109,0,16,HMG box domain binding,MF,
16406,GO:0071838,1,0.955363159131532,0,7,cell proliferation in bone marrow,BP,
16407,GO:0071839,1,0.96199748478488,0,6,apoptotic process in bone marrow cell,BP,
16409,GO:0071846,1,0.98721759611005,0,2,actin filament debranching,BP,
16410,GO:0071847,1,0.987127034651628,0,2,TNFSF11-mediated signaling pathway,BP,
16411,GO:0071848,1,0.993536885727411,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16412,GO:0071850,1,0.90143451720075,0,16,mitotic cell cycle arrest,BP,
16413,GO:0071855,1,0.846720871430619,0,26,neuropeptide receptor binding,MF,
16414,GO:0071863,1,0.961592456939125,0,6,regulation of cell proliferation in bone marrow,BP,
16415,GO:0071864,1,0.961592456939125,0,6,positive regulation of cell proliferation in bone marrow,BP,
16416,GO:0071865,1,0.968219345416523,0,5,regulation of apoptotic process in bone marrow cell,BP,
16417,GO:0071866,1,0.968219345416523,0,5,negative regulation of apoptotic process in bone marrow cell,BP,
16424,GO:0071873,1,0.980528597935029,0,3,response to norepinephrine,BP,
16425,GO:0071874,1,0.987135742269568,0,2,cellular response to norepinephrine stimulus,BP,
16426,GO:0071875,1,0.843164922907417,0,26,adrenergic receptor signaling pathway,BP,
16427,GO:0071877,1,0.993649703780491,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16428,GO:0071878,1,0.980281038992674,0,3,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16429,GO:0071879,1,0.986871110304646,0,2,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16430,GO:0071880,1,0.859611816493381,0,23,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16431,GO:0071881,1,0.987187689564765,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16432,GO:0071882,1,0.993497100798592,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16433,GO:0071885,1,0.987274370430642,0,2,N-terminal protein N-methyltransferase activity,MF,
16434,GO:0071886,1,0.987013747903075,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16435,GO:0071887,1,0.525140218733122,0,99,leukocyte apoptotic process,BP,
16436,GO:0071888,1,0.943286363747197,0,9,macrophage apoptotic process,BP,
16437,GO:0071889,1,0.820957132513098,0,30,14-3-3 protein binding,MF,
16438,GO:0071890,1,0.993401576605581,0,1,bicarbonate binding,MF,
16439,GO:0071893,1,0.993620720501988,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16440,GO:0071894,1,0.987159591989793,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16441,GO:0071895,1,0.9681557750846,0,5,odontoblast differentiation,BP,
16442,GO:0071896,1,0.960899941642743,0,6,protein localization to adherens junction,BP,
16444,GO:0071898,1,0.980808667663923,0,3,regulation of estrogen receptor binding,BP,
16445,GO:0071899,1,0.980808667663923,0,3,negative regulation of estrogen receptor binding,BP,
16449,GO:0071907,1,0.954813496015332,0,7,determination of digestive tract left/right asymmetry,BP,
16450,GO:0071908,1,0.993387447721668,0,1,determination of intestine left/right asymmetry,BP,
16451,GO:0071909,1,0.993387447721668,0,1,determination of stomach left/right asymmetry,BP,
16452,GO:0071910,1,0.961446557242594,0,6,determination of liver left/right asymmetry,BP,
16453,GO:0071911,1,0.993433494520763,0,1,synchronous neurotransmitter secretion,BP,
16454,GO:0071913,1,0.993632777137238,0,1,citrate secondary active transmembrane transporter activity,MF,
16455,GO:0071914,1,0.987034040090425,0,2,prominosome,CC,
16456,GO:0071916,1,0.993379027530122,0,1,dipeptide transmembrane transporter activity,MF,
16457,GO:0071918,1,0.96200859660048,0,6,urea transmembrane transport,BP,
16458,GO:0071919,1,0.993524105619419,0,1,G-quadruplex DNA formation,BP,
16459,GO:0071920,1,0.987205006976986,0,2,cleavage body,CC,
16460,GO:0071921,1,0.96754803830817,0,5,cohesin loading,BP,
16461,GO:0071922,1,0.973823992475208,0,4,regulation of cohesin loading,BP,
16463,GO:0071929,1,0.987135381645066,0,2,alpha-tubulin acetylation,BP,
16464,GO:0071930,1,0.980480890450966,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16465,GO:0071931,1,0.980870989787064,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16466,GO:0071932,1,0.980381680761785,0,3,replication fork reversal,BP,
16467,GO:0071933,1,0.924460548529301,0,12,Arp2/3 complex binding,MF,
16468,GO:0071934,1,0.980766136873752,0,3,thiamine transmembrane transport,BP,
16469,GO:0071936,1,0.942160664403433,0,9,coreceptor activity involved in Wnt signaling pathway,MF,
16470,GO:0071938,1,0.993552455871846,0,1,vitamin A transport,BP,
16471,GO:0071939,1,0.993552455871846,0,1,vitamin A import,BP,
16472,GO:0071941,1,0.925643578072641,0,12,nitrogen cycle metabolic process,BP,
16473,GO:0071942,1,0.980782837604891,0,3,XPC complex,CC,
16475,GO:0071947,1,0.973405351352156,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16477,GO:0071951,1,0.993558236361319,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16478,GO:0071953,1,0.974517058302072,0,4,elastic fiber,CC,
16479,GO:0071954,1,0.993517729948133,0,1,chemokine (C-C motif) ligand 11 production,BP,
16480,GO:0071955,1,0.980041973390034,0,3,recycling endosome to Golgi transport,BP,
16481,GO:0071960,1,0.993680412277699,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16482,GO:0071962,1,0.980932113839814,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16483,GO:0071963,1,0.987118809652218,0,2,establishment or maintenance of cell polarity regulating cell shape,BP,
16484,GO:0071971,1,0.955660834922731,0,7,extracellular exosome assembly,BP,
16485,GO:0071976,1,0.993527989797633,0,1,cell gliding,BP,
16486,GO:0071985,1,0.780967711893662,0,38,multivesicular body sorting pathway,BP,
16487,GO:0071986,1,0.961966885451775,0,6,Ragulator complex,CC,
16488,GO:0071987,1,0.974006575872803,0,4,WD40-repeat domain binding,MF,
16489,GO:0071988,1,0.986829709188952,0,2,protein localization to spindle pole body,BP,
16491,GO:0072003,1,0.980745139844136,0,3,kidney rudiment formation,BP,
16492,GO:0072004,1,0.987021321748086,0,2,kidney field specification,BP,
16494,GO:0072007,1,0.955425153093138,0,7,mesangial cell differentiation,BP,
16495,GO:0072008,1,0.961568640907368,0,6,glomerular mesangial cell differentiation,BP,
16497,GO:0072010,1,0.882312332422517,0,19,glomerular epithelium development,BP,
16498,GO:0072011,1,0.987228759931908,0,2,glomerular endothelium development,BP,
16500,GO:0072014,1,0.96025018628719,0,6,proximal tubule development,BP,
16501,GO:0072015,1,0.935234457759746,0,10,glomerular visceral epithelial cell development,BP,
16502,GO:0072016,1,0.993565040715604,0,1,glomerular parietal epithelial cell development,BP,
16503,GO:0072017,1,0.928963300705291,0,11,distal tubule development,BP,
16504,GO:0072019,1,0.993596898720476,0,1,proximal convoluted tubule development,BP,
16505,GO:0072021,1,0.979708794763485,0,3,ascending thin limb development,BP,
16506,GO:0072023,1,0.993639785950119,0,1,thick ascending limb development,BP,
16507,GO:0072024,1,0.993639785950119,0,1,macula densa development,BP,
16508,GO:0072025,1,0.974436578431787,0,4,distal convoluted tubule development,BP,
16509,GO:0072027,1,0.993571162266231,0,1,connecting tubule development,BP,
16511,GO:0072033,1,0.948103263675704,0,8,renal vesicle formation,BP,
16512,GO:0072034,1,0.980655061724714,0,3,renal vesicle induction,BP,
16513,GO:0072036,1,0.993504123174293,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16514,GO:0072038,1,0.968115414959412,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16515,GO:0072039,1,0.980592353770882,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16516,GO:0072040,1,0.980592353770882,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16517,GO:0072044,1,0.911253095162215,0,14,collecting duct development,BP,
16518,GO:0072046,1,0.993642118501879,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16519,GO:0072047,1,0.974708921958062,0,4,proximal/distal pattern formation involved in nephron development,BP,
16520,GO:0072048,1,0.94978435268492,0,8,renal system pattern specification,BP,
16521,GO:0072049,1,0.968180811766909,0,5,comma-shaped body morphogenesis,BP,
16522,GO:0072050,1,0.955590273618603,0,7,S-shaped body morphogenesis,BP,
16523,GO:0072051,1,0.993639785950119,0,1,juxtaglomerular apparatus development,BP,
16524,GO:0072053,1,0.98705741698661,0,2,renal inner medulla development,BP,
16525,GO:0072054,1,0.98705741698661,0,2,renal outer medulla development,BP,
16526,GO:0072055,1,0.993414040334807,0,1,renal cortex development,BP,
16527,GO:0072059,1,0.993414040334807,0,1,cortical collecting duct development,BP,
16528,GO:0072060,1,0.993494567725236,0,1,outer medullary collecting duct development,BP,
16529,GO:0072061,1,0.980810794068868,0,3,inner medullary collecting duct development,BP,
16530,GO:0072069,1,0.98074283726791,0,3,DCT cell differentiation,BP,
16531,GO:0072070,1,0.942302465521706,0,9,loop of Henle development,BP,
16532,GO:0072071,1,0.987296516563418,0,2,kidney interstitial fibroblast differentiation,BP,
16534,GO:0072074,1,0.889251334531734,0,18,kidney mesenchyme development,BP,
16535,GO:0072075,1,0.912443122243099,0,14,metanephric mesenchyme development,BP,
16536,GO:0072076,1,0.98028879844671,0,3,nephrogenic mesenchyme development,BP,
16541,GO:0072081,1,0.974708921958062,0,4,specification of nephron tubule identity,BP,
16542,GO:0072086,1,0.980975150283036,0,3,specification of loop of Henle identity,BP,
16546,GO:0072091,1,0.648968276450946,0,66,regulation of stem cell proliferation,BP,
16547,GO:0072092,1,0.979482789509901,0,3,ureteric bud invasion,BP,
16548,GO:0072093,1,0.973118875314633,0,4,metanephric renal vesicle formation,BP,
16549,GO:0072095,1,0.980625481757908,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16550,GO:0072096,1,0.993620720501988,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16551,GO:0072097,1,0.993620720501988,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16552,GO:0072098,1,0.987274525790186,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16553,GO:0072099,1,0.993620720501988,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16554,GO:0072100,1,0.993620720501988,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16555,GO:0072101,1,0.993620720501988,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16559,GO:0072106,1,0.974361524338941,0,4,regulation of ureteric bud formation,BP,
16560,GO:0072107,1,0.974361524338941,0,4,positive regulation of ureteric bud formation,BP,
16561,GO:0072108,1,0.974414319259198,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16562,GO:0072109,1,0.906929698375934,0,15,glomerular mesangium development,BP,
16563,GO:0072110,1,0.937112399544743,0,10,glomerular mesangial cell proliferation,BP,
16564,GO:0072111,1,0.883860297092987,0,19,cell proliferation involved in kidney development,BP,
16565,GO:0072112,1,0.899631459625709,0,16,glomerular visceral epithelial cell differentiation,BP,
16566,GO:0072114,1,0.99337403039786,0,1,pronephros morphogenesis,BP,
16567,GO:0072124,1,0.943381125329188,0,9,regulation of glomerular mesangial cell proliferation,BP,
16568,GO:0072125,1,0.980775057196766,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16569,GO:0072126,1,0.961880339612036,0,6,positive regulation of glomerular mesangial cell proliferation,BP,
16570,GO:0072127,1,0.993588792541698,0,1,renal capsule development,BP,
16571,GO:0072128,1,0.993588792541698,0,1,renal capsule morphogenesis,BP,
16572,GO:0072129,1,0.993588792541698,0,1,renal capsule formation,BP,
16573,GO:0072130,1,0.993588792541698,0,1,renal capsule specification,BP,
16574,GO:0072131,1,0.97402053529016,0,4,kidney mesenchyme morphogenesis,BP,
16575,GO:0072132,1,0.715655757832428,0,51,mesenchyme morphogenesis,BP,
16576,GO:0072133,1,0.97402053529016,0,4,metanephric mesenchyme morphogenesis,BP,
16577,GO:0072134,1,0.986615041816944,0,2,nephrogenic mesenchyme morphogenesis,BP,
16578,GO:0072135,1,0.980758903944217,0,3,kidney mesenchymal cell proliferation,BP,
16579,GO:0072136,1,0.980758903944217,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16580,GO:0072137,1,0.978921927953643,0,3,condensed mesenchymal cell proliferation,BP,
16581,GO:0072138,1,0.980865343605027,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16582,GO:0072139,1,0.987100014704789,0,2,glomerular parietal epithelial cell differentiation,BP,
16583,GO:0072141,1,0.987296516563418,0,2,renal interstitial fibroblast development,BP,
16584,GO:0072143,1,0.961620238439767,0,6,mesangial cell development,BP,
16585,GO:0072144,1,0.967803160401314,0,5,glomerular mesangial cell development,BP,
16586,GO:0072148,1,0.912731885201817,0,14,epithelial cell fate commitment,BP,
16587,GO:0072156,1,0.979401407419678,0,3,distal tubule morphogenesis,BP,
16588,GO:0072160,1,0.917287738029273,0,13,nephron tubule epithelial cell differentiation,BP,
16589,GO:0072161,1,0.955733128479105,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16590,GO:0072162,1,0.974352259579848,0,4,metanephric mesenchymal cell differentiation,BP,
16593,GO:0072165,1,0.993613468702107,0,1,anterior mesonephric tubule development,BP,
16594,GO:0072166,1,0.987198005593788,0,2,posterior mesonephric tubule development,BP,
16595,GO:0072167,1,0.993613468702107,0,1,specification of mesonephric tubule identity,BP,
16596,GO:0072168,1,0.993613468702107,0,1,specification of anterior mesonephric tubule identity,BP,
16597,GO:0072169,1,0.993613468702107,0,1,specification of posterior mesonephric tubule identity,BP,
16598,GO:0072170,1,0.864834664433356,0,22,metanephric tubule development,BP,
16601,GO:0072173,1,0.930214188307115,0,11,metanephric tubule morphogenesis,BP,
16602,GO:0072174,1,0.961769032056485,0,6,metanephric tubule formation,BP,
16604,GO:0072176,1,0.911593780129827,0,14,nephric duct development,BP,
16605,GO:0072177,1,0.954613189686538,0,7,mesonephric duct development,BP,
16606,GO:0072178,1,0.936767994100124,0,10,nephric duct morphogenesis,BP,
16607,GO:0072179,1,0.97452999776243,0,4,nephric duct formation,BP,
16608,GO:0072180,1,0.980963095034148,0,3,mesonephric duct morphogenesis,BP,
16609,GO:0072181,1,0.993642118501879,0,1,mesonephric duct formation,BP,
16610,GO:0072182,1,0.92959400324881,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16611,GO:0072183,1,0.987167843476787,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16612,GO:0072184,1,0.993613468702107,0,1,renal vesicle progenitor cell differentiation,BP,
16613,GO:0072185,1,0.987236338559989,0,2,metanephric cap development,BP,
16614,GO:0072186,1,0.987236338559989,0,2,metanephric cap morphogenesis,BP,
16616,GO:0072190,1,0.980850312463696,0,3,ureter urothelium development,BP,
16617,GO:0072191,1,0.974555404827546,0,4,ureter smooth muscle development,BP,
16618,GO:0072192,1,0.993620720501988,0,1,ureter epithelial cell differentiation,BP,
16619,GO:0072193,1,0.974555404827546,0,4,ureter smooth muscle cell differentiation,BP,
16620,GO:0072194,1,0.980785360449605,0,3,kidney smooth muscle tissue development,BP,
16621,GO:0072195,1,0.993634714618148,0,1,kidney smooth muscle cell differentiation,BP,
16623,GO:0072198,1,0.980938801117256,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16624,GO:0072199,1,0.980938801117256,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16625,GO:0072200,1,0.993620720501988,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16626,GO:0072201,1,0.949098321680885,0,8,negative regulation of mesenchymal cell proliferation,BP,
16628,GO:0072203,1,0.936877933733162,0,10,cell proliferation involved in metanephros development,BP,
16629,GO:0072204,1,0.986980912041294,0,2,cell-cell signaling involved in metanephros development,BP,
16630,GO:0072205,1,0.93575491357095,0,10,metanephric collecting duct development,BP,
16631,GO:0072206,1,0.993639785950119,0,1,metanephric juxtaglomerular apparatus development,BP,
16632,GO:0072207,1,0.853520431643496,0,24,metanephric epithelium development,BP,
16633,GO:0072208,1,0.987069152560847,0,2,metanephric smooth muscle tissue development,BP,
16634,GO:0072209,1,0.987152002423221,0,2,metanephric mesangial cell differentiation,BP,
16636,GO:0072213,1,0.993588792541698,0,1,metanephric capsule development,BP,
16637,GO:0072214,1,0.993414040334807,0,1,metanephric cortex development,BP,
16638,GO:0072215,1,0.877141741199998,0,20,regulation of metanephros development,BP,
16639,GO:0072216,1,0.925023640463112,0,12,positive regulation of metanephros development,BP,
16640,GO:0072217,1,0.955712320616691,0,7,negative regulation of metanephros development,BP,
16641,GO:0072218,1,0.979708794763485,0,3,metanephric ascending thin limb development,BP,
16642,GO:0072219,1,0.993414040334807,0,1,metanephric cortical collecting duct development,BP,
16643,GO:0072221,1,0.974436578431787,0,4,metanephric distal convoluted tubule development,BP,
16644,GO:0072223,1,0.967964523396276,0,5,metanephric glomerular mesangium development,BP,
16646,GO:0072227,1,0.993639785950119,0,1,metanephric macula densa development,BP,
16647,GO:0072229,1,0.993596898720476,0,1,metanephric proximal convoluted tubule development,BP,
16648,GO:0072233,1,0.993639785950119,0,1,metanephric thick ascending limb development,BP,
16649,GO:0072234,1,0.881770528016433,0,19,metanephric nephron tubule development,BP,
16650,GO:0072235,1,0.960772172188591,0,6,metanephric distal tubule development,BP,
16651,GO:0072236,1,0.973334063295941,0,4,metanephric loop of Henle development,BP,
16652,GO:0072237,1,0.986162229423561,0,2,metanephric proximal tubule development,BP,
16654,GO:0072240,1,0.98074283726791,0,3,metanephric DCT cell differentiation,BP,
16655,GO:0072243,1,0.875899485525181,0,20,metanephric nephron epithelium development,BP,
16656,GO:0072244,1,0.993350100598389,0,1,metanephric glomerular epithelium development,BP,
16657,GO:0072248,1,0.993350100598389,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16658,GO:0072249,1,0.993350100598389,0,1,metanephric glomerular visceral epithelial cell development,BP,
16659,GO:0072254,1,0.987152002423221,0,2,metanephric glomerular mesangial cell differentiation,BP,
16660,GO:0072255,1,0.993550710897748,0,1,metanephric glomerular mesangial cell development,BP,
16661,GO:0072257,1,0.954013776703759,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16662,GO:0072258,1,0.993613468702107,0,1,metanephric interstitial fibroblast differentiation,BP,
16663,GO:0072259,1,0.993613468702107,0,1,metanephric interstitial fibroblast development,BP,
16664,GO:0072262,1,0.980565280758414,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16665,GO:0072265,1,0.993588792541698,0,1,metanephric capsule morphogenesis,BP,
16666,GO:0072266,1,0.993588792541698,0,1,metanephric capsule formation,BP,
16667,GO:0072267,1,0.993588792541698,0,1,metanephric capsule specification,BP,
16668,GO:0072268,1,0.980939255949331,0,3,pattern specification involved in metanephros development,BP,
16669,GO:0072272,1,0.993615818738527,0,1,proximal/distal pattern formation involved in metanephric nephron development,BP,
16671,GO:0072274,1,0.993350100598389,0,1,metanephric glomerular basement membrane development,BP,
16675,GO:0072278,1,0.980602004728602,0,3,metanephric comma-shaped body morphogenesis,BP,
16676,GO:0072282,1,0.948416966626114,0,8,metanephric nephron tubule morphogenesis,BP,
16678,GO:0072284,1,0.967851552431977,0,5,metanephric S-shaped body morphogenesis,BP,
16679,GO:0072285,1,0.993504123174293,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16680,GO:0072286,1,0.993571162266231,0,1,metanephric connecting tubule development,BP,
16681,GO:0072287,1,0.992517897652328,0,1,metanephric distal tubule morphogenesis,BP,
16682,GO:0072289,1,0.974264190431303,0,4,metanephric nephron tubule formation,BP,
16683,GO:0072298,1,0.974239918765445,0,4,regulation of metanephric glomerulus development,BP,
16684,GO:0072299,1,0.993543713352771,0,1,negative regulation of metanephric glomerulus development,BP,
16685,GO:0072300,1,0.980572010953992,0,3,positive regulation of metanephric glomerulus development,BP,
16686,GO:0072301,1,0.98712169843865,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16687,GO:0072302,1,0.993543713352771,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16688,GO:0072303,1,0.993536670611557,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16689,GO:0072304,1,0.987021321748086,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16690,GO:0072305,1,0.987021321748086,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16691,GO:0072307,1,0.954013776703759,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16692,GO:0072308,1,0.993513359292508,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16693,GO:0072309,1,0.987021321748086,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16694,GO:0072310,1,0.929212244210723,0,11,glomerular epithelial cell development,BP,
16695,GO:0072311,1,0.893836261146132,0,17,glomerular epithelial cell differentiation,BP,
16696,GO:0072312,1,0.993350100598389,0,1,metanephric glomerular epithelial cell differentiation,BP,
16697,GO:0072313,1,0.993350100598389,0,1,metanephric glomerular epithelial cell development,BP,
16698,GO:0072318,1,0.961417265272574,0,6,clathrin coat disassembly,BP,
16699,GO:0072319,1,0.955256124865208,0,7,vesicle uncoating,BP,
16700,GO:0072320,1,0.974300235914441,0,4,volume-sensitive chloride channel activity,MF,
16701,GO:0072321,1,0.931864127566982,0,11,chaperone-mediated protein transport,BP,
16702,GO:0072329,1,0.432104993854626,0,129,monocarboxylic acid catabolic process,BP,
16706,GO:0072334,1,0.974740031870329,0,4,UDP-galactose transmembrane transport,BP,
16708,GO:0072338,1,0.980529864190238,0,3,cellular lactam metabolic process,BP,
16709,GO:0072340,1,0.993626487655239,0,1,cellular lactam catabolic process,BP,
16711,GO:0072343,1,0.987310048537763,0,2,pancreatic stellate cell proliferation,BP,
16712,GO:0072344,1,0.974437967700768,0,4,rescue of stalled ribosome,BP,
16713,GO:0072345,1,0.967919354080749,0,5,NAADP-sensitive calcium-release channel activity,MF,
16714,GO:0072348,1,0.745184412869127,0,45,sulfur compound transport,BP,
16715,GO:0072349,1,0.882945949008235,0,19,modified amino acid transmembrane transporter activity,MF,
16716,GO:0072350,1,0.919358804220707,0,13,tricarboxylic acid metabolic process,BP,
16717,GO:0072354,1,0.993625616674369,0,1,histone kinase activity (H3-T3 specific),MF,
16718,GO:0072355,1,0.993625616674369,0,1,histone H3-T3 phosphorylation,BP,
16719,GO:0072356,1,0.993487645841966,0,1,chromosome passenger complex localization to kinetochore,BP,
16720,GO:0072357,1,0.955266733503816,0,7,PTW/PP1 phosphatase complex,CC,
16722,GO:0072376,1,0.866939817440183,0,22,protein activation cascade,BP,
16723,GO:0072378,1,0.866939817440183,0,22,blood coagulation, fibrin clot formation,BP,
16724,GO:0072379,1,0.9681204623987,0,5,ER membrane insertion complex,CC,
16725,GO:0072380,1,0.9870089517251,0,2,TRC complex,CC,
16726,GO:0072382,1,0.992491135355865,0,1,minus-end-directed vesicle transport along microtubule,BP,
16727,GO:0072383,1,0.954406931153956,0,7,plus-end-directed vesicle transport along microtubule,BP,
16728,GO:0072384,1,0.593791767544281,0,79,organelle transport along microtubule,BP,
16729,GO:0072385,1,0.96688537318696,0,5,minus-end-directed organelle transport along microtubule,BP,
16730,GO:0072386,1,0.948062700479615,0,8,plus-end-directed organelle transport along microtubule,BP,
16731,GO:0072387,1,0.987146029395546,0,2,flavin adenine dinucleotide metabolic process,BP,
16732,GO:0072388,1,0.99360800250412,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16733,GO:0072389,1,0.993496871955458,0,1,flavin adenine dinucleotide catabolic process,BP,
16734,GO:0072393,1,0.922895081935428,0,12,microtubule anchoring at microtubule organizing center,BP,
16735,GO:0072394,1,0.993629533849245,0,1,detection of stimulus involved in cell cycle checkpoint,BP,
16736,GO:0072395,1,0.636742317609272,0,69,signal transduction involved in cell cycle checkpoint,BP,
16737,GO:0072396,1,0.961123850594051,0,6,response to cell cycle checkpoint signaling,BP,
16738,GO:0072401,1,0.641193250471757,0,68,signal transduction involved in DNA integrity checkpoint,BP,
16739,GO:0072402,1,0.961123850594051,0,6,response to DNA integrity checkpoint signaling,BP,
16740,GO:0072413,1,0.693474169986756,0,56,signal transduction involved in mitotic cell cycle checkpoint,BP,
16741,GO:0072414,1,0.993241012220347,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16742,GO:0072421,1,0.993629533849245,0,1,detection of DNA damage stimulus involved in DNA damage checkpoint,BP,
16743,GO:0072422,1,0.641193250471757,0,68,signal transduction involved in DNA damage checkpoint,BP,
16744,GO:0072423,1,0.961123850594051,0,6,response to DNA damage checkpoint signaling,BP,
16745,GO:0072425,1,0.930123803305802,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16746,GO:0072428,1,0.993615012928131,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16747,GO:0072429,1,0.980842547216879,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16748,GO:0072431,1,0.697996136015895,0,55,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16749,GO:0072432,1,0.993241012220347,0,1,response to G1 DNA damage checkpoint signaling,BP,
16750,GO:0072434,1,0.986441174488753,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16751,GO:0072487,1,0.97436028192843,0,4,MSL complex,CC,
16752,GO:0072488,1,0.948847178051162,0,8,ammonium transmembrane transport,BP,
16753,GO:0072492,1,0.993622733671697,0,1,host cell mitochondrial intermembrane space,CC,
16755,GO:0072498,1,0.907649968900106,0,15,embryonic skeletal joint development,BP,
16756,GO:0072501,1,0.967435620578228,0,5,cellular divalent inorganic anion homeostasis,BP,
16757,GO:0072502,1,0.967435620578228,0,5,cellular trivalent inorganic anion homeostasis,BP,
16759,GO:0072505,1,0.948630989185476,0,8,divalent inorganic anion homeostasis,BP,
16760,GO:0072506,1,0.948630989185476,0,8,trivalent inorganic anion homeostasis,BP,
16764,GO:0072513,1,0.980689198499721,0,3,positive regulation of secondary heart field cardioblast proliferation,BP,
16765,GO:0072517,1,0.993520353102423,0,1,host cell viral assembly compartment,CC,
16766,GO:0072518,1,0.986620023238716,0,2,Rho-dependent protein serine/threonine kinase activity,MF,
16767,GO:0072520,1,0.930243001458536,0,11,seminiferous tubule development,BP,
16771,GO:0072524,1,0.78662202079893,0,37,pyridine-containing compound metabolic process,BP,
16772,GO:0072525,1,0.817980793798177,0,31,pyridine-containing compound biosynthetic process,BP,
16773,GO:0072526,1,0.955708156534251,0,7,pyridine-containing compound catabolic process,BP,
16776,GO:0072529,1,0.792015975923402,0,36,pyrimidine-containing compound catabolic process,BP,
16777,GO:0072530,1,0.943671629482495,0,9,purine-containing compound transmembrane transport,BP,
16778,GO:0072531,1,0.931402491264534,0,11,pyrimidine-containing compound transmembrane transport,BP,
16779,GO:0072534,1,0.986586756975593,0,2,perineuronal net,CC,
16780,GO:0072535,1,0.987158480508812,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16781,GO:0072536,1,0.987177597053249,0,2,interleukin-23 receptor complex,CC,
16782,GO:0072537,1,0.930629770638704,0,11,fibroblast activation,BP,
16783,GO:0072538,1,0.849332812246301,0,25,T-helper 17 type immune response,BP,
16784,GO:0072539,1,0.86598389058385,0,22,T-helper 17 cell differentiation,BP,
16785,GO:0072540,1,0.937517316369571,0,10,T-helper 17 cell lineage commitment,BP,
16786,GO:0072542,1,0.925128973202327,0,12,protein phosphatase activator activity,MF,
16787,GO:0072544,1,0.993626353676866,0,1,L-DOPA binding,MF,
16788,GO:0072545,1,0.987262341403559,0,2,tyrosine binding,MF,
16789,GO:0072546,1,0.937344133048448,0,10,ER membrane protein complex,CC,
16790,GO:0072553,1,0.967978124155737,0,5,terminal button organization,BP,
16791,GO:0072554,1,0.987146744391448,0,2,blood vessel lumenization,BP,
16792,GO:0072557,1,0.974406204873784,0,4,IPAF inflammasome complex,CC,
16793,GO:0072558,1,0.974627729779349,0,4,NLRP1 inflammasome complex,CC,
16794,GO:0072559,1,0.949486339187723,0,8,NLRP3 inflammasome complex,CC,
16795,GO:0072560,1,0.987242814320685,0,2,type B pancreatic cell maturation,BP,
16797,GO:0072563,1,0.987209806101374,0,2,endothelial microparticle,CC,
16798,GO:0072564,1,0.987270279729974,0,2,blood microparticle formation,BP,
16799,GO:0072566,1,0.980800453623536,0,3,chemokine (C-X-C motif) ligand 1 production,BP,
16801,GO:0072570,1,0.986917688278001,0,2,ADP-D-ribose binding,MF,
16802,GO:0072571,1,0.99334418108366,0,1,mono-ADP-D-ribose binding,MF,
16803,GO:0072572,1,0.993596832420627,0,1,poly-ADP-D-ribose binding,MF,
16804,GO:0072573,1,0.993461379502464,0,1,tolerance induction to lipopolysaccharide,BP,
16808,GO:0072577,1,0.711314903331684,0,52,endothelial cell apoptotic process,BP,
16809,GO:0072578,1,0.916991171604087,0,13,neurotransmitter-gated ion channel clustering,BP,
16810,GO:0072579,1,0.993472472896888,0,1,glycine receptor clustering,BP,
16811,GO:0072583,1,0.747577426998245,0,44,clathrin-dependent endocytosis,BP,
16812,GO:0072584,1,0.924817880912494,0,12,caveolin-mediated endocytosis,BP,
16813,GO:0072586,1,0.993456055739517,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity,MF,
16814,GO:0072587,1,0.993456055739517,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity,MF,
16815,GO:0072588,1,0.968514748047333,0,5,box H/ACA RNP complex,CC,
16816,GO:0072589,1,0.974860120159832,0,4,box H/ACA scaRNP complex,CC,
16817,GO:0072590,1,0.986302986330857,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16818,GO:0072591,1,0.993350271928572,0,1,citrate-L-glutamate ligase activity,MF,
16819,GO:0072592,1,0.968377274506147,0,5,oxygen metabolic process,BP,
16822,GO:0072595,1,0.765281488758559,0,41,maintenance of protein localization in organelle,BP,
16824,GO:0072655,1,0.424325111158962,0,132,establishment of protein localization to mitochondrion,BP,
16825,GO:0072656,1,0.967956390050655,0,5,maintenance of protein location in mitochondrion,BP,
16827,GO:0072658,1,0.986000669262305,0,2,maintenance of protein location in membrane,BP,
16829,GO:0072660,1,0.986000669262305,0,2,maintenance of protein location in plasma membrane,BP,
16830,GO:0072662,1,0.643682364566445,0,68,protein localization to peroxisome,BP,
16831,GO:0072663,1,0.643682364566445,0,68,establishment of protein localization to peroxisome,BP,
16832,GO:0072665,1,0.656631869721578,0,64,protein localization to vacuole,BP,
16833,GO:0072666,1,0.724169164962002,0,49,establishment of protein localization to vacuole,BP,
16834,GO:0072669,1,0.956189838210856,0,7,tRNA-splicing ligase complex,CC,
16835,GO:0072671,1,0.993570319426232,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16836,GO:0072672,1,0.943237828293846,0,9,neutrophil extravasation,BP,
16838,GO:0072674,1,0.954523823912799,0,7,multinuclear osteoclast differentiation,BP,
16839,GO:0072675,1,0.960735647758287,0,6,osteoclast fusion,BP,
16841,GO:0072677,1,0.914138216298971,0,14,eosinophil migration,BP,
16842,GO:0072678,1,0.686330030832134,0,58,T cell migration,BP,
16843,GO:0072679,1,0.962178929258161,0,6,thymocyte migration,BP,
16844,GO:0072680,1,0.993535757787753,0,1,extracellular matrix-dependent thymocyte migration,BP,
16845,GO:0072681,1,0.993535757787753,0,1,fibronectin-dependent thymocyte migration,BP,
16846,GO:0072682,1,0.993521860261438,0,1,eosinophil extravasation,BP,
16847,GO:0072683,1,0.931124483482414,0,11,T cell extravasation,BP,
16848,GO:0072684,1,0.993499825840027,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
16849,GO:0072686,1,0.451026860202454,0,121,mitotic spindle,CC,
16850,GO:0072687,1,0.943004476295755,0,9,meiotic spindle,CC,
16851,GO:0072695,1,0.987188986863482,0,2,regulation of DNA recombination at telomere,BP,
16852,GO:0072697,1,0.930810489147816,0,11,protein localization to cell cortex,BP,
16853,GO:0072698,1,0.708810476155881,0,52,protein localization to microtubule cytoskeleton,BP,
16854,GO:0072702,1,0.993367358492159,0,1,response to methyl methanesulfonate,BP,
16855,GO:0072703,1,0.993367358492159,0,1,cellular response to methyl methanesulfonate,BP,
16856,GO:0072706,1,0.993569137400794,0,1,response to sodium dodecyl sulfate,BP,
16857,GO:0072707,1,0.993569137400794,0,1,cellular response to sodium dodecyl sulfate,BP,
16858,GO:0072708,1,0.968258278559175,0,5,response to sorbitol,BP,
16859,GO:0072709,1,0.98085433176426,0,3,cellular response to sorbitol,BP,
16860,GO:0072710,1,0.936491658989586,0,10,response to hydroxyurea,BP,
16861,GO:0072711,1,0.942568155920212,0,9,cellular response to hydroxyurea,BP,
16862,GO:0072714,1,0.993623605614367,0,1,response to selenite ion,BP,
16863,GO:0072715,1,0.993623605614367,0,1,cellular response to selenite ion,BP,
16864,GO:0072716,1,0.974289251932124,0,4,response to actinomycin D,BP,
16865,GO:0072717,1,0.980608492561572,0,3,cellular response to actinomycin D,BP,
16866,GO:0072718,1,0.942961481217537,0,9,response to cisplatin,BP,
16867,GO:0072719,1,0.961737220367124,0,6,cellular response to cisplatin,BP,
16868,GO:0072720,1,0.987155207697788,0,2,response to dithiothreitol,BP,
16869,GO:0072721,1,0.99355705431691,0,1,cellular response to dithiothreitol,BP,
16870,GO:0072733,1,0.980893040860109,0,3,response to staurosporine,BP,
16871,GO:0072734,1,0.980893040860109,0,3,cellular response to staurosporine,BP,
16872,GO:0072737,1,0.987204748701311,0,2,response to diamide,BP,
16873,GO:0072738,1,0.987204748701311,0,2,cellular response to diamide,BP,
16874,GO:0072739,1,0.987211062093626,0,2,response to anisomycin,BP,
16875,GO:0072740,1,0.993613267314378,0,1,cellular response to anisomycin,BP,
16876,GO:0072749,1,0.993618974946725,0,1,cellular response to cytochalasin B,BP,
16877,GO:0072750,1,0.993653954419938,0,1,cellular response to leptomycin B,BP,
16878,GO:0072752,1,0.986888666428761,0,2,cellular response to rapamycin,BP,
16879,GO:0072755,1,0.993503015065566,0,1,cellular response to benomyl,BP,
16880,GO:0072757,1,0.974355222383448,0,4,cellular response to camptothecin,BP,
16881,GO:0075044,1,0.955165401724346,0,7,positive regulation by symbiont of host autophagy,BP,
16882,GO:0075071,1,0.955165401724346,0,7,modulation by symbiont of host autophagy,BP,
16883,GO:0075136,1,0.980305876166821,0,3,response to host,BP,
16884,GO:0075294,1,0.937781045580802,0,10,positive regulation by symbiont of entry into host,BP,
16885,GO:0075341,1,0.993586604367437,0,1,host cell PML body,CC,
16886,GO:0075506,1,0.986863707792456,0,2,entry of viral genome into host nucleus through nuclear pore complex via importin,BP,
16887,GO:0075509,1,0.954995418783049,0,7,endocytosis involved in viral entry into host cell,BP,
16888,GO:0075512,1,0.993271585084109,0,1,clathrin-dependent endocytosis of virus by host cell,BP,
16889,GO:0075519,1,0.99369292632955,0,1,microtubule-dependent intracellular transport of viral material,BP,
16890,GO:0075521,1,0.99369292632955,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
16891,GO:0075522,1,0.936837587432619,0,10,IRES-dependent viral translational initiation,BP,
16892,GO:0075525,1,0.968223953049896,0,5,viral translational termination-reinitiation,BP,
16893,GO:0075606,1,0.99369292632955,0,1,transport of viral material towards nucleus,BP,
16894,GO:0075713,1,0.949745325094959,0,8,establishment of integrated proviral latency,BP,
16895,GO:0075732,1,0.973896404803436,0,4,viral penetration into host nucleus,BP,
16896,GO:0075733,1,0.711612620718387,0,52,intracellular transport of virus,BP,
16897,GO:0080008,1,0.816957744014695,0,31,Cul4-RING E3 ubiquitin ligase complex,CC,
16898,GO:0080009,1,0.907053816302308,0,15,mRNA methylation,BP,
16899,GO:0080019,1,0.987037948085173,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
16900,GO:0080025,1,0.848820666772515,0,25,phosphatidylinositol-3,5-bisphosphate binding,MF,
16901,GO:0080030,1,0.974398695322009,0,4,methyl indole-3-acetate esterase activity,MF,
16902,GO:0080033,1,0.99330761561877,0,1,response to nitrite,BP,
16903,GO:0080048,1,0.99355705431691,0,1,GDP-D-glucose phosphorylase activity,MF,
16904,GO:0080058,1,0.993648972653794,0,1,protein deglutathionylation,BP,
16905,GO:0080084,1,0.980115311607788,0,3,5S rDNA binding,MF,
16907,GO:0080101,1,0.993673285249299,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
16908,GO:0080111,1,0.854018011135356,0,24,DNA demethylation,BP,
16909,GO:0080120,1,0.987217544872559,0,2,CAAX-box protein maturation,BP,
16910,GO:0080121,1,0.987166187237356,0,2,AMP transport,BP,
16911,GO:0080122,1,0.987166187237356,0,2,AMP transmembrane transporter activity,MF,
16912,GO:0080129,1,0.993666742014599,0,1,proteasome core complex assembly,BP,
16913,GO:0080132,1,0.993578115964395,0,1,fatty acid alpha-hydroxylase activity,MF,
16916,GO:0080144,1,0.973759798019221,0,4,amino acid homeostasis,BP,
16917,GO:0080146,1,0.993623303821261,0,1,L-cysteine desulfhydrase activity,MF,
16918,GO:0080154,1,0.878220920673091,0,20,regulation of fertilization,BP,
16919,GO:0080163,1,0.993580261755815,0,1,regulation of protein serine/threonine phosphatase activity,BP,
16920,GO:0080170,1,0.99364358375921,0,1,hydrogen peroxide transmembrane transport,BP,
16921,GO:0080171,1,0.666261896921106,0,62,lytic vacuole organization,BP,
16922,GO:0080182,1,0.887488561373552,0,18,histone H3-K4 trimethylation,BP,
16923,GO:0080184,1,0.968388622893116,0,5,response to phenylpropanoid,BP,
16924,GO:0085017,1,0.993252681062779,0,1,entry into host cell by a symbiont-containing vacuole,BP,
16925,GO:0085018,1,0.993557999392919,0,1,maintenance of symbiont-containing vacuole by host,BP,
16926,GO:0085020,1,0.949670760107634,0,8,protein K6-linked ubiquitination,BP,
16928,GO:0085032,1,0.993528889549409,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
16934,GO:0086006,1,0.967426157457759,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
16935,GO:0086007,1,0.966391991957309,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16936,GO:0086008,1,0.913348789088221,0,14,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16937,GO:0086009,1,0.758988564951044,0,42,membrane repolarization,BP,
16938,GO:0086010,1,0.790041351531943,0,35,membrane depolarization during action potential,BP,
16939,GO:0086011,1,0.849995143496892,0,25,membrane repolarization during action potential,BP,
16940,GO:0086012,1,0.869022992888599,0,21,membrane depolarization during cardiac muscle cell action potential,BP,
16941,GO:0086013,1,0.866707181978912,0,22,membrane repolarization during cardiac muscle cell action potential,BP,
16945,GO:0086017,1,0.980377333312955,0,3,Purkinje myocyte action potential,BP,
16948,GO:0086020,1,0.993189806348414,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16949,GO:0086021,1,0.993189806348414,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16950,GO:0086023,1,0.953824163370959,0,7,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16951,GO:0086024,1,0.993144264001104,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16954,GO:0086028,1,0.961305607621736,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
16956,GO:0086030,1,0.993603220487984,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
16958,GO:0086038,1,0.99355705431691,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16959,GO:0086039,1,0.993133478716038,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16960,GO:0086040,1,0.993451055847917,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16961,GO:0086041,1,0.993227113794773,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
16962,GO:0086042,1,0.9548281410867,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16963,GO:0086043,1,0.961305607621736,0,6,bundle of His cell action potential,BP,
16964,GO:0086045,1,0.966311485741094,0,5,membrane depolarization during AV node cell action potential,BP,
16965,GO:0086046,1,0.966315482634806,0,5,membrane depolarization during SA node cell action potential,BP,
16966,GO:0086047,1,0.980377333312955,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
16967,GO:0086048,1,0.980222781418736,0,3,membrane depolarization during bundle of His cell action potential,BP,
16968,GO:0086050,1,0.993551767381471,0,1,membrane repolarization during bundle of His cell action potential,BP,
16969,GO:0086052,1,0.993551767381471,0,1,membrane repolarization during SA node cell action potential,BP,
16970,GO:0086053,1,0.993189806348414,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
16971,GO:0086056,1,0.979399917743672,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16972,GO:0086057,1,0.993497728688634,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16973,GO:0086059,1,0.986421029867543,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
16974,GO:0086060,1,0.993109688174575,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
16975,GO:0086061,1,0.993109688174575,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
16976,GO:0086062,1,0.986807329989181,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
16977,GO:0086063,1,0.993109688174575,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
16983,GO:0086069,1,0.91782808494306,0,13,bundle of His cell to Purkinje myocyte communication,BP,
16985,GO:0086072,1,0.993575253458169,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16986,GO:0086073,1,0.961004801806104,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16987,GO:0086075,1,0.986770430274409,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16988,GO:0086077,1,0.993189806348414,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16989,GO:0086080,1,0.917468022261301,0,13,protein binding involved in heterotypic cell-cell adhesion,MF,
16990,GO:0086082,1,0.993575253458169,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16991,GO:0086083,1,0.967263323264734,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16992,GO:0086087,1,0.993551767381471,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
16993,GO:0086089,1,0.974434355457494,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16994,GO:0086090,1,0.993551767381471,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
16995,GO:0086091,1,0.782757529182079,0,37,regulation of heart rate by cardiac conduction,BP,
16996,GO:0086092,1,0.987118003208154,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
16997,GO:0086096,1,0.993649703780491,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16998,GO:0086097,1,0.987079697280084,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
16999,GO:0086098,1,0.987090371094095,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17000,GO:0086100,1,0.955364046525816,0,7,endothelin receptor signaling pathway,BP,
17001,GO:0086103,1,0.929578076965543,0,11,G protein-coupled receptor signaling pathway involved in heart process,BP,
17002,GO:0089700,1,0.974147949541595,0,4,protein kinase D signaling,BP,
17003,GO:0089701,1,0.974779984671904,0,4,U2AF complex,CC,
17004,GO:0089709,1,0.961711458445749,0,6,L-histidine transmembrane transport,BP,
17007,GO:0089720,1,0.937878530542439,0,10,caspase binding,MF,
17008,GO:0090009,1,0.948884471626853,0,8,primitive streak formation,BP,
17009,GO:0090010,1,0.993600553466401,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17010,GO:0090022,1,0.818774031021,0,31,regulation of neutrophil chemotaxis,BP,
17011,GO:0090023,1,0.851311476376923,0,25,positive regulation of neutrophil chemotaxis,BP,
17012,GO:0090024,1,0.980597334164188,0,3,negative regulation of neutrophil chemotaxis,BP,
17014,GO:0090026,1,0.908118218284704,0,15,positive regulation of monocyte chemotaxis,BP,
17016,GO:0090030,1,0.930604321010492,0,11,regulation of steroid hormone biosynthetic process,BP,
17017,GO:0090031,1,0.980729939610416,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17018,GO:0090032,1,0.968111454799014,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17019,GO:0090034,1,0.993632777137238,0,1,regulation of chaperone-mediated protein complex assembly,BP,
17020,GO:0090035,1,0.993632777137238,0,1,positive regulation of chaperone-mediated protein complex assembly,BP,
17021,GO:0090036,1,0.894575524918637,0,17,regulation of protein kinase C signaling,BP,
17022,GO:0090037,1,0.943200142971902,0,9,positive regulation of protein kinase C signaling,BP,
17023,GO:0090038,1,0.973956811549904,0,4,negative regulation of protein kinase C signaling,BP,
17025,GO:0090043,1,0.935480530122515,0,10,regulation of tubulin deacetylation,BP,
17026,GO:0090044,1,0.993632777137238,0,1,positive regulation of tubulin deacetylation,BP,
17027,GO:0090045,1,0.9488691442215,0,8,positive regulation of deacetylase activity,BP,
17028,GO:0090049,1,0.790156337655352,0,36,regulation of cell migration involved in sprouting angiogenesis,BP,
17029,GO:0090050,1,0.883361027507725,0,19,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17030,GO:0090051,1,0.906337498913893,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17031,GO:0090063,1,0.967660790267461,0,5,positive regulation of microtubule nucleation,BP,
17032,GO:0090065,1,0.98717299975343,0,2,regulation of production of siRNA involved in RNA interference,BP,
17034,GO:0090067,1,0.993453709913066,0,1,regulation of thalamus size,BP,
17035,GO:0090068,1,0.176946225559679,0,263,positive regulation of cell cycle process,BP,
17036,GO:0090069,1,0.906787900388157,0,15,regulation of ribosome biogenesis,BP,
17037,GO:0090070,1,0.943333071464981,0,9,positive regulation of ribosome biogenesis,BP,
17038,GO:0090071,1,0.96767100176016,0,5,negative regulation of ribosome biogenesis,BP,
17039,GO:0090074,1,0.993327448563918,0,1,negative regulation of protein homodimerization activity,BP,
17040,GO:0090075,1,0.838552515598484,0,27,relaxation of muscle,BP,
17041,GO:0090076,1,0.98694627657673,0,2,relaxation of skeletal muscle,BP,
17042,GO:0090077,1,0.815688841312508,0,31,foam cell differentiation,BP,
17043,GO:0090079,1,0.521497200325244,0,100,translation regulator activity, nucleic acid binding,MF,
17044,GO:0090080,1,0.980591435543366,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17045,GO:0090081,1,0.974488032700291,0,4,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17046,GO:0090082,1,0.974488032700291,0,4,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17047,GO:0090083,1,0.905965321307837,0,15,regulation of inclusion body assembly,BP,
17048,GO:0090084,1,0.935741452852085,0,10,negative regulation of inclusion body assembly,BP,
17049,GO:0090085,1,0.930933340064661,0,11,regulation of protein deubiquitination,BP,
17050,GO:0090086,1,0.981061207834073,0,3,negative regulation of protein deubiquitination,BP,
17052,GO:0090088,1,0.987232882346578,0,2,regulation of oligopeptide transport,BP,
17053,GO:0090089,1,0.987232882346578,0,2,regulation of dipeptide transport,BP,
17055,GO:0090091,1,0.961324921749256,0,6,positive regulation of extracellular matrix disassembly,BP,
17057,GO:0090094,1,0.987236338559989,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17058,GO:0090095,1,0.99358229025915,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17059,GO:0090096,1,0.99358229025915,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17060,GO:0090100,1,0.511025981168612,0,102,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17062,GO:0090102,1,0.725594201108698,0,49,cochlea development,BP,
17063,GO:0090103,1,0.860816747462889,0,23,cochlea morphogenesis,BP,
17064,GO:0090107,1,0.980297661737348,0,3,regulation of high-density lipoprotein particle assembly,BP,
17065,GO:0090108,1,0.986563872861191,0,2,positive regulation of high-density lipoprotein particle assembly,BP,
17067,GO:0090110,1,0.906339687268134,0,15,COPII-coated vesicle cargo loading,BP,
17068,GO:0090113,1,0.97428368161292,0,4,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17069,GO:0090114,1,0.628431471475158,0,71,COPII-coated vesicle budding,BP,
17070,GO:0090116,1,0.980476417838515,0,3,C-5 methylation of cytosine,BP,
17071,GO:0090118,1,0.960824297181659,0,6,receptor-mediated endocytosis involved in cholesterol transport,BP,
17072,GO:0090119,1,0.987100815003053,0,2,vesicle-mediated cholesterol transport,BP,
17073,GO:0090122,1,0.99360509118065,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17074,GO:0090128,1,0.917699955483689,0,13,regulation of synapse maturation,BP,
17075,GO:0090129,1,0.948247949619135,0,8,positive regulation of synapse maturation,BP,
17077,GO:0090131,1,0.968404604286011,0,5,mesenchyme migration,BP,
17079,GO:0090133,1,0.993669882718904,0,1,mesendoderm migration,BP,
17080,GO:0090134,1,0.993669882718904,0,1,cell migration involved in mesendoderm migration,BP,
17081,GO:0090135,1,0.980698081057685,0,3,actin filament branching,BP,
17082,GO:0090136,1,0.906174726037502,0,15,epithelial cell-cell adhesion,BP,
17083,GO:0090138,1,0.993508125535763,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17084,GO:0090140,1,0.859425760845456,0,23,regulation of mitochondrial fission,BP,
17085,GO:0090141,1,0.906492061566265,0,15,positive regulation of mitochondrial fission,BP,
17086,GO:0090143,1,0.993693913124604,0,1,nucleoid organization,BP,
17087,GO:0090144,1,0.993693913124604,0,1,mitochondrial nucleoid organization,BP,
17088,GO:0090148,1,0.90628943100103,0,15,membrane fission,BP,
17089,GO:0090149,1,0.987079348680233,0,2,mitochondrial membrane fission,BP,
17091,GO:0090151,1,0.738461915430647,0,47,establishment of protein localization to mitochondrial membrane,BP,
17092,GO:0090152,1,0.993488909793949,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17093,GO:0090153,1,0.901418689423053,0,16,regulation of sphingolipid biosynthetic process,BP,
17094,GO:0090154,1,0.943411381448971,0,9,positive regulation of sphingolipid biosynthetic process,BP,
17095,GO:0090155,1,0.961632700650989,0,6,negative regulation of sphingolipid biosynthetic process,BP,
17096,GO:0090156,1,0.967976472360642,0,5,cellular sphingolipid homeostasis,BP,
17097,GO:0090158,1,0.968216745423416,0,5,endoplasmic reticulum membrane organization,BP,
17098,GO:0090160,1,0.943050104828522,0,9,Golgi to lysosome transport,BP,
17099,GO:0090161,1,0.911340492434337,0,14,Golgi ribbon formation,BP,
17100,GO:0090162,1,0.82074838198628,0,30,establishment of epithelial cell polarity,BP,
17101,GO:0090164,1,0.986799712270841,0,2,asymmetric Golgi ribbon formation,BP,
17102,GO:0090166,1,0.955637735937356,0,7,Golgi disassembly,BP,
17103,GO:0090168,1,0.974184718308961,0,4,Golgi reassembly,BP,
17104,GO:0090169,1,0.854342844947917,0,24,regulation of spindle assembly,BP,
17105,GO:0090170,1,0.974556307673805,0,4,regulation of Golgi inheritance,BP,
17106,GO:0090171,1,0.993499148127462,0,1,chondrocyte morphogenesis,BP,
17108,GO:0090175,1,0.500570172128117,0,106,regulation of establishment of planar polarity,BP,
17109,GO:0090176,1,0.980549843465956,0,3,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17110,GO:0090177,1,0.906079893139374,0,15,establishment of planar polarity involved in neural tube closure,BP,
17111,GO:0090178,1,0.911867856018081,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17112,GO:0090179,1,0.917886371965599,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17114,GO:0090182,1,0.987277387081523,0,2,regulation of secretion of lysosomal enzymes,BP,
17117,GO:0090185,1,0.913518583022647,0,14,negative regulation of kidney development,BP,
17118,GO:0090186,1,0.96784701955308,0,5,regulation of pancreatic juice secretion,BP,
17119,GO:0090187,1,0.993601419490681,0,1,positive regulation of pancreatic juice secretion,BP,
17120,GO:0090188,1,0.974081389538373,0,4,negative regulation of pancreatic juice secretion,BP,
17123,GO:0090191,1,0.987262883866805,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17124,GO:0090192,1,0.92511428728262,0,12,regulation of glomerulus development,BP,
17125,GO:0090193,1,0.943258880105653,0,9,positive regulation of glomerulus development,BP,
17126,GO:0090194,1,0.980775057196766,0,3,negative regulation of glomerulus development,BP,
17127,GO:0090199,1,0.742884380359275,0,46,regulation of release of cytochrome c from mitochondria,BP,
17128,GO:0090200,1,0.84037768044797,0,27,positive regulation of release of cytochrome c from mitochondria,BP,
17129,GO:0090201,1,0.884151642680224,0,19,negative regulation of release of cytochrome c from mitochondria,BP,
17130,GO:0090202,1,0.974013785058424,0,4,gene looping,BP,
17131,GO:0090204,1,0.980674378351021,0,3,protein localization to nuclear pore,BP,
17133,GO:0090206,1,0.968361885403268,0,5,negative regulation of cholesterol metabolic process,BP,
17134,GO:0090207,1,0.817531294378787,0,31,regulation of triglyceride metabolic process,BP,
17135,GO:0090208,1,0.884554063593227,0,19,positive regulation of triglyceride metabolic process,BP,
17136,GO:0090209,1,0.9549116717136,0,7,negative regulation of triglyceride metabolic process,BP,
17137,GO:0090210,1,0.980633018548709,0,3,regulation of establishment of blood-brain barrier,BP,
17138,GO:0090212,1,0.987087704695056,0,2,negative regulation of establishment of blood-brain barrier,BP,
17139,GO:0090214,1,0.986870121045008,0,2,spongiotrophoblast layer developmental growth,BP,
17140,GO:0090215,1,0.993510914594462,0,1,regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17141,GO:0090216,1,0.993510914594462,0,1,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17143,GO:0090219,1,0.98069623865963,0,3,negative regulation of lipid kinase activity,BP,
17144,GO:0090220,1,0.955032141155432,0,7,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17145,GO:0090222,1,0.986477698558267,0,2,centrosome-templated microtubule nucleation,BP,
17146,GO:0090224,1,0.778885165987688,0,38,regulation of spindle organization,BP,
17147,GO:0090226,1,0.993684169530725,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17148,GO:0090230,1,0.974071653163442,0,4,regulation of centromere complex assembly,BP,
17149,GO:0090231,1,0.912826692082268,0,14,regulation of spindle checkpoint,BP,
17150,GO:0090232,1,0.955178405244434,0,7,positive regulation of spindle checkpoint,BP,
17151,GO:0090233,1,0.993562427112928,0,1,negative regulation of spindle checkpoint,BP,
17152,GO:0090234,1,0.980509728106274,0,3,regulation of kinetochore assembly,BP,
17153,GO:0090235,1,0.947917223795872,0,8,regulation of metaphase plate congression,BP,
17154,GO:0090237,1,0.96182275945727,0,6,regulation of arachidonic acid secretion,BP,
17155,GO:0090238,1,0.968198990738867,0,5,positive regulation of arachidonic acid secretion,BP,
17156,GO:0090239,1,0.913266778799393,0,14,regulation of histone H4 acetylation,BP,
17157,GO:0090240,1,0.955545104655013,0,7,positive regulation of histone H4 acetylation,BP,
17158,GO:0090241,1,0.96210513172214,0,6,negative regulation of histone H4 acetylation,BP,
17159,GO:0090242,1,0.993529101376493,0,1,retinoic acid receptor signaling pathway involved in somitogenesis,BP,
17160,GO:0090244,1,0.973895634663125,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17161,GO:0090245,1,0.973492321349383,0,4,axis elongation involved in somitogenesis,BP,
17162,GO:0090246,1,0.993459081563851,0,1,convergent extension involved in somitogenesis,BP,
17163,GO:0090247,1,0.993567805908878,0,1,cell motility involved in somitogenic axis elongation,BP,
17164,GO:0090249,1,0.993567805908878,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17165,GO:0090251,1,0.992818354547099,0,1,protein localization involved in establishment of planar polarity,BP,
17167,GO:0090258,1,0.974149154020844,0,4,negative regulation of mitochondrial fission,BP,
17168,GO:0090259,1,0.967949829338746,0,5,regulation of retinal ganglion cell axon guidance,BP,
17169,GO:0090260,1,0.986950511669089,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17170,GO:0090261,1,0.974684252262299,0,4,positive regulation of inclusion body assembly,BP,
17171,GO:0090263,1,0.402459671087766,0,139,positive regulation of canonical Wnt signaling pathway,BP,
17172,GO:0090264,1,0.980940587308353,0,3,regulation of immune complex clearance by monocytes and macrophages,BP,
17173,GO:0090265,1,0.987227455127978,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17174,GO:0090266,1,0.912826692082268,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17175,GO:0090267,1,0.955178405244434,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17176,GO:0090269,1,0.948763635096782,0,8,fibroblast growth factor production,BP,
17177,GO:0090270,1,0.948763635096782,0,8,regulation of fibroblast growth factor production,BP,
17178,GO:0090271,1,0.967481426768517,0,5,positive regulation of fibroblast growth factor production,BP,
17179,GO:0090272,1,0.980659406815104,0,3,negative regulation of fibroblast growth factor production,BP,
17180,GO:0090273,1,0.987132956142118,0,2,regulation of somatostatin secretion,BP,
17181,GO:0090274,1,0.993534659899654,0,1,positive regulation of somatostatin secretion,BP,
17182,GO:0090275,1,0.99355705431691,0,1,negative regulation of somatostatin secretion,BP,
17186,GO:0090279,1,0.801600894910903,0,34,regulation of calcium ion import,BP,
17187,GO:0090280,1,0.889554620233935,0,18,positive regulation of calcium ion import,BP,
17188,GO:0090281,1,0.968575861175468,0,5,negative regulation of calcium ion import,BP,
17189,GO:0090282,1,0.993542915671291,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17190,GO:0090283,1,0.980530731544377,0,3,regulation of protein glycosylation in Golgi,BP,
17191,GO:0090284,1,0.993225665123652,0,1,positive regulation of protein glycosylation in Golgi,BP,
17192,GO:0090285,1,0.987219343301116,0,2,negative regulation of protein glycosylation in Golgi,BP,
17196,GO:0090290,1,0.993670246225417,0,1,positive regulation of osteoclast proliferation,BP,
17198,GO:0090292,1,0.979050973549502,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17199,GO:0090293,1,0.993596235981754,0,1,nitrogen catabolite regulation of transcription,BP,
17200,GO:0090294,1,0.993596235981754,0,1,nitrogen catabolite activation of transcription,BP,
17201,GO:0090296,1,0.974353859126274,0,4,regulation of mitochondrial DNA replication,BP,
17202,GO:0090297,1,0.993654419010253,0,1,positive regulation of mitochondrial DNA replication,BP,
17203,GO:0090298,1,0.986986065590896,0,2,negative regulation of mitochondrial DNA replication,BP,
17204,GO:0090299,1,0.993628764257942,0,1,regulation of neural crest formation,BP,
17205,GO:0090301,1,0.993628764257942,0,1,negative regulation of neural crest formation,BP,
17206,GO:0090303,1,0.717197670226888,0,51,positive regulation of wound healing,BP,
17209,GO:0090306,1,0.973786962570888,0,4,spindle assembly involved in meiosis,BP,
17210,GO:0090307,1,0.679528183941907,0,59,mitotic spindle assembly,BP,
17211,GO:0090308,1,0.930063062094847,0,11,regulation of DNA methylation-dependent heterochromatin assembly,BP,
17212,GO:0090309,1,0.942698619203175,0,9,positive regulation of DNA methylation-dependent heterochromatin assembly,BP,
17213,GO:0090310,1,0.986604251227503,0,2,negative regulation of DNA methylation-dependent heterochromatin assembly,BP,
17214,GO:0090311,1,0.758390179081115,0,42,regulation of protein deacetylation,BP,
17215,GO:0090312,1,0.877178388223918,0,20,positive regulation of protein deacetylation,BP,
17216,GO:0090313,1,0.802067723072813,0,34,regulation of protein targeting to membrane,BP,
17217,GO:0090314,1,0.823147660550068,0,30,positive regulation of protein targeting to membrane,BP,
17218,GO:0090315,1,0.96821823250219,0,5,negative regulation of protein targeting to membrane,BP,
17219,GO:0090316,1,0.310643010716316,0,178,positive regulation of intracellular protein transport,BP,
17220,GO:0090317,1,0.765917366135362,0,41,negative regulation of intracellular protein transport,BP,
17221,GO:0090322,1,0.813468682383514,0,32,regulation of superoxide metabolic process,BP,
17222,GO:0090323,1,0.993701867974549,0,1,prostaglandin secretion involved in immune response,BP,
17224,GO:0090325,1,0.974450462365343,0,4,regulation of locomotion involved in locomotory behavior,BP,
17225,GO:0090326,1,0.993528042703053,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17226,GO:0090327,1,0.993479209855665,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17227,GO:0090329,1,0.721796063982129,0,50,regulation of DNA-dependent DNA replication,BP,
17228,GO:0090330,1,0.877370902042322,0,20,regulation of platelet aggregation,BP,
17229,GO:0090331,1,0.924700441057724,0,12,negative regulation of platelet aggregation,BP,
17230,GO:0090335,1,0.859839710125857,0,23,regulation of brown fat cell differentiation,BP,
17231,GO:0090336,1,0.900269914235696,0,16,positive regulation of brown fat cell differentiation,BP,
17232,GO:0090340,1,0.993601419490681,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17233,GO:0090341,1,0.993635649479514,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17234,GO:0090342,1,0.740663713355589,0,46,regulation of cell aging,BP,
17235,GO:0090343,1,0.913920215566432,0,14,positive regulation of cell aging,BP,
17236,GO:0090344,1,0.859835781967304,0,23,negative regulation of cell aging,BP,
17237,GO:0090345,1,0.987247406253984,0,2,cellular organohalogen metabolic process,BP,
17238,GO:0090346,1,0.987247406253984,0,2,cellular organofluorine metabolic process,BP,
17239,GO:0090347,1,0.993633979868395,0,1,regulation of cellular organohalogen metabolic process,BP,
17240,GO:0090348,1,0.993633979868395,0,1,regulation of cellular organofluorine metabolic process,BP,
17241,GO:0090349,1,0.993633979868395,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17242,GO:0090350,1,0.993633979868395,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17243,GO:0090357,1,0.993656077753609,0,1,regulation of tryptophan metabolic process,BP,
17244,GO:0090360,1,0.980780845293611,0,3,platelet-derived growth factor production,BP,
17245,GO:0090361,1,0.980780845293611,0,3,regulation of platelet-derived growth factor production,BP,
17246,GO:0090362,1,0.98709735589731,0,2,positive regulation of platelet-derived growth factor production,BP,
17247,GO:0090370,1,0.973925363829888,0,4,negative regulation of cholesterol efflux,BP,
17248,GO:0090381,1,0.955237011762364,0,7,regulation of heart induction,BP,
17249,GO:0090382,1,0.741976012376683,0,46,phagosome maturation,BP,
17250,GO:0090383,1,0.840189590060686,0,27,phagosome acidification,BP,
17251,GO:0090384,1,0.993612562533813,0,1,phagosome-lysosome docking,BP,
17252,GO:0090385,1,0.943388824687902,0,9,phagosome-lysosome fusion,BP,
17253,GO:0090386,1,0.9866986990625,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17254,GO:0090387,1,0.9866986990625,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17255,GO:0090389,1,0.99318865712185,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17256,GO:0090394,1,0.930320886335291,0,11,negative regulation of excitatory postsynaptic potential,BP,
17257,GO:0090398,1,0.658698351114392,0,64,cellular senescence,BP,
17258,GO:0090399,1,0.918118756191723,0,13,replicative senescence,BP,
17259,GO:0090400,1,0.949391622871906,0,8,stress-induced premature senescence,BP,
17260,GO:0090402,1,0.98720211254134,0,2,oncogene-induced cell senescence,BP,
17261,GO:0090403,1,0.974331257683534,0,4,oxidative stress-induced premature senescence,BP,
17263,GO:0090409,1,0.993587028198598,0,1,malonyl-CoA synthetase activity,MF,
17264,GO:0090410,1,0.993587028198598,0,1,malonate catabolic process,BP,
17265,GO:0090416,1,0.993569416905227,0,1,nicotinate transmembrane transporter activity,MF,
17266,GO:0090420,1,0.993646113025072,0,1,naphthalene-containing compound metabolic process,BP,
17267,GO:0090422,1,0.98723499238184,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17268,GO:0090425,1,0.993540129524831,0,1,acinar cell differentiation,BP,
17269,GO:0090427,1,0.980595543403564,0,3,activation of meiosis,BP,
17270,GO:0090429,1,0.993629533849245,0,1,detection of endogenous biotic stimulus,BP,
17271,GO:0090435,1,0.94939717057035,0,8,protein localization to nuclear envelope,BP,
17272,GO:0090443,1,0.980657739890431,0,3,FAR/SIN/STRIPAK complex,CC,
17273,GO:0090461,1,0.973759798019221,0,4,glutamate homeostasis,BP,
17274,GO:0090472,1,0.993477484015873,0,1,dibasic protein processing,BP,
17275,GO:0090480,1,0.993532499008885,0,1,purine nucleotide-sugar transmembrane transport,BP,
17276,GO:0090481,1,0.931199590206313,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17277,GO:0090482,1,0.839116068481263,0,27,vitamin transmembrane transporter activity,MF,
17278,GO:0090486,1,0.99355705431691,0,1,small RNA 2'-O-methyltransferase,MF,
17281,GO:0090498,1,0.974197583705252,0,4,extrinsic component of Golgi membrane,CC,
17282,GO:0090500,1,0.974601662875369,0,4,endocardial cushion to mesenchymal transition,BP,
17283,GO:0090501,1,0.390649867693542,0,144,RNA phosphodiester bond hydrolysis,BP,
17284,GO:0090502,1,0.613336856334102,0,75,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17285,GO:0090503,1,0.760376773080434,0,42,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17286,GO:0090504,1,0.831258301870427,0,28,epiboly,BP,
17287,GO:0090505,1,0.837245349248462,0,27,epiboly involved in wound healing,BP,
17289,GO:0090521,1,0.97406521009332,0,4,glomerular visceral epithelial cell migration,BP,
17290,GO:0090522,1,0.993549179346723,0,1,vesicle tethering involved in exocytosis,BP,
17291,GO:0090527,1,0.937063778005458,0,10,actin filament reorganization,BP,
17292,GO:0090529,1,0.993616288817127,0,1,cell septum assembly,BP,
17294,GO:0090534,1,0.993625616674369,0,1,calcium ion-transporting ATPase complex,CC,
17295,GO:0090537,1,0.986892805331405,0,2,CERF complex,CC,
17296,GO:0090541,1,0.987063494061982,0,2,MIT domain binding,MF,
17297,GO:0090543,1,0.821247747459601,0,30,Flemming body,CC,
17298,GO:0090545,1,0.90541242071573,0,15,CHD-type complex,CC,
17299,GO:0090554,1,0.967077789468609,0,5,phosphatidylcholine floppase activity,MF,
17300,GO:0090555,1,0.986686033225357,0,2,phosphatidylethanolamine flippase activity,MF,
17301,GO:0090556,1,0.98622539062671,0,2,phosphatidylserine floppase activity,MF,
17302,GO:0090557,1,0.935793157770361,0,10,establishment of endothelial intestinal barrier,BP,
17304,GO:0090560,1,0.993595739313457,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17305,GO:0090571,1,0.962091406175588,0,6,RNA polymerase II transcription repressor complex,CC,
17306,GO:0090575,1,0.369512926464451,0,152,RNA polymerase II transcription regulator complex,CC,
17307,GO:0090576,1,0.942506639561232,0,9,RNA polymerase III transcription regulator complex,CC,
17308,GO:0090579,1,0.974013785058424,0,4,dsDNA loop formation,BP,
17309,GO:0090594,1,0.919792149964669,0,13,inflammatory response to wounding,BP,
17310,GO:0090596,1,0.19524358942072,0,247,sensory organ morphogenesis,BP,
17311,GO:0090598,1,0.974467382254126,0,4,male anatomical structure morphogenesis,BP,
17312,GO:0090599,1,0.967403646005754,0,5,alpha-glucosidase activity,MF,
17313,GO:0090600,1,0.993494857364421,0,1,alpha-1,3-glucosidase activity,MF,
17314,GO:0090601,1,0.993406836997533,0,1,enucleation,BP,
17315,GO:0090611,1,0.968142099967623,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17316,GO:0090615,1,0.987102276497066,0,2,mitochondrial mRNA processing,BP,
17317,GO:0090616,1,0.993449321048369,0,1,mitochondrial mRNA 3'-end processing,BP,
17318,GO:0090618,1,0.986783551695246,0,2,DNA clamp unloading,BP,
17319,GO:0090624,1,0.987155207697788,0,2,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17320,GO:0090625,1,0.99355705431691,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17321,GO:0090630,1,0.534871525729674,0,95,activation of GTPase activity,BP,
17322,GO:0090634,1,0.980899609922404,0,3,microglial cell mediated cytotoxicity,BP,
17323,GO:0090646,1,0.925469242972759,0,12,mitochondrial tRNA processing,BP,
17324,GO:0090647,1,0.949172024679114,0,8,modulation of age-related behavioral decline,BP,
17325,GO:0090648,1,0.993314769382707,0,1,response to environmental enrichment,BP,
17326,GO:0090649,1,0.936403741880429,0,10,response to oxygen-glucose deprivation,BP,
17327,GO:0090650,1,0.948424512559372,0,8,cellular response to oxygen-glucose deprivation,BP,
17328,GO:0090651,1,0.980598178882544,0,3,apical cytoplasm,CC,
17329,GO:0090656,1,0.912766743034244,0,14,t-circle formation,BP,
17330,GO:0090657,1,0.936869958354594,0,10,telomeric loop disassembly,BP,
17332,GO:0090660,1,0.974390352619578,0,4,cerebrospinal fluid circulation,BP,
17333,GO:0090661,1,0.974860120159832,0,4,box H/ACA telomerase RNP complex,CC,
17334,GO:0090663,1,0.987355751106027,0,2,galanin-activated signaling pathway,BP,
17335,GO:0090665,1,0.882382672203219,0,19,glycoprotein complex,CC,
17336,GO:0090666,1,0.968359354462714,0,5,scaRNA localization to Cajal body,BP,
17337,GO:0090667,1,0.993168528802205,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17338,GO:0090668,1,0.993168528802205,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17339,GO:0090669,1,0.974487722653066,0,4,telomerase RNA stabilization,BP,
17340,GO:0090670,1,0.884613362305829,0,19,RNA localization to Cajal body,BP,
17341,GO:0090671,1,0.884613362305829,0,19,telomerase RNA localization to Cajal body,BP,
17342,GO:0090672,1,0.884613362305829,0,19,telomerase RNA localization,BP,
17343,GO:0090673,1,0.967821668409314,0,5,endothelial cell-matrix adhesion,BP,
17344,GO:0090674,1,0.97443326536649,0,4,endothelial cell-matrix adhesion via fibronectin,BP,
17345,GO:0090675,1,0.993474506059225,0,1,intermicrovillar adhesion,BP,
17346,GO:0090677,1,0.968089137482399,0,5,reversible differentiation,BP,
17347,GO:0090678,1,0.987206960302379,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17348,GO:0090679,1,0.98063690200295,0,3,cell differentiation involved in phenotypic switching,BP,
17349,GO:0090685,1,0.884613362305829,0,19,RNA localization to nucleus,BP,
17350,GO:0090694,1,0.986549835690528,0,2,Scc2-Scc4 cohesin loading complex,CC,
17351,GO:0090713,1,0.931107880170605,0,11,immunological memory process,BP,
17352,GO:0090715,1,0.949130509317221,0,8,immunological memory formation process,BP,
17353,GO:0090716,1,0.981021250051968,0,3,adaptive immune memory response,BP,
17354,GO:0090720,1,0.993045685112016,0,1,primary adaptive immune response,BP,
17355,GO:0090721,1,0.993045685112016,0,1,primary adaptive immune response involving T cells and B cells,BP,
17356,GO:0090722,1,0.974212510059765,0,4,receptor-receptor interaction,MF,
17357,GO:0090724,1,0.974375719555911,0,4,central region of growth cone,CC,
17358,GO:0090725,1,0.993680412277699,0,1,peripheral region of growth cone,CC,
17359,GO:0090730,1,0.99357696814452,0,1,Las1 complex,CC,
17360,GO:0090731,1,0.993661049356776,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17361,GO:0090734,1,0.640678978822439,0,68,site of DNA damage,CC,
17362,GO:0090735,1,0.962136842821306,0,6,DNA repair complex assembly,BP,
17363,GO:0090737,1,0.912766743034244,0,14,telomere maintenance via telomere trimming,BP,
17364,GO:0090741,1,0.919783820845889,0,13,pigment granule membrane,CC,
17365,GO:0095500,1,0.850409975715871,0,25,acetylcholine receptor signaling pathway,BP,
17367,GO:0097003,1,0.987129879281113,0,2,adipokinetic hormone receptor activity,MF,
17368,GO:0097006,1,0.605149992621389,0,77,regulation of plasma lipoprotein particle levels,BP,
17369,GO:0097009,1,0.795074111276565,0,35,energy homeostasis,BP,
17370,GO:0097010,1,0.980585654277023,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17371,GO:0097011,1,0.949537577305784,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17372,GO:0097012,1,0.949537577305784,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17373,GO:0097013,1,0.974712328354415,0,4,phagocytic vesicle lumen,CC,
17375,GO:0097016,1,0.974441326845012,0,4,L27 domain binding,MF,
17376,GO:0097017,1,0.987173066454898,0,2,renal protein absorption,BP,
17377,GO:0097018,1,0.993573043847889,0,1,renal albumin absorption,BP,
17378,GO:0097020,1,0.993524290485447,0,1,COPII adaptor activity,MF,
17379,GO:0097021,1,0.961359333708166,0,6,lymphocyte migration into lymphoid organs,BP,
17380,GO:0097022,1,0.986569172812795,0,2,lymphocyte migration into lymph node,BP,
17381,GO:0097025,1,0.96800989095939,0,5,MPP7-DLG1-LIN7 complex,CC,
17382,GO:0097026,1,0.974362739166439,0,4,dendritic cell dendrite assembly,BP,
17383,GO:0097027,1,0.94956219662539,0,8,ubiquitin-protein transferase activator activity,MF,
17384,GO:0097028,1,0.767061242048034,0,41,dendritic cell differentiation,BP,
17385,GO:0097029,1,0.974752379219158,0,4,mature conventional dendritic cell differentiation,BP,
17386,GO:0097035,1,0.728200608287094,0,48,regulation of membrane lipid distribution,BP,
17387,GO:0097036,1,0.993643783512876,0,1,regulation of plasma membrane sterol distribution,BP,
17388,GO:0097037,1,0.980842292119177,0,3,heme export,BP,
17389,GO:0097038,1,0.87731431857084,0,20,perinuclear endoplasmic reticulum,CC,
17390,GO:0097039,1,0.974064283897154,0,4,protein linear polyubiquitination,BP,
17391,GO:0097045,1,0.993435692652615,0,1,phosphatidylserine exposure on blood platelet,BP,
17392,GO:0097048,1,0.93136016434893,0,11,dendritic cell apoptotic process,BP,
17393,GO:0097049,1,0.949457998454518,0,8,motor neuron apoptotic process,BP,
17395,GO:0097051,1,0.980270485217875,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17396,GO:0097052,1,0.968209514784824,0,5,L-kynurenine metabolic process,BP,
17397,GO:0097053,1,0.987256919431738,0,2,L-kynurenine catabolic process,BP,
17398,GO:0097055,1,0.987190921527269,0,2,agmatine biosynthetic process,BP,
17399,GO:0097056,1,0.980717008645644,0,3,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17400,GO:0097057,1,0.987303167876765,0,2,TRAF2-GSTP1 complex,CC,
17401,GO:0097058,1,0.987279230156405,0,2,CRLF-CLCF1 complex,CC,
17402,GO:0097059,1,0.987267161949253,0,2,CNTFR-CLCF1 complex,CC,
17404,GO:0097061,1,0.592384027691966,0,79,dendritic spine organization,BP,
17405,GO:0097062,1,0.88825014889532,0,18,dendritic spine maintenance,BP,
17406,GO:0097064,1,0.794673463004858,0,35,ncRNA export from nucleus,BP,
17407,GO:0097065,1,0.961646331060546,0,6,anterior head development,BP,
17408,GO:0097066,1,0.860632337583256,0,23,response to thyroid hormone,BP,
17409,GO:0097067,1,0.900430785504709,0,16,cellular response to thyroid hormone stimulus,BP,
17410,GO:0097068,1,0.974332559616549,0,4,response to thyroxine,BP,
17411,GO:0097069,1,0.987086242861852,0,2,cellular response to thyroxine stimulus,BP,
17412,GO:0097070,1,0.967720637063596,0,5,ductus arteriosus closure,BP,
17413,GO:0097079,1,0.993531249358711,0,1,selenite:proton symporter activity,MF,
17414,GO:0097080,1,0.993531249358711,0,1,plasma membrane selenite transport,BP,
17415,GO:0097084,1,0.943141464583191,0,9,vascular associated smooth muscle cell development,BP,
17416,GO:0097086,1,0.993508560498276,0,1,amniotic stem cell differentiation,BP,
17417,GO:0097089,1,0.980938702612226,0,3,methyl-branched fatty acid metabolic process,BP,
17419,GO:0097091,1,0.899013374278321,0,16,synaptic vesicle clustering,BP,
17420,GO:0097094,1,0.905995737830475,0,15,craniofacial suture morphogenesis,BP,
17421,GO:0097100,1,0.968279854151488,0,5,supercoiled DNA binding,MF,
17422,GO:0097101,1,0.980806858879045,0,3,blood vessel endothelial cell fate specification,BP,
17423,GO:0097102,1,0.987142648042558,0,2,endothelial tip cell fate specification,BP,
17424,GO:0097104,1,0.923159991308917,0,12,postsynaptic membrane assembly,BP,
17425,GO:0097105,1,0.935843186950054,0,10,presynaptic membrane assembly,BP,
17426,GO:0097106,1,0.808408343501159,0,32,postsynaptic density organization,BP,
17427,GO:0097107,1,0.887276276323637,0,18,postsynaptic density assembly,BP,
17429,GO:0097109,1,0.967300493805465,0,5,neuroligin family protein binding,MF,
17431,GO:0097111,1,0.98660072599922,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17432,GO:0097112,1,0.9740296600533,0,4,gamma-aminobutyric acid receptor clustering,BP,
17433,GO:0097113,1,0.941964389244994,0,9,AMPA glutamate receptor clustering,BP,
17434,GO:0097114,1,0.973383314010941,0,4,NMDA glutamate receptor clustering,BP,
17435,GO:0097115,1,0.993425430038218,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17436,GO:0097116,1,0.979907650486929,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17437,GO:0097117,1,0.993233170543016,0,1,guanylate kinase-associated protein clustering,BP,
17438,GO:0097118,1,0.973317401722529,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17439,GO:0097119,1,0.941587242435114,0,9,postsynaptic density protein 95 clustering,BP,
17440,GO:0097120,1,0.701603372323447,0,54,receptor localization to synapse,BP,
17441,GO:0097123,1,0.98724306911224,0,2,cyclin A1-CDK2 complex,CC,
17442,GO:0097124,1,0.974644475648218,0,4,cyclin A2-CDK2 complex,CC,
17443,GO:0097125,1,0.987263629410605,0,2,cyclin B1-CDK1 complex,CC,
17444,GO:0097129,1,0.987338364989657,0,2,cyclin D2-CDK4 complex,CC,
17445,GO:0097132,1,0.992792495085689,0,1,cyclin D2-CDK6 complex,CC,
17446,GO:0097134,1,0.980886136672104,0,3,cyclin E1-CDK2 complex,CC,
17447,GO:0097135,1,0.987190309960587,0,2,cyclin E2-CDK2 complex,CC,
17448,GO:0097136,1,0.96190393847104,0,6,Bcl-2 family protein complex,CC,
17449,GO:0097144,1,0.993685355464975,0,1,BAX complex,CC,
17450,GO:0097145,1,0.987318736454209,0,2,BAK complex,CC,
17451,GO:0097149,1,0.980663051152364,0,3,centralspindlin complex,CC,
17452,GO:0097150,1,0.857845819138523,0,23,neuronal stem cell population maintenance,BP,
17453,GO:0097151,1,0.954555652785344,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17454,GO:0097152,1,0.925152910046492,0,12,mesenchymal cell apoptotic process,BP,
17455,GO:0097153,1,0.919851099419481,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17457,GO:0097155,1,0.979776293853201,0,3,fasciculation of sensory neuron axon,BP,
17458,GO:0097156,1,0.98682139789693,0,2,fasciculation of motor neuron axon,BP,
17459,GO:0097157,1,0.92463140298033,0,12,pre-mRNA intronic binding,MF,
17460,GO:0097158,1,0.987279715257304,0,2,pre-mRNA intronic pyrimidine-rich binding,MF,
17462,GO:0097161,1,0.993304642559122,0,1,DH domain binding,MF,
17463,GO:0097162,1,0.993528995456759,0,1,MADS box domain binding,MF,
17464,GO:0097163,1,0.99363648391928,0,1,sulfur carrier activity,MF,
17465,GO:0097164,1,0.854440680983645,0,24,ammonium ion metabolic process,BP,
17466,GO:0097165,1,0.961782656143054,0,6,nuclear stress granule,CC,
17467,GO:0097166,1,0.986740535695574,0,2,lens epithelial cell proliferation,BP,
17468,GO:0097167,1,0.974221032203853,0,4,circadian regulation of translation,BP,
17469,GO:0097168,1,0.968345400674394,0,5,mesenchymal stem cell proliferation,BP,
17470,GO:0097169,1,0.974877202044853,0,4,AIM2 inflammasome complex,CC,
17471,GO:0097176,1,0.968390590987256,0,5,epoxide metabolic process,BP,
17472,GO:0097177,1,0.974725258178924,0,4,mitochondrial ribosome binding,MF,
17473,GO:0097178,1,0.776218642996065,0,39,ruffle assembly,BP,
17474,GO:0097179,1,0.974813398647847,0,4,protease inhibitor complex,CC,
17475,GO:0097180,1,0.987255755634022,0,2,serine protease inhibitor complex,CC,
17476,GO:0097181,1,0.993585465122445,0,1,protein C inhibitor-coagulation factor V complex,CC,
17477,GO:0097182,1,0.993585465122445,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17478,GO:0097183,1,0.993585465122445,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17479,GO:0097186,1,0.894658777273607,0,17,amelogenesis,BP,
17480,GO:0097187,1,0.961743161757845,0,6,dentinogenesis,BP,
17481,GO:0097188,1,0.993568331531998,0,1,dentin mineralization,BP,
17487,GO:0097195,1,0.980768294305748,0,3,pilomotor reflex,BP,
17488,GO:0097196,1,0.987207961992897,0,2,Shu complex,CC,
17489,GO:0097197,1,0.937237606682672,0,10,tetraspanin-enriched microdomain,CC,
17490,GO:0097198,1,0.96728367766965,0,5,histone H3-K36 trimethylation,BP,
17491,GO:0097199,1,0.943625727482092,0,9,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17492,GO:0097200,1,0.949541032208523,0,8,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17493,GO:0097201,1,0.925208281057792,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17494,GO:0097202,1,0.906601185468771,0,15,activation of cysteine-type endopeptidase activity,BP,
17495,GO:0097205,1,0.88346271183788,0,19,renal filtration,BP,
17496,GO:0097208,1,0.961948715373505,0,6,alveolar lamellar body,CC,
17497,GO:0097209,1,0.974112769471627,0,4,epidermal lamellar body,CC,
17498,GO:0097210,1,0.968070688824559,0,5,response to gonadotropin-releasing hormone,BP,
17499,GO:0097211,1,0.968070688824559,0,5,cellular response to gonadotropin-releasing hormone,BP,
17500,GO:0097212,1,0.981018647925857,0,3,lysosomal membrane organization,BP,
17501,GO:0097213,1,0.987330830148394,0,2,regulation of lysosomal membrane permeability,BP,
17502,GO:0097214,1,0.993700553734554,0,1,positive regulation of lysosomal membrane permeability,BP,
17503,GO:0097222,1,0.993449321048369,0,1,mitochondrial mRNA polyadenylation,BP,
17504,GO:0097224,1,0.955784098436002,0,7,sperm connecting piece,CC,
17505,GO:0097225,1,0.867159064355997,0,22,sperm midpiece,CC,
17506,GO:0097227,1,0.993315466056991,0,1,sperm annulus,CC,
17507,GO:0097228,1,0.878140149747566,0,20,sperm principal piece,CC,
17508,GO:0097229,1,0.987248520537934,0,2,sperm end piece,CC,
17509,GO:0097232,1,0.986847637356757,0,2,lamellar body membrane,CC,
17510,GO:0097233,1,0.986847637356757,0,2,alveolar lamellar body membrane,CC,
17511,GO:0097237,1,0.507445067003059,0,105,cellular response to toxic substance,BP,
17512,GO:0097238,1,0.987363133865867,0,2,cellular response to methylglyoxal,BP,
17513,GO:0097240,1,0.987164315777841,0,2,chromosome attachment to the nuclear envelope,BP,
17514,GO:0097241,1,0.974538879408922,0,4,hematopoietic stem cell migration to bone marrow,BP,
17516,GO:0097243,1,0.987310821647748,0,2,flavonoid binding,MF,
17517,GO:0097250,1,0.962588729123357,0,6,mitochondrial respirasome assembly,BP,
17518,GO:0097252,1,0.974030724014583,0,4,oligodendrocyte apoptotic process,BP,
17519,GO:0097254,1,0.993598524801629,0,1,renal tubular secretion,BP,
17520,GO:0097255,1,0.968487013639089,0,5,R2TP complex,CC,
17521,GO:0097264,1,0.961843774785785,0,6,self proteolysis,BP,
17522,GO:0097267,1,0.9742727670585,0,4,omega-hydroxylase P450 pathway,BP,
17523,GO:0097268,1,0.980640868408745,0,3,cytoophidium,CC,
17524,GO:0097272,1,0.987026965233372,0,2,ammonium homeostasis,BP,
17525,GO:0097273,1,0.993355490074216,0,1,creatinine homeostasis,BP,
17526,GO:0097274,1,0.986917180802408,0,2,urea homeostasis,BP,
17527,GO:0097275,1,0.993355490074216,0,1,cellular ammonium homeostasis,BP,
17528,GO:0097276,1,0.993355490074216,0,1,cellular creatinine homeostasis,BP,
17529,GO:0097277,1,0.993355490074216,0,1,cellular urea homeostasis,BP,
17530,GO:0097278,1,0.949216176488275,0,8,complement-dependent cytotoxicity,BP,
17531,GO:0097281,1,0.993629533849245,0,1,immune complex formation,BP,
17532,GO:0097283,1,0.968299957571277,0,5,keratinocyte apoptotic process,BP,
17533,GO:0097284,1,0.924953302735065,0,12,hepatocyte apoptotic process,BP,
17534,GO:0097291,1,0.993605893736387,0,1,renal phosphate ion absorption,BP,
17535,GO:0097296,1,0.974231542709366,0,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17536,GO:0097298,1,0.993493521075413,0,1,regulation of nucleus size,BP,
17539,GO:0097306,1,0.582212044197624,0,82,cellular response to alcohol,BP,
17540,GO:0097309,1,0.987155207697788,0,2,cap1 mRNA methylation,BP,
17541,GO:0097310,1,0.99355705431691,0,1,cap2 mRNA methylation,BP,
17543,GO:0097322,1,0.949295208171975,0,8,7SK snRNA binding,MF,
17544,GO:0097323,1,0.987213171052642,0,2,B cell adhesion,BP,
17545,GO:0097324,1,0.986494531606644,0,2,melanocyte migration,BP,
17546,GO:0097325,1,0.980587075980275,0,3,melanocyte proliferation,BP,
17547,GO:0097326,1,0.993404495823808,0,1,melanocyte adhesion,BP,
17548,GO:0097327,1,0.961976185607522,0,6,response to antineoplastic agent,BP,
17549,GO:0097332,1,0.987224205145764,0,2,response to antipsychotic drug,BP,
17550,GO:0097338,1,0.980577924934075,0,3,response to clozapine,BP,
17551,GO:0097340,1,0.937100282673952,0,10,inhibition of cysteine-type endopeptidase activity,BP,
17552,GO:0097341,1,0.937100282673952,0,10,zymogen inhibition,BP,
17553,GO:0097342,1,0.961811557159165,0,6,ripoptosome,CC,
17554,GO:0097343,1,0.980231201120409,0,3,ripoptosome assembly,BP,
17555,GO:0097344,1,0.987216559703244,0,2,Rix1 complex,CC,
17557,GO:0097346,1,0.849223781499556,0,25,INO80-type complex,CC,
17558,GO:0097350,1,0.968100446025867,0,5,neutrophil clearance,BP,
17559,GO:0097352,1,0.78622081963717,0,37,autophagosome maturation,BP,
17560,GO:0097354,1,0.936658331444028,0,10,prenylation,BP,
17561,GO:0097355,1,0.993630437004572,0,1,protein localization to heterochromatin,BP,
17562,GO:0097356,1,0.986577790050718,0,2,perinucleolar compartment,CC,
17563,GO:0097359,1,0.98634188627115,0,2,UDP-glucosylation,BP,
17565,GO:0097361,1,0.987035282905494,0,2,CIA complex,CC,
17566,GO:0097362,1,0.987122879694448,0,2,MCM8-MCM9 complex,CC,
17567,GO:0097363,1,0.980619182057477,0,3,protein O-GlcNAc transferase activity,MF,
17569,GO:0097368,1,0.967434337337521,0,5,establishment of Sertoli cell barrier,BP,
17570,GO:0097370,1,0.99355705431691,0,1,protein O-GlcNAcylation via threonine,BP,
17571,GO:0097371,1,0.954986497679729,0,7,MDM2/MDM4 family protein binding,MF,
17572,GO:0097372,1,0.993625080542958,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17573,GO:0097374,1,0.980738327083178,0,3,sensory neuron axon guidance,BP,
17574,GO:0097376,1,0.987271841200159,0,2,interneuron axon guidance,BP,
17575,GO:0097377,1,0.993586506612171,0,1,spinal cord interneuron axon guidance,BP,
17576,GO:0097378,1,0.993586506612171,0,1,dorsal spinal cord interneuron axon guidance,BP,
17577,GO:0097380,1,0.993586506612171,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17578,GO:0097381,1,0.900842947083048,0,16,photoreceptor disc membrane,CC,
17579,GO:0097384,1,0.936519728128069,0,10,cellular lipid biosynthetic process,BP,
17581,GO:0097393,1,0.992845986822309,0,1,telomeric repeat-containing RNA transcription,BP,
17582,GO:0097394,1,0.992845986822309,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17583,GO:0097396,1,0.961942393604325,0,6,response to interleukin-17,BP,
17584,GO:0097398,1,0.961942393604325,0,6,cellular response to interleukin-17,BP,
17585,GO:0097400,1,0.961942393604325,0,6,interleukin-17-mediated signaling pathway,BP,
17587,GO:0097402,1,0.986818370133541,0,2,neuroblast migration,BP,
17588,GO:0097403,1,0.9935428607537,0,1,cellular response to raffinose,BP,
17589,GO:0097409,1,0.993608940574979,0,1,glial cytoplasmic inclusion,CC,
17590,GO:0097411,1,0.967711727882253,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17591,GO:0097413,1,0.955859861710895,0,7,Lewy body,CC,
17592,GO:0097414,1,0.993608940574979,0,1,classical Lewy body,CC,
17594,GO:0097421,1,0.818055247632664,0,31,liver regeneration,BP,
17595,GO:0097422,1,0.9681030348681,0,5,tubular endosome,CC,
17597,GO:0097428,1,0.938014623900349,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17598,GO:0097431,1,0.825987434203448,0,29,mitotic spindle pole,CC,
17599,GO:0097433,1,0.968210284393207,0,5,dense body,CC,
17601,GO:0097440,1,0.887598316366837,0,18,apical dendrite,CC,
17602,GO:0097441,1,0.95464771524599,0,7,basal dendrite,CC,
17603,GO:0097442,1,0.980282049617987,0,3,CA3 pyramidal cell dendrite,CC,
17604,GO:0097443,1,0.961365307204977,0,6,sorting endosome,CC,
17608,GO:0097450,1,0.955230020251535,0,7,astrocyte end-foot,CC,
17609,GO:0097451,1,0.987015442906979,0,2,glial limiting end-foot,CC,
17610,GO:0097452,1,0.980707875252571,0,3,GAIT complex,CC,
17612,GO:0097454,1,0.980270245630301,0,3,Schwann cell microvillus,CC,
17613,GO:0097457,1,0.973406148233374,0,4,hippocampal mossy fiber,CC,
17614,GO:0097462,1,0.993608940574979,0,1,Lewy neurite,CC,
17615,GO:0097466,1,0.974026237899482,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17616,GO:0097468,1,0.931163115576486,0,11,programmed cell death in response to reactive oxygen species,BP,
17618,GO:0097472,1,0.83338043143075,0,28,cyclin-dependent protein kinase activity,MF,
17619,GO:0097473,1,0.993397417507683,0,1,retinal rod cell apoptotic process,BP,
17620,GO:0097474,1,0.986848060583889,0,2,retinal cone cell apoptotic process,BP,
17621,GO:0097475,1,0.973715259860159,0,4,motor neuron migration,BP,
17622,GO:0097476,1,0.986410322215937,0,2,spinal cord motor neuron migration,BP,
17623,GO:0097477,1,0.986410322215937,0,2,lateral motor column neuron migration,BP,
17624,GO:0097479,1,0.69657224940444,0,55,synaptic vesicle localization,BP,
17627,GO:0097486,1,0.968653917890271,0,5,multivesicular body lumen,CC,
17628,GO:0097487,1,0.97411958702578,0,4,multivesicular body, internal vesicle,CC,
17629,GO:0097489,1,0.993569603397152,0,1,multivesicular body, internal vesicle lumen,CC,
17630,GO:0097490,1,0.974096050771965,0,4,sympathetic neuron projection extension,BP,
17631,GO:0097491,1,0.974096050771965,0,4,sympathetic neuron projection guidance,BP,
17632,GO:0097493,1,0.916073523156544,0,11,structural molecule activity conferring elasticity,MF,
17633,GO:0097494,1,0.94317270118755,0,9,regulation of vesicle size,BP,
17634,GO:0097497,1,0.9935353557712,0,1,blood vessel endothelial cell delamination,BP,
17635,GO:0097498,1,0.9870005982173,0,2,endothelial tube lumen extension,BP,
17636,GO:0097499,1,0.93025812242561,0,11,protein localization to non-motile cilium,BP,
17637,GO:0097500,1,0.97411487481314,0,4,receptor localization to non-motile cilium,BP,
17638,GO:0097501,1,0.920327050670724,0,13,stress response to metal ion,BP,
17639,GO:0097502,1,0.806403236855125,0,33,mannosylation,BP,
17640,GO:0097503,1,0.877154673817659,0,20,sialylation,BP,
17641,GO:0097504,1,0.925220757271122,0,12,Gemini of coiled bodies,CC,
17642,GO:0097505,1,0.993357709446072,0,1,Rad6-Rad18 complex,CC,
17643,GO:0097506,1,0.97465069020277,0,4,deaminated base DNA N-glycosylase activity,MF,
17644,GO:0097510,1,0.993602719910334,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17645,GO:0097512,1,0.968504267176536,0,5,cardiac myofibril,CC,
17646,GO:0097513,1,0.979785052634088,0,3,myosin II filament,CC,
17648,GO:0097519,1,0.993285661034122,0,1,DNA recombinase complex,CC,
17649,GO:0097524,1,0.961457977014827,0,6,sperm plasma membrane,CC,
17650,GO:0097525,1,0.701412567211759,0,55,spliceosomal snRNP complex,CC,
17651,GO:0097526,1,0.82452720113608,0,30,spliceosomal tri-snRNP complex,CC,
17652,GO:0097527,1,0.949798966823977,0,8,necroptotic signaling pathway,BP,
17653,GO:0097528,1,0.987244743510858,0,2,execution phase of necroptosis,BP,
17656,GO:0097531,1,0.931097638157067,0,11,mast cell migration,BP,
17657,GO:0097532,1,0.987186969587289,0,2,stress response to acid chemical,BP,
17658,GO:0097533,1,0.987186969587289,0,2,cellular stress response to acid chemical,BP,
17659,GO:0097534,1,0.993183732397853,0,1,lymphoid lineage cell migration,BP,
17660,GO:0097535,1,0.993183732397853,0,1,lymphoid lineage cell migration into thymus,BP,
17661,GO:0097536,1,0.993598524801629,0,1,thymus epithelium morphogenesis,BP,
17662,GO:0097539,1,0.935916708020368,0,10,ciliary transition fiber,CC,
17663,GO:0097541,1,0.99355705431691,0,1,axonemal basal plate,CC,
17664,GO:0097542,1,0.759504123624719,0,42,ciliary tip,CC,
17665,GO:0097543,1,0.987102695041272,0,2,ciliary inversin compartment,CC,
17666,GO:0097546,1,0.839052572839881,0,27,ciliary base,CC,
17667,GO:0097549,1,0.64379086146888,0,67,chromatin organization involved in negative regulation of transcription,BP,
17668,GO:0097550,1,0.943630057365635,0,9,transcription preinitiation complex,CC,
17670,GO:0097573,1,0.993648972653794,0,1,glutathione oxidoreductase activity,MF,
17671,GO:0097574,1,0.98681435937419,0,2,lateral part of cell,CC,
17672,GO:0097575,1,0.98681435937419,0,2,lateral cell cortex,CC,
17673,GO:0097576,1,0.968368206676346,0,5,vacuole fusion,BP,
17674,GO:0097577,1,0.974867642952388,0,4,sequestering of iron ion,BP,
17676,GO:0097598,1,0.986985858454799,0,2,sperm cytoplasmic droplet,CC,
17677,GO:0097602,1,0.860740216585655,0,23,cullin family protein binding,MF,
17678,GO:0097603,1,0.987140914369293,0,2,temperature-gated ion channel activity,MF,
17679,GO:0097604,1,0.993618840652486,0,1,temperature-gated cation channel activity,MF,
17680,GO:0097617,1,0.918825762709779,0,13,annealing activity,MF,
17681,GO:0097621,1,0.993586376302338,0,1,monoamine oxidase activity,MF,
17682,GO:0097623,1,0.90141926761249,0,16,potassium ion export across plasma membrane,BP,
17683,GO:0097629,1,0.98059835278152,0,3,extrinsic component of omegasome membrane,CC,
17684,GO:0097630,1,0.99355705431691,0,1,intrinsic component of omegasome membrane,CC,
17685,GO:0097631,1,0.99355705431691,0,1,integral component of omegasome membrane,CC,
17686,GO:0097632,1,0.986998780437221,0,2,extrinsic component of phagophore assembly site membrane,CC,
17687,GO:0097635,1,0.986887763538846,0,2,extrinsic component of autophagosome membrane,CC,
17688,GO:0097636,1,0.987073965536772,0,2,intrinsic component of autophagosome membrane,CC,
17689,GO:0097637,1,0.987073965536772,0,2,integral component of autophagosome membrane,CC,
17690,GO:0097638,1,0.961304413276727,0,6,L-arginine import across plasma membrane,BP,
17691,GO:0097639,1,0.987199532015148,0,2,L-lysine import across plasma membrane,BP,
17692,GO:0097640,1,0.993590168884028,0,1,L-ornithine import across plasma membrane,BP,
17693,GO:0097642,1,0.962113481100225,0,6,calcitonin family receptor activity,MF,
17694,GO:0097643,1,0.974767241644686,0,4,amylin receptor activity,MF,
17695,GO:0097644,1,0.974540290660043,0,4,calcitonin family binding,MF,
17696,GO:0097646,1,0.962192868770885,0,6,calcitonin family receptor signaling pathway,BP,
17697,GO:0097647,1,0.968569181921847,0,5,amylin receptor signaling pathway,BP,
17698,GO:0097648,1,0.942982925550319,0,9,G protein-coupled receptor complex,CC,
17699,GO:0097651,1,0.973959930621922,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17700,GO:0097655,1,0.99355705431691,0,1,serpin family protein binding,MF,
17702,GO:0097676,1,0.973265075095958,0,4,histone H3-K36 dimethylation,BP,
17703,GO:0097677,1,0.954340415519457,0,7,STAT family protein binding,MF,
17704,GO:0097680,1,0.961426286198679,0,6,double-strand break repair via classical nonhomologous end joining,BP,
17705,GO:0097681,1,0.973023820931886,0,4,double-strand break repair via alternative nonhomologous end joining,BP,
17706,GO:0097682,1,0.993599089700839,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17707,GO:0097688,1,0.941964389244994,0,9,glutamate receptor clustering,BP,
17708,GO:0097692,1,0.948661118832194,0,8,histone H3-K4 monomethylation,BP,
17709,GO:0097694,1,0.979665300458028,0,3,establishment of RNA localization to telomere,BP,
17710,GO:0097695,1,0.979665300458028,0,3,establishment of protein-containing complex localization to telomere,BP,
17711,GO:0097696,1,0.474568089009197,0,114,receptor signaling pathway via STAT,BP,
17712,GO:0097698,1,0.993640252605593,0,1,telomere maintenance via base-excision repair,BP,
17713,GO:0097699,1,0.993459291343917,0,1,vascular endothelial cell response to fluid shear stress,BP,
17714,GO:0097707,1,0.987248029046968,0,2,ferroptosis,BP,
17716,GO:0097709,1,0.942964444945511,0,9,connective tissue replacement,BP,
17717,GO:0097711,1,0.538931219879942,0,94,ciliary basal body-plasma membrane docking,BP,
17718,GO:0097712,1,0.99355705431691,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17719,GO:0097718,1,0.820383916862324,0,30,disordered domain specific binding,MF,
17721,GO:0097722,1,0.61960863231068,0,73,sperm motility,BP,
17722,GO:0097726,1,0.993664856418496,0,1,LEM domain binding,MF,
17723,GO:0097728,1,0.992508087796785,0,1,9+0 motile cilium,CC,
17724,GO:0097729,1,0.564714821561133,0,87,9+2 motile cilium,CC,
17725,GO:0097730,1,0.412190854754195,0,135,non-motile cilium,CC,
17726,GO:0097731,1,0.476326335695756,0,113,9+0 non-motile cilium,CC,
17727,GO:0097732,1,0.955640091285791,0,7,9+2 non-motile cilium,CC,
17728,GO:0097733,1,0.542372462266681,0,93,photoreceptor cell cilium,CC,
17729,GO:0097734,1,0.89013745687381,0,18,extracellular exosome biogenesis,BP,
17730,GO:0097742,1,0.974186033147695,0,4,de novo centriole assembly,BP,
17731,GO:0097744,1,0.99346075490435,0,1,urate salt excretion,BP,
17732,GO:0097745,1,0.987273485181826,0,2,mitochondrial tRNA 5'-end processing,BP,
17734,GO:0097747,1,0.777231208481685,0,39,RNA polymerase activity,MF,
17735,GO:0097749,1,0.973984871347202,0,4,membrane tubulation,BP,
17736,GO:0097750,1,0.986910275860257,0,2,endosome membrane tubulation,BP,
17737,GO:0097752,1,0.987219734753622,0,2,regulation of DNA stability,BP,
17738,GO:0097753,1,0.987101702457885,0,2,membrane bending,BP,
17741,GO:0098038,1,0.993520009099479,0,1,non-replicative transposition, DNA-mediated,BP,
17742,GO:0098502,1,0.987335286242623,0,2,DNA dephosphorylation,BP,
17743,GO:0098505,1,0.937329860585317,0,10,G-rich strand telomeric DNA binding,MF,
17744,GO:0098506,1,0.993624477263957,0,1,polynucleotide 3' dephosphorylation,BP,
17745,GO:0098507,1,0.987129875137122,0,2,polynucleotide 5' dephosphorylation,BP,
17746,GO:0098508,1,0.987203354698377,0,2,endothelial to hematopoietic transition,BP,
17747,GO:0098518,1,0.980835593405806,0,3,polynucleotide phosphatase activity,MF,
17748,GO:0098519,1,0.97430614671716,0,4,nucleotide phosphatase activity, acting on free nucleotides,MF,
17749,GO:0098528,1,0.961712754947982,0,6,skeletal muscle fiber differentiation,BP,
17750,GO:0098530,1,0.993355148367012,0,1,positive regulation of strand invasion,BP,
17751,GO:0098531,1,0.724274869995894,0,49,ligand-activated transcription factor activity,MF,
17752,GO:0098532,1,0.973564370331489,0,4,histone H3-K27 trimethylation,BP,
17755,GO:0098535,1,0.974186033147695,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17756,GO:0098536,1,0.974285212070724,0,4,deuterosome,CC,
17758,GO:0098543,1,0.900729885927549,0,16,detection of other organism,BP,
17759,GO:0098547,1,0.99358957859975,0,1,lumenal side of Golgi membrane,CC,
17761,GO:0098553,1,0.851773827028746,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17762,GO:0098554,1,0.913443077720092,0,14,cytoplasmic side of endoplasmic reticulum membrane,CC,
17763,GO:0098556,1,0.968837499989572,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17764,GO:0098559,1,0.980830396584061,0,3,cytoplasmic side of early endosome membrane,CC,
17765,GO:0098560,1,0.987168574077048,0,2,cytoplasmic side of late endosome membrane,CC,
17766,GO:0098562,1,0.311778126565726,0,178,cytoplasmic side of membrane,CC,
17768,GO:0098573,1,0.623533242656066,0,73,intrinsic component of mitochondrial membrane,CC,
17769,GO:0098574,1,0.974505499588539,0,4,cytoplasmic side of lysosomal membrane,CC,
17770,GO:0098575,1,0.987234191472761,0,2,lumenal side of lysosomal membrane,CC,
17771,GO:0098576,1,0.824777133772991,0,30,lumenal side of membrane,CC,
17772,GO:0098577,1,0.993263355971432,0,1,inactive sex chromosome,CC,
17773,GO:0098581,1,0.872179006802338,0,21,detection of external biotic stimulus,BP,
17774,GO:0098582,1,0.993509428474531,0,1,innate vocalization behavior,BP,
17775,GO:0098583,1,0.987252610627966,0,2,learned vocalization behavior,BP,
17776,GO:0098586,1,0.736079931343173,0,47,cellular response to virus,BP,
17780,GO:0098591,1,0.967356180195513,0,5,external side of apical plasma membrane,CC,
17781,GO:0098592,1,0.980705908493284,0,3,cytoplasmic side of apical plasma membrane,CC,
17782,GO:0098594,1,0.993690030817455,0,1,mucin granule,CC,
17783,GO:0098595,1,0.99358977529149,0,1,perivitelline space,CC,
17784,GO:0098596,1,0.953143180957942,0,7,imitative learning,BP,
17785,GO:0098597,1,0.946194191951116,0,8,observational learning,BP,
17786,GO:0098598,1,0.940987299095323,0,9,learned vocalization behavior or vocal learning,BP,
17787,GO:0098599,1,0.925541816603852,0,12,palmitoyl hydrolase activity,MF,
17789,GO:0098629,1,0.99355705431691,0,1,trans-Golgi network membrane organization,BP,
17790,GO:0098630,1,0.993581645191367,0,1,aggregation of unicellular organisms,BP,
17793,GO:0098633,1,0.987149220288706,0,2,collagen fibril binding,MF,
17794,GO:0098634,1,0.954948285564009,0,7,cell-matrix adhesion mediator activity,MF,
17795,GO:0098636,1,0.789461724667556,0,36,protein complex involved in cell adhesion,CC,
17796,GO:0098637,1,0.993493287633461,0,1,protein complex involved in cell-matrix adhesion,CC,
17797,GO:0098639,1,0.967353655866326,0,5,collagen binding involved in cell-matrix adhesion,MF,
17798,GO:0098640,1,0.987180200542142,0,2,integrin binding involved in cell-matrix adhesion,MF,
17799,GO:0098641,1,0.890523151596383,0,18,cadherin binding involved in cell-cell adhesion,MF,
17800,GO:0098642,1,0.953763809226176,0,7,network-forming collagen trimer,CC,
17801,GO:0098643,1,0.922899205893344,0,12,banded collagen fibril,CC,
17802,GO:0098644,1,0.874055362825779,0,20,complex of collagen trimers,CC,
17803,GO:0098645,1,0.953763809226176,0,7,collagen network,CC,
17804,GO:0098646,1,0.9935656219776,0,1,collagen sheet,CC,
17805,GO:0098647,1,0.980323622773481,0,3,collagen beaded filament,CC,
17806,GO:0098648,1,0.99303420677743,0,1,collagen anchoring fibril,CC,
17807,GO:0098651,1,0.947460481673788,0,8,basement membrane collagen trimer,CC,
17808,GO:0098652,1,0.99303420677743,0,1,collagen type VII anchoring fibril,CC,
17812,GO:0098658,1,0.986758508273245,0,2,inorganic anion import across plasma membrane,BP,
17817,GO:0098664,1,0.86775258951518,0,22,G protein-coupled serotonin receptor signaling pathway,BP,
17818,GO:0098674,1,0.993075329635937,0,1,extrinsic component of neuronal dense core vesicle membrane,CC,
17819,GO:0098675,1,0.987142476565232,0,2,intrinsic component of neuronal dense core vesicle membrane,CC,
17820,GO:0098680,1,0.993488969734737,0,1,template-free RNA nucleotidyltransferase,MF,
17821,GO:0098683,1,0.993179582535585,0,1,cochlear hair cell ribbon synapse,CC,
17824,GO:0098686,1,0.816244606254789,0,31,hippocampal mossy fiber to CA3 synapse,CC,
17825,GO:0098687,1,0.137355453436497,0,301,chromosomal region,CC,
17826,GO:0098688,1,0.900426225983377,0,16,parallel fiber to Purkinje cell synapse,CC,
17827,GO:0098690,1,0.955580314000248,0,7,glycinergic synapse,CC,
17828,GO:0098691,1,0.925183060252403,0,12,dopaminergic synapse,CC,
17830,GO:0098694,1,0.993535543327298,0,1,regulation of synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
17831,GO:0098695,1,0.992948347632634,0,1,inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels,MF,
17832,GO:0098696,1,0.949036528713418,0,8,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
17833,GO:0098698,1,0.870132437031108,0,21,postsynaptic specialization assembly,BP,
17836,GO:0098704,1,0.961692751990522,0,6,carbohydrate import across plasma membrane,BP,
17837,GO:0098705,1,0.993436372167868,0,1,copper ion import across plasma membrane,BP,
17838,GO:0098708,1,0.967903928215444,0,5,glucose import across plasma membrane,BP,
17839,GO:0098711,1,0.980927014009821,0,3,iron ion import across plasma membrane,BP,
17840,GO:0098712,1,0.917334529540754,0,13,L-glutamate import across plasma membrane,BP,
17841,GO:0098713,1,0.968077688686632,0,5,leucine import across plasma membrane,BP,
17842,GO:0098718,1,0.993470052424229,0,1,serine import across plasma membrane,BP,
17843,GO:0098719,1,0.894355107434534,0,17,sodium ion import across plasma membrane,BP,
17844,GO:0098722,1,0.943035528502894,0,9,asymmetric stem cell division,BP,
17845,GO:0098725,1,0.99355705431691,0,1,symmetric cell division,BP,
17846,GO:0098727,1,0.355350091543218,0,157,maintenance of cell number,BP,
17847,GO:0098728,1,0.980854861232935,0,3,germline stem cell asymmetric division,BP,
17848,GO:0098732,1,0.501625681704631,0,105,macromolecule deacylation,BP,
17849,GO:0098734,1,0.925541816603852,0,12,macromolecule depalmitoylation,BP,
17851,GO:0098736,1,0.99307768176836,0,1,negative regulation of the force of heart contraction,BP,
17855,GO:0098743,1,0.882178897062533,0,19,cell aggregation,BP,
17856,GO:0098745,1,0.993623471488449,0,1,Dcp1-Dcp2 complex,CC,
17857,GO:0098746,1,0.993433494520763,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
17858,GO:0098749,1,0.980552891198442,0,3,cerebellar neuron development,BP,
17859,GO:0098751,1,0.809911632584641,0,32,bone cell development,BP,
17860,GO:0098753,1,0.993583389148761,0,1,anchored component of the cytoplasmic side of the plasma membrane,CC,
17861,GO:0098754,1,0.473213600814737,0,116,detoxification,BP,
17862,GO:0098756,1,0.955325072315124,0,7,response to interleukin-21,BP,
17863,GO:0098757,1,0.955325072315124,0,7,cellular response to interleukin-21,BP,
17864,GO:0098758,1,0.980791801325435,0,3,response to interleukin-8,BP,
17865,GO:0098759,1,0.980791801325435,0,3,cellular response to interleukin-8,BP,
17866,GO:0098760,1,0.838323982534947,0,27,response to interleukin-7,BP,
17867,GO:0098761,1,0.838323982534947,0,27,cellular response to interleukin-7,BP,
17868,GO:0098763,1,0.986954970037953,0,2,mitotic cell cycle phase,BP,
17869,GO:0098770,1,0.986343082192868,0,2,FBXO family protein binding,MF,
17872,GO:0098773,1,0.583261565855181,0,82,skin epidermis development,BP,
17873,GO:0098779,1,0.941426651726568,0,9,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
17874,GO:0098780,1,0.882218951464146,0,19,response to mitochondrial depolarisation,BP,
17875,GO:0098781,1,0.528648814151325,0,98,ncRNA transcription,BP,
17876,GO:0098782,1,0.993618840652486,0,1,mechanosensitived potassium channel activity,MF,
17877,GO:0098787,1,0.918630974799485,0,13,mRNA cleavage involved in mRNA processing,BP,
17878,GO:0098789,1,0.924657037214324,0,12,pre-mRNA cleavage required for polyadenylation,BP,
17880,GO:0098792,1,0.943242422672644,0,9,xenophagy,BP,
17883,GO:0098795,1,0.987110645633239,0,2,mRNA cleavage involved in gene silencing,BP,
17886,GO:0098798,1,0.247156817526387,0,217,mitochondrial protein complex,CC,
17887,GO:0098799,1,0.879163451515005,0,20,outer mitochondrial membrane protein complex,CC,
17888,GO:0098800,1,0.537402405374693,0,97,inner mitochondrial membrane protein complex,CC,
17889,GO:0098801,1,0.823536121974329,0,30,regulation of renal system process,BP,
17891,GO:0098803,1,0.65667098243303,0,66,respiratory chain complex,CC,
17893,GO:0098808,1,0.987206796253208,0,2,mRNA cap binding,MF,
17894,GO:0098809,1,0.993567127228303,0,1,nitrite reductase activity,MF,
17896,GO:0098813,1,0.213367620890158,0,233,nuclear chromosome segregation,BP,
17897,GO:0098814,1,0.924166180060582,0,12,spontaneous synaptic transmission,BP,
17899,GO:0098816,1,0.987162072718749,0,2,mini excitatory postsynaptic potential,BP,
17900,GO:0098821,1,0.967185767081179,0,5,BMP receptor activity,MF,
17901,GO:0098822,1,0.993576395629378,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
17902,GO:0098826,1,0.974524176856264,0,4,endoplasmic reticulum tubular network membrane,CC,
17903,GO:0098827,1,0.855230416342099,0,24,endoplasmic reticulum subcompartment,CC,
17904,GO:0098828,1,0.954555652785344,0,7,modulation of inhibitory postsynaptic potential,BP,
17905,GO:0098829,1,0.993293325861916,0,1,intestinal folate absorption,BP,
17906,GO:0098830,1,0.993432581164202,0,1,presynaptic endosome,CC,
17907,GO:0098831,1,0.902608910716707,0,15,presynaptic active zone cytoplasmic component,CC,
17909,GO:0098835,1,0.955543235273496,0,7,presynaptic endocytic zone membrane,CC,
17910,GO:0098837,1,0.949316915899686,0,8,postsynaptic recycling endosome,CC,
17912,GO:0098839,1,0.550703592544321,0,90,postsynaptic density membrane,CC,
17913,GO:0098840,1,0.656516959984039,0,64,protein transport along microtubule,BP,
17914,GO:0098842,1,0.980828327268441,0,3,postsynaptic early endosome,CC,
17915,GO:0098843,1,0.936873210962384,0,10,postsynaptic endocytic zone,CC,
17916,GO:0098844,1,0.967728205195011,0,5,postsynaptic endocytic zone membrane,CC,
17917,GO:0098845,1,0.913072987341645,0,14,postsynaptic endosome,CC,
17918,GO:0098847,1,0.919220229085495,0,13,sequence-specific single stranded DNA binding,MF,
17919,GO:0098850,1,0.974572907580714,0,4,extrinsic component of synaptic vesicle membrane,CC,
17921,GO:0098855,1,0.980268206547407,0,3,HCN channel complex,CC,
17922,GO:0098856,1,0.931346749527665,0,11,intestinal lipid absorption,BP,
17926,GO:0098867,1,0.993564918518656,0,1,intramembranous bone growth,BP,
17927,GO:0098868,1,0.81684396377034,0,31,bone growth,BP,
17928,GO:0098869,1,0.57057034050074,0,87,cellular oxidant detoxification,BP,
17929,GO:0098870,1,0.948662290710223,0,8,action potential propagation,BP,
17930,GO:0098871,1,0.967306206511625,0,5,postsynaptic actin cytoskeleton,CC,
17931,GO:0098872,1,0.99325670669263,0,1,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
17932,GO:0098874,1,0.993410050392828,0,1,spike train,BP,
17933,GO:0098875,1,0.993439077382255,0,1,epididymosome,CC,
17934,GO:0098876,1,0.579398096198085,0,83,vesicle-mediated transport to the plasma membrane,BP,
17935,GO:0098877,1,0.9070550436213,0,15,neurotransmitter receptor transport to plasma membrane,BP,
17936,GO:0098878,1,0.714396031626218,0,51,neurotransmitter receptor complex,CC,
17937,GO:0098879,1,0.980171439269754,0,3,structural constituent of postsynaptic specialization,MF,
17938,GO:0098880,1,0.960717504193501,0,6,maintenance of postsynaptic specialization structure,BP,
17939,GO:0098882,1,0.971434497700913,0,4,structural constituent of presynaptic active zone,MF,
17940,GO:0098883,1,0.931379181305039,0,11,synapse pruning,BP,
17941,GO:0098884,1,0.877117988641651,0,20,postsynaptic neurotransmitter receptor internalization,BP,
17942,GO:0098885,1,0.930281859352494,0,11,modification of postsynaptic actin cytoskeleton,BP,
17944,GO:0098887,1,0.949282205130425,0,8,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
17945,GO:0098888,1,0.961043130396347,0,6,extrinsic component of presynaptic membrane,CC,
17947,GO:0098890,1,0.941462216928036,0,9,extrinsic component of postsynaptic membrane,CC,
17948,GO:0098891,1,0.993434026294571,0,1,extrinsic component of presynaptic active zone membrane,CC,
17949,GO:0098892,1,0.960447521886747,0,6,extrinsic component of postsynaptic specialization membrane,CC,
17950,GO:0098894,1,0.986991680820413,0,2,extrinsic component of presynaptic endocytic zone membrane,CC,
17951,GO:0098895,1,0.974374339343089,0,4,postsynaptic endosome membrane,CC,
17952,GO:0098896,1,0.993535516528085,0,1,postsynaptic early endosome membrane,CC,
17953,GO:0098897,1,0.993404050748242,0,1,spine apparatus membrane,CC,
17954,GO:0098898,1,0.986590284837116,0,2,dense core granule lumen,CC,
17957,GO:0098902,1,0.967472676391901,0,5,regulation of membrane depolarization during action potential,BP,
17958,GO:0098903,1,0.948806930323977,0,8,regulation of membrane repolarization during action potential,BP,
17960,GO:0098905,1,0.993684169530725,0,1,regulation of bundle of His cell action potential,BP,
17962,GO:0098908,1,0.968224654337208,0,5,regulation of neuronal action potential,BP,
17963,GO:0098909,1,0.948231022209729,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
17966,GO:0098912,1,0.979315287423867,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
17967,GO:0098914,1,0.961525849896318,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17968,GO:0098915,1,0.913209137698186,0,14,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
17970,GO:0098917,1,0.936117544654006,0,10,retrograde trans-synaptic signaling,BP,
17971,GO:0098918,1,0.903377796871686,0,15,structural constituent of synapse,MF,
17972,GO:0098919,1,0.980171439269754,0,3,structural constituent of postsynaptic density,MF,
17973,GO:0098920,1,0.967651967581239,0,5,retrograde trans-synaptic signaling by lipid,BP,
17974,GO:0098921,1,0.967651967581239,0,5,retrograde trans-synaptic signaling by endocannabinoid,BP,
17975,GO:0098922,1,0.993075329635937,0,1,extrinsic component of dense core granule membrane,CC,
17976,GO:0098923,1,0.993234343943923,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
17977,GO:0098924,1,0.993234343943923,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
17978,GO:0098926,1,0.806877086565895,0,33,postsynaptic signal transduction,BP,
17979,GO:0098927,1,0.768890420195951,0,40,vesicle-mediated transport between endosomal compartments,BP,
17980,GO:0098928,1,0.984344952730727,0,2,presynaptic signal transduction,BP,
17981,GO:0098930,1,0.686178796815932,0,57,axonal transport,BP,
17982,GO:0098935,1,0.936241027611059,0,10,dendritic transport,BP,
17984,GO:0098937,1,0.961085480998061,0,6,anterograde dendritic transport,BP,
17985,GO:0098939,1,0.986870206283646,0,2,dendritic transport of mitochondrion,BP,
17986,GO:0098942,1,0.986830184635215,0,2,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
17987,GO:0098943,1,0.955961711328504,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
17988,GO:0098944,1,0.987155207697788,0,2,postsynaptic recycling endosome membrane,CC,
17989,GO:0098945,1,0.888317622099276,0,18,intrinsic component of presynaptic active zone membrane,CC,
17990,GO:0098948,1,0.610098324068997,0,75,intrinsic component of postsynaptic specialization membrane,CC,
17991,GO:0098949,1,0.987155207697788,0,2,intrinsic component of postsynaptic endosome membrane,CC,
17992,GO:0098951,1,0.987155207697788,0,2,intrinsic component of postsynaptic recycling endosome membrane,CC,
17993,GO:0098952,1,0.993404050748242,0,1,intrinsic component of spine apparatus membrane,CC,
17994,GO:0098953,1,0.943331964227816,0,9,receptor diffusion trapping,BP,
17995,GO:0098956,1,0.987142476565232,0,2,intrinsic component of dense core granule membrane,CC,
17996,GO:0098957,1,0.967802727622104,0,5,anterograde axonal transport of mitochondrion,BP,
17997,GO:0098958,1,0.987161968029845,0,2,retrograde axonal transport of mitochondrion,BP,
17998,GO:0098960,1,0.675330767443477,0,60,postsynaptic neurotransmitter receptor activity,MF,
17999,GO:0098961,1,0.980496674080225,0,3,dendritic transport of ribonucleoprotein complex,BP,
18000,GO:0098962,1,0.893503486366674,0,17,regulation of postsynaptic neurotransmitter receptor activity,BP,
18001,GO:0098963,1,0.980496674080225,0,3,dendritic transport of messenger ribonucleoprotein complex,BP,
18002,GO:0098966,1,0.973096406266933,0,4,perisynaptic extracellular matrix,CC,
18003,GO:0098967,1,0.96818994266299,0,5,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18004,GO:0098968,1,0.99340222653439,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18005,GO:0098969,1,0.9070550436213,0,15,neurotransmitter receptor transport to postsynaptic membrane,BP,
18006,GO:0098970,1,0.943331964227816,0,9,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18007,GO:0098971,1,0.973849434949818,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18008,GO:0098972,1,0.993289012121165,0,1,anterograde dendritic transport of mitochondrion,BP,
18009,GO:0098973,1,0.980884026149156,0,3,structural constituent of postsynaptic actin cytoskeleton,MF,
18010,GO:0098974,1,0.92999880860156,0,11,postsynaptic actin cytoskeleton organization,BP,
18011,GO:0098976,1,0.941522975655347,0,9,excitatory chemical synaptic transmission,BP,
18012,GO:0098977,1,0.993396025239173,0,1,inhibitory chemical synaptic transmission,BP,
18014,GO:0098981,1,0.943149850936886,0,9,cholinergic synapse,CC,
18015,GO:0098982,1,0.620257855265199,0,72,GABA-ergic synapse,CC,
18016,GO:0098983,1,0.97395902938636,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18018,GO:0098985,1,0.960877935159342,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18020,GO:0098989,1,0.986909705307663,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18021,GO:0098992,1,0.923339096939665,0,12,neuronal dense core vesicle,CC,
18022,GO:0098993,1,0.919890236534434,0,13,anchored component of synaptic vesicle membrane,CC,
18023,GO:0098998,1,0.993535516528085,0,1,extrinsic component of postsynaptic early endosome membrane,CC,
18024,GO:0098999,1,0.987054490873527,0,2,extrinsic component of postsynaptic endosome membrane,CC,
18026,GO:0099004,1,0.948158357693283,0,8,calmodulin dependent kinase signaling pathway,BP,
18028,GO:0099011,1,0.960519746142194,0,6,neuronal dense core vesicle exocytosis,BP,
18029,GO:0099012,1,0.973822674603612,0,4,neuronal dense core vesicle membrane,CC,
18030,GO:0099013,1,0.986590284837116,0,2,neuronal dense core vesicle lumen,CC,
18031,GO:0099020,1,0.993552570870591,0,1,perinuclear endoplasmic reticulum lumen,CC,
18032,GO:0099022,1,0.949005147493461,0,8,vesicle tethering,BP,
18033,GO:0099023,1,0.657930245189019,0,64,vesicle tethering complex,CC,
18034,GO:0099024,1,0.676359344793263,0,60,plasma membrane invagination,BP,
18036,GO:0099026,1,0.943240069161372,0,9,anchored component of presynaptic membrane,CC,
18037,GO:0099029,1,0.974489032657915,0,4,anchored component of presynaptic active zone membrane,CC,
18038,GO:0099030,1,0.980737922514856,0,3,anchored component of postsynaptic specialization membrane,CC,
18039,GO:0099031,1,0.980737922514856,0,3,anchored component of postsynaptic density membrane,CC,
18040,GO:0099033,1,0.987155207697788,0,2,anchored component of postsynaptic recycling endosome membrane,CC,
18041,GO:0099034,1,0.987155207697788,0,2,anchored component of postsynaptic endosome membrane,CC,
18042,GO:0099038,1,0.986609834319163,0,2,ceramide floppase activity,MF,
18043,GO:0099039,1,0.973056764998166,0,4,sphingolipid translocation,BP,
18044,GO:0099040,1,0.986609834319163,0,2,ceramide translocation,BP,
18045,GO:0099041,1,0.967533914705248,0,5,vesicle tethering to Golgi,BP,
18046,GO:0099044,1,0.987224977487137,0,2,vesicle tethering to endoplasmic reticulum,BP,
18047,GO:0099046,1,0.993643383992613,0,1,clearance of foreign intracellular nucleic acids,BP,
18048,GO:0099050,1,0.993559365727516,0,1,vesicle scission,BP,
18049,GO:0099053,1,0.980658717353938,0,3,activating signal cointegrator 1 complex,CC,
18053,GO:0099059,1,0.911594541007698,0,14,integral component of presynaptic active zone membrane,CC,
18054,GO:0099060,1,0.622138461366356,0,72,integral component of postsynaptic specialization membrane,CC,
18055,GO:0099061,1,0.723522165825422,0,49,integral component of postsynaptic density membrane,CC,
18056,GO:0099065,1,0.993404050748242,0,1,integral component of spine apparatus membrane,CC,
18057,GO:0099066,1,0.987142476565232,0,2,integral component of neuronal dense core vesicle membrane,CC,
18058,GO:0099068,1,0.81438624699025,0,31,postsynapse assembly,BP,
18059,GO:0099072,1,0.658127699059468,0,64,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
18060,GO:0099073,1,0.98702320199935,0,2,mitochondrion-derived vesicle,CC,
18061,GO:0099074,1,0.987132742759889,0,2,mitochondrion to lysosome transport,BP,
18062,GO:0099075,1,0.987132742759889,0,2,mitochondrion-derived vesicle mediated transport,BP,
18063,GO:0099077,1,0.993355789011112,0,1,histone-dependent DNA binding,MF,
18064,GO:0099078,1,0.974775314933938,0,4,BORC complex,CC,
18067,GO:0099082,1,0.987013988188975,0,2,retrograde trans-synaptic signaling by neuropeptide,BP,
18068,GO:0099083,1,0.993488309156085,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18069,GO:0099084,1,0.798032504986606,0,34,postsynaptic specialization organization,BP,
18070,GO:0099086,1,0.811980820706309,0,32,synaptonemal structure,CC,
18071,GO:0099087,1,0.99354954696155,0,1,anterograde axonal transport of messenger ribonucleoprotein complex,BP,
18072,GO:0099088,1,0.99354954696155,0,1,axonal transport of messenger ribonucleoprotein complex,BP,
18073,GO:0099089,1,0.992733607935975,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18074,GO:0099091,1,0.871797956711922,0,21,postsynaptic specialization, intracellular component,CC,
18075,GO:0099092,1,0.894752975807091,0,17,postsynaptic density, intracellular component,CC,
18076,GO:0099093,1,0.986980312033093,0,2,calcium export from the mitochondrion,BP,
18079,GO:0099098,1,0.993531647887378,0,1,microtubule polymerization based movement,BP,
18080,GO:0099103,1,0.974513349437307,0,4,channel activator activity,MF,
18081,GO:0099104,1,0.974513349437307,0,4,potassium channel activator activity,MF,
18083,GO:0099111,1,0.308129505437364,0,178,microtubule-based transport,BP,
18084,GO:0099115,1,0.986521539245837,0,2,chromosome, subtelomeric region,CC,
18085,GO:0099116,1,0.908247696657831,0,15,tRNA 5'-end processing,BP,
18086,GO:0099118,1,0.656516959984039,0,64,microtubule-based protein transport,BP,
18087,GO:0099122,1,0.949008197464971,0,8,RNA polymerase II C-terminal domain binding,MF,
18088,GO:0099142,1,0.993322767667789,0,1,intracellularly ATP-gated ion channel activity,MF,
18090,GO:0099146,1,0.709540886928487,0,52,intrinsic component of postsynaptic density membrane,CC,
18091,GO:0099147,1,0.966629112840638,0,5,extrinsic component of postsynaptic density membrane,CC,
18092,GO:0099149,1,0.924352077939885,0,12,regulation of postsynaptic neurotransmitter receptor internalization,BP,
18093,GO:0099150,1,0.918084397157741,0,13,regulation of postsynaptic specialization assembly,BP,
18094,GO:0099151,1,0.923990984556685,0,12,regulation of postsynaptic density assembly,BP,
18095,GO:0099152,1,0.987133807305809,0,2,regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18096,GO:0099154,1,0.987156435817676,0,2,serotonergic synapse,CC,
18097,GO:0099156,1,0.993525241258344,0,1,cell-cell signaling via exosome,BP,
18098,GO:0099158,1,0.993535516528085,0,1,regulation of recycling endosome localization within postsynapse,BP,
18099,GO:0099159,1,0.948915216404559,0,8,regulation of modification of postsynaptic structure,BP,
18100,GO:0099160,1,0.993505555949733,0,1,postsynaptic intermediate filament cytoskeleton,CC,
18101,GO:0099161,1,0.993483668270107,0,1,regulation of presynaptic dense core granule exocytosis,BP,
18102,GO:0099163,1,0.993234343943923,0,1,synaptic signaling by nitric oxide,BP,
18104,GO:0099171,1,0.906645543782918,0,15,presynaptic modulation of chemical synaptic transmission,BP,
18106,GO:0099173,1,0.339882064188527,0,163,postsynapse organization,BP,
18108,GO:0099175,1,0.516516735847637,0,100,regulation of postsynapse organization,BP,
18110,GO:0099178,1,0.987003975565267,0,2,regulation of retrograde trans-synaptic signaling by endocanabinoid,BP,
18111,GO:0099179,1,0.973866567606356,0,4,regulation of synaptic membrane adhesion,BP,
18112,GO:0099180,1,0.987253491919789,0,2,zinc ion import into synaptic vesicle,BP,
18113,GO:0099181,1,0.993484471826969,0,1,structural constituent of presynapse,MF,
18114,GO:0099183,1,0.974093121341061,0,4,trans-synaptic signaling by BDNF, modulating synaptic transmission,BP,
18115,GO:0099184,1,0.987078794798448,0,2,structural constituent of postsynaptic intermediate filament cytoskeleton,MF,
18116,GO:0099185,1,0.987078794798448,0,2,postsynaptic intermediate filament cytoskeleton organization,BP,
18117,GO:0099186,1,0.942509624531267,0,9,structural constituent of postsynapse,MF,
18118,GO:0099188,1,0.923954612891535,0,12,postsynaptic cytoskeleton organization,BP,
18119,GO:0099189,1,0.993165885364989,0,1,postsynaptic spectrin-associated cytoskeleton,CC,
18120,GO:0099191,1,0.974093121341061,0,4,trans-synaptic signaling by BDNF,BP,
18122,GO:0099243,1,0.917081198224187,0,13,extrinsic component of synaptic membrane,CC,
18123,GO:0099400,1,0.993035571048495,0,1,caveola neck,CC,
18124,GO:0099403,1,0.985896631169293,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18125,GO:0099404,1,0.985896631169293,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18126,GO:0099500,1,0.861519706282972,0,23,vesicle fusion to plasma membrane,BP,
18128,GO:0099502,1,0.9741997886268,0,4,calcium-dependent activation of synaptic vesicle fusion,BP,
18131,GO:0099505,1,0.960773475278538,0,6,regulation of presynaptic membrane potential,BP,
18132,GO:0099507,1,0.980148474122779,0,3,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18133,GO:0099508,1,0.980236511440125,0,3,voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18134,GO:0099509,1,0.900427594243934,0,16,regulation of presynaptic cytosolic calcium ion concentration,BP,
18135,GO:0099510,1,0.987256461136044,0,2,calcium ion binding involved in regulation of cytosolic calcium ion concentration,MF,
18136,GO:0099511,1,0.961387773778966,0,6,voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels,MF,
18139,GO:0099514,1,0.889852330470373,0,18,synaptic vesicle cytoskeletal transport,BP,
18140,GO:0099515,1,0.873847364762223,0,20,actin filament-based transport,BP,
18141,GO:0099517,1,0.889852330470373,0,18,synaptic vesicle transport along microtubule,BP,
18142,GO:0099518,1,0.640434302828357,0,67,vesicle cytoskeletal trafficking,BP,
18143,GO:0099519,1,0.928724799872283,0,11,dense core granule cytoskeletal transport,BP,
18144,GO:0099520,1,0.993513626978606,0,1,ion antiporter activity involved in regulation of presynaptic membrane potential,MF,
18145,GO:0099522,1,0.847763263371105,0,25,region of cytosol,CC,
18146,GO:0099523,1,0.911295675858403,0,14,presynaptic cytosol,CC,
18147,GO:0099524,1,0.88800193458429,0,18,postsynaptic cytosol,CC,
18148,GO:0099525,1,0.960519746142194,0,6,presynaptic dense core vesicle exocytosis,BP,
18149,GO:0099526,1,0.984344952730727,0,2,presynapse to nucleus signaling pathway,BP,
18150,GO:0099527,1,0.948890272557612,0,8,postsynapse to nucleus signaling pathway,BP,
18151,GO:0099528,1,0.943180361446874,0,9,G protein-coupled neurotransmitter receptor activity,MF,
18152,GO:0099529,1,0.735068092663098,0,47,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18153,GO:0099530,1,0.973701515100291,0,4,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18154,GO:0099532,1,0.942304461270383,0,9,synaptic vesicle endosomal processing,BP,
18155,GO:0099533,1,0.973927777088501,0,4,positive regulation of presynaptic cytosolic calcium concentration,BP,
18156,GO:0099534,1,0.987256461136044,0,2,calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18157,GO:0099535,1,0.973096406266933,0,4,synapse-associated extracellular matrix,CC,
18160,GO:0099538,1,0.974116717914432,0,4,synaptic signaling via neuropeptide,BP,
18161,GO:0099540,1,0.98033808097555,0,3,trans-synaptic signaling by neuropeptide,BP,
18162,GO:0099541,1,0.948126677699881,0,8,trans-synaptic signaling by lipid,BP,
18163,GO:0099542,1,0.948126677699881,0,8,trans-synaptic signaling by endocannabinoid,BP,
18164,GO:0099543,1,0.993234343943923,0,1,trans-synaptic signaling by soluble gas,BP,
18165,GO:0099544,1,0.966774271887071,0,5,perisynaptic space,CC,
18166,GO:0099545,1,0.948706261044574,0,8,trans-synaptic signaling by trans-synaptic complex,BP,
18167,GO:0099546,1,0.99336141551439,0,1,protein catabolic process, modulating synaptic transmission,BP,
18168,GO:0099547,1,0.980274683220817,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18169,GO:0099548,1,0.993234343943923,0,1,trans-synaptic signaling by nitric oxide,BP,
18170,GO:0099550,1,0.924229495212785,0,12,trans-synaptic signaling, modulating synaptic transmission,BP,
18171,GO:0099551,1,0.986769049098723,0,2,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18172,GO:0099552,1,0.980150160635167,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18173,GO:0099553,1,0.980150160635167,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18174,GO:0099557,1,0.98067333089224,0,3,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18175,GO:0099558,1,0.897962698786128,0,16,maintenance of synapse structure,BP,
18176,GO:0099560,1,0.830706817919196,0,28,synaptic membrane adhesion,BP,
18177,GO:0099562,1,0.973792357897771,0,4,maintenance of postsynaptic density structure,BP,
18179,GO:0099564,1,0.993530108284653,0,1,modification of synaptic structure, modulating synaptic transmission,BP,
18182,GO:0099567,1,0.993571162266231,0,1,calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18184,GO:0099569,1,0.964792737736256,0,5,presynaptic cytoskeleton,CC,
18185,GO:0099571,1,0.954451671951711,0,7,postsynaptic cytoskeleton,CC,
18187,GO:0099575,1,0.980773243066888,0,3,regulation of protein catabolic process at presynapse, modulating synaptic transmission,BP,
18188,GO:0099576,1,0.97376047678816,0,4,regulation of protein catabolic process at postsynapse, modulating synaptic transmission,BP,
18189,GO:0099578,1,0.987103357710081,0,2,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18190,GO:0099579,1,0.98705955279678,0,2,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18191,GO:0099580,1,0.986774814727699,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18192,GO:0099582,1,0.993552916301587,0,1,neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18193,GO:0099583,1,0.979915707721256,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18196,GO:0099589,1,0.86775258951518,0,22,serotonin receptor activity,MF,
18197,GO:0099590,1,0.838585240885238,0,27,neurotransmitter receptor internalization,BP,
18198,GO:0099601,1,0.617560444839547,0,73,regulation of neurotransmitter receptor activity,BP,
18199,GO:0099602,1,0.943964651429143,0,9,neurotransmitter receptor regulator activity,MF,
18201,GO:0099606,1,0.99309456701979,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18202,GO:0099607,1,0.986794939360564,0,2,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18203,GO:0099608,1,0.993410050392828,0,1,regulation of action potential firing pattern,BP,
18204,GO:0099609,1,0.986743326743147,0,2,microtubule lateral binding,MF,
18206,GO:0099617,1,0.987208692691953,0,2,matrix side of mitochondrial inner membrane,CC,
18207,GO:0099622,1,0.800345539066754,0,34,cardiac muscle cell membrane repolarization,BP,
18208,GO:0099623,1,0.853905470562708,0,24,regulation of cardiac muscle cell membrane repolarization,BP,
18209,GO:0099624,1,0.936312538602833,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18210,GO:0099625,1,0.854529653906781,0,24,ventricular cardiac muscle cell membrane repolarization,BP,
18211,GO:0099626,1,0.961387773778966,0,6,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,MF,
18212,GO:0099628,1,0.943331964227816,0,9,neurotransmitter receptor diffusion trapping,BP,
18213,GO:0099629,1,0.986694028758739,0,2,postsynaptic specialization of symmetric synapse,CC,
18214,GO:0099631,1,0.987364547177226,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18215,GO:0099633,1,0.871918146847175,0,21,protein localization to postsynaptic specialization membrane,BP,
18216,GO:0099634,1,0.46432999661013,0,116,postsynaptic specialization membrane,CC,
18217,GO:0099635,1,0.973927777088501,0,4,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,MF,
18218,GO:0099637,1,0.740310319110967,0,46,neurotransmitter receptor transport,BP,
18219,GO:0099638,1,0.936769124457756,0,10,endosome to plasma membrane protein transport,BP,
18220,GO:0099639,1,0.949282205130425,0,8,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18221,GO:0099640,1,0.917627649552118,0,13,axo-dendritic protein transport,BP,
18222,GO:0099641,1,0.94201774885961,0,9,anterograde axonal protein transport,BP,
18223,GO:0099642,1,0.986193394018377,0,2,retrograde axonal protein transport,BP,
18225,GO:0099645,1,0.871918146847175,0,21,neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
18227,GO:0099703,1,0.973927777088501,0,4,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,BP,
18228,GO:0099738,1,0.7613085371882,0,41,cell cortex region,CC,
18229,GO:0100001,1,0.986605793994005,0,2,regulation of skeletal muscle contraction by action potential,BP,
18230,GO:0100002,1,0.99355148126115,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18231,GO:0100012,1,0.974488032700291,0,4,regulation of heart induction by canonical Wnt signaling pathway,BP,
18232,GO:0100026,1,0.993487313144663,0,1,positive regulation of DNA repair by transcription from RNA polymerase II promoter,BP,
18233,GO:0101002,1,0.450489148040275,0,123,ficolin-1-rich granule,CC,
18234,GO:0101003,1,0.692982352531853,0,56,ficolin-1-rich granule membrane,CC,
18235,GO:0101005,1,0.589373520579877,0,80,ubiquitinyl hydrolase activity,MF,
18236,GO:0101006,1,0.980961998775774,0,3,protein histidine phosphatase activity,MF,
18237,GO:0101020,1,0.968212861083581,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18238,GO:0101021,1,0.993566696254439,0,1,estrogen 2-hydroxylase activity,MF,
18239,GO:0101023,1,0.876756226811344,0,20,vascular endothelial cell proliferation,BP,
18240,GO:0101030,1,0.987266203066139,0,2,tRNA-guanine transglycosylation,BP,
18241,GO:0101031,1,0.862236481202061,0,23,chaperone complex,CC,
18242,GO:0102007,1,0.981033071799383,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18243,GO:0102008,1,0.993418078005582,0,1,cytosolic dipeptidase activity,MF,
18244,GO:0102009,1,0.993613200187168,0,1,proline dipeptidase activity,MF,
18245,GO:0102076,1,0.993551881952435,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18246,GO:0102077,1,0.98724477340579,0,2,oleamide hydrolase activity,MF,
18247,GO:0102084,1,0.98717019565669,0,2,L-dopa O-methyltransferase activity,MF,
18248,GO:0102092,1,0.986804556961798,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18250,GO:0102113,1,0.993255544451043,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18251,GO:0102121,1,0.974413937684855,0,4,ceramidase activity,MF,
18252,GO:0102131,1,0.993109877834153,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18253,GO:0102132,1,0.993109877834153,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18254,GO:0102140,1,0.986537798299614,0,2,heparan sulfate N-deacetylase activity,MF,
18255,GO:0102148,1,0.987229916290303,0,2,N-acetyl-beta-D-galactosaminidase activity,MF,
18256,GO:0102158,1,0.974473775128644,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18257,GO:0102193,1,0.987302245005178,0,2,protein-ribulosamine 3-kinase activity,MF,
18258,GO:0102194,1,0.993644049831006,0,1,protein-fructosamine 3-kinase activity,MF,
18259,GO:0102200,1,0.993402145330824,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity,MF,
18260,GO:0102250,1,0.98067706331546,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18261,GO:0102258,1,0.993500332634649,0,1,1,3-diacylglycerol acylhydrolase activity,MF,
18262,GO:0102259,1,0.993500332634649,0,1,1,2-diacylglycerol acylhydrolase activity,MF,
18263,GO:0102264,1,0.99355705431691,0,1,tRNA-dihydrouridine20 synthase activity,MF,
18264,GO:0102279,1,0.993428059072322,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18265,GO:0102336,1,0.961852691979628,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18266,GO:0102337,1,0.961852691979628,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18267,GO:0102338,1,0.961852691979628,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18268,GO:0102339,1,0.993570849818343,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18269,GO:0102340,1,0.993570849818343,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18270,GO:0102341,1,0.993570849818343,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18271,GO:0102342,1,0.993570849818343,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18272,GO:0102343,1,0.974473775128644,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18273,GO:0102344,1,0.974473775128644,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18274,GO:0102345,1,0.974473775128644,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18275,GO:0102389,1,0.993563578402913,0,1,polyprenol reductase activity,MF,
18276,GO:0102390,1,0.99356467430751,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18277,GO:0102391,1,0.943209650963335,0,9,decanoate-CoA ligase activity,MF,
18278,GO:0102420,1,0.986897772763483,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18279,GO:0102483,1,0.993627324866982,0,1,scopolin beta-glucosidase activity,MF,
18280,GO:0102485,1,0.979977278720368,0,3,dATP phosphohydrolase activity,MF,
18281,GO:0102486,1,0.979977278720368,0,3,dCTP phosphohydrolase activity,MF,
18282,GO:0102487,1,0.979977278720368,0,3,dUTP phosphohydrolase activity,MF,
18283,GO:0102488,1,0.979977278720368,0,3,dTTP phosphohydrolase activity,MF,
18284,GO:0102489,1,0.979977278720368,0,3,GTP phosphohydrolase activity,MF,
18285,GO:0102490,1,0.979977278720368,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18286,GO:0102491,1,0.979977278720368,0,3,dGTP phosphohydrolase activity,MF,
18287,GO:0102499,1,0.98067706331546,0,3,SHG alpha-glucan phosphorylase activity,MF,
18288,GO:0102500,1,0.993228923395904,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18289,GO:0102521,1,0.993525716708597,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18290,GO:0102522,1,0.993592009222951,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18291,GO:0102524,1,0.99355705431691,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18292,GO:0102545,1,0.937109229410415,0,10,phosphatidyl phospholipase B activity,MF,
18293,GO:0102552,1,0.9936279274967,0,1,lipoyl synthase activity (acting on glycine-cleavage complex H protein,MF,
18294,GO:0102553,1,0.9936279274967,0,1,lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein),MF,
18295,GO:0102555,1,0.993675728155016,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18296,GO:0102559,1,0.993347443169783,0,1,protein-(glutamine-N5) methyltransferase activity,MF,
18297,GO:0102567,1,0.913395686047942,0,14,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18298,GO:0102568,1,0.913395686047942,0,14,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18299,GO:0102704,1,0.993549151096788,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18300,GO:0102707,1,0.993569914492127,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18301,GO:0102732,1,0.993619982067935,0,1,myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity,MF,
18302,GO:0102751,1,0.987184887261202,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18303,GO:0102752,1,0.993537909365421,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18304,GO:0102756,1,0.961852691979628,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18305,GO:0102758,1,0.9936615792634,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18306,GO:0102769,1,0.993630771430821,0,1,dihydroceramide glucosyltransferase activity,MF,
18307,GO:0102773,1,0.987049232987056,0,2,dihydroceramide kinase activity,MF,
18308,GO:0102797,1,0.993422238073592,0,1,geranial:oxygen oxidoreductase activity,MF,
18309,GO:0102798,1,0.993422238073592,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18310,GO:0102867,1,0.993559008417533,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18311,GO:0102938,1,0.98717019565669,0,2,orcinol O-methyltransferase activity,MF,
18312,GO:0102953,1,0.980842216261927,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18313,GO:0102965,1,0.987037948085173,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18314,GO:0102991,1,0.937811841417979,0,10,myristoyl-CoA hydrolase activity,MF,
18315,GO:0103025,1,0.987265288259839,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18316,GO:0103045,1,0.993601286206653,0,1,methione N-acyltransferase activity,MF,
18317,GO:0103046,1,0.993418078005582,0,1,alanylglutamate dipeptidase activity,MF,
18318,GO:0103053,1,0.987284968414728,0,2,1-ethyladenine demethylase activity,MF,
18319,GO:0103066,1,0.993632977628268,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18320,GO:0103067,1,0.993632977628268,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18321,GO:0103068,1,0.980842216261927,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18322,GO:0103073,1,0.98724477340579,0,2,anandamide amidohydrolase activity,MF,
18324,GO:0106001,1,0.961747553953536,0,6,intestinal hexose absorption,BP,
18325,GO:0106003,1,0.993276907053635,0,1,amyloid-beta complex,CC,
18326,GO:0106004,1,0.987316499739963,0,2,tRNA (guanine-N7)-methylation,BP,
18327,GO:0106005,1,0.993317641726585,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18328,GO:0106006,1,0.980482914454745,0,3,cytoskeletal protein-membrane anchor activity,MF,
18329,GO:0106014,1,0.968433014026825,0,5,regulation of inflammatory response to wounding,BP,
18330,GO:0106015,1,0.980995991473129,0,3,negative regulation of inflammatory response to wounding,BP,
18331,GO:0106016,1,0.987305290949235,0,2,positive regulation of inflammatory response to wounding,BP,
18332,GO:0106017,1,0.98026200287772,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18333,GO:0106018,1,0.942295593384306,0,9,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18335,GO:0106020,1,0.987124481143003,0,2,regulation of vesicle docking,BP,
18336,GO:0106022,1,0.993494132377966,0,1,positive regulation of vesicle docking,BP,
18337,GO:0106027,1,0.561487347298163,0,87,neuron projection organization,BP,
18338,GO:0106028,1,0.993428713728623,0,1,neuron projection retraction,BP,
18339,GO:0106029,1,0.980866997937706,0,3,tRNA pseudouridine synthase activity,MF,
18341,GO:0106035,1,0.993668858121244,0,1,protein maturation by [4Fe-4S] cluster transfer,BP,
18342,GO:0106040,1,0.993332896742626,0,1,regulation of GABA-A receptor activity,BP,
18343,GO:0106044,1,0.993677246056371,0,1,guanine deglycation,BP,
18344,GO:0106045,1,0.993677246056371,0,1,guanine deglycation, methylglyoxal removal,BP,
18345,GO:0106046,1,0.993677246056371,0,1,guanine deglycation, glyoxal removal,BP,
18346,GO:0106047,1,0.993561853625484,0,1,polyamine deacetylation,BP,
18347,GO:0106048,1,0.993561853625484,0,1,spermidine deacetylation,BP,
18348,GO:0106049,1,0.931203351163144,0,11,regulation of cellular response to osmotic stress,BP,
18349,GO:0106050,1,0.987206729659253,0,2,tRNA 2'-O-methyltransferase activity,MF,
18351,GO:0106057,1,0.912415763054599,0,14,negative regulation of calcineurin-mediated signaling,BP,
18352,GO:0106058,1,0.918101056327368,0,13,positive regulation of calcineurin-mediated signaling,BP,
18353,GO:0106064,1,0.993355319229239,0,1,regulation of cobalamin metabolic process,BP,
18354,GO:0106068,1,0.955897127183267,0,7,SUMO ligase complex,CC,
18355,GO:0106070,1,0.924438141639198,0,12,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18356,GO:0106071,1,0.967611782112114,0,5,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18357,GO:0106072,1,0.943273412824781,0,9,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18358,GO:0106073,1,0.986538544134,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18359,GO:0106074,1,0.949475733726058,0,8,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18360,GO:0106075,1,0.993537100975057,0,1,peptide N-succinyltransferase activity,MF,
18361,GO:0106077,1,0.974320308010017,0,4,histone succinylation,BP,
18362,GO:0106078,1,0.993537100975057,0,1,histone succinyltransferase activity,MF,
18363,GO:0106083,1,0.946350287273187,0,8,nuclear membrane protein complex,CC,
18364,GO:0106088,1,0.993259207999722,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18365,GO:0106089,1,0.993259207999722,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18366,GO:0106091,1,0.987315467953222,0,2,glial cell projection elongation,BP,
18367,GO:0106094,1,0.946350287273187,0,8,nuclear membrane microtubule tethering complex,CC,
18368,GO:0106096,1,0.993358903206799,0,1,response to ceramide,BP,
18369,GO:0106101,1,0.993616523860029,0,1,ER-dependent peroxisome localization,BP,
18370,GO:0106104,1,0.967049801208674,0,5,regulation of glutamate receptor clustering,BP,
18371,GO:0106105,1,0.99355705431691,0,1,Ala-tRNA(Thr) hydrolase activity,MF,
18372,GO:0106106,1,0.411501167817105,0,135,cold-induced thermogenesis,BP,
18374,GO:0106119,1,0.968361885403268,0,5,negative regulation of sterol biosynthetic process,BP,
18376,GO:0106121,1,0.993355319229239,0,1,positive regulation of cobalamin metabolic process,BP,
18377,GO:0106130,1,0.987374977828253,0,2,purine phosphoribosyltransferase activity,MF,
18378,GO:0106134,1,0.974200809438126,0,4,positive regulation of cardiac muscle cell contraction,BP,
18379,GO:0106135,1,0.987166265470263,0,2,negative regulation of cardiac muscle cell contraction,BP,
18380,GO:0106137,1,0.993513894490263,0,1,IkappaB kinase complex binding,MF,
18381,GO:0106138,1,0.993322767667789,0,1,Sec61 translocon complex binding,MF,
18382,GO:0106140,1,0.980647473892527,0,3,P-TEFb complex binding,MF,
18383,GO:0106153,1,0.993662605745273,0,1,phosphorylated histone binding,MF,
18384,GO:0110008,1,0.993541027765069,0,1,ncRNA deadenylation,BP,
18385,GO:0110009,1,0.980342804362872,0,3,formin-nucleated actin cable organization,BP,
18386,GO:0110011,1,0.966903960193866,0,5,regulation of basement membrane organization,BP,
18387,GO:0110017,1,0.987352269734397,0,2,cap-independent translational initiation of linear mRNA,BP,
18389,GO:0110021,1,0.980751257170029,0,3,cardiac muscle myoblast proliferation,BP,
18390,GO:0110022,1,0.980751257170029,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18391,GO:0110024,1,0.980751257170029,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18392,GO:0110025,1,0.987115223611685,0,2,DNA strand resection involved in replication fork processing,BP,
18393,GO:0110026,1,0.993540782502882,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18394,GO:0110028,1,0.993229466008014,0,1,positive regulation of mitotic spindle organization,BP,
18395,GO:0110030,1,0.98074743380276,0,3,regulation of G2/MI transition of meiotic cell cycle,BP,
18396,GO:0110032,1,0.98074743380276,0,3,positive regulation of G2/MI transition of meiotic cell cycle,BP,
18398,GO:0110057,1,0.993379530002856,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18399,GO:0110059,1,0.993379530002856,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18400,GO:0110061,1,0.986620023238716,0,2,regulation of angiotensin-activated signaling pathway,BP,
18401,GO:0110070,1,0.993610516163832,0,1,cellularization cleavage furrow,CC,
18402,GO:0110075,1,0.987248029046968,0,2,regulation of ferroptosis,BP,
18403,GO:0110076,1,0.987248029046968,0,2,negative regulation of ferroptosis,BP,
18404,GO:0110077,1,0.993547183282414,0,1,vesicle-mediated intercellular transport,BP,
18405,GO:0110088,1,0.974448952242114,0,4,hippocampal neuron apoptotic process,BP,
18406,GO:0110089,1,0.974448952242114,0,4,regulation of hippocampal neuron apoptotic process,BP,
18407,GO:0110090,1,0.987180280569989,0,2,positive regulation of hippocampal neuron apoptotic process,BP,
18408,GO:0110091,1,0.98710499340678,0,2,negative regulation of hippocampal neuron apoptotic process,BP,
18409,GO:0110095,1,0.950080942614431,0,8,cellular detoxification of aldehyde,BP,
18410,GO:0110096,1,0.937988396511414,0,10,cellular response to aldehyde,BP,
18411,GO:0110097,1,0.993586018131295,0,1,regulation of calcium import into the mitochondrion,BP,
18412,GO:0110104,1,0.980384082541399,0,3,mRNA alternative polyadenylation,BP,
18415,GO:0110112,1,0.987212242346001,0,2,regulation of lipid transporter activity,BP,
18416,GO:0110113,1,0.993555791525918,0,1,positive regulation of lipid transporter activity,BP,
18420,GO:0110151,1,0.764438993062809,0,41,positive regulation of biomineralization,BP,
18421,GO:0110154,1,0.924857912397098,0,12,RNA decapping,BP,
18422,GO:0110156,1,0.924857912397098,0,12,methylguanosine-cap decapping,BP,
18424,GO:0120001,1,0.987324003630694,0,2,apical plasma membrane urothelial plaque,CC,
18426,GO:0120009,1,0.790744877384241,0,36,intermembrane lipid transfer,BP,
18427,GO:0120013,1,0.801365014271928,0,34,lipid transfer activity,MF,
18428,GO:0120014,1,0.895788249222461,0,17,phospholipid transfer activity,MF,
18429,GO:0120015,1,0.888928117234748,0,18,sterol transfer activity,MF,
18430,GO:0120016,1,0.962041832900981,0,6,sphingolipid transfer activity,MF,
18431,GO:0120017,1,0.962041832900981,0,6,ceramide transfer activity,MF,
18432,GO:0120019,1,0.993627793590708,0,1,phosphatidylcholine transfer activity,MF,
18433,GO:0120020,1,0.894829888069692,0,17,cholesterol transfer activity,MF,
18436,GO:0120032,1,0.34940671795433,0,160,regulation of plasma membrane bounded cell projection assembly,BP,
18437,GO:0120033,1,0.855799433274161,0,24,negative regulation of plasma membrane bounded cell projection assembly,BP,
18438,GO:0120034,1,0.550144527853842,0,91,positive regulation of plasma membrane bounded cell projection assembly,BP,
18442,GO:0120040,1,0.961867388259531,0,6,regulation of macrophage proliferation,BP,
18443,GO:0120041,1,0.968099674980102,0,5,positive regulation of macrophage proliferation,BP,
18444,GO:0120042,1,0.993564430341048,0,1,negative regulation of macrophage proliferation,BP,
18445,GO:0120043,1,0.99345633869565,0,1,stereocilium shaft,CC,
18446,GO:0120044,1,0.986830611956281,0,2,stereocilium base,CC,
18447,GO:0120045,1,0.993574209895402,0,1,stereocilium maintenance,BP,
18448,GO:0120048,1,0.99355705431691,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18449,GO:0120049,1,0.987106158193199,0,2,snRNA (adenine-N6)-methylation,BP,
18450,GO:0120054,1,0.993691741969084,0,1,intestinal motility,BP,
18451,GO:0120055,1,0.993691741969084,0,1,small intestinal transit,BP,
18452,GO:0120057,1,0.993691741969084,0,1,regulation of small intestinal transit,BP,
18453,GO:0120058,1,0.993691741969084,0,1,positive regulation of small intestinal transit,BP,
18454,GO:0120060,1,0.987369938487842,0,2,regulation of gastric emptying,BP,
18455,GO:0120061,1,0.987369938487842,0,2,negative regulation of gastric emptying,BP,
18456,GO:0120063,1,0.987130823921166,0,2,stomach smooth muscle contraction,BP,
18457,GO:0120064,1,0.993404495823808,0,1,stomach pylorus smooth muscle contraction,BP,
18458,GO:0120065,1,0.993404495823808,0,1,pyloric antrum smooth muscle contraction,BP,
18459,GO:0120068,1,0.993685091946878,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18460,GO:0120069,1,0.993685091946878,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18461,GO:0120071,1,0.993404495823808,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18462,GO:0120072,1,0.993404495823808,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18463,GO:0120077,1,0.993259207999722,0,1,angiogenic sprout fusion,BP,
18464,GO:0120078,1,0.993259207999722,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18465,GO:0120092,1,0.993524343304257,0,1,crotonyl-CoA hydratase activity,MF,
18466,GO:0120093,1,0.993524343304257,0,1,regulation of peptidyl-lysine crotonylation,BP,
18467,GO:0120094,1,0.993524343304257,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18468,GO:0120103,1,0.942673327375648,0,9,centriolar subdistal appendage,CC,
18469,GO:0120111,1,0.567245284860091,0,86,neuron projection cytoplasm,CC,
18470,GO:0120114,1,0.624057213240303,0,73,Sm-like protein family complex,CC,
18471,GO:0120115,1,0.956399934692778,0,7,Lsm2-8 complex,CC,
18472,GO:0120117,1,0.993527989797633,0,1,T cell meandering migration,BP,
18473,GO:0120127,1,0.99358967693686,0,1,response to zinc ion starvation,BP,
18474,GO:0120134,1,0.992508087796785,0,1,proximal portion of axoneme,CC,
18475,GO:0120135,1,0.993110968114374,0,1,distal portion of axoneme,CC,
18476,GO:0120146,1,0.968381793750511,0,5,sulfatide binding,MF,
18477,GO:0120147,1,0.993599222672004,0,1,Formylglycine-generating oxidase activity,MF,
18478,GO:0120153,1,0.993650102508122,0,1,calcium-dependent carbohydrate binding,MF,
18479,GO:0120160,1,0.986922726460369,0,2,intraciliary transport particle A binding,MF,
18480,GO:0120161,1,0.411501167817105,0,135,regulation of cold-induced thermogenesis,BP,
18481,GO:0120162,1,0.553350573819953,0,90,positive regulation of cold-induced thermogenesis,BP,
18482,GO:0120163,1,0.749836433457518,0,44,negative regulation of cold-induced thermogenesis,BP,
18483,GO:0120168,1,0.993466250207999,0,1,detection of hot stimulus involved in thermoception,BP,
18484,GO:0120169,1,0.993442873768306,0,1,detection of cold stimulus involved in thermoception,BP,
18485,GO:0120170,1,0.967897838701224,0,5,intraciliary transport particle B binding,MF,
18486,GO:0120178,1,0.781940605549278,0,38,steroid hormone biosynthetic process,BP,
18487,GO:0120180,1,0.967493090313999,0,5,cell-substrate junction disassembly,BP,
18488,GO:0120181,1,0.967493090313999,0,5,focal adhesion disassembly,BP,
18489,GO:0120182,1,0.967493090313999,0,5,regulation of focal adhesion disassembly,BP,
18490,GO:0120183,1,0.967493090313999,0,5,positive regulation of focal adhesion disassembly,BP,
18491,GO:0120187,1,0.992947795630555,0,1,positive regulation of protein localization to chromatin,BP,
18492,GO:0120188,1,0.987081442646841,0,2,regulation of bile acid secretion,BP,
18493,GO:0120189,1,0.993434784661427,0,1,positive regulation of bile acid secretion,BP,
18494,GO:0120191,1,0.987155207697788,0,2,negative regulation of termination of RNA polymerase II transcription,BP,
18497,GO:0120222,1,0.993224260884326,0,1,regulation of blastocyst development,BP,
18498,GO:0120227,1,0.8678202560363,0,22,acyl-CoA binding,MF,
18499,GO:0120252,1,0.943669500550354,0,9,hydrocarbon metabolic process,BP,
18500,GO:0120253,1,0.980823929226101,0,3,hydrocarbon catabolic process,BP,
18502,GO:0120255,1,0.833669451269845,0,28,olefinic compound biosynthetic process,BP,
18503,GO:0120256,1,0.99359233845386,0,1,olefinic compound catabolic process,BP,
18504,GO:0140007,1,0.974576647794176,0,4,KICSTOR complex,CC,
18505,GO:0140009,1,0.974342927722787,0,4,L-aspartate import across plasma membrane,BP,
18506,GO:0140010,1,0.993504840627077,0,1,D-aspartate transmembrane transporter activity,MF,
18507,GO:0140013,1,0.395194934196466,0,142,meiotic nuclear division,BP,
18508,GO:0140014,1,0.171006990700949,0,266,mitotic nuclear division,BP,
18510,GO:0140030,1,0.414132508156157,0,134,modification-dependent protein binding,MF,
18511,GO:0140031,1,0.974188158776727,0,4,phosphorylation-dependent protein binding,MF,
18512,GO:0140033,1,0.86985957048656,0,21,acetylation-dependent protein binding,MF,
18513,GO:0140034,1,0.665506089787848,0,62,methylation-dependent protein binding,MF,
18514,GO:0140035,1,0.93087670096458,0,11,ubiquitination-like modification-dependent protein binding,MF,
18515,GO:0140036,1,0.942994379976177,0,9,ubiquitin-dependent protein binding,MF,
18516,GO:0140037,1,0.987157278818413,0,2,sumo-dependent protein binding,MF,
18517,GO:0140039,1,0.98691590327071,0,2,cell-cell adhesion in response to extracellular stimulus,BP,
18518,GO:0140041,1,0.993677246056371,0,1,cellular detoxification of methylglyoxal,BP,
18519,GO:0140042,1,0.943621286352133,0,9,lipid droplet formation,BP,
18520,GO:0140049,1,0.993628898115626,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18521,GO:0140051,1,0.993628898115626,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18522,GO:0140052,1,0.936570446069813,0,10,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18523,GO:0140053,1,0.365370979445854,0,156,mitochondrial gene expression,BP,
18524,GO:0140056,1,0.329557629790535,0,169,organelle localization by membrane tethering,BP,
18526,GO:0140059,1,0.955603549814602,0,7,dendrite arborization,BP,
18527,GO:0140064,1,0.993082140467003,0,1,peptide crotonyltransferase activity,MF,
18528,GO:0140065,1,0.993082140467003,0,1,peptide butyryltransferase activity,MF,
18529,GO:0140066,1,0.986650836535746,0,2,peptidyl-lysine crotonylation,BP,
18530,GO:0140067,1,0.993082140467003,0,1,peptidyl-lysine butyrylation,BP,
18531,GO:0140068,1,0.993082140467003,0,1,histone crotonyltransferase activity,MF,
18532,GO:0140069,1,0.993082140467003,0,1,histone butyryltransferase activity,MF,
18533,GO:0140074,1,0.987013775044073,0,2,cardiac endothelial to mesenchymal transition,BP,
18534,GO:0140078,1,0.956159915493211,0,7,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18535,GO:0140081,1,0.987261872629143,0,2,glycosylated region protein binding,MF,
18536,GO:0140090,1,0.980877478176944,0,3,membrane curvature sensor activity,MF,
18538,GO:0140097,1,0.279547360060973,0,194,catalytic activity, acting on DNA,MF,
18539,GO:0140098,1,0.112693288445745,0,333,catalytic activity, acting on RNA,MF,
18540,GO:0140101,1,0.537001568494968,0,96,catalytic activity, acting on a tRNA,MF,
18541,GO:0140102,1,0.896402864569946,0,17,catalytic activity, acting on a rRNA,MF,
18542,GO:0140103,1,0.883972936585029,0,19,catalytic activity, acting on a glycoprotein,MF,
18545,GO:0140112,1,0.87869414915462,0,20,extracellular vesicle biogenesis,BP,
18548,GO:0140135,1,0.97438758101329,0,4,mechanosensitive cation channel activity,MF,
18549,GO:0140142,1,0.831122801483588,0,28,nucleocytoplasmic carrier activity,MF,
18550,GO:0140157,1,0.98017026095454,0,3,ammonium import across plasma membrane,BP,
18551,GO:0140161,1,0.943652418282278,0,9,monocarboxylate:sodium symporter activity,MF,
18552,GO:0140192,1,0.980039393870709,0,3,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18553,GO:0140193,1,0.993649703780491,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18554,GO:0140194,1,0.993649703780491,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18555,GO:0140196,1,0.993234343943923,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18556,GO:0140199,1,0.986716065010571,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18557,GO:0140200,1,0.993144264001104,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18558,GO:0140205,1,0.986422547613534,0,2,oligopeptide import across plasma membrane,BP,
18559,GO:0140206,1,0.986422547613534,0,2,dipeptide import across plasma membrane,BP,
18560,GO:0140212,1,0.961370840831204,0,6,regulation of long-chain fatty acid import into cell,BP,
18561,GO:0140213,1,0.973808469512884,0,4,negative regulation of long-chain fatty acid import into cell,BP,
18562,GO:0140214,1,0.987231216925023,0,2,positive regulation of long-chain fatty acid import into cell,BP,
18563,GO:0140223,1,0.772173911938822,0,40,general transcription initiation factor activity,MF,
18565,GO:0140239,1,0.877117988641651,0,20,postsynaptic endocytosis,BP,
18566,GO:0140243,1,0.980274683220817,0,3,regulation of translation at synapse,BP,
18567,GO:0140245,1,0.987103357710081,0,2,regulation of translation at postsynapse,BP,
18568,GO:0140246,1,0.99336141551439,0,1,protein catabolic process at synapse,BP,
18569,GO:0140253,1,0.744668435756171,0,45,cell-cell fusion,BP,
18570,GO:0140261,1,0.993303460964053,0,1,BCOR complex,CC,
18571,GO:0140271,1,0.961692751990522,0,6,hexose import across plasma membrane,BP,
18573,GO:0140296,1,0.750005076778467,0,44,general transcription initiation factor binding,MF,
18575,GO:0140299,1,0.936694916903325,0,10,small molecule sensor activity,MF,
18576,GO:0140303,1,0.881884308052259,0,19,intramembrane lipid transporter activity,MF,
18577,GO:0140312,1,0.894853932157621,0,17,cargo adaptor activity,MF,
18578,GO:0140318,1,0.895700673025455,0,17,protein transporter activity,MF,
18579,GO:0140321,1,0.993421064509849,0,1,negative regulation by symbiont of host autophagy,BP,
18580,GO:0140323,1,0.848951115119936,0,25,solute:anion antiporter activity,MF,
18581,GO:0140326,1,0.929049473607718,0,11,ATPase-coupled intramembrane lipid transporter activity,MF,
18582,GO:0140327,1,0.960970019869733,0,6,flippase activity,MF,
18583,GO:0140328,1,0.960439383494905,0,6,floppase activity,MF,
18584,GO:0140333,1,0.986686033225357,0,2,glycerophospholipid flippase activity,MF,
18587,GO:0140354,1,0.900869951079809,0,16,lipid import into cell,BP,
18588,GO:0140375,1,0.464528168501308,0,118,immune receptor activity,MF,
18589,GO:0140410,1,0.960786825934242,0,6,solute:bicarbonate symporter activity,MF,
18590,GO:0140414,1,0.993694965537682,0,1,phosphopantetheine-dependent carrier activity,MF,
18591,GO:0140445,1,0.931325849007993,0,11,chromosome, telomeric repeat region,CC,
18592,GO:0140448,1,0.844716374304793,0,26,signaling receptor ligand precursor processing,BP,
18593,GO:0140455,1,0.993630035639127,0,1,cytoplasm protein quality control,BP,
18594,GO:0140457,1,0.84670769803748,0,25,protein demethylase activity,MF,
18595,GO:0140461,1,0.993630437004572,0,1,subtelomeric heterochromatin organization,BP,
18596,GO:0140462,1,0.987240233696719,0,2,pericentric heterochromatin organization,BP,
18598,GO:0140507,1,0.968306383188903,0,5,granzyme-mediated programmed cell death signaling pathway,BP,
18599,GO:0150001,1,0.986346620039642,0,2,primary dendrite,CC,
18600,GO:0150002,1,0.986911944383779,0,2,distal dendrite,CC,
18601,GO:0150003,1,0.960979805219603,0,6,regulation of spontaneous synaptic transmission,BP,
18602,GO:0150005,1,0.974716467641793,0,4,enzyme activator complex,CC,
18603,GO:0150007,1,0.986712667617397,0,2,clathrin-dependent synaptic vesicle endocytosis,BP,
18604,GO:0150011,1,0.910637547334416,0,14,regulation of neuron projection arborization,BP,
18605,GO:0150012,1,0.948669340169195,0,8,positive regulation of neuron projection arborization,BP,
18606,GO:0150014,1,0.993364432846303,0,1,apical distal dendrite,CC,
18607,GO:0150018,1,0.980501952495397,0,3,basal dendrite development,BP,
18608,GO:0150019,1,0.980501952495397,0,3,basal dendrite morphogenesis,BP,
18609,GO:0150020,1,0.980501952495397,0,3,basal dendrite arborization,BP,
18610,GO:0150024,1,0.99360135284646,0,1,oxidised low-density lipoprotein particle clearance,BP,
18611,GO:0150025,1,0.99360135284646,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18612,GO:0150031,1,0.986944237784735,0,2,regulation of protein localization to lysosome,BP,
18613,GO:0150032,1,0.993603287248385,0,1,positive regulation of protein localization to lysosome,BP,
18614,GO:0150033,1,0.993298508893062,0,1,negative regulation of protein localization to lysosome,BP,
18616,GO:0150051,1,0.966122777317958,0,5,postsynaptic Golgi apparatus,CC,
18617,GO:0150052,1,0.918084397157741,0,13,regulation of postsynapse assembly,BP,
18618,GO:0150056,1,0.98723059037847,0,2,amylin receptor complex 1,CC,
18619,GO:0150057,1,0.987238644754557,0,2,amylin receptor complex 2,CC,
18620,GO:0150058,1,0.987201851904031,0,2,amylin receptor complex 3,CC,
18621,GO:0150062,1,0.974427942672268,0,4,complement-mediated synapse pruning,BP,
18623,GO:0150064,1,0.980637122217114,0,3,vertebrate eye-specific patterning,BP,
18624,GO:0150065,1,0.92991129630126,0,11,regulation of deacetylase activity,BP,
18625,GO:0150066,1,0.98646288795133,0,2,negative regulation of deacetylase activity,BP,
18626,GO:0150070,1,0.993589447510989,0,1,regulation of arginase activity,BP,
18627,GO:0150072,1,0.993589447510989,0,1,positive regulation of arginase activity,BP,
18628,GO:0150073,1,0.993589447510989,0,1,regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18629,GO:0150074,1,0.993589447510989,0,1,positive regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18631,GO:0150077,1,0.827363707588076,0,29,regulation of neuroinflammatory response,BP,
18632,GO:0150078,1,0.924968148018512,0,12,positive regulation of neuroinflammatory response,BP,
18633,GO:0150079,1,0.930771369146975,0,11,negative regulation of neuroinflammatory response,BP,
18634,GO:0150089,1,0.993534152108704,0,1,multiple spine synapse organization,BP,
18635,GO:0150090,1,0.993534152108704,0,1,multiple spine synapse organization, single dendrite,BP,
18636,GO:0150093,1,0.954355035623465,0,7,amyloid-beta clearance by transcytosis,BP,
18637,GO:0150094,1,0.953550424291569,0,7,amyloid-beta clearance by cellular catabolic process,BP,
18638,GO:0150098,1,0.98703035765109,0,2,glial cell-neuron signaling,BP,
18639,GO:0150100,1,0.987350054460965,0,2,RNA binding involved in posttranscriptional gene silencing,MF,
18640,GO:0150104,1,0.931321316567451,0,11,transport across blood-brain barrier,BP,
18641,GO:0150105,1,0.917705147248583,0,13,protein localization to cell-cell junction,BP,
18642,GO:0150106,1,0.993386908371261,0,1,regulation of protein localization to cell-cell junction,BP,
18645,GO:0150117,1,0.830955177059226,0,28,positive regulation of cell-substrate junction organization,BP,
18646,GO:0150118,1,0.88786648183999,0,18,negative regulation of cell-substrate junction organization,BP,
18647,GO:0150146,1,0.883550414925465,0,19,cell junction disassembly,BP,
18648,GO:0150147,1,0.980564189710995,0,3,cell-cell junction disassembly,BP,
18649,GO:0150172,1,0.949600185200014,0,8,regulation of phosphatidylcholine metabolic process,BP,
18650,GO:0150173,1,0.980761484642341,0,3,positive regulation of phosphatidylcholine metabolic process,BP,
18651,GO:0150200,1,0.993661049356776,0,1,regulation of transport across blood-brain barrier,BP,
18652,GO:0150201,1,0.993661049356776,0,1,positive regulation of transport across blood-brain barrier,BP,
18654,GO:1900003,1,0.974198245138575,0,4,regulation of serine-type endopeptidase activity,BP,
18655,GO:1900004,1,0.974198245138575,0,4,negative regulation of serine-type endopeptidase activity,BP,
18656,GO:1900005,1,0.993029719560696,0,1,positive regulation of serine-type endopeptidase activity,BP,
18658,GO:1900010,1,0.993616960371134,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18659,GO:1900011,1,0.993616960371134,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18660,GO:1900015,1,0.770660255786653,0,40,regulation of cytokine production involved in inflammatory response,BP,
18661,GO:1900016,1,0.912980309933917,0,14,negative regulation of cytokine production involved in inflammatory response,BP,
18662,GO:1900017,1,0.889358355496787,0,18,positive regulation of cytokine production involved in inflammatory response,BP,
18663,GO:1900019,1,0.974210714824788,0,4,regulation of protein kinase C activity,BP,
18664,GO:1900020,1,0.974210714824788,0,4,positive regulation of protein kinase C activity,BP,
18665,GO:1900022,1,0.993516507776966,0,1,regulation of D-erythro-sphingosine kinase activity,BP,
18667,GO:1900025,1,0.924934724475615,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18669,GO:1900027,1,0.844981011351986,0,26,regulation of ruffle assembly,BP,
18670,GO:1900028,1,0.961936228437561,0,6,negative regulation of ruffle assembly,BP,
18671,GO:1900029,1,0.925211247831448,0,12,positive regulation of ruffle assembly,BP,
18673,GO:1900035,1,0.993560171902411,0,1,negative regulation of cellular response to heat,BP,
18674,GO:1900036,1,0.993583972046563,0,1,positive regulation of cellular response to heat,BP,
18675,GO:1900037,1,0.919203641573065,0,13,regulation of cellular response to hypoxia,BP,
18676,GO:1900038,1,0.955725940405942,0,7,negative regulation of cellular response to hypoxia,BP,
18677,GO:1900039,1,0.987224380473597,0,2,positive regulation of cellular response to hypoxia,BP,
18678,GO:1900044,1,0.923830890908666,0,12,regulation of protein K63-linked ubiquitination,BP,
18679,GO:1900045,1,0.954878798119373,0,7,negative regulation of protein K63-linked ubiquitination,BP,
18682,GO:1900048,1,0.850339870902156,0,25,positive regulation of hemostasis,BP,
18683,GO:1900052,1,0.987214187274666,0,2,regulation of retinoic acid biosynthetic process,BP,
18684,GO:1900053,1,0.993657868319067,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18685,GO:1900054,1,0.993515602722042,0,1,positive regulation of retinoic acid biosynthetic process,BP,
18686,GO:1900060,1,0.968279272113475,0,5,negative regulation of ceramide biosynthetic process,BP,
18687,GO:1900062,1,0.993505555949733,0,1,regulation of replicative cell aging,BP,
18688,GO:1900063,1,0.97997442772089,0,3,regulation of peroxisome organization,BP,
18689,GO:1900069,1,0.974325717153308,0,4,regulation of cellular hyperosmotic salinity response,BP,
18690,GO:1900073,1,0.99363448085481,0,1,regulation of neuromuscular synaptic transmission,BP,
18691,GO:1900075,1,0.99363448085481,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18692,GO:1900076,1,0.640717760107691,0,68,regulation of cellular response to insulin stimulus,BP,
18693,GO:1900077,1,0.811418271930514,0,32,negative regulation of cellular response to insulin stimulus,BP,
18694,GO:1900078,1,0.859499096447333,0,23,positive regulation of cellular response to insulin stimulus,BP,
18695,GO:1900079,1,0.993612562533813,0,1,regulation of arginine biosynthetic process,BP,
18696,GO:1900081,1,0.99307768176836,0,1,regulation of arginine catabolic process,BP,
18697,GO:1900082,1,0.99307768176836,0,1,negative regulation of arginine catabolic process,BP,
18699,GO:1900085,1,0.993562880886849,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18701,GO:1900087,1,0.790834762220463,0,36,positive regulation of G1/S transition of mitotic cell cycle,BP,
18702,GO:1900094,1,0.955515258721162,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18703,GO:1900095,1,0.992903312538264,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18704,GO:1900098,1,0.993619142811206,0,1,regulation of plasma cell differentiation,BP,
18705,GO:1900100,1,0.993619142811206,0,1,positive regulation of plasma cell differentiation,BP,
18707,GO:1900102,1,0.925268597276517,0,12,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18709,GO:1900104,1,0.98077960469934,0,3,regulation of hyaluranon cable assembly,BP,
18710,GO:1900106,1,0.98077960469934,0,3,positive regulation of hyaluranon cable assembly,BP,
18711,GO:1900107,1,0.955442409211023,0,7,regulation of nodal signaling pathway,BP,
18712,GO:1900108,1,0.980952237152433,0,3,negative regulation of nodal signaling pathway,BP,
18713,GO:1900109,1,0.980977737830624,0,3,regulation of histone H3-K9 dimethylation,BP,
18714,GO:1900110,1,0.987323093912526,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18715,GO:1900111,1,0.993573988963541,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18716,GO:1900112,1,0.936420603359833,0,10,regulation of histone H3-K9 trimethylation,BP,
18717,GO:1900113,1,0.968209919874263,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18718,GO:1900114,1,0.980465111407084,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18722,GO:1900118,1,0.931107985944713,0,11,negative regulation of execution phase of apoptosis,BP,
18724,GO:1900120,1,0.855407272399949,0,24,regulation of receptor binding,BP,
18725,GO:1900121,1,0.918752211971961,0,13,negative regulation of receptor binding,BP,
18726,GO:1900122,1,0.943325143253291,0,9,positive regulation of receptor binding,BP,
18727,GO:1900125,1,0.948772603638444,0,8,regulation of hyaluronan biosynthetic process,BP,
18728,GO:1900126,1,0.973865480882109,0,4,negative regulation of hyaluronan biosynthetic process,BP,
18729,GO:1900127,1,0.974240468160728,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18730,GO:1900130,1,0.993510968506391,0,1,regulation of lipid binding,BP,
18731,GO:1900131,1,0.993510968506391,0,1,negative regulation of lipid binding,BP,
18732,GO:1900133,1,0.980731377048049,0,3,regulation of renin secretion into blood stream,BP,
18733,GO:1900134,1,0.993500557474342,0,1,negative regulation of renin secretion into blood stream,BP,
18734,GO:1900135,1,0.987148116798147,0,2,positive regulation of renin secretion into blood stream,BP,
18735,GO:1900138,1,0.987103211831548,0,2,negative regulation of phospholipase A2 activity,BP,
18736,GO:1900139,1,0.993415944541412,0,1,negative regulation of arachidonic acid secretion,BP,
18737,GO:1900141,1,0.986742359076832,0,2,regulation of oligodendrocyte apoptotic process,BP,
18738,GO:1900142,1,0.993573043847889,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18739,GO:1900143,1,0.993125572424245,0,1,positive regulation of oligodendrocyte apoptotic process,BP,
18740,GO:1900145,1,0.967854541794508,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18741,GO:1900146,1,0.987323957424232,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18742,GO:1900147,1,0.979354007508479,0,3,regulation of Schwann cell migration,BP,
18743,GO:1900148,1,0.99355705431691,0,1,negative regulation of Schwann cell migration,BP,
18744,GO:1900149,1,0.98570576746702,0,2,positive regulation of Schwann cell migration,BP,
18745,GO:1900150,1,0.980925579582825,0,3,regulation of defense response to fungus,BP,
18746,GO:1900151,1,0.887658864405005,0,18,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18747,GO:1900152,1,0.993618169151267,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18748,GO:1900153,1,0.887658864405005,0,18,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18753,GO:1900159,1,0.993581645191367,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18754,GO:1900161,1,0.993555791525918,0,1,regulation of phospholipid scramblase activity,BP,
18755,GO:1900163,1,0.993555791525918,0,1,positive regulation of phospholipid scramblase activity,BP,
18756,GO:1900164,1,0.955515258721162,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18757,GO:1900166,1,0.980120897114814,0,3,regulation of glial cell-derived neurotrophic factor secretion,BP,
18758,GO:1900168,1,0.980120897114814,0,3,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18759,GO:1900169,1,0.986217831040528,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18760,GO:1900170,1,0.99355705431691,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18761,GO:1900175,1,0.967854541794508,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18762,GO:1900176,1,0.987323957424232,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18763,GO:1900180,1,0.464843702097582,0,117,regulation of protein localization to nucleus,BP,
18764,GO:1900181,1,0.837652323920675,0,27,negative regulation of protein localization to nucleus,BP,
18765,GO:1900182,1,0.60451737444738,0,77,positive regulation of protein localization to nucleus,BP,
18766,GO:1900186,1,0.974432812997434,0,4,negative regulation of clathrin-dependent endocytosis,BP,
18767,GO:1900190,1,0.993581645191367,0,1,regulation of single-species biofilm formation,BP,
18768,GO:1900191,1,0.993581645191367,0,1,negative regulation of single-species biofilm formation,BP,
18769,GO:1900193,1,0.949689867020455,0,8,regulation of oocyte maturation,BP,
18770,GO:1900194,1,0.980895720640155,0,3,negative regulation of oocyte maturation,BP,
18771,GO:1900195,1,0.980772118315056,0,3,positive regulation of oocyte maturation,BP,
18772,GO:1900200,1,0.987021321748086,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18773,GO:1900204,1,0.987021321748086,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18774,GO:1900205,1,0.987021321748086,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18775,GO:1900208,1,0.974798337995778,0,4,regulation of cardiolipin metabolic process,BP,
18776,GO:1900210,1,0.987309812639571,0,2,positive regulation of cardiolipin metabolic process,BP,
18777,GO:1900211,1,0.987021321748086,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18778,GO:1900212,1,0.987021321748086,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18779,GO:1900214,1,0.987021321748086,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18780,GO:1900215,1,0.987021321748086,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18781,GO:1900217,1,0.987021321748086,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18782,GO:1900218,1,0.987021321748086,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18783,GO:1900220,1,0.986722951236908,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18784,GO:1900221,1,0.911825959453906,0,14,regulation of amyloid-beta clearance,BP,
18785,GO:1900222,1,0.955455976299367,0,7,negative regulation of amyloid-beta clearance,BP,
18786,GO:1900223,1,0.960585950255448,0,6,positive regulation of amyloid-beta clearance,BP,
18787,GO:1900224,1,0.986563717852962,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18788,GO:1900225,1,0.924494655951663,0,12,regulation of NLRP3 inflammasome complex assembly,BP,
18789,GO:1900226,1,0.974233953897013,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18790,GO:1900227,1,0.955111287329998,0,7,positive regulation of NLRP3 inflammasome complex assembly,BP,
18791,GO:1900228,1,0.993581645191367,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18792,GO:1900229,1,0.993581645191367,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18793,GO:1900234,1,0.993386119435849,0,1,regulation of Kit signaling pathway,BP,
18794,GO:1900235,1,0.993386119435849,0,1,negative regulation of Kit signaling pathway,BP,
18795,GO:1900238,1,0.980592133740928,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18796,GO:1900239,1,0.96156643605454,0,6,regulation of phenotypic switching,BP,
18797,GO:1900240,1,0.986883409699786,0,2,negative regulation of phenotypic switching,BP,
18798,GO:1900241,1,0.987262424398147,0,2,positive regulation of phenotypic switching,BP,
18800,GO:1900243,1,0.993399296516858,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18801,GO:1900244,1,0.955093791633412,0,7,positive regulation of synaptic vesicle endocytosis,BP,
18802,GO:1900245,1,0.980083755980082,0,3,positive regulation of MDA-5 signaling pathway,BP,
18803,GO:1900246,1,0.960761414238135,0,6,positive regulation of RIG-I signaling pathway,BP,
18804,GO:1900247,1,0.943149673035978,0,9,regulation of cytoplasmic translational elongation,BP,
18805,GO:1900248,1,0.986763887442092,0,2,negative regulation of cytoplasmic translational elongation,BP,
18806,GO:1900259,1,0.993613267314378,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18807,GO:1900260,1,0.993613267314378,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18808,GO:1900262,1,0.943875284714986,0,9,regulation of DNA-directed DNA polymerase activity,BP,
18809,GO:1900264,1,0.943875284714986,0,9,positive regulation of DNA-directed DNA polymerase activity,BP,
18811,GO:1900272,1,0.924667068040382,0,12,negative regulation of long-term synaptic potentiation,BP,
18814,GO:1900275,1,0.986929756764731,0,2,negative regulation of phospholipase C activity,BP,
18815,GO:1900276,1,0.993520353102423,0,1,regulation of proteinase activated receptor activity,BP,
18816,GO:1900279,1,0.987194224909789,0,2,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18817,GO:1900280,1,0.993635649479514,0,1,negative regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18818,GO:1900281,1,0.993517729948133,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18819,GO:1900363,1,0.900900780499041,0,16,regulation of mRNA polyadenylation,BP,
18820,GO:1900364,1,0.949282777396789,0,8,negative regulation of mRNA polyadenylation,BP,
18821,GO:1900365,1,0.974195064748346,0,4,positive regulation of mRNA polyadenylation,BP,
18822,GO:1900368,1,0.974061609413588,0,4,regulation of RNA interference,BP,
18823,GO:1900369,1,0.986820630307457,0,2,negative regulation of RNA interference,BP,
18824,GO:1900370,1,0.993387613601898,0,1,positive regulation of RNA interference,BP,
18825,GO:1900371,1,0.80674804152047,0,33,regulation of purine nucleotide biosynthetic process,BP,
18826,GO:1900372,1,0.961927424330101,0,6,negative regulation of purine nucleotide biosynthetic process,BP,
18827,GO:1900373,1,0.895643982862098,0,17,positive regulation of purine nucleotide biosynthetic process,BP,
18828,GO:1900376,1,0.935803258409353,0,10,regulation of secondary metabolite biosynthetic process,BP,
18829,GO:1900377,1,0.980298798274441,0,3,negative regulation of secondary metabolite biosynthetic process,BP,
18830,GO:1900378,1,0.961353458757579,0,6,positive regulation of secondary metabolite biosynthetic process,BP,
18831,GO:1900383,1,0.993529684168764,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18834,GO:1900409,1,0.895458126209295,0,17,positive regulation of cellular response to oxidative stress,BP,
18835,GO:1900424,1,0.907316514597846,0,15,regulation of defense response to bacterium,BP,
18836,GO:1900425,1,0.967948880974641,0,5,negative regulation of defense response to bacterium,BP,
18837,GO:1900426,1,0.949733098328049,0,8,positive regulation of defense response to bacterium,BP,
18838,GO:1900449,1,0.664202307269315,0,62,regulation of glutamate receptor signaling pathway,BP,
18839,GO:1900450,1,0.980615500176766,0,3,negative regulation of glutamate receptor signaling pathway,BP,
18840,GO:1900451,1,0.906161113925875,0,15,positive regulation of glutamate receptor signaling pathway,BP,
18841,GO:1900452,1,0.911987911029967,0,14,regulation of long-term synaptic depression,BP,
18842,GO:1900453,1,0.980791513307593,0,3,negative regulation of long-term synaptic depression,BP,
18843,GO:1900454,1,0.961253985758369,0,6,positive regulation of long-term synaptic depression,BP,
18844,GO:1900477,1,0.993600953074704,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18845,GO:1900480,1,0.993559663952693,0,1,regulation of diacylglycerol biosynthetic process,BP,
18846,GO:1900533,1,0.993637618370531,0,1,palmitic acid metabolic process,BP,
18847,GO:1900535,1,0.993637618370531,0,1,palmitic acid biosynthetic process,BP,
18848,GO:1900542,1,0.508304061888126,0,103,regulation of purine nucleotide metabolic process,BP,
18849,GO:1900543,1,0.882910280389158,0,19,negative regulation of purine nucleotide metabolic process,BP,
18850,GO:1900544,1,0.784751060255565,0,37,positive regulation of purine nucleotide metabolic process,BP,
18851,GO:1900619,1,0.974496535693293,0,4,acetate ester metabolic process,BP,
18852,GO:1900620,1,0.987180811145068,0,2,acetate ester biosynthetic process,BP,
18853,GO:1900623,1,0.98047061420717,0,3,regulation of monocyte aggregation,BP,
18854,GO:1900625,1,0.98047061420717,0,3,positive regulation of monocyte aggregation,BP,
18855,GO:1900673,1,0.98075439427393,0,3,olefin metabolic process,BP,
18856,GO:1900736,1,0.974713620062068,0,4,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18857,GO:1900737,1,0.993520353102423,0,1,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18858,GO:1900738,1,0.981071830201881,0,3,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18859,GO:1900739,1,0.845400355842422,0,26,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18860,GO:1900740,1,0.845400355842422,0,26,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18861,GO:1900744,1,0.785645757314891,0,37,regulation of p38MAPK cascade,BP,
18862,GO:1900745,1,0.84997852268654,0,25,positive regulation of p38MAPK cascade,BP,
18863,GO:1900746,1,0.900707999829746,0,16,regulation of vascular endothelial growth factor signaling pathway,BP,
18864,GO:1900747,1,0.955418594576785,0,7,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18865,GO:1900748,1,0.967277381928966,0,5,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18866,GO:1900749,1,0.993528783654157,0,1,(R)-carnitine transport,BP,
18868,GO:1900753,1,0.993466453761889,0,1,doxorubicin transport,BP,
18869,GO:1900756,1,0.986801298078822,0,2,protein processing in phagocytic vesicle,BP,
18870,GO:1900825,1,0.974016506037644,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18871,GO:1900826,1,0.993648341094093,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18872,GO:1900827,1,0.992968551900818,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18873,GO:1900864,1,0.94974972773971,0,8,mitochondrial RNA modification,BP,
18876,GO:1901000,1,0.974325717153308,0,4,regulation of response to salt stress,BP,
18877,GO:1901003,1,0.987098243375882,0,2,negative regulation of fermentation,BP,
18878,GO:1901004,1,0.993654750822191,0,1,ubiquinone-6 metabolic process,BP,
18879,GO:1901006,1,0.993654750822191,0,1,ubiquinone-6 biosynthetic process,BP,
18880,GO:1901016,1,0.692342444321547,0,56,regulation of potassium ion transmembrane transporter activity,BP,
18881,GO:1901017,1,0.883341334788803,0,19,negative regulation of potassium ion transmembrane transporter activity,BP,
18882,GO:1901018,1,0.853833612707894,0,24,positive regulation of potassium ion transmembrane transporter activity,BP,
18884,GO:1901020,1,0.812866405748306,0,32,negative regulation of calcium ion transmembrane transporter activity,BP,
18886,GO:1901026,1,0.980231201120409,0,3,ripoptosome assembly involved in necroptotic process,BP,
18892,GO:1901033,1,0.943402045234157,0,9,positive regulation of response to reactive oxygen species,BP,
18893,GO:1901052,1,0.987236075804357,0,2,sarcosine metabolic process,BP,
18894,GO:1901053,1,0.993527170053586,0,1,sarcosine catabolic process,BP,
18895,GO:1901068,1,0.791304192852255,0,36,guanosine-containing compound metabolic process,BP,
18896,GO:1901069,1,0.993645181428393,0,1,guanosine-containing compound catabolic process,BP,
18897,GO:1901070,1,0.920369296247461,0,13,guanosine-containing compound biosynthetic process,BP,
18900,GO:1901073,1,0.986938687374885,0,2,glucosamine-containing compound biosynthetic process,BP,
18901,GO:1901074,1,0.980617286935576,0,3,regulation of engulfment of apoptotic cell,BP,
18902,GO:1901076,1,0.986972240509694,0,2,positive regulation of engulfment of apoptotic cell,BP,
18903,GO:1901077,1,0.937243485026232,0,10,regulation of relaxation of muscle,BP,
18904,GO:1901078,1,0.974081721508231,0,4,negative regulation of relaxation of muscle,BP,
18905,GO:1901079,1,0.987224810569097,0,2,positive regulation of relaxation of muscle,BP,
18906,GO:1901086,1,0.99341300588565,0,1,benzylpenicillin metabolic process,BP,
18907,GO:1901096,1,0.924178972758824,0,12,regulation of autophagosome maturation,BP,
18908,GO:1901097,1,0.974173923328772,0,4,negative regulation of autophagosome maturation,BP,
18909,GO:1901098,1,0.954559645520165,0,7,positive regulation of autophagosome maturation,BP,
18910,GO:1901099,1,0.807975786027668,0,33,negative regulation of signal transduction in absence of ligand,BP,
18914,GO:1901142,1,0.967843462580281,0,5,insulin metabolic process,BP,
18915,GO:1901143,1,0.986963921763681,0,2,insulin catabolic process,BP,
18916,GO:1901145,1,0.980592353770882,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18917,GO:1901147,1,0.987021321748086,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18918,GO:1901159,1,0.96844507163844,0,5,xylulose 5-phosphate biosynthetic process,BP,
18919,GO:1901160,1,0.911841996707386,0,14,primary amino compound metabolic process,BP,
18920,GO:1901162,1,0.968359231096076,0,5,primary amino compound biosynthetic process,BP,
18921,GO:1901163,1,0.925223382428476,0,12,regulation of trophoblast cell migration,BP,
18922,GO:1901164,1,0.961792997029111,0,6,negative regulation of trophoblast cell migration,BP,
18923,GO:1901165,1,0.961992193343711,0,6,positive regulation of trophoblast cell migration,BP,
18924,GO:1901166,1,0.967391693449846,0,5,neural crest cell migration involved in autonomic nervous system development,BP,
18925,GO:1901184,1,0.561517078760615,0,88,regulation of ERBB signaling pathway,BP,
18926,GO:1901185,1,0.726418117958092,0,49,negative regulation of ERBB signaling pathway,BP,
18927,GO:1901186,1,0.8005486385808,0,34,positive regulation of ERBB signaling pathway,BP,
18928,GO:1901187,1,0.986928916665178,0,2,regulation of ephrin receptor signaling pathway,BP,
18929,GO:1901189,1,0.993582516269034,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18930,GO:1901193,1,0.993664426243891,0,1,regulation of formation of translation preinitiation complex,BP,
18931,GO:1901194,1,0.993664426243891,0,1,negative regulation of formation of translation preinitiation complex,BP,
18932,GO:1901201,1,0.911473234443751,0,14,regulation of extracellular matrix assembly,BP,
18933,GO:1901202,1,0.9935829363224,0,1,negative regulation of extracellular matrix assembly,BP,
18934,GO:1901203,1,0.93585295361668,0,10,positive regulation of extracellular matrix assembly,BP,
18935,GO:1901207,1,0.987056046706953,0,2,regulation of heart looping,BP,
18936,GO:1901208,1,0.993523551006735,0,1,negative regulation of heart looping,BP,
18937,GO:1901210,1,0.993523551006735,0,1,regulation of cardiac chamber formation,BP,
18938,GO:1901211,1,0.993523551006735,0,1,negative regulation of cardiac chamber formation,BP,
18943,GO:1901219,1,0.993523551006735,0,1,regulation of cardiac chamber morphogenesis,BP,
18944,GO:1901220,1,0.993523551006735,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18946,GO:1901223,1,0.876999893026164,0,20,negative regulation of NIK/NF-kappaB signaling,BP,
18949,GO:1901229,1,0.993567805908878,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18950,GO:1901231,1,0.993567805908878,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18951,GO:1901232,1,0.993567805908878,0,1,regulation of convergent extension involved in axis elongation,BP,
18952,GO:1901233,1,0.993567805908878,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18953,GO:1901235,1,0.993528783654157,0,1,(R)-carnitine transmembrane transporter activity,MF,
18954,GO:1901246,1,0.987259689655934,0,2,regulation of lung ciliated cell differentiation,BP,
18955,GO:1901247,1,0.993654219907791,0,1,negative regulation of lung ciliated cell differentiation,BP,
18956,GO:1901248,1,0.993565040715604,0,1,positive regulation of lung ciliated cell differentiation,BP,
18957,GO:1901249,1,0.993654219907791,0,1,regulation of lung goblet cell differentiation,BP,
18958,GO:1901251,1,0.993654219907791,0,1,positive regulation of lung goblet cell differentiation,BP,
18959,GO:1901252,1,0.987183122852303,0,2,regulation of intracellular transport of viral material,BP,
18960,GO:1901253,1,0.993676916120149,0,1,negative regulation of intracellular transport of viral material,BP,
18961,GO:1901254,1,0.993465297851136,0,1,positive regulation of intracellular transport of viral material,BP,
18962,GO:1901255,1,0.986945058733567,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18963,GO:1901256,1,0.968200277292267,0,5,regulation of macrophage colony-stimulating factor production,BP,
18964,GO:1901257,1,0.993584880294264,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18965,GO:1901258,1,0.980816160383956,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18968,GO:1901291,1,0.993611891440171,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18971,GO:1901295,1,0.987242434706085,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18972,GO:1901296,1,0.993619377814711,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18973,GO:1901297,1,0.993582516269034,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18974,GO:1901298,1,0.943157342417807,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18975,GO:1901299,1,0.968120111668274,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18976,GO:1901300,1,0.974223459905289,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18977,GO:1901301,1,0.987050758686275,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18978,GO:1901303,1,0.993560321529714,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18979,GO:1901304,1,0.993626487655239,0,1,regulation of spermidine biosynthetic process,BP,
18980,GO:1901307,1,0.993626487655239,0,1,positive regulation of spermidine biosynthetic process,BP,
18981,GO:1901308,1,0.993586050681278,0,1,regulation of sterol regulatory element binding protein cleavage,BP,
18982,GO:1901310,1,0.993586050681278,0,1,positive regulation of sterol regulatory element binding protein cleavage,BP,
18983,GO:1901314,1,0.973651769841182,0,4,regulation of histone H2A K63-linked ubiquitination,BP,
18984,GO:1901315,1,0.973651769841182,0,4,negative regulation of histone H2A K63-linked ubiquitination,BP,
18985,GO:1901317,1,0.932015992667072,0,11,regulation of flagellated sperm motility,BP,
18986,GO:1901318,1,0.993611019233983,0,1,negative regulation of flagellated sperm motility,BP,
18987,GO:1901321,1,0.955237011762364,0,7,positive regulation of heart induction,BP,
18988,GO:1901328,1,0.993618974946725,0,1,response to cytochalasin B,BP,
18989,GO:1901329,1,0.980744562320383,0,3,regulation of odontoblast differentiation,BP,
18990,GO:1901331,1,0.993535114757867,0,1,positive regulation of odontoblast differentiation,BP,
18991,GO:1901337,1,0.987113073200532,0,2,thioester transport,BP,
18992,GO:1901338,1,0.919655080150405,0,13,catecholamine binding,MF,
18993,GO:1901339,1,0.955413483596089,0,7,regulation of store-operated calcium channel activity,BP,
18994,GO:1901340,1,0.993481328045942,0,1,negative regulation of store-operated calcium channel activity,BP,
18995,GO:1901341,1,0.967944072277452,0,5,positive regulation of store-operated calcium channel activity,BP,
18997,GO:1901343,1,0.473208818901006,0,114,negative regulation of vasculature development,BP,
18998,GO:1901344,1,0.993653954419938,0,1,response to leptomycin B,BP,
18999,GO:1901346,1,0.993590431432257,0,1,negative regulation of vasculature development involved in avascular cornea development in camera-type eye,BP,
19000,GO:1901355,1,0.980567444577106,0,3,response to rapamycin,BP,
19005,GO:1901373,1,0.993644915207127,0,1,lipid hydroperoxide transport,BP,
19006,GO:1901374,1,0.962077684530516,0,6,acetate ester transport,BP,
19007,GO:1901375,1,0.987235488320197,0,2,acetate ester transmembrane transporter activity,MF,
19008,GO:1901376,1,0.987256023000812,0,2,organic heteropentacyclic compound metabolic process,BP,
19009,GO:1901377,1,0.987256023000812,0,2,organic heteropentacyclic compound catabolic process,BP,
19012,GO:1901381,1,0.783231145692961,0,37,positive regulation of potassium ion transmembrane transport,BP,
19014,GO:1901383,1,0.986734604662368,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
19016,GO:1901386,1,0.919388148901008,0,13,negative regulation of voltage-gated calcium channel activity,BP,
19018,GO:1901388,1,0.954734477881775,0,7,regulation of transforming growth factor beta activation,BP,
19019,GO:1901389,1,0.99357066251008,0,1,negative regulation of transforming growth factor beta activation,BP,
19020,GO:1901390,1,0.993477484015873,0,1,positive regulation of transforming growth factor beta activation,BP,
19021,GO:1901392,1,0.993477484015873,0,1,regulation of transforming growth factor beta1 activation,BP,
19022,GO:1901394,1,0.993477484015873,0,1,positive regulation of transforming growth factor beta1 activation,BP,
19023,GO:1901398,1,0.993473229575174,0,1,regulation of transforming growth factor beta3 activation,BP,
19024,GO:1901401,1,0.980792817010812,0,3,regulation of tetrapyrrole metabolic process,BP,
19025,GO:1901403,1,0.993355319229239,0,1,positive regulation of tetrapyrrole metabolic process,BP,
19026,GO:1901407,1,0.98071215685017,0,3,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19027,GO:1901409,1,0.99358804032313,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19028,GO:1901419,1,0.993466657130638,0,1,regulation of response to alcohol,BP,
19029,GO:1901421,1,0.993466657130638,0,1,positive regulation of response to alcohol,BP,
19030,GO:1901423,1,0.993666576647194,0,1,response to benzene,BP,
19031,GO:1901463,1,0.987354303394558,0,2,regulation of tetrapyrrole biosynthetic process,BP,
19032,GO:1901474,1,0.93715335960742,0,10,azole transmembrane transporter activity,MF,
19033,GO:1901475,1,0.974493790403254,0,4,pyruvate transmembrane transport,BP,
19034,GO:1901480,1,0.993593558115241,0,1,oleate transmembrane transporter activity,MF,
19035,GO:1901483,1,0.98066036714513,0,3,regulation of transcription factor catabolic process,BP,
19036,GO:1901485,1,0.98066036714513,0,3,positive regulation of transcription factor catabolic process,BP,
19037,GO:1901490,1,0.967680507907695,0,5,regulation of lymphangiogenesis,BP,
19038,GO:1901491,1,0.980472321040175,0,3,negative regulation of lymphangiogenesis,BP,
19039,GO:1901492,1,0.986955973204312,0,2,positive regulation of lymphangiogenesis,BP,
19040,GO:1901494,1,0.992997617862815,0,1,regulation of cysteine metabolic process,BP,
19041,GO:1901503,1,0.930493771385656,0,11,ether biosynthetic process,BP,
19042,GO:1901505,1,0.70039520156618,0,55,carbohydrate derivative transmembrane transporter activity,MF,
19043,GO:1901506,1,0.993586050681278,0,1,regulation of acylglycerol transport,BP,
19044,GO:1901508,1,0.993586050681278,0,1,positive regulation of acylglycerol transport,BP,
19046,GO:1901522,1,0.859392200954727,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
19047,GO:1901523,1,0.962055668691544,0,6,icosanoid catabolic process,BP,
19048,GO:1901524,1,0.898090381857229,0,16,regulation of mitophagy,BP,
19049,GO:1901525,1,0.961434976740707,0,6,negative regulation of mitophagy,BP,
19050,GO:1901526,1,0.93413956897206,0,10,positive regulation of mitophagy,BP,
19051,GO:1901529,1,0.974041736334138,0,4,positive regulation of anion channel activity,BP,
19052,GO:1901532,1,0.583184969366262,0,83,regulation of hematopoietic progenitor cell differentiation,BP,
19053,GO:1901533,1,0.94941594594293,0,8,negative regulation of hematopoietic progenitor cell differentiation,BP,
19054,GO:1901534,1,0.967791580702598,0,5,positive regulation of hematopoietic progenitor cell differentiation,BP,
19055,GO:1901535,1,0.96056092679417,0,6,regulation of DNA demethylation,BP,
19056,GO:1901536,1,0.987127002447531,0,2,negative regulation of DNA demethylation,BP,
19057,GO:1901537,1,0.973090918935471,0,4,positive regulation of DNA demethylation,BP,
19058,GO:1901538,1,0.961138133218685,0,6,changes to DNA methylation involved in embryo development,BP,
19059,GO:1901545,1,0.9935428607537,0,1,response to raffinose,BP,
19060,GO:1901550,1,0.906727620116819,0,15,regulation of endothelial cell development,BP,
19061,GO:1901551,1,0.987034760509288,0,2,negative regulation of endothelial cell development,BP,
19062,GO:1901552,1,0.961758821095133,0,6,positive regulation of endothelial cell development,BP,
19063,GO:1901555,1,0.993252501983655,0,1,response to paclitaxel,BP,
19064,GO:1901557,1,0.993489925788297,0,1,response to fenofibrate,BP,
19065,GO:1901558,1,0.98696563522278,0,2,response to metformin,BP,
19066,GO:1901561,1,0.993503015065566,0,1,response to benomyl,BP,
19067,GO:1901563,1,0.967932919928586,0,5,response to camptothecin,BP,
19071,GO:1901567,1,0.846119257387153,0,26,fatty acid derivative binding,MF,
19073,GO:1901569,1,0.925490167219662,0,12,fatty acid derivative catabolic process,BP,
19075,GO:1901571,1,0.797081561289959,0,35,fatty acid derivative transport,BP,
19078,GO:1901580,1,0.992845986822309,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19079,GO:1901581,1,0.992845986822309,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19080,GO:1901582,1,0.992845986822309,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19081,GO:1901585,1,0.993553840687856,0,1,regulation of acid-sensing ion channel activity,BP,
19082,GO:1901588,1,0.980114032813647,0,3,dendritic microtubule,CC,
19083,GO:1901594,1,0.993480887574965,0,1,response to capsazepine,BP,
19086,GO:1901607,1,0.67269527174374,0,61,alpha-amino acid biosynthetic process,BP,
19087,GO:1901608,1,0.974328398620579,0,4,regulation of vesicle transport along microtubule,BP,
19088,GO:1901609,1,0.993650899818868,0,1,negative regulation of vesicle transport along microtubule,BP,
19089,GO:1901610,1,0.980555261024915,0,3,positive regulation of vesicle transport along microtubule,BP,
19090,GO:1901611,1,0.919177971128427,0,13,phosphatidylglycerol binding,MF,
19091,GO:1901612,1,0.943128572165722,0,9,cardiolipin binding,MF,
19096,GO:1901620,1,0.949363925571941,0,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19097,GO:1901621,1,0.96168922035302,0,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19098,GO:1901622,1,0.993568300584555,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19101,GO:1901626,1,0.917801463056132,0,13,regulation of postsynaptic membrane organization,BP,
19102,GO:1901627,1,0.993583907242047,0,1,negative regulation of postsynaptic membrane organization,BP,
19103,GO:1901628,1,0.974109627747498,0,4,positive regulation of postsynaptic membrane organization,BP,
19104,GO:1901629,1,0.993155283953462,0,1,regulation of presynaptic membrane organization,BP,
19105,GO:1901631,1,0.993155283953462,0,1,positive regulation of presynaptic membrane organization,BP,
19106,GO:1901639,1,0.993333458067306,0,1,XDP catabolic process,BP,
19107,GO:1901640,1,0.993333458067306,0,1,XTP binding,MF,
19108,GO:1901641,1,0.993333458067306,0,1,ITP binding,MF,
19109,GO:1901642,1,0.96209888136636,0,6,nucleoside transmembrane transport,BP,
19110,GO:1901645,1,0.99362856345896,0,1,regulation of synoviocyte proliferation,BP,
19111,GO:1901647,1,0.99362856345896,0,1,positive regulation of synoviocyte proliferation,BP,
19116,GO:1901656,1,0.974285379198513,0,4,glycoside transport,BP,
19117,GO:1901657,1,0.471728121308451,0,116,glycosyl compound metabolic process,BP,
19118,GO:1901658,1,0.788175494837658,0,37,glycosyl compound catabolic process,BP,
19119,GO:1901659,1,0.783076931097706,0,38,glycosyl compound biosynthetic process,BP,
19120,GO:1901660,1,0.936021279521271,0,10,calcium ion export,BP,
19121,GO:1901661,1,0.814227665189992,0,32,quinone metabolic process,BP,
19122,GO:1901662,1,0.974610389553405,0,4,quinone catabolic process,BP,
19123,GO:1901663,1,0.908204736650977,0,15,quinone biosynthetic process,BP,
19124,GO:1901664,1,0.980725724042377,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19125,GO:1901666,1,0.980725724042377,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19126,GO:1901668,1,0.968429677886043,0,5,regulation of superoxide dismutase activity,BP,
19127,GO:1901671,1,0.974711293553188,0,4,positive regulation of superoxide dismutase activity,BP,
19128,GO:1901673,1,0.895471730623234,0,17,regulation of mitotic spindle assembly,BP,
19129,GO:1901674,1,0.986812581800602,0,2,regulation of histone H3-K27 acetylation,BP,
19130,GO:1901675,1,0.993275045782339,0,1,negative regulation of histone H3-K27 acetylation,BP,
19131,GO:1901676,1,0.99349421953329,0,1,positive regulation of histone H3-K27 acetylation,BP,
19132,GO:1901678,1,0.919363831728653,0,13,iron coordination entity transport,BP,
19133,GO:1901679,1,0.95581178392122,0,7,nucleotide transmembrane transport,BP,
19134,GO:1901680,1,0.992997617862815,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19136,GO:1901682,1,0.780234824722702,0,38,sulfur compound transmembrane transporter activity,MF,
19137,GO:1901685,1,0.885959165522988,0,19,glutathione derivative metabolic process,BP,
19138,GO:1901687,1,0.885959165522988,0,19,glutathione derivative biosynthetic process,BP,
19139,GO:1901696,1,0.993565591350976,0,1,cannabinoid biosynthetic process,BP,
19144,GO:1901702,1,0.980824922652278,0,3,salt transmembrane transporter activity,MF,
19145,GO:1901706,1,0.993567929492266,0,1,mesenchymal cell differentiation involved in bone development,BP,
19146,GO:1901707,1,0.993653954419938,0,1,leptomycin B binding,MF,
19147,GO:1901722,1,0.925262916624564,0,12,regulation of cell proliferation involved in kidney development,BP,
19148,GO:1901723,1,0.968161309082363,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19149,GO:1901724,1,0.955704878660417,0,7,positive regulation of cell proliferation involved in kidney development,BP,
19150,GO:1901725,1,0.941863255303707,0,9,regulation of histone deacetylase activity,BP,
19151,GO:1901726,1,0.98646288795133,0,2,negative regulation of histone deacetylase activity,BP,
19152,GO:1901727,1,0.961062288021412,0,6,positive regulation of histone deacetylase activity,BP,
19153,GO:1901731,1,0.980673654475951,0,3,positive regulation of platelet aggregation,BP,
19154,GO:1901739,1,0.896425474937509,0,17,regulation of myoblast fusion,BP,
19155,GO:1901740,1,0.987310394942834,0,2,negative regulation of myoblast fusion,BP,
19156,GO:1901741,1,0.907958166627071,0,15,positive regulation of myoblast fusion,BP,
19157,GO:1901748,1,0.980842216261927,0,3,leukotriene D4 metabolic process,BP,
19158,GO:1901750,1,0.980842216261927,0,3,leukotriene D4 biosynthetic process,BP,
19159,GO:1901751,1,0.987192680916367,0,2,leukotriene A4 metabolic process,BP,
19160,GO:1901753,1,0.993569790012993,0,1,leukotriene A4 biosynthetic process,BP,
19161,GO:1901796,1,0.332570185189815,0,168,regulation of signal transduction by p53 class mediator,BP,
19162,GO:1901797,1,0.839477102763435,0,27,negative regulation of signal transduction by p53 class mediator,BP,
19163,GO:1901798,1,0.866283914378546,0,22,positive regulation of signal transduction by p53 class mediator,BP,
19164,GO:1901799,1,0.717177479143045,0,51,negative regulation of proteasomal protein catabolic process,BP,
19165,GO:1901800,1,0.507500744282898,0,104,positive regulation of proteasomal protein catabolic process,BP,
19166,GO:1901804,1,0.987247421356187,0,2,beta-glucoside metabolic process,BP,
19167,GO:1901805,1,0.987247421356187,0,2,beta-glucoside catabolic process,BP,
19168,GO:1901810,1,0.99355705431691,0,1,beta-carotene metabolic process,BP,
19169,GO:1901825,1,0.993566204593089,0,1,zeaxanthin metabolic process,BP,
19170,GO:1901827,1,0.993566204593089,0,1,zeaxanthin biosynthetic process,BP,
19171,GO:1901834,1,0.993623471488449,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19172,GO:1901835,1,0.993623471488449,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19173,GO:1901836,1,0.936933971606487,0,10,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19174,GO:1901838,1,0.942948714949389,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19175,GO:1901841,1,0.919178421547844,0,13,regulation of high voltage-gated calcium channel activity,BP,
19176,GO:1901842,1,0.974376631712427,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19177,GO:1901843,1,0.974340509618017,0,4,positive regulation of high voltage-gated calcium channel activity,BP,
19178,GO:1901844,1,0.943027672175762,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19179,GO:1901846,1,0.993455843324481,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19181,GO:1901857,1,0.955943050700788,0,7,positive regulation of cellular respiration,BP,
19182,GO:1901858,1,0.974326292093092,0,4,regulation of mitochondrial DNA metabolic process,BP,
19183,GO:1901859,1,0.993560082176145,0,1,negative regulation of mitochondrial DNA metabolic process,BP,
19184,GO:1901860,1,0.99330761561877,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19188,GO:1901873,1,0.973792758102393,0,4,regulation of post-translational protein modification,BP,
19189,GO:1901874,1,0.980522528376722,0,3,negative regulation of post-translational protein modification,BP,
19190,GO:1901876,1,0.987356777905696,0,2,regulation of calcium ion binding,BP,
19191,GO:1901877,1,0.987356777905696,0,2,negative regulation of calcium ion binding,BP,
19192,GO:1901879,1,0.588932326975287,0,80,regulation of protein depolymerization,BP,
19193,GO:1901880,1,0.658752336748934,0,63,negative regulation of protein depolymerization,BP,
19194,GO:1901881,1,0.900987019380868,0,16,positive regulation of protein depolymerization,BP,
19196,GO:1901889,1,0.809623104062142,0,32,negative regulation of cell junction assembly,BP,
19197,GO:1901890,1,0.542065375425722,0,93,positive regulation of cell junction assembly,BP,
19199,GO:1901895,1,0.980562829186488,0,3,negative regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19201,GO:1901897,1,0.96153194529934,0,6,regulation of relaxation of cardiac muscle,BP,
19202,GO:1901898,1,0.986660748587146,0,2,negative regulation of relaxation of cardiac muscle,BP,
19203,GO:1901899,1,0.987224810569097,0,2,positive regulation of relaxation of cardiac muscle,BP,
19204,GO:1901906,1,0.974515979575416,0,4,diadenosine pentaphosphate metabolic process,BP,
19205,GO:1901907,1,0.974515979575416,0,4,diadenosine pentaphosphate catabolic process,BP,
19206,GO:1901908,1,0.974515979575416,0,4,diadenosine hexaphosphate metabolic process,BP,
19207,GO:1901909,1,0.974515979575416,0,4,diadenosine hexaphosphate catabolic process,BP,
19208,GO:1901910,1,0.974515979575416,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19209,GO:1901911,1,0.974515979575416,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19210,GO:1901917,1,0.993558236361319,0,1,regulation of exoribonuclease activity,BP,
19211,GO:1901919,1,0.993558236361319,0,1,positive regulation of exoribonuclease activity,BP,
19212,GO:1901950,1,0.928724799872283,0,11,dense core granule transport,BP,
19213,GO:1901951,1,0.986942818283193,0,2,regulation of anterograde dense core granule transport,BP,
19214,GO:1901953,1,0.986942818283193,0,2,positive regulation of anterograde dense core granule transport,BP,
19215,GO:1901962,1,0.993591022606845,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19216,GO:1901963,1,0.987182760503395,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19217,GO:1901964,1,0.993620720501988,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19218,GO:1901970,1,0.918795610259732,0,13,positive regulation of mitotic sister chromatid separation,BP,
19219,GO:1901976,1,0.817624623711026,0,31,regulation of cell cycle checkpoint,BP,
19220,GO:1901977,1,0.961966141057789,0,6,negative regulation of cell cycle checkpoint,BP,
19221,GO:1901978,1,0.942887675099688,0,9,positive regulation of cell cycle checkpoint,BP,
19222,GO:1901979,1,0.96779606318818,0,5,regulation of inward rectifier potassium channel activity,BP,
19223,GO:1901980,1,0.98666986626116,0,2,positive regulation of inward rectifier potassium channel activity,BP,
19227,GO:1901985,1,0.765022572682404,0,41,positive regulation of protein acetylation,BP,
19228,GO:1901986,1,0.993646046491589,0,1,response to ketamine,BP,
19229,GO:1901987,1,0.0633718932910933,0,418,regulation of cell cycle phase transition,BP,
19230,GO:1901988,1,0.228180750346909,0,226,negative regulation of cell cycle phase transition,BP,
19231,GO:1901989,1,0.552557477658262,0,91,positive regulation of cell cycle phase transition,BP,
19232,GO:1901990,1,0.0743878627883907,0,394,regulation of mitotic cell cycle phase transition,BP,
19233,GO:1901991,1,0.245324524599492,0,215,negative regulation of mitotic cell cycle phase transition,BP,
19234,GO:1901992,1,0.59759822878656,0,79,positive regulation of mitotic cell cycle phase transition,BP,
19235,GO:1901993,1,0.961935533382829,0,6,regulation of meiotic cell cycle phase transition,BP,
19236,GO:1901994,1,0.987127908211796,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19237,GO:1901995,1,0.974482382226348,0,4,positive regulation of meiotic cell cycle phase transition,BP,
19238,GO:1901998,1,0.776084364505964,0,39,toxin transport,BP,
19239,GO:1901999,1,0.993642584796253,0,1,homogentisate metabolic process,BP,
19240,GO:1902000,1,0.993642584796253,0,1,homogentisate catabolic process,BP,
19241,GO:1902001,1,0.871057131159118,0,21,fatty acid transmembrane transport,BP,
19242,GO:1902003,1,0.820689935057222,0,30,regulation of amyloid-beta formation,BP,
19243,GO:1902004,1,0.888661288906347,0,18,positive regulation of amyloid-beta formation,BP,
19244,GO:1902010,1,0.993517783031319,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19245,GO:1902017,1,0.729786676719149,0,48,regulation of cilium assembly,BP,
19246,GO:1902018,1,0.931135604464534,0,11,negative regulation of cilium assembly,BP,
19247,GO:1902019,1,0.896560489756075,0,17,regulation of cilium-dependent cell motility,BP,
19248,GO:1902020,1,0.993611019233983,0,1,negative regulation of cilium-dependent cell motility,BP,
19249,GO:1902022,1,0.967577509877278,0,5,L-lysine transport,BP,
19250,GO:1902023,1,0.936817603580719,0,10,L-arginine transport,BP,
19251,GO:1902031,1,0.974417421272225,0,4,regulation of NADP metabolic process,BP,
19252,GO:1902033,1,0.943343443858783,0,9,regulation of hematopoietic stem cell proliferation,BP,
19253,GO:1902035,1,0.961847726030134,0,6,positive regulation of hematopoietic stem cell proliferation,BP,
19254,GO:1902036,1,0.635337809618496,0,70,regulation of hematopoietic stem cell differentiation,BP,
19255,GO:1902037,1,0.980796938707732,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19256,GO:1902038,1,0.993520220807032,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19258,GO:1902042,1,0.786866152898963,0,37,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19260,GO:1902044,1,0.980689758450974,0,3,regulation of Fas signaling pathway,BP,
19261,GO:1902045,1,0.993582677778861,0,1,negative regulation of Fas signaling pathway,BP,
19262,GO:1902047,1,0.962081345195992,0,6,polyamine transmembrane transport,BP,
19263,GO:1902064,1,0.993511372571024,0,1,regulation of transcription from RNA polymerase II promoter involved in spermatogenesis,BP,
19264,GO:1902065,1,0.930732911336143,0,11,response to L-glutamate,BP,
19265,GO:1902071,1,0.993661181840464,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19266,GO:1902073,1,0.993661181840464,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19267,GO:1902074,1,0.925627950602347,0,12,response to salt,BP,
19268,GO:1902075,1,0.9560127949441,0,7,cellular response to salt,BP,
19269,GO:1902076,1,0.992796704709803,0,1,regulation of lateral motor column neuron migration,BP,
19270,GO:1902078,1,0.992796704709803,0,1,positive regulation of lateral motor column neuron migration,BP,
19271,GO:1902080,1,0.987182010307613,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19272,GO:1902081,1,0.993625616674369,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19273,GO:1902082,1,0.993515469491067,0,1,positive regulation of calcium ion import into sarcoplasmic reticulum,BP,
19274,GO:1902083,1,0.967148539654542,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19275,GO:1902093,1,0.943976067892853,0,9,positive regulation of flagellated sperm motility,BP,
19276,GO:1902098,1,0.993440832014577,0,1,calcitriol binding,MF,
19277,GO:1902099,1,0.693438632776389,0,56,regulation of metaphase/anaphase transition of cell cycle,BP,
19278,GO:1902100,1,0.790325890611194,0,36,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19279,GO:1902101,1,0.912922490196676,0,14,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19280,GO:1902102,1,0.987196210458918,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19281,GO:1902103,1,0.993542175290034,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19282,GO:1902104,1,0.993613200187168,0,1,positive regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19284,GO:1902106,1,0.559634255118785,0,89,negative regulation of leukocyte differentiation,BP,
19287,GO:1902109,1,0.987287884581259,0,2,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19289,GO:1902115,1,0.312985119037478,0,176,regulation of organelle assembly,BP,
19290,GO:1902116,1,0.790690542791157,0,36,negative regulation of organelle assembly,BP,
19291,GO:1902117,1,0.668336873064499,0,61,positive regulation of organelle assembly,BP,
19292,GO:1902121,1,0.993440832014577,0,1,lithocholic acid binding,MF,
19293,GO:1902122,1,0.993596235981754,0,1,chenodeoxycholic acid binding,MF,
19294,GO:1902159,1,0.987050522935579,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19295,GO:1902161,1,0.993322767667789,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19296,GO:1902162,1,0.981010127661951,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19297,GO:1902164,1,0.981010127661951,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19298,GO:1902165,1,0.9019901354781,0,16,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19299,GO:1902166,1,0.913615239914489,0,14,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19300,GO:1902167,1,0.993700422297972,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19301,GO:1902170,1,0.889290179305455,0,18,cellular response to reactive nitrogen species,BP,
19302,GO:1902172,1,0.968299957571277,0,5,regulation of keratinocyte apoptotic process,BP,
19303,GO:1902174,1,0.980850291148907,0,3,positive regulation of keratinocyte apoptotic process,BP,
19304,GO:1902175,1,0.856407021475509,0,24,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19305,GO:1902176,1,0.896229316995543,0,17,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19306,GO:1902177,1,0.968299054705186,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19307,GO:1902178,1,0.993470352375305,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19308,GO:1902186,1,0.833274380938866,0,28,regulation of viral release from host cell,BP,
19309,GO:1902187,1,0.912511554795446,0,14,negative regulation of viral release from host cell,BP,
19310,GO:1902188,1,0.913295530130281,0,14,positive regulation of viral release from host cell,BP,
19311,GO:1902202,1,0.974426022307945,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19312,GO:1902203,1,0.99342129946631,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19313,GO:1902204,1,0.993605458960661,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19314,GO:1902205,1,0.993626018701236,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19315,GO:1902206,1,0.993626018701236,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19316,GO:1902211,1,0.99355705431691,0,1,regulation of prolactin signaling pathway,BP,
19317,GO:1902213,1,0.99355705431691,0,1,positive regulation of prolactin signaling pathway,BP,
19318,GO:1902214,1,0.980556775436523,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19319,GO:1902215,1,0.993626018701236,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19320,GO:1902216,1,0.986847754780304,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19321,GO:1902217,1,0.993651099116604,0,1,erythrocyte apoptotic process,BP,
19322,GO:1902218,1,0.961899028300498,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19323,GO:1902219,1,0.968031970780933,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19324,GO:1902220,1,0.993666576647194,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19325,GO:1902221,1,0.937924211363937,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19326,GO:1902222,1,0.937924211363937,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19327,GO:1902224,1,0.925439676071407,0,12,ketone body metabolic process,BP,
19328,GO:1902225,1,0.99355705431691,0,1,negative regulation of acrosome reaction,BP,
19329,GO:1902226,1,0.980963458570635,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19330,GO:1902227,1,0.98730474891189,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19331,GO:1902228,1,0.99357798824772,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19332,GO:1902229,1,0.792731227606068,0,36,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19333,GO:1902230,1,0.829185585026321,0,29,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19334,GO:1902231,1,0.962329224321595,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19335,GO:1902232,1,0.987148202533114,0,2,regulation of positive thymic T cell selection,BP,
19336,GO:1902233,1,0.993626018701236,0,1,negative regulation of positive thymic T cell selection,BP,
19338,GO:1902236,1,0.889698719479042,0,18,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19340,GO:1902238,1,0.993477226936121,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19341,GO:1902239,1,0.993477226936121,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19342,GO:1902250,1,0.993651099116604,0,1,regulation of erythrocyte apoptotic process,BP,
19343,GO:1902251,1,0.993651099116604,0,1,negative regulation of erythrocyte apoptotic process,BP,
19344,GO:1902253,1,0.839953055153049,0,27,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19345,GO:1902254,1,0.883990940297164,0,19,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19346,GO:1902255,1,0.968769096008588,0,5,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19347,GO:1902256,1,0.98067613533177,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19348,GO:1902257,1,0.987189060893114,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19349,GO:1902259,1,0.889157313450725,0,18,regulation of delayed rectifier potassium channel activity,BP,
19350,GO:1902260,1,0.937071308603693,0,10,negative regulation of delayed rectifier potassium channel activity,BP,
19351,GO:1902261,1,0.973814293845821,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19352,GO:1902262,1,0.968256243873758,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19353,GO:1902263,1,0.980270835386347,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19354,GO:1902267,1,0.968388513270588,0,5,regulation of polyamine transmembrane transport,BP,
19355,GO:1902268,1,0.981075959446611,0,3,negative regulation of polyamine transmembrane transport,BP,
19356,GO:1902269,1,0.987070279622378,0,2,positive regulation of polyamine transmembrane transport,BP,
19357,GO:1902270,1,0.993528783654157,0,1,(R)-carnitine transmembrane transport,BP,
19358,GO:1902271,1,0.987114094544196,0,2,D3 vitamins binding,MF,
19360,GO:1902282,1,0.931389597377748,0,11,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19361,GO:1902283,1,0.993488007991549,0,1,negative regulation of primary amine oxidase activity,BP,
19362,GO:1902284,1,0.78722199923146,0,36,neuron projection extension involved in neuron projection guidance,BP,
19363,GO:1902285,1,0.916367286214725,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19364,GO:1902287,1,0.92247108724602,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19365,GO:1902292,1,0.967928832141951,0,5,cell cycle DNA replication initiation,BP,
19366,GO:1902296,1,0.99352825434979,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19367,GO:1902298,1,0.986455274126068,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19368,GO:1902299,1,0.949456670626831,0,8,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19370,GO:1902306,1,0.917994871006565,0,13,negative regulation of sodium ion transmembrane transport,BP,
19372,GO:1902308,1,0.967991515658735,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19373,GO:1902309,1,0.980493575553982,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19374,GO:1902310,1,0.98725171362434,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19375,GO:1902311,1,0.993621458804803,0,1,regulation of copper ion transmembrane transport,BP,
19376,GO:1902315,1,0.967928832141951,0,5,nuclear cell cycle DNA replication initiation,BP,
19377,GO:1902319,1,0.99352825434979,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19378,GO:1902336,1,0.987131788372622,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19379,GO:1902337,1,0.930545825676228,0,11,regulation of apoptotic process involved in morphogenesis,BP,
19380,GO:1902338,1,0.968027598213477,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19381,GO:1902339,1,0.967678072873662,0,5,positive regulation of apoptotic process involved in morphogenesis,BP,
19382,GO:1902356,1,0.974618507925107,0,4,oxaloacetate(2-) transmembrane transport,BP,
19383,GO:1902358,1,0.912876279780284,0,14,sulfate transmembrane transport,BP,
19384,GO:1902359,1,0.987202113543495,0,2,Notch signaling pathway involved in somitogenesis,BP,
19385,GO:1902362,1,0.993555236205952,0,1,melanocyte apoptotic process,BP,
19386,GO:1902363,1,0.993229466008014,0,1,regulation of protein localization to spindle pole body,BP,
19387,GO:1902365,1,0.993229466008014,0,1,positive regulation of protein localization to spindle pole body,BP,
19388,GO:1902366,1,0.987202113543495,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19389,GO:1902367,1,0.987202113543495,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19390,GO:1902369,1,0.702256297796278,0,54,negative regulation of RNA catabolic process,BP,
19391,GO:1902370,1,0.986812197093363,0,2,regulation of tRNA catabolic process,BP,
19392,GO:1902371,1,0.986812197093363,0,2,negative regulation of tRNA catabolic process,BP,
19393,GO:1902373,1,0.744918358786146,0,45,negative regulation of mRNA catabolic process,BP,
19394,GO:1902374,1,0.993617699077859,0,1,regulation of rRNA catabolic process,BP,
19395,GO:1902378,1,0.993574430978759,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19396,GO:1902379,1,0.987085407179648,0,2,chemoattractant activity involved in axon guidance,MF,
19397,GO:1902380,1,0.993578371531918,0,1,positive regulation of endoribonuclease activity,BP,
19398,GO:1902387,1,0.968276433610245,0,5,ceramide 1-phosphate binding,MF,
19399,GO:1902388,1,0.968213476170459,0,5,ceramide 1-phosphate transfer activity,MF,
19400,GO:1902389,1,0.968213476170459,0,5,ceramide 1-phosphate transport,BP,
19401,GO:1902396,1,0.961009306895752,0,6,protein localization to bicellular tight junction,BP,
19402,GO:1902400,1,0.697996136015895,0,55,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19403,GO:1902402,1,0.693474169986756,0,56,signal transduction involved in mitotic DNA damage checkpoint,BP,
19404,GO:1902403,1,0.693474169986756,0,56,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19405,GO:1902410,1,0.861943616333463,0,23,mitotic cytokinetic process,BP,
19406,GO:1902412,1,0.961388290218335,0,6,regulation of mitotic cytokinesis,BP,
19407,GO:1902414,1,0.515815894331836,0,100,protein localization to cell junction,BP,
19408,GO:1902415,1,0.937469002674875,0,10,regulation of mRNA binding,BP,
19409,GO:1902416,1,0.949621396561735,0,8,positive regulation of mRNA binding,BP,
19410,GO:1902423,1,0.980641499994989,0,3,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19411,GO:1902425,1,0.980641499994989,0,3,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19412,GO:1902426,1,0.993562427112928,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19413,GO:1902430,1,0.917746136055885,0,13,negative regulation of amyloid-beta formation,BP,
19414,GO:1902435,1,0.986386786878133,0,2,regulation of male mating behavior,BP,
19415,GO:1902437,1,0.986386786878133,0,2,positive regulation of male mating behavior,BP,
19416,GO:1902440,1,0.99355705431691,0,1,protein localization to mitotic spindle pole body,BP,
19417,GO:1902442,1,0.99350423369335,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19418,GO:1902443,1,0.99350423369335,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19419,GO:1902444,1,0.993660486248529,0,1,riboflavin binding,MF,
19420,GO:1902445,1,0.981063690588966,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19421,GO:1902455,1,0.961784133288239,0,6,negative regulation of stem cell population maintenance,BP,
19422,GO:1902459,1,0.948726845548834,0,8,positive regulation of stem cell population maintenance,BP,
19423,GO:1902460,1,0.974588099146349,0,4,regulation of mesenchymal stem cell proliferation,BP,
19424,GO:1902462,1,0.974588099146349,0,4,positive regulation of mesenchymal stem cell proliferation,BP,
19425,GO:1902463,1,0.980664707781449,0,3,protein localization to cell leading edge,BP,
19426,GO:1902464,1,0.993462761767218,0,1,regulation of histone H3-K27 trimethylation,BP,
19427,GO:1902466,1,0.993462761767218,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19428,GO:1902473,1,0.848882337826386,0,25,regulation of protein localization to synapse,BP,
19429,GO:1902474,1,0.929959323098842,0,11,positive regulation of protein localization to synapse,BP,
19432,GO:1902480,1,0.993578179839538,0,1,protein localization to mitotic spindle,BP,
19433,GO:1902488,1,0.99308300260054,0,1,cholangiocyte apoptotic process,BP,
19434,GO:1902490,1,0.993607433199545,0,1,regulation of sperm capacitation,BP,
19435,GO:1902493,1,0.573461735763073,0,85,acetyltransferase complex,CC,
19438,GO:1902498,1,0.967096643161369,0,5,regulation of protein autoubiquitination,BP,
19439,GO:1902499,1,0.980420358858331,0,3,positive regulation of protein autoubiquitination,BP,
19440,GO:1902504,1,0.99354467960849,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19441,GO:1902510,1,0.931605807095976,0,11,regulation of apoptotic DNA fragmentation,BP,
19442,GO:1902511,1,0.980743084880703,0,3,negative regulation of apoptotic DNA fragmentation,BP,
19443,GO:1902512,1,0.968685878592124,0,5,positive regulation of apoptotic DNA fragmentation,BP,
19444,GO:1902513,1,0.937055323254204,0,10,regulation of organelle transport along microtubule,BP,
19445,GO:1902514,1,0.924530813339132,0,12,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19446,GO:1902523,1,0.974143200109129,0,4,positive regulation of protein K63-linked ubiquitination,BP,
19447,GO:1902524,1,0.98718598324266,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19448,GO:1902525,1,0.961831664294768,0,6,regulation of protein monoubiquitination,BP,
19449,GO:1902527,1,0.968120408202117,0,5,positive regulation of protein monoubiquitination,BP,
19450,GO:1902528,1,0.993117547683677,0,1,regulation of protein linear polyubiquitination,BP,
19451,GO:1902530,1,0.993117547683677,0,1,positive regulation of protein linear polyubiquitination,BP,
19455,GO:1902544,1,0.987254370476207,0,2,regulation of DNA N-glycosylase activity,BP,
19456,GO:1902546,1,0.993683378759476,0,1,positive regulation of DNA N-glycosylase activity,BP,
19457,GO:1902547,1,0.888575540775673,0,18,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19458,GO:1902548,1,0.942556723316667,0,9,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19459,GO:1902551,1,0.993553493485706,0,1,regulation of catalase activity,BP,
19460,GO:1902553,1,0.993553493485706,0,1,positive regulation of catalase activity,BP,
19461,GO:1902554,1,0.577126449482374,0,84,serine/threonine protein kinase complex,CC,
19462,GO:1902555,1,0.829026374794645,0,29,endoribonuclease complex,CC,
19463,GO:1902559,1,0.987245694080208,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19464,GO:1902560,1,0.987292812091904,0,2,GMP reductase complex,CC,
19465,GO:1902562,1,0.760359303778574,0,42,H4 histone acetyltransferase complex,CC,
19466,GO:1902563,1,0.924910375580436,0,12,regulation of neutrophil activation,BP,
19467,GO:1902564,1,0.967904043542831,0,5,negative regulation of neutrophil activation,BP,
19468,GO:1902565,1,0.974295658862264,0,4,positive regulation of neutrophil activation,BP,
19469,GO:1902566,1,0.974627269887416,0,4,regulation of eosinophil activation,BP,
19470,GO:1902567,1,0.987227721942249,0,2,negative regulation of eosinophil activation,BP,
19471,GO:1902568,1,0.987238159661105,0,2,positive regulation of eosinophil activation,BP,
19472,GO:1902569,1,0.993613602965508,0,1,negative regulation of activation of Janus kinase activity,BP,
19473,GO:1902570,1,0.919173202307563,0,13,protein localization to nucleolus,BP,
19474,GO:1902571,1,0.974198245138575,0,4,regulation of serine-type peptidase activity,BP,
19475,GO:1902572,1,0.974198245138575,0,4,negative regulation of serine-type peptidase activity,BP,
19476,GO:1902573,1,0.993029719560696,0,1,positive regulation of serine-type peptidase activity,BP,
19477,GO:1902576,1,0.97447306574786,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19478,GO:1902579,1,0.670781444628742,0,61,multi-organism localization,BP,
19479,GO:1902586,1,0.99359069410163,0,1,multi-organism intercellular transport,BP,
19480,GO:1902595,1,0.987247946281758,0,2,regulation of DNA replication origin binding,BP,
19482,GO:1902603,1,0.980852237328591,0,3,carnitine transmembrane transport,BP,
19483,GO:1902605,1,0.993558651722586,0,1,heterotrimeric G-protein complex assembly,BP,
19484,GO:1902606,1,0.987380419405567,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19485,GO:1902608,1,0.987380419405567,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19486,GO:1902612,1,0.993558354949594,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19487,GO:1902613,1,0.993558354949594,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19488,GO:1902616,1,0.974561698792962,0,4,acyl carnitine transmembrane transport,BP,
19489,GO:1902617,1,0.967848232490594,0,5,response to fluoride,BP,
19490,GO:1902618,1,0.993338331053701,0,1,cellular response to fluoride,BP,
19491,GO:1902622,1,0.782433282673249,0,38,regulation of neutrophil migration,BP,
19492,GO:1902623,1,0.974249502953437,0,4,negative regulation of neutrophil migration,BP,
19493,GO:1902624,1,0.834775258857814,0,28,positive regulation of neutrophil migration,BP,
19494,GO:1902626,1,0.98112948513416,0,3,assembly of large subunit precursor of preribosome,BP,
19495,GO:1902629,1,0.993648573788288,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19496,GO:1902630,1,0.98028942400452,0,3,regulation of membrane hyperpolarization,BP,
19497,GO:1902631,1,0.993249948606173,0,1,negative regulation of membrane hyperpolarization,BP,
19498,GO:1902636,1,0.980933445729046,0,3,kinociliary basal body,CC,
19499,GO:1902644,1,0.889758723907457,0,18,tertiary alcohol metabolic process,BP,
19500,GO:1902645,1,0.948521126320791,0,8,tertiary alcohol biosynthetic process,BP,
19504,GO:1902659,1,0.980797052025119,0,3,regulation of glucose mediated signaling pathway,BP,
19505,GO:1902661,1,0.980797052025119,0,3,positive regulation of glucose mediated signaling pathway,BP,
19506,GO:1902667,1,0.751689049357583,0,43,regulation of axon guidance,BP,
19507,GO:1902668,1,0.836695619641012,0,27,negative regulation of axon guidance,BP,
19508,GO:1902669,1,0.947177427255305,0,8,positive regulation of axon guidance,BP,
19511,GO:1902683,1,0.900524419763881,0,16,regulation of receptor localization to synapse,BP,
19512,GO:1902684,1,0.993650899818868,0,1,negative regulation of receptor localization to synapse,BP,
19513,GO:1902685,1,0.973671015500263,0,4,positive regulation of receptor localization to synapse,BP,
19515,GO:1902688,1,0.987098243375882,0,2,regulation of NAD metabolic process,BP,
19516,GO:1902689,1,0.987098243375882,0,2,negative regulation of NAD metabolic process,BP,
19517,GO:1902691,1,0.993538179267919,0,1,respiratory basal cell differentiation,BP,
19518,GO:1902692,1,0.815339445907627,0,31,regulation of neuroblast proliferation,BP,
19519,GO:1902710,1,0.888619956951749,0,18,GABA receptor complex,CC,
19520,GO:1902711,1,0.894572778007846,0,17,GABA-A receptor complex,CC,
19521,GO:1902722,1,0.980803185579556,0,3,positive regulation of prolactin secretion,BP,
19522,GO:1902723,1,0.974335973841114,0,4,negative regulation of skeletal muscle satellite cell proliferation,BP,
19523,GO:1902724,1,0.986859500750163,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19524,GO:1902725,1,0.974131052160859,0,4,negative regulation of satellite cell differentiation,BP,
19525,GO:1902728,1,0.986859500750163,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19526,GO:1902729,1,0.993474766872755,0,1,negative regulation of proteoglycan biosynthetic process,BP,
19527,GO:1902730,1,0.97429231073403,0,4,positive regulation of proteoglycan biosynthetic process,BP,
19528,GO:1902731,1,0.979797673759385,0,3,negative regulation of chondrocyte proliferation,BP,
19529,GO:1902732,1,0.968283825487581,0,5,positive regulation of chondrocyte proliferation,BP,
19530,GO:1902737,1,0.974182040162965,0,4,dendritic filopodium,CC,
19531,GO:1902742,1,0.800538161309524,0,34,apoptotic process involved in development,BP,
19533,GO:1902744,1,0.973947625096381,0,4,negative regulation of lamellipodium organization,BP,
19535,GO:1902746,1,0.94255881519154,0,9,regulation of lens fiber cell differentiation,BP,
19536,GO:1902747,1,0.961777699059874,0,6,negative regulation of lens fiber cell differentiation,BP,
19537,GO:1902748,1,0.986359182422519,0,2,positive regulation of lens fiber cell differentiation,BP,
19538,GO:1902749,1,0.268232275034972,0,201,regulation of cell cycle G2/M phase transition,BP,
19539,GO:1902750,1,0.54414221523786,0,94,negative regulation of cell cycle G2/M phase transition,BP,
19540,GO:1902751,1,0.828168204476965,0,29,positive regulation of cell cycle G2/M phase transition,BP,
19541,GO:1902761,1,0.993539261188962,0,1,positive regulation of chondrocyte development,BP,
19542,GO:1902766,1,0.987302844910768,0,2,skeletal muscle satellite cell migration,BP,
19543,GO:1902767,1,0.987138627578934,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19544,GO:1902769,1,0.992865259922889,0,1,regulation of choline O-acetyltransferase activity,BP,
19545,GO:1902771,1,0.992865259922889,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19546,GO:1902773,1,0.993541792228044,0,1,GTPase activator complex,CC,
19547,GO:1902774,1,0.955149628888353,0,7,late endosome to lysosome transport,BP,
19548,GO:1902775,1,0.980431674154999,0,3,mitochondrial large ribosomal subunit assembly,BP,
19549,GO:1902803,1,0.967574408821646,0,5,regulation of synaptic vesicle transport,BP,
19550,GO:1902804,1,0.993650899818868,0,1,negative regulation of synaptic vesicle transport,BP,
19551,GO:1902805,1,0.993364432846303,0,1,positive regulation of synaptic vesicle transport,BP,
19552,GO:1902806,1,0.354920705245592,0,158,regulation of cell cycle G1/S phase transition,BP,
19553,GO:1902807,1,0.513170404628916,0,102,negative regulation of cell cycle G1/S phase transition,BP,
19554,GO:1902808,1,0.750707797910359,0,44,positive regulation of cell cycle G1/S phase transition,BP,
19555,GO:1902809,1,0.974464894310288,0,4,regulation of skeletal muscle fiber differentiation,BP,
19556,GO:1902811,1,0.980791778328687,0,3,positive regulation of skeletal muscle fiber differentiation,BP,
19557,GO:1902816,1,0.96740302670247,0,5,regulation of protein localization to microtubule,BP,
19558,GO:1902817,1,0.96740302670247,0,5,negative regulation of protein localization to microtubule,BP,
19559,GO:1902822,1,0.974094727469375,0,4,regulation of late endosome to lysosome transport,BP,
19560,GO:1902823,1,0.986608239598006,0,2,negative regulation of late endosome to lysosome transport,BP,
19561,GO:1902824,1,0.987318334319974,0,2,positive regulation of late endosome to lysosome transport,BP,
19562,GO:1902834,1,0.993516082062855,0,1,regulation of proline import across plasma membrane,BP,
19563,GO:1902836,1,0.993516082062855,0,1,positive regulation of proline import across plasma membrane,BP,
19564,GO:1902838,1,0.993406836997533,0,1,regulation of nuclear migration along microtubule,BP,
19565,GO:1902841,1,0.973700059527684,0,4,regulation of netrin-activated signaling pathway,BP,
19566,GO:1902842,1,0.973700059527684,0,4,negative regulation of netrin-activated signaling pathway,BP,
19567,GO:1902846,1,0.993229466008014,0,1,positive regulation of mitotic spindle elongation,BP,
19568,GO:1902847,1,0.993552570870591,0,1,regulation of neuronal signal transduction,BP,
19569,GO:1902850,1,0.411196639359876,0,135,microtubule cytoskeleton organization involved in mitosis,BP,
19570,GO:1902855,1,0.942734686653606,0,9,regulation of non-motile cilium assembly,BP,
19571,GO:1902856,1,0.980541122787767,0,3,negative regulation of non-motile cilium assembly,BP,
19572,GO:1902857,1,0.96767163893803,0,5,positive regulation of non-motile cilium assembly,BP,
19573,GO:1902858,1,0.993596898720476,0,1,propionyl-CoA metabolic process,BP,
19574,GO:1902860,1,0.993596898720476,0,1,propionyl-CoA biosynthetic process,BP,
19575,GO:1902866,1,0.955692696737194,0,7,regulation of retina development in camera-type eye,BP,
19576,GO:1902867,1,0.99353645562527,0,1,negative regulation of retina development in camera-type eye,BP,
19577,GO:1902868,1,0.987214742689817,0,2,positive regulation of retina development in camera-type eye,BP,
19578,GO:1902869,1,0.980833017856327,0,3,regulation of amacrine cell differentiation,BP,
19579,GO:1902870,1,0.99353645562527,0,1,negative regulation of amacrine cell differentiation,BP,
19580,GO:1902871,1,0.987214742689817,0,2,positive regulation of amacrine cell differentiation,BP,
19583,GO:1902884,1,0.889707561450462,0,18,positive regulation of response to oxidative stress,BP,
19584,GO:1902889,1,0.993263355971432,0,1,protein localization to spindle microtubule,BP,
19585,GO:1902893,1,0.715716775384952,0,51,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19586,GO:1902894,1,0.911870879122406,0,14,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19587,GO:1902895,1,0.769885542919829,0,40,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19588,GO:1902896,1,0.980723178265636,0,3,terminal web assembly,BP,
19589,GO:1902897,1,0.980652233333994,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19590,GO:1902902,1,0.924862980780692,0,12,negative regulation of autophagosome assembly,BP,
19594,GO:1902908,1,0.987138768836807,0,2,regulation of melanosome transport,BP,
19595,GO:1902910,1,0.993471216481218,0,1,positive regulation of melanosome transport,BP,
19596,GO:1902911,1,0.525751829574754,0,98,protein kinase complex,CC,
19597,GO:1902912,1,0.99355705431691,0,1,pyruvate kinase complex,CC,
19598,GO:1902913,1,0.993535114757867,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19599,GO:1902914,1,0.865419136642155,0,22,regulation of protein polyubiquitination,BP,
19600,GO:1902915,1,0.942241788196733,0,9,negative regulation of protein polyubiquitination,BP,
19601,GO:1902916,1,0.930792012588571,0,11,positive regulation of protein polyubiquitination,BP,
19603,GO:1902931,1,0.919452174826151,0,13,negative regulation of alcohol biosynthetic process,BP,
19606,GO:1902937,1,0.98071192872987,0,3,inward rectifier potassium channel complex,CC,
19607,GO:1902938,1,0.980403521956777,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19608,GO:1902939,1,0.993549886906594,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19609,GO:1902941,1,0.986846501926876,0,2,regulation of voltage-gated chloride channel activity,BP,
19610,GO:1902943,1,0.986846501926876,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19611,GO:1902945,1,0.993492995387735,0,1,metalloendopeptidase activity involved in amyloid precursor protein catabolic process,MF,
19612,GO:1902946,1,0.935742511440159,0,10,protein localization to early endosome,BP,
19613,GO:1902947,1,0.936699487743246,0,10,regulation of tau-protein kinase activity,BP,
19614,GO:1902948,1,0.986346871677053,0,2,negative regulation of tau-protein kinase activity,BP,
19615,GO:1902949,1,0.961961091143153,0,6,positive regulation of tau-protein kinase activity,BP,
19616,GO:1902950,1,0.937085779416933,0,10,regulation of dendritic spine maintenance,BP,
19617,GO:1902951,1,0.980625749107143,0,3,negative regulation of dendritic spine maintenance,BP,
19618,GO:1902952,1,0.980679569264354,0,3,positive regulation of dendritic spine maintenance,BP,
19619,GO:1902953,1,0.973786849915888,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19620,GO:1902954,1,0.986107003150623,0,2,regulation of early endosome to recycling endosome transport,BP,
19621,GO:1902955,1,0.992865259922889,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19624,GO:1902958,1,0.981025434082331,0,3,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19625,GO:1902959,1,0.942512359403151,0,9,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19626,GO:1902960,1,0.986495520400031,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19627,GO:1902961,1,0.955420663234605,0,7,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19628,GO:1902962,1,0.986412063203053,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19629,GO:1902963,1,0.986412063203053,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19630,GO:1902965,1,0.948056101320101,0,8,regulation of protein localization to early endosome,BP,
19631,GO:1902966,1,0.948056101320101,0,8,positive regulation of protein localization to early endosome,BP,
19632,GO:1902969,1,0.906440973355402,0,15,mitotic DNA replication,BP,
19633,GO:1902975,1,0.967928832141951,0,5,mitotic DNA replication initiation,BP,
19634,GO:1902977,1,0.993611321121686,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19635,GO:1902983,1,0.99352825434979,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19636,GO:1902988,1,0.979908213733539,0,3,neurofibrillary tangle assembly,BP,
19637,GO:1902990,1,0.980687342146332,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19638,GO:1902991,1,0.789138951886821,0,36,regulation of amyloid precursor protein catabolic process,BP,
19639,GO:1902992,1,0.905903797300586,0,15,negative regulation of amyloid precursor protein catabolic process,BP,
19640,GO:1902993,1,0.87169752585255,0,21,positive regulation of amyloid precursor protein catabolic process,BP,
19641,GO:1902994,1,0.980725155946559,0,3,regulation of phospholipid efflux,BP,
19642,GO:1902995,1,0.980725155946559,0,3,positive regulation of phospholipid efflux,BP,
19643,GO:1902996,1,0.986463374735804,0,2,regulation of neurofibrillary tangle assembly,BP,
19644,GO:1902997,1,0.992865259922889,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19645,GO:1902998,1,0.993552570870591,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19646,GO:1903000,1,0.993661049356776,0,1,regulation of lipid transport across blood-brain barrier,BP,
19647,GO:1903002,1,0.993661049356776,0,1,positive regulation of lipid transport across blood-brain barrier,BP,
19648,GO:1903003,1,0.961820208892781,0,6,positive regulation of protein deubiquitination,BP,
19649,GO:1903004,1,0.993496871955458,0,1,regulation of protein K63-linked deubiquitination,BP,
19650,GO:1903006,1,0.993496871955458,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19651,GO:1903007,1,0.993496871955458,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19652,GO:1903008,1,0.50568330191542,0,104,organelle disassembly,BP,
19655,GO:1903012,1,0.949823387091383,0,8,positive regulation of bone development,BP,
19656,GO:1903015,1,0.987278154484154,0,2,regulation of exo-alpha-sialidase activity,BP,
19657,GO:1903016,1,0.993610516163832,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19658,GO:1903017,1,0.993627324866982,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19660,GO:1903019,1,0.913440611583711,0,14,negative regulation of glycoprotein metabolic process,BP,
19661,GO:1903020,1,0.85462690420661,0,24,positive regulation of glycoprotein metabolic process,BP,
19662,GO:1903025,1,0.924033738147445,0,12,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19663,GO:1903026,1,0.968170597225336,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19664,GO:1903027,1,0.980523659481604,0,3,regulation of opsonization,BP,
19665,GO:1903028,1,0.986850036256663,0,2,positive regulation of opsonization,BP,
19666,GO:1903031,1,0.987221262130271,0,2,regulation of microtubule plus-end binding,BP,
19667,GO:1903033,1,0.987221262130271,0,2,positive regulation of microtubule plus-end binding,BP,
19670,GO:1903036,1,0.671339881665878,0,61,positive regulation of response to wounding,BP,
19672,GO:1903038,1,0.479172555385562,0,113,negative regulation of leukocyte cell-cell adhesion,BP,
19674,GO:1903041,1,0.993539261188962,0,1,regulation of chondrocyte hypertrophy,BP,
19675,GO:1903043,1,0.993539261188962,0,1,positive regulation of chondrocyte hypertrophy,BP,
19676,GO:1903044,1,0.94958820365704,0,8,protein localization to membrane raft,BP,
19677,GO:1903045,1,0.993364517742791,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19678,GO:1903046,1,0.360177517193101,0,156,meiotic cell cycle process,BP,
19680,GO:1903050,1,0.254077450782188,0,209,regulation of proteolysis involved in cellular protein catabolic process,BP,
19681,GO:1903051,1,0.653806439042675,0,65,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19682,GO:1903052,1,0.456744555822315,0,120,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19683,GO:1903053,1,0.779124808575944,0,38,regulation of extracellular matrix organization,BP,
19684,GO:1903054,1,0.930911562474534,0,11,negative regulation of extracellular matrix organization,BP,
19685,GO:1903055,1,0.888669595034543,0,18,positive regulation of extracellular matrix organization,BP,
19686,GO:1903056,1,0.986714861579366,0,2,regulation of melanosome organization,BP,
19689,GO:1903061,1,0.974118172828378,0,4,positive regulation of protein lipidation,BP,
19690,GO:1903069,1,0.943526433673959,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19691,GO:1903070,1,0.980836966425614,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19692,GO:1903071,1,0.955794210935018,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19693,GO:1903072,1,0.993677246056371,0,1,regulation of death-inducing signaling complex assembly,BP,
19694,GO:1903073,1,0.993677246056371,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19695,GO:1903076,1,0.53730586633533,0,95,regulation of protein localization to plasma membrane,BP,
19696,GO:1903077,1,0.861129553833034,0,23,negative regulation of protein localization to plasma membrane,BP,
19697,GO:1903078,1,0.692546037346634,0,56,positive regulation of protein localization to plasma membrane,BP,
19698,GO:1903080,1,0.993669453079625,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19699,GO:1903082,1,0.993669453079625,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19700,GO:1903093,1,0.980695704203792,0,3,regulation of protein K48-linked deubiquitination,BP,
19701,GO:1903094,1,0.987370530394118,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19702,GO:1903095,1,0.987059038820619,0,2,ribonuclease III complex,CC,
19703,GO:1903096,1,0.993542175290034,0,1,protein localization to meiotic spindle midzone,BP,
19704,GO:1903108,1,0.980735744899751,0,3,regulation of mitochondrial transcription,BP,
19705,GO:1903109,1,0.987145425687186,0,2,positive regulation of mitochondrial transcription,BP,
19707,GO:1903116,1,0.974200809438126,0,4,positive regulation of actin filament-based movement,BP,
19708,GO:1903119,1,0.993486188892521,0,1,protein localization to actin cytoskeleton,BP,
19709,GO:1903121,1,0.974283561597313,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19710,GO:1903122,1,0.993677246056371,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19711,GO:1903123,1,0.993035571048495,0,1,regulation of thioredoxin peroxidase activity,BP,
19712,GO:1903124,1,0.993035571048495,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19713,GO:1903125,1,0.993035571048495,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19714,GO:1903126,1,0.993597296638665,0,1,negative regulation of centriole-centriole cohesion,BP,
19715,GO:1903131,1,0.800696271544685,0,34,mononuclear cell differentiation,BP,
19716,GO:1903135,1,0.974568519903513,0,4,cupric ion binding,MF,
19718,GO:1903140,1,0.906727620116819,0,15,regulation of establishment of endothelial barrier,BP,
19719,GO:1903141,1,0.987034760509288,0,2,negative regulation of establishment of endothelial barrier,BP,
19720,GO:1903142,1,0.961758821095133,0,6,positive regulation of establishment of endothelial barrier,BP,
19721,GO:1903143,1,0.980878171720748,0,3,adrenomedullin receptor complex,CC,
19722,GO:1903146,1,0.767526083447114,0,40,regulation of autophagy of mitochondrion,BP,
19723,GO:1903147,1,0.949212723524906,0,8,negative regulation of autophagy of mitochondrion,BP,
19724,GO:1903165,1,0.99356149217418,0,1,response to polycyclic arene,BP,
19725,GO:1903167,1,0.993677246056371,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19726,GO:1903168,1,0.993677246056371,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19728,GO:1903170,1,0.796669610070612,0,35,negative regulation of calcium ion transmembrane transport,BP,
19729,GO:1903173,1,0.987158194782415,0,2,fatty alcohol metabolic process,BP,
19730,GO:1903176,1,0.993677246056371,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19731,GO:1903178,1,0.993677246056371,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19732,GO:1903179,1,0.987245802702257,0,2,regulation of dopamine biosynthetic process,BP,
19733,GO:1903181,1,0.987245802702257,0,2,positive regulation of dopamine biosynthetic process,BP,
19734,GO:1903182,1,0.993659525454334,0,1,regulation of SUMO transferase activity,BP,
19735,GO:1903184,1,0.993677246056371,0,1,L-dopa metabolic process,BP,
19736,GO:1903185,1,0.993677246056371,0,1,L-dopa biosynthetic process,BP,
19737,GO:1903189,1,0.993677246056371,0,1,glyoxal metabolic process,BP,
19738,GO:1903190,1,0.993677246056371,0,1,glyoxal catabolic process,BP,
19739,GO:1903195,1,0.993677246056371,0,1,regulation of L-dopa biosynthetic process,BP,
19740,GO:1903197,1,0.993677246056371,0,1,positive regulation of L-dopa biosynthetic process,BP,
19741,GO:1903198,1,0.993677246056371,0,1,regulation of L-dopa decarboxylase activity,BP,
19742,GO:1903200,1,0.993677246056371,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19745,GO:1903203,1,0.85984084003468,0,23,regulation of oxidative stress-induced neuron death,BP,
19746,GO:1903204,1,0.894503746909312,0,17,negative regulation of oxidative stress-induced neuron death,BP,
19749,GO:1903207,1,0.974510738914181,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19750,GO:1903208,1,0.974510738914181,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19751,GO:1903209,1,0.912896893816336,0,14,positive regulation of oxidative stress-induced cell death,BP,
19752,GO:1903210,1,0.986767185520654,0,2,glomerular visceral epithelial cell apoptotic process,BP,
19753,GO:1903214,1,0.755260594780539,0,43,regulation of protein targeting to mitochondrion,BP,
19754,GO:1903215,1,0.95532347183778,0,7,negative regulation of protein targeting to mitochondrion,BP,
19755,GO:1903216,1,0.986740921105928,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19756,GO:1903217,1,0.986740921105928,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19757,GO:1903223,1,0.967644984512398,0,5,positive regulation of oxidative stress-induced neuron death,BP,
19758,GO:1903224,1,0.973898056569644,0,4,regulation of endodermal cell differentiation,BP,
19759,GO:1903225,1,0.980153294238446,0,3,negative regulation of endodermal cell differentiation,BP,
19760,GO:1903231,1,0.987350054460965,0,2,mRNA binding involved in posttranscriptional gene silencing,MF,
19761,GO:1903232,1,0.968426414624336,0,5,melanosome assembly,BP,
19762,GO:1903233,1,0.973734198148319,0,4,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19763,GO:1903235,1,0.993433494520763,0,1,positive regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19764,GO:1903236,1,0.918529851726133,0,13,regulation of leukocyte tethering or rolling,BP,
19765,GO:1903237,1,0.974894629585114,0,4,negative regulation of leukocyte tethering or rolling,BP,
19766,GO:1903238,1,0.949157506870745,0,8,positive regulation of leukocyte tethering or rolling,BP,
19767,GO:1903241,1,0.980722650190138,0,3,U2-type prespliceosome assembly,BP,
19768,GO:1903242,1,0.948560039460722,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19769,GO:1903243,1,0.961051267271737,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19770,GO:1903244,1,0.987007666347042,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19771,GO:1903248,1,0.99307768176836,0,1,regulation of citrulline biosynthetic process,BP,
19772,GO:1903249,1,0.99307768176836,0,1,negative regulation of citrulline biosynthetic process,BP,
19773,GO:1903251,1,0.955595813407447,0,7,multi-ciliated epithelial cell differentiation,BP,
19774,GO:1903265,1,0.937402476934839,0,10,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19777,GO:1903279,1,0.980571901884726,0,3,regulation of calcium:sodium antiporter activity,BP,
19778,GO:1903280,1,0.993380701370849,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19779,GO:1903281,1,0.987106701063697,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19783,GO:1903286,1,0.948227360874374,0,8,regulation of potassium ion import,BP,
19784,GO:1903288,1,0.954513336080742,0,7,positive regulation of potassium ion import across plasma membrane,BP,
19785,GO:1903292,1,0.987102531382694,0,2,protein localization to Golgi membrane,BP,
19786,GO:1903293,1,0.740994680011661,0,46,phosphatase complex,CC,
19787,GO:1903294,1,0.980462257369743,0,3,regulation of glutamate secretion, neurotransmission,BP,
19788,GO:1903296,1,0.980462257369743,0,3,positive regulation of glutamate secretion, neurotransmission,BP,
19789,GO:1903297,1,0.96822895075526,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19790,GO:1903298,1,0.96822895075526,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19791,GO:1903299,1,0.942949545033786,0,9,regulation of hexokinase activity,BP,
19792,GO:1903300,1,0.974581909240641,0,4,negative regulation of hexokinase activity,BP,
19793,GO:1903301,1,0.967550851339432,0,5,positive regulation of hexokinase activity,BP,
19794,GO:1903302,1,0.993603086978874,0,1,regulation of pyruvate kinase activity,BP,
19795,GO:1903305,1,0.36399071719085,0,154,regulation of regulated secretory pathway,BP,
19796,GO:1903306,1,0.866677865179732,0,22,negative regulation of regulated secretory pathway,BP,
19797,GO:1903307,1,0.707555559276184,0,53,positive regulation of regulated secretory pathway,BP,
19798,GO:1903311,1,0.125107278790128,0,316,regulation of mRNA metabolic process,BP,
19799,GO:1903312,1,0.612993861201668,0,75,negative regulation of mRNA metabolic process,BP,
19800,GO:1903313,1,0.599475820288946,0,78,positive regulation of mRNA metabolic process,BP,
19801,GO:1903314,1,0.993596235981754,0,1,regulation of nitrogen cycle metabolic process,BP,
19803,GO:1903318,1,0.838831390497341,0,27,negative regulation of protein maturation,BP,
19805,GO:1903320,1,0.237823718048739,0,219,regulation of protein modification by small protein conjugation or removal,BP,
19806,GO:1903321,1,0.5900545830311,0,81,negative regulation of protein modification by small protein conjugation or removal,BP,
19807,GO:1903322,1,0.43297396936768,0,128,positive regulation of protein modification by small protein conjugation or removal,BP,
19808,GO:1903326,1,0.986812197093363,0,2,regulation of tRNA metabolic process,BP,
19809,GO:1903327,1,0.986812197093363,0,2,negative regulation of tRNA metabolic process,BP,
19810,GO:1903332,1,0.925315165036454,0,12,regulation of protein folding,BP,
19811,GO:1903333,1,0.962110015500429,0,6,negative regulation of protein folding,BP,
19812,GO:1903334,1,0.974340112252696,0,4,positive regulation of protein folding,BP,
19813,GO:1903335,1,0.974094727469375,0,4,regulation of vacuolar transport,BP,
19814,GO:1903336,1,0.986608239598006,0,2,negative regulation of vacuolar transport,BP,
19815,GO:1903337,1,0.987318334319974,0,2,positive regulation of vacuolar transport,BP,
19816,GO:1903341,1,0.993331082223326,0,1,regulation of meiotic DNA double-strand break formation,BP,
19817,GO:1903343,1,0.993331082223326,0,1,positive regulation of meiotic DNA double-strand break formation,BP,
19818,GO:1903347,1,0.973952984494019,0,4,negative regulation of bicellular tight junction assembly,BP,
19819,GO:1903348,1,0.961867904059103,0,6,positive regulation of bicellular tight junction assembly,BP,
19820,GO:1903349,1,0.974279176845617,0,4,omegasome membrane,CC,
19823,GO:1903352,1,0.961349071410876,0,6,L-ornithine transmembrane transport,BP,
19824,GO:1903353,1,0.993428982986734,0,1,regulation of nucleus organization,BP,
19825,GO:1903358,1,0.906574619873429,0,15,regulation of Golgi organization,BP,
19826,GO:1903361,1,0.94987311161589,0,8,protein localization to basolateral plasma membrane,BP,
19828,GO:1903363,1,0.604683648182039,0,77,negative regulation of cellular protein catabolic process,BP,
19833,GO:1903371,1,0.9674270493126,0,5,regulation of endoplasmic reticulum tubular network organization,BP,
19834,GO:1903373,1,0.980356266715389,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19835,GO:1903375,1,0.980454908622329,0,3,facioacoustic ganglion development,BP,
19836,GO:1903376,1,0.955618922538196,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19837,GO:1903377,1,0.974514033497119,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19838,GO:1903378,1,0.987042957181543,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19839,GO:1903381,1,0.993452278385691,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19840,GO:1903382,1,0.993452278385691,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19841,GO:1903383,1,0.987280995240913,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19842,GO:1903384,1,0.987280995240913,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19843,GO:1903385,1,0.980597696372016,0,3,regulation of homophilic cell adhesion,BP,
19844,GO:1903387,1,0.993396435029035,0,1,positive regulation of homophilic cell adhesion,BP,
19845,GO:1903391,1,0.967814346257834,0,5,regulation of adherens junction organization,BP,
19846,GO:1903392,1,0.980636147575068,0,3,negative regulation of adherens junction organization,BP,
19847,GO:1903393,1,0.986927556328819,0,2,positive regulation of adherens junction organization,BP,
19848,GO:1903394,1,0.9935829363224,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19849,GO:1903400,1,0.948988683926064,0,8,L-arginine transmembrane transport,BP,
19850,GO:1903401,1,0.967577509877278,0,5,L-lysine transmembrane transport,BP,
19851,GO:1903402,1,0.993496585506695,0,1,regulation of renal phosphate excretion,BP,
19852,GO:1903403,1,0.993496585506695,0,1,negative regulation of renal phosphate excretion,BP,
19853,GO:1903405,1,0.925655956672741,0,12,protein localization to nuclear body,BP,
19854,GO:1903406,1,0.993509563868202,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19855,GO:1903408,1,0.993509563868202,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19857,GO:1903412,1,0.968476878124086,0,5,response to bile acid,BP,
19858,GO:1903413,1,0.968476878124086,0,5,cellular response to bile acid,BP,
19859,GO:1903416,1,0.968015846898177,0,5,response to glycoside,BP,
19860,GO:1903420,1,0.993300087748689,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19862,GO:1903422,1,0.986895219304733,0,2,negative regulation of synaptic vesicle recycling,BP,
19863,GO:1903423,1,0.942342328003028,0,9,positive regulation of synaptic vesicle recycling,BP,
19865,GO:1903427,1,0.838957089297246,0,27,negative regulation of reactive oxygen species biosynthetic process,BP,
19866,GO:1903428,1,0.745168255856166,0,45,positive regulation of reactive oxygen species biosynthetic process,BP,
19867,GO:1903429,1,0.865812849048088,0,22,regulation of cell maturation,BP,
19868,GO:1903430,1,0.961967390484179,0,6,negative regulation of cell maturation,BP,
19869,GO:1903431,1,0.936340164634504,0,10,positive regulation of cell maturation,BP,
19870,GO:1903432,1,0.817079675358534,0,31,regulation of TORC1 signaling,BP,
19871,GO:1903433,1,0.987094139253037,0,2,regulation of constitutive secretory pathway,BP,
19872,GO:1903434,1,0.993497557652032,0,1,negative regulation of constitutive secretory pathway,BP,
19873,GO:1903435,1,0.993555090343023,0,1,positive regulation of constitutive secretory pathway,BP,
19874,GO:1903436,1,0.986876177417081,0,2,regulation of mitotic cytokinetic process,BP,
19875,GO:1903438,1,0.986876177417081,0,2,positive regulation of mitotic cytokinetic process,BP,
19876,GO:1903439,1,0.968350533238926,0,5,calcitonin family receptor complex,CC,
19877,GO:1903440,1,0.974767241644686,0,4,amylin receptor complex,CC,
19878,GO:1903441,1,0.930662059784409,0,11,protein localization to ciliary membrane,BP,
19879,GO:1903442,1,0.993499374287033,0,1,response to lipoic acid,BP,
19880,GO:1903444,1,0.987136656052898,0,2,negative regulation of brown fat cell differentiation,BP,
19881,GO:1903445,1,0.980978418266466,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19882,GO:1903450,1,0.993096569042986,0,1,regulation of G1 to G0 transition,BP,
19883,GO:1903452,1,0.993096569042986,0,1,positive regulation of G1 to G0 transition,BP,
19884,GO:1903457,1,0.993603654499301,0,1,lactate catabolic process,BP,
19885,GO:1903461,1,0.993538125269423,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19886,GO:1903463,1,0.974281484158448,0,4,regulation of mitotic cell cycle DNA replication,BP,
19887,GO:1903464,1,0.987171395192451,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19888,GO:1903465,1,0.993366468805071,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19889,GO:1903487,1,0.980915626783685,0,3,regulation of lactation,BP,
19890,GO:1903489,1,0.987319349385226,0,2,positive regulation of lactation,BP,
19891,GO:1903490,1,0.986876177417081,0,2,positive regulation of mitotic cytokinesis,BP,
19892,GO:1903492,1,0.993685289586667,0,1,response to acetylsalicylate,BP,
19893,GO:1903494,1,0.993674275777176,0,1,response to dehydroepiandrosterone,BP,
19894,GO:1903496,1,0.993674275777176,0,1,response to 11-deoxycorticosterone,BP,
19895,GO:1903504,1,0.912826692082268,0,14,regulation of mitotic spindle checkpoint,BP,
19899,GO:1903509,1,0.508425223972749,0,104,liposaccharide metabolic process,BP,
19901,GO:1903512,1,0.993603554328525,0,1,phytanic acid metabolic process,BP,
19902,GO:1903513,1,0.844593723501548,0,26,endoplasmic reticulum to cytosol transport,BP,
19904,GO:1903515,1,0.986612519448229,0,2,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19905,GO:1903516,1,0.980760779839035,0,3,regulation of single strand break repair,BP,
19906,GO:1903517,1,0.99354954696155,0,1,negative regulation of single strand break repair,BP,
19907,GO:1903518,1,0.987129031612869,0,2,positive regulation of single strand break repair,BP,
19908,GO:1903519,1,0.987167194724238,0,2,regulation of mammary gland involution,BP,
19909,GO:1903521,1,0.987167194724238,0,2,positive regulation of mammary gland involution,BP,
19913,GO:1903525,1,0.961278640625566,0,6,regulation of membrane tubulation,BP,
19914,GO:1903526,1,0.987013510532048,0,2,negative regulation of membrane tubulation,BP,
19915,GO:1903527,1,0.973929890633559,0,4,positive regulation of membrane tubulation,BP,
19919,GO:1903533,1,0.601493985709743,0,78,regulation of protein targeting,BP,
19920,GO:1903537,1,0.987176141329795,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19921,GO:1903538,1,0.987176141329795,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19922,GO:1903539,1,0.76461054436788,0,41,protein localization to postsynaptic membrane,BP,
19923,GO:1903540,1,0.901275549520036,0,16,establishment of protein localization to postsynaptic membrane,BP,
19924,GO:1903541,1,0.913376715676731,0,14,regulation of exosomal secretion,BP,
19925,GO:1903542,1,0.987155237210914,0,2,negative regulation of exosomal secretion,BP,
19926,GO:1903543,1,0.913376715676731,0,14,positive regulation of exosomal secretion,BP,
19927,GO:1903544,1,0.993521543099334,0,1,response to butyrate,BP,
19928,GO:1903545,1,0.993521543099334,0,1,cellular response to butyrate,BP,
19929,GO:1903546,1,0.967219064541215,0,5,protein localization to photoreceptor outer segment,BP,
19930,GO:1903547,1,0.987366562159162,0,2,regulation of growth hormone activity,BP,
19931,GO:1903551,1,0.961857433173384,0,6,regulation of extracellular exosome assembly,BP,
19932,GO:1903553,1,0.974309270421511,0,4,positive regulation of extracellular exosome assembly,BP,
19933,GO:1903555,1,0.528515899189565,0,98,regulation of tumor necrosis factor superfamily cytokine production,BP,
19934,GO:1903556,1,0.73747538129536,0,47,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19935,GO:1903557,1,0.736371547106537,0,47,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19937,GO:1903564,1,0.954845051308098,0,7,regulation of protein localization to cilium,BP,
19938,GO:1903565,1,0.987087579779468,0,2,negative regulation of protein localization to cilium,BP,
19939,GO:1903566,1,0.973634204456858,0,4,positive regulation of protein localization to cilium,BP,
19940,GO:1903567,1,0.987145336090563,0,2,regulation of protein localization to ciliary membrane,BP,
19941,GO:1903568,1,0.993522335899357,0,1,negative regulation of protein localization to ciliary membrane,BP,
19942,GO:1903569,1,0.993581838606046,0,1,positive regulation of protein localization to ciliary membrane,BP,
19943,GO:1903570,1,0.993516108679885,0,1,regulation of protein kinase D signaling,BP,
19944,GO:1903572,1,0.993516108679885,0,1,positive regulation of protein kinase D signaling,BP,
19945,GO:1903573,1,0.732420763526076,0,48,negative regulation of response to endoplasmic reticulum stress,BP,
19946,GO:1903575,1,0.968398646304188,0,5,cornified envelope assembly,BP,
19947,GO:1903576,1,0.993601552792331,0,1,response to L-arginine,BP,
19950,GO:1903580,1,0.780002766501902,0,38,positive regulation of ATP metabolic process,BP,
19951,GO:1903584,1,0.993464683510922,0,1,regulation of histone deubiquitination,BP,
19952,GO:1903586,1,0.993464683510922,0,1,positive regulation of histone deubiquitination,BP,
19953,GO:1903587,1,0.924789490578498,0,12,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19954,GO:1903588,1,0.968105980026545,0,5,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19955,GO:1903589,1,0.961747434466989,0,6,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19956,GO:1903593,1,0.974753125630514,0,4,regulation of histamine secretion by mast cell,BP,
19957,GO:1903595,1,0.974753125630514,0,4,positive regulation of histamine secretion by mast cell,BP,
19958,GO:1903596,1,0.968219320191597,0,5,regulation of gap junction assembly,BP,
19959,GO:1903597,1,0.987204852781191,0,2,negative regulation of gap junction assembly,BP,
19960,GO:1903598,1,0.980770849048116,0,3,positive regulation of gap junction assembly,BP,
19961,GO:1903599,1,0.880204508037965,0,19,positive regulation of autophagy of mitochondrion,BP,
19962,GO:1903608,1,0.961725164566861,0,6,protein localization to cytoplasmic stress granule,BP,
19963,GO:1903609,1,0.993562880886849,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19964,GO:1903610,1,0.993611019233983,0,1,regulation of calcium-dependent ATPase activity,BP,
19965,GO:1903611,1,0.993611019233983,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19966,GO:1903613,1,0.961892657955612,0,6,regulation of protein tyrosine phosphatase activity,BP,
19967,GO:1903614,1,0.980939366325923,0,3,negative regulation of protein tyrosine phosphatase activity,BP,
19968,GO:1903615,1,0.980586895348115,0,3,positive regulation of protein tyrosine phosphatase activity,BP,
19969,GO:1903618,1,0.993488969734737,0,1,regulation of transdifferentiation,BP,
19970,GO:1903620,1,0.993488969734737,0,1,positive regulation of transdifferentiation,BP,
19971,GO:1903621,1,0.993609812038806,0,1,protein localization to photoreceptor connecting cilium,BP,
19972,GO:1903624,1,0.91902684357602,0,13,regulation of DNA catabolic process,BP,
19973,GO:1903625,1,0.974475921442564,0,4,negative regulation of DNA catabolic process,BP,
19974,GO:1903626,1,0.961758356882335,0,6,positive regulation of DNA catabolic process,BP,
19975,GO:1903627,1,0.993611019233983,0,1,regulation of dUTP diphosphatase activity,BP,
19976,GO:1903629,1,0.993611019233983,0,1,positive regulation of dUTP diphosphatase activity,BP,
19977,GO:1903630,1,0.987309597498989,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19978,GO:1903631,1,0.993611019233983,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19979,GO:1903632,1,0.993658464975048,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19980,GO:1903633,1,0.993611019233983,0,1,regulation of leucine-tRNA ligase activity,BP,
19981,GO:1903634,1,0.993611019233983,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19982,GO:1903636,1,0.993701867974549,0,1,regulation of protein insertion into mitochondrial outer membrane,BP,
19983,GO:1903638,1,0.993701867974549,0,1,positive regulation of protein insertion into mitochondrial outer membrane,BP,
19984,GO:1903644,1,0.968311998062331,0,5,regulation of chaperone-mediated protein folding,BP,
19985,GO:1903645,1,0.987409152824354,0,2,negative regulation of chaperone-mediated protein folding,BP,
19986,GO:1903646,1,0.9870089517251,0,2,positive regulation of chaperone-mediated protein folding,BP,
19987,GO:1903649,1,0.85989594447799,0,23,regulation of cytoplasmic transport,BP,
19988,GO:1903650,1,0.981006388185825,0,3,negative regulation of cytoplasmic transport,BP,
19989,GO:1903651,1,0.929942922263741,0,11,positive regulation of cytoplasmic transport,BP,
19990,GO:1903659,1,0.961718053365447,0,6,regulation of complement-dependent cytotoxicity,BP,
19991,GO:1903660,1,0.987265276127988,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19992,GO:1903661,1,0.99359049708829,0,1,positive regulation of complement-dependent cytotoxicity,BP,
19994,GO:1903671,1,0.843154390883,0,26,negative regulation of sprouting angiogenesis,BP,
19996,GO:1903673,1,0.993611589493306,0,1,mitotic cleavage furrow formation,BP,
19997,GO:1903674,1,0.99361205920099,0,1,regulation of cap-dependent translational initiation,BP,
19998,GO:1903676,1,0.99361205920099,0,1,positive regulation of cap-dependent translational initiation,BP,
19999,GO:1903677,1,0.980896348374491,0,3,regulation of cap-independent translational initiation,BP,
20000,GO:1903679,1,0.980896348374491,0,3,positive regulation of cap-independent translational initiation,BP,
20001,GO:1903689,1,0.959959825944001,0,6,regulation of wound healing, spreading of epidermal cells,BP,
20002,GO:1903690,1,0.973362418354434,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
20003,GO:1903691,1,0.986234315208217,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
20004,GO:1903697,1,0.993524977142953,0,1,negative regulation of microvillus assembly,BP,
20005,GO:1903699,1,0.992778725256985,0,1,tarsal gland development,BP,
20006,GO:1903701,1,0.993403402771139,0,1,substantia propria of cornea development,BP,
20007,GO:1903704,1,0.993488969734737,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
20009,GO:1903707,1,0.439548586243918,0,126,negative regulation of hemopoiesis,BP,
20011,GO:1903709,1,0.992778725256985,0,1,uterine gland development,BP,
20012,GO:1903710,1,0.993489029653295,0,1,spermine transmembrane transport,BP,
20013,GO:1903712,1,0.993504840627077,0,1,cysteine transmembrane transport,BP,
20014,GO:1903713,1,0.993606161356718,0,1,asparagine transmembrane transport,BP,
20015,GO:1903714,1,0.99338835963025,0,1,isoleucine transmembrane transport,BP,
20016,GO:1903715,1,0.961715146706524,0,6,regulation of aerobic respiration,BP,
20017,GO:1903719,1,0.955821185889459,0,7,regulation of I-kappaB phosphorylation,BP,
20018,GO:1903720,1,0.993482549069645,0,1,negative regulation of I-kappaB phosphorylation,BP,
20019,GO:1903721,1,0.962094002097446,0,6,positive regulation of I-kappaB phosphorylation,BP,
20020,GO:1903722,1,0.961781442944662,0,6,regulation of centriole elongation,BP,
20021,GO:1903723,1,0.987276533664088,0,2,negative regulation of centriole elongation,BP,
20022,GO:1903724,1,0.974179606879129,0,4,positive regulation of centriole elongation,BP,
20024,GO:1903726,1,0.949152206644766,0,8,negative regulation of phospholipid metabolic process,BP,
20026,GO:1903729,1,0.906645182025515,0,15,regulation of plasma membrane organization,BP,
20027,GO:1903742,1,0.987057043956566,0,2,regulation of anterograde synaptic vesicle transport,BP,
20028,GO:1903743,1,0.993650899818868,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
20029,GO:1903744,1,0.993364432846303,0,1,positive regulation of anterograde synaptic vesicle transport,BP,
20030,GO:1903747,1,0.629884434234872,0,71,regulation of establishment of protein localization to mitochondrion,BP,
20031,GO:1903748,1,0.942931597654139,0,9,negative regulation of establishment of protein localization to mitochondrion,BP,
20032,GO:1903749,1,0.68571610019521,0,58,positive regulation of establishment of protein localization to mitochondrion,BP,
20033,GO:1903750,1,0.980947559787158,0,3,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20034,GO:1903751,1,0.980947559787158,0,3,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20035,GO:1903753,1,0.961420417556293,0,6,negative regulation of p38MAPK cascade,BP,
20036,GO:1903755,1,0.993659525454334,0,1,positive regulation of SUMO transferase activity,BP,
20037,GO:1903760,1,0.980494019190955,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20038,GO:1903762,1,0.986991714595894,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20039,GO:1903763,1,0.967920161134256,0,5,gap junction channel activity involved in cell communication by electrical coupling,MF,
20040,GO:1903764,1,0.955605336140551,0,7,regulation of potassium ion export across plasma membrane,BP,
20041,GO:1903765,1,0.980754356452466,0,3,negative regulation of potassium ion export across plasma membrane,BP,
20042,GO:1903766,1,0.980819859566642,0,3,positive regulation of potassium ion export across plasma membrane,BP,
20043,GO:1903767,1,0.993569790012993,0,1,sweet taste receptor complex,CC,
20044,GO:1903768,1,0.993569790012993,0,1,taste receptor complex,CC,
20045,GO:1903770,1,0.99354954696155,0,1,negative regulation of beta-galactosidase activity,BP,
20046,GO:1903772,1,0.97468988424102,0,4,regulation of viral budding via host ESCRT complex,BP,
20047,GO:1903774,1,0.980911368303735,0,3,positive regulation of viral budding via host ESCRT complex,BP,
20048,GO:1903775,1,0.987162217300311,0,2,regulation of DNA double-strand break processing,BP,
20049,GO:1903778,1,0.993303154521112,0,1,protein localization to vacuolar membrane,BP,
20051,GO:1903781,1,0.980557608180476,0,3,positive regulation of cardiac conduction,BP,
20052,GO:1903786,1,0.986601103452792,0,2,regulation of glutathione biosynthetic process,BP,
20053,GO:1903788,1,0.993558829992923,0,1,positive regulation of glutathione biosynthetic process,BP,
20057,GO:1903795,1,0.960810816332144,0,6,regulation of inorganic anion transmembrane transport,BP,
20058,GO:1903796,1,0.986677061802272,0,2,negative regulation of inorganic anion transmembrane transport,BP,
20059,GO:1903797,1,0.986846501926876,0,2,positive regulation of inorganic anion transmembrane transport,BP,
20060,GO:1903798,1,0.866328340851254,0,22,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20061,GO:1903799,1,0.912233980354397,0,14,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20062,GO:1903800,1,0.937578326232988,0,10,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20063,GO:1903801,1,0.968077688686632,0,5,L-leucine import across plasma membrane,BP,
20064,GO:1903803,1,0.99361105277542,0,1,L-glutamine import across plasma membrane,BP,
20066,GO:1903806,1,0.99338835963025,0,1,L-isoleucine import across plasma membrane,BP,
20067,GO:1903810,1,0.993216227320241,0,1,L-histidine import across plasma membrane,BP,
20068,GO:1903812,1,0.993470052424229,0,1,L-serine import across plasma membrane,BP,
20069,GO:1903814,1,0.993682719691245,0,1,regulation of collecting lymphatic vessel constriction,BP,
20070,GO:1903815,1,0.993682719691245,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
20071,GO:1903817,1,0.931035359525809,0,11,negative regulation of voltage-gated potassium channel activity,BP,
20072,GO:1903818,1,0.906052083122777,0,15,positive regulation of voltage-gated potassium channel activity,BP,
20073,GO:1903823,1,0.99354954696155,0,1,telomere single strand break repair,BP,
20074,GO:1903824,1,0.99354954696155,0,1,negative regulation of telomere single strand break repair,BP,
20076,GO:1903826,1,0.948988683926064,0,8,arginine transmembrane transport,BP,
20077,GO:1903827,1,0.0300283498838722,0,527,regulation of cellular protein localization,BP,
20078,GO:1903828,1,0.493559184964739,0,108,negative regulation of cellular protein localization,BP,
20079,GO:1903829,1,0.119008575749134,0,322,positive regulation of cellular protein localization,BP,
20080,GO:1903830,1,0.906776100363004,0,15,magnesium ion transmembrane transport,BP,
20081,GO:1903837,1,0.99357512678926,0,1,regulation of mRNA 3'-UTR binding,BP,
20082,GO:1903839,1,0.99357512678926,0,1,positive regulation of mRNA 3'-UTR binding,BP,
20083,GO:1903840,1,0.99342744196779,0,1,response to arsenite(3-),BP,
20084,GO:1903841,1,0.99342744196779,0,1,cellular response to arsenite(3-),BP,
20085,GO:1903842,1,0.974280895664094,0,4,response to arsenite ion,BP,
20086,GO:1903843,1,0.974280895664094,0,4,cellular response to arsenite ion,BP,
20087,GO:1903844,1,0.462045157710699,0,117,regulation of cellular response to transforming growth factor beta stimulus,BP,
20088,GO:1903845,1,0.594321948923634,0,79,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
20089,GO:1903846,1,0.825946289962055,0,29,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
20090,GO:1903847,1,0.986544490796612,0,2,regulation of aorta morphogenesis,BP,
20091,GO:1903849,1,0.986544490796612,0,2,positive regulation of aorta morphogenesis,BP,
20092,GO:1903850,1,0.974707536547321,0,4,regulation of cristae formation,BP,
20093,GO:1903852,1,0.980975147805282,0,3,positive regulation of cristae formation,BP,
20095,GO:1903860,1,0.987244833988325,0,2,negative regulation of dendrite extension,BP,
20097,GO:1903862,1,0.943941107321469,0,9,positive regulation of oxidative phosphorylation,BP,
20098,GO:1903867,1,0.942816503266713,0,9,extraembryonic membrane development,BP,
20099,GO:1903881,1,0.993505638353356,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
20100,GO:1903883,1,0.993505638353356,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
20101,GO:1903884,1,0.993505638353356,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
20102,GO:1903886,1,0.993505638353356,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
20103,GO:1903891,1,0.97438763638293,0,4,regulation of ATF6-mediated unfolded protein response,BP,
20104,GO:1903892,1,0.987116910852453,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
20105,GO:1903893,1,0.993573610577979,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
20106,GO:1903894,1,0.919121721525349,0,13,regulation of IRE1-mediated unfolded protein response,BP,
20107,GO:1903895,1,0.968235155485992,0,5,negative regulation of IRE1-mediated unfolded protein response,BP,
20108,GO:1903896,1,0.961497229672175,0,6,positive regulation of IRE1-mediated unfolded protein response,BP,
20110,GO:1903898,1,0.968114161275408,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
20112,GO:1903900,1,0.40948872772723,0,137,regulation of viral life cycle,BP,
20113,GO:1903901,1,0.630503557888713,0,71,negative regulation of viral life cycle,BP,
20114,GO:1903902,1,0.680719497031405,0,59,positive regulation of viral life cycle,BP,
20115,GO:1903903,1,0.980454435780141,0,3,regulation of establishment of T cell polarity,BP,
20116,GO:1903905,1,0.986811290818322,0,2,positive regulation of establishment of T cell polarity,BP,
20117,GO:1903906,1,0.993559038169924,0,1,regulation of plasma membrane raft polarization,BP,
20118,GO:1903909,1,0.9298939590173,0,11,regulation of receptor clustering,BP,
20119,GO:1903910,1,0.993583907242047,0,1,negative regulation of receptor clustering,BP,
20120,GO:1903911,1,0.967912331749723,0,5,positive regulation of receptor clustering,BP,
20121,GO:1903912,1,0.974217455266911,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
20122,GO:1903916,1,0.993581129866679,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20123,GO:1903917,1,0.993581129866679,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20124,GO:1903918,1,0.993198889344575,0,1,regulation of actin filament severing,BP,
20125,GO:1903919,1,0.993198889344575,0,1,negative regulation of actin filament severing,BP,
20126,GO:1903921,1,0.986801298078822,0,2,regulation of protein processing in phagocytic vesicle,BP,
20127,GO:1903923,1,0.986801298078822,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
20128,GO:1903924,1,0.993591285544336,0,1,estradiol binding,MF,
20129,GO:1903925,1,0.993615012928131,0,1,response to bisphenol A,BP,
20130,GO:1903926,1,0.993615012928131,0,1,cellular response to bisphenol A,BP,
20131,GO:1903929,1,0.987158103952906,0,2,primary palate development,BP,
20132,GO:1903935,1,0.968357840563912,0,5,response to sodium arsenite,BP,
20133,GO:1903936,1,0.968357840563912,0,5,cellular response to sodium arsenite,BP,
20134,GO:1903939,1,0.986896672349343,0,2,regulation of TORC2 signaling,BP,
20135,GO:1903943,1,0.99360884004526,0,1,regulation of hepatocyte apoptotic process,BP,
20136,GO:1903944,1,0.99360884004526,0,1,negative regulation of hepatocyte apoptotic process,BP,
20137,GO:1903946,1,0.987166265470263,0,2,negative regulation of ventricular cardiac muscle cell action potential,BP,
20138,GO:1903947,1,0.986991714595894,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
20139,GO:1903949,1,0.987017647636673,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
20140,GO:1903952,1,0.993490757779734,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20141,GO:1903954,1,0.993490757779734,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20142,GO:1903955,1,0.811399334539695,0,32,positive regulation of protein targeting to mitochondrion,BP,
20145,GO:1903961,1,0.936677104169515,0,10,positive regulation of anion transmembrane transport,BP,
20147,GO:1903964,1,0.980720765389772,0,3,monounsaturated fatty acid metabolic process,BP,
20148,GO:1903965,1,0.993647842407249,0,1,monounsaturated fatty acid catabolic process,BP,
20149,GO:1903966,1,0.986991106898991,0,2,monounsaturated fatty acid biosynthetic process,BP,
20150,GO:1903969,1,0.968140984152194,0,5,regulation of response to macrophage colony-stimulating factor,BP,
20151,GO:1903970,1,0.98730474891189,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20152,GO:1903971,1,0.980592274039776,0,3,positive regulation of response to macrophage colony-stimulating factor,BP,
20153,GO:1903972,1,0.968140984152194,0,5,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20154,GO:1903973,1,0.98730474891189,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20155,GO:1903974,1,0.980592274039776,0,3,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20156,GO:1903975,1,0.906447061993155,0,15,regulation of glial cell migration,BP,
20157,GO:1903976,1,0.974588888833998,0,4,negative regulation of glial cell migration,BP,
20158,GO:1903977,1,0.936074108371355,0,10,positive regulation of glial cell migration,BP,
20159,GO:1903978,1,0.900089490410972,0,16,regulation of microglial cell activation,BP,
20160,GO:1903979,1,0.955428642003572,0,7,negative regulation of microglial cell activation,BP,
20161,GO:1903980,1,0.961087408239577,0,6,positive regulation of microglial cell activation,BP,
20162,GO:1903981,1,0.987313769171462,0,2,enterobactin binding,MF,
20163,GO:1903984,1,0.980484139733817,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20164,GO:1903988,1,0.993524818679468,0,1,iron ion export across plasma membrane,BP,
20165,GO:1903995,1,0.948933150503278,0,8,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20166,GO:1903996,1,0.993640852484119,0,1,negative regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20167,GO:1903997,1,0.955008981103818,0,7,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20170,GO:1904000,1,0.986817945336734,0,2,positive regulation of eating behavior,BP,
20171,GO:1904008,1,0.993646046491589,0,1,response to monosodium glutamate,BP,
20172,GO:1904009,1,0.993646046491589,0,1,cellular response to monosodium glutamate,BP,
20173,GO:1904010,1,0.993646046491589,0,1,response to Aroclor 1254,BP,
20174,GO:1904016,1,0.973913856695561,0,4,response to Thyroglobulin triiodothyronine,BP,
20175,GO:1904017,1,0.986621362355914,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20178,GO:1904020,1,0.980808848401605,0,3,regulation of G protein-coupled receptor internalization,BP,
20179,GO:1904021,1,0.987194825053365,0,2,negative regulation of G protein-coupled receptor internalization,BP,
20180,GO:1904022,1,0.993532020092422,0,1,positive regulation of G protein-coupled receptor internalization,BP,
20181,GO:1904023,1,0.987098243375882,0,2,regulation of glucose catabolic process to lactate via pyruvate,BP,
20182,GO:1904024,1,0.987098243375882,0,2,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
20183,GO:1904026,1,0.96795508381421,0,5,regulation of collagen fibril organization,BP,
20184,GO:1904027,1,0.987106113448623,0,2,negative regulation of collagen fibril organization,BP,
20185,GO:1904028,1,0.987034169420404,0,2,positive regulation of collagen fibril organization,BP,
20186,GO:1904029,1,0.528610813533225,0,98,regulation of cyclin-dependent protein kinase activity,BP,
20187,GO:1904030,1,0.822310740915598,0,30,negative regulation of cyclin-dependent protein kinase activity,BP,
20188,GO:1904031,1,0.806555578258998,0,33,positive regulation of cyclin-dependent protein kinase activity,BP,
20190,GO:1904036,1,0.780362774437369,0,38,negative regulation of epithelial cell apoptotic process,BP,
20191,GO:1904037,1,0.811855745017097,0,32,positive regulation of epithelial cell apoptotic process,BP,
20192,GO:1904041,1,0.993528148521336,0,1,regulation of cystathionine beta-synthase activity,BP,
20193,GO:1904042,1,0.993528148521336,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20194,GO:1904044,1,0.968354367486796,0,5,response to aldosterone,BP,
20195,GO:1904045,1,0.993592140894113,0,1,cellular response to aldosterone,BP,
20196,GO:1904046,1,0.993680412277699,0,1,negative regulation of vascular endothelial growth factor production,BP,
20197,GO:1904047,1,0.919597070152288,0,13,S-adenosyl-L-methionine binding,MF,
20198,GO:1904048,1,0.986452174707215,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20199,GO:1904049,1,0.992953361251059,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20200,GO:1904050,1,0.993453138183425,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20201,GO:1904054,1,0.986766742406138,0,2,regulation of cholangiocyte proliferation,BP,
20202,GO:1904056,1,0.986766742406138,0,2,positive regulation of cholangiocyte proliferation,BP,
20203,GO:1904057,1,0.993631038942475,0,1,negative regulation of sensory perception of pain,BP,
20205,GO:1904059,1,0.979245645095163,0,3,regulation of locomotor rhythm,BP,
20209,GO:1904071,1,0.971177905171054,0,4,presynaptic active zone assembly,BP,
20210,GO:1904073,1,0.993224260884326,0,1,regulation of trophectodermal cell proliferation,BP,
20211,GO:1904075,1,0.993224260884326,0,1,positive regulation of trophectodermal cell proliferation,BP,
20212,GO:1904090,1,0.974813398647847,0,4,peptidase inhibitor complex,CC,
20213,GO:1904092,1,0.974357036943613,0,4,regulation of autophagic cell death,BP,
20214,GO:1904093,1,0.993669453079625,0,1,negative regulation of autophagic cell death,BP,
20215,GO:1904098,1,0.980716242371096,0,3,regulation of protein O-linked glycosylation,BP,
20216,GO:1904100,1,0.980716242371096,0,3,positive regulation of protein O-linked glycosylation,BP,
20217,GO:1904106,1,0.993557614913893,0,1,protein localization to microvillus,BP,
20218,GO:1904108,1,0.993509834476086,0,1,protein localization to ciliary inversin compartment,BP,
20219,GO:1904109,1,0.992427154022935,0,1,positive regulation of cholesterol import,BP,
20220,GO:1904115,1,0.690609842002678,0,56,axon cytoplasm,CC,
20221,GO:1904116,1,0.980524631786921,0,3,response to vasopressin,BP,
20222,GO:1904117,1,0.980524631786921,0,3,cellular response to vasopressin,BP,
20223,GO:1904118,1,0.993537909365421,0,1,regulation of otic vesicle morphogenesis,BP,
20224,GO:1904120,1,0.993537909365421,0,1,positive regulation of otic vesicle morphogenesis,BP,
20225,GO:1904121,1,0.993627793590708,0,1,phosphatidylethanolamine transfer activity,MF,
20226,GO:1904124,1,0.956037146106341,0,7,microglial cell migration,BP,
20227,GO:1904139,1,0.956037146106341,0,7,regulation of microglial cell migration,BP,
20228,GO:1904140,1,0.993638585641762,0,1,negative regulation of microglial cell migration,BP,
20229,GO:1904141,1,0.962160200085862,0,6,positive regulation of microglial cell migration,BP,
20230,GO:1904149,1,0.980899609922404,0,3,regulation of microglial cell mediated cytotoxicity,BP,
20231,GO:1904151,1,0.980899609922404,0,3,positive regulation of microglial cell mediated cytotoxicity,BP,
20232,GO:1904152,1,0.919080762754982,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20233,GO:1904153,1,0.943303799056309,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20234,GO:1904154,1,0.980695529351325,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20235,GO:1904155,1,0.986983510571961,0,2,DN2 thymocyte differentiation,BP,
20236,GO:1904156,1,0.993525478975508,0,1,DN3 thymocyte differentiation,BP,
20237,GO:1904158,1,0.97997213986746,0,3,axonemal central apparatus assembly,BP,
20238,GO:1904161,1,0.987190939158305,0,2,DNA synthesis involved in UV-damage excision repair,BP,
20239,GO:1904170,1,0.987013760187482,0,2,regulation of bleb assembly,BP,
20240,GO:1904172,1,0.987013760187482,0,2,positive regulation of bleb assembly,BP,
20241,GO:1904177,1,0.94865928709159,0,8,regulation of adipose tissue development,BP,
20242,GO:1904178,1,0.987207653470258,0,2,negative regulation of adipose tissue development,BP,
20243,GO:1904179,1,0.960957048066709,0,6,positive regulation of adipose tissue development,BP,
20246,GO:1904182,1,0.949154821560214,0,8,regulation of pyruvate dehydrogenase activity,BP,
20247,GO:1904183,1,0.967781503353811,0,5,negative regulation of pyruvate dehydrogenase activity,BP,
20248,GO:1904184,1,0.987016331945296,0,2,positive regulation of pyruvate dehydrogenase activity,BP,
20249,GO:1904192,1,0.99308300260054,0,1,regulation of cholangiocyte apoptotic process,BP,
20250,GO:1904193,1,0.99308300260054,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20251,GO:1904195,1,0.99308300260054,0,1,regulation of granulosa cell proliferation,BP,
20252,GO:1904197,1,0.99308300260054,0,1,positive regulation of granulosa cell proliferation,BP,
20253,GO:1904199,1,0.993484902849537,0,1,positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization,BP,
20254,GO:1904200,1,0.986640092297461,0,2,iodide transmembrane transport,BP,
20255,GO:1904201,1,0.99308300260054,0,1,regulation of iodide transport,BP,
20256,GO:1904202,1,0.99308300260054,0,1,negative regulation of iodide transport,BP,
20257,GO:1904204,1,0.986444073487443,0,2,regulation of skeletal muscle hypertrophy,BP,
20258,GO:1904205,1,0.993315291909322,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20259,GO:1904206,1,0.99308300260054,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20260,GO:1904210,1,0.993647243880969,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20261,GO:1904211,1,0.987081278309905,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20262,GO:1904212,1,0.99308300260054,0,1,regulation of iodide transmembrane transport,BP,
20263,GO:1904213,1,0.99308300260054,0,1,negative regulation of iodide transmembrane transport,BP,
20264,GO:1904217,1,0.980874811507073,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20265,GO:1904219,1,0.980874811507073,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20266,GO:1904220,1,0.974553871719092,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20267,GO:1904222,1,0.980874811507073,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20268,GO:1904226,1,0.9935938551392,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20269,GO:1904227,1,0.9935938551392,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20270,GO:1904229,1,0.986811734409657,0,2,regulation of succinate dehydrogenase activity,BP,
20271,GO:1904231,1,0.993232719080104,0,1,positive regulation of succinate dehydrogenase activity,BP,
20272,GO:1904232,1,0.986939824077352,0,2,regulation of aconitate hydratase activity,BP,
20273,GO:1904234,1,0.986939824077352,0,2,positive regulation of aconitate hydratase activity,BP,
20274,GO:1904235,1,0.986471580965474,0,2,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20275,GO:1904237,1,0.986471580965474,0,2,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20276,GO:1904238,1,0.949204248726338,0,8,pericyte cell differentiation,BP,
20277,GO:1904239,1,0.993647243880969,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20278,GO:1904240,1,0.993647243880969,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20279,GO:1904245,1,0.987203951489551,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20280,GO:1904246,1,0.993623471488449,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20281,GO:1904247,1,0.993539695035517,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20282,GO:1904251,1,0.925176934886872,0,12,regulation of bile acid metabolic process,BP,
20283,GO:1904252,1,0.98713839087469,0,2,negative regulation of bile acid metabolic process,BP,
20284,GO:1904253,1,0.980831153782908,0,3,positive regulation of bile acid metabolic process,BP,
20285,GO:1904259,1,0.966903960193866,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20286,GO:1904261,1,0.966903960193866,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20287,GO:1904262,1,0.930694946256957,0,11,negative regulation of TORC1 signaling,BP,
20288,GO:1904263,1,0.907248896109264,0,15,positive regulation of TORC1 signaling,BP,
20289,GO:1904266,1,0.99322783780028,0,1,regulation of Schwann cell chemotaxis,BP,
20290,GO:1904268,1,0.99322783780028,0,1,positive regulation of Schwann cell chemotaxis,BP,
20291,GO:1904270,1,0.993640652537952,0,1,pyroptosome complex assembly,BP,
20292,GO:1904271,1,0.980605358654034,0,3,L-proline import across plasma membrane,BP,
20293,GO:1904273,1,0.980690962213986,0,3,L-alanine import across plasma membrane,BP,
20294,GO:1904274,1,0.993591351297065,0,1,tricellular tight junction assembly,BP,
20295,GO:1904282,1,0.993609778514401,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20296,GO:1904283,1,0.993609778514401,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20297,GO:1904288,1,0.974009425770317,0,4,BAT3 complex binding,MF,
20298,GO:1904289,1,0.987040794964516,0,2,regulation of mitotic DNA damage checkpoint,BP,
20299,GO:1904290,1,0.993454280460749,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20300,GO:1904292,1,0.822641842259815,0,30,regulation of ERAD pathway,BP,
20301,GO:1904293,1,0.913282881405655,0,14,negative regulation of ERAD pathway,BP,
20302,GO:1904294,1,0.906834672378634,0,15,positive regulation of ERAD pathway,BP,
20303,GO:1904298,1,0.985956669514448,0,2,regulation of transcytosis,BP,
20304,GO:1904300,1,0.985956669514448,0,2,positive regulation of transcytosis,BP,
20305,GO:1904301,1,0.99348063536873,0,1,regulation of maternal process involved in parturition,BP,
20306,GO:1904303,1,0.99348063536873,0,1,positive regulation of maternal process involved in parturition,BP,
20307,GO:1904304,1,0.968226539413734,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20308,GO:1904306,1,0.968226539413734,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20309,GO:1904313,1,0.993491231333169,0,1,response to methamphetamine hydrochloride,BP,
20310,GO:1904315,1,0.749579130875085,0,44,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20311,GO:1904316,1,0.99348063536873,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20312,GO:1904317,1,0.99348063536873,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20313,GO:1904321,1,0.929196489282473,0,11,response to forskolin,BP,
20314,GO:1904322,1,0.929196489282473,0,11,cellular response to forskolin,BP,
20315,GO:1904323,1,0.993549264120569,0,1,regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20316,GO:1904325,1,0.993549264120569,0,1,positive regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20317,GO:1904327,1,0.986873147278505,0,2,protein localization to cytosolic proteasome complex,BP,
20318,GO:1904328,1,0.993559962599739,0,1,regulation of myofibroblast contraction,BP,
20319,GO:1904338,1,0.943100819250939,0,9,regulation of dopaminergic neuron differentiation,BP,
20320,GO:1904339,1,0.986915906806292,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20321,GO:1904340,1,0.974697480983282,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20322,GO:1904341,1,0.993404495823808,0,1,regulation of colon smooth muscle contraction,BP,
20323,GO:1904343,1,0.993404495823808,0,1,positive regulation of colon smooth muscle contraction,BP,
20324,GO:1904344,1,0.987307058657525,0,2,regulation of gastric mucosal blood circulation,BP,
20325,GO:1904346,1,0.987307058657525,0,2,positive regulation of gastric mucosal blood circulation,BP,
20326,GO:1904347,1,0.987137430516114,0,2,regulation of small intestine smooth muscle contraction,BP,
20327,GO:1904349,1,0.987137430516114,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20329,GO:1904351,1,0.974274175347886,0,4,negative regulation of protein catabolic process in the vacuole,BP,
20331,GO:1904353,1,0.843040372546629,0,26,regulation of telomere capping,BP,
20332,GO:1904354,1,0.948116933243318,0,8,negative regulation of telomere capping,BP,
20333,GO:1904355,1,0.895158323450055,0,17,positive regulation of telomere capping,BP,
20334,GO:1904356,1,0.68399521593644,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20335,GO:1904357,1,0.8537694874854,0,24,negative regulation of telomere maintenance via telomere lengthening,BP,
20336,GO:1904358,1,0.785660756714599,0,37,positive regulation of telomere maintenance via telomere lengthening,BP,
20337,GO:1904370,1,0.993486188892521,0,1,regulation of protein localization to actin cortical patch,BP,
20338,GO:1904372,1,0.993486188892521,0,1,positive regulation of protein localization to actin cortical patch,BP,
20339,GO:1904373,1,0.987163877451512,0,2,response to kainic acid,BP,
20340,GO:1904375,1,0.471007327301636,0,115,regulation of protein localization to cell periphery,BP,
20341,GO:1904376,1,0.850022329096665,0,25,negative regulation of protein localization to cell periphery,BP,
20342,GO:1904377,1,0.661450315562054,0,63,positive regulation of protein localization to cell periphery,BP,
20343,GO:1904378,1,0.980445916667657,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20344,GO:1904379,1,0.986873147278505,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20345,GO:1904380,1,0.906181001946351,0,15,endoplasmic reticulum mannose trimming,BP,
20346,GO:1904381,1,0.980527686617318,0,3,Golgi apparatus mannose trimming,BP,
20347,GO:1904382,1,0.974026237899482,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20348,GO:1904383,1,0.987187385576548,0,2,response to sodium phosphate,BP,
20350,GO:1904386,1,0.967984296213966,0,5,response to L-phenylalanine derivative,BP,
20351,GO:1904387,1,0.987086242861852,0,2,cellular response to L-phenylalanine derivative,BP,
20352,GO:1904389,1,0.993636650778215,0,1,rod bipolar cell differentiation,BP,
20353,GO:1904391,1,0.993636650778215,0,1,response to ciliary neurotrophic factor,BP,
20354,GO:1904393,1,0.974023290604855,0,4,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20355,GO:1904394,1,0.993583907242047,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20356,GO:1904395,1,0.986835057391416,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20357,GO:1904396,1,0.936332359606182,0,10,regulation of neuromuscular junction development,BP,
20358,GO:1904397,1,0.987260980124243,0,2,negative regulation of neuromuscular junction development,BP,
20359,GO:1904398,1,0.973737676943864,0,4,positive regulation of neuromuscular junction development,BP,
20360,GO:1904399,1,0.980662419585316,0,3,heparan sulfate binding,MF,
20361,GO:1904400,1,0.993538746806461,0,1,response to Thyroid stimulating hormone,BP,
20362,GO:1904404,1,0.993214499093636,0,1,response to formaldehyde,BP,
20363,GO:1904406,1,0.912622580222315,0,14,negative regulation of nitric oxide metabolic process,BP,
20364,GO:1904407,1,0.785863304584482,0,37,positive regulation of nitric oxide metabolic process,BP,
20365,GO:1904408,1,0.993663499552189,0,1,melatonin binding,MF,
20366,GO:1904412,1,0.99351061792185,0,1,regulation of cardiac ventricle development,BP,
20367,GO:1904414,1,0.99351061792185,0,1,positive regulation of cardiac ventricle development,BP,
20368,GO:1904415,1,0.961847379835243,0,6,regulation of xenophagy,BP,
20369,GO:1904417,1,0.961847379835243,0,6,positive regulation of xenophagy,BP,
20370,GO:1904423,1,0.987004131214085,0,2,dehydrodolichyl diphosphate synthase complex,CC,
20371,GO:1904424,1,0.924372005029865,0,12,regulation of GTP binding,BP,
20372,GO:1904425,1,0.987114481275413,0,2,negative regulation of GTP binding,BP,
20373,GO:1904426,1,0.986902716102433,0,2,positive regulation of GTP binding,BP,
20375,GO:1904428,1,0.960335963407406,0,6,negative regulation of tubulin deacetylation,BP,
20376,GO:1904429,1,0.961778893201911,0,6,regulation of t-circle formation,BP,
20377,GO:1904430,1,0.980645690423592,0,3,negative regulation of t-circle formation,BP,
20378,GO:1904431,1,0.980764565933057,0,3,positive regulation of t-circle formation,BP,
20379,GO:1904432,1,0.987323616040726,0,2,regulation of ferrous iron binding,BP,
20380,GO:1904434,1,0.987323616040726,0,2,positive regulation of ferrous iron binding,BP,
20381,GO:1904435,1,0.987323616040726,0,2,regulation of transferrin receptor binding,BP,
20382,GO:1904437,1,0.987323616040726,0,2,positive regulation of transferrin receptor binding,BP,
20383,GO:1904438,1,0.993664657882254,0,1,regulation of iron ion import across plasma membrane,BP,
20384,GO:1904439,1,0.993664657882254,0,1,negative regulation of iron ion import across plasma membrane,BP,
20386,GO:1904448,1,0.986727960000236,0,2,regulation of aspartate secretion,BP,
20387,GO:1904450,1,0.986727960000236,0,2,positive regulation of aspartate secretion,BP,
20388,GO:1904456,1,0.993614811486309,0,1,negative regulation of neuronal action potential,BP,
20389,GO:1904457,1,0.993579587886027,0,1,positive regulation of neuronal action potential,BP,
20390,GO:1904464,1,0.967779689906096,0,5,regulation of matrix metallopeptidase secretion,BP,
20391,GO:1904465,1,0.987253856280088,0,2,negative regulation of matrix metallopeptidase secretion,BP,
20392,GO:1904466,1,0.986931188904789,0,2,positive regulation of matrix metallopeptidase secretion,BP,
20393,GO:1904470,1,0.993650235406605,0,1,regulation of endothelin production,BP,
20394,GO:1904472,1,0.993650235406605,0,1,positive regulation of endothelin production,BP,
20395,GO:1904475,1,0.980243870405173,0,3,regulation of Ras GTPase binding,BP,
20396,GO:1904477,1,0.993304642559122,0,1,positive regulation of Ras GTPase binding,BP,
20397,GO:1904478,1,0.962021761584706,0,6,regulation of intestinal absorption,BP,
20398,GO:1904479,1,0.987313797301,0,2,negative regulation of intestinal absorption,BP,
20399,GO:1904480,1,0.993586050681278,0,1,positive regulation of intestinal absorption,BP,
20400,GO:1904481,1,0.987207013938763,0,2,response to tetrahydrofolate,BP,
20401,GO:1904482,1,0.987207013938763,0,2,cellular response to tetrahydrofolate,BP,
20402,GO:1904491,1,0.9558938015066,0,7,protein localization to ciliary transition zone,BP,
20405,GO:1904499,1,0.993521120114323,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20406,GO:1904501,1,0.993521120114323,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20407,GO:1904502,1,0.966991737254086,0,5,regulation of lipophagy,BP,
20408,GO:1904504,1,0.966991737254086,0,5,positive regulation of lipophagy,BP,
20409,GO:1904505,1,0.974098133219605,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20410,GO:1904506,1,0.974098133219605,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20411,GO:1904508,1,0.993636517291837,0,1,regulation of protein localization to basolateral plasma membrane,BP,
20412,GO:1904510,1,0.993636517291837,0,1,positive regulation of protein localization to basolateral plasma membrane,BP,
20413,GO:1904515,1,0.986896672349343,0,2,positive regulation of TORC2 signaling,BP,
20414,GO:1904526,1,0.936887369179434,0,10,regulation of microtubule binding,BP,
20415,GO:1904527,1,0.986775070975003,0,2,negative regulation of microtubule binding,BP,
20416,GO:1904528,1,0.961933618341317,0,6,positive regulation of microtubule binding,BP,
20417,GO:1904529,1,0.986947761056916,0,2,regulation of actin filament binding,BP,
20418,GO:1904530,1,0.993538476422751,0,1,negative regulation of actin filament binding,BP,
20419,GO:1904531,1,0.993366850178882,0,1,positive regulation of actin filament binding,BP,
20420,GO:1904533,1,0.980672718579481,0,3,regulation of telomeric loop disassembly,BP,
20421,GO:1904534,1,0.987138301957793,0,2,negative regulation of telomeric loop disassembly,BP,
20422,GO:1904535,1,0.993451019811716,0,1,positive regulation of telomeric loop disassembly,BP,
20423,GO:1904538,1,0.993421769014287,0,1,regulation of glycolytic process through fructose-6-phosphate,BP,
20424,GO:1904539,1,0.993421769014287,0,1,negative regulation of glycolytic process through fructose-6-phosphate,BP,
20425,GO:1904542,1,0.993563456946416,0,1,regulation of free ubiquitin chain polymerization,BP,
20426,GO:1904544,1,0.993563456946416,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20427,GO:1904550,1,0.993601619449722,0,1,response to arachidonic acid,BP,
20428,GO:1904555,1,0.980605358654034,0,3,L-proline transmembrane transport,BP,
20429,GO:1904556,1,0.987070366645416,0,2,L-tryptophan transmembrane transport,BP,
20430,GO:1904557,1,0.974419363545105,0,4,L-alanine transmembrane transport,BP,
20431,GO:1904562,1,0.98645172142315,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20434,GO:1904567,1,0.993543355450236,0,1,response to wortmannin,BP,
20435,GO:1904568,1,0.993543355450236,0,1,cellular response to wortmannin,BP,
20436,GO:1904569,1,0.987368824049974,0,2,regulation of selenocysteine incorporation,BP,
20437,GO:1904570,1,0.993623605614367,0,1,negative regulation of selenocysteine incorporation,BP,
20438,GO:1904571,1,0.993705481007011,0,1,positive regulation of selenocysteine incorporation,BP,
20439,GO:1904572,1,0.993623605614367,0,1,negative regulation of mRNA binding,BP,
20440,GO:1904573,1,0.993623605614367,0,1,regulation of selenocysteine insertion sequence binding,BP,
20441,GO:1904574,1,0.993623605614367,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20442,GO:1904576,1,0.987222669963831,0,2,response to tunicamycin,BP,
20443,GO:1904577,1,0.987222669963831,0,2,cellular response to tunicamycin,BP,
20444,GO:1904578,1,0.980818651811599,0,3,response to thapsigargin,BP,
20445,GO:1904579,1,0.980818651811599,0,3,cellular response to thapsigargin,BP,
20446,GO:1904580,1,0.980800655992399,0,3,regulation of intracellular mRNA localization,BP,
20447,GO:1904582,1,0.980800655992399,0,3,positive regulation of intracellular mRNA localization,BP,
20448,GO:1904585,1,0.993595640020286,0,1,response to putrescine,BP,
20449,GO:1904586,1,0.993595640020286,0,1,cellular response to putrescine,BP,
20450,GO:1904587,1,0.961590387087551,0,6,response to glycoprotein,BP,
20451,GO:1904588,1,0.993656542061027,0,1,cellular response to glycoprotein,BP,
20452,GO:1904589,1,0.679073391877692,0,59,regulation of protein import,BP,
20453,GO:1904590,1,0.918468428311674,0,13,negative regulation of protein import,BP,
20454,GO:1904591,1,0.763873957312004,0,41,positive regulation of protein import,BP,
20455,GO:1904594,1,0.980104177957859,0,3,regulation of termination of RNA polymerase II transcription,BP,
20456,GO:1904595,1,0.992858142606386,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20457,GO:1904596,1,0.993650235406605,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20458,GO:1904597,1,0.993650235406605,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20459,GO:1904602,1,0.987249035137505,0,2,serotonin-activated cation-selective channel complex,CC,
20460,GO:1904606,1,0.987176374879249,0,2,fat cell apoptotic process,BP,
20461,GO:1904612,1,0.974081526437609,0,4,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20462,GO:1904613,1,0.986833663865769,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20463,GO:1904616,1,0.986947761056916,0,2,regulation of actin binding,BP,
20464,GO:1904617,1,0.993538476422751,0,1,negative regulation of actin binding,BP,
20465,GO:1904618,1,0.993366850178882,0,1,positive regulation of actin binding,BP,
20466,GO:1904627,1,0.974540241206722,0,4,response to phorbol 13-acetate 12-myristate,BP,
20467,GO:1904628,1,0.974540241206722,0,4,cellular response to phorbol 13-acetate 12-myristate,BP,
20468,GO:1904631,1,0.993590201695882,0,1,response to glucoside,BP,
20469,GO:1904633,1,0.986767185520654,0,2,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20470,GO:1904635,1,0.986767185520654,0,2,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20471,GO:1904636,1,0.974157703744095,0,4,response to ionomycin,BP,
20472,GO:1904637,1,0.974157703744095,0,4,cellular response to ionomycin,BP,
20473,GO:1904638,1,0.986889093454626,0,2,response to resveratrol,BP,
20474,GO:1904639,1,0.99330761561877,0,1,cellular response to resveratrol,BP,
20475,GO:1904640,1,0.980674828971836,0,3,response to methionine,BP,
20476,GO:1904643,1,0.993302804248433,0,1,response to curcumin,BP,
20477,GO:1904645,1,0.733549688549342,0,47,response to amyloid-beta,BP,
20478,GO:1904646,1,0.777980400678953,0,38,cellular response to amyloid-beta,BP,
20479,GO:1904647,1,0.993047092370812,0,1,response to rotenone,BP,
20480,GO:1904649,1,0.987176374879249,0,2,regulation of fat cell apoptotic process,BP,
20481,GO:1904651,1,0.993521172994364,0,1,positive regulation of fat cell apoptotic process,BP,
20483,GO:1904666,1,0.862007816699908,0,23,regulation of ubiquitin protein ligase activity,BP,
20484,GO:1904667,1,0.944208195361861,0,9,negative regulation of ubiquitin protein ligase activity,BP,
20485,GO:1904668,1,0.919011922757426,0,13,positive regulation of ubiquitin protein ligase activity,BP,
20486,GO:1904672,1,0.949307979269334,0,8,regulation of somatic stem cell population maintenance,BP,
20487,GO:1904673,1,0.980592353770882,0,3,negative regulation of somatic stem cell population maintenance,BP,
20488,GO:1904674,1,0.987035991919607,0,2,positive regulation of somatic stem cell population maintenance,BP,
20489,GO:1904675,1,0.993547463256452,0,1,regulation of somatic stem cell division,BP,
20490,GO:1904677,1,0.993547463256452,0,1,positive regulation of somatic stem cell division,BP,
20491,GO:1904679,1,0.992802326995617,0,1,myo-inositol import across plasma membrane,BP,
20492,GO:1904680,1,0.838834275143612,0,27,peptide transmembrane transporter activity,MF,
20493,GO:1904681,1,0.99356149217418,0,1,response to 3-methylcholanthrene,BP,
20495,GO:1904684,1,0.973472799181915,0,4,negative regulation of metalloendopeptidase activity,BP,
20497,GO:1904688,1,0.967937025765465,0,5,regulation of cytoplasmic translational initiation,BP,
20498,GO:1904689,1,0.993664426243891,0,1,negative regulation of cytoplasmic translational initiation,BP,
20499,GO:1904690,1,0.974110186761359,0,4,positive regulation of cytoplasmic translational initiation,BP,
20500,GO:1904691,1,0.987318164009996,0,2,negative regulation of type B pancreatic cell proliferation,BP,
20501,GO:1904692,1,0.987235135307528,0,2,positive regulation of type B pancreatic cell proliferation,BP,
20502,GO:1904693,1,0.980252306587499,0,3,midbrain morphogenesis,BP,
20504,GO:1904695,1,0.987210923264066,0,2,positive regulation of vascular associated smooth muscle contraction,BP,
20505,GO:1904697,1,0.993685289586667,0,1,regulation of acinar cell proliferation,BP,
20506,GO:1904699,1,0.993685289586667,0,1,positive regulation of acinar cell proliferation,BP,
20508,GO:1904701,1,0.993619377814711,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20509,GO:1904702,1,0.993386908371261,0,1,regulation of protein localization to adherens junction,BP,
20510,GO:1904705,1,0.721439123073187,0,50,regulation of vascular associated smooth muscle cell proliferation,BP,
20511,GO:1904706,1,0.895677037094467,0,17,negative regulation of vascular associated smooth muscle cell proliferation,BP,
20512,GO:1904707,1,0.800517744110183,0,34,positive regulation of vascular associated smooth muscle cell proliferation,BP,
20514,GO:1904710,1,0.993666576647194,0,1,positive regulation of granulosa cell apoptotic process,BP,
20515,GO:1904711,1,0.993619377814711,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20516,GO:1904713,1,0.986637051156221,0,2,beta-catenin destruction complex binding,MF,
20519,GO:1904716,1,0.993581967599629,0,1,positive regulation of chaperone-mediated autophagy,BP,
20520,GO:1904717,1,0.967049801208674,0,5,regulation of AMPA glutamate receptor clustering,BP,
20521,GO:1904719,1,0.987106503639948,0,2,positive regulation of AMPA glutamate receptor clustering,BP,
20522,GO:1904723,1,0.993619377814711,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20523,GO:1904724,1,0.716044512980109,0,52,tertiary granule lumen,CC,
20524,GO:1904729,1,0.974593006378662,0,4,regulation of intestinal lipid absorption,BP,
20525,GO:1904730,1,0.993562850607424,0,1,negative regulation of intestinal lipid absorption,BP,
20526,GO:1904731,1,0.993586050681278,0,1,positive regulation of intestinal lipid absorption,BP,
20527,GO:1904732,1,0.968063367287737,0,5,regulation of electron transfer activity,BP,
20528,GO:1904734,1,0.993710930571523,0,1,positive regulation of electron transfer activity,BP,
20530,GO:1904742,1,0.97379991539322,0,4,regulation of telomeric DNA binding,BP,
20531,GO:1904743,1,0.986316368001692,0,2,negative regulation of telomeric DNA binding,BP,
20532,GO:1904744,1,0.987311637854189,0,2,positive regulation of telomeric DNA binding,BP,
20533,GO:1904746,1,0.968027598213477,0,5,negative regulation of apoptotic process involved in development,BP,
20534,GO:1904747,1,0.967678072873662,0,5,positive regulation of apoptotic process involved in development,BP,
20535,GO:1904748,1,0.930545825676228,0,11,regulation of apoptotic process involved in development,BP,
20536,GO:1904749,1,0.949380344466519,0,8,regulation of protein localization to nucleolus,BP,
20537,GO:1904750,1,0.993277792836378,0,1,negative regulation of protein localization to nucleolus,BP,
20538,GO:1904751,1,0.97457692498002,0,4,positive regulation of protein localization to nucleolus,BP,
20540,GO:1904753,1,0.967674938604046,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20542,GO:1904760,1,0.974056325603175,0,4,regulation of myofibroblast differentiation,BP,
20543,GO:1904761,1,0.980441028859309,0,3,negative regulation of myofibroblast differentiation,BP,
20544,GO:1904762,1,0.99348920927597,0,1,positive regulation of myofibroblast differentiation,BP,
20545,GO:1904764,1,0.993603888263979,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20546,GO:1904766,1,0.993256170345959,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20547,GO:1904768,1,0.987163673469337,0,2,all-trans-retinol binding,MF,
20548,GO:1904772,1,0.99356519354714,0,1,response to tetrachloromethane,BP,
20549,GO:1904776,1,0.942854017554383,0,9,regulation of protein localization to cell cortex,BP,
20550,GO:1904777,1,0.99355705431691,0,1,negative regulation of protein localization to cell cortex,BP,
20551,GO:1904778,1,0.96128791146401,0,6,positive regulation of protein localization to cell cortex,BP,
20552,GO:1904779,1,0.93578814152139,0,10,regulation of protein localization to centrosome,BP,
20553,GO:1904780,1,0.986970363635014,0,2,negative regulation of protein localization to centrosome,BP,
20554,GO:1904781,1,0.954279353239883,0,7,positive regulation of protein localization to centrosome,BP,
20555,GO:1904782,1,0.987002814496764,0,2,negative regulation of NMDA glutamate receptor activity,BP,
20556,GO:1904783,1,0.968234538238849,0,5,positive regulation of NMDA glutamate receptor activity,BP,
20557,GO:1904784,1,0.993379195051286,0,1,NLRP1 inflammasome complex assembly,BP,
20558,GO:1904790,1,0.993547547321298,0,1,regulation of shelterin complex assembly,BP,
20559,GO:1904792,1,0.993547547321298,0,1,positive regulation of shelterin complex assembly,BP,
20560,GO:1904793,1,0.993521120114323,0,1,regulation of euchromatin binding,BP,
20561,GO:1904796,1,0.955324051500912,0,7,regulation of core promoter binding,BP,
20562,GO:1904797,1,0.987018979966933,0,2,negative regulation of core promoter binding,BP,
20563,GO:1904798,1,0.967892355940884,0,5,positive regulation of core promoter binding,BP,
20564,GO:1904799,1,0.993491880288178,0,1,regulation of neuron remodeling,BP,
20565,GO:1904800,1,0.993491880288178,0,1,negative regulation of neuron remodeling,BP,
20566,GO:1904803,1,0.993700422297972,0,1,regulation of translation involved in cellular response to UV,BP,
20567,GO:1904806,1,0.987155207697788,0,2,regulation of protein oxidation,BP,
20568,GO:1904808,1,0.987155207697788,0,2,positive regulation of protein oxidation,BP,
20569,GO:1904809,1,0.986942818283193,0,2,regulation of dense core granule transport,BP,
20570,GO:1904811,1,0.986942818283193,0,2,positive regulation of dense core granule transport,BP,
20571,GO:1904812,1,0.993491968588613,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20572,GO:1904813,1,0.450489148040275,0,123,ficolin-1-rich granule lumen,CC,
20573,GO:1904814,1,0.919415339368145,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20574,GO:1904815,1,0.993547547321298,0,1,negative regulation of protein localization to chromosome, telomeric region,BP,
20575,GO:1904816,1,0.925390998034139,0,12,positive regulation of protein localization to chromosome, telomeric region,BP,
20576,GO:1904823,1,0.98085956405763,0,3,purine nucleobase transmembrane transport,BP,
20577,GO:1904825,1,0.974531315059401,0,4,protein localization to microtubule plus-end,BP,
20578,GO:1904826,1,0.993191138781943,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20579,GO:1904828,1,0.993191138781943,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20580,GO:1904829,1,0.993623303821261,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20581,GO:1904831,1,0.993623303821261,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20582,GO:1904833,1,0.974711293553188,0,4,positive regulation of removal of superoxide radicals,BP,
20583,GO:1904835,1,0.987005016713402,0,2,dorsal root ganglion morphogenesis,BP,
20584,GO:1904837,1,0.820783497281091,0,30,beta-catenin-TCF complex assembly,BP,
20585,GO:1904841,1,0.987278634315444,0,2,TORC2 complex binding,MF,
20586,GO:1904842,1,0.987262274836642,0,2,response to nitroglycerin,BP,
20587,GO:1904843,1,0.993595573832411,0,1,cellular response to nitroglycerin,BP,
20588,GO:1904844,1,0.980879502704873,0,3,response to L-glutamine,BP,
20589,GO:1904845,1,0.980879502704873,0,3,cellular response to L-glutamine,BP,
20591,GO:1904848,1,0.993659525454334,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20592,GO:1904849,1,0.980401508162442,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20593,GO:1904850,1,0.993547547321298,0,1,negative regulation of establishment of protein localization to telomere,BP,
20594,GO:1904851,1,0.937674971014146,0,10,positive regulation of establishment of protein localization to telomere,BP,
20595,GO:1904854,1,0.993533671582301,0,1,proteasome core complex binding,MF,
20596,GO:1904855,1,0.993653556149668,0,1,proteasome regulatory particle binding,MF,
20597,GO:1904861,1,0.842015230429479,0,26,excitatory synapse assembly,BP,
20598,GO:1904862,1,0.900095439560232,0,16,inhibitory synapse assembly,BP,
20599,GO:1904863,1,0.993500754008468,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20600,GO:1904864,1,0.993500754008468,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20601,GO:1904867,1,0.925655956672741,0,12,protein localization to Cajal body,BP,
20602,GO:1904868,1,0.986028494837621,0,2,telomerase catalytic core complex assembly,BP,
20603,GO:1904869,1,0.931607805630046,0,11,regulation of protein localization to Cajal body,BP,
20604,GO:1904871,1,0.931607805630046,0,11,positive regulation of protein localization to Cajal body,BP,
20605,GO:1904872,1,0.890303901216587,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20606,GO:1904874,1,0.908219506213061,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20607,GO:1904875,1,0.98718904312137,0,2,regulation of DNA ligase activity,BP,
20608,GO:1904876,1,0.993549603578293,0,1,negative regulation of DNA ligase activity,BP,
20609,GO:1904877,1,0.993598558020637,0,1,positive regulation of DNA ligase activity,BP,
20610,GO:1904878,1,0.986547111245234,0,2,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20611,GO:1904879,1,0.987102279867701,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20612,GO:1904880,1,0.980592337866248,0,3,response to hydrogen sulfide,BP,
20613,GO:1904881,1,0.986934975116037,0,2,cellular response to hydrogen sulfide,BP,
20614,GO:1904882,1,0.986028494837621,0,2,regulation of telomerase catalytic core complex assembly,BP,
20615,GO:1904884,1,0.986028494837621,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20616,GO:1904885,1,0.967168582782525,0,5,beta-catenin destruction complex assembly,BP,
20617,GO:1904886,1,0.894051438782677,0,17,beta-catenin destruction complex disassembly,BP,
20618,GO:1904887,1,0.993035571048495,0,1,Wnt signalosome assembly,BP,
20620,GO:1904889,1,0.906269731172771,0,15,regulation of excitatory synapse assembly,BP,
20621,GO:1904891,1,0.980835978016092,0,3,positive regulation of excitatory synapse assembly,BP,
20622,GO:1904892,1,0.541527512502333,0,94,regulation of receptor signaling pathway via STAT,BP,
20623,GO:1904893,1,0.877386489822308,0,20,negative regulation of receptor signaling pathway via STAT,BP,
20624,GO:1904894,1,0.650797531008027,0,66,positive regulation of receptor signaling pathway via STAT,BP,
20625,GO:1904895,1,0.99362856345896,0,1,ESCRT complex assembly,BP,
20626,GO:1904896,1,0.937543826737868,0,10,ESCRT complex disassembly,BP,
20627,GO:1904897,1,0.993526694290642,0,1,regulation of hepatic stellate cell proliferation,BP,
20628,GO:1904899,1,0.993526694290642,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20629,GO:1904902,1,0.99362856345896,0,1,ESCRT III complex assembly,BP,
20630,GO:1904903,1,0.937543826737868,0,10,ESCRT III complex disassembly,BP,
20631,GO:1904904,1,0.97443326536649,0,4,regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20632,GO:1904906,1,0.97443326536649,0,4,positive regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20633,GO:1904907,1,0.985896631169293,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20634,GO:1904908,1,0.985896631169293,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20635,GO:1904910,1,0.993547547321298,0,1,regulation of establishment of RNA localization to telomere,BP,
20636,GO:1904911,1,0.993547547321298,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20637,GO:1904913,1,0.993547547321298,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20638,GO:1904914,1,0.993547547321298,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20639,GO:1904923,1,0.917146596686415,0,13,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20640,GO:1904924,1,0.993579427614789,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20641,GO:1904925,1,0.923078016294104,0,12,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20642,GO:1904928,1,0.979957053881167,0,3,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20643,GO:1904929,1,0.961438221557647,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20644,GO:1904933,1,0.993349843576017,0,1,regulation of cell proliferation in midbrain,BP,
20645,GO:1904934,1,0.993349843576017,0,1,negative regulation of cell proliferation in midbrain,BP,
20647,GO:1904938,1,0.966981158273491,0,5,planar cell polarity pathway involved in axon guidance,BP,
20648,GO:1904947,1,0.993542531500193,0,1,folate import into mitochondrion,BP,
20649,GO:1904948,1,0.906843772724011,0,15,midbrain dopaminergic neuron differentiation,BP,
20650,GO:1904949,1,0.606571541473678,0,76,ATPase complex,CC,
20653,GO:1904953,1,0.936696558341876,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20654,GO:1904954,1,0.980834634357176,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20655,GO:1904955,1,0.993349843576017,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20656,GO:1904956,1,0.968257142125617,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20657,GO:1904958,1,0.980905946923036,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20658,GO:1904959,1,0.968063367287737,0,5,regulation of cytochrome-c oxidase activity,BP,
20659,GO:1904960,1,0.993710930571523,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20660,GO:1904970,1,0.98042951066621,0,3,brush border assembly,BP,
20661,GO:1904971,1,0.993447576014988,0,1,regulation of viral translation,BP,
20662,GO:1904973,1,0.993447576014988,0,1,positive regulation of viral translation,BP,
20663,GO:1904975,1,0.986941398254925,0,2,response to bleomycin,BP,
20664,GO:1904976,1,0.986941398254925,0,2,cellular response to bleomycin,BP,
20665,GO:1904977,1,0.987215002779367,0,2,lymphatic endothelial cell migration,BP,
20666,GO:1904978,1,0.980396300407894,0,3,regulation of endosome organization,BP,
20667,GO:1904979,1,0.99359069410163,0,1,negative regulation of endosome organization,BP,
20668,GO:1904980,1,0.993239391942904,0,1,positive regulation of endosome organization,BP,
20669,GO:1904983,1,0.993597761130561,0,1,glycine import into mitochondrion,BP,
20670,GO:1904984,1,0.993656077753609,0,1,regulation of quinolinate biosynthetic process,BP,
20671,GO:1904985,1,0.993656077753609,0,1,negative regulation of quinolinate biosynthetic process,BP,
20672,GO:1904990,1,0.993577318475809,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20673,GO:1904992,1,0.993577318475809,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20674,GO:1904994,1,0.843661661635352,0,26,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20675,GO:1904995,1,0.968602764883021,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20676,GO:1904996,1,0.877486361896481,0,20,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20677,GO:1904997,1,0.980868181814859,0,3,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20678,GO:1904998,1,0.993547743604013,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20679,GO:1904999,1,0.987238916011547,0,2,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20680,GO:1905000,1,0.993105559735555,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20681,GO:1905003,1,0.993656077753609,0,1,picolinic acid metabolic process,BP,
20682,GO:1905004,1,0.993656077753609,0,1,picolinic acid biosynthetic process,BP,
20683,GO:1905005,1,0.961475780253446,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20684,GO:1905006,1,0.987058782344764,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20685,GO:1905007,1,0.967657586493642,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20686,GO:1905008,1,0.99356854826303,0,1,regulation of L-lysine import across plasma membrane,BP,
20687,GO:1905010,1,0.99356854826303,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20688,GO:1905012,1,0.993656077753609,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20689,GO:1905024,1,0.974159070979235,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20690,GO:1905025,1,0.993540292627664,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20691,GO:1905026,1,0.986991714595894,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20692,GO:1905030,1,0.986595452498401,0,2,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20693,GO:1905031,1,0.967441037237856,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20694,GO:1905032,1,0.993540292627664,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20695,GO:1905033,1,0.986991714595894,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20696,GO:1905034,1,0.987202044282866,0,2,regulation of antifungal innate immune response,BP,
20697,GO:1905035,1,0.993547911993653,0,1,negative regulation of antifungal innate immune response,BP,
20698,GO:1905036,1,0.993613334442618,0,1,positive regulation of antifungal innate immune response,BP,
20699,GO:1905037,1,0.551273861064429,0,91,autophagosome organization,BP,
20700,GO:1905038,1,0.901418689423053,0,16,regulation of membrane lipid metabolic process,BP,
20702,GO:1905040,1,0.993574430978759,0,1,otic placode development,BP,
20703,GO:1905041,1,0.993590103266034,0,1,regulation of epithelium regeneration,BP,
20704,GO:1905042,1,0.993590103266034,0,1,negative regulation of epithelium regeneration,BP,
20705,GO:1905044,1,0.99355705431691,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20706,GO:1905045,1,0.99355705431691,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20708,GO:1905049,1,0.953755715500934,0,7,negative regulation of metallopeptidase activity,BP,
20710,GO:1905051,1,0.987344861341909,0,2,regulation of base-excision repair,BP,
20711,GO:1905053,1,0.987344861341909,0,2,positive regulation of base-excision repair,BP,
20712,GO:1905056,1,0.979757667647868,0,3,calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
20713,GO:1905059,1,0.993070234445195,0,1,calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20714,GO:1905060,1,0.980271155557588,0,3,calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20715,GO:1905062,1,0.993560681059633,0,1,positive regulation of cardioblast proliferation,BP,
20716,GO:1905063,1,0.912728822705283,0,14,regulation of vascular associated smooth muscle cell differentiation,BP,
20717,GO:1905064,1,0.949120219405759,0,8,negative regulation of vascular associated smooth muscle cell differentiation,BP,
20718,GO:1905065,1,0.961677390600206,0,6,positive regulation of vascular associated smooth muscle cell differentiation,BP,
20719,GO:1905066,1,0.987242434706085,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20720,GO:1905067,1,0.993619377814711,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20721,GO:1905068,1,0.993582516269034,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20722,GO:1905069,1,0.987123489668258,0,2,allantois development,BP,
20723,GO:1905071,1,0.98688130358328,0,2,tight junction disassembly,BP,
20724,GO:1905073,1,0.98688130358328,0,2,regulation of tight junction disassembly,BP,
20725,GO:1905075,1,0.98688130358328,0,2,positive regulation of tight junction disassembly,BP,
20726,GO:1905089,1,0.992726801282454,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20727,GO:1905090,1,0.992726801282454,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20728,GO:1905097,1,0.954975371096783,0,7,regulation of guanyl-nucleotide exchange factor activity,BP,
20729,GO:1905098,1,0.974227308338161,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20730,GO:1905099,1,0.993304642559122,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20731,GO:1905103,1,0.980617201886897,0,3,integral component of lysosomal membrane,CC,
20733,GO:1905115,1,0.99365700630751,0,1,regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20734,GO:1905116,1,0.99365700630751,0,1,positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20735,GO:1905123,1,0.986969357813004,0,2,regulation of glucosylceramidase activity,BP,
20736,GO:1905132,1,0.987196210458918,0,2,regulation of meiotic chromosome separation,BP,
20737,GO:1905133,1,0.993542175290034,0,1,negative regulation of meiotic chromosome separation,BP,
20738,GO:1905134,1,0.993613200187168,0,1,positive regulation of meiotic chromosome separation,BP,
20739,GO:1905135,1,0.987083423549635,0,2,biotin import across plasma membrane,BP,
20740,GO:1905143,1,0.993636050040832,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20741,GO:1905144,1,0.838844615025933,0,27,response to acetylcholine,BP,
20742,GO:1905145,1,0.838844615025933,0,27,cellular response to acetylcholine,BP,
20744,GO:1905150,1,0.955557365782327,0,7,regulation of voltage-gated sodium channel activity,BP,
20745,GO:1905152,1,0.993343751485486,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20746,GO:1905153,1,0.900836819376632,0,16,regulation of membrane invagination,BP,
20747,GO:1905154,1,0.987054635361151,0,2,negative regulation of membrane invagination,BP,
20748,GO:1905155,1,0.918581128010104,0,13,positive regulation of membrane invagination,BP,
20749,GO:1905161,1,0.993399296516858,0,1,protein localization to phagocytic vesicle,BP,
20750,GO:1905162,1,0.980748801529448,0,3,regulation of phagosome maturation,BP,
20751,GO:1905164,1,0.993613334442618,0,1,positive regulation of phagosome maturation,BP,
20753,GO:1905166,1,0.974274175347886,0,4,negative regulation of lysosomal protein catabolic process,BP,
20755,GO:1905168,1,0.936323471781453,0,10,positive regulation of double-strand break repair via homologous recombination,BP,
20756,GO:1905169,1,0.993399296516858,0,1,regulation of protein localization to phagocytic vesicle,BP,
20757,GO:1905171,1,0.993399296516858,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20758,GO:1905172,1,0.980478144549735,0,3,RISC complex binding,MF,
20759,GO:1905174,1,0.987206960302379,0,2,regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20760,GO:1905176,1,0.993550710897748,0,1,positive regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20761,GO:1905178,1,0.987212571662295,0,2,regulation of cardiac muscle tissue regeneration,BP,
20762,GO:1905179,1,0.987212571662295,0,2,negative regulation of cardiac muscle tissue regeneration,BP,
20763,GO:1905184,1,0.993542367033875,0,1,positive regulation of protein serine/threonine phosphatase activity,BP,
20764,GO:1905186,1,0.993613200187168,0,1,regulation of metaphase/anaphase transition of meiosis I,BP,
20765,GO:1905188,1,0.993613200187168,0,1,positive regulation of metaphase/anaphase transition of meiosis I,BP,
20766,GO:1905198,1,0.986990390900592,0,2,manchette assembly,BP,
20767,GO:1905199,1,0.993574494173141,0,1,manchette disassembly,BP,
20768,GO:1905202,1,0.987119229810633,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20769,GO:1905203,1,0.973927400399943,0,4,regulation of connective tissue replacement,BP,
20770,GO:1905204,1,0.993650235406605,0,1,negative regulation of connective tissue replacement,BP,
20771,GO:1905205,1,0.980152381151683,0,3,positive regulation of connective tissue replacement,BP,
20772,GO:1905206,1,0.967886533664183,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20776,GO:1905214,1,0.925018211577495,0,12,regulation of RNA binding,BP,
20777,GO:1905215,1,0.993623605614367,0,1,negative regulation of RNA binding,BP,
20778,GO:1905216,1,0.943338424104651,0,9,positive regulation of RNA binding,BP,
20779,GO:1905217,1,0.993538746806461,0,1,response to astaxanthin,BP,
20780,GO:1905219,1,0.986146091357008,0,2,regulation of platelet formation,BP,
20781,GO:1905221,1,0.986146091357008,0,2,positive regulation of platelet formation,BP,
20782,GO:1905222,1,0.993536482491547,0,1,atrioventricular canal morphogenesis,BP,
20783,GO:1905223,1,0.986569722639115,0,2,epicardium morphogenesis,BP,
20784,GO:1905224,1,0.980480156955096,0,3,clathrin-coated pit assembly,BP,
20785,GO:1905225,1,0.987235868252102,0,2,response to thyrotropin-releasing hormone,BP,
20786,GO:1905226,1,0.99365402079382,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20787,GO:1905229,1,0.993656542061027,0,1,cellular response to thyrotropin-releasing hormone,BP,
20788,GO:1905232,1,0.967916966220545,0,5,cellular response to L-glutamate,BP,
20789,GO:1905239,1,0.99341744684845,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20790,GO:1905240,1,0.99341744684845,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20791,GO:1905242,1,0.987126858905069,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20792,GO:1905243,1,0.993562185467611,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20793,GO:1905244,1,0.924299891002197,0,12,regulation of modification of synaptic structure,BP,
20794,GO:1905245,1,0.93646301184561,0,10,regulation of aspartic-type peptidase activity,BP,
20795,GO:1905246,1,0.986495520400031,0,2,negative regulation of aspartic-type peptidase activity,BP,
20796,GO:1905247,1,0.949289297380066,0,8,positive regulation of aspartic-type peptidase activity,BP,
20797,GO:1905255,1,0.993296226335888,0,1,regulation of RNA binding transcription factor activity,BP,
20798,GO:1905258,1,0.987353929820265,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20799,GO:1905259,1,0.987353929820265,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20800,GO:1905267,1,0.980874821338383,0,3,endonucleolytic cleavage involved in tRNA processing,BP,
20802,GO:1905269,1,0.525536167193772,0,98,positive regulation of chromatin organization,BP,
20803,GO:1905271,1,0.993697464345969,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20804,GO:1905273,1,0.993697464345969,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20805,GO:1905274,1,0.967472397366575,0,5,regulation of modification of postsynaptic actin cytoskeleton,BP,
20806,GO:1905276,1,0.888467651940939,0,18,regulation of epithelial tube formation,BP,
20807,GO:1905277,1,0.993540211064586,0,1,negative regulation of epithelial tube formation,BP,
20808,GO:1905278,1,0.974361524338941,0,4,positive regulation of epithelial tube formation,BP,
20809,GO:1905279,1,0.980266647966629,0,3,regulation of retrograde transport, endosome to Golgi,BP,
20810,GO:1905280,1,0.993544182183655,0,1,negative regulation of retrograde transport, endosome to Golgi,BP,
20811,GO:1905285,1,0.99351061792185,0,1,fibrous ring of heart morphogenesis,BP,
20812,GO:1905286,1,0.980823767212193,0,3,serine-type peptidase complex,CC,
20813,GO:1905288,1,0.94270493109068,0,9,vascular associated smooth muscle cell apoptotic process,BP,
20814,GO:1905289,1,0.979435817103228,0,3,regulation of CAMKK-AMPK signaling cascade,BP,
20815,GO:1905291,1,0.993669453079625,0,1,positive regulation of CAMKK-AMPK signaling cascade,BP,
20816,GO:1905292,1,0.980637451372503,0,3,regulation of neural crest cell differentiation,BP,
20817,GO:1905294,1,0.980637451372503,0,3,positive regulation of neural crest cell differentiation,BP,
20818,GO:1905301,1,0.980440752803883,0,3,regulation of macropinocytosis,BP,
20819,GO:1905302,1,0.993453138183425,0,1,negative regulation of macropinocytosis,BP,
20820,GO:1905303,1,0.986902717574403,0,2,positive regulation of macropinocytosis,BP,
20821,GO:1905304,1,0.993083098376319,0,1,regulation of cardiac myofibril assembly,BP,
20822,GO:1905305,1,0.993083098376319,0,1,negative regulation of cardiac myofibril assembly,BP,
20823,GO:1905309,1,0.992947795630555,0,1,positive regulation of cohesin loading,BP,
20824,GO:1905310,1,0.980637451372503,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20825,GO:1905312,1,0.980637451372503,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20826,GO:1905313,1,0.993592799671384,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20827,GO:1905314,1,0.789083284407595,0,36,semi-lunar valve development,BP,
20828,GO:1905317,1,0.993444645315498,0,1,inferior endocardial cushion morphogenesis,BP,
20829,GO:1905319,1,0.980894504169972,0,3,mesenchymal stem cell migration,BP,
20830,GO:1905320,1,0.980894504169972,0,3,regulation of mesenchymal stem cell migration,BP,
20831,GO:1905322,1,0.980894504169972,0,3,positive regulation of mesenchymal stem cell migration,BP,
20832,GO:1905323,1,0.960938534440207,0,6,telomerase holoenzyme complex assembly,BP,
20833,GO:1905327,1,0.993634714618148,0,1,tracheoesophageal septum formation,BP,
20835,GO:1905331,1,0.900413501919426,0,16,negative regulation of morphogenesis of an epithelium,BP,
20837,GO:1905333,1,0.974888431579412,0,4,regulation of gastric motility,BP,
20838,GO:1905335,1,0.979900001669394,0,3,regulation of aggrephagy,BP,
20839,GO:1905337,1,0.979900001669394,0,3,positive regulation of aggrephagy,BP,
20840,GO:1905340,1,0.974581091123222,0,4,regulation of protein localization to kinetochore,BP,
20841,GO:1905341,1,0.993562427112928,0,1,negative regulation of protein localization to kinetochore,BP,
20842,GO:1905342,1,0.974581091123222,0,4,positive regulation of protein localization to kinetochore,BP,
20843,GO:1905344,1,0.980867958995444,0,3,prostaglandin catabolic process,BP,
20844,GO:1905347,1,0.96194489731211,0,6,endodeoxyribonuclease complex,CC,
20845,GO:1905348,1,0.797419609912333,0,35,endonuclease complex,CC,
20846,GO:1905349,1,0.993554508041304,0,1,ciliary transition zone assembly,BP,
20847,GO:1905354,1,0.856282535219053,0,24,exoribonuclease complex,CC,
20849,GO:1905359,1,0.993542175290034,0,1,protein localization to meiotic spindle,BP,
20850,GO:1905360,1,0.813053767890289,0,32,GTPase complex,CC,
20851,GO:1905364,1,0.993615214374777,0,1,regulation of endosomal vesicle fusion,BP,
20852,GO:1905365,1,0.99359069410163,0,1,regulation of intralumenal vesicle formation,BP,
20853,GO:1905366,1,0.99359069410163,0,1,negative regulation of intralumenal vesicle formation,BP,
20854,GO:1905368,1,0.585106121935954,0,83,peptidase complex,CC,
20855,GO:1905369,1,0.658029738403458,0,65,endopeptidase complex,CC,
20856,GO:1905370,1,0.993579427614789,0,1,serine-type endopeptidase complex,CC,
20857,GO:1905371,1,0.987004700257117,0,2,ceramide phosphoethanolamine metabolic process,BP,
20858,GO:1905373,1,0.987004700257117,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20859,GO:1905377,1,0.993450550931208,0,1,response to D-galactose,BP,
20860,GO:1905380,1,0.974559004922278,0,4,regulation of snRNA transcription by RNA polymerase II,BP,
20861,GO:1905382,1,0.974559004922278,0,4,positive regulation of snRNA transcription by RNA polymerase II,BP,
20862,GO:1905383,1,0.929965742036872,0,11,protein localization to presynapse,BP,
20863,GO:1905384,1,0.987213769495928,0,2,regulation of protein localization to presynapse,BP,
20864,GO:1905386,1,0.987213769495928,0,2,positive regulation of protein localization to presynapse,BP,
20865,GO:1905394,1,0.967176429142555,0,5,retromer complex binding,MF,
20866,GO:1905395,1,0.98091556902157,0,3,response to flavonoid,BP,
20867,GO:1905396,1,0.993650733728302,0,1,cellular response to flavonoid,BP,
20868,GO:1905397,1,0.987284689432885,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20869,GO:1905402,1,0.987284689432885,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20870,GO:1905403,1,0.993607433199545,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20871,GO:1905404,1,0.993636984467201,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20872,GO:1905405,1,0.992947795630555,0,1,regulation of mitotic cohesin loading,BP,
20873,GO:1905406,1,0.992947795630555,0,1,positive regulation of mitotic cohesin loading,BP,
20874,GO:1905407,1,0.987182907289582,0,2,regulation of creatine transmembrane transporter activity,BP,
20875,GO:1905408,1,0.987182907289582,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20876,GO:1905413,1,0.993452923481291,0,1,regulation of dense core granule exocytosis,BP,
20877,GO:1905414,1,0.993483668270107,0,1,negative regulation of dense core granule exocytosis,BP,
20878,GO:1905415,1,0.993483668270107,0,1,positive regulation of dense core granule exocytosis,BP,
20879,GO:1905420,1,0.98063690200295,0,3,vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
20880,GO:1905424,1,0.987205742451087,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20881,GO:1905426,1,0.987205742451087,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20882,GO:1905429,1,0.980710889188435,0,3,response to glycine,BP,
20883,GO:1905430,1,0.987156059371584,0,2,cellular response to glycine,BP,
20884,GO:1905432,1,0.993483668270107,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20885,GO:1905433,1,0.993483668270107,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20886,GO:1905435,1,0.987105181727901,0,2,regulation of histone H3-K4 trimethylation,BP,
20887,GO:1905437,1,0.987105181727901,0,2,positive regulation of histone H3-K4 trimethylation,BP,
20888,GO:1905438,1,0.987033822904313,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20889,GO:1905443,1,0.993456621349501,0,1,regulation of clathrin coat assembly,BP,
20890,GO:1905445,1,0.993456621349501,0,1,positive regulation of clathrin coat assembly,BP,
20893,GO:1905448,1,0.968528351659125,0,5,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20894,GO:1905449,1,0.954873327864125,0,7,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20895,GO:1905450,1,0.986766545529087,0,2,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20896,GO:1905451,1,0.967683300086709,0,5,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20897,GO:1905453,1,0.993578947207367,0,1,regulation of myeloid progenitor cell differentiation,BP,
20898,GO:1905454,1,0.993578947207367,0,1,negative regulation of myeloid progenitor cell differentiation,BP,
20899,GO:1905456,1,0.948439332325827,0,8,regulation of lymphoid progenitor cell differentiation,BP,
20900,GO:1905457,1,0.980453162220654,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20901,GO:1905458,1,0.98699598186046,0,2,positive regulation of lymphoid progenitor cell differentiation,BP,
20902,GO:1905459,1,0.94270493109068,0,9,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20903,GO:1905460,1,0.986654542821212,0,2,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20904,GO:1905461,1,0.955461776958202,0,7,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20905,GO:1905462,1,0.961929502144528,0,6,regulation of DNA duplex unwinding,BP,
20906,GO:1905463,1,0.980652696080005,0,3,negative regulation of DNA duplex unwinding,BP,
20907,GO:1905464,1,0.980911110462376,0,3,positive regulation of DNA duplex unwinding,BP,
20908,GO:1905468,1,0.993399296516858,0,1,regulation of clathrin-coated pit assembly,BP,
20909,GO:1905469,1,0.993399296516858,0,1,negative regulation of clathrin-coated pit assembly,BP,
20910,GO:1905474,1,0.993639919287708,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20911,GO:1905475,1,0.301568371389828,0,183,regulation of protein localization to membrane,BP,
20912,GO:1905476,1,0.822986166097437,0,30,negative regulation of protein localization to membrane,BP,
20913,GO:1905477,1,0.456257942218075,0,120,positive regulation of protein localization to membrane,BP,
20914,GO:1905483,1,0.992796704709803,0,1,regulation of motor neuron migration,BP,
20915,GO:1905485,1,0.992796704709803,0,1,positive regulation of motor neuron migration,BP,
20916,GO:1905492,1,0.993513894490263,0,1,positive regulation of branching morphogenesis of a nerve,BP,
20917,GO:1905502,1,0.98712675725675,0,2,acetyl-CoA binding,MF,
20918,GO:1905503,1,0.993620921871391,0,1,regulation of motile cilium assembly,BP,
20919,GO:1905505,1,0.993620921871391,0,1,positive regulation of motile cilium assembly,BP,
20920,GO:1905508,1,0.803342934469034,0,33,protein localization to microtubule organizing center,BP,
20921,GO:1905512,1,0.993569416905227,0,1,regulation of short-term synaptic potentiation,BP,
20922,GO:1905513,1,0.993569416905227,0,1,negative regulation of short-term synaptic potentiation,BP,
20923,GO:1905515,1,0.720605007219141,0,50,non-motile cilium assembly,BP,
20924,GO:1905516,1,0.924713839585416,0,12,positive regulation of fertilization,BP,
20926,GO:1905518,1,0.993425430038218,0,1,regulation of presynaptic active zone assembly,BP,
20927,GO:1905520,1,0.993425430038218,0,1,positive regulation of presynaptic active zone assembly,BP,
20929,GO:1905522,1,0.943569887044719,0,9,negative regulation of macrophage migration,BP,
20931,GO:1905524,1,0.993184883909915,0,1,negative regulation of protein autoubiquitination,BP,
20932,GO:1905526,1,0.987088731412983,0,2,regulation of Golgi lumen acidification,BP,
20933,GO:1905528,1,0.993455134053272,0,1,positive regulation of Golgi lumen acidification,BP,
20934,GO:1905532,1,0.987157538209783,0,2,regulation of leucine import across plasma membrane,BP,
20935,GO:1905533,1,0.987157538209783,0,2,negative regulation of leucine import across plasma membrane,BP,
20936,GO:1905535,1,0.993400437590889,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20937,GO:1905537,1,0.993400437590889,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20938,GO:1905538,1,0.967908134808615,0,5,polysome binding,MF,
20939,GO:1905541,1,0.99356854826303,0,1,regulation of L-arginine import across plasma membrane,BP,
20940,GO:1905546,1,0.993587485036605,0,1,cellular response to phenylpropanoid,BP,
20941,GO:1905547,1,0.993630437004572,0,1,regulation of subtelomeric heterochromatin assembly,BP,
20942,GO:1905549,1,0.993630437004572,0,1,positive regulation of subtelomeric heterochromatin assembly,BP,
20943,GO:1905550,1,0.987273580638535,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20944,GO:1905552,1,0.987273580638535,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20945,GO:1905553,1,0.974571053171184,0,4,regulation of blood vessel branching,BP,
20946,GO:1905555,1,0.980799909972706,0,3,positive regulation blood vessel branching,BP,
20947,GO:1905562,1,0.876756226811344,0,20,regulation of vascular endothelial cell proliferation,BP,
20948,GO:1905563,1,0.967649723747523,0,5,negative regulation of vascular endothelial cell proliferation,BP,
20949,GO:1905564,1,0.90609716903409,0,15,positive regulation of vascular endothelial cell proliferation,BP,
20950,GO:1905572,1,0.993553146953966,0,1,ganglioside GM1 transport to membrane,BP,
20951,GO:1905573,1,0.987205845685162,0,2,ganglioside GM1 binding,MF,
20952,GO:1905574,1,0.993553146953966,0,1,ganglioside GM2 binding,MF,
20953,GO:1905575,1,0.993553146953966,0,1,ganglioside GM3 binding,MF,
20955,GO:1905577,1,0.993553146953966,0,1,ganglioside GP1c binding,MF,
20956,GO:1905578,1,0.993577095497508,0,1,regulation of ERBB3 signaling pathway,BP,
20957,GO:1905580,1,0.993577095497508,0,1,positive regulation of ERBB3 signaling pathway,BP,
20958,GO:1905581,1,0.987218569239435,0,2,positive regulation of low-density lipoprotein particle clearance,BP,
20959,GO:1905589,1,0.99356854826303,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20960,GO:1905590,1,0.993536831936185,0,1,fibronectin fibril organization,BP,
20961,GO:1905594,1,0.993663499552189,0,1,resveratrol binding,MF,
20962,GO:1905595,1,0.9871809376372,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20963,GO:1905596,1,0.993509536794293,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20964,GO:1905597,1,0.993630470449032,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20965,GO:1905598,1,0.986691524732186,0,2,negative regulation of low-density lipoprotein receptor activity,BP,
20966,GO:1905599,1,0.993630470449032,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20967,GO:1905600,1,0.974078516394112,0,4,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20968,GO:1905601,1,0.986691524732186,0,2,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20969,GO:1905602,1,0.987218569239435,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20970,GO:1905603,1,0.955232262655902,0,7,regulation of blood-brain barrier permeability,BP,
20971,GO:1905604,1,0.987116819838504,0,2,negative regulation of blood-brain barrier permeability,BP,
20972,GO:1905605,1,0.96770342754501,0,5,positive regulation of blood-brain barrier permeability,BP,
20974,GO:1905607,1,0.993619377814711,0,1,negative regulation of presynapse assembly,BP,
20975,GO:1905608,1,0.993425430038218,0,1,positive regulation of presynapse assembly,BP,
20976,GO:1905610,1,0.993400437590889,0,1,regulation of mRNA cap binding,BP,
20977,GO:1905612,1,0.993400437590889,0,1,positive regulation of mRNA cap binding,BP,
20978,GO:1905616,1,0.980506031951635,0,3,regulation of miRNA mediated inhibition of translation,BP,
20979,GO:1905618,1,0.980506031951635,0,3,positive regulation of miRNA mediated inhibition of translation,BP,
20980,GO:1905634,1,0.967116882635421,0,5,regulation of protein localization to chromatin,BP,
20981,GO:1905636,1,0.980423110114991,0,3,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20982,GO:1905642,1,0.99355705431691,0,1,negative regulation of DNA methylation,BP,
20983,GO:1905643,1,0.980590467701223,0,3,positive regulation of DNA methylation,BP,
20984,GO:1905647,1,0.980605358654034,0,3,proline import across plasma membrane,BP,
20985,GO:1905651,1,0.980308378638433,0,3,regulation of artery morphogenesis,BP,
20986,GO:1905653,1,0.980308378638433,0,3,positive regulation of artery morphogenesis,BP,
20987,GO:1905661,1,0.980807830250364,0,3,regulation of telomerase RNA reverse transcriptase activity,BP,
20988,GO:1905662,1,0.99358232253883,0,1,negative regulation of telomerase RNA reverse transcriptase activity,BP,
20989,GO:1905663,1,0.987143818113217,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20990,GO:1905664,1,0.97456516653659,0,4,regulation of calcium ion import across plasma membrane,BP,
20991,GO:1905665,1,0.987201851904031,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20992,GO:1905666,1,0.91787258168887,0,13,regulation of protein localization to endosome,BP,
20993,GO:1905667,1,0.993494277612909,0,1,negative regulation of protein localization to endosome,BP,
20994,GO:1905668,1,0.923887884286178,0,12,positive regulation of protein localization to endosome,BP,
20995,GO:1905671,1,0.974488587128371,0,4,regulation of lysosome organization,BP,
20996,GO:1905673,1,0.993585465122445,0,1,positive regulation of lysosome organization,BP,
20997,GO:1905674,1,0.981021250051968,0,3,regulation of adaptive immune memory response,BP,
20998,GO:1905675,1,0.987301631540771,0,2,negative regulation of adaptive immune memory response,BP,
20999,GO:1905676,1,0.993639652606539,0,1,positive regulation of adaptive immune memory response,BP,
21000,GO:1905684,1,0.980462643170326,0,3,regulation of plasma membrane repair,BP,
21001,GO:1905687,1,0.993355789011112,0,1,regulation of diacylglycerol kinase activity,BP,
21002,GO:1905689,1,0.993355789011112,0,1,positive regulation of diacylglycerol kinase activity,BP,
21003,GO:1905693,1,0.993596235981754,0,1,regulation of phosphatidic acid biosynthetic process,BP,
21004,GO:1905695,1,0.993596235981754,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
21005,GO:1905696,1,0.986890827159173,0,2,regulation of polysome binding,BP,
21006,GO:1905698,1,0.993447576014988,0,1,positive regulation of polysome binding,BP,
21007,GO:1905702,1,0.974268454872039,0,4,regulation of inhibitory synapse assembly,BP,
21008,GO:1905703,1,0.993604623244322,0,1,negative regulation of inhibitory synapse assembly,BP,
21009,GO:1905704,1,0.987027532672903,0,2,positive regulation of inhibitory synapse assembly,BP,
21010,GO:1905705,1,0.993252501983655,0,1,cellular response to paclitaxel,BP,
21011,GO:1905706,1,0.993571600250961,0,1,regulation of mitochondrial ATP synthesis coupled proton transport,BP,
21012,GO:1905709,1,0.955144111082345,0,7,negative regulation of membrane permeability,BP,
21014,GO:1905711,1,0.993500810126899,0,1,response to phosphatidylethanolamine,BP,
21015,GO:1905719,1,0.987146822045812,0,2,protein localization to perinuclear region of cytoplasm,BP,
21016,GO:1905720,1,0.993229466008014,0,1,cytoplasmic microtubule bundle,CC,
21017,GO:1905721,1,0.980859833628246,0,3,mitotic spindle astral microtubule end,CC,
21018,GO:1905725,1,0.974531315059401,0,4,protein localization to microtubule end,BP,
21019,GO:1905735,1,0.993516082062855,0,1,regulation of L-proline import across plasma membrane,BP,
21020,GO:1905737,1,0.993516082062855,0,1,positive regulation of L-proline import across plasma membrane,BP,
21021,GO:1905747,1,0.987252610627966,0,2,negative regulation of saliva secretion,BP,
21022,GO:1905748,1,0.987252610627966,0,2,hard palate morphogenesis,BP,
21023,GO:1905749,1,0.974126834069485,0,4,regulation of endosome to plasma membrane protein transport,BP,
21024,GO:1905751,1,0.986825190273849,0,2,positive regulation of endosome to plasma membrane protein transport,BP,
21025,GO:1905764,1,0.980520803672759,0,3,regulation of protection from non-homologous end joining at telomere,BP,
21026,GO:1905765,1,0.980520803672759,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
21027,GO:1905767,1,0.993268652688804,0,1,regulation of double-stranded telomeric DNA binding,BP,
21028,GO:1905768,1,0.993268652688804,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
21029,GO:1905770,1,0.961915450715978,0,6,regulation of mesodermal cell differentiation,BP,
21030,GO:1905771,1,0.981009067108271,0,3,negative regulation of mesodermal cell differentiation,BP,
21031,GO:1905772,1,0.993537047150672,0,1,positive regulation of mesodermal cell differentiation,BP,
21032,GO:1905773,1,0.98042015909341,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
21033,GO:1905774,1,0.968362053931274,0,5,regulation of DNA helicase activity,BP,
21034,GO:1905775,1,0.987209184214232,0,2,negative regulation of DNA helicase activity,BP,
21035,GO:1905776,1,0.980911110462376,0,3,positive regulation of DNA helicase activity,BP,
21036,GO:1905777,1,0.980778569711672,0,3,regulation of exonuclease activity,BP,
21037,GO:1905778,1,0.987138301957793,0,2,negative regulation of exonuclease activity,BP,
21038,GO:1905779,1,0.993558236361319,0,1,positive regulation of exonuclease activity,BP,
21039,GO:1905784,1,0.987188282691488,0,2,regulation of anaphase-promoting complex-dependent catabolic process,BP,
21040,GO:1905786,1,0.987188282691488,0,2,positive regulation of anaphase-promoting complex-dependent catabolic process,BP,
21041,GO:1905787,1,0.993560801035551,0,1,regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21042,GO:1905788,1,0.993560801035551,0,1,negative regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21043,GO:1905793,1,0.986313500782511,0,2,protein localization to pericentriolar material,BP,
21044,GO:1905794,1,0.992952659841626,0,1,response to puromycin,BP,
21045,GO:1905795,1,0.992952659841626,0,1,cellular response to puromycin,BP,
21046,GO:1905799,1,0.993425507597842,0,1,regulation of intraciliary retrograde transport,BP,
21047,GO:1905802,1,0.993552226090051,0,1,regulation of cellular response to manganese ion,BP,
21048,GO:1905809,1,0.854282407569241,0,24,negative regulation of synapse organization,BP,
21049,GO:1905818,1,0.666710532232122,0,62,regulation of chromosome separation,BP,
21050,GO:1905819,1,0.785328653580281,0,37,negative regulation of chromosome separation,BP,
21051,GO:1905820,1,0.90673590342684,0,15,positive regulation of chromosome separation,BP,
21052,GO:1905828,1,0.993557644462967,0,1,regulation of prostaglandin catabolic process,BP,
21053,GO:1905832,1,0.966819301945212,0,5,positive regulation of spindle assembly,BP,
21054,GO:1905834,1,0.993622364687005,0,1,response to pyrimidine ribonucleotide,BP,
21055,GO:1905835,1,0.993622364687005,0,1,cellular response to pyrimidine ribonucleotide,BP,
21056,GO:1905838,1,0.987138301957793,0,2,regulation of telomeric D-loop disassembly,BP,
21057,GO:1905839,1,0.987138301957793,0,2,negative regulation of telomeric D-loop disassembly,BP,
21058,GO:1905843,1,0.992850802786552,0,1,regulation of cellular response to gamma radiation,BP,
21059,GO:1905853,1,0.993661049356776,0,1,regulation of heparan sulfate binding,BP,
21060,GO:1905855,1,0.993661049356776,0,1,positive regulation of heparan sulfate binding,BP,
21061,GO:1905856,1,0.993567929492266,0,1,negative regulation of pentose-phosphate shunt,BP,
21062,GO:1905858,1,0.993661049356776,0,1,regulation of heparan sulfate proteoglycan binding,BP,
21063,GO:1905860,1,0.993661049356776,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
21064,GO:1905863,1,0.986588956599314,0,2,invadopodium organization,BP,
21066,GO:1905868,1,0.980865452498036,0,3,regulation of 3'-UTR-mediated mRNA stabilization,BP,
21067,GO:1905869,1,0.99355705431691,0,1,negative regulation of 3'-UTR-mediated mRNA stabilization,BP,
21068,GO:1905870,1,0.987226917077171,0,2,positive regulation of 3'-UTR-mediated mRNA stabilization,BP,
21069,GO:1905874,1,0.900247658511022,0,16,regulation of postsynaptic density organization,BP,
21070,GO:1905875,1,0.993547715552325,0,1,negative regulation of postsynaptic density organization,BP,
21071,GO:1905878,1,0.992984261085794,0,1,invadopodium disassembly,BP,
21072,GO:1905879,1,0.93078148966224,0,11,regulation of oogenesis,BP,
21073,GO:1905880,1,0.974248149435666,0,4,negative regulation of oogenesis,BP,
21074,GO:1905881,1,0.967810889051027,0,5,positive regulation of oogenesis,BP,
21075,GO:1905883,1,0.993586050681278,0,1,regulation of triglyceride transport,BP,
21076,GO:1905885,1,0.993586050681278,0,1,positive regulation of triglyceride transport,BP,
21077,GO:1905890,1,0.993661049356776,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
21078,GO:1905891,1,0.993552570870591,0,1,regulation of cellular response to thapsigargin,BP,
21079,GO:1905892,1,0.993552570870591,0,1,negative regulation of cellular response to thapsigargin,BP,
21080,GO:1905894,1,0.993552570870591,0,1,regulation of cellular response to tunicamycin,BP,
21081,GO:1905895,1,0.993552570870591,0,1,negative regulation of cellular response to tunicamycin,BP,
21084,GO:1905899,1,0.993634714618148,0,1,regulation of smooth muscle tissue development,BP,
21085,GO:1905900,1,0.993634714618148,0,1,negative regulation of smooth muscle tissue development,BP,
21086,GO:1905901,1,0.993634714618148,0,1,positive regulation of smooth muscle tissue development,BP,
21087,GO:1905902,1,0.961915450715978,0,6,regulation of mesoderm formation,BP,
21088,GO:1905903,1,0.981009067108271,0,3,negative regulation of mesoderm formation,BP,
21089,GO:1905904,1,0.993537047150672,0,1,positive regulation of mesoderm formation,BP,
21090,GO:1905906,1,0.95560585430793,0,7,regulation of amyloid fibril formation,BP,
21091,GO:1905907,1,0.974548123469692,0,4,negative regulation of amyloid fibril formation,BP,
21092,GO:1905908,1,0.974308883831661,0,4,positive regulation of amyloid fibril formation,BP,
21093,GO:1905912,1,0.987229105399768,0,2,regulation of calcium ion export across plasma membrane,BP,
21094,GO:1905913,1,0.993616691748666,0,1,negative regulation of calcium ion export across plasma membrane,BP,
21095,GO:1905915,1,0.98063690200295,0,3,regulation of cell differentiation involved in phenotypic switching,BP,
21096,GO:1905916,1,0.986883409699786,0,2,negative regulation of cell differentiation involved in phenotypic switching,BP,
21097,GO:1905917,1,0.993671303521141,0,1,positive regulation of cell differentiation involved in phenotypic switching,BP,
21098,GO:1905918,1,0.987325679796741,0,2,regulation of CoA-transferase activity,BP,
21099,GO:1905920,1,0.987325679796741,0,2,positive regulation of CoA-transferase activity,BP,
21100,GO:1905927,1,0.992984261085794,0,1,regulation of invadopodium disassembly,BP,
21101,GO:1905929,1,0.992984261085794,0,1,positive regulation of invadopodium disassembly,BP,
21102,GO:1905930,1,0.98063690200295,0,3,regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21103,GO:1905931,1,0.986883409699786,0,2,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21104,GO:1905932,1,0.993671303521141,0,1,positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21105,GO:1905933,1,0.993642851218205,0,1,regulation of cell fate determination,BP,
21106,GO:1905934,1,0.993642851218205,0,1,negative regulation of cell fate determination,BP,
21107,GO:1905936,1,0.974780846945284,0,4,regulation of germ cell proliferation,BP,
21108,GO:1905937,1,0.980987490993431,0,3,negative regulation of germ cell proliferation,BP,
21109,GO:1905938,1,0.993674275777176,0,1,positive regulation of germ cell proliferation,BP,
21110,GO:1905939,1,0.883964568171884,0,19,regulation of gonad development,BP,
21111,GO:1905940,1,0.968122029863706,0,5,negative regulation of gonad development,BP,
21112,GO:1905941,1,0.931266844044993,0,11,positive regulation of gonad development,BP,
21114,GO:1905953,1,0.789600864937318,0,36,negative regulation of lipid localization,BP,
21116,GO:1905956,1,0.987067745776531,0,2,positive regulation of endothelial tube morphogenesis,BP,
21117,GO:1905957,1,0.993466657130638,0,1,regulation of cellular response to alcohol,BP,
21118,GO:1905959,1,0.993466657130638,0,1,positive regulation of cellular response to alcohol,BP,
21119,GO:1905961,1,0.949443275468926,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
21120,GO:1905962,1,0.968244956189179,0,5,glutamatergic neuron differentiation,BP,
21121,GO:1990000,1,0.895625330909842,0,17,amyloid fibril formation,BP,
21122,GO:1990001,1,0.961651723005548,0,6,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
21123,GO:1990005,1,0.987223199505293,0,2,granular vesicle,CC,
21124,GO:1990008,1,0.993625482651768,0,1,neurosecretory vesicle,CC,
21125,GO:1990009,1,0.973964561762403,0,4,retinal cell apoptotic process,BP,
21127,GO:1990023,1,0.917690268082447,0,13,mitotic spindle midzone,CC,
21128,GO:1990026,1,0.986975177039709,0,2,hippocampal mossy fiber expansion,CC,
21129,GO:1990030,1,0.987111372413407,0,2,pericellular basket,CC,
21130,GO:1990031,1,0.993535195079544,0,1,pinceau fiber,CC,
21131,GO:1990032,1,0.993457643424133,0,1,parallel fiber,CC,
21132,GO:1990034,1,0.954989106724806,0,7,calcium ion export across plasma membrane,BP,
21133,GO:1990036,1,0.974063401635731,0,4,calcium ion import into sarcoplasmic reticulum,BP,
21134,GO:1990037,1,0.980949548631357,0,3,Lewy body core,CC,
21135,GO:1990038,1,0.993608940574979,0,1,Lewy body corona,CC,
21136,GO:1990044,1,0.993632376111974,0,1,protein localization to lipid droplet,BP,
21137,GO:1990046,1,0.993654419010253,0,1,stress-induced mitochondrial fusion,BP,
21138,GO:1990047,1,0.993587615637909,0,1,spindle matrix,CC,
21139,GO:1990048,1,0.954009718748608,0,7,anterograde neuronal dense core vesicle transport,BP,
21140,GO:1990049,1,0.966574134223584,0,5,retrograde neuronal dense core vesicle transport,BP,
21141,GO:1990050,1,0.974785286018485,0,4,phosphatidic acid transfer activity,MF,
21142,GO:1990051,1,0.968120386130898,0,5,activation of protein kinase C activity,BP,
21143,GO:1990070,1,0.993688187480479,0,1,TRAPPI protein complex,CC,
21144,GO:1990071,1,0.9869795605522,0,2,TRAPPII protein complex,CC,
21145,GO:1990072,1,0.987285504319084,0,2,TRAPPIII protein complex,CC,
21146,GO:1990074,1,0.993516294961835,0,1,polyuridylation-dependent mRNA catabolic process,BP,
21147,GO:1990075,1,0.973497439401214,0,4,periciliary membrane compartment,CC,
21148,GO:1990079,1,0.98048964308558,0,3,cartilage homeostasis,BP,
21149,GO:1990086,1,0.974231980196091,0,4,lens fiber cell apoptotic process,BP,
21150,GO:1990089,1,0.715034328854308,0,51,response to nerve growth factor,BP,
21151,GO:1990090,1,0.729144658555948,0,48,cellular response to nerve growth factor stimulus,BP,
21152,GO:1990092,1,0.993530691847354,0,1,calcium-dependent self proteolysis,BP,
21153,GO:1990108,1,0.980270006254328,0,3,protein linear deubiquitination,BP,
21154,GO:1990111,1,0.974475402831591,0,4,spermatoproteasome complex,CC,
21155,GO:1990112,1,0.987155207697788,0,2,RQC complex,CC,
21156,GO:1990114,1,0.993629901837533,0,1,RNA polymerase II core complex assembly,BP,
21157,GO:1990116,1,0.987155207697788,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
21158,GO:1990117,1,0.993685355464975,0,1,B cell receptor apoptotic signaling pathway,BP,
21159,GO:1990120,1,0.980384082541399,0,3,messenger ribonucleoprotein complex assembly,BP,
21160,GO:1990124,1,0.936527590992036,0,10,messenger ribonucleoprotein complex,CC,
21161,GO:1990126,1,0.865868398155356,0,22,retrograde transport, endosome to plasma membrane,BP,
21162,GO:1990127,1,0.993477226936121,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
21163,GO:1990130,1,0.968130949397375,0,5,GATOR1 complex,CC,
21164,GO:1990131,1,0.974538223858191,0,4,Gtr1-Gtr2 GTPase complex,CC,
21165,GO:1990134,1,0.993416063312631,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
21166,GO:1990136,1,0.99357272944211,0,1,linoleate 9S-lipoxygenase activity,MF,
21168,GO:1990144,1,0.955875969548976,0,7,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
21169,GO:1990145,1,0.987097503471232,0,2,maintenance of translational fidelity,BP,
21170,GO:1990147,1,0.993527355112617,0,1,talin binding,MF,
21171,GO:1990164,1,0.97445702946148,0,4,histone H2A phosphorylation,BP,
21172,GO:1990165,1,0.993604756923246,0,1,single-strand break-containing DNA binding,MF,
21173,GO:1990166,1,0.99358232253883,0,1,protein localization to site of double-strand break,BP,
21174,GO:1990167,1,0.986649005620613,0,2,protein K27-linked deubiquitination,BP,
21175,GO:1990168,1,0.980327103262363,0,3,protein K33-linked deubiquitination,BP,
21176,GO:1990169,1,0.932327372650389,0,11,stress response to copper ion,BP,
21177,GO:1990170,1,0.993605158042286,0,1,stress response to cadmium ion,BP,
21178,GO:1990172,1,0.993346499401612,0,1,G protein-coupled receptor catabolic process,BP,
21179,GO:1990173,1,0.919552639637415,0,13,protein localization to nucleoplasm,BP,
21180,GO:1990174,1,0.986874103810873,0,2,phosphodiesterase decapping endonuclease activity,MF,
21181,GO:1990175,1,0.993493404393671,0,1,EH domain binding,MF,
21182,GO:1990180,1,0.980942157730296,0,3,mitochondrial tRNA 3'-end processing,BP,
21183,GO:1990182,1,0.89591330946104,0,17,exosomal secretion,BP,
21184,GO:1990183,1,0.993682719691245,0,1,lymphatic vascular process in circulatory system,BP,
21185,GO:1990184,1,0.987083499056468,0,2,amino acid transport complex,CC,
21186,GO:1990186,1,0.993682719691245,0,1,regulation of lymphatic vessel size,BP,
21187,GO:1990188,1,0.993565683242089,0,1,euchromatin binding,MF,
21188,GO:1990189,1,0.98096591631648,0,3,peptide-serine-N-acetyltransferase activity,MF,
21189,GO:1990190,1,0.987359064993001,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
21190,GO:1990192,1,0.993682719691245,0,1,collecting lymphatic vessel constriction,BP,
21191,GO:1990204,1,0.546021805834057,0,94,oxidoreductase complex,CC,
21192,GO:1990221,1,0.986916111986284,0,2,L-cysteine desulfurase complex,CC,
21193,GO:1990226,1,0.955760732835945,0,7,histone methyltransferase binding,MF,
21195,GO:1990238,1,0.993285661034122,0,1,double-stranded DNA endodeoxyribonuclease activity,MF,
21196,GO:1990239,1,0.961519893392183,0,6,steroid hormone binding,MF,
21197,GO:1990246,1,0.96819367496301,0,5,uniplex complex,CC,
21198,GO:1990247,1,0.955035079587375,0,7,N6-methyladenosine-containing RNA binding,MF,
21199,GO:1990248,1,0.993567929492266,0,1,regulation of transcription from RNA polymerase II promoter in response to DNA damage,BP,
21200,GO:1990253,1,0.948833697569001,0,8,cellular response to leucine starvation,BP,
21201,GO:1990254,1,0.968063539408441,0,5,keratin filament binding,MF,
21202,GO:1990256,1,0.992775552011312,0,1,signal clustering,BP,
21203,GO:1990258,1,0.980362387720076,0,3,histone glutamine methylation,BP,
21204,GO:1990259,1,0.993661711728357,0,1,histone-glutamine methyltransferase activity,MF,
21205,GO:1990261,1,0.99355705431691,0,1,pre-mRNA catabolic process,BP,
21206,GO:1990262,1,0.993558354949594,0,1,anti-Mullerian hormone signaling pathway,BP,
21207,GO:1990264,1,0.947562316595585,0,8,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
21208,GO:1990266,1,0.530830411978551,0,98,neutrophil migration,BP,
21209,GO:1990267,1,0.987170409845286,0,2,response to transition metal nanoparticle,BP,
21210,GO:1990268,1,0.99353191372327,0,1,response to gold nanoparticle,BP,
21211,GO:1990269,1,0.974374206219763,0,4,RNA polymerase II C-terminal domain phosphoserine binding,MF,
21212,GO:1990275,1,0.993550312670813,0,1,preribosome binding,MF,
21213,GO:1990276,1,0.99355847360704,0,1,RNA 5'-methyltransferase activity,MF,
21214,GO:1990280,1,0.993263355971432,0,1,RNA localization to chromatin,BP,
21215,GO:1990298,1,0.993595937940486,0,1,bub1-bub3 complex,CC,
21216,GO:1990314,1,0.954353933796661,0,7,cellular response to insulin-like growth factor stimulus,BP,
21217,GO:1990316,1,0.948486698645339,0,8,Atg1/ULK1 kinase complex,CC,
21218,GO:1990332,1,0.993488007991549,0,1,Ire1 complex,CC,
21219,GO:1990349,1,0.974442687922421,0,4,gap junction-mediated intercellular transport,BP,
21221,GO:1990356,1,0.993659525454334,0,1,sumoylated E2 ligase complex,CC,
21222,GO:1990357,1,0.974396826217679,0,4,terminal web,CC,
21223,GO:1990379,1,0.962214822747344,0,6,lipid transport across blood-brain barrier,BP,
21224,GO:1990380,1,0.934932433383091,0,10,Lys48-specific deubiquitinase activity,MF,
21225,GO:1990381,1,0.895435816873191,0,17,ubiquitin-specific protease binding,MF,
21226,GO:1990384,1,0.95569259946176,0,7,hyaloid vascular plexus regression,BP,
21227,GO:1990385,1,0.993479876539415,0,1,meiotic spindle midzone,CC,
21228,GO:1990386,1,0.993607634108975,0,1,mitotic cleavage furrow ingression,BP,
21229,GO:1990390,1,0.993518843844864,0,1,protein K33-linked ubiquitination,BP,
21230,GO:1990391,1,0.80503960328455,0,33,DNA repair complex,CC,
21231,GO:1990393,1,0.96771665664535,0,5,3M complex,CC,
21232,GO:1990399,1,0.993590103266034,0,1,epithelium regeneration,BP,
21233,GO:1990401,1,0.987173115165355,0,2,embryonic lung development,BP,
21234,GO:1990402,1,0.987287537982043,0,2,embryonic liver development,BP,
21235,GO:1990403,1,0.924832678403014,0,12,embryonic brain development,BP,
21236,GO:1990404,1,0.900264053859228,0,16,protein ADP-ribosylase activity,MF,
21237,GO:1990405,1,0.954780988628561,0,7,protein antigen binding,MF,
21238,GO:1990406,1,0.987139144440489,0,2,CGRP receptor complex,CC,
21239,GO:1990407,1,0.99367909327251,0,1,calcitonin gene-related peptide binding,MF,
21240,GO:1990408,1,0.987139144440489,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
21241,GO:1990409,1,0.987147198077908,0,2,adrenomedullin binding,MF,
21242,GO:1990410,1,0.974641644251128,0,4,adrenomedullin receptor signaling pathway,BP,
21243,GO:1990414,1,0.949058829955479,0,8,replication-born double-strand break repair via sister chromatid exchange,BP,
21244,GO:1990415,1,0.980752621579274,0,3,Pex17p-Pex14p docking complex,CC,
21245,GO:1990416,1,0.9361510596427,0,10,cellular response to brain-derived neurotrophic factor stimulus,BP,
21246,GO:1990418,1,0.98084387444643,0,3,response to insulin-like growth factor stimulus,BP,
21247,GO:1990422,1,0.993677246056371,0,1,glyoxalase (glycolic acid-forming) activity,MF,
21248,GO:1990423,1,0.980454181806446,0,3,RZZ complex,CC,
21249,GO:1990425,1,0.979398393864896,0,3,ryanodine receptor complex,CC,
21250,GO:1990426,1,0.986455274126068,0,2,mitotic recombination-dependent replication fork processing,BP,
21251,GO:1990427,1,0.99321322487076,0,1,stereocilia tip-link density,CC,
21252,GO:1990428,1,0.980712322342478,0,3,miRNA transport,BP,
21253,GO:1990429,1,0.980752621579274,0,3,peroxisomal importomer complex,CC,
21254,GO:1990430,1,0.967529297005713,0,5,extracellular matrix protein binding,MF,
21255,GO:1990435,1,0.99321322487076,0,1,upper tip-link density,CC,
21256,GO:1990437,1,0.993590956890924,0,1,snRNA 2'-O-methylation,BP,
21257,GO:1990438,1,0.993590956890924,0,1,U6 2'-O-snRNA methylation,BP,
21258,GO:1990439,1,0.993546819867454,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21259,GO:1990440,1,0.931515208086383,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21260,GO:1990441,1,0.97450984627644,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21261,GO:1990442,1,0.981111970361896,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21263,GO:1990444,1,0.987063350690223,0,2,F-box domain binding,MF,
21264,GO:1990446,1,0.968637370808779,0,5,U1 snRNP binding,MF,
21265,GO:1990447,1,0.99366740341628,0,1,U2 snRNP binding,MF,
21266,GO:1990448,1,0.993281686163897,0,1,exon-exon junction complex binding,MF,
21267,GO:1990452,1,0.987077586646266,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21268,GO:1990454,1,0.923922762869698,0,12,L-type voltage-gated calcium channel complex,CC,
21269,GO:1990456,1,0.980517304135118,0,3,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21271,GO:1990460,1,0.974095186477489,0,4,leptin receptor binding,MF,
21272,GO:1990462,1,0.987080080240076,0,2,omegasome,CC,
21273,GO:1990467,1,0.993596169739984,0,1,NuA3a histone acetyltransferase complex,CC,
21274,GO:1990468,1,0.993596169739984,0,1,NuA3b histone acetyltransferase complex,CC,
21275,GO:1990478,1,0.987272125247486,0,2,response to ultrasound,BP,
21276,GO:1990481,1,0.968259881934796,0,5,mRNA pseudouridine synthesis,BP,
21277,GO:1990498,1,0.980052844227039,0,3,mitotic spindle microtubule,CC,
21278,GO:1990502,1,0.98041876353643,0,3,dense core granule maturation,BP,
21279,GO:1990504,1,0.941589276398579,0,9,dense core granule exocytosis,BP,
21280,GO:1990505,1,0.986455274126068,0,2,mitotic DNA replication maintenance of fidelity,BP,
21281,GO:1990511,1,0.9742772691437,0,4,piRNA biosynthetic process,BP,
21282,GO:1990513,1,0.986882378577472,0,2,CLOCK-BMAL transcription complex,CC,
21283,GO:1990518,1,0.980627368735361,0,3,single-stranded 3'-5' DNA helicase activity,MF,
21284,GO:1990519,1,0.987128423034646,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21285,GO:1990523,1,0.980763750187129,0,3,bone regeneration,BP,
21286,GO:1990529,1,0.993469150001234,0,1,glycosylphosphatidylinositol-mannosyltransferase I complex,CC,
21287,GO:1990535,1,0.941825747245093,0,9,neuron projection maintenance,BP,
21288,GO:1990539,1,0.99358494523866,0,1,fructose import across plasma membrane,BP,
21289,GO:1990540,1,0.993531249358711,0,1,mitochondrial manganese ion transmembrane transport,BP,
21290,GO:1990542,1,0.62315576157534,0,73,mitochondrial transmembrane transport,BP,
21291,GO:1990546,1,0.993632777137238,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21292,GO:1990548,1,0.993542531500193,0,1,mitochondrial FAD transmembrane transport,BP,
21293,GO:1990564,1,0.968395126181225,0,5,protein polyufmylation,BP,
21294,GO:1990565,1,0.987239250876467,0,2,HSP90-CDC37 chaperone complex,CC,
21295,GO:1990569,1,0.967787875852904,0,5,UDP-N-acetylglucosamine transmembrane transport,BP,
21296,GO:1990572,1,0.993488969734737,0,1,TERT-RMRP complex,CC,
21297,GO:1990573,1,0.739701367462413,0,46,potassium ion import across plasma membrane,BP,
21298,GO:1990575,1,0.98083795812116,0,3,mitochondrial L-ornithine transmembrane transport,BP,
21299,GO:1990578,1,0.98697076694787,0,2,perinuclear endoplasmic reticulum membrane,CC,
21300,GO:1990579,1,0.993488007991549,0,1,peptidyl-serine trans-autophosphorylation,BP,
21301,GO:1990583,1,0.993607634108975,0,1,phospholipase D activator activity,MF,
21302,GO:1990584,1,0.981158264482686,0,3,cardiac Troponin complex,CC,
21303,GO:1990589,1,0.986656659332876,0,2,ATF4-CREB1 transcription factor complex,CC,
21304,GO:1990590,1,0.987242937850418,0,2,ATF1-ATF4 transcription factor complex,CC,
21305,GO:1990592,1,0.968395126181225,0,5,protein K69-linked ufmylation,BP,
21306,GO:1990597,1,0.986987831922337,0,2,AIP1-IRE1 complex,CC,
21307,GO:1990599,1,0.980520803672759,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21308,GO:1990604,1,0.980602659927686,0,3,IRE1-TRAF2-ASK1 complex,CC,
21309,GO:1990613,1,0.993515922332252,0,1,mitochondrial membrane fusion,BP,
21310,GO:1990617,1,0.987343905279337,0,2,CHOP-ATF4 complex,CC,
21311,GO:1990619,1,0.987169877302622,0,2,histone H3-K9 deacetylation,BP,
21312,GO:1990622,1,0.98732208239925,0,2,CHOP-ATF3 complex,CC,
21313,GO:1990630,1,0.993488007991549,0,1,IRE1-RACK1-PP2A complex,CC,
21314,GO:1990635,1,0.961359271309826,0,6,proximal dendrite,CC,
21315,GO:1990637,1,0.980505069872871,0,3,response to prolactin,BP,
21316,GO:1990641,1,0.980900920578593,0,3,response to iron ion starvation,BP,
21317,GO:1990646,1,0.993543355450236,0,1,cellular response to prolactin,BP,
21318,GO:1990654,1,0.993425546372356,0,1,sebum secreting cell proliferation,BP,
21319,GO:1990665,1,0.987339779702666,0,2,AnxA2-p11 complex,CC,
21320,GO:1990666,1,0.986949057156544,0,2,PCSK9-LDLR complex,CC,
21321,GO:1990667,1,0.9871809376372,0,2,PCSK9-AnxA2 complex,CC,
21322,GO:1990668,1,0.968217469057228,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21323,GO:1990678,1,0.993473983378802,0,1,histone H4-K16 deacetylation,BP,
21324,GO:1990682,1,0.987108415962797,0,2,CSF1-CSF1R complex,CC,
21325,GO:1990696,1,0.986339068848501,0,2,USH2 complex,CC,
21326,GO:1990697,1,0.993591417057097,0,1,protein depalmitoleylation,BP,
21327,GO:1990698,1,0.987153534535916,0,2,palmitoleoyltransferase activity,MF,
21328,GO:1990699,1,0.993591417057097,0,1,palmitoleyl hydrolase activity,MF,
21329,GO:1990700,1,0.993492644036998,0,1,nucleolar chromatin organization,BP,
21330,GO:1990705,1,0.979675787835222,0,3,cholangiocyte proliferation,BP,
21331,GO:1990707,1,0.992845986822309,0,1,nuclear subtelomeric heterochromatin,CC,
21332,GO:1990708,1,0.993528942501548,0,1,conditioned place preference,BP,
21333,GO:1990709,1,0.946113316187567,0,8,presynaptic active zone organization,BP,
21335,GO:1990715,1,0.980791562919645,0,3,mRNA CDS binding,MF,
21336,GO:1990716,1,0.979982798937549,0,3,axonemal central apparatus,CC,
21337,GO:1990718,1,0.992991342771743,0,1,axonemal central pair projection,CC,
21338,GO:1990723,1,0.986373605395889,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21339,GO:1990726,1,0.968736661148185,0,5,Lsm1-7-Pat1 complex,CC,
21340,GO:1990729,1,0.99360884004526,0,1,primary miRNA modification,BP,
21341,GO:1990730,1,0.987053058412258,0,2,VCP-NSFL1C complex,CC,
21342,GO:1990731,1,0.993510887635227,0,1,UV-damage excision repair, DNA incision,BP,
21343,GO:1990736,1,0.993484902849537,0,1,regulation of vascular associated smooth muscle cell membrane depolarization,BP,
21344,GO:1990737,1,0.980673949208223,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21345,GO:1990739,1,0.99308300260054,0,1,granulosa cell proliferation,BP,
21346,GO:1990742,1,0.980754643001013,0,3,microvesicle,CC,
21347,GO:1990743,1,0.973887342102444,0,4,protein sialylation,BP,
21348,GO:1990744,1,0.99360884004526,0,1,primary miRNA methylation,BP,
21349,GO:1990745,1,0.980521372256401,0,3,EARP complex,CC,
21350,GO:1990748,1,0.531363792234701,0,98,cellular detoxification,BP,
21351,GO:1990751,1,0.99322783780028,0,1,Schwann cell chemotaxis,BP,
21352,GO:1990752,1,0.807349895573447,0,32,microtubule end,CC,
21353,GO:1990755,1,0.99355705431691,0,1,mitotic spindle microtubule depolymerization,BP,
21354,GO:1990756,1,0.913698999481842,0,14,ubiquitin ligase-substrate adaptor activity,MF,
21355,GO:1990757,1,0.980602294201011,0,3,ubiquitin ligase activator activity,MF,
21356,GO:1990758,1,0.993617296148694,0,1,mitotic sister chromatid biorientation,BP,
21357,GO:1990760,1,0.980502627043287,0,3,osmolarity-sensing cation channel activity,MF,
21358,GO:1990761,1,0.980167786427273,0,3,growth cone lamellipodium,CC,
21360,GO:1990764,1,0.993559962599739,0,1,myofibroblast contraction,BP,
21361,GO:1990765,1,0.993404495823808,0,1,colon smooth muscle contraction,BP,
21362,GO:1990768,1,0.987307058657525,0,2,gastric mucosal blood circulation,BP,
21363,GO:1990769,1,0.974356173039633,0,4,proximal neuron projection,CC,
21364,GO:1990770,1,0.987137430516114,0,2,small intestine smooth muscle contraction,BP,
21365,GO:1990771,1,0.993327448563918,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21366,GO:1990773,1,0.967779689906096,0,5,matrix metallopeptidase secretion,BP,
21367,GO:1990774,1,0.980746078600572,0,3,tumor necrosis factor secretion,BP,
21368,GO:1990775,1,0.993650235406605,0,1,endothelin production,BP,
21370,GO:1990777,1,0.823516541127653,0,30,lipoprotein particle,CC,
21372,GO:1990780,1,0.993486188892521,0,1,cytoplasmic side of dendritic spine plasma membrane,CC,
21373,GO:1990782,1,0.543785123359811,0,93,protein tyrosine kinase binding,MF,
21374,GO:1990784,1,0.987085580156587,0,2,response to dsDNA,BP,
21375,GO:1990785,1,0.973904518611238,0,4,response to water-immersion restraint stress,BP,
21376,GO:1990786,1,0.987085580156587,0,2,cellular response to dsDNA,BP,
21377,GO:1990787,1,0.993206204627715,0,1,negative regulation of hh target transcription factor activity,BP,
21379,GO:1990798,1,0.993685289586667,0,1,pancreas regeneration,BP,
21380,GO:1990809,1,0.974524112662606,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21381,GO:1990811,1,0.99355705431691,0,1,MWP complex,CC,
21382,GO:1990812,1,0.974220194107473,0,4,growth cone filopodium,CC,
21383,GO:1990814,1,0.993645846882711,0,1,DNA/DNA annealing activity,MF,
21384,GO:1990817,1,0.993587876941037,0,1,RNA adenylyltransferase activity,MF,
21385,GO:1990822,1,0.930576468756092,0,11,basic amino acid transmembrane transport,BP,
21387,GO:1990825,1,0.93734326546426,0,10,sequence-specific mRNA binding,MF,
21388,GO:1990828,1,0.993595640020286,0,1,hepatocyte dedifferentiation,BP,
21389,GO:1990829,1,0.987184869243865,0,2,C-rich single-stranded DNA binding,MF,
21391,GO:1990832,1,0.993603888263979,0,1,slow axonal transport,BP,
21392,GO:1990833,1,0.993603888263979,0,1,clathrin-uncoating ATPase activity,MF,
21393,GO:1990834,1,0.974455532947685,0,4,response to odorant,BP,
21394,GO:1990836,1,0.993484656693745,0,1,lysosomal matrix,CC,
21396,GO:1990838,1,0.99355705431691,0,1,poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends,MF,
21397,GO:1990839,1,0.987098599495304,0,2,response to endothelin,BP,
21398,GO:1990841,1,0.696781114255175,0,55,promoter-specific chromatin binding,MF,
21399,GO:1990843,1,0.99330761561877,0,1,subsarcolemmal mitochondrion,CC,
21400,GO:1990844,1,0.99330761561877,0,1,interfibrillar mitochondrion,CC,
21401,GO:1990845,1,0.387500265770295,0,144,adaptive thermogenesis,BP,
21402,GO:1990851,1,0.98002840000352,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21403,GO:1990859,1,0.993585790343595,0,1,cellular response to endothelin,BP,
21404,GO:1990863,1,0.993685289586667,0,1,acinar cell proliferation,BP,
21405,GO:1990864,1,0.993685289586667,0,1,response to growth hormone-releasing hormone,BP,
21406,GO:1990867,1,0.993685289586667,0,1,response to gastrin,BP,
21409,GO:1990874,1,0.721439123073187,0,50,vascular associated smooth muscle cell proliferation,BP,
21410,GO:1990876,1,0.993280713461059,0,1,cytoplasmic side of nuclear pore,CC,
21411,GO:1990878,1,0.993685289586667,0,1,cellular response to gastrin,BP,
21412,GO:1990879,1,0.987155207697788,0,2,CST complex,CC,
21413,GO:1990882,1,0.993491968588613,0,1,rRNA acetylation,BP,
21414,GO:1990883,1,0.993491968588613,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21415,GO:1990884,1,0.993491968588613,0,1,RNA acetylation,BP,
21416,GO:1990889,1,0.987180835890737,0,2,H4K20me3 modified histone binding,MF,
21417,GO:1990890,1,0.986903824490109,0,2,netrin receptor binding,MF,
21418,GO:1990904,1,0.0145262090592119,0,641,ribonucleoprotein complex,CC,
21419,GO:1990907,1,0.92994191702717,0,11,beta-catenin-TCF complex,CC,
21420,GO:1990909,1,0.929072458953311,0,11,Wnt signalosome,CC,
21421,GO:1990910,1,0.974532254018037,0,4,response to hypobaric hypoxia,BP,
21422,GO:1990911,1,0.974517052045233,0,4,response to psychosocial stress,BP,
21423,GO:1990913,1,0.974483268945208,0,4,sperm head plasma membrane,CC,
21424,GO:1990917,1,0.99357066251008,0,1,ooplasm,CC,
21425,GO:1990918,1,0.974170218453146,0,4,double-strand break repair involved in meiotic recombination,BP,
21426,GO:1990922,1,0.993526694290642,0,1,hepatic stellate cell proliferation,BP,
21427,GO:1990923,1,0.980800680277467,0,3,PET complex,CC,
21428,GO:1990926,1,0.980694917338181,0,3,short-term synaptic potentiation,BP,
21429,GO:1990927,1,0.986896354116637,0,2,calcium ion regulated lysosome exocytosis,BP,
21430,GO:1990928,1,0.746505332723108,0,45,response to amino acid starvation,BP,
21431,GO:1990930,1,0.993634714618148,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21432,GO:1990931,1,0.987033477442415,0,2,RNA N6-methyladenosine dioxygenase activity,MF,
21433,GO:1990935,1,0.981022675756566,0,3,splicing factor binding,MF,
21434,GO:1990936,1,0.987206960302379,0,2,vascular associated smooth muscle cell dedifferentiation,BP,
21435,GO:1990938,1,0.993489029653295,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21436,GO:1990939,1,0.789582575062746,0,34,ATP-dependent microtubule motor activity,MF,
21437,GO:1990948,1,0.968749558526737,0,5,ubiquitin ligase inhibitor activity,MF,
21438,GO:1990949,1,0.993613200187168,0,1,metaphase/anaphase transition of meiosis I,BP,
21439,GO:1990955,1,0.993483544291113,0,1,G-rich single-stranded DNA binding,MF,
21440,GO:1990959,1,0.993509103281684,0,1,eosinophil homeostasis,BP,
21441,GO:1990960,1,0.993509103281684,0,1,basophil homeostasis,BP,
21442,GO:1990961,1,0.949454686271544,0,8,xenobiotic detoxification by transmembrane export across the plasma membrane,BP,
21443,GO:1990962,1,0.967905504111605,0,5,xenobiotic transport across blood-brain barrier,BP,
21444,GO:1990963,1,0.993605860287338,0,1,establishment of blood-retinal barrier,BP,
21445,GO:1990966,1,0.974370571849971,0,4,ATP generation from poly-ADP-D-ribose,BP,
21446,GO:1990968,1,0.993296226335888,0,1,modulation by host of RNA binding by virus,BP,
21447,GO:1990969,1,0.993296226335888,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21448,GO:1990971,1,0.993493287633461,0,1,EMILIN complex,CC,
21449,GO:1990983,1,0.993568114974399,0,1,tRNA demethylation,BP,
21450,GO:1990984,1,0.98708037866097,0,2,tRNA demethylase activity,MF,
21451,GO:2000001,1,0.901626710107322,0,16,regulation of DNA damage checkpoint,BP,
21452,GO:2000002,1,0.96820101382814,0,5,negative regulation of DNA damage checkpoint,BP,
21453,GO:2000003,1,0.99355705431691,0,1,positive regulation of DNA damage checkpoint,BP,
21454,GO:2000004,1,0.993620720501988,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21455,GO:2000005,1,0.993620720501988,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21456,GO:2000006,1,0.993620720501988,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21457,GO:2000007,1,0.993620720501988,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21458,GO:2000008,1,0.774471471721959,0,39,regulation of protein localization to cell surface,BP,
21459,GO:2000009,1,0.918846460681299,0,13,negative regulation of protein localization to cell surface,BP,
21460,GO:2000010,1,0.894307994693936,0,17,positive regulation of protein localization to cell surface,BP,
21461,GO:2000011,1,0.993592601965037,0,1,regulation of adaxial/abaxial pattern formation,BP,
21462,GO:2000015,1,0.974604416193182,0,4,regulation of determination of dorsal identity,BP,
21463,GO:2000016,1,0.987334134288346,0,2,negative regulation of determination of dorsal identity,BP,
21464,GO:2000017,1,0.987108613589902,0,2,positive regulation of determination of dorsal identity,BP,
21465,GO:2000018,1,0.943172120286317,0,9,regulation of male gonad development,BP,
21466,GO:2000019,1,0.993495030922634,0,1,negative regulation of male gonad development,BP,
21467,GO:2000020,1,0.949350818299632,0,8,positive regulation of male gonad development,BP,
21470,GO:2000035,1,0.936986869175105,0,10,regulation of stem cell division,BP,
21471,GO:2000036,1,0.816509089075876,0,31,regulation of stem cell population maintenance,BP,
21472,GO:2000040,1,0.987107446899612,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21473,GO:2000041,1,0.987107446899612,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21474,GO:2000042,1,0.917682684187771,0,13,negative regulation of double-strand break repair via homologous recombination,BP,
21475,GO:2000043,1,0.993583324430233,0,1,regulation of cardiac cell fate specification,BP,
21476,GO:2000045,1,0.384227203662165,0,146,regulation of G1/S transition of mitotic cell cycle,BP,
21477,GO:2000047,1,0.888580145358079,0,18,regulation of cell-cell adhesion mediated by cadherin,BP,
21478,GO:2000048,1,0.94268643702058,0,9,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21479,GO:2000049,1,0.942637031146309,0,9,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21480,GO:2000050,1,0.859588684916986,0,23,regulation of non-canonical Wnt signaling pathway,BP,
21481,GO:2000051,1,0.96077195428791,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21482,GO:2000052,1,0.91880850615764,0,13,positive regulation of non-canonical Wnt signaling pathway,BP,
21483,GO:2000053,1,0.993459081563851,0,1,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21484,GO:2000054,1,0.993459081563851,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21485,GO:2000056,1,0.99361427433561,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21486,GO:2000057,1,0.99361427433561,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21487,GO:2000058,1,0.372354341159966,0,151,regulation of ubiquitin-dependent protein catabolic process,BP,
21488,GO:2000059,1,0.745045192811199,0,45,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21489,GO:2000060,1,0.530978837682651,0,97,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21490,GO:2000061,1,0.993634714618148,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21491,GO:2000062,1,0.993634714618148,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21492,GO:2000063,1,0.993634714618148,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21493,GO:2000064,1,0.955069821504773,0,7,regulation of cortisol biosynthetic process,BP,
21494,GO:2000065,1,0.974443764686646,0,4,negative regulation of cortisol biosynthetic process,BP,
21495,GO:2000066,1,0.993495030922634,0,1,positive regulation of cortisol biosynthetic process,BP,
21496,GO:2000074,1,0.949355570104485,0,8,regulation of type B pancreatic cell development,BP,
21497,GO:2000077,1,0.986875320868638,0,2,negative regulation of type B pancreatic cell development,BP,
21498,GO:2000078,1,0.98098938720599,0,3,positive regulation of type B pancreatic cell development,BP,
21499,GO:2000079,1,0.993459081563851,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21500,GO:2000080,1,0.993459081563851,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21501,GO:2000095,1,0.906753666495864,0,15,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21502,GO:2000096,1,0.943132466962102,0,9,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21503,GO:2000097,1,0.980893143307228,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
21504,GO:2000098,1,0.987239895444394,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
21505,GO:2000101,1,0.993547463256452,0,1,regulation of mammary stem cell proliferation,BP,
21506,GO:2000103,1,0.993547463256452,0,1,positive regulation of mammary stem cell proliferation,BP,
21507,GO:2000104,1,0.889078765277127,0,18,negative regulation of DNA-dependent DNA replication,BP,
21508,GO:2000105,1,0.924009436472558,0,12,positive regulation of DNA-dependent DNA replication,BP,
21509,GO:2000106,1,0.606030987539587,0,77,regulation of leukocyte apoptotic process,BP,
21510,GO:2000107,1,0.756498037281441,0,43,negative regulation of leukocyte apoptotic process,BP,
21511,GO:2000108,1,0.850187502062672,0,25,positive regulation of leukocyte apoptotic process,BP,
21512,GO:2000109,1,0.955493940250103,0,7,regulation of macrophage apoptotic process,BP,
21513,GO:2000110,1,0.98070444068085,0,3,negative regulation of macrophage apoptotic process,BP,
21514,GO:2000111,1,0.980596205973398,0,3,positive regulation of macrophage apoptotic process,BP,
21517,GO:2000114,1,0.887791972694783,0,18,regulation of establishment of cell polarity,BP,
21520,GO:2000118,1,0.974513360003481,0,4,regulation of sodium-dependent phosphate transport,BP,
21521,GO:2000119,1,0.993545400005887,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21522,GO:2000120,1,0.987282761579383,0,2,positive regulation of sodium-dependent phosphate transport,BP,
21523,GO:2000121,1,0.931548045951168,0,11,regulation of removal of superoxide radicals,BP,
21525,GO:2000134,1,0.519904403554763,0,100,negative regulation of G1/S transition of mitotic cell cycle,BP,
21526,GO:2000136,1,0.905924187961975,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21527,GO:2000137,1,0.979539359635347,0,3,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21528,GO:2000138,1,0.96776044867613,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21529,GO:2000142,1,0.749128759637162,0,44,regulation of DNA-templated transcription, initiation,BP,
21530,GO:2000143,1,0.961732784116966,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21531,GO:2000144,1,0.789305685474945,0,36,positive regulation of DNA-templated transcription, initiation,BP,
21535,GO:2000152,1,0.968368154907132,0,5,regulation of ubiquitin-specific protease activity,BP,
21536,GO:2000155,1,0.943976067892853,0,9,positive regulation of cilium-dependent cell motility,BP,
21537,GO:2000156,1,0.987089477056784,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21538,GO:2000157,1,0.987370530394118,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21539,GO:2000158,1,0.987185348487347,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21540,GO:2000167,1,0.993387447721668,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21541,GO:2000169,1,0.948584022189731,0,8,regulation of peptidyl-cysteine S-nitrosylation,BP,
21542,GO:2000170,1,0.980811244378319,0,3,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21543,GO:2000171,1,0.836851187669259,0,27,negative regulation of dendrite development,BP,
21544,GO:2000172,1,0.967578611885727,0,5,regulation of branching morphogenesis of a nerve,BP,
21545,GO:2000173,1,0.993491880288178,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21546,GO:2000174,1,0.993490817047684,0,1,regulation of pro-T cell differentiation,BP,
21547,GO:2000176,1,0.993490817047684,0,1,positive regulation of pro-T cell differentiation,BP,
21549,GO:2000178,1,0.865819538241045,0,22,negative regulation of neural precursor cell proliferation,BP,
21551,GO:2000180,1,0.993495030922634,0,1,negative regulation of androgen biosynthetic process,BP,
21552,GO:2000181,1,0.511904681768233,0,102,negative regulation of blood vessel morphogenesis,BP,
21553,GO:2000182,1,0.974184179004516,0,4,regulation of progesterone biosynthetic process,BP,
21554,GO:2000184,1,0.986992853271888,0,2,positive regulation of progesterone biosynthetic process,BP,
21555,GO:2000191,1,0.889616770634383,0,18,regulation of fatty acid transport,BP,
21556,GO:2000192,1,0.967395164377581,0,5,negative regulation of fatty acid transport,BP,
21557,GO:2000193,1,0.919625262858,0,13,positive regulation of fatty acid transport,BP,
21558,GO:2000194,1,0.925109188428496,0,12,regulation of female gonad development,BP,
21559,GO:2000195,1,0.974462513130715,0,4,negative regulation of female gonad development,BP,
21560,GO:2000196,1,0.980961025736346,0,3,positive regulation of female gonad development,BP,
21561,GO:2000197,1,0.954931145294534,0,7,regulation of ribonucleoprotein complex localization,BP,
21562,GO:2000199,1,0.993538503450623,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21563,GO:2000200,1,0.993538503450623,0,1,regulation of ribosomal subunit export from nucleus,BP,
21564,GO:2000202,1,0.993538503450623,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21565,GO:2000206,1,0.993538503450623,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21566,GO:2000208,1,0.993538503450623,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21567,GO:2000209,1,0.871616399660339,0,21,regulation of anoikis,BP,
21568,GO:2000210,1,0.968262039614098,0,5,positive regulation of anoikis,BP,
21569,GO:2000211,1,0.980141220075235,0,3,regulation of glutamate metabolic process,BP,
21570,GO:2000212,1,0.993415865344697,0,1,negative regulation of glutamate metabolic process,BP,
21571,GO:2000213,1,0.993596235981754,0,1,positive regulation of glutamate metabolic process,BP,
21572,GO:2000224,1,0.980944900779919,0,3,regulation of testosterone biosynthetic process,BP,
21573,GO:2000225,1,0.987206699423981,0,2,negative regulation of testosterone biosynthetic process,BP,
21574,GO:2000226,1,0.993642851218205,0,1,regulation of pancreatic A cell differentiation,BP,
21575,GO:2000227,1,0.993642851218205,0,1,negative regulation of pancreatic A cell differentiation,BP,
21576,GO:2000229,1,0.987310048537763,0,2,regulation of pancreatic stellate cell proliferation,BP,
21577,GO:2000230,1,0.993615718009131,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21578,GO:2000231,1,0.993654219907791,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21579,GO:2000232,1,0.918766231360452,0,13,regulation of rRNA processing,BP,
21580,GO:2000233,1,0.980445218085561,0,3,negative regulation of rRNA processing,BP,
21581,GO:2000234,1,0.943333071464981,0,9,positive regulation of rRNA processing,BP,
21582,GO:2000241,1,0.400788410301398,0,140,regulation of reproductive process,BP,
21583,GO:2000242,1,0.737481346856892,0,47,negative regulation of reproductive process,BP,
21584,GO:2000243,1,0.625553140904999,0,72,positive regulation of reproductive process,BP,
21586,GO:2000250,1,0.993242046813189,0,1,negative regulation of actin cytoskeleton reorganization,BP,
21587,GO:2000251,1,0.884805154370287,0,19,positive regulation of actin cytoskeleton reorganization,BP,
21589,GO:2000253,1,0.967591219836518,0,5,positive regulation of feeding behavior,BP,
21590,GO:2000254,1,0.974780846945284,0,4,regulation of male germ cell proliferation,BP,
21591,GO:2000255,1,0.980987490993431,0,3,negative regulation of male germ cell proliferation,BP,
21592,GO:2000256,1,0.993674275777176,0,1,positive regulation of male germ cell proliferation,BP,
21593,GO:2000269,1,0.894909137862314,0,17,regulation of fibroblast apoptotic process,BP,
21594,GO:2000270,1,0.955128329992106,0,7,negative regulation of fibroblast apoptotic process,BP,
21595,GO:2000271,1,0.949009595877904,0,8,positive regulation of fibroblast apoptotic process,BP,
21596,GO:2000272,1,0.761317734543799,0,42,negative regulation of signaling receptor activity,BP,
21598,GO:2000275,1,0.974733283432312,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21599,GO:2000276,1,0.987262440615006,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21600,GO:2000277,1,0.993677246056371,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21602,GO:2000279,1,0.805997750245382,0,33,negative regulation of DNA biosynthetic process,BP,
21603,GO:2000282,1,0.980494313944338,0,3,regulation of cellular amino acid biosynthetic process,BP,
21604,GO:2000283,1,0.99307768176836,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21605,GO:2000284,1,0.993677246056371,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21606,GO:2000286,1,0.980758220360345,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21607,GO:2000287,1,0.993589972053084,0,1,positive regulation of myotome development,BP,
21608,GO:2000288,1,0.943147345313741,0,9,positive regulation of myoblast proliferation,BP,
21609,GO:2000290,1,0.993589972053084,0,1,regulation of myotome development,BP,
21610,GO:2000291,1,0.912846503490857,0,14,regulation of myoblast proliferation,BP,
21612,GO:2000296,1,0.987390094417306,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21613,GO:2000297,1,0.980541932749853,0,3,negative regulation of synapse maturation,BP,
21614,GO:2000298,1,0.973933467970602,0,4,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21615,GO:2000299,1,0.980227619942948,0,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21616,GO:2000300,1,0.60289901520372,0,77,regulation of synaptic vesicle exocytosis,BP,
21617,GO:2000301,1,0.974410123501634,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21618,GO:2000302,1,0.924002175779224,0,12,positive regulation of synaptic vesicle exocytosis,BP,
21619,GO:2000303,1,0.907653119470778,0,15,regulation of ceramide biosynthetic process,BP,
21620,GO:2000304,1,0.943411381448971,0,9,positive regulation of ceramide biosynthetic process,BP,
21621,GO:2000307,1,0.987158480508812,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21622,GO:2000308,1,0.993581645191367,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21623,GO:2000309,1,0.993535757787753,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21624,GO:2000310,1,0.798616052109809,0,34,regulation of NMDA receptor activity,BP,
21625,GO:2000311,1,0.848109208947444,0,25,regulation of AMPA receptor activity,BP,
21626,GO:2000312,1,0.980438639394623,0,3,regulation of kainate selective glutamate receptor activity,BP,
21627,GO:2000313,1,0.987282718807681,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21628,GO:2000314,1,0.993628764257942,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21629,GO:2000316,1,0.900875122208202,0,16,regulation of T-helper 17 type immune response,BP,
21630,GO:2000317,1,0.942691414140637,0,9,negative regulation of T-helper 17 type immune response,BP,
21631,GO:2000318,1,0.955667178071863,0,7,positive regulation of T-helper 17 type immune response,BP,
21632,GO:2000319,1,0.912658900215394,0,14,regulation of T-helper 17 cell differentiation,BP,
21633,GO:2000320,1,0.948833985177705,0,8,negative regulation of T-helper 17 cell differentiation,BP,
21634,GO:2000321,1,0.961893804423034,0,6,positive regulation of T-helper 17 cell differentiation,BP,
21635,GO:2000322,1,0.949241034643463,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21636,GO:2000323,1,0.961597323949231,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21637,GO:2000324,1,0.987155244609511,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21638,GO:2000325,1,0.98026474571165,0,3,regulation of nuclear receptor transcription coactivator activity,BP,
21639,GO:2000327,1,0.986544307387112,0,2,positive regulation of nuclear receptor transcription coactivator activity,BP,
21640,GO:2000328,1,0.974625615517572,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21641,GO:2000329,1,0.987146904274587,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21642,GO:2000330,1,0.987317309028489,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21643,GO:2000331,1,0.987063486677874,0,2,regulation of terminal button organization,BP,
21644,GO:2000332,1,0.987270279729974,0,2,regulation of blood microparticle formation,BP,
21645,GO:2000334,1,0.987270279729974,0,2,positive regulation of blood microparticle formation,BP,
21646,GO:2000338,1,0.980800453623536,0,3,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21647,GO:2000340,1,0.980800453623536,0,3,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21649,GO:2000342,1,0.98717087077191,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21651,GO:2000344,1,0.943014202936209,0,9,positive regulation of acrosome reaction,BP,
21653,GO:2000346,1,0.980744501967741,0,3,negative regulation of hepatocyte proliferation,BP,
21655,GO:2000348,1,0.961885598959956,0,6,regulation of CD40 signaling pathway,BP,
21656,GO:2000349,1,0.987108799392875,0,2,negative regulation of CD40 signaling pathway,BP,
21657,GO:2000350,1,0.993669453079625,0,1,positive regulation of CD40 signaling pathway,BP,
21658,GO:2000351,1,0.740785881713442,0,46,regulation of endothelial cell apoptotic process,BP,
21659,GO:2000352,1,0.843813955469675,0,26,negative regulation of endothelial cell apoptotic process,BP,
21660,GO:2000353,1,0.883733629026514,0,19,positive regulation of endothelial cell apoptotic process,BP,
21661,GO:2000354,1,0.961995622584208,0,6,regulation of ovarian follicle development,BP,
21662,GO:2000355,1,0.987255528754495,0,2,negative regulation of ovarian follicle development,BP,
21663,GO:2000356,1,0.993634714618148,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21664,GO:2000357,1,0.993634714618148,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21665,GO:2000358,1,0.993634714618148,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21666,GO:2000359,1,0.987277006618741,0,2,regulation of binding of sperm to zona pellucida,BP,
21667,GO:2000360,1,0.987277006618741,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21668,GO:2000361,1,0.980567200888387,0,3,regulation of prostaglandin-E synthase activity,BP,
21669,GO:2000363,1,0.980567200888387,0,3,positive regulation of prostaglandin-E synthase activity,BP,
21670,GO:2000367,1,0.980873173574553,0,3,regulation of acrosomal vesicle exocytosis,BP,
21671,GO:2000368,1,0.987297217171614,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21672,GO:2000369,1,0.887335786161692,0,18,regulation of clathrin-dependent endocytosis,BP,
21673,GO:2000370,1,0.967654034706839,0,5,positive regulation of clathrin-dependent endocytosis,BP,
21674,GO:2000371,1,0.967774187187853,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21675,GO:2000373,1,0.967774187187853,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21676,GO:2000374,1,0.981098680084442,0,3,regulation of oxygen metabolic process,BP,
21677,GO:2000376,1,0.987415725325324,0,2,positive regulation of oxygen metabolic process,BP,
21679,GO:2000378,1,0.722429712106906,0,50,negative regulation of reactive oxygen species metabolic process,BP,
21681,GO:2000380,1,0.901030778917188,0,16,regulation of mesoderm development,BP,
21682,GO:2000381,1,0.955614415505522,0,7,negative regulation of mesoderm development,BP,
21683,GO:2000382,1,0.967807487442231,0,5,positive regulation of mesoderm development,BP,
21684,GO:2000383,1,0.993498240883376,0,1,regulation of ectoderm development,BP,
21685,GO:2000384,1,0.993498240883376,0,1,negative regulation of ectoderm development,BP,
21686,GO:2000386,1,0.987173859552748,0,2,positive regulation of ovarian follicle development,BP,
21687,GO:2000387,1,0.993646911318008,0,1,regulation of antral ovarian follicle growth,BP,
21688,GO:2000388,1,0.993646911318008,0,1,positive regulation of antral ovarian follicle growth,BP,
21689,GO:2000389,1,0.968149436212158,0,5,regulation of neutrophil extravasation,BP,
21690,GO:2000391,1,0.97440758877242,0,4,positive regulation of neutrophil extravasation,BP,
21692,GO:2000393,1,0.987005668413886,0,2,negative regulation of lamellipodium morphogenesis,BP,
21694,GO:2000395,1,0.987349373854694,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21695,GO:2000397,1,0.987349373854694,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21699,GO:2000404,1,0.776428785527377,0,39,regulation of T cell migration,BP,
21700,GO:2000405,1,0.968202848498052,0,5,negative regulation of T cell migration,BP,
21701,GO:2000406,1,0.833779627916768,0,28,positive regulation of T cell migration,BP,
21702,GO:2000407,1,0.96825651064908,0,5,regulation of T cell extravasation,BP,
21703,GO:2000408,1,0.993529578175962,0,1,negative regulation of T cell extravasation,BP,
21704,GO:2000409,1,0.980831528873019,0,3,positive regulation of T cell extravasation,BP,
21705,GO:2000410,1,0.974608973282612,0,4,regulation of thymocyte migration,BP,
21706,GO:2000412,1,0.980889319906059,0,3,positive regulation of thymocyte migration,BP,
21707,GO:2000413,1,0.993535757787753,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21708,GO:2000415,1,0.993535757787753,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21709,GO:2000416,1,0.974481784149598,0,4,regulation of eosinophil migration,BP,
21710,GO:2000417,1,0.987176424092221,0,2,negative regulation of eosinophil migration,BP,
21711,GO:2000418,1,0.987142103783908,0,2,positive regulation of eosinophil migration,BP,
21712,GO:2000419,1,0.993521860261438,0,1,regulation of eosinophil extravasation,BP,
21713,GO:2000420,1,0.993521860261438,0,1,negative regulation of eosinophil extravasation,BP,
21714,GO:2000422,1,0.993565162973259,0,1,regulation of eosinophil chemotaxis,BP,
21715,GO:2000424,1,0.993565162973259,0,1,positive regulation of eosinophil chemotaxis,BP,
21716,GO:2000425,1,0.93690819777927,0,10,regulation of apoptotic cell clearance,BP,
21717,GO:2000426,1,0.987184399236437,0,2,negative regulation of apoptotic cell clearance,BP,
21718,GO:2000427,1,0.949135102463713,0,8,positive regulation of apoptotic cell clearance,BP,
21719,GO:2000431,1,0.993493521075413,0,1,regulation of cytokinesis, actomyosin contractile ring assembly,BP,
21720,GO:2000434,1,0.981024909908427,0,3,regulation of protein neddylation,BP,
21721,GO:2000435,1,0.987408777515499,0,2,negative regulation of protein neddylation,BP,
21722,GO:2000436,1,0.993535543327298,0,1,positive regulation of protein neddylation,BP,
21723,GO:2000437,1,0.97423084373623,0,4,regulation of monocyte extravasation,BP,
21724,GO:2000438,1,0.993266651168057,0,1,negative regulation of monocyte extravasation,BP,
21725,GO:2000439,1,0.980836431223978,0,3,positive regulation of monocyte extravasation,BP,
21726,GO:2000446,1,0.980862767274081,0,3,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21727,GO:2000448,1,0.98731310864106,0,2,positive regulation of macrophage migration inhibitory factor signaling pathway,BP,
21728,GO:2000449,1,0.980922285837238,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21729,GO:2000451,1,0.987230323976163,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21730,GO:2000452,1,0.987267788064455,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21731,GO:2000454,1,0.993616221662371,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21732,GO:2000458,1,0.987234927582536,0,2,regulation of astrocyte chemotaxis,BP,
21734,GO:2000464,1,0.993573484549642,0,1,positive regulation of astrocyte chemotaxis,BP,
21735,GO:2000465,1,0.955034955717163,0,7,regulation of glycogen (starch) synthase activity,BP,
21736,GO:2000466,1,0.980491390496582,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21737,GO:2000467,1,0.974087822182649,0,4,positive regulation of glycogen (starch) synthase activity,BP,
21739,GO:2000469,1,0.993035571048495,0,1,negative regulation of peroxidase activity,BP,
21741,GO:2000471,1,0.987031203189003,0,2,regulation of hematopoietic stem cell migration,BP,
21742,GO:2000473,1,0.987031203189003,0,2,positive regulation of hematopoietic stem cell migration,BP,
21743,GO:2000474,1,0.987105212854854,0,2,regulation of opioid receptor signaling pathway,BP,
21744,GO:2000479,1,0.883089355155588,0,19,regulation of cAMP-dependent protein kinase activity,BP,
21745,GO:2000480,1,0.943524506097263,0,9,negative regulation of cAMP-dependent protein kinase activity,BP,
21746,GO:2000481,1,0.967427697789715,0,5,positive regulation of cAMP-dependent protein kinase activity,BP,
21747,GO:2000485,1,0.987138204614668,0,2,regulation of glutamine transport,BP,
21748,GO:2000486,1,0.993521172994364,0,1,negative regulation of glutamine transport,BP,
21749,GO:2000487,1,0.993575824062632,0,1,positive regulation of glutamine transport,BP,
21750,GO:2000489,1,0.961676171721987,0,6,regulation of hepatic stellate cell activation,BP,
21751,GO:2000490,1,0.987155555260041,0,2,negative regulation of hepatic stellate cell activation,BP,
21752,GO:2000491,1,0.974192383214134,0,4,positive regulation of hepatic stellate cell activation,BP,
21753,GO:2000492,1,0.99354467960849,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21754,GO:2000494,1,0.99354467960849,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21756,GO:2000502,1,0.987363983873622,0,2,negative regulation of natural killer cell chemotaxis,BP,
21758,GO:2000504,1,0.993582677778861,0,1,positive regulation of blood vessel remodeling,BP,
21759,GO:2000508,1,0.943884457100871,0,9,regulation of dendritic cell chemotaxis,BP,
21760,GO:2000509,1,0.993527831095836,0,1,negative regulation of dendritic cell chemotaxis,BP,
21761,GO:2000510,1,0.950036395555531,0,8,positive regulation of dendritic cell chemotaxis,BP,
21762,GO:2000511,1,0.993658266100689,0,1,regulation of granzyme A production,BP,
21763,GO:2000513,1,0.993658266100689,0,1,positive regulation of granzyme A production,BP,
21764,GO:2000514,1,0.699900173655675,0,55,regulation of CD4-positive, alpha-beta T cell activation,BP,
21765,GO:2000515,1,0.839058107527437,0,27,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21766,GO:2000516,1,0.81331830059015,0,32,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21767,GO:2000517,1,0.993658266100689,0,1,regulation of T-helper 1 cell activation,BP,
21768,GO:2000518,1,0.993658266100689,0,1,negative regulation of T-helper 1 cell activation,BP,
21769,GO:2000520,1,0.980946784903199,0,3,regulation of immunological synapse formation,BP,
21770,GO:2000521,1,0.987271150853643,0,2,negative regulation of immunological synapse formation,BP,
21771,GO:2000522,1,0.993594912291517,0,1,positive regulation of immunological synapse formation,BP,
21772,GO:2000523,1,0.980870346843327,0,3,regulation of T cell costimulation,BP,
21773,GO:2000524,1,0.993635649479514,0,1,negative regulation of T cell costimulation,BP,
21774,GO:2000525,1,0.987153749184187,0,2,positive regulation of T cell costimulation,BP,
21775,GO:2000526,1,0.993594912291517,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21776,GO:2000527,1,0.993681071647269,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21777,GO:2000529,1,0.993681071647269,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21778,GO:2000532,1,0.993573043847889,0,1,regulation of renal albumin absorption,BP,
21779,GO:2000533,1,0.993573043847889,0,1,negative regulation of renal albumin absorption,BP,
21780,GO:2000535,1,0.961491017386803,0,6,regulation of entry of bacterium into host cell,BP,
21781,GO:2000536,1,0.993252681062779,0,1,negative regulation of entry of bacterium into host cell,BP,
21782,GO:2000537,1,0.987166280656328,0,2,regulation of B cell chemotaxis,BP,
21783,GO:2000538,1,0.987166280656328,0,2,positive regulation of B cell chemotaxis,BP,
21784,GO:2000539,1,0.993573232644133,0,1,regulation of protein geranylgeranylation,BP,
21785,GO:2000541,1,0.993573232644133,0,1,positive regulation of protein geranylgeranylation,BP,
21786,GO:2000542,1,0.961376629884622,0,6,negative regulation of gastrulation,BP,
21787,GO:2000543,1,0.968290017292337,0,5,positive regulation of gastrulation,BP,
21789,GO:2000545,1,0.993659525454334,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21790,GO:2000546,1,0.980401508162442,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21791,GO:2000547,1,0.981089096767638,0,3,regulation of dendritic cell dendrite assembly,BP,
21792,GO:2000548,1,0.993681071647269,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21793,GO:2000549,1,0.993693847343053,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21794,GO:2000551,1,0.943740422553924,0,9,regulation of T-helper 2 cell cytokine production,BP,
21795,GO:2000552,1,0.987252380823735,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21796,GO:2000553,1,0.955931735158034,0,7,positive regulation of T-helper 2 cell cytokine production,BP,
21797,GO:2000554,1,0.968308469611173,0,5,regulation of T-helper 1 cell cytokine production,BP,
21798,GO:2000556,1,0.968308469611173,0,5,positive regulation of T-helper 1 cell cytokine production,BP,
21799,GO:2000557,1,0.993658266100689,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21800,GO:2000558,1,0.993658266100689,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21801,GO:2000559,1,0.993266651168057,0,1,regulation of CD24 production,BP,
21802,GO:2000560,1,0.993266651168057,0,1,positive regulation of CD24 production,BP,
21803,GO:2000561,1,0.931843375984512,0,11,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21804,GO:2000562,1,0.950133566498964,0,8,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21805,GO:2000563,1,0.968327504110753,0,5,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21806,GO:2000564,1,0.955771260955037,0,7,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21807,GO:2000566,1,0.974706761077706,0,4,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21808,GO:2000567,1,0.993636250300545,0,1,regulation of memory T cell activation,BP,
21809,GO:2000568,1,0.993636250300545,0,1,positive regulation of memory T cell activation,BP,
21810,GO:2000569,1,0.993529207308875,0,1,regulation of T-helper 2 cell activation,BP,
21811,GO:2000570,1,0.993529207308875,0,1,positive regulation of T-helper 2 cell activation,BP,
21812,GO:2000571,1,0.993517729948133,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21813,GO:2000572,1,0.993517729948133,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21815,GO:2000574,1,0.943274703176137,0,9,regulation of microtubule motor activity,BP,
21816,GO:2000575,1,0.993364432846303,0,1,negative regulation of microtubule motor activity,BP,
21817,GO:2000576,1,0.974766365802747,0,4,positive regulation of microtubule motor activity,BP,
21818,GO:2000580,1,0.981088670039905,0,3,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21819,GO:2000582,1,0.981088670039905,0,3,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21820,GO:2000583,1,0.973759534312576,0,4,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21821,GO:2000584,1,0.99349835451981,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21822,GO:2000586,1,0.947738851545202,0,8,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21823,GO:2000587,1,0.973126938847618,0,4,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21824,GO:2000588,1,0.980296059206141,0,3,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21825,GO:2000589,1,0.980592133740928,0,3,regulation of metanephric mesenchymal cell migration,BP,
21826,GO:2000591,1,0.980592133740928,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21827,GO:2000592,1,0.987021321748086,0,2,regulation of metanephric DCT cell differentiation,BP,
21828,GO:2000594,1,0.987021321748086,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21829,GO:2000595,1,0.993482486668847,0,1,regulation of optic nerve formation,BP,
21830,GO:2000597,1,0.993482486668847,0,1,positive regulation of optic nerve formation,BP,
21831,GO:2000601,1,0.942769385990317,0,9,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21832,GO:2000606,1,0.993540211064586,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21833,GO:2000607,1,0.993540211064586,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21834,GO:2000609,1,0.968188490185203,0,5,regulation of thyroid hormone generation,BP,
21835,GO:2000611,1,0.974412692131757,0,4,positive regulation of thyroid hormone generation,BP,
21836,GO:2000612,1,0.993496871955458,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21837,GO:2000615,1,0.930553998802522,0,11,regulation of histone H3-K9 acetylation,BP,
21838,GO:2000616,1,0.99340494056417,0,1,negative regulation of histone H3-K9 acetylation,BP,
21839,GO:2000617,1,0.948926237238417,0,8,positive regulation of histone H3-K9 acetylation,BP,
21840,GO:2000618,1,0.961425877043862,0,6,regulation of histone H4-K16 acetylation,BP,
21841,GO:2000619,1,0.98080825800374,0,3,negative regulation of histone H4-K16 acetylation,BP,
21842,GO:2000620,1,0.986621187654541,0,2,positive regulation of histone H4-K16 acetylation,BP,
21843,GO:2000622,1,0.974006986418097,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21844,GO:2000623,1,0.974006986418097,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21845,GO:2000625,1,0.980514432177051,0,3,regulation of miRNA catabolic process,BP,
21846,GO:2000627,1,0.980514432177051,0,3,positive regulation of miRNA catabolic process,BP,
21847,GO:2000628,1,0.936427429603872,0,10,regulation of miRNA metabolic process,BP,
21848,GO:2000630,1,0.961721206800523,0,6,positive regulation of miRNA metabolic process,BP,
21849,GO:2000631,1,0.986951294270124,0,2,regulation of pre-miRNA processing,BP,
21850,GO:2000632,1,0.986951294270124,0,2,negative regulation of pre-miRNA processing,BP,
21851,GO:2000634,1,0.980586448476014,0,3,regulation of primary miRNA processing,BP,
21852,GO:2000635,1,0.980586448476014,0,3,negative regulation of primary miRNA processing,BP,
21853,GO:2000637,1,0.861018126349103,0,23,positive regulation of gene silencing by miRNA,BP,
21854,GO:2000638,1,0.961856247057657,0,6,regulation of SREBP signaling pathway,BP,
21855,GO:2000639,1,0.980756379950424,0,3,negative regulation of SREBP signaling pathway,BP,
21856,GO:2000640,1,0.987138359834021,0,2,positive regulation of SREBP signaling pathway,BP,
21857,GO:2000641,1,0.895242899761942,0,17,regulation of early endosome to late endosome transport,BP,
21858,GO:2000642,1,0.98738155059213,0,2,negative regulation of early endosome to late endosome transport,BP,
21859,GO:2000643,1,0.94902796541046,0,8,positive regulation of early endosome to late endosome transport,BP,
21860,GO:2000644,1,0.936454177852124,0,10,regulation of receptor catabolic process,BP,
21861,GO:2000645,1,0.980671938706406,0,3,negative regulation of receptor catabolic process,BP,
21862,GO:2000646,1,0.961130689253269,0,6,positive regulation of receptor catabolic process,BP,
21863,GO:2000647,1,0.930470739952842,0,11,negative regulation of stem cell proliferation,BP,
21864,GO:2000648,1,0.754663851861353,0,43,positive regulation of stem cell proliferation,BP,
21866,GO:2000650,1,0.923827032719694,0,12,negative regulation of sodium ion transmembrane transporter activity,BP,
21867,GO:2000651,1,0.899518415274155,0,16,positive regulation of sodium ion transmembrane transporter activity,BP,
21868,GO:2000653,1,0.973717441265784,0,4,regulation of genetic imprinting,BP,
21869,GO:2000654,1,0.993498439703457,0,1,regulation of cellular response to testosterone stimulus,BP,
21870,GO:2000655,1,0.993498439703457,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21871,GO:2000656,1,0.99361427433561,0,1,regulation of apolipoprotein binding,BP,
21872,GO:2000657,1,0.99361427433561,0,1,negative regulation of apolipoprotein binding,BP,
21873,GO:2000659,1,0.949526379945237,0,8,regulation of interleukin-1-mediated signaling pathway,BP,
21874,GO:2000660,1,0.968167823980026,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21875,GO:2000661,1,0.993426050119044,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21876,GO:2000668,1,0.93136016434893,0,11,regulation of dendritic cell apoptotic process,BP,
21877,GO:2000669,1,0.955989457932952,0,7,negative regulation of dendritic cell apoptotic process,BP,
21878,GO:2000670,1,0.974248300801577,0,4,positive regulation of dendritic cell apoptotic process,BP,
21879,GO:2000671,1,0.968117773681638,0,5,regulation of motor neuron apoptotic process,BP,
21880,GO:2000672,1,0.974449906917407,0,4,negative regulation of motor neuron apoptotic process,BP,
21881,GO:2000674,1,0.943383255202951,0,9,regulation of type B pancreatic cell apoptotic process,BP,
21882,GO:2000675,1,0.961774057894228,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21883,GO:2000676,1,0.980885631185618,0,3,positive regulation of type B pancreatic cell apoptotic process,BP,
21884,GO:2000677,1,0.74004287256573,0,46,regulation of transcription regulatory region DNA binding,BP,
21885,GO:2000678,1,0.883705371646409,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21886,GO:2000679,1,0.872064822776136,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21887,GO:2000683,1,0.987135020020824,0,2,regulation of cellular response to X-ray,BP,
21888,GO:2000685,1,0.993553580223093,0,1,positive regulation of cellular response to X-ray,BP,
21889,GO:2000690,1,0.993473295237682,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21890,GO:2000691,1,0.993473295237682,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21891,GO:2000696,1,0.900133636308406,0,16,regulation of epithelial cell differentiation involved in kidney development,BP,
21892,GO:2000697,1,0.968315118340111,0,5,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21893,GO:2000698,1,0.968072674862725,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21894,GO:2000699,1,0.993540211064586,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21895,GO:2000701,1,0.993540211064586,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21896,GO:2000702,1,0.993540211064586,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21897,GO:2000703,1,0.993540211064586,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21898,GO:2000705,1,0.980323406081898,0,3,regulation of dense core granule biogenesis,BP,
21899,GO:2000706,1,0.993508560498276,0,1,negative regulation of dense core granule biogenesis,BP,
21900,GO:2000707,1,0.986729554219769,0,2,positive regulation of dense core granule biogenesis,BP,
21901,GO:2000718,1,0.993680412277699,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21902,GO:2000719,1,0.993680412277699,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21903,GO:2000721,1,0.980371701362,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21904,GO:2000722,1,0.980511117919822,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21905,GO:2000723,1,0.993562911170247,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21906,GO:2000724,1,0.98686448962259,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21910,GO:2000729,1,0.987237471389818,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21911,GO:2000730,1,0.993535328984749,0,1,regulation of termination of RNA polymerase I transcription,BP,
21912,GO:2000733,1,0.993540211064586,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21913,GO:2000734,1,0.993540211064586,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21915,GO:2000737,1,0.882480834672398,0,19,negative regulation of stem cell differentiation,BP,
21916,GO:2000738,1,0.872054300853743,0,21,positive regulation of stem cell differentiation,BP,
21918,GO:2000740,1,0.993508560498276,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21919,GO:2000741,1,0.973739818209476,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21920,GO:2000742,1,0.993600420300672,0,1,regulation of anterior head development,BP,
21921,GO:2000744,1,0.993600420300672,0,1,positive regulation of anterior head development,BP,
21922,GO:2000752,1,0.993555791525918,0,1,regulation of glucosylceramide catabolic process,BP,
21923,GO:2000753,1,0.993555791525918,0,1,positive regulation of glucosylceramide catabolic process,BP,
21924,GO:2000754,1,0.993555791525918,0,1,regulation of sphingomyelin catabolic process,BP,
21925,GO:2000755,1,0.993555791525918,0,1,positive regulation of sphingomyelin catabolic process,BP,
21928,GO:2000758,1,0.811284451102505,0,32,positive regulation of peptidyl-lysine acetylation,BP,
21929,GO:2000759,1,0.993429136768013,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21930,GO:2000761,1,0.993429136768013,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21931,GO:2000763,1,0.993582096633424,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21932,GO:2000764,1,0.993582096633424,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21933,GO:2000765,1,0.844057557458785,0,26,regulation of cytoplasmic translation,BP,
21934,GO:2000766,1,0.948799343223288,0,8,negative regulation of cytoplasmic translation,BP,
21935,GO:2000767,1,0.936840853308965,0,10,positive regulation of cytoplasmic translation,BP,
21936,GO:2000768,1,0.993493521075413,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21937,GO:2000772,1,0.765167434864563,0,41,regulation of cellular senescence,BP,
21938,GO:2000773,1,0.882490882860932,0,19,negative regulation of cellular senescence,BP,
21939,GO:2000774,1,0.925830576827101,0,12,positive regulation of cellular senescence,BP,
21940,GO:2000775,1,0.993600087468788,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21941,GO:2000777,1,0.987232284581787,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21942,GO:2000779,1,0.631154274558583,0,70,regulation of double-strand break repair,BP,
21943,GO:2000780,1,0.842541320041341,0,26,negative regulation of double-strand break repair,BP,
21944,GO:2000781,1,0.831213638784037,0,28,positive regulation of double-strand break repair,BP,
21945,GO:2000785,1,0.800665632188167,0,34,regulation of autophagosome assembly,BP,
21946,GO:2000786,1,0.948681568276544,0,8,positive regulation of autophagosome assembly,BP,
21947,GO:2000790,1,0.986683772053417,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21948,GO:2000791,1,0.986683772053417,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21949,GO:2000793,1,0.97277059441568,0,4,cell proliferation involved in heart valve development,BP,
21950,GO:2000794,1,0.948988365394774,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21951,GO:2000795,1,0.993141267385396,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21952,GO:2000797,1,0.993508560498276,0,1,regulation of amniotic stem cell differentiation,BP,
21953,GO:2000798,1,0.993508560498276,0,1,negative regulation of amniotic stem cell differentiation,BP,
21954,GO:2000800,1,0.993628898115626,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21955,GO:2000802,1,0.993628898115626,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21956,GO:2000804,1,0.980104177957859,0,3,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21957,GO:2000805,1,0.987155207697788,0,2,negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21958,GO:2000806,1,0.992858142606386,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21959,GO:2000807,1,0.942198409664114,0,9,regulation of synaptic vesicle clustering,BP,
21960,GO:2000808,1,0.993374240866269,0,1,negative regulation of synaptic vesicle clustering,BP,
21961,GO:2000809,1,0.967513899778683,0,5,positive regulation of synaptic vesicle clustering,BP,
21962,GO:2000810,1,0.860434531340725,0,23,regulation of bicellular tight junction assembly,BP,
21963,GO:2000811,1,0.900509711737206,0,16,negative regulation of anoikis,BP,
21964,GO:2000812,1,0.993496298615182,0,1,regulation of barbed-end actin filament capping,BP,
21965,GO:2000815,1,0.987002401621857,0,2,regulation of mRNA stability involved in response to oxidative stress,BP,
21966,GO:2000816,1,0.785328653580281,0,37,negative regulation of mitotic sister chromatid separation,BP,
21967,GO:2000818,1,0.987214401340151,0,2,negative regulation of myoblast proliferation,BP,
21968,GO:2000819,1,0.980745654047341,0,3,regulation of nucleotide-excision repair,BP,
21969,GO:2000820,1,0.980613515237098,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21970,GO:2000821,1,0.967719708641373,0,5,regulation of grooming behavior,BP,
21972,GO:2000825,1,0.974439170078196,0,4,positive regulation of androgen receptor activity,BP,
21973,GO:2000826,1,0.779364612973781,0,38,regulation of heart morphogenesis,BP,
21974,GO:2000827,1,0.993574494173141,0,1,mitochondrial RNA surveillance,BP,
21975,GO:2000828,1,0.987021781815472,0,2,regulation of parathyroid hormone secretion,BP,
21976,GO:2000830,1,0.993366468805071,0,1,positive regulation of parathyroid hormone secretion,BP,
21977,GO:2000831,1,0.90215520961864,0,16,regulation of steroid hormone secretion,BP,
21978,GO:2000832,1,0.986882895419554,0,2,negative regulation of steroid hormone secretion,BP,
21979,GO:2000833,1,0.94401791365565,0,9,positive regulation of steroid hormone secretion,BP,
21980,GO:2000834,1,0.993528995456759,0,1,regulation of androgen secretion,BP,
21981,GO:2000836,1,0.993528995456759,0,1,positive regulation of androgen secretion,BP,
21982,GO:2000843,1,0.98682768422265,0,2,regulation of testosterone secretion,BP,
21983,GO:2000845,1,0.98682768422265,0,2,positive regulation of testosterone secretion,BP,
21984,GO:2000846,1,0.919678438561329,0,13,regulation of corticosteroid hormone secretion,BP,
21985,GO:2000847,1,0.986882895419554,0,2,negative regulation of corticosteroid hormone secretion,BP,
21986,GO:2000848,1,0.956189343966475,0,7,positive regulation of corticosteroid hormone secretion,BP,
21987,GO:2000849,1,0.943761195881859,0,9,regulation of glucocorticoid secretion,BP,
21988,GO:2000850,1,0.986882895419554,0,2,negative regulation of glucocorticoid secretion,BP,
21989,GO:2000851,1,0.968650475663626,0,5,positive regulation of glucocorticoid secretion,BP,
21990,GO:2000852,1,0.974782480968429,0,4,regulation of corticosterone secretion,BP,
21991,GO:2000854,1,0.987358089850856,0,2,positive regulation of corticosterone secretion,BP,
21992,GO:2000855,1,0.974496728206376,0,4,regulation of mineralocorticoid secretion,BP,
21993,GO:2000857,1,0.987139645714016,0,2,positive regulation of mineralocorticoid secretion,BP,
21994,GO:2000858,1,0.974496728206376,0,4,regulation of aldosterone secretion,BP,
21995,GO:2000860,1,0.987139645714016,0,2,positive regulation of aldosterone secretion,BP,
21998,GO:2000870,1,0.987352120439242,0,2,regulation of progesterone secretion,BP,
21999,GO:2000872,1,0.993707254109875,0,1,positive regulation of progesterone secretion,BP,
22000,GO:2000878,1,0.987232882346578,0,2,positive regulation of oligopeptide transport,BP,
22001,GO:2000880,1,0.987232882346578,0,2,positive regulation of dipeptide transport,BP,
22002,GO:2000896,1,0.993535543327298,0,1,amylopectin metabolic process,BP,
22003,GO:2000909,1,0.986032515460747,0,2,regulation of sterol import,BP,
22004,GO:2000911,1,0.992427154022935,0,1,positive regulation of sterol import,BP,
22005,GO:2000969,1,0.94857801544253,0,8,positive regulation of AMPA receptor activity,BP,
22006,GO:2000970,1,0.993579011226295,0,1,regulation of detection of glucose,BP,
22007,GO:2000971,1,0.993579011226295,0,1,negative regulation of detection of glucose,BP,
22008,GO:2000973,1,0.954656239158568,0,7,regulation of pro-B cell differentiation,BP,
22009,GO:2000974,1,0.980453162220654,0,3,negative regulation of pro-B cell differentiation,BP,
22010,GO:2000975,1,0.993463037265516,0,1,positive regulation of pro-B cell differentiation,BP,
22011,GO:2000977,1,0.968435515777701,0,5,regulation of forebrain neuron differentiation,BP,
22012,GO:2000978,1,0.98108869743255,0,3,negative regulation of forebrain neuron differentiation,BP,
22013,GO:2000979,1,0.993540129524831,0,1,positive regulation of forebrain neuron differentiation,BP,
22014,GO:2000980,1,0.955349500323375,0,7,regulation of inner ear receptor cell differentiation,BP,
22015,GO:2000981,1,0.974105477164743,0,4,negative regulation of inner ear receptor cell differentiation,BP,
22016,GO:2000983,1,0.993658266100689,0,1,regulation of ATP citrate synthase activity,BP,
22017,GO:2000984,1,0.993658266100689,0,1,negative regulation of ATP citrate synthase activity,BP,
22020,GO:2001012,1,0.955733128479105,0,7,mesenchymal cell differentiation involved in renal system development,BP,
22021,GO:2001013,1,0.973932365926686,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
22022,GO:2001014,1,0.883364309277585,0,19,regulation of skeletal muscle cell differentiation,BP,
22023,GO:2001015,1,0.961435550839059,0,6,negative regulation of skeletal muscle cell differentiation,BP,
22024,GO:2001016,1,0.961661116418029,0,6,positive regulation of skeletal muscle cell differentiation,BP,
22025,GO:2001020,1,0.269213819937482,0,200,regulation of response to DNA damage stimulus,BP,
22026,GO:2001021,1,0.625060647206849,0,72,negative regulation of response to DNA damage stimulus,BP,
22027,GO:2001022,1,0.551377433147399,0,91,positive regulation of response to DNA damage stimulus,BP,
22028,GO:2001023,1,0.967206311784558,0,5,regulation of response to drug,BP,
22029,GO:2001025,1,0.99355705431691,0,1,positive regulation of response to drug,BP,
22031,GO:2001027,1,0.980173299945895,0,3,negative regulation of endothelial cell chemotaxis,BP,
22032,GO:2001028,1,0.912091734932054,0,14,positive regulation of endothelial cell chemotaxis,BP,
22033,GO:2001029,1,0.993376007086455,0,1,regulation of cellular glucuronidation,BP,
22034,GO:2001031,1,0.993376007086455,0,1,positive regulation of cellular glucuronidation,BP,
22035,GO:2001032,1,0.871140427245092,0,21,regulation of double-strand break repair via nonhomologous end joining,BP,
22036,GO:2001033,1,0.961771148544007,0,6,negative regulation of double-strand break repair via nonhomologous end joining,BP,
22037,GO:2001034,1,0.929642358100512,0,11,positive regulation of double-strand break repair via nonhomologous end joining,BP,
22038,GO:2001035,1,0.987132983517839,0,2,regulation of tongue muscle cell differentiation,BP,
22039,GO:2001037,1,0.987132983517839,0,2,positive regulation of tongue muscle cell differentiation,BP,
22040,GO:2001038,1,0.980493626254294,0,3,regulation of cellular response to drug,BP,
22041,GO:2001040,1,0.99355705431691,0,1,positive regulation of cellular response to drug,BP,
22042,GO:2001044,1,0.907075329319639,0,15,regulation of integrin-mediated signaling pathway,BP,
22043,GO:2001045,1,0.980422672799693,0,3,negative regulation of integrin-mediated signaling pathway,BP,
22044,GO:2001046,1,0.955380001247581,0,7,positive regulation of integrin-mediated signaling pathway,BP,
22045,GO:2001049,1,0.993606763679216,0,1,regulation of tendon cell differentiation,BP,
22046,GO:2001051,1,0.993606763679216,0,1,positive regulation of tendon cell differentiation,BP,
22047,GO:2001053,1,0.931362378808036,0,11,regulation of mesenchymal cell apoptotic process,BP,
22048,GO:2001054,1,0.943403544056096,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
22049,GO:2001055,1,0.987243851192819,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
22051,GO:2001057,1,0.637001118557077,0,69,reactive nitrogen species metabolic process,BP,
22052,GO:2001065,1,0.993650102508122,0,1,mannan binding,MF,
22053,GO:2001069,1,0.955529856994949,0,7,glycogen binding,MF,
22054,GO:2001070,1,0.986999510182024,0,2,starch binding,MF,
22055,GO:2001074,1,0.987205010944381,0,2,regulation of metanephric ureteric bud development,BP,
22056,GO:2001076,1,0.987205010944381,0,2,positive regulation of metanephric ureteric bud development,BP,
22057,GO:2001106,1,0.980243870405173,0,3,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22058,GO:2001108,1,0.993304642559122,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22059,GO:2001109,1,0.986740535695574,0,2,regulation of lens epithelial cell proliferation,BP,
22060,GO:2001111,1,0.986740535695574,0,2,positive regulation of lens epithelial cell proliferation,BP,
22061,GO:2001112,1,0.99342129946631,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
22062,GO:2001113,1,0.99342129946631,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
22063,GO:2001135,1,0.936393165124966,0,10,regulation of endocytic recycling,BP,
22064,GO:2001136,1,0.993525135610541,0,1,negative regulation of endocytic recycling,BP,
22065,GO:2001137,1,0.973613327907781,0,4,positive regulation of endocytic recycling,BP,
22066,GO:2001138,1,0.931066113393839,0,11,regulation of phospholipid transport,BP,
22067,GO:2001140,1,0.931066113393839,0,11,positive regulation of phospholipid transport,BP,
22069,GO:2001142,1,0.993569416905227,0,1,nicotinate transport,BP,
22070,GO:2001144,1,0.993594053229294,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22071,GO:2001145,1,0.993594053229294,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22072,GO:2001148,1,0.987232882346578,0,2,regulation of dipeptide transmembrane transport,BP,
22073,GO:2001150,1,0.987232882346578,0,2,positive regulation of dipeptide transmembrane transport,BP,
22074,GO:2001151,1,0.993532020092422,0,1,regulation of renal water transport,BP,
22075,GO:2001153,1,0.993532020092422,0,1,positive regulation of renal water transport,BP,
22076,GO:2001160,1,0.987169333221007,0,2,regulation of histone H3-K79 methylation,BP,
22077,GO:2001162,1,0.987169333221007,0,2,positive regulation of histone H3-K79 methylation,BP,
22078,GO:2001163,1,0.99358804032313,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22079,GO:2001165,1,0.99358804032313,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22080,GO:2001166,1,0.968019727910841,0,5,regulation of histone H2B ubiquitination,BP,
22081,GO:2001168,1,0.974259242653859,0,4,positive regulation of histone H2B ubiquitination,BP,
22082,GO:2001169,1,0.907379197863615,0,15,regulation of ATP biosynthetic process,BP,
22083,GO:2001170,1,0.980733433043697,0,3,negative regulation of ATP biosynthetic process,BP,
22084,GO:2001171,1,0.937265329449108,0,10,positive regulation of ATP biosynthetic process,BP,
22085,GO:2001173,1,0.993597296638665,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
22086,GO:2001176,1,0.993583324430233,0,1,regulation of mediator complex assembly,BP,
22087,GO:2001178,1,0.993583324430233,0,1,positive regulation of mediator complex assembly,BP,
22088,GO:2001185,1,0.89573734770433,0,17,regulation of CD8-positive, alpha-beta T cell activation,BP,
22089,GO:2001186,1,0.968371921745476,0,5,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
22090,GO:2001187,1,0.949448813737244,0,8,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
22091,GO:2001188,1,0.96229937730565,0,6,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22092,GO:2001189,1,0.980903957727357,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22093,GO:2001190,1,0.981036851744698,0,3,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22094,GO:2001191,1,0.993551538450257,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
22095,GO:2001193,1,0.993551538450257,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
22096,GO:2001197,1,0.966903960193866,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
22097,GO:2001198,1,0.925827296429351,0,12,regulation of dendritic cell differentiation,BP,
22098,GO:2001199,1,0.962209961077098,0,6,negative regulation of dendritic cell differentiation,BP,
22099,GO:2001200,1,0.974509703108494,0,4,positive regulation of dendritic cell differentiation,BP,
22100,GO:2001204,1,0.936178444316613,0,10,regulation of osteoclast development,BP,
22101,GO:2001205,1,0.973681418172813,0,4,negative regulation of osteoclast development,BP,
22102,GO:2001206,1,0.974655173837577,0,4,positive regulation of osteoclast development,BP,
22103,GO:2001207,1,0.993500388867616,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
22104,GO:2001208,1,0.993500388867616,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
22105,GO:2001212,1,0.901040982857726,0,16,regulation of vasculogenesis,BP,
22106,GO:2001213,1,0.993357453520874,0,1,negative regulation of vasculogenesis,BP,
22107,GO:2001214,1,0.924957308143578,0,12,positive regulation of vasculogenesis,BP,
22109,GO:2001223,1,0.942220951178021,0,9,negative regulation of neuron migration,BP,
22110,GO:2001224,1,0.910187460371931,0,14,positive regulation of neuron migration,BP,
22111,GO:2001225,1,0.936687340058915,0,10,regulation of chloride transport,BP,
22112,GO:2001226,1,0.980734791713736,0,3,negative regulation of chloride transport,BP,
22113,GO:2001228,1,0.985492621187397,0,2,regulation of response to gamma radiation,BP,
22114,GO:2001229,1,0.992589363914253,0,1,negative regulation of response to gamma radiation,BP,
22119,GO:2001237,1,0.527144536349919,0,98,negative regulation of extrinsic apoptotic signaling pathway,BP,
22121,GO:2001239,1,0.751767551032884,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22122,GO:2001240,1,0.807975786027668,0,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22123,GO:2001241,1,0.930703653868586,0,11,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22125,GO:2001243,1,0.554139624678333,0,91,negative regulation of intrinsic apoptotic signaling pathway,BP,
22127,GO:2001245,1,0.96820472683972,0,5,regulation of phosphatidylcholine biosynthetic process,BP,
22128,GO:2001246,1,0.993492115653698,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
22129,GO:2001247,1,0.980761484642341,0,3,positive regulation of phosphatidylcholine biosynthetic process,BP,
22130,GO:2001248,1,0.993596235981754,0,1,regulation of ammonia assimilation cycle,BP,
22131,GO:2001250,1,0.993596235981754,0,1,positive regulation of ammonia assimilation cycle,BP,
22133,GO:2001252,1,0.331739098381953,0,168,positive regulation of chromosome organization,BP,
22134,GO:2001253,1,0.980600622510814,0,3,regulation of histone H3-K36 trimethylation,BP,
22135,GO:2001255,1,0.986973941027539,0,2,positive regulation of histone H3-K36 trimethylation,BP,
22136,GO:2001256,1,0.919280505347472,0,13,regulation of store-operated calcium entry,BP,
22138,GO:2001258,1,0.766734082524927,0,41,negative regulation of cation channel activity,BP,
22140,GO:2001260,1,0.980740155173104,0,3,regulation of semaphorin-plexin signaling pathway,BP,
22141,GO:2001262,1,0.993582096633424,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
22143,GO:2001268,1,0.96228271932808,0,6,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22145,GO:2001270,1,0.968141265276604,0,5,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22146,GO:2001271,1,0.980534367459101,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22147,GO:2001272,1,0.987363337976573,0,2,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22148,GO:2001279,1,0.93129493613296,0,11,regulation of unsaturated fatty acid biosynthetic process,BP,
22149,GO:2001280,1,0.949483891404719,0,8,positive regulation of unsaturated fatty acid biosynthetic process,BP,
22150,GO:2001286,1,0.955215193069876,0,7,regulation of caveolin-mediated endocytosis,BP,
22151,GO:2001287,1,0.987178104581173,0,2,negative regulation of caveolin-mediated endocytosis,BP,
22152,GO:2001288,1,0.973972197620602,0,4,positive regulation of caveolin-mediated endocytosis,BP,
22153,GO:2001293,1,0.986670555809764,0,2,malonyl-CoA metabolic process,BP,
22154,GO:2001294,1,0.993593327189849,0,1,malonyl-CoA catabolic process,BP,
22155,GO:2001295,1,0.993033036880822,0,1,malonyl-CoA biosynthetic process,BP,
22156,GO:2001300,1,0.956055363354303,0,7,lipoxin metabolic process,BP,
22157,GO:2001301,1,0.956055363354303,0,7,lipoxin biosynthetic process,BP,
22158,GO:2001302,1,0.980832176681796,0,3,lipoxin A4 metabolic process,BP,
22159,GO:2001303,1,0.980832176681796,0,3,lipoxin A4 biosynthetic process,BP,
22160,GO:2001304,1,0.99358203211151,0,1,lipoxin B4 metabolic process,BP,
22161,GO:2001306,1,0.99358203211151,0,1,lipoxin B4 biosynthetic process,BP,
22162,GO:2001311,1,0.987239431515224,0,2,lysobisphosphatidic acid metabolic process,BP,
8326,GO:0032371,1,0.750239642852657,0,44,regulation of sterol transport,BP,
15826,GO:0070816,1,0.924540653546673,0,12,phosphorylation of RNA polymerase II C-terminal domain,BP,
16230,GO:0071526,1,0.766667179610061,0,40,semaphorin-plexin signaling pathway,BP,
703,GO:0001912,1.00000000000001,0.752682176447982,0,44,positive regulation of leukocyte mediated cytotoxicity,BP,
16,GO:0000030,1.00000000000001,0.833369387966492,0,28,mannosyltransferase activity,MF,
11996,GO:0045684,1.00000000000001,0.806501264441993,0,33,positive regulation of epidermis development,BP,
7614,GO:0031050,1.00000000000001,0.725422935995795,0,49,dsRNA processing,BP,
15894,GO:0070918,1.00000000000001,0.725422935995795,0,49,production of small RNA involved in gene silencing by RNA,BP,
15381,GO:0062237,1.00000000000001,0.744562517524953,0,45,protein localization to postsynapse,BP,
14269,GO:0060008,1.00000000000001,0.888643946224744,0,18,Sertoli cell differentiation,BP,
3714,GO:0007398,1.00000000000001,0.883380451127576,0,19,ectoderm development,BP,
10254,GO:0036452,1.00000000000001,0.845582139194736,0,26,ESCRT complex,CC,
13682,GO:0051305,1.00000000000001,0.954913544776129,0,7,chromosome movement towards spindle pole,BP,
17754,GO:0098534,1.00000000000001,0.784438817850085,0,37,centriole assembly,BP,
